PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Al-Saffar, NMS; Agliano, A; Marshall, LV; Jackson, LE; Balarajah, G; Sidhu, J; Clarke, PA; Jones, C; Workman, P; Pearson, ADJ; Leach, MO				Al-Saffar, Nada M. S.; Agliano, Alice; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.			In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; HIGH-GRADE GLIOMA; BRAIN-TUMORS; CLINICAL-TRIALS; CHILDREN; ADULT; PATHWAY; AGENTS; AKT; PHOSPHOCHOLINE	Recent experimental data showed that the PI3K pathway contributes to resistance to temozolomide (TMZ) in paediatric glioblastoma and that this effect is reversed by combination treatment of TMZ with a PI3K inhibitor. Our aim is to assess whether this combination results in metabolic changes that are detectable by nuclear magnetic resonance (NMR) spectroscopy, potentially providing metabolic biomarkers for PI3K inhibition and TMZ combination treatment. Using two genetically distinct paediatric glioblastoma cell lines, SF188 and KNS42, in vitro H-1-NMR analysis following treatment with the dual pan-Class I PI3K/mTOR inhibitor PI-103 resulted in a decrease in lactate and phosphocholine (PC) levels (P<0.02) relative to control. In contrast, treatment with TMZ caused an increase in glycerolphosphocholine (GPC) levels (P <= 0.05). Combination of PI-103 with TMZ showed metabolic effects of both agents including a decrease in the levels of lactate and PC (P<0.02) while an increase in GPC (P<0.05). We also report a decrease in the protein expression levels of HK2, LDHA and CHKA providing likely mechanisms for the depletion of lactate and PC, respectively. Our results show that our in vitro NMR-detected changes in lactate and choline metabolites may have potential as non-invasive biomarkers for monitoring response to combination of PI3K/mTOR inhibitors with TMZ during clinical trials in children with glioblastoma, subject to further in vivo validation.	[Al-Saffar, Nada M. S.; Agliano, Alice; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Leach, Martin O.] Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK Canc Imaging Ctr, London, England; [Al-Saffar, Nada M. S.; Agliano, Alice; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Sidhu, Jasmin; Jones, Chris; Pearson, Andrew D. J.; Leach, Martin O.] Royal Marsden NHS Fdn Trust, London, England; [Marshall, Lynley V.; Jones, Chris; Pearson, Andrew D. J.] Inst Canc Res, Div Canc Therapeut, London, England; [Marshall, Lynley V.; Jones, Chris] Inst Canc Res, Div Mol Pathol, London, England; [Marshall, Lynley V.; Pearson, Andrew D. J.] Inst Canc Res, Div Clin Studies, London, England; [Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Div Canc Therapeut, London, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Al-Saffar, NMS (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK Canc Imaging Ctr, London, England.; Al-Saffar, NMS (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	Nada.Al-Saffar@icr.ac.uk	leach, martin o/C-2248-2008; Jones, Chris/ABE-6059-2021	leach, martin o/0000-0002-0756-5368; Jones, Chris/0000-0001-8118-2296; Al-Saffar, Nada/0000-0002-1292-0889; Clarke, Paul/0000-0001-9342-1290	Brain Tumour Charity [6/54]; Oak Foundation [OCay-04-169]; Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334, C1060/6916]; Cancer Research UK Life Chair and Programme Grant within a Cancer Research UK ICR Core Award [C347/A15403]; Cancer Research UK [C309/A2187, C309/A8274]; National Health Service; Cancer Research UK [16464] Funding Source: researchfish; The Brain Tumour Charity [6/54] Funding Source: researchfish	Brain Tumour Charity; Oak Foundation; Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK Life Chair and Programme Grant within a Cancer Research UK ICR Core Award; Cancer Research UK(Cancer Research UK); National Health Service; Cancer Research UK(Cancer Research UK); The Brain Tumour Charity	This work was supported by The Brain Tumour Charity grant 6/54 for N.M.S.A, GB and AA; The Oak Foundation grant OCay-04-169 for LVM; Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, C1060/6916 for MOL, NMSA, LEJ and TE; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award (C347/A15403) to AP; Cancer Research UK (C309/A2187, C309/A8274) to PW and PAC. PW is a Cancer Research UK Life Fellow; MOL is an NIHR senior investigator. The Institute of Cancer Research co-authors acknowledge National Health Service funding to the Biomedical Research Centre. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Agnihotri S, 2014, CANCER DISCOV, V4, P1198, DOI 10.1158/2159-8290.CD-14-0157; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Al-Saffar NMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103835; Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Arias-Mendoza F, 2013, ACAD RADIOL, V20, P1122, DOI 10.1016/j.acra.2013.04.013; Bartels U, 2011, CURR ONCOL, V18, pE19; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2010, BRIT J CANCER, V102, P1, DOI 10.1038/sj.bjc.6605457; Beloueche-Babari M, 2011, CELL CYCLE, V10, P2883, DOI 10.4161/cc.10.17.17192; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; Chaumeil MM, 2015, BRAIN PATHOL, V25, P769, DOI 10.1111/bpa.12310; Chaumeil MM, 2012, NEUROIMAGE, V59, P193, DOI 10.1016/j.neuroimage.2011.07.034; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clarke PA, 2012, J CLIN ONCOL, V30, P331, DOI 10.1200/JCO.2011.38.7167; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173; Gadian DG, 1995, INFORMATION AVAILABL, P29; Figueiras RG, 2011, RADIOGRAPHICS, V31, P2059, DOI 10.1148/rg.317115108; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Glunde K, 2015, EXPERT REV MOL DIAGN, V15, P735, DOI 10.1586/14737159.2015.1039515; Gutte H, 2015, AM J NUCL MED MOLEC, V5, P548; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; Harris LM, 2015, NMR BIOMED, V28, P338, DOI 10.1002/nbm.3255; Hourani R, 2006, J MAGN RESON IMAGING, V23, P99, DOI 10.1002/jmri.20480; Jones C., 2016, NEUROONCOL; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Kwak EL, 2007, CLIN CANCER RES, V13, P5232, DOI 10.1158/1078-0432.CCR-07-1385; Lee SC, 2013, NMR BIOMED, V26, P106, DOI 10.1002/nbm.2825; McKnight TR, 2004, SEMIN ONCOL, V31, P605, DOI 10.1053/j.seminoncol.2004.07.003; Moller-Hartmann W, 2002, NEURORADIOLOGY, V44, P371, DOI 10.1007/s00234-001-0760-0; Murphy PS, 2004, BRIT J CANCER, V90, P781, DOI 10.1038/sj.bjc.6601593; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Novaka J, 2014, EUR J RADIOL, V83, pE106, DOI 10.1016/j.ejrad.2013.11.009; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Radoul M, 2016, MOL CANCER THER, V15, P1113, DOI 10.1158/1535-7163.MCT-15-0769; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu ZY, 2015, CANCER LETT, V367, P58, DOI 10.1016/j.canlet.2015.07.007	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180263	10.1371/journal.pone.0180263	http://dx.doi.org/10.1371/journal.pone.0180263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704425	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700034
J	Nishikawa, Y; Morishita, S; Horie, T; Fukumoto, M; Sato, T; Kida, T; Oku, H; Sugasawa, J; Ikeda, T; Nakamura, K				Nishikawa, Yuko; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Sato, Takaki; Kida, Teruyo; Oku, Hidehiro; Sugasawa, Jun; Ikeda, Tsunehiko; Nakamura, Kimitoshi			A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases	PLOS ONE			English	Article							ZEBRA FINCH BRAIN; AROMATASE EXPRESSION; MACULAR HOLE; RAT-BRAIN; ESTROGEN; NEUROSTEROIDS; INJURY; ESTRADIOL; NEURONS; RETINA	The purpose of this study was to compare steroid hormone concentration levels in the vitreous and serum of vitreoretinal disease patients to elucidate the possibility of neurosteroid production in the retina. Serum and vitreous samples were collected from vitrectomy patients, and estradiol (E2) and testosterone (T) concentrations were measured using electro-chemiluminescence immunoassay. We measured E2 in epiretinal membrane (ERM, n = 14), macular hole (MH, n = 18), proliferative diabetic retinopathy (PDR, n = 20), and retinal detachment (RD, n = 19) cases, and T in ERM (n = 14), MH (n = 17), PDR (n = 13), and RD (n = 17) cases. No statistically significant age differences existed among the groups. Mean respective E2 concentrations (pg/ml) in the male/female vitreous were ERM: 6.67 +/- 4.04/18.82 +/- 7.10, MH: 10.3 +/- 7.02/17.00 +/- 4.8, PDR: 4.2 +/- 3.05/15.83 +/- 3.46, and RD: 10.00 +/- 4.58/16.06 +/- 4.57, while those in serum were ERM: 31.67 +/- 5.51/5.82 +/- 1.08, MH: 21.00 +/- 8.89/7.53 +/- 3.2, PDR: 29.20 +/- 7.07/12.75 +/- 10.62, and RD: 24.33 +/- 6.51/7.5 +/- 4.42. E2 concentrations were significantly higher (P<0.001) in the male serum than vitreous, yet significantly higher in the female vitreous than serum. Mean respective T concentrations (ng/ml) in the male/female vitreous were ERM: 0.15 +/- 0.03/0.15 +/- 0.01, MH: 0.15 +/- 0.01/0.15 +/- 0.01, PDR: 0.15 +/- 0.03/0.16 +/- 0.12, and RD: 0.14 +/- 0.01/0.17 +/- 0.08, while those in serum were ERM: 4.54 +/- 1.46/0.16 +/- 0.01, MH: 8.04 +/- 2.29/0.16 +/- 0.10, PDR: 5.14 +/- 1.54/0.22 +/- 0.11, and RD: 3.24 +/- 0.75/0.17 +/- 0.10. T concentrations were high in the male serum, yet extremely low in the male and female vitreous and female serum. High concentrations of E2 were found in the vitreous, and women, in particular, exhibited significantly higher concentrations in the vitreous than in the serum. This finding suggests the possibility that in vitreoretinal disease cases, the synthesis of E2 is increased locally only in female eyes.	[Nishikawa, Yuko; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Sato, Takaki; Kida, Teruyo; Oku, Hidehiro; Sugasawa, Jun; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan; [Nakamura, Kimitoshi] Nakamura Eye Clin, Matsumoto, Nagano, Japan	Osaka Medical College	Ikeda, T (corresponding author), Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan.	tikeda@osaka-med.ac.jp	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219	Japanese Ministry of Education [15K10910]	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Japanese Ministry of Education grant 15K10910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Chong AP, 1996, ANN ACAD MED SINGAP, V15, P606; Conrad CD, 2010, PROG BRAIN RES, V182, P31, DOI 10.1016/S0079-6123(10)82002-3; CORPECHOT C, 1983, BRAIN RES, V270, P119, DOI 10.1016/0006-8993(83)90797-7; Diotel N, 2013, HORM BEHAV, V63, P193, DOI 10.1016/j.yhbeh.2012.04.003; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; GELINAS D, 1993, J NEUROENDOCRINOL, V5, P635, DOI 10.1111/j.1365-2826.1993.tb00533.x; Guarneri P, 2003, ANN NY ACAD SCI, V1007, P117, DOI 10.1196/annals.1286.012; Hutchison JB, 1990, BRAIN RES DEV BRAIN, V57, P185; Inokuchi N, 2015, CLIN OPHTHALMOL, V9, P549, DOI 10.2147/OPTH.S80754; Ishida S, 2000, RETINA-J RET VIT DIS, V20, P176, DOI 10.1097/00006982-200003000-00010; Ishikawa M, 2014, INVEST OPHTH VIS SCI, V55, P8531, DOI 10.1167/iovs.14-15624; JO D-H, 1989, Steroids, V54, P287, DOI 10.1016/0039-128X(89)90003-2; Kawato S, 2002, METHOD ENZYMOL, V357, P241; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Lepore G, 2011, CELL TISSUE RES, V344, P407, DOI 10.1007/s00441-011-1160-3; Liu B, 2013, INVEST OPHTH VIS SCI, V54, P444, DOI 10.1167/iovs.12-10774; McCullough LD, 2003, J NEUROSCI, V23, P8701; McTernan PG, 2000, INT J OBESITY, V24, P875, DOI 10.1038/sj.ijo.0801254; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Nakazawa T, 2006, BRAIN RES, V1093, P141, DOI 10.1016/j.brainres.2006.03.084; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Salyer DL, 2001, DEV BRAIN RES, V126, P131, DOI 10.1016/S0165-3806(00)00147-4; Tsutsui K, 1999, COMP BIOCHEM PHYS C, V124, P121, DOI 10.1016/S0742-8413(99)00065-1; Tsutsui K, 2000, NEUROSCI RES, V36, P261, DOI 10.1016/S0168-0102(99)00132-7; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Yuen EY, 2016, J STEROID BIOCHEM, V160, P221, DOI 10.1016/j.jsbmb.2015.08.028	34	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180933	10.1371/journal.pone.0180933	http://dx.doi.org/10.1371/journal.pone.0180933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704441	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700062
J	Butcher, BG; Bao, ZM; Wilson, J; Stodghill, P; Swingle, B; Filiatrault, M; Schneider, D; Cartinhour, S				Butcher, Bronwyn G.; Bao, Zhongmeng; Wilson, Janet; Stodghill, Paul; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel			The ECF sigma factor, PSPTO_1043, in Pseudomonas syringae pv. tomato DC3000 is induced by oxidative stress and regulates genes involved in oxidative stress response	PLOS ONE			English	Article							SINGLET OXYGEN; ESCHERICHIA-COLI; HRPL REGULON; EXPRESSION; PATHOGEN; SYSTEM; ARABIDOPSIS; VIRULENCE; PLASMIDS; SEQUENCE	The bacterial plant pathogen Pseudomonas syringae adapts to changes in the environment by modifying its gene expression profile. In many cases, the response is mediated by the activation of extracytoplasmic function (ECF) sigma factors that direct RNA polymerase to transcribe specific sets of genes. In this study we focus on PSPTO_1043, one of ten ECF sigma factors in P. syringae pv. tomato DC3000 (DC3000). PSPTO_1043, together with PSPTO_1042, encode an RpoERsp/ChrR-like sigma/anti-sigma factor pair. Although this gene pair is unique to the P. syringae group among the pseudomonads, homologous genes can be found in photosynthetic genera such as Rhodospirillum, Thalassospira, Phaeospirillum and Parvibaculum. Using ChIP-Seq, we detected 137 putative PSPTO_1043 binding sites and identified a likely promoter motif. We characterized 13 promoter candidates, six of which regulate genes that appear to be found only in P. syringae. PSPTO_1043 responds to the presence of singlet oxygen (O-1(2)) and tert-butyl hydroperoxide (tBOOH) and several of the genes regulated by PSPTO_1043 appear to be involved in response to oxidative stress.	[Butcher, Bronwyn G.; Bao, Zhongmeng; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Wilson, Janet; Stodghill, Paul; Swingle, Bryan; Filiatrault, Melanie; Schneider, David; Cartinhour, Samuel] USDA ARS, Robert W Holley Ctr, 583 Tower Rd, Ithaca, NY 14853 USA; [Butcher, Bronwyn G.] Cornell Univ, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA; [Wilson, Janet] Ctr Dis Control & Prevent, Div Select Agents & Toxins, 1600 Clifton Rd,NE MS A46, Atlanta, GA 30333 USA; [Schneider, David] Univ Saskatchewan, Global Inst Food Secur, 110 Gymnasium Pl, Saskatoon, SK S7N 4J8, Canada	Cornell University; United States Department of Agriculture (USDA); Cornell University; Centers for Disease Control & Prevention - USA; University of Saskatchewan	Stodghill, P (corresponding author), USDA ARS, Robert W Holley Ctr, 583 Tower Rd, Ithaca, NY 14853 USA.	paul.stodghill@ars.usda.gov	Swingle, Bryan/AAX-6102-2021; Schneider, David J/H-2236-2012	Schneider, David J/0000-0002-2124-8385; Stodghill, Paul/0000-0003-3875-8450				Anthony JR, 2004, J MOL BIOL, V341, P345, DOI 10.1016/j.jmb.2004.06.018; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berghoff BA, 2011, ENVIRON MICROBIOL, V13, P775, DOI 10.1111/j.1462-2920.2010.02381.x; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Flors C, 2006, ACCOUNTS CHEM RES, V39, P293, DOI 10.1021/ar0402863; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; Gupta N, 2013, MICROBIOL-SGM, V159, P205, DOI 10.1099/mic.0.061937-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ishiga Y, 2016, MOL PLANT MICROBE IN, V29, P119, DOI 10.1094/MPMI-09-15-0204-R; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; Kim JJ, 2011, APPL ENVIRON MICROB, V67, P1405; King E, 1954, J LAB CLIN MED, V44; Lam HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106115; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; Marchler-Bauer A, 2016, NUCLEIC ACIDS RES, V45, pD200; Markel E, 2016, J BACTERIOL, V198, P2330, DOI 10.1128/JB.00276-16; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Mishra MN, 2011, MICROBIOL-SGM, V157, P988, DOI 10.1099/mic.0.046672-0; Oguiza JA, 2005, TRENDS MICROBIOL, V13, P565, DOI 10.1016/j.tim.2005.10.005; Park SH, 2014, MICROBIOL-SGM, V160, P941, DOI 10.1099/mic.0.076497-0; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schindler D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-638; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Tamir-Ariel D, 2011, MOL PLANT PATHOL, V12, P57, DOI 10.1111/j.1364-3703.2010.00652.x; Tarkowski P, 2014, BIOTECHNOL ADV, V32, P215, DOI 10.1016/j.biotechadv.2013.11.001; Thakur PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058846; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321	44	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180340	10.1371/journal.pone.0180340	http://dx.doi.org/10.1371/journal.pone.0180340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700608	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600028
J	Darter, BJ; Bastian, AJ; Wolf, EJ; Husson, EM; Labrecque, BA; Hendershot, BD				Darter, Benjamin J.; Bastian, Amy J.; Wolf, Erik J.; Husson, Elizabeth M.; Labrecque, Bethany A.; Hendershot, Brad D.			Locomotor adaptability in persons with unilateral transtibial amputation	PLOS ONE			English	Article							SPLIT-BELT TREADMILL; STEP-LENGTH ASYMMETRY; LOWER-LIMB AMPUTEES; MOTOR ADAPTATION; PARKINSONS-DISEASE; KNEE AMPUTEES; ENERGY-COST; WALKING; GAIT; INDIVIDUALS	Background Locomotor adaptation enables walkers to modify strategies when faced with challenging walking conditions. While a variety of neurological injuries can impair locomotor adaptability, the effect of a lower extremity amputation on adaptability is poorly understood. Objective Determine if locomotor adaptability is impaired in persons with unilateral transtibial amputation (TTA). Methods The locomotor adaptability of 10 persons with a TTA and 8 persons without an amputation was tested while walking on a split-belt treadmill with the parallel belts running at the same (tied) or different (split) speeds. In the split condition, participants walked for 15 minutes with the respective belts moving at 0.5 m/s and 1.5 m/s. Temporal spatial symmetry measures were used to evaluate reactive accommodations to the perturbation, and the adaptive/deadaptive response. Results Persons with TTA and the reference group of persons without amputation both demonstrated highly symmetric walking at baseline. During the split adaptation and tied postadaptation walking both groups responded with the expected reactive accommodations. Likewise, adaptive and de-adaptive responses were observed. The magnitude and rate of change in the adaptive and de-adaptive responses were similar for persons with TTA and those without an amputation. Furthermore, adaptability was no different based on belt assignment for the prosthetic limb during split adaptation walking. Conclusions Reactive changes and locomotor adaptation in response to a challenging and novel walking condition were similar in persons with TTA to those without an amputation. Results suggest persons with TTA have the capacity to modify locomotor strategies to meet the demands of most walking conditions despite challenges imposed by an amputation and use of a prosthetic limb.	[Darter, Benjamin J.; Labrecque, Bethany A.] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23284 USA; [Darter, Benjamin J.] Hunter Holmes McGuire Veteran Affairs Med Ctr, Dept Res, Richmond, VA 23224 USA; [Bastian, Amy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Bastian, Amy J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; [Wolf, Erik J.; Husson, Elizabeth M.; Hendershot, Brad D.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA; [Wolf, Erik J.; Hendershot, Brad D.] DoD VA Extrem Trauma & Amputat Ctr Excellence, Bethesda, MD USA; [Husson, Elizabeth M.] Univ Delaware, BADER Consortium, Newark, DC USA; [Hendershot, Brad D.] Uniformed Serv Univ Hlth Sci, Dept Rehabil Med, Bethesda, MD 20814 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Kennedy Krieger Institute; Johns Hopkins University; Walter Reed National Military Medical Center; University of Delaware; Uniformed Services University of the Health Sciences - USA	Darter, BJ (corresponding author), Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA 23284 USA.; Darter, BJ (corresponding author), Hunter Holmes McGuire Veteran Affairs Med Ctr, Dept Res, Richmond, VA 23224 USA.	bjdarter@vcu.edu	Hendershot, Brad/AAG-7046-2020	Darter, Benjamin/0000-0003-3490-8562	Clinical and Translational Science Awards (CTSA) from National Center for Advancing Translational Sciences [KL2TR000057]; BADER Consortium via the Congressionally Designated Medical Research Program [W81XWH-11-2-0222]; DoD-VA Extremity Trauma and Amputation Center of Excellence [110-417]	Clinical and Translational Science Awards (CTSA) from National Center for Advancing Translational Sciences; BADER Consortium via the Congressionally Designated Medical Research Program; DoD-VA Extremity Trauma and Amputation Center of Excellence	Support for this project was provided, in part, by Clinical and Translational Science Awards (CTSA) No. KL2TR000057 from the National Center for Advancing Translational Sciences, the BADER Consortium via the Congressionally Designated Medical Research Program (Award number W81XWH-11-2-0222), and the DoD-VA Extremity Trauma and Amputation Center of Excellence (Public Law 110-417, National Defense Authorization Act 2009, Section 723). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOONSTRA AM, 1994, SCAND J REHABIL MED, V26, P217; Bruijn SM, 2012, J NEUROPHYSIOL, V108, P1149, DOI 10.1152/jn.00018.2012; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Esposito ER, 2014, J REHABIL RES DEV, V51, P1287, DOI 10.1682/JRRD.2014.06.0141; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; Gajewski Donald, 2006, J Am Acad Orthop Surg, V14, pS183; Gates DH, 2013, GAIT POSTURE, V38, P570, DOI 10.1016/j.gaitpost.2013.01.024; Genin JJ, 2008, EUR J APPL PHYSIOL, V103, P655, DOI 10.1007/s00421-008-0764-0; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Hak L, 2014, PHYS THER, V94, P1480, DOI 10.2522/ptj.20130431; Hoogkamer W, 2015, J NEUROPHYSIOL, V114, P1705, DOI 10.1152/jn.00937.2014; IJ T, 2015, J NEUROENGINEERING R, V12, P70; Isakov E, 1997, SCAND J REHABIL MED, V29, P75; Kannape OA, 2016, IEEE ENG MED BIO, P5469, DOI 10.1109/EMBC.2016.7591964; Layne CS, 2015, SOMATOSENS MOT RES, V32, P31, DOI 10.3109/08990220.2014.949007; Malone LA, 2016, NEUROBIOL LEARN MEM, V128, P1, DOI 10.1016/j.nlm.2015.11.003; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin J., 2010, J PROSTHETICS ORTHOT, V22, P183, DOI [10.1097/JPO.0b013e3181e8fe8a, DOI 10.1097/JPO.0B013E3181E8FE8A]; Mohammadi F, 2015, NEUROREHAB NEURAL RE, V29, P132, DOI 10.1177/1545968314545175; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Mueller MJ, 1998, GAIT POSTURE, V7, P200, DOI 10.1016/S0966-6362(98)00015-0; Munin MC, 2001, J REHABIL RES DEV, V38, P379; Ogawa T, 2014, J NEUROPHYSIOL, V111, P722, DOI 10.1152/jn.00497.2012; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Roemmich RT, 2016, CURR BIOL, V26, P2707, DOI 10.1016/j.cub.2016.08.012; Roemmich RT, 2014, CLIN NEUROPHYSIOL, V125, P313, DOI 10.1016/j.clinph.2013.07.003; Sanderson DJ, 1997, GAIT POSTURE, V6, P126, DOI 10.1016/S0966-6362(97)01112-0; Selgrade BP, 2017, J BIOMECH, V53, P136, DOI 10.1016/j.jbiomech.2017.01.012; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105	37	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181120	10.1371/journal.pone.0181120	http://dx.doi.org/10.1371/journal.pone.0181120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704467	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600061
J	Suzuki, T; Nunes, MA; Espana, MU; Namin, HH; Jin, PY; Bensoussan, N; Zhurov, V; Rahman, T; De Clercq, R; Hilson, P; Grbic, V; Grbic, M				Suzuki, Takeshi; Nunes, Maria Andreia; Espana, Maria Urizarna; Namin, Hooman Hosseinzadeh; Jin, Pengyu; Bensoussan, Nicolas; Zhurov, Vladimir; Rahman, Tawhid; De Clercq, Rebecca; Hilson, Pierre; Grbic, Vojislava; Grbic, Miodrag			RNAi-based reverse genetics in the chelicerate model Tetranychus urticae: A comparative analysis of five methods for gene silencing	PLOS ONE			English	Article							C-ELEGANS; INTERFERENCE; INSECT; GENOME; DSRNA; ARABIDOPSIS; EUKARYOTES; GENERATION; SEQUENCE; ACIDS	RNA interference (RNAi) can be used for the protection against agricultural pests through the silencing of genes required for pest fitness. To assess the potential of RNAi approaches in the two-spotted spider mite, Tetranychus urticae, we compared 5 methods for the delivery of double-stranded RNA (dsRNA). These methods include mite feeding on either (i) leaves floating on a dsRNA solution, (ii) dsRNA-expressing plants, (iii) artificial diet supplemented with dsRNA, or (iv) dsRNA-coated leaves, and (v) mite soaking in a dsRNA solution. In all cases, the gene targeted for method validation was the Vacuolar-type H (+)-ATPase (TuVAT-Pase), encoding a constitutively expressed ATP-driven proton pump located in the membrane. Down-regulation of TuVATPase increased mortality and/ or reduced fecundity in all methods, but with variable efficiency. The most efficient methods for dsRNA delivery were direct soaking of mites in the dsRNA solution and mite feeding on dsRNA-coated leaves that mimics dsRNA application as a sprayable pesticide. Both resulted in a dark-body phenotype not observed in mites treated with a control dsRNA. Although with lower efficiency, dsRNA designed for TuVATPase silencing and expressed in transgenic Arabidopsis plants impacted the fitness of mites feeding on these plants. RNAi may thus be a valuable strategy to control spider mite populations, either as a sprayable pesticide or through transgenic crops. This comparative methodological study focusing on the induction of RNAi-based gene silencing in T. urticae paves the way for reverse genetics approaches in this model chelicerate system and prepares large-scale systematic RNAi screens as a first step towards the development of specific RNA-based pesticides. Such alternative molecules may help control spider mites that cause significant damages to crops and ornamental plant species, as well as other chelicerates detrimental to agriculture and health.	[Suzuki, Takeshi; Nunes, Maria Andreia; Espana, Maria Urizarna; Namin, Hooman Hosseinzadeh; Jin, Pengyu; Bensoussan, Nicolas; Zhurov, Vladimir; Rahman, Tawhid; Grbic, Vojislava; Grbic, Miodrag] Univ Western Ontario, Dept Biol, London, ON, Canada; [De Clercq, Rebecca; Hilson, Pierre] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Hilson, Pierre] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Hilson, Pierre] Saclay Plant Sci, UMR INRA AgroParisTech 1318, Inst Jean Pierre Bourgin, Versailles, France; [Grbic, Miodrag] Univ La Rioja, Logrono, Spain; [Suzuki, Takeshi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo, Japan; [Nunes, Maria Andreia] Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Cordeiropolis, SP, Brazil; [Rahman, Tawhid] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada	Western University (University of Western Ontario); Flanders Institute for Biotechnology (VIB); Ghent University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidad de La Rioja; Tokyo University of Agriculture & Technology; Instituto Agronomico de Campinas (IAC); Agriculture & Agri Food Canada	Grbic, V; Grbic, M (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.; Grbic, M (corresponding author), Univ La Rioja, Logrono, Spain.	vgrbic@uwo.ca; mgrbic@uwo.ca	Grbic, Miodrag/AID-4825-2022; Suzuki, Takeshi/F-7548-2012	Suzuki, Takeshi/0000-0002-7930-1425; Zhurov, Vladimir/0000-0002-7120-4655; Bensoussan, Nicolas/0000-0002-6761-3480	Government of Canada through the Ontario Research Fund Research Excellence Round 8 [RE08-067]; University of Western Ontario through the Western Strategic Support program; Postdoctoral Fellowship for Research Abroad; KAKENHI - Japan Society for the Promotion of Science (JSPS) [16K18661]; National Counsel of Technological and Scientific Development (CNPq/Brazil); Grants-in-Aid for Scientific Research [16K18661] Funding Source: KAKEN	Government of Canada through the Ontario Research Fund Research Excellence Round 8; University of Western Ontario through the Western Strategic Support program; Postdoctoral Fellowship for Research Abroad; KAKENHI - Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Counsel of Technological and Scientific Development (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Government of Canada through the Ontario Research Fund Research Excellence Round 8 (RE08-067) to MG and VG) and the University of Western Ontario through the Western Strategic Support program (to VG). TS has been supported by the Postdoctoral Fellowship for Research Abroad and KAKENHI (16K18661) funded by the Japan Society for the Promotion of Science (JSPS) and MAN by the National Counsel of Technological and Scientific Development (CNPq/Brazil).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badillo-Vargas IE, 2015, J INSECT PHYSIOL, V76, P36, DOI 10.1016/j.jinsphys.2015.03.009; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bensoussan N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01105; Brusca RC, 2003, INVERTEBRATES; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Chu CC, 2014, PESTIC BIOCHEM PHYS, V110, P1, DOI 10.1016/j.pestbp.2014.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demaeght P, 2013, INSECT BIOCHEM MOLEC, V43, P544, DOI 10.1016/j.ibmb.2013.03.007; Dunlop JA, 2008, J ZOOL SYST EVOL RES, V46, P1, DOI 10.1111/j.1439-0469.2007.00429.x; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Garbutt JS, 2013, J INSECT PHYSIOL, V59, P171, DOI 10.1016/j.jinsphys.2012.05.013; Grbic M, 2007, BIOESSAYS, V29, P489, DOI 10.1002/bies.20564; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Halliday R.B., 2000, P192; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Jonckheere W, 2016, MOL CELL PROTEOMICS; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; KIRBY KS, 1956, BIOCHEM J, V64, P405, DOI 10.1042/bj0640405; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Kwon DH, 2013, PESTIC BIOCHEM PHYS, V105, P69, DOI 10.1016/j.pestbp.2012.12.001; Kwon DH, 2015, PESTIC BIOCH PHYSL; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Migeon A., 2006, SPIDER MITES WEB COM; San Miguel K, 2016, PEST MANAG SCI, V72, P801, DOI 10.1002/ps.4056; Schmitt-Engel C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8822; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Suzuki T, 2017, PLOS ONE; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; VANDERGEEST LPS, 1983, ENTOMOL EXP APPL, V33, P297, DOI 10.1111/j.1570-7458.1983.tb03272.x; Wang KX, 2016, INSECT BIOCHEM MOLEC, V77, P1, DOI 10.1016/j.ibmb.2016.07.007; Whalon M, 2000, ARTHROPOD PESTICIDE; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	44	46	47	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180654	10.1371/journal.pone.0180654	http://dx.doi.org/10.1371/journal.pone.0180654			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704448	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600039
J	Diestelhorst, J; Junge, N; Schlue, J; Falk, CS; Manns, MP; Baumann, U; Jaeckel, E; Taubert, R				Diestelhorst, Jana; Junge, Norman; Schlue, Jerome; Falk, Christine S.; Manns, Michael P.; Baumann, Ulrich; Jaeckel, Elmar; Taubert, Richard			Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy	PLOS ONE			English	Article							IMMUNE REGULATION; OVERLAP SYNDROME; ALLOGRAFTS; REJECTION; DIAGNOSIS; DISEASES; RECEPTOR; IMPACT	Background & Aims The autoimmune hepatitis (AIH) is a chronic hepatitis driven by the adaptive immunity that affects all age groups. A functional and numerical regulatory T cell (Treg) defect has been reported in pediatric AIH (pAIH), while an intrahepatic increase in adult AIH (aAIH) patients has been detected in current research findings. Methods Therefore, we quantified the intrahepatic numbers of Treg, T and B cells, as well as serum cytokine levels before and during therapy in pAIH. Results We found a disproportional intrahepatic enrichment of Tregs in untreated pAIH compared to pediatric non-alcoholic fatty liver disease. The increase of Treg/ total T cells was even more pronounced than in aAIH due to fewer infiltrating T and B cells. Portal densities of Treg, as well as total T and B cells, declined significantly during therapy. However, portal Treg densities decreased disproportionately, leading to even decreasing ratios of Treg to T and B cells during therapy. Out of 28 serum cytokines IL-2 showed the strongest (10fold) decrease under therapy. This decline of IL-2 was associated with decreasing intrahepatic Treg numbers under therapy. None of the baseline T and B cell infiltration parameters were associated with the subsequent treatment response in pAIH. Conclusions Intrahepatic Tregs are rather enriched in untreated pAIH. The disproportional decrease of Tregs during therapy may be caused by a decrease of IL-2 levels. New therapies should, therefore, aim in strengthening intrahepatic immune regulation.	[Diestelhorst, Jana; Manns, Michael P.; Jaeckel, Elmar; Taubert, Richard] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Diestelhorst, Jana; Junge, Norman; Baumann, Ulrich] Hannover Med Sch, Dept Paediat Kidney Liver & Metab Dis, Pediat Gastroenterol & Hepatol, Hannover, Germany; [Schlue, Jerome] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplantat Immunol, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Taubert, R (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Taubert.richard@mh-hannover.de	Junge, Norman/AAA-5542-2022; Falk, Christine/Q-4143-2016	Junge, Norman/0000-0002-3099-2667; Falk, Christine/0000-0003-1376-7318	German Research Foundation [KFO250, SFBTR127, HA6880/2-1]; Else-KroEner-Fresenius-Foundation, MD dissertation program (KlinStrucMed); Hannover Medical School	German Research Foundation(German Research Foundation (DFG)); Else-KroEner-Fresenius-Foundation, MD dissertation program (KlinStrucMed); Hannover Medical School	The work was supported by grants from the German Research Foundation (KFO250 project 7; SFBTR127 projectA4; HA6880/2-1). JD was supported by the Else-KroEner-Fresenius-Foundation'' as part of the MD dissertation program (KlinStrucMed) and RT was supported by the Young Faculty program from the Hannover Medical School	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Baumann AK, 2016, LIVER TRANSPLANT, V22, P943, DOI 10.1002/lt.24427; Chen YY, 2016, HEPATOLOGY, V64, P138, DOI 10.1002/hep.28517; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Floreani A, 2013, J AUTOIMMUN, V46, P7, DOI 10.1016/j.jaut.2013.08.004; Furukawa A, 2016, TRANSPLANTATION, V100, P2288, DOI 10.1097/TP.0000000000001379; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Grant CR, 2014, HEPATOLOGY, V59, P1007, DOI 10.1002/hep.26583; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Groribaek L, 2014, J HEPATOL, V60, P612, DOI 10.1016/j.jhep.2013.10.020; Hardtke-Wolenski M, 2013, HEPATOLOGY, V58, P718, DOI 10.1002/hep.26380; He Q, 2011, TRANSPL P, V43, P1696, DOI 10.1016/j.transproceed.2011.03.084; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jeffery HC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00334; Junge N, 2016, EUR J PEDIATR, V175, P527, DOI 10.1007/s00431-015-2662-x; Kirstein MM, 2015, HEPATOLOGY, V62, P1524, DOI 10.1002/hep.27983; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036; Liberal R, 2015, HEPATOLOGY, V62, P863, DOI 10.1002/hep.27884; Liberal R, 2012, HEPATOLOGY, V56, P677, DOI 10.1002/hep.25682; Liberal R, 2011, BEST PRACT RES CL GA, V25, P653, DOI 10.1016/j.bpg.2011.09.009; Longhi MS, 2013, J AUTOIMMUN, V41, P146, DOI 10.1016/j.jaut.2012.12.003; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Taubert R, 2012, AM J TRANSPLANT, V12, P3425, DOI 10.1111/j.1600-6143.2012.04264.x; Taubert R, 2015, AM J TRANSPLANT	31	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181107	10.1371/journal.pone.0181107	http://dx.doi.org/10.1371/journal.pone.0181107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700730	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400031
J	Fan, WT; Zhong, YS; Qin, MY; Lin, BM; Chen, FY; Yan, HC; Li, WC; Lin, JR				Fan, Wentao; Zhong, Yangsheng; Qin, Mingyue; Lin, Bimin; Chen, Fangyan; Yan, Huichao; Li, Wenchu; Lin, Jianrong			Differentially expressed microRNAs in diapausing versus HCl-treated Bombyx embryos	PLOS ONE			English	Article							SORBITOL DEHYDROGENASE; GENE-EXPRESSION; SILKWORM; EGGS; MORI; DROSOPHILA; REDUCTASE; HORMONE; CLONING	Differentially expressed microRNAs were detected to explore the molecular mechanisms of diapause termination. The total small RNA of diapause-destined silkworm eggs and HCl-treated eggs was extracted and then sequenced using HiSeq high-throughput method. 44 novel miRNAs were discovered. Compared to those in the diapause-destined eggs, 61 miRNAs showed significant changes in the acid-treated eggs, with 23 being up-regulated and 38 being down-regulated. The potential target genes of differentially expressed miRNAs were predicted by miRanda. Gene Ontology and KEGG pathway enrichment analysis of these potential target genes revealed that they were mainly located within cells and organelles, involved in cellular and metabolic processes, and participated in protein production, processing and transportation. Two differentially expressed genes, Bombyx mori SDH and Bmo-miR-2761-3p, were further analyzed with qRT-PCR. BmSDH was significantly up-regulated in the HCl-treated eggs, while Bmo-miR-2761-3p was down-regulated. These results suggested that these two genes were well coordinated in silkworm eggs. Dual luciferase reporter assay demonstrated that Bmo-miR-2761-3p inhibited the expression of BmSDH.	[Fan, Wentao; Zhong, Yangsheng; Qin, Mingyue; Lin, Bimin; Chen, Fangyan; Yan, Huichao; Li, Wenchu; Lin, Jianrong] South China Agr Univ, Coll Anim Sci, Dept Sericulture, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Lin, JR (corresponding author), South China Agr Univ, Coll Anim Sci, Dept Sericulture, Guangzhou, Guangdong, Peoples R China.	jianronglinscau@hotmail.com	æ, ææ/ABE-2840-2020		National Natural Science Foundation of China [31272368]; National Modern Agricultural Industrial Technological System construction projects of China [CARS-22]; special Public Welfare Industry (agriculture) Research [201403064]; Science and Technology Project of Guangdong Province, China [2014A020208120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Modern Agricultural Industrial Technological System construction projects of China; special Public Welfare Industry (agriculture) Research; Science and Technology Project of Guangdong Province, China	This project was supported by grants from the National Natural Science Foundation of China (31272368), National Modern Agricultural Industrial Technological System construction projects of China (CARS-22), the special Public Welfare Industry (agriculture) Research (201403064) and Science and Technology Project of Guangdong Province, China (2014A020208120).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andronescu MS, 2010, RNA, V16, P26, DOI 10.1261/rna.1689910; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Enright AJ, 2004, GENOME BIOL, V5; Fan LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060386; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Iwasaki H, 1997, INSECT MOL BIOL, V6, P131, DOI 10.1111/j.1365-2583.1997.tb00081.x; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; NIIMI T, 1992, COMP BIOCHEM PHYS B, V102, P169, DOI 10.1016/0305-0491(92)90291-X; NIIMI T, 1993, EUR J BIOCHEM, V213, P1125, DOI 10.1111/j.1432-1033.1993.tb17862.x; Pan MH, 2013, SCI CHINA LIFE SCI, V56, P360, DOI 10.1007/s11427-013-4459-3; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rubio RO, 2011, INSECT BIOCHEM MOLEC, V41, P378, DOI 10.1016/j.ibmb.2011.02.007; Sasibhushan S, 2013, GENOMICS, V102, P379, DOI 10.1016/j.ygeno.2013.07.007; Sasibhushan S, 2013, BRAZ ARCH BIOL TECHN, V56, P1, DOI 10.1590/S1516-89132013000100001; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Xu YM, 2011, INSECT BIOCHEM MOLEC, V41, P572, DOI 10.1016/j.ibmb.2011.03.009; YAGINUMA T, 1979, INSECT BIOCHEM, V9, P547, DOI 10.1016/0020-1790(79)90075-1; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; YASUKOCHI Y, 1979, J BIOL CHEM, V254, P7097; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	32	6	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180085	10.1371/journal.pone.0180085	http://dx.doi.org/10.1371/journal.pone.0180085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700597	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400007
J	Freundt-Revilla, J; Kegler, K; Baumgartner, W; Tipold, A				Freundt-Revilla, Jessica; Kegler, Kristel; Baumgaertner, Wolfgang; Tipold, Andrea			Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system	PLOS ONE			English	Article							RAT SPINAL-CORD; MESSENGER-RNA LEVELS; ENDOCANNABINOID SYSTEM; BASAL GANGLIA; ENDOGENOUS CANNABINOIDS; IMMUNOHISTOCHEMICAL LOCALIZATION; NEURONAL SUBPOPULATIONS; INDUCED ANTINOCICEPTION; GABAERGIC TRANSMISSION; SYNAPTIC-TRANSMISSION	The endocannabinoid system is a regulatory pathway consisting of two main types of cannabinoid receptors (CB1 and CB2) and their endogenous ligands, the endocannabinoids. The CB1 receptor is highly expressed in the central and peripheral nervous systems (PNS) in mammalians and is involved in neuromodulatory functions. Since endocannabinoids were shown to be elevated in cerebrospinal fluid of epileptic dogs, knowledge about the species specific CB receptor expression in the nervous system is required. Therefore, we assessed the spatial distribution of CB1 receptors in the normal canine CNS and PNS. Immunohistochemistry of several regions of the brain, spinal cord and peripheral nerves from a healthy four-week-old puppy, three six-month-old dogs, and one ten-year-old dog revealed strong dot-like immunoreactivity in the neuropil of the cerebral cortex, Cornu Ammonis (CA) and dentate gyrus of the hippocampus, midbrain, cerebellum, medulla oblongata and grey matter of the spinal cord. Dense CB1 expression was found in fibres of the globus pallidus and substantia nigra surrounding immunonegative neurons. Astrocytes were constantly positive in all examined regions. CB1 labelled neurons and satellite cells of the dorsal root ganglia, and myelinating Schwann cells in the PNS. These results demonstrate for the first time the spatial distribution of CB1 receptors in the healthy canine CNS and PNS. These results can be used as a basis for further studies aiming to elucidate the physiological consequences of this particular anatomical and cellular distribution.	[Freundt-Revilla, Jessica; Tipold, Andrea] Univ Vet Med, Dept Small Anim Med & Surg, Hannover Fdn, Hannover, Germany; [Freundt-Revilla, Jessica; Kegler, Kristel; Baumgaertner, Wolfgang; Tipold, Andrea] Ctr Syst Neurosci, Hannover, Germany; [Kegler, Kristel; Baumgaertner, Wolfgang] Univ Vet Med, Hannover Fdn, Dept Pathol, Hannover, Germany; [Kegler, Kristel] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Bern	Freundt-Revilla, J (corresponding author), Univ Vet Med, Dept Small Anim Med & Surg, Hannover Fdn, Hannover, Germany.; Freundt-Revilla, J (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	Jessica.Freundt.Revilla@tiho-hannover.de			Deutscher Akademischer Austauschdienst (DAAD, Germany) [GR 6220 22681]	Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD))	JFR recieved funding from the Deutscher Akademischer Austauschdienst (DAAD, Germany), Grant number: GR 6220 22681, https://www.daad.de. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Ahluwalia J, 2000, NEUROSCIENCE, V100, P685, DOI 10.1016/S0306-4522(00)00389-4; Anday JK, 2005, PHARMACOL RES, V52, P463, DOI 10.1016/j.phrs.2005.07.005; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Bilkei-Gorzo A, 2012, PHILOS T R SOC B, V367, P3326, DOI 10.1098/rstb.2011.0388; Blair RE, 2006, J PHARMACOL EXP THER, V317, P1072, DOI 10.1124/jpet.105.100354; Breivogel CS, 1998, NEUROBIOL DIS, V5, P417, DOI 10.1006/nbdi.1998.0229; Burns HD, 2007, P NATL ACAD SCI USA, V104, P9800, DOI 10.1073/pnas.0703472104; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Condie R, 1996, J BIOL CHEM, V271, P13175, DOI 10.1074/jbc.271.22.13175; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Dall'Aglio C, 2010, VET RES COMMUN, V34, pS9, DOI 10.1007/s11259-010-9379-0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Eggan SM, 2007, CEREB CORTEX, V17, P175, DOI 10.1093/cercor/bhj136; Elphick MR, 2001, PHILOS T R SOC B, V356, P381, DOI 10.1098/rstb.2000.0787; Farquhar-Smith WP, 2000, MOL CELL NEUROSCI, V15, P510, DOI 10.1006/mcne.2000.0844; Fede C, 2016, EUR J HISTOCHEM, V60, P130, DOI 10.4081/ejh.2016.2643; Garcia-Ovejero D, 2013, J COMP NEUROL, V521, P233, DOI 10.1002/cne.23184; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gesell FK, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-262; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hofmann ME, 2013, EXP NEUROL, V244, P43, DOI 10.1016/j.expneurol.2011.11.047; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Kegler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133916; LICHTMAN AH, 1991, J PHARMACOL EXP THER, V258, P517; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; MAILLEUX P, 1992, NEUROSCI LETT, V148, P173, DOI 10.1016/0304-3940(92)90832-R; Malinova L, 2015, SCRIPTA SCI MEDICA, V45, p43 ; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MARTIN BR, 1975, PHARMACOL BIOCHEM BE, V3, P849, DOI 10.1016/0091-3057(75)90116-1; MARTIN WJ, 1995, LIFE SCI, V56, P2103, DOI 10.1016/0024-3205(95)00195-C; Mechoulam R., 1986, CANNABINOIDS THERAPE; Meng XD, 2014, INT J CLIN EXP PATHO, V7, P2825; Mercati F, 2012, ACTA HISTOCHEM, V114, P68, DOI 10.1016/j.acthis.2011.01.003; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Moore SA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00012; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Paniagua-Torija B, 2015, SCI REP-UK, V5, DOI 10.1038/srep17745; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Pirone A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1616-0; Potschka H, 2012, EPILEPTIC DISORD, V14, P226, DOI 10.1684/epd.2012.0532; RAZDAN RK, 1986, PHARMACOL REV, V38, P75; Richardson JD, 1998, EUR J PHARMACOL, V345, P145, DOI 10.1016/S0014-2999(97)01621-X; Richardson JD, 1998, J NEUROSCI, V18, P451; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Romero J, 2002, PHARMACOL THERAPEUT, V95, P137, DOI 10.1016/S0163-7258(02)00253-X; Romero J, 1998, NEUROSCIENCE, V84, P1075, DOI 10.1016/S0306-4522(97)00552-6; Sagan S, 1999, EUR J NEUROSCI, V11, P691, DOI 10.1046/j.1460-9568.1999.00480.x; Salio C, 2002, NEUROSCI LETT, V329, P13, DOI 10.1016/S0304-3940(02)00549-9; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Sanudo-Pena MC, 1999, ACTA PHARMACOL SIN, V20, P1115; Sanudo-Pena MC, 1999, LIFE SCI, V65, P703, DOI 10.1016/S0024-3205(99)00293-3; SanudoPena MC, 1997, J NEUROPHYSIOL, V77, P1635, DOI 10.1152/jn.1997.77.3.1635; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tomas-Roig J, 2016, CNS NEUROSCI THER, V22, P387, DOI 10.1111/cns.12506; Tomlinson L, 2012, TOXICOL SCI, V129, P268, DOI 10.1093/toxsci/kfs217; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Tsou K, 1996, NEUROSCIENCE, V70, P791, DOI 10.1016/S0306-4522(96)83015-6; von Ruden EL, 2015, NEUROBIOL DIS, V73, P334, DOI 10.1016/j.nbd.2014.08.001; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WILSON RS, 1979, J MED CHEM, V22, P886, DOI 10.1021/jm00193a027	92	36	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181064	10.1371/journal.pone.0181064	http://dx.doi.org/10.1371/journal.pone.0181064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700706	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800117
J	O'Brien, KM; Whelan, DR; Sandler, DP; Hall, JE; Weinberg, CR				O'Brien, Katie M.; Whelan, Denis R.; Sandler, Dale P.; Hall, Janet E.; Weinberg, Clarice R.			Predictors and long-term health outcomes of eating disorders	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANOREXIA-NERVOSA; PERINATAL OUTCOMES; CIGARETTE-SMOKING; CONTROLLED FAMILY; WOMEN; WEIGHT; PREVALENCE; PREGNANCY; BIRTH	Anorexia and bulimia nervosa may have long-term effects on overall and reproductive health. We studied predictors of self-reported eating disorders and associations with later health events. We estimated odds ratios (ORs) for these associations in 47,759 participants from the Sister Study. Two percent (n = 967) of participants reported a history of an eating disorder. Risk factors included being non- Hispanic white, having well-educated parents, recent birth cohort (OR = 2.16, 95% confidence interval [CI]: 2.01-2.32 per decade), and having a sister with an eating disorder (OR = 3.68, CI: 1.92-7.02). As adults, women who had experienced eating disorders were more likely to smoke, to be underweight, to have had depression, to have had a later first birth, to have experienced bleeding or nausea during pregnancy, or to have had a miscarriage or induced abortion. In this descriptive analysis, we identified predictors of and possible long-term health consequences of eating disorders. Eating disorders may have become more common over time. Interventions should focus on prevention and mitigation of long-term adverse health effects.	[O'Brien, Katie M.; Whelan, Denis R.; Weinberg, Clarice R.] NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Whelan, Denis R.] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Pubic Hlth, Atlanta, GA 30322 USA; [Sandler, Dale P.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC USA; [Hall, Janet E.] NIEHS, Clin Res Ctr, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weinberg, CR (corresponding author), NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	weinber2@niehs.nih.gov	Hall, Janet E/F-3516-2019; O'Brien, Katie/G-8579-2014	Hall, Janet E/0000-0003-4644-3061; O'Brien, Katie/0000-0002-1931-1349; Weinberg, Clarice/0000-0002-7713-8556	Intramural Research Program of the National Institutes of Health; National Institute of Environmental Health Sciences [Z01-ES044005, Z01- ES102245]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044005, ZIAES102245] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, the National Institute of Environmental Health Sciences (project Z01-ES044005 to DPS and Z01- ES102245 to CRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria M, 2007, INT J EAT DISORDER, V40, pS15, DOI 10.1002/eat.20406; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Baker JL, 2008, AM J CLIN NUTR, V88, P1543, DOI 10.3945/ajcn.2008.26379; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik CM, 2010, OBSTET GYNECOL, V116, P1136, DOI 10.1097/AOG.0b013e3181f7efdc; Easter A, 2011, BJOG-INT J OBSTET GY, V118, P1491, DOI 10.1111/j.1471-0528.2011.03077.x; Ekeus C, 2006, BJOG-INT J OBSTET GY, V113, P925, DOI 10.1111/j.1471-0528.2006.01012.x; Franko DL, 2007, INT J EAT DISORDER, V40, pS31, DOI 10.1002/eat.20455; Fulkerson JA, 2003, J ADOLESCENT HEALTH, V32, P306, DOI 10.1016/S1054-139X(02)00566-9; GERSHON ES, 1984, AM J PSYCHIAT, V141, P1419; HABERLAND CA, 1995, CLIN J SPORT MED, V5, P246, DOI 10.1097/00042752-199510000-00007; Harrell FE, 2001, REGRESSION MODELING; Hjern A, 2006, BRIT J PSYCHIAT, V189, P428, DOI 10.1192/bjp.bp.105.018820; Hoffman EB, 2001, BIOMETRIKA, V88, P1121, DOI 10.1093/biomet/88.4.1121; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; HUDSON JI, 1987, PSYCHOL MED, V17, P883, DOI 10.1017/S0033291700000684; HUDSON JI, 1983, BRIT J PSYCHIAT, V142, P133, DOI 10.1192/bjp.142.2.133; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Linna MS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.067; Linna MS, 2013, INT J EAT DISORDER, V46, P826, DOI 10.1002/eat.22179; LUCAS AR, 1992, PEDIATR ANN, V21, P746; Mendelsohn FA, 2010, ENDOCRIN METAB CLIN, V39, P155, DOI 10.1016/j.ecl.2009.11.002; Micali N, 2016, BJOG-INT J OBSTET GY, V123, P1301, DOI 10.1111/1471-0528.13825; Micali N, 2014, BJOG-INT J OBSTET GY, V121, P408, DOI 10.1111/1471-0528.12503; Micali N, 2012, BJOG-INT J OBSTET GY, V119, P1493, DOI 10.1111/j.1471-0528.2012.03467.x; Micali N, 2009, J PEDIATR-US, V154, P55, DOI 10.1016/j.jpeds.2008.07.003; Micali N, 2007, BRIT J PSYCHIAT, V190, P255, DOI 10.1192/bjp.bp.106.020768; Misra M, 2004, PEDIATRICS, V114, P1574, DOI 10.1542/peds.2004-0540; Mitchison D, 2014, CLIN EPIDEMIOL, V6, P89, DOI 10.2147/CLEP.S40841; O'Brien KM, 2016, CANC EPIDEMIOLOGY; Pinheiro AP, 2007, INT J EAT DISORDER, V40, P424, DOI 10.1002/eat.20388; Ruuska J, 2003, EUR CHILD ADOLES PSY, V12, P214, DOI 10.1007/s00787-003-0340-4; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Solmi F, 2014, EPIDEMIOL REV, V36, P49, DOI 10.1093/epirev/mxt004; Stanford School of Medicine, STANFORD RESEARCH IN; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P1, DOI 10.1002/eat.22293; STROBER M, 1985, J PSYCHIATR RES, V19, P239, DOI 10.1016/0022-3956(85)90024-X; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Torgersen L, 2008, INT J EAT DISORDER, V41, P722, DOI 10.1002/eat.20564; Torgersen L, 2010, MATERN CHILD NUTR, V6, P243, DOI 10.1111/j.1740-8709.2009.00208.x; Wade TD, 2013, INT J EAT DISORDER, V46, P594, DOI 10.1002/eat.22133; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Warren M P, 1999, J Am Med Womens Assoc (1972), V54, P115; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7	46	37	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181104	10.1371/journal.pone.0181104	http://dx.doi.org/10.1371/journal.pone.0181104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700663	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800122
J	Ogden, AJ; Gargouri, M; Park, J; Gang, DR; Kahn, ML				Ogden, Aaron J.; Gargouri, Mahmoud; Park, JeongJin; Gang, David R.; Kahn, Michael L.			Integrated analysis of zone-specific protein and metabolite profiles within nitrogen-fixing Medicago truncatula-Sinorhizobium medicae nodules	PLOS ONE			English	Article							GENE-EXPRESSION; ROOT-NODULE; MELILOTI; LEGUME; PLANT; RHIZOBIUM; INFECTION; TRANSPORT; FIXATION; ORGANOGENESIS	Symbiotic nitrogen fixation (SNF) between rhizobia and legumes requires metabolic coordination within specialized root organs called nodules. Nodules formed in the symbiosis between S. medicae and barrel medic (M. truncatula) are indeterminate, cylindrical, and contain spatially distinct developmental zones. Bacteria in the infection zone II (ZII), interzone II-III (IZ), and nitrogen fixation zone III (ZIII) represent different stages in the metabolic progression from free-living bacteria into nitrogen fixing bacteroids. To better understand the coordination of plant and bacterial metabolism within the nodule, we used liquid and gas chromatography coupled to tandem mass spectrometry (MS) to observe protein and metabolite profiles representative of ZII, IZ, ZIII, whole-nodule, and primary root. Our MS-based approach confidently identified 361 S. medicae proteins and 888 M. truncatula proteins, as well as 160 metabolites from each tissue. The data are consistent with several organ-and zone-specific protein and metabolite localization patterns characterized previously. We used our comprehensive dataset to demonstrate how multiple branches of primary metabolism are coordinated between symbionts and zones, including central carbon, fatty acid, and amino acid metabolism. For example, M. truncatula glycolysis enzymes accumulate from zone I to zone III within the nodule, while equivalent S. medicae enzymes decrease in abundance. We also show the localization of S. medicae's transition to dicarboxylic acid-dependent carbon metabolism within the IZ. The spatial abundance patterns of S. medicae fatty acid (FA) biosynthesis enzymes indicate an increased demand for FA production in the IZ and ZIII as compared to ZI. These observations provide a resource for those seeking to understand coordinated physiological changes during the development of SNF.	[Ogden, Aaron J.; Gang, David R.; Kahn, Michael L.] Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA; [Ogden, Aaron J.; Gargouri, Mahmoud; Park, JeongJin; Gang, David R.; Kahn, Michael L.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Gargouri, Mahmoud] Ctr Biotechnol Borj Cedria, BP 901 Hammam Lif, Ben Arous, Tunisia; [Park, JeongJin] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA	Washington State University; Washington State University; Centre de Biotechnologie de Borj Cedria; University of Virginia	Kahn, ML (corresponding author), Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA.; Kahn, ML (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	kahn@wsu.edu	Gargouri, Mahmoud/AAT-4329-2020	Gargouri, Mahmoud/0000-0002-7476-9854; /0000-0003-0043-4661	US National Science Foundation [DGE-1347973]; Protein Biotechnology predoctoral traineeship; US National Institutes of Health National Institute of General Medical Sciences [T32GM008336]; Waters Synapt G2S LC-IMS-MS [DBI-1229749]; US National Science Foundation; US Department of Energy-Basic Energy Sciences-Physical Biosciences Program [DE-FG03-96ER20225]; College of Agricultural, Human and Natural Resource Sciences at Washington State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Protein Biotechnology predoctoral traineeship; US National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Waters Synapt G2S LC-IMS-MS; US National Science Foundation(National Science Foundation (NSF)); US Department of Energy-Basic Energy Sciences-Physical Biosciences Program(United States Department of Energy (DOE)); College of Agricultural, Human and Natural Resource Sciences at Washington State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AO was supported by predoctoral fellowship #DGE-1347973 from the US National Science Foundation and a Protein Biotechnology predoctoral traineeship from the US National Institutes of Health National Institute of General Medical Sciences #T32GM008336. Acquisition of the Waters Synapt G2S LC-IMS-MS was enabled through grant #DBI-1229749 to DG from the US National Science Foundation. Research support was obtained from grant #DE-FG03-96ER20225 to MK from the US Department of Energy-asic Energy Sciences-Physical Biosciences Program and support from the College of Agricultural, Human and Natural Resource Sciences at Washington State University.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Barker DG, 2006, NOBLE ORGMEDICAGOHAN; Catalano CM, 2004, ELECTROPHORESIS, V25, P519, DOI 10.1002/elps.200305711; DEBILLY F, 1991, PLANT J, V1, P27, DOI 10.1111/j.1365-313X.1991.00027.x; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Foucher F, 2000, PLANT MOL BIOL, V43, P773, DOI 10.1023/A:1006405029600; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Haag AF, 2012, FEMS MICROBIOL REV, P364; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Liu JQ, 2006, PLANT PHYSIOL, V141, P167, DOI 10.1104/pp.106.076711; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Long S, BIOCHEMISTRY AND MOL, P711; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Marx H, 2016, NAT BIOTECHNOL, V34, P1198, DOI 10.1038/nbt.3681; MCDERMOTT TR, 1992, J BACTERIOL, V174, P4790, DOI 10.1128/JB.174.14.4790-4797.1992; Monahan-Giovanelli H, 2006, PLANT PHYSIOL, V140, P661, DOI 10.1104/pp.105.072876; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Patriarca EJ, 2004, INT REV CYTOL, V234, P201, DOI 10.1016/S0074-7696(04)34005-2; Peltzer MD, 2008, MOL PLANT MICROBE IN, V21, P1232, DOI 10.1094/MPMI-21-9-1232; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Queiroux C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-74; Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042; ROLFE BG, 1988, ANNU REV PLANT PHYS, V39, P297, DOI 10.1146/annurev.pp.39.060188.001501; Roux B, 2014, PLANT J, V77, P817, DOI 10.1111/tpj.12442; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; SOUPENE E, 1995, P NATL ACAD SCI USA, V92, P3759, DOI 10.1073/pnas.92.9.3759; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Sulieman S, 2013, CRIT REV BIOTECHNOL, V33, P309, DOI 10.3109/07388551.2012.695770; Temple SJ, 1998, TRENDS PLANT SCI, V3, P51, DOI 10.1016/S1360-1385(97)01159-X; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshioka H, 1999, MOL PLANT MICROBE IN, V12, P263, DOI 10.1094/MPMI.1999.12.4.263; Yurgel SN, 2005, J BACTERIOL, V187, P1161, DOI 10.1128/JB.187.3.1161-1172.2005; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002	48	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180894	10.1371/journal.pone.0180894	http://dx.doi.org/10.1371/journal.pone.0180894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700717	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800093
J	Roy, A; Lim, LZ; Srivastava, S; Lu, YM; Song, JX				Roy, Amrita; Lim, Liangzhong; Srivastava, Shagun; Lu, Yimei; Song, Jianxing			Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants	PLOS ONE			English	Article							NONCOMPETITIVE INHIBITORS; STRUCTURAL BIOLOGY; NS3 PROTEASES; VIRUS; DENGUE; PROTEIN; COMPLEX; DESIGN; TRANSMISSION; ACTIVATION	The recent Zika viral (ZIKV) epidemic has been associated with severe neurological pathologies such as neonatal microcephaly and Guillain-Barre syndrome but unfortunately no vaccine or medication is effectively available yet. Zika NS2B-NS3pro is essential for the proteolysis of the viral polyprotein and thereby viral replication. Thus NS2B-NS3pro represents an attractive target for anti-Zika drug discovery/design. Here, we have characterized the solution conformations and catalytic parameters of both linked and unlinked Zika NS2BNS3pro complexes and found that the unlinked complex manifested well-dispersed NMR spectra. Subsequently with selective isotope-labeling using NMR spectroscopy, we demonstrated that C-terminal residues (R73-K100) of NS2B is highly disordered without any stable tertiary and secondary structures in the Zika NS2B-NS3pro complex in the free state. Upon binding to the well-characterized serine protease inhibitor, bovine pancreatic trypsin inhibitor (BPTI), only the extreme C-terminal residues (L86-K100) remain disordered. Additionally, we have identified five flavonoids and one natural phenol rich in edible plants including fruits and vegetables, which inhibit Zika NS2B-NS3pro in a non-competitive mode, with Ki ranging from 770 nM for Myricetin to 34.02 ae M for Apigenin. Molecular docking showed that they all bind to a pocket on the back of the active site and their structure-activity relationship was elucidated. Our study provides valuable insights into the solution conformation of Zika NS2B-NS3pro and further deciphers its susceptibility towards allosteric inhibition by natural products. As these natural product inhibitors fundamentally differ from the currently-known active site inhibitors in terms of both inhibitory mode and chemical scaffold, our finding might open a new avenue for development of better allosteric inhibitors to fight ZIKV infection.	[Roy, Amrita; Lim, Liangzhong; Srivastava, Shagun; Lu, Yimei; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore	National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore.	dbssjx@nus.edu.sg		Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) Tier 3 [R-154002-580-112]; Ministry of Education of Singapore (MOE) Tier 2 [MOE2015-T2-1-111]	Ministry of Education of Singapore (MOE) Tier 3; Ministry of Education of Singapore (MOE) Tier 2	This study is supported by Ministry of Education of Singapore (MOE) Tier 3 Grant R-154002-580-112; Tier 2 Grant MOE2015-T2-1-111 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011; Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002; Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017; Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018; Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116; Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W., 2016, NAT IMMUNOL; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g; de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015; Gupta G., 2015, PLOS ONE, V10; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; Iempridee T, 2008, BBA-GEN SUBJECTS, V1780, P989, DOI 10.1016/j.bbagen.2008.03.018; Jordan J, 2016, CLIN DIS; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Lee H, 2016, ANTIVIR RES; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Ma BY, 2016, NAT CHEM BIOL, V12, P890, DOI 10.1038/nchembio.2212; Ma BY, 2013, TOP CURR CHEM, V337, P123, DOI 10.1007/128_2012_316; Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Organization WH. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005), 2016, EM COMM ZIKV OBS INC; Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Song JX, 1998, BIOCHEM CELL BIOL, V76, P177; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375; Vogiatzoglou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128132; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h	62	53	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180632	10.1371/journal.pone.0180632	http://dx.doi.org/10.1371/journal.pone.0180632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700665	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800059
J	Winger, EE; Reed, JL; Ji, XH				Winger, Edward E.; Reed, Jane L.; Ji, Xuhuai			Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: Proof of concept	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DECIDUA; BIRTH; EXPRESSION; MORTALITY; OUTCOMES	Objective We investigated the capacity of first trimester peripheral blood mononuclear cell (PBMC) microRNA to determine risk of spontaneous preterm birth among pregnant women. Study design The study included 39 pregnant women with the following delivery outcomes: 25 with a full term delivery (38-42 weeks gestation) 14 with spontaneous preterm birth (< 38 weeks gestation). Of the 14 women experiencing spontaneous preterm birth, 7 delivered at 34-< 38 weeks gestation (late preterm) and 7 delivered at < 34 weeks gestation (early preterm). Samples were collected at a mean of 7.9 +/- 3.0 weeks gestation. Quantitative rtPCR was performed on 30 selected microRNAs. MicroRNA Risk Scores were calculated and Area-Under the Curve-Receiver-Operational-Characteristic (AUC-ROC) curves derived. Results The AUC-ROC for the group delivering preterm (< 38 weeks) was 0.95 (p> 0.0001). The AUC-ROC for early preterm group (< 34 weeks) was 0.98 (p< 0.0001) and the AUC-ROC for the late preterm group (34-< 38 weeks) was 0.92 (p< 0.0001). Conclusion Quantification of first trimester peripheral blood PBMC MicroRNA may provide sensitive and specific prediction of spontaneous preterm birth in pregnant women. Larger studies are needed for confirmation.	[Winger, Edward E.; Reed, Jane L.] Lab Reprod Med & Immunol, San Francisco, CA USA; [Ji, Xuhuai] Stanford Univ, Human Immune Monitoring Ctr, Stanford, CA 94305 USA	Stanford University	Winger, EE (corresponding author), Lab Reprod Med & Immunol, San Francisco, CA USA.	ewinger@sbcglobal.net		Reed, Jane/0000-0002-2565-951X				[Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Behrma RE, 2007, NATL RES COUNCIL PRE, P400; Beta J, 2008, PRENAT DIAGN, V31, P75; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Cantonwine DE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.005; Chen CP, 2015, REPROD SCI, V22, P1461, DOI 10.1177/1933719115585148; Conde-Agudelo A, 2011, BJOG-INT J OBSTET GY, V118, P1042, DOI 10.1111/j.1471-0528.2011.02923.x; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Elovitz MA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.023; Enquobahrie DA, 2016, REPROD SCI, V23, P731, DOI 10.1177/1933719115612925; Escudero CA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00098; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; He C, 2016, GUT, V65, P1938, DOI 10.1136/gutjnl-2015-309389; Huang TH, 2010, PRENATAL DIAG, V30, P471, DOI 10.1002/pd.2505; Jelliffe-Pawlowski LL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.012; Kanai T, 2001, AM J REPROD IMMUNOL, V45, P94, DOI 10.1111/j.8755-8920.2001.450205.x; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Moffett A, 2004, BMJ-BRIT MED J, V329, P1283, DOI 10.1136/bmj.329.7477.1283; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Ratsep MT, 2015, REPRODUCTION, V149, pR91, DOI 10.1530/REP-14-0271; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Saade GR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.001; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schjenken JE, 2016, AM J REPROD IMMUNOL, V75, P272, DOI 10.1111/aji.12490; Sheikh AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160808; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Sweeting A, 2015, BEST PRACT RES CL OB, V29, P183, DOI 10.1016/j.bpobgyn.2014.09.006; To MS, 2006, ULTRASOUND OBST GYN, V27, P362, DOI 10.1002/uog.2773; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Wang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09571; Winger EE, 2015, J REPROD IMMUNOL, V110, P22, DOI 10.1016/j.jri.2015.03.005; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287	43	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180124	10.1371/journal.pone.0180124	http://dx.doi.org/10.1371/journal.pone.0180124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692679	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800025
J	Yoo, HN; Park, KH; Jung, EY; Kim, YM; Kook, SY; Jeon, SJ				Yoo, Ha-Na; Park, Kyo Hoon; Jung, Eun Young; Kim, Yu Mi; Kook, Song Yi; Jeon, Se Jeong			Non-invasive prediction of preterm birth in women with cervical insufficiency or an asymptomatic short cervix (<= 25 mm) by measurement of biomarkers in the cervicovaginal fluid	PLOS ONE			English	Article							D-BINDING PROTEIN; AMNIOTIC-FLUID; MULTIPLE-PROTEINS; LABOR; PREGNANCY; CERCLAGE; LENGTH; PARTURITION; DICKKOPF-3; INFECTION	( Objective To determine whether various proteins in the cervicovaginal fluid (CVF) known to be involved in immune regulation, alone or in combination with clinical risk factors, can predict spontaneous preterm delivery (SPTD) in women with cervical insufficiency or a short cervix (<= 25 mm). Methods This retrospective cohort study included 62 asymptomatic women with cervical insufficiency (n = 27) or an asymptomatic short cervix (n = 35) at 18-27 weeks. CVF swab samples were taken for assays of vitamin D binding protein (VDBP), interleukin (IL)-8, matrix metalloproteinases (MMP)-9, tissue inhibitor of metalloproteinases (TIMP)-1, and Dickkopf-related protein 3 (DKK3) before cervical examination, and maternal blood was collected for the determination of the C-reactive protein (CRP) level. The primary outcome measurement was SPTD at <32 weeks of gestation. Logistic regression analysis and receiver operating characteristic curves were used for the statistical analyses. Results The rate of SPTD at <32 weeks was 40.3% (25/62). The CVF levels of VDBP, TIMP-1, and DKK3, but not IL-8 and MMP-9, were significantly higher in the women who had SPTD at <32 weeks than in those who did not deliver spontaneously at <32 weeks. The women who had SPTD at <32 weeks had a significantly more advanced cervical dilatation at presentation and a higher level of serum CRP. Using the stepwise regression analysis, a prediction model was developed by combining various proteins in the CVF and clinical factors, resulting in the inclusion of cervical dilatation, CVF VDBP, and use of corticosteroids (area under curve, 0.909). Conclusions In women with cervical insufficiency or a short cervix, VDBP, TIMP-1, and DKK3 in the CVF may be useful as non-invasive predictors of SPTD at <32 weeks. A combination of these markers and clinical factors appears to improve the predictability of SPTD compared with the markers alone.	[Yoo, Ha-Na; Park, Kyo Hoon; Jung, Eun Young; Kim, Yu Mi; Kook, Song Yi; Jeon, Se Jeong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org			Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. HI 14C1798).	Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754; Alfirevic Z, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008991.pub2; Athayde N, 1999, J Matern Fetal Med, V8, P213; Boots AB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.004; Brown R, 2013, J OBSTET GYNAECOL CA, V35, P1115, DOI 10.1016/S1701-2163(15)30764-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DiMartino SJ, 1999, J IMMUNOL, V163, P2135; Eckmann-Scholz C, 2016, ARCH GYNECOL OBSTET, V293, P1213, DOI 10.1007/s00404-015-3931-7; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; ELLIOTT JP, 1995, OBSTET GYNECOL, V85, P250, DOI 10.1016/0029-7844(94)00355-H; EMERSON DL, 1985, AM J REPROD IM MIC, V7, P15; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GUHA C, 1995, HEPATOLOGY, V21, P1675; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Jung EY, 2017, REPROD SCI, V24, P142, DOI 10.1177/1933719116651149; Jung EY, 2016, INT J GYNECOL OBSTET, V132, P165, DOI 10.1016/j.ijgo.2015.07.011; Jung EY, 2016, J OBSTET GYNAECOL RE, V42, P158, DOI 10.1111/jog.12882; Jung EY, 2015, ARCH GYNECOL OBSTET, V292, P579, DOI 10.1007/s00404-015-3684-3; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Lee SM, 2016, J OBSTET GYNAECOL RE, V42, P776, DOI 10.1111/jog.12976; Li XQ, 2014, PLACENTA, V35, P291, DOI 10.1016/j.placenta.2014.03.005; LIDEGAARD O, 1994, ACTA OBSTET GYN SCAN, V73, P35, DOI 10.3109/00016349409013390; Liong S, 2015, BJOG-INT J OBSTET GY, V122, P370, DOI 10.1111/1471-0528.12993; Liong S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076490; Locksmith GJ, 2001, AM J OBSTET GYNECOL, V184, P159, DOI 10.1067/mob.2001.108860; Ludwig J, 2015, J IMMUNOL, V194, P2624, DOI 10.4049/jimmunol.1402160; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Meister M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00078; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NWOSU UC, 1976, OBSTET GYNECOL, V47, P137; Romero R, 2006, AM J OBSTET GYNECOL, V194, P1, DOI 10.1016/j.ajog.2005.12.002; Sakai M, 2004, AM J REPROD IMMUNOL, V51, P220, DOI 10.1111/j.1600-0897.2004.00145.x; Suh YH, 2007, J KOREAN MED SCI, V22, P89, DOI 10.3346/jkms.2007.22.1.89; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Xiang TX, 2013, J CELL MOL MED, V17, P1236, DOI 10.1111/jcmm.12099; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	40	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180878	10.1371/journal.pone.0180878	http://dx.doi.org/10.1371/journal.pone.0180878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700733	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800091
J	Ciarlillo, D; Celeste, C; Carmeliet, P; Boerboom, D; Theoret, C				Ciarlillo, Domenic; Celeste, Christophe; Carmeliet, Peter; Boerboom, Derek; Theoret, Christine			A hypoxia response element in the Vegfa promoter is required for basal Vegfa expression in skin and for optimal granulation tissue formation during wound healing in mice	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; INDUCIBLE FACTOR-1-ALPHA; CONSTITUTIVE EXPRESSION; KERATINOCYTE PROLIFERATION; OXYGEN; HIF-1; ANGIOGENESIS; HIF-1-ALPHA; MEDIATOR; PATHWAY	Hypoxia in skin wounds is thought to contribute to healing through the induction of hypoxia inducible factor-1 (HIF-1). Although HIF-1 can regulate the expression of vascular endothelial growth factor A (Vegfa), whether hypoxia and HIF-1 are required to induce Vegfa expression in the context of wound healing is unknown. To test this hypothesis, we evaluated Vegfa expression and wound healing in mutant mice that lack a functional HIF-1 binding site in the Vegfa promoter. Full-thickness excisional wounds were made using a biopsy punch, left to heal by second intention, and granulation tissue isolated on a time course during healing. mRNA levels of Vegfa and its target genes platelet-derived growth factors B (Pdgfb) and stromal cell-derived factor-1 (Sdf1) were measured by RT-qPCR, and HIF-1alpha and VEGFA protein levels measured by immunoblotting. Lower levels of Vegfa, Pdgf1 and Sdf1 mRNA were found in intact skin of mutant mice relative to wild-type controls (n = 6 mice / genotype), whereas levels in granulation tissue during wound healing were unaltered. VEGFA protein levels were also lower in intact skin of the mutant versus the wild-type mice. Decreased Vegfa mRNA levels in skin of mutant mice could not be attributed to decreased HIF-1alpha protein expression, and were therefore a consequence of the loss of HIF-1 responsiveness of the Vegfa promoter. Comparative histologic analyses of healing wounds in mutant and wild-type mice (n = 8 mice / genotype) revealed significant defects in granulation tissue in the mutant mice, both in terms of quantity and capillary density, although epithelialization and healing rates were unaltered. We conclude that HIF-1 is not a major regulator of Vegfa expression during wound healing; rather, it serves to maintain basal levels of expression of Vegfa and its target genes in intact skin, which are required for optimal granulation tissue formation in response to wounding.	[Ciarlillo, Domenic; Celeste, Christophe; Boerboom, Derek; Theoret, Christine] Univ Montreal, Fac Med Vet, Dept Biomed Vet, St Hyacinthe, PQ, Canada; [Carmeliet, Peter] Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Vasc Metab, Leuven, Belgium	Universite de Montreal; KU Leuven	Theoret, C (corresponding author), Univ Montreal, Fac Med Vet, Dept Biomed Vet, St Hyacinthe, PQ, Canada.	christine.theoret@umontreal.ca	Carmeliet, Peter/AAQ-5140-2020; Theoret, Christine/C-7320-2015	Carmeliet, Peter/0000-0001-7961-1821; Theoret, Christine/0000-0002-7893-2495	Natural Sciences and Engineering Research Council of Canada [250231]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (CT), grant #250231 (http://www.nserc-crsng.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2001, CANCER RES, V61, P6548; Ben-Shoshan J, 2008, STEM CELLS, V26, P2634, DOI 10.1634/stemcells.2008-0369; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Cowburn AS, 2013, P NATL ACAD SCI USA, V110, P17570, DOI 10.1073/pnas.1306942110; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Davidson JM, 2013, ADV WOUND CARE, V2, P142, DOI 10.1089/wound.2012.0424; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Deschene K, 2011, WOUND REPAIR REGEN, V19, P250, DOI 10.1111/j.1524-475X.2010.00663.x; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Milanini J, 1998, J BIOL CHEM; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Wilgus TA, 2008, LAB INVEST, V88, P579, DOI 10.1038/labinvest.2008.36; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x	38	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180586	10.1371/journal.pone.0180586	http://dx.doi.org/10.1371/journal.pone.0180586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686658	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100078
J	Ellis, CK; Rice, S; Maurer, D; Stahl, R; Waters, WR; Palmer, MV; Nol, P; Rhyan, JC; VerCauteren, KC; Koziel, JA				Ellis, Christine K.; Rice, Somchai; Maurer, Devin; Stahl, Randal; Waters, W. Ray; Palmer, Mitchell V.; Nol, Pauline; Rhyan, Jack C.; VerCauteren, Kurt C.; Koziel, Jacek A.			Use of fecal volatile organic compound analysis to discriminate between nonvaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge	PLOS ONE			English	Article							WHITE-TAILED DEER; TUBERCULOSIS; INFECTION; BREATH; BIOMARKERS; DISEASE; METABOLOMICS; METABOLISM; DIAGNOSIS; SYNTHASE	Bovine tuberculosis is a zoonotic disease of global public health concern. Development of diagnostic tools to improve test accuracy and efficiency in domestic livestock and enable surveillance of wildlife reservoirs would improve disease management and eradication efforts. Use of volatile organic compound analysis in breath and fecal samples is being developed and optimized as a means to detect disease in humans and animals. In this study we demonstrate that VOCs present in fecal samples can be used to discriminate between non-vaccinated and BCG-vaccinated cattle prior to and after Mycobacterium bovis challenge.	[Ellis, Christine K.; Stahl, Randal; VerCauteren, Kurt C.] USDA, Natl Wildlife Res Ctr, Anim Plant & Hlth Inspect Serv, Wildlife Serv, Ft Collins, CO 80524 USA; [Rice, Somchai; Maurer, Devin; Koziel, Jacek A.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Waters, W. Ray; Palmer, Mitchell V.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Nol, Pauline; Rhyan, Jack C.] USDA, Anim Plant & Hlth Inspect Serv, Vet Serv, Wildlife Livestock Dis Invest Team, Ft Collins, CO USA	United States Department of Agriculture (USDA); Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ellis, CK (corresponding author), USDA, Natl Wildlife Res Ctr, Anim Plant & Hlth Inspect Serv, Wildlife Serv, Ft Collins, CO 80524 USA.	Christine.K.Ellis@aphis.usda.gov	Palmer, Mitchell/R-7091-2018; Rice, Somchai/AAG-8148-2019; Maurer, Devin L/B-6633-2014; Stahl, Randal/AAC-6492-2021; Koziel, Jacek A./B-5483-2014; Rice, Somchai/O-1426-2015	Palmer, Mitchell/0000-0002-5902-3333; Rice, Somchai/0000-0001-8868-3202; Maurer, Devin L/0000-0002-4605-1263; Koziel, Jacek A./0000-0002-2387-0354; Rice, Somchai/0000-0001-8868-3202				Anchana Devi C., 2012, IOSR JPBS, V4, P01; Aoki KF, 2002, USING KEGG DATABASE; AVIGAN J, 1967, BIOCHIM BIOPHYS ACTA, V144, P127, DOI 10.1016/0005-2760(67)90084-7; Bass KE, 2013, CLIN VACCINE IMMUNOL, V20, P1827, DOI 10.1128/CVI.00519-13; Bayn A, 2013, ANAL CHEM, V85, P11146, DOI 10.1021/ac403134f; Bergmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123980; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; Burciaga-Robles LO, 2009, AM J VET RES, V70, P1291, DOI 10.2460/ajvr.70.10.1291; Cai LS, 2006, ANAL BIOANAL CHEM, V386, P1791, DOI 10.1007/s00216-006-0799-1; Carrion O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7579; CHEN S, 1970, J LAB CLIN MED, V75, P628; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cosgrove MK, 2012, WILDLIFE RES, V39, P104, DOI 10.1071/WR11147; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; ElliottMartin RJ, 1997, J AGR ENG RES, V67, P267, DOI 10.1006/jaer.1997.0168; Ellis CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089280; Engelke UFH, 2005, NMR BIOMED, V18, P331, DOI 10.1002/nbm.966; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Fletcher W. H., 2012, KFNGRAM; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Hung AW, 2016, CHEMMEDCHEM, V11, P38, DOI 10.1002/cmdc.201500414; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; KAJI H, 1978, J CHROMATOGR, V145, P464, DOI 10.1016/S0378-4347(00)81377-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman L., 2009, FINDING GROUPS DATA; Knobloch H, 2009, OLFACTION ELECT NOS; Knobloch H, 2009, AIP C SER; LACHMANN PJ, 1968, J IMMUNOL, V100, P691; Larsen MH, 2005, CURRENT PROTOCOLS MI; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; LEE YM, 1991, J BIOL CHEM, V266, P2715; LEOPOLD DA, 1990, ARCH OTOLARYNGOL, V116, P354; LIDDELL K, 1976, POSTGRAD MED J, V52, P136, DOI 10.1136/pgmj.52.605.136; Ma WD, 1995, J CHEM ECOL, V21, P1895, DOI 10.1007/BF02033850; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; McNerney R, 2012, FEMS MICROBIOL LETT, V328, P150, DOI 10.1111/j.1574-6968.2011.02493.x; Miller RS, 2013, EPIDEMIOL INFECT, V141, P1357, DOI 10.1017/S0950268813000976; Mottram TT, 1999, LIVEST PROD SCI, V61, P7, DOI 10.1016/S0301-6226(99)00045-7; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Nakajima K, 2014, AMELIORATION EFFECT; Nawrath T, 2012, BEILSTEIN J ORG CHEM, V8, P290, DOI 10.3762/bjoc.8.31; O'Brien DJ, 2002, PREV VET MED, V54, P47, DOI 10.1016/S0167-5877(02)00010-7; Oyarzun MP, 2009, J MED ENTOMOL, V46, P1320, DOI 10.1603/033.046.0610; Palmer MV, 2007, CURR TOP MICROBIOL, V315, P195; Palmer MV, 2010, ZOONOSES PUBLIC HLTH, V57, pE206, DOI 10.1111/j.1863-2378.2010.01329.x; Palmer MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097031; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Palmer MV, 2001, J VET DIAGN INVEST, V13, P530, DOI 10.1177/104063870101300614; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips M, 2004, J HEART LUNG TRANSPL, V23, P701, DOI 10.1016/j.healun.2003.07.017; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; Raja S., 2011, International Journal of ChemTech Research, V3, P1926; Rinehart D, 2014, NAT BIOTECHNOL, V32, P524, DOI 10.1038/nbt.2927; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schmitt SM, 2002, ANN NY ACAD SCI, V969, P262, DOI 10.1111/j.1749-6632.2002.tb04390.x; Scott-Thomas A, 2013, TUBERCULOSIS, V93, P312, DOI 10.1016/j.tube.2013.01.005; Shaw SL, 2007, ENVIRON SCI TECHNOL, V41, P1310, DOI 10.1021/es061475e; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Stahl R, 2014, HEAD SPACE ANAL NONI; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Turner C, 2012, BIOSYST ENG, V112, P75, DOI 10.1016/j.biosystemseng.2012.03.001; USDA, 2005, BOV TUB ER UN METH R, V603, P1; Venables W., 2002, MODERN APPL STAT USI; Verhoeven NM, 1998, J INHERIT METAB DIS, V21, P697, DOI 10.1023/A:1005476631419; Waters W, 2011, VET MED INT, V2011; Waters WR, 2016, CLIN VACCINE IMMUNOL, V23, P168, DOI 10.1128/CVI.00637-15; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; World Health Organization, 2015, GLOB TUB REP 2015	84	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179914	10.1371/journal.pone.0179914	http://dx.doi.org/10.1371/journal.pone.0179914			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686691	Green Published, gold			2022-12-27	WOS:000405464100026
J	Locke, B; Semberg, E; Forsgren, E; de Miranda, JR				Locke, Barbara; Semberg, Emilia; Forsgren, Eva; de Miranda, Joachim R.			Persistence of subclinical deformed wing virus infections in honeybees following Varroa mite removal and a bee population turnover	PLOS ONE			English	Article							APIS-MELLIFERA; VERTICAL-TRANSMISSION; COLONIES; REPLICATION; PHYSIOLOGY; LIFE; DWV	Deformed wing virus (DWV) is a lethal virus of honeybees (Apis mellifera) implicated in elevated colony mortality rates worldwide and facilitated through vector transmission by the ectoparasitic mite Varroa destructor. Clinical, symptomatic DWV infections are almost exclusively associated with high virus titres during pupal development, usually acquired through feeding by Varroa mites when reproducing on bee pupae. Control of the mite population, generally through acaricide treatment, is essential for breaking the DWV epidemic and minimizing colony losses. In this study, we evaluated the effectiveness of remedial mite control on clearing DWV from a colony. DWV titres in adult bees and pupae were monitored at 2 week intervals through summer and autumn in acaricide-treated and untreated colonies. The DWV titres in Apistan treated colonies was reduced 1000-fold relative to untreated colonies, which coincided with both the removal of mites and also a turnover of the bee population in the colony. This adult bee population turnover is probably more critical than previously realized for effective clearing of DWV infections. After this initial reduction, subclinical DWV titres persisted and even increased again gradually during autumn, demonstrating that alternative non-Varroa transmission routes can maintain the DWV titres at significant subclinical levels even after mite removal. The implications of these results for practical recommendations to mitigate deleterious subclinical DWV infections and improving honeybee health management are discussed.	[Locke, Barbara; Semberg, Emilia; Forsgren, Eva; de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Locke, B (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	barbara.locke@slu.se	locke, barbara/X-1857-2019	locke, barbara/0000-0001-6083-9981; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket; Swedish Research Council, Formas	Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket; Swedish Research Council, Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support was provided to BL by the Swedish Board of Agriculture (Nationella Honungsprogrammet, Jordbruksverket) and The Swedish Research Council, Formas (diarienr. 20121060). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Bailey L., 1991, HONEY BEE PATHOLOGY; Benaets K, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2149; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boecking O, 2008, J APICULT RES, V49, P60; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doke MA, 2015, CURR OPIN INSECT SCI, V10, P185, DOI 10.1016/j.cois.2015.05.014; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2011, J APICULT RES, V50, P138, DOI 10.3896/IBRA.1.50.2.05; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Hansson A, 1980, BIN OCH BIODLING; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Martin SJ, 2001, J APICULT RES, V49, P72; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Santillan-Galicia MT, 2008, J GEN VIROL, V89, P1685, DOI 10.1099/vir.0.83223-0; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; Wells T, 2016, ENV MICROBIOL REP, V8, P728, DOI 10.1111/1758-2229.12434; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	42	22	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180910	10.1371/journal.pone.0180910	http://dx.doi.org/10.1371/journal.pone.0180910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686725	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000405464100121
J	Stamboul, K; Zeller, M; Rochette, L; Cottin, Y; Cochet, A; Leclercq, T; Porot, G; Guenancia, C; Fichot, M; Maillot, N; Vergely, C; Lorgis, L				Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Cochet, Alexandre; Leclercq, Thibault; Porot, Guillaume; Guenancia, Charles; Fichot, Marie; Maillot, Nicolas; Vergely, Catherine; Lorgis, Luc			Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction	PLOS ONE			English	Article							LONG-TERM; LEUKOCYTE; DIMETHYLARGININE; DEFINITION; MORTALITY; DISEASE	Main objective To better understand the role of myeloperoxidases (MPO) in microvascular obstruction (MO) phenomenon and infarct size (IS) using cardiac magnetic resonance (CMR) data in patients with acute myocardial infarction (AMI). Method 40 consecutive patients classified according to the median level of MPO in the culprit artery. A CMR study was performed during the week following AMI and at 6 months, with late gadolinium enhancement sequences. Results Persistent MO was observed in the same proportion (50 vs. 65%, p = 0.728) between the low vs. high MPO group levels. However, the extent of the microvascular obstruction was significantly greater in the high-MPO group (6 (0-9) vs. 16.5 (0-31), p = 0.027), together with a greater infarct size, and a trend towards a lower left ventricular ejection fraction (LVEF) (p = 0.054) at one week. CMR data at 6 months showed that reverse systolic remodeling was two fold more present in the low-MPO group (p = 0.058). Interestingly, the extent of MO (8.5 (6.5-31) vs. 4.1 (3-11.55), p = 0.042) and IS remained significantly greater (24.5 (9.75-35) vs. 7.5 (2.5-18.75), p = 0.022) in the high-MPO group. Moreover, MPO in the culprit artery appeared to correlate positively with MPO in non-culprit arteries and serum, and with troponin levels and peak CK. Conclusion This patient-based study revealed in patients after AMI that high MPO levels in the culprit artery were associated with more severe microvascular obstruction and greater IS. These findings may provide new insights pathophysiology explanation for the adverse prognostic impact of MO.	[Stamboul, Karim; Cottin, Yves; Leclercq, Thibault; Porot, Guillaume; Guenancia, Charles; Fichot, Marie; Maillot, Nicolas; Lorgis, Luc] Univ Hosp, Dept Cardiol, Bd Lattre de Tassigny, Dijon, France; [Stamboul, Karim; Cottin, Yves; Cochet, Alexandre; Guenancia, Charles; Lorgis, Luc] Univ Hosp, MRI Unit, Dijon, France; [Stamboul, Karim; Cottin, Yves; Cochet, Alexandre; Guenancia, Charles; Lorgis, Luc] Univ Hosp, UMR CNRS LE2I 6306, Dijon, France; [Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Guenancia, Charles; Vergely, Catherine; Lorgis, Luc] Univ Burgundy, Lab Cerebrovasc Pathophysiol & Epidemiol PEC2, Dijon, France; [Stamboul, Karim; Zeller, Marianne; Rochette, Luc; Cottin, Yves; Guenancia, Charles; Vergely, Catherine; Lorgis, Luc] Univ Burgundy, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne	Lorgis, L (corresponding author), Univ Hosp, Dept Cardiol, Bd Lattre de Tassigny, Dijon, France.; Lorgis, L (corresponding author), Univ Hosp, MRI Unit, Dijon, France.; Lorgis, L (corresponding author), Univ Hosp, UMR CNRS LE2I 6306, Dijon, France.	luc.lorgis@chu-dijon.fr	COTTIN, YVES/ABA-4622-2020; Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714	University Hospital of Dijon; Faculty of Medicine of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie (FFC)	University Hospital of Dijon; Faculty of Medicine of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie (FFC)	This work was supported by the University Hospital of Dijon, the Faculty of Medicine of Dijon, the Association de Cardiologie de Bourgogne, and by grants from the Union Regionale des Caisses dAssurance Maladie de Bourgogne (URCAM), the Agence Regionale de Sante (ARS) de Bourgogne, the Conseil Regional de Bourgogne and the Federation Francaise de Cardiologie (FFC).	Amir O, 2006, AM J CARDIOL, V98, P754, DOI 10.1016/j.amjcard.2006.04.013; Biere L, 2016, INT J CARDIOL, V209, P17, DOI 10.1016/j.ijcard.2016.02.009; Bodi V, 2016, RADIOLOGY, V278, P54, DOI 10.1148/radiol.2015142674; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Cavusoglu E, 2007, AM J CARDIOL, V99, P1364, DOI 10.1016/j.amjcard.2006.12.060; Durante A, 2015, INT J CARDIOL, V187, P273, DOI 10.1016/j.ijcard.2015.03.359; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; Funayama H, 2010, INT J CARDIOL, V139, P187, DOI 10.1016/j.ijcard.2008.10.018; Goldmann BU, 2009, FREE RADICAL BIO MED, V47, P79, DOI 10.1016/j.freeradbiomed.2009.04.004; Karatzis EN, 2006, AM J CARDIOL, V98, P1424, DOI 10.1016/j.amjcard.2006.06.043; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018; Lorgis L, 2009, BMJ-BRIT MED J, V338, P1605; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Reffelmann T, 2003, CIRCULATION, V108, P2911, DOI 10.1161/01.CIR.0000101917.80668.E1; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Yunoki K, 2010, AM J CARDIOL, V105, P922, DOI 10.1016/j.amjcard.2009.11.013; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zhang CX, 2001, J BIOL CHEM, V276, P27159, DOI 10.1074/jbc.M100191200; Zhang CX, 2001, AM J PHYSIOL-HEART C, V281, pH1469, DOI 10.1152/ajpheart.2001.281.4.H1469	31	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179929	10.1371/journal.pone.0179929	http://dx.doi.org/10.1371/journal.pone.0179929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704420	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700020
J	Yamaoka, M; Shimizu, H; Takahashi, T; Omori, E; Morimatsu, H				Yamaoka, Masakazu; Shimizu, Hiroko; Takahashi, Toru; Omori, Emiko; Morimatsu, Hiroshi			Dynamic changes in Bach1 expression in the kidney of rhabdomyolysis-associated acute kidney injury	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; DELTA-AMINOLEVULINATE SYNTHASE; OXIDATIVE STRESS-RESPONSE; PROTECTIVE ROLE; ERYTHROID-DIFFERENTIATION; HEMORRHAGIC-SHOCK; HEPATOMA-CELLS; NUCLEAR EXPORT; MESSENGER-RNA; INDUCTION	Free heme, a pro-oxidant released from myoglobin, is thought to contribute to the pathogenesis of rhabdomyolysis-associated acute kidney injury (RM-AKI), because renal overexpression of heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, confers protection against RM-AKI. BTB and CNC homology 1 (Bach1) is a heme-responsive transcription factor that represses HO-1. Here, we examined the changes with time in the gene expression of Bach1, HO-1, and d-aminolevulinate synthase (ALAS1, a heme biosynthetic enzyme) in the rat kidney using an RM-AKI model induced by the injection of 50% glycerol (10 mL/kg body weight) into bilateral limbs. We also examined the protein expression of Bach1 in the nucleus and cytosol, and HO-1 in the rat kidney. Glycerol treatment induced significant elevation of serum creatinine kinase and aspartate aminotransferase levels followed by the marked elevation of serum blood urea nitrogen and creatinine levels, which caused serious damage to renal tubules. Following glycerol treatment, HO-1 mRNA and protein levels were significantly up-regulated, while ALAS1 mRNA expression was down-regulated, suggesting an increase in the free renal heme concentration. The Bach1 mRNA level was drastically increased 3 h after glycerol treatment, and the increased level was maintained for 12 h. Nuclear Bach1 protein levels were significantly decreased 3 h after treatment. Conversely, cytosolic Bach1 protein levels abruptly increased after 6 h. In conclusion, we demonstrate the dynamic changes in Bach1 expression in a rat model of RM-AKI. Our findings suggest that the increase in Bach1 mRNA and cytosolic Bach1 protein expression may reflect de novo Bach1 protein synthesis to compensate for the depletion of nuclear Bach1 protein caused by the induction of HO-1 by free heme.	[Yamaoka, Masakazu; Shimizu, Hiroko; Omori, Emiko; Morimatsu, Hiroshi] Okayama Univ, Dept Anesthesiol & Resuscitol, Med Sch, Okayama, Japan; [Takahashi, Toru] Okayama Prefectural Univ, Dept Fac Hlth & Welf Sci, Okayama, Japan	Okayama University; Okayama Prefectural University	Yamaoka, M (corresponding author), Okayama Univ, Dept Anesthesiol & Resuscitol, Med Sch, Okayama, Japan.	mskz16@yahoo.co.jp	Morimatsu, Hiroshi/B-2236-2011	Morimatsu, Hiroshi/0000-0002-6744-0508	Japan Society for the Promotion of Science (JSPS) [JP15K10980, 16K10972]; Grants-in-Aid for Scientific Research [16K10972] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) Grant Number JP15K10980 and 16K10972. The funder had the role in prepraration of the manuscript.	ALAM J, 1989, J BIOL CHEM, V264, P6371; Boutaud O, 2011, FREE RADICAL BIO MED, V51, P1062, DOI 10.1016/j.freeradbiomed.2010.10.704; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; Gburek J, 2003, AM J PHYSIOL-RENAL, V285, pF451, DOI 10.1152/ajprenal.00062.2003; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; IWASA F, 1989, BIOCHEM J, V262, P807, DOI 10.1042/bj2620807; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Maeshima K, 2005, BIOCHEM PHARMACOL, V69, P1667, DOI 10.1016/j.bcp.2005.03.007; Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Nakahira K, 2003, BIOCHEM PHARMACOL, V66, P1091, DOI 10.1016/S0006-2952(03)00444-1; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okada S, 2010, J BIOL CHEM, V285, P23581, DOI 10.1074/jbc.M109.068197; Ozono R, 2006, CURR PHARM BIOTECHNO, V7, P87, DOI 10.2174/138920106776597630; Raval CM, 2012, FREE RADICAL BIO MED, V52, P227, DOI 10.1016/j.freeradbiomed.2011.10.494; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; SHAH SV, 1988, AM J PHYSIOL, V255, pF438, DOI 10.1152/ajprenal.1988.255.3.F438; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Tanioka N, 2014, BIOMED REP, V2, P359, DOI 10.3892/br.2014.235; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973	31	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180934	10.1371/journal.pone.0180934	http://dx.doi.org/10.1371/journal.pone.0180934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704479	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700063
J	Dembia, CL; Silder, A; Uchida, TK; Hicks, JL; Delp, SL				Dembia, Christopher L.; Silder, Amy; Uchida, Thomas K.; Hicks, Jennifer L.; Delp, Scott L.			Simulating ideal assistive devices to reduce the metabolic cost of walking with heavy loads	PLOS ONE			English	Article							MUSCLE-TENDON MECHANICS; ENERGY-COST; ENERGETICS; EXOSKELETON; CARRIAGE; HIP; ASSISTANCE; BIOMECHANICS; MODELS; MASS	Wearable robotic devices can restore and enhance mobility. There is growing interest in designing devices that reduce the metabolic cost of walking; however, designers lack guidelines for which joints to assist and when to provide the assistance. To help address this problem, we used musculoskeletal simulation to predict how hypothetical devices affect muscle activity and metabolic cost when walking with heavy loads. We explored 7 massless devices, each providing unrestricted torque at one degree of freedom in one direction (hip abduction, hip flexion, hip extension, knee flexion, knee extension, ankle plantarflexion, or ankle dorsiflexion). We used the Computed Muscle Control algorithm in OpenSim to find device torque profiles that minimized the sum of squared muscle activations while tracking measured kinematics of loaded walking without assistance. We then examined the metabolic savings provided by each device, the corresponding device torque profiles, and the resulting changes in muscle activity. We found that the hip flexion, knee flexion, and hip abduction devices provided greater metabolic savings than the ankle plantarflexion device. The hip abduction device had the greatest ratio of metabolic savings to peak instantaneous positive device power, suggesting that frontal-plane hip assistance may be an efficient way to reduce metabolic cost. Overall, the device torque profiles generally differed from the corresponding net joint moment generated by muscles without assistance, and occasionally exceeded the net joint moment to reduce muscle activity at other degrees of freedom. Many devices affected the activity of muscles elsewhere in the limb; for example, the hip flexion device affected muscles that span the ankle joint. Our results may help experimentalists decide which joint motions to target when building devices and can provide intuition for how devices may interact with the musculoskeletal system. The simulations are freely available online, allowing others to reproduce and extend our work.	[Dembia, Christopher L.; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Silder, Amy; Uchida, Thomas K.; Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dembia, CL (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	dembia@stanford.edu		Uchida, Thomas/0000-0002-7700-7476; Delp, Scott/0000-0002-9643-7551; Hicks, Jennifer/0000-0002-2516-9334	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065690] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Afschrift M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-111; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Arch ES, 2016, PROSTHET ORTHOT INT, V40, P606, DOI 10.1177/0309364615592693; Au SK, 2008, IEEE ROBOT AUTOM MAG, V15, P52, DOI 10.1109/MRA.2008.927697; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bretz F., 2011, MULTIPLE COMPARISONS; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Ding Y, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0196-8; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Dorn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121407; Farris DJ, 2014, J EXP BIOL, V217, P4018, DOI 10.1242/jeb.107656; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Ferris DP, 2007, INT J HUM ROBOT, V4, P507, DOI 10.1142/S0219843607001138; Ferris DP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-17; Galle S, 2015, GAIT POSTURE, V41, P246, DOI 10.1016/j.gaitpost.2014.10.015; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Gregorczyk KN, 2010, ERGONOMICS, V53, P1263, DOI 10.1080/00140139.2010.512982; Handford ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep19983; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Jackson RW, 2015, J APPL PHYSIOL, V119, P541, DOI 10.1152/japplphysiol.01133.2014; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Lenzi T, 2013, IEEE T NEUR SYS REH, V21, P938, DOI 10.1109/TNSRE.2013.2248749; Lewis CL, 2011, J BIOMECH, V44, P789, DOI 10.1016/j.jbiomech.2011.01.030; Lusk G, 1924, J BIOL CHEM, V59, P41; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Markowitz J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004912; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-151; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; NEUMANN DA, 1994, J ORTHOP SPORT PHYS, V19, P296, DOI 10.2519/jospt.1994.19.5.296; NEWHAM DJ, 1983, CLIN SCI, V64, P55, DOI 10.1042/cs0640055; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; RCore Team, 2020, R LANG ENV STAT COMP; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; Ruby BC, 2003, INT J WILDLAND FIRE, V12, P111, DOI 10.1071/WF02025; Samuels ML, 1999, STATISTICS FOR THE L; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2016, IEEE T BIO-MED ENG, V63, P914, DOI 10.1109/TBME.2015.2491224; Selinger JC, 2016, IEEE T NEUR SYS REH, V24, P364, DOI 10.1109/TNSRE.2015.2510546; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Seo K, 2016, IEEE INT CONF ROBOT, P4628, DOI 10.1109/ICRA.2016.7487663; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Steele KM, 2012, J BIOMECH, V45, P2564, DOI 10.1016/j.jbiomech.2012.07.028; Strickland E, 2012, IEEE SPECTRUM, V49, P30, DOI 10.1109/MSPEC.2012.6117830; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150378; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; van Vuuren BJ, 2005, AM J IND MED, V47, P451, DOI 10.1002/ajim.20164; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Yagn N., 1890, US Patents, Patent No. 440684	69	63	64	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180320	10.1371/journal.pone.0180320	http://dx.doi.org/10.1371/journal.pone.0180320			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700630	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600026
J	Di Simone, N; Di Nicuolo, F; Marana, R; Castellani, R; Ria, F; Veglia, M; Scambia, G; Surbek, D; Barnea, E; Mueller, M				Di Simone, Nicoletta; Di Nicuolo, Fiorella; Marana, Riccardo; Castellani, Roberta; Ria, Francesco; Veglia, Manuela; Scambia, Giovanni; Surbek, Daniel; Barnea, Eytan; Mueller, Martin			Synthetic PreImplantation Factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response	PLOS ONE			English	Article							RECURRENT PREGNANCY LOSS; PLACENTAL WEIGHT/BIRTHWEIGHT RATIO; OXIDATIVE STRESS; TROPHOBLAST INVASION; EMBRYO DEVELOPMENT; T-CELL; EXPRESSION; MODEL; ACTIVATION; PREECLAMPSIA	Maternal control of inflammation is essential during pregnancy and an exaggerated response is one of the underlying causes of fetal loss. Inflammatory response is mediated by multiple factors and Toll-like receptors (TLRs) are central. Activation of TLRs results in NALP-3 mediated assembly of apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1 into the inflammasome and production of pro-inflammatory cytokines IL-1 beta and IL-18. Given that preventing measures are lacking, we investigated PreImplantation Factor (PIF) as therapeutic option as PIF modulates Inflammation in pregnancy. Additionally, synthetic PIF (PIF analog) protects against multiple immune disorders. We used a LPS induced murine model of fetal loss and synthetic PIF reduced this fetal loss and increased the embryo weight significantly. We detected increased PIF expression in the placentae after LPS insult. The LPS induced serum and placenta cytokines were abolished by synthetic PIF treatment and importantly synthetic PIF modulated key members of inflammasome complex NALP-3, ASC, and caspase-1 as well. In conclusion our results indicate that synthetic PIF protects against LPS induced fetal loss, likely through modulation of inflammatory response especially the inflammasome complex. Given that synthetic PIF is currently tested in autoimmune diseases of non-pregnant subjects (clinicaltrials. gov, NCT02239562), therapeutic approach during pregnancy can be envisioned.	[Di Simone, Nicoletta; Di Nicuolo, Fiorella; Marana, Riccardo; Castellani, Roberta; Veglia, Manuela; Scambia, Giovanni] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Dept Obstet & Gynecol, Rome, Italy; [Di Nicuolo, Fiorella; Marana, Riccardo] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Int Sci Inst Paolo VI, ISI, Rome, Italy; [Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy; [Surbek, Daniel; Mueller, Martin] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Barnea, Eytan] SIEP, Cherry Hill, NJ USA; [Barnea, Eytan] BioIncept LLC, Cherry Hill, NJ USA; [Mueller, Martin] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Bern; University Hospital of Bern; Yale University	Mueller, M (corresponding author), Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland.; Mueller, M (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	martin.mueller@insel.ch	Barnea, Eytan/AAK-9467-2021; Di Sante, Gabriele/N-5280-2018; Barnea, Eytan/AAC-9910-2021; Mueller, Martin/J-9682-2019; Ria, Francesco/AAD-1174-2022	Barnea, Eytan/0000-0003-4677-4370; Di Sante, Gabriele/0000-0001-6608-3388; Mueller, Martin/0000-0001-5594-0532; Ria, Francesco/0000-0001-7455-4290; Surbek, Daniel/0000-0001-7705-1584; DI SIMONE, NICOLETTA/0000-0003-1273-3335	Universita Cattolica del Sacro Cuore [D1]; Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy	Universita Cattolica del Sacro Cuore; Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy	The work was supported by a research grant from the Universita Cattolica del Sacro Cuore (D1, 2014) and by Istituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy. Dr. Eytan R. Barnea is the (uncompensated) Chief Scientist for BioIncept, LLC. BioIncept, LLC did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abumaree MH, 2012, J REPROD IMMUNOL, V94, P131, DOI 10.1016/j.jri.2012.03.488; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Al-Amin MM, 2016, NEUROSCIENCE, V318, P84, DOI 10.1016/j.neuroscience.2016.01.002; Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2016, J REPROD IMMUNOL, V114, P58, DOI 10.1016/j.jri.2015.06.002; Barnea ER, 2015, PHARMACOL THERAPEUT, V156, P10, DOI 10.1016/j.pharmthera.2015.10.008; Barnea ER, 2007, ANN NY ACAD SCI, V1110, P602, DOI 10.1196/annals.1423.064; Barnea ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100263; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bersani I, 2015, IMMUNOL RES, V61, P4, DOI 10.1007/s12026-014-8568-2; Chau SE, 2013, HUM REPROD, V28, P1497, DOI 10.1093/humrep/det060; Chen YC, 2016, THROMB HAEMOSTASIS, V115, P1010, DOI 10.1160/TH15-08-0640; Christiansen OB, 2013, MOL IMMUNOL, V55, P8, DOI 10.1016/j.molimm.2012.08.025; Clark DA, 2001, MOL HUM REPROD, V7, P185, DOI 10.1093/molehr/7.2.185; Clark DA, 2004, AM J REPROD IMMUNOL, V52, P370, DOI 10.1111/j.1600-0897.2004.00237.x; Clark DA, 2008, AM J REPROD IMMUNOL, V59, P277, DOI 10.1111/j.1600-0897.2008.00580.x; Clark DA, 2016, J REPROD IMMUNOL, V116, P60, DOI 10.1016/j.jri.2016.04.288; D'Ippolito S, 2016, FERTIL STERIL, V105, P111, DOI 10.1016/j.fertnstert.2015.09.027; de Jongh BE, 2015, MATERN CHILD HLTH J, V19, P1553, DOI 10.1007/s10995-014-1662-1; Dunne A, 2011, BIOCHEM SOC T, V39, P669, DOI 10.1042/BST0390669; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Ghazal S, 2015, EMBO MOL MED, V7, P996, DOI 10.15252/emmm.201505245; Goodale LF, 2017, ONCOTARGET, V8, P32419, DOI 10.18632/oncotarget.16028; Haavaldsen C, 2013, ACTA OBSTET GYN SCAN, V92, P583, DOI 10.1111/aogs.12105; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Hur SK, 2016, P NATL ACAD SCI USA, V113, P10938, DOI 10.1073/pnas.1603066113; Ida A, 2000, J REPROD IMMUNOL, V47, P65, DOI 10.1016/S0165-0378(00)00058-9; Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kiniwa T, 2016, P NATL ACAD SCI USA, V113, P10139, DOI 10.1073/pnas.1600112113; Korucuoglu U, 2010, EUR J OBSTET GYN R B, V149, P77, DOI 10.1016/j.ejogrb.2009.12.007; Kuypers E, 2015, PEDIATR RES, V77, P29, DOI 10.1038/pr.2014.152; Li LP, 2015, MOL HUM REPROD, V21, P369, DOI 10.1093/molehr/gav001; Lissauer D, 2015, EUR J IMMUNOL, V45, P2858, DOI 10.1002/eji.201445404; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; McNamara H, 2014, PAEDIATR PERINAT EP, V28, P97, DOI 10.1111/ppe.12104; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Mueller M, 2015, CELL DEATH DIFFER, V22, P2078, DOI 10.1038/cdd.2015.55; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Nahum R, 2004, HUM REPROD, V19, P715, DOI 10.1093/humrep/deh099; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Perfetto CO, 2015, J ASSIST REPROD GEN, V32, P977, DOI 10.1007/s10815-015-0481-7; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pontillo A, 2013, REPROD SCI, V20, P563, DOI 10.1177/1933719112459240; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Rose DR, 2017, BRAIN BEHAV IMMUN, V63, P60, DOI 10.1016/j.bbi.2016.11.020; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Roussev RG, 2013, REPROD BIOMED ONLINE, V26, P79, DOI 10.1016/j.rbmo.2012.09.017; Shainer R, 2016, ONCOTARGET; Silver RM, 1997, AM J OBSTET GYNECOL, V176, P544, DOI 10.1016/S0002-9378(97)70545-3; Smit AL, 2016, REPROD SCI, V23, P257, DOI 10.1177/1933719115602759; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Su MT, 2011, FERTIL STERIL, V96, P1435, DOI 10.1016/j.fertnstert.2011.09.030; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Xue PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124001	69	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180642	10.1371/journal.pone.0180642	http://dx.doi.org/10.1371/journal.pone.0180642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704412	gold, Green Published			2022-12-27	WOS:000405649600038
J	Ding, M; Yuan, CZ; Gaskins, AJ; Field, AE; Missmer, SA; Michels, KB; Hu, F; Zhang, CL; Gillman, MW; Chavarro, J				Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Zhang, Cuilin; Gillman, Matthew W.; Chavarro, Jorge			Smoking during pregnancy in relation to grandchild birth weight and BMI trajectories	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL SMOKING; CHILD OVERWEIGHT; GRANDMOTHERS SMOKING; DNA METHYLATION; OBESITY; DISEASE; COHORT; RISK; ASSOCIATION	Background Maternal smoking has been linked to lower birth weight and higher risk of childhood obesity. However, it is unknown whether grand-maternal smoking during pregnancy is associated with grandchildren birth weight and body mass index BMI) trajectories. Methods We investigated associations of smoking during pregnancy with birth weight, risks of overweight and BMI trajectories among 46,858 mother-child dyads and 6,583 grandmothermother-child triads of three cohort studies of related individuals. Smoking during pregnancy was reported by mothers, and anthropometric data were provided by participants in each cohort. Results Compared to grandchildren of non-smoking women, grandchildren of women who smoked more than 14 cigarettes per day throughout pregnancy were 70 g 95% CI: 12, 129 g; P for trend = 0.01) heavier at birth, and 18% 95% CI: 4%, 34%; P for trend = 0.01) more likely to become overweight. The mean BMI of grandchildren of women who smoked during pregnancy was 0.45 kg/ m 2 95% CI: 0.14, 0.75 kg/ m 2; P for trend = 0.006) higher through adolescence and young adulthood than that of grandchildren of non-smoking mothers. Conclusions Grandmothers' smoking during pregnancy was associated with higher birth weight, higher risk of overweight, and higher BMI through adolescence and young adulthood.	[Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Hu, Frank; Chavarro, Jorge] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ding, Ming; Yuan, Changzheng; Gaskins, Audrey J.; Field, Alison E.; Michels, Karin B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Field, Alison E.; Missmer, Stacey A.; Hu, Frank; Chavarro, Jorge] Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA 02115 USA; [Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Gillman, Matthew W.; Chavarro, Jorge] Harvard Med Sch, Boston, MA 02115 USA; [Field, Alison E.; Missmer, Stacey A.; Michels, Karin B.; Hu, Frank; Chavarro, Jorge] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Missmer, Stacey A.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil, 75 Francis St, Boston, MA 02115 USA; [Michels, Karin B.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA; [Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Epidemiol Stat & Prevent Res, Bethesda, MD USA; [Gillman, Matthew W.] Harvard Pilgrim HealthCare, Dept Populat Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard Pilgrim Health Care	Chavarro, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Chavarro, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	jchavarr@hsph.harvard.edu	Chavarro, Jorge E/AAE-5665-2021; Field, Alison/AAA-4508-2021; Gaskins, Audrey/K-6246-2019	Chavarro, Jorge E/0000-0002-4436-9630; 	National Institutes of Health [UM1-CA176726, P30-DK046200, U54-CA155626, T32-DK007703-16, HL096905, DK084001, MH087786, R37 HD034568, N02-RC-17027, PO 263 MQ 411027]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants UM1-CA176726, P30-DK046200, U54-CA155626, T32-DK007703-16, HL096905, DK084001, MH087786, R37 HD034568, N02-RC-17027 and PO 263 MQ 411027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AK, 2005, AM J CLIN NUTR, V82, P393, DOI 10.1093/ajcn/82.2.393; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P986; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collins JW, 2011, MATERN CHILD HLTH J, V15, P438, DOI 10.1007/s10995-010-0603-x; Dougan MM, 2015, INT J OBESITY; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Harris HR, 2013, INT J OBESITY, V37, P1356, DOI 10.1038/ijo.2013.101; Huang JY, 2015, AM J EPIDEMIOL, V182, P568, DOI 10.1093/aje/kwv148; Hypponen E, 2003, BMJ-BRIT MED J, V327, P898, DOI 10.1136/bmj.327.7420.898; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Lee KW, 2014, ENV HLTH PERSPECT; Lee S, 2012, CANCER CAUSE CONTROL, V23, P117, DOI 10.1007/s10552-012-9914-0; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; McDonald SD, 2006, BJOG-INT J OBSTET GY, V113, P1289, DOI 10.1111/j.1471-0528.2006.01089.x; Michels KB, 2007, INT J OBESITY, V31, P1078, DOI 10.1038/sj.ijo.0803622; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2005, OBES RES, V13, P2021, DOI 10.1038/oby.2005.248; Rillamas-Sun E, 2014, MATERN CHILD HLTH J, V18, P1691, DOI 10.1007/s10995-013-1411-x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SHOPLAND DR, 1990, SEMIN ONCOL, V17, P402; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179368	10.1371/journal.pone.0179368	http://dx.doi.org/10.1371/journal.pone.0179368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700699	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600007
J	Leuko, S; Koskinen, K; Sanna, L; D'Angeli, IM; De Waele, J; Marcia, P; Moissl-Eichinger, C; Rettberg, P				Leuko, Stefan; Koskinen, Kaisa; Sanna, Laura; D'Angeli, Ilenia M.; De Waele, Jo; Marcia, Paolo; Moissl-Eichinger, Christine; Rettberg, Petra			The influence of human exploration on the microbial community structure and ammonia oxidizing potential of the Su Bentu limestone cave in Sardinia, Italy	PLOS ONE			English	Article							PROFILING BACTERIAL DIVERSITY; FERROMANGANESE DEPOSITS; PHYLOGENETIC DIVERSITY; KARTCHNER CAVERNS; ARCHAEA; OXIDATION; ABUNDANCE; BIOMINERALIZATION; GEOMICROBIOLOGY; NITRIFICATION	The bacterial diversity in the Su Bentu Cave in Sardinia was investigated by means of 16S rRNA gene-based analysis. This 15 km long cave, carved in Jurassic limestone, hosts a variety of calcite speleothems, and a long succession of subterranean lakes with mixed granite and carbonate sands. The lower level is occasionally flooded by a rising groundwater level, but with only scarce input of organic remains (leaves and charcoal fragments). On the quiet cave pools there are visible calcite rafts, whereas walls are locally coated with manganese deposits. In the drier upper levels, where organic input is much more subdued, moonmilk-a hydrated calcium-magnesium carbonate speleothem -can be found. Relative humidity approaches 100% and the measured mean annual cave air temperature is 14.8 degrees C. Samples were obtained in 2014 from calcite rafts, moonmilk, manganese oxide deposits and soil (limestone and granite grains). Microclimatic conditions in the cave near the sampling sites, sample properties, physico-chemical parameters of water, and sediment composition were determined. The microbial community of this system is predominately composed of the phyla Proteobacteria, Actinobacteria, Acidobacteria, Nitrospirae, and Firmicutes. Sampling sites near the entrance of the cave and in close proximity of the underground campsite -located 500 meters deep into the cave -revealed the highest diversity as well as the highest number of human associated microorganisms. Two samples obtained in very close proximity of each other near the campsite, indicate that the human impact is localized and is not distributed freely within the system. Analysis of the abundance of bacterial and archaeal amoA genes revealed a far greater abundance of archaeal amoA genes compared to bacterial representatives. The results of this study highlight that human impact is confined to locations that are utilized as campsites and that exploration leaves little microbial trails. Furthermore, we uncovered a highly specialized microbiome, which is perfectly adapted to survive and thrive in an environment with low nutrient availability.	[Leuko, Stefan; Rettberg, Petra] German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Germany; [Koskinen, Kaisa; Moissl-Eichinger, Christine] Med Univ Graz, Sect Infect Dis & Trop Med, Dept Internal Med, BioTechMed, Graz, Austria; [Sanna, Laura] Natl Res Council Italy, Inst Biometeorol, Sassari, Italy; [D'Angeli, Ilenia M.; De Waele, Jo] Univ Bologna, Italian Inst Speleol, Bologna, Italy; [Marcia, Paolo] Univ Sassari, Dipartimento Sci Nat & Terr, Sassari, Italy	Helmholtz Association; German Aerospace Centre (DLR); Medical University of Graz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Bologna; University of Sassari	Leuko, S (corresponding author), German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Germany.	stefan.leuko@dlr.de	Rettberg, Petra/AAI-4493-2021; Sanna, Laura/C-2560-2013; Moissl-Eichinger, Christine/A-6682-2015; Koskinen, Kaisa/T-9905-2017; De Waele, Jo/A-7509-2008	Rettberg, Petra/0000-0003-4439-2395; Sanna, Laura/0000-0003-4326-1115; Moissl-Eichinger, Christine/0000-0001-6755-6263; Koskinen, Kaisa/0000-0001-5727-8415; De Waele, Jo/0000-0001-5325-5208; D'Angeli, Ilenia M./0000-0002-2471-6236	EUROPLANET [15-EPN-029]; European Union's Horizon 2020 research and innovation program [654208]	EUROPLANET; European Union's Horizon 2020 research and innovation program	Research was conducted in the framework of the ESA CAVES program. Funding for Next generation sequencing was provided by EUROPLANET (15-EPN-029) to SL. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 654208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetutu EM, 2012, INT J SPELEOL, V41, P137, DOI 10.5038/1827-806X.41.2.2; Badino G, 2010, ACTA CARSOLOGICA, V39, P427; Barton H.A., 2007, MICROBE, V2, P132; Barton HA, 2001, GEOMICROBIOL J, V18, P359, DOI 10.1080/01490450152467840; Barton HA, 2014, LIFE EXTREME ENV MIC; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Barton HA, 2007, J CAVE KARST STUD, V69, P163; Barton HA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00615; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Biddau R, 2017, ITAL J GEOSCI, V136, P113, DOI 10.3301/IJG.2016.03; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Cabras S, 2008, ACTA CARSOLOGICA, V37, P227; Cao CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00366; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carmichael MJ, 2013, GEOMICROBIOL J, V30, P779, DOI 10.1080/01490451.2013.769651; Chessa PA, 1999, THEOR APPL CLIMATOL, V63, P195, DOI 10.1007/s007040050103; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Crits-Christoph A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-28; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; de Freitas CR, 2010, ACTA CARSOLOGICA, V39, P477; Dhami NK, 2013, J MICROBIOL BIOTECHN, V23, P707, DOI 10.4014/jmb.1212.11087; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Ercole C., 2001, INT J SPELEOL, V30, P6; Franzini M., 1972, X-RAY SPECTROM, V1, P151, DOI [10.1002/xrs.1300010406, DOI 10.1002/XRS.1300010406]; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P221, DOI 10.1080/01490451.2012.752424; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P205, DOI 10.1080/01490451.2013.777491; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Hose LD, 2000, CHEM GEOL, V169, P399, DOI 10.1016/S0009-2541(00)00217-5; Ikner LA, 2007, MICROB ECOL, V53, P30, DOI 10.1007/s00248-006-9135-8; Jimenez-Lopez C, 2008, INT BIODETER BIODEGR, V62, P352, DOI 10.1016/j.ibiod.2008.03.002; JONES B, 1989, CAN J EARTH SCI, V26, P654, DOI 10.1139/e89-056; Kambura AK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0748-x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LEONI L, 1982, X-RAY SPECTROM, V11, P156, DOI 10.1002/xrs.1300110404; Linan C, 2008, INT J SPELEOL, V37, P99, DOI 10.5038/1827-806X.37.2.2; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Northup DE, 2003, ENVIRON MICROBIOL, V5, P1071, DOI 10.1046/j.1462-2920.2003.00500.x; Northup DE, 2011, KARST MANAGEMENT, P225, DOI 10.1007/978-94-007-1207-2_10; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Ortiz M, 2014, ISME J, V8, P478, DOI 10.1038/ismej.2013.159; Ortiz M, 2013, MICROB ECOL, V65, P371, DOI 10.1007/s00248-012-0143-6; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pasci S, 1997, B SOC GEOL FR, V168, P301; Pasic L, 2010, FEMS MICROBIOL ECOL, V71, P50, DOI 10.1111/j.1574-6941.2009.00789.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Peter H, 2016, ISME J, V10, P1545, DOI 10.1038/ismej.2015.245; Portillo MC, 2011, MICROB ECOL, V61, P182, DOI 10.1007/s00248-010-9731-5; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rusznyak A, 2012, APPL ENVIRON MICROB, V78, P1157, DOI 10.1128/AEM.06568-11; Sanchez-Canete EP, 2013, INT J SPELEOL, V42, P1, DOI 10.5038/1827-806X.42.1.1; Schabereiter-Gurtner C, 2004, FEMS MICROBIOL ECOL, V47, P235, DOI 10.1016/S0168-6496(03)00280-0; Schabereiter-Gurtner C, 2002, ENVIRON MICROBIOL, V4, P392, DOI 10.1046/j.1462-2920.2002.00303.x; Schleper C, 1997, APPL ENVIRON MICROB, V63, P321, DOI 10.1128/AEM.63.1.321-323.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; Stieglmeier M., 2014, PROKARYOTES OTHER MA; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Tisato N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15525; Tomczyk-Zak K, 2015, GEOMICROBIOL J, P1; Trajano E., 2012, ENCY CAVES, V2nd ed., P295; Villalobos M, 2003, GEOCHIM COSMOCHIM AC, V67, P2649, DOI 10.1016/S0016-7037(03)00217-5; Vorkapic D, 2016, CURR GENET, V62, P71, DOI 10.1007/s00294-015-0514-x; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; White WB., 1976, INT BIODETER BIODEGR, P267; Wu YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00244; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhao R, 2016, GEOMICROBIOL J; Zhou JP, 2007, J MICROBIOL, V45, P105; Zimmermann J, 2005, GEOMICROBIOL J, V22, P379, DOI 10.1080/01490450500248986	84	15	16	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180700	10.1371/journal.pone.0180700	http://dx.doi.org/10.1371/journal.pone.0180700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704427	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600044
J	Feraudet-Tarisse, C; Mazuet, C; Pauillac, S; Kruger, M; Lacroux, C; Popoff, MR; Dorner, BG; Andreoletti, O; Plaisance, M; Volland, H; Simon, S				Feraudet-Tarisse, Cecile; Mazuet, Christelle; Pauillac, Serge; Krueger, Maren; Lacroux, Caroline; Popoff, Michel R.; Dorner, Brigitte G.; Andreoletti, Olivier; Plaisance, Marc; Volland, Herve; Simon, Stephanie			Highly sensitive sandwich immunoassay and immunochromatographic test for the detection of Clostridial epsilon toxin in complex matrices	PLOS ONE			English	Article							PERFRINGENS TYPE-D; STAPHYLOCOCCAL-ENTEROTOXIN-B; PORE-FORMING TOXIN; MONOCLONAL-ANTIBODIES; ENZYME IMMUNOASSAYS; GAS-GANGRENE; MEMBRANE; DIAGNOSIS; PEPTIDE; CELLS	Epsilon toxin is one of the four major toxins of Clostridium perfringens. It is the third most potent clostridial toxin after botulinum and tetanus toxins and is thus considered as a potential biological weapon classified as category B by the Centers for Disease Control and Prevention (CDC). In the case of a bioterrorist attack, there will be a need for a rapid, sensitive and specific detection method to monitor food and water contamination by this toxin, and for a simple human diagnostic test. We have produced and characterized five monoclonal antibodies against common epitopes of epsilon toxin and prototoxin. Three of them neutralize the cytotoxic effects of epsilon toxin in vitro. With these antibodies, we have developed highly sensitive tests, overnight and 4-h sandwich enzyme immunoassays and an immunochromatographic test performed in 20 min, reaching detection limits of at least 5 pg/mL (0.15 pM), 30 pg/mL (0.9 pM) and 100 pg/mL (3.5 pM) in buffer, respectively. These tests were also evaluated for detection of epsilon toxin in different matrices: milk and tap water for biological threat detection, serum, stool and intestinal content for human or veterinary diagnostic purposes. Detection limits in these complex matrices were at least 5-fold better than those described in the literature (around 1 to 5 ng/mL), reaching 10 to 300 pg/mL using the enzyme immunoassay and 100 to 2000 pg/mL using the immunochromatographic test.	[Feraudet-Tarisse, Cecile; Plaisance, Marc; Volland, Herve; Simon, Stephanie] Univ Paris Saclay, SPI, INRA, CEA, Gif Sur Yvette, France; [Mazuet, Christelle; Pauillac, Serge; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Krueger, Maren; Dorner, Brigitte G.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Biol Toxins, Berlin, Germany; [Lacroux, Caroline; Andreoletti, Olivier] Ecole Natl Vet Toulouse, INRA, UMR 1225, Interact Hotes Agents Pathogenes, Toulouse, France	CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Robert Koch Institute; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Feraudet-Tarisse, C (corresponding author), Univ Paris Saclay, SPI, INRA, CEA, Gif Sur Yvette, France.	cecile.feraudet-tarisse@cea.fr	Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255; Kruger, Maren/0000-0001-9775-3110; Dorner, Brigitte/0000-0002-5100-2546				Alves GG, 2014, ANAEROBE, V30, P102, DOI 10.1016/j.anaerobe.2014.08.016; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; BULLEN JJ, 1952, J PATHOL BACTERIOL, V64, P201, DOI 10.1002/path.1700640120; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Dupre M, 2015, ANAL CHEM, V87, P8473, DOI 10.1021/acs.analchem.5b01900; ELIDRISSI AH, 1992, VET MICROBIOL, V31, P89, DOI 10.1016/0378-1135(92)90144-I; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; GLEESONWHITE MH, 1955, LANCET, V1, P384; Gokce HI, 2007, TURK J VET ANIM SCI, V31, P355; GRASSI J, 1989, J IMMUNOL METHODS, V123, P193, DOI 10.1016/0022-1759(89)90223-8; HANVANICH M, 1985, J CLIN MICROBIOL, V21, P184, DOI 10.1128/JCM.21.2.184-188.1985; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Khreich N, 2008, ANAL BIOCHEM, V377, P182, DOI 10.1016/j.ab.2008.02.032; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOHN J, 1955, LANCET, V1, P385; Layana JE, 2006, ANAEROBE, V12, P204, DOI 10.1016/j.anaerobe.2006.05.001; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; MARTIN PK, 1994, RES VET SCI, V56, P259, DOI 10.1016/0034-5288(94)90114-7; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; NAGAHAMA M, 1991, FEMS MICROBIOL LETT, V84, P41, DOI [10.1111/j.1574-6968.1991.tb04566.x, 10.1016/S0378-1097(99)00655-2]; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Seyer A, 2012, ANAL CHEM, V84, P5103, DOI 10.1021/ac300880x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Uzal EA, 2003, J VET DIAGN INVEST, V15, P94, DOI 10.1177/104063870301500202; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; vila RA, 2017, BRAZ J MICROBIOL PUB; VISCIDI R, 1984, J IMMUNOL METHODS, V67, P129, DOI 10.1016/0022-1759(84)90092-9; WEDDELL W, 1985, NEW ZEAL VET J, V33, P36, DOI 10.1080/00480169.1985.35148	39	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181013	10.1371/journal.pone.0181013	http://dx.doi.org/10.1371/journal.pone.0181013			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700661	Green Published, gold			2022-12-27	WOS:000405649400027
J	Garabedian, C; Champion, C; Servan-Schreiber, E; Butruille, L; Aubry, E; Sharma, D; Logier, R; Deruelle, P; Storme, L; Houfflin-Debarge, V; De Jonckheere, J				Garabedian, C.; Champion, C.; Servan-Schreiber, E.; Butruille, L.; Aubry, E.; Sharma, D.; Logier, R.; Deruelle, P.; Storme, L.; Houfflin-Debarge, V.; De Jonckheere, J.			A new analysis of heart rate variability in the assessment of fetal parasympathetic activity: An experimental study in a fetal sheep model	PLOS ONE			English	Article							SPECTRAL-ANALYSIS	Analysis of heart rate variability (HRV) is a recognized tool in the assessment of autonomic nervous system (ANS) activity. Indeed, both time and spectral analysis techniques enable us to obtain indexes that are related to the way the ANS regulates the heart rate. However, these techniques are limited in terms of the lack of thresholds of the numerical indexes, which is primarily due to high inter-subject variability. We proposed a new fetal HRV analysis method related to the parasympathetic activity of the ANS. The aim of this study was to evaluate the performance of our method compared to commonly used HRV analysis, with regard to i) the ability to detect changes in ANS activity and ii) inter-subject variability. This study was performed in seven sheep fetuses. In order to evaluate the sensitivity and specificity of our index in evaluating parasympathetic activity, we directly administered 2.5 mg intravenous atropine, to inhibit parasympathetic tone, and 5 mg propranolol to block sympathetic activity. Our index, as well as time analysis (root mean square of the successive differences; RMSSD) and spectral analysis (high frequency (HF) and low frequency (LF) spectral components obtained via fast Fourier transform), were measured before and after injection. Inter-subject variability was estimated by the coefficient of variance (% CV). In order to evaluate the ability of HRV parameters to detect fetal parasympathetic decrease, we also estimated the effect size for each HRV parameter before and after injections. As expected, our index, the HF spectral component, and the RMSSD were reduced after the atropine injection. Moreover, our index presented a higher effect size. The % CV was far lower for our index than for RMSSD, HF, and LF. Although LF decreased after propranolol administration, fetal stress index, RMSSD, and HF were not significantly different, confirming the fact that those indexes are specific to the parasympathetic nervous system. In conclusion, our method appeared to be effective in detecting parasympathetic inhibition. Moreover, inter-subject variability was much lower, and effect size higher, with our method compared to other HRV analysis methods.	[Garabedian, C.; Champion, C.; Servan-Schreiber, E.; Butruille, L.; Aubry, E.; Sharma, D.; Deruelle, P.; Storme, L.; Houfflin-Debarge, V.; De Jonckheere, J.] Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France; [Garabedian, C.; Servan-Schreiber, E.; Deruelle, P.; Houfflin-Debarge, V.] CHU Lille, Dept Obstet, Lille, France; [Champion, C.; Aubry, E.; Sharma, D.] CHU Lille, Dept Pediat Surg, Lille, France; [Logier, R.; De Jonckheere, J.] CHU Lille, CIC IT 1403, MRRC, Lille, France; [Storme, L.] CHU Lille, Dept Neonatol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Garabedian, C (corresponding author), Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France.; Garabedian, C (corresponding author), CHU Lille, Dept Obstet, Lille, France.	charles.garabedian@chru-lille.fr		Garabedian, Charles/0000-0003-2105-9784; BUTRUILLE, Laura/0000-0001-5760-1489				Akselrod S, 2000, PHYSIOL MEAS, V21, P319, DOI 10.1088/0967-3334/21/2/311; Aubry E, 2013, J PEDIATR SURG, V48, P481, DOI 10.1016/j.jpedsurg.2012.08.024; Camm AJ, 1996, EUR HEART J, V17, P354; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; De Jonckheere J, 2005, P ANN INT IEEE EMBS, P6739, DOI 10.1109/IEMBS.2005.1616051; Frasch MG, 2009, REPROD SCI, V16, P509, DOI 10.1177/1933719108327597; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Houfflin-Debarge V, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.049; Jeanne M, 2009, IEEE ENG MED BIO, P1840, DOI 10.1109/IEMBS.2009.5332598; Logier R, 2004, P ANN INT IEEE EMBS, V26, P3937; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Siira SM, 2005, BJOG-INT J OBSTET GY, V112, P418, DOI 10.1111/j.1471-0528.2004.00454.x; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Ugwumadu A, 2013, BEST PRACT RES CL OB, V27, P509, DOI 10.1016/j.bpobgyn.2013.04.002; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x	16	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180653	10.1371/journal.pone.0180653	http://dx.doi.org/10.1371/journal.pone.0180653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700617	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800063
J	Ackerman, JE; Geary, MB; Orner, CA; Bawany, F; Loiselle, AE				Ackerman, Jessica E.; Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Loiselle, Alayna E.			Obesity/Type II diabetes alters macrophage polarization resulting in a fibrotic tendon healing response	PLOS ONE			English	Article							INJURY; ACTIVATION; ADHESIONS; REPAIR; TISSUE; STAGE	Type II Diabetes (T2DM) dramatically impairs the tendon healing response, resulting in decreased collagen organization and mechanics relative to non-diabetic tendons. Despite this burden, there remains a paucity of information regarding the mechanisms that govern impaired healing of diabetic tendons. Mice were placed on either a high fat diet (T2DM) or low fat diet (lean) and underwent flexor tendon transection and repair surgery. Healing was assessed via mechanical testing, histology and changes in gene expression associated with collagen synthesis, matrix remodeling, and macrophage polarization. Obese/diabetic tendons healed with increased scar formation and impaired mechanical properties. Consistent with this, prolonged and excess expression of extracellular matrix (ECM) components were observed in obese/T2DM tendons. Macrophages are involved in both inflammatory and matrix deposition processes during healing. Obese/T2DM tendons healed with increased expression of markers of pro- inflammatory M1 macrophages, and elevated and prolonged expression of M2 macrophages markers that are involved in ECM deposition. Here we demonstrate that tendons from obese/diabetic mice heal with increased scar formation and increased M2 polarization, identifying excess M2 macrophage activity and matrix synthesis as a potential mechanism of the fibrotic healing phenotype observed in T2DM tendons, and as such a potential target to improve tendon healing in T2DM.	[Ackerman, Jessica E.; Geary, Michael B.; Orner, Caitlin A.; Bawany, Fatima; Loiselle, Alayna E.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.	Alayna_Loiselle@urmc.rochester.edu		Loiselle, Alayna/0000-0002-7548-6653	NIAMS/NIH [K01AR068386, P30 AR061307]; University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health [TL1 TR000096]; University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship;  [R01 AR056696];  [P30 AR069655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069655, K01AR068386, P30AR061307] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS/NIH grants K01AR068386 and P30 AR061307 Pilot (to AEL), as well as R01 AR056696, and P30 AR069655. MBG was supported by the University of Rochester CTSA award number TL1 TR000096 from the National Center for Advancing Translational Sciences of the National Institutes of Health. CAO was supported by the University of Rochester School of Medicine Office for Medical Education Year-out Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Ackerman JE, 2016, JOVE-J VIS EXP, DOI 10.3791/54433; Ahmed AS, 2014, CELL TISSUE RES, V357, P109, DOI 10.1007/s00441-014-1871-3; Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Aydin Atakan, 2004, Acta Orthop Traumatol Turc, V38, P54; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Bedi A, 2010, J SHOULDER ELB SURG, V19, P978, DOI 10.1016/j.jse.2009.11.045; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Connizzo BK, 2014, ANN BIOMED ENG, V42, P1880, DOI 10.1007/s10439-014-1031-7; David MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091234; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Fitzgibbons PG, 2008, J HAND SURG-AM, V33A, P771, DOI 10.1016/j.jhsa.2008.01.038; Geary MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136351; Glasner MF, 2017, BIORXIV; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu T., 2014, COMP MATH MATH PHYS, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088362; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Loiselle AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040602; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Prevention CfDCa, 2014, NAT DIAB STAT REP; Romanic AM, 2001, AM J PHYSIOL-RENAL, V281, pF309, DOI 10.1152/ajprenal.2001.281.2.F309; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Shen H, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0406-0; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	39	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181127	10.1371/journal.pone.0181127	http://dx.doi.org/10.1371/journal.pone.0181127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686669	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100134
J	Hennenberg, EM; Eyking, A; Reis, H; Cario, E				Hennenberg, Eva Maria; Eyking, Annette; Reis, Henning; Cario, Elke			MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PLATELET-ACTIVATING-FACTOR; P-GLYCOPROTEIN EXPRESSION; COLORECTAL-CANCER RISK; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; NEOPLASTIC PROGRESSION; MULTIDRUG TRANSPORTER; GENE POLYMORPHISM; RESISTANCE GENE	Patients with Ulcerative Colitis (UC) have an increased risk to develop colitis-associated colorectal cancer (CAC). Here, we found that protein expression of ABCB1 (ATP Binding Cassette Subfamily B Member 1) /MDR1 (multidrug resistance 1) was diminished in the intestinal mucosa of patients with active UC with or without CAC, but not in non-UC patients with sporadic colon cancer. We investigated the consequences of ABCB1/MDR1 loss-offunction in a common murine model for CAC (AOM/DSS). Mice deficient in MDR1A (MDR1A KO) showed enhanced intratumoral inflammation and cellular damage, which were associated with reduced colonic tumor size and decreased degree of dysplasia, when compared to wild-type (WT). Increased cell injury correlated with reduced capacity for growth of MDR1A KO tumor spheroids cultured ex-vivo. Gene expression analysis by microarray demonstrated that MDR1A deficiency shaped the inflammatory response towards an anti-tumorigenic microenvironment by downregulating genes known to be important mediators of cancer progression (PTGS2 (COX2), EREG, IL-11). MDR1A KO tumors showed increased gene expression of TNFSF10 (TRAIL), a known inducer of cancer cell death, and CCL12, a strong trigger of B cell chemotaxis. Abundant B220+ B lymphocyte infiltrates with interspersed CD138+ plasma cells were recruited to the MDR1A KO tumor microenvironment, concomitant with high levels of immunoglobulin light chain genes. In contrast, MDR1A deficiency in RAG2 KO mice that lack both B and T cells aggravated colonic tumor progression. MDR1A KO CD19+ B cells, but not WT CD19+ B cells, suppressed growth of colonic tumor-derived spheroids from AOM/DSS-WT mice in an ex-vivo co-culture system, implying that B-cell regulated immune responses contributed to delayed tumor development in MDR1A deficiency. In conclusion, we provide first evidence that loss of ABCB1/MDR1 function may represent an essential tumor-suppressive host defense mechanism in CAC.	[Hennenberg, Eva Maria; Eyking, Annette; Cario, Elke] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Expt Gastroenterol, Essen, Germany; [Hennenberg, Eva Maria; Eyking, Annette; Reis, Henning; Cario, Elke] Univ Duisburg Essen, Med Sch, Essen, Germany; [Reis, Henning] Univ Hosp Essen, Inst Pathol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Cario, E (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Expt Gastroenterol, Essen, Germany.; Cario, E (corresponding author), Univ Duisburg Essen, Med Sch, Essen, Germany.	elke.cario@uni-due.de	Reis, Henning/AAX-9545-2020	Reis, Henning/0000-0003-1373-5295	Deutsche Forschungsgemeinschaft [CA226/4-3]; Interne Forschungsforderung Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interne Forschungsforderung Essen	This study was supported by the Deutsche Forschungsgemeinschaft (Grant CA226/4-3 to E.C.) and intramural funding (Interne Forschungsforderung Essen to E.C.). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Belliard AM, 2004, J PHARM SCI-US, V93, P1524, DOI 10.1002/jps.20072; Bosman FT, 2010, WHO CLASSIFICATION T, DOI [10.4049/jimmunol.1402481, DOI 10.4049/jimmunol.1402481]; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032784; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2017, WORLD J GASTROENTERO, V23, P1513, DOI 10.3748/wjg.v23.i9.1513; Cario E, 2013, CURR OPIN GASTROEN, V29, P85, DOI 10.1097/MOG.0b013e32835a670e; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Cleynen I, 2014, GUT, V63, P1265, DOI 10.1136/gutjnl-2012-303205; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ernest S, 1999, J AM SOC NEPHROL, V10, P2306; Ey B, 2013, J IMMUNOL, V190, P5676, DOI 10.4049/jimmunol.1201592; Ey B, 2009, J BIOL CHEM, V284, P22332, DOI 10.1074/jbc.M901619200; Eyking A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156871; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Fernandez C, 2004, J PHARM PHARM SCI, V7, P359; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Frank M, 2015, J IMMUNOL, V194, P1983, DOI 10.4049/jimmunol.1402481; Georgopoulos NT, 2014, J CELL SCI, V127, P2967, DOI 10.1242/jcs.150888; Gutmann H, 2008, DIGESTION, V78, P154, DOI 10.1159/000179361; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Ho GT, 2005, GASTROENTEROLOGY, V128, P288, DOI 10.1053/j.gastro.2004.11.019; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Hopper-Borge EA, 2009, EXPERT OPIN THER TAR, V13, P339, DOI [10.1517/14712590902735795 , 10.1517/14712590902735795]; Hu Y, 2005, INT J CANCER, V115, P561, DOI 10.1002/ijc.20876; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Katayama K., 2014, NEW J SCI, V2014, P1, DOI [DOI 10.1155/2014/476974, 10.1155/2014/476974]; Katayama K, 2013, CANCER SCI, V104, P694, DOI 10.1111/cas.12145; Kemp TJ, 2004, J IMMUNOL, V173, P892, DOI 10.4049/jimmunol.173.2.892; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kurzawski M, 2005, EUR J CLIN PHARMACOL, V61, P389, DOI 10.1007/s00228-005-0926-5; LANGHOLZ E, 1992, GASTROENTEROLOGY, V103, P1444, DOI 10.1016/0016-5085(92)91163-X; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Miyoshi H, 2017, EMBO J, V36, P5, DOI 10.15252/embj.201694660; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; MULLER C, 1995, J CELL PHYSIOL, V163, P538, DOI 10.1002/jcp.1041630314; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Panwala CM, 1998, J IMMUNOL, V161, P5733; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044307; Park EJ, 2017, INT IMMUNOLOGY; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Patel VA, 2002, J BIOL CHEM, V277, P38915, DOI 10.1074/jbc.M206855200; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Shimabukuro-Vornhagen A, 2014, ONCOTARGET, V5, P4651, DOI 10.18632/oncotarget.1701; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Souza PS, 2015, EXP CELL RES, V336, P318, DOI 10.1016/j.yexcr.2015.06.005; Stanko G, 2016, GASTROENTEROL REV, V11, P35, DOI 10.5114/pg.2015.51185; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Xia ZX, 2015, CURR CANCER DRUG TAR, V15, P519, DOI 10.2174/1568009615666150506093643; Yaeger R, 2016, GASTROENTEROLOGY, V151, P278, DOI 10.1053/j.gastro.2016.04.001; Yamada T, 2003, CANCER RES, V63, P895; Yamada T, 2000, CANCER RES, V60, P4761; Zhang WD, 2000, J CELL PHYSIOL, V184, P17, DOI 10.1002/(SICI)1097-4652(200007)184:1<17::AID-JCP2>3.0.CO;2-U	84	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180834	10.1371/journal.pone.0180834	http://dx.doi.org/10.1371/journal.pone.0180834			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686677	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100113
J	Zereyesus, YA; Dalton, TJ				Zereyesus, Yacob A.; Dalton, Timothy J.			Rates of return to sorghum and millet research investments: A meta-analysis	PLOS ONE			English	Article								Sorghum and millet grow in some of the most heterogeneous and austere agroecologies around the world. These crops are amongst the top five cereal sources of food and feed. Yet, few studies document the impact of sorghum and millet genetic enhancement. The Internal Rate of Return (ROR) is one of the most popular metrics used to measure the economic return on investment on agricultural research and development (R&D). This study conducted a meta-analysis of 59 sorghum and millet ROR estimates obtained from 25 sources published between 1958 and 2015. The average rate of return to sorghum and millet R&D investment is between 54-76 percent per year. All studies computed social rather than private RORs because the technologies were developed using public funds originating from host country National Agricultural Research Systems (NARS) and international organizations such as the INTSORMIL CRSP, ICRISAT and others. Nearly three quarter of the studies focused only on sorghum (72 percent) and around one tenth of the studies (8 percent) on millet. Regression models analyzed the determinants of variation in the reported RORs. Results show that ex-ante type and self-evaluated type of analyses are positively and significantly associated with the ROR estimates. Compared to estimates conducted by a university, results from international institutions and other mixed organizations provided significantly smaller estimates. Estimates conducted at national level also are significantly lower than those conducted at sub-national levels. The ROR is higher for studies conducted in the United States and for those conducted more recently. The study also reconstructed modified internal rate of return (MIRR) for a sub-sample of the reported RORs following recent methods from the literature. These results show that the MIRR estimates are significantly smaller than the reported ROR estimates. Both results indicate that investment in sorghum and millet research generates high social rates of return.	[Zereyesus, Yacob A.; Dalton, Timothy J.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA	Kansas State University	Dalton, TJ (corresponding author), Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA.	tdalton@ksu.edu			United States Agency for International Development (USAID); United States Agency for International Development (USAID) [AID-OAA-A-13-00047]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the support of the American People provided to the Feed the Future Innovation Lab for Collaborative Research on Sorghum and Millet through the United States Agency for International Development (USAID). The contents are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Program activities are funded by the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-OAA-A-13-00047.	Alston J. M., 2000, META ANAL RATES RETU; Alston JM, 2011, AM J AGR ECON, V93, P1257, DOI 10.1093/ajae/aar044; Anderson MA, 2013, AGR EC, V3, P287; Athanasopoulos PJ, 1978, ENG ECON, V2, P131; FAO, 2017, PRODUCTION CROPS; Huffman WE, 2006, AM J AGR ECON, V88, P783, DOI 10.1111/j.1467-8276.2006.00898.x; Huffman WE, 2011, AMES COUNCIL AGR SCI; Huffman WE, 2010, AMES DEP EC WORKING; Hurley T. M., 2016, RETURNS FOOD AGR R D; Hurley TM, 2014, AM J AGR ECON, V96, P1492, DOI 10.1093/ajae/aau047; Kierulff H, 2008, BUS HORIZONS, V51, P321, DOI 10.1016/j.bushor.2008.02.005; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Maredia MK, 2010, FOOD POLICY, V5, P531; Negrete GL, 1978, ENG ECON, V2, P133; Pardey PG, 2016, FOOD POLICY, V65, P1, DOI 10.1016/j.foodpol.2016.09.009; Ryan PA, 2002, J BUSINESS MANAGEMEN, V4, P355; Shadish WR, 1994, HDB RES SYNTHESIS ME, P257; Stanley TD, 2013, J ECON SURV, V27, P390, DOI 10.1111/joes.12008; TRAXLER G, 1992, AM J AGR ECON, V74, P573, DOI 10.2307/1242570	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180414	10.1371/journal.pone.0180414	http://dx.doi.org/10.1371/journal.pone.0180414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686700	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100061
J	Tsuji, M; Kawasaki, T; Matsuda, T; Arai, T; Gojo, S; Takeuchi, JK				Tsuji, Masato; Kawasaki, Takanori; Matsuda, Takeru; Arai, Tomio; Gojo, Satoshi; Takeuchi, Jun K.			Sexual dimorphisms of mRNA and miRNA in human/murine heart disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BIOPSY-PROVEN MYOCARDITIS; RECEPTOR TRANSGENIC MICE; LARGE GENE LISTS; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MICRORNA-150 PROTECTS; GENDER-DIFFERENCES	Background Sexual dimorphisms are well recognized in various cardiac diseases such as ischemic cardiomyopathy (ICM), hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Thorough understanding of the underlying genetic programs is crucial to optimize treatment strategies specified for each gender. By performing meta-analysis and microarray analysis, we sought to comprehensively characterize the sexual dimorphisms in the healthy and diseased heart at the level of both mRNA and miRNA transcriptome. Results Existing mRNA microarray data of both mouse and human heart were integrated, identifying dozens/hundreds of sexually dimorphic genes in healthy heart, ICM, HCM, and DCM. These sexually dimorphic genes overrepresented gene ontologies (GOs) important for cardiac homeostasis. Further, microarray of miRNA, isolated from mouse sham left ventricle (LV) (n = 6 & n = 5 for male & female) and chronic MI LV (n = 19 & n = 19) and from human normal LV (n = 6 & n = 6) and ICM LV (n = 4 & n = 5), was conducted. This revealed that 13 mouse miRNAs are sexually dimorphic in MI and 6 in normal heart. In human, 3 miRNAs were sexually dimorphic in ICM and 15 in normal heart. These data revealed miRNA-mRNA networks that operate in a sexually-biased fashion. Conclusions mRNA and miRNA transcriptome of normal and disease heart show significant sex differences, which might impact the cardiac homeostasis. Together this study provides the first comprehensive picture of the genome-wide program underlying the heart sexual dimorphisms, laying the foundation for gender specific treatment strategies.	[Tsuji, Masato; Takeuchi, Jun K.] Tokyo Med Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Tokyo, Japan; [Tsuji, Masato; Takeuchi, Jun K.] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan; [Kawasaki, Takanori; Gojo, Satoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Matsuda, Takeru] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo, Japan; [Arai, Tomio] Inst Gerontol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Kyoto Prefectural University of Medicine; University of Tokyo; Tokyo Metropolitan Institute of Gerontology	Tsuji, M; Takeuchi, JK (corresponding author), Tokyo Med Dent Univ, Med Res Inst, Div Bioinformat Pharmacol, Tokyo, Japan.; Tsuji, M; Takeuchi, JK (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan.	mtsuji172@gmail.com; junjunjunta@gmail.com			Japan Agency for Medical Research and Development [16bk0104012h0004]; Japan Society for the Promotion of Science [25291049]; Takeda Medical Research Foundation; Banyu Life Science Foundation International; Nanken-Kyoten; TMDU	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation; Banyu Life Science Foundation International(Banyu Life Science Foundation International); Nanken-Kyoten; TMDU	This work was supported by the Japan Agency for Medical Research and Development: 16bk0104012h0004 (JT); Japan Society for the Promotion of Science: 25291049 (JT); Takeda Medical Research Foundation: 2013 (JT); and Banyu Life Science Foundation International: 2012 (JT). This study was supported by Nanken-Kyoten, TMDU.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Antoniucci D, 2001, AM J CARDIOL, V87, P289, DOI 10.1016/S0002-9149(00)01360-6; Arimura T, 2013, CARDIOVASC RES, V99, P382, DOI 10.1093/cvr/cvt106; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; BUENO H, 1995, CIRCULATION, V92, P1133, DOI 10.1161/01.CIR.92.5.1133; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Cao QX, 2015, ONCOL REP, V33, P2606, DOI 10.3892/or.2015.3861; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cavasin MA, 2006, AM J PHYSIOL-HEART C, V290, pH2043, DOI 10.1152/ajpheart.01121.2005; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Chen M, 2014, INT J CARDIOL, V173, P65, DOI 10.1016/j.ijcard.2014.02.007; Chen Q, 2010, J MOL CELL CARDIOL, V49, P801, DOI 10.1016/j.yjmcc.2010.08.002; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Chiavacci E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050536; Cocker MS, 2009, HEART, V95, P1925, DOI 10.1136/hrt.2008.164061; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Coronado MJ, 2012, AM J PHYSIOL-HEART C, V302, pH1726, DOI 10.1152/ajpheart.00783.2011; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; Ding W, 2015, CARDIOVASC RES, V106, P131, DOI 10.1093/cvr/cvv030; Duan QL, 2015, J CELL PHYSIOL, V230, P1964, DOI 10.1002/jcp.24942; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fliegner D, 2010, FEMALE SEX ESTROGEN, P1597; Frisancho-Kiss S, 2007, J IMMUNOL, V178, P6710, DOI 10.4049/jimmunol.178.11.6710; Fulminant THE, 1946, AM J, VXXII; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Haddad GE, 2008, PHYSIOL GENOMICS, V33, P267, DOI 10.1152/physiolgenomics.00265.2007; Hammett CJK, 2004, J AM COLL CARDIOL, V44, P2411, DOI 10.1016/j.jacc.2004.09.030; Heidecker B, 2010, EUR HEART J, V31, P1188, DOI 10.1093/eurheartj/ehp549; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Izarra A, 2014, STEM CELL REP, V3, P1029, DOI 10.1016/j.stemcr.2014.10.010; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Johnson BD, 2006, EUR HEART J, V27, P1408, DOI 10.1093/eurheartj/ehl040; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joladarashi D, 2014, INT J MOL SCI, V15, P15891, DOI 10.3390/ijms150915891; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kararigas G, 2011, PHYSIOL GENOMICS, V43, P438, DOI 10.1152/physiolgenomics.00199.2010; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; Kubo T, 2010, J CARDIOL, V56, P314, DOI 10.1016/j.jjcc.2010.07.004; Li MM, 2014, CELL PHYSIOL BIOCHEM, V33, P1988, DOI 10.1159/000362975; Li XB, 2013, ACTA BIOCH BIOPH SIN, V45, P734, DOI 10.1093/abbs/gmt067; LIAO YL, 1995, CIRCULATION, V92, P805, DOI 10.1161/01.CIR.92.4.805; Lin CL, 1999, JPN CIRC J, V63, P859, DOI 10.1253/jcj.63.859; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Liu Z, 2015, CIRC-CARDIOVASC GENE, V8, P11, DOI 10.1161/CIRCGENETICS.114.000598; Lv GW, 2014, J CELL BIOCHEM, V115, P93, DOI 10.1002/jcb.24636; LYDEN DC, 1987, AM J PATHOL, V126, P432; Magnani JW, 2006, AM HEART J, V151, P463, DOI 10.1016/j.ahj.2005.03.037; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Meyer S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/ejhf.15; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Nikolic I, 2007, J MOL CELL CARDIOL, V42, P769, DOI 10.1016/j.yjmcc.2007.01.014; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olson MB, 2003, EUR HEART J, V24, P1506, DOI 10.1016/S0195-668X(03)00279-3; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pilbrow AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039574; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SAINANI GS, 1968, MEDICINE, V47, P133, DOI 10.1097/00005792-196803000-00003; SHAPIRA I, 1987, CHEST, V92, P219, DOI 10.1378/chest.92.2.219; Shioura KM, 2008, AM J PHYSIOL-REG I, V295, pR528, DOI 10.1152/ajpregu.90342.2008; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Tang YP, 2015, CARDIOVASC RES, V106, P387, DOI 10.1093/cvr/cvv121; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; van Rijsingen IAW, 2013, EUR J HEART FAIL, V15, P376, DOI 10.1093/eurjhf/hfs191; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang YT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-72; With C., 1991, IN HOSP 1 YEAR MORTA, P484; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; WOODRUFF JF, 1980, AM J PATHOL, V101, P425; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	99	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0177988	10.1371/journal.pone.0177988	http://dx.doi.org/10.1371/journal.pone.0177988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704447	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700005
J	Xiang, N; Lawrence, KS; Kloepper, JW; Donald, PA; McInroy, JA				Xiang, Ni; Lawrence, Kathy S.; Kloepper, Joseph W.; Donald, Patricia A.; McInroy, John A.			Biological control of Heterodera glycines by spore-forming plant growth-promoting rhizobacteria (PGPR) on soybean	PLOS ONE			English	Article							CYST-NEMATODE; MELOIDOGYNE-INCOGNITA; SYSTEMIC RESISTANCE; BIOCONTROL; BACTERIA; FUNGI	Heterodera glycines, the soybean cyst nematode, is the most economically important plantparasitic nematode on soybean production in the U.S. The objectives of this study were to evaluate the potential of plant growth-promoting rhizobacteria (PGPR) strains for mortality of H. glycines J2 in vitro and for reducing nematode population density on soybean in greenhouse, microplot, and field trials. The major group causing mortality to H. glycines in vitro was the genus Bacillus that consisted of 92.6% of the total 663 PGPR strains evaluated. The subsequent greenhouse, microplot, and field trials indicated that B. velezensis strain Bve2 consistently reduced H. glycines cyst population density at 60 DAP. Bacillus mojavensis strain Bmo3 suppressed H. glycines cyst and total H. glycines population density under greenhouse conditions. Bacillus safensis strain Bsa27 and Mixture 1 (Bve2 + Bal13) reduced H. glycines cyst population density at 60 DAP in the field trials. Bacillus subtilis subsp. subtilis strains Bsssu2 and Bsssu3, and B. velezensis strain Bve12 increased early soybean growth including plant height and plant biomass in the greenhouse trials. Bacillus altitudinis strain Bal13 increased early plant growth on soybean in the greenhouse and microplot trials. Mixture 2 (Abamectin + Bve2 + Bal13) increased early plant growth in the microplot trials at 60 DAP, and also enhanced soybean yield at harvest in the field trials. These results demonstrated that individual PGPR strains and mixtures can reduce H. glycines population density in the greenhouse, microplot, and field conditions, and increased yield of soybean.	[Xiang, Ni; Lawrence, Kathy S.; Kloepper, Joseph W.; Donald, Patricia A.; McInroy, John A.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Lawrence, KS (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lawrekk@auburn.edu	Xiang, Ni/I-3176-2019; Lawrence, Kathy/AAA-3808-2020	Xiang, Ni/0000-0003-0805-7901; Lawrence, Kathy/0000-0002-5358-2011				Askary TH, 2014, BIOCONTROL AGENTS OF PHYTONEMATODES, P446; Burkett-Cadena M, 2008, BIOL CONTROL, V47, P55, DOI 10.1016/j.biocontrol.2008.07.008; Castillo JD, 2013, PLANT DIS, V97, P967, DOI 10.1094/PDIS-10-12-0978-RE; Chen S., 2004, BIOL MANAGEMENT SOYB, P207; Chen SY, 2005, BIOL CONTROL, V32, P208, DOI 10.1016/j.biocontrol.2004.09.013; Hallmann J, 2010, ROOT-KNOT NEMATODES, P380, DOI 10.1079/9781845934927.0380; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Keren-Zur M, 2000, PROC BRIGHTON CROP, V1-3, P47; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; KLOEPPER JW, 1992, PLANT SOIL, V139, P75, DOI 10.1007/BF00012844; Liu K, 2016, BIOL CONTROL, V99, P8, DOI 10.1016/j.biocontrol.2016.04.007; Liu XZ, 2000, BIOL CONTROL, V19, P161, DOI 10.1006/bcon.2000.0855; Micnroy, 2014, P 2014 BELTW COTT C, V1, P258; NASS. National Agricultural Statistics Service | USDA, 2016, CROP PROD 2015 SUMM, P46; NISHIZAWA T, 1987, J NEMATOL, V19, P546; Nitao JK, 2002, NEMATOLOGY, V4, P55, DOI 10.1163/156854102760082203; NOEL GR, 1994, J NEMATOL, V26, P612; Raupach GS, 2000, PLANT DIS, V84, P1073, DOI 10.1094/PDIS.2000.84.10.1073; RIGGS RD, 1991, J NEMATOL, V23, P149; Schrimsher DW, 2014, J NEMATOL, V46, P365; Sharma R. D., 1996, Nematologia Brasileira, V20, P53; Sharma Ravi Datt, 1995, Nematologia Brasileira, V19, P72; Tian HL, 2000, J NEMATOL, V32, P377; Tian HL, 2000, J NEMATOL, V32, P370; TYLKA GL, 1991, J NEMATOL, V23, P122; Wilson MJ, 2013, BIOCONTROL, V58, P715, DOI 10.1007/s10526-013-9511-5; WINSTEAD N. N., 1955, PLANT DIS REPORTER, V39, P9; Wrather A., 2010, PLANT HLTH PROGR; Wrather JA., 2009, EFFECTS DISEASES SOY; Xiang N, 2017, PLANT DIS, V101, P774, DOI 10.1094/PDIS-09-16-1369-RE; Xiang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154818	31	32	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181201	10.1371/journal.pone.0181201	http://dx.doi.org/10.1371/journal.pone.0181201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704498	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700104
J	Liu, W; Ghouri, F; Yu, H; Li, X; Yu, SH; Shahid, MQ; Liu, XD				Liu, Wen; Ghouri, Fozia; Yu, Hang; Li, Xiang; Yu, Shuhong; Shahid, Muhammad Qasim; Liu, Xiangdong			Genome wide re-sequencing of newly developed Rice Lines from common wild rice (Oryza rufipogon Griff.) for the identification of NBS-LRR genes	PLOS ONE			English	Article							BLAST RESISTANCE GENE; BLIGHT RESISTANCE; ASSOCIATION; MARKERS; INDICA; POLYMORPHISMS; CONSERVATION; POPULATION; DIVERSITY; JAPONICA	Common wild rice (Oryza rufipogon Griff.) is an important germplasm for rice breeding, which contains many resistance genes. Re-sequencing provides an unprecedented opportunity to explore the abundant useful genes at whole genome level. Here, we identified the nucleotide-binding site leucine-rich repeat (NBS-LRR) encoding genes by re-sequencing of two wild rice lines (i.e. Huaye 1 and Huaye 2) that were developed from common wild rice. We obtained 128 to 147 million reads with approximately 32.5-fold coverage depth, and uniquely covered more than 89.6% (> = 1 fold) of reference genomes. Two wild rice lines showed high SNP (single-nucleotide polymorphisms) variation rate in 12 chromosomes against the reference genomes of Nipponbare (japonica cultivar) and 93-11 (indica cultivar). InDels (insertion/deletion polymorphisms) count-length distribution exhibited normal distribution in the two lines, and most of the InDels were ranged from -5 to 5 bp. With reference to the Nipponbare genome sequence, we detected a total of 1,209,308 SNPs, 161,117 InDels and 4,192 SVs (structural variations) in Huaye 1, and 1,387,959 SNPs, 180,226 InDels and 5,305 SVs in Huaye 2. A total of 44.9% and 46.9% genes exhibited sequence variations in two wild rice lines compared to the Nipponbare and 93-11 reference genomes, respectively. Analysis of NBS-LRR mutant candidate genes showed that they were mainly distributed on chromosome 11, and NBS domain was more conserved than LRR domain in both wild rice lines. NBS genes depicted higher levels of genetic diversity in Huaye 1 than that found in Huaye 2. Furthermore, protein-protein interaction analysis showed that NBS genes mostly interacted with the cytochrome C protein (Os05g0420600, Os01g0885000 and BGIOSGA038922), while some NBS genes interacted with heat shock protein, DNA-binding activity, Phosphoinositide 3-kinase and a coiled coil region. We explored abundant NBSLRR encoding genes in two common wild rice lines through genome wide re-sequencing, which proved to be a useful tool to exploit elite NBS-LRR genes in wild rice. The data here provide a foundation for future work aimed at dissecting the genetic basis of disease resistance in rice, and the two wild rice lines will be useful germplasm for the molecular improvement of cultivated rice.	[Liu, Wen; Ghouri, Fozia; Yu, Hang; Li, Xiang; Yu, Shuhong; Shahid, Muhammad Qasim; Liu, Xiangdong] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Liu, Wen] Guangdong Agr Ind Business Polytech Coll, Dept Trop Crops, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Shahid, MQ; Liu, XD (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	qasim@scau.edu.cn; xdliu@scau.edu.cn	Shahid, Muhammad Qasim/F-2908-2013; Shahid, Muhammad Qasim/K-2304-2019	Shahid, Muhammad Qasim/0000-0002-6767-4355; Shahid, Muhammad Qasim/0000-0002-6767-4355; Xiang, Li/0000-0003-2757-0305; Ghouri, Fozia/0000-0001-5579-5179	Guangdong provincial key Natural Science Foundation [2014A030311042]; Guangzhou Science and Technology Key Program [201606201026123]	Guangdong provincial key Natural Science Foundation; Guangzhou Science and Technology Key Program	This work was supported by the Guangdong provincial key Natural Science Foundation (2014A030311042 to XD Liu) and the Guangzhou Science and Technology Key Program (Application No. 201606201026123 to XD Liu and MQ Shahid).	Arai-Kichise Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086312; Cheng ZQ, 2012, RICE SCI, V19, P21, DOI 10.1016/S1672-6308(12)60016-X; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gao LZ, 2000, HEREDITAS, V133, P47, DOI 10.1111/j.1601-5223.2000.00047.x; [高明君 Gao Mingjun], 2013, [中国科学. 生命科学, Scientia Sinica Vitae], V43, P1016; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kim SR, 2016, RICE, V9, DOI 10.1186/s12284-016-0084-7; Kottapalli KR, 2007, BIOCHEM BIOPH RES CO, V355, P295, DOI 10.1016/j.bbrc.2007.01.134; Kumari A, 2013, EUR J PLANT PATHOL, V137, P55, DOI 10.1007/s10658-013-0216-5; Liu Ren-Hu, 2003, Yichuan, V25, P317; LIU W, 2015, PLOS ONE, V10; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Lu PL, 2012, GENOME RES, V22, P508, DOI 10.1101/gr.127522.111; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Ngu MeeSiing, 2010, Tropical Plant Biology, V3, P227, DOI 10.1007/s12042-010-9060-3; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Qiu J, 2014, PLANTA, V240, P1353, DOI 10.1007/s00425-014-2159-2; Ramkumar G., 2014, J GENOMES EXOMES, V3, P7; Ray S, 2012, TRANSGENIC RES, V21, P351, DOI 10.1007/s11248-011-9535-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Shirasawa K, 2013, DNA RES, V20, P593, DOI 10.1093/dnares/dst033; Song ZP, 2005, PLANT SPEC BIOL, V20, P83, DOI 10.1111/j.1442-1984.2005.00128.x; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang XM, 2013, PLANT MOL BIOL REP, V31, P649, DOI 10.1007/s11105-012-0537-0; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xie J, 2010, GENET RESOUR CROP EV, V57, P597, DOI 10.1007/s10722-009-9498-z; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yang Y, 2011, J PLANT PHYSIOL, V168, P1701, DOI 10.1016/j.jplph.2011.02.012; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang LG, 2012, PLANT CELL, V24, P4407, DOI 10.1105/tpc.112.102269; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	43	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180662	10.1371/journal.pone.0180662	http://dx.doi.org/10.1371/journal.pone.0180662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700714	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400016
J	Foley, MM; Magilligan, FJ; Torgersen, CE; Major, JJ; Anderson, CW; Connolly, PJ; Wieferich, D; Shafroth, PB; Evans, JE; Infante, D; Craig, LS				Foley, Melissa M.; Magilligan, Francis J.; Torgersen, Christian E.; Major, Jon J.; Anderson, Chauncey W.; Connolly, Patrick J.; Wieferich, Daniel; Shafroth, Patrick B.; Evans, James E.; Infante, Dana; Craig, Laura S.			Landscape context and the biophysical response of rivers to dam removal in the United States	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; FISH; RESTORATION; MACROINVERTEBRATE; LESSONS; ASSEMBLAGES; WASHINGTON; CHANNEL; TIME	Dams have been a fundamental part of the U. S. national agenda over the past two hundred years. Recently, however, dam removal has emerged as a strategy for addressing aging, obsolete infrastructure and more than 1,100 dams have been removed since the 1970s. However, only 130 of these removals had any ecological or geomorphic assessments, and fewer than half of those included before-and after-removal (BAR) studies. In addition, this growing, but limited collection of dam-removal studies is limited to distinct landscape settings. We conducted a meta-analysis to compare the landscape context of existing and removed dams and assessed the biophysical responses to dam removal for 63 BAR studies. The highest concentration of removed dams was in the Northeast and Upper Midwest, and most have been removed from 3 rd and 4 th order streams, in low-elevation (< 500 m) and low-slope (< 5%) watersheds that have small to moderate upstream watershed areas (10-1000 km 2) with a low risk of habitat degradation. Many of the BAR-studied removals also have these characteristics, suggesting that our understanding of responses to dam removals is based on a limited range of landscape settings, which limits predictive capacity in other environmental settings. Biophysical responses to dam removal varied by landscape cluster, indicating that landscape features are likely to affect biophysical responses to dam removal. However, biophysical data were not equally distributed across variables or clusters, making it difficult to determine which landscape features have the strongest effect on dam-removal response. To address the inconsistencies across dam-removal studies, we provide suggestions for prioritizing and standardizing data collection associated with dam removal activities.	[Foley, Melissa M.] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA; [Magilligan, Francis J.] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [Torgersen, Christian E.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Seattle, WA USA; [Major, Jon J.] US Geol Survey, Volcano Sci Ctr, Cascades Volcano Observ, Vancouver, WA USA; [Anderson, Chauncey W.] US Geol Survey Portland, Oregon Water Sci Ctr, Portland, OR USA; [Connolly, Patrick J.] US Geol Survey, Columbia River Res Lab, Western Fisheries Res Ctr, Cook, WA USA; [Wieferich, Daniel] US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA; [Shafroth, Patrick B.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Evans, James E.] Bowling Green State Univ, Dept Geol, Bowling Green, OH 43403 USA; [Infante, Dana] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Craig, Laura S.] Amer Rivers, Washington, DC USA; [Foley, Melissa M.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	United States Department of the Interior; United States Geological Survey; Dartmouth College; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University System of Ohio; Bowling Green State University; Michigan State University; University of California System; University of California Santa Cruz	Foley, MM (corresponding author), US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA.; Foley, MM (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	mfoley@ucsc.edu	Van Cleave, Keith/AAN-2338-2021; Evans, James/U-7695-2019	Evans, James/0000-0002-9382-1910; Magilligan, Francis/0000-0002-0082-5526; Anderson, Chauncey/0000-0002-1016-3781; Foley, Melissa/0000-0002-5832-6404; Wieferich, Daniel/0000-0003-1554-7992	US Geological Survey John Wesley Powell Center for Analysis and Synthesis	US Geological Survey John Wesley Powell Center for Analysis and Synthesis	This work was supported by the US Geological Survey John Wesley Powell Center for Analysis and Synthesis (https://powellcenter.usgs.gov/). The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript	Ahearn DS, 2005, LIMNOL OCEANOGR, V50, P1752, DOI 10.4319/lo.2005.50.6.1752; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Bernhardt ES, 2007, RESTOR ECOL, V15, P482, DOI 10.1111/j.1526-100X.2007.00244.x; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bulak J, 2011, TWELVEMILE CREEK DAM; Burdick SM, 2006, T AM FISH SOC, V135, P1290, DOI 10.1577/T05-190.1; Burroughs BA, 2010, T AM FISH SOC, V139, P1595, DOI 10.1577/T09-056.1; Catalano MJ, 2002, EVALUATING FISH HABI; Chaplin JJ, EFFECTS REMOVING GOO; CHURCH M, 1995, REGUL RIVER, V11, P3, DOI 10.1002/rrr.3450110103; Claeson SM, 2016, RIVER RES APPL, V32, P1143, DOI 10.1002/rra.2935; Clarke KR, 2015, PRIMER V7 USER MANUA; Crawford S., 2016, FISHS EYE STATUS FIS; Daniel WM, 2015, NATL FISH HABITAT PA; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Doyle MW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001714; East AE, 2015, GEOMORPHOLOGY, V228, P765, DOI 10.1016/j.geomorph.2014.08.028; Foley MM, COASTAL HAB IN PRESS; Foley MM, WATER RESOU IN PRESS; Gibson AM, 2011, ECOSYSTEM RESPONSES; Grant GE, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 3: RIVER BASINS, RESERVOIR SEDIMENTATION AND WATER RESOURCES, P31, DOI 10.1007/978-3-319-09054-2_7; Hansen JF, 2012, RIVER RES APPL, V28, P1540, DOI 10.1002/rra.1540; Harbold W, 2013, PATAPSCO RIVER DAM R; Hart DD, 2002, BIOSCIENCE, V52, P669, DOI 10.1641/0006-3568(2002)052[0669:DRCAOF]2.0.CO;2; Herreman K, 2015, NATL FISH HABITAT PA; Hitt NP, 2012, T AM FISH SOC, V141, P1171, DOI 10.1080/00028487.2012.675918; Hoenke KM, 2014, ECOL ENG, V64, P27, DOI 10.1016/j.ecoleng.2013.12.009; Hogg RS, 2015, T AM FISH SOC, V144, P467, DOI 10.1080/00028487.2015.1007164; Howard G, 2007, CARBONTON DAM DEEP R; Hutchison B., 2008, FISH MACROINVERTEBRA; Jolley JC, 2013, OCCURRENCE DETECTION; Kemp PS, 2010, FISHERIES MANAG ECOL, V17, P297, DOI 10.1111/j.1365-2400.2010.00751.x; Knittel MJ, 2010, IMPACT SMALL DAM REM; Kornis MS, 2015, AQUAT SCI, V77, P465, DOI 10.1007/s00027-014-0391-2; Magilligan F, 2016, ELEMENTA, V4; Major J. J., 2017, GRAVELBED RIVERS PRO, P355; Major JJ, 2012, GEOMORPHIC RESPONSE; Maloney KO, 2008, FRESHWATER BIOL, V53, P1055, DOI 10.1111/j.1365-2427.2008.01956.x; Marks JC, 2010, RESTOR ECOL, V18, P934, DOI 10.1111/j.1526-100X.2009.00574.x; McHenry M., 2015, SPAWNING DISTRIBUTIO; McKay SK, 2013, ECOL APPL, V23, P1396, DOI 10.1890/12-1564.1; Neeson TM, 2015, P NATL ACAD SCI USA, V112, P6236, DOI 10.1073/pnas.1423812112; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Orr CH, 2006, J N AM BENTHOL SOC, V25, P556, DOI 10.1899/0887-3593(2006)25[556:CMAPUF]2.0.CO;2; Ostroff S, 2013, 2012 NATL ANTHROPOGE; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer MA, 2009, ESTUAR COAST, V32, P1, DOI 10.1007/s12237-008-9129-5; Pess G, ECOSYSTEM R IN PRESS; Pohl MM, 2002, J AM WATER RESOUR AS, V38, P1511, DOI 10.1111/j.1752-1688.2002.tb04361.x; Pollard AI, 2004, HYDROBIOLOGIA, V513, P51, DOI 10.1023/B:hydr.0000018164.17234.4f; QGIS, 2016, QGIS GEOGR INF SYST; Sawaske SR, 2012, GEOMORPHOLOGY, V151, P50, DOI 10.1016/j.geomorph.2012.01.013; Shafroth PB, 2002, BIOSCIENCE, V52, P703, DOI 10.1641/0006-3568(2002)052[0703:PRORVT]2.0.CO;2; Sherman M., 2013, POTENTIAL IMPACTS SM; Somerfield PJ, 2014, MAR ENVIRON RES, V102, P51, DOI 10.1016/j.marenvres.2014.06.004; Stanley EH, 2003, FRONT ECOL ENVIRON, V1, P15, DOI 10.1890/1540-9295(2003)001[0015:TOTEEO]2.0.CO;2; Stanley EH, 2002, BIOSCIENCE, V52, P693, DOI 10.1641/0006-3568(2002)052[0693:AGPONR]2.0.CO;2; Stewart GB, 2006, PATTERNS PROCESSES S; SWANSON FJ, 1990, BIOSCIENCE, V40, P502, DOI 10.2307/1311318; Thomson JR, 2005, J N AM BENTHOL SOC, V24, P192, DOI 10.1899/0887-3593(2005)024<0192:EOROAS>2.0.CO;2; Tonitto C, 2016, SUST WAT RESOUR MAN, V2, P489, DOI 10.1007/s40899-016-0062-7; Tullos DD, 2016, J AM WATER RESOUR AS, V52, P1179, DOI 10.1111/1752-1688.12450; Tullos DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108091; Ward J., 1983, DYNAMICS LOTIC ECOSY, P29, DOI 10.2307/2259560; Whitener P., 2013, 12 MILE CREEK CHANNE; Wieferich DJ, NATL DAM REMOVAL SCI	67	29	30	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180107	10.1371/journal.pone.0180107	http://dx.doi.org/10.1371/journal.pone.0180107			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692693	Green Published, gold			2022-12-27	WOS:000405544800024
J	Hudak, R; Szekely, EG; Kovacs, KR; Nagy, A; Hofgart, G; Berenyi, E; Csiba, L; Kappelmayer, J; Bagoly, Z				Hudak, Renata; Szekely, Edina G.; Kovacs, Katalin R.; Nagy, Attila; Hofgart, Gergely; Berenyi, Ervin; Csiba, Laslo; Kappelmayer, Janos; Bagoly, Zsuzsa			Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis	PLOS ONE			English	Article							ASSAYS; HEMOPHILIA; HEMORRHAGE; MANAGEMENT; RISK	Thrombolysis by intravenous recombinant tissue plasminogen activator (rt-PA) is an effective therapy in acute ischemic stroke (AIS). Thrombin generation test (TGT) is a global hemostasis test providing information about the speed and amount of generated thrombin in plasma. Here we aimed to find out whether results of this test before the initiation of thrombolysis might predict outcomes. Study population included 120 consecutive AIS patients, all within 4.5 hours of their symptom onset, who underwent thrombolysis by rt-PA. Blood samples were collected from all patients upon admission and TGT was performed using platelet poor plasma. Clinical data of patients including the NIHSS were registered at admission, day 1 and 7 after therapy. The ASPECT score was assessed using CT images taken before and 24 hours after thrombolysis. Long-term functional outcome was defined 3 months after the event by the modified Rankin Scale. Endogenous Thrombin Potential (ETP) and Peak Thrombin were significantly lower in patients with cardioembolic IS. Symptomatic intracranial hemorrhage (SICH) was found in 6 patients and was significantly associated with low ETP and Peak Thrombin levels. A multiple logistic regression model revealed that an ETP result in the lower quartile is an independent predictor of mortality within the first two weeks (OR: 6.03; 95% CI: 1.2-30.16, p< 0.05) and three months after the event (OR: 5.28; 95% CI: 1.27-21.86, p< 0.05). Low levels of ETP and Peak Thrombin parameters increase the risk of therapy associated SICH. A low ETP result is an independent predictor of short-and longterm mortality following thrombolysis.	[Hudak, Renata; Kappelmayer, Janos] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary; [Szekely, Edina G.; Bagoly, Zsuzsa] Univ Debrecen, Fac Med, Dept Lab Med, Div Clin Lab Sci, Debrecen, Hungary; [Kovacs, Katalin R.; Hofgart, Gergely; Csiba, Laslo] Univ Debrecen, Fac Med, Dept Neurol, Debrecen, Hungary; [Nagy, Attila] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Berenyi, Ervin] Univ Debrecen, Fac Med, Dept Radiol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Bagoly, Z (corresponding author), Univ Debrecen, Fac Med, Dept Lab Med, Div Clin Lab Sci, Debrecen, Hungary.	bagoly@med.unideb.hu	Bagoly, Zsuzsa/AAB-3553-2020; Bagoly, Zsolt/K-6365-2018	Bagoly, Zsolt/0000-0002-2679-7594; Bagoly, Zsuzsa/0000-0001-5314-5607; Nagy, Attila/0000-0002-0554-7350	National Research, Development and Innovation Fund (OTKA) [K109712, PD111929]; National Development Agency [TAMOP 4.2.2.A-11/1/KONV-2012-0045]; European Union; European Regional Development Fund [GINOP-2.3.2-15-2016-00043]; Janos Bolyai fellowship; European Social Fund [TAMOP -4.2.4.A/2-11/1-2012-0001]	National Research, Development and Innovation Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Union(European Commission); European Regional Development Fund(European Commission); Janos Bolyai fellowship(Hungarian Academy of Sciences); European Social Fund(European Social Fund (ESF))	This work was supported by grants from the National Research, Development and Innovation Fund (OTKA K109712, PD111929), the National Development Agency (TAMOP 4.2.2.A-11/1/KONV-2012-0045) and by the European Union and the European Regional Development Fund, GINOP-2.3.2-15-2016-00043. ZB is the recipient of Janos Bolyai fellowship and Lajos Szodoray Prize. RH was supported by the European Social Fund in the frame of TAMOP -4.2.4.A/2-11/1-2012-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Ay Y, 2013, CLIN APPL THROMB-HEM, V19, P389, DOI 10.1177/1076029612438611; Bosch Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-154; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brummel-Ziedins KE, 2014, CURR OPIN HEMATOL, V21, P395, DOI 10.1097/MOH.0000000000000074; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X; Cocho D, 2006, STROKE, V37, P996, DOI 10.1161/01.STR.0000206461.71624.50; Fugate Jennifer E, 2010, Front Neurol, V1, P139, DOI 10.3389/fneur.2010.00139; Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16; Gissel M, 2010, THROMB RES, V126, P262, DOI 10.1016/j.thromres.2010.07.002; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Haidl H, 2006, THROMB HAEMOSTASIS, V95, P772, DOI 10.1160/TH05-10-0685; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Lance MD, 2015, THROMB J, V13, DOI 10.1186/1477-9560-13-1; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Perrin J, 2015, THROMB RES, V136, P125, DOI 10.1016/j.thromres.2014.12.015; Rooth E, 2013, SCAND J CLIN LAB INV, V73, P576, DOI 10.3109/00365513.2013.826817; Seet RCS, 2012, CEREBROVASC DIS, V34, P106, DOI 10.1159/000339675; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Young G, 2013, BLOOD, V121, P1944, DOI 10.1182/blood-2012-08-378935	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180477	10.1371/journal.pone.0180477	http://dx.doi.org/10.1371/journal.pone.0180477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692682	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000405544800045
J	Kim, JH; Choi, SH; Jang, JH; Lee, DH; Lee, KJ; Lee, WJ; Moon, JY; Kim, YC; Kang, DH				Kim, Jae-Hun; Choi, Soo-Hee; Jang, Joon Hwan; Lee, Do-Hyeong; Lee, Kyung-Jun; Lee, Won Joon; Moon, Jee Youn; Kim, Yong Chul; Kang, Do-Hyung			Impaired insula functional connectivity associated with persistent pain perception in patients with complex regional pain syndrome	PLOS ONE			English	Article							OLD-WORLD MONKEY; CORTEX FUNCTION; BRAIN; DYSFUNCTION; ABNORMALITIES; ACTIVATION; ALLODYNIA; INVENTORY; GRAY	Given that the insula plays a contributory role in the perception of chronic pain, we examined the resting-state functional connectivity between the insular cortex and other brain regions to investigate neural underpinnings of persisting perception of background pain in patients with complex regional pain syndrome (CRPS). A total of 25 patients with CRPS and 25 matched healthy controls underwent functional magnetic resonance imaging at rest. With the anterior and posterior insular cortices as seed regions, we compared the strength of the= resting-state functional connectivity between the two groups. Functional connectivity between the anterior and posterior insular cortices and the postcentral and inferior frontal gyri, cingulate cortices was reduced in patients with CRPS compared with controls. Additionally, greater reductions in functional connectivity between the anterior insula and right postcentral gyrus were associated with more severe sensory pain in patients with CRPS (short-form McGill Pain Questionnaire sensory subscores, r = -. 517, P =.023). The present results imply a possible role of the insula in aberrant processing of pain information in patients with CRPS. The findings suggest that a functional derangement of the connection between one of the somatosensory cortical functions of perception and one of the insular functions of awareness can play a significant role in the persistent experience of regional pain that is not confined to a specific nerve territory.	[Kim, Jae-Hun] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Choi, Soo-Hee; Lee, Do-Hyeong; Lee, Kyung-Jun; Lee, Won Joon; Kang, Do-Hyung] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Choi, Soo-Hee; Kang, Do-Hyung] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Soo-Hee; Kang, Do-Hyung] Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea; [Jang, Joon Hwan] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Moon, Jee Youn; Kim, Yong Chul] Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, DH (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Kang, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Kang, DH (corresponding author), Seoul Natl Univ, Coll Med, Inst Human Behav Sci, Seoul, South Korea.	basuare@hanmail.net		Kim, Jae-Hun/0000-0003-3064-6948	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT FuturePlanning [2014R1A1A1004553]; Aspiring Researcher Program through Seoul National University (SNU)	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT FuturePlanning; Aspiring Researcher Program through Seoul National University (SNU)	This study was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & FuturePlanning (2014R1A1A1004553) and Aspiring Researcher Program through Seoul National University (SNU) in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Bar KJ, 2013, ACTA PSYCHIAT SCAND, V127, P269, DOI 10.1111/j.1600-0447.2012.01896.x; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Barad MJ, 2014, J PAIN, V15, P197, DOI 10.1016/j.jpain.2013.10.011; Becerra L, 2014, NEUROIMAGE-CLIN, V6, P347, DOI 10.1016/j.nicl.2014.07.012; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bentley WJ, 2016, CEREB CORTEX, V26, P346, DOI 10.1093/cercor/bhu260; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Birklein F, 2015, NEUROLOGY, V84, P89, DOI 10.1212/WNL.0000000000001095; Birklein F, 2014, J PAIN, V15, P485, DOI 10.1016/j.jpain.2014.01.490; Bolwerk A, 2013, J PAIN, V14, P1107, DOI 10.1016/j.jpain.2013.04.007; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; BRUEHL S, 1992, CLIN J PAIN, V8, P287, DOI 10.1097/00002508-199212000-00003; Bruehl S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h2730; Bussa M, 2015, ACTA ANAESTH SCAND, V59, P685, DOI 10.1111/aas.12489; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Cohen H, 2013, EUR J PAIN, V17, P527, DOI 10.1002/j.1532-2149.2012.00213.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig AD, 2009, NATURE REVIEWS NEURO, P10; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Di Pietro F, 2015, HUM BRAIN MAPP, V36, P508, DOI 10.1002/hbm.22643; Di Pietro F, 2013, J PAIN, V14, P1270, DOI 10.1016/j.jpain.2013.07.004; Di Pietro F, 2013, J PAIN, V14, P1001, DOI 10.1016/j.jpain.2013.04.001; Erpelding N, 2016, BRAIN STRUCT FUNCT, V221, P1095, DOI 10.1007/s00429-014-0957-8; Erpelding N, 2014, J NEUROPHYSIOL, V111, P239, DOI 10.1152/jn.00405.2013; First M. B, 1996, STRUCTURED CLINICAL; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Galer BS, 1998, CLIN J PAIN, V14, P48, DOI 10.1097/00002508-199803000-00007; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Hahn HM, 1986, J KOREAN NEUROPSYCHI, V25, P487; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Kim ZS., 1997, KOREAN J CLIN PSYCHO, V16, P185; Landro NI, 2013, PAIN, V154, P972, DOI 10.1016/j.pain.2013.01.013; Lee DH, 2015, J PAIN, V16, P580, DOI 10.1016/j.jpain.2015.03.006; Lee DH, 2014, PSYCHIAT INVEST, V11, P32, DOI 10.4306/pi.2014.11.1.32; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Monti DA, 1998, CLIN J PAIN, V14, P295, DOI 10.1097/00002508-199812000-00005; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Pleger B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085372; Ploner M, 2000, J NEUROPHYSIOL, V83, P1770, DOI 10.1152/jn.2000.83.3.1770; Simons LE, 2014, PAIN, V155, P1727, DOI 10.1016/j.pain.2014.05.023; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857	57	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180479	10.1371/journal.pone.0180479	http://dx.doi.org/10.1371/journal.pone.0180479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692702	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800046
J	Moriuchi, T; Otsuka, N; Hiramatsu, Y; Shibayama, K; Kamachi, K				Moriuchi, Takumi; Otsuka, Nao; Hiramatsu, Yukihiro; Shibayama, Keigo; Kamachi, Kazunari			A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; FILAMENTOUS HEMAGGLUTININ; IMMUNOGLOBULIN-G; IGG ANTIBODIES; WHOLE-CELL; ASSAY; ADOLESCENTS; INFECTION; AVIDITY; SEROEPIDEMIOLOGY	In 2013, national serosurveillance detected a high seroprevalence of antibodies to pertussis toxin ( PT) from Bordetella pertussis among Japanese adults. Thus, we aimed to determine the cause(s) of this high seroprevalence, and analyzed the titers of antibodies to PT and filamentous hemagglutinin (FHA) among adults (35-44 years old), young children (4-7 years old), and older children (10-14 years old). Our quantitative analyses revealed that adults had higher seroprevalences of anti-PT IgG and PT-neutralizing antibodies, and similar titers of anti-FHA IgG, compared to the young and older children. Positive correlations were observed between the titers of PT-neutralizing antibodies and anti-PT IgG in all age groups (rs values of 0.326-0.522), although the correlation tended to decrease with age. The ratio of PT-neutralizing antibodies to anti-PT IgG was significantly different when we compared the serum and purified IgG fractions among adults (p = 0.016), although this result was not observed among young and older children. Thus, it appears that some adults had non-IgG immunoglobulins to PT. Our analyses also revealed that adults had high-avidity anti-PT IgG ( avidity index: 63.5%, similar results were observed among the children); however, the adults had lower-avidity anti-FHA IgG (37.9%, p < 0.05). It is possible that low-avidity antiFHA IgG is related to infection with other respiratory pathogens (e.g., Bordetella parapertussis, Haemophilus influenzae, or Mycoplasma pneumoniae), which produces antibodies to FHA-like proteins. Our observations suggest that these adults had been infected with B. pertussis and other pathogen(s) during their adulthood.	[Moriuchi, Takumi; Otsuka, Nao; Hiramatsu, Yukihiro; Shibayama, Keigo; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Moriuchi, Takumi] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Hiramatsu, Yukihiro] Osaka Univ, Res Inst Microbial Dis, Dept Mol Bacteriol, Osaka, Japan	National Institute of Infectious Diseases (NIID); Saint Marianna University; Osaka University	Kamachi, K (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kamachi@nih.go.jp		Hiramatsu, Yukihiro/0000-0002-6340-864X; Kamachi, Kazunari/0000-0001-5259-1744	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED [14525508, 15545359]	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED (No. 14525508 and 15545359, KK, http://www.amed.go.jp/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2013, J IMMUNOL METHODS, V387, P36, DOI 10.1016/j.jim.2012.09.008; Amirthalingam G, 2013, ARCH DIS CHILD, V98, P552, DOI 10.1136/archdischild-2012-302968; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Barkoff AM, 2012, VACCINE, V30, P6897, DOI 10.1016/j.vaccine.2012.09.003; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dalby T, 2010, APMIS, V118, P968, DOI 10.1111/j.1600-0463.2010.02664.x; Dalby T, 2009, DIAGN MICR INFEC DIS, V63, P354, DOI 10.1016/j.diagmicrobio.2008.12.004; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Dominguez A, 2001, EPIDEMIOL INFECT, V126, P205, DOI 10.1017/S0950268801005325; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; HALLANDER HO, 1991, J INFECT DIS, V163, P1046, DOI 10.1093/infdis/163.5.1046; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Jogi P, 2014, VACCINE, V32, P5311, DOI 10.1016/j.vaccine.2014.07.066; Kamachi K., 2015, New Microbes and New Infections, V8, P70, DOI 10.1016/j.nmni.2015.10.001; Konda T, 2002, VACCINE, V20, P1711, DOI 10.1016/S0264-410X(02)00045-2; Lee SY, 2014, J KOREAN MED SCI, V29, P652, DOI 10.3346/jkms.2014.29.5.652; Li XM, 2015, HUM VACC IMMUNOTHER, V11, P2434, DOI 10.1080/21645515.2015.1062954; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Otsuka N, 2016, MICROBIOL IMMUNOL, V60, P326, DOI 10.1111/1348-0421.12378; Palazzo R, 2016, J MED MICROBIOL, V65, P649, DOI 10.1099/jmm.0.000264; Prelog M, 2013, VACCINE, V31, P387, DOI 10.1016/j.vaccine.2012.10.105; Sakakibara Y, 2016, INTERNAL MED, V55, P3257, DOI 10.2169/internalmedicine.55.6973; SATO H, 1987, INFECT IMMUN, V55, P909, DOI 10.1128/IAI.55.4.909-915.1987; SATO Y, 1991, DEV BIOLOGICALS, V73, P167; Scott S, 2015, PEDIATR INFECT DIS J, V34, P333, DOI 10.1097/INF.0000000000000576; Sheridan SL, 2014, EXPERT REV VACCINES, V13, P1081, DOI 10.1586/14760584.2014.944167; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; TROLLFORS B, 1988, J INFECT DIS, V158, P991, DOI 10.1093/infdis/158.5.991; Van der Wielen M, 2003, VACCINE, V21, P2412, DOI 10.1016/S0264-410X(03)00062-8; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181181	10.1371/journal.pone.0181181	http://dx.doi.org/10.1371/journal.pone.0181181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700751	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800129
J	Rong, YH; Van Slyke, G; Vance, DJ; Westfall, J; Ehrbar, D; Mantis, NJ				Rong, Yinghui; Van Slyke, Greta; Vance, David J.; Westfall, Jennifer; Ehrbar, Dylan; Mantis, Nicholas J.			Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin's binding subunit	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PROTECTIVE IMMUNITY; GALACTOSE; IDENTIFICATION; SURFACE; MICE	Ricin toxin's binding subunit (RTB) is a galactose-/N-acetylgalactosamine (Gal/GalNac)specific lectin that mediates uptake and intracellular trafficking of ricin within mammalian cells. Structurally, RTB consists of two globular domains, each divided into three homologous sub-domains (alpha, beta, gamma). In this report, we describe five new murine IgG monoclonal antibodies (mAbs) against RTB: MH3, 8A1, 8B3, LF1, and LC5. The mAbs have similar binding affinities (K-D) for ricin holotoxin, but displayed a wide range of in vitro toxin-neutralizing activities. Competition ELISAs indicate that the two most potent toxin-neutralizing mAbs (MH3, 8A1), as well as one of the moderate toxin-neutralizing mAbs (LF1), recognize distinct epitopes near the low affinity Gal recognition domain in RTB subdomain 1 alpha. Evaluated in a mouse model of systemic ricin challenge, all five mAbs afforded some benefit against intoxication, but only MH3 was protective. However, neither MH3 nor 24B11, another well-characterized mAb against RTB subdomain 1a, could passively protect mice against a mucosal (intranasal) ricin challenge. This is in contrast to SylH3, a previously characterized mAb directed against an epitope near RTB's high affinity Gal/GalNac recognition element in subdomain 2 gamma, which protected animals against systemic and mucosal ricin exposure. SylH3 was significantly more effective than MH3 and 24B11 at blocking ricin attachment to host cell receptors, suggesting that mucosal immunity to ricin is best imparted by antibodies that target RTB's high affinity Gal/GalNac recognition element in subdomain 2 gamma, not the low affinity Gal recognition domain in subdomain 1 alpha.	[Rong, Yinghui; Van Slyke, Greta; Vance, David J.; Westfall, Jennifer; Ehrbar, Dylan; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12237 USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12237 USA.; Mantis, NJ (corresponding author), SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12222 USA.	nicholas.mantis@health.ny.gov	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Van Slyke, Greta/0000-0003-2646-3030; Ehrbar, Dylan/0000-0001-7872-3338; Mantis, Nicholas/0000-0002-5083-8640; Doering, Jennifer/0000-0001-8749-774X	National Institutes of Allergy and Infectious Diseases [HHSN272201400021C]; National Institutes of Health	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this work was supported by Contract No. HHSN272201400021C from the National Institutes of Allergy and Infectious Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2016, VIRULENCE, P1; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Brey RN, 2016, HUM VACC IMMUNOTHER, V12, P1196, DOI 10.1080/21645515.2015.1124202; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Hayden EC., 2013, NATURE NEWS; Mantis N.J., 2013, CURR PROTOC TOXICOL; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Hara JM, 2014, IMMUNOL LETT, V158, P7, DOI 10.1016/j.imlet.2013.11.009; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Pincus SH, 2015, TOXINS, V7, P2121, DOI 10.3390/toxins7062121; Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; R Core Team, 2014, A LANGUAGE AND ENVIR; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Therneau T. M., 2015, A PACKAGE FOR SURVIV; Therneau T.M., 2000, MODELING SURVIVAL DA; Van Slyke G, 2016, CLIN VACCINE IMMUNOL, V23, P795, DOI 10.1128/CVI.00088-16; WALES R, 1991, J BIOL CHEM, V266, P19172; Yermakova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22721; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180999	10.1371/journal.pone.0180999	http://dx.doi.org/10.1371/journal.pone.0180999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700745	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800112
J	Barinov, A; Galgano, A; Krenn, G; Tanchot, C; Vasseur, F; Rocha, B				Barinov, Aleksandr; Galgano, Alessia; Krenn, Gerald; Tanchot, Corinne; Vasseur, Florence; Rocha, Benedita			CD4/CD8/Dendritic cell complexes in the spleen: CD8 T+ cells can directly bind CD4(+) T cells and modulate their response	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; IN-VIVO; ANTIGEN; MEMORY; NAIVE; EXPRESSION; LYMPHOCYTES; HELP; REPERTOIRE	CD4(+) T cell help to CD8(+) T cell responses requires that CD4(+) and CD8(+) T cells interact with the same antigen presenting dendritic cell (Ag + DC), but it remains controversial whether helper signals are delivered indirectly through a licensed DC and/or involve direct CD4(+) CD8(+) T cell contacts and/or the formation of ternary complexes. We here describe the first in vivo imaging of the intact spleen, aiming to evaluate the first interactions between antigen-specific CD4(+), CD8(+) T cells and Ag+ DCs. We show that in contrast to CD4(+) T cells which form transient contacts with Ag+ DC, CD8(+) T cells form immediate stable contacts and activate the Ag + DC, acquire fragments of the DC membranes by trogocytosis, leading to their acquisition of some of the DC properties. They express MHC class II, and become able to present the specific Marilyn peptide to naive Marilyn CD4 (+) T cells, inducing their extensive division. In vivo, these CD8 (+) T cells form direct stable contacts with motile naive CD4 + T cells, recruiting them to Ag + DC binding and to the formation of ternary complexes, where CD4 (+) and CD8 (+) T cells interact with the DC and with one another. The presence of CD8 (+) T cells during in vivo immune responses leads to the early activation and up-regulation of multiple functions by CD4 (+) T lymphocytes. Thus, while CD4(+) T cell help is important to CD8 (+) T cell responses, CD8 (+) T cells can interact directly with naive CD4 (+) T cells impacting their recruitment and differentiation.	[Barinov, Aleksandr; Galgano, Alessia; Krenn, Gerald; Vasseur, Florence; Rocha, Benedita] Fac Med Rene Descartes, INSERM, U1020, Paris, France; [Tanchot, Corinne] Univ Paris 05, INSERM, U970, Ctr Rech Cardiovasc HEGP, Paris, France; [Barinov, Aleksandr; Vasseur, Florence; Rocha, Benedita] Inst Pasteur, Immunol Dept, Paris, France; [Galgano, Alessia] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rocha, B (corresponding author), Fac Med Rene Descartes, INSERM, U1020, Paris, France.; Rocha, B (corresponding author), Inst Pasteur, Immunol Dept, Paris, France.	benedita.rocha@pasteur.fr		BARINOV, Aleksandr/0000-0003-2530-5081; Tanchot, Corinne/0000-0002-2913-1755	European Research Council [ERC-2008-AdG]	European Research Council(European Research Council (ERC)European Commission)	The European Research Council supported this work (Grant Nr. ERC-2008-AdG).	Ahmed KA, 2012, J LEUKOCYTE BIOL, V92, P289, DOI 10.1189/jlb.1211631; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Crowley MT, 1999, J IMMUNOL, V163, P4894; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de Sousa M, 1979, Adv Exp Med Biol, V114, P51; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Faure M, 2004, CELL IMMUNOL, V228, P8, DOI 10.1016/j.cellimm.2004.04.002; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Goncalves P, 2017, MOL IMMUNOL, V85, P66, DOI 10.1016/j.molimm.2017.01.026; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Legrand N, 2001, J IMMUNOL, V167, P6150, DOI 10.4049/jimmunol.167.11.6150; MacInnes H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024448; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rapetti L, 2008, J IMMUNOL, V181, P299, DOI 10.4049/jimmunol.181.1.299; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Romagnoli PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056999; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sung HC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00452; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Zehn D, 2004, EUR J IMMUNOL, V34, P1551, DOI 10.1002/eji.200324355; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	44	18	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180644	10.1371/journal.pone.0180644	http://dx.doi.org/10.1371/journal.pone.0180644			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686740	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100084
J	Brown, KR; Krouse, RZ; Calatroni, A; Visness, CM; Sivaprasad, U; Kercsmar, CM; Matsui, EC; West, JB; Makhija, MM; Gill, MA; Kim, H; Kattan, M; Pillai, D; Gern, JE; Busse, WW; Togias, A; Liu, AH; Hershey, GKK				Brown, K. R.; Krouse, R. Z.; Calatroni, A.; Visness, C. M.; Sivaprasad, U.; Kercsmar, C. M.; Matsui, E. C.; West, J. B.; Makhija, M. M.; Gill, M. A.; Kim, H.; Kattan, M.; Pillai, D.; Gern, J. E.; Busse, W. W.; Togias, A.; Liu, A. H.; Hershey, G. K. Khurana			Endotypes of difficult-to-control asthma in inner-city African American children	PLOS ONE			English	Article							CLUSTER-ANALYSIS; NEUTROPHILIC INFLAMMATION; NATIONAL INSTITUTES; UNITED-STATES; IL-17A; PHENOTYPE; CELLS; HYPERRESPONSIVENESS; IDENTIFICATION; POPULATION	African Americans have higher rates of asthma prevalence, morbidity, and mortality in comparison with other racial groups. We sought to characterize endotypes of childhood asthma severity in African American patients in an inner-city pediatric asthma population. Baseline blood neutrophils, blood eosinophils, and 38 serum cytokine levels were measured in a sample of 235 asthmatic children (6-17 years) enrolled in the NIAID (National Institute of Allergy and Infectious Diseases)-sponsored Asthma Phenotypes in the Inner City (APIC) study (ICAC (Inner City Asthma Consortium)-19). Cytokines were quantified using a MILLIPLEX panel and analyzed on a Luminex analyzer. Patients were classified as Easy-to-Control or Difficult-to-Control based on the required dose of controller medications over one year of prospective management. A multivariate variable selection procedure was used to select cytokines associated with Difficult-to-Control versus Easy-to-Control asthma, adjusting for age, sex, blood eosinophils, and blood neutrophils. In inner-city African American children, 12 cytokines were significant predictors of Difficult-to-Control asthma (n = 235). CXCL-1, IL-5, IL-8, and IL-17A were positively associated with Difficult-to-Control asthma, while IL-4 and IL-13 were positively associated with Easy-to-Control asthma. Using likelihood ratio testing, it was observed that in addition to blood eosinophils and neutrophils, serum cytokines improved the fit of the model. In an inner-city pediatric population, serum cytokines significantly contributed to the definition of Difficult-to-Control asthma endotypes in African American children. Mixed responses characterized by T(H)2 (IL-5) and T(H)17-associated cytokines were associated with Difficult-to-Control asthma. Collectively, these data may contribute to risk stratification of Difficult-to-Control asthma in the African American population.	[Brown, K. R.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH USA; [Krouse, R. Z.; Calatroni, A.; Visness, C. M.] Rho Fed Syst Div Inc, Chapel Hill, NC USA; [Sivaprasad, U.; Hershey, G. K. Khurana] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Dept Pediat, Cincinnati, OH 45220 USA; [Kercsmar, C. M.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, Cincinnati, OH USA; [Matsui, E. C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [West, J. B.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Makhija, M. M.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Gill, M. A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kim, H.] Henry Ford Hlth Syst, Detroit, MI USA; [Kattan, M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Pillai, D.] Childrens Natl Hlth Syst, Washington, DC USA; [Gern, J. E.; Busse, W. W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Togias, A.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Liu, A. H.] Natl Jewish Hlth, Denver, CO USA; [Liu, A. H.] Childrens Hosp Colorado, Aurora, CO USA; [Liu, A. H.] Univ Colorado, Sch Med, Aurora, CO USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Boston University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas; Henry Ford Health System; Henry Ford Hospital; Columbia University; Children's National Health System; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hershey, GKK (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Dept Pediat, Cincinnati, OH 45220 USA.	gurjit.hershey@cchmc.org		Matsui, Elizabeth/0000-0001-8134-5593	Russian Foundation for Basic Research [15-51-15008, 17-04-01309]; Russian Academy of Sciences; Grant of President of Russian Federation [MK-9245.2016.4, MD-229.2017.4]; Russian Science Foundation [16-14-00-224]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000451, UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM2AI117870] Funding Source: NIH RePORTER	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Grant of President of Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by Russian Foundation for Basic Research grants 15-51-15008 and 17-04-01309 to MAP; by Russian Academy of Sciences grants to FIA (Molecular and Cellular Biology, Basic Research for Development of Biomedical Technologies, Molecular Mechanisms of Physiologic Functions) and to MAP (Basic Science for Medicine); by Grant of President of Russian Federation MK-9245.2016.4 to AMS and MD-229.2017.4 to MAP. Theoretical modelling was supported by grant from Russian Science Foundation 16-14-00-224 to FIA (sections Computational model of fibrin clot growth and lysis and Computer simulation of spatial clot growth and lysis; Figures 6 and 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2016, ALLERGY, V71, P1192, DOI 10.1111/all.12906; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Bourdin A, 2014, J ALLERGY CLIN IMMUN, V134, P1043, DOI 10.1016/j.jaci.2014.04.038; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brandt EB, 2015, J ALLERGY CLIN IMMUN, V136, P295, DOI 10.1016/j.jaci.2014.11.043; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P529, DOI 10.1016/j.jaci.2010.01.036; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Gelfand EW, 2015, J ALLERGY CLIN IMMUN, V135, P1196, DOI 10.1016/j.jaci.2015.01.032; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill TD, 2011, CURR ALLERGY ASTHM R, V11, P85, DOI 10.1007/s11882-010-0159-2; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Just J, 2012, EUR RESPIR J, V40, P55, DOI 10.1183/09031936.00123411; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Lenoir Michael, 2008, J Natl Med Assoc, V100, P1; Levy BD, 2015, AM J RESP CRITICAL C; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Moorman JE., 2011, MMWR SURVEILL SUMM S, V60, P84; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newcomb DC, 2012, J IMMUNOL, V188, P1027, DOI 10.4049/jimmunol.1102216; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Ownby DR, 2015, J ALLERGY CLIN IMMUN, V136, P595, DOI 10.1016/j.jaci.2015.02.007; Parkitny L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/890706; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Pongracic JA, 2016, J ALLERGY C IN PRESS; Ray NF, 1998, CHEST, V113, P1277, DOI 10.1378/chest.113.5.1277; Redd SC, 2002, ENVIRON HEALTH PERSP, V110, P557, DOI 10.1289/ehp.02110s4557; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Schramm A, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0157-6; Sheehan WJ, 2015, CURR OPIN ALLERGY CL, V15, P397, DOI 10.1097/ACI.0000000000000195; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180778	10.1371/journal.pone.0180778	http://dx.doi.org/10.1371/journal.pone.0180778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686637	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100101
J	Buschiazzo, J; Rios, GL; Canizo, JR; Antollini, SS; Alberio, RH				Buschiazzo, Jorgelina; Rios, Glenda L.; Canizo, Jesica R.; Antollini, Silvia S.; Alberio, Ricardo H.			Free cholesterol and cholesterol esters in bovine oocytes: Implications in survival and membrane raft organization after cryopreservation	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EPIDERMAL-GROWTH-FACTOR; LIPID RAFTS; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION EMBRYOS; ADDING CHOLESTEROL; MASS-SPECTROMETRY; CYCLODEXTRINS; VITRIFICATION; MATURATION	Part of the damage caused by cryopreservation of mammalian oocytes occurs at the plasma membrane. The addition of cholesterol to cell membranes as a strategy to make it more tolerant to cryopreservation has been little addressed in oocytes. In order to increase the survival of bovine oocytes after cryopreservation, we proposed not only to increase cholesterol level of oocyte membranes before vitrification but also to remove the added cholesterol after warming, thus recovering its original level. Results from our study showed that modulation of membrane cholesterol by methyl-beta-cyclodextrin (M beta CD) did not affect the apoptotic status of oocytes and improved viability after vitrification yielding levels of apoptosis closer to those of fresh oocytes. Fluorometric measurements based on an enzyme-coupled reaction that detects both free cholesterol (membrane) and cholesteryl esters (stored in lipid droplets), revealed that oocytes and cumulus cells present different levels of cholesterol depending on the seasonal period. Variations at membrane cholesterol level of oocytes were enough to account for the differences found in total cholesterol. Differences found in total cholesterol of cumulus cells were explained by the differences found in both the content of membrane cholesterol and of cholesterol esters. Cholesterol was incorporated into the oocyte plasma membrane as evidenced by comparative labeling of a fluorescent cholesterol. Oocytes and cumulus cells increased membrane cholesterol after incubation with M beta CD/cholesterol and recovered their original level after cholesterol removal, regardless of the season. Finally, we evaluated the effect of vitrification on the putative raft molecule GM1. Cholesterol modulation also preserved membrane organization by maintaining ganglioside level at the plasma membrane. Results suggest a distinctive cholesterol metabolic status of cumulus-oocyte complexes (COCs) among seasons and a dynamic organizational structure of cholesterol homeostasis within the COC. Modulation of membrane cholesterol by M beta CD improved survival of bovine oocytes and preserved integrity of GM1-related rafts after vitrification.	[Buschiazzo, Jorgelina; Rios, Glenda L.; Canizo, Jesica R.; Alberio, Ricardo H.] EEA Balcarce, INTA, Dept Prod Anim, Biotecnol Reprod, Balcarce, Argentina; [Antollini, Silvia S.] CONICET UNS, Inst Invest Bioquim Bahia Blanca, Camino Carringanda, Bahia Blanca, Buenos Aires, Argentina; [Antollini, Silvia S.] UNS, Dept Biol Bioquim & Farm, Bahia Blanca, Buenos Aires, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Buschiazzo, J (corresponding author), EEA Balcarce, INTA, Dept Prod Anim, Biotecnol Reprod, Balcarce, Argentina.	buschiazzo.jorgelina@inta.gob.ar		Alberio, Ricardo Horacio/0000-0003-2760-8932; Canizo, Jesica Romina/0000-0003-2559-5867	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-0534, PICT-2746]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-0273, PIP-00239]; Universidad Nacional del Sur [PGI 24/B217]; Comision de Investigaciones Cientificas [CIC-832]; Instituto Nacional de Tecnologia Agropecuaria [PNSA-1115033]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur; Comision de Investigaciones Cientificas; Instituto Nacional de Tecnologia Agropecuaria	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-0534) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-0273) to JB; Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2746), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-00239), and Universidad Nacional del Sur (PGI 24/B217) to SSA; and Comision de Investigaciones Cientificas (CIC-832) and Instituto Nacional de Tecnologia Agropecuaria (PNSA-1115033) to RHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim EAM, 2009, CRYOBIOLOGY, V58, P210, DOI 10.1016/j.cryobiol.2008.12.007; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; Barcelo-Fimbres M, 2011, THERIOGENOLOGY, V75, P434, DOI 10.1016/j.theriogenology.2010.09.007; Behrman EJ, 2005, J CHEM EDUC, V82, P1791, DOI 10.1021/ed082p1791; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Bromfield EG, 2013, REPRODUCTION, V145, pR31, DOI 10.1530/REP-12-0316; Buschiazzo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062919; Cerri RLA, 2009, J DAIRY SCI, V92, P1520, DOI 10.3168/jds.2008-1614; Checura CM, 2007, THERIOGENOLOGY, V67, P919, DOI 10.1016/j.theriogenology.2006.09.044; Christian AE, 1997, J LIPID RES, V38, P2264; Comiskey M, 2007, DEV BIOL, V303, P727, DOI 10.1016/j.ydbio.2006.12.009; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; Di Rienzo J. A., 2016, INFOSTAT VERSION 201; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Dupont J, 2014, ANIMAL, V8, P1031, DOI 10.1017/S1751731114000937; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; Ferreira CR, 2015, REPROD FERT DEVELOP, V27, P621, DOI 10.1071/RD14310; Fouladi-Nashta AA, 2007, BIOL REPROD, V77, P9, DOI 10.1095/biolreprod.106.058578; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Gonzalez-Serrano AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074981; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Hwang IS, 2014, BIOMED RES INT; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Lapa M, 2011, REPROD DOMEST ANIM, V46, P904, DOI 10.1111/j.1439-0531.2011.01762.x; Leao BC, 2016, REPROD FERTIL DEV; Leao BCS, 2015, ZYGOTE, V23, P732, DOI 10.1017/S0967199414000380; Leroy JL, REPROD DOMEST ANIM, V43, P623; Leroy JLMR, 2015, REPROD FERT DEVELOP, V27, P693, DOI 10.1071/RD14363; Lonergan P, 1996, BIOL REPROD, V54, P1420, DOI 10.1095/biolreprod54.6.1420; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P320; Marquardt D, 2016, CHEM PHYS LIPIDS, V199, P17, DOI 10.1016/j.chemphyslip.2016.04.001; Marquez YC, 2005, REPROD DOMEST ANIM, V40, P553, DOI 10.1111/j.1439-0531.2005.00632.x; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Moce E, 2010, REPROD DOMEST ANIM, V45, P57, DOI 10.1111/j.1439-0531.2010.01635.x; Moore AI, 2005, CRYOBIOLOGY, V51, P241, DOI 10.1016/j.cryobiol.2005.07.004; Moraes EA, 2010, ANIM REPROD SCI, V118, P148, DOI 10.1016/j.anireprosci.2009.08.002; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Ortiz-Escribano N, 2016, THERIOGENOLOGY, V86, P635, DOI 10.1016/j.theriogenology.2016.02.015; PARASASSI T, 1995, FREE RADICAL BIO MED, V19, P511, DOI 10.1016/0891-5849(95)00038-Y; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rios GL, 2015, THERIOGENOLOGY, V83, P874, DOI 10.1016/j.theriogenology.2014.11.022; Santos JEP, 2008, REPROD DOMEST ANIM, V43, P23, DOI 10.1111/j.1439-0531.2008.01139.x; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Sato B, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-22; Sekhavati MH, 2012, CELL REPROGRAM, V14, P295, DOI 10.1089/cell.2012.0014; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Spizziri BE, 2010, ANIM REPROD SCI, V118, P255, DOI 10.1016/j.anireprosci.2009.08.001; Spricigo JFW, 2012, CRYOBIOLOGY, V65, P319, DOI 10.1016/j.cryobiol.2012.09.001; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Van Blerkom J, 2016, REPROD BIOMED ONLINE, V33, P458, DOI 10.1016/j.rbmo.2016.06.029; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Soom A, 2002, REPROD DOMEST ANIM, V37, P144, DOI 10.1046/j.1439-0531.2002.00345.x; Yesilaltay A, 2014, P NATL ACAD SCI USA, V111, pE4972, DOI 10.1073/pnas.1418954111; Zachut M, 2010, J DAIRY SCI, V93, P529, DOI 10.3168/jds.2009-2167; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2001, REPRODUCTION, V121, P447, DOI 10.1530/rep.0.1210447; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	66	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180451	10.1371/journal.pone.0180451	http://dx.doi.org/10.1371/journal.pone.0180451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686720	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100065
J	Kaleita, AL; Schott, LR; Hargreaves, SK; Hofmockel, KS				Kaleita, Amy L.; Schott, Linda R.; Hargreaves, Sarah K.; Hofmockel, Kirsten S.			Differences in soil biological activity by terrain types at the sub-field scale in central Iowa US	PLOS ONE			English	Article							MICROBIAL BIOMASS CALIBRATION; FUMIGATION-EXTRACTION METHOD; SPATIAL VARIABILITY; NITROGEN; CARBON; RESOURCES; COMMUNITIES	Soil microbial communities are structured by biogeochemical processes that occur at many different spatial scales, which makes soil sampling difficult. Because soil microbial communities are important in nutrient cycling and soil fertility, it is important to understand how microbial communities function within the heterogeneous soil landscape. In this study, a self-organizing map was used to determine whether landscape data can be used to characterize the distribution of microbial biomass and activity in order to provide an improved understanding of soil microbial community function. Points within a row crop field in southcentral Iowa were clustered via a self-organizing map using six landscape properties into three separate landscape clusters. Twelve sampling locations per cluster were chosen for a total of 36 locations. After the soil samples were collected, the samples were then analysed for various metabolic indicators, such as nitrogen and carbon mineralization, extractable organic carbon, microbial biomass, etc. It was found that sampling locations located in the potholes and toe slope positions had significantly greater microbial biomass nitrogen and carbon, total carbon, total nitrogen and extractable organic carbon than the other two landscape position clusters, while locations located on the upslope did not differ significantly from the other landscape clusters. However, factors such as nitrate, ammonia, and nitrogen and carbon mineralization did not differ significantly across the landscape. Overall, this research demonstrates the effectiveness of a terrain-based clustering method for guiding soil sampling of microbial communities.	[Kaleita, Amy L.] Iowa State Univ, Agr & Biosyst Engn, Ames, IA 50011 USA; [Schott, Linda R.] Univ Nebraska, Biol Syst Engn, Lincoln, NE USA; [Hargreaves, Sarah K.] Ecol Farmers Assoc Ontario, Guelph, ON, Canada; [Hargreaves, Sarah K.; Hofmockel, Kirsten S.] Iowa State Univ, Ecol Evolutionary & Organismal Biol, Ames, IA USA; [Hofmockel, Kirsten S.] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA	Iowa State University; University of Nebraska System; University of Nebraska Lincoln; Iowa State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kaleita, AL (corresponding author), Iowa State Univ, Agr & Biosyst Engn, Ames, IA 50011 USA.	kaleita@iastate.edu	Kaleita, Amy/O-5105-2019	Kaleita, Amy/0000-0002-8906-3408; Hofmockel, Kirsten/0000-0003-1586-2167; Schott, Linda/0000-0001-8600-0535				Adamchuk VI, 2004, COMPUT ELECTRON AGR, V44, P71, DOI 10.1016/j.compag.2004.03.002; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Brevik E, 2003, PRECIS AGRIC, V4, P71; Cavigelli MA, 2005, APPL SOIL ECOL, V29, P99, DOI 10.1016/j.apsoil.2004.12.007; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Dupuis EM, 2007, CAN J SOIL SCI, V87, P479, DOI 10.4141/CJSS07001; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Florinsky IV, 2004, GEODERMA, V119, P33, DOI 10.1016/S0016-7061(03)00224-6; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Fromin N, 2013, GEODERMA, V197, P98, DOI 10.1016/j.geoderma.2012.12.009; Giraudel JL, 2001, ECOL MODEL, V146, P329, DOI 10.1016/S0304-3800(01)00324-6; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; Hargreaves SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134345; Hedley CB, 2013, GEODERMA, V199, P22, DOI 10.1016/j.geoderma.2012.07.018; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kalteh AM, 2008, ENVIRON MODELL SOFTW, V23, P835, DOI 10.1016/j.envsoft.2007.10.001; Katsalirou E, 2010, EUR J SOIL BIOL, V46, P181, DOI 10.1016/j.ejsobi.2010.04.005; Kiang MY, 2001, COMPUT STAT DATA AN, V38, P161, DOI 10.1016/S0167-9473(01)00040-8; Kohonen T., 2001, SELF ORG MAPS; Landesman WJ, 2011, MICROB ECOL, V62, P228, DOI 10.1007/s00248-011-9811-1; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mele PM, 2008, AGR ECOSYST ENVIRON, V126, P139, DOI 10.1016/j.agee.2007.12.008; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Peigne J, 2009, EUR J SOIL BIOL, V45, P488, DOI 10.1016/j.ejsobi.2009.09.002; Pennock DJ, 2005, J SOIL WATER CONSERV, V60, P396; Robertson G, 2011, P AM MATH SOC, V139, P2705, DOI 10.1090/S0002-9939-2011-10808-6; Shennan C, 2008, PHILOS T R SOC B, V363, P717, DOI 10.1098/rstb.2007.2180; Simfukwe P, 2011, SOIL BIOL BIOCHEM, V43, P1688, DOI 10.1016/j.soilbio.2011.04.014; Stenrod M, 2006, SOIL BIOL BIOCHEM, V38, P962, DOI 10.1016/j.soilbio.2005.08.014; Tajik S, 2012, ENVIRON ENG SCI, V29, P798, DOI 10.1089/ees.2011.0313; Van Arkel Z, 2014, WATER RESOUR RES, V50, P7050, DOI 10.1002/2013WR015015; Vesanto J., 2000, A57 HELS U TECHN, P60; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Yang L.Y., 2010, THESIS	38	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180596	10.1371/journal.pone.0180596	http://dx.doi.org/10.1371/journal.pone.0180596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686652	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100081
J	Mao, B; Mao, R; Zeng, DH				Mao, Bing; Mao, Rong; Zeng, De-Hui			Species diversity and chemical properties of litter influence non-additive effects of litter mixtures on soil carbon and nitrogen cycling	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION DYNAMICS; FUNCTIONAL DIVERSITY; MICROBIAL COMMUNITIES; ORGANIC-CARBON; MASS-LOSS; FOREST; MINERALIZATION; MANIPULATION; CHEMISTRY	Decomposition of litter mixtures generally cannot be predicted from the component species incubated in isolation. Therefore, such non-additive effects of litter mixing on soil C and N dynamics remain poorly understood in terrestrial ecosystems. In this study, litters of Mongolian pine and three dominant understory species and soil were collected from a Mongolian pine plantation in Northeast China. In order to examine the effects of mixed-species litter on soil microbial biomass N, soil net N mineralization and soil respiration, four single litter species and their mixtures consisting of all possible 2-, 3-and 4-species combinations were added to soils, respectively. In most instances, species mixing produced synergistic nonadditive effects on soil microbial biomass N and soil respiration, but antagonistic non-additive effects on net N mineralization. Species composition rather than species richness explained the non-additive effects of species mixing on soil microbial biomass N and net N mineralization, due to the interspecific differences in litter chemical composition. Both litter species composition and richness explained non-additive soil respiration responses to mixed-species litter, while litter chemical diversity and chemical composition did not. Our study indicated that litter mixtures promoted soil microbial biomass N and soil respiration, and inhibited net N mineralization. Soil N related processes rather than soil respiration were partly explained by litter chemical composition and chemical diversity, highlighting the importance of functional diversity of litter on soil N cycling.	[Mao, Bing; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China; [Mao, Bing; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang, Peoples R China; [Mao, Rong] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS	Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Peoples R China.; Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang, Peoples R China.	zengdh@iae.ac.cn	Mao, Rong/Q-2595-2019	Mao, Rong/0000-0002-0469-2281	National Natural Science Foundation of China [31270668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31270668).	Aka H, 2005, EUR J SOIL BIOL, V41, P31, DOI 10.1016/j.ejsobi.2005.05.001; Ball BA, 2008, J ECOL, V96, P303, DOI 10.1111/j.1365-2745.2007.01346.x; Ball BA, 2014, SOIL BIOL BIOCHEM, V69, P71, DOI 10.1016/j.soilbio.2013.10.048; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bottollier-Curtet M, 2015, PLANT SOIL, V390, P265, DOI 10.1007/s11104-015-2394-8; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen YC, 2015, BIOL FERT SOILS, V51, P791, DOI 10.1007/s00374-015-1025-0; Cong WF, 2014, J ECOL, V102, P1163, DOI 10.1111/1365-2745.12280; Duan JC, 2013, SOIL BIOL BIOCHEM, V57, P841, DOI 10.1016/j.soilbio.2012.08.009; Fang X, 2015, PLANT SOIL, V392, P139, DOI 10.1007/s11104-015-2450-4; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Giesselmann UC, 2010, APPL SOIL ECOL, V46, P283, DOI 10.1016/j.apsoil.2010.07.006; Gogo S, 2016, J SOIL SEDIMENT, V16, P13, DOI 10.1007/s11368-015-1178-3; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Han TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18166; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HELBERT JR, 1957, ANAL CHEM, V29, P1464, DOI 10.1021/ac60130a020; Hobbie SE, 2015, TRENDS ECOL EVOL, V30, P357, DOI 10.1016/j.tree.2015.03.015; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Hu YL, 2006, PLANT SOIL, V282, P379, DOI 10.1007/s11104-006-0004-5; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Jiang J, 2013, PLANT SOIL, V373, P931, DOI 10.1007/s11104-013-1859-x; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Kraus TEC, 2004, SOIL BIOL BIOCHEM, V36, P309, DOI 10.1016/j.soilbio.2003.10.006; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Ma L, 2013, BIOGEOSCIENCES, V10, P7361, DOI 10.5194/bg-10-7361-2013; Mao B, 2015, PLANT SOIL, V396, P339, DOI 10.1007/s11104-015-2593-3; McIntyre RES, 2009, SOIL BIOL BIOCHEM, V41, P92, DOI 10.1016/j.soilbio.2008.09.021; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1447, DOI 10.1016/j.soilbio.2010.05.005; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Muller Robert N., 2003, P15; Mulvaney R. L., 1996, Methods of soil analysis. Part 3 - chemical methods., P1123; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; Redin M, 2014, SOIL BIOL BIOCHEM, V78, P65, DOI 10.1016/j.soilbio.2014.07.014; Rinnan R, 2008, APPL SOIL ECOL, V39, P271, DOI 10.1016/j.apsoil.2007.12.014; Rudolf VHW, 2013, ECOLOGY, V94, P1046, DOI 10.1890/12-0378.1; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Schadler M, 2005, SOIL BIOL BIOCHEM, V37, P329, DOI 10.1016/j.soilbio.2004.07.042; Scheibe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114040; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Waterman PG, 1994, BLACKWELL SCI PUBLIC, V38, P1064, DOI DOI 10.1007/BF03028669; Xu S, 2013, BIOGEOSCIENCES, V10, P7423, DOI 10.5194/bg-10-7423-2013; Zeng DH, 2009, PLANT SOIL, V317, P121, DOI 10.1007/s11104-008-9793-z	63	5	7	16	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180422	10.1371/journal.pone.0180422	http://dx.doi.org/10.1371/journal.pone.0180422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686660	Green Published, gold			2022-12-27	WOS:000405464100062
J	Zhou, P; Hu, J; Xi, P; Zhang, N; Yang, B; Zheng, J; Wang, XQ				Zhou, Ping; Hu, Jian; Xi, Ping; Zhang, Ning; Yang, Bo; Zheng, Jie; Wang, Xiaoqin			Survey on the levels of 25-hydroxy vitamin D and bone metabolic markers and evaluation of their correlations with osteoporosis in perimenopausal woman in Xi'an region	PLOS ONE			English	Article							D DEFICIENCY; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; HIGH PREVALENCE; D INSUFFICIENCY; PREGNANT-WOMEN; TURNOVER MARKERS; FRACTURE RISK; SERUM; CALCIUM	It has been accepted that vitamin D (VD) plays an important role in bone metabolism. However, the levels of VD in people of different regions are quite different and there is still no final conclusion on the significant correlation between VD and osteoporosis. 245 cases of peri-menopausal women were collected to study the relationship between VD and osteoporosis in western China. The mean value of 25-hydroxyvitamin D for the participants was 14.39 ng/mL. The average values of parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) were 47.62 pg/mL, 2.26 mmol/L and 1.18 mmol/L, respectively. The average value of bone mineral density (BMD) in lumbar vertebrae was -1.20 SD and that in femoral neck was -0.04 SD. Compared with normal group, PTH of VD deficiency group was significantly increased (P < 0.05), Ca was remarkably decreased (P < 0.01) while the BMD between these two groups showed no significant difference (P > 0.05). VD was in positive correlation with the age (P < 0.01) and Ca (< 0.01) of the participants, negative correlation with PTH (P < 0.01) while no significant correlation with the BMD of lumbar vertebrae and femoral neck (P > 0.05). The risk factors resulting in the occurrence of osteoporosis in the lumbar vertebrae of the participants covered Ca increase (OR = 66.247, P < 0.05), age growth (OR = 1.194, P < 0.01) and menopause (OR = 2.285, P < 0.05). This study has found that the status of VD deficiency showed no significant correlation with the level of BMD, which hinted that independent measurement of the bone metabolic markers, including Ca, P, VD and PTH, was difficult to accurately reflect the status of BMD in peri-menopausal women of this region. It's necessary to combine multi-site bone scanning to diagnose the patients' status of osteoporosis so as to provide reasonable guidance for early clinical prevention and treatment.	[Zhou, Ping; Hu, Jian; Zhang, Ning; Yang, Bo; Wang, Xiaoqin] Xi An Jiao Tong Univ, Lab Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Xi, Ping] Xi An Jiao Tong Univ, Endocrinol Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Zheng, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Coll, Clin Res Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, XQ (corresponding author), Xi An Jiao Tong Univ, Lab Dept, Med Coll, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	21107028@zju.edu.cn						Ardawi MSM, 2011, OSTEOPOROSIS INT, V22, P463, DOI 10.1007/s00198-010-1249-7; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Casado-Diaz A, 2013, J STEROID BIOCHEM, V136, P187, DOI 10.1016/j.jsbmb.2012.09.026; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hwang YC, 2013, CALCIFIED TISSUE INT, V92, P68, DOI 10.1007/s00223-012-9669-3; Kuchuk NO, 2009, J BONE MINER RES, V24, P693, DOI 10.1359/JBMR.081209; Li S, 2014, ANN NUTR METAB, V64, P13, DOI 10.1159/000358340; Lim JS, 2012, J CLIN ENDOCR METAB, V97, P1995, DOI 10.1210/jc.2011-3098; Mata G, 2013, ARCH OSTEOPOROS, V8, P124, DOI DOI 10.1007/S11657-013-0124-5; Need AG, 2008, BONE, V42, P1021, DOI 10.1016/j.bone.2008.01.012; Nguyen HTT, 2012, BONE, V51, P1029, DOI 10.1016/j.bone.2012.07.023; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rizzoli R, 2013, CURR MED RES OPIN, V29, P305, DOI 10.1185/03007995.2013.766162; Robinson PJ, 2013, AUSTRALAS J AGEING, V32, P177, DOI 10.1111/j.1741-6612.2011.00553.x; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Sadat-Ali M, 2011, ANN SAUDI MED, V31, P602, DOI 10.4103/0256-4947.87097; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tao MF, 2012, J MATERN-FETAL NEO M, V25, P237, DOI 10.3109/14767058.2011.569613; Wang J, 2010, WORLD J PEDIATR, V6, P265, DOI 10.1007/s12519-010-0224-x; Wang XY, 2012, CHINESE J WOMAN CHIL, V23, P20; Xiang F, 2013, J ENDOCRINOL INVEST, V36, P503, DOI 10.3275/8814; Zhao J, 2011, MENOPAUSE, V18, P1237, DOI 10.1097/gme.0b013e31821d7ff7; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024; 中国老年学学会骨质疏松委员会维生素D学科组专家委员会, 2014, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V20, P1011	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180366	10.1371/journal.pone.0180366	http://dx.doi.org/10.1371/journal.pone.0180366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686649	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100055
J	Pinna, C; Carta, L; Deiana, V; Camarda, I				Pinna, Claudia; Carta, Luisa; Deiana, Vitale; Camarda, Ignazio			Phyto-toponyms of Arbutus unedo L. and their distribution in Sardinia (Italy)	PLOS ONE			English	Article							GEOGRAPHICAL FEATURES; PLACE-NAMES; EXAMPLE	The study shows the results of an inventory of place names connected to Arbutus unedo L., a Mediterranean species, widespread throughout Sardinia. The main aim was to compare the past distribution of place names, referring to the strawberry tree, to the current distribution of the species on the island. In addition, we investigated the meaning and the diversity of these local place names in the various communities. The result was a collection of 432 phyto-toponyms. 248 of them were used for an analysis of their distribution in the habitats, indicated on the Map of the Nature System in Sardinia, defined on the basis of the current vegetation typology. The persistence of the species in the various habitats was either confirmed or negated with in site investigations and interviews. 47.5% of municipalities have place names related to the strawberry tree. Of the 248 phyto-toponyms, 127 fall in the habitats where the species currently persists proving a correspondence between their regional distribution and the current distribution of the species. The remaining 121 phyto-toponyms fall in habitats where the strawberry tree is currently absent. Most of them are found in man-made habitats where man has transformed the forest cover which previously included the strawberry tree. This study also contributes to promoting and conserving the linguistic heritage of local communities.	[Pinna, Claudia; Carta, Luisa; Deiana, Vitale; Camarda, Ignazio] Univ Sassari, Dept Agr, Viale Italia, Sassari, Italy	University of Sassari	Pinna, C (corresponding author), Univ Sassari, Dept Agr, Viale Italia, Sassari, Italy.	clpinna@uniss.it						A.A.V.V, 1916, NOTES QUERIES MEDIUM, VII; Andre J., 1985, NOMES PLANTES ROME A; [Anonymous], 2002, 8 UN C STAND GEOGR N; Associazione archeologica etnografica abbasantese, 1993, TOP TERR ABB; Bacchetta G, 2000, RENDICONTI SEMINARIO, V70, P200; Barrera-Bassols N, 2006, CATENA, V65, P118, DOI 10.1016/j.catena.2005.11.001; Blasco Ferrer Eduardo, 1984, STORIA LINGUISTICA S; Boillat S, 2013, ENVIRON MANAGE, V51, P663, DOI 10.1007/s00267-012-9969-4; Burrill MF, 1956, TOPONYMIC GENERICS, VI; Burrill MF, 1956, TOPONYMIC GENERICS, VII; Camarda I, 2006, P 4 INT C ETHN AUG 2, P527; Camarda I., 1992, PICCOLI ARBUSTI LIAN; Camarda I, 2015, ISPRA SERIE, V222; Camarda I., 2010, CHISTIONARE NATURA L; Camarda I., 2008, ALBERI ARBUSTI SPONT; Camarda I., 1990, B SOC SARDA SCI NAT, V27, P147; Camarda I, 2014, QUAD BOT AMB APPL, V25, P125; Camarda I., 1998, PIANO PAESAGGISTICO; CAMARDA I, 1983, ALBERI ARBUSTI SPONT; Caria R., 1990, IL MONDO CALIC STUDI; Conedera M, 2007, J HIST GEOGR, V33, P729, DOI 10.1016/j.jhg.2006.11.002; Contini M, 2001, DICT LANGUES MONDE; Contini M., 1993, PARLARE SCRIVERE SAR; Cuccu I., 1989, TOPONOMASTICA TERRIT; Dedola S., 2001, SENTIERO SARDEGNA SE; Durmishi I., 2013, ANGLISTICUM J IJLLIS, V2, P60; Elwes HJ, 1906, TREES GREAT BRITAIN, VIII; ESRI, 2010, RCGIS DESKTOP 10 0 S, P380; Farina L., 2002, BOCABOLARIU; Ferrer E Blasco, 2010, PALEOSARDO ORIGINI L; Fidalgo HC, 2015, CUADERNOS GEOGRAFICO, V54, P220; Frigau C, TOPONIMI TERRITORIO; Gasperini L., 1992, ATT 9 CONV AFR ROM 1, P571; Gomila RR, 2005, INT CART C LA COR SP; Gelabert MG, 2009, DOC ANAL GEOGR, V55, P93; Hough Carole, 2016, OXFORD HDB NAMES NAM; Hunn E., 1996, J LINGUIST ANTHROPOL, V6, P3, DOI [DOI 10.1525/JLIN.1996.6.1.3, 10.1525/jlin.1996.6.1.3]; Imazato S., 2013, SEMESTRALE STUDI RIC, V2, P27; Joyce PW, 1883, ORIGIN HIST IRISH NA, VII; Logus Nioi O., 2007, MICROTOPONIMI NURRI; Luo W, 2010, GEOJOURNAL, V75, P93, DOI 10.1007/s10708-009-9291-8; Manos G., 1993, VILLAGRANDE STRISAIL; Marcialis E., 2005, VOCABOLARI; Maxia Mauro, 2010, STUDI SARDO CORSI DI; Maxia Mauro, 1994, NOMI LUOGO ANGLONA B; Miglior I., 1989, SARDEGNA D PAESI SCO; Muller-Wille L., 1989, B SOC SUISSE AM, V53-54, P17; Negre E., 1996, TOPONYMIE GENERATE F, V194; Negre E., 1996, TOPONYMIE GENERATE F, V2; Nieto Ballester E, 2013, SEMESTRALE STUDI RIC, P123; Nocentini A, TOPONOMASTICA IGM FI; Panedda Dionigi, 1991, NOMI GEOGRAFICI AGRO; Patil DA, 2015, INT DAILY J SPECIES, V12, P6; Paulis G., 1992, NOMI POPOLARI PIANTE; Paulis G, 2004, ATT CONV GALL LING D, P15; Paulis Giulio, 1987, NOMI LUOGO SARDEGNA, VI; Pegorier A, 2006, NOMS LIEUX FRANCE GL; Penko Seidl N, 2015, ANN SERIES HIST SOCI, V25, P595; Perkovsky E. E., 2015, Vestnik Zoologii, V49, P407, DOI 10.1515/vzoo-2015-0046; Piante Camarda I, 2005, BIOL VEGETALE BENI C, VII, P336; Pinna A, 2 TERRITOR ATZARA TR; Pittau M, 2004, LINGUA CIVILTA SARDE; Pittau M., 2014, VOCABOLARIO LINGUA S; Pittau M, 2011, TOPONIMI SARDEGNA SI; Pittau M., NOMI PIANTE PROTOSAR; Plaisant L, 2007, MANNU SORTU OLIVI MI; Poddie R., 2010, TONARA NOMI LUOGO RI; Puddu M., 2002, DITZIONA A RIU SA LI; Quezel P., 1976, FOR TS MAQUIS M DITE, VVolume 2, P9; R Core Team, 2018, R LANG ENV STAT COMP; Radding L, 2010, GEOGR REV, V100, P394, DOI 10.1111/j.1931-0846.2010.00043.x; Rodriguez JF, 2013, SABUCO REV ESTUDIOS, V9, P133; Rubattu A., 2001, DIZIONARIO UNIVERSAL; Scully RW, 1916, FLORA COUNTY KERRY, P179; SEALY JR, 1950, J ECOL, V38, P223, DOI 10.2307/2256540; SEALY JR, 1949, J ECOL, V37, P365, DOI 10.2307/2256613; Shi GH, 2015, ENTROPY-SWITZ, V17, P984, DOI 10.3390/e17030984; Smith D, 2016, J CULT GEOGR, V33, P1, DOI 10.1080/08873631.2015.1060689; Spiggia S., 1997, API NELLA TRADIZIONE, P90; Sweeney S, 2017, LANDSCAPE ECOLOGY, V22, P1007; Tagliavini C., ORIGINI LINGUE NEOLA; Tamine M., 2013, P 2 INT C ON ICON MA, P384; Tichelaar T., 2002, TOPONYMY LANGUAGE, P1; Tort J., 2009, P 23 INT C ON SCI, P976; Trischitta D., 1983, TOPONIMI PAESAGGIO N; Tsinkoburova M, 2014, INT MULTI SCI GEOCO, P161; Valdes B, EURO MED PLANTBASE I; Verde A., BOT FILE 4 WINTER 20; Villar L, 2005, ALAZET, V17, P239; Virdis M, 2009, P 1 SEM REG STUD TOP; Wagner Max Leopold, 1960, DIZIONARIO ETIMOLOGI, V1; WAGNER Max Leopold, 1997, LINGUA SARDA STORIA; Wagner ML, 1960, DIZIONARIO ETIMOLOGI, VIII; Wagner ML, 1960, DIZIONARIO ETIMOLOGI, VII; Wolf HeinzJ., 1998, TOPONOMASTICA BARBAR; Zirottu G., 2004, MAMOIADA RACCONTO TE	96	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181174	10.1371/journal.pone.0181174	http://dx.doi.org/10.1371/journal.pone.0181174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704491	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700103
J	Wang, YD; Chen, Y; Mao, L; Zhao, GJ; Hong, GL; Li, MF; Wu, B; Chen, XR; Tan, M; Wang, N; Lu, ZQ				Wang, Yadong; Chen, Yao; Mao, Lu; Zhao, Guangju; Hong, Guangliang; Li, Mengfang; Wu, Bin; Chen, Xiaorong; Tan, Meng; Wang, Na; Lu, Zhongqiu			Effects of hemoperfusion and continuous renal replacement therapy on patient survival following paraquat poisoning	PLOS ONE			English	Article							REGIONAL CITRATE ANTICOAGULATION; STRESS	Mortality in patients with paraquat (PQ) poisoning is related to plasma PQ levels. Concentrations lower than 5,000 ng/mL are considered critical but curable. This study assessed the effects of hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the survival of PQ-poisoned patients with plasma PQ levels below 5,000ng/mL. We analyzed the records of 164 patients with PQ poisoning who were treated at the First Affiliated Hospital of Wenzhou Medical University in China between January 2011 and May 2015. We divided these patients into six sub-groups based on baseline plasma PQ levels and treatment, compared their clinical characteristics, and analyzed their survival rates. Patient subgroups did not differ in terms of age, sex, time between poisoning and hospital admission, or time to first gavage. Biochemical indicators improved over time in all sub-groups following treatment, and the combined HP and CRRT treatment yielded better results than HP or CRRT alone. Fatality rates in the three treatment sub-groups did not differ among patients with baseline plasma PQ levels of 50-1,000 ng/mL, but in patients with 1,000-5,000 ng/mL levels, the mortality rate was 59.2% (HP treatment group), 48% (CRRT treatment group), and 37.9% (combined treatment group). Mortality rates were higher 10-30 days after hospitalization than in the first 10 days after admission. In the early stages of PQ poisoning, CRRT is effective in reducing patient fatality rates, particularly when combined with HP. Our data could be useful in increasing survival in acute PQ poisoning patients.	[Wang, Yadong; Chen, Yao; Mao, Lu; Zhao, Guangju; Hong, Guangliang; Li, Mengfang; Wu, Bin; Chen, Xiaorong; Tan, Meng; Wang, Na; Lu, Zhongqiu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Chen, Yao] Gannan Med Univ, Affiliated Hosp 1, Intens Care Unit, Ganzhou, Jiangxi, Peoples R China; [Mao, Lu] Zhengzhou First Peoples Hosp, Med Grp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China	Wenzhou Medical University; Gannan Medical University	Lu, ZQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou, Zhejiang, Peoples R China.	lzq_640815@163.com		LU, Zhongqiu/0000-0002-0569-4182	fund of the key construction academic subject (Medical Innovation) of Zhejiang province, China [11-CX26]	fund of the key construction academic subject (Medical Innovation) of Zhejiang province, China	This work was supported by fund of the key construction academic subject (Medical Innovation) of Zhejiang province (11-CX26), China. The funder had role in data collection and analysis, decision to publish and preparation of the manuscript.	Amano I, 1991, COMPLICATIONS SIDE S, V49, P649; Amirshahrokhi K, 2013, INT IMMUNOPHARMACOL, V17, P210, DOI 10.1016/j.intimp.2013.06.005; BAUD FJ, 1988, J TOXICOL-CLIN TOXIC, V26, P35, DOI 10.3109/15563658808995396; Chen GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001212; DARKE PGG, 1977, VET REC, V100, P275, DOI 10.1136/vr.100.14.275; Del Rio MJ, 2008, GROWTH FACTORS, V26, P49, DOI 10.1080/08977190801984205; HART TB, 1987, HUM TOXICOL, V6, P13, DOI 10.1177/096032718700600103; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hong GL, 2016, J PHARMACOL TOX MET, V80, P75, DOI 10.1016/j.vascn.2016.05.010; Hong SY, 2002, TOXICOL LETT, V126, P51, DOI 10.1016/S0378-4274(01)00431-3; Hu LF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/298253; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kirwan CJ, 2016, BLOOD PURIFICAT, V42, P349, DOI 10.1159/000452755; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Liu Yao, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P735; MATTHEW H, 1968, BRIT MED J, V3, P759, DOI 10.1136/bmj.3.5621.759; Myung W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128980; Rico MP, 2017, PEDIATR NEPHROL, V32, P703, DOI 10.1007/s00467-016-3544-9; Roebuck KA, 1999, INT J MOL MED, V4, P223; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Seok S, 2012, J KOREAN MED SCI, V27, P993, DOI 10.3346/jkms.2012.27.9.993; Shi XF, 2015, INT J CLIN EXP MED, V8, P14018; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Suh GJ, 2008, AM J EMERG MED, V26, P641, DOI 10.1016/j.ajem.2007.09.022; Sun L, 2014, EXP THER MED, V8, P652, DOI 10.3892/etm.2014.1773; Villa G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1551-7; Wu Y, 2016, EXP THER MED, V12, P2997, DOI 10.3892/etm.2016.3691; Xu XL, 2011, WORLD J EMERG MED, V2, P45, DOI 10.5847/wjem.j.issn.1920-8642.2011.02.008	29	19	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181207	10.1371/journal.pone.0181207	http://dx.doi.org/10.1371/journal.pone.0181207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704509	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700106
J	Wei, CH; Chen, XE; Wang, ZY; Liu, QY; Li, H; Zhang, Y; Ma, JX; Yang, JQ; Zhang, X				Wei, Chunhua; Chen, Xiner; Wang, Zhongyuan; Liu, Qiyan; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian			Genetic mapping of the LOBED LEAF 1 (ClLL1) gene to a 127.6-kb region in watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; LEAF SHAPE EVOLUTION; EXPRESSION; MERISTEM; IDENTIFICATION; ALIGNMENT; GROWTH; LOCUS	The lobed leaf character is a unique morphologic trait in crops, featuring many potential advantages for agricultural productivity. Although the majority of watermelon varieties feature lobed leaves, the genetic factors responsible for lobed leaf formation remain elusive. The F2:3 leaf shape segregating population offers the opportunity to study the underlying mechanism of lobed leaf formation in watermelon. Genetic analysis revealed that a single dominant allele (designated ClLL1) controlled the lobed leaf trait. A large-sized F3:4 population derived from F2:3 individuals was used to map ClLL1. A total of 5,966 reliable SNPs and indels were identified genome-wide via a combination of BSA and RNA-seq. Using the validated SNP and indel markers, the location of ClLL1 was narrowed down to a 127.6-kb region between markers W08314 and W07061, containing 23 putative ORFs. Expression analysis via qRT-PCR revealed differential expression patterns (fold-changes above 2-fold or below 0.5-fold) of three ORFs (ORF3, ORF11, and ORF18) between lobed and nonlobed leaf plants. Based on gene annotation and expression analysis, ORF18 (encoding an uncharacterized protein) and ORF22 (encoding a homeobox-leucine zipper-like protein) were considered as most likely candidate genes. Furthermore, sequence analysis revealed no polymorphisms in cDNA sequences of ORF18; however, two notable deletions were identified in ORF22. This study is the first report to map a leaf shape gene in watermelon and will facilitate cloning and functional characterization of ClLL1 in future studies.	[Wei, Chunhua; Chen, Xiner; Wang, Zhongyuan; Liu, Qiyan; Li, Hao; Zhang, Yong; Ma, Jianxiang; Yang, Jianqiang; Zhang, Xian] Northwest A&F Univ, Coll Hort, Yangling, Peoples R China	Northwest A&F University - China	Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Peoples R China.	zhangxian098@126.com	chen, xiner/GVU-3933-2022		Scientific Startup Foundation for Doctors of Northwest A and F University [Z109021604]; Basal Research Foundation of Northwest A and F University [Z109021612]; Modern Agro-industry Technology Research System of China [CARS-26-18]	Scientific Startup Foundation for Doctors of Northwest A and F University; Basal Research Foundation of Northwest A and F University; Modern Agro-industry Technology Research System of China	This work was supported by Scientific Startup Foundation for Doctors of Northwest A and F University (Z109021604), Basal Research Foundation of Northwest A and F University (Z109021612), and the Modern Agro-industry Technology Research System of China (No. CARS-26-18).	Andres RJ, 2017, P NATL ACAD SCI USA, V114, pE57, DOI 10.1073/pnas.1613593114; Andres RJ, 2014, THEOR APPL GENET, V127, P167, DOI 10.1007/s00122-013-2208-4; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Chang J, 2016, THEOR APPL GENET, V129, P1531, DOI 10.1007/s00122-016-2722-2; DYUTIN KE, 1979, GENETIKA+, V16, P176; Ferris KG, 2015, ANN BOT-LONDON, V116, P213, DOI 10.1093/aob/mcv080; Gao XW, 2014, EUPHYTICA, V200, P337, DOI 10.1007/s10681-014-1151-z; Goliber T, 1999, CURR TOP DEV BIOL, V43, P259; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Herrington M, 1988, QUEENSLAND J AGR ANI; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Jasinski S, 2007, PLANTA, V226, P1255, DOI 10.1007/s00425-007-0572-5; Jiao KY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0552-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YP, 2014, THEOR APPL GENET, V127, P2243, DOI 10.1007/s00122-014-2376-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082333; Liu HQ, 2015, THEOR APPL GENET, V128, P2375, DOI 10.1007/s00122-015-2592-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ni XY, 2015, EUPHYTICA, V204, P29, DOI 10.1007/s10681-014-1319-6; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Pu HM, 2001, CHIN J OIL CROP SCI, V23, P60; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Saddic LA, 2006, DEVELOPMENT, V133, P1673, DOI 10.1242/dev.02331; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; Sluis A, 2015, TRENDS GENET, V31, P300, DOI 10.1016/j.tig.2015.04.004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Tsukaya Hirokazu, 2013, Arabidopsis Book, V11, pe0163, DOI [10.1199/tab.0072, 10.1199/tab.0163]; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Yu HL, 2013, J EXP BOT, V64, P599, DOI 10.1093/jxb/ers352; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhou CN, 2013, PLANT CELL, V25, P4845, DOI 10.1105/tpc.113.117788	43	17	17	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180741	10.1371/journal.pone.0180741	http://dx.doi.org/10.1371/journal.pone.0180741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704497	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700049
J	Yaguchi, A; Tatemichi, S; Takeda, H; Kobayashi, M				Yaguchi, Atsushi; Tatemichi, Satoshi; Takeda, Hiroo; Kobayashi, Mamoru			PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; LANTHANUM CARBONATE; SEVELAMER HYDROCHLORIDE; VASCULAR CALCIFICATION; DIALYSIS PATIENTS; SERUM PHOSPHORUS; BONE DISORDER; HYPERPHOSPHATEMIA; MORTALITY	The effects of PA21, a novel iron- based and non- calcium- based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease- mineral and bone disorder (CKD-MBD) were evaluated. Rats with adenine-induced chronic renal failure (CRF) were prepared by feeding them an adenine-containing diet for four weeks. They were also freely fed a diet that contained PA21 (0.5, 1.5, and 5%), sevelamer hydrochloride (0.6 and 2%) or lanthanum carbonate hydrate (0.6 and 2%) for four weeks. Blood biochemical parameters were measured and bone histomorphometry was performed for femurs, which were isolated after drug treatment. Serum phosphorus and parathyroid hormone (PTH) levels were higher in the CRF rats. Administration of phosphate binders for four weeks decreased serum phosphorus and PTH levels in a dose-dependent manner and there were significant decreases in the AUC(0-28) day of these parameters in 5% PA21, 2% sevelamer hydrochloride, and 2% lanthanum carbonate hydrate groups compared with that in the CRF control group. Moreover, osteoid volume improved significantly in 5% of the PA21 group, and fibrosis volume and cortical porosity were ameliorated in 5% PA21, 2% sevelamer hydrochloride, and 2% lanthanum carbonate hydrate groups. These results suggest that PA21 is effective against hyperphosphatemia, secondary hyperparathyroidism, and bone abnormalities in CKD-MBD as sevelamer hydrochloride and lanthanum carbonate hydrate are, and that PA21 is a new potential alternative to phosphate binders.	[Yaguchi, Atsushi; Tatemichi, Satoshi; Takeda, Hiroo; Kobayashi, Mamoru] Kissei Pharmaceut Co Ltd, Pharmacol Res Lab, R&D, Azumino City, Nagano, Japan	Kissei Pharmaceutical Co Ltd	Yaguchi, A (corresponding author), Kissei Pharmaceut Co Ltd, Pharmacol Res Lab, R&D, Azumino City, Nagano, Japan.	atsushi_yaguchi@pharm.kissei.co.jp			Kissei Pharmaceutical Co., Ltd.	Kissei Pharmaceutical Co., Ltd.(Kissei Pharmaceutical Co Ltd)	The authors received no specific funding for this work. Kissei Pharmaceutical Co., Ltd., http://www.kissei.co.jp/e_contents/index.html, provided support in the form of salaries for authors AY, ST, HT and MK and acquisition of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section below.	Akizawa T, 2014, THER APHER DIAL, V18, P122, DOI 10.1111/1744-9987.12068; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Bousher A, 2014, CLIN THER, V36, P2082, DOI 10.1016/j.clinthera.2014.09.021; Bronner F, 2008, CLIN PHARMACOKINET, V47, P543, DOI 10.2165/00003088-200847080-00004; Cernaro V, 2014, EXPERT OPIN INV DRUG, V23, P1459, DOI 10.1517/13543784.2014.962652; Damment S, 2011, NEPHROL DIAL TRANSPL, V26, P1803, DOI 10.1093/ndt/gfq682; Floege J, 2014, KIDNEY INT, V86, P638, DOI 10.1038/ki.2014.58; Fouque D, 2014, AM J KIDNEY DIS, V64, P143, DOI 10.1053/j.ajkd.2014.01.429; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Guo YC, 2015, INT J ORAL SCI, V7, P8, DOI 10.1038/ijos.2015.1; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Hruska KA, 2007, SEMIN DIALYSIS, V20, P309, DOI 10.1111/j.1525-139X.2007.00300.x; Hutchison AJ, 2009, KIDNEY INT, V75, P906, DOI 10.1038/ki.2009.60; Iida A, 2013, AM J NEPHROL, V37, P346, DOI 10.1159/000348805; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Katsumata K, 2003, KIDNEY INT, V64, P441, DOI 10.1046/j.1523-1755.2003.00126.x; Koiwa F, 2005, THER APHER DIAL, V9, P340, DOI 10.1111/j.1744-9987.2005.00294.x; Maeno Y, 2009, CALCIFIED TISSUE INT, V85, P310, DOI 10.1007/s00223-009-9278-y; Mittalhenkle A, 2004, AM J KIDNEY DIS, V44, P672, DOI 10.1053/j.ajkd.2004.07.001; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Phan O, 2015, J HYPERTENS, V33, pE16, DOI 10.1097/01.hjh.0000467394.66592.05; Phan O, 2011, J PHARMACOL EXP THER, V346, P281; Phan O, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/515606; Sarvari BKD, 2015, INDIAN J CLIN BIOCHE, V30, P66, DOI 10.1007/s12291-013-0399-8; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shigematsu T, 2008, THER APHER DIAL, V12, P55, DOI 10.1111/j.1744-9987.2007.00541.x; Shigematsu T, 2010, CLIN EXP NEPHROL, V14, P589, DOI 10.1007/s10157-010-0339-3; Shinaberger CS, 2008, AM J CLIN NUTR, V88, P1511, DOI 10.3945/ajcn.2008.26665; Spasovski GB, 2006, NEPHROL DIAL TRANSPL, V21, P2217, DOI 10.1093/ndt/gfl146; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; Wuthrich RP, 2013, CLIN J AM SOC NEPHRO, V8, P280, DOI 10.2215/CJN.08230811	36	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180430	10.1371/journal.pone.0180430	http://dx.doi.org/10.1371/journal.pone.0180430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704404	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700039
J	Catala-Lopez, F; Hutton, B; Nunez-Beltran, A; Page, MJ; Ridao, M; St-Gerons, DM; Catala, MA; Tabares-Seisdedos, R; Moher, D				Catala-Lopez, Ferran; Hutton, Brian; Nunez-Beltran, Amparo; Page, Matthew J.; Ridao, Manuel; Macias St-Gerons, Diego; Catala, Miguel A.; Tabares-Seisdedos, Rafael; Moher, David			The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials	PLOS ONE			English	Review							CHILDHOOD PSYCHIATRIC-DISORDER; DEFICIT/HYPERACTIVITY DISORDER; COMPLEX INTERVENTIONS; CONSORT STATEMENT; CLINICAL-TRIALS; ADHD; METHYLPHENIDATE; CARE; BIAS; INCONSISTENCY	Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. Methods and findings We performed a systematic review with network meta-analyses. Randomised controlled trials (>= 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacological (stimulants, non-stimulants, antidepressants, antipsychotics, and other unlicensed drugs), psychological (behavioural, cognitive training and neurofeedback) and complementary and alternative medicine (dietary therapy, fatty acids, amino acids, minerals, herbal therapy, homeopathy, and physical activity). The primary outcomes were efficacy (treatment response) and acceptability (all-cause discontinuation). Secondary outcomes included discontinuation due to adverse events (tolerability), as well as serious adverse events and specific adverse events. Random-effects Bayesian network meta-analyses were conducted to obtain estimates as odds ratios (ORs) with 95% credibility intervals. We analysed interventions by class and individually. 190 randomised trials (52 different interventions grouped in 32 therapeutic classes) that enrolled 26114 participants with ADHD were included in complex networks. At the class level, behavioural therapy (alone or in combination with stimulants), stimulants, and non-stimulant seemed significantly more efficacious than placebo. Behavioural therapy in combination with stimulants seemed superior to stimulants or non-stimulants. Stimulants seemed superior to behavioural therapy, cognitive training and non-stimulants. Behavioural therapy, stimulants and their combination showed the best profile of acceptability. Stimulants and non-stimulants seemed well tolerated. Among medications, methylphenidate, amphetamine, atomoxetine, guanfacine and clonidine seemed significantly more efficacious than placebo. Methylphenidate and amphetamine seemed more efficacious than atomoxetine and guanfacine. Methylphenidate and clonidine seemed better accepted than placebo and atomoxetine. Most of the efficacious pharmacological treatments were associated with harms (anorexia, weight loss and insomnia), but an increased risk of serious adverse events was not observed. There is lack of evidence for cognitive training, neurofeedback, antidepressants, antipsychotics, dietary therapy, fatty acids, and other complementary and alternative medicine. Overall findings were limited by the clinical and methodological heterogeneity, small sample sizes of trials, short-term follow-up, and the absence of high-quality evidence; consequently, results should be interpreted with caution. Conclusions Clinical differences may exist between the pharmacological and non-pharmacological treatment used for the management of ADHD. Uncertainties about therapies and the balance between benefits, costs and potential harms should be considered before starting treatment. There is an urgent need for high-quality randomised trials of the multiple treatments for ADHD in children and adolescents. PROSPERO, number CRD42014015008.	[Catala-Lopez, Ferran; Hutton, Brian; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Catala-Lopez, Ferran; Ridao, Manuel] Fdn Inst Invest Serv Salud, Valencia, Spain; [Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain; [Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael] CIBERSAM, Valencia, Spain; [Hutton, Brian; Moher, David] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Nunez-Beltran, Amparo] Reg Hlth Council, CAID Norte, Madrid, Spain; [Page, Matthew J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Page, Matthew J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Ridao, Manuel] IACS, REDISSEC, Zaragoza, Spain; [Macias St-Gerons, Diego] AEMPS, Spanish Med & Healthcare Prod Agcy, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Catala, Miguel A.] Univ Valencia, Fac Med, Valencia, Spain; [Nunez-Beltran, Amparo] Dionisia Plaza Rehabil Ctr, Madrid, Spain	University of Ottawa; Ottawa Hospital Research Institute; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Ottawa; Monash University; University of Bristol; University of Valencia	Catala-Lopez, F (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Catala-Lopez, F (corresponding author), Fdn Inst Invest Serv Salud, Valencia, Spain.; Catala-Lopez, F (corresponding author), Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.; Catala-Lopez, F (corresponding author), CIBERSAM, Valencia, Spain.	ferran_catala@hotmail.com	Moher, David/I-3408-2019; Macias Saint-Gerons, Diego/AFY-2165-2022; Tabares-Seisdedos, Rafael/H-6432-2013; Catalá-López, Ferrán/N-6018-2018	Moher, David/0000-0003-2434-4206; Macias Saint-Gerons, Diego/0000-0002-2572-2160; Catalá-López, Ferrán/0000-0002-3833-9312; Hutton, Brian/0000-0001-5662-8647; Page, Matthew/0000-0002-4242-7526; Tabares-Seisdedos, Rafael/0000-0002-1089-2204				Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P802, DOI 10.1097/01.chi.0000128791.10014.ac; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2011, GUID REC ADHD CHILDR; [Anonymous], 2014, LANCET, V384, P104, DOI DOI 10.1016/S0140-6736(14)61146-6; Attention Deficit Hyperactivity Disorder, 2009, NICE GUID DIAGN MAN; Austin PC, 2004, STAT MED, V23, P1159, DOI 10.1002/sim.1687; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bero LA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000075; Bonini S, 2014, NEW ENGL J MED, V371, P2452, DOI 10.1056/NEJMp1409464; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bowers S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6082; Boyle MH, 1999, CAN J PSYCHIAT, V44, P991, DOI 10.1177/070674379904401005; Caldwell DM, 2016, EVID-BASED MENT HEAL, V19, P16, DOI 10.1136/eb-2015-102275; Carlson Gabrielle A, 2007, Child Adolesc Psychiatry Ment Health, V1, P10, DOI 10.1186/1753-2000-1-10; Catala-Lopez F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001971; Catala-Lopez F, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0005-7; Catala-Lopez F, 2014, RHEUMATOL INT, V34, P1489, DOI 10.1007/s00296-014-2994-2; Catala-Lopez F, 2014, REV ESP CARDIOL, V67, P597, DOI 10.1016/j.rec.2013.11.016; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan E, 2016, JAMA-J AM MED ASSOC, V315, P1997, DOI 10.1001/jama.2016.5453; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clyburne-Sherin AVP, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0954-0; Coates J, 2015, J ATTEN DISORD, V19, P831, DOI 10.1177/1087054714535952; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Connor DF, 2000, CLIN PEDIATR, V39, P15, DOI 10.1177/000992280003900102; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Del Re AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063509; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dopfner M, 2004, EUR CHILD ADOLES PSY, V13, P117, DOI 10.1007/s00787-004-1011-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein JN, 2014, PEDIATRICS, V134, P1136, DOI 10.1542/peds.2014-1500; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gotzsche PC., 2014, COCHRANE LIB; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hodgson K, 2014, J ATTEN DISORD, V18, P275, DOI 10.1177/1087054712444732; Hutton B, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0099-y; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Hutton B, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-44; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jakobsen JC, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1173-2; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Keen D, 2011, BMJ CLIN EVID, V02, P312; King S, 2006, HEALTH TECHNOL ASSES, V10, P1; Kollins SH, 2011, PEDIATRICS, V127, pE1406, DOI 10.1542/peds.2010-1260; Kurlan R, 2002, NEUROLOGY, V58, P527; Linden S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3199; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; Melendez-Torres GJ, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0040-z; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; National Collaborating Centre for Mental Health (UK), 2018, BR PSYCHOL SOC; Palumbo DR, 2008, J AM ACAD CHILD PSY, V47, P180, DOI 10.1097/chi.0b013e31815d9af7; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1209, DOI 10.1016/j.jclinepi.2013.06.004; Phillips CB, 2006, PLOS MED, V3, P433, DOI 10.1371/journal.pmed.0030182; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Punja S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009996.pub2; Renoux C, 2016, BRIT J CLIN PHARMACO, V82, P858, DOI 10.1111/bcp.13000; Richardson M, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19450; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P755, DOI 10.1016/j.jclinepi.2007.10.003; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Scottish Intercollegiate Guidelines Network, 2009, MANAGEMENT OF ATTENT; Seixas M, 2012, J PSYCHOPHARMACOL, V26, P753, DOI 10.1177/0269881111412095; Shin JY, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2550; Snell T, 2013, J CHILD PSYCHOL PSYC, V54, P977, DOI 10.1111/jcpp.12055; So CYC, 2008, BEHAV RES THER, V46, P983, DOI 10.1016/j.brat.2008.06.007; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Steele M, 2006, CLIN THER, V28, P1892, DOI 10.1016/j.clinthera.2006.11.006; Sterne JAC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000076; Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2; Storebo OJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5203; Stuhec M, 2015, J AFFECT DISORDERS, V178, P149, DOI 10.1016/j.jad.2015.03.006; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Thomas R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6172; US Food and Drug Administration, 2004, FDA LAUNCH MULT STRA; US Food and Drugs Administration, 2007, MOD MARK PROV SER SK; van der Oord S, 2007, EUR CHILD ADOLES PSY, V16, P48, DOI 10.1007/s00787-006-0574-z; Verkuijl N, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2168; Visser SN, 2016, MMWR-MORBID MORTAL W, V65, P443, DOI 10.15585/mmwr.mm6517e1; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Welton NJ, 2009, AM J EPIDEMIOL, V169, P1158, DOI 10.1093/aje/kwp014; Wilens TE, 2012, J AM ACAD CHILD PSY, V51, P74, DOI 10.1016/j.jaac.2011.10.012; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Wykes T, 2015, LANCET PSYCHIAT, V2, P1036, DOI 10.1016/S2215-0366(15)00332-6	101	142	151	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180355	10.1371/journal.pone.0180355	http://dx.doi.org/10.1371/journal.pone.0180355			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700715	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600029
J	Iannuzzi, A; Pereira, J; Iannuzzi, C; Fu, BY; Ferguson-Smith, M				Iannuzzi, Alessandra; Pereira, Jorge; Iannuzzi, Clara; Fu, Beiyuan; Ferguson-Smith, Malcolm			Pooling strategy and chromosome painting characterize a living zebroid for the first time	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SHEEP-GOAT HYBRID; MAMMALIAN CHROMOSOMES; HIGH-RESOLUTION; G-BAND; KARYOTYPE; DONKEY; REARRANGEMENTS; FISH; CYTOGENETICS	We have investigated the complex karyotype of a living zebra-donkey hybrid for the first time using chromosome-specific painting probes produced from flow-sorted chromosomes from a zebra (Equus burchelli) and horse (Equus caballus). As the chromosomes proved difficult to distinguish from one another, a successful new strategy was devised to resolve the difficulty and characterize each chromosome. This was based on selecting five panels of whole chromosome painting probes that could differentiate zebra and donkey chromosomes by labelling the probes with either FITC or Cy3 fluorochromes. Each panel was hybridized sequentially to the same G-Q-banded metaphases and the results combined so that every zebra and donkey chromosome in each suitable metaphase could be identified. A diploid number of 2n = 53, XY was found, containing haploid sets of 22 chromosomes from the zebra and 31 chromosomes from the donkey, without evidence of chromosome rearrangement. This new strategy, developed for the first time, may have several applications in the resolution of other complex hybrid karyotypes and chromosomal aberrations.	[Iannuzzi, Alessandra] ISPAAM, Natl Res Council Italy, Lab Anim Cytogenet & Genom, Naples, Italy; [Pereira, Jorge] Cytocell Ltd, Cambridge, England; [Iannuzzi, Clara] Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Fu, Beiyuan] Wellcome Trust Sanger Inst, Cytogenet Facil, Hinxton, England; [Ferguson-Smith, Malcolm] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Dept Vet Med, Cambridge, England	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); Universita della Campania Vanvitelli; Wellcome Trust Sanger Institute; University of Cambridge	Iannuzzi, A (corresponding author), ISPAAM, Natl Res Council Italy, Lab Anim Cytogenet & Genom, Naples, Italy.	alessandra.iannuzzi@ispaam.cnr.it	Iannuzzi, Alessandra/B-8085-2015; Pereira, Jorge C/T-1822-2017	Pereira, Jorge C/0000-0002-1472-1613; IANNUZZI, Clara/0000-0003-0092-5997	MIUR (Finanziamento per Rientro dei Cervelli "Rita Levi Montalcini")	MIUR (Finanziamento per Rientro dei Cervelli "Rita Levi Montalcini")(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from MIUR (Finanziamento per Rientro dei Cervelli Rita Levi Montalcini). Cytocell Ltd provided support in the form of a salary for one of the authors (JP). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	BENIRSCHKE K, 1964, CHROMOSOMA, V15, P1, DOI 10.1007/BF00326911; Chudoba I, 1999, CYTOGENET CELL GENET, V84, P156, DOI 10.1159/000015245; Di Meo GP, 2009, CYTOGENET GENOME RES, V125, P266, DOI 10.1159/000235932; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Gray AP, 1972, MAMMALIAN HYBRIDS CH, P115; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; HANSEN KM, 1975, HEREDITAS, V81, P133; Hito I, 2015, SCI REP, V5, P13171; IANNUZZI L, 1985, HEREDITAS, V103, P153, DOI 10.1111/j.1601-5223.1985.tb00495.x; IANNUZZI L, 1989, HEREDITAS, V110, P43, DOI 10.1111/j.1601-5223.1989.tb00415.x; Iannuzzi L, 2008, J APPL GENET, V49, P357, DOI 10.1007/BF03195634; KING M, 1987, HEREDITY, V59, P1, DOI 10.1038/hdy.1987.90; MCGOVERN PT, 1975, BRIT VET J, V131, P691, DOI 10.1016/S0007-1935(17)35141-2; Megersa B., 2006, ANIM PROD RES ADV, V2, P148, DOI DOI 10.4314/APRA.V2I3.36328; Mine OM, 2000, SMALL RUMINANT RES, V37, P141, DOI 10.1016/S0921-4488(99)00146-7; Muller S, 1997, HUM GENET, V100, P271, DOI 10.1007/s004390050504; Musilova P, 2013, CHROMOSOME RES, V21, P175, DOI 10.1007/s10577-013-9346-z; Pauciullo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34781; Pauciullo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110297; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roberts I, 1999, GENE CHROMOSOME CANC, V25, P241, DOI 10.1002/(SICI)1098-2264(199907)25:3<241::AID-GCC6>3.0.CO;2-7; RYDER OA, 1985, J HERED, V76, P379; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; STEWARTSCOTT IA, 1990, NEW ZEAL VET J, V38, P7, DOI 10.1080/00480169.1990.35605; Tumennasan K, 1997, CYTOGENET CELL GENET, V78, P69, DOI 10.1159/000134633; Yang F, 2003, CYTOGENET GENOME RES, V102, P235, DOI 10.1159/000075755; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a	28	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180158	10.1371/journal.pone.0180158	http://dx.doi.org/10.1371/journal.pone.0180158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700625	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600018
J	Borgdorff, H; van der Veer, C; van Houdt, R; Alberts, CJ; de Vries, HJ; Bruisten, SM; Snijder, MB; Prins, M; Geerlings, SE; van der Loeff, MFS; van de Wijgert, JHHM				Borgdorff, Hanneke; van der Veer, Charlotte; van Houdt, Robin; Alberts, Catharina J.; de Vries, Henry J.; Bruisten, Sylvia M.; Snijder, Marieke B.; Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim; van de Wijgert, Janneke H. H. M.			The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LONGITUDINAL ANALYSIS; RACIAL-DIFFERENCES; RISK-FACTORS; WOMEN; EPIDEMIOLOGY; HIV; IDENTIFICATION; PREVALENCE; INFECTION	Objective To evaluate whether ethnicity is independently associated with vaginal microbiota (VMB) composition in women living in Amsterdam, the Netherlands, as has been shown for American women. Methods Women (18 -34 years, non-pregnant, N = 610) representing the six largest ethnic groups (Dutch, African Surinamese, South-Asian Surinamese, Turkish, Moroccan, and Ghanaian) were sampled from the population-based HELIUS study. Sampling was performed irrespective of health status or healthcare seeking behavior. DNA was extracted from self-sampled vaginal swabs and sequenced by Illumina MiSeq (16S rRNA gene V3-V4 region). Results The overall prevalence of VMBs not dominated by lactobacilli was 38.5%: 32.2% had a VMB resembling bacterial vaginosis and another 6.2% had a VMB dominated by Bifidobacteriaceae (not including Gardnerella vaginalis), Corynebacterium, or pathobionts (streptococci, staphylococci, Proteus or Enterobacteriaceae). The most prevalent VMB in ethnically Dutch women was a Lactobacillus crispatus-dominated VMB, in African Surinamese and Ghanaian women a polybacterial G. vaginalis-containing VMB, and in the other ethnic groups a L. iners-dominated VMB. After adjustment for sociodemographic, behavioral and clinical factors, African Surinamese ethnicity (adjusted odds ratio (aOR) 5.1, 95% confidence interval (CI) 2.1-12.0) and Ghanaian ethnicity (aOR 4.8, 95% CI 1.8-12.6) were associated with having a polybacterial G. vaginalis-containing VMB, and African Surinamese ethnicity with a L. iners-dominated VMB (aOR 2.8, 95% CI 1.2-6.2). Shorter steady relationship duration, inconsistent condom use with casual partners, and not using hormonal contraception were also associated with having a polybacterial G. vaginalis-containing VMB, but human papillomavirus infection was not. Other sexually transmitted infections were uncommon. Conclusions The overall prevalence of having a VMB not dominated by lactobacilli in this populationbased cohort of women aged 18-34 years in Amsterdam was high (38.5%), and women of sub-Saharan African descent were significantly more likely to have a polybacterial G. vaginalis-containing VMB than Dutch women independent of modifiable behaviors.	[Borgdorff, Hanneke; van de Wijgert, Janneke H. H. M.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Borgdorff, Hanneke; Alberts, Catharina J.; de Vries, Henry J.; Bruisten, Sylvia M.; Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim; van de Wijgert, Janneke H. H. M.] Acad Med Ctr, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands; [van der Veer, Charlotte; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam GGD, Publ Hlth Lab, Amsterdam, Netherlands; [van der Veer, Charlotte; van Houdt, Robin] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands; [Alberts, Catharina J.; de Vries, Henry J.; Prins, Maria; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Dept Infect Dis, Amsterdam, Netherlands; [de Vries, Henry J.] Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Snijder, Marieke B.] Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Snijder, Marieke B.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Prins, Maria; Geerlings, Suzanne E.; van der Loeff, Maarten F. Schim] Acad Med Ctr, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	van de Wijgert, JHHM (corresponding author), Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.; van de Wijgert, JHHM (corresponding author), Acad Med Ctr, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands.; van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England.	snijder@amc.uva.nl; j.vandewijgert@liverpool.ac.uk	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Veer, Charlotte/0000-0002-1685-1622; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Alberts, Catharina Johanna/0000-0002-5604-3689	Aids Fonds Netherlands [201102]; Academic Medical Center Amsterdam; Public Health Service of Amsterdam; Dutch Heart Foundation [2010T084]; Netherlands Organization for Health Research and Development [200500003, 7115 0001, 204005002]; European Union (FP-7) [278901]; SURF Foundation	Aids Fonds Netherlands; Academic Medical Center Amsterdam; Public Health Service of Amsterdam; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union (FP-7)(European Commission); SURF Foundation	This work was supported by the Aids Fonds Netherlands [grant number 201102; https://aidsfonds.nl/], the Academic Medical Center Amsterdam [institutional funding; https://www.amc.nl/web/Zorg.htm], the Public Health Service of Amsterdam [institutional funding; http://www.ggd.amsterdam.nl/english/], the Dutch Heart Foundation [grant number 2010T084; https://www.hartstichting.nl/], the Netherlands Organization for Health Research and Development (ZonMw) [grant numbers 200500003, 7115 0001, and 204005002; https://www.zonmw.nl/en/], and the European Union (FP-7) [grant number 278901; https://ec.europa.eu/research/fp7/index_en.cfm]. Some analyses were carried out on the Dutch national e-infrastructure with the support of SURF Foundation [https://www.surf.nl/en]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts CJ, 2016, SEX TRANSM INFECT, V92, P611, DOI 10.1136/sextrans-2015-052397; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doh Kunihiko, 2004, Infect Dis Obstet Gynecol, V12, P79, DOI 10.1080/10647440400003667; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esber A, 2015, J INFECT DIS, V212, P8, DOI 10.1093/infdis/jiv017; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Garland SM, 2002, J REPROD IMMUNOL, V57, P169, DOI 10.1016/S0165-0378(02)00018-9; Gautam R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0831-1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Jespers V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0825-z; Kenyon C, 2015, AIDS, V29, P641, DOI 10.1097/QAD.0000000000000566; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Korshunov V. M., 1999, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P74; Kwatra G, 2016, LANCET INFECT DIS, V16, P1076, DOI 10.1016/S1473-3099(16)30055-X; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Machado A, 2015, J INFECT DIS, V212, P1856, DOI 10.1093/infdis/jiv338; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Ness RB, 2003, J NATL MED ASSOC, V95, P201; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ryckman KK, 2008, J REPROD IMMUNOL, V78, P166, DOI 10.1016/j.jri.2008.01.003; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x	42	87	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181135	10.1371/journal.pone.0181135	http://dx.doi.org/10.1371/journal.pone.0181135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700747	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400033
J	Jie, ZW; Zhang, Y; Wang, C; Shen, B; Guan, X; Ren, ZH; Ding, XX; Dai, W; Jiang, YP				Jie, Zhenwang; Zhang, Yu; Wang, Chen; Shen, Bin; Guan, Xin; Ren, Zhihua; Ding, Xinxin; Dai, Wei; Jiang, Yongping			Large-scale ex vivo generation of human neutrophils from cord blood CD34(+) cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; STEM-CELLS; HEMATOPOIETIC DIFFERENTIATION; EXPANSION; TRANSPLANTATION; KINETICS; RECONSTITUTION; TRANSFUSIONS; EXPRESSION; PHENOTYPE	Conventional high-dose chemotherapy frequently leads to severe neutropenia, during which patients experience a high risk of infection. Although support care with donor's neutrophils is possible this choice is largely hampered by the limited availability of matched donors. To overcome this problem, we explored a large-scale ex vivo production of neutrophils from hematopoietic stem cells (HSCs) using a four-stage culture approach in a roller-bottle production platform. We expanded CD34(+) HSCs isolated from umbilical cord blood (UCB) using our in-house special medium supplemented with cytokine cocktails and achieved about 49000-fold expansion of cells, among which about 61% were differentiated mature neutrophils. Ex vivo differentiated neutrophils exhibited a chemotactic activity similar to those from healthy donors and were capable of killing E. coli in vitro. The expansion yield as reported herein was at least 5 times higher than any other methods reported in the literature. Moreover, the cost of our modified medium was only a small fraction (<1/60) of the StemSpan (TM) SFEM. Therefore, our ex vivo expansion platform, coupled with a low cost of stem cell culture due to the use of a modified medium, makes large-scale manufacturing neutrophils possible, which should be able to greatly ameliorate neutrophil shortage for transfusion in the clinic.	[Jie, Zhenwang; Zhang, Yu; Shen, Bin; Guan, Xin; Ren, Zhihua; Ding, Xinxin; Dai, Wei; Jiang, Yongping] Tsinghua Univ, Peking Union Med Coll, Biopharmaceut R&D Ctr, Suzhou, Peoples R China; [Wang, Chen; Ren, Zhihua; Jiang, Yongping] Biopharmagen Corp, Suzhou, Peoples R China; [Ding, Xinxin] SUNY Polytech Inst, Coll Nanoscale Sci & Engn, Albany, NY USA; [Dai, Wei] NYU Langone Med Ctr, Environm Med, New York, NY USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; SUNY Polytechnic Institute; NYU Langone Medical Center	Jiang, YP (corresponding author), Tsinghua Univ, Peking Union Med Coll, Biopharmaceut R&D Ctr, Suzhou, Peoples R China.; Jiang, YP (corresponding author), Biopharmagen Corp, Suzhou, Peoples R China.	yjiang@biopharmagen.com		Dai, Wei/0000-0003-0169-8327	State Scientific Key Projects for New Drug Research and Development [2014ZX09101042-004, 2011ZX09401-027]; International Cooperation and Exchange Program, China [2013DFA30830]; Biopharmagen Corp	State Scientific Key Projects for New Drug Research and Development; International Cooperation and Exchange Program, China; Biopharmagen Corp	This work was funded by the State Scientific Key Projects for New Drug Research and Development (2014ZX09101042-004 and 2011ZX09401-027) and the International Cooperation and Exchange Program (2013DFA30830), China. Biopharmagen Corp provided support in the form of salaries for authors [C.W. and Z.R.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Buono KD, 2015, J NEUROSCI, V35, P8855, DOI 10.1523/JNEUROSCI.2868-12.2015; Chaiworapongsa T, 2011, J PERINAT MED, V39, P653, DOI [10.1515/JPM.2011.072, 10.1515/jpm.2011.072]; Chaurasia P, J CLIN INVESTIGATION, V124, P2378; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Covey MV, 2007, NEUROSCIENCE, V148, P501, DOI 10.1016/j.neuroscience.2007.06.015; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; De Bruyn C, 2003, CYTOTHERAPY, V5, P87, DOI 10.1080/14653240310000119; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dick EP, 2008, STEM CELLS, V26, P2552, DOI 10.1634/stemcells.2008-0328; Doshi M, 2006, INT J HEMATOL, V84, P231, DOI 10.1532/IJH97.06040; Edvardsson L, 2004, BRIT J HAEMATOL, V127, P451, DOI 10.1111/j.1365-2141.2004.05227.x; Engels EA, 1999, CLIN INFECT DIS, V28, P256, DOI 10.1086/515103; Evans CA, 1999, BLOOD, V94, P1504, DOI 10.1182/blood.V94.5.1504.417a27_1504_1514; Gorczyca W., 2010, FLOW CYTOMETRY NEOPL; Guan X, 2016, SAFETY EFFICACY MEGA; HAM RG, 1963, EXP CELL RES, V29, P515, DOI 10.1016/S0014-4827(63)80014-2; HARVATH L, 1980, J IMMUNOL METHODS, V37, P39, DOI 10.1016/0022-1759(80)90179-9; HAYLOCK DN, 1992, BLOOD, V80, P1405; Hino M, 2000, BRIT J HAEMATOL, V109, P314, DOI 10.1046/j.1365-2141.2000.02054.x; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Hughes WT AD, 2002, CLIN INFECT DIS, V15, P730; Jacobs L, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-64; Jiang YP, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-28; Keohane E, 1993, RODAKS HEMATOLOGY CL; Lachmann N, 2015, STEM CELL REP, V4, P282, DOI 10.1016/j.stemcr.2015.01.005; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; McNiece I, 2000, EXP HEMATOL, V28, P1181, DOI 10.1016/S0301-472X(00)00520-8; Morishima T, 2011, J CELL PHYSIOL, V226, P1283, DOI 10.1002/jcp.22456; Morris J, 2010, LAB EQUIPMENT; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Oza A, 2006, TRANSFUSION, V46, P14, DOI 10.1111/j.1537-2995.2005.00665.x; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Posadas I, 2000, N-S ARCH PHARMACOL, V361, P98, DOI 10.1007/s002109900150; Price TH, 2006, TRANSFUSION, V46, P1, DOI 10.1111/j.1537-2995.2006.00693.x; Price TH, 1996, BLOOD, V88, P335; Price TH, 2000, BLOOD, V95, P3302, DOI 10.1182/blood.V95.11.3302.010k35_3302_3309; Qin M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0482-9; Ren Z, 2016, STEM CELL INVESTIGAT, V3; Rodak B. F., 2013, HEMATOLOGY CLIN PRIN; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; Scheding S, 2000, EXP HEMATOL, V28, P460, DOI 10.1016/S0301-472X(00)00133-8; Shen B, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0413-1; Shen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141485; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Stevens A, 2002, WHEATERS BASIC HISTO; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Sweeney CL, 2016, STEM CELLS, V34, P1513, DOI 10.1002/stem.2332; Timmins NE, 2009, BIOTECHNOL BIOENG, V104, P832, DOI 10.1002/bit.22433; Timmins NE, 2009, TRENDS BIOTECHNOL, V27, P415, DOI 10.1016/j.tibtech.2009.03.008; TO LB, 1990, BONE MARROW TRANSPL, V6, P109; Tura Olga RB G, 2007, J TRANSL MED, V5, P1; van Raam BJ, 2008, BLOOD, V112, P2046, DOI 10.1182/blood-2008-04-149575; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Zimmerman TM, 2000, BONE MARROW TRANSPL, V26, P505, DOI 10.1038/sj.bmt.1702543	59	10	10	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180832	10.1371/journal.pone.0180832	http://dx.doi.org/10.1371/journal.pone.0180832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700636	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400019
J	Chen, VCH; Hsu, TC; Chen, LJ; Chou, HC; Weng, JC; Tzang, BS				Chen, Vincent Chin-Hung; Hsu, Tsai-Ching; Chen, Li-Jeng; Chou, Hong-Chun; Weng, Jun-Cheng; Tzang, Bor-Show			Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; LOW-FREQUENCY FLUCTUATION; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; AMYGDALA MORPHOLOGY; ATTENTION; ADHD; CHILDREN; AMPLITUDE; INFLAMMATION	Attention deficit hyperactivity disorder (ADHD) is a global behavior illness among children and adults. To investigate the effects of taurine on resting-state fMRI activity in ADHD, a spontaneously hypertensive rat (SHR) animal model was adopted. Significantly decreased serum C-reactive protein (CRP) was detected in rats of Wistar Kyoto (WKY) high-taurine group and significantly decreased interleukin (IL)-1 beta and CRP were detected in rats of SHR low-taurine and high-taurine groups. Moreover, significantly higher horizontal locomotion was detected in rats of WKY low-taurine and SHR low-taurine groups than in those of controls. In contrast, significantly lower horizontal locomotion was detected in rats of the SHR high-taurine group than in those of the SHR control group. Additionally, significantly lower functional connectivity (FC) and mean amplitude of low-frequency fluctuation (mALFF) in the bilateral hippocampus in rats of WKY high-taurine and SHR high-taurine groups was detected. Notably, the mALFF in rats of the SHR low-taurine and high-taurine groups was significantly lower than in those of the SHR control group. These findings suggest that the administration of a high-dose taurine probably improves hyperactive behavior in SHR rats by ameliorating the inflammatory cytokines and modulating brain functional signals in SHR rats.	[Chen, Vincent Chin-Hung] Chang Gung Univ, Dept Psychiat, Taoyuan, Taiwan; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Hsu, Tsai-Ching; Chen, Li-Jeng; Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Hsu, Tsai-Ching; Tzang, Bor-Show] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Chou, Hong-Chun; Weng, Jun-Cheng] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Weng, Jun-Cheng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung University; Chung Shan Medical University	Tzang, BS (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Tzang, BS (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan.; Weng, JC (corresponding author), Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.; Weng, JC (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Tzang, BS (corresponding author), Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan.	jcweng@mail.cgu.edu.tw; bstzang@csmu.edu.tw		Bor-Show, Tzang/0000-0003-0140-9943	Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [CMRPG6E0261]; Ministry of Science and Technology, Taipei, Taiwan [MOST104-2628-E-040-001-MY2]	Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Ministry of Science and Technology, Taipei, Taiwan	This study was funded by Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital and Chang Gung University, Chiayi, Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (CMRPG6E0261). This study was also funded by the Ministry of Science and Technology, Taipei, Taiwan (MOST104-2628-E-040-001-MY2).	Arnsten AFT, 2009, J PEDIATR-US, V154, pS22, DOI 10.1016/j.jpeds.2009.01.018; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bhattarai JP, 2015, NEUROSCI LETT, V608, P51, DOI 10.1016/j.neulet.2015.10.012; Bidri M., 2003, Annales Pharmaceutiques Francaises, V61, P385; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Cortese S, 2012, EUR J PAEDIATR NEURO, V16, P422, DOI 10.1016/j.ejpn.2012.01.009; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; El Idrissi A, 2009, ADV EXP MED BIOL, V643, P207, DOI 10.1007/978-0-387-75681-3_21; Ericson M, 2006, EUR J NEUROSCI, V23, P3225, DOI 10.1111/j.1460-9568.2006.04868.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; GARCIADEYEBENESPROUS J, 1978, N-S ARCH PHARMACOL, V304, P95; Hennig E. M., 1995, Tidsskrift for den Norske Laegeforening, V115, P1632; Holtmann M, 2013, Z KINDER JUG-PSYCH, V41, P393, DOI 10.1024/1422-4917/a000255; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; Kamikawa H, 1998, AM J PHYSIOL-REG I, V275, pR803, DOI 10.1152/ajpregu.1998.275.3.R803; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kontro P, 1987, Adv Exp Med Biol, V217, P347; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Lacosta S, 1998, PSYCHOPHARMACOLOGY, V137, P351, DOI 10.1007/s002130050630; Li F, 2014, RADIOLOGY, V272, P514, DOI 10.1148/radiol.14131622; Li XW, NUTR NEUROSCI; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Lima L, 2001, NUTR NEUROSCI, V4, P439, DOI 10.1080/1028415X.2001.11747379; Lovell B, 2012, PSYCHONEUROENDOCRINO, V37, P534, DOI 10.1016/j.psyneuen.2011.08.003; Mitchell RHB, 2014, J AM ACAD CHILD PSY, V53, P274, DOI 10.1016/j.jaac.2013.11.013; Mitterschiffthaler MT, 2006, J MAGN RESON IMAGING, V23, P851, DOI 10.1002/jmri.20590; O'Shea TM, 2014, PEDIATR RES, V75, P781, DOI 10.1038/pr.2014.41; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Perlov E, 2008, J PSYCHIATR NEUROSCI, V33, P509; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Toyoda A, 2013, ADV EXP MED BIOL, V775, P29, DOI 10.1007/978-1-4614-6130-2_3; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Umehara M, 2013, EUR J PHARMACOL, V702, P250, DOI 10.1016/j.ejphar.2013.01.033; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028; Yue YY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/505479; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang CG, 2007, ANN NUTR METAB, V51, P379, DOI 10.1159/000107687; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zubarev O E, 2011, Ross Fiziol Zh Im I M Sechenova, V97, P1048	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181122	10.1371/journal.pone.0181122	http://dx.doi.org/10.1371/journal.pone.0181122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700674	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800125
J	Krajewska, J; Modrak-Wojcik, A; Arent, ZJ; Wieckowski, D; Zolkiewski, M; Bzowska, A; Kedzierska-Mieszkowska, S				Krajewska, Joanna; Modrak-Wojcik, Anna; Arent, Zbigniew J.; Wieckowski, Daniel; Zolkiewski, Michal; Bzowska, Agnieszka; Kedzierska-Mieszkowska, Sabina			Characterization of the molecular chaperone ClpB from the pathogenic spirochaete Leptospira interrogans	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRESS TOLERANCE; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; ATPASE CLPB; DNAK; ULTRACENTRIFUGATION; THERMOTOLERANCE; OLIGOMERIZATION; VIRULENCE	Leptospira interrogans is a spirochaete responsible for leptospirosis in mammals. The molecular mechanisms of the Leptospira virulence remain mostly unknown. Recently, it has been demonstrated that an AAA + chaperone ClpB ( a member of the Hsp100 family) from L. interrogans (ClpBLi) is not only essential for survival of Leptospira under the thermal and oxidative stresses, but also during infection of a host. The aim of this study was to provide further insight into the role of ClpB in the pathogenic spirochaetes and explore its biochemical properties. We found that a non-hydrolysable ATP analogue, ATP.S, but not AMP-PNP induces the formation of ClpBLi hexamers and stabilizes the associated form of the chaperone. ADP also induces structural changes in ClpBLi and promotes its self-assembly, but does not produce full association into the hexamers. We also demonstrated that ClpBLi exhibits a weak ATPase activity that is stimulated by.-casein and poly-lysine, and may mediate protein disaggregation independently from the DnaK chaperone system. Unexpectedly, the presence of E.coli DnaK/DnaJ/GrpE did not significantly affect the disaggregation activity of ClpBLi and ClpBLi did not substitute for the ClpBEc function in the clpB-null E. coli strain. This result underscores the species-specificity of the ClpB cooperation with the cochaperones and is most likely due to a loss of interactions between the ClpBLi middle domain and the E. coli DnaK. We also found that ClpBLi interacts more efficiently with the aggregated G6PDH in the presence of ATP.S rather than ATP. Our results indicate that ClpB's importance during infection might be due to its role as a molecular chaperone involved in reactivation of protein aggregates.	[Krajewska, Joanna; Wieckowski, Daniel; Kedzierska-Mieszkowska, Sabina] Univ Gdansk, Fac Biol, Dept Gen & Med Biochem, Gdansk, Poland; [Modrak-Wojcik, Anna; Bzowska, Agnieszka] Univ Warsaw, Fac Phys, Inst Expt Phys, Div Biophys, Warsaw, Poland; [Arent, Zbigniew J.] Agr Univ Krakow, Univ Ctr Vet Med UJ UR, Krakow, Poland; [Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Fahrenheit Universities; University of Gdansk; University of Warsaw; Agricultural University Krakow; Kansas State University	Kedzierska-Mieszkowska, S (corresponding author), Univ Gdansk, Fac Biol, Dept Gen & Med Biochem, Gdansk, Poland.	sabina.kedzierska-mieszkowska@biol.ug.edu.pl	Arent, Zbigniew/ABB-8706-2020; Kędzierska-Mieszkowska, Sabina/AAF-2737-2021	Kędzierska-Mieszkowska, Sabina/0000-0001-5756-3013; Arent, Zbigniew/0000-0002-5997-2555; Bzowska, Agnieszka/0000-0002-3976-429X; Krajewska, Joanna/0000-0003-0412-4265	National Science Center (Poland) [2015/17/N/NZ6/03493]; UG grants [538-L130-B588-14, 538-L130-B929-15]; NanoFun laboratories; European Regional Development Fund within Innovation Economy Operational Program [POIG.02.02.00-00-025/09]	National Science Center (Poland); UG grants; NanoFun laboratories; European Regional Development Fund within Innovation Economy Operational Program	This work was supported by the Preludium Grant number 2015/17/N/NZ6/03493 (to JK) from the National Science Center (Poland) and UG grants for Young Scientists numbers 538-L130-B588-14 and 538-L130-B929-15 (to JK). The analytical ultracentrifugation experiments were performed in the NanoFun laboratories co-financed by the European Regional Development Fund within the Innovation Economy Operational Program, project no. POIG.02.02.00-00-025/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2011, VET MICROBIOL, V153, P73, DOI 10.1016/j.vetmic.2011.02.055; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Arent Z, 2013, VET REC, V173, DOI 10.1136/vr.101969; Arent ZJ, 2013, EPIDEMIOL INFECT, V141, P1148, DOI 10.1017/S0950268812002087; Arent ZJ, 2013, VET REC, V172, DOI 10.1136/vr.101239; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chastanet A, 2004, J BACTERIOL, V186, P1165, DOI 10.1128/JB.186.4.1165-1174.2004; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harlow E., 1988, ANTIBODIES LAB MANUA; Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krajewska J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0774-8; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lin JB, 2015, PROTEINS, V83, P2008, DOI 10.1002/prot.24914; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; Ngansop F, 2013, BIOCHEM BIOPH RES CO, V439, P191, DOI 10.1016/j.bbrc.2013.08.064; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; Rosenzweig R, 2015, P NATL ACAD SCI USA, V112, pE6872, DOI 10.1073/pnas.1512783112; Ryan EG, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-8; Schacherl M, 2013, ACTA CRYSTALLOGR D, V69, P2440, DOI 10.1107/S0907444913022683; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlee S, 2004, J MOL BIOL, V336, P275, DOI 10.1016/j.jmb.2003.12.013; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Strub C, 2003, FEBS LETT, V553, P125, DOI 10.1016/S0014-5793(03)00985-2; Sugimoto S, 2006, J BACTERIOL, V188, P8070, DOI 10.1128/JB.00404-06; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Zblewska K, 2014, ARCH BIOCHEM BIOPHYS, V555, P23, DOI 10.1016/j.abb.2014.05.012; Zmijewski MA, 2004, J MOL BIOL, V336, P539, DOI 10.1016/j.jmb.2003.12.053; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	43	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181118	10.1371/journal.pone.0181118	http://dx.doi.org/10.1371/journal.pone.0181118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700685	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800124
J	Sui, S; Yang, Y; Sun, Y; Wang, XM; Wang, GL; Shan, GL; Wang, JC; Yu, J				Sui, Shuo; Yang, Yu; Sun, Yi; Wang, Xumin; Wang, Guoliang; Shan, Guangle; Wang, Jiancheng; Yu, Jun			On the core bacterial flora of Ixodes persulcatus (Taiga tick)	PLOS ONE			English	Article							METAGENOMICS; MICROBIOME; METATRANSCRIPTOMICS; ENDOSYMBIONTS; COMMUNITIES; DIVERSITY; PROVINCE	Ixodes persulcatus is a predominant hard tick species that transmits a wide range of human and animal pathogens. Since bacterial flora of the tick dwelling in the wild always vary according to their hosts and the environment, it is highly desirable that species-associated microbiomes are fully determined by using next-generation sequencing and based on comparative metagenomics. Here, we examine such metagenomic changes of I. persulcatus starting with samples collected from the wild ticks and followed by the reared animals under pathogen-free laboratory conditions over multiple generations. Based on high-coverage genomic sequences from three experimental groups-wild, reared for a single generation or R1, and reared for eight generations or R8-we identify the core bacterial flora of I. persulcatus, which contains 70 species that belong to 69 genera of 8 phyla; such a core is from the R8 group, which is reduced from 4625 species belonging to 1153 genera of 29 phyla in the wild group. Our study provides a novel example of tick core bacterial flora acquired based on wild-to-reared comparison, which paves a way for future research on tick metagenomics and tick-borne disease pandemics.	[Sui, Shuo; Wang, Xumin; Wang, Guoliang; Shan, Guangle; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Sui, Shuo; Wang, Xumin; Yu, Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Yu; Wang, Jiancheng] Chinese Acad Inspect & Quarantine, Beijing, Peoples R China; [Sun, Yi] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Inspection & Quarantine; Beijing Institute of Microbiology & Epidemiology	Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Yu, J (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	junyu@big.ac.cn	wang, xumin/HII-8627-2022		Quality Inspection Public Welfare Program of China [201410020]; National key R D plan [2016YFC1202700]; CAIQ project [2016JK031]	Quality Inspection Public Welfare Program of China; National key R D plan; CAIQ project	This work was supported by Quality Inspection Public Welfare Program of China [201410020] (http://www.aqsiq.gov.cn/) YY, National key R & D plan [2016YFC1202700] (http://www.most.gov.cn/) YY,CAIQ project [2016JK031] (http://www.caiq.org.cn/) YY. The funders paid all the fee in the study design,data collection and analysis,decision to publish the manuscript.	Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436; Bikel S, 2015, COMPUT STRUCT BIOTEC, V13, P390, DOI 10.1016/j.csbj.2015.06.001; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cao WC, 2003, AM J TROP MED HYG, V68, P547, DOI 10.4269/ajtmh.2003.68.547; Cao WC, 2000, J CLIN MICROBIOL, V38, P4208, DOI 10.1128/JCM.38.11.4208-4210.2000; Chengxu AI, 1991, EPIDEMIOLOGICAL AETI, V19, P1061; de la Fuente J, 2003, CLIN DIAGN LAB IMMUN, V10, P182, DOI 10.1128/CDLI.10.1.182-184.2003; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Igolkina Y, 2016, TICKS TICK-BORNE DIS, V7, P1284, DOI 10.1016/j.ttbdis.2016.06.005; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Jia N, 2013, NEW ENGL J MED, V369, P1176, DOI 10.1056/NEJMc1303625; Kageyama Daisuke, 2012, Insects, V3, P161, DOI 10.3390/insects3010161; Kurilshikov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131413; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Niu QL, 2016, INFECT GENET EVOL, V41, P8, DOI 10.1016/j.meegid.2016.03.007; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462; Papa A, 2017, TICKS TICK-BORNE DIS, V8, P31, DOI 10.1016/j.ttbdis.2016.09.011; Ponnusamy Loganathan AG, 2013, APPL ENV MICROBIOLOG, V80; Porter L, 2015, TICKS TICK-BORNE DIS, V6, P16, DOI 10.1016/j.ttbdis.2014.08.002; Sun JM, 2015, EXP APPL ACAROL, V65, P403, DOI 10.1007/s10493-015-9880-9; Sun Y, 2008, VET PARASITOL, V156, P333, DOI 10.1016/j.vetpar.2008.05.026; Turaev D, 2016, CURR OPIN BIOTECH, V39, P174, DOI 10.1016/j.copbio.2016.04.011; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Williams-Newkirk AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102130; Zhang XC, 2014, TICKS TICK-BORNE DIS, V5, P864, DOI 10.1016/j.ttbdis.2014.07.009	29	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180150	10.1371/journal.pone.0180150	http://dx.doi.org/10.1371/journal.pone.0180150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692666	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800026
J	Ebeid, M; Sripal, P; Pecka, J; Beisel, KW; Kwan, K; Soukup, GA				Ebeid, Michael; Sripal, Prashanth; Pecka, Jason; Beisel, Kirk W.; Kwan, Kelvin; Soukup, Garrett A.			Transcriptome-wide comparison of the impact of Atoh1 and miR-183 family on pluripotent stem cells and multipotent otic progenitor cells	PLOS ONE			English	Article							MOUSE INNER-EAR; NOTCH SIGNALING PATHWAY; HAIR-CELLS; MAMMALIAN COCHLEA; GENE-EXPRESSION; IN-VIVO; DIRECT TARGETS; MATH1; DIFFERENTIATION; IDENTIFICATION	Over 5% of the global population suffers from disabling hearing loss caused by multiple factors including aging, noise exposure, genetic predisposition, or use of ototoxic drugs. Sensorineural hearing loss is often caused by the loss of sensory hair cells (HCs) of the inner ear. A barrier to hearing restoration after HC loss is the limited ability of mammalian auditory HCs to spontaneously regenerate. Understanding the molecular mechanisms orchestrating HC development is expected to facilitate cell replacement therapies. Multiple events are known to be essential for proper HC development including the expression of Atoh1 transcription factor and the miR-183 family. We have developed a series of vectors expressing the miR-183 family and/or Atoh1 that was used to transfect two different developmental cell models: pluripotent mouse embryonic stem cells (mESCs) and immortalized multipotent otic progenitor (iMOP) cells representing an advanced developmental stage. Transcriptome profiling of transfected cells show that the impact of Atoh1 is contextually dependent with more HC-specific effects on iMOP cells. miR-183 family expression in combination with Atoh1 not only appears to fine tune gene expression in favor of HC fate, but is also required for the expression of some HC-specific genes. Overall, the work provides novel insight into the combined role of Atoh1 and the miR-183 family during HC development that may ultimately inform strategies to promote HC regeneration or maintenance.	[Ebeid, Michael; Sripal, Prashanth; Pecka, Jason; Beisel, Kirk W.; Soukup, Garrett A.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Kwan, Kelvin] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Creighton University; Rutgers State University New Brunswick	Soukup, GA (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	garrettsoukup@creighton.edu		Kwan, Kelvin/0000-0002-8617-5543	Bellucci DePaoli Family Foundation; Nebraska Stem Cell Research Act [LB606]; Nebraska Health Care Funding Act [LB692]; National Institute of General Medical Sciences [P20GM103471]; National Institute on Deafness and Other Communication Disorders [R01DC009025]	Bellucci DePaoli Family Foundation; Nebraska Stem Cell Research Act; Nebraska Health Care Funding Act; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for this work was provided by the Bellucci DePaoli Family Foundation (GAS), Nebraska Stem Cell Research Act LB606 (GAS and KWB), Nebraska Health Care Funding Act LB692 (GAS and KWB), National Institute of General Medical Sciences P20GM103471 (GAS), and National Institute on Deafness and Other Communication Disorders R01DC009025 (GAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Felfly H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02277; Funke B, 2001, HUM MOL GENET, V10, P2549, DOI 10.1093/hmg/10.22.2549; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Gu CH, 2013, TOXICOL IN VITRO, V27, P486, DOI 10.1016/j.tiv.2012.07.008; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hartman BH, 2007, DEV DYNAM, V236, P2875, DOI 10.1002/dvdy.21307; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; KELLY MC, 2012, THE JOURNAL OF NEURO, V32, P6699, DOI DOI 10.1523/JNEUROSCI.5420-11.2012; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kraaijenga VJC, 2016, CLIN OTOLARYNGOL, V41, P585, DOI 10.1111/coa.12571; Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Kwan KY, 2015, STEM CELL REP, V4, P47, DOI 10.1016/j.stemcr.2014.11.001; Lai HC, 2011, J NEUROSCI, V31, P10859, DOI 10.1523/JNEUROSCI.0445-11.2011; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Masuda M, 2011, NEUROSCIENCE, V197, P48, DOI 10.1016/j.neuroscience.2011.09.033; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Mulvaney J, 2012, JARO-J ASSOC RES OTO, V13, P281, DOI 10.1007/s10162-012-0317-4; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216; Wang XR, 2012, HEARING RES, V286, P55, DOI 10.1016/j.heares.2012.02.005; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; World Health Organisation, DEAFN HEAR LOSS; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	55	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							E0180855	10.1371/journal.pone.0180855	http://dx.doi.org/10.1371/journal.pone.0180855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686713	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100115
J	Landman, J; Brewster, RC; Weinert, FM; Phillips, R; Kegel, WK				Landman, Jasper; Brewster, Robert C.; Weinert, Franz M.; Phillips, Rob; Kegel, Willem K.			Self-consistent theory of transcriptional control in complex regulatory architectures	PLOS ONE			English	Article							REPRESSOR CAP INTERACTION; ESCHERICHIA-COLI; GENE-EXPRESSION; LAC REPRESSOR; DNA; SEQUENCE; PROTEIN; OPERON; KINETICS; MODEL	Individual regulatory proteins are typically charged with the simultaneous regulation of a battery of different genes. As a result, when one of these proteins is limiting, competitive effects have a significant impact on the transcriptional response of the regulated genes. Here we present a general framework for the analysis of any generic regulatory architecture that accounts for the competitive effects of the regulatory environment by isolating these effects into an effective concentration parameter. These predictions are formulated using the grand-canonical ensemble of statistical mechanics and the fold-change in gene expression is predicted as a function of the number of transcription factors, the strength of interactions between the transcription factors and their DNA binding sites, and the effective concentration of the transcription factor. The effective concentration is set by the transcription factor interactions with competing binding sites within the cell and is determined self-consistently. Using this approach, we analyze regulatory architectures in the grand-canonical ensemble ranging from simple repression and simple activation to scenarios that include repression mediated by DNA looping of distal regulatory sites. It is demonstrated that all the canonical expressions previously derived in the case of an isolated, non-competing gene, can be generalised by a simple substitution to their grand canonical counterpart, which allows for simple intuitive incorporation of the influence of multiple competing transcription factor binding sites. As an example of the strength of this approach, we build on these results to present an analytical description of transcriptional regulation of the lac operon.	[Landman, Jasper; Kegel, Willem K.] Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Utrecht, Netherlands; [Landman, Jasper] European Synchrotron Radiat Facil, Grenoble, France; [Brewster, Robert C.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Weinert, Franz M.; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Utrecht University; European Synchrotron Radiation Facility (ESRF); University of Massachusetts System; University of Massachusetts Worcester; California Institute of Technology; California Institute of Technology	Kegel, WK (corresponding author), Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Utrecht, Netherlands.; Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.; Phillips, R (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu; w.k.kegel@uu.nl	Kegel, Willem K/H-4084-2016	Brewster, Robert/0000-0002-7656-4086	Netherlands Organisation for Scientific Research [022.004.016]; European Synchrotron Radiation Facility; La Fondation Pierre Gilles de Gennes; National Institutes of Health through the Directors Pioneer Award [DP1OD000217, R01GM085286]; John Templeton Foundation	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Synchrotron Radiation Facility; La Fondation Pierre Gilles de Gennes; National Institutes of Health through the Directors Pioneer Award; John Templeton Foundation	This work was supported by the Netherlands Organisation for Scientific Research grant 022.004.016 (JL), by the European Synchrotron Radiation Facility (JL), by La Fondation Pierre Gilles de Gennes (RP), by the National Institutes of Health through the Directors Pioneer Award DP1OD000217 (RP) and through R01GM085286 (RP), and by the John Templeton Foundation (RP and FMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Alberts B, 2008, MOL BIOL CELL; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Boedicker JQ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.018101; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Burger A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041920; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; Einav T, 2016, J PHYS CHEM B, V120, P6021, DOI 10.1021/acs.jpcb.6b01911; Fried MG, 1996, SCIENCE, V274, P1930, DOI 10.1126/science.274.5294.1930; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gibbs JW, 1928, COLLECTED WORKS, VII; Gowetski DB, 2013, NUCLEIC ACIDS RES, V41, P8253, DOI 10.1093/nar/gkt553; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; Hill TL, 1994, THERMODYNAMICS SMA 1; Hill TL, 1994, THERMODYNAMICS SMA 2; HUDSON JM, 1990, J MOL BIOL, V214, P381, DOI 10.1016/0022-2836(90)90188-R; Karapetyan S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062712; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kwon H, 2001, EUR J BIOCHEM, V268, P565, DOI 10.1046/j.1432-1327.2001.01897.x; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Lengyel IM, 2014, PAPERS IN PHYS, V6, P1; Michel D, 2010, PROG BIOPHYS MOL BIO, V102, P16, DOI 10.1016/j.pbiomolbio.2009.12.007; Mitarai N, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022710; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Narang A, 2007, J THEOR BIOL, V247, P695, DOI 10.1016/j.jtbi.2007.03.030; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Okahata Y, 1998, BIOCHEMISTRY-US, V37, P5666, DOI 10.1021/bi980037k; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Perros M, 1996, SCIENCE, V274, P1929, DOI 10.1126/science.274.5294.1929; Phillips R., 2012, PHYS BIOL CELL; Phillips R, 2015, ANNU REV CONDEN MA P, V6, P85, DOI 10.1146/annurev-conmatphys-031214-014558; Razo-Mejia M, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026005; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Rydenfelt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114347; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Saiz L, 2008, IET SYST BIOL, V2, P247, DOI 10.1049/iet-syb:20080091; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Saiz L, 2008, NUCLEIC ACIDS RES, V36, P726, DOI 10.1093/nar/gkm1034; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Vilar JMG, 2013, ACS SYNTH BIOL, V2, P576, DOI 10.1021/sb400013w; Vilar JMG, 2011, NUCLEIC ACIDS RES, V39, P6854, DOI 10.1093/nar/gkr272; Vilar JMG, 2010, BIOINFORMATICS, V26, P2060, DOI 10.1093/bioinformatics/btq328; Weinert FM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.258101; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136	66	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179235	10.1371/journal.pone.0179235	http://dx.doi.org/10.1371/journal.pone.0179235			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686609	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000405464100011
J	Ohsugi, H; Ikuno, Y; Shoujou, T; Oshima, K; Ohsugi, E; Tabuchi, H				Ohsugi, Hideharu; Ikuno, Yasushi; Shoujou, Tomohiro; Oshima, Kanako; Ohsugi, Eiko; Tabuchi, Hitoshi			Axial length changes in highly myopic eyes and influence of myopic macular complications in Japanese adults	PLOS ONE			English	Article							TRACTION MACULOPATHY; PATHOLOGICAL MYOPIA; FOLLOW-UP; FOVEOSCHISIS; POPULATION	Purpose To investigate changes of the axial length in normal eyes and highly myopic eyes and influence of myopic macular complications in Japanese adults. Study design Retrospective longitudinal case series. Methods The changes in the axial length of 316 eyes from 316 patients (mean age, 63.8 +/- 9.0 years; range, 34-82; 240 females) examined using IOLMaster with a follow-up period of at least 1 year were studied. This study included 85 non-highly myopic eyes (| refractive error| <= 5 diopters; 63 females; non-highly myopic group), 165 highly myopic eyes (refractive error <=-6 diopters or axial length >= 26 mm; 124 females) without macular complications (no complications group), 32 eyes (25 females) with myopic traction maculopathy (MTM group), and 34 eyes (28 females) with myopic choroidal neovascularization (CNV group). All groups showed a significant increase in the axial length during the follow-up period (mean follow-up, 28.7 +/- 16.8 months; range, 12-78) (P < 0.01). Changes in the axial length/year in the no complications group (0.041 +/- 0.05 mm) were significantly greater than those in the non-highly myopic group (0.007 +/- 0.02 mm) (P < 0.0001). Furthermore, changes in the CNV group (0.081 +/- 0.04 mm) were significantly greater than those in the no complications (P < 0.0001) and MTM (0.040 +/- 0.05 mm) (P = 0.0059) groups, whereas no significant difference was found between the changes in the MTM and no complications groups (P = 0.91). Multiple regression analyses indicated that CNV eyes (P < 0.0001) and female patients' eyes (P = 0.04) showed greater changes in the axial length/year. Conclusions All groups showed an increase in the axial length, which was greater for highly myopic eyes. In particular, CNV eyes showed greater increases, indicating that larger changes in the axial length may require careful follow-up.	[Ohsugi, Hideharu; Shoujou, Tomohiro; Oshima, Kanako; Ohsugi, Eiko; Tabuchi, Hitoshi] Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Ikuno, Yasushi] Ikuno Eye Ctr, Osaka, Japan		Ohsugi, H (corresponding author), Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	h.ohsugi@tsukazaki-eye.net						Bando H, 2005, AM J OPHTHALMOL, V139, P197, DOI 10.1016/j.ajo.2004.07.027; CURTIN BJ, 1971, AM J OPHTHALMOL, V71, P42, DOI 10.1016/0002-9394(71)91092-0; Fledelius HC, 2010, ACTA OPHTHALMOL, V88, P472, DOI 10.1111/j.1755-3768.2008.01472.x; Fotedar R, 2008, OPHTHALMOLOGY, V115, P1273, DOI 10.1016/j.ophtha.2007.11.003; Gaucher D, 2007, AM J OPHTHALMOL, V143, P455, DOI 10.1016/j.ajo.2006.10.053; Gudmundsdottir E, 2005, OPHTHALMOLOGY, V112, P672, DOI 10.1016/j.ophtha.2004.11.039; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; He MG, 2014, JAMA OPHTHALMOL, V132, P978, DOI 10.1001/jamaophthalmol.2014.1011; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P3721, DOI 10.1167/iovs.09-3493; LARSEN JS, 1971, ACTA OPHTHALMOL, V49, P873; Miyake M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107923; Panozzo G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1455, DOI 10.1001/archopht.122.10.1455; Saka N, 2013, GRAEF ARCH CLIN EXP, V251, P495, DOI 10.1007/s00417-012-2066-9; Saka N, 2010, AM J OPHTHALMOL, V150, P562, DOI 10.1016/j.ajo.2010.05.009; Takano M, 1999, AM J OPHTHALMOL, V128, P472, DOI 10.1016/S0002-9394(99)00186-5; Wakazono T, 2016, OPHTHALMOLOGY, V123, P919, DOI 10.1016/j.ophtha.2015.10.031	16	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180851	10.1371/journal.pone.0180851	http://dx.doi.org/10.1371/journal.pone.0180851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686709	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100114
J	Suzuki, T; Espana, MU; Nunes, MA; Zhurov, V; Dermauw, W; Osakabe, M; Van Leeuwen, T; Grbic, M; Grbic, V				Suzuki, Takeshi; Espana, Maria Urizarna; Nunes, Maria Andreia; Zhurov, Vladimir; Dermauw, Wannes; Osakabe, Masahiro; Van Leeuwen, Thomas; Grbic, Miodrag; Grbic, Vojislava			Protocols for the delivery of small molecules to the two-spotted spider mite, Tetranychus urticae	PLOS ONE			English	Article							GREEN PEACH APHID; RNA INTERFERENCE; INDOLE GLUCOSINOLATE; BEMISIA-TABACI; HONEY-BEE; GENE; DSRNA; DIET; IMPROVEMENT; ELEGANS	The two-spotted spider mite, Tetranychus urticae, is a chelicerate herbivore with an extremely wide host range and an extraordinary ability to develop pesticide resistance. Due to its responsiveness to natural and synthetic xenobiotics, the spider mite is becoming a prime pest herbivore model for studies of the evolution of host range, plant-herbivore interactions and mechanisms of xenobiotic resistance. The spider mite genome has been sequenced and its transcriptional responses to developmental and various biotic and abiotic cues have been documented. However, to identify biological and evolutionary roles of T. urticae genes and proteins, it is necessary to develop methods for the efficient manipulation of mite gene function or protein activity. Here, we describe protocols developed for the delivery of small molecules into spider mites. Starting with mite maintenance and the preparation of the experimental mite populations of developmentally synchronized larvae and adults, we describe 3 methods for delivery of small molecules including artificial diet, leaf coating, and soaking. The presented results define critical steps in these methods and demonstrate that they can successfully deliver tracer dyes into mites. Described protocols provide guidelines for high-throughput setups for delivery of experimental compounds that could be used in reverse genetics platforms to modulate gene expression or protein activity, or for screens focused on discovery of new molecules for mite control. In addition, described protocols could be adapted for other Tetranychidae and related species of economic importance such as Varroa, dust and poultry mites.	[Suzuki, Takeshi; Espana, Maria Urizarna; Nunes, Maria Andreia; Zhurov, Vladimir; Grbic, Miodrag; Grbic, Vojislava] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dermauw, Wannes; Van Leeuwen, Thomas] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Ghent, Belgium; [Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto, Japan; [Van Leeuwen, Thomas] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Evolutionary Biol, Amsterdam, Netherlands; [Grbic, Miodrag] Univ La Rioja, Logrono, Spain; [Suzuki, Takeshi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo, Japan; [Nunes, Maria Andreia] Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Cordeiropolis, SP, Brazil	Western University (University of Western Ontario); Ghent University; Kyoto University; University of Amsterdam; Universidad de La Rioja; Tokyo University of Agriculture & Technology; Instituto Agronomico de Campinas (IAC)	Grbic, M; Grbic, V (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.; Grbic, M (corresponding author), Univ La Rioja, Logrono, Spain.	mgrbic@uwo.ca; vgrbic@uwo.ca	Dermauw, Wannes/H-1583-2015; Suzuki, Takeshi/F-7548-2012; Grbic, Miodrag/AID-4825-2022; Osakabe, Masahiro/H-8587-2019	Dermauw, Wannes/0000-0003-4612-8969; Suzuki, Takeshi/0000-0002-7930-1425; Osakabe, Masahiro/0000-0002-2246-3431; Grbic, Vojislava/0000-0001-6570-8796; Zhurov, Vladimir/0000-0002-7120-4655; Van Leeuwen, Thomas/0000-0003-4651-830X	Ontario Research FundResearch Excellence Round 8 [RE08-067]; Postdoctoral Fellowship for Research Abroad - Japan Society for the Promotion of Science (JSPS); National Counsel of Technological and Scientific Development (CNPq/Brazil); Grants-in-Aid for Scientific Research [16K18661] Funding Source: KAKEN	Ontario Research FundResearch Excellence Round 8; Postdoctoral Fellowship for Research Abroad - Japan Society for the Promotion of Science (JSPS); National Counsel of Technological and Scientific Development (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Development of described protocols was supported by the Ontario Research Fund Research Excellence Round 8 (RE08-067) (to MG and VG). TS has been supported by the Postdoctoral Fellowship for Research Abroad funded by the Japan Society for the Promotion of Science (JSPS) and MAN by the National Counsel of Technological and Scientific Development (CNPq/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bensoussan N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01105; Bosse TC, 1996, PHYSIOL ENTOMOL, V21, P188, DOI 10.1111/j.1365-3032.1996.tb00854.x; Campbell EM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-73; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Cazaux M, 2014, JOVE-J VIS EXP, DOI 10.3791/51738; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conte D, 2015, CURR PROTOC MOL BIOL, V109; EKKA I, 1971, J INSECT PHYSIOL, V17, P1393, DOI 10.1016/0022-1910(71)90148-X; Ekka I., 1969, REARING 2 SPOTTED SP; FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gotoh T, 2008, INT J ACAROL, V34, P393, DOI 10.1080/17088180809434783; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; HARE JD, 1988, ENTOMOL EXP APPL, V47, P137, DOI 10.1007/BF00367479; Ikegami Y, 2000, APPL ENTOMOL ZOOL, V35, P339, DOI 10.1303/aez.2000.339; Jonckheere W, 2016, MOL CELL PROTEOMICS, V15, P3594, DOI 10.1074/mcp.M116.058081; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kim YH, 2015, PESTIC BIOCHEM PHYS, V120, P109, DOI 10.1016/j.pestbp.2015.01.002; Kola VSR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00119; Kranthi K.R., 2005, INSECTICIDE RESISTAN; Kwon DH, 2016, PESTIC BIOCHEM PHYS, V130, P1, DOI 10.1016/j.pestbp.2015.11.005; Kwon DH, 2013, PESTIC BIOCHEM PHYS, V105, P69, DOI 10.1016/j.pestbp.2012.12.001; Li JJ, 2015, PEST MANAG SCI, V71, P1175, DOI 10.1002/ps.3903; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Migeon A., 2006, SPIDER MITES WEB COM; PROSSER WA, 1992, J INSECT PHYSIOL, V38, P93, DOI 10.1016/0022-1910(92)90037-E; Protocols CSH, 2006, COLD SPRING HARBOR P, V2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Ubara M, 2015, ENVIRON ENTOMOL, V44, P1210, DOI 10.1093/ee/nvv080; Van Leeuwen T, 2015, PESTIC BIOCHEM PHYS, V121, P12, DOI 10.1016/j.pestbp.2014.12.009; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; VANDERGEEST LPS, 1983, ENTOMOL EXP APPL, V33, P297, DOI 10.1111/j.1570-7458.1983.tb03272.x; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x	43	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180658	10.1371/journal.pone.0180658	http://dx.doi.org/10.1371/journal.pone.0180658			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686745	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100088
J	Guyette, R; Stambaugh, MC; Dey, D; Muzika, RM				Guyette, Richard; Stambaugh, Michael C.; Dey, Daniel; Muzika, Rose Marie			The theory, direction, and magnitude of ecosystem fire probability as constrained by precipitation and temperature	PLOS ONE			English	Article							HISTORY; CLIMATE; USA; DYNAMICS; REGIMES; HUMANS; VEGETATION; FREQUENCY; LANDSCAPE; CHEMISTRY	The effects of climate on wildland fire confronts society across a range of different ecosystems. Water and temperature affect the combustion dynamics, irrespective of whether those are associated with carbon fueled motors or ecosystems, but through different chemical, physical, and biological processes. We use an ecosystem combustion equation developed with the physical chemistry of atmospheric variables to estimate and simulate fire probability and mean fire interval (MFI). The calibration of ecosystem fire probability with basic combustion chemistry and physics offers a quantitative method to address wildland fire in addition to the well-studied forcing factors such as topography, ignition, and vegetation. We develop a graphic analysis tool for estimating climate forced fire probability with temperature and precipitation based on an empirical assessment of combustion theory and fire prediction in ecosystems. Climate-affected fire probability for any period, past or future, is estimated with given temperature and precipitation. A graphic analyses of wildland fire dynamics driven by climate supports a dialectic in hydrologic processes that affect ecosystem combustion: 1) the water needed by plants to produce carbon bonds (fuel) and 2) the inhibition of successful reactant collisions by water molecules (humidity and fuel moisture). These two postulates enable a classification scheme for ecosystems into three or more climate categories using their position relative to change points defined by precipitation in combustion dynamics equations. Three classifications of combustion dynamics in ecosystems fire probability include: 1) precipitation insensitive, 2) precipitation unstable, and 3) precipitation sensitive. All three classifications interact in different ways with variable levels of temperature.	[Guyette, Richard; Stambaugh, Michael C.; Muzika, Rose Marie] Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA; [Dey, Daniel] US Forest Serv, Northern Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	Muzika, RM (corresponding author), Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA.	muzika@missouri.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture, McIntire Stennis [1001125]; USDA Northern Research Station Cooperative agreement [FS11-JV-112442311-054]	National Institute of Food and Agriculture, U.S. Department of Agriculture, McIntire Stennis; USDA Northern Research Station Cooperative agreement	This work was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, McIntire Stennis Project 1001125, https://nifa.usda.gov/program/mcintire-stennisc apacity-grant and the USDA Northern Research Station Cooperative agreement FS11-JV-112442311-054, http://www.nrs.fs.fed.us/.	Alexander ME, 1979, 2 HALF CENTURIES REC; Baisan CH, 1995, INT J WILDLAND FIRE, V6, P97; Baisan CH, 1998, FIRE HIST PONDEROSA; Bale AM, 2007, THESIS; Banks JCG, 1982, THESIS; Batek MJ, 1999, J BIOGEOGR, V26, P397, DOI 10.1046/j.1365-2699.1999.00292.x; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brose PH, 2013, CAN J FOREST RES, V43, P757, DOI 10.1139/cjfr-2012-0463; Brown P.M., 2001, PALEOBOTANIST, V50, P133; Brown PM, 1996, INT J WILDLAND FIRE, V6, P97, DOI 10.1071/WF9960097; Donnegan JA, 2001, CAN J FOREST RES, V31, P1526, DOI 10.1139/cjfr-31-9-1526; Guyette RP, 2006, FOREST ECOL MANAG, V234, P293, DOI 10.1016/j.foreco.2006.07.016; Guyette Richard P., 2015, Great Plains Research, V25, P139; Guyette RP, 2014, FOREST SCI, V60, P862, DOI 10.5849/forsci.13-108; Guyette RP, 2012, ECOSYSTEMS, V15, P322, DOI 10.1007/s10021-011-9512-0; Guyette RP, 2002, ECOSYSTEMS, V5, P472, DOI 10.1007/s10021-002-0115-7; Guyette RP, UNPUB; Heyerdahl EK, 2002, HOLOCENE, V12, P597, DOI 10.1191/0959683602hl570rp; Heyerdahl EK, 2006, FOREST ECOL MANAG, V230, P107, DOI 10.1016/j.foreco.2006.04.024; Huffman M., 2006, THESIS; Keane RE, 2015, ECOL MODEL, V309, P33, DOI 10.1016/j.ecolmodel.2015.04.009; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Medler M., 2015, WILDLAND FIRE DEFICI; Morrison PH, 1990, TECH REP; Muzika RM, 2015, J SUSTAIN FOREST, V34, P49, DOI 10.1080/10549811.2014.973991; Parks SA, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00294.1; Russell AP, 2007, CANADIAN J FOREST RE, V37, P1605; Stambaugh MC, 2014, FOREST ECOL MANAG, V320, P83, DOI 10.1016/j.foreco.2014.02.022; Stambaugh MC, 2011, J VEG SCI, V22, P1094, DOI 10.1111/j.1654-1103.2011.01322.x; Swetnam TW, 1991, YOS CENT S P NAT AR, P249; Swetnam TW, 1989, 32 COOP NAT PARK RES; Veblen TT, 1999, ECOL MONOGR, V69, P47, DOI 10.1890/0012-9615(1999)069[0047:FHINPT]2.0.CO;2; Wendel R, 2010, NORTHWEST SCI, V84, P88, DOI 10.3955/046.084.0109; Whitman E, 2015, J BIOGEOGR, P1	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180956	10.1371/journal.pone.0180956	http://dx.doi.org/10.1371/journal.pone.0180956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704457	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700066
J	Li, N; Li, SM; Zhang, KP; Chen, WJ; Zhang, B; Wang, DW; Liu, DC; Liu, BL; Zhang, HG				Li, Na; Li, Shiming; Zhang, Kunpu; Chen, Wenjie; Zhang, Bo; Wang, Daowen; Liu, Dengcai; Liu, Baolong; Zhang, Huaigang			ThMYC4E, candidate Blue aleurone 1 gene controlling the associated trait in Triticum aestivum	PLOS ONE			English	Article							BLUE-GRAINED WHEAT; REGULATORY GENES; DEVELOPING SEEDS; DIPLOID WHEAT; ANTHOCYANIN; EXPRESSION; BIOSYNTHESIS; CLONING; PURPLE; ORIGIN	Blue aleurone is a useful and interesting trait in common wheat that was derived from related species. Here, transcriptomes of blue and white aleurone were compared for isolating Blue aleurone 1 (Ba1) transferred from Thinopyrum ponticum. In the genes involved in anthocyanin biosynthesis, only a basic helix-loop-helix (bHLH) transcription factor, ThMYC4E, had a higher transcript level in blue aleurone phenotype, and was homologous to the genes on chromosome 4 of Triticum aestivum. ThMYC4E carried the characteristic domains (bHLH-MYC_ N, HLH and ACT-like) of a bHLH transcription factor, and clustered with genes regulating anthocyanin biosynthesis upon phylogenetic analysis. The over-expression of ThMYC4E regulated anthocyanin biosynthesis with the coexpression of the MYB transcription factor ZmC1 from maize. ThM YC4E existed in the genomes of the addition, substitution and near isogenic lines with the blue aleurone trait derived from Th. ponticum, and could not be detected in any germplasm of T. urartu, T. monococcum, T. turgidum, Aegilops tauschii or T. aestivum, with white aleurone. These results suggested that ThMYC4E was candidate Ba1 gene controlling the blue aleurone trait in T. aestivum genotypes carrying Th. ponticum introgression. The ThMYC4E isolation aids in better understanding the genetic mechanisms of the blue aleurone trait and in its more effective use during wheat breeding.	[Li, Na; Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Baolong; Zhang, Huaigang] Qinghai Prov Key Lab Crop Mol Breeding, Xining, Peoples R China; [Li, Na] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Shiming; Chen, Wenjie; Zhang, Bo; Liu, Baolong; Zhang, Huaigang] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Xining, Qinghai, Peoples R China; [Zhang, Kunpu; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Liu, Dengcai] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Sichuan Agricultural University	Liu, BL; Zhang, HG (corresponding author), Qinghai Prov Key Lab Crop Mol Breeding, Xining, Peoples R China.; Liu, BL; Zhang, HG (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota AEPB, Xining, Qinghai, Peoples R China.	blliu@nwipb.cas.cn; hgzhang@nwipb.cas.cn	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; Liu, Dengcai/0000-0001-5508-1125; liu, bao long/0000-0002-6756-4033	Ministry of Science and Technology of China [2016YFD0100500]; Basic Research Projects of Qinghai Province [2015-ZJ-701]; West Light Foundation of the Chinese Academy of Sciences; National Natural Science Foundation of China [31071417, 31260322]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08030106]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Basic Research Projects of Qinghai Province; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by the Ministry of Science and Technology of China (2016YFD0100500), the Basic Research Projects of Qinghai Province (2015-ZJ-701), the West Light Foundation of the Chinese Academy of Sciences, the National Natural Science Foundation of China (31071417, 31260322) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA08030106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2003, J AGR FOOD CHEM, V51, P2174, DOI 10.1021/jf021043x; Ahmed N, 2003, BREEDING SCI, V53, P29; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bowen-Forbes CS, 2010, J FOOD COMPOS ANAL, V23, P554, DOI 10.1016/j.jfca.2009.08.012; Buresova V, 2015, THEOR APPL GENET, V128, P273, DOI 10.1007/s00122-014-2427-3; Carpenter R, 1990, GENE DEV, V4, P537; Dorn KM, 2013, PLANT J, V75, P1028, DOI 10.1111/tpj.12267; Dubcovsky J, 1996, GENETICS, V143, P983; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hucl P, 2001, CROP SCI, V41, P1348, DOI 10.2135/cropsci2001.4141348x; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; LI ZS, 1986, CEREAL RES COMMUN, V14, P133; Liu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155428; Metzger RJ, 2004, CROP SCI, V44, P2281, DOI 10.2135/cropsci2004.2281; Mori M, 2009, BIOSCI BIOTECH BIOCH, V73, P2329, DOI 10.1271/bbb.90349; Morrison LA, 2004, CROP SCI, V44, P2063, DOI 10.2135/cropsci2004.2063; Petroni K, 2000, GENETICS, V155, P323; Procissi A, 1997, PLANT CELL, V9, P1547, DOI 10.1105/tpc.9.9.1547; Qiu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151067; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Singh K, 2007, THEOR APPL GENET, V115, P301, DOI 10.1007/s00122-007-0543-z; Styles ED, 2011, GENOME, V15, P59; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TONELLI C, 1991, MOL GEN GENET, V225, P401, DOI 10.1007/BF00261680; Troian V, 2004, J CEREAL SCI, V59, P48; Wang CX, 2007, CHINESE SCI BULL, V52, P3097, DOI 10.1007/s11434-007-0472-x; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Whang SS, 2011, J PLANT BIOL, V54, P209, DOI 10.1007/s12374-011-9158-7; Whelan ED, 2011, GENOME, V32, P30; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Yang GH, 2004, ACTA BOT SIN, V46, P588; Yang GH, 2003, ACTA BOT SIN, V45, P1329; ZELLER FJ, 1991, THEOR APPL GENET, V81, P551, DOI 10.1007/BF00219448; ZEVEN AC, 1991, EUPHYTICA, V56, P243, DOI 10.1007/BF00042371; Zhang N, 2014, MOL BIOL REP, V41, P505, DOI 10.1007/s11033-013-2886-7; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zheng Q, 2006, EUPHYTICA, V152, P51, DOI 10.1007/s10681-006-9176-6; Zheng Q, 2009, J GENET GENOMICS, V36, P575, DOI 10.1016/S1673-8527(08)60149-6; Zhou KJ, 2006, CROP SCI, V46, P250, DOI 10.2135/cropsci2005.0029	43	23	27	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181116	10.1371/journal.pone.0181116	http://dx.doi.org/10.1371/journal.pone.0181116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704468	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700091
J	Singh, C; Levy, WB				Singh, Chandan; Levy, William B.			A consensus layer V pyramidal neuron can sustain interpulse-interval coding	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; SODIUM-CHANNEL; SIMPLE CELLS; DIFFUSION-APPROXIMATION; DIRECTION SELECTIVITY; BAYESIAN-INFERENCE; PERSISTENT SODIUM; MODEL NEURON; POPULATION; NOISE	In terms of a single neuron's long-distance communication, interpulse intervals (IPIs) are an attractive alternative to rate and binary codes. As a proxy for an IPI, a neuron's time-to-spike can be found in the biophysical and experimental intracellular literature. Using the current, consensus layer V pyramidal neuron, the present study examines the feasibility of IPI-coding and examines the noise sources that limit the information rate of such an encoding. In descending order of importance, the noise sources are (i) synaptic variability, (ii) sodium channel shot-noise, followed by (iii) thermal noise. The biophysical simulations allow the calculation of mutual information, which is about 3.0 bits/spike. More importantly, while, by any conventional definition, the biophysical model is highly nonlinear, the underlying function that relates input intensity to the defined output variable is linear. When one assumes the perspective of a neuron coding via first hitting-time, this result justifies a pervasive and simplifying assumption of computational modelers D that a class of cortical neurons can be treated as linearly additive, computational devices.	[Levy, William B.] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA; Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Levy, WB (corresponding author), Univ Virginia, Dept Neurosurg, Charlottesville, VA 22903 USA.	wbl@virginia.edu			US National Science Foundation [1162449]; Department of Neurosurgery	US National Science Foundation(National Science Foundation (NSF)); Department of Neurosurgery	We thank the Department of Neurosurgery for their financial support and also are thankful for the US National Science Foundation Grant 1162449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; [Anonymous], 2001, ION CHANNELS EXCITAB; Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bahl A, 2012, J NEUROSCI METH, V210, P22, DOI 10.1016/j.jneumeth.2012.04.006; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Baranauskas G, 2013, P NATL ACAD SCI USA, V110, P4051, DOI 10.1073/pnas.1215125110; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Barbour A.D., 1992, POISSON APPROXIMATIO; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Berger T, 2010, IEEE T INFORM THEORY, V56, P852, DOI 10.1109/TIT.2009.2037089; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Berry MJ, 1998, J NEUROSCI, V18, P2200; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; CAPOCELLI RM, 1971, KYBERNETIK, V8, P214, DOI 10.1007/BF00288750; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carnevale NT, 2006, NEURON BOOK; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; CHEN LHY, 1975, ANN PROBAB, V3, P534, DOI 10.1214/aop/1176996359; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; CONTI F, 1976, J PHYSIOL-LONDON, V262, P699, DOI 10.1113/jphysiol.1976.sp011616; Cook EP, 2007, PROG BRAIN RES, V165, P1, DOI 10.1016/S0079-6123(06)65001-2; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Ermentrout G., 2010, MATH FDN NEUROSCIENC, V35; Faisal A. A., 2012, COMPUTATIONAL SYSTEM, P227, DOI [10.1007/978-94-007-3858-4-8, DOI 10.1007/978-94-007-3858-4-8]; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Ferster David, 1994, Current Opinion in Neurobiology, V4, P563, DOI 10.1016/0959-4388(94)90058-2; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gerwinn S, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00012; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GIORNO V, 1988, BIOL CYBERN, V58, P387, DOI 10.1007/BF00361346; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; HILLE B, 1978, BIOPHYS J, V22, P283, DOI 10.1016/S0006-3495(78)85489-7; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Iyengar S, 1997, BIOL CYBERN, V77, P289, DOI 10.1007/s004220050390; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jie Xing, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P2964, DOI 10.1109/ISIT.2012.6284081; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Lansky P, 2001, PHYS LETT A, V285, P132, DOI 10.1016/S0375-9601(01)00340-1; LANSKY P, 1995, BIOL CYBERN, V72, P397, DOI 10.1007/BF00201415; Lansky P., 1990, TRENDS BIOL CYBERN, V1, P153; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; LEVY W B, 1988, Society for Neuroscience Abstracts, V14, P168; Levy W. B., 2016, IEEE T MOL BIOL MULT, V2, P154; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; Levy WB, 1990, ELEMENTAL ADAPTIVE P, V187; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McDonnell MD, 2011, BIOL CYBERN, V105, P55, DOI 10.1007/s00422-011-0451-9; Morel D, 2008, BMC NEUROSCI, V9, P1; Morel D, 2007, NEUROCOMPUTING, V70, P1635, DOI 10.1016/j.neucom.2006.10.054; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Reinagel P., 1998, Society for Neuroscience Abstracts, V24, P139; Revah O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132108; RICCIARDI LM, 1979, BIOL CYBERN, V35, P1, DOI 10.1007/BF01845839; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; RIEKE F, 1993, EUROPHYS LETT, V22, P151, DOI 10.1209/0295-5075/22/2/013; Rieke F, 1997, ROB RUYTER STEVENINC; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rotaru DC, 2007, J PHYSIOL-LONDON, V581, P981, DOI 10.1113/jphysiol.2007.130864; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schrodinger E., 1968, STAT THERMODYNAMICS; Sengupta B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003439; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; Steinmetz PN, 2000, J COMPUT NEUROSCI, V9, P133, DOI 10.1023/A:1008967807741; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Sugihara T, 2011, J NEUROPHYSIOL, V106, P374, DOI 10.1152/jn.00928.2010; Sungkar M., 2016, IEEE T MOL BIOL MULT, V2, P166; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Tuckwell H. C., 2005, INTRO THEORETICAL NE, V8; Tuckwell H. C., 2005, INTRO THEORETICAL NE, V2; Tuckwell HC, 2016, ARXIV160404796; van Rossum MCW, 2003, J NEUROPHYSIOL, V89, P2406, DOI 10.1152/jn.01106.2002; Wald A., 1973, SEQUENTIAL ANAL; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Warland DK, 1991, READING SPIKES REAL; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Yarom Y, 2011, PHYSIOL REV, V91, P917, DOI 10.1152/physrev.00019.2010; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	110	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180839	10.1371/journal.pone.0180839	http://dx.doi.org/10.1371/journal.pone.0180839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704450	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700054
J	Lynch, ZR; Schlenke, TA; Morran, LT; de Roode, JC				Lynch, Zachary R.; Schlenke, Todd A.; Morran, Levi T.; de Roode, Jacobus C.			Ethanol confers differential protection against generalist and specialist parasitoids of Drosophila melanogaster	PLOS ONE			English	Article							OVIPOSITION-SITE PREFERENCE; ANTIMICROBIAL PEPTIDE GENES; ALCOHOL-DEHYDROGENASE; SELF-MEDICATION; LEPTOPILINA-HETEROTOMA; RESOURCE UTILIZATION; ASOBARA-TABIDA; HOST-DEFENSE; RESISTANCE; EVOLUTION	As parasites coevolve with their hosts, they can evolve counter-defenses that render host immune responses ineffective. These counter-defenses are more likely to evolve in specialist parasites than generalist parasites; the latter face variable selection pressures between the different hosts they infect. Natural populations of the fruit fly Drosophila melanogaster are commonly threatened by endoparasitoid wasps in the genus Leptopilina, including the specialist L. boulardi and the generalist L. heterotoma, and both wasp species can incapacitate the cellular immune response of D. melanogaster larvae. Given that ethanol tolerance is high in D. melanogaster and stronger in the specialist wasp than the generalist, we tested whether fly larvae could use ethanol as an anti-parasite defense and whether its effectiveness would differ against the two wasp species. We found that fly larvae benefited from eating ethanol-containing food during exposure to L. heterotoma; we observed a two-fold decrease in parasitization intensity and a 24-fold increase in fly survival to adulthood. Although host ethanol consumption did not affect L. boulardi parasitization rates or intensities, it led to a modest increase in fly survival. Thus, ethanol conferred stronger protection against the generalist wasp than the specialist. We tested whether fly larvae can self-medicate by seeking ethanol-containing food after being attacked by wasps, but found no support for this hypothesis. We also allowed female flies to choose between control and ethanol-containing oviposition sites in the presence vs. absence of wasps and generally found significant preferences for ethanol regardless of wasp presence. Overall, our results suggest that D. melanogaster larvae obtain protection from certain parasitoid wasp species through their mothers' innate oviposition preferences for ethanol-containing food sources.	[Lynch, Zachary R.; Schlenke, Todd A.; Morran, Levi T.; de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Schlenke, Todd A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Emory University; University of Arizona	Lynch, ZR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	zach.lynch1@gmail.com		Schlenke, Todd/0000-0003-3091-3057				Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Allemand R, 2002, ANN SOC ENTOMOL FR, V38, P319, DOI 10.1080/00379271.2002.10697346; Anagnostou C, 2010, OIKOS, V119, P533, DOI 10.1111/j.1600-0706.2009.18001.x; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BOULETREAU M, 1981, EVOLUTION, V35, P395, DOI 10.2307/2407848; CARTON Y, 1981, BIOL J LINN SOC, V16, P227, DOI 10.1111/j.1095-8312.1981.tb01849.x; Carton Y., 1986, P347; CAVENER D, 1979, BEHAV GENET, V9, P359, DOI 10.1007/BF01066974; DAVID JR, 1983, COMP BIOCHEM PHYS A, V74, P283, DOI 10.1016/0300-9629(83)90601-1; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; de Roode Jacobus C., 2012, Insects, V3, P789, DOI 10.3390/insects3030789; Dweck HKM, 2013, CURR BIOL, V23, P2472, DOI 10.1016/j.cub.2013.10.047; Eslin P, 2000, J INSECT PHYSIOL, V46, P1161, DOI 10.1016/S0022-1910(99)00227-9; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoang D, 2015, PEERJ, V3, P16; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kacsoh BZ, 2015, GENETICS, V199, P1143, DOI 10.1534/genetics.114.172221; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Labrosse C, 2003, J INSECT PHYSIOL, V49, P513, DOI 10.1016/S0022-1910(03)00054-4; Lefevre T, 2012, BIOL LETTERS, V8, P230, DOI 10.1098/rsbl.2011.0725; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lynch ZR, 2016, J EVOLUTION BIOL, V29, P1016, DOI 10.1111/jeb.12842; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; MCKENZIE JA, 1979, OECOLOGIA, V40, P299, DOI 10.1007/BF00345326; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; MERCOT H, 1994, EVOLUTION, V48, P746, DOI 10.1111/j.1558-5646.1994.tb01358.x; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; PARSONS PA, 1977, OECOLOGIA, V30, P141, DOI 10.1007/BF00345417; PARSONS PA, 1977, EXPERIENTIA, V33, P898, DOI 10.1007/BF01951269; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; R Development Core team, 2014, R A LANGUAGE AND ENV; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; RIZKI TM, 1990, EXP PARASITOL, V70, P466, DOI 10.1016/0014-4894(90)90131-U; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Siegal ML, 1999, BEHAV GENET, V29, P199, DOI 10.1023/A:1021648103496; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Sumethasorn M, 2016, BIOL OPEN, V5, P1642, DOI 10.1242/bio.019380; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Zhu J, 2015, ENTOMOL EXP APPL, V155, P64, DOI 10.1111/eea.12285	57	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180182	10.1371/journal.pone.0180182	http://dx.doi.org/10.1371/journal.pone.0180182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700600	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600022
J	Rodriguez, A; Tembl, J; Mesa-Gresa, P; Munoz, MA; Montoya, P; Rey, B				Rodriguez, Alejandro; Tembl, Jose; Mesa-Gresa, Patricia; Angel Munoz, Miguel; Montoya, Pedro; Rey, Beatriz			Altered cerebral blood flow velocity features in fibromyalgia patients in resting-state conditions	PLOS ONE			English	Article							LEMPEL-ZIV COMPLEXITY; COGNITIVE TASKS; DOMAIN ANALYSIS; BRAIN ACTIVITY; PAIN; DEPRESSION; RESPONSES; CONNECTIVITY; ENTROPY; EEG	The aim of this study is to characterize in resting-state conditions the cerebral blood flow velocity (CBFV) signals of fibromyalgia patients. The anterior and middle cerebral arteries of both hemispheres from 15 women with fibromyalgia and 15 healthy women were monitored using Transcranial Doppler (TCD) during a 5-minute eyes-closed resting period. Several signal processing methods based on time, information theory, frequency and time-frequency analyses were used in order to extract different features to characterize the CBFV signals in the different vessels. Main results indicated that, in comparison with control subjects, fibromyalgia patients showed a higher complexity of the envelope CBFV and a different distribution of the power spectral density. In addition, it has been observed that complexity and spectral features show correlations with clinical pain parameters and emotional factors. The characterization features were used in a lineal model to discriminate between fibromyalgia patients and healthy controls, providing a high accuracy. These findings indicate that CBFV signals, specifically their complexity and spectral characteristics, contain information that may be relevant for the assessment of fibromyalgia patients in resting-state conditions.	[Rodriguez, Alejandro; Rey, Beatriz] Univ Politecn Valencia, Dept Ingn Graf, Camino Vera S-N, Valencia, Spain; [Tembl, Jose] Hosp Univ & Politecn La Fe, Dept Neurol, Valencia, Spain; [Mesa-Gresa, Patricia] Univ Valencia, Fac Psicol, Dept Psicobiol, Blasco Ibanez 21, Valencia, Spain; [Angel Munoz, Miguel] Univ Granada, Dept Personalidad Evaluac & Tratamientos Psicol, Granada, Spain; [Montoya, Pedro] Univ Illes Balears, IUNICS, Palma De Mallorca, Spain	Universitat Politecnica de Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; University of Granada; Universitat de les Illes Balears	Rey, B (corresponding author), Univ Politecn Valencia, Dept Ingn Graf, Camino Vera S-N, Valencia, Spain.	beareyso@dig.upv.es	Montoya, Pedro/A-4666-2009; Mesa, Patricia/M-3773-2014; Ortega, Alejandro Rodríguez/AAC-2208-2019; Muñoz, Miguel Angel/A-8067-2017; Rey, Beatriz/P-6897-2014	Montoya, Pedro/0000-0001-8652-948X; Ortega, Alejandro Rodríguez/0000-0003-4781-6368; Muñoz, Miguel Angel/0000-0002-8361-7297; Rey, Beatriz/0000-0001-9213-1443				Abasolo D, 2006, MED ENG PHYS, V28, P315, DOI 10.1016/j.medengphy.2005.07.004; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Aleem IS, 2012, ONLINE ENV CONTROL M; Mendez MA, 2012, J PSYCHOPHARMACOL, V26, P636, DOI 10.1177/0269881111408966; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bornas X, 2006, BIOL PSYCHOL, V73, P272, DOI 10.1016/j.biopsycho.2006.05.004; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craggs JG, 2012, J PAIN, V13, P390, DOI 10.1016/j.jpain.2012.01.002; Davis KD, 2000, NEUROL RES, V22, P313; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; Duschek S, 2012, PSYCHOSOM MED, V74, P802, DOI 10.1097/PSY.0b013e3182676d08; Duschek S, 2012, PAIN MED, V13, P419, DOI 10.1111/j.1526-4637.2012.01329.x; Duschek S, 2011, ANN BEHAV MED, V41, P235, DOI 10.1007/s12160-010-9237-x; Fallon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159198; Ferrer V. A., 1993, DOLOR, V8, P153; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Gonzalez-Roldan AM, 2016, PAIN MED, V17, P1058, DOI 10.1093/pm/pnw023; Huang H., 2013, CHARACTERIZATI UNPUB; Huang HR, 2013, ULTRASOUND MED BIOL, V39, P2285, DOI 10.1016/j.ultrasmedbio.2013.06.016; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Kim JY, 2013, PAIN, V154, P1792, DOI 10.1016/j.pain.2013.05.040; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li M, 2014, NEUROSCI RES, V84, P19, DOI 10.1016/j.neures.2014.02.009; Li YJ, 2008, CLIN NEUROPHYSIOL, V119, P1232, DOI 10.1016/j.clinph.2008.01.104; Lu J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00199; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Meagher MW, 2001, PSYCHOSOM MED, V63, P79, DOI 10.1097/00006842-200101000-00010; Montoro CI, 2016, PAIN MED, V17, P2256, DOI 10.1093/pm/pnw082; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Morton DL, 2016, J PAIN RES, V9, P613, DOI 10.2147/JPR.S60433; Myrden AJB, 2011, THESIS; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Rey B, 2010, ULTRASOUND MED BIOL, V36, P383, DOI 10.1016/j.ultrasmedbio.2009.11.001; del Paso GAR, 2015, J CLIN EXP NEUROPSYC, V37, P414, DOI 10.1080/13803395.2015.1023265; del Paso GAR, 2011, J PSYCHOSOM RES, V70, P125, DOI 10.1016/j.jpsychores.2010.09.012; del Paso GAR, 2010, PSYCHOSOM MED, V72, P462, DOI 10.1097/PSY.0b013e3181da91f1; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Sanz J., 2003, ANAL MODIF CONDUCT, P239, DOI DOI 10.6018/ANALESPS.29.1.130532; Sejdic E., 2010, BMC RES, V3, DOI DOI 10.1186/1756-0500-3-269; Sejdic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055405; Sluka KA, 2016, NEUROSCIENCE, V338, P114, DOI 10.1016/j.neuroscience.2016.06.006; Spielberger C. D., 1970, MANUAL STATE TRAIT I; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Ucar M, 2015, J INT MED RES, V43, P679, DOI 10.1177/0300060515587578; Weisenberg M, 1998, PAIN, V76, P365, DOI 10.1016/S0304-3959(98)00069-4; Witting N, 2006, PAIN, V120, P145, DOI 10.1016/j.pain.2005.10.034; Zhang Y, 2015, J AFFECT DISORDERS, V188, P310, DOI 10.1016/j.jad.2015.09.017	65	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180253	10.1371/journal.pone.0180253	http://dx.doi.org/10.1371/journal.pone.0180253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700720	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600024
J	Dobrovolny, HM; Beauchemin, CAA				Dobrovolny, Hana M.; Beauchemin, Catherine A. A.			Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; 2009 PANDEMIC INFLUENZA; VIRUS IN-VITRO; A VIRUS; VIRAL FITNESS; INTRACELLULAR-TRANSPORT; AMANTADINE-RESISTANT; REPLICATION FITNESS; APICAL SURFACE; UNITED-STATES	The emergence of influenza drug resistance has become of particular interest as current planning for an influenza pandemic involves using massive amounts of antiviral drugs. We use semi-stochastic simulations to examine the emergence of drug resistant mutants during the course of a single infection within a patient in the presence and absence of antiviral therapy. We specifically examine three factors and their effect on the emergence of drugresistant mutants: antiviral mechanism, the immune response, and surface proteins. We find that adamantanes, because they act at the start of the replication cycle to prevent infection, are less likely to produce drug-resistant mutants than NAIs, which act at the end of the replication cycle. A mismatch between surface proteins and internal RNA results in drugresistant mutants being less likely to emerge, and emerging later in the infection because the mismatch gives antivirals a second chance to prevent propagation of the mutation. The immune response subdues slow growing infections, further reducing the probability that a drug resistant mutant will emerge and yield a drug-resistant infection. These findings improve our understanding of the factors that contribute to the emergence of drug resistance during the course of a single influenza infection.	[Dobrovolny, Hana M.] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA; [Dobrovolny, Hana M.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Beauchemin, Catherine A. A.] RIKEN, Interdisciplinary Theoret Sci iTHES Res Grp, Wako, Saitama, Japan	Texas Christian University; Toronto Metropolitan University; RIKEN	Dobrovolny, HM (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.; Dobrovolny, HM (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	h.dobrovolny@tcu.edu	Beauchemin, Catherine AA/G-4619-2011; Dobrovolny, Hana M./A-2447-2013	Beauchemin, Catherine AA/0000-0003-0599-0069; Dobrovolny, Hana M./0000-0003-3592-6770	Natural Sciences and Engineering Research Council of Canada [355837-2013]; Ministry of Research and Innovation of the Government of Ontario [ER13-09-040]; iTHES research programme at RIKEN	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Research and Innovation of the Government of Ontario; iTHES research programme at RIKEN	This research was supported in part by Discovery Grant 355837-2013 from the Natural Sciences and Engineering Research Council of Canada (to C.A.A.B.), Early Researcher Award ER13-09-040 (to C.A.A.B) from the Ministry of Research and Innovation of the Government of Ontario, with additional support through the iTHES research programme at RIKEN (to C.A.A.B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Abed Y, 2006, ANTIVIR THER, V11, P971; Abed Y, 2014, J VIROL, V88, P1652, DOI 10.1128/JVI.02681-13; Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Althouse BM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002912; Atkinson K., 2004, ELEMENTARY NUMERICAL, V3rd; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baranovich T, 2011, CURR OPIN VIROL, V1, P574, DOI 10.1016/j.coviro.2011.08.006; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Boianelli A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00060; Bourret V, 2015, INFECT GENET EVOL, V33, P47, DOI 10.1016/j.meegid.2015.04.009; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Brown AN, 2010, ANTIMICROB AGENTS CH, V54, P3442, DOI 10.1128/AAC.01385-09; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568; Chao DL, 2012, J R SOC INTERFACE, V9, P648, DOI 10.1098/rsif.2011.0427; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Crystal RG, 1991, THE LUNG SCIENTIFIC; DANIELS PU, 1989, FEBS LETT, V244, P57, DOI 10.1016/0014-5793(89)81161-5; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; ENAMI M, 1985, VIROLOGY, V142, P68, DOI 10.1016/0042-6822(85)90423-4; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hamelin ME, 2011, ANTIVIR THER, V16, P775, DOI 10.3851/IMP1794; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; HAY AJ, 1996, ANTIVIRAL DRUG RESIS, P43; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; HUGHEY PG, 1992, J VIROL, V66, P5542, DOI 10.1128/JVI.66.9.5542-5552.1992; Hur KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068235; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Loverdo C, 2013, EVOLUTION, V67, P1815, DOI 10.1111/evo.12048; Loverdo C, 2012, EVOLUTION, V66, P3462, DOI 10.1111/j.1558-5646.2012.01687.x; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Palmer J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40210; Paradis EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126115; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Petrie SM, 2015, J THEOR BIOL, V382, P259, DOI 10.1016/j.jtbi.2015.07.003; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Pizzorno A, 2012, ANTIMICROB AGENTS CH, V56, P1208, DOI 10.1128/AAC.05994-11; Robinson M, 2013, MATH BIOSCI, V243, P163, DOI 10.1016/j.mbs.2013.03.003; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Vester D, 2010, J VIROL METHODS, V168, P63, DOI 10.1016/j.jviromet.2010.04.017; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wargo AR, 2012, CURR OPIN VIROL, V2, P538, DOI 10.1016/j.coviro.2012.07.007; Wong DDY, 2012, J VIROL, V86, P10558, DOI 10.1128/JVI.00985-12; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Wutzler P, 2004, J CLIN VIROL, V31, P84, DOI 10.1016/j.jcv.2004.05.009; Xiao YY, 2016, J MATH BIOL, V72, P343, DOI 10.1007/s00285-015-0887-y; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09; Zhao X, 2012, ANTIVIR RES, V96, P91, DOI 10.1016/j.antiviral.2012.09.001	83	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180582	10.1371/journal.pone.0180582	http://dx.doi.org/10.1371/journal.pone.0180582			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700622	Green Published, gold			2022-12-27	WOS:000405544800057
J	Fatukasi, TV; Cole, SR; Moore, RD; Mathews, WC; Edwards, JK; Eron, JJ				Fatukasi, Terra V.; Cole, Stephen R.; Moore, Richard D.; Mathews, William C.; Edwards, Jessie K.; Eron, Joseph J.		CNICS Investigators	Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients	PLOS ONE			English	Article							VIROLOGICAL SUPPRESSION; INFECTED PATIENTS; DISPARITIES; MORTALITY; TRENDS; CARE; RACE	Prompt initiation of combination antiretroviral therapy (ART) is important to reduce comorbidity and mortality among people living with HIV, especially for those with a low CD4 cell count. However there is evidence that not everyone receives prompt initiation of ART after enrolling into HIV care. The current study investigated factors associated with failure to initiate ART within two years of entering into care among those with a CD4 count at or below 350 cells/mm 3. The sample included 4,907 ART-naive patients with a CD4 count at or below 350 cells/mm 3 enrolled between January 1, 2003 and December 31, 2012 at any of eight clinical sites in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS). The two-year risk of delayed ART initiation was estimated using a log-binomial regression model with stabilized inverse probability of censoring weights for those lost to follow-up. Adjusting for other factors, an earlier enrollment date was the sole demographic characteristic associated with an increased risk of delayed ART initiation. Higher CD4 count, lower viral load, and a prevalent AIDS diagnosis were clinical characteristics associated with delayed ART initiation. Gender, age, race/ethnicity and HIV risk factors such as reported male-to-male sexual contact and injection drug use were not associated with delayed ART initiation. This study identified characteristics of patients for whom treatment was strongly to moderately recommended but who did not initiate ART within two years of entering care. Despite the known benefits of early antiretroviral therapy initiation, a lower viral load measurement may continue to be an important clinical characteristic in the more recent era with current ART initiation guidelines. These findings provide a target for closer monitoring and intervention to reduce disparities in HIV care.	[Fatukasi, Terra V.; Cole, Stephen R.; Edwards, Jessie K.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Moore, Richard D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mathews, William C.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Eron, Joseph J.] Univ North Carolina Chapel Hill, Dept Med, Div Infect Dis, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fatukasi, TV (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.	tvmack@med.unc.edu		Edwards, Jessie/0000-0002-1741-335X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI100654]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, P30AI036214, P30AI027757, P30AI036219, P30AI027763, P30AI050410, P30AI060354, P30AI027767] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this thesis was supported by National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI100654 (https://www.niaid.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abara WE, 2014, AM J PUBLIC HEALTH, V104, pE135, DOI 10.2105/AJPH.2014.302227; Adedinsewo DA, 2014, AIDS PATIENT CARE ST, V28, P613, DOI 10.1089/apc.2014.0194; Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Centers for Disease Control and Prevention, STAT OV; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Hanna DB, 2013, CLIN INFECT DIS, V56, P1174, DOI 10.1093/cid/cit003; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsu LC, 2014, J INFECT DIS, V209, P1310, DOI 10.1093/infdis/jit599; Lemly DC, 2009, J INFECT DIS, V199, P991, DOI 10.1086/597124; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Novak RM, 2015, JAIDS-J ACQ IMM DEF, V70, P23, DOI 10.1097/QAI.0000000000000652; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412	18	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180843	10.1371/journal.pone.0180843	http://dx.doi.org/10.1371/journal.pone.0180843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700693	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800087
J	McDonald, LT; Johnson, SD; Russell, DL; Young, MRI; LaRue, AC				McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; Young, M. Rita I.; LaRue, Amanda C.			Role of a novel immune modulating DDR2-expressing population in silica-induced pulmonary fibrosis	PLOS ONE			English	Article							CELL-POPULATION; DENDRITIC CELLS; MICE; FIBROBLASTS; FIBROCYTES; MECHANISMS; BLEOMYCIN; DYNAMICS	Micro-injuries associated with chronic inhaled particle exposures are linked with activation of the immune response and are thought to contribute to progression of fibrotic disease. In the pulmonary environment, we have previously demonstrated a heterogeneous population of circulating fibroblast precursors (CFPs), which are defined by expression of the pan-leukocyte marker CD45 and the collagen receptor, discoidin domain receptor-2 (DDR2). This population is derived from the hematopoietic stem cell, expresses collagen, and has a fibro-blastic morphology in vitro. Herein, we demonstrate a novel subset of CFPs expressing immune markers CD11b, CD11c, and major histocompatibility complex II (MHC II). The CFP population was skewed toward this immune marker expressing subset in animals with silica-induced pulmonary fibrosis. Data indicate that this CFP subset upregulates co-stimulatory molecules and MHC II expression in response to silica-induced fibrosis in vivo. Functionally, this population was shown to promote T cell skewing away from a Th1 response and toward a pro-inflammatory profile. These studies represent the first direct flow cytometric and functional evaluation of the novel immune marker expressing CFP subset in an exposure-induced model of pulmonary fibrosis. Elucidating the role of this CFP subset may enhance our understanding of the complex immune balance critical to mediating exposures at the pulmonary-host interface and may be a valuable target for the treatment of exposure-induced pulmonary fibrosis.	[McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; Young, M. Rita I.; LaRue, Amanda C.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA; [McDonald, Lindsay T.; Johnson, Sara D.; Russell, Dayvia L.; LaRue, Amanda C.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Young, M. Rita I.] Med Univ South Carolina, Dept Otolaryngol, Charleston, SC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	LaRue, AC (corresponding author), Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA.; LaRue, AC (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	laruerc@musc.edu	McDonald, Lindsay/K-2122-2019	McDonald, Lindsay/0000-0003-3967-4435; Russell, Dayvia/0000-0002-7804-2951; Sidles, Sara/0000-0001-7177-0270	Department of Veterans Affairs, VA Merit Award [BX-002277]; Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	Department of Veterans Affairs, VA Merit Award; Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Veterans Affairs, VA Merit Award BX-002277 (ACL). The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government. This work was supported in part by the Cell Evaluation & Therapy (Flow Cytometry & Cell Sorting Unit) Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).	Abangan RS, 2010, AM J PATHOL, V176, P1914, DOI 10.2353/ajpath.2010.080839; Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC; Beamer CA, 2007, AM J RESP CELL MOL, V37, P729, DOI 10.1165/rcmb.2007-0099OC; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brass DM, 2010, AM J PHYSIOL-LUNG C, V299, pL664, DOI 10.1152/ajplung.00389.2009; Ebihara Y, 2006, EXP HEMATOL, V34, P219, DOI 10.1016/j.exphem.2005.10.008; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Kang Kyeongah, 2012, Immune Netw, V12, P104, DOI 10.4110/in.2012.12.3.104; KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003; Kuhn C, 1993, Monogr Pathol, P78; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee JE, 2007, BIOCHEM BIOPH RES CO, V352, P244, DOI 10.1016/j.bbrc.2006.11.010; McDonald LT, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/159713; McDonald LT, 2015, NEOPLASIA, V17, P434, DOI 10.1016/j.neo.2015.04.004; MCDONALD LT, 2015, J BONE MARROW RES, V3; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zelko IN, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0478-5	23	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180724	10.1371/journal.pone.0180724	http://dx.doi.org/10.1371/journal.pone.0180724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700752	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800069
J	Neerland, BE; Krogseth, M; Juliebo, V; Ranhoff, AH; Engedal, K; Frihagen, F; Raeder, J; Wyller, TB; Watne, LO				Neerland, Bjorn Erik; Krogseth, Maria; Juliebo, Vibeke; Ranhoff, Anette Hylen; Engedal, Knut; Frihagen, Frede; Raeder, Johan; Wyller, Torgeir Bruun; Watne, Leiv Otto			Perioperative hemodynamics and risk for delirium and new onset dementia in hip fracture patients; A prospective follow-up study	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; ELDERLY-PATIENTS; INTRAOPERATIVE HYPOTENSION; COGNITIVE DECLINE; AUTOREGULATION; PRESSURE; REPAIR; TRIAL; OSLO	Background Delirium is common in hip fracture patients and many risk factors have been identified. Controversy exists regarding the possible impact of intraoperative control of blood pressure upon acute (delirium) and long term (dementia) cognitive decline. We explored possible associations between perioperative hemodynamic changes, use of vasopressor drugs, risk of delirium and risk of new-onset dementia. Methods Prospective follow-up study of 696 hip fracture patients, assessed for delirium pre- and post-operatively, using the Confusion Assessment Method. Pre-fracture cognitive function was assessed using the Informant Questionnaire of Cognitive Decline in the Elderly and by consensus diagnosis. The presence of new-onset dementia was determined at follow-up evaluation at six or twelve months after surgery. Blood pressure was recorded at admission, perioperatively and postoperatively. Results Preoperative delirium was present in 149 of 536 (28%) assessable patients, and 124 of 387 (32%) developed delirium postoperatively (incident delirium). The following risk factors for incident delirium in patients without pre-fracture cognitive impairment were identified: low body mass index, low level of functioning, severity of physical illness, and receipt of >= 2 blood transfusions. New-onset dementia was diagnosed at follow-up in 26 of 213 (12%) patients, associated with severity of physical illness, delirium, receipt of vasopressor drugs perioperatively and high mean arterial pressure postoperatively. Conclusion Risk factors for incident delirium seem to differ according to pre-fracture cognitive status. The use of vasopressors during surgery and/or postoperative hypertension is associated with new-onset dementia after hip fracture.	[Neerland, Bjorn Erik; Krogseth, Maria; Juliebo, Vibeke; Engedal, Knut; Wyller, Torgeir Bruun; Watne, Leiv Otto] Oslo Univ Hosp, Dept Geriatr Med, Oslo Delirium Res Grp, Oslo, Norway; [Neerland, Bjorn Erik; Engedal, Knut; Raeder, Johan; Wyller, Torgeir Bruun] Univ Oslo, Inst Clin Med, Oslo, Norway; [Krogseth, Maria] Telemark Hosp Trust, Old Age Psychiat Res Network, Tonsberg, Norway; [Krogseth, Maria] Vestfold Hosp Trust, Tonsberg, Norway; [Krogseth, Maria] Univ Coll Southeast Norway, Fac Hlth Sci, Drammen, Norway; [Ranhoff, Anette Hylen] Diakonhjemmet Hosp, Oslo, Norway; [Ranhoff, Anette Hylen] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Engedal, Knut] Vestfold Hlth Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Frihagen, Frede] Oslo Univ Hosp, Dept Orthopaed Surg, Oslo, Norway; [Raeder, Johan] Oslo Univ Hosp, Dept Anaesthesiol, Oslo, Norway; [Watne, Leiv Otto] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo; Telemark Hospital Trust; University College of Southeast Norway; Diakonhjemmet Hospital; University of Bergen; University of Oslo; University of Oslo; University of Oslo	Neerland, BE (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Oslo Delirium Res Grp, Oslo, Norway.; Neerland, BE (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	bjorn.erik@neerland.net		Frihagen, Frede/0000-0002-4811-669X; Neerland, Bjorn Erik/0000-0001-5335-9146	Research Council of Norway; The University of Oslo; Research into Ageing; Norwegian Health Association	Research Council of Norway(Research Council of Norway); The University of Oslo; Research into Ageing; Norwegian Health Association	This study was funded by the Research Council of Norway; The University of Oslo; Research into Ageing; Norwegian Health Association. The sponsors had no role in the design, methods, subject recruitment, data collection, analysis or preparation of the manuscript	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anesthesiologists ASo, 1963, ANESTHESIOLOGY, V24; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Brady K, 2013, ANESTHESIOLOGY, V119, P495, DOI 10.1097/ALN.0b013e3182a10cce; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Burkhart CS, 2011, BRIT J ANAESTH, V107, P742, DOI 10.1093/bja/aer252; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Harrison JK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010772.pub2; Hirsch J, 2015, BRIT J ANAESTH, V115, P418, DOI 10.1093/bja/aeu458; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson TA, 2016, AGE AGEING; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Juliebo V, 2009, J AM GERIATR SOC, V57, P1354, DOI 10.1111/j.1532-5415.2009.02377.x; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Lincoln N B, 1992, Disabil Rehabil, V14, P41; MAHONEY F I, 1965, Md State Med J, V14, P61; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; O'Callaghan Susan, 2016, Yale Journal of Biology and Medicine, V89, P59; Oh ES, 2015, INT J GERIATR PSYCH, V30, P900, DOI 10.1002/gps.4233; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Stoen RO, 2012, OSTEOPOROSIS INT, V23, P2527, DOI 10.1007/s00198-011-1888-3; Tognoni P, 2011, ARCH GERONTOL GERIAT, V52, pE166, DOI 10.1016/j.archger.2010.10.021; Wang NY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123892; Watne LO, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-63; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Williams-Russo P, 1999, ANESTHESIOLOGY, V91, P926, DOI 10.1097/00000542-199910000-00011; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; World Health Organization, ICD 10 CLASS MENT BE; World Health Organization, 1992, INT STAT CLASS DIS R	45	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180641	10.1371/journal.pone.0180641	http://dx.doi.org/10.1371/journal.pone.0180641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700610	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800061
J	Rasmussen, SL; Krarup, HB; Sunesen, KG; Johansen, MB; Stender, MT; Pedersen, IS; Madsen, PH; Thorlacius-Ussing, O				Rasmussen, Simon Ladefoged; Krarup, Henrik Bygum; Sunesen, Kare Gotschalck; Johansen, Martin Berg; Stender, Mogens Tornby; Pedersen, Inge Sokilde; Madsen, Poul Henning; Thorlacius-Ussing, Ole			Hypermethylated DNA, a circulating biomarker for colorectal cancer detection	PLOS ONE			English	Article							BLOOD; DIAGNOSIS; TRIAL	Background Colorectal cancer (CRC) is one of the most common cancers in the western world. Screening is an efficient method of reducing cancer-related mortality. Molecular biomarkers for cancer in general and CRC in particular have been proposed, and hypermethylated DNA from stool or blood samples are already implemented as biomarkers for CRC screening. We aimed to evaluate the performance of proven hypermethylated DNA promoter regions as plasma based biomarkers for CRC detection. Methods We conducted a cross-sectional case-control study of 193 CRC patients and 102 colonoscopy-verified healthy controls. Using methylation specific polymerase chain reaction, we evaluated 30 DNA promoter regions previously found to be CRC specific. We used multivariable logistic regression with stepwise backwards selection, and subsequent leave-pair-out cross validation, to calculate the optimism corrected area under the receiver operating characteristics curve (AUC) for all stage as well as early stage CRC. Results None of the individual DNA promoter regions provided an overall sensitivity above 30% at a reasonable specificity. However, seven hypermethylated promoter regions (ALX4, BMP3, NPTX2, RARB, SDC2, SEPT9, and VIM) along with the covariates sex and age yielded an optimism corrected AUC of 0.86 for all stage CRC and 0.85 for early stage CRC. Overall sensitivity for CRC detection was 90.7% at 72.5% specificity using a cut point value of 0.5. Conclusions Individual hypermethylated DNA promoter regions have limited value as CRC screening markers. However, a panel of seven hypermethylated promoter regions show great promise as a model for CRC detection.	[Rasmussen, Simon Ladefoged; Sunesen, Kare Gotschalck; Stender, Mogens Tornby; Thorlacius-Ussing, Ole] Aalborg Univ Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark; [Rasmussen, Simon Ladefoged; Krarup, Henrik Bygum; Pedersen, Inge Sokilde; Madsen, Poul Henning; Thorlacius-Ussing, Ole] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Rasmussen, Simon Ladefoged; Thorlacius-Ussing, Ole] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Krarup, Henrik Bygum; Pedersen, Inge Sokilde; Madsen, Poul Henning] Aalborg Univ Hosp, Sect Mol Diagnost, Clin Biochem, Aalborg, Denmark; [Johansen, Martin Berg] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Rasmussen, SL (corresponding author), Aalborg Univ Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark.; Rasmussen, SL (corresponding author), Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark.; Rasmussen, SL (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	simon.rasmussen@rn.dk	Pedersen, Inge Søkilde/ABB-1019-2020; Johansen, Martin Nygård/L-6845-2014	Pedersen, Inge Søkilde/0000-0002-9902-8040; Johansen, Martin Nygård/0000-0001-9790-0985; Thorlacius-Ussing, Ole/0000-0003-4963-1551; Rasmussen, Simon Ladefoged/0000-0002-2560-4877; Gotschalck, Kare Andersson/0000-0001-5119-2231; Krarup, Henrik/0000-0001-5294-2428	Aalborg University and Aalborg University Hospital; Region Nordjyllands Forskningsfond; Heinrich Kopps Legat; Eva og Henry Frankels Mindefond	Aalborg University and Aalborg University Hospital; Region Nordjyllands Forskningsfond; Heinrich Kopps Legat; Eva og Henry Frankels Mindefond	This study was primarily funded by Aalborg University and Aalborg University Hospital. Grant support was received from Region Nordjyllands Forskningsfond, Heinrich Kopps Legat, and Eva og Henry Frankels Mindefond.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Collins GS, 2015, BRIT J SURG, V102, P148, DOI 10.1002/bjs.9736; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Leong KJ, 2014, BRIT J SURG, V101, P1299, DOI 10.1002/bjs.9571; Lindebjerg J, 2014, DAN MED J, V61; Litovkin K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130651; Melotte V, 2015, CANCER PREV RES, V8, P157, DOI 10.1158/1940-6207.CAPR-14-0198; Oh T, 2013, J MOL DIAGN, P498; Payne SR, 2010, EPIGENOMICS-UK, V2, P575, DOI [10.2217/epi.10.35, 10.2217/EPI.10.35]; Pedersen IS, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-12; Rasmussen SL, 2016, COLORECTAL DIS, V18, P549, DOI 10.1111/codi.13336; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Song MM, 2015, JNCI-J NATL CANCER I, P107; Stender MT, 2008, THROMB HAEMOSTASIS, V99, P396, DOI 10.1160/TH07-06-0397; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050	23	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180809	10.1371/journal.pone.0180809	http://dx.doi.org/10.1371/journal.pone.0180809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700744	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800080
J	Reichert, JL; Chocholous, M; Leiss, U; Pletschko, T; Kasprian, G; Furtner, J; Kollndorfer, K; Krajnik, J; Slavc, I; Prayer, D; Czech, T; Schopf, V; Dorfer, C				Reichert, Johanna L.; Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Kasprian, Gregor; Furtner, Julia; Kollndorfer, Kathrin; Krajnik, Jacqueline; Slavc, Irene; Prayer, Daniela; Czech, Thomas; Schoepf, Veronika; Dorfer, Christian			Neuronal correlates of cognitive function in patients with childhood cerebellar tumor lesions	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; INDEPENDENT COMPONENT ANALYSIS; PEDIATRIC BRAIN-TUMORS; POSTERIOR-FOSSA TUMORS; MRI DATA; CHILDREN; CONNECTIVITY; TOPOGRAPHY; SURVIVORS; NETWORKS	While it has been shown that cerebellar tumor lesions have an impact on cognitive functions, the extent to which they shape distant neuronal pathways is still largely undescribed. Thus, the present neuroimaging study was designed to investigate different aspects of cognitive function and their neuronal correlates in patients after childhood cerebellar tumor surgery. An alertness task, a working memory task and an incompatibility task were performed by 11 patients after childhood cerebellar tumor surgery and 17 healthy controls. Neuronal correlates as reflected by alterations in functional networks during tasks were assessed using group independent component analysis. We were able to identify eight networks involved during task performance: default mode network, precuneus, anterior salience network, executive control network, visual network, auditory and sensorimotor network and a cerebellar network. For the most 'basic' cognitive tasks, a weaker task-modulation of default mode network, left executive control network and the cerebellar network was observed in patients compared to controls. Results for higher-order tasks are in line with a partial restoration of networks responsible for higher-order task execution. Our results provide tentative evidence that the synchronicity of brain activity in patients was at least partially restored in the course of neuroplastic reorganization, particularly for networks related to higher-order cognitive processes. The complex activation patterns underline the importance of testing several cognitive functions to assess the specificity of cognitive deficits and neuronal reorganization processes after brain lesions.	[Reichert, Johanna L.; Schoepf, Veronika] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Reichert, Johanna L.; Schoepf, Veronika] BioTechMed, Graz, Austria; [Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Slavc, Irene] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Chocholous, Monika; Leiss, Ulrike; Pletschko, Thomas; Furtner, Julia; Slavc, Irene; Czech, Thomas; Dorfer, Christian] Med Univ Vienna, Comprehens Canc Ctr, CNS Tumors Unit CCC CNS, Vienna, Austria; [Kasprian, Gregor; Furtner, Julia; Kollndorfer, Kathrin; Krajnik, Jacqueline; Prayer, Daniela; Schoepf, Veronika] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Krajnik, Jacqueline; Czech, Thomas; Dorfer, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria	University of Graz; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Dorfer, C (corresponding author), Med Univ Vienna, Comprehens Canc Ctr, CNS Tumors Unit CCC CNS, Vienna, Austria.; Dorfer, C (corresponding author), Med Univ Vienna, Dept Neurosurg, Vienna, Austria.	christian.dorfer@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Dorfer, Christian/AAP-1990-2020	Kasprian, Gregor/0000-0003-3858-3347; Pletschko, Thomas/0000-0002-7865-0164; Furtner, Julia/0000-0001-8258-3681; Leiss, Ulrike/0000-0003-2605-8334; Schopf, Veronika/0000-0003-1937-4216; Dorfer, Christian/0000-0002-1843-7732	Austrian Science Fund (FWF) [KLI 252]; FWF [KLI252, P23205-B09]; BioTechMed Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); BioTechMed Graz	This study was part of a project (KLI 252) funded by the Austrian Science Fund (FWF) dedicated to CD. JK, TP and KK were supported by the FWF (JK: KLI252 to CD, P23205-B09 to VS, TP: KLI252 to CD, KK: P23205-B09 to VS). JR is supported by BioTechMed Graz.	Aarsen FK, 2004, NEUROLOGY, V62, P1311, DOI 10.1212/01.WNL.0000120549.77188.36; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Bleyer A, 1998, P ANN M AM SOC CLINC, P1498; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen HB, 2016, NEUROIMAGE-CLIN, V11, P339, DOI 10.1016/j.nicl.2016.02.010; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Chiricozzi FR, 2008, NEUROPSYCHOLOGIA, V46, P1940, DOI 10.1016/j.neuropsychologia.2008.01.024; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Hoang DH, 2014, J NEUROSURG-PEDIATR, V14, P136, DOI 10.3171/2014.5.PEDS13571; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Justus T, 2005, BRAIN LANG, V95, P304, DOI 10.1016/j.bandl.2005.02.001; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; King TZ, 2015, J INT NEUROPSYCH SOC, V21, P494, DOI 10.1017/S135561771500051X; Kirschen MP, 2008, BEHAV NEUROL, V20, P39, DOI [10.1155/2008/817253, 10.3233/BEN-2008-0216]; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Peterburs J, 2015, NEUROPSYCHOLOGIA, V68, P139, DOI 10.1016/j.neuropsychologia.2015.01.017; Peterburs J, 2013, CEREBELLUM, V12, P1, DOI 10.1007/s12311-012-0386-2; Peterburs J, 2012, NEUROPSYCHOLOGIA, V50, P379, DOI 10.1016/j.neuropsychologia.2011.12.009; Peterburs J, 2010, CEREBELLUM, V9, P375, DOI 10.1007/s12311-010-0171-z; Piscione PJ, 2014, NEURO-ONCOLOGY, V16, P147, DOI 10.1093/neuonc/not138; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; POLLACK IF, 1994, NEW ENGL J MED, V331, P1500, DOI 10.1056/NEJM199412013312207; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Robinson KE, 2015, CHILD NEUROPSYCHOL, V21, P779, DOI 10.1080/09297049.2014.924492; Robinson KE, 2014, NEUROPSYCHOLOGY, V28, P791, DOI 10.1037/neu0000077; Robinson KE, 2013, J INT NEUROPSYCH SOC, V19, P44, DOI 10.1017/S1355617712000987; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Silveri MC, 1998, BRAIN, V121, P2175, DOI 10.1093/brain/121.11.2175; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Von Aster M, 2006, DEUTSCHSPRACHIGE BEA; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Zakrzewski K, 2003, FOLIA NEUROPATHOL, V41, P251; Zimmermann P, 2007, TESTBATTERIE AUFMERK	55	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180200	10.1371/journal.pone.0180200	http://dx.doi.org/10.1371/journal.pone.0180200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692686	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800030
J	Xu, EG; Mager, EM; Grosell, M; Stieglitz, JD; Hazard, ES; Hardiman, G; Schlenk, D				Xu, Elvis Genbo; Mager, Edward M.; Grosell, Martin; Stieglitz, John D.; Hazard, E. Starr; Hardiman, Gary; Schlenk, Daniel			Developmental transcriptomic analyses for mechanistic insights into critical pathways involved in embryogenesis of pelagic mahimahi (Coryphaena hippurus)	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; NITRIC-OXIDE; CRUDE-OIL; GENE-EXPRESSION; AROMATIC-HYDROCARBONS; LARVAL DEVELOPMENT; SKELETAL-MUSCLE; NMDA RECEPTORS; IN-VIVO; CALCIUM	Mahi-mahi (Coryphaena hippurus) is a commercially and ecologically important species of fish occurring in tropical and temperate waters worldwide. Understanding early life events is crucial for predicting effects of environmental stress, which is largely restricted by a lack of genetic resources regarding expression of early developmental genes and regulation of pathways. The need for anchoring developmental stages to transcriptional activities is highlighted by increasing evidence on the impacts of recurrent worldwide oil spills in this sensitive species during early development. By means of high throughput sequencing, we characterized the developmental transcriptome of mahi-mahi at three critical developmental stages, from pharyngula embryonic stage (24 hpf) to 48 hpf yolk-sac larva (transition 1), and to 96 hpf free-swimming larva (transition 2). With comparative analysis by multiple bioinformatic tools, a larger number of significantly altered genes and more diverse gene ontology terms were observed during transition 2 than transition 1. Cellular and tissue development terms were more significantly enriched in transition 1, while metabolism related terms were more enriched in transition 2, indicating a switch progressing from general embryonic development to metabolism during the two transitions. Special focus was given on the most significant common canonical pathways (e.g. calcium signaling, glutamate receptor signaling, cAMP response element-binding protein signaling, cardiac beta-adrenergic signaling, etc.) and expression of developmental genes (e.g. collagens, myosin, notch, glutamate metabotropic receptor etc.), which were associated with morphological changes of nervous, muscular, and cardiovascular system. These data will provide an important basis for understanding embryonic development and identifying molecular mechanisms of abnormal development in fish species.	[Xu, Elvis Genbo; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Mager, Edward M.] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Grosell, Martin; Stieglitz, John D.] Univ Miami, Dept Marine Biol & Ecol, Miami, FL USA; [Hazard, E. Starr; Hardiman, Gary] Med Univ South Carolina, Ctr Genom Med, Charleston, SC USA; [Hazard, E. Starr] Med Univ South Carolina, Computat Biol Resource Ctr, Charleston, SC USA; [Hardiman, Gary] Med Univ South Carolina, Dept Med, Charleston, SC USA; [Hardiman, Gary] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Hardiman, Gary] Hollings Marine Lab, Lab Marine Syst Biol, Charleston, SC USA	University of California System; University of California Riverside; University of North Texas System; University of North Texas Denton; University of Miami; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Xu, EG; Schlenk, D (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.	genboxu@ucr.edu; daniel.schlenk@ucr.edu	Xu, Elvis Genbo/AAA-9267-2020	Xu, Elvis Genbo/0000-0002-4414-1978; Hardiman, Gary/0000-0003-4558-0400	Gulf of Mexico Research Initiative [SA-1520]; Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER); Medical University of South Carolina College of Medicine for start-up funds; Genomics Shared Resource, Hollings Cancer Center	Gulf of Mexico Research Initiative; Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER); Medical University of South Carolina College of Medicine for start-up funds; Genomics Shared Resource, Hollings Cancer Center	This research was made possible by a grant from The Gulf of Mexico Research Initiative, Grant No: SA-1520; Name: Relationship of Effects of Cardiac Outcomes in fish for Validation of Ecological Risk (RECOVER). The authors are grateful to the Gulf of Mexico Research Initiative Information and Data Cooperative (GRIIDC) for supporting data management system to store the data generated. GRIIDC doi:10.7266/N7GX48ND. GH acknowledges the Medical University of South Carolina College of Medicine for start-up funds. This research was supported in part by the Genomics Shared Resource, Hollings Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; Bannai H, 2015, CELL REP, V13, P2768, DOI 10.1016/j.celrep.2015.12.002; Berman N, 2001, J NEUROPHYSIOL, V86, P1612, DOI 10.1152/jn.2001.86.4.1612; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brusle J., 1996, FISH MORPHOLOGY, P77, DOI DOI 10.1201/9780203755990-6; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Darias MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/s10126-007-9078-1; Davidson E. H., 2001, DEV EVOLUTION; Davis-Turak J, 2017, EXPERT REV MOL DIAGN, V17, P225, DOI 10.1080/14737159.2017.1282822; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esbaugh AJ, 2016, SCI TOTAL ENVIRON, V543, P644, DOI 10.1016/j.scitotenv.2015.11.068; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Ferraresso S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-315; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Heintz RA, 2007, INTEGR ENVIRON ASSES, V3, P351, DOI 10.1002/ieam.5630030306; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; HOUDE ED, 1994, ICES J MAR SCI, V51, P91, DOI 10.1006/jmsc.1994.1008; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Jung JH, 2015, ENVIRON SCI TECHNOL, V49, P13639, DOI 10.1021/acs.est.5b03729; Khursigara AJ, 2016, SCIENCE OF THE TOTAL; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Krol E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2473-0; Laine R, 1998, MOL PHARMACOL, V54, P305, DOI 10.1124/mol.54.2.305; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Mager EM, 2014, ENVIRON SCI TECHNOL, V48, P7053, DOI 10.1021/es501628k; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Mazurais D, 2011, CAN J ZOOL, V89, P599, DOI [10.1139/z11-036, 10.1139/Z11-036]; MITO SATOSHI, 1960, BULL JAPANESE SOC SCI FISH, V26, P223; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muhling BA, 2012, MAR POLLUT BULL, V64, P679, DOI 10.1016/j.marpolbul.2012.01.034; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Pasparakis C, 2016, AQUAT TOXICOL, V181, P113, DOI 10.1016/j.aquatox.2016.10.022; Rodriguez-Zas SL, 2008, REPRODUCTION, V135, P129, DOI 10.1530/REP-07-0426; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; Sorhus E, 2016, DEV BIOL, V411, P301, DOI 10.1016/j.ydbio.2016.02.012; Stieglitz JD, 2017, AQUACULTURE, V479, P1, DOI 10.1016/j.aquaculture.2017.05.006; Stieglitz JD, 2012, AQUAC RES, V43, P1557, DOI 10.1111/j.1365-2109.2011.02961.x; Sweet LE, 2016, ENVIRONMENTAL TOXICO; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Xu EG, 2016, ENVIRON SCI TECHNOL, V50, P7842, DOI 10.1021/acs.est.6b02205; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Yadetie F, 2013, AQUAT TOXICOL, V126, P314, DOI 10.1016/j.aquatox.2012.09.013	56	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180454	10.1371/journal.pone.0180454	http://dx.doi.org/10.1371/journal.pone.0180454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692652	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800042
J	Yoon, H; Walters, G; Paulsen, AR; Scarisbrick, IA				Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.			Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; DIFFERENTIAL EXPRESSION; THROMBIN RECEPTOR; GFAP; OLIGODENDROCYTES; ASTROGLIOSIS; RECOVERY; MICE; GLIA	Astrocytes have emerged as essential regulators of function and response to injury in the brain and spinal cord, yet very little is known about regional differences that exist. Here we compare the expression of key astroglial markers (glial fibrillary acidic protein (GFAP) and Aldehyde Dehydrogenase-1 Family Member L1 (ALDH1L1)) across these disparate poles of the neuraxis, tracking their expression developmentally and in the context of demyelination. In addition, we document changes in the astrocyte regulatory cytokine interleukin 6 (IL-6), and its signaling partner signal transducer and activator of transcription 3 (STAT3), in vivo and in vitro. Results demonstrate that GFAP expression is higher in the developing and adult spinal cord relative to brain. Comparisons between GFAP and ALDH1L1 expression suggest elevations in spinal cord GFAP during the early postnatal period reflect an accelerated appearance of astrocytes, while elevations in adulthood reflect higher expression by individual astrocytes. Notably, increases in spinal cord compared to whole brain GFAP were paralleled by higher levels of IL-6 and STAT3. Equivalent elevations in GFAP, GFAP/ALDH1L1 ratios, and in IL-6, were observed in primary astrocyte cultures derived from spinal cord compared to cortex. Also, higher levels of GFAP were observed in the spinal cord compared to the brain after focal demyelinating injury. Altogether, these studies point to key differences in astrocyte abundance and the expression of GFAP and IL-6 across the brain and spinal cord that are positioned to influence regional specialization developmentally and responses occurring in the context of injury and disease.	[Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.] Mayo Clin, Dept Phys Med & Rehabil, Rehabil Med Res Ctr, Rochester, MN 55905 USA; [Yoon, Hyesook; Walters, Grant; Paulsen, Alex R.; Scarisbrick, Isobel A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Scarisbrick, Isobel A.] Mayo Clin, Neurobiol Dis Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Scarisbrick, IA (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, Rehabil Med Res Ctr, Rochester, MN 55905 USA.; Scarisbrick, IA (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Scarisbrick, IA (corresponding author), Mayo Clin, Neurobiol Dis Program, Rochester, MN 55905 USA.	Scarisbrick.Isobel@mayo.edu		Walters, Grant/0000-0001-5081-3104	National Institutes of Health, National Multiple Sclerosis Society [R01NS052741, RG4958]; Mayo Clinic Rehabilitation Medicine Research Center (IAS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052741] Funding Source: NIH RePORTER	National Institutes of Health, National Multiple Sclerosis Society; Mayo Clinic Rehabilitation Medicine Research Center (IAS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Studies were supported by the National Institutes of Health (https://www.nih.gov) R01NS052741 (IAS), RG4958 (IAS) from the National Multiple Sclerosis Society (http://www. nationalmssociety.org), and the Mayo Clinic Rehabilitation Medicine Research Center (IAS)	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Brunello AG, 2000, AM J PATHOL, V157, P1485, DOI 10.1016/S0002-9440(10)64787-6; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Constantinescu CS, 2005, J NEUROCHEM, V95, P331, DOI 10.1111/j.1471-4159.2005.03368.x; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Iwama S, 2011, GLIA, V59, P452, DOI 10.1002/glia.21114; Kim S, 2012, BRAIN PATHOL, V22, P41, DOI 10.1111/j.1750-3639.2011.00501.x; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Ming XT, 2013, J NEUROSCI, V33, P12528, DOI 10.1523/JNEUROSCI.0536-13.2013; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Neymeyer V, 1997, BRAIN RES, V766, P195, DOI 10.1016/S0006-8993(97)00528-3; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Olsen JV, 2007, BRAIN RES, V1134, P95, DOI 10.1016/j.brainres.2006.11.082; Ono K, 2008, DEV BIOL, V320, P456, DOI 10.1016/j.ydbio.2008.06.001; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Radulovic M, 2015, NEUROBIOL DIS, V83, P75, DOI 10.1016/j.nbd.2015.08.021; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Ridder MC, 2011, BRAIN, V134, P3342, DOI 10.1093/brain/awr255; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; Scarisbrick IA, 2012, BIOL CHEM, V393, P355, DOI 10.1515/hsz-2011-0241; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Thrane VR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02582; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Wang N, 2014, NEUROPHARMACOLOGY, V79, P282, DOI 10.1016/j.neuropharm.2013.12.004; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wasseff SK, 2011, NEUROBIOL DIS, V42, P506, DOI 10.1016/j.nbd.2011.03.003; WU E, 1992, LAB INVEST, V67, P88; Yeh TH, 2009, MICROARRAY ANAL REVE, P57; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; Yoon H, 2013, J NEUROCHEM, V127, P283, DOI 10.1111/jnc.12293; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhou M, 2000, MOL BRAIN RES, V76, P121, DOI 10.1016/S0169-328X(99)00341-1; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	83	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180697	10.1371/journal.pone.0180697	http://dx.doi.org/10.1371/journal.pone.0180697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700615	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800067
J	Chen, YZ; Li, JL; Ju, WM; Ruan, HH; Qin, ZH; Huang, YY; Jeelani, N; Padarian, JA; Propastin, P				Chen, Yizhao; Li, Jianlong; Ju, Weimin; Ruan, Honghua; Qin, Zhihao; Huang, Yiye; Jeelani, Nasreen; Padarian, Jose A.; Propastin, Pavel			Quantitative assessments of water-use efficiency in Temperate Eurasian Steppe along an aridity gradient	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; CLIMATE-CHANGE; CARBON SEQUESTRATION; TERRESTRIAL ECOSYSTEMS; GRASSLAND ECOSYSTEMS; VEGETATION GROWTH; INNER-MONGOLIA; PROCESS MODEL; LAND-SURFACE; SOIL CARBON	Water-use efficiency (WUE), defined as the ratio of net primary productivity (NPP) to evapotranspiration (ET), is an important indicator to represent the trade-off pattern between vegetation productivity and water consumption. Its dynamics under climate change are important to ecohydrology and ecosystem management, especially in the drylands. In this study, we modified and used a late version of Boreal Ecosystem Productivity Simulator (BEPS), to quantify the WUE in the typical dryland ecosystems, Temperate Eurasian Steppe (TES). The Aridity Index (AI) was used to specify the terrestrial water availability condition. The regional results showed that during the period of 1999-2008, the WUE has a clear decreasing trend in the spatial distribution from arid to humid areas. The highest annual average WUE was in dry and semi-humid sub-region (DSH) with 0.88 gC mm (-1) and the lowest was in arid sub-region (AR) with 0.22 gC mm (-1). A two-stage pattern of WUE was found in TES. That is, WUE would enhance with lower aridity stress, but decline under the humid environment. Over 65% of the region exhibited increasing WUE. This enhancement, however, could not indicate that the grasslands were getting better because the NPP even slightly decreased. It was mainly attributed to the reduction of ET over 70% of the region, which is closely related to the rainfall decrease. The results also suggested a similar negative spatial correlation between the WUE and the mean annual precipitation (MAP) at the driest and the most humid ends. This regional pattern reflected the different roles of water in regulating the terrestrial ecosystems under different aridity levels. This study could facilitate the understanding of the interactions between terrestrial carbon and water cycles, and thus contribute to a sustainable management of nature resources in the dryland ecosystems.	[Chen, Yizhao; Ruan, Honghua] Nanjing Forestry Univ, Coll Biol & Environm, Joint Innovat Ctr Modern Forestry Studies, Nanjing, Jiangsu, Peoples R China; [Chen, Yizhao; Li, Jianlong] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Ju, Weimin] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing, Jiangsu, Peoples R China; [Qin, Zhihao] Chinese Acad Agr Sci, Inst Agroresources & Reg Planning, Beijing, Peoples R China; [Huang, Yiye] Nanjing Univ, Sch Atmospher Sci, Nanjing, Jiangsu, Peoples R China; [Jeelani, Nasreen] Nanjing Univ, Dept Ecol, Nanjing, Jiangsu, Peoples R China; [Padarian, Jose A.] Univ Sydney, Fac Agr & Environm, Sydney, NSW, Australia; [Propastin, Pavel] Georg August Univ Gottingen, Inst Geog, Gottingen, Germany; [Propastin, Pavel] Georg August Univ Gottingen, Busgen Inst, Dept Bioclimatol, Gottingen, Germany	Nanjing Forestry University; Nanjing University; Nanjing University; Chinese Academy of Agricultural Sciences; Nanjing University; Nanjing University; University of Sydney; University of Gottingen; University of Gottingen	Li, JL (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China.	jianlongli@gmail.com	Padarian, José/AAZ-4340-2020	Jeelani, Nasreen/0000-0002-3887-7321	National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems [2016YFC0500202]; National Key Research and Development Program of China for Global Change and Adaptation [2016YFA0600202]; APN Global Change Fund Project [ARCP2013-16NMY-Li]; National Natural Science Foundation of China [41271361]; National Key Research Program of China [2016YFC0500202]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems; National Key Research and Development Program of China for Global Change and Adaptation; APN Global Change Fund Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China for Ecological Restoration and Conservation in Typical Ecosystems (2016YFC0500202); National Key Research and Development Program of China for Global Change and Adaptation (2016YFA0600202); APN Global Change Fund Project (No. ARCP2013-16NMY-Li); the National Natural Science Foundation of China (No. 41271361); the National Key Research Program of China (2016YFC0500202); and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA S., 2012, J ARID LAND, V1; Arora VK, 2003, AGR FOREST METEOROL, V118, P21, DOI 10.1016/S0168-1923(03)00073-X; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Bai YY, 2010, ACTA OECOL, V36, P393, DOI 10.1016/j.actao.2010.03.007; Barger NN, 2004, J RANGE MANAGE, V57, P613, DOI 10.2307/4004017; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Belelli Marchesini L, 2007, BIOGEOSCI DISCUSS, V4, P165; BJORKMAN O, 1984, PLANTA, V161, P490, DOI 10.1007/BF00407081; BONAN GB, 1995, J GEOPHYS RES-ATMOS, V100, P2817, DOI 10.1029/94JD02961; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Chen BZ, 2007, J HYDROMETEOROL, V8, P123, DOI 10.1175/JHM566.1; Chen FH, 2011, SCI CHINA EARTH SCI, V54, P1812, DOI 10.1007/s11430-011-4333-8; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; Chen YZ, 2016, RANGELAND ECOL MANAG, V69, P84, DOI 10.1016/j.rama.2015.09.003; Craine JM, 2013, NAT CLIM CHANGE, V3, P63, DOI [10.1038/NCLIMATE1634, 10.1038/nclimate1634]; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Fahu Chen, 2009, Frontiers of Earth Science in China, V3, P42, DOI 10.1007/s11707-009-0013-9; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Feng X, 2007, J ENVIRON MANAGE, V85, P563, DOI 10.1016/j.jenvman.2006.09.021; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Gao ZQ, 2008, CHINESE SCI BULL, V53, P434, DOI 10.1007/s11434-008-0097-8; He C, 2005, J ARID ENVIRON, V63, P814, DOI 10.1016/j.jaridenv.2005.03.028; Holzel N., 2002, Journal for Nature Conservation, V10, P75, DOI 10.1078/1617-1381-00009; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Hulme M, 1996, GEOPHYS RES LETT, V23, P61, DOI 10.1029/95GL03586; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; Ju WM, 2007, J ENVIRON MANAGE, V85, P538, DOI 10.1016/j.jenvman.2006.04.028; Ju WM, 2006, AGR FOREST METEOROL, V140, P136, DOI 10.1016/j.agrformet.2006.08.008; Le Houerou HN, 2001, J ARID ENVIRON, V48, P103, DOI 10.1006/jare.2000.0679; LEHOUEROU HN, 1984, J ARID ENVIRON, V7, P213; LEHOUEROU HN, 1977, J RANGE MANAGE, V30, P181; Li CF, 2015, GLOBAL CHANGE BIOL, V21, P1951, DOI 10.1111/gcb.12846; Li CF, 2013, ECOL MODEL, V267, P148, DOI 10.1016/j.ecolmodel.2013.06.007; Li SY, 2012, REG ENVIRON CHANGE, V12, P461, DOI 10.1007/s10113-011-0264-3; LIANG YM, 1989, OECOLOGIA, V80, P148, DOI 10.1007/BF00380143; Lioubimtseva E, 2005, J ARID ENVIRON, V62, P285, DOI 10.1016/j.jaridenv.2004.11.005; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; Liu J, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001680; Liu J, 1997, REMOTE SENS ENVIRON, V62, P158, DOI 10.1016/S0034-4257(97)00089-8; Liu Y, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002084; Liu Y, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/258514; Lu XL, 2010, REMOTE SENS ENVIRON, V114, P1924, DOI 10.1016/j.rse.2010.04.001; Ma ZG, 2007, SCI CHINA SER D, V50, P776, DOI 10.1007/s11430-007-0036-6; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Matsushita B, 2002, REMOTE SENS ENVIRON, V81, P58, DOI 10.1016/S0034-4257(01)00331-5; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; [孟祥新 MENG Xiangxin], 2009, [气候与环境研究, Climatic and Environmental Research], V14, P352; Mitchell SW, 2001, ECOL MODEL, V139, P101, DOI 10.1016/S0304-3800(01)00229-0; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mohammat A, 2013, AGR FOREST METEOROL, V178, P21, DOI 10.1016/j.agrformet.2012.09.014; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; Mu Q, 2005, J GEOPHYS RES BIOGEO, V113; Mu SJ, 2013, GLOBAL PLANET CHANGE, V108, P29, DOI 10.1016/j.gloplacha.2013.06.007; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Partel M, 2007, J ECOL, V95, P574, DOI 10.1111/j.1365-2745.2007.01230.x; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Pomfret R, 2006, CENT ASIA RES FORUM, P77; POST WM, 1990, AM SCI, V78, P310; Prieto Calvo P, 2008, PHENOLOGY BIOMASS CO; Propastin P, 2012, GISCI REMOTE SENS, V49, P538, DOI 10.2747/1548-1603.49.4.538; Propastin PA, 2012, INT J REMOTE SENS, V33, P1465, DOI 10.1080/01431161.2011.577105; Qi JG, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015202; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Saunders IR, 1997, CAG CAN G, P222; Schaffrath D, 2013, J ARID ENVIRON, V88, P184, DOI 10.1016/j.jaridenv.2012.07.021; Schulze E-D, 1982, PHYSL PLANT ECOLOGY, P615; Schwalm CR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001229; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Sui XH, 2013, CLIMATIC CHANGE, V117, P259, DOI 10.1007/s10584-012-0533-2; Suzuki Yukio, 2013, MONGOLIAN ECOSYSTEM, P269, DOI DOI 10.1007/978-4-431-54052-6_20; Tian YH, 2002, REMOTE SENS ENVIRON, V83, P414, DOI 10.1016/S0034-4257(02)00047-0; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; Tsialtas JT, 2001, FUNCT ECOL, V15, P605, DOI 10.1046/j.0269-8463.2001.00555.x; Wang XH, 2007, LAND USE POLICY, V24, P417, DOI 10.1016/j.landusepol.2006.05.005; Wesche K., 2012, EURASIAN STEPPES ECO, P3, DOI [10.1007/978-94-007-3886-7_1, DOI 10.1007/978-94-007-3886-7_]; Wesche K, 2005, ERFORSCH BIOL RESS M, V9, P133; Whitehead D. C., 2000, Nutrient elements in grassland: soil-plant-animal relationships, DOI 10.1079/9780851994376.0000; XING Xianxu, 2010, GEOGR SCI, V20, P193; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Yang YT, 2016, J GEOPHYS RES-BIOGEO, V121, P2125, DOI 10.1002/2016JG003475; Yang YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23284; Yang YT, 2015, GEOPHYS RES LETT, V42, P9825, DOI 10.1002/2015GL066835; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Yusupov SU, 2003, INTERACTION LIVESTOC; Zhang C, 2013, ECOL MODEL, V267, P158, DOI 10.1016/j.ecolmodel.2013.06.008; Zhang FM, 2014, THEOR APPL CLIMATOL, V116, P359, DOI 10.1007/s00704-013-0949-2; Zhang GG, 2011, GLOBAL CHANGE BIOL, V17, P377, DOI 10.1111/j.1365-2486.2010.02237.x; Zhang SW Q., 2013, AGR SCI TECHNOLOGY, V14, P7; Zhang Y., 2012, CHINESE SCI BULL, V57, P11, DOI DOI 10.1360/972011-; [张彦敏 Zhang Yanmin], 2012, [生态学报, Acta Ecologica Sinica], V32, P5907; Zhou Y, 2007, J ENVIRON MANAGE, V85, P574, DOI 10.1016/j.jenvman.2006.04.024	99	19	25	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179875	10.1371/journal.pone.0179875	http://dx.doi.org/10.1371/journal.pone.0179875			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686667	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100025
J	Hammer, MF; Ishii, A; Johnstone, L; Tchourbanov, A; Lau, B; Sprissler, R; Hallmark, B; Zhang, M; Zhou, J; Watkins, J; Hirose, S				Hammer, Michael F.; Ishii, Atsushi; Johnstone, Laurel; Tchourbanov, Alexander; Lau, Branden; Sprissler, Ryan; Hallmark, Brian; Zhang, Miao; Zhou, Jin; Watkins, Joseph; Hirose, Shinichi			Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome	PLOS ONE			English	Article							FEBRILE SEIZURES PLUS; SODIUM-CHANNEL; GLUCOCORTICOID-RECEPTOR; GENERALIZED EPILEPSY; MOUSE MODEL; MODIFIER; STRESS; MUTATION; POLYMORPHISMS; LOCUS	Dravet syndrome (DS) is a rare, devastating form of childhood epilepsy that is often associated with mutations in the voltage-gated sodium channel gene, SCN1A. There is considerable variability in expressivity within families, as well as among individuals carrying the same primary mutation, suggesting that clinical outcome is modulated by variants at other genes. To identify modifier gene variants that contribute to clinical outcome, we sequenced the exomes of 22 individuals at both ends of a phenotype distribution (i. e., mild and severe cognitive condition). We controlled for variation associated with different mutation types by limiting inclusion to individuals with a de novo truncation mutation resulting in SCN1A haploinsufficiency. We performed tests aimed at identifying 1) single common variants that are enriched in either phenotypic group, 2) sets of common or rare variants aggregated in and around genes associated with clinical outcome, and 3) rare variants in 237 candidate genes associated with neuronal excitability. While our power to identify enrichment of a common variant in either phenotypic group is limited as a result of the rarity of mild phenotypes in individuals with SCN1A truncation variants, our top candidates did not map to functional regions of genes, or in genes that are known to be associated with neurological pathways. In contrast, we found a statistically-significant excess of rare variants predicted to be damaging and of small effect size in genes associated with neuronal excitability in severely affected individuals. A KCNQ2 variant previously associated with benign neonatal seizures is present in 3 of 12 individuals in the severe category. To compare our results with the healthy population, we performed a similar analysis on whole exome sequencing data from 70 Japanese individuals in the 1000 genomes project. Interestingly, the frequency of rare damaging variants in the same set of neuronal excitability genes in healthy individuals is nearly as high as in severely affected individuals. Rather than a single common gene/variant modifying clinical outcome in SCN1A-related epilepsies, our results point to the cumulative effect of rare variants with little to no measurable phenotypic effect (i.e., typical genetic background) unless present in combination with a disease-causing truncation mutation in SCN1A.	[Hammer, Michael F.; Ishii, Atsushi; Johnstone, Laurel; Tchourbanov, Alexander; Lau, Branden; Sprissler, Ryan] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA; [Hammer, Michael F.] Univ Arizona, Neurol Dept, Tucson, AZ 85721 USA; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Dept Pediat, Sch Med, Fukuoka, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathogeneses Epilepsy, Fukuoka, Japan; [Hallmark, Brian; Zhang, Miao] Univ Arizona, Interdisciplinary Program Stat, Tucson, AZ USA; [Zhou, Jin] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA; [Watkins, Joseph] Univ Arizona, Dept Math, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Fukuoka University; Fukuoka University; University of Arizona; University of Arizona; University of Arizona	Hammer, MF (corresponding author), Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA.; Hammer, MF (corresponding author), Univ Arizona, Neurol Dept, Tucson, AZ 85721 USA.; Hirose, S (corresponding author), Fukuoka Univ, Dept Pediat, Sch Med, Fukuoka, Japan.; Hirose, S (corresponding author), Fukuoka Univ, Cent Res Inst Mol Pathogeneses Epilepsy, Fukuoka, Japan.	mfh@email.arizona.edu; hirose@fukuoka-u.ac.jp		HIROSE, Shinichi/0000-0001-6796-3790; Johnstone, Laurel/0000-0001-7335-3972; Hammer, Michael/0000-0003-0172-429X	Dravet Syndrome Foundation; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106116] Funding Source: NIH RePORTER	Dravet Syndrome Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Dravet Syndrome Foundation (www.dravetfoundation. org).	Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gaily E, 2013, EPILEPSIA, V54, P1577, DOI 10.1111/epi.12256; Genin E, 2008, HUM GENET, V124, P357, DOI 10.1007/s00439-008-0560-2; Goldberg-Stern H, 2014, J CHILD NEUROL, V29, P221, DOI 10.1177/0883073813509016; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guerrini R, 2010, EPILEPSIA, V51, P2474, DOI 10.1111/j.1528-1167.2010.02790.x; Hawkins NA, 2012, GENES BRAIN BEHAV, V11, P452, DOI 10.1111/j.1601-183X.2012.00790.x; Hawkins NA, 2016, EPILEPSY RES, V119, P20, DOI 10.1016/j.eplepsyres.2015.11.016; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Ishii A, 2016, EPILEPSIA; Kearney JA, 2006, HUM MOL GENET, V15, P1043, DOI 10.1093/hmg/ddl019; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lee IC, 2016, J FORMOS MED ASS; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Maguire J, 2013, EPILEPSY BEHAV, V26, P352, DOI 10.1016/j.yebeh.2012.09.040; Maiaru M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab3376; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Meng H. B., 2015, J HARBIN ENG U, V36, P1, DOI DOI 10.1002/HUMU.22782; Miller AR, 2014, GENES BRAIN BEHAV, V13, P163, DOI 10.1111/gbb.12099; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ohmori I, 2013, NEUROBIOL DIS, V50, P209, DOI 10.1016/j.nbd.2012.10.016; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rubinstein M, 2015, NEUROBIOL DIS, V73, P106, DOI 10.1016/j.nbd.2014.09.017; Sawyer NT, 2014, PSYCHONEUROENDOCRINO, V39, P225, DOI 10.1016/j.psyneuen.2013.09.018; Sharma S, 2016, ANNU REV PSYCHOL, V67, P239, DOI 10.1146/annurev-psych-122414-033408; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Stephens MAC, 2016, PSYCHONEUROENDOCRINO, V66, P47, DOI 10.1016/j.psyneuen.2015.12.021; Suls A, 2010, NEUROLOGY, V75, P72, DOI 10.1212/WNL.0b013e3181e62088; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	44	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180485	10.1371/journal.pone.0180485	http://dx.doi.org/10.1371/journal.pone.0180485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686619	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100067
J	El Masri, A; Kolt, GS; Astell-Burt, T; George, ES				El Masri, Aymen; Kolt, Gregory S.; Astell-Burt, Thomas; George, Emma S.			Lifestyle behaviours of Lebanese-Australians: Cross-sectional findings from The 45 and Up Study	PLOS ONE			English	Article							SELF-REPORT MEASURES; PHYSICAL-ACTIVITY; RISK-FACTORS; MIGRANTS; DURATION; INDEX; METAANALYSIS; IMMIGRANTS; RESIDENCE; OUTCOMES	Little is known regarding the health and lifestyle behaviours of Australians of Lebanese ethnicity. The available evidence suggests that Australians of Lebanese ethnicity who were born in Lebanon reportedly have higher rates of cardiovascular disease-related and type 2 diabetes-related complications when compared with the wider Australian population. The aim of this study is to compare lifestyle behaviours of middle-aged to older adults of Lebanese ethnicity born in Lebanon, Australia, and elsewhere to those of Australian ethnicity. Participants were 37,419 Australians aged >= 45 years, from the baseline dataset of The 45 and Up Study which included 4 groups of interest: those of Australian ethnicity (n = 36,707) [Reference]; those of Lebanese ethnicity born in Lebanon (n = 346); 302 those of Lebanese ethnicity born in Australia (n = 302); and those of Lebanese ethnicity born elsewhere (n = 64). Multilevel logistic regression was used to examine the odds of those of Lebanese ethnicity reporting suboptimal lifestyle behaviours (insufficient physical activity, prolonged sitting, smoking, sleep duration, and various diet-related behaviours) relative to those of Australian ethnicity. Multilevel linear regression was used to examine the clustering of suboptimal lifestyle behaviours through a 'lifestyle index' score ranging from 0-9 (sum of all lifestyle behaviours for each subject). The lifestyle index score was lower among Lebanese-born (-0.36, 95% CI -0.51, -0.22, p<0.001) and Australian- born (-0.17, 95% CI -0.32, -0.02, p = 0.031) people of Lebanese ethnicity in comparison to those of Australian ethnicity. Those of Lebanese ethnicity born in Lebanon had higher odds of reporting suboptimal lifestyle behaviours for physical activity, smoking, and sleep duration, and lower odds of reporting optimal lifestyle behaviours for sitting time, fruit, processed meat, and alcohol consumption, when compared with those of Australian ethnicity. Differences in the individual lifestyle behaviours for those of Lebanese ethnicity born in Australia and elsewhere compared with those of Australian ethnicity were fewer. Lifestyle behaviours of those of Lebanese ethnicity vary by country of birth and a lower level of suboptimal lifestyle behaviour clustering was apparent among Lebanese-born and Australian- born middle-aged to older adults of Lebanese ethnicity.	[El Masri, Aymen; Kolt, Gregory S.; George, Emma S.] Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia; [Astell-Burt, Thomas] Univ Wollongong, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab PowerLab, Fac Social Sci, Wollongong, NSW, Australia; [Astell-Burt, Thomas] Univ Wollongong, Early Start Res Inst, Fac Social Sci, Wollongong, NSW, Australia	Western Sydney University; University of Wollongong; University of Wollongong	George, ES (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia.	e.george@westernsydney.edu.au	George, Emma/AAU-4754-2021; Kolt, Gregory/W-1342-2019; Astell-Burt, Thomas/B-9341-2018	George, Emma/0000-0001-9936-1911; Kolt, Gregory/0000-0002-9223-3324; Astell-Burt, Thomas/0000-0002-1498-4851				Agyemang C, 2012, ETHNIC HEALTH, V17, P579, DOI 10.1080/13557858.2012.730607; Anikeeva O, 2010, ASIA-PAC J PUBLIC HE, V22, P159, DOI 10.1177/1010539509358193; Astell-Burt T, 2013, SOC SCI MED, V93, P70, DOI 10.1016/j.socscimed.2013.06.006; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2011, MAIN STRUCTURE GREAT, V.1; Australian Bureau of Statistics, 2012, REFL NAT STOR 2011 C; Australian Bureau of Statistics 2008, 2008, PERSP MIGR; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Banks E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0281-z; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Centre for Epidemiology and Research, 2010, REP AD HLTH COUNTR B; Chau JY, 2013, PLOS ONE, V8, P14; Craig CL, 2003, MED SCI SPORTS EXERC, V35, P1104; Department of Health, 2013, HLTH COMM IN CANB; Department of Health, 2014, PHYS ACT SED BEH GUI; Department of Health, 2008, HLTH PEOPL NEW S WAL; Department of Immigrant and Citizenship, 2014, COMM INF SUMM LEB BO; Department of Immigration and Border Protection, 2014, PEOPL NEW S WAL ACT; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ding D, 2016, AM J PREV MED, V51, P170, DOI 10.1016/j.amepre.2016.01.019; Ding D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001917; Ding D, 2014, PREV MED, V60, P102, DOI 10.1016/j.ypmed.2013.12.021; Feng XQ, 2014, PREV MED, V69, P172, DOI 10.1016/j.ypmed.2014.09.015; Feng XQ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002713; Feng XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072643; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gray L, 2007, EUR J PUBLIC HEALTH, V17, P550, DOI 10.1093/eurpub/ckm008; Griffin B, 2014, ANN BEHAV MED, V48, P205, DOI 10.1007/s12160-014-9589-8; Heesch KC, 2011, J SCI MED SPORT, V14, P233, DOI 10.1016/j.jsams.2010.11.004; Hosper K, 2007, EUR J EPIDEMIOL, V22, P163, DOI 10.1007/s10654-007-9104-7; Jupp J., 2001, AUSTR PEOPLE ENCY NA; Kristensen Jette Kolding, 2007, Prim Care Diabetes, V1, P159, DOI 10.1016/j.pcd.2007.07.007; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Organization WH, 2009, GLOB HLTH RISKS MORT; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Reeske A, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-26; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Sarich PEA, 2015, PREV MED, V81, P209, DOI 10.1016/j.ypmed.2015.09.004; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Shahwan-Akl L, 2010, INT J RES NURS, V1, P1, DOI [10.3844/ijrnsp.2010.1.7, DOI 10.3844/IJRNSP.2010.1.7]; Sibai A, 2010, WHO STEPS CHRONIC DI; Supramaniam R, 2006, CANC INCIDENCE NEW S; Thomson MD, 2009, SOC SCI MED, V69, P983, DOI 10.1016/j.socscimed.2009.05.011; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Trewin D., 2001, SOCIOECONOMIC INDEXE	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181217	10.1371/journal.pone.0181217	http://dx.doi.org/10.1371/journal.pone.0181217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704508	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700108
J	Nakagawa, I; Park, HS; Yokoyama, S; Yamada, S; Motoyama, Y; Park, YS; Wada, T; Kichikawa, K; Nakase, H				Nakagawa, Ichiro; Park, Hun Soo; Yokoyama, Shohei; Yamada, Shuichi; Motoyama, Yasushi; Park, Young Su; Wada, Takeshi; Kichikawa, Kimihiko; Nakase, Hiroyuki			Indocyanine green kinetics with near-infrared spectroscopy predicts cerebral hyperperfusion syndrome after carotid artery stenting	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BLOOD-FLOW; NONINVASIVE MEASUREMENT; HEMODYNAMIC IMPAIRMENT; ENDARTERECTOMY; OXYGENATION; PERFUSION; HEMORRHAGE; BRAIN; SPECT	Background Cerebral hyperperfusion syndrome (HPS) is a potentially life-threatening complication following carotid artery stenting (CAS) and carotid endoarterectomy (CEA). Early prediction and treatment of patients at risk for HPS are required in patients undergoing CAS because HPS occurs significantly earlier after CAS than CEA. Near-infrared spectroscopy (NIRS) is often used for monitoring, and indocyanine green (ICG) kinetics by NIRS (ICG-NIRS) can detect reductions in cerebral perfusion in patients with acute stroke. However, whether ICGNIRS can predict postoperative hyperperfusion phenomenon (HP) after carotid revascularization is unclear. Objective Here, we evaluated whether the blood flow index (BFI) ratio calculated from a time-intensity curve from ICG-NIRS monitoring can predict HPS after CAS. Methods The BFI ratio was prospectively monitored using ICG-NIRS in 135 patients undergoing CAS. Preoperative cerebrovascular reactivity (CVR) and the postoperative asymmetry index (AI) were also assessed with single-photon emission computed tomography before and after CAS, and the correlation was evaluated. In addition, patients were divided into two groups, a non-HP group (n = 113) and an HP group (n = 22), and we evaluated the correlation with hemodynamic impairment in the ipsilateral hemisphere and clinical results. Results Twenty-two cases (16%) showed HP, and four (3%) showed HPS after CAS. The BFI ratio calculated from ICG-NIRS showed a significant linear correlation with preoperative CVR and postoperative AI (r = -0.568, 0.538, P < 0.001, < 0.001, respectively). The degree of stenosis, the rate of no cross flow, preoperative CVR, and the incidence of HPS were significantly different between the groups. Conclusions Measurement of ICG kinetics by NIRS is useful for detection of HPS in patients who underwent CAS.	[Nakagawa, Ichiro; Park, Hun Soo; Yokoyama, Shohei; Yamada, Shuichi; Motoyama, Yasushi; Park, Young Su; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Nara, Japan; [Wada, Takeshi; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Nara, Japan	Nara Medical University; Nara Medical University	Nakagawa, I (corresponding author), Nara Med Univ, Dept Neurosurg, Nara, Japan.	nakagawa@nmu-gw.naramed-u.ac.jp						Akutsu N, 2012, AM J NEURORADIOL, V33, P1557, DOI 10.3174/ajnr.A3002; Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Buczek J, 2013, CEREBROVASC DIS, V35, P531, DOI 10.1159/000350736; Chiu FY, 2012, EUR J RADIOL, V81, P4087, DOI 10.1016/j.ejrad.2012.07.018; Dalman JE, 1999, EUR J VASC ENDOVASC, V18, P222, DOI 10.1053/ejvs.1999.0846; Fujisaka S, 2016, ADV EXP MED BIOL, V876, P427, DOI 10.1007/978-1-4939-3023-4_54; GERMON TJ, 1995, J NEUROL NEUROSUR PS, V58, P477, DOI 10.1136/jnnp.58.4.477; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; HASHIKAWA K, 1994, J NUCL MED, V35, P1226; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Hopton P, 1999, J APPL PHYSIOL, V87, P1981, DOI 10.1152/jappl.1999.87.5.1981; Hosoda K, 2003, STROKE, V34, P1187, DOI 10.1161/01.STR.0000068781.31429.BE; Kawai N, 2014, J STROKE CEREBROVASC, V23, pE55, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.012; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Kohl-Bareis M, 2002, J BIOMED OPT, V7, P464, DOI 10.1117/1.1482719; Komoribayashi N, 2006, J CEREBR BLOOD F MET, V26, P878, DOI 10.1038/sj.jcbfm.9600244; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; Kusaka T, 2001, NEUROIMAGE, V13, P944, DOI 10.1006/nimg.2001.0755; Liang FY, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-84; Matsumoto S, 2009, NEUROLOGY, V72, P1512, DOI 10.1212/WNL.0b013e3181a2e846; Moriwaki H, 1998, J NUCL MED, V39, P1348; Ogasawara K, 2003, J NEUROSURG, V99, P504, DOI 10.3171/jns.2003.99.3.0504; Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130; Park HS, 2016, WORLD NEUROSURGERY; Pennekamp CWA, 2012, CEREBROVASC DIS, V34, P314, DOI 10.1159/000343229; PIEPGRAS DG, 1988, J NEUROSURG, V68, P532, DOI 10.3171/jns.1988.68.4.0532; Rothoerl RD, 2003, NEUROL RES, V25, P528, DOI 10.1179/016164103101201779; Sam K, 2014, CEREBROVASC DIS, V38, P94, DOI 10.1159/000362084; Springett R, 2001, PHYS MED BIOL, V46, P2209, DOI 10.1088/0031-9155/46/8/312; Suga Y, 2007, STROKE, V38, P2712, DOI 10.1161/STROKEAHA.107.483495; Terborg C, 2004, J NEUROL NEUROSUR PS, V75, P38; Terborg C, 2009, EUR NEUROL, V62, P338, DOI 10.1159/000239794; van Mook WNKA, 2005, LANCET NEUROL, V4, P877, DOI 10.1016/S1474-4422(05)70251-9; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yokose N, 2010, WORLD NEUROSURG, V73, P508, DOI 10.1016/j.wneu.2010.02.061; Yoshimura S, 2009, NEUROSURGERY, V64, pS122, DOI 10.1227/01.NEU.0000334046.41985.BB	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180684	10.1371/journal.pone.0180684	http://dx.doi.org/10.1371/journal.pone.0180684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704454	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600043
J	Zhang, XJ; Liu, XY; Zhang, DF; Tang, HJ; Sun, BC; Li, CH; Hao, LY; Liu, C; Li, YX; Shi, YS; Xie, XQ; Song, YC; Wang, TY; Li, Y				Zhang, Xiaojing; Liu, Xuyang; Zhang, Dengfeng; Tang, Huaijun; Sun, Baocheng; Li, Chunhui; Hao, Luyang; Liu, Cheng; Li, Yongxiang; Shi, Yunsu; Xie, Xiaoqing; Song, Yanchun; Wang, Tianyu; Li, Yu			Genome-wide identification of gene expression in contrasting maize inbred lines under field drought conditions reveals the significance of transcription factors in drought tolerance	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ORYZA-SATIVA L.; STRESS RESPONSES; WATER-DEFICIT; TRANSGENIC ARABIDOPSIS; MOLECULAR CHAPERONES; PRIMARY ROOTS; ZEA-MAYS; RNA-SEQ; PHYSIOLOGICAL-RESPONSES	Drought is a major threat to maize growth and production. Understanding the molecular regulation network of drought tolerance in maize is of great importance. In this study, two maize inbred lines with contrasting drought tolerance were tested in the field under natural soil drought and well-watered conditions. In addition, the transcriptomes of their leaves was analyzed by RNA-Seq. In total, 555 and 2,558 genes were detected to specifically respond to drought in the tolerant and the sensitive line, respectively, with a more positive regulation tendency in the tolerant genotype. Furthermore, 4,700, 4,748, 4,403 and 4,288 genes showed differential expression between the two lines under moderate drought, severe drought and their well-watered controls, respectively. Transcription factors were enriched in both genotypic differentially expressed genes and specifically responsive genes of the tolerant line. It was speculated that the genotype`-specific response of 20 transcription factors in the tolerance line and the sustained genotypically differential expression of 22 transcription factors might enhance tolerance to drought in maize. Our results provide new insight into maize drought tolerance-related regulation systems and provide gene resources for subsequent studies and drought tolerance improvement.	[Zhang, Xiaojing; Liu, Xuyang; Zhang, Dengfeng; Li, Chunhui; Hao, Luyang; Li, Yongxiang; Shi, Yunsu; Song, Yanchun; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Tang, Huaijun; Sun, Baocheng; Liu, Cheng; Xie, Xiaoqing] Xinjiang Acad Agr Sci, Inst Grain Crops, Urumqi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, TY; Li, Y (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangtianyu@263.net; liyu03@caas.cn	li, yong/HDN-3885-2022; li, yongxiang/GPW-6930-2022		Chinese Academy of Agricultural Sciences [1610092016208]	Chinese Academy of Agricultural Sciences	This work was supported by Chinese Academy of Agricultural Sciences (the Innovation Program, 1610092016208).	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Blum A, 2014, FUNCT PLANT BIOL, V41, P1191, DOI 10.1071/FP14018; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dey S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00640; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gahlaut V, 2016, THEOR APPL GENET, V129, P2019, DOI 10.1007/s00122-016-2794-z; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Harrison MT, 2014, GLOBAL CHANGE BIOL, V20, P867, DOI 10.1111/gcb.12381; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Humbert S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-3; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Jung H, 2015, PLANT SCI, V236, P304, DOI 10.1016/j.plantsci.2015.04.018; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li HY, 2007, DNA SEQUENCE, V18, P443, DOI 10.1080/10425170701292051; Li MJ, 2016, J PLANT RES, V129, P1097, DOI 10.1007/s10265-016-0857-5; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Li YZ, 2009, PLANT CELL PHYSIOL, V50, P2092, DOI 10.1093/pcp/pcp145; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lu HF, 2011, THEOR APPL GENET, V123, P943, DOI 10.1007/s00122-011-1638-0; Lu M, 2013, PLANT CELL TISS ORG, V115, P443, DOI 10.1007/s11240-013-0375-2; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Luo M, 2010, J INTEGR PLANT BIOL, V52, P1059, DOI 10.1111/j.1744-7909.2010.01000.x; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Mao HD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9326; Marcolino-Gomes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139051; Murakami T, 2004, MOL BREEDING, V13, P165, DOI 10.1023/B:MOLB.0000018764.30795.c1; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Oono Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096946; Opitz N, 2016, J EXP BOT, V67, P1095, DOI 10.1093/jxb/erv453; Opitz N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-741; Poroyko V, 2007, J EXP BOT, V58, P279, DOI 10.1093/jxb/erl119; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Qin YZ, 2008, SCI CHINA SER C, V51, P391, DOI 10.1007/s11427-008-0059-z; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Shan XH, 2013, PLANT MOL BIOL REP, V31, P1485, DOI 10.1007/s11105-013-0622-z; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silveira RDD, 2015, GENET MOL RES, V14, P8181, DOI 10.4238/2015.July.27.6; Singh KL, 2015, PLANTA, V242, P997, DOI 10.1007/s00425-015-2338-9; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Song L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2378-y; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang CT, 2011, ACTA PHYSIOL PLANT, V33, P575, DOI 10.1007/s11738-010-0582-y; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang YJ, 2012, MOL BIOL REP, V39, P2401, DOI 10.1007/s11033-011-0991-z; Wu G, 2007, J PLANT INTERACT, V2, P135, DOI 10.1080/17429140701586357; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Yang WQ, 2008, J GENET GENOMICS, V35, P531, DOI 10.1016/S1673-8527(08)60073-9; Yu LX, 2003, PLANT PHYSIOL, V131, P1921; Zhao JF, 2009, PLANT MOL BIOL, V69, P661, DOI 10.1007/s11103-008-9445-y; Zheng J, 2004, PLANT MOL BIOL, V55, P807, DOI 10.1007/s11103-005-1969-9; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zhuang Y, 2007, PLANT CELL REP, V26, P2137, DOI 10.1007/s00299-007-0419-3; Zinselmeier C, 2002, FIELD CROP RES, V75, P111, DOI 10.1016/S0378-4290(02)00021-7; Zou J, 2012, J PLANT PHYSIOL, V169, P628, DOI 10.1016/j.jplph.2011.12.014; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	82	35	39	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179477	10.1371/journal.pone.0179477	http://dx.doi.org/10.1371/journal.pone.0179477			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700592	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600008
J	Greco, N; Cluigt, N; Cline, A; Liljesthrom, G				Greco, Nancy; Cluigt, Nicolas; Cline, Andrew; Liljesthroem, Gerardo			Life history traits and life table analysis of Lobiopa insularis (Coleoptera: Nitidulidae) fed on strawberry	PLOS ONE			English	Article							SAP BEETLE COLEOPTERA; SPECIES COLEOPTERA; ENVIRONMENTS	Lobiopa insularis is a newly reported pest of strawberry in Argentina. We investigated characteristics of its biology in the laboratory, including survivorship and reproduction. We also estimated population growth for L. insularis fed ripe strawberry fruits. Lobiopa insularis was not observed ovipositing on strawberry fruits. A higher proportion of egg masses were recorded from a depth of 1 cm within the soil than on either the soil surface or deeper than 1cm (i.e. between 1and 2 cm) within the soil. The duration of preimaginal developmental stages represented similar to 18.5% of the total life cycle, while the adult stage represented 81.5%. Survival from egg to adult was 64.20% and mean longevity of females and males adults was 121.84, (SE = 8.86) and 118.58 (SE = 5.90) days, respectively. Females laid eggs only when they were with a male, so reproductive period was dependent on male presence. The number of eggs/female/day was 18.01 (SE = 1.71); and total fecundity was 1655 (ES = 249.53) eggs/female. The long life span of adults and high reproductive output, i.e high fecundity and long reproductive period, indicate that availability and concentration of suitable developmental resources are important factors in the population dynamics of Lobiopa insularis associated with strawberry crops.	[Greco, Nancy; Cluigt, Nicolas; Liljesthroem, Gerardo] UNLP, CONICET, Fac Ciencias Nat & Museo, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina; [Greco, Nancy] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Cline, Andrew] Calif Dept Food & Agr, Plant Pest Diagnost Branch, Sacramento, CA 95814 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Comision de Investigaciones Cientificas; California Department of Food & Agriculture	Greco, N (corresponding author), UNLP, CONICET, Fac Ciencias Nat & Museo, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina.; Greco, N (corresponding author), Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina.	ngreco@cepave.edu.ar			BID FONCyT, PICT [2012-1624]; Programa de Incentivos UNLP [N712]	BID FONCyT, PICT; Programa de Incentivos UNLP	This research was partially supported by grants from BID FONCyT, PICT 2012-1624, and Programa de Incentivos UNLP, N712. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BEGON M, 2006, ECOLOGY FROM INDIVID; Berryman AA, 2008, POPULATION SYSTEMS A; Bortli LC, 2014, PESQUI AGROPECU BRAS, V49, P144, DOI [10.1590/S0100-204X2013000200009, 10.1590/S0100-204X2014000200009]; Bortolozzo AR, 2007, PRODUCE AO DE MORANG; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Carey JR, 1993, APPLIED DEMOGRAPHY F; Cline AR, 2008, ZOOTAXA, P1; Cline AR, 2012, PAN-PAC ENTOMOL, V88, P202, DOI 10.3956/2012-25.1; Cline AR, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2237.1.2; Cline AR, 2004, COLEOPTS BULL, V58, P355, DOI 10.1649/630; Cline AR, 2005, THESIS; Cluigt N, 30 E CONGRESO ARGENT; Denno RF, 1983, VARIABLE PLANTS AND; DESANTIS L, 1964, ANALES COMISION INVE, V4, P9; Dowd PF, 1994, J ECON ENTOMOL, V93, P1714; Ebert TA, 1999, PLANT AND ANIMAL POP; Ellis JD, 2008, J APICULT RES, V47, P188, DOI 10.1080/00218839.2008.11101456; Galford JR, 1991, RES PAP NE 654; Galford JR, 1991, RES PAP NE 644; GEHAN EA, 1969, BIOMETRIKA, V56, P127, DOI 10.2307/2334697; Guimaraes JA, COMUNICADO TECNICO 7; Hayashi C., 1978, MATH SCI, V3, P117; Hunter MD, 1992, EFFECTS OF RESOURCE; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Loughner RL, 2007, ENVIRON ENTOMOL, V36, P1059, DOI 10.1603/0046-225X(2007)36[1059:EOSSBC]2.0.CO;2; Majka CG, 2006, CAN ENTOMOL, V138, P314; Majka CG, 2008, ZOOKEYS, P337, DOI 10.3897/zookeys.2.23; Myers L., 2004, NITIDULIDAE; Parsons Carl T., 1943, BULL MUS COMP ZOOL HARVARD UNIV, V92, P121; PIMM SL, 1982, FOOD WEBS; Price JF, 2001, BERRY TIMES, V1; Price Michele B., 2006, Insecta Mundi, V20, P69; Price PW, 2011, INSECT ECOLOGY; Rabb R.L., 1978, Bulletin of the Entomological Society of America, V24, P55; Rondon SI, 2011, MANAGEMENT IN STRAWB, P1; Salles LAB., 2005, SISTEMA DE PRODUCE D; SANFORD J. W., 1963, P N CENTRAL BRANCH E, V18, P39; Schowalter T.D., 2006, INSECT ECOLOGY, Vsecond; Stearns SC, 1992, THE EVOLUTION OF LIF; Stinner R.E., 1979, P199; Sunderland KD, 2002, AGROECOLOGY OF CARABID BEETLES, P165; TINKLE DW, 1969, AM NAT, V103, P501, DOI 10.1086/282617; TULJAPURKAR S, 1990, P NATL ACAD SCI USA, V87, P1139, DOI 10.1073/pnas.87.3.1139; TULJAPURKAR S, 1989, THEOR POPUL BIOL, V35, P227, DOI 10.1016/0040-5809(89)90001-4; WILLIAMS RN, 1986, FLA ENTOMOL, V69, P298, DOI 10.2307/3494932; Williams RN, 1984, SUMMARY EXPT CONTROL, V283, P66	47	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180093	10.1371/journal.pone.0180093	http://dx.doi.org/10.1371/journal.pone.0180093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700607	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400008
J	Raviv, B; Aghajanyan, L; Granot, G; Makover, V; Frenkel, O; Gutterman, Y; Grafi, G				Raviv, Buzi; Aghajanyan, Lusine; Granot, Gila; Makover, Vardit; Frenkel, Omer; Gutterman, Yitzchak; Grafi, Gideon			The dead seed coat functions as a long-term storage for active hydrolytic enzymes	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; POLYACRYLAMIDE-GEL ELECTROPHORESIS; ANASTATICA-HIEROCHUNTICA L; DEFENSIN-LIKE PEPTIDES; ARABIDOPSIS-THALIANA; PLANT DEFENSINS; ANTIMICROBIAL PEPTIDES; ENHANCED RESISTANCE; FUNGAL PATHOGEN; HOST-DEFENSE	Seed development culminates in programmed cell death (PCD) and hardening of organs enclosing the embryo (e.g., pericarp, seed coat) providing essentially a physical shield for protection during storage in the soil. We examined the proposal that dead organs enclosing embryos are unique entities that store and release upon hydration active proteins that might increase seed persistence in soil, germination and seedling establishment. Proteome analyses of dead seed coats of Brassicaceae species revealed hundreds of proteins being stored in the seed coat and released upon hydration, many are stress-associated proteins such as nucleases, proteases and chitinases. Functional analysis revealed that dead seed coats function as long-term storage for multiple active hydrolytic enzymes (e.g., nucleases) that can persist in active forms for decades. Substances released from the dead seed coat of the annual desert plant Anastatica hierochuntica displayed strong antimicrobial activity. Our data highlighted a previously unrecognized feature of dead organs enclosing embryos ( e.g., seed coat) functioning not only as a physical shield for embryo protection but also as a longterm storage for active proteins and other substances that are released upon hydration to the "seedsphere" and could contribute to seed persistence in the soil, germination and seedling establishment.	[Raviv, Buzi; Aghajanyan, Lusine; Granot, Gila; Gutterman, Yitzchak; Grafi, Gideon] Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Makover, Vardit] Ben Gurion Univ Negev, Inst Desert Res, Zuckerberg Inst Water Res, Midreshet Ben Gurion, Israel; [Frenkel, Omer] ARO, Volcani Ctr, Dept Plant Pathol & Weed Res, Bet Dagan, Israel	Ben Gurion University; Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Grafi, G (corresponding author), Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il		Aghajanyan, Lusine/0000-0003-4486-6095	Harbour Foundation; Margolin foundation	Harbour Foundation; Margolin foundation	This work was supported by the Harbour Foundation to B.R. and by the Margolin foundation to G. Grafi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; Beeckman T, 2000, J PLANT RES, V113, P139, DOI 10.1007/PL00013924; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; Chen F, 2002, J EXP BOT, V53, P215, DOI 10.1093/jexbot/53.367.215; Coca M, 2004, PLANT MOL BIOL, V54, P245, DOI 10.1023/B:PLAN.0000028791.34706.80; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; DEBOLLE MFC, 1995, PLANT MOL BIOL, V28, P713, DOI 10.1007/BF00021195; DeBono AG, 2006, CAN J BOT, V84, P791, DOI 10.1139/B06-034; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FRIEDMAN J, 1981, OECOLOGIA, V51, P400, DOI 10.1007/BF00540912; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Gechev TS, 2014, BIOTECHNOL ADV, V32, P1091, DOI 10.1016/j.biotechadv.2014.03.005; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Givaty-Rapp Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170067; GOLDBERG RB, 1989, CELL, V56, P149, DOI 10.1016/0092-8674(89)90888-X; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Granot G, 2015, BBA-GENE REGUL MECH, V1849, P239, DOI 10.1016/j.bbagrm.2014.12.003; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Gutterman Y, 1997, J ARID ENVIRON, V35, P695, DOI 10.1006/jare.1996.0192; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Hegazy AK, 2007, ACTA OECOL, V31, P332, DOI 10.1016/j.actao.2007.01.006; HENDRY GAF, 1994, FUNCT ECOL, V8, P658, DOI 10.2307/2389929; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Hugot K, 2002, MOL PLANT MICROBE IN, V15, P243, DOI 10.1094/MPMI.2002.15.3.243; Husebye H, 2002, PLANT PHYSIOL, V128, P1180, DOI 10.1104/pp.010925; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Miernyk JA, 2013, J PROTEOMICS, V89, P265, DOI 10.1016/j.jprot.2013.05.013; Mohamed AA, 2010, GRASAS ACEITES, V61, P67, DOI 10.3989/gya.064509; MOHAMEDYASSEEN Y, 1994, BOT REV, V60, P426, DOI 10.1007/BF02857926; Moise JA, 2005, IN VITRO CELL DEV-PL, V41, P620, DOI 10.1079/IVP2005686; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Patton T, 2006, J MICROBIOL METH, V64, P84, DOI 10.1016/j.mimet.2005.04.007; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Radulovic NS, 2013, CURR MED CHEM, V20, P932; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Raviv B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177537; Rose TL, 2006, PLANT SOIL, V286, P181, DOI 10.1007/s11104-006-9036-0; Sanchez-Pons N, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-186; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Shukla P, 2014, FUNCT INTEGR GENOMIC, V14, P307, DOI 10.1007/s10142-014-0367-2; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; Sun Y, 2012, AUST J BOT, V60, P439, DOI 10.1071/BT11314; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Thompson K., 1997, SOIL SEED BANKS OF N; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Voegele A, 2011, J EXP BOT, V62, P5131, DOI 10.1093/jxb/err214; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Western TL, 2012, SEED SCI RES, V22, P1, DOI 10.1017/S0960258511000249; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Windsor JB, 2000, PLANT J, V22, P483, DOI 10.1046/j.1365-313x.2000.00756.x; Yang XJ, 2012, PERSPECT PLANT ECOL, V14, P434, DOI 10.1016/j.ppees.2012.09.002; Yang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024346	75	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181102	10.1371/journal.pone.0181102	http://dx.doi.org/10.1371/journal.pone.0181102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700755	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400030
J	Shimizu, A; Shiratori, I; Horii, K; Waga, I				Shimizu, Akihisa; Shiratori, Ikuo; Horii, Katsunori; Waga, Iwao			Molecular evolution of versatile derivatives from a GFP-like protein in the marine copepod Chiridius poppei	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EXPRESSION; VARIANTS; MUTANTS; BRIGHT	Fluorescent proteins are now indispensable tools in molecular research. They have also been adapted for a wide variety of uses in cases involving creative applications, including textiles, aquarium fish, and ornamental plants. Our colleagues have previously cloned a yellow GFP-like protein derived from the marine copepod Chiridius poppei (YGFP), and moreover, succeeded in generating transgenic flowers with clearly visible fluorescence, without the need for high-sensitivity imaging equipment. However, due to the low Stokes shift of YGFP (10 nm), it is difficult to separate emitted light of a labeled object from the light used for excitation; hence, limitations for various applications remain. In this study, which was aimed at developing YGFP mutants with increased Stokes shifts, we conducted stepwise molecular evolution experiments on YGFP by screening random mutations at three key amino acids, based on their fluorescent characteristics and structural stabilities, followed by optimization of their fluorescence output by DNA shuffling of the entire coding sequence. We successfully identified an eYGFPuv that had an excitation maximum in UV wavelengths and a 24-fold increase in fluorescence intensity compared to the previously reported YGFP mutant (H52D). In addition, eYGFPuv exhibited almost 9-fold higher fluorescence intensity compared to the commercially available GFPuv when expressed in human colon carcinoma HCT116 cells and without any differences in cytotoxicity. Thus, this novel mutant with the desirable characteristics of bright fluorescence, long Stokes shift, and low cytotoxity, may be particularly well suited to a variety of molecular and biological applications.	[Shimizu, Akihisa; Shiratori, Ikuo; Horii, Katsunori; Waga, Iwao] NEC Solut Innovators Ltd, Innovat Labs, Koto Ku, Tokyo, Japan		Shiratori, I (corresponding author), NEC Solut Innovators Ltd, Innovat Labs, Koto Ku, Tokyo, Japan.	iku-shiratori@xc.jp.nec.com		Shiratori, Ikuo/0000-0003-3713-4910				Ansari AM, 2016, STEM CELL REV REP, V12, P553, DOI 10.1007/s12015-016-9670-8; Arpino JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047132; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Bomati EK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05469; BOYD D, 1988, CANCER RES, V48, P3112; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Fradkov AF, 2000, FEBS LETT, V479, P127, DOI 10.1016/S0014-5793(00)01895-0; Gong ZY, 2003, BIOCHEM BIOPH RES CO, V308, P58, DOI 10.1016/S0006-291X(03)01282-8; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365; Ilagan RP, 2010, FEBS J, V277, P1967, DOI 10.1111/j.1742-4658.2010.07618.x; Ito Y, 1999, BIOCHEM BIOPH RES CO, V264, P556, DOI 10.1006/bbrc.1999.1541; Kawasaki M, 2001, BIOCHEM BIOPH RES CO, V280, P842, DOI 10.1006/bbrc.2000.4229; Knight J, 2003, NATURE, V426, P372, DOI 10.1038/426372b; Knop M, 2002, BIOTECHNIQUES, V33, P592, DOI 10.2144/02333rr02_11819a; Laviv T, 2016, NAT METHODS, V13, P989, DOI [10.1038/NMETH.4046, 10.1038/nmeth.4046]; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; ROSE HN, 1975, SCIENCE, V190, P673, DOI 10.1126/science.1188362; Sasaki K, 2014, PLANT BIOTECHNOL-NAR, V31, P309, DOI 10.5511/plantbiotechnology.14.0907a; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171257; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Suto K, 2009, GENES CELLS, V14, P727, DOI 10.1111/j.1365-2443.2009.01305.x; Takai A, 2015, P NATL ACAD SCI USA, V112, P4352, DOI 10.1073/pnas.1418468112; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3	34	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181186	10.1371/journal.pone.0181186	http://dx.doi.org/10.1371/journal.pone.0181186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700734	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649400036
J	Iwayama, K; Kawabuchi, R; Nabekura, Y; Kurihara, R; Park, I; Kobayashi, M; Ogata, H; Kayaba, M; Omi, N; Satoh, M; Tokuyama, K				Iwayama, Kaito; Kawabuchi, Ryosuke; Nabekura, Yoshiharu; Kurihara, Reiko; Park, Insung; Kobayashi, Masashi; Ogata, Hitomi; Kayaba, Momoko; Omi, Naomi; Satoh, Makoto; Tokuyama, Kumpei			Exercise before breakfast increases 24-h fat oxidation in female subjects	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ENDURANCE EXERCISE; FASTED STATE; INDIRECT CALORIMETRY; SUBSTRATE OXIDATION; ENERGY-EXPENDITURE; SEX-DIFFERENCES; METABOLISM; CARBOHYDRATE; INTENSITY	Background Exercise performed in a postprandial state does not increase 24-h fat oxidation of male and female subjects. Conversely, it has been shown in male subjects that exercise performed in a postabsorptive state increases 24-h fat oxidation compared with that in sedentary control and that with exercise trials performed after breakfast, lunch, or dinner. There is a paucity of study evaluating the effect of exercise performed in a postabsorptive state in female subjects. Method Nine young female subjects participated in indirect calorimetry measurement over 24-h using a room-size metabolic chamber in which subjects remained sedentary or performed 60 min exercise before breakfast at 50% of VO2 max. Exercise was accompanied by an increase in energy intake to ensure that subjects were in a similar state of energy balance over 24 h for the two trials. Findings Compared with the sedentary condition, exercise performed before breakfast increased 24h fat oxidation (519 +/- 37 vs. 400 +/- 41 kcal/day). Time courses of relative energy balance differed between trials with transient negative energy balance observed before breakfast. The lowest values of relative energy balance observed during the 24-h calorimetry, i.e., transient energy deficit, were greater in exercise trials than in sedentary trials. The transient deficit in carbohydrate balance was also observed before breakfast, and magnitude of the deficit was greater in exercise trial compared to that of sedentary trial. Interpretation Under energy-balanced conditions, exercise performed in a post-absorptive state increases 24-h fat oxidation in female subjects. The effect of exercise performed before breakfast can be attributed to nutritional state: a transient deficit in energy and carbohydrate at the end of exercise.	[Iwayama, Kaito; Kawabuchi, Ryosuke; Nabekura, Yoshiharu; Kurihara, Reiko; Park, Insung; Kobayashi, Masashi; Ogata, Hitomi; Omi, Naomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Sports Med, Tennodai 1-1-1, Tsukuba, Ibaraki, Japan; [Kayaba, Momoko; Satoh, Makoto] Univ Tsukuba, Int Inst Integrat Sleep Med, Tennodai 1-1-1, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Tokuyama, K (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Sports Med, Tennodai 1-1-1, Tsukuba, Ibaraki, Japan.	tokuyama@taiiku.tsukuba.ac.jp	PARK, Insung/AFR-8117-2022	PARK, Insung/0000-0001-6389-1937	Grants-in-Aid for Scientific Research [16H01877] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 2013, SURVEY TIME USE LEIS; [Anonymous], 2010, DIETARY REFERENCE IN; Berthon PM, 1998, J APPL PHYSIOL, V85, P148, DOI 10.1152/jappl.1998.85.1.148; COYLE EF, 1995, AM J CLIN NUTR, V61, p968S, DOI 10.1093/ajcn/61.4.968S; De Bock K, 2008, J APPL PHYSIOL, V104, P1045, DOI 10.1152/japplphysiol.01195.2007; Devries MC, 2006, AM J PHYSIOL-REG I, V291, pR1120, DOI 10.1152/ajpregu.00700.2005; Dionne I, 1999, AM J CLIN NUTR, V69, P927; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FLATT JP, 1988, DIABETES METAB REV, V4, P571, DOI 10.1002/dmr.5610040603; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Henderson GC, 2014, J APPL PHYSIOL, V116, P95, DOI 10.1152/japplphysiol.00956.2013; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE828, DOI 10.1152/ajpendo.1999.276.5.E828; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Horton TJ, 1998, J APPL PHYSIOL, V85, P1823, DOI 10.1152/jappl.1998.85.5.1823; Iwayama K, 2015, EBIOMEDICINE, V2, P2003, DOI 10.1016/j.ebiom.2015.10.029; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Kim HK, 2016, J SPORT SCI MED, V15, P467; Melanson EL, 2009, J APPL PHYSIOL, V107, P1847, DOI 10.1152/japplphysiol.00958.2009; Melanson EL, 2009, EXERC SPORT SCI REV, V37, P93, DOI 10.1097/JES.0b013e31819c2f0b; Melanson EL, 2002, J APPL PHYSIOL, V92, P1045, DOI 10.1152/japplphysiol.00706.2001; Miller VM, 2012, J APPL PHYSIOL, V112, P1427, DOI 10.1152/japplphysiol.00303.2012; Naka T, 2006, JPN J PHYS FIT SPORT, V55, P49; Nordby P, 2006, SCAND J MED SCI SPOR, V16, P209, DOI 10.1111/j.1600-0838.2005.00480.x; Nybo L, 2009, ACTA PHYSIOL, V197, P117, DOI 10.1111/j.1748-1716.2009.01996.x; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Romijn JA, 2000, J APPL PHYSIOL, V88, P1707, DOI 10.1152/jappl.2000.88.5.1707; Saris WHM, 2004, INT J OBESITY, V28, P759, DOI 10.1038/sj.ijo.0802631; Sato M, 2011, OBES RES CLIN PRACT, V5, pE220, DOI 10.1016/j.orcp.2011.02.001; Schoenfeld BJ, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0054-7; Shimada K, 2013, METABOLISM, V62, P793, DOI 10.1016/j.metabol.2012.12.008; Stannard SR, 2010, J SCI MED SPORT, V13, P465, DOI 10.1016/j.jsams.2010.03.002; Stisen AB, 2006, EUR J APPL PHYSIOL, V98, P497, DOI 10.1007/s00421-006-0290-x; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Treuth MS, 1996, MED SCI SPORT EXER, V28, P1138, DOI 10.1097/00005768-199609000-00009; Van Proeyen K, 2011, J APPL PHYSIOL, V110, P236, DOI 10.1152/japplphysiol.00907.2010; Van Proeyen K, 2010, J PHYSIOL-LONDON, V588, P4289, DOI 10.1113/jphysiol.2010.196493; Wallis GA, 2006, AM J PHYSIOL-ENDOC M, V290, pE708, DOI 10.1152/ajpendo.00357.2005	44	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180472	10.1371/journal.pone.0180472	http://dx.doi.org/10.1371/journal.pone.0180472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692687	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800044
J	Krautter, M; Diefenbacher, K; Schultz, JH; Maatouk, I; Herrmann-Werner, A; Koehl-Hackert, N; Herzog, W; Nikendei, C				Krautter, Markus; Diefenbacher, Katja; Schultz, Jobst-Hendrik; Maatouk, Imad; Herrmann-Werner, Anne; Koehl-Hackert, Nadja; Herzog, Wolfgang; Nikendei, Christoph			Physical examination skills training: Faculty staff vs. patient instructor feedback -A controlled trial	PLOS ONE			English	Article							OF-THE-LITERATURE; STANDARDIZED PATIENTS; MEDICAL-EDUCATION; CLINICAL-PERFORMANCE; SIMULATED PATIENTS; STUDENTS; COMPETENCE; OSCE; CHECKLISTS; TEACHERS	Background Standardized patients are widely used in training of medical students, both in teaching and assessment. They also frequently lead complete training sessions delivering physical examination skills without the aid of faculty teaching staff -acting as "patient instructors " (PIs). An important part of this training is their ability to provide detailed structured feedback to students which has a strong impact on their learning success. Yet, to date no study has assessed the quality of physical examination related feedback by PIs. Therefore, we conducted a randomized controlled study comparing feedback of PIs and faculty staff following a physical examination assessed by students and video assessors. Methods 14 PIs and 14 different faculty staff physicians both delivered feedback to 40 medical students that had performed a physical examination on the respective PI while the physicians observed the performance. The physical examination was rated by two independent video assessors to provide an objective performance standard (gold standard). Feedback of PI and physicians was content analyzed by two different independent video assessors based on a provided checklist and compared to the performance standard. Feedback of PIs and physicians was also rated by medical students and video assessors using a questionnaire consisting of 12 items. Results There was no statistical significant difference concerning overall matching of physician or PI feedback with gold standard ratings by video assessment (p =.219). There was also no statistical difference when focusing only on items that were classified as major key steps (p=.802), mistakes or parts that were left out during physical examination (p =.219) or mistakes in communication items (p=.517). The feedback of physicians was significantly better rated than PI feedback both by students (p=.043) as well as by video assessors (p=.034). Conclusions In summary, our study demonstrates that trained PIs are able to provide feedback of equal quantitative value to that of faculty staff physicians with regard to a physical examination performed on them. However, both the students and the video raters judged the quality of the feedback given by the physicians to be significantly better than that of the PIs.	[Krautter, Markus] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Diefenbacher, Katja; Schultz, Jobst-Hendrik; Maatouk, Imad; Herzog, Wolfgang; Nikendei, Christoph] Heidelberg Univ, Med Ctr, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Herrmann-Werner, Anne] Univ Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Koehl-Hackert, Nadja] Heidelberg Univ, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg	Nikendei, C (corresponding author), Heidelberg Univ, Med Ctr, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	christoph.nikendei@med.uni-heidelberg.de		Herrmann-Werner, Anne/0000-0003-2413-7047				Aamodt CB, 2006, FAM MED, V38, P326; Adamo G, 2003, MED TEACH, V25, P262, DOI 10.1080/0142159031000100300; Barley GE, 2006, ACAD MED, V81, pS95, DOI 10.1097/00001888-200610001-00024; BARROWS HS, 1993, ACAD MED, V68, P443, DOI 10.1097/00001888-199306000-00002; Bokken L, 2009, MED EDUC, V43, P202, DOI 10.1111/j.1365-2923.2008.03268.x; Bosek MS, 2007, INT J NURSING ED SCH, V4, DOI DOI 10.2202/1548-923X.1437; Bowman Dixie H, 2016, J Allied Health, V45, P3; Chalabian J, 1997, Best Pract Benchmarking Healthc, V2, P174; Cleland JA, 2009, MED TEACH, V31, P477, DOI 10.1080/01421590903002821; Davidson R, 2001, ACAD MED, V76, P840, DOI 10.1097/00001888-200108000-00019; DeChamplain AE, 1997, ACAD MED, V72, pS85, DOI 10.1097/00001888-199710001-00029; Doyle Howley L, 2009, THE EFFICACY OF STAN; Dull P, 2003, FAM MED, V35, P343; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Fletcher KE, 2004, TEACH LEARN MED, V16, P171, DOI 10.1207/s15328015tlm1602_9; Hartl A, 2015, GMS Z MED AUSBILD, V32; Hatala R, 2007, ACAD MED, V82, pS26, DOI 10.1097/ACM.0b013e31814002f1; Hatala R, 2008, MED EDUC, V42, P628, DOI 10.1111/j.1365-2923.2007.02953.x; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Holmboe ES, 1998, ANN INTERN MED, V129, P42, DOI 10.7326/0003-4819-129-1-199807010-00011; Homer M, 2009, MED TEACH, V31, P420, DOI 10.1080/01421590802520949; Kluger AN, 1996, PSYCHOL B, V119; Krautter M, 2015, Z EVIDENZ FORTBILD Q, V109, P59, DOI 10.1016/j.zefq.2015.01.003; Lopreiato JO, 2015, ACAD PEDIATR, V15, P134, DOI 10.1016/j.acap.2014.10.010; Martens MJC, 2009, MED EDUC, V43, P184, DOI 10.1111/j.1365-2923.2008.03283.x; May W, 2009, MED TEACH, V31, P487, DOI 10.1080/01421590802530898; May W, 2008, KAOHSIUNG J MED SCI, V24, P640, DOI 10.1016/S1607-551X(09)70029-4; Nikendei C, 2008, MED TEACH, V30, P88, DOI 10.1080/01421590701753468; Nikendei C, 2016, GMS J MED EDU, V33, DOI 10.3205/zma001053; Nikendei C, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0292-7; Ortiz-Neu C, 2001, TEACH LEARN MED, V13, P161, DOI 10.1207/S15328015TLM1303_5; Pjontek R, 2012, HEIDELBERGER STANDAR; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Reilly BM, 2003, LANCET, V362, P1100, DOI 10.1016/S0140-6736(03)14464-9; STILLMAN PL, 1990, ACAD MED, V65, P288, DOI 10.1097/00001888-199005000-00002; Swanson DB, 2013, TEACH LEARN MED, V25, pS17, DOI 10.1080/10401334.2013.842916; Tuzer H, 2016, NURS EDUC TODAY, V45, P120, DOI 10.1016/j.nedt.2016.07.002; van de Ridder JMM, 2008, MED EDUC, V42, P189, DOI 10.1111/j.1365-2923.2007.02973.x; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665; Wright B, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-199; Wykurz G, 2002, BRIT MED J, V325, P818, DOI 10.1136/bmj.325.7368.818	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180308	10.1371/journal.pone.0180308	http://dx.doi.org/10.1371/journal.pone.0180308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692703	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800033
J	Thomasini, RL; Pereira, DS; Pereira, FSM; Mateo, EC; Mota, TN; Guimaraes, GG; Pereira, LSM; Lima, CX; Teixeira, MM; Teixeira, AL				Thomasini, Ronaldo Luis; Pereira, Daniele Sirineu; Maximo Pereira, Fabiana Souza; Mateo, Elvis Cueva; Mota, Thamires Nader; Guimaraes, Gabrielle Gontijo; Maximo Pereira, Leani Souza; Lima, Cristiano Xavier; Teixeira, Mauro Martins; Teixeira Junior, Antonio Lucio			Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; INFECTION; PEOPLE; ADULTS	Immunosenescence is an age-related reduction of immune system activity that can be associated with frailty. This study aimed to compare cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations (based on viremias) between young and elderly women who had a chronic CMV and/or EBV infection (i.e., an IgG(+) serostatus) without an acute infection (i.e., an IgM-serostatus), and among the elderly group categorized according to frailty status. DNA was extracted from plasma using standard protocols and serostatus was determined by enzyme-linked immunosorbent assay. Quantitative real-time polymerase chain reaction analyses for CMV and EBV were carried out and viral loads were determined. Among elderly women (n = 71), 59% were positive for CMV, in contrast to only 8% of young women (n = 73). Elderly women classified as frail, pre-frail, and non-frail presented 82%, 56%, and 48% positivity for CMV, respectively. Frequency and viral load were significantly higher in the elderly group vs. the young group (p < 0.0001 and p = 0.01, respectively) and in elderly with frailty vs. those without frailty (p = 0.007 and p = 0.03, respectively). The frequency of CMV reactivation presented odds ratios of 11.77 for aging and 6.13 for frailty, and relative risks of 5.39 for aging and 1.93 for frailty. EBV was detected in 30% of the elderly women and 15% of the young women (p = 0.04); however, the viral load did not significantly differ between the two age groups. The frequency of EBV reactivation presented odds ratios of 2.36 for aging and 2.90 for frailty, and relative risks of 1.96 for aging and 2.12 for frailty. However, no difference in EBV viral load among the frailty status subgroups was found. In conclusion, the frequency of CMV reactivation was associated with aging and ongoing frailty, whereas the frequency of EBV reactivation was associated only with aging.	[Thomasini, Ronaldo Luis; Maximo Pereira, Fabiana Souza] Univ Fed Vales Jequinhonha & Mucuri, Fac Med Diamantina FAMED, NEPii, Diamantina, MG, Brazil; [Pereira, Daniele Sirineu] Univ Fed Alfenas, Escola Enfermagem, Curso Fisioterapia, Alfenas, MG, Brazil; [Mateo, Elvis Cueva; Mota, Thamires Nader; Guimaraes, Gabrielle Gontijo; Lima, Cristiano Xavier; Teixeira Junior, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Maximo Pereira, Leani Souza] Univ Fed Minas Gerais, Dept Fisioterapia, Belo Horizonte, MG, Brazil; [Maximo Pereira, Leani Souza] Univ Fed Minas Gerais, Programa Ciencias Reabilitacao, Belo Horizonte, MG, Brazil; [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil	Universidade Federal de Alfenas; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Thomasini, RL (corresponding author), Univ Fed Vales Jequinhonha & Mucuri, Fac Med Diamantina FAMED, NEPii, Diamantina, MG, Brazil.	ronaldothomasini@gmail.com	PEREIRA, LSM/L-2541-2014; LIMA, CRISTIANO/AAH-9402-2021; PEREIRA, DANIELE/AAB-9374-2020; Lima, Cristiano/B-1874-2013; Teixeira, Antonio L/N-3315-2014	Teixeira, Antonio L/0000-0002-9621-5422; Thomasini, Ronaldo/0000-0003-4967-0948; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG; Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG and Instituto Nacional de Ciencia e Tecnologia em Dengue - INCT em Dengue.	[Anonymous], 2006, ENVELHECIMENTO SAU P; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bennett JM, 2012, BRAIN BEHAV IMMUN, V26, P739, DOI 10.1016/j.bbi.2011.11.007; Caruso Calogero, 2009, Immun Ageing, V6, P10, DOI 10.1186/1742-4933-6-10; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Derhovanessian E, 2014, J IMMUNOL, V193, P3624, DOI 10.4049/jimmunol.1303361; El Hayderi L, 2011, MED ORAL PATOL ORAL, V16, pE15, DOI 10.4317/medoral.16.e15; Frantzeskaki F, 2014, J CRIT CARE CRIT CAR, V2; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gardella C., 2009, GLOB LIB WOMENS MED; Gary R, 2012, J CARDIOVASC NURS, V27, P120, DOI 10.1097/JCN.0b013e318239f4a4; Lyndon Helen, 2014, Nurs Older People, V26, P16, DOI [10.7748/nop.26.5.16.s21, 10.7748/nop.26.8.16.s22, 10.7748/nop.26.6.16.s21]; Griffiths SJ, 2013, J IMMUNOL, V190, P5363, DOI 10.4049/jimmunol.1203267; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Hesse J, 2013, J GEN VIROL, V94, P376, DOI 10.1099/vir.0.045682-0; Kekre N, 2013, BIOL BLOOD MARROW TR, V19, P1719, DOI 10.1016/j.bbmt.2013.09.013; King-Kallimanis BL, 2014, J CLIN EPIDEMIOL, V67, P1008, DOI 10.1016/j.jclinepi.2014.05.002; Koch S, 2006, MECH AGEING DEV, V127, P538, DOI 10.1016/j.mad.2006.01.011; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; Nogalski MT, 2014, METHODS MOL BIOL, V1119, P15, DOI 10.1007/978-1-62703-788-4_2; Oliveira DR, 2013, REV LAT-AM ENFERM, V21, P891, DOI 10.1590/S0104-11692013000400009; Pereira DS, 2013, AGE, V35, P2455, DOI 10.1007/s11357-013-9515-1; Razonable RR, 2013, CLIN MICROBIOL REV, V26, P703, DOI 10.1128/CMR.00015-13; Sansoni P, 2014, EXP GERONTOL, V55, P54, DOI 10.1016/j.exger.2014.03.020; Seckert CK, 2012, MED MICROBIOL IMMUN, V201, P551, DOI 10.1007/s00430-012-0273-y; Smeltzer JP, 2014, CASE REP HEMATOL, V2014, DOI 10.1155/2014/641483; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; de Franca TRT, 2012, CLIN ORAL INVEST, V16, P659, DOI 10.1007/s00784-011-0548-5; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Wang GC, 2014, TRANSL MED UNISA, V9, P1; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wolf J, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-1; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	37	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180841	10.1371/journal.pone.0180841	http://dx.doi.org/10.1371/journal.pone.0180841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700679	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800086
J	Wheelock, KM; Cai, J; Looker, HC; Merchant, ML; Nelson, RG; Fufaa, GD; Weil, EJ; Feldman, HI; Vasan, RS; Kimmel, PL; Rovin, BH; Mauer, M; Klein, JB				Wheelock, Kevin M.; Cai, Jian; Looker, Helen C.; Merchant, Michael L.; Nelson, Robert G.; Fufaa, Gudeta D.; Weil, E. Jennifer; Feldman, Harold I.; Vasan, Ramachandran S.; Kimmel, Paul L.; Rovin, Brad H.; Mauer, Michael; Klein, Jon B.		CKD Biomarkers Consortium	Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GLOMERULAR VOLUME; MESSENGER-RNA; B2 RECEPTOR; HUMANS; B1; PROLYLCARBOXYPEPTIDASE; LOSARTAN; THERAPY; KININS	Objective To examine the association of bradykinin and related peptides with the development of diabetic nephropathy lesions in 243 participants with type 1 diabetes (T1D) from the ReninAngiotensin System Study who, at baseline, were normoalbuminuric, normotensive and had normal or increased glomerular filtration rate (GFR). Design Plasma concentrations of bradykinin and related peptides were measured at baseline by quantitative mass spectrometry. All participants were randomly assigned at baseline to receive placebo, enalapril or losartan during the 5 years between kidney biopsies. Kidney morphometric data were available from kidney biopsies at baseline and after 5 years. Relationships of peptides with changes in morphometric variables were assessed using multiple linear regression after adjustment for age, sex, diabetes duration, HbA1c, mean arterial pressure, treatment assignment and, for longitudinal analyses, baseline structure. Results Baseline median albumin excretion rate of study participants was 5.0 mu g/ min, and mean GFR was 128 mL/min/ 1.73 m(2). After multivariable adjustment, higher plasma concentration of bradykinin (1 -8) was associated with greater glomerular volume (partial r = 0.191, P = 0.019) and total filtration surface area (partial r = 0.211, P = 0.010), and higher bradykinin (1 -7) and hyp3-bradykinin (1 -7) were associated with lower cortical interstitial fractional volume (partial r = -0.189, P = 0.011; partial r = -0.164, P = 0.027 respectively). In longitudinal analyses, higher bradykinin was associated with preservation of surface density of the peripheral glomerular basement membrane (partial r = 0.162, P = 0.013), and for participants randomized to losartan, higher hyp3-bradykinin (1 -8) was associated with more limited increase in cortical interstitial fractional volume (partial r = -0.291, P = 0.033). Conclusions Higher plasma bradykinin and related peptide concentrations measured before clinical onset of diabetic nephropathy in persons with T1D were associated with preservation of glomerular structures, suggesting that elevations of these kinin concentrations may reflect adaptive responses to early renal structural changes in diabetic nephropathy.	[Wheelock, Kevin M.; Looker, Helen C.; Nelson, Robert G.; Fufaa, Gudeta D.; Weil, E. Jennifer] NIDDK, Phoenix, AZ 85016 USA; [Cai, Jian; Merchant, Michael L.; Klein, Jon B.] Univ Louisville, Louisville, KY 40292 USA; [Feldman, Harold I.] Univ Penn, Philadelphia, PA 19104 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kimmel, Paul L.] NIDDK, Bethesda, MD 20892 USA; [Rovin, Brad H.] Ohio State Univ, Columbus, OH 43210 USA; [Mauer, Michael] Univ Minnesota, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Louisville; University of Pennsylvania; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Nelson, RG (corresponding author), NIDDK, Phoenix, AZ 85016 USA.	rnelson@nih.gov	Merchant, Michael/F-7109-2013; Mauer, Michael/ABD-5415-2020; Ramachandran, Vasan/Y-2527-2019; Klein, Jon/B-9833-2013; Merchant, Michael/N-7444-2013	Ramachandran, Vasan/0000-0001-7357-5970; Merchant, Michael/0000-0003-4128-4057	Chronic Kidney Disease Biomarker Consortium - National Institute of Diabetes and Digestive and Kidney Diseases [U01DK85649, U01DK085673, U01DK085660, U01DK085688, U01DK085651, U01DK085689]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085689, U01DK085660, ZIADK069062] Funding Source: NIH RePORTER	Chronic Kidney Disease Biomarker Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Chronic Kidney Disease Biomarker Consortium funded by National Institute of Diabetes and Digestive and Kidney Diseases U01DK85649, U01DK085673, U01DK085660, U01DK085688, U01DK085651 and U01DK085689, and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The National Institute of Diabetes and Digestive and Kidney Diseases had no role in study design, data collection and analysis, or decision to publish. The project officer representing the National Institute of Diabetes and Digestive and Kidney Diseases had a role in the preparation of the manuscript.	Ahluwalia A, 1996, J IMMUNOL, V156, P269; BILOUS RW, 1989, DIABETES, V38, P1142, DOI 10.2337/diabetes.38.9.1142; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Campbell DJ, 2005, CIRCULATION, V111, P315, DOI 10.1161/01.CIR.0000153269.07762.3B; Campbell DJ, 1999, HYPERTENSION, V34, P171, DOI 10.1161/01.HYP.34.2.171; CAMPBELL DJ, 1993, HYPERTENSION, V21, P155, DOI 10.1161/01.HYP.21.2.155; Caramori ML, 2013, J AM SOC NEPHROL, V24, P1175, DOI 10.1681/ASN.2012070739; Caramori ML, 2002, DIABETES, V51, P506, DOI 10.2337/diabetes.51.2.506; Chajkowski SM, 2011, BIOCHEM BIOPH RES CO, V405, P338, DOI 10.1016/j.bbrc.2010.12.036; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Duncan AM, 2000, AM J PHYSIOL-REG I, V278, pR897, DOI 10.1152/ajpregu.2000.278.4.R897; FIORETTO P, 1994, DIABETES, V43, P1358, DOI 10.2337/diabetes.43.11.1358; Fufaa GD, 2015, NEPHROL DIAL TRANSPL, V30, P599, DOI 10.1093/ndt/gfv012; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; HONG SL, 1980, THROMB RES, V18, P787, DOI 10.1016/0049-3848(80)90201-7; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Katz A, 2002, KIDNEY INT, V61, P2058, DOI 10.1046/j.1523-1755.2002.00370.x; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Kuoppala A, 2000, AM J PHYSIOL-HEART C, V278, pH1069, DOI 10.1152/ajpheart.2000.278.4.H1069; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mackie FE, 2002, KIDNEY INT, V61, P555, DOI 10.1046/j.1523-1755.2002.00141.x; Mallela J, 2009, INT J BIOCHEM CELL B, V41, P477, DOI 10.1016/j.biocel.2008.02.022; Mauer M, 2002, J RENIN-ANGIO-ALDO S, V3, P262, DOI 10.3317/jraas.2002.048; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Merchant ML, 2013, KIDNEY INT, V83, P1177, DOI 10.1038/ki.2013.8; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Pavkov ME, 2016, KIDNEY INT, V89, P226, DOI 10.1038/ki.2015.278; Paykov ME, 2015, KIDNEY INT, V87, P812, DOI 10.1038/ki.2014.330; REGOLI D, 1991, AGENTS ACTIONS, V34, P138, DOI 10.1007/BF01993260; Spillmann F, 2002, INT IMMUNOPHARMACOL, V2, P1823, DOI 10.1016/S1567-5769(02)00174-1; Sumino H, 1999, AM J HYPERTENS, V12, P1044, DOI 10.1016/S0895-7061(99)00094-1; Tabrizian Tahmineh, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P114, DOI 10.2174/1871525713666150911112916; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; United States Renal Data System, 2015, USRDS ANNUAL DATA RE; Xu SY, 2012, CLIN CHEM, V58, P1110, DOI 10.1373/clinchem.2011.179291; Zeitz CJ, 2003, HYPERTENSION, V41, P482, DOI 10.1161/01.HYP.0000054976.67487.08	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180964	10.1371/journal.pone.0180964	http://dx.doi.org/10.1371/journal.pone.0180964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700653	gold, Green Submitted, Green Published			2022-12-27	WOS:000405544800106
J	Xu, GY; Han, X; Yuan, GX; An, LP; Du, PG				Xu, Guangyu; Han, Xiao; Yuan, Guangxin; An, Liping; Du, Peige			Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury	PLOS ONE			English	Article							NF-KAPPA-B; CANCER SUSCEPTIBILITY; OXIDATIVE STRESS; FIBROSIS; PATHWAY; RATS; INFLAMMATION; ACTIVATION; RESISTANCE; MUTATIONS	Liver injury is a common pathological basis of various liver diseases, and long-term liver injury is often an important initiation factor leading to liver fibrosis and even liver cirrhosis and hepatocellular carcinoma (HCC). It has been reported that deproteinized extract of calf blood (DECB) can inhibit the replication of hepatitis B virus and confers a protective effect on the liver after traumatic liver injury. However, few studies on the regulatory factors and mechanisms of DECB have been reported. In this current study, an acute mouse liver injury model was established with carbon tetrachloride (CCl4\). The differentially expressed genes and related cell signal transduction pathways were screened using mRNA expression microarray. STEM software V1.3.6 was used for clustering gene functions, and the DAVID and KEGG databases were applied for the analysis. A total of 1355 differentially expressed genes were selected, among which nine were validated by RT-qPCR. The results showed that the Fas, IL1b, Pik3r1, Pik3r5, Traf2, Traf2, Csf2rb2, Map3k14, Pik3cd and Ppp3cc genes were involved in the regulation of DECB in an acute mouse liver injury model. Targets of the protective effects of DECB and its related mechanisms were found in mice with acute liver injury induced by carbon tetrachloride, which may provide an important theoretical basis for further DECB research.	[Xu, Guangyu; Han, Xiao; Yuan, Guangxin; An, Liping; Du, Peige] Beihua Univ, Coll Pharm, Jilin, Jilin, Peoples R China	Beihua University	An, LP; Du, PG (corresponding author), Beihua Univ, Coll Pharm, Jilin, Jilin, Peoples R China.	alp960@126.com; dupeige2001@126.com		xu, guangyu/0000-0002-5802-4457	Health Department of Jilin Province [2014Z078]; Sci-tech Department of Jilin Province [20140311084YY]; National and Local United Engineering Research and Development Center	Health Department of Jilin Province; Sci-tech Department of Jilin Province; National and Local United Engineering Research and Development Center	This work was financially supported by project 2014Z078 of the Health Department of Jilin Province, project 20140311084YY Sci-tech Department of Jilin Province and also supported by National and Local United Engineering Research and Development Center for Research on Active Peptides of Medicinal Plants and Animals in Changbai Mountains.	Alsheblak MM, 2016, EUR CYTOKINE NETW, V27, P6, DOI 10.1684/ecn.2016.0372; Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X; Cabal-Hierro L, 2014, CELL SIGNAL, V26, P2658, DOI 10.1016/j.cellsig.2014.08.011; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao Lei, 2016, J Cell Death, V9, P19, DOI 10.4137/JCD.S39824; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chung JY, 2002, J CELL SCI, V115, P679; Craft JM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-15; Crank MC, 2014, J CLIN IMMUNOL, V34, P272, DOI 10.1007/s10875-014-0012-9; Domitrovic R, 2012, ACTA PHARMACOL SIN, V33, P1260, DOI 10.1038/aps.2012.62; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gimson AES, 1996, BRIT J ANAESTH, V77, P90, DOI 10.1093/bja/77.1.90; Hsieh CW, 2016, ASIAN PAC J TROP MED, V9, P409, DOI 10.1016/j.apjtm.2016.03.029; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088498; Jeong JH, 2017, MOL CELL, V65, P154, DOI 10.1016/j.molcel.2016.11.034; Jung JU, 2016, CURR BIOL, V26, P3288, DOI 10.1016/j.cub.2016.10.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee M, 1985, Nichidai Koko Kagaku, V11, P90; Li CG, 2013, TUMOR BIOL, V34, P3477, DOI 10.1007/s13277-013-0925-6; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Milanovic D, 2016, NEUROTOX RES, V30, P434, DOI 10.1007/s12640-016-9629-1; Mitupatum Thantip, 2015, Asian Pac J Cancer Prev, V16, P1771; Mohammed A, 2016, CLIN EXP PHARMACOL P, V43, P760, DOI 10.1111/1440-1681.12591; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; O'Connell J, 1999, IMMUNOL TODAY, V20, P46, DOI 10.1016/S0167-5699(98)01382-6; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; [任丽萍 REN Li-ping], 2009, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V29, P209; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Shi Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139552; Shu-ping R., 2006, CHINESE J NEUROMEDIC, V5, p767 ; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Weiskirchen R, 2016, DIGEST DIS, V34, P410, DOI 10.1159/000444556; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhong M, 2013, CELL PHYSIOL BIOCHEM, V31, P209, DOI 10.1159/000343362	39	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180899	10.1371/journal.pone.0180899	http://dx.doi.org/10.1371/journal.pone.0180899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700704	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800096
J	Bastias, JM; Balladares, P; Acuna, S; Quevedo, R; Munoz, O				Bastias, Jose M.; Balladares, Pamela; Acuna, Sergio; Quevedo, Roberto; Munoz, Ociel			Determining the effect of different cooking methods on the nutritional composition of salmon (Salmo salar) and chilean jack mackerel (Trachurus murphyi) fillets	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MUSCLE-TISSUE; CONSUMPTION; OXIDATION; FISH; TEXTURE	The effect of four cooking methods was evaluated for proximate composition, fatty acid, calcium, iron, and zinc content in salmon and Chilean jack mackerel. The moisture content of steamed salmon decreased (64.94%) compared to the control (68.05%); a significant decrease was observed in Chilean jack mackerel in all the treatments when compared to the control (75.37%). Protein content in both salmon and Chilean jack mackerel significantly increased under the different treatments while the most significant decrease in lipids was found in oven cooking and canning for salmon and microwaving for Chilean jack mackerel. Ash concentration in both salmon and Chilean jack mackerel did not reveal any significant differences. Iron and calcium content only had significant changes in steaming while zinc did not undergo any significant changes in the different treatments. Finally, no drastic changes were observed in the fatty acid profile in both salmon and Chilean jack mackerel.	[Bastias, Jose M.; Balladares, Pamela; Acuna, Sergio] Univ Bio Bio, Dept Food Engn, Chillan, Chile; [Quevedo, Roberto] Univ Los Lagos, Dept Aquaculture & Agrifood Resources, Osorno, Chile; [Munoz, Ociel] Univ Austral Chile, Inst Food Sci & Technol, Valdivia, Chile	Universidad del Bio-Bio; Universidad de Los Lagos; Universidad Austral de Chile	Bastias, JM (corresponding author), Univ Bio Bio, Dept Food Engn, Chillan, Chile.	jobastias@ubiobio.cl	Bastias, Jose/AGI-3305-2022; Acuña, Sergio M./N-3875-2019; Acuña, Sergio M./D-4071-2016	Acuña, Sergio M./0000-0003-1365-9851; Acuña, Sergio M./0000-0003-1365-9851; Quevedo, Roberto/0000-0001-8132-838X; Bastias, Jose/0000-0003-3387-6917	Universidad del Bio-Bio [GI 152322/EF]; Center CRHIAM-FONDAP-CONICYT [15130015]; Direction of research and development of University Austral de Chile [DID S-2015-11]	Universidad del Bio-Bio; Center CRHIAM-FONDAP-CONICYT; Direction of research and development of University Austral de Chile	We gratefully acknowledge the Universidad del Bio-Bio through Project GI 152322/EF, Center CRHIAM-FONDAP-CONICYT through Project 15130015, and to the Direction of research and development of University Austral de Chile (DID S-2015-11).	AOAC, 1996, OFFICIAL METHODS ANA, V16th; AOAC. Association of Official Analitical Chemistry, 1996, OFF METH AN, P3; Arab-Tehrany E, 2012, TRENDS FOOD SCI TECH, V25, P24, DOI 10.1016/j.tifs.2011.12.002; Bastias JM, 2015, INNOV FOOD SCI EMERG, V30, P98, DOI 10.1016/j.ifset.2015.05.011; Belitz H. D., 2009, QUIMICA ALIMENTOS; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Campo MM, 2013, J FOOD COMPOS ANAL, V31, P185, DOI 10.1016/j.jfca.2013.05.010; Castro-Gonzalez M, 2010, ALAN, V60; Colli C, 2008, MINERALES ALIMENTOS, P43; de Castro FAF, 2007, FOOD CHEM, V103, P1080, DOI 10.1016/j.foodchem.2006.10.002; Delgado-Andrade C, 2008, FOOD CHEM, V107, P631, DOI 10.1016/j.foodchem.2007.08.055; Dominguez R, 2014, MEAT SCI, V97, P223, DOI 10.1016/j.meatsci.2014.01.023; Ersoy B, 2006, FOOD CHEM, V99, P748, DOI 10.1016/j.foodchem.2005.08.055; Ersoy B, 2009, FOOD CHEM, V115, P419, DOI 10.1016/j.foodchem.2008.12.018; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Gladyshev MI, 2006, FOOD CHEM, V96, P446, DOI 10.1016/j.foodchem.2005.02.034; Gladyshev MI, 2007, FOOD CHEM, V101, P1694, DOI 10.1016/j.foodchem.2006.04.029; Gladyshev MI, 2009, FOOD CHEM, V115, P545, DOI 10.1016/j.foodchem.2008.12.062; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Hartman L, 1973, Lab Pract, V22, P475; Hosseini H, 2014, FOOD CHEM, V148, P86, DOI 10.1016/j.foodchem.2013.10.012; Huynh MD, 2009, FOOD CHEM, V114, P912, DOI 10.1016/j.foodchem.2008.10.038; Castro-Gonzalez MI, 2013, ARCH LATINOAM NUTR, V63, P74; Kong FB, 2007, J FOOD ENG, V83, P510, DOI 10.1016/j.jfoodeng.2007.04.002; Loughrill E, 2016, FOOD CHEM, V197, P783, DOI 10.1016/j.foodchem.2015.10.141; Márquez Figueroa Yunilde del Valle, 2006, Zootecnia Trop., V24, P17; Mendil D, 2010, FOOD CHEM TOXICOL, V48, P865, DOI 10.1016/j.fct.2009.12.023; Perea A, 2008, ARCH LATINOAM NUTR, V58, P91; Quitral V, 2006, ARCH LATINOAM NUTR, V56, P69; Rincon L, 2016, AQUACULTURE, V451, P195, DOI 10.1016/j.aquaculture.2015.09.016; Saldanha T, 2008, FOOD CHEM, V106, P619, DOI 10.1016/j.foodchem.2007.06.021; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Teague H, 2016, J NUTR BIOCHEM, V28, P30, DOI 10.1016/j.jnutbio.2015.09.012; Toppe J, 2007, COMP BIOCHEM PHYS B, V146, P395, DOI 10.1016/j.cbpb.2006.11.020; Un H, 2007, MONATSSCHR PHARM, V30, P138; Valenzuela A, 2009, REV CHIL NUTR, V36, P246; Weber J, 2008, FOOD CHEM, V106, P140, DOI 10.1016/j.foodchem.2007.05.052	37	32	32	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180993	10.1371/journal.pone.0180993	http://dx.doi.org/10.1371/journal.pone.0180993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686742	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100129
J	Chang, JC; Morton, DB				Chang, Jer-Cherng; Morton, David B.			Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALS-LINKED TDP-43; IN MOUSE MODEL; MOTOR-NEURONS; TARDBP MUTATIONS; ANIMAL-MODELS; MITOCHONDRIAL DYSFUNCTION; LOCOMOTION DEFECTS; PROGRESSIVE MOTOR	Mutations in TDP-43 are associated with proteinaceous inclusions in neurons and are believed to be causative in neurodegenerative diseases such as frontotemporal dementia or amyotrophic lateral sclerosis. Here we describe a Drosophila system where we have engineered the genome to replace the endogenous TDP-43 orthologue with wild type or mutant human TDP-43(hTDP-43). In contrast to other models, these flies express both mutant and wild type hTDP-43 at similar levels to those of the endogenous gene and importantly, no age-related TDP-43 accumulation observed among all the transgenic fly lines. Immunoprecipitation of TDP-43 showed that flies with hTDP-43 mutations had increased levels of ubiquitination and phosphorylation of the hTDP-43 protein. Furthermore, histologically, flies expressing hTDP-43 M337V showed global, robust neuronal staining for phospho-TDP. All three lines: wild type hTDP-43, -G294A and -M337V were homozygous viable, with no defects in development, life span or behaviors observed. The primary behavioral defect was that flies expressing either hTDP-43 G294A or M337V showed a faster decline with age in negative geotaxis. Together, these observations implied that neurons could handle these TDP-43 mutations by phosphorylation-and ubiquitin-dependent proteasome systems, even in a background without the wild type TDP-43. Our findings suggest that these two specific TDP-43 mutations are not inherently toxic, but may require additional environmental or genetic factors to affect longevity or survival.	[Chang, Jer-Cherng; Morton, David B.] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA	Oregon Health & Science University	Morton, DB (corresponding author), Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA.	mortonda@ohsu.edu			National Institutes of Health [NS071186]; Amyotrophic Lateral Sclerosis Association [23VU14]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotrophic Lateral Sclerosis Association; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [grant number NS071186] and the Amyotrophic Lateral Sclerosis Association [grant number 23VU14]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caroppo P, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000080; Chang JC, 2014, BRAIN RES, V1584, P39, DOI 10.1016/j.brainres.2013.11.019; Cheng CW, 2015, J NEUROGENET, V29, P59, DOI 10.3109/01677063.2015.1077832; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Cragnaz L, 2015, NEUROSCIENCE, V311, P415, DOI 10.1016/j.neuroscience.2015.10.037; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Diaper DC, 2013, HUM MOL GENET, V22, P3883, DOI 10.1093/hmg/ddt243; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Gareau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055342; Gareau C, 2013, BIOL OPEN, V2, P68, DOI 10.1242/bio.20123012; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Greenspan RJ, 2004, FLY PUSHING; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hazelett DJ, 2012, G3-GENES GENOM GENET, V2, P789, DOI 10.1534/g3.112.002998; Heemels MT, 2016, NATURE, V539, P179, DOI 10.1038/539179a; Huang C, 2012, J CLIN INVEST, V122, P107, DOI 10.1172/JCI59130; Huang C, 2010, INT J BIOL SCI, V6, P396; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Janssens J, 2013, MOL NEUROBIOL, V48, P22, DOI 10.1007/s12035-013-8427-5; Jawaid A, 2014, J BIOL CHEM, V289, P18593, DOI 10.1074/jbc.L114.572651; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Koyama A, 2016, NUCLEIC ACIDS RES, V44, P5820, DOI 10.1093/nar/gkw499; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu YC, 2013, INT J MOL SCI, V14, P20079, DOI 10.3390/ijms141020079; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Mitchell JC, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0212-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Origone P, 2010, AMYOTROPH LATERAL SC, V11, P223, DOI 10.3109/17482960903165039; Pamphlett R, 2009, NEUROPATH APPL NEURO, V35, P222, DOI 10.1111/j.1365-2990.2008.00982.x; Picher-Martel V, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0340-5; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tian TA, 2011, INT J BIOL SCI, V7, P234, DOI 10.7150/ijbs.7.234; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Vanderwerf SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136167; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiong HL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-8; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	86	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180828	10.1371/journal.pone.0180828	http://dx.doi.org/10.1371/journal.pone.0180828			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686708	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100111
J	Chen, L; Zhao, L; Samanta, A; Mahmoudi, SM; Buehler, T; Cantilena, A; Vincent, RJ; Girgis, M; Breeden, J; Asante, S; Xuan, YT; Dawn, B				Chen, Lei; Zhao, Lin; Samanta, Anweshan; Mahmoudi, Seyed Morteza; Buehler, Tanner; Cantilena, Amy; Vincent, Robert J.; Girgis, Magdy; Breeden, Joshua; Asante, Samuel; Xuan, Yu-Ting; Dawn, Buddhadeb			STAT3 balances myocyte hypertrophy vis-a-vis autophagy in response to Angiotensin II by modulating the AMPKa/ mTOR axis	PLOS ONE			English	Article							PROTEIN-KINASE REGULATION; JAK/STAT PATHWAY; MYOCARDIAL-INFARCTION; SIGNAL TRANSDUCER; MAMMALIAN TARGET; AT(1) RECEPTOR; HEART-FAILURE; ACTIVATION; CARDIOMYOCYTES; EXPRESSION	Signal transducers and activators of transcription 3 (STAT3) is known to participate in various cardiovascular signal transduction pathways, including those responsible for cardiac hypertrophy and cytoprotection. However, the role of STAT3 signaling in cardiomyocyte autophagy remains unclear. We tested the hypothesis that Angiotensin II (Ang II)-induced cardiomyocyte hypertrophy is effected, at least in part, through STAT3-mediated inhibition of cellular autophagy. In H9c2 cells, Ang II treatment resulted in STAT3 activation and cellular hypertrophy in a dose-dependent manner. Ang II enhanced autophagy, albeit without impacting AMPK alpha/mTOR signaling or cellular ADP/ATP ratio. Pharmacologic inhibition of STAT3 with WP1066 suppressed Ang II-induced myocyte hypertrophy and mRNA expression of hypertrophy-related genes ANP and beta-MHC. These molecular events were recapitulated in cells with STAT3 knockdown. Genetic or pharmacologic inhibition of STAT3 significantly increased myocyte ADP/ATP ratio and enhanced autophagy through AMPK alpha/mTOR signaling. Pharmacologic activation and inhibition of AMPK alpha attenuated and exaggerated, respectively, the effects of Ang II on ANP and beta-MHC gene expression, while concomitant inhibition of STAT3 accentuated the inhibition of hypertrophy. Together, these data indicate that novel nongenomic effects of STAT3 influence myocyte energy status and modulate AMPK alpha/mTOR signaling and autophagy to balance the transcriptional hypertrophic response to Ang II stimulation. These findings may have significant relevance for various cardiovascular pathological processes mediated by Ang II signaling.	[Chen, Lei; Zhao, Lin; Samanta, Anweshan; Mahmoudi, Seyed Morteza; Buehler, Tanner; Cantilena, Amy; Vincent, Robert J.; Girgis, Magdy; Breeden, Joshua; Asante, Samuel; Xuan, Yu-Ting; Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Dawn, B (corresponding author), Univ Kansas, Med Ctr, Cardiovasc Res Inst, Kansas City, KS 66103 USA.	bdawn@kumc.edu	Zhao, Lin/T-3047-2019		National Institutes of Health [R01 HL-117730]; National Institutes of Health COBRE grant [P20GM104936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the National Institutes of Health grant R01 HL-117730. We wish to acknowledge the Electron Microscopy Research Laboratory (EMRL) at the University of Kansas Medical Center for assistance with scanning electron microscopic studies. The EMRL is supported in part by the National Institutes of Health COBRE grant P20GM104936	Bairwa SC, 2016, BBA-MOL BASIS DIS, V1862, P2199, DOI 10.1016/j.bbadis.2016.07.001; Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Hernandez JS, 2014, J CELL MOL MED, V18, P709, DOI 10.1111/jcmm.12220; Hilfiker-Kleiner D, 2010, CIRCULATION, V122, P145, DOI 10.1161/CIRCULATIONAHA.109.933127; Hopkins TA, 2003, BIOCHEM SOC T, V31, P207, DOI 10.1042/bst0310207; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kodama H, 1998, CIRC RES, V82, P244; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Li Y., 2014, INT J ANTENN PROPAG, V2014, P1, DOI DOI 10.1101/GR.181990.114; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Tian YK, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-53; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yan CH, 2015, BBA-MOL BASIS DIS, V1852, P353, DOI 10.1016/j.bbadis.2014.05.027; Yu XW, 2003, J BIOL CHEM, V278, P16304, DOI 10.1074/jbc.M212321200; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505; Zou YZ, 1998, CIRC RES, V82, P337, DOI 10.1161/01.RES.82.3.337	36	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179835	10.1371/journal.pone.0179835	http://dx.doi.org/10.1371/journal.pone.0179835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686615	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100021
J	Gong, XX; Shi, ZJ; Wang, Y; Tian, YM; Li, WJ; Liu, L				Gong, Xiaoxing; Shi, Zejin; Wang, Yong; Tian, Yaming; Li, Wenjie; Liu, Lei			Characteristics and origin of the relatively high-quality tight reservoir in the Silurian Xiaoheba Formation in the southeastern Sichuan Basin	PLOS ONE			English	Article							SECONDARY POROSITY; GAS-RESERVOIRS; SANDSTONE	A mature understanding of the sandstone gas reservoir in the Xiaoheba Formation in the southeastern Sichuan Basin remains lacking. To assess the reservoir characteristics and the origin of the high-quality reservoir in the Xiaoheba Formation, this paper uses systematic field investigations, physical property analysis, thin section identification, scanning electron microscopy and electron microprobe methods. The results indicate that the Xiaoheba sandstone is an ultra-tight and ultra-low permeability reservoir, with an average porosity of 2.97% and an average permeability of 0.56x10(-3) mu m(2). This promising reservoir is mainly distributed in the Lengshuixi and Shuangliuba regions and the latter has a relatively high-quality reservoir with an average porosity of 5.28% and average permeability of 0.53x10(-3) mu m(2). The reservoir space comprises secondary intergranular dissolved pores, moldic pores and fractures. Microfacies, feldspar dissolution and fracture connectivity control the quality of this reservoir. The relatively weak compaction and cementation in the interbedded delta front distal bar and interdistributary bay microfacies indirectly protected the primary intergranular pores and enhanced late-stage dissolution. Late-stage potassium feldspar dissolution was controlled by the earlystage organic acid dissolution intensity and the distance from the hydrocarbon generation center. Early-stage fractures acted as pathways for organic acid migration and were therefore important factors in the formation of the reservoir. Based on these observations, the area to the west of the Shuangliuba and Lengshuixi regions has potential for gas exploration.	[Gong, Xiaoxing; Shi, Zejin; Li, Wenjie] Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China; [Shi, Zejin] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Wang, Yong; Tian, Yaming; Liu, Lei] Chengdu Univ Technol, Coll Earth Sci, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; Chengdu University of Technology	Shi, ZJ (corresponding author), Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China.; Shi, ZJ (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	zejin_shi@126.com		Gong, Xiaoxing/0000-0002-1471-1888; Li, Wenjie/0000-0001-6463-4131	National Natural Science Foundation of China [40739903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 40739903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORLYKKE K, 1993, SEDIMENT GEOL, V86, P137, DOI 10.1016/0037-0738(93)90137-T; Bruce S.H., 2006, AAPG BULL, V90, P1519; Cao Q., 2013, THESIS; Castle JW, 2005, AAPG BULL, V89, P41, DOI 10.1306/08170404028; [陈洪德 Chen Hongde], 2007, [石油实验地质, Petroleum Geology & Experiment], V29, P13; [戴少武 Dai Shaowu], 2002, [石油与天然气地质, Oil & Gas Geology], V23, P229; [丁晓琪 Ding Xiaoqi], 2014, [地质论评, Geological Review], V60, P145; El-ghali MAK, 2006, SEDIMENT GEOL, V190, P299, DOI 10.1016/j.sedgeo.2006.05.021; EMERY D, 1990, GEOLOGY, V18, P1178, DOI 10.1130/0091-7613(1990)018<1178:ASEAFL>2.3.CO;2; Folk RL, 1974, PETROLOGY SEDIMENTAR; Franca AB, 2003, AAPG BULL, V87, P1073, DOI 10.1306/02260301071; Franks SG, 2010, AAPG BULL, V94, P1133, DOI 10.1306/04211009142; [郭英海 Guo Yinghai], 2004, [古地理学报, Journal of palaeogeography], V6, P20; Huang Jie, 2007, Geological Science and Technology Information, V26, P76; [黄金亮 Huang Jinliang], 2012, [煤炭学报, Journal of China Coal Society], V37, P782; [黄可可 HUANG Ke-ke], 2009, [地质通报, Geological Bulletin of China], V28, P474; Huang SF, 2009, J MED BIOL ENG, V29, P25; [黄思静 HUANG Si-jing], 2009, [地球化学, Geochimica], V38, P498; Jin C., 2010, THESIS; Jin ZJ, 2012, SCI CHINA EARTH SCI, V12, P1791; LAUBACH SE, 1988, TECTONOPHYSICS, V156, P37, DOI 10.1016/0040-1951(88)90281-8; Law B. E., 1986, GEOLOGY TIGHT GAS RE, V24, P253; Liu S.F., 2014, FORMATION PROCESS ME; Lu ZX, 2009, ACTA PETROL SIN, V25, P2373; Ma DF, 2011, MARINE ORIGIN PETROL, V1, P14; Meng WB, 2011, ACTA PETROL SIN, V27, P2371; Norbert C, 1999, AAPG BULL, V83, P62; [邱隆伟 Qiu Longwei], 2002, [沉积学报, Acta Sedimentologica Sinica], V20, P621; [任拥军 REN Yongjun], 2010, [地质学报, Acta Geologica Sinica], V84, P257; Ronald CS, 1993, AAPG BULL, V77, P1509; ROSSO KM, 1995, GEOCHIM COSMOCHIM AC, V59, P3961, DOI 10.1016/0016-7037(95)94441-H; Salem AM, 2005, J SEDIMENT RES, V75, P572, DOI 10.2110/jsr.2005.047; Schegg R, 1997, OIL GAS J, V95, P102; SPENCER CW, 1985, J PETROL TECHNOL, V37, P1308, DOI 10.2118/11647-PA; Surdam R.C, 1989, AAPG BULL, V73, P23; Surdam R.C., 1984, AAPG MEM, V37, P127; SURDAM RC, 1987, ANNU REV EARTH PL SC, V15, P141; Tan XF, 2014, OIL GAS GEOLOGY, V1, P56; [万友利 Wan Youli], 2014, [沉积学报, Acta Sedimentologica Sinica], V32, P138; Wang G, 2011, EVID-BASED COMPL ALT, V2011, P7, DOI DOI 10.1016/J.F0REC0.2011.04.007; Wang Y, 2010, J CHENGDU U TECHNOLO, V3, P244; Wang Y., 2010, THESIS; [王勇 Wang Yong], 2011, [石油与天然气地质, Oil & Gas Geology], V32, P75; [王正和 Wang Zhenghe], 2013, [石油与天然气地质, Oil & Gas Geology], V34, P499; [魏国齐 Wei Guoqi], 2016, [天然气地球科学, Natural Gas Geoscience], V27, P199; [文玲 Wen Ling], 2002, [石油勘探与开发, Petroleum Exploration and Development], V29, P11; Xie T, 2011, NATURAL GAS EXPLORAT, V3, P16; [徐二社 Xu Ershe], 2015, [石油实验地质, Petroleum Geology & Experiment], V37, P494; Yan DP, 2003, TECTONOPHYSICS, V361, P239, DOI 10.1016/S0040-1951(02)00646-7; [杨志安 YANG ZhiAn], 2009, [机械强度, Journal of Mechanical Strength], V31, P166; [张林 Zhang Lin], 2005, [天然气工业, Natural Gas Industry], V25, P6; [张哨楠 Zhang Shaonan], 2008, [石油与天然气地质, Oil & Gas Geology], V29, P1; [周恳恳 Zhou Kenken], 2014, [石油勘探与开发, Petroleum Exploration and Development], V41, P623; Zhu GY, 2012, J ASIAN EARTH SCI, V50, P88, DOI 10.1016/j.jseaes.2012.01.008; [朱志军 ZHU Zhi-jun], 2010, [沉积学报, Acta Sedimentologica Sinica], V28, P243; [朱志军 Zhu Zhijun], 2012, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V42, P1590; [朱志军 Zhu Zhijun], 2012, [中国地质, Geology of China], V39, P64; [卓皆文 ZHUO Jie-wen], 2009, [沉积与特提斯地质, Sedimentary Geology and Tethyan Geology], V29, P1	58	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180980	10.1371/journal.pone.0180980	http://dx.doi.org/10.1371/journal.pone.0180980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686735	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100125
J	Littera, R; Piredda, G; Argiolas, D; Lai, S; Congeddu, E; Ragatzu, P; Melis, M; Carta, E; Michittu, MB; Valentini, D; Cappai, L; Porcella, R; Alba, F; Serra, M; Loi, V; Maddi, R; Orru, S; La Nasa, G; Caocci, G; Cusano, R; Arras, M; Frongia, M; Pani, A; Carcassi, C				Littera, Roberto; Piredda, Gianbenedetto; Argiolas, Davide; Lai, Sara; Congeddu, Elena; Ragatzu, Paola; Melis, Maurizio; Carta, Elisabetta; Michittu, Maria Benigna; Valentini, Donatella; Cappai, Luisella; Porcella, Rita; Alba, Francesco; Serra, Maria; Loi, Valentina; Maddi, Roberta; Orru, Sandro; La Nasa, Giorgio; Caocci, Giovanni; Cusano, Roberto; Arras, Marcella; Frongia, Mauro; Pani, Antonello; Carcassi, Carlo			KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; RENAL-ALLOGRAFT REJECTION; MYELOID-LEUKEMIA PATIENTS; NK-CELL-RECEPTOR; T-CELLS; MOLECULES; DISEASE; SPECIFICITY; RECOGNITION; ACTIVATION	Background Kidney transplantation is a life-saving treatment for patients with end-stage renal disease. However, despite progress in surgical techniques and patient management, immunological rejection continues to have a negative impact on graft function and overall survival. Incompatibility between donors and recipients for human leukocyte antigens (HLA) of the major histocompatibility complex (MHC) generates a series of complex cellular and humoral immune response mechanisms that are largely responsible for rejection and loss of graft function. Within this context, a growing amount of evidence shows that alloreactive natural killer (NK) cells play a critical role in the immune response mechanisms elicited by the allograft. Killer immunoglobulin-like receptors (KIRs) are prominent mediators of NK cell alloreactivity. Methods and findings A cohort of 174 first cadaveric kidney allograft recipients and their donors were selected from a total cohort of 657 transplanted patients for retrospective immunogenetic analyses. Patients with HLA Class II mismatches were excluded. HLA Class I allele frequencies were compared among patients with chronic rejection, patients with stable graft function and a group of 2388 healthy controls. Activating and inhibitory KIR gene frequencies, KIR haplotypes, KIR-HLA ligand matches/mismatches and combinations of recipient KIRs and donor HLA Class I ligands were compared among patients with and without chronic rejection and a group of 221 healthy controls. Patients transplanted from donors homozygous for HLA-C1 antigens had a significantly higher risk for chronic rejection than patients transplanted from donors homozygous or heterozygous for HLA-C2 antigens or with epitopes belonging to the HLA-Bw4 ligand group. The Kaplan-Meier curves obtained by dividing the patients into 3 groups according to the presence or absence of one or both of the combinations of recipient KIRs and donor HLA ligands (rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4) showed a significantly higher cumulative incidence of chronic rejection in the group of patients completely lacking these functional units. These patients showed a progressively stronger decline in modification of diet in renal disease-estimated glomerular filtration rate. Conclusions KIR genotyping should be performed at the time of enrolment of patients on the waiting list for organ transplantation. In our study, a significantly higher risk of chronic rejection after kidney transplantation was observed when recipient (r) and donor (d) pairs completely lacked the two functional rKIR-dHLA ligand combinations rKIR2DL1/dHLA-C2 and rKIR3DL1/dHLA-Bw4. This immunogenetic profile corresponds to low levels of NK cell inhibition. Therefore, patients with this high risk profile could benefit from immunosuppressive therapy aimed at reducing NK-cell cytotoxicity.	[Littera, Roberto; Melis, Maurizio] ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Reg Transplant Ctr, Cagliari, Italy; [Piredda, Gianbenedetto; Argiolas, Davide; Congeddu, Elena; Ragatzu, Paola; Carta, Elisabetta; Michittu, Maria Benigna] G Brotzu Hosp, Dept Renal Dieases, Kidney Transplant Unit, Cagliari, Italy; [Lai, Sara; Valentini, Donatella; Cappai, Luisella; Porcella, Rita; Alba, Francesco; Serra, Maria; Loi, Valentina; Maddi, Roberta; Orru, Sandro; Carcassi, Carlo] ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Med Genet, Cagliari, Italy; [Orru, Sandro; Carcassi, Carlo] Univ Cagliari, Dept Med Sci & Publ Hlth, Med Genet, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni; Arras, Marcella] ATS Sardegna, Bone Marrow Transplant Ctr, R Binaghi Hosp, ASSL Cagliari, Cagliari, Italy; [La Nasa, Giorgio; Caocci, Giovanni] Univ Cagliari, Dept Med Sci & Publ Hlth, Hematol Unit, Cagliari, Italy; [Cusano, Roberto] Ctr Adv Studies Res & Dev CRS4, Biomed Sect, Polaris Technol Pk, Cagliari, Italy; [Frongia, Mauro] G Brotzu Hosp, Complex Struct Urol Kidney Transplantat & Robot S, Cagliari, Italy; [Pani, Antonello] G Brotzu Hosp, Complex Struct Nephrol & Dialysis, Dept Renal Dis, Cagliari, Italy	University of Cagliari; University of Cagliari	Littera, R (corresponding author), ATS Sardegna, ASSL Cagliari, R Binaghi Hosp, Reg Transplant Ctr, Cagliari, Italy.	roby.litter@gmail.com	LAI, SARA/GXV-2963-2022; Pani, Antonello/HDN-3366-2022; Littera, Roberto/N-9759-2016; Caocci, Giovanni/AAM-6674-2020	Littera, Roberto/0000-0003-3143-3792; Caocci, Giovanni/0000-0002-6585-5187; Lai, Sara/0000-0002-8040-0631; Melis, Maurizio/0000-0002-5857-781X; ORRU, SANDRO/0000-0001-5085-7975; Cusano, Roberto/0000-0001-5543-7881	"Fondazione Sardegna" [2014-1861]	"Fondazione Sardegna"(Fondazione Banco di Sardegna)	The research performed in this report falls within the institutional responsibilities of the investigators of the participating centers, all of which pertain to the Italian National Public Health Service. The authors received no specific funding for this work. Grant funding (2014-1861) for part of the reagents was received from the Fondazione Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN CB, 1994, APMIS, V102, P23, DOI 10.1111/j.1699-0463.1994.tb04841.x; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bontadini A, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-44; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; Boucherma R, 2013, J IMMUNOL, V191, P583, DOI 10.4049/jimmunol.1300483; Broeders N, 2015, TRANSPL P, V47, P267, DOI 10.1016/j.transproceed.2014.12.018; Caocci G, 2015, EXP HEMATOL, V43, P1015, DOI 10.1016/j.exphem.2015.08.004; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; COOKSEY G, 1984, BRIT J SURG, V71, P874, DOI 10.1002/bjs.1800711124; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Eissens DN, 2010, AM J TRANSPLANT, V10, P1981, DOI 10.1111/j.1600-6143.2010.03242.x; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; HANCOCK WW, 1985, TRANSPLANTATION, V39, P430, DOI 10.1097/00007890-198504000-00018; Kikuchi-Maki A, 2003, J IMMUNOL, V171, P3415, DOI 10.4049/jimmunol.171.7.3415; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kuzushima K, 2003, BLOOD, V101, P1460, DOI 10.1182/blood-2002-04-1240; La Nasa G, 2007, BIOL BLOOD MARROW TR, V13, P1358, DOI 10.1016/j.bbmt.2007.07.011; La Nasa G, 2013, EXP HEMATOL, V41, P424, DOI 10.1016/j.exphem.2013.01.008; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liu J, 2012, J VIROL, V86, P13281, DOI 10.1128/JVI.01841-12; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Nowak I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044718; Opelz G, 1999, COLLABORATIVE TRANSP, p1334 ; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Thewissen M, 2007, J IMMUNOL, V179, P6514, DOI 10.4049/jimmunol.179.10.6514; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	34	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180831	10.1371/journal.pone.0180831	http://dx.doi.org/10.1371/journal.pone.0180831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686681	gold, Green Published			2022-12-27	WOS:000405464100112
J	Machado, CEP; Flores, MRP; Lima, LNC; Tinoco, RLR; Franco, A; Bezerra, ACB; Evison, MP; Guimaraes, MA				Palhares Machado, Carlos Eduardo; Pinheiro Flores, Marta Regina; Correia Lima, Laise Nascimento; Ribeiro Tinoco, Rachel Lima; Franco, Ademir; Barreto Bezerra, Ana Cristina; Evison, Martin Paul; Guimaraes, Marco Aureilio			A new approach for the analysis of facial growth and age estimation: Iris ratio	PLOS ONE			English	Article								The study of facial growth is explored in many fields of science, including anatomy, genetics, and forensics. In the field of forensics, it acts as a valuable tool for combating child pornography. The present research proposes a new method, based on relative measurements and fixed references of the human face-specifically considering measurements of the diameter of the iris (iris ratio)-for the analysis of facial growth in association with age in children and sub-adults. The experimental sample consisted of digital photographs of 1000 Brazilian subjects, aged between 6 and 22 years, distributed equally by sex and divided into five specific age groups (6, 10, 14, 18, and 22 year olds +/- one month). The software package SAFF-2D (R) (Forensic Facial Analysis System, Brazilian Federal Police, Brazil) was used for positioning 11 landmarks on the images. Ten measurements were calculated and used as fixed references to evaluate the growth of the other measurements for each age group, as well the accumulated growth (6-22 years old). The Intraclass Correlation Coefficient (ICC) was applied for the evaluation of intra-examiner and inter-examiner reliability within a specific set of images. Pearson's Correlation Coefficient was used to assess the association between each measurement taken and the respective age groups. ANOVA and Post-hoc Tukey tests were used to search for statistical differences between the age groups. The outcomes indicated that facial structures grow with different timing in children and adolescents. Moreover, the growth allometry expressed in this study may be used to understand what structures have more or less proportional variation in function for the age ranges studied. The diameter of the iris was found to be the most stable measurement compared to the others and represented the best cephalometric measurement as a fixed reference for facial growth ratios (or indices). The method described shows promising potential for forensic applications, especially as part of the armamentarium against crimes involving child pornography and child abuse.	[Palhares Machado, Carlos Eduardo] Minist Justice, Brazilian Fed Police, Natl Inst Criminalist, Brasilia, DF, Brazil; [Palhares Machado, Carlos Eduardo; Barreto Bezerra, Ana Cristina] Univ Brasilia, Hlth Sci Coll, Brasilia, DF, Brazil; [Palhares Machado, Carlos Eduardo; Guimaraes, Marco Aureilio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Medico Legal Ctr, Ribeirao Preto, SP, Brazil; [Pinheiro Flores, Marta Regina] Univ Sao Paulo, Sch Dent, Sao Paulo, SP, Brazil; [Correia Lima, Laise Nascimento] Univ Fed Maranhao, Sch Dent, Sao Luis, Maranhao, Brazil; [Correia Lima, Laise Nascimento] Univ Estadual Campinas, Piracicaba Dent Sch, Piracicaba, SP, Brazil; [Ribeiro Tinoco, Rachel Lima] Univ Salgado de Oliveira, Sch Dent, Niteroi, RJ, Brazil; [Ribeiro Tinoco, Rachel Lima] Univ Fed Rio de Janeiro, Natl Museum, Dept Anthropol, Rio De Janeiro, RJ, Brazil; [Franco, Ademir] Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; [Evison, Martin Paul] Northumbria Univ, Ctr Forens Sci, Dept Appl Sci, Newcastle, England	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Maranhao; Universidade Estadual de Campinas; Universidade Salgado de Oliveira; Universidade Federal do Rio de Janeiro; KU Leuven; Northumbria University	Machado, CEP (corresponding author), Minist Justice, Brazilian Fed Police, Natl Inst Criminalist, Brasilia, DF, Brazil.; Machado, CEP (corresponding author), Univ Brasilia, Hlth Sci Coll, Brasilia, DF, Brazil.; Machado, CEP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Medico Legal Ctr, Ribeirao Preto, SP, Brazil.	palhares.cepm@dpf.gov.br	Evison, Martin P/L-5112-2014; Franco, Ademir/D-6665-2017	Evison, Martin P/0000-0002-4405-4751; Franco, Ademir/0000-0002-1417-2781				Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Augusteyn RC, 2012, EXP EYE RES, V102, P70, DOI 10.1016/j.exer.2012.06.009; Bergman RT, 2014, ANGLE ORTHOD, V84, P48, DOI 10.2319/041513-291.1; Byers S., 2004, INTRO FORENSIC ANTHR, P254, DOI 10.4324/9781315642031; Cattaneo C, 2012, INT J LEGAL MED, V126, P139, DOI 10.1007/s00414-011-0564-7; Cattaneo C, 2009, FORENSIC SCI INT, V183, pE21, DOI 10.1016/j.forsciint.2008.09.005; Chakravarty MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020241; Cunha E, 2009, FORENSIC SCI INT, V193, P1, DOI 10.1016/j.forsciint.2009.09.008; Driessen JP, 2011, INT J PEDIATR OTORHI, V75, P579, DOI 10.1016/j.ijporl.2011.01.023; Enlow D. H., 1990, FACIAL GROWTH; Evison MP, 2010, COMPUTER-AIDED FORENSIC FACIAL COMPARISON, P1, DOI 10.1201/9781439811344; Farkas L G, 1987, ANTHROPOMETRIC FACIA; Ferrario VF, 1999, PLAST RECONSTR SURG, V103, P768, DOI 10.1097/00006534-199903000-00002; FISHMAN LS, 1979, ANGLE ORTHOD, V49, P181; Flores-Mir C, 2004, ANGLE ORTHOD, V74, P118; Garamendi PM, 2005, FORENSIC SCI INT, V154, P3, DOI 10.1016/j.forsciint.2004.08.018; Gayon J, 2000, AM ZOOL, V40, P748, DOI 10.1668/0003-1569(2000)040[0748:HOTCOA]2.0.CO;2; George R, 2007, FACIAL GEOMETRY GRAP; Goldstein MS, 1936, AM J PHYS ANTHROPOL, V22, P37, DOI 10.1002/ajpa.1330220104; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Iscan M.Y., 1993, FORENSIC ANAL SKULL; Kolar JC., 1997, CRANIOFACIAL ANTHROP; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Kuc-Michalska M, 2010, ANGLE ORTHOD, V80, P54, DOI 10.2319/020309-69.1; Olze A, 2008, J FORENSIC LEG MED, V15, P426, DOI 10.1016/j.jflm.2008.02.008; Olze A, 2007, J FORENSIC SCI, V52, P1161, DOI 10.1111/j.1556-4029.2007.00534.x; Santoro V, 2009, FORENSIC SCI INT, V193, DOI 10.1016/j.forsciint.2009.09.014; Schmeling A, 2008, INT J LEGAL MED, V122, P457, DOI 10.1007/s00414-008-0254-2; Schmeling A, 2004, FORENSIC SCI INT, V144, P243, DOI 10.1016/j.forsciint.2004.04.059; Stanford C, 2005, BIOL ANTHR NATURAL H; Stavrianos C., 2012, Research Journal of Medical Sciences, V6, P77; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P1, DOI 10.1017/CBO9781139049566; Zebrick B, 2014, AM J ORTHOD DENTOFAC, V146, P603, DOI 10.1016/j.ajodo.2014.07.021	33	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180330	10.1371/journal.pone.0180330	http://dx.doi.org/10.1371/journal.pone.0180330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686631	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100051
J	Sharpe, AL; Varela, E; Beckstead, MJ				Sharpe, Amanda L.; Varela, Erika; Beckstead, Michael J.			Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation	PLOS ONE			English	Article							DOPAMINE; PSYCHOSTIMULANT; ACTIVATION; STRIATUM; RAT	Methamphetamine (METH) is a psychostimulant that exhibits significant abuse potential. Although METH addiction is a major health and societal concern, no drug is currently approved for its therapeutic management. METH activates the central dopaminergic "reward" circuitry, and with repeated use increases levels of the neuromodulatory peptide neurotensin in the nucleus accumbens and ventral tegmental area. Previous studies in rats suggest that neurotensin agonism decreases METH self-administration, but these studies did not examine the effect of neurotensin agonism on the pattern of self-administration or open field locomotion. In our studies, we established intravenous METH self-administration in male, DBA/2J mice (fixed ratio 3, 2 hr sessions) and examined the effect of pretreatment with the NTS1 receptor agonist PD149163 on METH self-administration behavior. Locomotion following PD149163 was also measured up to 2 hours after injection on a rotarod and in an open field. Pretreatment with PD149163 (0.05 and 0.10 mg/kg, s.c.) significantly decreased METH self-administration. The pattern of responding suggested that PD149163 decreased motivation to self-administer METH initially in the session with more normal intake in the second hour of access. Voluntary movement in the open-field was significantly decreased by both 0.05 and 0.10 mg/kg (s.c.) PD149163 from 10-120 minutes after injection, but rotarod performance suggested that PD149163 did not cause frank sedation. These results suggest that a systemically delivered NTS1 receptor agonist decreases METH self-administration in mice. The pattern of self-administration suggests that PD149163 may acutely decrease motivation to self-administer METH before the drug is experienced, but cannot rule out that depression of voluntary movement plays a role in the decreased self-administration.	[Sharpe, Amanda L.] Univ Incarnate Word, Feik Sch Pharm, Dept Pharmaceut Sci, San Antonio, TX 78209 USA; [Sharpe, Amanda L.; Varela, Erika; Beckstead, Michael J.] UT Hlth, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Beckstead, Michael J.] UT Hlth, Ctr Biomed Neurosci, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sharpe, AL (corresponding author), Univ Incarnate Word, Feik Sch Pharm, Dept Pharmaceut Sci, San Antonio, TX 78209 USA.; Sharpe, AL (corresponding author), UT Hlth, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	sharpe@uiwtx.edu		Sharpe, Amanda/0000-0003-3971-5946	National Institutes of Health [K01 DA21699, R01 DA32701]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA021699, R01DA032701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded by National Institutes of Health grants K01 DA21699 and R01 DA32701 to MJB. The funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Binder EB, 2001, PHARMACOL REV, V53, P453; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Boules M, 2011, NEUROPEPTIDES, V45, P9, DOI 10.1016/j.npep.2010.09.003; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CASTEL MN, 1994, EUR J NEUROSCI, V6, P646, DOI 10.1111/j.1460-9568.1994.tb00310.x; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; DEUTCH AY, 1992, ANN NY ACAD SCI, V668, P232, DOI 10.1111/j.1749-6632.1992.tb27353.x; Feifel D, 2008, PSYCHOPHARMACOLOGY, V200, P197, DOI 10.1007/s00213-008-1197-5; Frankel PS, 2011, J PHARMACOL EXP THER, V336, P809, DOI 10.1124/jpet.110.176610; Fuxe K, 2014, PROG BRAIN RES, V211, P113, DOI 10.1016/B978-0-444-63425-2.00005-2; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; Grimond-Billa SK, 2007, PSYCHOPHARMACOLOGIA, V22, P290; Hanson GR, 2012, NEUROSCIENCE, V203, P99, DOI 10.1016/j.neuroscience.2011.12.037; Hanson GR, 2013, J PHARMACOL EXP THER, V346, P173, DOI 10.1124/jpet.113.205310; HAWKINS MF, 1986, PHYSIOL BEHAV, V36, P1, DOI 10.1016/0031-9384(86)90064-8; HAWKINS MF, 1986, PHARMACOL BIOCHEM BE, V24, P1195, DOI 10.1016/0091-3057(86)90170-X; Holly EN, 2011, EUR NEUROPSYCHOPHARM, V21, P526, DOI 10.1016/j.euroneuro.2010.12.004; LEE TF, 1987, AM J PHYSIOL, V252, pE102, DOI 10.1152/ajpendo.1987.252.1.E102; LEVINE AS, 1983, PHARMACOL BIOCHEM BE, V19, P23, DOI 10.1016/0091-3057(83)90305-2; LUTTINGER D, 1982, EUR J PHARMACOL, V81, P499, DOI 10.1016/0014-2999(82)90116-9; MEISENBERG G, 1985, PHARMACOL BIOCHEM BE, V22, P189, DOI 10.1016/0091-3057(85)90376-4; Prus AJ, 2014, DRUG DEVELOP RES, V75, P47, DOI 10.1002/ddr.21171; Richelson E, 2003, LIFE SCI, V73, P679, DOI 10.1016/S0024-3205(03)00388-6; Sharpe AL, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu073; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vadnie CA, 2014, NEUROPHARMACOLOGY, V85, P482, DOI 10.1016/j.neuropharm.2014.05.046; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180710	10.1371/journal.pone.0180710	http://dx.doi.org/10.1371/journal.pone.0180710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686721	gold, Green Submitted, Green Published			2022-12-27	WOS:000405464100093
J	Sprague, DA; House, T				Sprague, Daniel A.; House, Thomas			Evidence for complex contagion models of social contagion from observational data	PLOS ONE			English	Article							BEHAVIOR	Social influence can lead to behavioural 'fads' that are briefly popular and quickly die out. Various models have been proposed for these phenomena, but empirical evidence of their accuracy as real-world predictive tools has so far been absent. Here we find that a 'complex contagion' model accurately describes the spread of behaviours driven by online sharing. We found that standard, 'simple', contagion often fails to capture both the rapid spread and the long tails of popularity seen in real fads, where our complex contagion model succeeds. Complex contagion also has predictive power: it successfully predicted the peak time and duration of the ALS Icebucket Challenge. The fast spread and longer duration of fads driven by complex contagion has important implications for activities such as publicity campaigns and charity drives.	[Sprague, Daniel A.] Spectra Analyt, 40-42 Scrutton St, London EC2A 4PP, England; [House, Thomas] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England	University of Manchester	House, T (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	thomas.house@manchester.ac.uk		House, Thomas/0000-0001-5835-8062	EPSRC [EP/I01358X/1, EP/N033701/1]; Spectra Analytics; Engineering and Physical Sciences Research Council [EP/N033701/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Spectra Analytics; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	While working on this manuscript, DS received a stipend from EPSRC (Grant number EP/I01358X/1) followed by a salary from Spectra Analytics, a data analysis company that he founded. TH received a contribution to his salary from EPSRC (Grant number and EP/N033701/1). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1974, IEEE T AUTOMATIC CON; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bauckhage C., 2013, P 7 INT C WEBLOGS SO, P22; Bentley RA, 2011, BEHAV ECOL SOCIOBIOL, V65, P537, DOI 10.1007/s00265-010-1102-1; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2007, NEW ENGLAND J MED; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; DIETZ K, 1967, J R STAT SOC SER A-G, V130, P505, DOI 10.2307/2982521; Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701; Gleeson JP, 2014, P NATL ACAD SCI USA, V111, P10411, DOI 10.1073/pnas.1313895111; Grinblatt M, 2008, REV ECON STAT, V90, P735, DOI 10.1162/rest.90.4.735; House T, 2011, J R SOC INTERFACE, V8, P909, DOI 10.1098/rsif.2011.0014; Isham V, 2010, PHYSICA A, V389, P561, DOI 10.1016/j.physa.2009.10.001; Kahan DM, 1997, VA LAW REV, V83, P349, DOI 10.2307/1073780; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KURTZ TG, 1971, J APPL PROBAB, V8, P344, DOI 10.2307/3211904; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Murray JD, 2003, MATH BIOL, V3; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Stylianou C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-73	28	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180802	10.1371/journal.pone.0180802	http://dx.doi.org/10.1371/journal.pone.0180802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686719	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100108
J	Bi, XA; Zhao, JX				Bi, Xia-an; Zhao, Junxia			Hierarchical trie packet classification algorithm based on expectation-maximization clustering	PLOS ONE			English	Article								With the development of computer network bandwidth, packet classification algorithms which are able to deal with large-scale rule sets are in urgent need. Among the existing algorithms, researches on packet classification algorithms based on hierarchical trie have become an important packet classification research branch because of their widely practical use. Although hierarchical trie is beneficial to save large storage space, it has several shortcomings such as the existence of backtracking and empty nodes. This paper proposes a new packet classification algorithm, Hierarchical Trie Algorithm Based on Expectation-Maximization Clustering (HTEMC). Firstly, this paper uses the formalization method to deal with the packet classification problem by means of mapping the rules and data packets into a two-dimensional space. Secondly, this paper uses expectation-maximization algorithm to cluster the rules based on their aggregate characteristics, and thereby diversified clusters are formed. Thirdly, this paper proposes a hierarchical trie based on the results of expectation-maximization clustering. Finally, this paper respectively conducts simulation experiments and real-environment experiments to compare the performances of our algorithm with other typical algorithms, and analyzes the results of the experiments. The hierarchical trie structure in our algorithm not only adopts trie path compression to eliminate backtracking, but also solves the problem of low efficiency of trie updates, which greatly improves the performance of the algorithm.	[Bi, Xia-an; Zhao, Junxia] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Bi, XA (corresponding author), Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China.	bixiaan@hnu.edu.cn			National Science Foundation of China [61502167, 11271121, 11671129]; Hunan Provincial Education Department Scientific Research Fund of PR China [15C0825]; Hunan Provincial Science and Technology Program Project of PR China [2015JC3066]; Scientific Research Foundation for Ph.D Hunan Normal University [Math 120641]; Youth Scientific Research Fund of Hunan Normal University [11301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Education Department Scientific Research Fund of PR China; Hunan Provincial Science and Technology Program Project of PR China; Scientific Research Foundation for Ph.D Hunan Normal University; Youth Scientific Research Fund of Hunan Normal University	This work is supported by the National Science Foundation of China (No. 61502167, 11271121, 11671129); the Hunan Provincial Education Department Scientific Research Fund of PR China (No. 15C0825); Hunan Provincial Science and Technology Program Project of PR China (No. 2015JC3066); Scientific Research Foundation for Ph.D Hunan Normal University (No. Math 120641); Youth Scientific Research Fund of Hunan Normal University (No.11301).	Antichi G, 2014, IEEE INT CONF HIGH, P32, DOI 10.1109/HPSR.2014.6900878; Baboescu F, 2003, IEEE INFOCOM SER, P53; Banerjee T, 2015, IEEE T COMPUT, V64, P1104, DOI 10.1109/TC.2014.2315645; Chang DY, 2016, IEEE ACM T NETWORK, V24, P1125, DOI 10.1109/TNET.2015.2411274; Chang YK, 2013, IEEE ACM T NETWORK, V21, P1201, DOI 10.1109/TNET.2012.2220566; Chen XJ, 2013, IEEE T KNOWL DATA EN, V25, P932, DOI 10.1109/TKDE.2011.262; Cheng YC, 2015, IEEE T COMPUT, V64, P582, DOI 10.1109/TC.2013.227; Erdem O, 2012, IEEE INFOCOM SER, P1898, DOI 10.1109/INFCOM.2012.6195565; Frigui H, 1999, IEEE T PATTERN ANAL, V21, P450, DOI 10.1109/34.765656; Ganegedara T, 2014, IEEE T PARALL DISTR, V25, P1135, DOI 10.1109/TPDS.2013.261; Gupta P, 1999, COMP COMM R, V29, P147, DOI 10.1145/316194.316217; Han WT, 2013, IEEE GLOB COMM CONF, P1342, DOI 10.1109/GLOCOM.2013.6831260; Hanmandlu M, 2013, NEUROCOMPUTING, V120, P235, DOI 10.1016/j.neucom.2012.09.043; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Jiang YZ, 2014, J INTELL FUZZY SYST, V27, P1639, DOI 10.3233/IFS-141130; Lee CL, 2012, IEICE T INF SYST, VE95D, P472, DOI 10.1587/transinf.E95.D.472; Leira R., 2013, SMART COMM NETW TECH, P1; Li W., 2013, THESIS, P1; Lim H, 2015, ELEVENTH 2015 ACM/IEEE SYMPOSIUM ON ARCHITECTURES FOR NETWORKING AND COMMUNICATIONS SYSTEMS, P183, DOI 10.1109/ANCS.2015.7110131; Lim H, 2014, IEEE ACM T NETWORK, V22, P443, DOI 10.1109/TNET.2013.2254124; Lu W, 2014, 2014 28TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P49, DOI 10.1109/WAINA.2014.16; Pak W, 2015, IEEE T DEPENDABLE SE; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Shen RS, 2014, J SUPERCOMPUT, V69, P673, DOI 10.1007/s11227-014-1109-x; Singh S, 2003, ACM SIGCOMM COMP COM, V33, P213; Taylor DE, 2005, IEEE INFOCOM SER, P2068; Trivedi U, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P112, DOI 10.1109/ICACCI.2014.6968202; Wang G, 2013, 2013 IEEE 15TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS & 2013 IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND UBIQUITOUS COMPUTING (HPCC_EUC), P1329, DOI 10.1109/HPCC.and.EUC.2013.189; Wang Jun, 2012, Control and Decision, V27, P321; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Zhou S., 2014, 2014 IEEE HIGH PERFO, P1, DOI 10.1109/HPEC.2014.7041005	31	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181049	10.1371/journal.pone.0181049	http://dx.doi.org/10.1371/journal.pone.0181049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704476	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700082
J	Devos, FC; Pollaris, L; Cremer, J; Seys, S; Hoshino, T; Ceuppens, J; Talavera, K; Nemery, B; Hoet, PHM; Vanoirbeek, JAJ				Devos, Fien C.; Pollaris, Lore; Cremer, Jonathan; Seys, Sven; Hoshino, Tomoaki; Ceuppens, Jan; Talavera, Karel; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.			IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice	PLOS ONE			English	Article							SMOOTH-MUSCLE; TOLUENE DIISOCYANATE; ASTHMA PHENOTYPES; ALLERGIC-ASTHMA; MOUSE MODEL; T-CELLS; INTERLEUKIN-13; PATHOGENESIS; INFLAMMATION; CHALLENGE	Background While the importance of the Th2 cytokine IL-13 as a central mediator of airway hyperreactivity (AHR) has been described in allergic protein-induced asthma, this has never been investigated in chemical-induced asthma. Objective We examined the importance of IL-13 in a mouse model of chemical-induced AHR, using toluene-2,4-diisocyanate (TDI). Methods In a first set-up, wild type (WT) and IL-13 knockout (KO) C57Bl/6 mice were dermally treated on days 1 and 8 with 1% TDI or vehicle (acetone/olive oil) on both ears. On day 15, mice received an intranasal instillation with 0.1% TDI or vehicle. In a second set-up, WT mice sensitized with 1% TDI or vehicle, received i.v. either anti-IL-13 or control antibody prior to the intranasal challenge. Results TDI-sensitized and TDI-challenged WT mice showed AHR to methacholine, in contrast to TDI-sensitized and TDI-challenged IL-13 KO mice, which also showed lower levels of total serum IgE. TDI-sensitized and TDI-challenged IL-13 KO mice had lower numbers of T-cells in the auricular lymph nodes. TDI-treated WT mice, receiving anti-IL-13, showed no AHR, in contrast to those receiving control antibody, despite increased levels of IgE. Anti-IL-13 treatment in TDI-treated WT mice resulted in lower levels of serum IL-13, but did not induce changes in T-and B-cell numbers, and in the cytokine production profile. Conclusion and clinical relevance We conclude that IL-13 plays a critical role in the effector phase of chemical-induced, immune-mediated AHR. This implicates that anti-IL-13 treatment could have a beneficial effect in patients with this asthma phenotype.	[Devos, Fien C.; Pollaris, Lore; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.] Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Environm & Hlth, Leuven, Belgium; [Cremer, Jonathan; Seys, Sven; Ceuppens, Jan] Univ Leuven, Dept Microbiol & Immunol, Lab Clin Immunol, Leuven, Belgium; [Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Med 1, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka, Japan; [Talavera, Karel] Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Leuven, Belgium	KU Leuven; KU Leuven; Kurume University; KU Leuven	Vanoirbeek, JAJ (corresponding author), Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Environm & Hlth, Leuven, Belgium.	jeroen.vanoirbeek@kuleuven.be	Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019; Vanoirbeek, Jeroen/D-5183-2016	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689; Vanoirbeek, Jeroen/0000-0001-5508-3518; Seys, Sven/0000-0002-4399-9892; Ceuppens, Jan/0000-0003-4502-2679	Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy [P7/30]; KU Leuven Research Council (PF-TRPLe) [GOA/14/011]; Flemish Research Foundation [1.5.049.12N]	Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven Research Council (PF-TRPLe); Flemish Research Foundation(FWO)	The project was supported by a grant of the Interuniversity Attraction Poles Program-Belgian State-Belgian Science Policy (P7/30), by two grants from the KU Leuven Research Council (PF-TRPLe and GOA/14/011) and by a grant of the Flemish Research Foundation (research grant 1.5.049.12N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	De Vooght V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083228; De Vooght V, 2011, TOXICOLOGY, V279, P85, DOI 10.1016/j.tox.2010.09.014; Devos FC, 2016, EUR RESPIR J, V48, P380, DOI 10.1183/13993003.01778-2015; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hacha J, 2012, AM J RESP CELL MOL, V47, P709, DOI 10.1165/rcmb.2012-0031OC; Herrick CA, 2002, J ALLERGY CLIN IMMUN, V109, P873, DOI 10.1067/mai.2002.123533; Herrick CA, 2003, J ALLERGY CLIN IMMUN, V111, P1087, DOI 10.1067/mai.2003.1413; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Ishmael FT, 2011, J AM OSTEOPATH ASSOC, V111, pS11; Jiang HH, 2010, J PHARMACOL EXP THER, V334, P703, DOI 10.1124/jpet.110.168518; Kellner J, 2007, INT ARCH ALLERGY IMM, V142, P199, DOI 10.1159/000097022; Kirstein F, 2010, J ALLERGY CLIN IMMUN, V126, P347, DOI 10.1016/j.jaci.2010.04.028; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Matsumoto H, 2012, CYTOKINE, V57, P19, DOI 10.1016/j.cyto.2011.10.014; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Pollaris L, 2016, ARCH TOXICOL, V90, P1709, DOI 10.1007/s00204-015-1606-6; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Scheerens H, 2014, CLIN EXP ALLERGY, V44, P38, DOI 10.1111/cea.12220; Scheurer S, 2015, CLIN EXP ALLERGY, V45, P1150, DOI 10.1111/cea.12571; Shore SA, 2004, CURR OPIN PHARMACOL, V4, P235, DOI 10.1016/j.coph.2004.01.008; Siddiqui Salman, 2007, Allergy Asthma Clin Immunol, V3, P60, DOI 10.1186/1710-1492-3-2-60; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Singer M, 2002, AM J RESP CELL MOL, V26, P74, DOI 10.1165/ajrcmb.26.1.4618; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wagers S, 1985, J APPL PHYSIOL, V96, P2019; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang GY, 2005, J PHARMACOL EXP THER, V313, P8, DOI 10.1124/jpet.104.076133; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620	41	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180690	10.1371/journal.pone.0180690	http://dx.doi.org/10.1371/journal.pone.0180690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704401	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700047
J	Khagayi, S; Amek, N; Bigogo, G; Odhiambo, F; Vounatsou, P				Khagayi, Sammy; Amek, Nyaguara; Bigogo, Godfrey; Odhiambo, Frank; Vounatsou, Penelope			Bayesian spatio-temporal modeling of mortality in relation to malaria incidence in Western Kenya	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE SYSTEM; TRANSMISSION INTENSITY; PLASMODIUM-FALCIPARUM; CHILDHOOD MORTALITY; CIVIL REGISTRATION; HEALTH FACILITY; AFRICA; PATTERNS; DISTANCE; CARE	Introduction The effect of malaria exposure on mortality using health facility incidence data as a measure of transmission has not been well investigated. Health and demographic surveillance systems (HDSS) routinely capture data on mortality, interventions and other household related indicators, offering a unique platform for estimating and monitoring the incidence-mortality relationship in space and time. Methods Mortality data from the HDSS located in Western Kenya collected from 2007 to 2012 and linked to health facility incidence data were analysed using Bayesian spatio-temporal survival models to investigate the relation between mortality (all-cause/malaria-specific) and malaria incidence across all age groups. The analysis adjusted for insecticide-treated net (ITN) ownership, socio-economic status (SES), distance to health facilities and altitude. The estimates obtained were used to quantify excess mortality due to malaria exposure. Results Our models identified a strong positive relationship between slide positivity rate (SPR) and all-cause mortality in young children 1-4 years (HR = 4.29; 95% CI: 2.78-13.29) and all ages combined (HR = 1.55; 1.04-2.80). SPR had a strong positive association with malariaspecific mortality in young children (HR = 9.48; 5.11-37.94), however, in older children (5-14 years), it was associated with a reduction in malaria specific mortality (HR = 0.02; 0.003-0.33). Conclusion SPR as a measure of transmission captures well the association between malaria transmission intensity and all-cause/malaria mortality. This offers a quick and efficient way to monitor malaria burden. Excess mortality estimates indicate that small changes in malaria incidence substantially reduce overall and malaria specific mortality.	[Khagayi, Sammy; Amek, Nyaguara; Bigogo, Godfrey; Odhiambo, Frank] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Khagayi, Sammy; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Khagayi, Sammy; Vounatsou, Penelope] Univ Basel, Basel, Switzerland	Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Vounatsou, P (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Vounatsou, P (corresponding author), Univ Basel, Basel, Switzerland.	penelope.vounatsou@unibas.ch	Bigogo, Godfrey/W-3591-2019	Vounatsou, Penelope/0000-0002-4904-5352	European Research Council (ERC) IMCCA [323180]; Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D) [IZ01Z0-147286]	European Research Council (ERC) IMCCA; Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D)	This work was supported by the European Research Council (ERC) IMCCA grant number 323180 and the Swiss National Foundation (SNF) program for Research on Global Issues for Development (R4D) project number IZ01Z0-147286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amek NO, 2013, BAYESIAN SPATIOTEMPO; Amek N, 2015, ACTA TROP, V144, P24, DOI 10.1016/j.actatropica.2015.01.006; Amek NO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25581; [Anonymous], 2012, LANCET, V379, P385, DOI 10.1016/S0140-6736(12)60169-X; [Anonymous], 2013, HOUS SURV IND MAL CO; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bi Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-117; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Boyce RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152410; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; de Savigny D, 2005, MEASURING HLTH EQUIT; Desai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106197; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Division of Malaria Control[Ministry of Public Health and Sanitation] KNB of SIMMD and HS (DHS), 2011, 2010 KEN MAL IND SUR, P2013; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Gething PW, 2016, N ENGL J MED; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; INDEPTH Network, 2000, POP HLTH DEV COUNTR; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Karra M, 2017, INT J EPIDEMIOL, V46, P817, DOI 10.1093/ije/dyw062; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Lo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121763; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Manda S, 2005, J R STAT SOC A STAT, V168, P439, DOI 10.1111/j.1467-985X.2005.00357.x; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Ombok M, 2010, TROP MED INT HEALTH, V15, P423, DOI 10.1111/j.1365-3156.2010.02467.x; Ross A, 2006, AM J TROP MED HYG, V75, P74, DOI 10.4269/ajtmh.2006.75.74; Rumisha SF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-124; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Sedda L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1024-5; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Stanisic DI, 2014, INFECT IMMUN; World Health Organization, 2015, WORLD MAL REP 2015; Ye Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-741	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180516	10.1371/journal.pone.0180516	http://dx.doi.org/10.1371/journal.pone.0180516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704417	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000405649700041
J	Toyomaki, A; Koga, M; Okada, E; Nakai, Y; Miyazaki, A; Tamakoshi, A; Kiso, Y; Kusumi, I				Toyomaki, Atsuhito; Koga, Minori; Okada, Emiko; Nakai, Yukiei; Miyazaki, Akane; Tamakoshi, Akiko; Kiso, Yoshinobu; Kusumi, Ichiro			The relationship between a low grain intake dietary pattern and impulsive behaviors in middle-aged Japanese people	PLOS ONE			English	Article							CLUSTER-ANALYSIS; DEPRESSIVE SYMPTOMS; NUTRITIONAL ADEQUACY; SLEEP QUALITY; CHILD HEALTH; ADULTS; WOMEN; WORKERS; ASSOCIATIONS; COHORT	Several studies indicate that dietary habits are associated with mental health. We are interested in identifying not a specific single nutrient/food group but the population preferring specific food combinations that can be related to mental health. Very few studies have examined relationships between dietary patterns and multifaceted mental states using cluster analysis. The purpose of this study was to investigate population-level dietary patterns associated with mental state using cluster analysis. We focused on depressive state, sleep quality, subjective well-being, and impulsive behaviors using rating scales. Two hundred and seventy-nine Japanese middle-aged people participated in the present study. Dietary pattern was estimated using a brief self-administered diet-history questionnaire (the BDHQ). We conducted K-means cluster analysis using thirteen BDHQ food groups: milk, meat, fish, egg, pulses, potatoes, green and yellow vegetables, other vegetables, mushrooms, seaweed, sweets, fruits, and grain. We identified three clusters characterized as ''vegetable and fruit dominant,'' ''grain dominant,'' and ''low grain tendency'' subgroups. The vegetable and fruit dominant group showed increases in several aspects of subjective wellbeing demonstrated by the SF-8. Differences in mean subject characteristics across clusters were tested using ANOVA. The low frequency intake of grain group showed higher impulsive behavior, demonstrated by BIS-11 deliberation and sum scores. The present study demonstrated that traditional Japanese dietary patterns, such as eating rice, can help with beneficial changes in mental health.	[Toyomaki, Atsuhito; Koga, Minori; Nakai, Yukiei; Miyazaki, Akane; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Okada, Emiko; Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Kiso, Yoshinobu] Hokkaido Univ, Ctr Innovat & Business Promot, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Toyomaki, A (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	toyomaki@med.hokudai.ac.jp	Kiso, Yoshinobu/D-5424-2012		Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	his work was supported by Ministry of Agriculture, Forestry and Fisheries of Japan. This work was supported by Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency SaT, 2005, STAND TABL FOOD COMP, V5th; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Ashby-Mitchell K, 2015, NUTRIENTS, V7, P1052, DOI 10.3390/nu7021052; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Freitas-Vilela AA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12353; Gougeon L, 2015, J NUTR HEALTH AGING, V19, P431, DOI 10.1007/s12603-014-0562-9; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; James DCS, 2009, J AM DIET ASSOC, V109, P255, DOI 10.1016/j.jada.2008.10.052; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Katagiri R, 2014, J OCCUP HEALTH, V56, P359, DOI 10.1539/joh.14-0051-OA; Kim J, 2015, NUTRIENTS, V7, P4154, DOI 10.3390/nu7064154; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kurotani K, 2015, SLEEP MED, V16, P298, DOI 10.1016/j.sleep.2014.09.017; Mimura C, 2011, CLIN PSYCHIATR, V53, P15, DOI [10.11477/mf.1405101760, DOI 10.11477/MF.1405101760]; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Okubo H, 2012, BRIT J NUTR, V107, P1526, DOI 10.1017/S0007114511004636; Okubo H, 2011, PUBLIC HEALTH NUTR, V14, P611, DOI 10.1017/S1368980010002521; Okubo H, 2010, ASIA PAC J CLIN NUTR, V19, P555; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Ruano C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061490; Smith ADAC, 2011, EUR J CLIN NUTR, V65, P1102, DOI 10.1038/ejcn.2011.96; Sugawara N, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-24; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Tanaka E, 2013, J EPIDEMIOL, V23, P132, DOI 10.2188/jea.JE20120101; Tsuruya K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116677; Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0; Wirfalt E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40; Woo HD, 2014, NUTRIENTS, V6, P1539, DOI 10.3390/nu6041539; Yoneyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105198	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181057	10.1371/journal.pone.0181057	http://dx.doi.org/10.1371/journal.pone.0181057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704469	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700085
J	Wang, C; Zhang, X; Li, H; Li, X; Lin, YS				Wang, Chen; Zhang, Xin; Li, Hui; Li, Xin; Lin, Yansong			Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis	PLOS ONE			English	Article							BRAF V600E MUTATION; 30 MU-IU/ML; STIMULATED THYROGLOBULIN; PREABLATIVE THYROGLOBULIN; RADIOIODINE THERAPY; DISTANT METASTASIS; THYROTROPIN LEVEL; PAPILLARY; CARCINOMA; ASSOCIATION	Objective Current diagnosis of radioactive iodine (RAI)-refractory (RAIR) differentiated thyroid cancer (DTC) is based on the imaging technique, which is of a high cost. Serum thyroglobulin (Tg) is a sensitive and easily obtained biomarker. Hence, we aimed to assess the predicting value of quantitative response of Tg in earlier identifying the RAIR-DTC with pulmonary metastasis. Patients and methods Pulmonary metastatic DTC patients who underwent total or near-total thyroidectomy and at least two times of RAI therapy were included in this study. The pre-ablative stimulated Tg at the first and second RAI therapy were defined as pstim-Tg1 and pstim-Tg2, while the suppressed Tg before and after the second RAI therapy were designated sup-Tg1 and supTg2. The predicted value of pstim-Tg2/Tg1 and sup-Tg2/Tg1 ratio were detected using the receiver operating characteristic (ROC) curve and logistic regression analyses. Results Totally 115 patients were involved in this study. ROC curves showed a cut-off value of 0.544 for pstim-Tg2/pstim-Tg1 in detecting RAIR, with a sensitivity of 0.9 and specificity of 0.477, and an area under the curve (AUC) of 0.744. Similarly, the cut-off of sup-Tg2/sup-Tg1 was 0.972, with a sensitivity of 0.733 and specificity of 0.935, and AUC of 0.898. Univariate analysis illustrated that age, tumor size, pstim-Tg2/Tg1, sup-Tg2/sup-Tg1 and BRAF V600E mutation were eligible to predict RAIR. While from multivariate analysis, only age, pstimTg2/Tg1, sup-Tg2/sup-Tg1 and BRAF (V600E) mutation were verified to be the independent predictive factors. Conclusion The quantitative Tg response was encouraging in identifying RAIR-DTC with pulmonary metastasis. Age, BRAF (V600E) mutation and Tg response were independent predictors in predicting RAIR-DTC.	[Wang, Chen; Zhang, Xin; Li, Hui; Lin, Yansong] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China; [Li, Xin] Zhejiang Canc Hosp, Dept Nucl Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang Cancer Hospital	Lin, YS (corresponding author), Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China.	linys@pumch.cn		Wang, Chen/0000-0003-2271-5587	National Natural Science Foundation of China [81571714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No 81571714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Haugen BR, 2015, 2015 AM THYROID ASS; Kim HJ, 2013, WORLD J SURG, V37, P2845, DOI 10.1007/s00268-013-2213-4; Lin YS, 2011, CLIN NUCL MED, V36, P1102, DOI 10.1097/RLU.0b013e3182291c65; Sampson E, 2007, CANCER, V110, P1451, DOI 10.1002/cncr.22956; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schlumberger M, 2014, LANCET DIABETES ENDO, V2, P356, DOI 10.1016/S2213-8587(13)70215-8; Song HJ, 2015, EUR J ENDOCRINOL, V173, P399, DOI 10.1530/EJE-15-0296; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Yang K, 2014, CLIN NUCL MED, V39, P675, DOI 10.1097/RLU.0000000000000498; Yang X, 2016, J CLIN ENDOCR METAB, V101, P1307, DOI 10.1210/jc.2015-4016; Yang X, 2015, CHINESE MED J-PEKING, V128, P1058, DOI 10.4103/0366-6999.155086; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298; Zhao D, 2012, J NUCL MED, V53, P1872, DOI 10.2967/jnumed.112.107821; Zhao T, 2016, ENDOCRINE, V53, P166, DOI 10.1007/s12020-015-0842-0; Zhao T, 2016, CLIN NUCL MED, V41, P454, DOI 10.1097/RLU.0000000000001167; Zhao T, 2016, NUCL MED COMMUN, V37, P632, DOI 10.1097/MNM.0000000000000485	20	10	14	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179664	10.1371/journal.pone.0179664	http://dx.doi.org/10.1371/journal.pone.0179664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704384	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700013
J	Lee, CH; Lin, JC; Ho, CL; Sun, M; Yen, WT; Lin, C				Lee, Cho-Hao; Lin, Jung-Chung; Ho, Ching-Liang; Sun, Min; Yen, Wel-Ting; Lin, Chin			Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							NEWER ANTIFUNGAL AGENTS; HEMATOPOIETIC-CELL TRANSPLANTATION; SEQUENTIAL-ANALYSIS; INFORMATION SIZE; BONE-MARROW; PROPHYLAXIS; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE; MULTICENTER	Background Current studies that compare the efficacy and safety of micafungin (MCFG) with that of triazoles for the prophylaxis and treatment of invasive fungal infections (IFIs) demonstrate a lack of sufficient evidence and yield conflicting results. To compare the efficacy and safety of MCFG and triazoles in the prevention and treatment of IFIs, we conducted a meta-analysis and trial sequential analysis (TSA). Methods For the meta-analysis, we systematically searched the databases of PubMed, Embase and Cochrane Central Register of Controlled Trials and relevant database articles for randomized controlled studies published through November 2016. Comparative studies of the efficacy and safety of MCFG versus triazoles in the prevention and treatment of IFIs were selected. Meta-analysis was performed by R software with the ''metafor '' package. Pooled results were expressed as risk ratios (RRs) with corresponding 95% confidence intervals (CI). TSA was adopted to assess the studies' power with TSA version 0.9 beta. Results Nine current studies were included in the meta-analysis (1049 cases and 959 controls). Pooled trial comparisons indicated that MCFG does have significantly higher treatment success rates (RR = 1.13; 95% CI, 1.02-1.25; p = 0.0205) and reduces the number of overall IFIs (RR = 0.75; 95% CI, 0.61-0.92; p = 0.0056). However, MCFG demonstrates no difference in all-cause mortality (RR = 0.76; 95% CI, 0.52-1.12, p = 0.1624). For the safety evaluation, MCFG had a significantly lower incidence of severe adverse events (AEs) (RR = 0.45; 95% CI, 0.25-0.83; p = 0.0105), hepatic impairment (RR = 0.70; 95% CI, 0.50-0.97; p = 0.0363) and premature discontinuation (RR = 0.51; 95% CI, 0.34-0.76, p = 0.0010). Meta-regression analysis disclosed the correction of mean age and treatment success rates (P < 0.0001). Meanwhile, TSA demonstrated sufficient power to show efficacy. Conclusions The treatment success rate of MCFG is superior to that of triazoles for the prophylaxis and treatment of IFIs, and correction of the mean patient age demonstrates that efficacy increases as patient age decreases. MCFG appears to be well-tolerated with manageable side effects and lower withdrawal rates. However, additional clinical trials should be conducted on specific drug-related mortality and AEs to gather sufficient evidence on these matters.	[Lee, Cho-Hao; Ho, Ching-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Hematol & Oncol Med, Taipei, Taiwan; [Lee, Cho-Hao; Lin, Jung-Chung; Ho, Ching-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Lin, Jung-Chung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Infect Dis & Trop Med, Taipei, Taiwan; [Sun, Min] Hubei Univ Med, Taihe Hosp, Dept Gen Surg, Shiyan, Peoples R China; [Yen, Wel-Ting] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Lin, Chin] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, Chin] Natl Def Med Ctr, Dept Res & Dev, Taipei, Taiwan; [Lin, Chin] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Dept Hematol & Oncol Med, Taipei, Taiwan; [Lin, Chin] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Hubei University of Medicine; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lin, C (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Lin, C (corresponding author), Natl Def Med Ctr, Dept Res & Dev, Taipei, Taiwan.; Lin, C (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	xup6fup@gmail.com	Lee, Cho-Hao/AAT-1548-2021; Sun, Min/AAA-2773-2019; Lin, Chin/M-2832-2015	Lee, Cho-Hao/0000-0002-6061-5168; Lin, Chin/0000-0003-2337-2096				[Anonymous], 2012, META METAANALYSIS R; Baddley JW, 2010, CLIN INFECT DIS, V50, P1559, DOI 10.1086/652768; Bow EJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0855-6; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Cheikh J, 2007, BONE MARROW TRANSPL, V39, P301, DOI 10.1038/sj.bmt.1705592; GOODMAN JL, 1992, NEW ENGL J MED, V326, P845, DOI 10.1056/NEJM199203263261301; Hamza NS, 2004, BONE MARROW TRANSPL, V34, P377, DOI 10.1038/sj.bmt.1704603; Hiemenz J, 2005, ANTIMICROB AGENTS CH, V49, P1331, DOI 10.1128/AAC.49.4.1331-1336.2005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Hiramatsu Y, 2008, INT J HEMATOL, V88, P588, DOI 10.1007/s12185-008-0196-y; Huang XJ, 2012, BIOL BLOOD MARROW TR, V18, P1509, DOI 10.1016/j.bbmt.2012.03.014; Jeong SH, 2016, ANN HEMATOL, V95, P337, DOI 10.1007/s00277-015-2545-2; Kobayashi C, 2015, J INFECT CHEMOTHER, V21, P438, DOI 10.1016/j.jiac.2015.01.016; MAHMOUD AH, 2016, THESIS; Oyake T, 2016, EUR J HAEMATOL, V96, P602, DOI 10.1111/ejh.12641; Park JS, 2010, ACTA HAEMATOL-BASEL, V124, P92, DOI 10.1159/000315558; Park S, 2016, J INFECT; Perfect J.R, 2017, NAT REV DRUG DISCOV; Rogers TR, 2011, BRIT J HAEMATOL, V153, P681, DOI 10.1111/j.1365-2141.2011.08650.x; Rogers TR, 2009, BRIT J HAEMATOL, V144, P629, DOI 10.1111/j.1365-2141.2008.07412.x; Sawada Akihisa, 2009, Rinsho Ketsueki, V50, P1692; Shang W, 2012, J CLIN PHARM THER, V37, P652, DOI 10.1111/j.1365-2710.2012.01362.x; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; van Burik JAH, 2004, CLIN INFECT DIS, V39, P1407, DOI 10.1086/422312; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wang JF, 2015, EUR J CLIN MICROBIOL, V34, P651, DOI 10.1007/s10096-014-2287-4; Wang JL, 2010, ANTIMICROB AGENTS CH, V54, P2409, DOI 10.1128/AAC.01657-09; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Winston DJ, 2003, ANN INTERN MED, V138, P705, DOI 10.7326/0003-4819-138-9-200305060-00006; Xu SX, 2016, EUR REV MED PHARMACO, V20, P381; Xu SX, 2013, TRANSPL P, V45, P407, DOI 10.1016/j.transproceed.2012.07.149; Yamaguchi M, 2011, ANN HEMATOL, V90, P1209, DOI 10.1007/s00277-011-1277-1; 2010, J STAT SOFTWARE, V36, P1	40	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180050	10.1371/journal.pone.0180050	http://dx.doi.org/10.1371/journal.pone.0180050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700646	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600016
J	Wei, XL; Schmitt, I; Hodkinson, B; Flakus, A; Kukwa, M; Divakar, PK; Kirika, PM; Otte, J; Meiser, A; Lumbsch, HT				Wei, Xinli; Schmitt, Imke; Hodkinson, Brendan; Flakus, Adam; Kukwa, Martin; Divakar, Pradeep K.; Kirika, Paul M.; Otte, Juergen; Meiser, Anjuli; Lumbsch, H. Thorsten			Circumscription of the genus Lepra, a recently resurrected genus to accommodate the "Variolaria" - group of Pertusaria sensu lato (Pertusariales, Ascomycota)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; LECANOROMYCETES ASCOMYCOTA; LICHENIZED FUNGI; EVOLUTION; INFERENCE; CLASSIFICATION; ALIGNMENTS; DEPSONES; MRBAYES; BLOCKS	Pertusarialean lichens include more than 300 species belonging to several independent phylogenetic lineages. Only some of these phylogenetic clades have been comprehensively sampled for molecular data, and formally described as genera. Here we present a taxonomic treatment of a group of pertusarialean lichens formerly known as "Pertusaria amaragroup", "Monomurata-group", or "Variolaria-group", which includes widespread and well-known taxa such as P. amara, P. albescens, or P. ophthalmiza. We generated a 6-locus data set with 79 OTUs representing 75 species. The distinction of the Variolaria clade is supported and consequently, the resurrection of the genus Lepra is followed. Thirty-five new combinations into Lepra are proposed and the new species Lepra austropacifica is described from mangroves in the South Pacific. Lepra is circumscribed to include species with disciform ascomata, a weakly to non-amyloid hymenial gel, strongly amyloid asci without clear apical amyloid structures, containing 1 or 2, single-layered, thin-walled ascospores. Chlorinated xanthones are not present, but thamnolic and picrolichenic acids occur frequently, as well as orcinol depsides. Seventy-one species are accepted in the genus. Although the distinction of the genus from Pertusaria is strongly supported, the relationships of Lepra remain unresolved and the genus is tentatively placed in Pertusariales incertae sedis.	[Wei, Xinli] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Schmitt, Imke; Meiser, Anjuli] Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany; [Schmitt, Imke] Goethe Univ, Inst Ecol Evolut & Divers, Dept Biol Sci, Frankfurt, Germany; [Hodkinson, Brendan] Squamules Unltd, Henrico, VA USA; [Flakus, Adam] Polish Acad Sci, W Szafer Inst Bot, Lab Lichenol, Lubicz 46, Krakow, Poland; [Kukwa, Martin] Univ Gdansk, Dept Plant Taxon & Nat Conservat, WitaStwosza 59, Gdansk, Poland; [Divakar, Pradeep K.] Univ Complutense, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon & Cajal S-N, Madrid, Spain; [Kirika, Paul M.] Natl Museums Kenya, Bot Dept, Nairobi, Kenya; [Lumbsch, H. Thorsten] Field Museum, Sci & Educ, Chicago, IL USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Polish Academy of Sciences; W. Szafer Institute of Botany of the Polish Academy of Sciences; Fahrenheit Universities; University of Gdansk; Complutense University of Madrid; Field Museum of Natural History (Chicago)	Wei, XL (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	weixl@im.ac.cn	Flakus, Adam/V-4849-2019; Divakar, Pradeep K/E-5603-2014; Kukwa, Martin/X-9510-2019	Flakus, Adam/0000-0002-0712-0529; Divakar, Pradeep K/0000-0002-0300-0124; Kukwa, Martin/0000-0003-1560-909X; Lumbsch, Thorsten/0000-0003-1512-835X; wei, xin li/0000-0001-5470-9590; Calchera, Anjuli/0000-0002-3420-6336	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research; Arts; Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation; Mohamed bin Zayed Species Conservation Fund; Negaunee Foundation; NSF Award [1145898]; National Science Center [2015/17/B/NZ8/02441]	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research; Arts; Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation; Mohamed bin Zayed Species Conservation Fund; Negaunee Foundation; NSF Award(National Science Foundation (NSF)); National Science Center(National Science Centre, Poland)	This study was funded by LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of Hesses Ministry of Higher Education, Research, and the Arts. The field work was financially supported by the Critical Ecosystem Partnership Fund (Conservation International), Warwick Foundation, The Mohamed bin Zayed Species Conservation Fund, the Negaunee Foundation and NSF Award No. 1145898 to MVK. AF and MK received support from the National Science Center (project no. 2015/17/B/NZ8/02441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer AW, 2010, A PRELIMINARY WORLD; Buaruang K, 2017, MYCOKEYS, V22; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; ELIX JA, 1994, AUST J CHEM, V47, P1345, DOI 10.1071/CH9941345; ELIX JA, 1991, AUST J CHEM, V44, P1487, DOI 10.1071/CH9911487; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hafellner J., 2016, STAPFIA, V104, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch W. M., 2016, SYLLABUS PLAMT FAMIL, V1/2, P150; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kondratyuk Sergii Y., 2015, Studia Botanica Hungarica, V46, P95, DOI 10.17110/StudBot.2015.46.2.95; Lendemer JC, 2017, BRYOLOGIST, V120, P183, DOI 10.1639/0007-2745-120.2.183; Lucking R, 2016, BRYOLOGIST, V119, P361, DOI 10.1639/0007-2745-119.4.361; LUMBSCH H. T., 2006, FUNGI MULTIFACETED M, P153; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2001, LICHENOLOGIST, V33, P161, DOI 10.1006/lich.2000.0309; Lumbsch HT, 1995, BIBLIOTHECA LICHENOL, V57, P355; LUMBSCH HT, 1994, J HATTORI BOT LAB, V75, P295; Lumbsch HT, 2002, LICHENOLOGY, V1, P37; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Printzen C, 2010, PROG BOT, V71, P233, DOI 10.1007/978-3-642-02167-1_10; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schmitt I., 2010, MYCOLOGY, V1, P75, DOI DOI 10.1080/21501201003631540; Schmitt I, 2006, J HATTORI BOT LAB, P753; Schmitt I, 2012, MYCOKEYS, P23, DOI 10.3897/mycokeys.4.3545; Schmitt I, 2009, MOL PHYLOGENET EVOL, V52, P34, DOI 10.1016/j.ympev.2009.03.017; Schmitz Kerstin E., 1994, Acta Botanica Fennica, V150, P153; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	40	9	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180284	10.1371/journal.pone.0180284	http://dx.doi.org/10.1371/journal.pone.0180284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700682	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400011
J	Jafari, Z; Mehla, J; Afrashteh, N; Kolb, BE; Mohajerani, MH				Jafari, Zahra; Mehla, Jogender; Afrashteh, Navvab; Kolb, Bryan E.; Mohajerani, Majid H.			Corticosterone response to gestational stress and postpartum memory function in mice	PLOS ONE			English	Article							ALTERS DENDRITIC MORPHOLOGY; AFFECTS SPATIAL REFERENCE; NOISE-INDUCED HEARING; MORRIS WATER MAZE; PRENATAL STRESS; HIPPOCAMPAL NEUROGENESIS; MATERNAL STRESS; WORKING-MEMORY; PLASMA-CORTICOSTERONE; PREFRONTAL CORTEX	Maternal stress is a common adversity during pregnancy. Gestational corticosterone alternations are thought to contribute to the etiology of postpartum behavioral disturbances. However, the impact of stress during pregnancy, in particular noise exposure, on gestational corticosterone fluctuations and spatial cognition in postpartum mice has not been fully understood yet. We hypothesized that noise exposure during pregnancy negatively affects gestational corticosterone levels and postpartum memory function in the dams similar to the physical stressors. Pregnant C57BL/6 mice were randomly assigned to either one of two stress conditions or a control condition. The noise stress (NS) was induced by presenting a loud intermittent 3000 Hz frequency on gestational days (GDs) 12, 14, and 16 for 24 hours, whereas the physical stress ( PS) consisted of restraint and exposure to an elevated platform on GDs 12 -16. Plasma corticosterone level was collected on GDs 11 and 17, and Morris water task (MWT) was carried out 30 days after parturition. Compared to the control group, the level of corticosterone in the stressed groups was significantly increased on GD17 relative to GD11. Significantly longer swim time and lower swim speed were observed in both stressed groups relative to the control group. Probe time was significantly shorter in the NS group than the other groups. The delta corticosterone level was significantly correlated with the swim time as well as the probe time in the three groups. Given the results, the adverse effects of gestational noise exposure on the hypothalamic pituitary-adrenal (HPA) axis activation and postpartum spatial learning and memory function were as large as/or a bit stronger than the physical stresses. The findings suggest the significance of conservation against loud noise exposure in daily living, as well as need to further notice to the different aspects of gestational stress in mothers' behavior like offspring.	[Jafari, Zahra; Mehla, Jogender; Afrashteh, Navvab; Kolb, Bryan E.; Mohajerani, Majid H.] Univ Lethbridge, CCBN, Dept Neurosci, Lethbridge, AB, Canada; [Jafari, Zahra] Iran Univ Med Sci IUMS, Sch Rehabil Sci, Tehran, Iran	University of Lethbridge; Iran University of Medical Sciences	Kolb, BE; Mohajerani, MH (corresponding author), Univ Lethbridge, CCBN, Dept Neurosci, Lethbridge, AB, Canada.	kolb@uleth.ca; mohajerani@uleth.ca	Jafari, Zahra/GXF-1615-2022; Mehla, Jogender/M-1055-2019	Afrashteh, Navvab/0000-0002-3451-4793; Mohajerani, Majid H./0000-0003-0964-2977	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [40352]; Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Canadian Institute for Advanced Research grant [43300]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Canadian Institute for Advanced Research grant	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program (MHM), and a Canadian Institute for Advanced Research grant #43300 (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsu S, 2015, NEUROSCI RES, V101, P15, DOI 10.1016/j.neures.2015.07.002; ARCK PC, 1995, AM J REPROD IMMUNOL, V33, P74, DOI 10.1111/j.1600-0897.1995.tb01141.x; Baldi E, 2005, NEUROSCI LETT, V378, P176, DOI 10.1016/j.neulet.2004.12.029; Barriga C, 2001, J PINEAL RES, V30, P180, DOI 10.1034/j.1600-079X.2001.300307.x; Barzegar M, 2015, HIPPOCAMPUS, V25, P187, DOI 10.1002/hipo.22363; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Belnoue L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072972; Benoit JD, 2015, BEHAV BRAIN RES, V281, P1, DOI 10.1016/j.bbr.2014.12.001; Berglund B, 1996, J ACOUST SOC AM, V99, P2985, DOI 10.1121/1.414863; Browne CA, 2014, STRESS, V17, P471, DOI 10.3109/10253890.2014.954104; Burton PJ, 1996, BIOL REPROD, V55, P1023, DOI 10.1095/biolreprod55.5.1023; Bustamante C, 2010, INT J DEV NEUROSCI, V28, P605, DOI 10.1016/j.ijdevneu.2010.07.229; Chang TY, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-37; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Del Cerro MCR, 2015, HORM BEHAV, V73, P142, DOI 10.1016/j.yhbeh.2015.07.004; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; Diaz R, 1998, J NEUROSCI, V18, P2570; Erickson ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092132, 10.1371/journal.pone.0107491]; Gatewood JD, 2005, BRAIN RES BULL, V66, P91, DOI 10.1016/j.brainresbull.2005.03.016; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Gonzalez-Perez O, 2011, NEUROSCI RES, V70, P243, DOI 10.1016/j.neures.2011.03.013; Graignic-Philippe R, 2014, NEUROSCI BIOBEHAV R, V43, P137, DOI 10.1016/j.neubiorev.2014.03.022; Haque SF, 2004, J REPROD DEVELOP, V50, P185, DOI 10.1262/jrd.50.185; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hu LL, 2014, PHYSIOL BEHAV, V123, P105, DOI 10.1016/j.physbeh.2013.09.010; Jafari Z, 2016, REV NEUROSCI; Jafari Z, SCI REP IN PRESS; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kondoh E, 2009, HUM REPROD, V24, P945, DOI 10.1093/humrep/den461; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lemaire V, 2006, EUR J NEUROSCI, V23, P3368, DOI 10.1111/j.1460-9568.2006.04870.x; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Liu LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20374; Love G, 2005, BEHAV NEUROSCI, V119, P1084, DOI 10.1037/0735-7044.119.4.1084; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828; Mazurek B, 2010, HEARING RES, V259, P55, DOI 10.1016/j.heares.2009.10.006; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; Mychasiuk R, 2012, SYNAPSE, V66, P308, DOI 10.1002/syn.21512; Negron-Oyarzo I, 2015, CEREB CORTEX, V25, P3132, DOI 10.1093/cercor/bhu108; OHKAWA T, 1991, EXP CLIN ENDOCRINOL, V98, P123, DOI 10.1055/s-0029-1211108; Ortega-Martinez S, 2015, BEHAV BRAIN RES, V281, P309, DOI 10.1016/j.bbr.2014.12.036; Pawluski JL, 2015, NEUROSCIENCE, V290, P379, DOI 10.1016/j.neuroscience.2015.01.048; Pawluski JL, 2006, HORM BEHAV, V49, P143, DOI 10.1016/j.yhbeh.2005.05.016; Pawluski JL, 2006, BEHAV BRAIN RES, V175, P157, DOI 10.1016/j.bbr.2006.08.017; PEDERSEN CA, 1991, LIFE SCI, V48, P1537, DOI 10.1016/0024-3205(91)90278-J; Plamondon A, 2015, EARLY HUM DEV, V91, P23, DOI 10.1016/j.earlhumdev.2014.11.004; Reid KM, 2015, SOC SCI RES, V54, P246, DOI 10.1016/j.ssresearch.2015.08.009; Roes M, 2016, SEX DIFFERENCES IN THE CENTRAL NERVOUS SYSTEM, P197, DOI 10.1016/B978-0-12-802114-9.00009-3; Salari AA, 2016, BEHAV BRAIN RES, V311, P354, DOI 10.1016/j.bbr.2016.05.062; SAPOLSKY RM, 1994, ANN NY ACAD SCI, V746, P294; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Weinstock M, 2017, NEUROBIOL STRESS, V6, P3, DOI 10.1016/j.ynstr.2016.08.004; White DR, 1998, J ACOUST SOC AM, V103, P1566, DOI 10.1121/1.421303; Zhao DP, 2013, J NEUROSCI RES, V91, P535, DOI 10.1002/jnr.23172	70	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180306	10.1371/journal.pone.0180306	http://dx.doi.org/10.1371/journal.pone.0180306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692696	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800032
J	Pelerito, A; Cordeiro, R; Matos, R; Santos, MA; Soeiro, S; Santos, J; Manita, C; Rio, C; Santo, M; Paixao, E; Nunes, A; Nuncio, S				Pelerito, Ana; Cordeiro, Rita; Matos, Rita; Santos, Maria Augusta; Soeiro, Sofia; Santos, Joao; Manita, Carla; Rio, Carla; Santo, M.; Paixao, Eleonora; Nunes, Alexandra; Nuncio, Sofia			Human brucellosis in Portugal-Retrospective analysis of suspected clinical cases of infection from 2009 to 2016	PLOS ONE			English	Article								Brucellosis is a zoonosis that is emerging in some regions of the world. Although brucellosis is a disease of obligatory declaration and is not eradicated in Portugal, no prevalence data is available in this country. In this study, we retrospectively analyzed the data available at the Reference Laboratory at the Portuguese National Institute of Health during the past 7 years (2009 -2016) in order to get insight into the epidemiological scenario of brucellosis in Portugal. A total of 2313 biological samples from patients with clinical suspicion of brucellosis were subjected to immunological techniques for laboratory diagnosis. From 2010 to 2015, a subset of 259 samples was subjected to molecular methods. According to the available data, 167 out of 2313 (7.2%) samples had positive serology for Brucella spp. and 43 out of 259 samples (16.6%) were positive for B. melitensis by real time PCR, being classified as biovar 1 and 3. This study draws attention to the importance of integrating clinical and laboratory data of human cases in order to increase the efficacy of the response measures in case of outbreaks.	[Pelerito, Ana; Cordeiro, Rita; Nuncio, Sofia] Natl Inst Hlth, Dept Infect Dis, Emergency Response & Biopreparedness Unit, Lisbon, Portugal; [Matos, Rita; Santos, Maria Augusta; Soeiro, Sofia; Santos, Joao; Manita, Carla; Rio, Carla; Santo, M.] Natl Inst Hlth, Dept Infect Dis, Immunol Lab, Lisbon, Portugal; [Paixao, Eleonora] Alentejo Reg Adm Hlth, Nucleus Support Area Stat, Lisbon, Portugal; [Nunes, Alexandra] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal		Pelerito, A (corresponding author), Natl Inst Hlth, Dept Infect Dis, Emergency Response & Biopreparedness Unit, Lisbon, Portugal.	ana.pelerito@insa.min-saude.pt	Nunes, Alexandra/ABE-3699-2020; Cordeiro, Rita/GYV-1929-2022	Nunes, Alexandra/0000-0001-6449-8053; Almeida Santos, Joao/0000-0002-8564-1098; Nuncio, Maria Sofia/0000-0001-5182-6150; Cordeiro, Rita/0000-0001-5321-3657				Araj GF, 2010, INT J ANTIMICROB AG, V36, pS12, DOI 10.1016/j.ijantimicag.2010.06.014; Baldi PC, 2013, REV SCI TECH OIE, V32, P117; CDC, 1999, MMWR-MORBID MORTAL W, V49, P509; Corbel M.J, 2006, BRUC HUM AN; deSa I., 2013, MAGAZINE DA SPM; Ferreira Ana Cristina, 2012, PLoS One, V7, pe42514, DOI 10.1371/journal.pone.0042514; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gopaul KK, 2008, BMC MICROBIOL, P1; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; Jacobs MK, 2004, DERMATOL CLIN, V22, P231, DOI 10.1016/j.det.2004.03.008; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Tzaneva V, 2007, EUROSURVEILLANCE 200, V14; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Young EJ, 2005, PRINCIPLES PRACTICE, V6th, P2669	18	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179667	10.1371/journal.pone.0179667	http://dx.doi.org/10.1371/journal.pone.0179667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692674	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800012
J	Suzuki, Y; Imayoshi, I				Suzuki, Yusuke; Imayoshi, Itaru			Network analysis of exploratory behaviors of mice in a spatial learning and memory task	PLOS ONE			English	Article							FREELY MOVING RATS; ALZHEIMERS-DISEASE; WATER-MAZE; COGNITIVE IMPAIRMENT; THETA PHASE; PLACE CELLS; MOUSE MODEL; PERFORMANCE; DEFICITS; BETA	The Barnes maze is one of the main behavioral tasks used to study spatial learning and memory. The Barnes maze is a task conducted on "dry land" in which animals try to escape from a brightly lit exposed circular open arena to a small dark escape box located under one of several holes at the periphery of the arena. In comparison with another classical spatial learning and memory task, the Morris water maze, the negative reinforcements that motivate animals in the Barnes maze are less severe and less stressful. Furthermore, the Barnes maze is more compatible with recently developed cutting-edge techniques in neural circuit research, such as the miniature brain endoscope or optogenetics. For this study, we developed a lift-type task start system and equipped the Barnes maze with it. The subject mouse is raised up by the lift and released into the maze automatically so that it can start navigating the maze smoothly from exactly the same start position across repeated trials. We believe that a Barnes maze test with a lift-type task start system may be useful for behavioral experiments when combined with head-mounted or wire-connected devices for online imaging and intervention in neural circuits. Furthermore, we introduced a network analysis method for the analysis of the Barnes maze data. Each animal's exploratory behavior in the maze was visualized as a network of nodes and their links, and spatial learning in the maze is described by systematic changes in network structures of search behavior. Network analysis was capable of visualizing and quantitatively analyzing subtle but significant differences in an animal's exploratory behavior in the maze.	[Suzuki, Yusuke; Imayoshi, Itaru] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, SK Project, Kyoto, Japan; [Imayoshi, Itaru] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Imayoshi, Itaru] Kyoto Univ, Hakubi Ctr, Kyoto, Japan; [Imayoshi, Itaru] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan; [Imayoshi, Itaru] Kyoto Univ, World Premier Int Res Initiat, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Imayoshi, Itaru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Suzuki, Y; Imayoshi, I (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, SK Project, Kyoto, Japan.; Imayoshi, I (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.; Imayoshi, I (corresponding author), Kyoto Univ, Hakubi Ctr, Kyoto, Japan.; Imayoshi, I (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan.; Imayoshi, I (corresponding author), Kyoto Univ, World Premier Int Res Initiat, Inst Integrated Cell Mat Sci, Kyoto, Japan.; Imayoshi, I (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan.	suzuki@sk.med.kyoto-u.ac.jp; iimayosh@virus.kyoto-u.ac.jp		Suzuki, Yusuke/0000-0002-5379-4030	Shionogi CO., LTD; Ministry of Education, Culture, Sports, Science and the Technology of Japan (MEXT) [JSPS 15H05570, JSPS 16H06529]; Japan Science and Technology Agency (JST) PRESTO program; Human Frontier Science Program	Shionogi CO., LTD; Ministry of Education, Culture, Sports, Science and the Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) PRESTO program(Japan Science & Technology Agency (JST)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported in part by research funds from Shionogi & CO., LTD; by Grant-in-Aid for Scientific Research on Young Scientists (A)(JSPS 15H05570) (II); Grant-in-Aid for Scientific Research on Innovative Area (JSPS 16H06529) (II) from the Ministry of Education, Culture, Sports, Science and the Technology of Japan (MEXT); by Japan Science and Technology Agency (JST) PRESTO program (II); and by the Human Frontier Science Program (II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2015, NAT NEUROSCI, V18, P1202, DOI 10.1038/nn.4106; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BARNES CA, 1980, CAN J PSYCHOL, V34, P29, DOI 10.1037/h0081022; BARNES CA, 1990, NEUROBIOL AGING, V11, P499, DOI 10.1016/0197-4580(90)90110-L; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bounova G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016117; Brown JE, 2002, PHYSIOL BEHAV, V77, P743, DOI 10.1016/S0031-9384(02)00928-9; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Das P, 2012, MOL NEURODEGENER, V7, P1; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Douchamps V, 2013, J NEUROSCI, V33, P8689, DOI 10.1523/JNEUROSCI.4483-12.2013; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Goto A, 2015, P NATL ACAD SCI USA, V112, P6718, DOI 10.1073/pnas.1507121112; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang ZB, 2011, BEHAV BRAIN RES, V221, P604, DOI 10.1016/j.bbr.2010.05.032; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; INGRAM DK, 1994, LIFE SCI, V55, P2037, DOI 10.1016/0024-3205(94)00384-X; Jercog P, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021824; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; Lever C, 2010, HIPPOCAMPUS, V20, P229, DOI 10.1002/hipo.20671; Lo AC, 2014, NEUROPHARMACOLOGY, V85, P178, DOI 10.1016/j.neuropharm.2014.05.013; Manns JR, 2007, NEUROBIOL LEARN MEM, V87, P9, DOI 10.1016/j.nlm.2006.05.007; Markowska AL, 1998, PHYSIOL BEHAV, V64, P15, DOI 10.1016/S0031-9384(98)00011-0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Newman EL, 2013, J NEUROSCI, V33, P19635, DOI 10.1523/JNEUROSCI.2586-13.2013; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; Sun MK, 2004, NEUROSCIENCE, V129, P129, DOI 10.1016/j.neuroscience.2004.07.041; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Weiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040760; WHISHAW IQ, 1985, BEHAV BRAIN RES, V17, P103, DOI 10.1016/0166-4328(85)90023-3; Yamashita N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00216; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180789	10.1371/journal.pone.0180789	http://dx.doi.org/10.1371/journal.pone.0180789			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700627	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800076
J	Zhang, Y; Hou, YL; Wang, XY; Ping, JH; Ma, ZY; Suo, C; Lei, ZH; Li, X; Zhang, Z; Jia, CC; Su, J				Zhang, Ying; Hou, Yuanlong; Wang, Xiaoyan; Ping, Jihui; Ma, Zhiyu; Suo, Chuan; Lei, Zhihai; Li, Xiang; Zhang, Zheng; Jia, Cuicui; Su, Juan			The effects of kisspeptin-10 on serum metabolism and myocardium in rats	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FOCAL ADHESION KINASE; CARDIAC-HYPERTROPHY; ARACHIDONIC-ACID; HEART-FAILURE; CELL-ADHESION; AMINO-ACIDS; INTEGRINS; GENE; MODULATION	Kisspeptin is a peptide encoded by the Kiss 1 gene and is also called metastin. Previous studies have generally focused on several functions of this peptide, including metastasis, puberty, vasoconstriction and reproduction. However, few studies have focused on the cardiac functions of kisspeptin. In the present study, cardiac histomorphology was observed via TEM (transmission electron microscope) and HE and Masson staining to observe instinctive changes. Serum metabolites levels were also measured and analyzed using GC/TOF-MS after injection with kisspeptin-10. A gene chip was employed to screen the potential genes and pathways in the myocardium at the transcriptional leve, while RT-PCR and Western Blot were conducted to verify the relevant mRNA and protein expression, respectively. Histopathological findings demonstrated that there were many irregular wavy contractions through HE staining and increased fibrosis around the heart cells through Masson staining after treatment with kisspeptin-10. Additionally, the main changes in ultrastructure, including changes in mitochondrial and broken mitochondrial cristae, could be observed with TEM after treatment with kisspeptin-10. The PCA scores plot of the serum metabolites was in the apparent partition after injection of kisspeptin-10. Twenty-six obviously changed metabolites were detected and classified as amino acids, carbohydrate metabolites, organic acids and other metabolites. Furthermore, gene chip analysis showed 1112 differentially expressed genes after treatment with kisspeptin-10, including 330 up-regulated genes and 782 downregulated genes. These genes were enriched in several signaling pathways related to heart diseases. The RT-PCR result for ITGB8, ITGA4, ITGB7, MYL7, HIF1-a and BNP corresponded with the gene chip assay. Moreover, the upregulated genes ITGB8, ITGA4 and BNP also displayed consistent protein levels in Western Blot results. In summary, these findings suggest that kisspeptin-10 could alter the morphology and structure of myocardial cells, serum metabolite levels, and expression of genes and proteins in heart tissues. Our work determined the profound effects of kisspeptin-10 on the heart, which could further lead to the development of therapeutics related to kisspeptin-10, including antagonists and analogs.	[Zhang, Ying; Hou, Yuanlong; Ping, Jihui; Ma, Zhiyu; Suo, Chuan; Lei, Zhihai; Li, Xiang; Zhang, Zheng; Jia, Cuicui; Su, Juan] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoyan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, Shanghai, Peoples R China; [Wang, Xiaoyan] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China	Nanjing Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Su, J (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	sujuan@njau.edu.cn		Wang, Xiaoyan/0000-0001-5568-2131	Priority Academic Program Development of Jiangsu Higher Education Institutions [280100745113]; Fundamental research funds for the central Universities [KYZ201526]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental research funds for the central Universities(Fundamental Research Funds for the Central Universities)	All the fundings of support received during this specific study: 1. A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Grant Number: 280100745113. The URLs: http://jsycw.ec.js.edu.cn/default.aspx; 2. The Fundamental research funds for the central Universities. Grant Number: KYZ201526. b. Roles of the funder in the study: Purchasing animal and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Baylin A, 2004, J NUTR, V134, P3095, DOI 10.1093/jn/134.11.3095; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; BING RJ, 1953, AM J MED, V15, P284, DOI 10.1016/0002-9343(53)90082-5; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125209; Del Vesco AP, 2014, J ANIM SCI, V92, P806, DOI 10.2527/jas.2013-6829; Gullberg Donald, 1998, Frontiers in Bioscience, V3, pD1039; Hill JA, 2011, PEDIATR CARDIOL, V32, P282, DOI 10.1007/s00246-010-9883-6; Hjelte LE, 2005, J NUTR, V135, P2271, DOI 10.1093/jn/135.9.2271; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Hou YL, 2015, J PROTEOME RES, V14, P1495, DOI 10.1021/pr501312t; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Katta A, 2010, AM J PHYSIOL-REG I, V299, pR1666, DOI 10.1152/ajpregu.00229.2010; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Li F, 2014, J PHARMACEUT BIOMED, V88, P225, DOI 10.1016/j.jpba.2013.09.002; Li RJ, 2015, J HAZARD MATER, V287, P392, DOI 10.1016/j.jhazmat.2015.02.006; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liu YT, 2014, J PHARMACEUT BIOMED, V90, P35, DOI 10.1016/j.jpba.2013.11.008; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Maguire JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027601; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishijima Y, 2011, CARDIOVASC RES, V91, P71, DOI 10.1093/cvr/cvr087; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; Osborne John D, 2007, Methods Mol Biol, V377, P223; PEGG AE, 1980, AM J PHYSIOL, V239, pE372, DOI 10.1152/ajpendo.1980.239.5.E372; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; Qiu YP, 2014, CLIN CANCER RES, V20, P2136, DOI 10.1158/1078-0432.CCR-13-1939; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Ross RS, 1998, CIRC RES, V82, P1160, DOI 10.1161/01.RES.82.11.1160; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Sawyer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014671; Schwartz MA, 2001, J CELL SCI, V114, P2553; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Wang XY, 2012, J PROTEOME RES, V11, P6223, DOI 10.1021/pr300891v; West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566; WINKELMANN DA, 1991, J CELL BIOL, V114, P701, DOI 10.1083/jcb.114.4.701; Wu Y, 2009, OMICS, V13, P81, DOI 10.1089/omi.2008.0061; Xu G, 2001, DIABETES, V50, P353, DOI 10.2337/diabetes.50.2.353; YANG JT, 1995, DEVELOPMENT, V121, P549	61	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179164	10.1371/journal.pone.0179164	http://dx.doi.org/10.1371/journal.pone.0179164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692647	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800008
J	Han, C; Kim, MJ; Ding, DL; Park, HJ; White, K; Walker, L; Gu, TJ; Tanokura, M; Yamasoba, T; Linser, P; Salvi, R; Someya, S				Han, Chul; Kim, Mi-Jung; Ding, Dalian; Park, Hyo-Jin; White, Karessa; Walker, Logan; Gu, Tongjun; Tanokura, Masaru; Yamasoba, Tatsuya; Linser, Paul; Salvi, Richard; Someya, Shinichi			GSR is not essential for the maintenance of antioxidant defenses in mouse cochlea: Possible role of the thioredoxin system as a functional backup for GSR	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE; HEARING-LOSS; INBRED STRAINS; NOISE EXPOSURE; DEFICIENCY; GENE; METABOLISM; MECHANISMS; PROTECTION; CATALYSIS	Glutathione reductase (GSR), a key member of the glutathione antioxidant defense system, converts oxidized glutathione (GSSG) to reduced glutathione (GSH) and maintains the intracellular glutathione redox state to protect the cells from oxidative damage. Previous reports have shown that Gsr deficiency results in defects in host defense against bacterial infection, while diquat induces renal injury in Gsr hypomorphic mice. In flies, overexpression of GSR extended lifespan under hyperoxia. In the current study, we investigated the roles of GSR in cochlear antioxidant defense using Gsr homozygous knockout mice that were backcrossed onto the CBA/CaJ mouse strain, a normal-hearing strain that does not carry a specific Cdh23 mutation that causes progressive hair cell degeneration and early onset of hearing loss. Gsr(-/-) mice displayed a significant decrease in GSR activity and GSH/GSSG ratios in the cytosol of the inner ears. However, Gsr deficiency did not affect ABR (auditory brainstem response) hearing thresholds, wave I amplitudes or wave I latencies in young mice. No histological abnormalities were observed in the cochlea of Gsr(-/-) mice. Furthermore, there were no differences in the activities of cytosolic glutathione-related enzymes, including glutathione peroxidase and glutamate-cysteine ligase, or the levels of oxidative damage markers in the inner ears between WT and Gsr(-/-) mice. In contrast, Gsr deficiency resulted in increased activities of cytosolic thioredoxin and thioredoxin reductase in the inner ears. Therefore, under normal physiological conditions, GSR is not essential for the maintenance of antioxidant defenses in mouse cochlea. Given that the thioredoxin system is known to reduce GSSG to GSH in multiple species, our findings suggest that the thioredoxin system can support GSSG reduction in the mouse peripheral auditory system.	[Han, Chul; Kim, Mi-Jung; Park, Hyo-Jin; White, Karessa; Walker, Logan; Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA; [Ding, Dalian; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA; [Park, Hyo-Jin; Linser, Paul] Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32086 USA; [Gu, Tongjun] Univ Florida, Bioinformat, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Yayoi, Japan; [Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Tokyo, Japan	State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Tokyo; University of Tokyo	Someya, S (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.	someya@ufl.edu	Gu, Tongjun/AAE-4801-2020	Tanokura, Masaru/0000-0001-5072-2480; White, Karessa/0000-0003-3967-4486	National Institute of Health and National Institute on Deafness and Communication Disorders [R03 DC011840, R01 DC012552, R01 DC014437]; American Federation for Aging Research [12388]; National Institute of Health and National Institute on Aging [1 P30 AG028740]; Japan Society for the Promotion of Science (JSPS) [23228003]; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011840, R01DC012552] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210] Funding Source: NIH RePORTER	National Institute of Health and National Institute on Deafness and Communication Disorders; American Federation for Aging Research; National Institute of Health and National Institute on Aging; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by R03 DC011840 (Shinichi Someya), R01 DC012552 (Shinichi Someya) and R01 DC014437 (Shinichi Someya) and from the National Institute of Health and National Institute on Deafness and Communication Disorders, American Federation for Aging Research Grant 12388 (Shinichi Someya), the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1 P30 AG028740) from the National Institute of Health and National Institute on Aging, and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (S) (Grant number, 23228003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2007, INTRO CATEGORICAL DA, Vxvii; Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; Chen GD, 2014, HEARING RES, V317, P1, DOI 10.1016/j.heares.2014.08.004; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; DiMauro S., 1993, GENEREVIEWS R; Ding D, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P510; Ding DL, 2016, AGING-US, V8, P730, DOI 10.18632/aging.100927; Ding DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079817; Evans P, 1999, ANN NY ACAD SCI, V884, P19, DOI 10.1111/j.1749-6632.1999.tb08633.x; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Han C, 2016, NEUROBIOL AGING, V43, P58, DOI 10.1016/j.neurobiolaging.2016.03.023; Henderson D, 1999, ANN NY ACAD SCI, V884, P368, DOI 10.1111/j.1749-6632.1999.tb08655.x; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Li MN, 2014, BIOMED REP, V2, P831, DOI 10.3892/br.2014.359; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Mockett RJ, 1999, FASEB J, V13, P1733, DOI 10.1096/fasebj.13.13.1733; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Njalsson R, 2005, CELL MOL LIFE SCI, V62, P1938, DOI 10.1007/s00018-005-5163-7; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ohinata Y, 2000, HEARING RES, V146, P28, DOI 10.1016/S0378-5955(00)00096-4; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001; Rogers LK, 2004, TOXICOL SCI, V82, P367, DOI 10.1093/toxsci/kfh268; Rogers LK, 2006, TOXICOL APPL PHARM, V217, P289, DOI 10.1016/j.taap.2006.08.012; SCHUKNECHT HF, 1974, LARYNGOSCOPE, V84, P1777; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tanaka C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.027; Tipple TE, 2007, AM J RESP CELL MOL, V37, P405, DOI 10.1165/rcmb.2006-0376OC; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yamasoba T, 1998, BRAIN RES, V804, P72, DOI 10.1016/S0006-8993(98)00660-X; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Yan J, 2013, FREE RADICAL BIO MED, V61, P320, DOI 10.1016/j.freeradbiomed.2013.04.015; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	52	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180817	10.1371/journal.pone.0180817	http://dx.doi.org/10.1371/journal.pone.0180817			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686716	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100110
J	Ji, WP; Wang, B; Fan, QP; Xu, C; He, YW; Chen, YF				Ji, Weiping; Wang, Bo; Fan, Qiuping; Xu, Chao; He, Youwu; Chen, Youfen			Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; DOXORUBICIN; PROTEINS; NANOPARTICLES; CARCINOMA; TOXICITY; MRP1	Multidrug resistance (MDR) against chemotherapeutic agents has become the major obstacle to successful cancer therapy and multidrug resistance-associated proteins (MRPs) mediated drug efflux is the key factor for MDR. Indomethacin (IND), one of the non-steroidal anti-inflammatory agents, has been demonstrated to increase cytotoxic effects of anti-tumor agents as MRP substrates. In this study, dextran-g-indomethacin (DEX-IND) polymeric micelles were designed to delivery paclitaxel (PTX) for the treatment of MDR tumors. The DEX-IND polymer could effectively encapsulate PTX with high loading content and DEXIND/ PTX micelles present a small size distribution. Compared with free PTX, the release of PTX from DEX-IND/PTX micelles could be prolonged to 48 h. Cellular uptake test showed that the internalization of DEX-IND/PTX micelles by drug-sensitive MCF-7/ADR cells was significantly higher than free PTX benefiting from the inhibitory effect of IND on MRPs. In vitro cytotoxicity test further demonstrated that DEX-IND/PTX micelles could enhance the cytotoxicity of PTX against MCF-7/ADR tumor cells. In vivo pharmacokinetic results showed that DEX-IND/PTX micelles had longer systemic circulation time and slower plasma elimination rate in comparison to PTX. The anti-tumor efficacy test showed that DEX-IND/PTX micelles exhibited greater tumor growth-inhibition effects on MDR tumor-bearing mice, with good correlation between in vitro and in vivo. Overall, the cumulative evidence indicates that DEX-IND/PTX micelles hold significant promise for the treatment of MDR tumors.	[Ji, Weiping; Wang, Bo; Fan, Qiuping; Xu, Chao; He, Youwu] Wenzhou Med Univ, Dept Orthoped, Affiliated Hosp 6, Lishui, Peoples R China; [Chen, Youfen] Ningbo Univ, Affiliated Yangming Hosp, Dept Hematol & Oncol, Yuyao, Peoples R China	Wenzhou Medical University; Ningbo University	Chen, YF (corresponding author), Ningbo Univ, Affiliated Yangming Hosp, Dept Hematol & Oncol, Yuyao, Peoples R China.	youfen_chen@126.com		He, You-Wu/0000-0002-4036-5843				Arts HJG, 1999, CLIN CANCER RES, V5, P2798; Cheng TJ, 2016, THERANOSTICS, V6, P1277, DOI 10.7150/thno.15133; Du YZ, 2010, ACS NANO, V4, P6894, DOI 10.1021/nn100927t; Du YZ, 2010, CARBOHYD POLYM, V79, P1034, DOI 10.1016/j.carbpol.2009.10.032; Duffy CP, 1998, EUR J CANCER, V34, P1250, DOI 10.1016/S0959-8049(98)00045-8; Hu R, 2012, THERANOSTICS, V2, P723, DOI 10.7150/thno.4275; Joshi AA, 2016, PHARM RES-DORDR, V33, P2847, DOI 10.1007/s11095-016-2028-8; Li C, 2016, DRUG DELIV, V23, P888, DOI 10.3109/10717544.2014.920429; Lu JF, 2015, DRUG METAB REV, V47, P406, DOI 10.3109/03602532.2015.1105253; Matsunaga S, 2006, CANCER CHEMOTH PHARM, V58, P348, DOI 10.1007/s00280-005-0162-9; Reinecke P, 2000, CANCER INVEST, V18, P614, DOI 10.3109/07357900009032828; Rezazadeh M, 2016, DRUG DELIV, V23, P1707, DOI 10.3109/10717544.2014.954281; Silverman J A, 1999, Pharm Biotechnol, V12, P353; Situ JQ, 2015, INT J NANOMED, V10, P665, DOI 10.2147/IJN.S76307; Sodani K, 2012, CHIN J CANCER, V31, P58, DOI 10.5732/cjc.011.10329; Stein WD, 2004, CURR DRUG TARGETS, V5, P333, DOI 10.2174/1389450043345489; Yuan H, 2008, INT J PHARMACEUT, V348, P137, DOI 10.1016/j.ijpharm.2007.07.012; Zhang YK, 2015, AAPS J, V17, P802, DOI 10.1208/s12248-015-9757-1; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	19	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180037	10.1371/journal.pone.0180037	http://dx.doi.org/10.1371/journal.pone.0180037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686704	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100033
J	Kim, MA; Yoon, HS; Park, SH; Kim, DY; Pyo, A; Kim, HS; Min, JJ; Hong, Y				Kim, Min-A; Yoon, Hee Seung; Park, Seung-Hwan; Kim, Dong-Yeon; Pyo, Ayoung; Kim, Hyeon Sik; Min, Jung-Joon; Hong, Yeongjin			Engineering of monobody conjugates for human EphA2-specific optical imaging	PLOS ONE			English	Article							EPHA2 RECEPTOR; TYROSINE KINASE; IN-VIVO; PROTEIN; TUMOR; LIGAND; BINDING; EXPRESSION; INVASION; EPHRINS	In a previous study, we developed an E1 monobody specific for the tumor biomarker hEphA2 [PLoS ONE (2015) 10(7): e0132976]. E1 showed potential as a molecular probe for in vitro and in vivo targeting of cancers overexpressing hEphA2. In the present study, we constructed expression vectors for E1 conjugated to optical reporters such as Renilla luciferase variant 8 (Rluc8) or enhanced green fluorescent protein (EGFP) and purified such recombinant proteins by affinity chromatography in E. coli. E1-Rluc8 and E1-EGFP specifically bound to hEphA2 in human prostate cancer PC3 cells but not in human cervical cancer HeLa cells, which express hEphA2 at high and low levels, respectively. These recombinant proteins maintained >40% activity in mouse serum at 24 h. In vivo optical imaging for 24 h did not detect E1-EGFP signals, whereas E1-Rluc8 showed tumor-specific luminescence signals in PC3 but not in HeLa xenograft mice. E1-Rluc8 signals were detected at 4 h, peaked at 12 h, and were undetectable at 24 h. These results suggest the potential of E1-Rluc8 as an EphA2-specific optical imaging agent.	[Kim, Min-A; Hong, Yeongjin] Chonnam Natl Univ, Dept Microbiol, Med Sch, Gwangju, South Korea; [Kim, Min-A; Yoon, Hee Seung] Chonnam Natl Univ, Dept Mol Med BK21Plus, Med Sch, Gwangju, South Korea; [Yoon, Hee Seung; Kim, Dong-Yeon; Pyo, Ayoung; Kim, Hyeon Sik; Min, Jung-Joon] Chonnam Natl Univ, Dept Nucl Med, Med Sch, Gwangju, South Korea; [Park, Seung-Hwan] KRIBB, Biol Resource Ctr, Jeongeup, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hong, Y (corresponding author), Chonnam Natl Univ, Dept Microbiol, Med Sch, Gwangju, South Korea.	yjhong@jnu.ac.kr		Park, Seung-Hwan/0000-0003-4613-4680	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01060171]; Basic Science Research Program throug NRF - Ministry of Education [NRF-2014R1A6A3A04057492]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program throug NRF - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01060171). S.-H.P. was supported by the Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2014R1A6A3A04057492).	Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; Choy Garry, 2003, Mol Imaging, V2, P303, DOI 10.1162/153535003322750646; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gobin AM, 2008, INT J NANOMED, V3, P351; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Lee HY, 2016, CANCER INVEST, V34, P293, DOI 10.1080/07357907.2016.1201678; Lee JW, 2010, CLIN CANCER RES, V16, P2562, DOI 10.1158/1078-0432.CCR-10-0017; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mitra S, 2010, BIOCHEMISTRY-US, V49, P6687, DOI 10.1021/bi1006223; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Park SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132976; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; RUIZ JC, 1994, MECH DEVELOP, V46, P87; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Venisnik KM, 2006, PROTEIN ENG DES SEL, V19, P453, DOI 10.1093/protein/gzl030; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244	40	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180786	10.1371/journal.pone.0180786	http://dx.doi.org/10.1371/journal.pone.0180786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686661	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100105
J	Luo, JX; Lv, PY; Zhang, J; Fane, AG; McDougald, D; Rice, SA				Luo, Jinxue; Lv, Pengyi; Zhang, Jinsong; Fane, Anthony G.; McDougald, Diane; Rice, Scott A.			Succession of biofilm communities responsible for biofouling of membrane bioreactors (MBRs)	PLOS ONE			English	Article							WASTE-WATER TREATMENT; MICROBIAL COMMUNITY; BACTERIAL COMMUNITY; ACTIVATED-SLUDGE; SCALE; IMPACT; DIVERSITY; SPACE; FLUX; RNA	Biofilm formation is one of the main factors associated with membrane biofouling in membrane bioreactors (MBRs). As such, it is important to identify the responsible organisms to develop targeted strategies to control biofouling. This study investigated the composition and changes in the microbial communities fouling MBR membranes over time and correlated those changes with an increase in transmembrane pressure (TMP). Based on qPCR data, bacteria were the dominant taxa of the biofilm (92.9-98.4%) relative to fungi (1.5-6.9%) and archaea (0.03-0.07%). NMDS analysis indicated that during the initial stages of operation, the biofilm communities were indistinguishable from those found in the sludge. However, the biofilm community significantly diverged from the sludge over time and ultimately showed a unique biofilm profile. This suggested that there was strong selection for a group of organisms that were biofilm specialists. This pattern of succession and selection was correlated with the rapid increase in TMP, where bacteria including Rhodospirillales, Sphingomonadales and Rhizobiales dominated the biofilm at this time. While most of the identified fungal OTUs matched Candida sp., the majority of fungal communities were unclassified by 18S rRNA gene sequencing. Collectively, the data suggests that bacteria, primarily, along with fungi may play an important role in the rapid TMP increase and loss of system performance.	[Luo, Jinxue; McDougald, Diane; Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Luo, Jinxue] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Nanyang Environm & Water Res Inst, Singapore, Singapore; [Luo, Jinxue] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lv, Pengyi] China Univ Min & Technol, Sch Chem & Environm Engn, Beijing, Peoples R China; [Zhang, Jinsong; Fane, Anthony G.] Nanyang Technol Univ, Singapore Membrane Technol Ctr, Nanyang Environm & Water Res Inst, Singapore, Singapore; [McDougald, Diane; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [McDougald, Diane; Rice, Scott A.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Rice, Scott A.] Univ New South Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); China University of Mining & Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Technology Sydney; University of New South Wales Sydney	Rice, SA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Rice, SA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.; Rice, SA (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia.; Rice, SA (corresponding author), Univ New South Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	RSCOTT@NTU.EDU.SG	McDougald, Diane/AAF-4799-2020; Rice, Scott/A-6084-2019; McDougald, Diane/B-5564-2009	McDougald, Diane/0000-0001-5827-8441; Rice, Scott/0000-0002-9486-2343; McDougald, Diane/0000-0001-5827-8441	EWI Singapore [MEWRC651/06/177, 1301-IRIS-57]; National Research Foundation Singapore; Ministry of Education; Nanyang Technological University; National University of Singapore; Research Centre of Excellence Programme	EWI Singapore; National Research Foundation Singapore(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University(Nanyang Technological University); National University of Singapore(National University of Singapore); Research Centre of Excellence Programme	This study was supported by EWI Singapore (MEWRC651/06/177 and 1301-IRIS-57). Specific funding support for this project from The National Research Foundation Singapore, Ministry of Education, Nanyang Technological University and National University of Singapore, under its Research Centre of Excellence Programme, for general support of laboratories and infrastructure.	Ahn S, 2008, DESALINATION, V221, P494, DOI 10.1016/j.desal.2007.01.110; Al Ashhab A, 2014, WATER RES, V50, P341, DOI 10.1016/j.watres.2013.10.044; Awad M. F., 2011, Mycology - An International Journal on Fungal Biology, V2, P276; Awad MF, 2011, CAN J MICROBIOL, V57, P693, DOI [10.1139/W11-056, 10.1139/w11-056]; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bojsen RK, 2012, FEMS IMMUNOL MED MIC, V65, P169, DOI 10.1111/j.1574-695X.2012.00943.x; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Calderon K, 2011, BIORESOURCE TECHNOL, V102, P4618, DOI 10.1016/j.biortech.2011.01.007; Chandrasekar PH, 2008, FUTURE MICROBIOL, V3, P19, DOI 10.2217/17460913.3.1.19; Chong TH, 2008, J MEMBRANE SCI, V325, P840, DOI 10.1016/j.memsci.2008.09.011; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cytryn E, 2012, APPL ENVIRON MICROB, V78, P6576, DOI 10.1128/AEM.01545-12; de Andrade LH, 2014, DESALIN WATER TREAT, V52, P2920, DOI 10.1080/19443994.2013.799048; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Foster M Lauren, 2013, Vet Med Int, V2013, P658373, DOI 10.1155/2013/658373; Gillings M. R., 2006, BIOFILMS, V3, P19; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hai FI, 2013, BIORESOURCE TECHNOL, V141, P29, DOI 10.1016/j.biortech.2013.02.020; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Huang LN, 2008, ENVIRON SCI TECHNOL, V42, P8360, DOI 10.1021/es801283q; Hung CH, 2011, INT J HYDROGEN ENERG, V36, P8704, DOI 10.1016/j.ijhydene.2010.06.010; Hwang BK, 2012, J MEMBRANE SCI, V419, P33, DOI 10.1016/j.memsci.2012.06.031; Ivnitsky H, 2007, WATER RES, V41, P3924, DOI 10.1016/j.watres.2007.05.021; Kraume M, 2010, CHEM ENG TECHNOL, V33, P1251, DOI 10.1002/ceat.201000104; Lan WS, 2010, MICROB ECOL, V60, P105, DOI 10.1007/s00248-010-9707-5; Lee C, 2008, FEMS MICROBIOL ECOL, V65, P544, DOI 10.1111/j.1574-6941.2008.00530.x; Li J, 2013, APPL MECH MATER, V295-298, P1045, DOI 10.4028/www.scientific.net/AMM.295-298.1045; Lim S, 2012, DESALINATION, V287, P209, DOI 10.1016/j.desal.2011.09.030; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Luo JX, 2015, MICROB BIOTECHNOL, V8, P549, DOI 10.1111/1751-7915.12261; Luo JX, 2015, J ENVIRON SCI-CHINA, V29, P115, DOI 10.1016/j.jes.2014.07.025; Luo JX, 2014, BIOFOULING, V30, P1093, DOI 10.1080/08927014.2014.971238; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P632, DOI 10.1021/es0615371; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Mutamim NSA, 2013, CHEM ENG J, V225, P109, DOI 10.1016/j.cej.2013.02.131; Pang CM, 2005, ENVIRON SCI TECHNOL, V39, P7541, DOI 10.1021/es050170h; Piasecka A, 2012, BIOFOULING, V28, P225, DOI 10.1080/08927014.2012.662640; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramesh A, 2007, APPL MICROBIOL BIOT, V74, P699, DOI 10.1007/s00253-006-0706-x; Ravi S, 2009, MYCOPATHOLOGIA, V167, P307, DOI 10.1007/s11046-008-9180-6; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Suwarno SR, 2012, J MEMBRANE SCI, V405, P219, DOI 10.1016/j.memsci.2012.03.012; Wang ZJ, 2013, BIORESOURCE TECHNOL, V144, P74, DOI 10.1016/j.biortech.2013.06.093; Xia SQ, 2010, BIORESOURCE TECHNOL, V101, P6601, DOI 10.1016/j.biortech.2010.03.082; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Zhang K, 2008, WATER ENVIRON RES, V80, P2209, DOI 10.2175/106143008X325809; Zhang QY, 2014, WATER RES, V58, P141, DOI 10.1016/j.watres.2014.03.052	50	30	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179855	10.1371/journal.pone.0179855	http://dx.doi.org/10.1371/journal.pone.0179855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686622	Green Published, gold			2022-12-27	WOS:000405464100023
J	Rifbjerg-Madsen, S; Christensen, AW; Christensen, R; Hetland, ML; Bliddal, H; Kristensen, LE; Danneskiold-Samsoe, B; Amris, K				Rifbjerg-Madsen, S.; Christensen, A. W.; Christensen, R.; Hetland, M. L.; Bliddal, H.; Kristensen, L. E.; Danneskiold-Samsoe, B.; Amris, K.			Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; CHRONIC WIDESPREAD PAIN; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; CENTRAL SENSITIZATION; PSORIATIC-ARTHRITIS; NEUROPATHIC PAIN; FIBROMYALGIA; OSTEOARTHRITIS; PAINDETECT	Background Central pain mechanisms may be prominent in subsets of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other spondyloarthritis (SpA). The painDETECT questionnaire (PDQ) identifies neuropathic pain features, which may act as a proxy for centrally mediated pain. The objectives were to quantify and characterize pain phenotypes (non-neuropathic vs. neuropathic features) among Danish arthritis patients using the PDQ, and to assess the association with on-going inflammation. Methods The PDQ was included onto the DANBIO touch screens at 22 departments of Rheumatology in Denmark for six months. Clinical data and patient reported outcomes were obtained from DANBIO. A PDQ-score 18 indicated neuropathic pain features, 13-18 unclear pain mechanism and <13 non-neuropathic pain. Results Pain data (visual analogue scale, VAS) was available for 15,978 patients. 7,054 patients completed the PDQ (RA: 3,826, PsA: 1,180, SpA: 1,093). 52% of all patients and 63% of PDQcompleters had VAS pain score >= 30 mm. The distribution of the PDQ classification-groups (<13/13-18/> 8) were; RA: 56%/24%/20%. PsA: 45%/27%/28%. SpA: 55% /24%/21%. More patients with PsA had PDQ score > 18 compared to RA and SpA (p<0.001). For PDQ > 18 significantly higher scores were found for all patient reported outcomes and disease activity scores. No clinical difference in CRP or swollen joint count was found. Logistic regression showed increased odds for having VAS pain >= 39mm(the median) for a PDQ-score >18 compared to <13 (OR = 10.4; 95% CI 8.6-12.5). Conclusions More than 50% of the Danish arthritis patients reported clinically significant pain. More than 20% of the PDQ-completers had indication of neuropathic pain features, which was related to a high pain-level. PDQ-score was associated with DAS28-CRP and VAS pain but not with indicators of peripheral inflammation (CRP and SJC). Thus, pain classification by PDQ may assist in mechanism-based pain treatment.	[Rifbjerg-Madsen, S.; Christensen, A. W.; Christensen, R.; Bliddal, H.; Kristensen, L. E.; Danneskiold-Samsoe, B.; Amris, K.] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark; [Hetland, M. L.] Rigshosp, Ctr Rheumatol & Spine Dis, DANBIO, Glostrup, Denmark; [Hetland, M. L.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Amris, K.] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Rheumatol, Frederiksberg, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Rifbjerg-Madsen, S (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark.	PARKER.Frederiksberg@regionh.dk	amris, kirstine/AAZ-2007-2020; Hetland, Merete L/AAE-5297-2019; Kristensen, Lars Erik/AAZ-2615-2020; Bliddal, Henning/AAB-3168-2019	Hetland, Merete L/0000-0003-4229-6818; Bliddal, Henning/0000-0002-7951-1668; Christensen, Robin/0000-0002-6600-0631				Ahmed S, 2014, J PAIN RES, V7, P579, DOI 10.2147/JPR.S69011; Almodovar R, 2010, CLIN EXP RHEUMATOL, V28, pS33; Aloush V, 2007, RHEUMATOL INT, V27, P865, DOI 10.1007/s00296-007-0344-3; Amris K, 2010, PAIN, V151, P664, DOI 10.1016/j.pain.2010.08.023; Azevedo VF, 2010, REV BRAS REUMATOL, V50, P650; BLACKMORE MG, 1995, J RHEUMATOL, V22, P886; CALIN A, 1994, J RHEUMATOL, V21, P2281; Eder L, 2017, ARTHRITIS RHEUMATOL, V69, P622, DOI 10.1002/art.39973; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hetland ML, 2008, ANN RHEUM DIS, V67, P1023, DOI 10.1136/ard.2007.087262; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2014, CLIN EXP RHEUMAT S85, V32, pS; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; JENKINSON TR, 1994, J RHEUMATOL, V21, P1694; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Koop SMW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0761-8; Koroschetz J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-55; Kristensen LE, 2014, ARTHRIT CARE RES, V66, P173, DOI 10.1002/acr.22107; Lage-Hansen PR, 2016, SCAND J RHEUMATOL, V45, P45, DOI 10.3109/03009742.2015.1046484; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3353; Magrey MN, 2013, ARTHRITIS, V2013; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; Marchesoni A, 2012, J RHEUMATOL, V39, P849, DOI 10.3899/jrheum.110893; Meeus M, 2012, SEMIN ARTHRITIS RHEU, V41, P556, DOI 10.1016/j.semarthrit.2011.08.001; Moreton BJ, 2015, ARTHRIT CARE RES, V67, P519, DOI 10.1002/acr.22431; Mundal I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-213; Ohtori S, 2012, YONSEI MED J, V53, P801, DOI 10.3349/ymj.2012.53.4.801; Pollard LC, 2012, J RHEUMATOL, V39, P28, DOI 10.3899/jrheum.110668; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Roussou E, 2010, CLIN RHEUMATOL, V29, P869, DOI 10.1007/s10067-010-1411-9; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, P552; Salaffi F, 2014, RHEUMATOL INT; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Thorsen H, 2001, SCAND J RHEUMATOL, V30, P103; Tubach F, 2012, ARTHRIT CARE RES, V64, P1699, DOI 10.1002/acr.21747; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; Wolfe F, 2004, J RHEUMATOL, V31, P695; Wolfe F, 2007, J RHEUMATOL, V34, P1674; Wolfe F, 2014, ARTHRIT CARE RES, V66, P1465, DOI 10.1002/acr.22300; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu Q, 2013, ARTHRITIS RHEUM	44	63	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180014	10.1371/journal.pone.0180014	http://dx.doi.org/10.1371/journal.pone.0180014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686639	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100030
J	Wu, ZX; Li, SF; Chen, H; Song, JX; Gao, YF; Zhang, F; Cao, CF				Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu			The changes of gut microbiota after acute myocardial infarction in rats	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; INTESTINAL MICROBIOTA; HEART-FAILURE; BACTERIAL MUTUALISM; L-CARNITINE; DIVERSITY; METABOLISM; DISEASE; PERMEABILITY; SEQUENCES	Recent studies suggested that gut microbiota was involved in the development of coronary artery disease. However, the changes of gut microbiota following acute myocardial infarction (AMI) remain unknown. In this study, a total of 66 male Wistar rats were randomly divided into control, AMI and SHAM groups. The controls (n = 6) were sacrificed after anesthesia. The AMI model was built by ligation of left anterior descending coronary artery. The rats of AMI and SHAM groups were sacrificed at 12 h, 1 d, 3 d, 7 d and 14 d post-operation respectively. Gut microbiota was analyzed by 16S rDNA high throughput sequencing. The gut barrier injuries were evaluated through histopathology, transmission electron microscope and immunohistochemical staining. The richness of gut microbiota was significantly higher in AMI group than SHAM group at 7 d after AMI (P<0.05). Principal coordinate analysis with unweighted UniFrac distances revealed microbial differences between AMI and SHAM groups at 7 d. The gut barrier impairment was also the most significant at 7 d post-AMI. We further identified the differences of microorganisms between AMI and SHAM group at 7 d. The abundance of Synergistetes phylum, Spirochaetes phylum, Lachnospiraceae family, Syntrophomonadaceae family and Tissierella Soehngenia genus was higher in AMI group compared with SHAM group at 7 d post-operation (q<0.05). Our study showed the changes of gut microbiota at day 7 post AMI which was paralleled with intestinal barrier impairment. We also identified the microbial organisms that contribute most.	[Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Dept Cardiol, Peoples Hosp, Beijing, Peoples R China; [Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Peoples Hosp, Beijing Key Lab Early Predict & Intervent Acute M, Beijing, Peoples R China; [Wu, Ze-Xuan; Li, Su-Fang; Chen, Hong; Song, Jun-Xian; Gao, Yuan-Feng; Zhang, Feng; Cao, Cheng-Fu] Peking Univ, Peoples Hosp, Ctr Cardiovasc Translat Res, Beijing, Peoples R China; [Wu, Ze-Xuan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Peking University; Peking University; Peking University; Sun Yat Sen University	Chen, H (corresponding author), Peking Univ, Dept Cardiol, Peoples Hosp, Beijing, Peoples R China.; Chen, H (corresponding author), Peking Univ, Peoples Hosp, Beijing Key Lab Early Predict & Intervent Acute M, Beijing, Peoples R China.; Chen, H (corresponding author), Peking Univ, Peoples Hosp, Ctr Cardiovasc Translat Res, Beijing, Peoples R China.	chenhongbj@medmail.com.cn		Li, Sufang/0000-0002-3904-0881	National Natural Science Foundation of China [81470473, 81270274]; Beijing Science and Technology Major Project [D141100003014002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Major Project	This work was supported by the National Natural Science Foundation of China (81470473, 81270274) and Beijing Science and Technology Major Project (No. D141100003014002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2014, SYST APPL MICROBIOL, V37, P23, DOI 10.1016/j.syapm.2013.09.007; Allen-Blevins CR, 2017, PEERJ, V5, DOI 10.7717/peerj.2876; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng PK, 2016, ADV SCI, V3, DOI 10.1002/advs.201600254; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; FREIS ED, 1952, J CLIN INVEST, V31, P131, DOI 10.1172/JCI102584; Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978; Hsiao JK, 2009, INVEST RADIOL, V44, P329, DOI 10.1097/RLI.0b013e3181a16762; Huang Ying, 2014, Zhongguo Weishengtaxixue Zazhi / Chinese Journal of Microecology, V26, P1004; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Khan MS, 2014, J PAK MED ASSOC, V64, P488; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kosik-Bogacka DI, 2011, EXP PARASITOL, V127, P398, DOI 10.1016/j.exppara.2010.09.001; Mao Y, 2011, INT J CARDIOL, V146, P432, DOI 10.1016/j.ijcard.2010.10.102; Marchandin H, 2010, RES MICROBIOL, V161, P91, DOI 10.1016/j.resmic.2009.12.008; Marcinkiewicz AL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00328; Nagatomo Y, 2015, J CARD FAIL, V21, P973, DOI 10.1016/j.cardfail.2015.09.017; Nakamura S, 2017, METHODS MOL BIOL, V1593, P243, DOI 10.1007/978-1-4939-6927-2_19; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Seropian IM, 2015, EUROPEAN HEART J ACU; SMITH GLF, 1989, ORAL MICROBIOL IMMUN, V4, P135, DOI 10.1111/j.1399-302X.1989.tb00240.x; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Tran CD, 2015, FUTURE MICROBIOL, V10, P1339, DOI 10.2217/FMB.15.54; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Troseid M., 2017, EUR HEART J; Ussher JR, 2013, ATHEROSCLEROSIS, V231, P456, DOI 10.1016/j.atherosclerosis.2013.10.013; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu XL, 2016, MICROB PATHOGENESIS, V94, P90, DOI 10.1016/j.micpath.2015.11.029	42	35	40	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180717	10.1371/journal.pone.0180717	http://dx.doi.org/10.1371/journal.pone.0180717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686722	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100096
J	Horton, KC; Dueger, EL; Kandeel, A; Abdallat, M; El-Kholy, A; Al-Awaidy, S; Kohlani, AH; Amer, H; El-Khal, AL; Said, M; House, B; Pimentel, G; Talaat, M				Horton, Katherine C.; Dueger, Erica L.; Kandeel, Amr; Abdallat, Mohamed; El-Kholy, Amani; Al-Awaidy, Salah; Kohlani, Abdul Hakim; Amer, Hanaa; El-Khal, Abel Latif; Said, Mayar; House, Brent; Pimentel, Guillermo; Talaat, Maha			Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007-2014	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTIONS; POLYMERASE-CHAIN-REACTION; SYNCYTIAL VIRUS; YOUNG-CHILDREN; EPIDEMIOLOGY; INFANTS; SURVEILLANCE; SYMPTOMS; DISEASE; BURDEN	Introduction Little is known about the role of viral respiratory pathogens in the etiology, seasonality or severity of severe acute respiratory infections (SARI) in the Eastern Mediterranean Region. Methods Sentinel surveillance for SARI was conducted from December 2007 through February 2014 at 20 hospitals in Egypt, Jordan, Oman, Qatar and Yemen. Nasopharyngeal and oropharyngeal swabs were collected from hospitalized patients meeting SARI case definitions and were analyzed for infection with influenza, respiratory syncytial virus (RSV), adenovirus (AdV), human metapneumovirus (hMPV) and human parainfluenza virus types 1-3 (hPIV1-3). We analyzed surveillance data to calculate positivity rates for viral respiratory pathogens, describe the seasonality of those pathogens and determine which pathogens were responsible for more severe outcomes requiring ventilation and/or intensive care and/or resulting in death. Results At least one viral respiratory pathogen was detected in 8,753/28,508 (30.7%) samples tested for at least one pathogen and 3,497/9,315 (37.5%) of samples tested for all pathogens-influenza in 3,345/28,438 (11.8%), RSV in 3,942/24,503 (16.1%), AdV in 923/9,402 (9.8%), hMPV in 617/9,384 (6.6%), hPIV1 in 159/9,402 (1.7%), hPIV2 in 85/9,402 (0.9%) and hPIV3 in 365/9,402 (3.9%). Multiple pathogens were identified in 501/9,316 (5.4%) participants tested for all pathogens. Monthly variation, indicating seasonal differences in levels of infection, was observed for all pathogens. Participants with hMPV infections and participants less than five years of age were significantly less likely than participants not infected with hMPV and those older than five years of age, respectively, to experience a severe outcome, while participants with a pre-existing chronic disease were at increased risk of a severe outcome, compared to those with no reported pre-existing chronic disease. Conclusions Viral respiratory pathogens are common among SARI patients in the Eastern Mediterranean Region. Ongoing surveillance is important to monitor changes in the etiology, seasonality and severity of pathogens of interest.	[Horton, Katherine C.; Dueger, Erica L.; Talaat, Maha] US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt; [Horton, Katherine C.; Dueger, Erica L.; Said, Mayar; House, Brent; Pimentel, Guillermo; Talaat, Maha] US Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt; [Dueger, Erica L.] US Ctr Dis Control & Prevent, Global Dis Detect Branch, Atlanta, GA USA; [Kandeel, Amr] Minist Hlth & Populat, Prevent Sect, Cairo, Egypt; [Abdallat, Mohamed] Minist Hlth, Communicable Dis Dept, Amman, Jordan; [El-Kholy, Amani] Cairo Univ Hosp, Clin Pathol Dept, Cairo, Egypt; [Al-Awaidy, Salah] Minist Hlth, Communicable Dis Dept, Muscat, Oman; [Kohlani, Abdul Hakim] Minist Hlth, Communicable Dis Dept, Sanaa, Yemen; [Amer, Hanaa] Ain Shams Univ, Clin Pathol Dept, Cairo, Egypt; [El-Khal, Abel Latif] Hamad Med Corp, Sect Med, Doha, Qatar	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University; Hamad Medical Corporation	Horton, KC (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt.; Horton, KC (corresponding author), US Naval Med Res Unit, Global Dis Detect & Response Program, Cairo, Egypt.	katherinehorton12@gmail.com	Kholy, Amani El/ABA-4759-2020; Awaidy, Salah Al/AAF-5884-2020	Awaidy, Salah Al/0000-0001-5112-3893; El Kholy, Amani/0000-0002-0645-7664; Horton, Katherine/0000-0002-7542-4065	Global Emerging Infections Surveillance Program [GEIS847705.821000.25GB.E0018]; U.S. Centers for Disease Control	Global Emerging Infections Surveillance Program; U.S. Centers for Disease Control	The study was funded through the Global Emerging Infections Surveillance Program (GEIS847705.821000.25GB.E0018) and the U.S. Centers for Disease Control. Authors have no commercial or other associations that might pose a conflict of interest.	Akhter J, 2011, HUMAN RESP SYNCYTIAL; Al-Abdallat M, 2016, INFLUENZA OTHER RESP; Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Al-Awaidy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144186; Al-Thani A, 2010, FUTURE VIROL, V5, P355, DOI 10.2217/FVL.10.13; Al-Toum R., 2009, Jordan Medical Journal, V43, P171; Ali SA, 2010, J MED VIROL, V82, P1012, DOI 10.1002/jmv.21768; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Bezerra P, 2011, PLOS ONE, V6, P1; Breiman RF, 2013, J INFECT DIS, V208, pS167, DOI 10.1093/infdis/jit462; Bruno R, 2009, NEW MICROBIOL, V32, P297; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; Falsey AR, 2006, J CLIN VIROL, V35, P46, DOI 10.1016/j.jcv.2005.04.004; Fattouh AM, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-14; Feikin D, 2012, PLOS ONE, V7, P1; Fry AM, 2006, CLIN INFECT DIS, V43, P1016, DOI 10.1086/507638; Heikkinen T, 2008, EMERG INFECT DIS, V14, P101, DOI 10.3201/eid1401.070251; Henrickson KJ, 2007, PEDIATR INFECT DIS J, V26, pS36, DOI 10.1097/INF.0b013e318157da6f; Hess B, 2012, COMMUNICATIONS, V13, P5; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kandeel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161301; Khamis FA, 2012, J MED VIROL, V84, P1323, DOI 10.1002/jmv.23330; Khuri-Bulos N, 2010, SCAND J INFECT DIS, V42, P368, DOI 10.3109/00365540903496544; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Mameli C, 2013, CURRENT INFECT DIS R; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Mohamed MS Embarek, 2014, INT J MICROBIOLOGY, V2014; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Pan American Health Organization, 2006, PAHOHDMCDV41106; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Sackesen C, 2005, TURKISH J PEDIATR, V47, P227; Sakthivel SK, 2012, J VIROL METHODS, V185, P259, DOI 10.1016/j.jviromet.2012.07.010; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; WHO Initiative for Vaccine Research, 2009, RESP SYNC VIR PAR VI; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; World Health Organization, 2011, WHO GLOB TECHN CONS	45	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180954	10.1371/journal.pone.0180954	http://dx.doi.org/10.1371/journal.pone.0180954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704440	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000405649700065
J	O'Connor, TF; Fach, ME; Miller, R; Root, SE; Mercier, PP; Lipomi, DJ				O'Connor, Timothy F.; Fach, Matthew E.; Miller, Rachel; Root, Samuel E.; Mercier, Patrick P.; Lipomi, Darren J.			The Language of Glove: Wireless gesture decoder with low-power and stretchable hybrid electronics	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; STRAIN SENSOR; MOTION; TRANSPARENT; ACCURACY; SYSTEM; SKIN	This communication describes a glove capable of wirelessly translating the American Sign Language (ASL) alphabet into text displayable on a computer or smartphone. The key components of the device are strain sensors comprising a piezoresistive composite of carbon particles embedded in a fluoroelastomer. These sensors are integrated with a wearable electronic module consisting of digitizers, a microcontroller, and a Bluetooth radio. Finiteelement analysis predicts a peak strain on the sensors of 5% when the knuckles are fully bent. Fatigue studies suggest that the sensors successfully detect the articulation of the knuckles even when bent to their maximal degree 1,000 times. In concert with an accelerometer and pressure sensors, the glove is able to translate all 26 letters of the ASL alphabet. Lastly, data taken from the glove are used to control a virtual hand; this application suggests new ways in which stretchable and wearable electronics can enable humans to interface with virtual environments. Critically, this system was constructed of components costing less than $100 and did not require chemical synthesis or access to a cleanroom. It can thus be used as a test bed for materials scientists to evaluate the performance of new materials and flexible and stretchable hybrid electronics.	[O'Connor, Timothy F.; Miller, Rachel; Root, Samuel E.; Lipomi, Darren J.] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Fach, Matthew E.; Mercier, Patrick P.] Univ Calif San Diego, Dept Elect & Comp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lipomi, DJ (corresponding author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dlipomi@eng.ucsd.edu	Root, Samuel/AAM-9143-2020	Miller, Rachel/0000-0001-8488-8286; Mercier, Patrick/0000-0003-1488-5076	NIBIB NIH HHS [DP2 EB022358] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB022358] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Akter T, 2012, ACS APPL MATER INTER, V4, P1855, DOI 10.1021/am300058j; Albert DR, 2012, J CHEM EDUC, V89, P1432, DOI 10.1021/ed200829d; Amjadi M, 2014, ACS NANO, V8, P5154, DOI 10.1021/nn501204t; Ch EAR, 2008, RES REP, P21; Datta V, 2001, J AM COLL SURGEONS, V193, P479, DOI 10.1016/S1072-7515(01)01041-9; Gerratt AP, 2015, ADV FUNCT MATER, V25, P2287, DOI 10.1002/adfm.201404365; Gong S, 2015, ACS APPL MATER INTER, V7, P19700, DOI 10.1021/acsami.5b05001; Haj-Omar A, 2016, IEEE ANTENNAS PROP, P459, DOI 10.1109/APS.2016.7695938; Lapides P., 2008, 2008 3rd ACM/IEEE International Conference on Human-Robot Interaction (HRI 2008), P343; Lim S, 2015, ADV FUNCT MATER, V25, P375, DOI 10.1002/adfm.201402987; Lin YL, 2015, SMALL, V11, P6397, DOI 10.1002/smll.201502692; Maletsky LP, 2007, J BIOMECH, V40, P682, DOI 10.1016/j.jbiomech.2006.01.017; Marescaux J, 2001, NATURE, V413, P379, DOI 10.1038/35096636; Mastorakis G, 2014, J REAL-TIME IMAGE PR, V9, P635, DOI 10.1007/s11554-012-0246-9; Milne AD, 1996, J BIOMECH, V29, P791, DOI 10.1016/0021-9290(96)83335-5; Muth JT, 2014, ADV MATER, V26, P6307, DOI 10.1002/adma.201400334; Nagi J, 2014, ACMIEEE INT CONF HUM, DOI 10.1145/2559636.2559833; Nunes RCR, 2000, POLYM TEST, V19, P93, DOI 10.1016/S0142-9418(98)00075-0; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Park J, 2015, CHEMPHYSCHEM, V16, P1155, DOI 10.1002/cphc.201402810; Savagatrup S, 2015, ADV FUNCT MATER, V25, P427, DOI 10.1002/adfm.201401758; Schausberger SE, 2015, IEEE ACCESS, V3, P556, DOI 10.1109/ACCESS.2015.2433398; Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054; Stuck R, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/1/015012; Wang T, 2016, SMALL, V12, P3748, DOI 10.1002/smll.201601049; Wang Z, 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1002/APP; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Yan CY, 2014, ADV MATER, V26, P2022, DOI 10.1002/adma.201304742; Ying M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/34/344004; Zhao HC, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aai7529; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001; Zhou H, 2008, MED ENG PHYS, V30, P123, DOI 10.1016/j.medengphy.2006.11.010	33	40	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0179766	10.1371/journal.pone.0179766	http://dx.doi.org/10.1371/journal.pone.0179766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700603	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600011
J	Wongsuk, T; Pumeesat, P; Luplertlop, N				Wongsuk, Thanwa; Pumeesat, Potjaman; Luplertlop, Natthanej			Genetic variation analysis and relationships among environmental strains of Scedosporium apiospermum sensu stricto in Bangkok, Thailand	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENT; SPECIES COMPLEX; MITOCHONDRIAL-DNA; CYSTIC-FIBROSIS; BRAIN-ABSCESS; EVOLUTIONARY; INFECTIONS; FUNGI; MOLDS; PCR	The Scedosporium apiospermum species complex is an emerging filamentous fungi that has been isolated from environment. It can cause a wide range of infections in both immunocompetent and immunocompromised individuals. We aimed to study the genetic variation and relationships between 48 strains of S. apiospermum sensu stricto isolated from soil in Bangkok, Thailand. For PCR, sequencing and phylogenetic analysis, we used the following genes: actin; calmodulin exons 3 and 4; the second largest subunit of the RNA polymerase II; beta-tubulin exon 2-4; manganese superoxide dismutase; internal transcribed spacer; transcription elongation factor 1 alpha; and beta-tubulin exons 5 and 6. The present study is the first phylogenetic analysis of relationships among S. apiospermum sensu stricto in Thailand and South-east Asia. This result provides useful information for future epidemiological study and may be correlated to clinical manifestation.	[Wongsuk, Thanwa; Pumeesat, Potjaman; Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Wongsuk, Thanwa] Navamindradhiraj Univ, Vajira Hosp, Fac Med, Dept Clin Pathol, Bangkok, Thailand; [Pumeesat, Potjaman] Bansomdejchaopraya Rajabhat Univ, Fac Sci & Technol, Dept Med Technol, Bangkok, Thailand	Mahidol University; Bansomdejchaopraya Rajabhat University	Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	natthanej.lup@mahidol.ac.th	Wongsuk, Thanwa/I-7585-2016; Wongsuk, Thanwa/AAG-5728-2019	Wongsuk, Thanwa/0000-0001-9904-4334; luplertlop, natthanej/0000-0001-7964-5298	Health System Research Institute (HSRI); National Research Council of Thailand (NRCT); Tropical Medicine grant; Faculty of Tropical Medicine, Mahid of University	Health System Research Institute (HSRI); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Tropical Medicine grant; Faculty of Tropical Medicine, Mahid of University	This study was supported by Health System Research Institute (HSRI) 2016, National Research Council of Thailand (NRCT) 2016 and Tropical Medicine grant 2014, Faculty of Tropical Medicine, Mahid of University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007; Bernhardt A, 2015, INT J MED MICROBIOL, V305, P724, DOI 10.1016/j.ijmm.2015.08.024; Borghi E, 2010, MED MYCOL, V48, pS108, DOI 10.3109/13693786.2010.504239; Chen M, 2016, FUNGAL BIOL-UK, V120, P137, DOI 10.1016/j.funbio.2015.09.003; Debourgogne A, 2010, J MICROBIOL METH, V82, P319, DOI 10.1016/j.mimet.2010.07.008; Garzoni C, 2005, EMERG INFECT DIS, V11, P1591, DOI 10.3201/eid1110.050715; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Giraud S, 2014, CURR FUNGAL INFECT R, V8, P211, DOI 10.1007/s12281-014-0192-z; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heath CH, 2009, CLIN MICROBIOL INFEC, V15, P689, DOI 10.1111/j.1469-0691.2009.02802.x; Hoffmann K, 2007, MYCOL RES, V111, P1169, DOI 10.1016/j.mycres.2007.07.002; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larbcharoensub N, 2013, SE ASIAN J TROP MED, V44, P484; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lu QY, 2011, J CLIN MICROBIOL, V49, P960, DOI 10.1128/JCM.01813-10; Luplertlop N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159869; Matray O, 2016, MED MYCOL, V54, P409, DOI 10.1093/mmy/myv080; Pounder JI, 2007, J CLIN MICROBIOL, V45, P568, DOI 10.1128/JCM.01684-06; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Ramsperger M, 2014, CURR CLIN MICROBIOL, V1, P27, DOI 10.1007/s40588-014-0001-z; Rougeron A, 2015, ENVIRON MICROBIOL, V17, P1039, DOI 10.1111/1462-2920.12472; Satirapoj B, 2008, TRANSPL P, V40, P2425, DOI 10.1016/j.transproceed.2008.07.030; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Wang HQ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765985	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181083	10.1371/journal.pone.0181083	http://dx.doi.org/10.1371/journal.pone.0181083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704511	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600058
J	Huang, CM; Chen, HH; Chen, DC; Huang, YC; Liu, SP; Lin, YJ; Chang, YY; Lin, HW; Chen, SY; Tsai, FJ				Huang, Chung-Ming; Chen, Hsin-Han; Chen, Da-Chung; Huang, Yu-Chuen; Liu, Shih-Ping; Lin, Ying-Ju; Chang, Yuan-Yen; Lin, Hui-Wen; Chen, Shih-Yin; Tsai, Fuu-Jen			Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR; DISEASE; BURDEN; GENE; INFLAMMATION; PREVALENCE; RESISTANCE; MORTALITY; ISOFORMS	Objective We have previously described the association of rheumatoid arthritis (RA) prevalence and two epidermal growth factor receptor (EGFR) SNPs (rs17337023 and rs2227983) among the Taiwanese population. This present study aimed to elucidate whether the SNPs can alter the expression of EGFR in the progression of RA. Methods The cohort study included 366 Taiwan's Han Chinese RA patients and 326 age and gender matched healthy controls. Blood samples collected from the participants were analyzed to determine their serum EGFR levels and to identify EGFR SNPs from their genomic DNA. Genotyping for EGFR SNPs was performed by restriction fragment length polymorphism (RFLP) assay. The relationship between EGFR SNP and the clinical manifestations of RA was evaluated. Results Our results showed that a statistically significant difference in genotype frequency distributions at rs17337023 SNP for RA patients and controls (p < 0.05). In addition, compared with the haplotype frequencies between case and control groups, the RA patient with the GT haplotype appeared to be a significant "protective" haplotype compared with other haplotypes (OR: 0.73, 95% CI: 0.59-0.91; p = 0.005). Furthermore, the increased serum level of EGFR was also observed in RA patients (p < 0.001). Conclusion Our study showed that RA is associated with rs17337023 SNP in EGFR gene and increased serum level of the EGFR protein. These findings suggest EGFR is worthy of further investigation as a therapeutic target for RA.	[Huang, Chung-Ming; Huang, Yu-Chuen; Lin, Ying-Ju; Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Huang, Chung-Ming] China Med Univ Hosp, Dept Internal Med, Div Rheumatol & Immunol, Taichung, Taiwan; [Chen, Hsin-Han] China Med Univ Hosp, Div Plast & Reconstruct Surg, Taichung, Taiwan; [Chen, Da-Chung; Chen, Shih-Yin] Taiwan LandSeed Hosp, Taoyuan, Taiwan; [Huang, Yu-Chuen; Lin, Ying-Ju] China Med Univ Hosp, Genet Ctr, Dept Med Res, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Chang, Yuan-Yen] Chung Shan Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Chang, Yuan-Yen] Chung Shan Med Univ, Sch Med, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Hui-Wen] Asia Univ, Dept Optometry, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, SY; Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Chen, SY (corresponding author), Taiwan LandSeed Hosp, Taoyuan, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Pediat, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan.	chenshihy@gmail.com; d0704@mail.cmuh.org.tw		Liu, Shih-Ping/0000-0002-5803-4460; Chang, Yuan-Yen/0000-0001-6395-4280	China Medical University Hospital in Taiwan [DMR-99-015, DMR-100-013, DMR-102-013]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; National Science Council in Taiwan [NSC99-2314-B-039-005-MY3]	China Medical University Hospital in Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by China Medical University Hospital in Taiwan (DMR-99-015, DMR-100-013 and DMR-102-013), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and National Science Council in Taiwan (NSC99-2314-B-039-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Araujo A, 2007, ONCOLOGIST, V12, P201, DOI 10.1634/theoncologist.12-2-201; Bai J, 2012, ASIAN PAC J CANCER P, V13, P4879, DOI 10.7314/APJCP.2012.13.10.4879; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; Crowson CS, 2009, J RHEUMATOL, V36, P1606, DOI 10.3899/jrheum.081188; Dabertrand F, 2007, AM J PHYSIOL-CELL PH, V293, pC848, DOI 10.1152/ajpcell.00069.2007; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Guillaudeau A, 2012, INT J ONCOL, V40, P1142, DOI 10.3892/ijo.2011.1287; Hashemi M, 2013, INT J IMMUNOGENET, V40, P299, DOI 10.1111/iji.12038; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120699; Killock David, 2012, Nat Rev Rheumatol, V8, P247, DOI 10.1038/nrrheum.2012.45; Krasinskas A. M., 2011, PATHOLOG RES INT, V2011, P6, DOI DOI 10.4061/2011/932932; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lal P, 2011, ARTHRITIS RHEUM-US, V63, P3681, DOI 10.1002/art.30596; Langley Paul C, 2011, J Med Econ, V14, P709, DOI 10.3111/13696998.2011.611201; Lin YJ, 2014, BIOMEDICINE-TAIWAN, V4, P18, DOI 10.7603/s40681-014-0010-5; Lo SF, 2012, RHEUMATOL INT, V32, P2301, DOI 10.1007/s00296-011-1961-4; Maetzel A, 2004, ANN RHEUM DIS, V63, P395, DOI 10.1136/ard.2003.006031; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orlewska E, 2011, MED SCI MONITOR, V17, pSR1, DOI 10.12659/MSM.881697; Palmer G, 2006, ARTHRITIS RHEUM, V54, P2707, DOI 10.1002/art.22062; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Silverman GJ, 2003, ARTHRITIS RES THER, V5, pS1, DOI 10.1186/ar1010; Swanson CD, 2012, J IMMUNOL, V188, P3513, DOI 10.4049/jimmunol.1102693; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Walker F, 2009, HUM PATHOL, V40, P1517, DOI 10.1016/j.humpath.2009.05.010; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YEN JH, 1995, J RHEUMATOL, V22, P1450; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yuan FL, 2013, CLIN RHEUMATOL, V32, P289, DOI 10.1007/s10067-012-2119-9	38	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180604	10.1371/journal.pone.0180604	http://dx.doi.org/10.1371/journal.pone.0180604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700691	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649400015
J	Jung, S; Choi, M; Choi, K; Kwon, EB; Kang, M; Kim, D; Jeong, H; Kim, J; Kim, JH; Kim, MO; Han, SB; Cho, S				Jung, Sunhee; Choi, Miri; Choi, Kwangman; Kwon, Eun Bin; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Kim, Janghwan; Kim, Jong Heon; Kim, Mun Ock; Han, Sang-Bae; Cho, Sungchan			Inactivation of human DGAT2 by oxidative stress on cysteine residues	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE ACTIVITY; GLYCEROL PHOSPHATE ACYLTRANSFERASE; SYNTHESIZED FATTY-ACIDS; TRIACYLGLYCEROL SYNTHESIS; ENDOPLASMIC-RETICULUM; ACYL-COA; TRIGLYCERIDE SYNTHESIS; LIVER; IDENTIFICATION; MITOCHONDRIA	Diacylglycerol acyltransferases (DGATs) have a crucial role in the biosynthesis of triacylglycerol (TG), the major storage form of metabolic energy in eukaryotic organisms. Even though DGAT2, one of two distinct DGATs, has a vital role in TG biosynthesis, little is known about the regulation of DGAT2 activity. In this study, we examined the role of cysteine and its oxidation in the enzymatic activity of human DGAT2 in vitro. Human DGAT2 activity was considerably inhibited not only by thiol-modifying reagents (NEM and IA) but also by ROSrelated chemicals ( H2O2 and beta-lapachone), while human DGAT1 and GPAT1 were little affected. Particularly, ROS-related chemicals concomitantly induced intermolecular disulfide crosslinking of human DGAT2. Both the oxidative inactivation and disulfide crosslinking were almost completely reversed by the treatment with DTT, a disulfide-reducing agent. These results clearly demonstrated the significant role of ROS-induced intermolecular crosslinking in the inactivation of human DGAT2 and also suggested DGAT2 as a redoxsensitive regulator in TG biosynthesis.	[Jung, Sunhee; Choi, Miri; Choi, Kwangman; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea; [Jung, Sunhee; Choi, Miri; Kwon, Eun Bin; Kang, Mingu; Kim, Dongeun; Jeong, Hyejeong; Han, Sang-Bae] Chungbuk Natl Univ, Coll Pharm, 1 Chungdae Ro Seowon Gu, Cheongju, Chungcheongbuk, South Korea; [Kwon, Eun Bin; Kim, Mun Ock] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea; [Kim, Janghwan] Korea Res Inst Biosci & Biotechnol, Stem Cell Res Ctr, 125 Gwahak Ro, Daejeon, South Korea; [Kim, Jong Heon] Natl Canc Ctr, Res Inst, Canc Cell & Mol Biol Branch, Goyang Si, Gyeonggi Do, South Korea; [Cho, Sungchan] Korea Univ Sci & Technol, Dept Biomol Sci, 217 Gajeong Ro, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC); University of Science & Technology (UST)	Cho, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju, Chungcheongbuk, South Korea.; Cho, S (corresponding author), Korea Univ Sci & Technol, Dept Biomol Sci, 217 Gajeong Ro, Daejeon, South Korea.	sungchan@kribb.re.kr			Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI) - ministry of Health Welfare [HI14C2124]; National Research Foundation of Korea [NRF-2016K1A1A8A01938649, NRF-2015M3A9C7030128]; KRIBB Research Initiative Programs	Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI) - ministry of Health Welfare; National Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative Programs	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Heath Industry Development Institute (KHIDI), funded by the ministry of Health & Welfare (HI14C2124), the National Research Foundation of Korea (NRF-2016K1A1A8A01938649 & NRF-2015M3A9C7030128), and the KRIBB Research Initiative Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; BATES EJ, 1979, BIOCHEM J, V182, P751, DOI 10.1042/bj1820751; BOVERIS A, 1978, BIOCHEM J, V175, P431, DOI 10.1042/bj1750431; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen YI, 2016, AM J TRANSL RES, V8, P1626; Choi K, 2014, FEBS J, V281, P3048, DOI 10.1111/febs.12841; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jin YZ, 2014, J BIOL CHEM, V289, P28237, DOI 10.1074/jbc.M114.571190; KAMISAKA Y, 1993, LIPIDS, V28, P583, DOI 10.1007/BF02536050; Kim H, 2016, DIS MODEL MECH, V9, P839, DOI 10.1242/dmm.025668; Kim MO, 2013, BIOL PHARM BULL, V36, P1167, DOI 10.1248/bpb.b13-00152; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Liu Q, 2010, BIOCHEMISTRY-US, V49, P3237, DOI 10.1021/bi9020499; Lozeman FJ, 2001, COMP BIOCHEM PHYS B, V130, P105, DOI 10.1016/S1096-4959(01)00413-4; Lu XH, 2002, J BIOL CHEM, V277, P711, DOI 10.1074/jbc.M109427200; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; MONROY G, 1972, J BIOL CHEM, V247, P6884; NIMMO HG, 1979, BIOCHEM J, V177, P283, DOI 10.1042/bj1770283; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; RLaA Kuksist, 1996, PROG LIPID RES, V35, P169; Sahebkar A, 2014, PROG LIPID RES, V56, P47, DOI 10.1016/j.plipres.2014.07.002; SAURO VS, 1990, BIOCHEM CELL BIOL, V68, P1393, DOI 10.1139/o90-202; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Wang DQH, 2013, COMPR PHYSIOL, V3, P1493, DOI 10.1002/cphy.c130001; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wurie HR, 2012, FEBS J, V279, P3033, DOI 10.1111/j.1742-4658.2012.08684.x; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zammit VA, 2013, BIOCHEM J, V451, P1, DOI 10.1042/BJ20121689	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181076	10.1371/journal.pone.0181076	http://dx.doi.org/10.1371/journal.pone.0181076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700690	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400029
J	Lund, M; Dahle, MK; Timmerhaus, G; Alarcon, M; Powell, M; Aspehaug, V; Rimstad, E; Jorgensen, SM				Lund, Morten; Dahle, Maria Krudtaa; Timmerhaus, Gerrit; Alarcon, Marta; Powell, Mark; Aspehaug, Vidar; Rimstad, Espen; Jorgensen, Sven Martin			Hypoxia tolerance and responses to hypoxic stress during heart and skeletal muscle inflammation in Atlantic salmon (Salmo salar)	PLOS ONE			English	Article							PISCINE REOVIRUS PRV; ENVIRONMENTAL HYPOXIA; L.; ERYTHROCYTES; PERFORMANCE; METABOLISM; PHYSIOLOGY; ANEMIA; GROWTH; SMOLT	Heart and skeletal muscle inflammation (HSMI) is associated with Piscine orthoreovirus (PRV) infection and is an important disease in Atlantic salmon (Salmo salar) aquaculture. Since PRV infects erythrocytes and farmed salmon frequently experience environmental hypoxia, the current study examined mutual effects of PRV infection and hypoxia on pathogenesis and fish performance. Furthermore, effects of HSMI on hypoxia tolerance, cardiorespiratory performance and blood oxygen transport were studied. A cohabitation trial including PRV-infected post-smolts exposed to periodic hypoxic stress (4 h of 40% O-2; PRV-H) at 4, 7 and 10 weeks post-infection (WPI) and infected fish reared under normoxic conditions (PRV) was conducted. Periodic hypoxic stress did not influence infection levels or histopathological changes in the heart. Individual incipient lethal oxygen saturation (ILOS) was examined using a standardized hypoxia challenge test (HCT). At 7 WPI, i.e. peak level of infection, both PRV and PRV-H groups exhibited reduced hypoxia tolerance compared to non-infected fish. Three weeks later (10 WPI), during peak levels of pathological changes, reduced hypoxia tolerance was still observed for the PRV group while PRV-H performed equal to non-infected fish, implying a positive effect of the repeated exposure to hypoxic stress. This was in line with maximum heart rate (fHmax) measurements, showing equal performance of PRV-H and non-infected groups, but lower fHmax above 19 degrees C as well as lower temperature optimum (T-opt) for aerobic scope for PRV, suggesting reduced cardiac performance and thermal tolerance. In contrast, the PRV-H group had reduced hemoglobinoxygen affinity compared to non-infected fish. In conclusion, Atlantic salmon suffering from HSMI have reduced hypoxia tolerance and cardiac performance, which can be improved by preconditioning fish to transient hypoxic stress episodes.	[Lund, Morten; Dahle, Maria Krudtaa; Alarcon, Marta] Norwegian Vet Inst, Sect Immunol, Oslo, Norway; [Lund, Morten; Dahle, Maria Krudtaa; Alarcon, Marta] Norwegian Vet Inst, Sect Immunol, Harstad, Norway; [Timmerhaus, Gerrit; Jorgensen, Sven Martin] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [Powell, Mark] Univ Bergen, Bergen, Norway; [Powell, Mark] Norwegian Inst Water Res, Bergen, Norway; [Rimstad, Espen] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Aspehaug, Vidar] PatoGen AS, Alesund, Norway	Norwegian Veterinary Institute; Norwegian Veterinary Institute; Nofima; University of Bergen; Norwegian Institute for Water Research (NIVA); Norwegian University of Life Sciences	Lund, M (corresponding author), Norwegian Vet Inst, Sect Immunol, Oslo, Norway.; Lund, M (corresponding author), Norwegian Vet Inst, Sect Immunol, Harstad, Norway.	Morten.Lund@vetinst.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X	Research Council of Norway [235788/E40, 237315/E40]; Norwegian Seafood Research Fund [901001]; Norwegian Seafood Research Fund	Research Council of Norway(Research Council of Norway); Norwegian Seafood Research Fund; Norwegian Seafood Research Fund	The Research Council of Norway provided support in the form of salary for two authors [ML] (#235788/E40) and [MKD] (#237315/E40), (http://www.forskningsradet.no/en/Home_page/1177315753906) and #901001 of the Norwegian Seafood Research Fund (http://www.fhf.no/om-fhf/about-fhf/). The Research Council of Norway provided support in the form of salary for one author [ML], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Norwegian Seafood Research Fund provided support in the form of funding the challenge trial and the analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The authors employed by NOFIMA AS and PatoGen AS contributed solely with scientific expertise in the study and in the preparation of the manuscript	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Anttila K, 2014, FRONT MAR SCI, P1; Anttila K, 2013, J EXP BIOL, V216, P1183, DOI 10.1242/jeb.080556; AXELSSON M, 1993, AM J PHYSIOL, V264, pR963, DOI 10.1152/ajpregu.1993.264.5.R963; Bjorgen H, 2015, VET RES, V46, DOI 10.1186/s13567-015-0244-6; BOUTILIER RG, 1989, CAN J ZOOL, V67, P2986, DOI 10.1139/z89-421; Burt K, 2012, AQUAC RES, V43, P607, DOI 10.1111/j.1365-2109.2011.02867.x; Claireaux G, 2016, J FISH BIOL, V88, P232, DOI 10.1111/jfb.12833; Claireaux G, 2013, AQUAT TOXICOL, V130, P160, DOI 10.1016/j.aquatox.2013.01.004; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Farrell AP, 2007, J EXP BIOL, V210, P1715, DOI 10.1242/jeb.02781; Farrell AP, 2009, CAN J ZOOL, V87, P835, DOI 10.1139/Z09-092; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; GAMPERL AK, 1995, AM J PHYSIOL-REG I, V269, pR1258, DOI 10.1152/ajpregu.1995.269.5.R1258; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garver KA, 2016, J FISH DIS, V39, P117, DOI 10.1111/jfd.12329; Gattuso A, 2002, DIS AQUAT ORGAN, V52, P11, DOI 10.3354/dao052011; Glover KA, 2013, PLOS ONE, P8; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Johansson D, 2007, AQUACULTURE, V265, P271, DOI 10.1016/j.aquaculture.2006.12.047; Johansson D, 2006, AQUACULTURE, V254, P594, DOI 10.1016/j.aquaculture.2005.10.029; Jopling C, 2012, CIRCULATION, V126, P3017, DOI 10.1161/CIRCULATIONAHA.112.107888; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kocan R, 2006, J FISH DIS, V29, P521, DOI 10.1111/j.1365-2761.2006.00745.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kongtorp RT, 2009, SALMO SALAR L, P253; Krasnov A, 2013, GEN COMP ENDOCR, V192, P181, DOI 10.1016/j.ygcen.2013.04.026; Kvamme BO, 2013, FISH SHELLFISH IMMUN, V34, P55, DOI 10.1016/j.fsi.2012.10.006; Leonard MO, 2016, INDUCTION GLUCOCOR T; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-8; Lund M, 2016, VET RES IN PRESS; Lund SG, 2000, J EXP BIOL, V203, P2219; Manchenkov T, 2015, G3-GENES GENOM GENET, V5, P1107, DOI 10.1534/g3.115.018010; Markussen T, 2013, PLOS ONE, P8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2012, PLOS ONE, P7; Morera D, 2011, PLOS ONE, P6; Nikinmaa Mikko, 2006, P153; Nilsson GE, 2008, BIOL REV, V83, P173, DOI 10.1111/j.1469-185X.2008.00038.x; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pan Y.K., 2016, J FISH BIOL; Parente V, 2013, PLOS ONE, P8; Phillips MCL, 2000, J EXP BIOL, V203, P1039; Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730; RANDALL D, 1982, J EXP BIOL, V100, P275; Randall DJ, 2014, J EXP BIOL, V217, P1205, DOI 10.1242/jeb.093526; Rehulka J, 2003, DIS AQUAT ORGAN, V56, P185, DOI 10.3354/dao056185; Remen M, 2012, AQUACULTURE, V326, P148, DOI 10.1016/j.aquaculture.2011.11.036; Rimstad E, 2011, AQUAC RES, V42, P86, DOI 10.1111/j.1365-2109.2010.02670.x; Rodger HD, 2014, J FISH DIS, V37, P935, DOI 10.1111/jfd.12186; ROMBOUGH PJ, 1988, CAN J ZOOL, V66, P651, DOI 10.1139/z88-097; Roze T, 2013, J THERM BIOL, V38, P98, DOI 10.1016/j.jtherbio.2012.12.001; Rummer JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139477; Rytkonen KT, 2012, PHYSIOL GENOMICS, V44, P1090, DOI 10.1152/physiolgenomics.00081.2012; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; SCHMIDT W, 1994, BLOOD, V83, P3746; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; SOIVIO A, 1980, J COMP PHYSIOL, V136, P83, DOI 10.1007/BF00688627; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Thorud K, 1988, B EUR ASSOC FISH PAT, P8; Tucker VA, 1967, J APPL PHYSIOL, P23; WEBER RE, 1994, BLOOD, V84, P638; Zhang Y, 2016, AQUACULTURE	71	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181109	10.1371/journal.pone.0181109	http://dx.doi.org/10.1371/journal.pone.0181109			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700748	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000405649400032
J	Sasaki, K; Sasaki, D; Okai, N; Tanaka, K; Nomoto, R; Fukuda, I; Yoshida, K; Kondo, A; Osawa, R				Sasaki, Kengo; Sasaki, Daisuke; Okai, Naoko; Tanaka, Kosei; Nomoto, Ryohei; Fukuda, Itsuko; Yoshida, Ken-ichi; Kondo, Akihiko; Osawa, Ro			Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; DIETARY TAURINE; EXPERIMENTAL-MODELS; ESCHERICHIA-COLI; SUPPLEMENTATION; PROTEIN; IMPACT; MICE	Accumulating evidence suggests that dietary taurine (2-aminoethanesulfonic acid) exerts beneficial anti-inflammatory effects in the large intestine. In this study, we investigated the possible impact of taurine on human colonic microbiota using our single-batch fermentation system (Kobe University Human Intestinal Microbiota Model; KUHIMM). Fecal samples from eight humans were individually cultivated with and without taurine in the KUHIMM. The results showed that taurine remained largely undegraded after 30 h of culturing in the absence of oxygen, although some 83% of the taurine was degraded after 30 h of culturing under aerobic conditions. Diversity in bacterial species in the cultures was analyzed by 16S rRNA gene sequencing, revealing that taurine caused no significant change in the diversity of the microbiota; both operational taxonomic unit and Shannon-Wiener index of the cultures were comparable to those of the respective source fecal samples. In addition, principal coordinate analysis indicated that taurine did not alter the composition of bacterial species, since the 16S rRNA gene profile of bacterial species in the original fecal sample was maintained in each of the cultures with and without taurine. Furthermore, metabolomic analysis revealed that taurine did not affect the composition of short-chain fatty acids produced in the cultures. These results, under these controlled but artificial conditions, suggested that the beneficial anti-inflammatory effects of dietary taurine in the large intestine are independent of the intestinal microbiota. We infer that dietary taurine may act directly in the large intestine to exert anti-inflammatory effects.	[Sasaki, Kengo; Sasaki, Daisuke; Okai, Naoko; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Tanaka, Kosei; Nomoto, Ryohei; Yoshida, Ken-ichi; Osawa, Ro] Kobe Univ, Org Adv Sci & Technol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Fukuda, Itsuko; Yoshida, Ken-ichi; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Fukuda, Itsuko; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Res Ctr Food Safety & Secur, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan; [Kondo, Akihiko] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan	Kobe University; Kobe University; Kobe University; Kobe University; RIKEN	Sasaki, K (corresponding author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo, Japan.	sikengo@people.kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015; Sasaki, Kengo/O-6739-2018; Nomoto, Ryohei/AAV-3469-2020; SASAKI, Daisuke/F-9597-2015	Sasaki, Kengo/0000-0002-5764-1429; 	Japan Innovative Bioproduction Kobe	Japan Innovative Bioproduction Kobe	This work was supported by Japan Innovative Bioproduction Kobe (http://www.org.kobe-u.ac.jp/bioproduction/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119137; Anderson CMH, 2009, J PHYSIOL-LONDON, V587, P731, DOI 10.1113/jphysiol.2008.164228; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backus RC, 1994, J NUTR, V124, p2540S; Camargo RL, 2015, AMINO ACIDS, V47, P2419, DOI 10.1007/s00726-015-2035-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen W, 2012, MOL NUTR FOOD RES, V56, P681, DOI 10.1002/mnfr.201100799; Cuttitta CM, 2013, ADV EXP MED BIOL, V775, P299, DOI 10.1007/978-1-4614-6130-2_25; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichhorn E, 2000, J BACTERIOL, V182, P2687, DOI 10.1128/JB.182.10.2687-2695.2000; Farrell B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-78; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Gondo Y, 2012, BIOCHEM BIOPH RES CO, V426, P433, DOI 10.1016/j.bbrc.2012.08.116; Huang CX, 2014, POULTRY SCI, V93, P1475, DOI 10.3382/ps.2013-03533; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ito T, 2015, J PHARMACOL SCI, V129, P59, DOI 10.1016/j.jphs.2015.08.007; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kawaguchi H, 2015, BIORESOURCE TECHNOL, V198, P410, DOI 10.1016/j.biortech.2015.09.024; Kim H, 2006, MOL PHARMACOL, V69, P1405, DOI 10.1124/mol.105.020578; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Maia AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105851; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rosa FT, 2014, EUR J NUTR, V53, P823, DOI 10.1007/s00394-013-0586-7; Rycroft CE, 2001, J APPL MICROBIOL, V91, P878, DOI 10.1046/j.1365-2672.2001.01446.x; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shimizu M, 2009, ADV EXP MED BIOL, V643, P265, DOI 10.1007/978-0-387-75681-3_27; Takagi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160533; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; URIANICKELSEN MR, 1993, J GEN MICROBIOL, V139, P203, DOI 10.1099/00221287-139-2-203; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; Venema K, 2013, BEST PRACT RES CL GA, V27, P115, DOI 10.1016/j.bpg.2013.03.002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; Ward RJ, 2011, BIOCHEM PHARMACOL, V81, P743, DOI 10.1016/j.bcp.2010.12.030; Wu GF, 2009, ADV EXP MED BIOL, V643, P313, DOI 10.1007/978-0-387-75681-3_32; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57; Yu HN, 2016, AMINO ACIDS, V48, P1601, DOI 10.1007/s00726-016-2219-y; Zhao Z, 2008, AMINO ACIDS, V35, P217, DOI 10.1007/s00726-007-0562-8	46	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180991	10.1371/journal.pone.0180991	http://dx.doi.org/10.1371/journal.pone.0180991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700670	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800110
J	Williams, RM; Winkfein, RJ; Ginger, RS; Green, MR; Schnetkamp, PP; Wheeler, GN				Williams, Ruth M.; Winkfein, Robert J.; Ginger, Rebecca S.; Green, Martin R.; Schnetkamp, Paul P.; Wheeler, Grant N.			A functional approach to understanding the role of NCKX5 in Xenopus pigmentation	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGER; MOLECULAR-CLONING; GENE FAMILY; EXPRESSION; RESIDUES; SLC24A5; CA2+; MUTATIONS; ALBINISM; MEMBER	NCKX5 is an ion exchanger expressed mostly in pigment cells; however, the functional role for this protein in melanogenesis is not clear. A variant allele of SLC24A5, the gene encoding NCKX5, has been shown to correlate with lighter skin pigmentation in humans, indicating a key role for SLC24A5 in determining human skin colour. SLC24A5 expression has been found to be elevated in melanoma. Knockdown analyses have shown SLC24A5 to be important for pigmentation, but to date the function of this ion exchanger in melanogenesis has not been fully established. Our data suggest NCKX5 may have an alternative activity that is key to its role in the regulation of pigmentation. Here Xenopus laevis is employed as an in vivo model system to further investigate the function of NCKX5 in pigmentation. SLC24A5 is expressed in the melanophores as they differentiate from the neural crest and develop in the RPE of the eye. Morpholino knockdown and rescue experiments were designed to elucidate key residues and regions of the NCKX5 protein. Unilateral morpholino injection at the 2 cell stage resulted in a reduction of pigmentation in the eye and epidermis of one lateral side of the tadpole. Xenopus and human SLC24A5 can rescue the morpholino effects. Further rescue experiments including the use of ion exchange inactive SLC24A5 constructs raise the possibility that full ion exchanger function of NCKX5 may not be required for rescue of pigmentation.	[Williams, Ruth M.; Wheeler, Grant N.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Winkfein, Robert J.; Schnetkamp, Paul P.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Ginger, Rebecca S.; Green, Martin R.] Unilever Res Labs, Colworth Sci Pk, Sharnbrook, Beds, England; [Williams, Ruth M.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of East Anglia; University of Calgary; Unilever; University of Oxford	Wheeler, GN (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.	grant.wheeler@uea.ac.uk	Wheeler, Grant N/D-3023-2009	Wheeler, Grant N/0000-0002-4335-8577	Unilever RD; BBSRC	Unilever RD(Unilever); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Unilever R&D provided support in the form of salaries for MG and RSG in addition to a supplement to the student stipend of RMW and a contribution to the research costs of the project. The specific roles of these authors are articulated in the author contributions section. Unilever R&D was also involved in the design of the project and analysis of the results. They had no further role in the decision to publish or preparation of the manuscript. This project was part of a BBSRC funded CASE Studentship.	Boissy RE, 2011, GIORN ITAL DERMAT V, V146, P69; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Garcia-Morales C, 2009, DEV BIOL, V335, P143, DOI 10.1016/j.ydbio.2009.08.021; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Jalloul AH, 2016, J BIOL CHEM, V291, P13113, DOI 10.1074/jbc.M116.728824; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; KIMURA M, 1993, J BIOL CHEM, V268, P6874; Kinjo TG, 2004, BIOCHEMISTRY-US, V43, P7940, DOI 10.1021/bi049538y; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Kumasaka M, 2003, PIGM CELL RES, V16, P455, DOI 10.1034/j.1600-0749.2003.00064.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Li XF, 2014, J BIOL CHEM, V289, P25445, DOI 10.1074/jbc.M114.564450; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Mallick CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003912; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Poon S, 2000, AM J PHYSIOL-CELL PH, V278, pC651, DOI 10.1152/ajpcell.2000.278.4.C651; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Schnetkamp PPM, 2013, MOL ASPECTS MED, V34, P455, DOI 10.1016/j.mam.2012.07.008; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P198; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Tanaka Toshihiro, 2005, Nihon Rinsho, V63 Suppl 12, P29; Tomlinson ML, 2009, MOL BIOSYST, V5, P376, DOI 10.1039/b818695b; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Walters ZS, 2009, J PHYSIOL-LONDON, V587, P521, DOI 10.1113/jphysiol.2008.161562; Wei AH, 2013, J INVEST DERMATOL, V133, P1834, DOI 10.1038/jid.2013.49; Wilson S, 2013, ADV EXP MED BIOL, V961, P95, DOI 10.1007/978-1-4614-4756-6_9; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180465	10.1371/journal.pone.0180465	http://dx.doi.org/10.1371/journal.pone.0180465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692664	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405544800043
J	Wu, HY; Cottingham, C; Chen, LP; Wang, HX; Che, PL; Liu, KX; Wang, Q				Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Liu, Kexiang; Wang, Qin			Age-dependent differential regulation of anxiety-and depression-related behaviors by neurabin and spinophilin	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; DSM-IV DISORDERS; SUBCELLULAR-DISTRIBUTION; PROTEIN; RECEPTOR; ACTIN; BINDING; PHOSPHATASE-1; MORPHOGENESIS; COMORBIDITY	Affective disorders impact nearly 10% of the adult population in the United States in a given year. Synaptic dysfunction has recently emerged as a key neurobiological mechanism underlying affective disorders such as anxiety and depression. In this study, we investigate the potential role of two synaptic scaffolding proteins, neurabin and spinophilin, in regulating anxiety-and depression-related behaviors at different ages using genetically deficient mice. Loss of the neurabin gene reduces anxiety-like behavior in the elevated zero maze in young adult mice (3-5 months old), but not in middle aged mice (11-13 months old), whereas loss of spinophilin decreases anxiety in middle-aged mice, but not in young adult mice. Neurabin knockout (KO) mice also show reduced immobility in the repeated force swim test (FST) at 3-5 months, but not 11-3 months, of age, compared to age-and strain-matched wild type (WT) controls. Conversely, spinophilin KO mice display a lower level of this behavioral despair than matched WT controls after repeated FST trials at the middle age (11-13 months) but not the young age (3-5 months). Together, these data indicate that, despite their structural similarities and overlapping function in regulating synaptic cytoskeleton, the two homologs neurabin and spinophilin play important yet distinct roles in the regulation of anxietyand depression-like behaviors in an age-dependent manner. Our studies provide new insights into the complex neurobiology of affective disorders.	[Wu, Huiying] Jilin Univ, Hosp 2, Ultrason Diag Dept, Changchun, Jilin, Peoples R China; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Cell, Birmingham, AL 35294 USA; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Mol, Birmingham, AL 35294 USA; [Wu, Huiying; Cottingham, Christopher; Chen, Liping; Wang, Hongxia; Che, Pulin; Wang, Qin] Univ Alabama Birmingham, Dept Dev Biol, Birmingham, AL 35294 USA; [Cottingham, Christopher] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA; [Liu, Kexiang] Jilin Univ, Hosp 2, Dept Cardiovasc Surg, Changchun, Jilin, Peoples R China	Jilin University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Morehead State University; Jilin University	Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Cell, Birmingham, AL 35294 USA.; Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Mol, Birmingham, AL 35294 USA.; Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Dev Biol, Birmingham, AL 35294 USA.	qinwang@uab.edu	Wang, Hongxia/G-6655-2018	Wang, Qin/0000-0002-1079-5914	Nationa lInstitute of Mental Health [MH081917]; Brain & Behavior Research Foundation (Independent Investigator Award); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	Nationa lInstitute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain & Behavior Research Foundation (Independent Investigator Award); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study has been supported by the Nationa lInstitute of Mental Health (MH081917 to QW) and the Brain & Behavior Research Foundation (Independent Investigator Award to QW).	Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Boucher AA, 2011, NEUROSCIENCE, V189, P170, DOI 10.1016/j.neuroscience.2011.05.049; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Di Sebastiano AR, 2016, J BIOL CHEM, V291, P17602, DOI 10.1074/jbc.M116.722355; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Evans JC, 2015, J BIOL CHEM, V290, P10295, DOI 10.1074/jbc.M114.605543; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Finn DA, 2003, NEUROGENETICS, V4, P109, DOI 10.1007/s10048-003-0143-2; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; Luscher C, 2009, J PHYSIOL-LONDON, V587, P727, DOI 10.1113/jphysiol.2008.167742; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Mul JD, 2016, CJ MICE ENEURO, V3; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Sweatt JD, 2010, MECHANISMS MEMORY; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180638	10.1371/journal.pone.0180638	http://dx.doi.org/10.1371/journal.pone.0180638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700667	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800060
J	Bryant, AC; Cios, KJ				Bryant, Avory C.; Cios, Krzysztof J.			SOTXTSTREAM: Density-based self-organizing clustering of text streams	PLOS ONE			English	Article								A streaming data clustering algorithm is presented building upon the density-based self-organizing stream clustering algorithm SOSTREAM. Many density-based clustering algorithms are limited by their inability to identify clusters with heterogeneous density. SOSTREAM addresses this limitation through the use of local (nearest neighbor-based) density determinations. Additionally, many stream clustering algorithms use a two-phase clustering approach. In the first phase, a micro-clustering solution is maintained online, while in the second phase, the micro-clustering solution is clustered offline to produce a macro solution. By performing self-organization techniques on micro-clusters in the online phase, SOSTREAM is able to maintain a macro clustering solution in a single phase. Leveraging concepts from SOSTREAM, a new density-based self-organizing text stream clustering algorithm, SOTXTSTREAM, is presented that addresses several shortcomings of SOSTREAM. Gains in clustering performance of this new algorithm are demonstrated on several real-world text stream datasets.	[Bryant, Avory C.; Cios, Krzysztof J.] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Bryant, Avory C.] US Navy, Naval Surface Warfare Ctr, Dahlgren Div, Dahlgren, VA 22448 USA; [Cios, Krzysztof J.] Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland	Virginia Commonwealth University; Polish Academy of Sciences; Institute of Theoretical & Applied Informatics of the Polish Academy of Sciences	Bryant, AC (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA.; Bryant, AC (corresponding author), US Navy, Naval Surface Warfare Ctr, Dahlgren Div, Dahlgren, VA 22448 USA.	bryantac@vcu.edu			Naval Surface Warfare Center Dahlgren Division's In-house Laboratory Independent Research Program	Naval Surface Warfare Center Dahlgren Division's In-house Laboratory Independent Research Program	This work was funded in part by the Naval Surface Warfare Center Dahlgren Division's In-house Laboratory Independent Research Program. There was no additional external funding received for this study	Agarwal MK, 2012, PROC VLDB ENDOW, V5, P980, DOI 10.14778/2336664.2336671; Aggarwal C. C., 2003, VLDB, P29; Aggarwal C. C., 2012, P 2012 SIAM INT C DA, P624, DOI DOI 10.1137/1.9781611972825.54; Aggarwal CC, 2010, KNOWL INF SYST, V24, P171, DOI 10.1007/s10115-009-0241-z; Allan J., 1998, Proceedings of the 21st Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P37, DOI 10.1145/290941.290954; Angel A, 2012, PROC VLDB ENDOW, V5, P574, DOI 10.14778/2168651.2168658; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Banerjee A, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P431; Brants T., 2003, SIGIR, P330, DOI DOI 10.1145/860435.860495; Broder AZ, 2000, J COMPUT SYST SCI, V60, P630, DOI 10.1006/jcss.1999.1690; Bun KK, 2002, WISE 2002: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS ENGINEERING, P73, DOI 10.1109/WISE.2002.1181645; Cai D., 2009, TEXT DATASETS MATLAB; Callan J., 1996, SIGIR Forum, P262; Campello Ricardo J. G. B., 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P160, DOI 10.1007/978-3-642-37456-2_14; Cao F, 2006, SIAM PROC S, P328, DOI 10.1137/1.9781611972764.29; Cataldi Mario, 2010, ACM MIN KDD WORKSH M, P4, DOI DOI 10.1145/1814245.1814249; Charikar M.S., 2002, P 34 ANN ACM S THEOR, V34, P380, DOI DOI 10.1145/509907.509965; Chitta R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P607, DOI 10.1109/ICDMW.2015.31; Cieri C, 2002, KLUW S INF, V12, P33; Delany S., ECUE SPAM DATASETS; Demsar J, 2006, J MACH LEARN RES, V7, P1; Duda R.O., 2000, PATTERN CLASSIFICATI; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Ester M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases, P323; Feigenblat G, 2010, THEOR COMPUT SCI, V411, P3048, DOI 10.1016/j.tcs.2010.04.029; Fung Gabriel Pui Cheong, 2005, P 31 INT C VER LARG, P181; Hassani M., 2015, J MACHINE LEARNING R, P49; Hassani M, 2014, LECT NOTES ARTIF INT, V8556, P134, DOI 10.1007/978-3-319-08979-9_11; He Q, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P491, DOI 10.1137/1.9781611972771.50; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Isaksson Charlie, 2012, Machine Learning and Data Mining in Pattern Recognition. Proceedings 8th International Conference, MLDM 2012, P264, DOI 10.1007/978-3-642-31537-4_21; Jaliobaite Gama, 2014, ACM COMPUT SURV, V46; Kleinberg J., 2002, BURSTY HIERARCHICAL, DOI 10.1145/775060.775061; Kohonen T., 2001, SELF ORG MAPS; Kranen P, 2011, KNOWL INF SYST, V29, P249, DOI 10.1007/s10115-010-0342-8; Lang K., 20 NEWSGROUPS DATA S; Lee CH, 2012, EXPERT SYST APPL, V39, P9623, DOI 10.1016/j.eswa.2012.02.136; Lee CH, 2011, LECT NOTES COMPUT SC, V6677, P548, DOI 10.1007/978-3-642-21111-9_62; Lewis David D, REUTERS 21578; Liu YB, 2008, J COMPUT SCI TECH-CH, V23, P112, DOI 10.1007/s11390-008-9115-1; Moore B, 1988, P 1988 CONN MOD SUMM, P174; Petrovi S, 2010, HUMAN LANGUAGE TECHN, P181; PhridviRaj MSB, 2014, PROCEDIA COMPUT SCI, V31, P976, DOI 10.1016/j.procs.2014.05.350; Reed W, 2006, 2006 5 INT C MACHINE, P258, DOI DOI 10.1109/ICMLA.2006.50; Sohler C., 2010, J EXPT ALGORITHMICS, V17, DOI [10.1145/2133803.2184450, DOI 10.1145/2133803.2184450]; Tasoulis DK, 2007, LECT NOTES COMPUT SC, V4723, P81; Wan L, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1552303.1552307; Wen JR, 2002, ACM T INFORM SYST, V20, P59, DOI 10.1145/503104.503108; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang Y., 1998, P 21 ANN INT ACM SIG, P28, DOI [DOI 10.1145/290941.290953, 10.1145/290941.290953]; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]; Zhong S, 2005, NEURAL NETWORKS, V18, P790, DOI 10.1016/j.neunet.2005.06.008	54	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180543	10.1371/journal.pone.0180543	http://dx.doi.org/10.1371/journal.pone.0180543			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686655	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100075
J	Clark, RSB; Empey, PE; Bay, H; Rosario, BL; Poloyac, SM; Kochanek, PM; Nolin, TD; Au, AK; Horvat, CM; Wisniewski, SR; Bell, MJ				Clark, Robert S. B.; Empey, Philip E.; Bay, Hulya; Rosario, Bedda L.; Poloyac, Samuel M.; Kochanek, Patrick M.; Nolin, Thomas D.; Au, Alicia K.; Horvat, Christopher M.; Wisniewski, Stephen R.; Bell, Michael J.			Phase I randomized clinical trial of Nacetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children	PLOS ONE			English	Article							N-ACETYLCYSTEINE; DOUBLE-BLIND; PHARMACOKINETICS; EFFICACY; GLUTATHIONE; SYSTEMS	Background There are no therapies shown to improve outcome after severe traumatic brain injury (TBI) in humans, a leading cause of morbidity and mortality. We sought to verify brain exposure of the systemically administered antioxidant N-acetylcysteine (NAC) and the synergistic adjuvant probenecid, and identify adverse effects of this drug combination after severe TBI in children. Methods IRB-approved, randomized, double- blind, placebo controlled Phase I study in children 2 to 18 years-of-age admitted to a Pediatric Intensive Care Unit after severe TBI (Glasgow Coma Scale [GCS] score <= 8) requiring an externalized ventricular drain for measurement of intracranial pressure (ICP). Patients were recruited from November 2011-August 2013. Fourteen patients (n = 7/group) were randomly assigned after obtaining informed consent to receive probenecid (25 mg/kg load, then 10 mg/kg/dose q6hx11 doses) and NAC (140 mg/kg load, then 70 mg/kg/dose q4hx17 doses), or placebos via naso/orogastric tube. Serum and CSF samples were drawn pre-bolus and 1-96 h after randomization and drug concentrations were measured via UPLC-MS/MS. Glasgow Outcome Scale (GOS) score was assessed at 3 months. Results There were no adverse events attributable to drug treatment. One patient in the placebo group was withdrawn due to adverse effects. In the treatment group, NAC concentrations ranged from 16,977.3 +/- 2,212.3 to 16,786.1 +/- 3,285.3 in serum and from 269.3 +/- 113.0 to 467.9 +/- 262.7 ng/mL in CSF, at 24 to 72 h post-bolus, respectively; and probenecid concentrations ranged from 75.4.3 +/- 10.0 to 52.9 +/- 25.8 in serum and 5.4 +/- 1.0 to 4.6 +/- 2.1 mu g/mL in CSF, at 24 to 72 h post-bolus, respectively (mean +/- SEM). Temperature, mean arterial pressure, ICP, use of ICP-directed therapies, surveillance serum brain injury biomarkers, and GOS at 3 months were not different between groups. Conclusions Treatment resulted in detectable concentrations of NAC and probenecid in CSF and was not associated with undesirable effects after TBI in children.	[Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Clark, Robert S. B.; Empey, Philip E.; Kochanek, Patrick M.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Empey, Philip E.; Poloyac, Samuel M.; Nolin, Thomas D.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Ctr Clin Pharmaceut Sci, Pittsburgh, PA USA; [Bay, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Rosario, Bedda L.; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's National Health System	Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Nolin, Thomas/AAB-7311-2020; Empey, Philip/L-9604-2019	Nolin, Thomas/0000-0003-4339-1382; Empey, Philip/0000-0001-7474-2339	NIH [R01NS069247]; NCATS [KL2TR000146, U01NS081041]; Children's Hospital of Pittsburgh of UPMC Scientific Program and Brain Care Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Children's Hospital of Pittsburgh of UPMC Scientific Program and Brain Care Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grants R01NS069247 (RSBC, PEE, MJB, PMK), NCATS KL2TR000146 (PEE), and U01NS081041 (MJB, SRW, PMK); and the Children's Hospital of Pittsburgh of UPMC Scientific Program and Brain Care Institute. The funding sources had no role in study design, data collection, data analysis, data interpretation, or writing of there port.	Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berk M, 2014, J CLIN PSYCHIAT, V75, P628, DOI 10.4088/JCP.13m08454; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; BURNELL JM, 1951, J CLIN INVEST, V30, P697, DOI 10.1172/JCI102482; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Giustarini D, 2012, BIOCHEM PHARMACOL, V84, P1522, DOI 10.1016/j.bcp.2012.09.010; Hagos FT, 2016, XENOBIOTICA, P1; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Katz M, 2015, PARKINSONISM RELAT D, V21, P500, DOI 10.1016/j.parkreldis.2015.02.020; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Levin SW, 2014, LANCET NEUROL, V13, P777, DOI 10.1016/S1474-4422(14)70142-5; Maeda K, 2014, EUR J PHARM SCI, V59, P94, DOI 10.1016/j.ejps.2014.04.004; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nikoo M, 2015, CLIN NEUROPHARMACOL, V38, P11, DOI 10.1097/WNF.0000000000000063; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SELEN A, 1982, J PHARM SCI, V71, P1238, DOI 10.1002/jps.2600711114; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Wiest DB, 2014, J PEDIATR-US, V165, P672, DOI 10.1016/j.jpeds.2014.06.044; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	28	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180280	10.1371/journal.pone.0180280	http://dx.doi.org/10.1371/journal.pone.0180280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686657	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100047
J	Lumbreras, B; Vilar, J; Gonzalez-Alvarez, I; Guilabert, M; Pastor-Valero, M; Parker, LA; Vilar-Palop, J; Hernandez-Aguado, I				Lumbreras, Blanca; Vilar, Jose; Gonzalez-Alvarez, Isabel; Guilabert, Mercedes; Pastor-Valero, Maria; Parker, Lucy Anne; Vilar-Palop, Jorge; Hernandez-Aguado, Ildefonso			Avoiding fears and promoting shared decision-making: How should physicians inform patients about radiation exposure from imaging tests?	PLOS ONE			English	Article							RISK; KNOWLEDGE; CT; AWARENESS; BENEFITS	Objective We aimed to evaluate the population's awareness about the radiation exposure associated with five specific imaging tests, and their preference regarding three different formats for receiving the information before undergoing an imaging test. Methods A quantitative and qualitative evaluation through a survey and focal groups including general population from two health departments in Spain. The sampling was carried out in stages (according to health department size) and stratified by age and sex, to get a representative sample. We randomly selected the participants from these stages to be contacted by telephone by a trained nurse. Oral informed consent was obtained. Results xdOf 602 participants in the quantitative survey, 418 (70.3%) stated that they were aware of the risk associated with radiation. While the majority of these 418 participants knew that x-rays involve radiation (85.4%), fewer were aware that CT (42%) and mammography (38%) also involve radiation, and a substantial proportion believed, incorrectly, that MRI (38%) and ultrasound (18.4%) expose patients to radiation. The population preference was to receive the information using both oral and written formats, accompanied by a table showing the equivalence of the radiation associated with the imaging test to either a number of chest Xrays and exposure number of days of background radiation. Discussion The general population does not receive enough information regarding radiation exposure and the associated risks related to imaging tests. Initiatives should be designed to reinforce the patient's awareness when ordering a diagnostic imaging test.	[Lumbreras, Blanca; Pastor-Valero, Maria; Parker, Lucy Anne; Hernandez-Aguado, Ildefonso] Miguel Hernandez Univ, Dept Publ Hlth Hist Sci & Gynecol, Alicante, Spain; [Lumbreras, Blanca; Pastor-Valero, Maria; Parker, Lucy Anne; Hernandez-Aguado, Ildefonso] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Vilar, Jose] Peset Hosp, Radiodiagnost Dept, Valencia, Spain; [Gonzalez-Alvarez, Isabel] San Juan Hosp, Radiodiagnost Dept, Alicante, Spain; [Guilabert, Mercedes] Miguel Hernandez Univ, Psychol Dept, Alicante, Spain; [Vilar-Palop, Jorge] Ctr Nacl Dosimetria Radon, Valencia, Spain; [Vilar-Palop, Jorge] CRC, Valencia, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad Miguel Hernandez de Elche	Lumbreras, B (corresponding author), Miguel Hernandez Univ, Dept Publ Hlth Hist Sci & Gynecol, Alicante, Spain.; Lumbreras, B (corresponding author), CIBER Epidemiol & Salud Publ, Madrid, Spain.	blumbreras@umh.es	Guilabert, Mercedes/U-6135-2019; Hernandez-Aguado, Ildefonso/I-2634-2015	Guilabert, Mercedes/0000-0002-0706-9911; Vilar Palop, Jorge/0000-0003-4845-4282; Hernandez-Aguado, Ildefonso/0000-0003-1911-5759; Pastor-Valero, Maria/0000-0001-9282-5787; Lumbreras, Blanca/0000-0003-1665-0860	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I) [PI13/01576]; Fondo Europeo de Desarrollo Regional (FEDER)	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study has received funding by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (Plan Nacional de I+D+I) PI13/01576 and co-funded by the Fondo Europeo de Desarrollo Regional (FEDER). Role of the Sponsors: Funders had no involvement in any aspect of the design of this study, preparation of results, or decision to submit for publication.	Caverly TJ, 2013, JAMA INTERN MED, V173, P1658, DOI 10.1001/jamainternmed.2013.8194; Dauer LT, 2011, AM J ROENTGENOL, V196, P756, DOI 10.2214/AJR.10.5956; Elliott A, 2009, J RADIOL PROT, V29, pA107, DOI 10.1088/0952-4746/29/2A/S07; European Commission (EC), 2013, OFF J EUR COMMUN L, V124, P210, DOI [10.3000/19770677.L_2013.124.eng, DOI 10.3000/19770677.L_2013.124.ENG]; Harpaz-Rotem I, 2009, ARCH GEN PSYCHIAT, V66, P417, DOI 10.1001/archgenpsychiatry.2008.536; Lam DL, 2014, AM J ROENTGENOL, V203, P952, DOI 10.2214/AJR.14.13049; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Ludwig Rebecca L, 2002, J Allied Health, V31, P159; Malone J, 2012, BRIT J RADIOL, V85, P523, DOI 10.1259/bjr/42893576; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Pandharipande PV, 2013, AM J ROENTGENOL, V200, P1275, DOI 10.2214/AJR.12.10011; Picano E, 2004, BMJ-BRIT MED J, V329, P849, DOI 10.1136/bmj.329.7470.849; Puri S, 2012, AM J ROENTGENOL, V199, P1328, DOI 10.2214/AJR.12.8581; Ricketts ML, 2013, CAN ASSOC RADIOL J, V64, P208, DOI 10.1016/j.carj.2012.05.002; Sheridan SL, 2016, JAMA INTERN MED, V176, P31, DOI 10.1001/jamainternmed.2015.7339; Takakuwa KM, 2010, AM J ROENTGENOL, V195, P1151, DOI 10.2214/AJR.09.3847; Youssef NA, 2014, J EMERG MED, V46, P208, DOI 10.1016/j.jemermed.2013.07.016; Zwank MD, 2014, EMERG MED J, V31, P824, DOI 10.1136/emermed-2012-202294	18	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180592	10.1371/journal.pone.0180592	http://dx.doi.org/10.1371/journal.pone.0180592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686656	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100080
J	Engel, M; Endesfelder, D; Schloter-Hai, B; Kublik, S; Granitsiotis, MS; Boschetto, P; Stendardo, M; Barta, I; Dome, B; Deleuze, JF; Boland, A; Muller-Quernheim, J; Prasse, A; Welte, T; Hohlfeld, J; Subramanian, D; Parr, D; Gut, IG; Greulich, T; Koczulla, AR; Nowinski, A; Gorecka, D; Singh, D; Gupta, S; Brightling, CE; Hoffmann, H; Frankenberger, M; Hofer, TP; Burggraf, D; Heiss-Neumann, M; Ziegler-Heitbrock, L; Schloter, M; zu Castell, W				Engel, Marion; Endesfelder, David; Schloter-Hai, Brigitte; Kublik, Susanne; Granitsiotis, Michael S.; Boschetto, Piera; Stendardo, Mariarita; Barta, Imre; Dome, Balazs; Deleuze, Jean-Francois; Boland, Anne; Mueller-Quernheim, Joachim; Prasse, Antje; Welte, Tobias; Hohlfeld, Jens; Subramanian, Deepak; Parr, David; Gut, Ivo Glynne; Greulich, Timm; Koczulla, Andreas Rembert; Nowinski, Adam; Gorecka, Dorota; Singh, Dave; Gupta, Sumit; Brightling, Christopher E.; Hoffmann, Harald; Frankenberger, Marion; Hofer, Thomas P.; Burggraf, Dorothe; Heiss-Neumann, Marion; Ziegler-Heitbrock, Loems; Schloter, Michael; zu Castell, Wolfgang			Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; ORAL EPITHELIAL-CELLS; FUSOBACTERIUM-NUCLEATUM; PREVOTELLA-INTERMEDIA; BACTERIA; MACROPHAGES; DIVERSITY; SEQUENCE; COAGGREGATION; INFLAMMATION	Background Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited. Methods Bacterial community composition derived from brush samples from lungs of 16 patients suffering from different CT defined subtypes of COPD and 9 healthy subjects was analyzed using a cultivation independent barcoding approach applying 454-pyrosequencing of 16S rRNA gene fragment amplicons. Results We could show that bacterial community composition in patients with changes in CT (either airway or emphysema type changes, designated as severe subtypes) was different from community composition in lungs of patients without visible changes in CT as well as from healthy subjects (designated as mild COPD subtype and control group) (PC1, P-adj = 0.002). Higher abundance of Prevotella in samples from patients with mild COPD subtype and from controls and of Streptococcus in the severe subtype cases mainly contributed to the separation of bacterial communities of subjects. No significant effects of treatment with inhaled glucocorticoids on bacterial community composition were detected within COPD cases with and without abnormalities in CT in PCoA. Co-occurrence analysis suggests the presence of networks of co-occurring bacteria. Four communities of positively correlated bacteria were revealed. The microbial communities can clearly be distinguished by their associations with the CT defined disease phenotype. Conclusion Our findings indicate that CT detectable structural changes in the lung of COPD patients, which we termed severe subtypes, are associated with alterations in bacterial communities, which may induce further changes in the interaction between microbes and host cells. This might result in a changed interplay with the host immune system.	[Engel, Marion; Endesfelder, David; zu Castell, Wolfgang] Helmholtz Zentrum Munchen, Inst Computat Biol, Sci Comp Res Unit, Neuherberg, Germany; [Engel, Marion; Schloter-Hai, Brigitte; Kublik, Susanne; Granitsiotis, Michael S.; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Comparat Microbiome Anal, Neuherberg, Germany; [Boschetto, Piera; Stendardo, Mariarita] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Barta, Imre; Dome, Balazs] Natl Koranyi Inst TB & Pulmonol, Dept Pathophysiol, Budapest, Hungary; [Deleuze, Jean-Francois; Boland, Anne] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Mueller-Quernheim, Joachim] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Prasse, Antje; Welte, Tobias; Hohlfeld, Jens] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Prasse, Antje; Welte, Tobias; Hohlfeld, Jens; Greulich, Timm; Koczulla, Andreas Rembert] Member German Ctr Lung Res DZL, Giessen, Germany; [Hohlfeld, Jens] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Subramanian, Deepak; Parr, David] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Resp Med, Coventry, W Midlands, England; [Subramanian, Deepak; Parr, David] Warwickshire NHS Trust, Coventry, W Midlands, England; [Gut, Ivo Glynne] Barcelona Inst Sci & Technol, Ctr Genom Regulat, CNAG CRG, Barcelona, Spain; [Greulich, Timm; Koczulla, Andreas Rembert] Univ Med Ctr Giessen, Pulm & Crit Care Med, Dept Med, Marburg, Germany; [Greulich, Timm; Koczulla, Andreas Rembert] Univ Philipps Marburg, Marburg, Germany; [Nowinski, Adam; Gorecka, Dorota] Natl TB & Lung Dis Res Inst, Dept Resp Med 2, Warsaw, Poland; [Singh, Dave] Univ Manchester, Medicines Evaluat Unit, Manchester, Lancs, England; [Singh, Dave] Univ Hosp, South Manchester Fdn Trust, Manchester, Lancs, England; [Gupta, Sumit; Brightling, Christopher E.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Hoffmann, Harald] Synlab MVZ Gauting & IML red GmbH, Inst Microbiol, Gauting, Germany; [Hoffmann, Harald] Synlab MVZ Gauting & IML red GmbH, Lab Med, Gauting, Germany; [Frankenberger, Marion] Ludwig Maximilians Univ Munchen, Helmholtz Zentrum Munchen, CPC Comprehens Pneumol Ctr, Munich, Germany; [Frankenberger, Marion] Asklepios Klin Gauting, Munich, Germany; [Hofer, Thomas P.; Burggraf, Dorothe; Heiss-Neumann, Marion; Ziegler-Heitbrock, Loems] Helmholtz Zentrum Muenchen, EvA Study Ctr, Gauting, Germany; [zu Castell, Wolfgang] Tech Univ Munich, Dept Math, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Ferrara; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Hannover Medical School; Fraunhofer Gesellschaft; University of Warwick; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Leicester; SYNLAB Group; SYNLAB Group; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich	Engel, M (corresponding author), Helmholtz Zentrum Munchen, Inst Computat Biol, Sci Comp Res Unit, Neuherberg, Germany.; Engel, M (corresponding author), Helmholtz Zentrum Munchen, Res Unit Comparat Microbiome Anal, Neuherberg, Germany.	marion.engel@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Prasse, Antje/AAY-6279-2020; Gut, Ivo/ABF-3188-2020; Boschetto, Piera/AAM-3247-2020; Prasse, Antje/AAM-7521-2021; Singh, Dave/AAH-4342-2020	Gut, Ivo/0000-0001-7219-632X; Boschetto, Piera/0000-0003-3889-1681; Prasse, Antje/0000-0002-7336-7458; Singh, Dave/0000-0001-8918-7075; brightling, chris/0000-0002-9345-4903; Dome, Balazs/0000-0001-8799-8624; PARR, DAVID/0000-0002-0099-7918	Synlab MVZ Gauting IML red GmbH; National Institute for Health Research [CL-2012-11-002] Funding Source: researchfish	Synlab MVZ Gauting IML red GmbH; National Institute for Health Research(National Institute for Health Research (NIHR))	The funder Synlab MVZ Gauting & IML red GmbH provided support in the form of salaries for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barbosa GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138687; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134209; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BRANDTZAEG P, 1992, J INFECT DIS, V165, pS167, DOI 10.1093/infdis/165-Supplement_1-S167; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dorn BR, 1998, INFECT IMMUN, V66, P6054, DOI 10.1128/IAI.66.12.6054-6057.1998; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Falkow S, PROKARYOTES, V52006, P602; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fouhy F, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0738-z; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOB STRAT DIAGN MAN; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; GREEN GM, 1968, ANNU REV MED, V19, P315, DOI 10.1146/annurev.me.19.020168.001531; Hahn A, 2016, J MICROBIOL METH, V130, P95, DOI 10.1016/j.mimet.2016.09.002; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Johnson M, 2001, CHEST, V120, P258, DOI 10.1378/chest.120.1.258; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kim V, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-52; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Larsen JM, 2015, IMMUNOLOGY, V144, P333, DOI 10.1111/imm.12376; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Lee JH, 2010, RESP MED, V104, P542, DOI 10.1016/j.rmed.2009.10.024; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Mosher JJ, 2014, J MICROBIOL METH, V104, P59, DOI 10.1016/j.mimet.2014.06.012; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Rutten EPA, 2011, PULMONARY MED, V2011, P6; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SCHAFFNER A, 1985, J CLIN INVEST, V76, P1755, DOI 10.1172/JCI112166; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Singh D, 2016, AM J RESP CRIT CARE, V194, P541, DOI 10.1164/rccm.201606-1179PP; Strombeck L, 2007, APMIS, V115, P241, DOI 10.1111/j.1600-0463.2007.apm_512.x; Subramanian DR, 2016, EUR RESPIR J, V48, P92, DOI 10.1183/13993003.01878-2015; Sze MA, 2015, AM J RESP CRITICAL C; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Sze MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006677; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Timmers RA, 2012, APPL MICROBIOL BIOT, V94, P537, DOI 10.1007/s00253-012-3894-6; Tulek B, 2013, CAN RESPIR J, V20, P91, DOI 10.1155/2013/727523; TUOMANEN E, 1988, J EXP MED, V168, P267, DOI 10.1084/jem.168.1.267; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; Wang Z, 2016, EUROPEAN RESP J; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; World Health Organization, CHRON OBSTR PULM DIS; XIE H, 1991, ORAL MICROBIOL IMMUN, V6, P257, DOI 10.1111/j.1399-302X.1991.tb00488.x; Ziegler-Heitbrock L, 2012, EUR RESPIR J, V40, P823, DOI 10.1183/09031936.00142811	73	23	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180859	10.1371/journal.pone.0180859	http://dx.doi.org/10.1371/journal.pone.0180859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704452	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700056
J	Romero-Alvarez, D; Escobar, LE; Varela, S; Larkin, DJ; Phelps, NBD				Romero-Alvarez, Daniel; Escobar, Luis E.; Varela, Sara; Larkin, Daniel J.; Phelps, Nicholas B. D.			Forecasting distributions of an aquatic invasive species (Nitellopsis obtusa) under future climate scenarios	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; MAXIMUM-ENTROPY; COMPLEXITY; CHAROPHYCEAE; CHARACEAE; RANGES; SPACE	Starry stonewort (Nitellopsis obtusa) is an alga that has emerged as an aquatic invasive species of concern in the United States. Where established, starry stonewort can interfere with recreational uses of water bodies and potentially have ecological impacts. Incipient invasion of starry stonewort in Minnesota provides an opportunity to predict future expansion in order to target early detection and strategic management. We used ecological niche models to identify suitable areas for starry stonewort in Minnesota based on global occurrence records and present-day and future climate conditions. We assessed sensitivity of forecasts to different parameters, using four emission scenarios (i.e., RCP 2.6, RCP 4.5, RCP 6, and RCP 8.5) from five future climate models (i.e., CCSM, GISS, IPSL, MIROC, and MRI). From our niche model analyses, we found that (i) occurrences from the entire range, instead of occurrences restricted to the invaded range, provide more informed models; (ii) default settings in Maxent did not provide the best model; (iii) the model calibration area and its background samples impact model performance; (iv) model projections to future climate conditions should be restricted to analogous environments; and (v) forecasts in future climate conditions should include different future climate models and model calibration areas to better capture uncertainty in forecasts. Under present climate, the most suitable areas for starry stonewort are predicted to be found in central and southeastern Minnesota. In the future, suitable areas for starry stonewort are predicted to shift in geographic range under some future climate models and to shrink under others, with most permutations indicating a net decrease of the species' suitable range. Our suitability maps can serve to design shortterm plans for surveillance and education, while future climate models suggest a plausible reduction of starry stonewort spread in the long-term if the trends in climate warming remain.	[Romero-Alvarez, Daniel] Hosp Gen Enrique Garces, Unidad Epidemiol, Quito, Ecuador; [Escobar, Luis E.; Larkin, Daniel J.; Phelps, Nicholas B. D.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Varela, Sara] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Invalidenstr 43, Berlin, Germany	University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Escobar, LE (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	lescobar@umn.edu	Escobar, Luis E./I-2204-2019; Romero-Alvarez, Daniel/K-2270-2019	Escobar, Luis E./0000-0001-5735-2750; Larkin, Daniel/0000-0001-6378-0495; Phelps, Nicholas/0000-0003-3116-860X	Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment; Institute on the Environment Mini Grants program; Natural Resources Trust Fund	Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment; Institute on the Environment Mini Grants program; Natural Resources Trust Fund	Funding for this project was provided through the Minnesota Aquatic Invasive Species Research Center from the Minnesota Environment and Natural Resources Trust Fund. The Institute on the Environment Mini Grants program provided funding for the internship of DRA at the University of Minnesota.	Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; Anderson RP, 2014, 1 S BIOG ACT RET, P11; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Brainard AS, 2016, FRESHW SCI IN PRESS, V36; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; DNR M., 2015, DNR TAK FURTH STEPS; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Escobar L. E., 2014, GEOSPAT HLTH, V11, P221, DOI DOI 10.4081/GH.2014.19; Escobar LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29037; Escobar LE, 2015, ACTA TROP, V149, P202, DOI 10.1016/j.actatropica.2015.05.028; Escobar LE, 2013, REV PANAM SALUD PUBL, V34, P135; GEIS JW, 1981, PHYCOLOGIA, V20, P211, DOI 10.2216/i0031-8884-20-2-211.1; Gelviz-Gelvez SM, 2015, ECOL ENG, V74, P302, DOI 10.1016/j.ecoleng.2014.09.082; GISIN, 2015, GLOB INV SPEC INF NE; Golicher D, 2012, INT J GEOGR INF SCI, V26, P2049, DOI 10.1080/13658816.2012.719626; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; HELCOM, 2013, RED LIST NIT OBT, P2012; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Joint Nature Conservation Committee, 2010, UK PRIOR SPEC PAG VE; Kato S, 2014, PHYCOL RES, V62, P222, DOI 10.1111/pre.12057; Kipp RM, NITELLOPSIS OBTUSA N; LIMARIBEIRO MS, 2015, BIODIVERS INFORM, V10, DOI 10.17161/bi.v10i0.4955; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockwood J, 2006, INVASION ECOLOGY; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Midwood JD, 2016, J GREAT LAKES RES, V42, P348, DOI 10.1016/j.jglr.2016.01.005; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Papes M, 2016, FRESHWATER BIOL, V61, P457, DOI 10.1111/fwb.12719; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pullman GD., 2010, LAKELINE, V52, P36; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Sleith RS, 2015, BRITTONIA, V67, P166, DOI 10.1007/s12228-015-9372-6; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; U.S. Fish & Wildlife Service, 2015, NAT WETL INV; Waltari E, 2014, METHODS ECOL EVOL, V5, P1033, DOI 10.1111/2041-210X.12264; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	53	20	21	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180930	10.1371/journal.pone.0180930	http://dx.doi.org/10.1371/journal.pone.0180930			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704433	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700061
J	Wu, WS; Tu, BW; Chen, TT; Hou, SW; Tseng, JT				Wu, Wei-Sheng; Tu, Bor-Wen; Chen, Tsung-Te; Hou, Shang-Wei; Tseng, Joseph T.			CSmiRTar: Condition-Specific microRNA targets database	PLOS ONE			English	Article							IN-VIVO; RESOURCE; MIRNA; EXPRESSION; GENE; GENOMICS; SIRNAS; ATLAS; CERNA; PTEN	MicroRNAs (miRNAs) are functional RNA molecules which play important roles in the post transcriptional regulation. miRNAs regulate their target genes by repressing translation or inducing degradation of the target genes' mRNAs. Many databases have been constructed to provide computationally predicted miRNA targets. However, they cannot provide the miRNA targets expressed in a specific tissue and related to a specific disease at the same time. Moreover, they cannot provide the common targets of multiple miRNAs and the common miRNAs of multiple genes at the same time. To solve these two problems, we construct a database called CSmiRTar (Condition-Specific miRNA Targets). CSmiRTar collects computationally predicted targets of 2588 human miRNAs and 1945 mouse miRNAs from four most widely used miRNA target prediction databases (miRDB, TargetScan, microRNA. org and DIANA-microT) and implements functional filters which allows users to search (i) a miRNA's targets expressed in a specific tissue or/and related to a specific disease, (ii) multiple miRNAs' common targets expressed in a specific tissue or/and related to a specific disease, (iii) a gene's miRNAs related to a specific disease, and (iv) multiple genes' common miRNAs related to a specific disease. We believe that CSmiRTar will be a useful database for biologists to study the molecular mechanisms of post-transcriptional regulation in human or mouse.	[Wu, Wei-Sheng; Tu, Bor-Wen; Chen, Tsung-Te; Hou, Shang-Wei] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan; [Tseng, Joseph T.] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.; Tseng, JT (corresponding author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.	wessonwu@gmail.com; tctseng@mail.ncku.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018; Wu, Wei-Sheng/P-5367-2019	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; 	National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]	National Cheng Kung University and Ministry of Science and Technology of Taiwan	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Deu-Pons J, 2015, DATABASE; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wang DF, 2014, BIOINFORMATICS, V30, P2237, DOI 10.1093/bioinformatics/btu155; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181231	10.1371/journal.pone.0181231	http://dx.doi.org/10.1371/journal.pone.0181231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704505	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700111
J	Muscella, A; Vetrugno, C; Cossa, LG; Antonaci, G; Barca, A; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Cossa, Luca Giulio; Antonaci, Giovanna; Barca, Amilcare; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			Apoptosis by [Pt(O, O '-acac)(Y-acac)(DMS)] requires PKC-delta mediated p53 activation in malignant pleural mesothelioma	PLOS ONE			English	Article							KINASE-C-DELTA; BREAST-CANCER CELLS; PROTEIN-KINASE; XENOGRAFT MODEL; PHASE-II; IN-VITRO; CISPLATIN; BCL-2; PT(O,O'-ACAC)(GAMMA-ACAC)(DMS); CARCINOMA	Mesothelioma cancer cells have epithelioid or sarcomatoid morphology. The worst prognosis is associated with sarcomatoid phenotype and resistance to therapy is affected by cells heterogeneity. We recently showed that in ZL55 mesothelioma cell line of epithelioid origin [Pt(O,O '-acac)(Y-acac)(DMS)] (Ptac2S) has an antiproliferative effect in vitro and in vivo. Aim of this work was to extend the study on the effects of Ptac2S on ZL34 cell line, representative of sarcomatoid mesothelioma. ZL34 cells were used to assay the antitumor activity of Ptac2S in a mouse xenograft model in vivo. Then, both ZL34 and ZL55 cells were used in order to assess the involvement of p53 protein in (a) the processes underlying the sensitivity to chemotherapy and (b) the activation of various transduction proteins involved in apoptosis/survival processes. Ptac2S increases ZL34 cell death in vivo compared with cisplatin and, in vitro, Ptac2S was more efficacious than cisplatin in inducing apoptosis. In Ptac2S-treated ZL34 and ZL55 cells, p53 regulated gene products of apoptotic BAX and anti-apoptotic Bcl-2 proteins via transcriptional activation. Ptac2S activated PKC-delta and PKC-epsilon; their inhibition by PKC-siRNA decreased the apoptotic death of cells. PKC-delta was responsible for JNK1/2 activation that has a role in p53 activation. In addition, PKC-e activation provoked phosphorylation of p38MAPK, concurring to apoptosis. In ZL34 cells, Ptac2S also activated PKC-a thus provoking ERK1/2 activation; inhibition of PKC-alpha, or ERK1/ 2, increased Ptac2S cytotoxicity. Results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, giving a substantial starting point for its further validation.	[Muscella, Antonella; Vetrugno, Carla] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy; [Cossa, Luca Giulio; Antonaci, Giovanna; Marsigliante, Santo] Univ Salento, Lab Cell Physiol DiSTeBA, Lecce, Italy; [Barca, Amilcare] Univ Salento, Lab Physiol DiSTeBA, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Univ Salento, DiSTeBA, Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento; University of Salento	Muscella, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy.	antonella.muscella@unisalento.it	Barca, Amilcare/I-1281-2019; Muscella, Antonella/AAE-8075-2019; Fanizzi, Francesco Paolo/K-5766-2012	Barca, Amilcare/0000-0002-3117-2724; Muscella, Antonella/0000-0002-2822-9929; Fanizzi, Francesco Paolo/0000-0003-3073-5772; MARSIGLIANTE, Santo/0000-0001-6535-3286				Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; Bandoh N, 2002, CANCER, V94, P1968, DOI 10.1002/cncr.10388; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Chen LJ, 2010, BLOOD, V115, P61, DOI 10.1182/blood-2009-03-210526; Communal C, 2002, P NATL ACAD SCI USA, V99, P6252, DOI 10.1073/pnas.092022999; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Fan MY, 2001, CANCER RES, V61, P4450; Favoni RE, 2011, TRENDS PHARMACOL SCI, V32, P463, DOI 10.1016/j.tips.2011.03.011; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Hillerdal G, 2008, J THORAC ONCOL, V3, P1325, DOI 10.1097/JTO.0b013e31818b174d; Hopkins-Donaldson S, 2003, INT J CANCER, V106, P160, DOI 10.1002/ijc.11209; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Ko HW, 2000, J NEUROCHEM, V74, P2455, DOI 10.1046/j.1471-4159.2000.0742455.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Mor O, 1997, AM J RESP CELL MOL, V16, P9, DOI 10.1165/ajrcmb.16.1.8998073; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2005, BIOCHEM PHARMACOL, V71, P50, DOI 10.1016/j.bcp.2005.10.022; Muscella A, 2016, BRIT J PHARMACOL, V173, P2633, DOI 10.1111/bph.13543; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165154; Muscella A, 2015, BIOCHEM PHARMACOL, V98, P29, DOI 10.1016/j.bcp.2015.08.103; Muscella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112186; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nilsonne G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-92; Pasello G, 2009, CURR DRUG TARGETS, V10, P1235, DOI 10.2174/138945009789753200; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Powell CT, 1996, CELL GROWTH DIFFER, V7, P419; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Saha MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030215; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Streffer JR, 2002, J NEURO-ONCOL, V56, P43, DOI 10.1023/A:1014448721327; Sun XJ, 2006, CANCER LETT, V232, P161, DOI 10.1016/j.canlet.2005.02.022; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181114	10.1371/journal.pone.0181114	http://dx.doi.org/10.1371/journal.pone.0181114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704484	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600060
J	Yi, XY; Lin, J; Luo, H; Wang, C; Liu, YY				Yi, Xingyang; Lin, Jing; Luo, Hua; Wang, Chun; Liu, Yingying			Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients	PLOS ONE			English	Article							THROMBOXANE A2 RECEPTOR; CEREBRAL INFARCTION; MOLECULAR-MECHANISMS; METABOLITE LEVELS; ATHEROSCLEROSIS; POLYMORPHISM; COX-2; RISK; STENOSIS; EVENTS	Eicosanoids may play a role in ischemic stroke. However, the associations of variants in cyclooxygenase (COX) pathway genes and interaction among these variants with carotid plaque vulnerability are not fully understood. In present study, twelve variants in COX pathway genes were examined using matrix-assisted laser desorption ionization time-of-flight mass spectrometry method in 396 patients with ischemic stroke and 291 controls. Platelet aggregation, platelet-leukocyte aggregates, and urine 11-dehydrothromboxane B2 (11-dTxB2) were also measured. According to the results of carotid high-resolution B-mode ultrasound, the patients were stratified into the following groups [i.e., non-carotid plaque and carotid plaque. The carotid plaque was further classified into subgroups of echolucent plaque (ELP) and echogenic plaque (EGP)]. Additionally, gene-gene interactions were analyzed to assess whether there was any interactive role for assessed variants in affecting carotid plaque vulnerability, platelet activation and 11-dTxB2 levels. There were no significant differences in the frequencies of genotypes of the twelve variants between patients and controls. Among 396 patients, 294 cases (74.2%) had carotid plaques (106 had ELP, 188 had EGP). Frequency of PTGS2 rs20417CC, TXAS1 rs2267679TT, TXAS1 rs41708TT, PTGIS rs5602CC, and TXA2R rs1131882TT genotype was significantly higher in patients with plaque compared with patients without plaque, or in patients with ELP compared with patients with EGP. 11dTxB2 levels, platelet aggregation and platelet-leukocyte aggregates were significantly higher in patients with ELP compared with patients without plaque or with EGP. Multivariate logistic regression analysis revealed that PTGS2 rs20417CC, TXA2R rs1131882TT, and high-risk interaction among variants in PTGS2 rs20417, TXA2R rs1131882 and TXAS1 rs41708 were independently associated with the risk of ELP after adjusting for confounding variables. The variants in COX pathway genes and the high-risk interactions among variants in PTGS2 rs20417, TXA2R rs1131882 and TXAS1 rs41708 were associated with high 11-dTxB2 and platelet activation, and independently associated with the risk of carotid plaque vulnerability. These variants might be potential markers for plaque instability.	[Yi, Xingyang; Wang, Chun; Liu, Yingying] Peoples Hosp Deyang City, Dept Neurol, Deyang, Sichuan, Peoples R China; [Lin, Jing] Wenzhou Med Univ, Affiliated Hosp 3, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Luo, Hua] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China	Wenzhou Medical University; Southwest Medical University	Lin, J (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Neurol, Wenzhou, Zhejiang, Peoples R China.; Luo, H (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China.	22350277@qq.com; lzlh@sina.com	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		Deyang City Science and Technology Research Foundation [2015SZ064]	Deyang City Science and Technology Research Foundation	This study was supported by the Deyang City Science and Technology Research Foundation (Grant No. 2015SZ064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran-Sarmiento E, 2016, AM J CANCER RES, V6, P341; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Borow KM, 2015, ATHEROSCLEROSIS, V242, P357, DOI 10.1016/j.atherosclerosis.2015.07.035; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; de Bray JM, 1998, CEREBROVASC DIS, V8, P273, DOI 10.1159/000015865; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fang YC, 2006, J CEREBR BLOOD F MET, V26, P491, DOI 10.1038/sj.jcbfm.9600205; Fritsche E, 2001, J PHARMACOL EXP THER, V299, P468; Gardener H, 2011, STROKE, V42, P889, DOI 10.1161/STROKEAHA.110.591065; Gronholdt MLM, 1997, EUR J VASC ENDOVASC, V14, P439, DOI 10.1016/S1078-5884(97)80121-9; Han SW, 2007, EUR NEUROL, V57, P96, DOI 10.1159/000098059; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165, DOI 10.1177/15910199000060S125; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee C, 2008, CLIN PHARMACOL THER, V83, P52, DOI 10.1038/sj.clpt.6100221; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Mahajan CN, 2015, PEDIATR RES, V77, P455, DOI 10.1038/pr.2014.209; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Nakayama T, 2000, AM J HYPERTENS, V13, P1263, DOI 10.1016/S0895-7061(00)01216-4; Oliveira J, 2015, J STROKE CEREBROVASC, V24, P1817, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.018; Orbe J, 2006, CLIN CHIM ACTA, V368, P138, DOI 10.1016/j.cca.2005.12.019; Park SA, 2009, BMB REP, V42, P200, DOI 10.5483/BMBRep.2009.42.4.200; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Shao JX, 2015, CURR NEUROVASC RES, V12, P15, DOI 10.2174/1567202612666150102125221; Shao MJ, 2015, J FORMOS MED ASSOC, V114, P422, DOI 10.1016/j.jfma.2013.12.004; Wang S, 2003, AM J EPIDEMIOL, V158, P899, DOI 10.1093/aje/kwg233; Yi XY, 2016, J ATHEROSCLER THROMB, V23, P330, DOI 10.5551/jat.31120; Yi XY, 2017, J STROKE CEREBROVASC, V26, P1128, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.032; Yi XY, 2016, J NEUROL, V263, P1612, DOI 10.1007/s00415-016-8181-5; Yi XY, 2016, J ATHEROSCLER THROMB, V23, P621, DOI 10.5551/jat.32714; Yi XY, 2015, J ATHEROSCLER THROMB, V22, P1148, DOI 10.5551/jat.29025; Yi XY, 2014, J STROKE CEREBROVASC, V23, P1975, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.022; Yi XY, 2013, J ATHEROSCLER THROMB, V20, P65, DOI 10.5551/jat.14092; Zhao J, 2013, NEUROL SCI, V34, P1791, DOI 10.1007/s10072-013-1340-x	41	20	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180704	10.1371/journal.pone.0180704	http://dx.doi.org/10.1371/journal.pone.0180704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704403	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600045
J	Meyer, AJ; Patten, C; Fregly, BJ				Meyer, Andrew J.; Patten, Carolynn; Fregly, Benjamin J.			Lower extremity EMG-driven modeling of walking with automated adjustment of musculoskeletal geometry	PLOS ONE			English	Article							KNEE ADDUCTION MOMENT; JOINT MOMENTS; MUSCLE FORCES; LOWER-LIMB; HUMAN GAIT; CONTACT FORCE; PARAMETERS; MECHANICS; REHABILITATION; OSTEOARTHRITIS	Neuromusculoskeletal disorders affecting walking ability are often difficult to manage, in part due to limited understanding of how a patient's lower extremity muscle excitations contribute to the patient's lower extremity joint moments. To assist in the study of these disorders, researchers have developed electromyography (EMG) driven neuromusculoskeletal models utilizing scaled generic musculoskeletal geometry. While these models can predict individual muscle contributions to lower extremity joint moments during walking, the accuracy of the predictions can be hindered by errors in the scaled geometry. This study presents a novel EMG-driven modeling method that automatically adjusts surrogate representations of the patient's musculoskeletal geometry to improve prediction of lower extremity joint moments during walking. In addition to commonly adjusted neuromusculoskeletal model parameters, the proposed method adjusts model parameters defining muscle-tendon lengths, velocities, and moment arms. We evaluated our EMG-driven modeling method using data collected from a high-functioning hemiparetic subject walking on an instrumented treadmill at speeds ranging from 0.4 to 0.8 m/s. EMG-driven model parameter values were calibrated to match inverse dynamic moments for five degrees of freedom in each leg while keeping musculoskeletal geometry close to that of an initial scaled musculoskeletal model. We found that our EMG-driven modeling method incorporating automated adjustment of musculoskeletal geometry predicted net joint moments during walking more accurately than did the same method without geometric adjustments. Geometric adjustments improved moment prediction errors by 25% on average and up to 52%, with the largest improvements occurring at the hip. Predicted adjustments to musculoskeletal geometry were comparable to errors reported in the literature between scaled generic geometric models and measurements made from imaging data. Our results demonstrate that with appropriate experimental data, joint moment predictions for walking generated by an EMG-driven model can be improved significantly when automated adjustment of musculoskeletal geometry is included in the model calibration process.	[Meyer, Andrew J.; Fregly, Benjamin J.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Patten, Carolynn] Univ Florida, Dept Phys Therapy, Gainesville, FL USA; [Patten, Carolynn] Malcom Randall VA Med Ctr, Neural Control Movement Lab, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Fregly, BJ (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	fregly@ufl.edu	Fregly, Benjamin J./AAP-8377-2020; Patten, Carolynn/B-4804-2009	Fregly, Benjamin J./0000-0003-1166-4358; Patten, Carolynn/0000-0002-9948-0045; Meyer, Andrew/0000-0003-4544-1064	Directorate For Engineering [1404767] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Aisen ML, 2011, LANCET NEUROL, V10, P844, DOI 10.1016/S1474-4422(11)70176-4; Amarantini D, 2004, J BIOMECH, V37, P1393, DOI 10.1016/j.jbiomech.2003.12.020; AN KN, 1984, J BIOMECH ENG-T ASME, V106, P280, DOI 10.1115/1.3138494; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Barrios JA, 2010, J BIOMECH, V43, P2208, DOI 10.1016/j.jbiomech.2010.03.040; Bogey RA, 2005, IEEE T NEUR SYS REH, V13, P302, DOI 10.1109/TNSRE.2005.851768; Buchanan TS, 2005, MED SCI SPORT EXER, V37, P1911, DOI 10.1249/01.mss.0000176684.24008.6f; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Cronin NJ, 2015, NEUROSCIENCE, V300, P19, DOI 10.1016/j.neuroscience.2015.05.003; De Groote F, 2012, COMPUT METHOD BIOMEC, V15, P1093, DOI 10.1080/10255842.2011.571679; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Doorenbosch CAM, 2003, CLIN BIOMECH, V18, P142, DOI 10.1016/S0268-0033(02)00183-3; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Fregly BJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-18; Gardinier ES, 2013, GAIT POSTURE, V38, P1051, DOI 10.1016/j.gaitpost.2013.03.014; Gerus P, 2010, ANN BIOMED ENG, V38, P2406, DOI 10.1007/s10439-010-9987-4; Gill P.R., 1981, LEVENBERG MARQUARDT; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; HE JP, 1991, IEEE T AUTOMAT CONTR, V36, P322, DOI 10.1109/9.73565; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Kellis E, 1997, EUR J APPL PHYSIOL O, V76, P253, DOI 10.1007/s004210050244; Kumar D, 2012, J ORTHOP RES, V30, P377, DOI 10.1002/jor.21544; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Manal K, 2003, J BIOMECH, V36, P1197, DOI 10.1016/S0021-9290(03)00152-0; Menegaldo LL, 2004, J BIOMECH, V37, P1447, DOI 10.1016/j.jbiomech.2003.12.017; Meyer AJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00077; Meyer AJ, 2013, J ORTHOP RES, V31, P921, DOI 10.1002/jor.22304; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Mulroy SJ, 2010, PHYS THER, V90, P209, DOI 10.2522/ptj.20090141; OLNEY SJ, 1985, J BIOMECH, V18, P9, DOI 10.1016/0021-9290(85)90041-7; Perotto A, 2005, ANATOMICAL GUIDE FOR; Prieto-Alhambra D., 2013, ANN RHEUM DIS; Racinais S, 2013, J CLIN NEUROPHYSIOL, V30, P415, DOI 10.1097/WNP.0b013e31829ddcf1; Reinbolt JA, 2007, IEEE T BIO-MED ENG, V54, P782, DOI 10.1109/TBME.2006.889187; Sartori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052618; Sartori M, 2012, J BIOMECH, V45, P595, DOI 10.1016/j.jbiomech.2011.10.040; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2008, GAIT POSTURE, V28, P358, DOI 10.1016/j.gaitpost.2008.05.002; Sherman MA, 2013, 9 INT C MULT SYST B, V7B; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Simonsen EB, 2012, EXP BRAIN RES, V219, P163, DOI 10.1007/s00221-012-3075-y; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Tsai LC, 2012, MED SCI SPORT EXER, V44, P305, DOI 10.1249/MSS.0b013e31822dfdb3; WALKER PS, 1988, J BIOMECH, V21, P965, DOI 10.1016/0021-9290(88)90135-2; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	55	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179698	10.1371/journal.pone.0179698	http://dx.doi.org/10.1371/journal.pone.0179698			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700708	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400005
J	Watson, T; Andrews, N; Davis, S; Bugeon, L; Dallman, MD; McGinty, J				Watson, Thomas; Andrews, Natalie; Davis, Samuel; Bugeon, Laurence; Dallman, Margaret D.; McGinty, James			OPTiM: Optical projection tomography integrated microscope using open-source hardware and software	PLOS ONE			English	Article								We describe the implementation of an OPT plate to perform optical projection tomography (OPT) on a commercial wide-field inverted microscope, using our open-source hardware and software. The OPT plate includes a tilt adjustment for alignment and a stepper motor for sample rotation as required by standard projection tomography. Depending on magnification requirements, three methods of performing OPT are detailed using this adaptor plate: a conventional direct OPT method requiring only the addition of a limiting aperture behind the objective lens; an external optical-relay method allowing conventional OPT to be performed at magnifications >4x; a remote focal scanning and region-of-interest method for improved spatial resolution OPT (up to similar to 1.6 mu m). All three methods use the microscope's existing incoherent light source (i.e. arc-lamp) and all of its inherent functionality is maintained for day-to-day use. OPT acquisitions are performed on in vivo zebrafish embryos to demonstrate the implementations' viability.	[Watson, Thomas; Andrews, Natalie; Davis, Samuel; McGinty, James] Imperial Coll, Dept Phys, Photon Grp, London, England; [Bugeon, Laurence; Dallman, Margaret D.] Imperial Coll, Dept Life Sci, London, England	Imperial College London; Imperial College London	Watson, T (corresponding author), Imperial Coll, Dept Phys, Photon Grp, London, England.	tjw310@ic.ac.uk		Davis, Samuel/0000-0002-0871-8880; Bugeon, Laurence/0000-0002-6978-2878	UK Biotechnology and Biological Sciences Research Council [BBSRC BB/L018039/1]; UK Engineering and Physical Sciences Research Council (EPSRC) and Natalie Andrews an EPSRC Doctoral Prize Fellowship; Biotechnology and Biological Sciences Research Council [BB/L018039/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1380916] Funding Source: researchfish; BBSRC [BB/L018039/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council (EPSRC) and Natalie Andrews an EPSRC Doctoral Prize Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC BB/L018039/1). Thomas Watson and Samuel Davis acknowledge Ph.D. studentships from the UK Engineering and Physical Sciences Research Council (EPSRC) and Natalie Andrews an EPSRC Doctoral Prize Fellowship.	[Anonymous], ZEISS LIGHTSH Z1 PRO; Chan KG, 2016, I S BIOMED IMAGING, P253, DOI 10.1109/ISBI.2016.7493257; Chen LL, 2014, BIOMED OPT EXPRESS, V5, P3367, DOI 10.1364/BOE.5.003367; Edelstein Arthur D, 2014, J Biol Methods, V1; Engelbrecht CJ, 2006, OPT LETT, V31, P1477, DOI 10.1364/OL.31.001477; Farrell D, RADON TRANSFORM; Fauver M, 2005, OPT EXPRESS, V13, P4210, DOI 10.1364/OPEX.13.004210; George N, SPINNING DISK VS LAS; Gualda EJ, 2013, NAT METHODS, V10, P599, DOI 10.1038/nmeth.2508; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; KIKUCHI S, 1994, OPT COMMUN, V107, P432, DOI 10.1016/0030-4018(94)90361-1; Miao Q, 2010, OPT LETT, V35, P3363, DOI 10.1364/OL.35.003363; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073491	15	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180309	10.1371/journal.pone.0180309	http://dx.doi.org/10.1371/journal.pone.0180309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700724	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649400012
J	Banshodani, M; Kawanishi, H; Fukuma, S; Moriishi, M; Shintaku, S; Tsuchiya, S				Banshodani, Masataka; Kawanishi, Hideki; Fukuma, Shingo; Moriishi, Misaki; Shintaku, Sadanori; Tsuchiya, Shinichiro			The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; NOCTURNAL HEMODIALYSIS; CONVENTIONAL HEMODIALYSIS; INTERDIALYTIC INTERVALS; FREQUENT HEMODIALYSIS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; BLOOD-PRESSURE; HEART-RATE; LONG-TERM	There have been no studies as yet that have evaluated how hemodialysis (HD) schedules affect the day of the week of hospitalization for cardiovascular diseases (CVDs) and infectious diseases (IDs), over a period of time. Herein, we performed a retrospective observational cohort study (1995 -2014) evaluating 11,111 hospitalizations in 1,953 patients with end-stage renal disease, receiving HD 3 times a week (following either a Monday-Wednesday-Friday [MWF] schedule or a Tuesday-Thursday-Saturday [TTS] schedule) or receiving frequent HD (FHD) at least 4 times a week. Overall, hospitalization rates for CVDs and IDs were the highest on Monday in the MWF schedule and Tuesday in the TTS schedule compared to the average rates for all the days of the week. When generalized estimating equations (GEEs) were used in conjunction with robust variance estimators of each type of CVD, the risk for pulmonary edema was found to be significantly higher on Sunday and Monday in the MWF schedule and Monday and Tuesday in the TTS schedule. For both cerebrovascular and ischemic heart disease, the risks were significantly higher on Tuesday in the MWF schedule and Wednesday in the TTS schedule. Moreover, there were significant differences in the day of the week risks among the various CVD types. On trend analysis, the overall hospitalization rate for CVDs on the first HD day did not decrease (P = 0.2); however, the hospitalization rate for IDs on the first HD day significantly decreased (P = 0.02) over a span of 20 years. When GEEs were used in the case of FHD patients with severe heart failure, the hospitalization rate on the first HD day (Monday) significantly decreased after FHD initiation (P = 0.04). It was found that HD schedules affected the day of the week of hospitalization for CVDs. FHD may lower the day of the week risk.	[Banshodani, Masataka; Kawanishi, Hideki; Moriishi, Misaki; Shintaku, Sadanori; Tsuchiya, Shinichiro] Tsuchiya Gen Hosp, Akane Fdn, Dept Artificial Organs, Hiroshima, Japan; [Kawanishi, Hideki] Hiroshima Univ, Fac Med, Hiroshima, Japan; [Fukuma, Shingo] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan	Hiroshima University; Kyoto University	Kawanishi, H (corresponding author), Tsuchiya Gen Hosp, Akane Fdn, Dept Artificial Organs, Hiroshima, Japan.; Kawanishi, H (corresponding author), Hiroshima Univ, Fac Med, Hiroshima, Japan.	h-kawanishi@tsuchiya-hp.jp		Fukuma, Shingo/0000-0002-8379-8761				Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Bonomini V, 1972, Proc Eur Dial Transplant Assoc, V9, P44; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Chan C, 2002, NEPHROL DIAL TRANSPL, V17, P1518, DOI 10.1093/ndt/17.8.1518; Chan CT, 2014, NEPHROL DIAL TRANSPL, V29, P168, DOI 10.1093/ndt/gft212; Chan CT, 2013, CLIN J AM SOC NEPHRO, V8, P2106, DOI 10.2215/CJN.03280313; Chan CT, 2005, KIDNEY INT, V68, P338, DOI 10.1111/j.1523-1755.2005.00411.x; Chan CT, 2004, KIDNEY INT, V65, P661, DOI 10.1111/j.1523-1755.2004.00384.x; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dalrymple LS, 2010, AM J KIDNEY DIS, V56, P522, DOI 10.1053/j.ajkd.2010.04.016; Flythe JE, 2011, KIDNEY INT, V79, P250, DOI 10.1038/ki.2010.383; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Fotheringham J, 2015, KIDNEY INT, V88, P569, DOI 10.1038/ki.2015.141; Hanafusa N, 2011, KIDNEY INT S, V5, P15; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Johansen KL, 2009, KIDNEY INT, V76, P984, DOI 10.1038/ki.2009.291; KALANTARZADEH K, 2009, CIRCULATION, V119, P671, DOI [DOI 10.1097/01.ASN.0000043141.67989.39, DOI 10.1161/CIRCULATI0NAHA.108.807362]; Kjellstrand CM, 1978, KIDNEY INT S, pS120; Krishnasamy R, 2013, AM J KIDNEY DIS, V61, P96, DOI 10.1053/j.ajkd.2012.07.008; Liu FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169203; Obokata M, 2015, AM HEART J, V169, P523, DOI 10.1016/j.ahj.2015.02.003; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P689, DOI 10.1053/j.ajkd.2011.12.020; TESCHAN PE, 1960, ANN INTERN MED, V53, P992, DOI 10.7326/0003-4819-53-5-992; Ting GO, 2003, AM J KIDNEY DIS, V42, P1020, DOI 10.1016/j.ajkd.2003.07.020; Tsilonis K, 2016, AM J KIDNEY DIS, V68, P772, DOI 10.1053/j.ajkd.2016.06.017; Wong MMY, 2017, AM J KIDNEY DIS, V69, P367, DOI 10.1053/j.ajkd.2016.08.030; Woods JD, 1999, KIDNEY INT, V55, P2467, DOI 10.1046/j.1523-1755.1999.00493.x; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x; Zhang H, 2012, KIDNEY INT, V81, P1108, DOI 10.1038/ki.2011.481; Zimmerman DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097135	37	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180577	10.1371/journal.pone.0180577	http://dx.doi.org/10.1371/journal.pone.0180577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700621	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800056
J	Ferreiro, A; Lombardi, R				Ferreiro, Alejandro; Lombardi, Raul			Acute kidney injury after cardiac surgery is associated with mid-term but not long-term mortality: A cohort-based study	PLOS ONE			English	Article							SURGICAL-PATIENTS; RENAL-FUNCTION; RISK-FACTORS; METAANALYSIS; SURVIVAL; OUTCOMES; DISEASE; COSTS; DEATH; AKI	Acute kidney injury (AKI) in cardiac surgery is associated with complications, early and late mortality and increased health care expenditures. The overall dynamic comorbidity-adjusted contributions of an episode of AKI on mortality during long-term follow-up have not been fully explored. A longitudinal cohort of 7075 adult patients admitted for cardiac surgery were enrolled in the study. Follow-up data were obtained through telephonic survey after 1, 5, 10, and 15 years or from the National Mortality Registry. All-cause mortality was assessed at five time intervals: I) 30 days after surgery to 1 year; II) 1 to 3 years; III)3 to 5 years; IV) 5 to 10 years; and V) 10 to 15 years. For the adjustment of mortality for comorbidity and pre-,intra- and postoperative variables, Cox proportional hazard regression models were conducted within each period. The overall incidence of AKI was 36.1%. AKI was an independent predictor of death only during the first five years after surgery ( 30 days to 1 year: HR 1.834, 95% CI 1.459 to 2.306; 1 to 3 years: HR 1.285, 95% CI 1.023 to 1.610; and 3 to five years: HR 1.330, 95% CI 1.123 to 1.750). Only age, diabetes mellitus and CHF were associated with increased risk of death over the entire follow-up period. Our study demonstrates a transient association of AKI with long-term mortality that progressively decreases and vanishes five years after surgery. The knowledge of this dynamic is crucial to understanding this complex association, planning health care and allocating resources.	[Ferreiro, Alejandro; Lombardi, Raul] Univ Republica, Ctr Nefrol, Montevideo, Uruguay; [Ferreiro, Alejandro; Lombardi, Raul] Inst Nacl Cirugia Cardiaca, Montevideo, Uruguay; [Lombardi, Raul] Serv Med Integral, Dept Med Crt, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Lombardi, R (corresponding author), Univ Republica, Ctr Nefrol, Montevideo, Uruguay.; Lombardi, R (corresponding author), Inst Nacl Cirugia Cardiaca, Montevideo, Uruguay.; Lombardi, R (corresponding author), Serv Med Integral, Dept Med Crt, Montevideo, Uruguay.	lombardi.raul2@gmail.com		Lombardi, Raul/0000-0002-2398-794X				Abstract, 2012, KIDNEY INT S; Aronson S, 2007, CIRCULATION, V115, P733, DOI 10.1161/CIRCULATIONAHA.106.623538; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Corredor C, 2016, J CARDIOTHOR VASC AN, V30, P69, DOI 10.1053/j.jvca.2015.07.013; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; Gallaher S, 2014, THORAC CARDIOVASC SU, V147, P989; Haase M, 2007, CONTRIB NEPHROL, V156, P340; Hansen MK, 2015, J CARDIOTHOR VASC AN, V29, P617, DOI 10.1053/j.jvca.2014.08.020; Hansen MK, 2013, CRIT CARE, V17, DOI 10.1186/cc13158; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lombardi R, 2008, RENAL FAILURE, V30, P155, DOI 10.1080/08860220701808129; Lopez-Delgado JC, 2013, CRIT CARE, V17, DOI 10.1186/cc13159; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; O'Neal JB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1352-z; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Sawhney S, AM J KIDNEY DIS; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331	26	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181158	10.1371/journal.pone.0181158	http://dx.doi.org/10.1371/journal.pone.0181158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700753	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800128
J	Huang, XYN; Ribeiro, JD; Musacchio, KM; Franklin, JC				Huang, Xieyining; Ribeiro, Jessica D.; Musacchio, Katherine M.; Franklin, Joseph C.			Demographics as predictors of suicidal thoughts and behaviors: A meta-analysis	PLOS ONE			English	Article							PUBLICATION BIAS; RISK-FACTORS; EFFECT SIZE; FOLLOW-UP; PREVALENCE; IDEATION; PERSONALITY; MORTALITY; RELIGION; DIVORCE	Background Certain demographic factors have long been cited to confer risk or protection for suicidal thoughts and behaviors. However, many studies have found weak or non-significant effects. Determining the effect strength and clinical utility of demographics as predictors is crucial for suicide risk assessment and theory development. As such, we conducted a meta-analysis to determine the effect strength and clinical utility of demographics as predictors. Methods We searched PsycInfo, PubMed, and GoogleScholar for studies published before January 1st, 2015. Inclusion criteria required that studies use at least one demographic factor to longitudinally predict suicide ideation, attempt, or death. The initial search yielded 2,541 studies, 159 of which were eligible. A total of 752 unique statistical tests were included in analysis. Results Suicide death was the most commonly studied outcome, followed by attempt and ideation. The average follow-up length was 9.4 years. The overall effects of demographic factors studied in the field as risk factors were significant but weak, and that of demographic factors studied as protective factors were non-significant. Adjusting for publication bias further reduced effect estimates. No specific demographic factors appeared to be strong predictors. The effects were consistent across multiple moderators. Conclusions At least within the narrow methodological constraints of the existing literature, demographic factors were statistically significant risk factors, but not protective factors. Even as risk factors, demographics offer very little improvement in predictive accuracy. Future studies that go beyond the limitations of the existing literature are needed to further understand the effects of demographics.	[Huang, Xieyining; Ribeiro, Jessica D.; Musacchio, Katherine M.; Franklin, Joseph C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Ribeiro, Jessica D.] Mil Suicide Res Consortium, Tallahassee, FL USA	State University System of Florida; Florida State University	Huang, XYN (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	huang@psy.fsu.edu	Ribeiro, Jessica/AAN-7502-2021		Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181]; National Institute of Mental Health (NIH) [T32MH18921]	Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs; National Institute of Mental Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by funding from the Military Suicide Research Consortium (MSRC; msrc.fsu.edu), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs (Award No. W81XWH-10-2-0181). This work was also supported in part through a training grant (T32MH18921) from the National Institute of Mental Health (NIH; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies.	Angst J, 1998, J AFFECT DISORDERS, V51, P55, DOI 10.1016/S0165-0327(98)00156-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blosnich JR, 2013, AM J PUBLIC HEALTH, V103, pE27, DOI 10.2105/AJPH.2013.301507; Borenstein M., 2009, INTRO METAANALYSIS; Centers for Disease Control and Prevention, 2016, SUICIDE RISK AND PRO; Cha CB, ACCOUNTING DIVERSITY; Chan LF, 2014, PSYCHIAT RES, V220, P867, DOI 10.1016/j.psychres.2014.08.055; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Corcoran P, 2010, SOC PSYCH PSYCH EPID, V45, P795, DOI 10.1007/s00127-009-0120-7; CULLBERG J, 1988, ACTA PSYCHIAT SCAND, V77, P598, DOI 10.1111/j.1600-0447.1988.tb05173.x; Dekovic M, 1999, J YOUTH ADOLESCENCE, V28, P667, DOI 10.1023/A:1021635516758; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eynan R, 2002, SUICIDE LIFE-THREAT, V32, P418, DOI 10.1521/suli.32.4.418.22341; HOYER G, 1993, ARCH GEN PSYCHIAT, V50, P134; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Kaplan KJ, 2012, SUICIDE LIFE-THREAT, V42, P614, DOI 10.1111/j.1943-278X.2012.00116.x; Kessler RC, 2005, TRENDS SUICIDE IDEAT, V293, P1990; Kposowa AJ, 2001, PSYCHOL MED, V31, P127, DOI 10.1017/S0033291799002925; Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Loas G, 2009, PSYCHOPATHOLOGY, V42, P185, DOI 10.1159/000209331; Lukaschek K, 2014, BRIT J PSYCHIAT, V205, P398, DOI 10.1192/bjp.bp.113.139352; LUTHAR SS, 1993, J CHILD PSYCHOL PSYC, V34, P441, DOI 10.1111/j.1469-7610.1993.tb01030.x; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; O'Connor RC, 2013, J CONSULT CLIN PSYCH, V81, P1137, DOI 10.1037/a0033751; Okamura T, 2014, SOC PSYCH PSYCH EPID, V49, P573, DOI 10.1007/s00127-013-0791-y; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Panczak R, 2013, SUICIDE LIFE-THREAT, V43, P213, DOI 10.1111/sltb.12009; Platt B, 2010, OCCUP MED-OXFORD, V60, P436, DOI 10.1093/occmed/kqq044; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Rahman A, 2003, ACTA PSYCHIAT SCAND, V108, P392, DOI 10.1034/j.1600-0447.2003.00220.x; Rahman S, 2014, PLOS ONE, V9; Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X; Rasic DT, 2009, J AFFECT DISORDERS, V114, P32, DOI 10.1016/j.jad.2008.08.007; Ribeiro JD, 2016, PSYCHOL MED, V46, P2009, DOI 10.1017/S0033291716000611; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Russell ST, 2001, AM J PUBLIC HEALTH, V91, P1276, DOI 10.2105/AJPH.91.8.1276; Sauvola A, 2001, EUR J PUBLIC HEALTH, V11, P284, DOI 10.1093/eurpub/11.3.284; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Shneidman ES, 1998, SUICIDE LIFE-THREAT, V28, P245; SHNEIDMAN ES, 1993, J NERV MENT DIS, V181, P145, DOI 10.1097/00005053-199303000-00001; Shneidman ES, 1999, PERTURBATION LETHALI; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Soloff PH, 2012, AM J PSYCHIAT, V169, P484, DOI 10.1176/appi.ajp.2011.11091378; STACK S, 1990, SOCIOL QUART, V31, P359, DOI 10.1111/j.1533-8525.1990.tb00333.x; TROVATO F, 1987, J MARRIAGE FAM, V49, P193, DOI 10.2307/352683; Tyssen R, 2001, PHYSIOL REV, V11, P10; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428; VEVEA JL, 1995, PSYCHOMETRIKA, V60, P419, DOI 10.1007/BF02294384; Votta E, 2004, J ADOLESCENT HEALTH, V34, P237, DOI 10.1016/j.jadohealth.2003.06.002; Wells K, 2009, RES SOCIAL WORK PRAC, V19, P52, DOI 10.1177/1049731508317278; World Health Organization, 2016, SUICIDE; Wyder M, 2009, J AFFECT DISORDERS, V116, P208, DOI 10.1016/j.jad.2008.11.007	61	49	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180793	10.1371/journal.pone.0180793	http://dx.doi.org/10.1371/journal.pone.0180793			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700728	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800077
J	Pervez, Z; Ahmad, M; Khattak, AM; Ramzan, N; Khan, WA				Pervez, Zeeshan; Ahmad, Mahmood; Khattak, Asad Masood; Ramzan, Naeem; Khan, Wajahat Ali			OS2: Oblivious similarity based searching for encrypted data outsourced to an untrusted domain	PLOS ONE			English	Article							PRIVACY	Public cloud storage services are becoming prevalent and myriad data sharing, archiving and collaborative services have emerged which harness the pay-as-you-go business model of public cloud. To ensure privacy and confidentiality often encrypted data is outsourced to such services, which further complicates the process of accessing relevant data by using search queries. Search over encrypted data schemes solve this problem by exploiting cryptographic primitives and secure indexing to identify outsourced data that satisfy the search criteria. Almost all of these schemes rely on exact matching between the encrypted data and search criteria. A few schemes which extend the notion of exact matching to similarity based search, lack realism as those schemes rely on trusted third parties or due to increase storage and computational complexity. In this paper we propose Oblivious Similarity based Search (OS2) for encrypted data. It enables authorized users to model their own encrypted search queries which are resilient to typographical errors. Unlike conventional methodologies, OS2 ranks the search results by using similarity measure offering a better search experience than exact matching. It utilizes encrypted bloom filter and probabilistic homomorphic encryption to enable authorized users to access relevant data without revealing results of search query evaluation process to the untrusted cloud service provider. Encrypted bloom filter based search enables OS2 to reduce search space to potentially relevant encrypted data avoiding unnecessary computation on public cloud. The efficacy of OS2 is evaluated on Google App Engine for various bloom filter lengths on different cloud configurations.	[Pervez, Zeeshan; Ramzan, Naeem] Univ West Scotland, Sch Engn & Comp, Paisley PA1 2BE, Renfrew, Scotland; [Ahmad, Mahmood; Khan, Wajahat Ali] Kyung Hee Univ, Dept Comp Engn, Ubiquitous Comp Lab, Global Campus,1 Seocheon Dong, Yongin 446701, Gyeonggi Do, South Korea; [Khattak, Asad Masood] Zayed Univ, Coll Technol Innovat, Abu Dhabi Campus, Abu Dhabi, U Arab Emirates	University of West Scotland; Kyung Hee University; Zayed University	Khan, WA (corresponding author), Kyung Hee Univ, Dept Comp Engn, Ubiquitous Comp Lab, Global Campus,1 Seocheon Dong, Yongin 446701, Gyeonggi Do, South Korea.	wajahat.alikhan@oslab.khu.ac.kr	Ahmad, Raye Mahmood/AAF-1016-2022; Khan, Wajahat Ali/AAG-8299-2020; Ahmad, Raye Mahmood/AFF-8422-2022	PERVEZ, Zeeshan/0000-0002-3618-779X; Ramzan, Naeem/0000-0002-5088-1462; Khan, Wajahat Ali/0000-0003-4118-7855	Kyung Hee University [KHU-20170427]; Zayed University Research Cluster Award [R16086]	Kyung Hee University; Zayed University Research Cluster Award	This work was supported by a grant from Kyung Hee University in 2017 (KHU-20170427). Part of this research was also supported by Zayed University Research Cluster Award (R16086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asharov G, 2016, ACM S THEORY COMPUT, P1101, DOI 10.1145/2897518.2897562; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Boldyreva A, 2015, LECT NOTES COMPUT SC, V8540, P613, DOI 10.1007/978-3-662-46706-0_31; Boneh D, 2003, PUBLIC KEY ENCRYPTIO; Cao N, 2014, IEEE T PARALL DISTR, V25, P222, DOI 10.1109/TPDS.2013.45; Cash D, 2013, LECT NOTES COMPUT SC, V8042, P353, DOI 10.1007/978-3-642-40041-4_20; Chang RM, 2014, DECIS SUPPORT SYST, V63, P67, DOI 10.1016/j.dss.2013.08.008; Chang YC, 2005, LECT NOTES COMPUT SC, V3531, P442; Cheng R., 2015, P 10 ACM S INFORM CO, P621, DOI DOI 10.1145/2714576.2714623; Curtmola R, 2006, SEARCHABLE SYMMETRIC; Dong X, 2014, COMPUT SECUR, V42, P151, DOI 10.1016/j.cose.2013.12.002; Goh E-J., 2003, IACR CRYPTOLOGY EPRI, DOI DOI 10.1145/1183081.1183087; Goldreich O, 1995, FDN CRYPTOGRAPHY; Hacigumus H, 2002, P 2002 ACM SIGMOD IN, DOI DOI 10.1145/564691.564717; Hahn F, 2014, CCS'14: PROCEEDINGS OF THE 21ST ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P310, DOI 10.1145/2660267.2660297; Harrower W., 2009, EARCHING ENCRYPTED D; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Ishai Y, 2016, P CT RSA, p90 , DOI DOI 10.1007/978-3-319-29485-8_6; Kamara S, 2011, MSRTR201158 MICR; Kamara S, 2010, LECT NOTES COMPUT SC, V6054, P136, DOI 10.1007/978-3-642-14992-4_13; Kambatla K, 2014, J PARALLEL DISTR COM, V74, P2561, DOI 10.1016/j.jpdc.2014.01.003; Kandukuri BR, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON SERVICES COMPUTING, P517, DOI 10.1109/SCC.2009.84; Kuzu M, 2012, PROC INT CONF DATA, P1156, DOI 10.1109/ICDE.2012.23; Li J., 2010, I ATMOS PHYS CHIN AC, P1, DOI DOI 10.1109/INFCOM.2010.5462196; Li J, 2013, FUTURE GENER COMP SY; Li M, 2011, INT CON DISTR COMP S, P383, DOI 10.1109/ICDCS.2011.55; Manyika J., 2011, BIG DATA NEXT FRONTI; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Park KW, 2013, IEEE T SERV COMPUT, V6, P300, DOI 10.1109/TSC.2012.1; Pearson S., 2010, 2 IEEE INT C CLOUD C, P693, DOI DOI 10.1109/CLOUDCOM.2010.66; Pervez Z, 2013, J SUPERCOMPUT, V63, P538, DOI 10.1007/s11227-012-0829-z; Pota M, 2014, KNOWL-BASED SYST, V67, P1, DOI 10.1016/j.knosys.2014.06.021; Roche K, 2009, BEGINNING JAVA GOOGL; Sakr S., 2012, 2012 IEEE 5th International Conference on Cloud Computing (CLOUD), P360, DOI 10.1109/CLOUD.2012.11; Singh A, 2009, ACM T WEB, V3, DOI 10.1145/1594173.1594175; Song DX, 2000, SP 00, p44 ; Sun W., 2013, P 8 ACM SIGSAC S INF, P71, DOI DOI 10.1145/2484313.2484322; Tang Q., 2012, IACR CRYPTOLOGY EPRI; Wang C, 2010, INT CON DISTR COMP S, DOI 10.1109/ICDCS.2010.34; Wei LF, 2014, INFORM SCIENCES, V258, P371, DOI 10.1016/j.ins.2013.04.028; Yang ZQ, 2006, LECT NOTES COMPUT SC, V4189, P479; Yu SC, 2010, IEEE INFOCOM SER, DOI 10.1109/INFCOM.2010.5462174	42	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179720	10.1371/journal.pone.0179720	http://dx.doi.org/10.1371/journal.pone.0179720			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692697	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800014
J	Bartel, A; Gohler, A; Hopf, V; Breitbach, K				Bartel, Alexander; Goehler, Andre; Hopf, Verena; Breitbach, Katrin			Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-DEATH; IN-VITRO; ACTIVATION; APOPTOSIS; SURVIVAL; IMMUNITY; INTERLEUKIN-10; MELIOIDOSIS; INTERFERON	Caspase-6 is a member of the executioner caspases and known to play a role in innate and adaptive immune processes. However, its role in infectious diseases has rarely been addressed yet. We here examined the impact of caspase-6 in an in vivo infection model using the Gram-negative rod Burkholderia pseudomallei, causing the infectious disease melioidosis that is endemic in tropical and subtropical areas around the world. Caspase-6(-/-) and C57BL/6 wild type mice were challenged with B. pseudomallei for comparing mortality, bacterial burden and inflammatory cytokine expression. Bone-marrow derived macrophages were used to analyse the bactericidal activity in absence of caspase-6. Caspase-6 deficiency was associated with higher mortality and bacterial burden in vivo after B. pseudomallei infection. The bactericidal activity of caspase-6(-/-)macrophages was impaired compared to wild type cells. Caspase-6(-/-)mice showed higher expression of the IL-1 beta gene, known to be detrimental in murine melioidosis. Expression of the IL-10 gene was also increased in caspase6(-/-)mice as early as 6 hours after infection. Treatment with exogenous IL-10 rendered mice more susceptible against B. pseudomallei challenge. Thus, caspase-6 seems to play a crucial role for determining resistance against the causative agent of melioidosis. To our knowledge this is the first report showing that caspase-6 is crucial for mediating resistance in an in vivo infection model. Caspase-6 influences the expression of detrimental cytokines and therefore seems to be important for achieving a well-balanced immune response that contributes for an efficient elimination of the pathogen.	[Bartel, Alexander; Goehler, Andre; Hopf, Verena; Breitbach, Katrin] Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany; [Hopf, Verena] Fzmb GmbH, Res Ctr Med Technol & Biotechnol, Bad Langensalza, Germany; [Breitbach, Katrin] Schon Klin Bad Bramstedt, Bad Bramstedt, Germany	Friedrich Loeffler Institute; Greifswald Medical School	Breitbach, K (corresponding author), Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany.; Breitbach, K (corresponding author), Schon Klin Bad Bramstedt, Bad Bramstedt, Germany.	breitbach.katrin@gmail.com	Goehler, André/AAZ-7067-2020	Goehler, André/0000-0002-4006-3511; Bartel, Alexander/0000-0002-1280-6138				Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Breitbach K, 2009, INFECT IMMUN, V77, P1589, DOI 10.1128/IAI.01257-08; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Eske K, 2009, J IMMUNOL METHODS, V342, P13, DOI 10.1016/j.jim.2008.11.011; Gafni J, 2012, J NEUROSCI, V32, P7454, DOI 10.1523/JNEUROSCI.6379-11.2012; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Nyormoi O, 2001, MOL CELL BIOL, V21, P4856, DOI 10.1128/MCB.21.15.4856-4867.2001; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Schmeck B, 2004, INFECT IMMUN, V72, P4940, DOI 10.1128/IAI.72.9.4940-4947.2004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tattoli I, 2008, MICROBES INFECT, V10, P1114, DOI 10.1016/j.micinf.2008.06.004; Tsao CH, 2008, J GEN VIROL, V89, P1930, DOI 10.1099/vir.0.2008/000182-0; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; van Raam BJ, 2013, CELL DEATH DIFFER, V20, P86, DOI 10.1038/cdd.2012.98; Wang XJ, 2015, ANNU REV PHARMACOL, V55, P553, DOI 10.1146/annurev-pharmtox-010814-124414; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180203	10.1371/journal.pone.0180203	http://dx.doi.org/10.1371/journal.pone.0180203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686630	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100039
J	Cassim, H; Otwombe, K; Lazarus, E; Liberty, A; Gray, GE; Greeff, OBW; Violari, A				Cassim, Haseena; Otwombe, Kennedy; Lazarus, Erica; Liberty, Afaaf; Gray, Glenda E.; Greeff, Oppel B. W.; Violari, Avy			A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa	PLOS ONE			English	Article							THERAPY; GROWTH	Introduction The current World Health Organization guideline for first line antiretroviral therapy (ART) in HIV-infected children recommends the use of abacavir and lamivudine as nucleoside backbones and no longer includes stavudine. We compared treatment outcomes with abacavir (ABC) versus stavudine (d4T) in a cohort of HIV-1 infected children 6 and 12 months after antiretroviral therapy was initiated. Methods This was a retrospective case-cohort study, using programmatic data from children enrolled in the Paediatric Wellness Programme at the Perinatal HIV Research Unit in Soweto, South Africa between 2005 and 2013. Children on abacavir/stavudine who had initiated ART at age < 3 years with a regimen including lamivudine and lopinavir/ritonavir and had at least one 6 or 12 month viral load result were eligible. All ABC cases identified were matched for age at ART initiation and gender to eligible d4T controls (1: 2). Outcomes analysed at 6 and 12 months post ART initiation included virological failure, mortality, immunological failure and anthropometry. Chi-square tests compared categorical measures while Kruskal-Wallis compared continuous measures. Results We identified 57 eligible ABC cases and selected 114 matched d4T controls. Overall, 57% were females and 89% started treatment at age < 1year. The median age at ART initiation was 3.11 (IQR: 1.98-6.05) months. There was no difference in the proportion of children virologically suppressed between the groups at 6 (ABC 54.5% vs. d4T 67.0%, p = 0.125) and 12 (ABC 66.7% vs. d4T 71.6%, p = 0.53) months post ART-initiation. The proportion of children with adherence levels > 90% for ABC and d4T were similar too (95% in ABC vs. 86% in d4T, p = 0.10). The proportion of children who died over 12 months was 3.5% in the ABC and 7.9% in the d4T group (p = 0.27). Similarly, the anthropometric measures were comparable. Conclusions It is reassuring that in the short term, in this group of patients, the treatment outcomes were similar.	[Cassim, Haseena; Otwombe, Kennedy; Lazarus, Erica; Liberty, Afaaf; Gray, Glenda E.; Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Gray, Glenda E.] South African Med Res Council, Cape Town, South Africa; [Greeff, Oppel B. W.] Univ Pretoria, Dept Pharmacol, Pretoria, South Africa	University of Witwatersrand; South African Medical Research Council; University of Pretoria	Cassim, H (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa.	cassimh@phru.co.za			South Africa Mission of the US Agency for International Development (USAID) [674-A-0 0-08-00009-00]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069453] Funding Source: NIH RePORTER	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Perinatal HIV Research Unit received funding for their paediatric HIV observational cohort "Paediatric Wellness Programme" from the South Africa Mission of the US Agency for International Development (USAID) under the terms of Cooperative Agreement Number 674-A-0 0-08-00009-00 (HC,KO,EL,AL,GEG,AV). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Adetokunboh OO, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1183-6; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Gsponer T, 2012, PEDIATRICS, V130, pE966, DOI 10.1542/peds.2011-3020; Lancet, 2002, LANCET, V359; Musiime V, 2014, REV ANTIVIRAL THER I, V6; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; Technau K, 2013, POOR EARLY VIROLOGIC; Technau KG, 2014, PEDIATR INFECT DIS J, V33, P617, DOI 10.1097/INF.0000000000000222; UNAIDS, 2014, THE GAP REP; UNICEF, 2015, PAEDIAT TREATM CAR; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; WHO, GLOB UPD HIV TREATM; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organisation, ANT TER HIV INF INF	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180645	10.1371/journal.pone.0180645	http://dx.doi.org/10.1371/journal.pone.0180645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686654	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100085
J	Ran, G; Ying, L; Li, L; Yan, QQ; Yi, WJ; Ying, CJ; Wu, HM; Ye, XL				Ran, Gai; Ying, Li; Li, Lin; Yan, Qiaoqiao; Yi, Weijie; Ying, Chenjiang; Wu, Hongmei; Ye, Xiaolei			Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio)	PLOS ONE			English	Article							INDUCED OBESITY; CALORIE RESTRICTION; HEPATIC STEATOSIS; PPAR-GAMMA; AUTOPHAGY; EXPRESSION; MICE; CAVEOLIN-1; ADIPOCYTES; CELLS	Defective lipid metabolism is associated with increased risk of various chronic diseases, such as obesity, cardiovascular diseases, and diabetes. Resveratrol (RSV), a natural polyphenol, has been shown the potential of ameliorating disregulations of lipid metabolism. The objective of this study was to investigate the effects of feed intake and RSV on lipid metabolism in zebrafish (Danio rerio). The adult males were randomly allocated to 6 groups: control (Con, 8 mg cysts/fish/day), control with 20 ae mol/L RSV (Con+ RSV), calorie restriction (CR, 5 mg cysts/fish/day), calorie restriction with RSV (CR+ RSV), overfeed (OF, 60 mg cysts/fish/day), and overfeed with RSV (OF+ RSV) groups. The treatment period was 8 weeks. Results showed that CR reduced body length, body weight, and condition factor of zebrafish. CR reduced levels of plasma triglyceride (TG) and induced protein expression of phosphorylated AMP-activated protein kinase-a (pAMPK alpha), silent information regulator 2 homolog 1 (Sirt1), and peroxisome proliferator activated receptor gamma coactivator-1a (PGC1 alpha). RSV attenuated CR-induced pAMPKa/AMPKaincreases. RSV increased levels of Sirt1 protein in the OF zebrafish, and decreased OF-induced increase in peroxisome proliferator-activated receptor-gamma (PPAR gamma) protein level. Additionally, RSV down-regulated caveolin-1 and up-regulated microtubule-associated protein 1 light chain 3 -II (LC3-II) protein levels in OF zebrafish. In conclusion, these results suggest that 1) CR reduces plasma TG level through activation of the AMPK alpha-Sirt1-PGC1 alpha pathway; 2) under different dietary stress conditions RSV might regulate AMPK phosphorylation bi-directionally; 3) RSV might regulate lipid metabolism through the AMPK alpha-Sirt1-PPAR. pathway in OF zebrafish.	[Ran, Gai; Li, Lin; Yan, Qiaoqiao; Wu, Hongmei; Ye, Xiaolei] Wenzhou Med Univ, Sch Publ Hlth & Management, Dept Prevent Med, Wenzhou, Peoples R China; [Ying, Li] Wenzhou Med Univ, Sch Stomatol, Wenzhou, Peoples R China; [Yi, Weijie; Ying, Chenjiang] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Nutr & Food Hyg, Tongji Med Coll, Wuhan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Huazhong University of Science & Technology	Wu, HM; Ye, XL (corresponding author), Wenzhou Med Univ, Sch Publ Hlth & Management, Dept Prevent Med, Wenzhou, Peoples R China.	hongmeiwwu@hotmail.com; yexiaolei302@163.com	Ying, Chen/GRX-5695-2022; Ying, Chen Jiang/H-7708-2019	Ying, Chen Jiang/0000-0003-4813-5951	National Natural Science Foundation of China [81273060, 81373007, 81302423]; National Training Programs of Innovation and Entrepreneurship for Undergraduates [201310343013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Training Programs of Innovation and Entrepreneurship for Undergraduates	This work was supported by National Natural Science Foundation of China: Grant No. 81273060; No. 81373007; No. 81302423, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; National Training Programs of Innovation and Entrepreneurship for Undergraduates: Grant No. 201310343013.	Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen ZH, 2014, AM J PHYSIOL-LUNG C, V306, pL1016, DOI 10.1152/ajplung.00268.2013; Choi MS, 2013, EXP DERMATOL, V22, P491, DOI 10.1111/exd.12175; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Earle K.E., 1994, J NUTR, V124, p2616S, DOI [10.1093/jn/, DOI 10.1093/JN]; Echarri A, 2015, J CELL SCI, V128, P2747, DOI 10.1242/jcs.153940; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Joseph AM, 2013, EXP GERONTOL, V48, P858, DOI 10.1016/j.exger.2013.05.061; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; la Fleur SE, 2011, INT J OBESITY, V35, P595, DOI 10.1038/ijo.2010.164; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016; Peng XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113716; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qin L, 2014, ACTA PHARMACOL SIN, V35, P1129, DOI 10.1038/aps.2014.10; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Schirmer H, 2012, MOL BIOL REP, V39, P3281, DOI 10.1007/s11033-011-1096-4; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; Walczak R, 2002, J LIPID RES, V43, P177; Wang BS, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/693573; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Wang SB, 2015, EXPERT REV ENDOCRINO, V10, P561, DOI 10.1586/17446651.2015.1096771; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu YY, 2011, CELL PHYSIOL BIOCHEM, V27, P539, DOI 10.1159/000329955; Zhang Y, 2015, MOL NUTR FOOD RES, V59, P1443, DOI 10.1002/mnfr.201500016	45	34	35	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180865	10.1371/journal.pone.0180865	http://dx.doi.org/10.1371/journal.pone.0180865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686680	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100117
J	Caballero, D; Li, YW; Fetene, J; Ponsetto, J; Chen, A; Zhu, CL; Braddock, DT; Bergwitz, C				Caballero, Daniel; Li, Yuwen; Fetene, Jonathan; Ponsetto, Julian; Chen, Alyssa; Zhu, Chuanlong; Braddock, Demetrios T.; Bergwitz, Clemens			Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice	PLOS ONE			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; SODIUM-PHOSPHATE COTRANSPORTER; GENERALIZED ARTERIAL CALCIFICATION; INORGANIC PYROPHOSPHATE; MINERALIZATION DISORDERS; ECTOPIC MINERALIZATION; URINARY-EXCRETION; STONE FORMERS; HYPERCALCIURIA; OSTEOPONTIN	Mutations in the proximal tubular sodium-dependent phosphate co-transporters NPT2a and NPT2c have been reported in patients with renal stone disease and nephrocalcinosis, however the relative contribution of genotype, dietary calcium and phosphate, and modifiers of mineralization such as pyrophosphate (PPi) to the formation of renal mineral deposits is unclear. In the present study, we used Npt2a(-/-) mice to model the renal calcifications observed in these disorders. We observed elevated urinary excretion of PPi in Npt2a(-/-) mice when compared to WT mice. Presence of two hypomorphic Extracellular nucleotide pyrophosphatase phosphodiesterase 1 (Enpp1(asj/asj)) alleles decreased urine PPi and worsened renal calcifications in Npt2a(-/-) mice. These studies suggest that PPi is a thus far unrecognized factor protecting Npt2a(-/-) mice from the development of renal mineral deposits. Consistent with this conclusion, we next showed that renal calcifications in these mice can be reduced by intraperitoneal administration of sodium pyrophosphate. If confirmed in humans, urine PPi could therefore be of interest for developing new strategies to prevent the nephrocalcinosis and nephrolithiasis seen in phosphaturic disorders.	[Caballero, Daniel; Fetene, Jonathan; Ponsetto, Julian; Chen, Alyssa; Bergwitz, Clemens] Yale Univ, Sch Med, Dept Med, Sect Endocrinol, New Haven, CT 06510 USA; [Li, Yuwen] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Li, Yuwen; Zhu, Chuanlong] Harvard Med Sch, Boston, MA USA; [Li, Yuwen] Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Chuanlong] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Zhu, Chuanlong] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Braddock, Demetrios T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanjing Medical University; Harvard University; Massachusetts General Hospital; Nanjing Medical University; Yale University	Bergwitz, C (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Endocrinol, New Haven, CT 06510 USA.	clemens.bergwitz@yale.edu	Zhu, Chuanlong/GPF-5191-2022; li, yuwen/HGU-6435-2022; Caballero, Daniel/GXV-3082-2022; Li, yu/HHZ-5236-2022	Caballero, Daniel/0000-0001-9232-8991	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [5K08-DK078361]; Center for Skeletal Research Core NIH [P30 AR066261]; Young Investigator Awards by the National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China [81271713]; Scientific research fund of Anhui Medical University [2011xkj074]; Yale O'Brien Center (Pilot grant); NIH [P30DK079310]; Yale Mouse Metabolic Phenotyping Center NIH [U24 DK-059635]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, P30DK079310, K08DK078361] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core NIH; Young Investigator Awards by the National Kidney Foundation; American Society for Clinical Investigation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific research fund of Anhui Medical University; Yale O'Brien Center (Pilot grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Center NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grant 5K08-DK078361 (to C.B.), Center for Skeletal Research Core NIH P30 AR066261, Young Investigator Awards by the National Kidney Foundation, and the American Society for Clinical Investigation (to C.B.), National Natural Science Foundation of China grant 81271713 (to C.Z.) and the Scientific research fund of Anhui Medical University 2011xkj074 (to Y.L.). We are grateful to the Yale OBrien Center (Pilot grant to C.B., NIH P30DK079310), the Yale Mouse Metabolic Phenotyping Center NIH U24 DK-059635 for help with biochemical analysis, the Yale Dept. of Orthopaedics Histology and Histomorphometry Laboratory for help with histological and the Yale Center for Cellular and Molecular Imaging (YCCMI) for electron microscopic analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; ALON U, 1992, J PEDIATR-US, V120, P899, DOI 10.1016/S0022-3476(05)81957-2; Arcidiacono T, 2014, AM J NEPHROL, V40, P499, DOI 10.1159/000369833; Baumann J M, 1977, Z Urol Nephrol, V70, P449; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; BURR RG, 1985, BRIT J UROL, V57, P275, DOI 10.1111/j.1464-410X.1985.tb06342.x; Caballero D, 2016, AM J PHYSL RENAL PHY; Caballero D, 2017, AM J PHYSIOL-RENAL, V312, pF77, DOI 10.1152/ajprenal.00367.2016; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Carr G, 2007, CELL PHYSIOL BIOCHEM, V20, P507, DOI 10.1159/000107534; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Hunter GK, 2013, CALCIFIED TISSUE INT, V93, P348, DOI 10.1007/s00223-013-9698-6; Khan SR, 2011, J UROLOGY, V186, P1107, DOI 10.1016/j.juro.2011.04.109; LAMINSKI NA, 1990, NEPHRON, V56, P379, DOI 10.1159/000186179; Li QL, 2016, J INVEST DERMATOL, V136, P550, DOI 10.1016/j.jid.2015.10.065; Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Li Y, 2017, RESPONSE NPT2A UNPUB; Li YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176232; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; March JG, 2001, CLIN CHIM ACTA, V314, P187, DOI 10.1016/S0009-8981(01)00695-7; Moochhala SH, 2008, EXP PHYSIOL, V93, P43, DOI 10.1113/expphysiol.2007.040790; Moochhala SH, 2012, NEPHRON PHYSIOL, V120, P33, DOI 10.1159/000341597; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Rendenbach C, 2014, CALCIFIED TISSUE INT, V94, P474, DOI 10.1007/s00223-013-9831-6; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; RUSSELL RGG, 1976, ARTHRITIS RHEUM-US, V19, P465, DOI 10.1002/1529-0131(197605/06)19:3+<465::AID-ART1780190722>3.0.CO;2-#; Schlingmann KP, 2015, J AM SOC NEPHROL; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; SHARMA S, 1992, UROL INT, V48, P404, DOI 10.1159/000282364; Tenenhouse HS, 2004, AM J PHYSIOL-RENAL, V286, pF675, DOI 10.1152/ajprenal.00362.2003; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; TIEDER M, 1992, NEPHRON, V62, P176, DOI 10.1159/000187029; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D	48	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180098	10.1371/journal.pone.0180098	http://dx.doi.org/10.1371/journal.pone.0180098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704395	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700028
J	Jeet, G; Thakur, JS; Prinja, S; Singh, M				Jeet, Gursimer; Thakur, J. S.; Prinja, Shankar; Singh, Meenu			Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications	PLOS ONE			English	Article							COST-EFFECTIVENESS; PRIMARY-CARE; SMOKING-CESSATION; DIABETIC-PATIENTS; BLOOD-PRESSURE; INTERVENTION; MANAGEMENT; PROGRAM; RISK; HYPERTENSION	Background National programs for non-communicable diseases (NCD) prevention and control in different low middle income countries have a strong community component. A community health worker (CHW) delivers NCD preventive services using informational as well as behavioural approaches. Community education and interpersonal communication on lifestyle modifications is imparted with focus on primordial prevention of NCDs and screening is conducted as part of early diagnosis and management. However, the effectiveness of health promotion and screening interventions delivered through community health workers needs to be established. Objective This review synthesised evidence on effectiveness of CHW delivered NCD primary prevention interventions in low and middle-income countries (LMICs). Methods A systematic review of trials that utilised community health workers for primary prevention/early detection strategy in the management of NCDs (Diabetes, cardiovascular diseases (CVD), cancers, stroke, Chronic Obstructive Pulmonary Diseases (COPD)) in LMICs was conducted. Digital databases like PubMed, EMBASE, OVID, Cochrane library, dissertation abstracts, clinical trials registry web sites of different LMIC were searched for such publications between years 2000 and 2015. We focussed on community based randomised controlled trial and cluster randomised trials without any publication language limitation. The primary outcome of review was percentage change in population with different behavioural risk factors. Additionally, mean overall changes in levels of several physical or biochemical parameters were studied as secondary outcomes. Subgroup analyses was performed by the age and sex of participants, and sensitivity analyses was conducted to assess the robustness of the findings. Results Sixteen trials meeting the inclusion criteria were included in the review. Duration, study populations and content of interventions varied across trials. The duration of the studies ranged from mean follow up of 4 months for some risk factors to 19 months, and primary responsibilities of health workers included health promotion, treatment adherence and follow ups. Only a single trial reported all-cause mortality. The pooled effect computed indicated an increase in tobacco cessation (RR: 2.0, 95% CI: 1.11, 3.58, moderate-quality evidence) and a decrease in systolic blood pressure ((MD: -4.80, 95% CI: -8.12, -1.49, I-2 = 93%, very lowquality evidence), diastolic blood pressure ((MD: -2.88, 95% CI: -5.65, -0.10, I-2 = 96%, very low-quality evidence)) and blood sugar levels (glycated haemoglobin MD: -0.83%, 95% CI: -1.25,-0.41). None of the included trials reported on adverse events. Conclusions Evidence on the implementation of primary prevention strategies using community health workers is still developing. Existing evidence suggests that, compared with standard care, using CHWs in health programmes have the potential to be effective in LMICs, particularly for tobacco cessation, blood pressure and diabetes control.	[Jeet, Gursimer; Thakur, J. S.; Prinja, Shankar] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Singh, Meenu] Post Grad Inst Med Educ & Res, Adv Paediat Ctr, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	jsthakur64@gmail.com		/0000-0003-3727-9941				Adogu P., 2015, AM J MED MED SCI, V5, P150; Aluttis C, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23611; [Anonymous], 2014, REV MAN REVMAN COMP; [Anonymous], 2017, DIABETES MELLITUS DE; Bhutta ZA, 2010, WHO GLOBAL HLTH WORK; Bolton L, 2015, HELPDESK REPORT COST; Brown HS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120074; Brownson CA, 2009, DIABETES EDUCATOR, V35, P761, DOI 10.1177/0145721709340931; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; Chandler J, 2013, METHODOLOGICAL EXPEC; Chow CK, 2009, AM HEART J, V158, P349, DOI 10.1016/j.ahj.2009.05.034; Christopher JB, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-27; Colagiuri S, 2008, HEALTH AFFAIR, V27, P256, DOI 10.1377/hlthaff.27.1.256; DePue JD, 2013, DIABETES EDUCATOR, V39, P751, DOI 10.1177/0145721713504630; Ebrahim S., 2011, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD001561.PUB3; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Garcia-Pena C, 2002, SALUD PUBLICA MEXICO, V44, P14, DOI 10.1590/S0036-36342002000100002; Goldhaber-Fiebert JD, 2003, DIABETES CARE, V26, P24, DOI 10.2337/diacare.26.1.24; Hasandokht T, 2015, J RES MED SCI, V20, P54; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jafar TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140550; Jafar TH, 2011, CIRCULATION, V124, P1615, DOI 10.1161/CIRCULATIONAHA.111.039990; Jayakrishnan R, 2013, ASIAN PAC J CANCER P, V14, P6797, DOI 10.7314/APJCP.2013.14.11.6797; Jeet G, 2015, PROSPERO, V2015; Jeet Gursimer, 2013, Indian J Public Health, V57, P113, DOI 10.4103/0019-557X.115007; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Joshi R, 2012, J AM COLL CARDIOL, V59, P1188, DOI 10.1016/j.jacc.2011.10.901; Lee LL, 2007, PREV MED, V44, P160, DOI 10.1016/j.ypmed.2006.09.001; Lewin S A, 2005, Cochrane Database Syst Rev, pCD004015; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lin JS, 2014, US PREVENTIVE SERVIC; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; Maher D, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-14; Mash R, PATIENT ED COUNSELIN, V98, P622; Mash RJ, 2014, DIABETIC MED, V31, P987, DOI 10.1111/dme.12475; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mendis S, 2010, B WORLD HEALTH ORGAN, V88, P412, DOI 10.2471/BLT.08.062364; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohlman MK, 2013, NICOTINE TOB RES, V15, P1372, DOI 10.1093/ntr/nts333; Ogedegbe G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005983; Pazoki R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-216; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Prinja S, 2014, PLOS ONE, V9; Sahoo AK, 2014, 330 ISEC; Stricker PD, 2012, BJU INT, V110, P30, DOI 10.1111/j.1464-410X.2012.11621.x; Thankappan KR, 2014, DIABETES CARE, V37, pE256, DOI 10.2337/dc14-1863; Thomson Reuters, 2012, ENDNOTE X7; Uthman OA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011163.pub2; Vaughan K, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0070-y; Wattana C, 2007, NURS HEALTH SCI, V9, P135, DOI 10.1111/j.1442-2018.2007.00315.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization (WHO) Mortality Database, HLTH STAT INF SYST; Zhong XF, 2015, ANN FAM MED, V13, pS50, DOI 10.1370/afm.1799	54	97	97	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180640	10.1371/journal.pone.0180640	http://dx.doi.org/10.1371/journal.pone.0180640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704405	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700044
J	Ashrafi, S; Helaly, S; Schroers, HJ; Stadler, M; Richert-Poeggeler, KR; Dababat, AA; Maier, W				Ashrafi, Samad; Helaly, Soleiman; Schroers, Hans-Josef; Stadler, Marc; Richert-Poeggeler, Katja R.; Dababat, Abdelfattah A.; Maier, Wolfgang			Ijuhya vitellina sp.nov., a novel source for chaetoglobosin A, is a destructive parasite of the cereal cyst nematode Heterodera filipjevi	PLOS ONE			English	Article							RIBOSOMAL DNA; SECONDARY METABOLITES; NEMATOCIDAL ACTIVITY; NEMATOPHAGOUS FUNGI; CLONOSTACHYS-ROSEA; GEN. NOV; CHAETOMIUM; BIONECTRIACEAE; HYPOCREALES; ASCOMYCOTA	Cyst nematodes are globally important pathogens in agriculture. Their sedentary lifestyle and long-term association with the roots of host plants render cyst nematodes especially good targets for attack by parasitic fungi. In this context fungi were specifically isolated from nematode eggs of the cereal cyst nematode Heterodera filipjevi. Here, Ijuhya vitellina (Ascomycota, Hypocreales, Bionectriaceae), encountered in wheat fields in Turkey, is newly described on the basis of phylogenetic analyses, morphological characters and life-style related inferences. The species destructively parasitises eggs inside cysts of H. filipjevi. The parasitism was reproduced in in vitro studies. Infected eggs were found to harbour microsclerotia produced by I. vitellina that resemble long-term survival structures also known from other ascomycetes. Microsclerotia were also formed by this species in pure cultures obtained from both, solitarily isolated infected eggs obtained from fields and artificially infected eggs. Hyphae penetrating the eggshell colonised the interior of eggs and became transformed into multicellular, chlamydospore-like structures that developed into microsclerotia. When isolated on artificial media, microsclerotia germinated to produce multiple emerging hyphae. The specific nature of morphological structures produced by I. vitellina inside nematode eggs is interpreted as a unique mode of interaction allowing long-term survival of the fungus inside nematode cysts that are known to survive periods of drought or other harsh environmental conditions. Generic classification of the new species is based on molecular phylogenetic inferences using five different gene regions. I. vitellina is the only species of the genus known to parasitise nematodes and produce microsclerotia. Metabolomic analyses revealed that within the Ijuhya species studied here, only I. vitellina produces chaetoglobosin A and its derivate 19-O-acetylchaetoglobosin A. Nematicidal and nematode- inhibiting activities of these compounds have been demonstrated suggesting that the production of these compounds may represent an adaptation to nematode parasitism.	[Ashrafi, Samad; Richert-Poeggeler, Katja R.; Maier, Wolfgang] Fed Res Ctr Cultivated Plants, JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Ashrafi, Samad] Univ Kassel, Fac Organ Agr Sci, Dept Ecol Plant Protect, Witzenhausen, Germany; [Helaly, Soleiman; Stadler, Marc] Helmholtz Ctr Infect Res GmbH HZI, Dept Microbial Drugs, Braunschweig, Germany; [Helaly, Soleiman] Aswan Univ, Fac Sci, Dept Chem, Aswan, Egypt; [Schroers, Hans-Josef] Agr Inst Slovenia, Ljubljana, Slovenia; [Dababat, Abdelfattah A.] Int Maize & Wheat Improvement Ctr, CIMMYT, PK 39, TR-06511 Ankara, Turkey	Julius Kuhn-Institut; Universitat Kassel; Helmholtz Association; Helmholtz-Center for Infection Research; Egyptian Knowledge Bank (EKB); Aswan University; Agricultural Institute Slovenia; Ministry of Food, Agriculture & Livestock - Turkey	Ashrafi, S (corresponding author), Fed Res Ctr Cultivated Plants, JKI, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany.; Ashrafi, S (corresponding author), Univ Kassel, Fac Organ Agr Sci, Dept Ecol Plant Protect, Witzenhausen, Germany.	samad.ashrafi@julius-kuehn.de	Stadler, Marc/AHB-7016-2022; Stadler, Marc/P-8882-2014	Stadler, Marc/0000-0002-7284-8671; Stadler, Marc/0000-0002-7284-8671; Helaly, Soleiman/0000-0002-2159-478X; Ashrafi, Samad/0000-0003-0426-7039; DABABAT, Abdelfattah/0000-0002-3172-0452				Ahmed M, 2014, BIOCONTROL SCI TECHN, V24, P389, DOI 10.1080/09583157.2013.863827; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Anke H., 2011, MYCOTA, P151; Baral HO, 2017, MYCOL PROGR; BIRD AF, 1976, PARASITOLOGY, V72, P19, DOI 10.1017/S0031182000043158; Castlebury LA, 2004, MYCOL RES, V108, P864, DOI 10.1017/S0953756204000607; Chaverri P, 2008, STUD MYCOL, P1, DOI 10.3114/sim.2008.60.01; Chaverri P, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.68.03; Chepkirui C, 2016, PHYTOCHEMISTRY, V132, P95, DOI 10.1016/j.phytochem.2016.10.001; Coyne D. L., 2007, Practical plant nematology: a field and laboratory guide; Crous PW, 2016, PERSOONIA, V36, P316, DOI 10.3767/003158516X692185; Curtis RHC, 2011, PROG BIOL CONTROL, V11, P115, DOI 10.1007/978-1-4020-9648-8_5; CUTLER HG, 1980, J AGR FOOD CHEM, V28, P139, DOI 10.1021/jf60227a011; DACKMAN C, 1985, J NEMATOL, V17, P50; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; DIJKSTERHUIS J, 1991, MYCOL RES, V95, P873, DOI 10.1016/S0953-7562(09)80052-X; DIJKSTERHUIS J, 1994, ADV MICROB PHYSIOL, V36, P111, DOI 10.1016/S0065-2911(08)60178-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gams W, 1998, CBS COURSE OF MYCOLO; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghisalberti EL, 2002, STUD NAT PROD CHEM, P425; GOFFART H., 1932, ARB BIOL REICHSANST LAND U FORST WIRTSCH BERLIN DAHLEM, V20, P1; Grum-Grzhimaylo AA, 2013, IMA FUNGUS, V4, P213, DOI 10.5598/imafungus.2013.04.02.07; Helaly SE, 2016, TETRAHEDRON LETT, V57, P5911, DOI 10.1016/j.tetlet.2016.11.075; Herrera CS, 2013, MYCOLOGIA, V105, P1287, DOI 10.3852/12-395; Hirooka Y., 2013, Mycosystema, V32, P485; Hirooka Y, 2012, STUD MYCOL, P1, DOI 10.3114/sim0001; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hirooka Y, 2010, MYCOLOGIA, V102, P418, DOI 10.3852/09-137; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch WM, 2014, PERSOONIA, V33, P182, DOI 10.3767/003158514X685211; Jaklitsch WM, 2011, MYCOLOGIA, V103, P431, DOI 10.3852/10-240; Jansson HB, 1999, MYCOL RES, V103, P249, DOI 10.1017/S0953756298007084; Jansson HB, 2001, MYCOLOGY TRICHOMYCET, P145; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawahara T, 2013, J ANTIBIOT, V66, P727, DOI 10.1038/ja.2013.75; KERRY B R, 1975, Bulletin OEPP, V5, P353, DOI 10.1111/j.1365-2338.1975.tb02485.x; Kerry B. R., 1982, Crop Protection, V1, P99, DOI 10.1016/0261-2194(82)90061-8; KERRY BR, 1974, NEMATOLOGICA, V20, P259, DOI 10.1163/187529274X00230; KERRY BR, 1980, T BRIT MYCOL SOC, V74, P119, DOI 10.1016/S0007-1536(80)80017-9; Khan A, 2006, BIOCONTROL, V51, P643, DOI 10.1007/s10526-005-4241-y; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiyuna T, 2011, MYCOSCIENCE, V52, P1, DOI 10.1007/s10267-010-0063-6; Kornerup A, 1967, METHUEN HANDBOOK OF; Kuhn J, 1877, Z VEREINS RUBENZUCKE, V27, P452; Kuhnert E, 2015, PHYTOCHEMISTRY, V117, P116, DOI 10.1016/j.phytochem.2015.06.002; Kundu A, 2016, J ASIA-PAC ENTOMOL, V19, P631, DOI 10.1016/j.aspen.2016.06.003; Lechat C, 2015, ASCOMYCETE, V7, P101; Lechat C, 2017, ASCOMYCETEORG, V9, P11; Lechat C, 2012, MYCOTAXON, V121, P275, DOI 10.5248/121.275; Lechat C, 2012, MYCOTAXON, V119, P249, DOI 10.5248/119.249; Lechat C, 2010, MYCOTAXON, V113, P443, DOI 10.5248/113.443; Li Guohong, 2007, Recent Pat Biotechnol, V1, P212, DOI 10.2174/187220807782330165; Lopez-Llorcz LV, 2002, MYCOL RES, V106, P499, DOI 10.1017/S0953756202005798; LOW I, 1979, ANAL BIOCHEM, V95, P14, DOI 10.1016/0003-2697(79)90178-7; Luo J, 2010, MYCOTAXON, V113, P243, DOI 10.5248/113.243; Luo J, 2010, MYCOL PROG, V9, P17, DOI 10.1007/s11557-009-0613-5; MARUYAMA K, 1986, BIOCHIM BIOPHYS ACTA, V874, P137, DOI 10.1016/0167-4838(86)90110-X; Meyer SLF, 2004, NEMATOLOGY, V6, P23, DOI 10.1163/156854104323072883; Morton CO, 2004, NEMATOLOGY, V6, P161, DOI 10.1163/1568541041218004; Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1, DOI DOI 10.1002/JPLN.19771400220; Niu XM, 2010, J AGR FOOD CHEM, V58, P828, DOI 10.1021/jf903259n; Nordbring-Hertz B, 2001, ELS, DOI [10.1038/npg.els.0004293, DOI 10.1038/NPG.ELS.0004293]; Nylander JAA., 2004, BIOINFORMATICS; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; PERRY R N, 1986, Revue de Nematologie, V9, P399; Platas G, 2008, FUNGAL PLANET, V24; PROBST A, 1981, HELV CHIM ACTA, V64, P2056, DOI 10.1002/hlca.19810640710; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Richter C, 2016, J NAT PROD, V79, P1684, DOI 10.1021/acs.jnatprod.6b00194; RODRIGUEZKABANA R, 1988, J NEMATOL, V20, P191; Rossman AY, 2001, MYCOLOGIA, V93, P100, DOI 10.2307/3761609; Rossman AY, 1999, STUD MYCOL, P1; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salgado-Salazar C, 2012, MYCOLOGIA, V104, P1325, DOI 10.3852/12-055; SAMUELS G J, 1976, New Zealand Journal of Botany, V14, P231; SAMUELS G J, 1988, Memoirs of the New York Botanical Garden, V48, P1; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; SAMUELS GJ, 1978, NEW ZEAL J BOT, V16, P73, DOI 10.1080/0028825X.1978.10429659; Schroers HJ, 2001, STUD MYCOL, P1; SEKITA S, 1973, TETRAHEDRON LETT, P2109; SEKITA S, 1977, TETRAHEDRON LETT, P2771; SEKITA S, 1976, TETRAHEDRON LETT, P1351, DOI 10.1016/S0040-4039(00)78062-2; SEKITA S, 1982, CHEM PHARM BULL, V30, P1629, DOI 10.1248/cpb.30.1629; Senyu Chen, 2004, P979, DOI 10.1079/9780851996462.0979; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; SILVERTON JV, 1976, TETRAHEDRON LETT, P1349, DOI 10.1016/S0040-4039(00)78061-0; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; SPONDLIN C, 1988, HELV CHIM ACTA, V71, P1881, DOI 10.1002/hlca.19880710806; SPRINGER JP, 1976, TETRAHEDRON LETT, P1355, DOI 10.1016/S0040-4039(00)78063-4; STADLER M, 1993, J ANTIBIOT, V46, P961; STADLER M, 1994, PLANTA MED, V60, P128, DOI 10.1055/s-2006-959433; Stadler M, 2001, MYCOTAXON, V77, P379; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stenroos S, 2010, CLADISTICS, V26, P281, DOI 10.1111/j.1096-0031.2009.00284.x; Stirling GR, 2014, BIOLOGICAL CONTROL O; STLEGER RJ, 1991, J INVERTEBR PATHOL, V57, P299, DOI 10.1016/0022-2011(91)90134-C; Summerbell RC, 2011, STUD MYCOL, P139, DOI 10.3114/sim.2011.68.06; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xue M, 2012, CHIRALITY, V24, P668, DOI 10.1002/chir.22068; Yang EC, 2012, P NATL ACAD SCI USA, V109, P10960, DOI 10.1073/pnas.1120915109; Zhang L, 2008, APPL MICROBIOL BIOT, V78, P983, DOI 10.1007/s00253-008-1392-7; Zheng QC, 2014, FITOTERAPIA, V93, P126, DOI 10.1016/j.fitote.2013.12.022	109	28	29	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180032	10.1371/journal.pone.0180032	http://dx.doi.org/10.1371/journal.pone.0180032			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700638	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600015
J	Oparinde, A; Abdoulaye, T; Mignouna, DB; Bamire, AS				Oparinde, Adewale; Abdoulaye, Tahirou; Mignouna, Djana Babatima; Bamire, Adebayo Simeon			Will farmers intend to cultivate Provitamin A genetically modified (GM) cassava in Nigeria? Evidence from a k-means segmentation analysis of beliefs and attitudes	PLOS ONE			English	Article							PLANNED BEHAVIOR; STAKEHOLDER ATTITUDES; EXPERIMENTAL AUCTIONS; CONSUMER ACCEPTANCE; SOUTH-AFRICA; FOOD; CROPS; BIOTECHNOLOGY; INFORMATION; BENEFITS	Analysis of market segments within a population remains critical to agricultural systems and policy processes for targeting new innovations. Patterns in attitudes and intentions toward cultivating Provitamin A GM cassava are examined through the use of a combination of behavioural theory and k-means cluster analysis method, investigating the interrelationship among various behavioural antecedents. Using a state-level sample of smallholder cassava farmers in Nigeria, this paper identifies three distinct classes of attitude and intention denoted as low opposition, medium opposition and high opposition farmers. It was estimated that only 25% of the surveyed population of farmers was highly opposed to cultivating Provitamin A GM cassava.	[Oparinde, Adewale] Int Food Policy Res Inst, Washington, DC 20036 USA; [Abdoulaye, Tahirou; Mignouna, Djana Babatima] Int Inst Trop Agr, Ibadan, Nigeria; [Bamire, Adebayo Simeon] Obafemi Awolowo Univ, Ife, Nigeria	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Institute of Tropical Agriculture (IITA); Obafemi Awolowo University	Oparinde, A (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	a.oparinde@cgiar.org		Oparinde, Adewale/0000-0002-4518-9404				Abubakar A., 2016, COUNTRY PROFILE RELI; Adenle A. A., 2012, AGR FOOD SECURITY, V1, P15; Aerni P, 2006, WORLD DEV, V34, P557, DOI 10.1016/j.worlddev.2005.08.007; Aerni P, 2005, ENVIRON SCI POLICY, V8, P464, DOI 10.1016/j.envsci.2005.07.001; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Ajzen I, 2007, SCOPE OF SOCIAL PSYCHOLOGY: THEORY AND APPLICATIONS, P43; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Berman J, 2013, PLANT MOL BIOL, V83, P5, DOI 10.1007/s11103-013-0027-2; Birol E., 2012, AgBioForum, V15, P175; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bredahl L., 1998, MAPP Working Paper, DOI 10.1023/A:1006940724167; Breustedt G, 2008, J AGR ECON, V59, P237, DOI 10.1111/j.1477-9552.2007.00147.x; Brown DR, 2006, AFJARE, V1; Buah J. N., 2011, American Journal of Food Technology, V6, P541, DOI 10.3923/ajft.2011.541.554; Burke D, 2004, EMBO REP, V5, P432, DOI 10.1038/sj.embor.7400160; Burkhalter JE, 2009, NICOTINE TOB RES, V11, P1312, DOI 10.1093/ntr/ntp140; Chern Wen S., 2002, AgBioForum, V5, P105; Chung JW, 2006, LECT NOTES COMPUT SC, V4224, P807; Coleman J., 1990, FDN SOCIAL THEORY; Cooke J. G., 2010, REPORT CSIS GLOBAL F; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; Curtis K. R., 2004, AgBioForum, V7, P70; De Moura FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129436; De Wit JBF, 2000, PSYCHOL HEALTH, V15, P325, DOI 10.1080/08870440008401996; Demont M, 2013, NEW BIOTECHNOL, V30, P426, DOI 10.1016/j.nbt.2013.04.004; Dofonsou S.G., 2007, AM AGR EC ASS ANN M; DOWNS DS, 2005, J PHYS ACT HEALTH, V2, P76, DOI DOI 10.1123/jpah.2.1.76; Everitt B. S., 2001, CLUSTER ANAL; FAO, 2009, FEED WORLD 2050 SPEC; Fishbein M., 1975, BELIEF ATTITUDE INTE; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Gonzalez C, 2009, J AGR ECON, V60, P604, DOI 10.1111/j.1477-9552.2009.00219.x; Grebmer K., 2014, 2014 GLOBAL HUNGER I; Gyau A, 2009, INT FOOD AGRIBUS MAN, V12, P61; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Hebden WC, 2005, CHOICES, V20, P243; Herring JR, 2009, GLOBAL RIFTS BIOTECH; Huffman WE, 2007, J ECON BEHAV ORGAN, V63, P193, DOI 10.1016/j.jebo.2005.04.019; Kikulwe EM, 2011, APPETITE, V57, P401, DOI 10.1016/j.appet.2011.06.001; Kimenju SC, 2005, AFR J BIOTECHNOL, V4, P1066; Kolady D. E., 2006, AgBioForum, V9, P94; Lewis CP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-407; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; Lyon F, 2009, CAMB J ECON, V33, P903, DOI 10.1093/cje/bem008; Manyong V.M., 2000, CONTRIBUTION IITA IM; Maziya-Dixon BB, 2006, J NUTR, V136, P2255, DOI 10.1093/jn/136.8.2255; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Morris SH, 2001, BRIT FOOD J, V102, P669; Mushunje A., 2011, African Journal of Agricultural Research, V6, P5918; Pachico D, 2002, P 6 INT ICABR C JUL, P155; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rousu M. C., 2009, AgBioForum, V12, P226; Sahin I., 2006, TURKISH ONLINE J ED, V5; Sampson IT, 2014, OXF J LAW RELIG, V3, P311, DOI 10.1093/ojlr/rwt026; Sayre R. T., 2011, BIOFORTIFICATION CAS; Scoones I, 2008, J AGRAR CHANGE, V8, P315, DOI 10.1111/j.1471-0366.2008.00172.x; Seppanen E., 2005, IND MARKET MANAG, V36, P249; Skevas T., 2012, AgBioForum, V15, P242; Smale M., 2007, Research Report - International Food Policy Research Institute; Smale Melinda, 2003, African Journal of Biotechnology, V2, P586; Spence A, 2006, RISK ANAL, V26, P657, DOI 10.1111/j.1539-6924.2006.00777.x; Stead M, 2005, HEALTH EDUC RES, V20, P36, DOI 10.1093/her/cyg093; Stone GD, 2002, CURR ANTHROPOL, V43, P611, DOI 10.1086/341532; Tegene A, 2003, USDA TECHNICAL BULLE, V1903; Vermeulen H, 2005, AGREKON, V44, P657; Zhang C, 2004, AM AGR EC ASS ANN M; Zhang XY, 2010, FOOD POLICY, V35, P456, DOI 10.1016/j.foodpol.2010.04.008	71	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179427	10.1371/journal.pone.0179427	http://dx.doi.org/10.1371/journal.pone.0179427			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700605	Green Published, gold			2022-12-27	WOS:000405649400003
J	Cao, SY; Shen, DD; Wang, YD; Li, LX; Zhou, LP; Wang, YX				Cao, Shuyan; Shen, Dandan; Wang, Yadong; Li, Linxi; Zhou, Liping; Wang, Yuxue			Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection	PLOS ONE			English	Article							NF-KAPPA-B; ONCOGENIC RAS; P53; ACTIVATION; THERAPY; CELLS; INFLAMMATION; SUPPRESSION; SENESCENCE; EXPRESSION	Mycoplasma infection has been reported in immunocompromised cancer patients; nevertheless, it is not clear if persistent Mycoplasma infection could facilitate the proliferation of cancer cells in immunocompromised organisms. The aim of this study was to examine the relationship between persistent Mycoplasma infection and malignant transformation in an immunodeficient host model. Immunodeficient mouse model was established using cyclophosphamide and mice gastric mucosal cells were infected with Mycoplasma penetrans (Mpe). After 18 weeks, mice were sacrificed and gastric mucosal Mpe infected cells were identified by fluorescence in situ hybridization (FISH). Moreover, pathological and ultrastructural changes in mice gastric mucosa were evaluated and the expression of multiple protooncogenes was examined by Western blot. Our data show that Mpe infection was detected in the blood of immunodeficient mice and Mpe persistent infection in mice gastric mucosa was confirmed by FISH. There were pathological and ultrastructural malignant transformation occurred in the gastric mucosa of infected mice compared to control mice. Mpe infected mice showed lower expression of p53 and p21 and higher H-ras expression compared to the control group. Moreover, expression of NF-kappa B p65 subunit increased in Mpe infected mice, similar to the TNF-alpha expression. Bax expression in gastric mucosa of Mpe infected mice was lower while Bcl-2 expression was higher than in the uninfected control group. Collectively these data demonstrate that persistent Mpe infection is associated with aberrant expression of multiple proto-oncogenes in gastric mucosa of immunodeficient mice which potentially facilitate the malignant transformation.	[Cao, Shuyan; Li, Linxi] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Cao, Shuyan; Li, Linxi] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Shen, Dandan] Shanghai Tenth Peoples Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Wang, Yadong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Zhou, Liping] Wenzhou Med Univ, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Yuxue] Hubei Univ Chinese Med, Dept Lab Med, Wuhan, Hubei, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Hubei University of Chinese Medicine	Wang, YX (corresponding author), Hubei Univ Chinese Med, Dept Lab Med, Wuhan, Hubei, Peoples R China.	wangyuxue@hbtcm.edu.cn			Wenzhou public welfare science and technology plan project [Y20080182, Y20160190]; Natural Science Foundation of Hubei Province (CN) [2015CFB291]	Wenzhou public welfare science and technology plan project; Natural Science Foundation of Hubei Province (CN)	This work was supported by Wenzhou public welfare science and technology plan project (grant number Y20080182 and Y20160190). Approvalunit: Wenzhou Bureau of Science and Technology in Zhejiang province, China. Natural Science Foundation of Hubei Province (CN) (grant number 2015CFB291).Approvalunit: Department of Science and Technology in Hubei province, China	Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Chen YF, 2016, J BIOL CHEM, V291, P12688, DOI 10.1074/jbc.M116.714147; Cimolai N, 2001, CAN J MICROBIOL, V47, P691, DOI 10.1139/cjm-47-8-691; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fernandez A, 2014, DRUG DISCOV TODAY, V19, P1427, DOI 10.1016/j.drudis.2014.03.022; Frum RA, 2016, MOL CANCER RES, V14, P423, DOI 10.1158/1541-7786.MCR-15-0363; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Klein OR, 2016, BIOL BLOOD MARROW TR, V22, P895, DOI 10.1016/j.bbmt.2016.02.001; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Li EC, 2015, ONCOTARGET, V6, P8900, DOI 10.18632/oncotarget.3561; Liu WB, 2011, BIOL RES, V44, P383, DOI [10.4067/S0716-97602011000400011, /S0716-97602011000400011]; Logunov DY, 2008, ONCOGENE, V27, P4521, DOI 10.1038/onc.2008.103; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Muller I, 2015, J INVEST DERMATOL, V135, P851, DOI 10.1038/jid.2014.481; Natarajan V, 2014, P NATL ACAD SCI USA, V111, pE474, DOI 10.1073/pnas.1311945111; Pinnix CC, 2016, CL LYMPH MYELOM LEUK, V16, P122, DOI 10.1016/j.clml.2015.12.008; Rajalakshmy AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125419; Sinkovics JG, 2012, INT J ONCOL, V40, P305, DOI 10.3892/ijo.2011.1248; Sutton SS, 2016, PHARMACOTHERAPY, V36, P385, DOI 10.1002/phar.1728; Tian W, 2016, DEV COMP IMMUNOL, V59, P39, DOI 10.1016/j.dci.2016.01.008; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Yoon BN, 2013, AM J OTOLARYNG, V34, P22, DOI 10.1016/j.amjoto.2012.07.008; Zhang BX, 1997, P SOC EXP BIOL MED, V214, P359; Zhou J, 2010, ULTRASOUND MED BIOL, V36, P1876, DOI 10.1016/j.ultrasmedbio.2010.08.013; Zhu YP, 2016, CANCER LETT, V380, P369, DOI 10.1016/j.canlet.2016.04.030	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180514	10.1371/journal.pone.0180514	http://dx.doi.org/10.1371/journal.pone.0180514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692662	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800049
J	Suprynowicz, FA; Kamonjoh, CM; Krawczyk, E; Agarwal, S; Wellstein, A; Agboke, FA; Choudhury, S; Liu, XF; Schlegel, R				Suprynowicz, Frank A.; Kamonjoh, Christopher M.; Krawczyk, Ewa; Agarwal, Seema; Wellstein, Anton; Agboke, Fadeke A.; Choudhury, Sujata; Liu, Xuefeng; Schlegel, Richard			Conditional cell reprogramming involves non-canonical beta-catenin activation and mTOR-mediated inactivation of Akt	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; PROTEIN; PHOSPHORYLATION; INHIBITION; SURVIVAL; TARGET; CANCER; SIGNAL; PP2A	The combination of irradiated fibroblast feeder cells and Rho kinase inhibitor, Y-267362, converts primary epithelial cells growing in vitro into an undifferentiated adult stem cell-like state that is characterized by long-term proliferation. This cell culture method also maintains the proliferation of adult epithelial stem cells from various tissues. Both primary and adult stem cells retain their tissue-specific differentiation potential upon removal of the culture conditions. Due to the ability to modulate the proliferation and differentiation of the cells, this method is referred to as conditional reprogramming and it is increasingly being used in studies of tumor heterogeneity, personalized medicine and regenerative medicine. However, little is known about the biology of these conditionally reprogrammed (CR) cells. Previously we showed that beta-catenin activation, a hallmark of stem cells in vivo, occurs in CR human ectocervical cells (HECs). Here we show that beta-catenin-dependent transcription is necessary for the induction of epithelial stem cell markers, and that beta-catenin is activated via a non-canonical pathway that is independent of Wnt and Akt/GSK-3. Active Akt actually decreases due to increased mTOR signaling, with a consequent increase in dephosphorylated, active GSK-3. Despite the increase in active GSK-3, beta-catenin associates with protein phosphatase 2A (PP2A) and is activated. Inhibition of PP2A catalytic activity reduces both the level of active beta-catenin and the acute induction of stem cell markers, suggesting an important role for PP2A in the activation of beta-catenin. Moreover, we demonstrate similar results using human prostate and breast cells, indicating that these changes are not restricted to ectocervical epithelial cells and may represent a more fundamental property of conditional reprogramming.	[Suprynowicz, Frank A.; Kamonjoh, Christopher M.; Krawczyk, Ewa; Agarwal, Seema; Wellstein, Anton; Agboke, Fadeke A.; Choudhury, Sujata; Liu, Xuefeng; Schlegel, Richard] Georgetown Univ, Sch Med, Ctr Cell Reprogramming, Washington, DC 20057 USA	Georgetown University	Suprynowicz, FA (corresponding author), Georgetown Univ, Sch Med, Ctr Cell Reprogramming, Washington, DC 20057 USA.	suprynfa@georgetown.edu			National Cancer Institute [R33CA177466]; Center for Cell Reprogramming (Georgetown)	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cell Reprogramming (Georgetown)	This study was funded in part by a grant from the National Cancer Institute to R.S. (R33CA177466) and internal funds from the Center for Cell Reprogramming (Georgetown). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher LD, 2001, J BIOL CHEM, V276, P21017, DOI 10.1074/jbc.C100136200; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JANICOT M, 1988, BIOCHEM J, V253, P735, DOI 10.1042/bj2530735; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Ji XN, 2014, INT J MOL SCI, V15, P13275, DOI 10.3390/ijms150813275; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7; Kimura M, 2016, STEM CELL REP, V6, P834, DOI 10.1016/j.stemcr.2016.04.012; Krawczyk E, 2010, J VIROL, V84, P1696, DOI 10.1128/JVI.01968-09; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2011, MOL CELL BIOL, V31, P3366, DOI 10.1128/MCB.01403-10; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rosner M, 2012, AMINO ACIDS, V42, P2251, DOI 10.1007/s00726-011-0965-4; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Singla DK, 2006, BIOCHEM BIOPH RES CO, V345, P789, DOI 10.1016/j.bbrc.2006.04.125; Suprynowicz FA, 2005, VIROLOGY, V332, P102, DOI 10.1016/j.virol.2004.11.011; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Suprynowicz FA, 2010, J VIROL, V84, P10619, DOI 10.1128/JVI.00831-10; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180897	10.1371/journal.pone.0180897	http://dx.doi.org/10.1371/journal.pone.0180897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700668	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800094
J	Wei, JF; Zhang, HF; Zhao, WQ; Zhao, Q				Wei, Jiufeng; Zhang, Hufang; Zhao, Wanqing; Zhao, Qing			Niche shifts and the potential distribution of Phenacoccus solenopsis (Hemiptera: Pseudococcidae) under climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; COTTON; IMPACT; CONSERVATISM; PREDICTION; INVASIONS; PATHWAYS; THREAT; PLANTS; BIRDS	The cotton mealybug, Phenacoccus solenopsis Tinsley (Hemiptera: Pseudococcidae), is a serious invasive species that significantly damages plants of approximately 60 families around the world. It is originally from North America and has also been introduced to other continents. Our goals were to create a current and future potential global distribution map for this pest under climate change with MaxEnt software. We tested the hypothesis of niche conservatism for P. solenopsis by comparing its native niche in North America to its invasive niches on other continents using Principal components analyses (PCA) in R. The potentially suitable habitat for P. solenopsis in its native and non-native ranges is presented in the present paper. The results suggested that the mean temperature of the wettest quarter and the mean temperature of the driest quarter are the most important environmental variables determining the potential distribution of P. solenopsis. We found strong evidence for niche shifts in the realized climatic niche of this pest in South America and Australia due to niche unfilling; however, a niche shift in the realized climatic niche of this pest in Eurasian owing to niche expansion.	[Wei, Jiufeng; Zhao, Wanqing; Zhao, Qing] Shanxi Agr Univ, Dept Entomol, Taigu, Shanxi, Peoples R China; [Zhang, Hufang] Xinzhou Teachers Univ, Xinzhou, Shanxi, Peoples R China	Shanxi Agricultural University; Xinzhou Teachers University	Zhao, Q (corresponding author), Shanxi Agr Univ, Dept Entomol, Taigu, Shanxi, Peoples R China.	zhaoqing86623@163.com	Zhao, Qing/AAW-1409-2021; Zhao, Q./AAO-7751-2021; JIufeng, Wei/ABD-4026-2020		National Science Foundation Project of China [31301899, 31501876]; Natural Science Foundation of Shanxi [201601D021122]; Shanxi Agricultural University of Science and Technology Innovation fund projects [2015YJ03]	National Science Foundation Project of China; Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); Shanxi Agricultural University of Science and Technology Innovation fund projects	This project was supported by the National Science Foundation Project of China (no. 31301899 and no. 31501876), supported by Natural Science Foundation of Shanxi (no. 201601D021122) and Shanxi Agricultural University of Science and Technology Innovation fund projects (2015YJ03).	Abbas Ghulam, 2005, Pakistan Entomologist, V27, P83; Abbas G, 2010, INT J AGRIC BIOL, V12, P421; Almalki M, 2015, APPL ECOL ENV RES, V13, P67; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Charleston K., 2010, AUSTR COTTON GROWER, V31, P18; Dellinger AS, 2016, NEW PHYTOL, V209, P1313, DOI 10.1111/nph.13694; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Ekesi S, 2016, ANNU REV ENTOMOL, V61, P219, DOI 10.1146/annurev-ento-010715-023603; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fand BB, 2014, J ENVIRON BIOL, V35, P973; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Febbraro MD, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0066559; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gallagher RV, 2010, J ECOL, V98, P1126; Gao YL, 2017, PEST MANAG SCI; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Garcia M, 2017, SCALENET A LITERATUR; Granara de Willink MC., 2003, REV SOC ENTOMOLOGICA, V62, P80; Gray DR, 2017, BIOL INVASIONS, V19, P913, DOI 10.1007/s10530-016-1291-2; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Gulik MP, 2005, ZOOTAXA, V964, P1; Hameed A, 2012, PAK J ZOOL, V44, P685; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodgson C, 2008, ZOOTAXA, P1; Hojsgaard D, 2016, NEW PHYTOL, V209, P1; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ibrahim Samah Sayed, 2015, Journal of Plant Protection Research, V55, P48, DOI 10.1515/jppr-2015-0007; Jiang HJ, 2017, PLOS ONE, V11; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Joshi M. D., 2010, Agricultural Reviews, V31, P113; Kolanowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077352; Kumar S, 2015, ECOLOGY AND EVOLUTIO, V5, P4268; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mainka SA, 2010, INTEGR ZOOL, V5, P102, DOI 10.1111/j.1749-4877.2010.00193.x; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mwase ET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002714; Nagrare VS, 2009, B ENTOMOL RES, V99, P537, DOI 10.1017/S0007485308006573; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T, 2011, ECOLOGICAL NICHES GE, DOI 10.23943/princeton/9780691136868.001.0001; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Sarma RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143724; Shabani F, 2015, ECOL INFORM, V29, P57, DOI 10.1016/j.ecoinf.2015.07.006; Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Tingley R, 2016, ECOGRAPHY, V39, P270, DOI 10.1111/ecog.01576; Tinsley J.B., 1898, CAN ENTOMOL, V30, P47, DOI [DOI 10.4039/ENT3047-2, 10.4039/Ent3047-2]; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Walsh JR, 2016, P NATL ACAD SCI USA, V113, P4081, DOI 10.1073/pnas.1600366113; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wise MS, 2008, DIVERSITY AND DISTRI, V14, P129; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Worth JRP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1186, DOI 10.1111/geb.12239; Wu San-An, 2009, Chinese Bulletin of Entomology, V46, P159	71	27	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180913	10.1371/journal.pone.0180913	http://dx.doi.org/10.1371/journal.pone.0180913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700721	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800098
J	Pereira, APD; de Andrade, PAM; Bini, D; Durrer, A; Robin, A; Bouillet, JP; Andreote, FD; Cardoso, EJBN				de Araujo Pereira, Arthur Prudencio; Maia de Andrade, Pedro Avelino; Bini, Daniel; Durrer, Ademir; Robin, Agnes; Bouillet, Jean Pierre; Andreote, Fernando Dini; Bran Nogueira Cardoso, Elke Jurandy			Shifts in the bacterial community composition along deep soil profiles in monospecific and mixed stands of Eucalyptus grandis and Acacia mangium	PLOS ONE			English	Article							SPECIES PLANTATIONS; MICROBIAL COMMUNITIES; GROWTH DYNAMICS; NITROGEN; CARBON; DIVERSITY; BRAZIL; TREES; QUANTIFICATION; RHIZOSPHERE	Our knowledge of the rhizosphere bacterial communities in deep soils and the role of Eucalyptus and Acacia on the structure of these communities remains very limited. In this study, we targeted the bacterial community along a depth profile (0 to 800 cm) and compared community structure in monospecific or mixed plantations of Acacia mangium and Eucalyptus grandis. We applied quantitative PCR (qPCR) and sequence the V6 region of the 16S rRNA gene to characterize composition of bacterial communities. We identified a decrease in bacterial abundance with soil depth, and differences in community patterns between monospecific and mixed cultivations. Sequence analysis indicated a prevalent effect of soil depth on bacterial communities in the mixed plant cultivation system, and a remarkable differentiation of bacterial communities in areas solely cultivated with Eucalyptus. The groups most influenced by soil depth were Proteobacteria and Acidobacteria (more frequent in samples between 0 and 300 cm). The predominant bacterial groups differentially displayed in the monospecific stands of Eucalyptus were Firmicutes and Proteobacteria. Our results suggest that the addition of an N2-fixing tree in a monospecific cultivation system modulates bacterial community composition even at a great depth. We conclude that co-cultivation systems may represent a key strategy to improve soil resources and to establish more sustainable cultivation of Eucalyptus in Brazil.	[de Araujo Pereira, Arthur Prudencio; Maia de Andrade, Pedro Avelino; Durrer, Ademir; Andreote, Fernando Dini; Bran Nogueira Cardoso, Elke Jurandy] Univ Sao Paulo, ESALQ USP, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil; [Bini, Daniel] Univ Ctr Oeste, UNICTR, Guarapuava, Parana, Brazil; [Robin, Agnes; Bouillet, Jean Pierre] CIRAD, Agr Res Dev, Montpellier, France	Universidade de Sao Paulo; CIRAD	Pereira, APD (corresponding author), Univ Sao Paulo, ESALQ USP, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, SP, Brazil.	arthur.prudencio@usp.br; ejbncard@usp.br	de Araujo Pereira, Arthur Prudêncio/H-2275-2018; Andrade, Pedro Avelino A M/K-2384-2017; de Araujo Pereira, Arthur Prudêncio/Y-4251-2019; Andreote, Fernando Dini/B-8499-2012; Robin, Agnes/C-5238-2015	de Araujo Pereira, Arthur Prudêncio/0000-0001-9402-3243; Andrade, Pedro Avelino A M/0000-0001-7767-9101; de Araujo Pereira, Arthur Prudêncio/0000-0001-9402-3243; Andreote, Fernando Dini/0000-0002-9883-9968; Robin, Agnes/0000-0003-3044-2304	FAPESP [122790]; CNPq [476122]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following: FAPESP (proc.no 122790); CNPq(proc. no 476122)	ABRAF-Brazilian Association of Forest Plantation Producers, 2013, YB STAT ABRAF 2013 B; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bini D, 2013, APPL SOIL ECOL, V63, P57, DOI 10.1016/j.apsoil.2012.09.012; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bouillet JP, 2008, FOREST ECOL MANAG, V255, P3918, DOI 10.1016/j.foreco.2007.10.050; Bouillet JP, 2013, FOREST ECOL MANAG, V301, P89, DOI 10.1016/j.foreco.2012.09.019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K.R., 2006, PRIMER; Curtis P, 2002, ARCH MICROBIOL, V178, P65, DOI 10.1007/s00203-002-0427-1; De Bellis T, 2007, MYCOLOGIA, V99, P356, DOI 10.3852/mycologia.99.3.356; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; EMBRAPA, 1997, MANUAL METODOS ANALI; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Forrester DI, 2004, FOREST ECOL MANAG, V193, P81, DOI 10.1016/j.foreco.2004.01.024; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Grayston SJ, 2001, SOIL BIOL BIOCHEM, V33, P533, DOI 10.1016/S0038-0717(00)00194-2; Gregory PJ, 2006, EUR J SOIL SCI, V57, P2, DOI 10.1111/j.1365-2389.2005.00778.x; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Helgason BL, 2014, AGR ECOSYST ENVIRON, V196, P94, DOI 10.1016/j.agee.2014.06.029; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; JAMES R, 2005, PLANTED FORESTS TREE; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jourdan C, 2008, FOREST ECOL MANAG, V256, P396, DOI 10.1016/j.foreco.2008.04.034; Kasel S, 2008, SOIL BIOL BIOCHEM, V40, P1724, DOI 10.1016/j.soilbio.2008.02.011; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Laclau JP, 2008, FOREST ECOL MANAG, V255, P3905, DOI 10.1016/j.foreco.2007.10.049; Laclau JP, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00243; Laclau JP, 2013, OECOLOGIA, V172, P903, DOI 10.1007/s00442-012-2526-2; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lejon DPH, 2005, MICROB ECOL, V50, P614, DOI 10.1007/s00248-005-5130-8; Li CH, 2014, SOIL BIOL BIOCHEM, V75, P264, DOI 10.1016/j.soilbio.2014.04.023; Liu Hua, 2010, Journal of Sustainable Development, V3, P197; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Lopez-Mondejar R, 2015, SOIL BIOL BIOCHEM, V87, P43, DOI 10.1016/j.soilbio.2015.04.008; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Nouvellon Y, 2012, TREE PHYSIOL, V32, P680, DOI 10.1093/treephys/tps041; Paula RR, 2015, SOIL BIOL BIOCHEM, V91, P99, DOI 10.1016/j.soilbio.2015.08.017; Peralta RM, 2013, SCI TOTAL ENVIRON, V443, P725, DOI 10.1016/j.scitotenv.2012.11.052; Rachid CTCC, 2013, SOIL BIOL BIOCHEM, V66, P146, DOI 10.1016/j.soilbio.2013.07.005; Rachid CTCC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-170; Raij BV, 1997, EMBRAPA, V285, P29; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rampelotto Pabulo Henrique, 2010, Sustainability, V2, P1602, DOI 10.3390/su2061602; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schutz K, 2010, FEMS MICROBIOL ECOL, V72, P445, DOI 10.1111/j.1574-6941.2010.00855.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stone MM, 2015, SOIL BIOL BIOCHEM, V80, P273, DOI 10.1016/j.soilbio.2014.10.019; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Uroz S, 2013, MICROB ECOL, V66, P404, DOI 10.1007/s00248-013-0199-y; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	62	56	56	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180371	10.1371/journal.pone.0180371	http://dx.doi.org/10.1371/journal.pone.0180371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686690	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100057
J	Gasljevic, G; Edhemovic, I; Cemazar, M; Brecelj, E; Gadzijev, EM; Music, MM; Sersa, G				Gasljevic, Gorana; Edhemovic, Ibrahim; Cemazar, Maja; Brecelj, Erik; Gadzijev, Eldar M.; Music, Maja M.; Sersa, Gregor			Histopathological findings in colorectal liver metastases after electrochemotherapy	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; HEPATOCELLULAR-CARCINOMA; RAT MODEL; TUMORS; BLEOMYCIN; ABLATION	Electrochemotherapy of colorectal liver metastases has been proven to be feasible, safe and effective in a phase I/II study. In that study, a specific group of patients underwent two-stage operation, and the detailed histopathological evaluation of the resected tumors is presented here. Regressive changes in electrochemotherapy-treated liver metastases were evaluated after the second operation (in 8-10 weeks) in 7 patients and 13 metastases when the treated metastases were resected. Macroscopic and microscopic changes were analyzed. Electrochemotherapy induced coagulation necrosis in the treated area encompassing both tumor and a narrow band of normal tissue. The area became necrotic, encapsulated in a fibrous envelope while preserving the functionality of most of the vessels larger than 5 mm in diameter and a large proportion of biliary structures, but the smaller blood vessels displayed various levels of damage. At the time of observation, 8-10 weeks after electrochemo-therapy, regenerative changes were already seen in the peripheral parts of the treated area. This study demonstrates regressive changes in the whole electrochemotherapy-treated area of the liver. Further evidence of disruption of vessels less than 5mm in diameter and preservation of the larger vessels by electrochemotherapy is provided. These findings are important because electrochemotherapy has been indicated for the therapy of metastases near major blood vessels in the liver to provide a safe approach with good antitumor efficacy.	[Gasljevic, Gorana] Inst Oncol Ljubljana, Dept Pathol, Ljubljana, Slovenia; [Edhemovic, Ibrahim; Brecelj, Erik; Gadzijev, Eldar M.] Inst Oncol Ljubljana, Dept Surg Oncol, Ljubljana, Slovenia; [Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Music, Maja M.] Inst Oncol Ljubljana, Dept Radiol, Ljubljana, Slovenia; [Sersa, Gregor] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia	Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; University of Primorska; Institute of Oncology - Slovenia; University of Ljubljana	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Sersa, G (corresponding author), Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia.	gsersa@onko-i.si		Sersa, Gregor/0000-0002-7641-5670	Slovenian Research Agency (ARRS) [P3-003, J3-5505]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (ARRS), grant No. P3-003 and No. J3-5505. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H R, 2001, CANC PRINCIPLES PRAC; Aschoff AJ, 2001, J MAGN RESON IMAGING, V13, P57, DOI 10.1002/1522-2586(200101)13:1<57::AID-JMRI1009>3.0.CO;2-N; Campana LG, 2016, RADIOL ONCOL, V50, P1, DOI 10.1515/raon-2016-0006; Cemazar M, 2001, BRIT J CANCER, V84, P565, DOI 10.1054/bjoc.2000.1625; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Goldberg SN, 2009, J VASC INTERV RADIOL, V20; Gonzalez Hector Daniel, 2007, HPB (Oxford), V9, P251, DOI 10.1080/13651820701457992; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Jaroszeski MJ, 2001, EUR J CANCER, V37, P414, DOI 10.1016/S0959-8049(00)00407-X; Jaroszeski MJ, 2001, EUR J CANCER, V37, P422, DOI 10.1016/S0959-8049(00)00412-3; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Kasper HU, 2010, PATHOL INT, V60, P149, DOI 10.1111/j.1440-1827.2009.02498.x; Kos B, 2015, RADIOL ONCOL, V49, P234, DOI 10.1515/raon-2015-0031; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Miklavcic D, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-I1; Misiakos EP, 2011, WORLD J GASTROENTERO, V17, P4067, DOI 10.3748/wjg.v17.i36.4067; Niessen C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43687; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; TOUNEKTI O, 1995, EXP CELL RES, V217, P506, DOI 10.1006/excr.1995.1116; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622	26	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180709	10.1371/journal.pone.0180709	http://dx.doi.org/10.1371/journal.pone.0180709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686650	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100092
J	Reveiz, L; Haby, MM; Martinez-Vega, R; Pinzon-Flores, CE; Elias, V; Smith, E; Pinart, M; Broutet, N; Becerra-Posada, F; Aldighieri, S; Van Kerkhove, MD				Reveiz, Ludovic; Haby, Michelle M.; Martinez-Vega, Ruth; Pinzon-Flores, Carlos E.; Elias, Vanessa; Smith, Emma; Pinart, Mariona; Broutet, Nathalie; Becerra-Posada, Francisco; Aldighieri, Sylvain; Van Kerkhove, Maria D.			Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols	PLOS ONE			English	Review							GUILLAIN-BARRE-SYNDROME; UNITED-STATES; COHORT; SELECTION; DESIGN; ASSAY; EPIDEMIOLOGY; ASSOCIATION; JANUARY; TRIALS	Introduction Given the severity and impact of the current Zika virus (ZIKV) outbreak in the Americas, numerous countries have rushed to develop research studies to assess ZIKV and its potential health consequences. In an effort to ensure that studies are comprehensive, both internally and externally valid, and with reliable results, the World Health Organization, the Pan American Health Organization, Institut Pasteur, the networks of Fiocruz, the Consortia for the Standardization of Influenza Seroepidemiology (CONSISE) and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) have generated six standardized clinical and epidemiological research protocols and questionnaires to address key public health questions on ZIKV. Methods We conducted a systematic search of ongoing study protocols related to ZIKV research. We analyzed the content of protocols of 32 cohort studies and 13 case control studies for systematic bias that could produce erroneous results. Additionally we aimed to characterize the risks of bias and confounding in observational studies related to ZIKV and to propose ways to minimize them, including the use of six newly standardized research protocols. Results Observational studies of ZIKV face an array of challenges, including measurement of exposure and outcomes (microcephaly and Guillain-Barre A Syndrome). Potential confounders need to be measured where known and controlled for in the analysis. Selection bias due to non-random selection is a significant issue, particularly in the case-control design, and losses to follow-up is equally important for the cohort design. Conclusion Observational research seeking to answer key questions on the ZIKV should consider these restrictions and take precautions to minimize bias in an effort to provide reliable and valid results. Utilization of the standardized research protocols developed by the WHO, PAHO, Institut Pasteur, and CONSISE will harmonize the key methodological aspects of each study design to minimize bias at different stages of the study. Biases need to be considered by researchers implementing the standardized protocols as well as by users of observational epidemiological studies of ZIKV.	[Reveiz, Ludovic; Elias, Vanessa; Smith, Emma; Becerra-Posada, Francisco; Aldighieri, Sylvain] Pan Amer Hlth Org, Washington, DC 20037 USA; [Haby, Michelle M.] Univ Sonora, Dept Chem & Biol Sci, Hermosillo, Sonora, Mexico; [Martinez-Vega, Ruth] Univ Santander, Escuela Med, Bucaramanga, Colombia; [Pinzon-Flores, Carlos E.] Univ La Sabana, Grp Invest Salud, Bogota, Colombia; [Pinzon-Flores, Carlos E.] IETS, Subdirecc Prod Guias Pract Clin, Bogota, Colombia; [Smith, Emma] Yale Sch Publ Hlth, New Haven, CT USA; [Pinart, Mariona] Univ Nottingham, Cochrane Skin Grp, Nottingham, England; [Broutet, Nathalie; Van Kerkhove, Maria D.] WHO, Geneva, Switzerland; [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France	Pan American Health Organization; Universidad de Sonora; Universidad Industrial de Santander; Universidad de La Sabana; Yale University; University of Nottingham; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Reveiz, L (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	reveizl@paho.org	Haby, Michelle/AGL-3386-2022; Martínez-Vega, Ruth/AAD-3601-2019; Pinart Gilberga, Mariona/GLS-8842-2022	Haby, Michelle/0000-0001-6203-9195; Martínez-Vega, Ruth/0000-0002-6477-334X; Pinart Gilberga, Mariona/0000-0002-8223-1325; Van Kerkhove, Maria/0000-0002-6135-0018				Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389; [Anonymous], 2016, DIR GEN SUMM OUTC EM; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI 10.1016/j.zefq.2016.07.010; Bonita R., 2006, BASIC EPIDEMIOLOGY; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; CDC, 2016, REV DIAGN TEST ZIK C; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CORMAN VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI DOI 10.2471/BLT.16.175950; Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587; de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8; Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fitchett EJA, 2016, LANCET INFECT DIS, V16, pE202, DOI 10.1016/S1473-3099(16)30082-2; Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015; Gonzalez U, 2010, CLIN INFECT DIS, V51, P409, DOI 10.1086/655134; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Harville EW, 2016, PAEDIATR PERINAT EP, V30, P531, DOI 10.1111/ppe.12312; Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203; Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA; Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1; MAGIC, 2017, TOOL ASS RISK BIAS C; Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; PAHO, 2016, CAS DEF PAN AM HLTH; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Porta M, 2014, DICT EPIDEMIOLOGY; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6726; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253; Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Van Kerkhove MD, 2016, LANCET GLOB HLTH; Viswanathan M, 2013, AHRQ METHODS EFFECTI; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; White E, 1998, EPIDEMIOL REV, V20, P43, DOI 10.1093/oxfordjournals.epirev.a017971; WHO, 2016, ZIK VIR RES AG; WHO, 2016, SCREEN ASS MAN NEON; WHO, 2016, ZIK SIT REP ZIK VIR; WHO, 2016, CAS DEF PAN AM HLTH; WHO, 2016, WHOZIKVLAB161; WHO, 2016, WHOZIKVMOC164; WHO Institut Pasteur, 2016, STAND PROT CROSS SEC; WHO Institut Pasteur, 2016, STAND PROT PROSP LON; WHO Institut Pasteur, 2016, HARM ZIKV RES PROT A; WHO Institut Pasteur, 2016, STAND PROT CAS CONTR; Woodward M., 2013, EPIDEMIOLOGY STUDY D	62	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180220	10.1371/journal.pone.0180220	http://dx.doi.org/10.1371/journal.pone.0180220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686621	gold, Green Published			2022-12-27	WOS:000405464100041
J	Choo, MS; Choi, SR; Han, JH; Lee, SH; Shim, YS				Choo, Min Soo; Choi, Se Rin; Han, Jun Hyun; Lee, Seong Ho; Shim, Young Suk			Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; FEMORAL-NECK STRENGTH; MINERAL DENSITY; CHILDREN; HYPERINSULINEMIA; INDEXES; ADOLESCENTS; CHOLESTEROL; LIPOPROTEIN; POPULATION	Objective This study aimed to evaluate the relationship between insulin resistance and the bone mineral density (BMD) of femur and lumbar spine in Korean adults who are expected to exhibit near peak bone mass. Methods Data from the Korean National Health and Nutrition Examination Survey 2008-2010 were analyzed. A total of 2,750 participants aged 25-35 years were included. Insulin resistance was assessed using a homeostatic model assessment of insulin resistance (HOMA-IR) and serum fasting insulin. Results In a multivariate linear regression analysis, the HOMA-IR was significantly inversely associated with the BMD of the total hip (TH, beta = -0.052, P = 0.002), femoral neck (FN, beta = -0.072, P< 0.001), femoral trochanter (FTr, beta = -0.055, P = 0.003), femoral intertrochanter (FITr, beta = -0.041, P = 0.015), and lumbar spine (LS, beta = -0.063, P = 0.001) among all study subjects after adjustment for gender, age, height, weight, whole body fat mass percentage, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, vitamin D, smoking, alcohol intake, physical activity, education level, and household income in both genders as well as labor, the use of oral contraceptives, and age at menarche in females. The serum fasting insulin was significantly inversely associated with the BMD of the TH (beta = -0.055, P = 0.001), FN (beta= -0.072, P< 0.001), FTr (beta = -0.055, P = 0.003), FITr (beta = -0.045, P = 0.009), and LS (beta = -0.064, P = 0.001) among all subjects in a multivariate linear regression analysis. Conclusion Our results suggest that insulin resistance may be independently and inversely associated with the near peak bone mass of the femur and lumbar spine.	[Choo, Min Soo; Han, Jun Hyun; Lee, Seong Ho] Hallym Univ, Coll Med, Med Ctr, Dept Urol, Seoul, South Korea; [Choi, Se Rin; Shim, Young Suk] Hallym Univ, Coll Med, Dept Pediat, Med Ctr, Seoul, South Korea	Hallym University; Hallym University	Shim, YS (corresponding author), Hallym Univ, Coll Med, Dept Pediat, Med Ctr, Seoul, South Korea.	royjays0217@hallym.or.kr	Shim, Young Suk/AFX-0329-2022	Shim, Young Suk/0000-0002-0850-5279	Hallym University Research Fund [HURF-2016-36]	Hallym University Research Fund	This research was supported by Hallym University Research Fund 2016(HURF-2016-36)	Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; Ahn SH, 2016, CLIN ENDOCRINOL, V84, P185, DOI 10.1111/cen.12958; Arikan S, 2012, J CLIN DENSITOM, V15, P186, DOI 10.1016/j.jocd.2011.11.005; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; BarrettConnor E, 1996, DIABETES CARE, V19, P1388, DOI 10.2337/diacare.19.12.1388; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; de Paula FJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129764; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dennison EM, 2004, DIABETOLOGIA, V47, P1963, DOI 10.1007/s00125-004-1560-y; do Prado WL, 2009, J BONE MINER METAB, V27, P613, DOI 10.1007/s00774-009-0082-6; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hanley DA, 2003, J BONE MINER RES, V18, P784, DOI 10.1359/jbmr.2003.18.4.784; Ishii S, 2012, J CLIN ENDOCR METAB, V97, P190, DOI 10.1210/jc.2011-1883; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Lima JG, 2016, MED HYPOTHESES, V97, P94, DOI 10.1016/j.mehy.2016.10.025; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Makovey J, 2009, BONE, V44, P208, DOI 10.1016/j.bone.2008.09.020; Mather KJ, 2001, J CLIN ENDOCR METAB, V86, P5457, DOI 10.1210/jc.86.11.5457; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Pramojanee SN, 2013, J DENT RES, V92, P560, DOI 10.1177/0022034513485600; REID IR, 1993, AM J PHYSIOL, V265, pE655, DOI 10.1152/ajpendo.1993.265.4.E655; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, pS94, DOI 10.1007/BF01673412; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Shanbhogue VV, 2016, J CLIN ENDOCR METAB, V101, P3114, DOI 10.1210/jc.2016-1726; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shin D, 2014, J CLIN ENDOCR METAB, V99, P988, DOI 10.1210/jc.2013-3338; Stagi S, 2013, CLIN CASES MINER BON, V10, P172, DOI 10.11138/ccmbm/2013.10.3.172; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Stolk RP, 1996, BONE, V18, P545, DOI 10.1016/8756-3282(96)00079-8; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Verroken C, 2016, J CLIN ENDOCR METAB; Wang Xiaoyi, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.CMET.2015.09.010; Wei J, 2012, BMC P, V6, pP74; YANO H, 1994, ENDOCR J, V41, P293, DOI 10.1507/endocrj.41.293; Yi KH, 2014, DIABETES RES CLIN PR, V103, P106, DOI 10.1016/j.diabres.2013.10.021	44	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0177311	10.1371/journal.pone.0177311	http://dx.doi.org/10.1371/journal.pone.0177311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704413	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700003
J	Ledien, J; Sorn, S; Hem, S; Huy, R; Buchy, P; Tarantola, A; Cappelle, J				Ledien, Julia; Sorn, Sopheak; Hem, Sopheak; Huy, Rekol; Buchy, Philippe; Tarantola, Arnaud; Cappelle, Julien			Assessing the performance of remotelysensed flooding indicators and their potential contribution to early warning for leptospirosis in Cambodia	PLOS ONE			English	Article							WATER INDEX NDWI; INFECTIOUS-DISEASE; SURVEILLANCE; TRANSMISSION; THAILAND; CLIMATE; HEALTH; PONDS	Remote sensing can contribute to early warning for diseases with environmental drivers, such as flooding for leptospirosis. In this study we assessed whether and which remotelysensed flooding indicator could be used in Cambodia to study any disease for which flooding has already been identified as an important driver, using leptospirosis as a case study. The performance of six potential flooding indicators was assessed by ground truthing. The Modified Normalized Difference Water Index (MNDWI) was used to estimate the Risk Ratio (RR) of being infected by leptospirosis when exposed to floods it detected, in particular during the rainy season. Chi- square tests were also calculated. Another variable D the time elapsed since the first flooding of the year D was created using MNDWI values and was also included as explanatory variable in a generalized linear model (GLM) and in a boosted regression tree model (BRT) of leptospirosis infections, along with other explanatory variables. Interestingly, MNDWI thresholds for both detecting water and predicting the risk of leptospirosis seroconversion were independently evaluated at - 0.3. Value of MNDWI greater than - 0.3 was significantly related to leptospirosis infection (RR = 1.61 [ 1.10 - 1.52];x(2) = 5.64, p- value = 0.02, especially during the rainy season (RR = 2.03 [ 1.25 - 3.28];chi(2) = 8.15, p- value = 0.004). Time since the first flooding of the year was a significant risk factor in our GLM model (p- value = 0.042). These results suggest that MNDWI may be useful as a risk indicator in an early warning remote sensing tool for flood- driven diseases like leptospirosis in South East Asia.	[Ledien, Julia; Sorn, Sopheak; Tarantola, Arnaud; Cappelle, Julien] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Hem, Sopheak] Inst Pasteur Cambodge, Med Biol Unit, Phnom Penh, Cambodia; [Huy, Rekol] Ctr Natl Malariol, Phnom Penh, Cambodia; [Buchy, Philippe] GlaxoSmithKline, Vaccines R&D, Singapore, Singapore; [Tarantola, Arnaud] Inst Pasteur Nouvelle Caledonie, Epidemiol Unit, 11 Rue Paul Doumer, Noumea, New Caledonia; [Cappelle, Julien] CIRAD ES, UPR AGIRs, Montpellier, France; [Cappelle, Julien] Univ Lyon, VetAgro Sup, INRA, UMR EPIA, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; GlaxoSmithKline; CIRAD; INRAE; VetAgro Sup	Ledien, J (corresponding author), Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia.	jledien@pasteur-kh.org	Tarantola, Arnaud/D-2149-2015	Tarantola, Arnaud/0000-0002-6946-7958; BUCHY, Philippe/0000-0003-1372-3008; Ledien, Julia/0000-0002-6116-8371; Cappelle, Julien/0000-0001-7668-1971	scholarship from The University of Bordeaux; FidEx International program	scholarship from The University of Bordeaux; FidEx International program	The project was self-funded. Julia Ledien was supported by a scholarship from The University of Bordeaux and the FidEx International program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Berlioz-Arthaud A, 2010, Bull Soc Pathol Exot, V103, P111, DOI 10.1007/s13149-010-0043-2; Bertuzzo E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050723; Bhardwaj Pankaj, 2008, Indian J Med Sci, V62, P431, DOI 10.4103/0019-5359.48454; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boschetti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088741; Chadsuthi S, 2012, ASIAN PAC J TROP MED, V5, P539, DOI 10.1016/S1995-7645(12)60095-9; Clandillon S, 1995, EUROPEAN SYMPOSIUM O, P102, DOI [10.1117/12.227173, DOI 10.1117/12.227173]; Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Dechet AM, 2012, PLOS ONE, P7; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Forbes AE, 2012, QJM-INT J MED, V105, P1151, DOI 10.1093/qjmed/hcs145; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hamm NAS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004164; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hem S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151555; Hijmans Robert J., 2016, DISMO SPECIES DISTRI; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Ivanova S, 2012, AM J TROP MED HYG, V86, P1032, DOI 10.4269/ajtmh.2012.11-0349; Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Kazama S, 2012, SUSTAIN SCI, V7, P45, DOI 10.1007/s11625-011-0141-5; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Lau CL, 2012, PLOS NEGLECT TROP D, P6; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Leal-Castellanos CB, 2003, EPIDEMIOL INFECT, V131, P1149, DOI 10.1017/S0950268803001201; LINTHICUM KJ, 1987, SCIENCE, V235, P1656, DOI 10.1126/science.3823909; Lleo MM, 2008, CURR OPIN BIOTECH, V19, P307, DOI 10.1016/j.copbio.2008.04.001; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; R Core Team, 2014, R A LANGUAGE AND ENV; Remais J, 2008, ENVIRON SCI TECHNOL, V42, P2643, DOI 10.1021/es071052s; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rouse J.W, 1973, P 3 ERTS 1 S, P48; SMITH D. J. W., 1955, JOUR HYG, V53, P436; Soti V, 2010, HYDROL EARTH SYST SC, V14, P1449, DOI 10.5194/hess-14-1449-2010; Soti V, 2009, INT J APPL EARTH OBS, V11, P344, DOI 10.1016/j.jag.2009.05.005; Suwanpakdee S, 2015, EPIDEMIOL INFECT, V143, P2106, DOI 10.1017/S0950268815000205; Thai KTD, 2006, TROP MED INT HEALTH, V11, P738, DOI 10.1111/j.1365-3156.2006.01619.x; Torgerson PR, 2015, PLOS NEGLECT TROP D, P9; Tran A, 2010, INT J APPL EARTH OBS, V12, P1, DOI 10.1016/j.jag.2009.09.014; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; WHITE ME, 1978, PHOTOGRAMM ENG REM S, V44, P1421; WORK EA, 1976, PHOTOGRAMM ENG REM S, V42, P685; World Health Organization. International Leptospirosis Society, 2003, HUMAN LEPTOSPIROSIS; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179	53	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0181044	10.1371/journal.pone.0181044	http://dx.doi.org/10.1371/journal.pone.0181044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704461	Green Published, Green Accepted, gold			2022-12-27	WOS:000405649700080
J	Park, JM; Park, SY; Choi, CH; Chun, M; Han, JH; Cho, JD; Kim, JI				Park, Jong Min; Park, So-Yeon; Choi, Chang Heon; Chun, Minsoo; Han, Ji Hye; Cho, Jin Dong; Kim, Jung-in			Dosimetric characteristics of a reusable 3D radiochromic dosimetry material	PLOS ONE			English	Article							IMRT; RADIATION; THERAPY; BEAM; VMAT	Purpose To investigate the dosimetric characteristics of PRESAGE(REU) dosimeters. Methods Commercially available PRESAGE REU dosimeters (size of 10 mm x 10 mm x 45 mm) were divided into two groups, with one of the groups placed at room temperature of 22 degrees C (RT group) and another group placed at low temperature of 10 E C (LT group). A total of 3 dosimeters (set of dosimeters) were irradiated at a time, with doses of 1 Gy, 2 Gy, 4 Gy, 8 Gy, 12 Gy, 16 Gy, and 20 Gy, at a nominal dose rate of 400 MU/min at temperature of 22 degrees C. The dosimeters were irradiated three additional times by delivering the same doses as those during the initial irradiations (4 irradiation cycles). Optical density (OD) was assessed using optical CT scanning. Results Considering both linearity and sensitivity of the OD curves, R-2 above 0.95 and sensitivity above 0.04 Delta OD/Gy were observed at the 1 st irradiation (reading time <= 6 h) and 2 nd irradiation (reading time = 0.5 h) for the RT group. For the LT group, those values were observed at the 1 st irradiation (reading time <= 2 h), and the 3 rd and 4 th irradiations (both reading times = 0.5 h). Considering the reproducibility of signals in response to the same dose, dosimeters in the RT group showed average deviations among dosimeters less than 5% (the 1 st and 2 nd irradiations at the reading time of 0.5 h), while for dosimeters in the LT group showed average deviations among dosimeters less than 6% (the 3 rd and 4 th irradiations at the reading time of 0.5 h). For the rest, the OD curves were not linear, sensitivities of the dosimeters were lower than 0.04.OD/Gy, and OD deviations at the same dose were larger than 6%. Conclusions At room temperature, PRESAGE(REU) dosimeters could be used for dose measurement only for up to two dose measurement sessions. At low temperatures, usage of PRESAGE(REU) dosimeters for dose measurement seems to be possible from the 3 rd irradiation. When reusing PRESAGE REU dosimeters, the OD curve should be re-defined for every measurement session because the shape of this curve depends on the irradiation history.	[Park, Jong Min; Park, So-Yeon; Choi, Chang Heon; Chun, Minsoo; Han, Ji Hye; Cho, Jin Dong; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, Jong Min; Park, So-Yeon; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min; Park, So-Yeon; Choi, Chang Heon; Chun, Minsoo; Han, Ji Hye; Cho, Jin Dong; Kim, Jung-in] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.	madangin@gmail.com	Chun, Minsoo/C-4493-2014	Chun, Minsoo/0000-0001-8578-9976; Kim, Jung-in/0000-0002-0305-5969	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0059]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015M2B2A4028940]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MSIP)	This research was partially supported by agrant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI16C0059) and partially supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no.2015M2B2A4028940)	Adamovics J, 2006, RADIAT PROT DOSIM, V120, P107, DOI 10.1093/rpd/nci555; 송주영, 2015, [PROGRESS in MEDICAL PHYSICS, 의학물리], V26, P201; Alqathami M, 2013, RADIAT PHYS CHEM, V85, P204, DOI 10.1016/j.radphyschem.2012.11.006; Baldock C, 2010, PHYS MED BIOL, V55, pR1, DOI 10.1088/0031-9155/55/5/R01; BRAHME A, 1988, RADIOTHER ONCOL, V12, P129, DOI 10.1016/0167-8140(88)90167-3; Cho Woong, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P233, DOI 10.14316/pmp.2014.25.4.233; Ezzell GA, 2003, MED PHYS, V30, P2089, DOI 10.1118/1.1591194; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Gorjiara T, 2011, MED PHYS, V38, P2265, DOI 10.1118/1.3561509; Iqbal K, 2014, J APPL CLIN MED PHYS, V15, P363, DOI 10.1120/jacmp.v15i1.4531; Jackson J, 2015, PHYS MED BIOL, V60, P2217, DOI 10.1088/0031-9155/60/6/2217; Kim JY, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7954.; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Oldham M, 2012, INT J RADIAT ONCOL, V84, P540, DOI 10.1016/j.ijrobp.2011.12.015; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Park JM, 2015, PHYS MED BIOL, V60, P7101, DOI 10.1088/0031-9155/60/18/7101; Pierquet Michael, 2010, J Phys Conf Ser, V250, P1; Shih TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151300; Vidovic AK, 2014, PHYS MED BIOL, V59, P3893, DOI 10.1088/0031-9155/59/14/3893; Watanabe Y, 2013, MED PHYS, V40, DOI 10.1118/1.4813301	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180970	10.1371/journal.pone.0180970	http://dx.doi.org/10.1371/journal.pone.0180970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704443	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700068
J	Pendrill, F; Persson, UM				Pendrill, Florence; Persson, U. Martin			Combining global land cover datasets to quantify agricultural expansion into forests in Latin America: Limitations and challenges	PLOS ONE			English	Article							PROXIMATE CAUSES; TROPICAL FOREST; TIME-SERIES; DEFORESTATION; CROPLAND; ACCURACY; DYNAMICS; AMAZON; POLICY; MAPS	While we know that deforestation in the tropics is increasingly driven by commercial agriculture, most tropical countries still lack recent and spatially-explicit assessments of the relative importance of pasture and cropland expansion in causing forest loss. Here we present a spatially explicit quantification of the extent to which cultivated land and grassland expanded at the expense of forests across Latin America in 2001-2011, by combining two "state-of-the-art" global datasets (Global Forest Change forest loss and GlobeLand30-2010 land cover). We further evaluate some of the limitations and challenges in doing this. We find that this approach does capture some of the major patterns of land cover following deforestation, with GlobeLand30-2010's Grassland class (which we interpret as pasture) being the most common land cover replacing forests across Latin America. However, our analysis also reveals some major limitations to combining these land cover datasets for quantifying pasture and cropland expansion into forest. First, a simple one-to-one translation between GlobeLand30-2010's Cultivated land and Grassland classes into cropland and pasture respectively, should not be made without caution, as GlobeLand30-2010 defines its Cultivated land to include some pastures. Comparisons with the TerraClass dataset over the Brazilian Amazon and with previous literature indicates that Cultivated land in GlobeLand30-2010 includes notable amounts of pasture and other vegetation (e.g. in Paraguay and the Brazilian Amazon). This further suggests that the approach taken here generally leads to an underestimation (of up to similar to 60%) of the role of pasture in replacing forest. Second, a large share (similar to 33%) of the Global Forest Change forest loss is found to still be forest according to GlobeLand30-2010 and our analysis suggests that the accuracy of the combined datasets, especially for areas with heterogeneous land cover and/or small-scale forest loss, is still too poor for deriving accurate quantifications of land cover following forest loss.	[Pendrill, Florence; Persson, U. Martin] Chalmers Univ Technol, Dept Space Earth & Environm, Div Phys Resource Theory, Gothenburg, Sweden	Chalmers University of Technology	Pendrill, F (corresponding author), Chalmers Univ Technol, Dept Space Earth & Environm, Div Phys Resource Theory, Gothenburg, Sweden.	florence.pendrill@chalmers.se		Pendrill, Florence/0000-0003-2492-3865; Persson, U. Martin/0000-0001-7069-6734	Swedish Research Council Formas [231-2014-1181, 2016-00351]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Financial support from the Swedish Research Council Formas (http://www.formas.se/en/), grants 231-2014-1181 and 2016-00351, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2010, CARBON MANAG, V1, P271, DOI 10.4155/CMT.10.30; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; [Anonymous], 2016, MAPBIOMAS ANN SERIES; Arsanjani JJ, 2016, INT J DIGIT EARTH, V9, P873, DOI 10.1080/17538947.2016.1151956; Arsanjani JJ, 2016, HABITAT INT, V55, P25, DOI 10.1016/j.habitatint.2016.02.003; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Baumann M, 2017, REG ENVIRON CHANGE, P1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brovelli MA, 2015, REMOTE SENS-BASEL, V7, P4191, DOI 10.3390/rs70404191; Bustamante MMC, 2016, CONSERV LETT; Cad Almeida, 2009, INPE16621RPQ839; Caldas MM, 2015, J LAND USE SCI, V10, P1, DOI 10.1080/1747423X.2013.807314; Camara G, 2013, METODOLOGIA CALCULO; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Clark ML, 2012, REMOTE SENS ENVIRON, V126, P84, DOI 10.1016/j.rse.2012.08.013; Clark ML, 2010, REMOTE SENS ENVIRON, V114, P2816, DOI 10.1016/j.rse.2010.07.001; Congalton RG, 2014, REMOTE SENS-BASEL, V6, P12070, DOI 10.3390/rs61212070; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Coutinho AC, 2013, USO COBERTURA TERRA; Da Ponte E, 2015, INT J REMOTE SENS, V36, P3196, DOI 10.1080/01431161.2015.1058539; de Almeida CA, 2016, ACTA AMAZON, V46, P291, DOI 10.1590/1809-4392201505504; de Espindola GM, 2012, APPL GEOGR, V32, P240, DOI 10.1016/j.apgeog.2011.04.003; De Sy V, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124004; De Sy V, 2012, CURR OPIN ENV SUST, V4, P696, DOI 10.1016/j.cosust.2012.09.013; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dias LCP, 2016, GLOBAL CHANGE BIOL, V22, P2887, DOI 10.1111/gcb.13314; Embrapa INPE, 2013, LEV INF US COB TERR; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; Fanin T, 2015, BIOGEOSCIENCES, V12, P6033, DOI 10.5194/bg-12-6033-2015; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Fritz S, 2015, GLOBAL CHANGE BIOL, V21, P1980, DOI 10.1111/gcb.12838; Gainey L, 2014, REPORT INDEPENDENT V; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Giri C, 2013, INT J APPL EARTH OBS, V25, P30, DOI [10, 10.1016/j.jag.2013.03.005]; Godar J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035015; Godar J, 2015, ECOL ECON, V112, P25, DOI 10.1016/j.ecolecon.2015.02.003; Graesser J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034017; Grekousis G, 2015, INT J REMOTE SENS, V36, P5309, DOI 10.1080/01431161.2015.1093195; Hansen M, 2014, SCIENCE, V344, DOI 10.1126/science.1248817; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heilmayr R, 2016, P NATL ACAD SCI USA, V113, P2910, DOI 10.1073/pnas.1600394113; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Houghton RA, 2012, CURR OPIN ENV SUST, V4, P597, DOI 10.1016/j.cosust.2012.06.006; Hussain M, 2013, ISPRS J PHOTOGRAMM, V80, P91, DOI 10.1016/j.isprsjprs.2013.03.006; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Gasparri NI, 2015, CONSERV LETT, V8, P290, DOI 10.1111/conl.12121; Killeen TJ, 2008, ECOL SOC, V13; Kuemmerle T, 2013, CURR OPIN ENV SUST, V5, P484, DOI 10.1016/j.cosust.2013.06.002; Lambert MJ, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030232; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Liu JG, 2013, ECOL SOC, V18, DOI 10.5751/ES-05873-180226; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Matricardi EAT, 2014, P 2014 C SPAT ACC E; Meyfroidt P, 2016, J LAND USE SCI, V11, P501, DOI 10.1080/1747423X.2015.1117530; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mueller H, 2015, REMOTE SENS ENVIRON, V156, P490, DOI 10.1016/j.rse.2014.10.014; Muller R, 2012, REG ENVIRON CHANGE, V12, P445, DOI 10.1007/s10113-011-0259-0; Müller Robert, 2014, Ecología en Bolivia, V49, P20; Nahuelhual L, 2012, LANDSCAPE URBAN PLAN, V107, P12, DOI 10.1016/j.landurbplan.2012.04.006; National Geomatics Center of China, 2014, 2009AA122000 NATL GE; Newton P, 2013, GLOBAL ENVIRON CHANG, V23, P1761, DOI 10.1016/j.gloenvcha.2013.08.004; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Richards P, 2016, CONSERV LETT; Richards PD, 2011, PROF GEOGR, V63, P343, DOI 10.1080/00330124.2011.566516; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rufin P, 2015, INT J APPL EARTH OBS, V41, P1, DOI 10.1016/j.jag.2015.04.010; SEI GCP, 2017, SUPPL CHAIN TRANSP N; Serra P, 2003, INT J REMOTE SENS, V24, P3311, DOI 10.1080/0143116021000021189; Tropek R, 2014, SCIENCE, V344, DOI 10.1126/science.1248753; Tyukavina A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/074002; Tyukavina A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601047; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; Vihervaara P, 2012, FOREST POLICY ECON, V14, P58, DOI 10.1016/j.forpol.2011.08.008; Waldner F, 2015, REMOTE SENS-BASEL, V7, P7959, DOI 10.3390/rs70607959	86	16	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181202	10.1371/journal.pone.0181202	http://dx.doi.org/10.1371/journal.pone.0181202			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704510	Green Published, gold			2022-12-27	WOS:000405649700105
J	Willis, TA; West, R; Rushforth, B; Stokes, T; Glidewell, L; Carder, P; Faulkner, S; Foy, R				Willis, Thomas A.; West, Robert; Rushforth, Bruno; Stokes, Tim; Glidewell, Liz; Carder, Paul; Faulkner, Simon; Foy, Robbie		ASPIRE Programme Team	Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study	PLOS ONE			English	Article							UK PRIMARY-CARE; OF-CARE; OUTCOMES FRAMEWORK; CLINICAL CARE; PREDICTORS; PHYSICIANS; ADULTS; TRIAL; PAY	Background There are widely recognised variations in the delivery and outcomes of healthcare but an incomplete understanding of their causes. There is a growing interest in using routinely collected 'big data' in the evaluation of healthcare. We developed a set of evidence-based 'high impact' quality indicators (QIs) for primary care and examined variations in achievement of these indicators using routinely collected data in the United Kingdom (UK). Methods Cross-sectional analysis of routinely collected, electronic primary care data from a sample of general practices in West Yorkshire, UK (n = 89). The QIs covered aspects of care (including processes and intermediate clinical outcomes) in relation to diabetes, hypertension, atrial fibrillation, myocardial infarction, chronic kidney disease (CKD) and 'risky' prescribing combinations. Regression models explored the impact of practice and patient characteristics. Clustering within practice was accounted for by including a random intercept for practice. Results Median practice achievement of the QIs ranged from 43.2% (diabetes control) to 72.2% (blood pressure control in CKD). Considerable between-practice variation existed for all indicators: the difference between the highest and lowest performing practices was 26.3 percentage points for risky prescribing and 100 percentage points for anticoagulation in atrial fibrillation. Odds ratios associated with the random effects for practices emphasised this; there was a greater than ten-fold difference in the likelihood of achieving the hypertension indicator between the lowest and highest performing practices. Patient characteristics, in particular age, gender and comorbidity, were consistently but modestly associated with indicator achievement. Statistically significant practice characteristics were identified less frequently in adjusted models. Conclusions Despite various policy and improvement initiatives, there are enduring inappropriate variations in the delivery of evidence-based care. Much of this variation is not explained by routinely collected patient or practice variables, and is likely to be attributable to differences in clinical and organisational behaviour.	[Willis, Thomas A.; West, Robert; Glidewell, Liz; Foy, Robbie] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Rushforth, Bruno] Foundry Lane Surg, Leeds, W Yorkshire, England; [Stokes, Tim] Univ Otago, Dept Gen Practice & Rural Hlth, Dunedin Sch Med, Dunedin, New Zealand; [Carder, Paul] NHS Bradford Dist CCG, West Yorkshire Res & Dev, Bradford, W Yorkshire, England; [Faulkner, Simon] NHS Digital, Leeds, W Yorkshire, England	University of Leeds; University of Otago	Willis, TA (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.	t.a.willis@leeds.ac.uk; r.foy@leeds.ac.uk	Willis, Thomas A/M-7433-2017; Willis, Thomas/V-3140-2019; PAN, ZEQIANG/X-6341-2018; Glidewell, Liz/G-7338-2011	Willis, Thomas A/0000-0002-0252-9923; Willis, Thomas/0000-0002-0252-9923; Ward, Vicky/0000-0001-8684-0403; Lawton, Rebecca/0000-0002-5832-402X; Glidewell, Liz/0000-0003-2519-2654; Foy, Robbie/0000-0003-0605-7713; Stokes, Tim/0000-0002-1127-1952; McEachan, Rosemary/0000-0003-1302-6675; Farrin, Amanda/0000-0002-2876-0584; Hulme, Claire/0000-0003-2077-0419	National Institute for Health Research (NIHR) under Programme Grants for Applied Research scheme [RP-PG-1209-10040]; National Institute for Health Research [RP-PG-1209-10040, IPF-12-11] Funding Source: researchfish	National Institute for Health Research (NIHR) under Programme Grants for Applied Research scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-1209-10040); Principal Investigator: RF. The views expressed in this paper are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid AS, 2010, FAM PRACT, V27, P186, DOI 10.1093/fampra/cmp095; Ashworth Mark, 2006, BMC Fam Pract, V7, P68, DOI 10.1186/1471-2296-7-68; Baird B, 2016, UNDERSTANDING PRESSU; Baker R, 2002, BRIT J GEN PRACT, V52, pS2; Beaulieu MD, 2013, CAN MED ASSOC J, V185, pE590, DOI 10.1503/cmaj.121802; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooksey D, 2006, REV UK HLTH RES FUND; Dawda P, 2010, QUALITY IMPROVEMENT; Department of Health, 2013, CARD DIS OUTC STRAT; Down L, 2009, J CLIN EPIDEMIOL, V62, P67, DOI 10.1016/j.jclinepi.2008.02.014; Dreischulte T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-24; Dreischulte Tobias, 2012, BMC Clin Pharmacol, V12, P5, DOI 10.1186/1472-6904-12-5; Dumbreck S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h949; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Guthrie B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008270; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Kirk SA, 2003, QUAL SAF HEALTH CARE, V12, P421, DOI 10.1136/qhc.12.6.421; Kontopantelis E, 2013, BMJ OPEN, P3; Lau R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009993; Lawton R, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0479-2; Levine DA, 2013, JAMA INTERN MED, V173, P1619, DOI 10.1001/jamainternmed.2013.8090; Lord PA, 2016, FAM PRACT, V33, P200, DOI 10.1093/fampra/cmw003; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; McBride D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6267; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Ng CWL, 2013, BRIT J GEN PRACT, V63, pE604, DOI 10.3399/bjgp13X671588; Nouwens E, 2012, NETH J MED, V70, P298; Public Health England, 2014, NAT GEN PRACT PROF; Public Health England NHS England NHS Rightcare, 2015, NHS ATL VAR HEALTHC; Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Raleigh VS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1107; Reeves D, 2007, MED CARE, V45, P489, DOI 10.1097/MLR.0b013e31803bb479; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4060; Rushforth B, 2016, BRIT J GEN PRACT, V66, pE114, DOI 10.3399/bjgp16X683509; Rushforth B, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0350-6; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Smith J, 2013, SECURING FUTURE GEN; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; Stocks SJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5501; van den Hombergh P, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-23; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Willis TA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0387-5; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0; Wyatt KD, 2014, MED CARE, V52, pS92, DOI 10.1097/MLR.0b013e3182a51b3d	52	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0177949	10.1371/journal.pone.0177949	http://dx.doi.org/10.1371/journal.pone.0177949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704407	gold, Green Accepted, Green Published			2022-12-27	WOS:000405649700004
J	Peters, E; Shoots-Reinhard, B; Tompkins, MK; Schley, D; Meilleur, L; Sinayev, A; Tusler, M; Wagner, L; Crocker, J				Peters, Ellen; Shoots-Reinhard, Brittany; Tompkins, Mary Kate; Schley, Dan; Meilleur, Louise; Sinayev, Aleksander; Tusler, Martin; Wagner, Laura; Crocker, Jennifer			Improving numeracy through values affirmation enhances decision and STEM outcomes	PLOS ONE			English	Article							SELF-AFFIRMATION; FINANCIAL LITERACY; ACHIEVEMENT GAP; EDUCATION; IDENTITY; INTERVENTIONS; COMPREHENSION; PSYCHOLOGY; SELECTION; THINKING	Greater numeracy has been correlated with better health and financial outcomes in past studies, but causal effects in adults are unknown. In a 9-week longitudinal study, undergraduate students, all taking a psychology statistics course, were randomly assigned to a control condition or a values-affirmation manipulation intended to improve numeracy. By the final week in the course, the numeracy intervention (statistics-course enrollment combined with values affirmation) enhanced objective numeracy, subjective numeracy, and two decisionrelated outcomes (financial literacy and health-related behaviors). It also showed positive indirect-only effects on financial outcomes and a series of STEM-related outcomes (course grades, intentions to take more math-intensive courses, later math-intensive courses taken based on academic transcripts). All decision and STEM-related outcome effects were mediated by the changes in objective and/or subjective numeracy and demonstrated similar and robust enhancements. Improvements to abstract numeric reasoning can improve everyday outcomes.	[Peters, Ellen; Shoots-Reinhard, Brittany; Tompkins, Mary Kate; Meilleur, Louise; Sinayev, Aleksander; Tusler, Martin; Wagner, Laura; Crocker, Jennifer] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Schley, Dan] Erasmus Univ, Rotterdam Sch Management, Dept Mkt, Rotterdam, Netherlands	University System of Ohio; Ohio State University; Erasmus University Rotterdam	Peters, E (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	peters.498@osu.edu		Wagner, Laura/0000-0001-8557-4844	National Science Foundation [SES-1155924, SES-1558230]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation (https://www.nsf.gov/) provided support through grants SES-1155924 and -1558230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Banks J, 2007, FISC STUD, V28, P143, DOI 10.1111/j.1475-5890.2007.00052.x; Betz N. E., 2013, APA HDB TESTING ASSE, V2, P379, DOI [10.1037/14048-022, DOI 10.1037/14048-022]; BETZ NE, 1978, J COUNS PSYCHOL, V25, P441, DOI 10.1037/0022-0167.25.5.441; BETZ NE, 1983, J VOCAT BEHAV, V23, P329, DOI 10.1016/0001-8791(83)90046-5; Carr P. G., 2016, NAEP 2015 12 GRADE M; Cavanaugh K, 2008, ANN INTERN MED, V148, P737, DOI 10.7326/0003-4819-148-10-200805200-00006; Chen H., 2002, FINANCIAL SERVICES R, V11, P289, DOI DOI 10.1435/79783; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2014, ANNU REV PSYCHOL, V65, P333, DOI 10.1146/annurev-psych-010213-115137; Cohen GL, 2008, CURR DIR PSYCHOL SCI, V17, P365, DOI 10.1111/j.1467-8721.2008.00607.x; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Cook JE, 2012, J PERS SOC PSYCHOL, V102, P479, DOI 10.1037/a0026312; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; Dieckmann NF, 2015, CURR HIV RES, V13, P337, DOI 10.2174/1570162X13666150511123841; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Estrada CA, 2004, AM J MED SCI, V328, P88, DOI 10.1097/00000441-200408000-00004; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Fernandes D, 2014, MANAGE SCI, V60, P1861, DOI 10.1287/mnsc.2013.1849; FONG GT, 1986, COGNITIVE PSYCHOL, V18, P253, DOI 10.1016/0010-0285(86)90001-0; Ghazal S, 2014, JUDGM DECIS MAK, V9, P15; Hacker A., 2012, NY TIMES; HACKETT G, 1981, J VOCAT BEHAV, V18, P326, DOI 10.1016/0001-8791(81)90019-1; Hall CC, 2014, PSYCHOL SCI, V25, P619, DOI 10.1177/0956797613510949; Harackiewicz JM, 2014, J EDUC PSYCHOL, V106, P375, DOI 10.1037/a0034679; Huizinga MM, 2008, OBESITY, V16, P1966, DOI 10.1038/oby.2008.294; Inzlicht M, 2000, PSYCHOL SCI, V11, P365, DOI 10.1111/1467-9280.00272; Kaminski JA, 2008, SCIENCE, V320, P454, DOI 10.1126/science.1154659; Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111; LEHMAN DR, 1990, DEV PSYCHOL, V26, P952, DOI 10.1037/0012-1649.26.6.952; LEHMAN DR, 1988, AM PSYCHOL, V43, P431, DOI 10.1037/0003-066X.43.6.431; Logel C, 2012, PSYCHOL SCI, V23, P53, DOI 10.1177/0956797611421936; Lusardi A., 2012, NUMERACY, V5, P1, DOI 10.5038/1936-4660.5.1.2; Lusardi A, 2014, J ECON LIT, V52, P5, DOI 10.1257/jel.52.1.5; Martens A, 2006, J EXP SOC PSYCHOL, V42, P236, DOI 10.1016/j.jesp.2005.04.010; McQueen A, 2006, SELF IDENTITY, V5, P289, DOI 10.1080/15298860600805325; Miron-Shatz T, 2015, JUDGM DECIS MAK, V10, P386; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; NOVICK LR, 1988, J EXP PSYCHOL LEARN, V14, P510, DOI 10.1037/0278-7393.14.3.510; OECD, 2013, OECD SKILLS OUTL 201, P45, DOI 10.1787/9789264204256-5-en; Peters E, 2015, J PERS SOC PSYCHOL, V108, P802, DOI 10.1037/pspp0000019; Peters E, 2012, CURR DIR PSYCHOL SCI, V21, P31, DOI 10.1177/0963721411429960; Peters E, 2010, PSYCHOL SCI, V21, P1369, DOI 10.1177/0956797610381506; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rolison JJ, 2016, MED DECIS MAKING, V36, P876, DOI 10.1177/0272989X15602000; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Sherman DK, 2013, J PERS SOC PSYCHOL, V104, P591, DOI 10.1037/a0031495; Sherman DK, 2009, HEALTH PSYCHOL, V28, P554, DOI 10.1037/a0014663; SIMON B, 1987, J PERS SOC PSYCHOL, V53, P703, DOI 10.1037/0022-3514.53.4.703; Sinayev A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00532; Spencer SJ, 2005, J PERS SOC PSYCHOL, V89, P845, DOI 10.1037/0022-3514.89.6.845; Traczyk J, 2016, COGNITION, V151, P37, DOI 10.1016/j.cognition.2016.03.002; US National Science Board, 2010, SCIENCE AND ENGINEER; Wechsler D., 1997, WECHSLER ADULT INTEL; Weller JA, 2013, J BEHAV DECIS MAKING, V26, P198, DOI 10.1002/bdm.1751; Yeager DS, 2011, REV EDUC RES, V81, P267, DOI 10.3102/0034654311405999; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zunick PV, 2015, J PERS SOC PSYCHOL, V109, P1, DOI 10.1037/pspa0000027	61	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180674	10.1371/journal.pone.0180674	http://dx.doi.org/10.1371/journal.pone.0180674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28704410	Green Published, gold			2022-12-27	WOS:000405649600041
J	Ran, Q; Yang, JY; Yang, WJ; Wei, DT; Qiu, J; Zhang, D				Ran, Qian; Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang; Zhang, Dong			The association between resting functional connectivity and dispositional optimism	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURAL CIRCUITRY; EMOTION REGULATION; GENDER-DIFFERENCES; SUBJECTIVE VALUE; BRAIN ACTIVITY; STATE FMRI; ANXIETY; RESPONSES; BASES	Dispositional optimism is an individual characteristic that plays an important role in human experience. Optimists are people who tend to hold positive expectations for their future. Previous studies have focused on the neural basis of optimism, such as task response neural activity and brain structure volume. However, the functional connectivity between brain regions of the dispositional optimists are poorly understood. Previous study suggested that the ventromedial prefrontal cortex (vmPFC) are associated with individual differences in dispositional optimism, but it is unclear whether there are other brain regions that combine with the vmPFC to contribute to dispositional optimism. Thus, the present study used the resting-state functional connectivity (RSFC) approach and set the vmPFC as the seed region to examine if differences in functional brain connectivity between the vmPFC and other brain regions would be associated with individual differences in dispositional optimism. The results found that dispositional optimism was significantly positively correlated with the strength of the RSFC between vmPFC and middle temporal gyrus (mTG) and negativly correlated with RSFC between vmPFC and inferior frontal gyrus (IFG). These findings may be suggested that mTG and IFG which associated with emotion processes and emotion regulation also play an important role in the dispositional optimism.	[Ran, Qian; Zhang, Dong] Third Mil Med Univ, Xin Qiao Hosp, Dept Radiol, Chongqing, Peoples R China; [Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang] Minist Educ, SWU, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Yang, Junyi; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Army Medical University; Southwest University - China	Zhang, D (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Radiol, Chongqing, Peoples R China.; Qiu, J (corresponding author), Minist Educ, SWU, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; xqfskzd007@163.com						Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andersson G, 1996, PERS INDIV DIFFER, V21, P719, DOI 10.1016/0191-8869(96)00118-3; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], [No title captured]; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Blair KS, 2013, NEUROIMAGE, V78, P103, DOI 10.1016/j.neuroimage.2013.03.063; Blair KS, 2013, NEUROIMAGE; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1994, J RES PERS, V28, P133, DOI 10.1006/jrpe.1994.1011; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de Souza LC, 2010, NEUROPSYCHOLOGIA, V48, P3733, DOI 10.1016/j.neuropsychologia.2010.09.010; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Giltay EJ, 2006, ARCH INTERN MED, V166, P431, DOI 10.1001/.431; Goldin PR, 2005, NEUROIMAGE, V27, P26, DOI 10.1016/j.neuroimage.2005.03.018; Good C.D., 2002, BIOM IM 2002 5 IEEE; Goodin BR, 2012, J BEHAV MED, P1; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; HISCOCK M, 1994, J CLIN EXP NEUROPSYC, V16, P423, DOI 10.1080/01688639408402653; Johnstone T, 2006, SOC COGN AFFECT NEUR, V1, P242, DOI 10.1093/scan/nsl027; Kavallo D, 2003, HARVARD BUS REV; Kim K, 2015, SOC COGN AFFECT NEUR, V10, P494, DOI 10.1093/scan/nsu078; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Konick LC, 2001, BIOL PSYCHIAT, V49, P28, DOI 10.1016/S0006-3223(00)00974-4; KULYNYCH JJ, 1994, CEREB CORTEX, V4, P107, DOI 10.1093/cercor/4.2.107; Lai JCL, 2000, PERS INDIV DIFFER, V28, P781, DOI 10.1016/S0191-8869(99)00138-5; MacLeod AK, 2005, COGNITION EMOTION, V19, P357, DOI 10.1080/02699930441000247; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Peterson C, 2000, AM PSYCHOL, V55, P44, DOI 10.1037/0003-066X.55.1.44; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Ruthig JC, 2004, J APPL SOC PSYCHOL, V34, P709, DOI 10.1111/j.1559-1816.2004.tb02566.x; Schacter DL, 2007, NAT NEUROSCI, V10, P1345, DOI 10.1038/nn1107-1345; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sharot T, 2012, P NATL ACAD SCI USA, V109, P17058, DOI 10.1073/pnas.1205828109; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith DV, 2014, SOC COGN AFFECT NEUR, V9, P2017, DOI 10.1093/scan/nsu005; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wang ZQ, 2013, ARCH GERONTOL GERIAT, V56, P298, DOI 10.1016/j.archger.2012.08.016; Wu JF, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00618; Yan CG, 2013, NEUROIMAGE; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zung W.W.K., 1986, ASSESSMENT DEPRESSIO, P221, DOI 10.1007/978-3-642-70486-4n_21; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	75	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180334	10.1371/journal.pone.0180334	http://dx.doi.org/10.1371/journal.pone.0180334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700613	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600027
J	Koya, K; Chowdhury, G				Koya, Kushwanth; Chowdhury, Gobinda			Metric-based vs peer-reviewed evaluation of a research output: Lesson learnt from UK's national research assessment exercise	PLOS ONE			English	Article							IMPACT; INDICATORS	Purpose There is a general inquisition regarding the monetary value of a research output, as a substantial amount of funding in modern academia is essentially awarded to good research presented in the form of journal articles, conferences papers, performances, compositions, exhibitions, books and book chapters etc., which, eventually leads to another question if the value varies across different disciplines. Answers to these questions will not only assist academics and researchers, but will also help higher education institutions (HEIs) make informed decisions in their administrative and research policies. Design and methodology To examine both the questions, we applied the United Kingdom's recently concluded national research assessment exercise known as the Research Excellence Framework (REF) 2014 as a case study. All the data for this study is sourced from the openly available publications which arose from the digital repositories of REF's results and HEFCE's funding allocations. Findings A world leading output earns between 7504 pound and 14,639 pound per year within the REF cycle, whereas an internationally excellent output earns between 1876 pound and 3659 pound, varying according to their area of research. Secondly, an investigation into the impact rating of 25315 journal articles submitted in five areas of research by UK HEIs and their awarded funding revealed a linear relationship between the percentage of quartile-one journal publications and percentage of 4* outputs in Clinical Medicine, Physics and Psychology/Psychiatry/Neuroscience UoAs, and no relationship was found in the Classics and Anthropology/Development Studies UoAs, due to the fact that most publications in the latter two disciplines are not journal articles. Practical implications The findings provide an indication of the monetary value of a research output, from the perspectives of government funding for research, and also what makes a good output, i.e. whether a relationship exists between good quality output and the source of its publication. The findings may also influence future REF submission strategies in HEIs and ascertain that the impact rating of the journals is not necessarily a reflection of the quality of research in every discipline, and this may have a significant influence on the future of scholarly communications in general. Originality According to the author's knowledge, this is the first time an investigation has estimated the monetary value of a good research output.	[Koya, Kushwanth; Chowdhury, Gobinda] Northumbria Univ, Fac Engn & Environm, ISch Dept Comp & Informat Sci, Pandon Bldg,Camden St,Newcastle City Campus, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University	Koya, K (corresponding author), Northumbria Univ, Fac Engn & Environm, ISch Dept Comp & Informat Sci, Pandon Bldg,Camden St,Newcastle City Campus, Newcastle Upon Tyne, Tyne & Wear, England.	k.koya@northumbria.ac.uk	chowdhury, gobinda/K-3518-2019	chowdhury, gobinda/0000-0002-2122-9547; Koya, Kushwanth/0000-0002-7718-1116				Abramo G, 2011, SCIENTOMETRICS, V87, P499, DOI 10.1007/s11192-011-0352-7; Abramo G, 2009, RES POLICY, V38, P206, DOI 10.1016/j.respol.2008.11.001; Altmetrics Priem J., 2014, BIBLIOMETRICS HARNES; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Cramer D., 2003, ADV QUANTITATIVE DAT; Cramer D., 1998, FUNDAMENTAL STAT SOC; Feeney MK, 2012, PUBLIC ADMIN REV, V72, P272, DOI 10.1111/j.1540-6210.2011.02521.x; HEFCE, 2015, ANN FUND ALL; HESA, 2013, FIN PLUS 2011 2012; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Jayasinghe UW, 2001, EDUC EVAL POLICY AN, V23, P343, DOI 10.3102/01623737023004343; Jump P., 2015, TIMES HIGHER ED, V26, P6; Kousha K, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P289; Marks MS, 2013, TRAFFIC, V14, P611, DOI 10.1111/tra.12075; Martin B. R., 2007, RETH IMP BAS RES SOC; Moed HF, 2015, J ASSOC INF SCI TECH, V66, P1988, DOI 10.1002/asi.23314; REF, 2014, AB THE REF; REF, 2014, ASS FRAM GUID SUBM; Seglen PO, 1997, BRIT MED J, V314, P498; The Complete University Guide, 2016, METH BUILD LEAG TABL; Universities UK, 2015, IMP U UK EC; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Vieira ES, 2014, J INFORMETR, V8, P390, DOI 10.1016/j.joi.2014.01.012; Waltman L, 2016, J INFORMETR, V10, P365, DOI 10.1016/j.joi.2016.02.007; Watermeyer R, 2016, J EDUC POLICY, V31, P651, DOI 10.1080/02680939.2016.1170885; Wilsdon J., 2015, GUARDIAN; Wilsdon J., 2016, METRIC TIDE INDEPEND	27	4	4	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179722	10.1371/journal.pone.0179722	http://dx.doi.org/10.1371/journal.pone.0179722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700651	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000405649400006
J	Rusconi, P; Sacchi, S; Capellini, R; Brambilla, M; Cherubini, P				Rusconi, Patrice; Sacchi, Simona; Capellini, Roberta; Brambilla, Marco; Cherubini, Paolo			You are fair, but I expect you to also behave unfairly: Positive asymmetry in trait-behavior relations for moderate morality information	PLOS ONE			English	Article							PERSON PERCEPTION; IMPRESSION-FORMATION; DISPOSITIONAL ATTRIBUTION; INFERENTIAL PROCESSES; BAYESIAN-ANALYSIS; BRAIN POTENTIALS; EXTREMITY BIASES; AVERAGING MODEL; SOCIAL JUDGMENT; MECHANICAL TURK	Trait inference in person perception is based on observers' implicit assumptions about the relations between trait adjectives (e.g., fair) and the either consistent or inconsistent behaviors (e.g., having double standards) that an actor can manifest. This article presents new empirical data and theoretical interpretations on people' behavioral expectations, that is, people's perceived trait-behavior relations along the morality (versus competence) dimension. We specifically address the issue of the moderate levels of both traits and behaviors almost neglected by prior research by using a measure of the perceived general frequency of behaviors. A preliminary study identifies a set of competence-and morality-related traits and a subset of traits balanced for valence. Studies 1-2 show that moral target persons are associated with greater behavioral flexibility than immoral ones where abstract categories of behaviors are concerned. For example, participants judge it more likely that a fair person would behave unfairly than an unfair person would behave fairly. Study 3 replicates the results of the first 2 studies using concrete categories of behaviors (e.g., telling the truth/omitting some information). Study 4 shows that the positive asymmetry in morality-related trait-behavior relations holds for both North-American and European (i.e., Italian) individuals. A small-scale meta-analysis confirms the existence of a positive asymmetry in traitbehavior relations along both morality and competence dimensions for moderate levels of both traits and behaviors. We discuss these findings in relation to prior models and results on trait-behavior relations and we advance a motivational explanation based on selfprotection.	[Rusconi, Patrice] Univ Surrey, Sch Psychol, Guildford, Surrey, England; [Sacchi, Simona; Capellini, Roberta; Brambilla, Marco; Cherubini, Paolo] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Surrey; University of Milano-Bicocca	Rusconi, P (corresponding author), Univ Surrey, Sch Psychol, Guildford, Surrey, England.	p.rusconi@surrey.ac.uk	Cherubini, Paolo/AAD-5038-2022; Brambilla, Marco/I-9342-2018; Rusconi, Patrice/AAD-3242-2020	Brambilla, Marco/0000-0002-4774-3309; Rusconi, Patrice/0000-0002-0095-4061	Italian Ministry of Education, University, and Research [FIRB: RBFR128CR6]	Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by two grants from the Italian Ministry of Education, University, and Research to P.C. and S.S. (PRIN 2010-2011), and to S.S. and M.B. (FIRB: RBFR128CR6).	ANDERSON CA, 1991, J PERS SOC PSYCHOL, V60, P203; Aristotle, 2009, THE NICOMACHEAN ETHI; Ashton MC, 2001, EUR J PERSONALITY, V15, P327, DOI 10.1002/per.417; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biernat M, 2005, PERS SOC PSYCHOL B, V31, P483, DOI 10.1177/0146167204271712; BIRNBAUM MH, 1971, J EXP PSYCHOL, V88, P158, DOI 10.1037/h0030880; BIRNBAUM MH, 1974, J EXP PSYCHOL, V102, P543, DOI 10.1037/h0036014; BIRNBAUM MH, 1973, J EXP PSYCHOL, V99, P395, DOI 10.1037/h0035216; BIRNBAUM MH, 1972, J EXP PSYCHOL, V93, P35, DOI 10.1037/h0032589; Brambilla M, 2014, SOC COGNITION, V32, P397, DOI 10.1521/soco.2014.32.4.397; Brambilla M, 2013, J EXP SOC PSYCHOL, V49, P811, DOI 10.1016/j.jesp.2013.04.005; Brambilla M, 2012, BRIT J SOC PSYCHOL, V51, P149, DOI 10.1111/j.2044-8309.2010.02011.x; Brambilla M, 2011, EUR J SOC PSYCHOL, V41, P135, DOI 10.1002/ejsp.744; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cameron JA, 2004, SOC COGNITION, V22, P650, DOI 10.1521/soco.22.6.650.54818; Cohen J, 1988, STATISTICAL POWER AN; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Cumming G., 2012, UNDERSTANDING THE NE; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; De Raad B, 2005, EUR J PERSONALITY, V19, P451, DOI 10.1002/per.550; DEVINE PG, 1990, J PERS SOC PSYCHOL, V58, P952, DOI 10.1037/0022-3514.58.6.952; Duran A, 2007, SEX ROLES, V57, P763, DOI 10.1007/s11199-007-9293-2; EVETT SR, 1994, J EXP SOC PSYCHOL, V30, P456, DOI 10.1006/jesp.1994.1022; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; GIDRON D, 1993, PERS SOC PSYCHOL B, V19, P594, DOI 10.1177/0146167293195011; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Goodwin GP, 2015, CURR DIR PSYCHOL SCI, V24, P38, DOI 10.1177/0963721414550709; Goodwin GP, 2014, J PERS SOC PSYCHOL, V106, P148, DOI 10.1037/a0034726; Hammond KR, 2007, BEYOND RATIONALITY T; Heider F., 1958, THE PSYCHOLOGY OF IN; Kanouse D.E., 1972, ATTRIBUTION PERCEIV, P47; Kant I, 2015, CRITIQUE OF PRACTICA; Kohlberg L., 1981, ESSAYS ON MORAL DEVE, VI; Kohlberg Lawrence, 1984, ESSAYS ON MORAL DEVE, V2; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Lindzey G., 1998, HDB SOCIAL PSYCHOL, V4th ed., P89; Maass A, 1998, EUR J SOC PSYCHOL, V28, P383, DOI 10.1002/(SICI)1099-0992(199805/06)28:3<383::AID-EJSP870>3.0.CO;2-Q; MARTIJN C, 1992, EUR J SOC PSYCHOL, V22, P453, DOI 10.1002/ejsp.2420220504; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Meindl P, 2016, PERS SOC PSYCHOL B, V42, P540, DOI 10.1177/0146167216636625; Mende-Siedlecki P, 2013, J NEUROSCI, V33, P19406, DOI 10.1523/JNEUROSCI.2334-13.2013; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; QUATTRONE GA, 1982, J PERS SOC PSYCHOL, V42, P593, DOI 10.1037/0022-3514.42.4.593; Reeder G. D., 2006, POL PSYCHOL BULL, V37, P191; Reeder G.D., 1992, LANGUAGE INTERACTION, P37; REEDER GD, 1993, PERS SOC PSYCHOL B, V19, P586, DOI 10.1177/0146167293195010; Reeder GD, 1997, J EXP SOC PSYCHOL, V33, P171, DOI 10.1006/jesp.1996.1316; REEDER GD, 1980, J EXP SOC PSYCHOL, V16, P33, DOI 10.1016/0022-1031(80)90034-7; REEDER GD, 1979, PSYCHOL REV, V86, P61, DOI 10.1037/0033-295X.86.1.61; REEDER GD, 1982, J RES PERS, V16, P355, DOI 10.1016/0092-6566(82)90032-0; REEDER GD, 1983, J PERS SOC PSYCHOL, V44, P736, DOI 10.1037/0022-3514.44.4.736; ROTHBART M, 1986, J PERS SOC PSYCHOL, V50, P131, DOI 10.1037/0022-3514.50.1.131; Rusconi P, 2012, EXP PSYCHOL, V59, P243, DOI 10.1027/1618-3169/a000149; Sacchi S, 2012, BRIT J SOC PSYCHOL, V51, P606, DOI 10.1111/j.2044-8309.2011.02026.x; Singh R, 2000, BRIT J SOC PSYCHOL, V39, P537, DOI 10.1348/014466600164624; SKOWRONSKI JJ, 1987, J PERS SOC PSYCHOL, V52, P689, DOI 10.1037/0022-3514.52.4.689; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Trafimow D, 2001, SOC SCI J, V38, P421, DOI 10.1016/S0362-3319(01)00132-X; Trafimow D, 1999, PERS SOC PSYCHOL B, V25, P686, DOI 10.1177/0146167299025006004; TRAFIMOW D, 1994, J EXP SOC PSYCHOL, V30, P351, DOI 10.1006/jesp.1994.1017; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Trope Y, 1997, J PERS SOC PSYCHOL, V73, P229, DOI 10.1037/0022-3514.73.2.229; TROPE Y, 1974, J EXP SOC PSYCHOL, V10, P1, DOI 10.1016/0022-1031(74)90052-3; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; WOJCISZKE B, 1993, J PERS SOC PSYCHOL, V64, P327, DOI 10.1037/0022-3514.64.3.327; Wyer R.S, 1975, COGNITIVE ORG CHANGE	70	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180686	10.1371/journal.pone.0180686	http://dx.doi.org/10.1371/journal.pone.0180686			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700702	Green Published, gold			2022-12-27	WOS:000405649400017
J	Horvat, OJ; Tomas, AD; Kusturica, MMP; Savkov, AV; Bukumiric, DU; Tomic, ZS; Sabo, AJ				Horvat, Olga J.; Tomas, Ana D.; Kusturica, Milica M. Paut; Savkov, Alisa V.; Bukumiric, Dragica U.; Tomic, Zdenko S.; Sabo, Ana J.			Is the level of knowledge a predictor of rational antibiotic use in Serbia?	PLOS ONE			English	Article							PUBLIC KNOWLEDGE; SELF-MEDICATION; ATTITUDES; RESISTANCE; COMMUNITY; BEHAVIOR; HEALTH	Introduction The objective of this study was to investigate the knowledge, attitudes and behavior regarding antibiotics of the general population. Methods The study sample consisted of adult subjects who consulted general practitioners at health centers in Serbia and agreed to complete the questionnaire. A total of 668 questionnaires were distributed; 500 respondents completed the entire questionnaire (response rate 74.85%). Results The average age was 51.65 +/- 16.56 years, 60.80% of the respondents were women. The median antibiotic knowledge score was 9. Predictors of adequate antibiotic knowledge were higher education level and a family member whose ocuppation was related to health-care. Overall, 58.4% of respondents believed that antibiotics could be used to treat common cold. Around a half of the respondents (47.2%) self-medicated with antibiotics at least once during their life-time, and around a quarter (24.2%) during the last treatment of infection. Patients with inadequate knowledge had 3 times higher chances of self-medicating with antibiotics compared to those with adequate knowledge. Although 98.20% of respondents claimed that antibiotic treatment should be started after a visit to a doctor and receiving a prescription, only 65.8% obtained antibiotics with prescription from a doctor during the last infection. Conclusions Although these results demonstrate that respondents had a relatively adequate level of knowledge regarding antibiotics use, some areas of misconceptions and improper behavior were identified. Therefore, further rationalization should be focused on educational campaigns targeting the behavior of patients with regard to antibiotic use.	[Horvat, Olga J.; Tomas, Ana D.; Kusturica, Milica M. Paut] Univ Novi Sad, Fac Med Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad, Serbia; [Savkov, Alisa V.; Tomic, Zdenko S.; Sabo, Ana J.] Univ Novi Sad, Ctr Appl Stat, Novi Sad, Serbia; [Bukumiric, Dragica U.] Primary Hlth Care Ctr, Dept Planning Analysing & Stat, Pancevo, Serbia	University of Novi Sad; University of Novi Sad	Horvat, OJ (corresponding author), Univ Novi Sad, Fac Med Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad, Serbia.	olga.horvat@mf.uns.ac.rs	Tomas, Ana/L-4426-2018	Tomas, Ana/0000-0003-2361-872X	Ministry of Science and Technological development, Republic of Serbia [41012]; Provincial Secretariat for Science and Technological Development [142-451-3680/2016-03]	Ministry of Science and Technological development, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Provincial Secretariat for Science and Technological Development	This work was supported by the Ministry of Science and Technological development, Republic of Serbia, Project No. 41012. and Provincial Secretariat for Science and Technological Development-142-451-3680/2016-03.	[Anonymous], 2015, INT J ENV RES PUB HE, V12, P7002, DOI DOI 10.3390/IJERPH120607002; [Anonymous], 2014, ANT RES INV CLIN BAC; [Anonymous], 2014, ANN REPORT CENTRAL A; Awad AI, 2015, PLOS ONE, V10; BRITTEN N, 1995, BRIT MED J, V310, P1084, DOI 10.1136/bmj.310.6987.1084; Buke AC, 2003, INT J ANTIMICROB AG, V21, P63, DOI 10.1016/S0924-8579(02)00272-8; Chen Changhua, 2005, Journal of Microbiology Immunology and Infection, V38, P53; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; European Commission, 2013, SPEC EUR 107 ANT RES; Godycki-Cwirko M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109248; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hawkings NJ, 2008, PATIENT EDUC COUNS, V73, P146, DOI 10.1016/j.pec.2008.05.025; Horvat O., 2008, THESIS; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Kusturica MP, 2015, CENT EUR J PUBL HEAL, V23, P114; Lim Ka Keat, 2012, South Med Rev, V5, P26; Mangione-Smith R, 2001, ARCH PEDIAT ADOL MED, V155, P800, DOI 10.1001/archpedi.155.7.800; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Prostran M, 2001, ANTIBIOTICS 2001, P89; Pulcini C, 2011, CLIN MICROBIOL INFEC, V17, P80, DOI 10.1111/j.1469-0691.2010.03179.x; Radosevic N, 2009, PHARMACOEPIDEM DR S, V18, P691, DOI 10.1002/pds.1768; Rouusounides A, 2011, INT J ENV RES PUB HE, V8, P3246, DOI 10.3390/ijerph8083246; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; Velickovic-Radovanovic R, 2015, J CLIN PHARM THER, V40, P426, DOI 10.1111/jcpt.12283; VELICKOVICRADOV.R, 2012, NIS J CLIN PHARM THE, V37, P32, DOI DOI 10.1111/J.1365-2710.2010.01241.X; WHO, 2015, ANT RES MULT PUBL AW; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	34	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180799	10.1371/journal.pone.0180799	http://dx.doi.org/10.1371/journal.pone.0180799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700631	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800079
J	Samarasekera, N; Rodrigues, MA; Toh, PS; Salman, RA				Samarasekera, Neshika; Rodrigues, Mark Alexander; Toh, Pheng Shiew; Salman, Rustam Al-Shahi			Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis	PLOS ONE			English	Review							PATHOLOGICAL CORRELATION; DIAGNOSIS; LEUKOENCEPHALOPATHY; ASSOCIATION; HEMATOMA; DISEASE; BIOPSY; STROKE	Background We sought to summarize Computed Tomography (CT)/Magnetic Resonance Imaging (MRI) features of intracerebral hemorrhage (ICH) associated with cerebral amyloid angiopathy (CAA) in published observational radio-pathological studies. Methods In November 2016, two authors searched OVID Medline (1946-), Embase (1974-) and relevant bibliographies for studies of imaging features of lobar or cerebellar ICH with pathologically proven CAA ("CAA-associated ICH"). Two authors assessed studies' diagnostic test accuracy methodology and independently extracted data. Results We identified 22 studies (21 cases series and one cross-sectional study with controls) of CT features in 297 adults, two cross-sectional studies of MRI features in 81 adults and one study which reported both CT and MRI features in 22 adults. Methods of CAA assessment varied, and rating of imaging features was not masked to pathology. The most frequently reported CT features of CAA-associated ICH in 21 case series were: subarachnoid extension (pooled proportion 82%, 95% CI 69-93%, I-2 = 51%, 12 studies) and an irregular ICH border (64%, 95% CI 32-91%, I-2 = 85%, five studies). CAA-associated ICH was more likely to be multiple on CT than non-CAA ICH in one cross-sectional study (CAA-associated ICH 7/41 vs. non-CAA ICH 0/42;chi(2) = 7.8, p = 0.005). Superficial siderosis on MRI was present in 52% of CAA-associated ICH (95% CI 39-65%, I-2 = 35%, 3 studies). Conclusions Subarachnoid extension and an irregular ICH border are common imaging features of CAAassociated ICH, but methodologically rigorous diagnostic test accuracy studies are required to determine the sensitivity and specificity of these features.	[Samarasekera, Neshika; Rodrigues, Mark Alexander; Toh, Pheng Shiew; Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Rodrigues, MA (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	mark.rodrigues@ed.ac.uk		Rodrigues, Mark/0000-0002-4507-6872; Samarasekera, Neshika/0000-0001-6840-0199; Al-Shahi Salman, Rustam/0000-0002-2108-9222	Wellcome Trust Clinical Fellowship [203699/Z/16/Z]; Medical Research Council [G0900428, G1002605] Funding Source: researchfish; MRC [G1002605, G0900428] Funding Source: UKRI	Wellcome Trust Clinical Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Clinical Fellowship (Grant number 203699/Z/16/Z, https://wellcome.ac.uk/) to MAR.	Altman DG, PREFERRED REPORTING; Andoh Y, 1989, No To Shinkei, V41, P1217; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; BROWN RT, 1985, J CAN ASSOC RADIOL, V36, P308; Charidimou A, 2015, NEUROLOGY, V84, P1206, DOI [10.1212/WNL.0000000000003115, 10.1212/WNL.0000000000001398]; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Chen Chuang-Sin, 2004, Acta Neurol Taiwan, V13, P14; Chen GF, 2014, STROKE, V45, P258, DOI 10.1161/STROKEAHA.113.003524; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; COSGROVE GR, 1985, NEUROLOGY, V35, P625, DOI 10.1212/WNL.35.5.625; Delcourt C, 2016, STROKE, V47, P1227, DOI 10.1161/STROKEAHA.116.012921; Doden T, 2016, J STROKE CEREBROVASC, V25, P1736, DOI 10.1016/j.jstrokecerebrovasdis.2016.03.041; Farid K, 2017, NEUROIMAGE-CLIN, V15, P247, DOI 10.1016/j.nicl.2017.05.002; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; GRAY F, 1985, ANN NEUROL, V18, P54, DOI 10.1002/ana.410180110; Greenberg SM, 1997, STROKE, V28, P1418, DOI 10.1161/01.STR.28.7.1418; Hagen T, 1999, RADIOLOGE, V39, P847, DOI 10.1007/s001170050721; Haley KE, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0425-8; Hirohata M, 2010, EUR J NEUROL, V17, P823, DOI 10.1111/j.1468-1331.2009.02940.x; Izumihara A, 1999, STROKE, V30, P29, DOI 10.1161/01.STR.30.1.29; KALYANRAMAN UP, 1984, ANN NEUROL, V16, P321, DOI 10.1002/ana.410160308; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Lang EW, 2001, CEREBROVASC DIS, V12, P121, DOI 10.1159/000047691; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Miller JH, 1999, CLIN RADIOL, V54, P422, DOI 10.1016/S0009-9260(99)90825-5; MINAKAWA T, 1995, ACTA NEUROCHIR, V132, P48, DOI 10.1007/BF01404847; Oide T, 2003, AMYLOID, V10, P136, DOI 10.3109/13506120308998994; Panicker JN, 2010, ANN INDIAN ACAD NEUR, V13, P216, DOI 10.4103/0972-2327.70879; PATEL DV, 1984, RADIOLOGY, V151, P397, DOI 10.1148/radiology.151.2.6709910; Patel PV, 2009, ARCH NEUROL-CHICAGO, V66, P79, DOI 10.1001/archneur.66.1.79; RAMSAY DA, 1990, CAN J NEUROL SCI, V17, P336, DOI 10.1017/S0317167100030705; Samarasekera N, 2015, STROKE, V46, P361, DOI 10.1161/STROKEAHA.114.007953; Samarasekera N, 2012, J NEUROL NEUROSUR PS, V83, P275, DOI 10.1136/jnnp-2011-300371; SOBEL DF, 1985, NEURORADIOLOGY, V27, P318, DOI 10.1007/BF00339564; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; WAGLE WA, 1984, AM J NEURORADIOL, V5, P171; WAKAI S, 1992, J NEUROSURG, V76, P231, DOI 10.3171/jns.1992.76.2.0231; Wang X, 2000, CHINESE J NEUROLOGY, V33, P83; Xu H Q, 1990, Zhonghua Shen Jing Jing Shen Ke Za Zhi, V23, P345; YONG WH, 1992, ARCH NEUROL-CHICAGO, V49, P51, DOI 10.1001/archneur.1992.00530250055016	42	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180923	10.1371/journal.pone.0180923	http://dx.doi.org/10.1371/journal.pone.0180923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700676	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800100
J	Yoo, KD; Lee, JP; Lee, SM; Park, JY; Lee, H; Kim, DK; Kang, SW; Yang, CW; Kim, YL; Lim, CS; Joo, KW; Kim, YS				Yoo, Kyung Don; Lee, Jung Pyo; Lee, Su Mi; Park, Jae Yoon; Lee, Hajeong; Kim, Dong Ki; Kang, Shin-Wook; Yang, Chul Woo; Kim, Yong-Lim; Lim, Chun Soo; Joo, Kwon Wook; Kim, Yon Su			Cancer in Korean patients with end-stage renal disease: A 7-year follow-up	PLOS ONE			English	Article							CELL CARCINOMA; DIALYSIS PATIENTS; INCREASED RISK; KIDNEY; TRANSPLANTATION; MALIGNANCY; TAIWAN; IMMUNOSUPPRESSION; HEMODIALYSIS; POPULATION	Background The effectiveness of dialysis on the incidence of cancer in patients with end-stage renal disease (ESRD) remains to be clarified. In this study, we evaluated the incidence rate and type of cancer among patients with ESRD, compared to the general population, through a prospective 7-year follow-up. We also calculated the cumulative incidence rate of cancer associated with ESRD, with stratification to control for the competing risk of death. Methods This prospective observational cohort study was conducted using data from a nationwide study on patients with ESRD in Korea. A total of 5,235 patients, >= 18 years old, with ESRD were identified from the national registry as being treated by dialysis between August 2008 and December 2014. The standardized incidence ratio (SIR) and cumulative incidence rate of specific cancers were evaluated and compared to the general population. Results A total of 5,235 participants were included. During the 7 year observation period, 116 (2.2%) participants had been diagnosed as cancer. The SIR of overall cancer was 0.94 [ 95% confidence interval (CI), 0.72-1.19] and was comparable to the rate for the general population. Although the digestive organs were the most frequent site of a primary site cancer (N = 39, 33.6%), the SIR was highest for urinary tract cancer [ 4.7, 95% CI, 2.42-8.19]. The five year standardized cumulative incidence of cancer was higher for females than for males, and for non-diabetic compared to diabetic causes of ESRD. We estimated that the five year standardized cumulative incidence was highest [ 8.4, 95% CI, 5.07-13.75] in patients with ESRD, caused by glomerulonephritis. Conclusion A screening program should be necessary for urinary tract cancer in Korean patients with ESRD. Cancer screening programs for patients with ESRD in Korea should be emphasized on female patients and patients with non-diabetic ESRD.	[Yoo, Kyung Don; Park, Jae Yoon] Dongguk Univ, Dept Internal Med, Coll Med, Gyeongju, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Su Mi] Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea	Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Dong A University; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Catholic University of Korea; Kyungpook National University; Kyungpook National University Hospital	Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	yonsukim@snu.ac.kr	Kim, Dong Ki/J-5389-2012; Yoo, Kyung Don/AAK-8096-2020	Kim, Dong Ki/0000-0002-5195-7852; Yoo, Kyung Don/0000-0001-6545-6517	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1129]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1129).	AKIZAWA T, 1994, NEPHROL DIAL TRANSPL, V9, P162; Butler AM, 2015, AM J KIDNEY DIS, V65, P763, DOI 10.1053/j.ajkd.2014.12.013; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Chung CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044675; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Denton MD, 2002, KIDNEY INT, V61, P2201, DOI 10.1046/j.1523-1755.2002.00374.x; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; DUNN SR, 1990, J NATL CANCER I, V82, P783, DOI 10.1093/jnci/82.9.783; DUNNILL MS, 1977, J CLIN PATHOL, V30, P868, DOI 10.1136/jcp.30.9.868; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gallagher MP, 2010, J AM SOC NEPHROL, V21, P852, DOI 10.1681/ASN.2009101043; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Holley JL, 2007, CLIN J AM SOC NEPHRO, V2, P604, DOI 10.2215/CJN.03931106; Hughson MD, 1996, J AM SOC NEPHROL, V7, P2461; Imao T, 2007, CANCER-AM CANCER SOC, V109, P2109, DOI 10.1002/cncr.22636; ISHIKAWA I, 1990, AM J KIDNEY DIS, V16, P452, DOI 10.1016/S0272-6386(12)80058-8; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Kalbfleish JD, 1980, THE STATISTICAL ANAL; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kojima Y, 2006, INT J UROL, V13, P1045, DOI 10.1111/j.1442-2042.2006.01498.x; Lee JE, 2009, J KOREAN MED SCI, V24, pS95, DOI 10.3346/jkms.2009.24.S1.S95; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122856; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; MARUBINI E, 1995, ANALYSING SURVIVAL D; National Patient Safety Agency (NPSA) England, REDUCING RISK OF HAR; PENN I, 1986, TRANSPLANT P, V18, P210; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Satagopan JM, 2001, BRIT J CANCER, V91, P1229; Satoh S, 2005, J UROLOGY, V174, P1749, DOI 10.1097/01.ju.0000177489.98031.54; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vamvakas S, 1996, TRANSPLANT P, V28, P3468; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	40	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178649	10.1371/journal.pone.0178649	http://dx.doi.org/10.1371/journal.pone.0178649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692695	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800006
J	Almutairy, M; Torng, E				Almutairy, Meznah; Torng, Eric			The effects of sampling on the efficiency and accuracy of k-mer indexes: Theoretical and empirical comparisons using the human genome	PLOS ONE			English	Article							MAXIMAL EXACT MATCHES; SEARCH; GENERATION; ALGORITHM; BLAST	One of the most common ways to search a sequence database for sequences that are similar to a query sequence is to use a k-mer index such as BLAST. A big problem with k-mer indexes is the space required to store the lists of all occurrences of all k-mers in the database. One method for reducing the space needed, and also query time, is sampling where only some k-mer occurrences are stored. Most previous work uses hard sampling, in which enough k-mer occurrences are retained so that all similar sequences are guaranteed to be found. In contrast, we study soft sampling, which further reduces the number of stored k-mer occurrences at a cost of decreasing query accuracy. We focus on finding highly similar local alignments (HSLA) over nucleotide sequences, an operation that is fundamental to biological applications such as cDNA sequence mapping. For our comparison, we use the NCBI BLAST tool with the human genome and human ESTs. When identifying HSLAs, we find that soft sampling significantly reduces both index size and query time with relatively small losses in query accuracy. For the human genome and HSLAs of length at least 100 bp, soft sampling reduces index size 4-10 times more than hard sampling and processes queries 2.3-6.8 times faster, while still achieving retention rates of at least 96.6%. When we apply soft sampling to the problem of mapping ESTs against the genome, we map more than 98% of ESTs perfectly while reducing the index size by a factor of 4 and query time by 23.3%. These results demonstrate that soft sampling is a simple but effective strategy for performing efficient searches for HSLAs. We also provide a new model for sampling with BLAST that predicts empirical retention rates with reasonable accuracy by modeling two key problem factors.	[Almutairy, Meznah; Torng, Eric] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University	Almutairy, M; Torng, E (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	almutai4@msu.edu; torng@msu.edu		Almutairy, Meznah/0000-0001-7254-1867				Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Ahmadi A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1246; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chikhi R, 2014, LECT N BIOINFORMAT, V8394, P35, DOI 10.1007/978-3-319-05269-4_4; Danek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109384; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hatem A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-184; Hormozdiari F, 2011, BIOINFORMATICS, V27, P1915, DOI 10.1093/bioinformatics/btr303; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khiste N, 2015, BIOINFORMATICS, V31, P509, DOI 10.1093/bioinformatics/btu687; Li H., 2016, BIOINFORMATICS; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Movahedi NS, 2012, 2012 IEEE INT C BIOI, P1; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Roberts M, 2004, J COMPUT BIOL, V11, P734; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Vyverman M, 2013, BIOINFORMATICS, V29, P802, DOI 10.1093/bioinformatics/btt042; Wandelt S, 2015, PROC VLDB ENDOW, V8, P461, DOI 10.14778/2735479.2735480; Wandelt S, 2013, PROC VLDB ENDOW, V6, P1534, DOI 10.14778/2536258.2536265; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xin HY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S13; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179046	10.1371/journal.pone.0179046	http://dx.doi.org/10.1371/journal.pone.0179046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686614	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100007
J	Poll, G; Muller, C; Bodden, M; Teubl, F; Eichner, N; Lehmann, G; Griesenbeck, J; Tschochner, H; Milkereit, P				Poell, Gisela; Mueller, Christian; Bodden, Malena; Teubl, Fabian; Eichner, Norbert; Lehmann, Gerhard; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Structural transitions during large ribosomal subunit maturation analyzed by tethered nuclease structure probing in S.cerevisiae	PLOS ONE			English	Article							REMODELING EVENTS; RNA MATURATION; BIOGENESIS; PROTEINS; COMPLEX; SYSTEM; EXPORT; MODEL; ITS2	Yeast large ribosomal subunit (LSU) precursors are subject to substantial changes in protein composition during their maturation due to coordinated transient interactions with a large number of ribosome biogenesis factors and due to the assembly of ribosomal proteins. These compositional changes go along with stepwise processing of LSU rRNA precursors and with specific rRNA folding events, as revealed by recent cryo-electron microscopy analyses of late nuclear and cytoplasmic LSU precursors. Here we aimed to analyze changes in the spatial rRNA surrounding of selected ribosomal proteins during yeast LSU maturation. For this we combined a recently developed tethered tertiary structure probing approach with both targeted and high throughput readout strategies. Several structural features of late LSU precursors were faithfully detected by this procedure. In addition, the obtained data let us suggest that early rRNA precursor processing events are accompanied by a global transition from a flexible to a spatially restricted rRNA conformation. For intermediate LSU precursors a number of structural hallmarks could be addressed which include the fold of the internal transcribed spacer between 5.8S rRNA and 25S rRNA, the orientation of the central protuberance and the spatial organization of the interface between LSU rRNA domains I and III.	[Poell, Gisela; Mueller, Christian; Bodden, Malena; Teubl, Fabian; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany; [Eichner, Norbert; Lehmann, Gerhard] Univ Regensburg, Lehrstuhl Biochem 1, Regensburg, Germany; [Mueller, Christian] Max F Perutz Labs, Vienna, Austria; [Bodden, Malena] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany	University of Regensburg; University of Regensburg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Octapharma	Griesenbeck, J; Tschochner, H; Milkereit, P (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	joachim.griesenbeck@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de		Griesenbeck, Joachim/0000-0002-7817-6095	"Deutsche Forschungsgemeinschaft" [SFB 960]	"Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Biedka S, 2017, RNA BIOL; Burke D., 2000, METHODS YEAST GENETI; Coleman AW, 2015, TRENDS GENET TIG; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Dembowski JA, 2013, RNA, V19, P1639, DOI 10.1261/rna.041194.113; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Geerlings TH, 2000, RNA, V6, P1698, DOI 10.1017/S1355838200001540; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Greber BJ, 2016, RNA, V22, P1643, DOI 10.1261/rna.057927.116; Greber BJ, 2016, CELL, V164, P91, DOI 10.1016/j.cell.2015.11.027; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hierlmeier T, 2012, NUCL ACIDS RES; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Kielpinski LJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku167; Konikkat S, 2017, NUCLEIC ACIDS RES, V45, P4853, DOI 10.1093/nar/gkw1361; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ma CY, 2017, NAT STRUCT MOL BIOL, V24, P214, DOI 10.1038/nsmb.3364; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Malyutin AG, 2017, EMBO J; MIKULSKI AJ, 1969, J BIOL CHEM, V244, P6559; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Ohmayer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068412; Ohmayer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042449; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reiter A, 2012, EMBO J, V31, P3480, DOI 10.1038/emboj.2012.185; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarkar A, 2016, NAT STRUCT MOL BIOL; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Talkish J, 2014, MOL CELL BIOL, V34, P1863, DOI 10.1128/MCB.01322-13; Talkish J, 2014, RNA, V20, P713, DOI 10.1261/rna.042218.113; Thomson E, 2009, MOL CELL BIOL; Tutuncuoglu B, 2016, RNA, V22, P1386, DOI 10.1261/rna.055798.115; Venema J, 1998, METH MOL B, V77, P257; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wu S, 2016, NATURE, V534, P133, DOI 10.1038/nature17942; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S; Zhang J, 2016, NUCL ACIDS RES	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179405	10.1371/journal.pone.0179405	http://dx.doi.org/10.1371/journal.pone.0179405			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686620	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100016
J	Takii, R; Fujimoto, M; Matsuura, Y; Wu, FX; Oshibe, N; Takaki, E; Katiyar, A; Akashi, H; Makino, T; Kawata, M; Nakai, A				Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Akashi, Hiroshi; Makino, Takashi; Kawata, Masakado; Nakai, Akira			HSF1 and HSF3 cooperatively regulate the heat shock response in lizards	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BINDING-ACTIVITY; GENOME DUPLICATIONS; MOLECULAR-CLONING; FACTOR FAMILY; CELL-DEATH; FACTOR-I; STRESS; GENES; PROTEIN	Cells cope with temperature elevations, which cause protein misfolding, by expressing heat shock proteins (HSPs). This adaptive response is called the heat shock response (HSR), and it is regulated mainly by heat shock transcription factor (HSF). Among the four HSF family members in vertebrates, HSF1 is a master regulator of HSP expression during proteotoxic stress including heat shock in mammals, whereas HSF3 is required for the HSR in birds. To examine whether only one of the HSF family members possesses the potential to induce the HSR in vertebrate animals, we isolated cDNA clones encoding lizard and frog HSF genes. The reconstructed phylogenetic tree of vertebrate HSFs demonstrated that HSF3 in one species is unrelated with that in other species. We found that the DNA-binding activity of both HSF1 and HSF3 in lizard and frog cells was induced in response to heat shock. Unexpectedly, overexpression of lizard and frog HSF3 as well as HSF1 induced HSP70 expression in mouse cells during heat shock, indicating that the two factors have the potential to induce the HSR. Furthermore, knockdown of either HSF3 or HSF1 markedly reduced HSP70 induction in lizard cells and resistance to heat shock. These results demonstrated that HSF1 and HSF3 cooperatively regulate the HSR at least in lizards, and suggest complex mechanisms of the HSR in lizards as well as frogs.	[Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi, Japan; [Takii, Ryosuke; Fujimoto, Mitsuaki; Matsuura, Yuki; Wu, Fangxu; Oshibe, Namiko; Takaki, Eiichi; Katiyar, Arpit; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi, Japan; [Akashi, Hiroshi; Makino, Takashi; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Dept Ecol & Evolutionary Biol, Sendai, Miyagi, Japan; [Wu, Fangxu] Kyushu Univ, Med Inst Bioregulat, Fukuoka, Japan	Yamaguchi University; Yamaguchi University; Tohoku University; Kyushu University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi, Japan.; Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi, Japan.	anakai@yamaguchi-u.ac.jp	Makino, Takashi/AAC-5181-2019; Kawata, Masakado/E-3962-2012	Makino, Takashi/0000-0003-4600-9353; Akashi, Hiroshi/0000-0001-5053-3292	JSPS KAKENHI [26116720, 15H04706, 16K08625]; Takeda Science Foundation Special Project Research; Uehara Memorial Foundation; Kato memorial bioscience foundation; Yamaguchi University "Pump-Priming Program"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation Special Project Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato memorial bioscience foundation; Yamaguchi University "Pump-Priming Program"	This work was supported by JSPS KAKENHI grant numbers 26116720, 15H04706, 16K08625 (to A.N., R.T.), Takeda Science Foundation Special Project Research (to A.N.), Uehara Memorial Foundation (to A.N.), Kato memorial bioscience foundation (to R.T.), and The Yamaguchi University Pump-Priming Program (to A.N.).	Akashi HD, 2016, MOL ECOL, V25, P2273, DOI 10.1111/mec.13625; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; COHEN MM, 1968, CYTOGENETICS, V7, P16, DOI 10.1159/000129968; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; El Fatimy R, 2014, EMBO MOL MED, V6, P1043, DOI 10.15252/emmm.201303311; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Fujimoto M, 2008, J BIOL CHEM, V283, P29961, DOI 10.1074/jbc.M804629200; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Fujimoto M, 2010, MOL BIOL CELL, V21, P106, DOI 10.1091/mbc.E09-07-0639; Gordon S, 1997, DEV BIOL, V181, P47, DOI 10.1006/dbio.1996.8441; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; Hilgarth RS, 2004, CELL STRESS CHAPERON, V9, P214, DOI 10.1379/CSC-8R.1; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Kawazoe Y, 1999, EUR J BIOCHEM, V265, P688, DOI 10.1046/j.1432-1327.1999.00762.x; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Miozzo F, 2015, J MOL BIOL, V427, P3793, DOI 10.1016/j.jmb.2015.10.007; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Nakai, 2016, HEAT SHOCK FACTOR, DOI 10.1007/978-4-431-55852-1; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1379/1466-1268(1999)004<0086:NAITVH>2.3.CO;2; NAKAI A, 1993, MOL CELL BIOL, V13, P1983, DOI 10.1128/MCB.13.4.1983; NAKAI A, 1995, MOL CELL BIOL, V15, P5268; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; OVSENEK N, 1990, DEVELOPMENT, V110, P427; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; Shinkawa T, 2011, MOL BIOL CELL, V22, P3571, DOI 10.1091/mbc.E11-04-0330; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Sinzelle L, 2012, GENESIS, V50, P316, DOI 10.1002/dvg.20822; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; STUMP DG, 1995, GENE, V160, P207, DOI 10.1016/0378-1119(95)00176-7; Swan CL, 2012, CELL STRESS CHAPERON, V17, P623, DOI 10.1007/s12192-012-0337-3; Takii R, 2015, MOL CELL BIOL, V35, P11, DOI 10.1128/MCB.00754-14; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wakasa H, 2015, J EXP ZOOL PART B, V324, P410, DOI 10.1002/jez.b.22627; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wolff S, 2014, NATURE, V508, P328, DOI 10.1038/nature13220; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zatsepina OG, 2000, J EXP BIOL, V203, P1017; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	63	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180776	10.1371/journal.pone.0180776	http://dx.doi.org/10.1371/journal.pone.0180776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686674	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100100
J	Wei, WQ; Bastarache, LA; Carroll, RJ; Marlo, JE; Osterman, TJ; Gamazon, ER; Cox, NJ; Roden, DM; Denny, JC				Wei, Wei-Qi; Bastarache, Lisa A.; Carroll, Robert J.; Marlo, Joy E.; Osterman, Travis J.; Gamazon, Eric R.; Cox, Nancy J.; Roden, Dan M.; Denny, Joshua C.			Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenomewide association studies in the electronic health record	PLOS ONE			English	Article							MEDICAL-RECORDS; WIDE ASSOCIATION; OPPORTUNITIES; RISK	Objective To compare three groupings of Electronic Health Record (EHR) billing codes for their ability to represent clinically meaningful phenotypes and to replicate known genetic associations. The three tested coding systems were the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, the Agency for Healthcare Research and Quality Clinical Classification Software for ICD-9-CM (CCS), and manually curated "phecodes " designed to facilitate phenome-wide association studies (PheWAS) in EHRs. Methods and materials We selected 100 disease phenotypes and compared the ability of each coding system to accurately represent them without performing additional groupings. The 100 phenotypes included 25 randomly-chosen clinical phenotypes pursued in prior genome-wide association studies (GWAS) and another 75 common disease phenotypes mentioned across free-text problem lists from 189,289 individuals. We then evaluated the performance of each coding system to replicate known associations for 440 SNP-phenotype pairs. Results Out of the 100 tested clinical phenotypes, phecodes exactly matched 83, compared to 53 for ICD-9-CM and 32 for CCS. ICD-9-CM codes were typically too detailed (requiring custom groupings) while CCS codes were often not granular enough. Among 440 tested known SNP-phenotype associations, use of phecodes replicated 153 SNP-phenotype pairs compared to 143 for ICD-9-CM and 139 for CCS. Phecodes also generally produced stronger odds ratios and lower p-values for known associations than ICD-9-CM and CCS. Finally, evaluation of several SNPs via PheWAS identified novel potential signals, some seen in only using the phecode approach. Among them, rs7318369 in PEPD was associated with gastrointestinal hemorrhage. Conclusion Our results suggest that the phecode groupings better align with clinical diseases mentioned in clinical practice or for genomic studies. ICD-9-CM, CCS, and phecode groupings all worked for PheWAS-type studies, though the phecode groupings produced superior results.	[Wei, Wei-Qi; Bastarache, Lisa A.; Carroll, Robert J.; Marlo, Joy E.; Osterman, Travis J.; Roden, Dan M.; Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA; [Osterman, Travis J.; Roden, Dan M.; Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Div Med Genet, Nashville, TN USA; [Gamazon, Eric R.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, Amsterdam, Netherlands; [Gamazon, Eric R.] Univ Amsterdam, Acad Med Ctr, Dept Biostat & Bioinformat, Amsterdam, Netherlands; [Gamazon, Eric R.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Dept, Amsterdam, Netherlands; [Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Clin Pharmacol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vanderbilt University	Denny, JC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA.; Denny, JC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	josh.denny@Vanderbilt.Edu	Gamazon, Eric/I-6873-2018; Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021	Gamazon, Eric/0000-0003-4204-8734; Denny, Josh/0000-0002-3049-7332	NIH [1 R01 LM 010685, P50 GM115305, R01 HL133786, R01 GM103859, U01 HG008672]; AHA Scientist Development Grant [16SDG27490014]; Vanderbilt CTSA from NCATS/NIH [ULTR000445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133786] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105688, P50GM115305, R01GM103859] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Scientist Development Grant(American Heart Association); Vanderbilt CTSA from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project was supported by NIH grant 1 R01 LM 010685, P50 GM115305, R01 HL133786, R01 GM103859, U01 HG008672 and AHA Scientist Development Grant 16SDG27490014. The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU, which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Denny JC, 2003, J AM MED INFORM ASSN, V10, P351, DOI 10.1197/jamia.M1176; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002823; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Denny JC, 2007, STUD HEALTH TECHNOL, V129, P1283; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Elixhauser A, 2014, CLIN CLASSIFICATIONS; Gibson G, 2015, SCIENCE, V348, P640, DOI 10.1126/science.aab3002; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hall MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004678; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Hindorff LA, 2015, CATALOG PUBLISHED GE; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Leader Joseph B, 2015, AMIA Annu Symp Proc, V2015, P824; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mosley JD, 2016, PHARMACOGENOMICS J, V16, P231, DOI 10.1038/tpj.2015.51; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Neuraz A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003405; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Rastegar-Mojarad M, 2015, NAT BIOTECHNOL, V33, DOI 10.1038/nbt.3183; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roden DM, 2012, CLIN PHARMACOL THER, V91, P1083, DOI 10.1038/clpt.2012.42; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Turer RW, 2015, J AM MED INFORM ASSN, V22, P417, DOI 10.1093/jamia/ocu028; Warner JL, 2015, J AM MED INFORM ASSN, V22, P324, DOI 10.1136/amiajnl-2014-002965; Wei WQ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0166-y; Wei WQ, 2013, INT J MED INFORM, V82, P239, DOI 10.1016/j.ijmedinf.2012.05.015; Wei WQ, 2015, J AM MED INFORM ASS; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winnenburg R, 2014, COVERAGE PHENOTYPES	44	115	116	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0175508	10.1371/journal.pone.0175508	http://dx.doi.org/10.1371/journal.pone.0175508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686612	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100002
J	Hirata, E; Ohya, Y; Suzuki, K				Hirata, Eri; Ohya, Yoshikazu; Suzuki, Kuninori			Atg4 plays an important role in efficient expansion of autophagic isolation membranes by cleaving lipidated Atg8 in Saccharomyces cerevisiae	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; YEAST; PROTEINS; SYSTEM; BIOGENESIS; CYTOPLASM; DECONJUGATION; MECHANISMS; DELIVERY; GENES	Autophagy, an intracellular degradation system, is highly conserved among eukaryotes from yeast to mammalian cells. In the yeast Saccharomyces cerevisiae, most Atg (autophagy-related) proteins, which are essential for autophagosome formation, are recruited to a restricted region close to the vacuole, termed the vacuole-isolation membrane contact site (VICS), upon induction of autophagy. Subsequently, the isolation membrane (IM) expands and sequesters cytoplasmic materials to become a closed autophagosome. In S. cerevisiae, the ubiquitin-like protein Atg8 is C-terminally conjugated to the phospholipid phosphatidylethanolamine (PE) to generate Atg8-PE. During autophagosome formation, Atg8-PE is cleaved by Atg4 to release delipidated Atg8 (Atg8(G116)) and PE. Although delipidation of Atg8-PE is important for autophagosome formation, it remains controversial whether the delipidation reaction is required for targeting of Atg8 to the VICS or for subsequent IM expansion. We used an IM visualization technique to clearly demonstrate that delipidation of Atg8-PE is dispensable for targeting of Atg8 to the VICS, but required for IM expansion. Moreover, by overexpressing Atg8(G116), we showed that the delipidation reaction of Atg8-PE by Atg4 plays an important role in efficient expansion of the IM other than supplying unlipidated Atg8(G116). Finally, we suggested the existence of biological membranes at the Atg8labeled structures in Atg8-PE delipidation-defective cells, but not at those in atg2 Delta cells. Taken together, it is likely that Atg2 is involved in localization of biological membranes to the VICS, where Atg4 is responsible for IM expansion.	[Hirata, Eri; Ohya, Yoshikazu; Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.; Suzuki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan.	kuninori@k.u-tokyo.ac.jp	Ohya, Yoshikazu/AAW-2200-2021	Ohya, Yoshikazu/0000-0003-0837-1239				HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; SIKORSKI RS, 1989, GENETICS, V122, P19; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	28	23	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181047	10.1371/journal.pone.0181047	http://dx.doi.org/10.1371/journal.pone.0181047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704456	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700081
J	Lai, PS; Allen, JG; Hutchinson, DS; Ajami, NJ; Petrosino, JF; Winters, T; Hug, C; Wartenberg, GR; Vallarino, J; Christiani, DC				Lai, Peggy S.; Allen, Joseph G.; Hutchinson, Diane S.; Ajami, Nadim J.; Petrosino, Joseph F.; Winters, Thomas; Hug, Christopher; Wartenberg, Gary R.; Vallarino, Jose; Christiani, David C.			Impact of environmental microbiota on human microbiota of workers in academic mouse research facilities: An observational study	PLOS ONE			English	Article							LABORATORY-ANIMALS; ENDOTOXIN; ASTHMA; ALLERGY; COLONIZATION; EXPOSURES; HEALTH; RISK	Objectives To characterize the microbial environment of workers in academic mouse research facilities using endotoxin, 16S qPCR, and 16S amplicon sequencing. To determine whether the work microbiome contributes to the human microbiome of workers. Methods We performed area air sampling from the animal rooms, dirty, middle, and setup cage wash locations in four academic mouse research facilities. 10 workers in the dirty cage wash area underwent personal air sampling as well as repeated collection of nasal, oral, and skin samples before and after the work shift. Environmental samples underwent measurement of endotoxin, mouse allergen, bacteria copy number via 16S qPCR, and microbial identification via 16S rDNA sequencing. 16S rDNA sequencing was also performed on human samples before and after the work shift. SourceTracker was used to identify the contribution of the work microbiome to the human microbiome. Results Median endotoxin levels ranged from undetectable to 1.0 EU/m(3). Significant differences in mouse allergen levels, bacterial copy number, microbial richness, and microbial community structure were identified between animal, dirty, middle, and setup cage wash locations. Endotoxin levels had only a moderate correlation with microbial composition. Location within a facility was a stronger predictor of microbial community composition (R-2 = 0.41, p = 0.002) than facility. The contribution of the work microbiome to the pre-shift human microbiome of workers was estimated to be 0.1 +/- 0.1% for the oral microbiome; 3.1 +/- 1.9% for the nasal microbiome; and 3.0 +/- 1.5% for the skin microbiome. Conclusions The microbial environment of academic animal care facilities varies significantly by location rather than facility. Endotoxin is not a proxy for assessment of environmental microbial exposures using 16S qPCR or 16S rDNA sequencing. The work microbiome contributes to the composition of the nasal and skin microbiome of workers; the clinical implications of this observation should be further studied.	[Lai, Peggy S.; Christiani, David C.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Lai, Peggy S.; Allen, Joseph G.; Winters, Thomas; Vallarino, Jose; Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lai, Peggy S.; Wartenberg, Gary R.; Christiani, David C.] Harvard Med Sch, Boston, MA 02115 USA; [Hutchinson, Diane S.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Hug, Christopher] Boston Childrens Hosp, Div Pulm & Resp Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Baylor College of Medicine; Harvard University; Boston Children's Hospital	Lai, PS (corresponding author), Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA.; Lai, PS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.; Lai, PS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	pslai@hsph.harvard.edu	Petrosino, Joseph F./AAF-1621-2019	Lai, Peggy/0000-0001-9501-8606	NIH-NIEHS [K23ES023700, P3000002]; Harvard-NIOSH Education and Research Center [T42OH008416]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069, P30ES000002, K23ES023700] Funding Source: NIH RePORTER	NIH-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Harvard-NIOSH Education and Research Center(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH-NIEHS K23ES023700 and P3000002, and apilot project grant from the Harvard-NIOSH Education and Research Center (T42OH008416). The funders had no role in study design, data collection and nalysis, decision to publish, or preparation of the manuscript.	AOYAMA K, 1992, BRIT J IND MED, V49, P41; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; BLAND SM, 1986, J OCCUP ENVIRON MED, V28, P1151; Bush RK, 2003, ILAR J, V44, P28, DOI 10.1093/ilar.44.1.28; Callahan Ben J, 2016, F1000Res, V5, P1492; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, V138, P76, DOI 10.1016/j.jaci.2015.11.027; De Champs C, 2003, J CLIN MICROBIOL, V41, P1270, DOI 10.1128/JCM.41.3.1270-1273.2003; DECOS, 2010, ENDOTOXINS HEALTH BA; Dehus O, 2006, J ENDOTOXIN RES, V12, P171, DOI 10.1179/096805106X102156; Dicksved J, 2014, MBIO, V5, DOI 10.1128/mBio.01212-14; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elliott L, 2005, Occup Environ Med, V62, P766, DOI 10.1136/oem.2004.018739; Elliott L, 2005, J ALLERGY CLIN IMMUN, V116, P127, DOI 10.1016/j.jaci.2005.03.038; Fang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088826; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jang JH, 2009, ANN ALLERG ASTHMA IM, V102, P373, DOI 10.1016/S1081-1206(10)60507-8; Karkkainen PM, 2010, J ENVIRON MONITOR, V12, P759, DOI 10.1039/b917937b; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; LEVIN J, 1964, B JOHNS HOPKINS HOSP, V115, P265; Liebers V, 2008, ARCH TOXICOL, V82, P203, DOI 10.1007/s00204-008-0290-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Oksanen J, 2022, R PACKAGE VERSION; Pacheco KA, 2006, ANN OCCUP HYG, V50, P563, DOI 10.1093/annhyg/me1019; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sankaran K, 2014, J STAT SOFTW, V59; Schinasi L, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-54; Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29681; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tischer C, 2015, EUR RESPIR J, V45, P328, DOI 10.1183/09031936.00060214; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOESE CR, 1985, SYST APPL MICROBIOL, V6, P143, DOI 10.1016/S0723-2020(85)80047-3	46	24	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180969	10.1371/journal.pone.0180969	http://dx.doi.org/10.1371/journal.pone.0180969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704437	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700067
J	de Oliveira, JC; Beirigo, RM; Chiapini, M; do Nascimento, AF; Couto, EG; Vidal-Torrado, P				de Oliveira Junior, Jairo Calderari; Beirigo, Raphael Moreira; Chiapini, Mariane; do Nascimento, Alexandre Ferreira; Couto, Eduardo Guimaraes; Vidal-Torrado, Pablo			Origin of mounds in the Pantanal wetlands: An integrated approach between geomorphology, pedogenesis, ecology and soil micromorphology	PLOS ONE			English	Article							LOURENCO FLUVIAL MEGAFAN; CENTRAL BRAZIL; TERMITE MOUNDS; MATO-GROSSO; FERROLYSIS; STABILITY; SYSTEM; INDIA; NESTS; WATER	zVegetated mounds are an important geomorphological feature of the Pantanal, where the influence of floods dictates not only hydropedological processes, but also the distribution and ecology of the flora and fauna. This work aimed to identify factors and processes that influence the formation and spatial distribution of the mounds, which are commonly associated with termite activity. In order to characterize pedological processes, macro and micro morphological descriptions, satellite image interpretation, dating of the sandy sedimentary material using OSL and carbon dating using 14 C AMS were carried out. This dating of the materials indicates that the sediments in which the soils were formed were deposited during the Pleistocene, while the carbonates are from the Holocene. The basin- like format of the laminar structures suggests that part of the more clayey material was deposited in lacustrine environments. The more humid climate in the Holocene intensified argilluviation, which at an advanced stage, led to a more pronounced textural gradient, reducing drainage and leading to ferrolysis and thickening of the E horizon. Besides pedogenic processes, more erosive flooding during the Holocene began reducing and rounding the landscape's more elevated structures (paleolevees). In the final stage, these structures were occupied by termites to shelter from flooding. Thereafter, the bio-cementation action of the termite nests has increased the resistance of the vegetated mounds to processes of erosion.	[de Oliveira Junior, Jairo Calderari] Univ Tecnol Fed Parana, Dept Agron, Dois Vizinhos, Parana, Brazil; [Beirigo, Raphael Moreira] Univ Fed Paraiba, Agr Sci Ctr, Areia, Paraiba, Brazil; [Chiapini, Mariane; Vidal-Torrado, Pablo] Univ Sao Paulo, Dept Soil Sci, Piracicaba, SP, Brazil; [do Nascimento, Alexandre Ferreira] EMBRAPA, Embrapa Agrossilvipastoril, Sinop, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Dept Soil & Rural Engn, Cuiaba, MG, Brazil	Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal da Paraiba; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso	Vidal-Torrado, P (corresponding author), Univ Sao Paulo, Dept Soil Sci, Piracicaba, SP, Brazil.	pvidal@usp.br	Couto, Eduardo Guimarães/AAF-5790-2019; Oliveira, Jairo/A-2041-2012; Chiapini, Mariane/GWR-1681-2022; Vidal-Torrado, Pablo/C-4020-2012; Couto, Eduardo Guimarães/E-4240-2010; M. Beirigo, Raphael/A-7874-2018; Ferreira do Nascimento, Alexandre/A-2284-2016	Couto, Eduardo Guimarães/0000-0002-5271-9709; Oliveira, Jairo/0000-0003-3818-0513; Vidal-Torrado, Pablo/0000-0001-9228-9910; Couto, Eduardo Guimarães/0000-0002-5271-9709; M. Beirigo, Raphael/0000-0001-6857-149X; Ferreira do Nascimento, Alexandre/0000-0002-0837-343X; Chiapini, Mariane/0000-0001-7111-0555	Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/54372-0]; FAPESP [2011/11905-9, 2009/50422-3]; CNPQ [300189/2010-9]	Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Fundacao ao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Research Assistance 2009/54372-0. FAPESP PhD scholarships were given to JCOJ (2011/11905-9) and to AFN (2009/50422-3). PVT received a research grant from CNPQ (300189/2010-9).	Ackerman IL, 2007, APPL SOIL ECOL, V37, P267, DOI 10.1016/j.apsoil.2007.08.005; Assine ML, 2014, SEDIMENT GEOL, V301, P172, DOI 10.1016/j.sedgeo.2013.11.007; Assine ML, 2004, QUATERN INT, V114, P23, DOI 10.1016/S1040-6182(03)00039-9; Barbiero L, 2002, WETLANDS, V22, P528, DOI 10.1672/0277-5212(2002)022[0528:GOWAGW]2.0.CO;2; Beirigo RM, 2011, SOLOS RESERVA PARTIC; BRINKMAN R, 1970, GEODERMA, V3, P199, DOI 10.1016/0016-7061(70)90019-4; Bullock P., 1985, HDB SOIL THIN SECTIO; CORRADINI FA, 2012, REV BRAS GEOCIENC S1, V42, P20, DOI DOI 10.5327/Z0375-75362012000500003; Cramer MD, 2014, PALAEOGEOGR PALAEOCL, V409, P72, DOI 10.1016/j.palaeo.2014.04.026; Cunha CN., 1990, THESIS; Dematte J. L. I., 1992, Revista Brasileira de Ciencia do Solo, V16, P241; do Nascimento AF, 2013, REV BRAS CIENC SOLO, V37, P1113, DOI 10.1590/S0100-06832013000500001; Droubi A, 1976, EQUILIBRES ENTRE MIN, V1, P13; Durand N, 2007, QUATERN INT, V162, P35, DOI 10.1016/j.quaint.2006.10.026; Durand N, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P149, DOI 10.1016/B978-0-444-53156-8.00009-X; EITEN G, 1975, Biotropica, V7, P112, DOI 10.2307/2989754; EMBRAPA, 2011, MAN MET AN SOL, Vsecond; FAO, 2006, GUID SOIL DESCR; Fedoroff N, 1986, C INT SOC SOIL SCI 1, V5, P1551; Funch RR, 2015, J ARID ENVIRON, V122, P27, DOI 10.1016/j.jaridenv.2015.05.010; Furquim SAC, 2010, GEODERMA, V154, P518, DOI 10.1016/j.geoderma.2009.03.014; Gac JY, 1997, CHEM GEOL, V19, P215; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; Girard P, 2010, HYDROBIOLOGIA, V638, P223, DOI 10.1007/s10750-009-0046-9; Hasenack H, 2010, CLIMA RESERVA PARTIC; Johnson DL, 2012, GEOL SOC AM SPEC PAP, V490, P1, DOI 10.1130/2012.2490(00); Johnson MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064874; Jouquet P, 2004, EUR J SOIL BIOL, V40, P23, DOI 10.1016/j.ejsobi.2004.01.006; Jouquet P, 2015, APPL SOIL ECOL, V96, P282, DOI 10.1016/j.apsoil.2015.08.010; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kuhn P, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P217, DOI 10.1016/B978-0-444-53156-8.00011-8; Lindbo DL, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P129, DOI 10.1016/B978-0-444-53156-8.00008-8; Mathews A. G. A., 1977, STUDIES TERMITES MAT; McGlue MM, 2012, QUATERNARY RES, V78, P285, DOI 10.1016/j.yqres.2012.05.015; MdC Gutierrez-Castorena, 2010, INTERPRETATION MICRO, P109; Murphy C.P., 1986, THIN SECTION PREPARA; Nascimento AF, 2015, GEODERMA, V255, P58, DOI 10.1016/j.geoderma.2015.04.025; Nichols GJ, 2007, SEDIMENT GEOL, V195, P75, DOI 10.1016/j.sedgeo.2006.07.004; Oliveira ME, 2006, ASIAN WILD PIG NEWS, V6, P16; Pfahler V, 2015, J PLANT NUTR SOIL SC, V178, P468, DOI 10.1002/jpln.201400279; PIPUJOL MD, 1994, PALAEOGEOGR PALAEOCL, V110, P103, DOI 10.1016/0031-0182(94)90112-0; PONCE VM, 1993, J BIOGEOGR, V20, P219, DOI 10.2307/2845673; Renard D, 2012, PLANT SOIL, V351, P337, DOI 10.1007/s11104-011-0967-8; Sanches L, 2010, REV BRAS METEOROL, V5, P448; Sarcinelli TS, 2009, CATENA, V76, P107, DOI 10.1016/j.catena.2008.10.001; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Silva LCR, 2010, PLANT SOIL, V336, P3, DOI 10.1007/s11104-010-0329-y; Stoops G., 2003, GUIDELINES ANAL DESC; van Breemen N., 2002, SOIL FORMATION, VSecond; Van Ranst E, 2002, EUR J SOIL SCI, V53, P513, DOI 10.1046/j.1365-2389.2002.00475.x; Vidal-Torrado P., 1999, Revista Brasileira de Ciencia do Solo, V23, P909, DOI 10.1590/S0100-06831999000400018; Wallinga J, 2000, RADIAT MEAS, V32, P529, DOI 10.1016/S1350-4487(00)00091-3; Wiemann P., 2015, END LAKE DWELLINGS C, P101; World Reference Base for soil resources (WRB), 2014, WORLD SOIL RESOURCES	54	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179197	10.1371/journal.pone.0179197	http://dx.doi.org/10.1371/journal.pone.0179197			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700595	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600006
J	Gurfein, BT; Hasdemir, B; Milush, JM; Touma, C; Palme, R; Nixon, DF; Darcel, N; Hecht, FM; Bhargava, A				Gurfein, Blake T.; Hasdemir, Burcu; Milush, Jeffrey M.; Touma, Chadi; Palme, Rupert; Nixon, Douglas F.; Darcel, Nicholas; Hecht, Frederick M.; Bhargava, Aditi			Enriched environment and stress exposure influence splenic B lymphocyte composition	PLOS ONE			English	Article							CYTOKINE PRODUCTION; MICE; EXPRESSION; BRAIN; MOUSE; CORTICOSTERONE; TRAFFICKING; METABOLITES; EXCRETION; RESPONSES	Prolonged chronic stress has deleterious effects on immune function and is associated with numerous negative health outcomes. The spleen harbors one-fourth of the body's lymphocytes and mediates both innate and adaptive immune responses. However, the subset of splenic lymphocytes that respond, either adaptively or maladaptively, to various stressors remains largely unknown. Here we investigated the effects of unpredictable chronic mild stress (CMS) exposure on spleen composition in male mice housed in two different caging conditions: standard caging (Cntl) and enriched environment (EE). EE-caged mice exhibited the greatest absolute number of splenocytes and CMS exposure significantly lowered splenocyte numbers in both caging conditions. Glucocorticoid production, measured by mean fecal corticosterone metabolites (FCM), was significantly lower in EE-caged mice vs. Cntlcaged mice. Surprisingly, CMS exposure resulted in an increase in mean FCM in EE-caged mice, but no significant change in Cntl-caged mice. CMS altered the splenic B:T lymphocyte ratio; it reduced the frequency of B cells, but increased the frequency of T cells in EE-caged mice. Splenocyte number and B: T lymphocyte ratio showed a negative relationship with mean FCM. EE-caged mice had a lower frequency of immature and germinal B cells than Cntl-caged mice. CMS markedly increased the frequency of immature and marginal zone B cells, but decreased the frequency of follicular B cells in both caging conditions. Mean FCM correlated positively with frequency of immature, marginal zone and germinal center B cells, but negatively with frequency of follicular B cells. To conclude, splenic immune cells, particularly B lymphocyte composition, are modulated by caging environment and stress and may prime mice differently to respond to immune challenges.	[Gurfein, Blake T.; Hasdemir, Burcu; Hecht, Frederick M.; Bhargava, Aditi] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Gurfein, Blake T.; Milush, Jeffrey M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Touma, Chadi] Univ Osnabruck, Dept Behav Biol, Osnabruck, Germany; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Darcel, Nicholas] Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France; [Bhargava, Aditi] Univ Calif San Francisco, Dept ObGyn, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University Osnabruck; University of Veterinary Medicine Vienna; George Washington University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Francisco	Gurfein, BT; Bhargava, A (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.; Gurfein, BT (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.; Bhargava, A (corresponding author), Univ Calif San Francisco, Dept ObGyn, San Francisco, CA 94143 USA.	Blake.Gurfein@ucsf.edu; Aditi.Bhargava@ucsf.edu	Nixon, Douglas/AAU-5734-2020; Palme, Rupert/A-3499-2008	Nixon, Douglas/0000-0002-2801-1786; Palme, Rupert/0000-0001-9466-3662; Hecht, Frederick/0000-0002-5782-1171; Bhargava, Aditi/0000-0003-1334-0517	National Institutes of Health [K01AT007322]; NCCIH [T32 AT003997, K01 32 AT006153, K24 AT007827, DK080787]; National Center for Complementary & Integrative Health [K24AT007827, T32AT003997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080787, R01DK097518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health K01AT007322 to BG; BH was supported by T32 AT003997 from NCCIH, JMM by K01 32 AT006153, FMH by K24 AT007827 from NCCIH, and AB by DK080787.	CLAMAN HN, 1993, ANN NY ACAD SCI, V685, P288, DOI 10.1111/j.1749-6632.1993.tb35877.x; Cohen S, 1999, PSYCHOSOM MED, V61, P175, DOI 10.1097/00006842-199903000-00009; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gotovac K, 2003, CLIN EXP IMMUNOL, V131, P335, DOI 10.1046/j.1365-2249.2003.02075.x; Goujon E, 1995, BRAIN BEHAV IMMUN, V9, P292, DOI 10.1006/brbi.1995.1028; Gurfein BT, 2014, MOL MED, V20, P179, DOI 10.2119/molmed.2013.00158; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; KIECOLTGLASER JK, 1995, PSYCHOSOM MED, V57, P269, DOI 10.1097/00006842-199505000-00008; Miller GE, 2014, BRAIN BEHAV IMMUN, V41, P191, DOI 10.1016/j.bbi.2014.05.016; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; PERSOONS JHA, 1995, AM J RESP CRIT CARE, V152, P619, DOI 10.1164/ajrccm.152.2.7633716; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; YEHUDA R, 1993, BIOL PSYCHIAT, V34, P18, DOI 10.1016/0006-3223(93)90252-9; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180771	10.1371/journal.pone.0180771	http://dx.doi.org/10.1371/journal.pone.0180771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704473	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600049
J	Matusu, R; Senol, B; Yeroglu, C				Matusu, Radek; Senol, Bilal; Yeroglu, Celaleddin			Linear systems with unstructured multiplicative uncertainty: Modeling and robust stability analysis	PLOS ONE			English	Article							PARAMETRIC UNCERTAINTY; PERFORMANCE	This article deals with continuous-time Linear Time-Invariant (LTI) Single-Input Single-Output (SISO) systems affected by unstructured multiplicative uncertainty. More specifically, its aim is to present an approach to the construction of uncertain models based on the appropriate selection of a nominal system and a weight function and to apply the fundamentals of robust stability investigation for considered sort of systems. The initial theoretical parts are followed by three extensive illustrative examples in which the first order time-delay, second order and third order plants with parametric uncertainty are modeled as systems with unstructured multiplicative uncertainty and subsequently, the robust stability of selected feedback loops containing constructed models and chosen controllers is analyzed and obtained results are discussed.	[Matusu, Radek] Tomas Bata Univ Zlin, Fac Appl Informat, CEBIA Tech, Ctr Secur Informat & Adv Technol, Zlin, Czech Republic; [Senol, Bilal; Yeroglu, Celaleddin] Inonu Univ, Fac Engn, Dept Comp Engn, Malatya, Turkey	Tomas Bata University Zlin; Inonu University	Matusu, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, CEBIA Tech, Ctr Secur Informat & Adv Technol, Zlin, Czech Republic.	rmatusu@fai.utb.cz	Matušů, Radek/H-6355-2012; SENOL, Bilal/Y-5328-2018; Yeroglu, Celaleddin/ABG-9572-2020	SENOL, Bilal/0000-0002-3734-8807; Yeroglu, Celaleddin/0000-0002-6106-2374	European Regional Development Fund under the project CEBIA-Tech Instrumentation [CZ.1.05/2.1.00/19.0376]; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project [LO1303, MSMT-7778/2014]	European Regional Development Fund under the project CEBIA-Tech Instrumentation; Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project	This work was supported by the European Regional Development Fund under the project CEBIA-Tech Instrumentation No. CZ.1.05/2.1.00/19.0376 and by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project No. LO1303 (MSMT-7778/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann J, 1993, ROBUST CONTROL SYSTE; [Anonymous], 2005, POWER ELECTRONICS P; Barmish BR, 1994, NEW TOOLS ROBUSTNESS; Bhattacharyya SP, 2009, AUTOM CONTROL ENG SE, V33, pXVII; Bhattacharyya SP., 1995, ROBUST CONTROL PARAM; DOYLE J, 1982, IEE PROC-D, V129, P242, DOI 10.1049/ip-d.1982.0053; Doyle JC, 1992, FEEDBACK CONTROL THE; FAN MKH, 1991, IEEE T AUTOMAT CONTR, V36, P25, DOI 10.1109/9.62265; Geromel JC, 2006, SYST CONTROL LETT, V55, P81, DOI 10.1016/j.sysconle.2004.11.016; Gu D. -W., 2005, ADV TK CONT SIGN PRO; Ho MT, 2003, IEEE T AUTOMAT CONTR, V48, P1404, DOI 10.1109/TAC.2003.815028; Kasnakoglu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165017; Keel LH, 1999, AUTOMATICA, V35, P1717, DOI 10.1016/S0005-1098(99)00080-1; Kucera V., 2001, AUTOMA, V7, P43; Kucera V, 2007, INT J ROBUST NONLIN, V17, P682, DOI 10.1002/rnc.1127; KWAKERNAAK H, 1993, AUTOMATICA, V29, P255, DOI 10.1016/0005-1098(93)90122-A; LAUGHLIN DL, 1989, COMPUT VISION GRAPH, V47, P59, DOI 10.1016/0734-189X(89)90054-6; Matus R, 2011, P 13 WSEAS INT C AUT; Matusu R., 2011, INT J MATH MODELS ME, V5, P1011; Matusu R, 2011, T I MEAS CONTROL, V33, P274, DOI 10.1177/0142331210361409; Park P, 2007, AUTOMATICA, V43, P1855, DOI 10.1016/j.automatica.2007.02.022; Patre BM, 2007, ISA T, V46, P343, DOI 10.1016/j.isatra.2006.10.001; Sage HG, 1999, INT J CONTROL, V72, P1498, DOI 10.1080/002071799220137; Skogestad S., 2005, MULTIVARIABLE FEEDBA; Tan N, 2002, P 15 IFAC WORLD C BA; Xie L, 1997, SYST CONTROL LETT, V31, P165, DOI 10.1016/S0167-6911(97)00027-3; Zhong Q. C., 2006, ROBUST CONTROL TIME; Zhou K., 1996, ROBUST OPTIMAL CONTR	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181078	10.1371/journal.pone.0181078	http://dx.doi.org/10.1371/journal.pone.0181078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704471	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600057
J	Costa, MC; Tozzi, G; Cristofolini, L; Danesi, V; Viceconti, M; Dall'Ara, E				Costa, Maria Cristiana; Tozzi, Gianluca; Cristofolini, Luca; Danesi, Valentina; Viceconti, Marco; Dall'Ara, Enrico			Micro Finite Element models of the vertebral body: Validation of local displacement predictions	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; HUMAN CANCELLOUS BONE; TRABECULAR BONE; CORTICAL BONE; MECHANICAL-PROPERTIES; AUGMENTED VERTEBRAE; COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; STRAIN; TISSUE	The estimation of local and structural mechanical properties of bones with micro Finite Element (microFE) models based on Micro Computed Tomography images depends on the quality bone geometry is captured, reconstructed and modelled. The aim of this study was to validate microFE models predictions of local displacements for vertebral bodies and to evaluate the effect of the elastic tissue modulus on model's predictions of axial forces. Four porcine thoracic vertebrae were axially compressed in situ, in a step-wise fashion and scanned at approximately 39 mu m resolution in preloaded and loaded conditions. A global digital volume correlation (DVC) approach was used to compute the full-field displacements. Homogeneous, isotropic and linear elastic microFE models were generated with boundary conditions assigned from the interpolated displacement field measured from the DVC. Measured and predicted local displacements were compared for the cortical and trabecular compartments in the middle of the specimens. Models were run with two different tissue moduli defined from microindentation data (12.0GPa) and a back-calculation procedure (4.6GPa). The predicted sum of axial reaction forces was compared to the experimental values for each specimen. MicroFE models predicted more than 87% of the variation in the displacement measurements (R-2 = 0.87-0.99). However, model predictions of axial forces were largely overestimated (80-369%) for a tissue modulus of 12.0GPa, whereas differences in the range 10-80% were found for a back-calculated tissue modulus. The specimen with the lowest density showed a large number of elements strained beyond yield and the highest predictive errors. This study shows that the simplest microFE models can accurately predict quantitatively the local displacements and qualitatively the strain distribution within the vertebral body, independently from the considered bone types.	[Costa, Maria Cristiana; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Costa, Maria Cristiana; Viceconti, Marco; Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Tozzi, Gianluca] Univ Portsmouth, Zeiss Global Ctr, Sch Engn, Portsmouth, Hants, England; [Cristofolini, Luca; Danesi, Valentina] Alma Mater Studiorum Univ Bologna, Sch Engn & Architecture, Bologna, Italy; [Viceconti, Marco] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Portsmouth; University of Bologna; University of Sheffield	Dall'Ara, E (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Dall'Ara, E (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.	e.dallara@sheffield.ac.uk	Dall'Ara, Enrico/ABA-5046-2020; Viceconti, Marco/ABG-5546-2020; Danesi, Valentina/ABE-5647-2020; Cristofolini, Luca/C-4402-2013	Dall'Ara, Enrico/0000-0003-1471-5077; Viceconti, Marco/0000-0002-2293-1530; Danesi, Valentina/0000-0001-9261-6467; Cristofolini, Luca/0000-0002-7473-6868	Sheffield Hospital Charity [141515-1]; Engineering and Physical Sciences Research Council (MultiSim project) [EP/K03877X/1]; Royal Society [RG130831, RG150012]; European Society of Biomechanics (ESB mobility award); EPSRC [EP/K03877X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K03877X/1] Funding Source: researchfish	Sheffield Hospital Charity; Engineering and Physical Sciences Research Council (MultiSim project)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); European Society of Biomechanics (ESB mobility award); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was partially supported by Sheffield Hospital Charity (grant number: 141515-1; ED, MV; http://www.sheffieldhospitalscharity.org.uk/), the Engineering and Physical Sciences Research Council (MultiSim project, grant number: EP/K03877X/1; MV; https://www.epsrc.ac.uk/), the Royal Society (grant number: RG130831, GT; grant number: RG150012, ED; https://royalsociety.org/), and the European Society of Biomechanics (ESB mobility award 2014; VD; https://esbiomech.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020; Chen Y, 2017, J MECH BEHAV BIOMED, V65, P644, DOI 10.1016/j.jmbbm.2016.09.014; Chen Y, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028106; Chevalier Y, 2007, J BIOMECH, V40, P3333, DOI 10.1016/j.jbiomech.2007.05.004; Christen D, 2014, J MECH BEHAV BIOMED, V29, P500, DOI 10.1016/j.jmbbm.2013.10.010; Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Dall'Ara E, 2010, J BIOMECH, V43, P2374, DOI 10.1016/j.jbiomech.2010.04.023; Danesi V, 2016, CLIN BIOMECH, V39, P14, DOI 10.1016/j.clinbiomech.2016.07.010; Danesi V, 2014, J BIOMECH, V47, P313, DOI 10.1016/j.jbiomech.2013.10.005; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Feng L, 2012, J BIOMECH, V45, P1775, DOI 10.1016/j.jbiomech.2012.05.001; Fox J, 1990, MODERN METHODS DATA; Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014; Grassi L, 2015, J MECH BEHAV BIOMED, V50, P43, DOI 10.1016/j.jmbbm.2015.06.006; Gross T, 2012, COMPUT METHOD BIOMEC, V15, P1137, DOI 10.1080/10255842.2011.581236; Hambli R, 2013, BONE, V56, P363, DOI 10.1016/j.bone.2013.06.028; Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2; Hardisty MR, 2012, J ORTHOP RES, V30, P1032, DOI 10.1002/jor.22045; Harrison NM, 2013, BIOMECH MODEL MECHAN, V12, P225, DOI 10.1007/s10237-012-0394-7; Hojjat SP, 2012, J BIOMECH, V45, P2342, DOI 10.1016/j.jbiomech.2012.07.004; Homminga J, 2004, BONE, V34, P510, DOI 10.1016/j.bone.2003.12.001; Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9; Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013; Jackman TM, 2016, J BIOMECH, V49, P267, DOI 10.1016/j.jbiomech.2015.12.004; Jackman TM, 2015, J BONE MINER RES, P1; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017; Manda K, 2017, BIOMECH MODEL MECHAN, V16, P173, DOI 10.1007/s10237-016-0809-y; Mirzaali MJ, 2016, BONE, V93, P196, DOI 10.1016/j.bone.2015.11.018; Morgan EF, 2001, J BIOMECH ENG-T ASME, V123, P1, DOI 10.1115/1.1338122; Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x; Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4; Niebur GL, 1999, J BIOMECH ENG-T ASME, V121, P629, DOI 10.1115/1.2800865; Pahr DH, 2012, COMPUT METHOD BIOMEC, V15, P711, DOI 10.1080/10255842.2011.556627; Palanca M, 2017, J BIOMECH IN PRESS; Palanca M, 2016, J BIOMECH, V49, P3882, DOI 10.1016/j.jbiomech.2016.10.018; Rietbergen V., 2000, COMPUT SIMUL MODEL M, V1, P98; Roberts BC, 2014, J BIOMECH, V47, P923, DOI 10.1016/j.jbiomech.2014.01.001; Sandino C, 2015, J MECH BEHAV BIOMED, V44, P1, DOI 10.1016/j.jmbbm.2014.12.018; Schwiedrzik J, 2016, INT J NUMER METH BIO, V32, DOI 10.1002/cnm.2739; Schwiedrzik JJ, 2014, EXPT THEORETICAL NUM; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17420; Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202; Tozzi G, 2017, J MECH BEHAV BIOMED, V67, P117, DOI 10.1016/j.jmbbm.2016.12.006; Ulrich D, 1998, J BIOMECH, V31, P1187, DOI 10.1016/S0021-9290(98)00118-3; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; van Rietbergen B, 1998, Technol Health Care, V6, P413; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; Verhulp E, 2008, J BIOMECH, V41, P1479, DOI 10.1016/j.jbiomech.2008.02.032; Viceconti M., 2016, CAN WE TRUST MICRO F, P1; Wolfram U, 2010, J BIOMECH, V43, P1731, DOI 10.1016/j.jbiomech.2010.02.026; Wolfram U, 2010, BONE, V46, P348, DOI 10.1016/j.bone.2009.09.035; Zauel R, 2006, J BIOMECH ENG-T ASME, V128, P1, DOI 10.1115/1.2146001	57	46	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180151	10.1371/journal.pone.0180151	http://dx.doi.org/10.1371/journal.pone.0180151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700618	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000405649400009
J	Loneman, DM; Peddicord, L; Al-Rashid, A; Nikolau, BJ; Lauter, N; Yandeau-Nelson, MD				Loneman, Derek M.; Peddicord, Layton; Al-Rashid, Amani; Nikolau, Basil J.; Lauter, Nick; Yandeau-Nelson, Marna D.			A robust and efficient method for the extraction of plant extracellular surface lipids as applied to the analysis of silks and seedling leaves of maize	PLOS ONE			English	Article							CUTICULAR WAXES; GENOTYPES; MUTANTS; CUTICLE	Aerial plant organs possess a diverse array of extracellular surface lipids, including both non-polar and amphipathic constituents that collectively provide a primary line of defense against environmental stressors. Extracellular surface lipids on the stigmatic silks of maize are composed primarily of saturated and unsaturated linear hydrocarbons, as well as fatty acids, and aldehydes. To efficiently extract lipids of differing polarities from maize silks, five solvent systems (hexanes; hexanes:diethyl ether (95:5); hexanes:diethyl ether (90:10); chloroform:hexanes (1:1) and chloroform) were tested by immersing fresh silks in solvent for different extraction times. Surface lipid recovery and the relative composition of individual constituents were impacted to varying degrees depending on solvent choice and duration of extraction. Analyses were performed using both silks and leaves to demonstrate the utility of the solvent-and time-optimized protocol in comparison to extraction with the commonly used chloroform solvent. Overall, the preferred solvent system was identified as hexanes:diethyl ether (90:10), based on its effectiveness in extracting surface hydrocarbons and fatty acids as well as its reduced propensity to extract presumed internal fatty acids. Metabolite profiling of wildtype and glossy1 seedlings, which are impaired in surface lipid biosynthesis, demonstrated the ability of the preferred solvent to extract extracellular surface lipids rich in amphipathic compounds (aldehydes and alcohols). In addition to the expected deficiencies in dotriacontanal and dotriacontan-1-ol for gl1 seedlings, an unexpected increase in fatty acid recovery was observed in gl1 seedlings extracted in chloroform, suggesting that chloroform extracts lipids from internal tissues of gl1 seedlings. This highlights the importance of extraction method when evaluating mutants that have altered cuticular lipid compositions. Finally, metabolite profiling of silks from maize inbreds B73 and Mo17, exposed to different environments and harvested at different ages, revealed differences in hydrocarbon and fatty acid composition, demonstrating the dynamic nature of surface lipid accumulation on silks.	[Loneman, Derek M.; Al-Rashid, Amani; Yandeau-Nelson, Marna D.] Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Loneman, Derek M.; Nikolau, Basil J.; Yandeau-Nelson, Marna D.] Iowa State Univ, NSF Engn Res Ctr Biorenewable Chem, Ames, IA 50011 USA; [Peddicord, Layton; Lauter, Nick] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Peddicord, Layton; Nikolau, Basil J.; Lauter, Nick; Yandeau-Nelson, Marna D.] Iowa State Univ, Interdept Genet & Genom Grad Program, Ames, IA 50011 USA; [Al-Rashid, Amani] Iowa State Univ, Young Engineers & Scientists Res Program High Sch, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Nikolau, Basil J.; Yandeau-Nelson, Marna D.] Iowa State Univ, Ctr Metab Biol, Ames, IA 50011 USA; [Lauter, Nick] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Loneman, Derek M.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Peddicord, Layton] DuPont Pioneer, Johnston, IA USA; [Al-Rashid, Amani] Perry Community High Sch, Perry, IA USA	Iowa State University; National Science Foundation (NSF); Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Case Western Reserve University; DuPont; Pioneer Hi-Bred International, Inc.	Yandeau-Nelson, MD (corresponding author), Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, NSF Engn Res Ctr Biorenewable Chem, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, Interdept Genet & Genom Grad Program, Ames, IA 50011 USA.; Yandeau-Nelson, MD (corresponding author), Iowa State Univ, Ctr Metab Biol, Ames, IA 50011 USA.	myn@iastate.edu		Yandeau-Nelson, Marna/0000-0002-2742-7384	National Science Foundation [IOS-1354799]; United States Department of Agriculture National Institute of Food and Agriculture [2011-67003-30342]; Department of Energy Ames Laboratory	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Department of Energy Ames Laboratory	This work was supported by National Science Foundation (www.nsf.gov) grant IOS-1354799 awarded to NL, BJN and MDY-N; United States Department of Agriculture National Institute of Food and Agriculture (nifa.usda.gov) grant 2011-67003-30342 awarded to NL; and a seed grant from the Department of Energy Ames Laboratory (www.ameslab.gov) awarded to BJN and MDY-N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVATO P, 1985, PHYTOCHEMISTRY, V24, P1995, DOI 10.1016/S0031-9422(00)83108-8; AVATO P, 1990, PHYTOCHEMISTRY, V29, P1571, DOI 10.1016/0031-9422(90)80124-Y; Axelsson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089643; BIANCHI A, 1985, MAYDICA, V30, P179; BIANCHI G, 1977, MAYDICA, V22, P9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cavonius LR, 2014, ANAL BIOANAL CHEM, V406, P7313, DOI 10.1007/s00216-014-8155-3; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Fernandez-Moreno JP, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0982-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Holloway PJ, 1984, CRC HDB CHROMATOGRAP, P346; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; Jetter R, 2006, ANNU PLANT REV, V23, P145; Kates M., 1986, TECHNIQUES LIPIDOLOG, V2; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Lara I, 2015, J AGR FOOD CHEM, V63, P4005, DOI 10.1021/acs.jafc.5b00013; Lee JY, 2010, BIORESOURCE TECHNOL, V101, pS75, DOI 10.1016/j.biortech.2009.03.058; Lee SB, 2015, PLANT CELL REP, V34, P557, DOI 10.1007/s00299-015-1772-2; Miller SS, 2003, J AGR FOOD CHEM, V51, P6702, DOI 10.1021/jf0341363; Perera MADN, 2010, PLANT J, V64, P618, DOI 10.1111/j.1365-313X.2010.04355.x; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ranjan A, 2010, IND ENG CHEM RES, V49, P2979, DOI 10.1021/ie9016557; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; RIEDERER M, 1989, PHYSIOL PLANTARUM, V77, P373, DOI 10.1111/j.1399-3054.1989.tb05656.x; Sathish A, 2015, BIORESOURCE TECHNOL, V193, P15, DOI 10.1016/j.biortech.2015.06.052; SCHNABLE PS, 1994, MAYDICA, V39, P279; Stammitti L, 1996, PHYTOCHEMISTRY, V43, P45, DOI 10.1016/0031-9422(96)00241-5; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Walton T.J, 1990, LIPIDS MEMBRANES ASP, P106; YANG G, 1992, J AGR FOOD CHEM, V40, P1058, DOI 10.1021/jf00018a030; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180850	10.1371/journal.pone.0180850	http://dx.doi.org/10.1371/journal.pone.0180850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700694	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400020
J	Oliver, SV; Brooke, BD				Oliver, Shune V.; Brooke, Basil D.			The effects of ingestion of hormonal host factors on the longevity and insecticide resistance phenotype of the major malaria vector Anopheles arabiensis (Diptera: Culicidae)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; LIFE-SPAN; SIGNALING CASCADE; SOUTH-AFRICA; TGF-BETA; INSULIN; MOSQUITOS; STEPHENSI; TRANSMISSION	Exogenous vertebrate-derived factors circulating in the blood have the capacity to modulate the biology of haematophagous insects. These include insulin, insulin growth factor 1 ( IGF) and transforming growth factor beta 1 ( TGF beta). The effects of the consumption of these three proteins were examined on laboratory strains of Anopheles arabiensis. SENN, an insecticide susceptible strain and SENN DDT, a resistant strain selected from SENN, were fed with host factor-supplemented sucrose. Adult longevity was measured and insecticide resistance phenotype over time was assessed by WHO bioassay. Detoxification and oxidative stress defence enzyme activity was assessed calorimetrically. Insulin supplementation augmented insecticide resistance in young adult mosquitoes. This effect was due to the hormonal nature of the protein, as heat-denatured insulin did not elicit the same response. In contrast, IGF and TGF beta consumption generally reduced the expression of insecticide resistance. Insulin ingestion significantly reduced longevity in the insecticide susceptible strain. IGF elicited the same response in the susceptible strain, while TGF consumption had no effect on either strain. Consumption of all factors significantly decreased Glutathione Stransferase activity and increased cytochrome P450 and superoxide dismutase activity. This suggests that the altered detoxification phenotype is mediated primarily by cytochrome P450 activity, which would result in an increase in oxidative stress. The increased superoxide dismutase activity suggests that this enzyme class alleviates the oxidative stress as opposed to glutathione-based redox systems. Oxidative stress responses play a crucial role in insecticide resistance and longevity. These data show that ingested hormonal factors can affect mosquito longevity and insecticide susceptibility, both of which are important characteristics in terms of malaria transmission and control.	[Oliver, Shune V.; Brooke, Basil D.] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Oliver, Shune V.; Brooke, Basil D.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Oliver, SV (corresponding author), Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.; Oliver, SV (corresponding author), Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	shuneo@nicd.ac.za	Oliver, Shune/AAH-4961-2019	Oliver, Shune/0000-0003-0658-6658; Brooke, Basil/0000-0002-8857-1304	National Health Laboratory Services (NHLS) [2014-2-DEV-31-SOL1]; National Research and Foundation Thuthuka, South African [TTK13070120248]	National Health Laboratory Services (NHLS); National Research and Foundation Thuthuka, South African	This projected was funded by National Health Laboratory Services (NHLS) Research, grant: 2014-2-DEV-31-SOL1 to SVO; Trust grants to both Shune Oliver (Development grant) and Basil Brooke; as well as a National Research and Foundation Thuthuka Grant to Shune Oliver, grant: TTK13070120248. Both granting institutions are South African. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGDON WG, 1990, COMP BIOCHEM PHYS B, V96, P339, DOI 10.1016/0305-0491(90)90385-7; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Brooke B, 2013, SAMJ S AFR MED J, V103, P784, DOI [10.7196/SAMJ.7447, 10.7196/samj.7447]; Brooke BD, 2015, S AFR J SCI, V111, P190; Drexler A, 2013, J EXP BIOL, V216, P208, DOI 10.1242/jeb.078873; Drexler AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004231; Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072; Oliver SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151049; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Oliver SV, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-44; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; Pakpour N, 2014, CURR OPIN INSECT SCI, V3, P1, DOI 10.1016/j.cois.2014.07.001; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Planche T, 2005, CURR TOP MICROBIOL, V295, P105; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; WHITE NJ, 1987, LANCET, V1, P708	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180909	10.1371/journal.pone.0180909	http://dx.doi.org/10.1371/journal.pone.0180909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700639	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400023
J	Wang, RXW; Lee, CS; Haber, JE				Wang, Ruoxi W.; Lee, Cheng-Sheng; Haber, James E.			Position effects influencing intrachromosomal repair of a double-strand break in budding yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; MITOTIC RECOMBINATION; NUCLEAR ARCHITECTURE; ORGANIZATION; CHROMOSOME; REPLICATION; KINETOCHORE; COMPETITION; GENOME	Repair of a double-strand break (DSB) by an ectopic homologous donor sequence is subject to the three-dimensional arrangement of chromosomes in the nucleus of haploid budding yeast. The data for interchromosomal recombination suggest that searching for homology is accomplished by a random collision process, strongly influenced by the contact probability of the donor and recipient sequences. Here we explore how recombination occurs on the same chromosome and whether there are additional constraints imposed on repair. Specifically, we examined how intrachromosomal repair is affected by the location of the donor sequence along the 813-kb chromosome 2 (Chr2), with a site-specific DSB created on the right arm (position 625 kb). Repair correlates well with contact frequencies determined by chromosome conformation capture-based studies (r = 0.85). Moreover, there is a profound constraint imposed by the anchoring of the centromere (CEN2, position 238 kb) to the spindle pole body. Sequences at the same distance on either side of CEN2 are equivalently constrained in recombining with a DSB located more distally on one arm, suggesting that sequences on the opposite arm from the DSB are not otherwise constrained in their interaction with the DSB. The centromere constraint can be partially relieved by inducing transcription through the centromere to inactivate CEN2 tethering. In diploid cells, repair of a DSB via its allelic donor is strongly influenced by the presence and the position of an ectopic intrachromosomal donor.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Wang, Ruoxi W.] MIT, Dept Biol, Cambridge, MA USA; [Lee, Cheng-Sheng] Harvard Med Sch, Dept Genet, Boston, MA USA	Brandeis University; Brandeis University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	National Institutes of Health [GM20056]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant GM20056 to JEH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Avsaroglu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102474; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Chu Angela M., 2008, V416, P205, DOI 10.1007/978-1-59745-321-9_14; Coic E, 2011, GENETICS, V189, P1225, DOI 10.1534/genetics.111.132738; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Hager JE, 2014, GENOME STABILITY: DNA REPAIR AND RECOMBINATION, P1; HILL A, 1989, MOL CELL BIOL, V9, P1368, DOI 10.1128/MCB.9.3.1368; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Jin QW, 2000, J CELL SCI, V113, P1903; Lee CS, 2016, P NATL ACAD SCI USA, V113, pE146, DOI 10.1073/pnas.1523660113; LICHTEN M, 1989, GENETICS, V123, P261; Lorenz A, 2003, EUKARYOT CELL, V2, P856, DOI 10.1128/EC.2.5.856-866.2003; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mehta A, 2017, MOL CELL, V65, P515, DOI 10.1016/j.molcel.2016.12.003; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tsabar M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006021; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	22	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180994	10.1371/journal.pone.0180994	http://dx.doi.org/10.1371/journal.pone.0180994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700723	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400026
J	Du, ZC; Zhang, WJ; Zhang, DM; Yu, SC; Hao, YT				Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Yu, Shicheng; Hao, Yuantao			Estimating the basic reproduction rate of HFMD using the time series SIR model in Guangdong, China	PLOS ONE			English	Article							MOUTH-DISEASE HFMD; FOOT; HAND	Hand, foot, and mouth disease (HFMD) has caused a substantial burden of disease in China, especially in Guangdong Province. Based on notifiable cases, we use the time series Susceptible-Infected-Recovered model to estimate the basic reproduction rate (R0) and the herd immunity threshold, understanding the transmission and persistence of HFMD more completely for efficient intervention in this province. The standardized difference between the reported and fitted time series of HFMD was 0.009 (< 0.2). The median basic reproduction rate of total, enterovirus 71, and coxsackievirus 16 cases in Guangdong were 4.621 (IQR: 3.907 -5.823), 3.023 (IQR: 2.289 - 4.292) and 7.767 (IQR: 6.903 - 10.353), respectively. The heatmap of R0 showed semiannual peaks of activity, including a major peak in spring and early summer (about the 12 th week) followed by a smaller peak in autumn ( about the 36 th week). The county-level model showed that Longchuan (R0 = 33), Gaozhou ( R0 = 24), Huazhou (R0 = 23) and Qingxin (R0 = 19) counties have higher basic reproduction rate than other counties in the province. The epidemic of HFMD in Guangdong Province is still grim, and strategies like the World Health Organization's expanded program on immunization need to be implemented. An elimination of HFMD in Guangdong might need a Herd Immunity Threshold of 78%.	[Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Hlth Informat Res Ctr, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Key Lab Med, Guangzhou, Guangdong, Peoples R China; [Du, Zhicheng; Zhang, Wangjian; Zhang, Dingmei; Hao, Yuantao] Minist Educ, Key Lab Trop Dis & Control, Guangzhou, Guangdong, Peoples R China; [Yu, Shicheng] Chinese Ctr Dis Control & Prevent, Publ Hlth Surveillance & Informat Serv Ctr, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Center for Disease Control & Prevention	Hao, YT (corresponding author), Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Sun Yat Sen Univ, Hlth Informat Res Ctr, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Key Lab Med, Guangzhou, Guangdong, Peoples R China.; Hao, YT (corresponding author), Minist Educ, Key Lab Trop Dis & Control, Guangzhou, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Zhang, Wangjian/AAU-6705-2021; Zhang, Wang-Jian/K-2242-2019; Zhang, Dingmei/ABC-7476-2020	Zhang, Wangjian/0000-0001-9655-6385	National Natural Science Foundation of China [81473064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China, Grants 81473064	ANDERSON R M, 1991; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; CST F., 2008, 2 AS INT C MOD SIM A, P947; Daubechies I, 2010, COMMUN PUR APPL MATH, V63, P1, DOI 10.1002/cpa.20303; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Du ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36351; Finkenstadt BF, 2002, BIOSTATISTICS, V3, P493, DOI 10.1093/biostatistics/3.4.493; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Guangdong Health Department, 2016, NAT STAT EP SIT INF; KJ R, 1998, MODERN EPIDEMIOLOGY; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; National Health and Family Planning Commission of China, 2017, NAT STAT EP SIT INF; National Population and Health Science Data Sharing Platform, 2001, NAT POP HLTH SCI DAT; Nilimesh Halder, 2010, RES J APPL SCI, V5, P177, DOI [10.3923/rjasci.2010.177.182, DOI 10.3923/RJASCI.2010.177.182]; Public Health Action Support Team (PHAST), 2008, EP THEOR; Sanicas M., 2016, SEVERE HAND FOOT MOU; WHO, 2011, GUID CLINC MAN PUBL; Wu YF, 2016, J FRANKLIN I, V353, P4772, DOI 10.1016/j.jfranklin.2016.09.012; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang JY, 2013, J APPL MATHE COMPUT, V41, P99, DOI 10.1007/s12190-012-0597-1; Zhang WJ, 2016, SCI TOTAL ENVIRON, V553, P366, DOI 10.1016/j.scitotenv.2016.02.023; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu YT, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/234509	24	20	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179623	10.1371/journal.pone.0179623	http://dx.doi.org/10.1371/journal.pone.0179623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692654	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800011
J	Guiraud, I; Post, A; Diallo, SN; Lompo, P; Maltha, J; Thriemer, K; Tahita, CM; Ley, B; Derra, K; Bottieau, E; Kazienga, A; Schurmans, C; Ravinetto, R; Rouamba, E; Van Griensven, J; Bertrand, S; Tinto, H; Jacobs, J				Guiraud, Issa; Post, Annelies; Diallo, Seydou Nakanabo; Lompo, Palpouguini; Maltha, Jessica; Thriemer, Kamala; Tahita, Christian Marc; Ley, Benedikt; Derra, Karim; Bottieau, Emmanuel; Kazienga, Adama; Schurmans, Celine; Ravinetto, Raffaella; Rouamba, Eli; Van Griensven, Johan; Bertrand, Sophie; Tinto, Halidou; Jacobs, Jan			Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SEROVAR TYPHIMURIUM INFECTION; BLOOD-STREAM INFECTIONS; SUB-SAHARAN AFRICA; TYPHOID-FEVER; DISEASE; SURVEILLANCE; HEALTH; BACTEREMIA; RESISTANCE	Background Bloodstream infections (BSI) caused by Salmonella Typhi and invasive non-Typhoidal Salmonella (iNTS) frequently affect children living in rural sub-Saharan Africa but data about incidence and serotype distribution are rare. Objective The present study assessed the population-based incidence of Salmonella BSI and severe malaria in a Health and Demographic Surveillance System in a rural area with seasonal malaria transmission in Nanoro, Burkina Faso. Methods Children between 2 months D 15 years old with severe febrile illness were enrolled during a one-year surveillance period (May 2013 D May 2014). Thick blood films and blood cultures were sampled and processed upon admission. Population-based incidences were corrected for non-referral, health seeking behavior, non-inclusion and blood culture sensitivity. Adjusted incidence rates were expressed per 100,000 person-years of observations (PYO). Results Among children <5 years old, incidence rates for iNTS, Salmonella Typhi and severe malaria per 100,000 PYO were 4,138 (95% Confidence Interval (CI): 3,740-4,572), 224 (95% CI: 138-340) and 2,866 (95% CI: 2,538-3,233) respectively. Among those aged 5-15 years, corresponding incidence rates were 25 (95% CI: 8-60), 273 (95% CI: 203-355) and 135 (95% CI: 87-195) respectively. Most iNTS occurred during the peak of the rainy season and in parallel with the increase of Plasmodium falciparum malaria; for Salmonella Typhi no clear seasonal pattern was observed. Salmonella Typhi and iNTS accounted for 13.3% and 55.8% of all 118 BSI episodes; 71.6% of iNTS (48/67) isolates were Salmonella enterica serovar Typhimurium and 25.4% (17/67) Salmonella enterica serovar Enteritidis; there was no apparent geographical clustering. Conclusion The present findings from rural West-Africa confirm high incidences of Salmonella Typhi and iNTS, the latter with a seasonal and Plasmodium falciparum-related pattern. It urges prioritization of the development and implementation of Salmonella Typhi as well as iNTS vaccines in this setting.	[Guiraud, Issa; Diallo, Seydou Nakanabo; Lompo, Palpouguini; Tahita, Christian Marc; Derra, Karim; Kazienga, Adama; Rouamba, Eli; Tinto, Halidou] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Guiraud, Issa; Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium; [Post, Annelies; Maltha, Jessica; Thriemer, Kamala; Ley, Benedikt; Bottieau, Emmanuel; Schurmans, Celine; Van Griensven, Johan; Jacobs, Jan] ITM, Dept Clin Sci, Antwerp, Belgium; [Diallo, Seydou Nakanabo] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Maltha, Jessica] Univ Leuven, Ctr Mol & Vasc Biol, KU Leuven, Leuven, Belgium; [Thriemer, Kamala; Ley, Benedikt] Menzies Sch Hlth Res, Darwin, NT, Australia; [Ravinetto, Raffaella] ITM, Dept Publ Hlth, Antwerp, Belgium; [Bertrand, Sophie] Inst Publ Hlth, Brussels, Belgium	KU Leuven; Institute of Tropical Medicine (ITM); Centre Muraz; KU Leuven; Charles Darwin University; Menzies School of Health Research; Institute of Tropical Medicine (ITM)	Guiraud, I (corresponding author), IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso.; Guiraud, I (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium.; Post, A (corresponding author), ITM, Dept Clin Sci, Antwerp, Belgium.	guiraudis@yahoo.fr; annelies.post@gmail.com	Issa, GUIRAUD/AGU-8073-2022; Post, Annelies/Q-6745-2016; Kazienga, Adama/HGB-6079-2022; Jacobs, Jan/GRX-7316-2022; Derra, Karim/AAC-1323-2022	Post, Annelies/0000-0002-0471-8250; Derra, Karim/0000-0002-2090-9698; Kazienga, Adama/0000-0002-6093-9648; Tahita, Marc/0000-0003-2158-0182; Tinto, Halidou/0000-0002-0472-3586; Ley, Benedikt/0000-0002-5734-0845	Projects Network Laboratory Quality Management [126]; Clinical Research of the Third Framework [128]; Steunfonds Margeurite-Marie Delacroix; Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium) [V453812N]; Junior Mobility program of KU Leuven [JUMO/12/008]	Projects Network Laboratory Quality Management; Clinical Research of the Third Framework; Steunfonds Margeurite-Marie Delacroix; Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium)(FWO); Junior Mobility program of KU Leuven	This project was funded by the Projects Network Laboratory Quality Management (Nr. 126) and Clinical Research (128) of the Third Framework Agreement between the Belgian DGD (Ministry of Development Cooperation) and the Institute of Tropical Medicine (ITM), Belgium. (website: http://diplomatie.belgium.be/en/policy/development_cooperation/work_with_us/financing_opportunities/study_and_training_grants). The work of JM was partly funded by Steunfonds Margeurite-Marie Delacroix (No grant number available, website http://www.fondsmmdelacroix.org/nl/nos-activites/bourses-de-recherche/). For this study JM received additional grants from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium. Grant number V453812N, website http://www.fwo.be/en/) and the Junior Mobility program of KU Leuven (grant JUMO/12/008, website https://www.kuleuven.be/personeel/careercenter/youreca-career-center/yourecaENG/youreca-internationalmobility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BAS MAL MICR 1; Ao TT, 2015, EMERG INFECT DIS, V2010, P21, DOI DOI 10.3201/EID2106.140999; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Derra K, 2012, INT J EPIDEMIOL, V41, P1293, DOI 10.1093/ije/dys159; District sanitaire de Dande, 2018, PLAN ACT 2019 DISTR; Falay D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1604-1; Garrett JL, 1999, WORLD DEV, V27, P1955, DOI 10.1016/S0305-750X(99)00091-1; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Institut National de la Statistique et de la De A mographie (INSD), 2010, PHIQ SANT IND MULT B; Kalonji LM, 2015, CLIN INFECT DIS, V61, pS346, DOI 10.1093/cid/civ713; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Muthumbi E, 2015, CLIN INFECT DIS, V61, pS290, DOI 10.1093/cid/civ737; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; ONUSIDA Burkina Faso, 2014, RAPP ACT RIP SIDA BU; Panzner U, 2016, CLIN INFECT DIS, V62, pS56, DOI 10.1093/cid/civ891; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Sothmann P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139433; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Takem EN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-400; Tennant SM, VACCINE; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; World Health Organization, 2013, NUTR HLTH DEV	42	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178577	10.1371/journal.pone.0178577	http://dx.doi.org/10.1371/journal.pone.0178577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692655	gold, Green Submitted, Green Published			2022-12-27	WOS:000405544800005
J	Martos, AJ; Wilson, PA; Meyer, IH				Martos, Alexander J.; Wilson, Patrick A.; Meyer, Ilan H.			, gay, bisexual, and transgender (LGBT) health services in the United States: Origins, evolution, and contemporary landscape	PLOS ONE			English	Article							PUBLIC-HEALTH; LESBIANS; COMMUNITY; HIV/AIDS; IDENTITY; AIDS; CARE; MEN; SEX	Background LGBT community organizations in the United States have been providing health services since at least the 1970s. However, available explanations for the origins of LGBT health services do not sufficiently explain why health in particular has been so closely and consistently linked to LGBT activism. Little is also known regarding how LGBT health services may have evolved over time with the growing scientific understanding of LGBT health needs. Methods This study begins with a review of the early intersections of sexuality and health that led to an LGBT health movement in the United States, as well as the evolution of LGBT health services over time. Informed by this, an asset map displaying the location and types of services provided by | LGBT community health centers today in relation to the population density of LGBT people was explored. An online search of LGBT community health centers was conducted between September-December, 2015. Organizational details, including physical addresses and the services provided, were confirmed via an online database of federallyregistered non-profit organizations and organizational websites. The locations and types of services provided were analyzed and presented alongside county-level census data of same-sex households using geographic information system (GIS) software ArcGIS for Desktop. Findings LGBT community health centers are concentrated within urban hubs and coastal states, and are more likely to be present in areas with a high density of same-sex couples. LGBT community health centers do not operate in 13 states. The most common health services provided are wellness programs, HIV/STI services, and counseling services. Conclusions LGBT community health centers have adapted over time to meet the needs of LGBT people. However, significant gaps in service remain in the United States, and LGBT community health centers may require significant transformations going forward in order to continue serving LGBT people.	[Martos, Alexander J.; Wilson, Patrick A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [Martos, Alexander J.; Meyer, Ilan H.] UCLA Sch Law, Williams Inst, Los Angeles, CA 90095 USA	Columbia University	Martos, AJ (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.; Martos, AJ (corresponding author), UCLA Sch Law, Williams Inst, Los Angeles, CA 90095 USA.	ajm2230@cumc.columbia.edu	Meyer, Ilan H/A-2142-2009		National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [R01HD078526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078526] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this manuscript was supported by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award number R01HD078526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman Dennis, 1986, AIDS MIND AM; [Anonymous], 2016, HOWARD BROWN HLTH; [Anonymous], HLTH PEOPL 2020; Armstrong E.A., 2002, FORGING GAY IDENTITI; ARNO PS, 1986, AM J PUBLIC HEALTH, V76, P1325, DOI 10.2105/AJPH.76.11.1325; Austin EL, 2013, WOMEN HEALTH, V53, P41, DOI 10.1080/03630242.2012.743497; Barrett DC, 2005, SOCIOL QUART, V46, P437, DOI 10.1111/j.1533-8525.2005.00021.x; Bayer R., 1981, HOMOSEXUALITY AM PSY; Bernstein M, 2002, SOC SCI HIST, V26, P531, DOI 10.1215/01455532-26-3-531; Boston Women's Health Book Collective, 1973, OUR BOD OURS BOOK WO; Bowen D, 1997, LESBIAN HLTH BOOK CA, P299; Bradford J, 1988, NATL LESBIAN HLTH CA; Brier Jennifer, 2009, INFECT IDEAS US POLI; Burns R, 1988, SOURCEBOOK LESBIAN G, P24; Callen-Lorde Community Health Center, 2015, 2014 2015 ANN REP; CenterLink, 2016, CENTR LGBT COMM CTR; CenterLink MAP, 2016, LGBT COMMUNITY CTR S; CenterLink MAP, 2014, LGBT COMMUNITY CTR S; Centers for Disease Control and Prevention, 2016, LESB GY BIS TRANSG H; Currah P, 1997, HASTINGS LAW J, V48, P1363; D'Emilio J., 2012, SEXUAL POLITICS SEXU; Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; DEmilio John, 2012, DOCUMENTING INTIMATE; Deyton B, 1988, SOURCEBOOK LESBIAN G, P15; Epstein S., SEXUALITIES, V6, P131; ESTERBERG KG, 1990, J SEX RES, V27, P65, DOI 10.1080/00224499009551542; Ford CS, 1951, PATTERNSEXUAL BEHA; Forstein M, 2013, J GAY LESBIAN MENT H, V17, P40, DOI 10.1080/19359705.2013.740212; Foucault M., 1990, HIST SEXUALITY INTRO, VI; Gay Men's Health Crisis, 2016, GAY MENS HLTH CRIS; GOLDSTEIN N, 1995, WOMEN STUD, V24, P531, DOI 10.1080/00497878.1995.9979080; Hay Harry, 1996, RADICALLY GAY GAY LI; HOOKER E, 1957, J PROJ TECH PERS ASS, V21, P18, DOI 10.1080/08853126.1957.10380742; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Institute of Medicine (US) Committee on Lesbian Health Research Priorities; Solarz AL, 1999, LESB HLTH CURR ASS D; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; Koester KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071546; Laiteerapong N, 2014, HEALTH SERV RES, V49, P1498, DOI 10.1111/1475-6773.12178; Mail P. D., 2006, HDB LESBIAN GAY BISE, P11; Malebranche DJ, 2004, J NATL MED ASSOC, V96, P97; Mayer K. H., 2007, HLTH SEXUAL MINORITI, P693; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; MAYS VM, 1993, J HOMOSEXUAL, V25, P1, DOI 10.1300/J082v25n04_01; McCormack M., 2013, DECLINING SIGNIFICAN; Meyer IH, 2001, AM J PUBLIC HEALTH, V91, P856, DOI 10.2105/AJPH.91.6.856; Meyerowitz JJ, 2009, HOW SEX CHANGED; Minter Shannon, 2000, NEW YORK LAW SCH J H, V17, P589; Namaste Viviane, 2000, INVISIBLE LIVES ERAS; National Association of Community Health Centers, 2007, IMPR COMM REIMB COMM; Orel NancyA., 2004, J GERONTOLOGICAL SOC, V43, P57, DOI [10.1300/J083v43n02_05, DOI 10.1300/J083V43N02_05, DOI 10.1300/J083V43N02_]; Ormsby T., 2010, GETTING KNOW ARCGIS; Patton Cindy, 1986, SEX GERMS POLITICS A; Pew Research Center, 2016, SUPP STEAD SAM SEX M; Platzer H, 2000, NURS TIMES RES, V5, P194; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Savin-Williams, 2009, NEW GAY TEENAGER, V3; Shi LY, 2012, HEALTH SERV RES, V47, P2225, DOI 10.1111/j.1475-6773.2012.01418.x; Shin P., 2013, COMMUNITY HLTH CTR E; Smith Tom W., 2011, PUBLIC ATTITUDES HOM; STEVENS PE, 1991, INT J HEALTH SERV, V21, P291, DOI 10.2190/R2AW-MTCR-U0Q7-XMMY; Stryker Susan, 2008, TRANSGENDER HIST; Terry J., 1999, AM OBSESSION SCI MED; Weststrate NM, 2010, MEMORY, V18, P225, DOI 10.1080/09658210903153923; White J., 1998, J GAY LESBIAN MED AS, V2, P1; Williams Institute at the UCLA School of Law, 2011, CENS SNAPSH 2010 MET; Williams Institute at the UCLA School of Law, 2011, US CENS SNAPSH 2010; Wilson PA., 2007, HLTH SEXUAL MINORITI, P607; World Professional Association for Transgender Health, 2017, PAST LEAD; Young RM, 2005, AM J PUBLIC HEALTH, V95, P1144, DOI 10.2105/AJPH.2004.046714	70	54	55	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180544	10.1371/journal.pone.0180544	http://dx.doi.org/10.1371/journal.pone.0180544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28692659	Green Published, gold			2022-12-27	WOS:000405544800052
J	Morrone, E; Sguazzin, C; Bertolotti, G; Giordano, A; Braghiroli, A; Balestroni, GL; Manni, R; Strambi, LF; Castronovo, V; Zucconi, M; De Carli, F; Pinna, E; Ottonello, M; Giorgi, I; Terzaghi, M; Marelli, S; Fanfulla, F				Morrone, Elisa; Sguazzin, Cinzia; Bertolotti, Giorgio; Giordano, Andrea; Braghiroli, Alberto; Balestroni, Gian Luigi; Manni, Raffaele; Strambi, Luigi Ferini; Castronovo, Vincenza; Zucconi, Marco; De Carli, Fabrizio; Pinna, Eleonora; Ottonello, Marcella; Giorgi, Ines; Terzaghi, Michele; Marelli, Sara; Fanfulla, Francesco			Development and validation of the Maugeri Sleep Quality and Distress Inventory (MaSQuDI-17)	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; PSYCHOLOGICAL DISTRESS; CARDIOVASCULAR-DISEASE; INSOMNIA SYMPTOMS; DAYTIME FUNCTION; RASCH ANALYSIS; DEPRESSION; APNEA; COHORT; ANXIETY	Objectives The aim of this study was to develop and validate a questionnaire designed to measure the impact of sleep impairment on emotional distress in patients with various sleep disorders. Methods Five experts created an item data-bank pertaining to sleep-related psychological symptoms and somatic perceptions. Fifty patients in two focus groups examined each item for: a) word clarity (indicating any ambiguity of interpretation) and b) appropriateness for the target population. This process permitted to identify 36 appropriate items. Classical Test Theory and Rasch Analysis were used to further refine the questionnaire, yielding the final 17-item set. Concurrent validation of the new scale was tested with the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and the Anxiety and Depression questionnaires. Results Starting from the initial item data-bank, a 17-item questionnaire, the Maugeri Sleep Quality and Distress Inventory (MaSQuDI-17), was produced. Parallel Analysis on the MaSQuDI -17 confirmed the presence of a single dimension; exploratory factor analysis showed salient loading for each item, explaining 58.7% of total variance. Item-remainder correlation ranged from 0.72 to 0.39 and Cronbach alpha was 0.896. Rasch analysis revealed satisfactory psychometric properties of the new scale: the rating structure performed according to expectations, model fit was good and no item dependencies emerged. The scale presented good convergent validity and scores significantly distinguished healthy subjects from OSAS or Insomnia or BSD (p < 0.001). Conclusions MaSQuDI-17 shows good psychometric qualities, and can be used to assess the impact of sleep disorders such as Insomnia, OSAS, Central Hypersomnia and BSD on emotional stress.	[Morrone, Elisa; Fanfulla, Francesco] Sci Ist Pavia IRCCS, Sleep Med Unit, Ist Clin Sci Maugeri, Pavia, Italy; [Sguazzin, Cinzia; Pinna, Eleonora; Giorgi, Ines] Sci Ist Pavia IRCCS, Psychol Unit, Ist Clin Sci Maugeri, Pavia, Italy; [Bertolotti, Giorgio] Sci Ist Tradate IRCCS, Psychol Unit, ICS Maugeri, Tradate, Italy; [Giordano, Andrea] Sci Ist Veruno IRCCS, Unit Bioengn, Ist Clin Sci Maugeri, Veruno, Italy; [Braghiroli, Alberto] Sci Ist Veruno IRCCS, Ist Clin Sci Maugeri, Div Resp Dis, Veruno, Italy; [Balestroni, Gian Luigi] Sci Ist Veruno IRCCS, Ist Clin Sci Maugeri, Psychol Unit, Veruno, Italy; [Manni, Raffaele; Terzaghi, Michele] C Mondino Natl Neurol Inst, Unit Sleep Med & Epilepsy, Pavia, Italy; [Strambi, Luigi Ferini; Castronovo, Vincenza; Zucconi, Marco; Marelli, Sara] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Sleep Disorders Ctr, Dept Clin Neurosci, Milan, Italy; [De Carli, Fabrizio] Natl Res Council CNR, Inst Bioimaging & Mol Physiol, Genoa, Italy; [Ottonello, Marcella] Sci Ist Genova Nervi, Ist Clin Sci Maugeri, Psychol Unit, Genoa, Italy	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione Casimiro Mondino; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituti Clinici Scientifici Maugeri IRCCS	Fanfulla, F (corresponding author), Sci Ist Pavia IRCCS, Sleep Med Unit, Ist Clin Sci Maugeri, Pavia, Italy.	francesco.fanfulla@icsmaugeri.it	manni, raffaele/AAB-8804-2019; Zucconi, Marco/AAN-4994-2020; Bertolotti, Giorgio/AAJ-2692-2021; Fanfulla, Francesco/H-4215-2017; Braghiroli, Alberto/K-4839-2018; STRAMBI, Luigi FERINI/K-3620-2018; Fanfulla, Francesco/ABI-2221-2020; MORRONE, ELISA EM/K-4836-2018; De Carli, Fabrizio/F-8208-2013; ottonello, marcella/K-8134-2016; Balestroni, Gianluigi/F-1259-2019; Terzaghi, Michele/H-9299-2018	Bertolotti, Giorgio/0000-0002-3079-1945; Fanfulla, Francesco/0000-0002-8601-423X; Braghiroli, Alberto/0000-0001-7013-4280; STRAMBI, Luigi FERINI/0000-0003-2867-5424; Fanfulla, Francesco/0000-0002-8601-423X; MORRONE, ELISA EM/0000-0001-7258-2909; De Carli, Fabrizio/0000-0002-1841-5146; ottonello, marcella/0000-0001-6538-9270; Giordano, Andrea/0000-0002-6051-0067; Balestroni, Gianluigi/0000-0002-7794-7361; Terzaghi, Michele/0000-0001-9692-2218				American Psychiatric Association, 2014, DSM 5 MAN DIAGN STAT; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BERTOLOTTI G, 1990, J BEHAV THER EXP PSY, V21, P21, DOI 10.1016/0005-7916(90)90045-M; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bond T., 2001, APPL RASCH MODEL FUN; Cunningham TJ, 2015, ASS PSYCHOL DISTRESS; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; D'Alessandro L, 2003, ITALIAN VERSION EPWO, P295; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Drapeau A., 2011, EPIDEMIOLOGY PSYCHOL, P105; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Gallagher J, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0667-8; Gianfagna F, 2016, SLEEP MED, V21, P126, DOI 10.1016/j.sleep.2016.01.007; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; HARDINGE FM, 1995, RESP MED, V89, P617, DOI 10.1016/0954-6111(95)90230-9; Harris M, 2009, SLEEP MED REV, V13, P437, DOI 10.1016/j.smrv.2009.04.001; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hynninen MJ, 2013, SLEEP MED, V14, P1328, DOI 10.1016/j.sleep.2013.08.785; Khan A, 2014, INT J METH PSYCH RES, V23, P1, DOI 10.1002/mpr.1431; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kingshott RN, 2000, AM J RESP CRIT CARE, V161, P866, DOI 10.1164/ajrccm.161.3.9905053; Kjelsberg FN, 2005, SLEEP MED, V6, P341, DOI 10.1016/j.sleep.2005.02.004; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Law M, 2014, J CLIN SLEEP MED, V10, P163, DOI 10.5664/jcsm.3444; Lazzari R, 1980, QUESTIONARIO AUTOVAL; Lee SA, 2015, J PSYCHOSOM RES, V79, P32, DOI 10.1016/j.jpsychores.2015.01.012; Lee W, 2015, LUNG, V193, P261, DOI 10.1007/s00408-015-9687-9; Lee Y.-W., 2004, LANG TEST, V21, P74, DOI DOI 10.1191/0265532204LT260OA; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Linacre John M, 2002, J Appl Meas, V3, P85; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Pierobon A, 2008, SLEEP MED, V9, P882, DOI 10.1016/j.sleep.2007.10.017; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Poulin C, 2005, SOC PSYCH PSYCH EPID, V40, P1019, DOI 10.1007/s00127-005-0961-7; PREVILLE M, 1995, PSYCHOL REP, V77, P275, DOI 10.2466/pr0.1995.77.1.275; Rouquette A, 2011, INT J METH PSYCH RES, V20, P235, DOI 10.1002/mpr.352; Salo P, 2012, SLEEP MED, V13, P278, DOI 10.1016/j.sleep.2011.06.022; SANGAL RB, 1992, CHEST, V102, P699, DOI 10.1378/chest.102.3.699; Seixas AA, 2015, NEUROPSYCH DIS TREAT, V11, P2425, DOI 10.2147/NDT.S77909; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Sivertsen B, 2014, EUR CHILD ADOLES PSY, V23, P681, DOI 10.1007/s00787-013-0502-y; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Vedana L, 2001, CLIN VALIDATION ANXI, P101; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Witthoft M, 2016, PSYCHOL ASSESSMENT, V28, P109, DOI 10.1037/pas0000150; Wolfe Edward W, 2007, J Appl Meas, V8, P204; Wright BD, 1982, RATING SCALE ANAL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180743	10.1371/journal.pone.0180743	http://dx.doi.org/10.1371/journal.pone.0180743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700701	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800072
J	Podesta, TSV; Rosembach, TV; dos Santos, AA; Martins, ML				Vilela Podesta, Tatiane Souza; Rosembach, Tiago Venzel; dos Santos, Anesia Aparecida; Martins, Marcelo Lobato			Anomalous diffusion and q-Weibull velocity distributions in epithelial cell migration	PLOS ONE			English	Article							LEVY WALKS; MOTILITY; DYNAMICS; MOTION	In multicellular organisms, cell motility is central in all morphogenetic processes, tissue maintenance, wound healing and immune surveillance. Hence, the control of cell motion is a major demand in the creation of artificial tissues and organs. Here, cell migration assays on plastic 2D surfaces involving normal (MDCK) and tumoral (B16F10) epithelial cell lines were performed varying the initial density of plated cells. Through time-lapse microscopy quantities such as speed distributions, velocity autocorrelations and spatial correlations, as well as the scaling of mean-squared displacements were determined. We find that these cells exhibit anomalous diffusion with q-Weibull speed distributions that evolves non-monotonically to a Maxwellian distribution as the initial density of plated cells increases. Although short-ranged spatial velocity correlations mark the formation of small cell clusters, the emergence of collective motion was not observed. Finally, simulational results from a correlated random walk and the Vicsek model of collective dynamics evidence that fluctuations in cell velocity orientations are sufficient to produce q-Weibull speed distributions seen in our migration assays.	[Vilela Podesta, Tatiane Souza; Rosembach, Tiago Venzel; Martins, Marcelo Lobato] Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil; [dos Santos, Anesia Aparecida] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Martins, Marcelo Lobato] Natl Inst Sci & Technol Complex Syst, Vicosa, MG, Brazil; [Rosembach, Tiago Venzel] Univ Fed Minas Gerais, Dept Fis, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais	Martins, ML (corresponding author), Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil.; Martins, ML (corresponding author), Natl Inst Sci & Technol Complex Syst, Vicosa, MG, Brazil.	mmartins@ufv.br	Rosembach, Tiago Venzel/AAV-9443-2021	Venzel Rosembach, Tiago/0000-0001-9805-0951	FAPEMIG [APQ-04232-10, APQ-02710-14]; CNPq [306024/2013-6, 400412/2014-4]; CAPES (Podesta and Venzel graduate fellowships)	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Podesta and Venzel graduate fellowships)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors received funding for this work from FAPEMIG (APQ-04232-10 and APQ-02710-14), CNPq (306024/2013-6 and 400412/2014-4), and CAPES (Podesta and Venzel graduate fellowships).	Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Blitterswijk C.V., 2008, TISSUE ENG; Bray D, 2001, CELL MOVEMENTS MOL M; Carnell MJ, 2011, SEMIN CELL DEV BIOL, V22, P82, DOI 10.1016/j.semcdb.2010.12.003; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; da Silva PCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104253; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Le Bellac M, 2010, EQUILIBRIUM NONEQUIL; Levy P., 1954, THEORIE ADDITION VAR; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peruani F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010602; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Petroff AP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.158102; Picoli S, 2003, PHYSICA A, V324, P678, DOI 10.1016/S0378-4371(03)00071-2; Potdar AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009636; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rabani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083760; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsallis C, 1999, PHYS LETT A, V257, P93, DOI 10.1016/S0375-9601(99)00270-4; Tsallis C, 2009, INTRODUCTION TO NONE; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Viswanathan G. M., 2011, PHYS FORAGING; Wolgemuth CW, 2008, BIOPHYS J, V95, P1564, DOI 10.1529/biophysj.107.118257	33	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180777	10.1371/journal.pone.0180777	http://dx.doi.org/10.1371/journal.pone.0180777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700652	Green Published, gold			2022-12-27	WOS:000405544800074
J	Adragao, T; Ferreira, A; Frazao, JM; Papoila, AL; Pinto, I; Monier-Faugere, MC; Malluche, HH				Adragao, Teresa; Ferreira, Anibal; Frazao, Joao M.; Papoila, Ana Luisa; Pinto, Iola; Monier-Faugere, Marie-Claude; Malluche, Hartmut H.			Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; RENAL OSTEODYSTROPHY; CARDIOVASCULAR RISK; CALCIUM; STIFFNESS; HISTOMORPHOMETRY; PROGRESSION; MORTALITY; AGREEMENT; TURNOVER	Background and objectives In dialysis patients, there is an increasing evidence that altered bone metabolism is associated with cardiovascular calcifications. The main objective of this study was to analyse, in hemodialysis patients, the relationships between bone turnover, mineralization and volume, evaluated in bone biopsies, with a plain X-ray vascular calcification score. Design, setting, participants and measurements In a cross-sectional study, bone biopsies and evaluation of vascular calcifications were performed in fifty hemodialysis patients. Cancellous bone volume, mineralized bone volume, osteoid volume, activation frequency, bone formation rate/bone surface, osteoid thickness and mineralization lag time were determined by histomorphometry. Vascular calcifications were assessed by the simple vascular calcification score (SVCS) in plain X-Ray of pelvis and hands and, for comparison, by the Agatston score in Multi-Slice Computed Tomography (MSCT). Results SVCS >= 3 was present in 20 patients (40%). Low and high bone turnover were present in 54% and 38% of patients, respectively. Low bone volume was present in 20% of patients. In multivariable analysis, higher age (p = 0.015) and longer hemodialysis duration (p = 0.017) were associated with SVCS >= 3. Contrary to cancellous bone volume, the addition to this model of mineralized bone volume (OR = 0.863; 95% CI: 0.766, 0.971; p = 0.015), improved the performance of the model. For each increase of 1% in mineralized bone volume there was a 13.7% decrease in the odds of having SVCS >= 3 (p = 0.015). An Agatston score> 400 was observed in 80% of the patients with a SVCS >= 3 versus 4% of patients with a SVCS<3, (p<0.001). Conclusion Higher mineralized bone volume was associated with a lower plain X-ray vascular calcification. This study corroborates the hypothesis of the existence of a link between bone and vessel and reinforces the clinical utility of this simple and inexpensive vascular calcification score in dialysis patients.	[Adragao, Teresa] Santa Cruz Hosp, Nephrol Dept, Lisbon, Portugal; [Ferreira, Anibal] Curry Cabral Hosp, Nephrol Dept, Lisbon, Portugal; [Frazao, Joao M.] Univ Porto, S Joao Hosp, Med Sch, Nephrol Dept, Oporto, Portugal; [Frazao, Joao M.] Univ Porto, Nephrol Res & Dev Unit, Oporto, Portugal; [Papoila, Ana Luisa] New Univ, FCM, Nova Med Sch, CEAUL,CEDOC, Lisbon, Portugal; [Pinto, Iola] Univ Nova Lisboa, CMA FCT, ISEL, Lisbon, Portugal; [Monier-Faugere, Marie-Claude; Malluche, Hartmut H.] Univ Kentucky, Div Nephrol Bone & Mineral Metab, Lexington, KY USA	Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Universidade de Lisboa; Universidade Nova de Lisboa; Polytechnic Institute of Lisbon; Universidade Nova de Lisboa; University of Kentucky	Adragao, T (corresponding author), Santa Cruz Hosp, Nephrol Dept, Lisbon, Portugal.	tadragao@gmail.com	Papoila, Ana/S-2164-2019; Adragao, Teresa/Q-5536-2019; Frazão, João/J-9811-2013; Frazão, João/AGX-6125-2022; Papoila, Ana Luisa/S-2515-2016; Barretti, Pasqual/K-4156-2012; Ferreira, Anibal/AGO-9346-2022	Papoila, Ana/0000-0002-2918-8364; Adragao, Teresa/0000-0003-3919-1070; Frazão, João/0000-0002-8081-5474; Frazão, João/0000-0002-8081-5474; Papoila, Ana Luisa/0000-0002-2918-8364; Barretti, Pasqual/0000-0003-4979-4836; Ferreira, Anibal/0000-0002-3300-6033; Pinto, Iola/0000-0002-2945-1441	Genzyme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080770] Funding Source: NIH RePORTER	Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding provided by Genzyme for this study was exclusively to pay for the evaluation of vascular calcifications and for the transport of the patients to the clinical center where all the exams were performed. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Adragao T, 2004, NEPHROL DIAL TRANSPL, V19, P1480, DOI 10.1093/ndt/gfh217; Adragao T, 2010, OSTEOPOROSIS INT, V21, P619, DOI 10.1007/s00198-009-0988-9; Adragao T, 2008, PERITON DIALYSIS INT, V28, P668; Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; Adragao T, 2009, CLIN J AM SOC NEPHRO, V4, P450, DOI 10.2215/CJN.01870408; Asci G, 2011, NEPHROL DIAL TRANSPL, V26, P1010, DOI 10.1093/ndt/gfq491; Barreto DV, 2008, AM J KIDNEY DIS, V52, P1139, DOI 10.1053/j.ajkd.2008.06.024; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Braun J, 2005, NEPHROL DIAL TRANSPL, V20, P2054, DOI 10.1093/ndt/gfi030; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DENTON J, 1984, J CLIN PATHOL, V37, P136, DOI 10.1136/jcp.37.2.136; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Freemont T, 2005, CLIN NEPHROL, V63, P138; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Gorriz JL, 2015, CLIN J AM SOC NEPHRO, V10, P654, DOI 10.2215/CJN.07450714; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554; LILLIE PD, 1976, HISTOPATHOLOGIC TECH; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Malluche HH, 2015, J AM SOC NEPHROL, V26, P2534, DOI 10.1681/ASN.2014070686; MALLUCHE HH, 1982, CALCIFIED TISSUE INT, V34, P439, DOI 10.1007/BF02411282; Malluche HH, 1986, ATLAS MINERALIZED BO; MANAKA RC, 1981, COMPUT PROG BIOMED, V13, P191, DOI 10.1016/0010-468X(81)90098-2; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2002, KIDNEY INT, V61, P638, DOI 10.1046/j.1523-1755.2002.00170.x; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Ok E, 2016, J AM SOC NEPHROL, V27, P2475, DOI 10.1681/ASN.2015030268; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Raggi P, 2007, HYPERTENSION, V49, P1278, DOI 10.1161/HYPERTENSIONAHA.107.086942; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; Riser BL, 2011, NEPHROL DIAL TRANSPL, V26, P3349, DOI 10.1093/ndt/gfr039; Rodriguez-Garcia M, 2009, NEPHROL DIAL TRANSPL, V24, P239, DOI 10.1093/ndt/gfn466; Schlieper G, 2009, KIDNEY BLOOD PRESS R, V32, P161, DOI 10.1159/000221064; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Sprague SM, 2016, AM J KIDNEY DIS, V67, P559, DOI 10.1053/j.ajkd.2015.06.023; Viera AJ, 2005, FAM MED, V37, P360; Wang LJ, 2006, BIOINTERPHASES, V1, P106, DOI 10.1116/1.2354575	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179868	10.1371/journal.pone.0179868	http://dx.doi.org/10.1371/journal.pone.0179868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686736	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100024
J	Calazans, SH; Walters, LJ; Fernandes, FC; Ferreira, CEL; Hoffman, EA				Calazans C, Savio H.; Walters, Linda J.; Fernandes, Flavio C.; Ferreira, Carlos E. L.; Hoffman, Eric A.			Genetic structure provides insights into the geographic origins and temporal change in the invasive charru mussel (Sururu) in the southeastern United States	PLOS ONE			English	Article							MYTELLA-CHARRUANA; POPULATION-STRUCTURE; CREPIDULA-FORNICATA; BIVALVIA MYTILIDAE; DISPERSAL ABILITY; MARINE; DIVERSITY; PATTERNS; LAGOON; DIFFERENTIATION	In 2004, Mytella charruana (d'Orbigny, 1842) (Mollusca: Bivalvia: Mytilidae) became established along the coast of the southeastern United States (SE-US). Using mitochondrial DNA sequencing (cytochrome c oxidase subunit I), we compared genetic variation throughout its native range in South America to its invasive range in the SE-US. Samples from the SE-US were collected in 2006 and 2010 enabling a temporal comparison to evaluate possible genetic changes of the invasive population. We addressed two questions. First, what are the potential source populations (or geographic regions) for the SE-US invasion? Second, how has genetic diversity changed between the two sampling periods within the SE-US? We identified a total of 72 haplotypes, 64 of which were isolated to geographic sites and only 8 were shared among sites. The highly structured native range provides insight into the origin of invasive populations where our results suggest that the introduced SE-US population originated from multiple source populations with the Panama region as the primary source. Additionally, our results indicate that genetic composition of the non-native populations was unchanged between the two sampling periods. Mytella charruana exhibit a significant pattern of genetic structure among natural populations, owing to biogeographic barriers that limit natural dispersal, and an ability to persist in novel habitats, owing to a suite of life-history characters that favor survival under variable conditions. Overall, this study explains why M. charruana may become an increasing threat to locations founded by anthropogenic transportation.	[Calazans C, Savio H.; Ferreira, Carlos E. L.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Calazans C, Savio H.; Fernandes, Flavio C.] Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Oceanog, Arraial Do Cabo, RJ, Brazil; [Walters, Linda J.; Hoffman, Eric A.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Universidade Federal Fluminense; State University System of Florida; University of Central Florida	Hoffman, EA (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	eric.hoffman@ucf.edu	Calazans, Savio/AAE-5033-2019	Calazans, Savio/0000-0002-2725-9202; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Fernandes, Flavio/0000-0002-4838-1434	CAPES - National Council for Scientific and Technological Development; Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo [245894/2012-8]; US Fulbright program; USDA NIFA Award [2008-32320-04574]; Indian River Lagoon National Estuary Program; University of Central Florida; Universidade Federal Fluminense; Instituto de Estudos do Mar Almirante Paulo Moreira	CAPES - National Council for Scientific and Technological Development; Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo; US Fulbright program; USDA NIFA Award; Indian River Lagoon National Estuary Program; University of Central Florida; Universidade Federal Fluminense; Instituto de Estudos do Mar Almirante Paulo Moreira	Thanks for Brazilian CAPES - National Council for Scientific and Technological Development for the Ph.D. fellowship support to SHCC, and the Brazilian grant program - Bolsas no Exterior - Ciencia sem Fronteiras / Doutorado Sanduoiche - SWE (CsF) Numero do Processo: 245894/2012-8, and the US Fulbright program. This research was also supported by USDA NIFA Award No. 2008-32320-04574, the Indian River Lagoon National Estuary Program, the University of Central Florida, the Universidade Federal Fluminense and the Instituto de Estudos do Mar Almirante Paulo Moreira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FAS, 2012, J BIOSCI, V176-185; [Anonymous], 2011, PEGASUS REV UCF UNDE; Aristiza A, 2013, BOLETIN CENT INVESTI, V47, P165; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AYVAZIAN SG, 1994, MAR BIOL, V118, P25, DOI 10.1007/BF00699216; Bailey SA, 2015, AQUAT ECOSYST HEAL M, P18; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; Boehs G, 2004, SCI MAR, V68, P537, DOI 10.3989/scimar.2004.68n4537; Boudreaux ML, 2006, J SHELLFISH RES, V25, P1079; BULNHEIM HP, 1981, MAR BIOL, V64, P105, DOI 10.1007/BF00397099; Cardenas EB, 2000, B MAR SCI, V66, P13; Carlton James T., 1999, Population and Community Biology Series, V24, P195; Carlton JT, 1992, J SHELLFISH RES, V11; Pineda MC, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2829-7; Ceron-Souza I, 2005, BIOTROPICA, V37, P258, DOI 10.1111/j.1744-7429.2005.00035.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen OR, 2014, BIOL INVASIONS, V16, P1743, DOI 10.1007/s10530-013-0624-7; Corredor-Acosta Andrea, 2011, Bol. Invest. Mar. Cost., V40, P33; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; de Oliveira MEGC, 2005, GENET MOL RES, V4, P197; de Souza TO, 2015, ESTUAR COAST SHELF S, V156, P165, DOI 10.1016/j.ecss.2014.11.009; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Dupont L, 2003, MAR ECOL PROG SER, V253, P183, DOI 10.3354/meps253183; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Floeter SR, 2000, J FISH BIOL, V56, P1099, DOI 10.1111/j.1095-8649.2000.tb02126.x; Floeter SR, 2008, ATLANTIC REEF FISH B, P22; Foighil DO, 1999, BIOL BULL-US, V196, P122, DOI 10.2307/1542557; Galimany E, 2016, MAR ECOL PROG SER; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goldstien SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065656; Grantham BA, 2003, ECOL APPL, V13, pS108; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Hassan M, 2003, J EXP MAR BIOL ECOL, V291, P219, DOI 10.1016/S0022-0981(03)00139-4; Hassol SJ, 1995, REPORT ASPEN GLOBAL; Hilliard, 2004, GLOBAL INVASIVE SPEC; Holland BS, 2001, INVASION BOTTLENECK, P407; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kolbe JJ, 2008, ADMIXTURE DETERMINES, V6, P434; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee HG, 1987, IMIGRANT MUSSEL SETT; LEONEL R M V, 1988, Boletim de Fisiologia Animal (Sao Paulo), V12, P89; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Li W.H., 1997, MOL EVOLUTION, P487; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Mladenov PV, 1997, NEW ZEAL J MAR FRESH, V31, P261, DOI 10.1080/00288330.1997.9516763; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nash EF, 2011, UNDERSTANDING INVASI; NOAA, 2010, NATL WEATH SERV WEAT; Olden Julian D., 2011, P224; OLIVEIRA AM, 1993, ESTUAR COAST SHELF S, V37, P575, DOI 10.1006/ecss.1993.1074; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; Palumbi SR, 1998, J HERED, V89, P459; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Pereira-Barros J. B., 1846, B ESTUDOS PESCA, V9, P29; Puyana Mónica, 2012, Bol. Invest. Mar. Cost., V41, P213; R Core Team, 2012, R LANG ENV STAT COMP; Rilov G, 2004, BIOL INVASIONS, V6, P347, DOI 10.1023/B:BINV.0000034614.07427.96; Rios EC, 1994, SEASHELLS BRAZIL, V2nd; Rocha LA, 2003, PATTERNS DISTRIBUTIO, P1161; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Shefer S, 2004, MOL ECOL, V13, P2333, DOI 10.1111/j.1365-294X.2004.02227.x; SIBAJA WG, 1988, REV BIOL TROP, V36, P453; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Spinuzzi Samantha, 2013, Marine Biodiversity Records, V6, pe55, DOI 10.1017/S1755267213000316; Stenyakina A, 2010, MOL REPROD DEV, V77, P222, DOI 10.1002/mrd.21132; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; Stepien CA, 2002, J EVOLUTION BIOL, V15, P314, DOI 10.1046/j.1420-9101.2002.00385.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Szefer P, 1998, ENVIRON INT, V24, P359, DOI 10.1016/S0160-4120(98)00014-2; Tavare S, 1986, AM MATH SOC, V17, P57; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Viard F, 2006, HELGOLAND MAR RES, V60, P144, DOI 10.1007/s10152-006-0033-8; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wright S., 1969, EVOLUTION GENETICS P, V012; Yuan WS, 2016, BIOL INVASIONS, V18, P689, DOI 10.1007/s10530-015-1040-y; Yuan W, 2010, J SHELLFISH RES, V29, P415, DOI 10.2983/035.029.0218; Yuan WS, 2016, J MARINE BIOL, P14; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135; Zardus JD, 2005, MOL ECOL, V14, P3719, DOI 10.1111/j.1365-294X.2005.02701.x	103	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180619	10.1371/journal.pone.0180619	http://dx.doi.org/10.1371/journal.pone.0180619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686694	Green Published, gold			2022-12-27	WOS:000405464100083
J	Rejnmark, L; Bislev, LS; Cashman, KD; Eirisksdottir, G; Gaksch, M; Grubler, M; Grimnes, G; Gudnason, V; Lips, P; Pilz, S; van Schoor, NM; Kiely, M; Jorde, R				Rejnmark, Lars; Bislev, Lise Sofie; Cashman, Kevin D.; Eirisksdottir, Gudny; Gaksch, Martin; Gruebler, Martin; Grimnes, Guri; Gudnason, Vilmundur; Lips, Paul; Pilz, Stefan; van Schoor, Natasja M.; Kiely, Mairead; Jorde, Rolf			Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data	PLOS ONE			English	Review							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; RESPIRATORY-TRACT INFECTION; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; IMPAIRED GLUCOSE-TOLERANCE; PARATHYROID-HORMONE LEVELS; RENIN-ANGIOTENSIN SYSTEM; D DEFICIENCY; BLOOD-PRESSURE	Background A large number of observational studies have reported harmful effects of low 25-hydroxyvitamin D (25OHD) levels on non-skeletal outcomes. We performed a systematic quantitative review on characteristics of randomized clinical trials (RCTs) included in meta-analyses (MAs) on non-skeletal effects of vitamin D supplementation. Methods and findings We identified systematic reviews (SR) reporting summary data in terms of MAs of RCTs on selected non-skeletal outcomes. For each outcome, we summarized the results from available SRs and scrutinized included RCTs for a number of predefined characteristics. We identified 54 SRs including data from 210 RCTs. Most MAs as well as the individual RCTs reported null-findings on risk of cardiovascular diseases, type 2 diabetes, weight-loss, and malignant diseases. Beneficial effects of vitamin D supplementation was reported in 1 of 4 MAs on depression, 2 of 9 MAs on blood pressure, 3 of 7 MAs on respiratory tract infections, and 8 of 12 MAs on mortality. Most RCTs have primarily been performed to determine skeletal outcomes, whereas non-skeletal effects have been assessed as secondary outcomes. Only one-third of the RCTs had low level of 25OHD as a criterion for inclusion and a mean baseline 25OHD level below 50 nmol/L was only present in less than half of the analyses. Conclusions Published RCTs have mostly been performed in populations without low 25OHD levels. The fact that most MAs on results from RCTs did not show a beneficial effect does not disprove the hypothesis suggested by observational findings on adverse health outcomes of low 25OHD levels.	[Rejnmark, Lars; Bislev, Lise Sofie] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Cashman, Kevin D.; Kiely, Mairead] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin & Nutr Res D, Cork, Ireland; [Eirisksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gaksch, Martin; Gruebler, Martin; Pilz, Stefan] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria; [Gruebler, Martin] Univ Bern, Univ Hosp Bern, Dept Cardiol, Inselspital,Swiss Cardiovasc Ctr Bern, Bern, Switzerland; [Grimnes, Guri; Jorde, Rolf] UiT Arctic Univ Norway, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway; [Gudnason, Vilmundur] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Lips, Paul] Vrije Univ Amsterdam, Endocrinol Sect, Dept Internal Med, Amsterdam, Netherlands; [van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Aarhus University; University College Cork; Icelandic Heart Association; Medical University of Graz; University of Bern; University Hospital of Bern; UiT The Arctic University of Tromso; University of Iceland; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rejnmark, L (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	lars.rejnmark@rm.dk	Kiely, Mairead/I-8269-2019; Kiely, Mairead E/ABA-3235-2020; Gudnason, Vilmundur/AAE-7126-2019	Kiely, Mairead/0000-0003-0973-808X; Gudnason, Vilmundur/0000-0001-5696-0084; Rejnmark, Lars/0000-0002-2152-4247; Pilz, Stefan/0000-0002-7959-1311; van Schoor, Natasja/0000-0002-0870-0795; Bislev, Lise Sofie/0000-0002-9720-9518; Keppel, Martin/0000-0003-3448-3349	European Community's [613977]	European Community's(European Commission)	This project has received funding from the European Community's Seventh Frame work Programme (FP7/2007-2013) under grant ag reement 613977 for the ODIN Integrated Project [Food-based solutions for optimal vitamin D nutrition and health through the life cycle, http://www.odin-vitd.eu/]	Abbas S, 2007, NUTR CANCER, V59, P54, DOI 10.1080/01635580701390223; Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Aghajafari F, 2013, BMJ-BRIT MED J, V26, P346, DOI DOI 10.1136/BMJ51169.F1169-9; [Anonymous], [No title captured]; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203; Asemi Z, 2013, AM J CLIN NUTR, V98, P1425, DOI 10.3945/ajcn.113.072785; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Avenell A, 2009, AGE AGEING, V38, P606, DOI 10.1093/ageing/afp109; Barengolts E, 2010, ENDOCR PRACT, V16, P476, DOI 10.4158/EP09195.RA; Barnard K, 2010, AM J GERIATR PHARMAC, V8, P4, DOI 10.1016/j.amjopharm.2010.02.004; Bassuk SS, 2016, CONTEMP CLIN TRIALS, V47, P235, DOI 10.1016/j.cct.2015.12.022; Belcaro G, 2010, PANMINERVA MED, V52, P269; BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Bendik I, 2014, FRONT PHYSIOL, P5; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; Bertone-Johnson ER, 2012, AM J EPIDEMIOL, V176, P1, DOI 10.1093/aje/kwr482; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007469.pub2; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Black LJ, 2014, AUST NZ J PSYCHIAT, V48, P464, DOI 10.1177/0004867413512383; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Brachet P, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1779; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Brenner H, 2017, J NUTR; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Brown JM, 2014, HYPERTENSION, V63, P273, DOI 10.1161/HYPERTENSIONAHA.113.01910; Bryson KJ, 2014, EPIDEMIOL INFECT, V142, P1789, DOI 10.1017/S0950268814000193; BUFFINGTON C, 1993, OBES SURG, V3, P421, DOI 10.1381/096089293765559142; Caan B, 2007, ARCH INTERN MED, V167, P893, DOI 10.1001/archinte.167.9.893; CADE C, 1986, ENDOCRINOLOGY, V119, P84, DOI 10.1210/endo-119-1-84; Calton EK, 2017, EUR J CLIN NUTR; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carrillo AE, 2013, CLIN NUTR, V32, P375, DOI 10.1016/j.clnu.2012.08.014; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Cashman KD, 2015, SCAND J CLIN LAB INV, V75, P549, DOI 10.3109/00365513.2015.1057898; Cashman KD, 2014, P NUTR SOC, V73, P65, DOI 10.1017/S0029665113003595; Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182; Chandler PD, 2015, NUTR REV, V73, P577, DOI 10.1093/nutrit/nuv012; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Chen P, 2009, BREAST CANC RES TREA; Chen WR, 2014, ATHEROSCLEROSIS, V235, P102, DOI 10.1016/j.atherosclerosis.2014.04.011; CHERTOW BS, 1983, ENDOCRINOLOGY, V113, P1511, DOI 10.1210/endo-113-4-1511; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Chowdhury R, 2012, EUR J EPIDEMIOL, V27, P581, DOI 10.1007/s10654-012-9729-z; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Chung M, 2016, ANN INTERN MED; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cianferotti L, 2017, ENDOCRINE, V56, P245, DOI 10.1007/s12020-017-1290-9; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Das Rashmi Ranjan, 2013, ISRN Pediatr, V2013, P459160, DOI 10.1155/2013/459160; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; de Abreu DAF, 2011, J NEUROL SCI, V311, P64, DOI 10.1016/j.jns.2011.08.044; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; De-Regil LM, 2016, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20161343T2, 10.1002/14651858.CD008873.pub3]; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Deleskog A, 2012, DIABETOLOGIA, V55, P1668, DOI 10.1007/s00125-012-2529-x; DeLuca HF, 2014, J ANIM SCI, V92, P917, DOI 10.2527/jas.2013-7237; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Dijkstra SH, 2007, ARCH DIS CHILD, V92, P750, DOI 10.1136/adc.2006.105577; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Drincic AT, 2012, OBESITY RES; Dumville JC, 2006, J NUTR HEALTH AGING, V10, P151; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Engelman CD, 2013, J NUTR, V143, P17, DOI 10.3945/jn.112.169482; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Ford JA, 2014, AM J CLIN NUTR, V100, P746, DOI 10.3945/ajcn.113.082602; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Forman JP, 2010, HYPERTENSION, V55, P1283, DOI 10.1161/HYPERTENSIONAHA.109.148619; Forman JP, 2005, HYPERTENSION, V46, P676, DOI 10.1161/01.HYP.0000182662.82666.37; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Gaksch M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170791; Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Gillie O, 2016, PUBLIC HEALTH NUTR, V19, P409, DOI 10.1017/S1368980014002304; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; GIULIANO AR, 1991, ARCH BIOCHEM BIOPHYS, V285, P261, DOI 10.1016/0003-9861(91)90358-P; Gloth F M 3rd, 1999, J Nutr Health Aging, V3, P5; Golzarand M, 2016, NUTR METAB CARDIOVAS, V26, P663, DOI 10.1016/j.numecd.2016.04.011; Gorham ED, 2005, J STEROID BIOCHEM, V97, P179, DOI 10.1016/j.jsbmb.2005.06.018; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Gowda U, 2015, NUTRITION, V31, P421, DOI 10.1016/j.nut.2014.06.017; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Grant WB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176448; Grubler MR, 2016, J CLIN HYPERTENS; Gupta AK, 2011, DIABETES CARE, V34, P658, DOI 10.2337/dc10-1829; Gysin DV, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0162996, 1]; HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492; Halliday GM, 2014, J INVEST DERMATOL, V134, P1791, DOI 10.1038/jid.2014.33; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haroon NN, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0130-9; HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Hashemipour S, 2014, EUR J OBSTET GYN R B, V172, P15, DOI 10.1016/j.ejogrb.2013.10.010; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoffmann MR, 2015, J ACAD NUTR DIET, V115, P406, DOI 10.1016/j.jand.2014.10.023; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Hui S, 2010, SOUTH MED J, V103, P729, DOI 10.1097/SMJ.0b013e3181e6d389; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; ISHIDA H, 1988, MOL CELL ENDOCRINOL, V60, P109, DOI 10.1016/0303-7207(88)90169-4; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaddou HY, 2012, EUR ARCH PSY CLIN N, V262, P321, DOI 10.1007/s00406-011-0265-8; Jamka M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16142; Jiang WL, 2016, CLIN CARDIOL, V39, P56, DOI 10.1002/clc.22473; Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Jorde R, 2010, CYTOKINE, V50, P175, DOI 10.1016/j.cyto.2009.12.006; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; KAMEI Y, 1993, BIOCHEM BIOPH RES CO, V193, P948, DOI 10.1006/bbrc.1993.1717; Karras SN, 2015, J ENDOCRINOL INVEST, V38, P1265, DOI 10.1007/s40618-015-0363-y; KAUR J, 1991, NUTR RES, V11, P1077, DOI 10.1016/S0271-5317(05)80400-2; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; KHAJAVI A, 1977, CLIN PEDIATR, V16, P36, DOI 10.1177/000992287701600106; Khajehei M, 2009, INT J GYNECOL OBSTET, V105, P158, DOI 10.1016/j.ijgo.2009.01.016; Khoraminya N, 2013, AUST NZ J PSYCHIAT, V47, P271, DOI 10.1177/0004867412465022; Klampfer L, 2014, WORLD J GASTRO ONCOL, V6, P430, DOI 10.4251/wjgo.v6.i11.430; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6; Kristal AR, 2008, CANCER EPIDEM BIOMAR, V17, P3289, DOI 10.1158/1055-9965.EPI-08-1066; Kroll MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118108; Kuhlmann A, AM J; Kull M, 2009, INTERN MED J, V39, P256, DOI 10.1111/j.1445-5994.2009.01900.x; Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975; Kunutsor SK, 2014, EUR J EPIDEMIOL, V29, P1, DOI 10.1007/s10654-013-9874-z; Kupferschmidt K, 2012, SCIENCE, V337, P1476, DOI 10.1126/science.337.6101.1476; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lansdowne ATG, 1998, PSYCHOPHARMACOLOGY, V135, P319, DOI 10.1007/s002130050517; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Lee KJ, 2016, INT J CLIN PHARM TH, V54, P233, DOI 10.5414/CP202493; Li GW, 2014, J CLIN ENDOCR METAB, V99, P757, DOI 10.1210/jc.2013-3450; Li GW, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-64; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; Li M, 2014, J CLIN ENDOCR METAB; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lips P, 2007, J STEROID BIOCHEM, V103, P620, DOI 10.1016/j.jsbmb.2006.12.076; Liu D, 2014, J INVEST DERMATOL, V134, P1839, DOI 10.1038/jid.2014.27; Liu NQ, 2011, J IMMUNOL, V186, P5968, DOI 10.4049/jimmunol.1003332; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LJUNGHALL S, 1987, ACTA MED SCAND, V222, P361; Mahomed K, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000228; Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146; Malaise O, 2007, PREVALENCE VITAMIN D, V23, P1939; MALLET E, 1986, OBSTET GYNECOL, V68, P300, DOI 10.1097/00006250-198609000-00002; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; Manousopoulou A, 2015, EUR J CLIN INVEST, V45, P1113, DOI 10.1111/eci.12510; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Mao PJ, 2013, INT J CARDIOL, V169, P106, DOI 10.1016/j.ijcard.2013.08.055; Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Maruotti N, 2010, J RHEUMATOL, V37, P491, DOI 10.3899/jrheum.090797; Mason C, 2014, AM J CLIN NUTR, V99, P1015, DOI 10.3945/ajcn.113.073734; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; McCarty MF, 2003, MED HYPOTHESES, V61, P535, DOI 10.1016/S0306-9877(03)00227-5; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; MERKE J, 1987, CALCIFIED TISSUE INT, V41, P112, DOI 10.1007/BF02555253; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Moller UK, 2006, EUR J CLIN NUTR, V60, P1214, DOI 10.1038/sj.ejcn.1602440; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x; Moukayed M, 2017, REV ENDOCR METAB DIS, V18, P167, DOI 10.1007/s11154-017-9415-2; Mozaffari-Khosravi H, 2015, BLOOD PRESS MONIT, V20, P83, DOI 10.1097/MBP.0000000000000091; Mozaffari-Khosravi H, 2013, J CLIN PSYCHOPHARM, V33, P378, DOI 10.1097/JCP.0b013e31828f619a; Muscogiuri G, 2014, EUR J ENDOCRINOL, V171, pR101, DOI 10.1530/EJE-14-0158; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Nanri A, 2009, EUR J CLIN NUTR, V63, P1444, DOI 10.1038/ejcn.2009.96; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Okereke OI, 2016, J AFFECT DISORDERS, V198, P1, DOI 10.1016/j.jad.2016.03.022; Oplander C, 2009, CIRC RES, V105, P1031, DOI 10.1161/CIRCRESAHA.109.207019; Pan A, 2009, J AFFECT DISORDERS, V118, P240, DOI 10.1016/j.jad.2009.02.002; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pathak K, 2014, OBES REV, V15, P528, DOI 10.1111/obr.12162; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784; Pilz S, 2016, ANTICANCER RES, V36, P1379; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Polak MA, 2014, NUTRIENTS, V6, P4720, DOI 10.3390/nu6114720; Pourshahidi LK, 2014, P NUTR SOC; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Querfeld U, 1999, J AM SOC NEPHROL, V10, P2158; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; RESNICK LM, 1986, FASEB J, V45, P2739; Riek AE, 2010, J STEROID BIOCHEM, V121, P430, DOI 10.1016/j.jsbmb.2010.03.018; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Roth DE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-47; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Salehpour A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-78; Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544; Sarafin K, 2015, AM J CLIN NUTR, V102, P1044, DOI 10.3945/ajcn.114.103689; Schnatz PF, 2014, CLIN CHEM, V60, P600, DOI 10.1373/clinchem.2013.211037; Schnatz PF, 2012, MENOPAUSE, V19, P1074, DOI 10.1097/gme.0b013e31825499f0; Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Scragg R, 2017, JAMA CARDIOLOGY; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136; Sempos CT, 2017, OSTEOPOROSIS INT, V28, P1503, DOI 10.1007/s00198-017-3978-3; Shaffer JA, 2014, PSYCHOSOM MED, V76, P190, DOI 10.1097/PSY.0000000000000044; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Slomian J, 2014, PREVALENCE VITAMIN D, V59, P78; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Sneve M, 2008, EUR J ENDOCRINOL, V159, P675, DOI 10.1530/EJE-08-0339; Soares MJ, 2011, EUR J CLIN NUTR, V65, P994, DOI 10.1038/ejcn.2011.106; Sokol SI, 2011, CARDIOL REV, V19, P192, DOI 10.1097/CRD.0b013e31821da9a5; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Spedding S, 2014, NUTRIENTS, V6, P1501, DOI 10.3390/nu6041501; Sperati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069269; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Tabesh M, 2014, DIABETOLOGIA, V57, P2038, DOI 10.1007/s00125-014-3313-x; Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x; Theodoratou E, 2014, BMJ-BRIT MED J, V348; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Tomaschitz A, 2014, METABOLISM, V63, P20, DOI 10.1016/j.metabol.2013.08.016; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Upala S, 2016, SCAND CARDIOVASC J, V50, P230, DOI 10.3109/14017431.2016.1173226; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Veloudi P, 2016, PULSE, V4, P193, DOI 10.1159/000452742; Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; WAKASUGI M, 1991, PROSTAG OTH LIPID M, V42, P127, DOI 10.1016/0090-6980(91)90072-N; Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Wimalawansa S. J., 2016, J STEROID BIOCHEM; WION D, 1991, J NEUROSCI RES, V28, P110, DOI 10.1002/jnr.490280111; Witham MD, 2013, JAMA INTERN MED, V173, P1672, DOI 10.1001/jamainternmed.2013.9043; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133; Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812; Xiao LM, 2015, BRIT J NUTR, V114, P1026, DOI 10.1017/S000711451500207X; Xu YQ, 2014, TUMOR BIOL, V35, P4153, DOI 10.1007/s13277-013-1544-y; Yakoob MY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008824.pub2; Yalamanchili V, 2012, MENOPAUSE, V19, P697, DOI 10.1097/gme.0b013e31823bcec5; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhang M, 2011, NUTRITION, V27, P530, DOI 10.1016/j.nut.2010.05.016; Zhao GX, 2010, BRIT J NUTR, V104, P1696, DOI 10.1017/S0007114510002588; Zheng YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115850; Zheng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082109; Zittermann A, 2017, EUR HEART J, V38, P2279, DOI 10.1093/eurheartj/ehx235; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	303	153	158	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180512	10.1371/journal.pone.0180512	http://dx.doi.org/10.1371/journal.pone.0180512			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686645	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100072
J	Bjorkman, F; Edin, F; Mattsson, CM; Larsen, F; Ekblom, B				Bjorkman, Frida; Edin, Fredrik; Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn			Regular moist snuff dipping does not affect endurance exercise performance	PLOS ONE			English	Article							SMOKELESS TOBACCO USE; MIDDLE-AGED MEN; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; BASEBALL PLAYERS; NICOTINE; RISK; MORTALITY; CANCER; COTININE	Physiological and medical effects of snuff have previously been obtained either in cross-sectional studies or after snuff administration to non-tobacco users. The effects of snuff cessation after several years of daily use are unknown. 24 participants with >2 years of daily snuff-use were tested before and after >6 weeks snuff cessation (SCG). A control group (CO) of 11 snuff users kept their normal habits. Resting heart rate (HR) and blood pressure (BP) were significantly lower in SCG after snuff cessation, and body mass was increased by 1.4 +/- 1.7 kg. Total cholesterol increased from 4.12 +/- 0.54 (95% CI 3.89-4.35) to 4.46 +/- 0.70 (95% CI 4.16-4.75) mM L-1 in SCG, due to increased LDL, and this change was significantly different from CO. Resting values of HDL, C-reactive protein, and free fatty acids (FFA) remained unchanged in both groups. In SCG group, both HR and BP were reduced during a four-stage incremental cycling test (from 50 to 80% of VO(2)max) and a prolonged cycling test (60 min at 50% of VO(2)max). Oxygen uptake (VO2), respiratory exchange ratio, blood lactate (bLa) and blood glucose (bGlu) concentration, and rate of perceived exertion (RPE) were unchanged. In CO group, all measurements were unchanged. During the prolonged cycling test, FFA was reduced, but with no significant difference between groups. During the maximal treadmill running test peak values of VO2, pulmonary ventilation (VE), time to exhaustion and bLa were unchanged in both groups. In conclusion, endurance exercise performance (VO(2)dmax and maximal endurance time) does not seem to be affected by prolonged snuff use, while effects on cardiovascular risk factors are contradictory. HR and BP during rest and submaximal exercise are reduced after cessation of regular use of snuff. Evidently, the long-time adrenergic stress on circulation is reversible.	[Bjorkman, Frida; Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden; [Edin, Fredrik] Univ Gothenburg, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Mattsson, C. Mikael; Larsen, Filip; Ekblom, Bjorn] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Swedish School of Sport & Health Sciences; University of Gothenburg; Karolinska Institutet	Bjorkman, F (corresponding author), Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden.	frida.bjorkman@gih.se		Mattsson, C. Mikael/0000-0002-0642-4838; Bjorkman, Frida/0000-0001-8353-3766	Swedish National Institute of Public Health; Swedish School of Sport and Health Sciences	Swedish National Institute of Public Health; Swedish School of Sport and Health Sciences	The study was supported financially by grants from Swedish National Institute of Public Health (http://www.folkhalsomyndigheten.se) and the Swedish School of Sport and Health Sciences (www.gih.se).	Alaranta A, 2006, INT J SPORTS MED, V27, P581, DOI 10.1055/s-2005-865826; Arefalk G, 2014, CIRCULATION, V130, P325, DOI 10.1161/CIRCULATIONAHA.113.007252; Astrand PO K. R., 1986, TXB WORK PHYSL, P344; BAHRKE MS, 1988, MIL MED, V153, P229; BALDINI F, 1990, Medicine and Science in Sports and Exercise, V22, pS87, DOI 10.1249/00005768-199004000-00519; BALDINI FD, 1992, MIL MED, V157, P51, DOI 10.1093/milmed/157.2.51; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Bolinder G, 1997, ATHEROSCLEROSIS, V132, P95, DOI 10.1016/S0021-9150(97)00075-0; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; Bolinder G, 1997, EUR J CLIN INVEST, V27, P427, DOI 10.1046/j.1365-2362.1997.1290677.x; Borg G., 1962, PHYS PERFORMANCE PER; Cosgrove KP, 2009, ARCH GEN PSYCHIAT, V66, P666, DOI 10.1001/archgenpsychiatry.2009.41; Ebbert JO, 2004, ADDICT BEHAV, V29, P349, DOI 10.1016/j.addbeh.2003.08.046; EKBLOM B, 1971, ACTA PHYSIOL SCAND, V83, P399, DOI 10.1111/j.1748-1716.1971.tb05093.x; ELIASSON M, 1995, ATHEROSCLEROSIS, V113, P41, DOI 10.1016/0021-9150(94)05425-I; ERNSTER VL, 1990, JAMA-J AM MED ASSOC, V264, P218; Henninger S, 2015, INT J ENV RES PUB HE, V12, P7185, DOI 10.3390/ijerph120707185; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; KSIR C, 1986, J SPORT MED PHYS FIT, V26, P384; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Mundel T, 2006, EXP PHYSIOL, V91, P705, DOI 10.1113/expphysiol.2006.033373; PERKINS K A, 1991, Medicine and Science in Sports and Exercise, V23, P1283; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pulcipher J, 1989, MED SCI SPORTS EXERC, V21; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; SIEGEL D, 1992, AM J PUBLIC HEALTH, V82, P417, DOI 10.2105/AJPH.82.3.417; SIMON DL, 1957, JAMA-J AM MED ASSOC, V163, P354, DOI 10.1001/jama.1957.82970400003009a; Sponsiello-Wang Z, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-356; SQUIRES WG, 1984, PREV MED, V13, P195, DOI 10.1016/0091-7435(84)90051-3; TUCKER LA, 1989, AM J PUBLIC HEALTH, V79, P1048, DOI 10.2105/AJPH.79.8.1048; VANDUSER BL, 1992, MED SCI SPORT EXER, V24, P389	32	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181228	10.1371/journal.pone.0181228	http://dx.doi.org/10.1371/journal.pone.0181228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704507	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700110
J	Buerger, C; Shirsath, N; Lang, V; Berard, A; Diehl, S; Kaufmann, R; Boehncke, WH; Wolf, P				Buerger, Claudia; Shirsath, Nitesh; Lang, Victoria; Berard, Alina; Diehl, Sandra; Kaufmann, Roland; Boehncke, Wolf-Henning; Wolf, Peter			Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation	PLOS ONE			English	Article							LESIONAL PSORIATIC SKIN; EPIDERMAL DIFFERENTIATION; THERAPEUTIC TARGET; MAMMALIAN TARGET; GENE-EXPRESSION; RAPAMYCIN; ACTIVATION; PATHWAY; PHOSPHORYLATION; DEGRADATION	Psoriasis is a frequent and often severe inflammatory skin disease, characterized by altered epidermal homeostasis. Since we found previously that Akt/mTOR signaling is hyperactivated in psoriatic skin, we aimed at elucidating the role of aberrant mTORC1 signaling in this disease. We found that under healthy conditions mTOR signaling was shut off when keratinocytes switch from proliferation to terminal differentiation. Inflammatory cytokines (IL-1 beta, IL-17A, TNF-alpha) induced aberrant mTOR activity which led to enhanced proliferation and reduced expression of differentiation markers. Conversely, regular differentiation could be restored if mTORC1 signaling was blocked. In mice, activation of mTOR through the agonist MHY1485 also led to aberrant epidermal organization and involucrin distribution. In summary, these results not only identify mTORC1 as an important signal integrator pivotal for the cells fate to either proliferate or differentiate, but emphasize the role of inflammation-dependent mTOR activation as a psoriatic pathomechanism.	[Buerger, Claudia; Lang, Victoria; Berard, Alina; Diehl, Sandra; Kaufmann, Roland] Clin Goethe Univ, Dept Dermatol Venerol & Allergol, Frankfurt, Germany; [Shirsath, Nitesh; Wolf, Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Boehncke, Wolf-Henning] Geneva Univ Hosp, Dept Dermatol & Venereol, Geneva, Switzerland; [Boehncke, Wolf-Henning] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Graz; University of Geneva; University of Geneva	Buerger, C (corresponding author), Clin Goethe Univ, Dept Dermatol Venerol & Allergol, Frankfurt, Germany.	Claudia.buerger@kgu.de	Buerger, Claudia/AAE-4685-2019	Buerger, Claudia/0000-0002-7838-197X; Shirsath, Nitesh/0000-0002-8834-7249	German Research Foundation (DFG) [BU 1840/5-1]; Germany and FWF Austrian Science Fund [W1241]; PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria; Swiss National Fonds [ME 9965]	German Research Foundation (DFG)(German Research Foundation (DFG)); Germany and FWF Austrian Science Fund; PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria; Swiss National Fonds(Swiss National Science Foundation (SNSF))	This work was funded by a grant to C.B. from the German Research Foundation (DFG) BU 1840/5-1 (http://dfg.de/), Germany and FWF Austrian Science Fund no. W1241 (https://www.fwf.ac.at/) to P.W. N.S. was supported by the PhD program Molecular Fundamentals of Inflammation (MOLIN) from the Medical University of Graz, Austria. W.-H.B. is supported by the Swiss National Fonds ME 9965 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Buerger C, 2013, BRIT J DERMATOL, V169, P156, DOI 10.1111/bjd.12271; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Chamcheu JC, 2016, ACTA DERM-VENEREOL, V96, P854, DOI 10.2340/00015555-2359; Chen JQ, 2013, CELL BIOCHEM BIOPHYS, V66, P523, DOI 10.1007/s12013-012-9499-y; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Chowdhari S, 2016, CELL SIGNAL, V28, P25, DOI 10.1016/j.cellsig.2015.10.015; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Ding X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13226; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Frigerio E, 2007, BRIT J DERMATOL, V156, P372, DOI 10.1111/j.1365-2133.2006.07602.x; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Hickerson RP, 2009, J DERMATOL SCI, V56, P82, DOI 10.1016/j.jdermsci.2009.07.008; Huang T, 2014, ACTA DERM-VENEREOL, V94, P371, DOI 10.2340/00015555-1737; Huber LA, 2016, CURR OPIN CELL BIOL, V39, P8, DOI 10.1016/j.ceb.2016.01.006; Kjellerup RB, 2009, BRIT J DERMATOL, V161, P1059, DOI 10.1111/j.1365-2133.2009.09303.x; Korver JEM, 2006, BRIT J DERMATOL, V155, P688, DOI 10.1111/j.1365-2133.2006.07403.x; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Mitra AD, 2013, J INVEST DERMATOL, V133, P1556, DOI 10.1038/jid.2013.3; Naeem AS, 2015, CELL DEATH DIFFER, V22, P2123, DOI 10.1038/cdd.2015.62; Nandagopal N, 2015, REGULATION OF GLOBAL, V3; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; Orecchia V, 2015, EXP DERMATOL, V24, P29, DOI 10.1111/exd.12585; Ormerod AD, 2005, BRIT J DERMATOL, V152, P758, DOI 10.1111/j.1365-2133.2005.06438.x; Raychaudhuri SK, 2014, INDIAN J DERMATOL, V59, P67, DOI 10.4103/0019-5154.123499; Reitamo S, 2001, BRIT J DERMATOL, V145, P438, DOI 10.1046/j.1365-2133.2001.04376.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shirsath N, 2015, EXP DERMATOL, V24, P889, DOI 10.1111/exd.12779; Sully K, 2013, ONCOGENE, V32, P3254, DOI 10.1038/onc.2012.338; Tiberio R, 2002, FEBS LETT, V524, P139, DOI 10.1016/S0014-5793(02)03040-5; Wei KC, 2015, DERMATOL THER, V28, P25, DOI 10.1111/dth.12176; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zhao YM, 2008, J INVEST DERMATOL, V128, P2190, DOI 10.1038/jid.2008.81	43	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180853	10.1371/journal.pone.0180853	http://dx.doi.org/10.1371/journal.pone.0180853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700632	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800088
J	Clark, WR; Ding, XQ; Qiu, HB; Ni, ZH; Chang, P; Fu, P; Xu, JR; Wang, MM; Yang, L; Wang, J; Ronco, C				Clark, William R.; Ding, Xiaoqiang; Qiu, Haibo; Ni, Zhaohui; Chang, Ping; Fu, Ping; Xu, Jiarui; Wang, MinMin; Yang, Li; Wang, Jing; Ronco, Claudio			Renal replacement therapy practices for patients with acute kidney injury in China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RANDOMIZED CLINICAL-TRIAL; INTENSIVE-CARE-UNIT; CONTINUOUS HEMOFILTRATION; SURVIVAL; DIALYSIS; FAILURE; NOMENCLATURE; RECOVERY; SCORE	Recent data indicate AKI is very common among hospitalized Chinese patients and continuous renal replacement therapy (CRRT) is increasingly offered for treatment. However, only anecdotal information regarding CRRT's use in relation to other modalities and the specific manner in which it is prescribed exists currently. This report summarizes the results of a comprehensive physician survey designed to characterize contemporary dialytic management of AKI patients in China, especially with respect to the utilization of CRRT. The survey queried both nephrologists and critical care physicians across a wide spectrum of hospitals about factors influencing initial RRT modality selection, especially patient clinical characteristics and willingness to receive RRT, treatment location, and institutional capabilities. For patients initially treated with CRRT, data related to indication, timing of treatment initiation, dose, anticoagulation technique, and duration of therapy were also collected. Among AKI patients considered RRT candidates, the survey indicated 15.1% (95% CI, 12.3%-17.9%) did not actually receive dialysis at Chinese hospitals. The finding was largely attributed to prohibitively high therapy costs in the view of patients or their families. The survey confirmed the dichotomy in RRT delivery in China, occurring both in the nephrology department (with nephrologists responsible) and the intensive care unit (with critical care physicians responsible). For all patients who were offered and received RRT, the survey participants reported 63.9% (56.4%-71.3%) were treated initially with CRRT and 24.8% (19.2%-30.3%) with intermittent hemodialysis (HD) (P<0.001). The mean percentage of patients considered hemodynamically unstable at RRT initiation was 36.2% (31.3%-41.1%), although this figure was two-fold higher in patients treated initially with CRRT (43.1%; 35.8%-50.4%) in comparison to those initially treated with HD (22.4%; 16.4%-28.4%)(P<0.001). An overwhelming majority of intensive care patients were treated initially with CRRT (86.6%; 79.8-93.4%) while it was the initial modality in only 44.6% (33.5-55.7%) of patients treated in a nephrology department (P<0.001). Approximately 70% of respondents overall reported prescribing a CRRT dose in the range of 20-30 mL/kg/hr while approximately 20% of prescriptions fell above this range. Daily prescribed therapy duration demonstrated a marked divergence from values reported in the literature and standard clinical practice. Overall, the most common average prescribed value (50% of respondents) fell in the 10-20 hr range, with only 18% in the 20-24 hr range. Moreover, 32% of respondents reported an average prescribed value of less than 10 hrs per day. While the percentages for the 10-20 hrs range were essentially the same for nephrology and ICU programs, a daily duration of less than 10 hrs was much more common in nephrology programs (48.0%; 38.3%-57.9%) versus ICU programs (16%; 10.0%-24.6%)(P<0.001). Our analysis demonstrates both similarities and differences between RRT practices for AKI in China and those in the developed world. While some differences are driven by non-medical factors, future studies should explore these issues further as Chinese RRT practices are harmonized with those in the rest of the world.	[Clark, William R.] Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA; [Ding, Xiaoqiang; Xu, Jiarui] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai, Peoples R China; [Ding, Xiaoqiang; Xu, Jiarui] Shanghai Inst Kidney Dis & Dialysis, Shanghai Qual Control Ctr Dialysis, Shanghai, Peoples R China; [Qiu, Haibo] Southeast Univ, Nanjing Zhongda Hosp, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Ni, Zhaohui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China; [Fu, Ping] Southern Med Univ, Zhujiang Hosp, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Fu, Ping] Sichuan Univ, Div Nephrol, West China Hosp, Chengdu, Peoples R China; [Wang, MinMin; Yang, Li] Baxter Healthcare, Shanghai, Peoples R China; [Wang, Jing] Guanlan Networks CO LTD, Hangzhou, Zhejiang, Peoples R China; [Ronco, Claudio] San Bortolo Hosp, IRRIV, Vicenza, Italy; [Ronco, Claudio] San Bortolo Hosp, Dept Nephrol, Vicenza, Italy	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Fudan University; Southeast University - China; Shanghai Jiao Tong University; Southern Medical University - China; Sichuan University; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Clark, WR (corresponding author), Purdue Univ, Davidson Sch Chem Engn, W Lafayette, IN 47907 USA.	clarkw@purdue.edu	Qiu, Haibo/AAS-9047-2021; Wang, Minmin/AAR-3106-2021; xu, jia/GSD-6347-2022	Qiu, Haibo/0000-0001-8589-4717; Wang, Minmin/0000-0002-7556-2601; Ronco, Claudio/0000-0002-6697-4065	Baxter Healthcare	Baxter Healthcare	The study was supported by a grant from Baxter Healthcare to DXY.cn (GUANLAN NETWORKS (HANGZHOU) CO., Ltd., Hangzhou, China). The grantee at Guanlan Networks CO., LTD. was Dr. Jing Wang. Baxter Healthcare and Guanlan Networks CO., Ltd. provided support in the form of salaries for authors MW, YL, and JW. The funders did not have an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhoundi A, 2015, BLOOD PURIFICAT, V39, P333, DOI 10.1159/000380903; [Anonymous], 2015, MEDICAL DEVICES MARK; Bagshaw SM, 2016, NAT REV NEPHROL, V12, P445, DOI 10.1038/nrneph.2016.92; Bell M, 2007, INTENS CARE MED, V33, P773, DOI 10.1007/s00134-007-0590-6; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Clark WR, 2004, CONTRIB NEPHROL, V144, P264; Del Granado R Claure-, 2016, BMC NEPHROL, V17, P109; Fang Y, 2015, HEMODIAL INT, V19, P2, DOI 10.1111/hdi.12193; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Garzotto F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1355-9; HM Oudemans-van Straaten, 2014, CRIT CARE, V18, P661; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; KDIGO, 2012, KIDNEY INT S, V2; Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078; Lu RH, 2014, BLOOD PURIFICAT, V38, P140, DOI 10.1159/000366127; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; National health and family planning commission of the People's Republic of China, 2015, STAT YB CHIN HLTH FA; Neri M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1489-9; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pickkers P, 2017, INTENSIVE CARE MED; Rewa OG, 2016, INTENSIVE CARE MED; Ronco C, 2007, INT J ARTIF ORGANS, V30, P89, DOI 10.1177/039139880703000202; Ronco C, 2007, CLIN J AM SOC NEPHRO, V2, P597, DOI 10.2215/CJN.00430107; Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705; Vaara ST, 2016, KIDNEY INT, V89, P200, DOI [10.1038/ki.2015.269, 10.1016/j.kint.2015.12.007]; Vaara ST, 2014, CLIN J AM SOC NEPHRO, V9, P1577, DOI 10.2215/CJN.12691213; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11682; Vanholder R, 2011, CRIT CARE, V15, DOI 10.1186/cc9345; Vesconi S, 2009, CRIT CARE, V13, DOI 10.1186/cc7784; Villa G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1456-5; Wang YM, 2016, CONTRIB NEPHROL, V187, P1, DOI 10.1159/000443008; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X; Zaragoza JJ, 2015, BLOOD PURIFICAT, V39, P246, DOI 10.1159/000381009; Zhang P, 2012, NEPHROL DIAL TRANSPL, V27, P967, DOI 10.1093/ndt/gfr486; Zhu H, 2016, CHINESE HLTH SERVICE, V33, P512	39	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0178509	10.1371/journal.pone.0178509	http://dx.doi.org/10.1371/journal.pone.0178509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692694	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800004
J	Crouch, ML; Knowels, G; Stuppard, R; Ericson, NG; Bielas, JH; Marcinek, DJ; Syrjala, KL				Crouch, Marie-Laure; Knowels, Gary; Stuppard, Rudolph; Ericson, Nolan G.; Bielas, Jason H.; Marcinek, David J.; Syrjala, Karen L.			Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BREAST-CANCER SURVIVORS; CHILDHOOD-CANCER; ADULT SURVIVORS; INDUCED HEPATOTOXICITY; GLUTATHIONE DEPLETION; DOXORUBICIN ACTS; BODY-COMPOSITION; DNA DELETIONS; VITAMIN-E	Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7 +/- 10.6 vs. 49.0 +/- 16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 +/- 48.6 vs. 696.2 +/- 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 +/- 0.1 vs. 3.878 +/- 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-B p65 protein 1 day after drug exposure as compared to saline controls (0.091 +/- 0.017 vs. 0.053 +/- 0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.	[Crouch, Marie-Laure; Syrjala, Karen L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Knowels, Gary; Stuppard, Rudolph; Marcinek, David J.] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Bielas, Jason H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Syrjala, Karen L.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Syrjala, KL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Syrjala, KL (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	ksyrjala@fredhutch.org			National Institutes of Health/National Cancer Institute [P30 CA015704, R01 CA112631, R01 CA160684, R01 CA215134]; National Cancer Institute and National Institute on Aging [P20 CA103728]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA215134] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute and National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KLS: Private donation from Robert E. Frey. P30 CA015704, R01 CA112631, R01 CA160684, R01 CA215134, National Institutes of Health/National Cancer Institute; P20 CA103728, National Cancer Institute and National Institute on Aging.	Abraham P, 2011, HUM EXP TOXICOL, V30, P1924, DOI 10.1177/0960327111402240; Ahlberg K, 2003, LANCET, V362, P640, DOI 10.1016/S0140-6736(03)14186-4; al-Majid S, 2001, Biol Res Nurs, V2, P186, DOI 10.1177/109980040100200304; Anton E, 2002, INT J EXP PATHOL, V83, P47, DOI 10.1046/j.1365-2613.2002.00208.x; Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; Banthia R, 2006, J BEHAV MED, V29, P269, DOI 10.1007/s10865-006-9053-8; Bennett Jill A, 2013, Oncol Nurs Forum, V40, pE126, DOI 10.1188/13.ONF.E126-E134; Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067; Bertram LAC, 2011, CANCER CAUSE CONTROL, V22, P427, DOI 10.1007/s10552-010-9714-3; Bjelogrlic SK, 2005, BASIC CLIN PHARMACOL, V97, P311, DOI 10.1111/j.1742-7843.2005.pto_166.x; Bjelogrlic SK, 2013, BASIC CLIN PHARMACOL, V113, P228, DOI 10.1111/bcpt.12086; BLEI ML, 1993, P NATL ACAD SCI USA, V90, P7396, DOI 10.1073/pnas.90.15.7396; BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Bylow K, 2011, UROLOGY, V77, P934, DOI 10.1016/j.urology.2010.11.024; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; CROOK TR, 1986, CANCER RES, V46, P5035; CROOK TR, 1986, CANCER RES, V46, P5029; Cuce G, 2015, CHEM-BIOL INTERACT, V232, P7, DOI 10.1016/j.cbi.2015.02.016; DORR RT, 1994, CHEM-BIOL INTERACT, V93, P117, DOI 10.1016/0009-2797(94)90091-4; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; Gilliam LAA, 2011, AM J PHYSIOL-LUNG C, V300, pL225, DOI 10.1152/ajplung.00264.2010; Gilliam LAA, 2011, MUSCLE NERVE, V43, P94, DOI 10.1002/mus.21809; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752; HEINEMAN FW, 1990, MAGNET RESON MED, V13, P490, DOI 10.1002/mrm.1910130316; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Hochman DJ, 2014, ENVIRON TOXICOL, V29, P908, DOI 10.1002/tox.21818; Hoffman MC, 2013, J CLIN ONCOL, V31, P2799, DOI 10.1200/JCO.2012.47.8081; Hoffmeister PA, 2013, BIOL BLOOD MARROW TR, V19, P1081, DOI 10.1016/j.bbmt.2013.04.017; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Kim Sung-Hwan, 2013, Lab Anim Res, V29, P204, DOI 10.5625/lar.2013.29.4.204; Kumari KK, 2012, J BIOENERG BIOMEMBR, V44, P179, DOI 10.1007/s10863-012-9423-6; Kushmerick MJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1739, DOI 10.1152/ajpcell.1997.272.5.C1739; Kwolek-Mirek M, 2015, CELL BIOCHEM BIOPHYS, V71, P1525, DOI 10.1007/s12013-014-0376-8; Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863; Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF; Gomes PRL, 2014, REV BRAS GINECOL OBS, V36, P244, DOI 10.1590/S0100-720320140005004; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003; McDonald C, 2011, CANCER FORUM, V35, P102; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268; Ness KK, 2012, CANCER-AM CANCER SOC, V118, P828, DOI 10.1002/cncr.26337; Nishikawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131394; Patterson RE, 2011, BREAST CANCER RES TR, V127, P541, DOI 10.1007/s10549-010-1236-x; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002; Petrick JL, 2014, CANCER CAUSE CONTROL, V25, P1179, DOI 10.1007/s10552-014-0421-3; Rom O, 2013, FREE RADICAL BIO MED, V65, P190, DOI 10.1016/j.freeradbiomed.2013.06.024; Saquib N, 2011, PSYCHO-ONCOLOGY, V20, P252, DOI 10.1002/pon.1742; Sayed-Ahmed MM, 2014, INHI BITION OF GENE; Sehl M, 2013, J CANCER SURVIV, V7, P20, DOI 10.1007/s11764-012-0239-5; Sekeroglu V, 2011, ASIAN PAC J CANCER P, V12, P2925; Sheean PM, 2012, BREAST CANCER RES TR, V135, P663, DOI 10.1007/s10549-012-2200-8; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002; Siegel MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026963; Slater ME, 2015, BIOL BLOOD MARROW TR, V21, P1278, DOI 10.1016/j.bbmt.2015.04.007; Smith LB, 2014, THE ROLE OF IL 1BETA; Sun Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/170309; Syrjala KL, 2010, J CANCER SURVIV, V4, P225, DOI 10.1007/s11764-010-0126-x; Taylor D J, 1983, Mol Biol Med, V1, P77; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012; Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5; Wei C, 2015, PEDIATR BLOOD CANCER, V62, P1992, DOI 10.1002/pbc.25601; Winters-Stone KM, 2011, BREAST CANCER RES TR, V127, P447, DOI 10.1007/s10549-011-1444-z; Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536	87	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181086	10.1371/journal.pone.0181086	http://dx.doi.org/10.1371/journal.pone.0181086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700655	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800119
J	Olivito, G; Dayan, M; Battistoni, V; Clausi, S; Cercignani, M; Molinari, M; Leggio, M; Bozzali, M				Olivito, Giusy; Dayan, Michael; Battistoni, Valentina; Clausi, Silvia; Cercignani, Mara; Molinari, Marco; Leggio, Maria; Bozzali, Marco			Bilateral effects of unilateral cerebellar lesions as detected by voxel based morphometry and diffusion imaging	PLOS ONE			English	Article							CROSSED CEREBELLOCEREBRAL DIASCHISIS; WHITE-MATTER TRACTS; FUNCTIONAL CONNECTIVITY; SPATIAL STATISTICS; GRAY-MATTER; IN-VIVO; BRAIN; STROKE; TRACTOGRAPHY; MRI	Over the last decades, the importance of cerebellar processing for cortical functions has been acknowledged and consensus was reached on the strict functional and structural cortico-cerebellar interrelations. From an anatomical point of view strictly contralateral interconnections link the cerebellum to the cerebral cortex mainly through the middle and superior cerebellar peduncle. Diffusion MRI(dMRI) based tractography has already been applied to address cortico-cerebellar-cortical loops in healthy subjects and to detect diffusivity alteration patterns in patients with neurodegenerative pathologies of the cerebellum. In the present study we used dMRI-based tractography to determine the degree and pattern of pathological changes of cerebellar white matter microstructure in patients with focal cerebellar lesions. Diffusion imaging and high-resolution volumes were obtained in patients with left cerebellar lesions and in normal controls. Middle cerebellar peduncles and superior cerebellar peduncles were reconstructed by multi fiber diffusion tractography. From each tract, measures of microscopic damage were assessed, and despite the presence of unilateral lesions, bilateral diffusivity differences in white matter tracts were found comparing patients with normal controls. Consistently, bilateral alterations were also evidenced in specific brain regions linked to the cerebellum and involved in higher-level functions. This could be in line with the evidence that in the presence of unilateral cerebellar lesions, different cognitive functions can be affected and they are not strictly linked to the side of the cerebellar lesion.	[Olivito, Giusy; Clausi, Silvia; Leggio, Maria] Santa Lucia Fdn, Ataxia Lab, Rome, Italy; [Olivito, Giusy; Dayan, Michael; Battistoni, Valentina; Cercignani, Mara; Bozzali, Marco] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Dayan, Michael] Ist Italiano Tecnol, Pattern Anal & Comp Vis, Genoa, Italy; [Clausi, Silvia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Falmer, England; [Molinari, Marco] Santa Lucia Fdn, Neurol & Spinal Cord Injury Rehabil, Dept A, Rome, Italy; [Bozzali, Marco] Univ Sussex, Brighton & Sussex Med Sch, Dept Neurosci, Falmer, England	IRCCS Santa Lucia; IRCCS Santa Lucia; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; University of Brighton; University of Sussex; IRCCS Santa Lucia; University of Brighton; University of Sussex	Olivito, G (corresponding author), Santa Lucia Fdn, Ataxia Lab, Rome, Italy.; Olivito, G (corresponding author), Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	g.olivito@hsantalucia.it	Leggio, Maria G/D-1269-2010; Bozzali, Marco/AAC-1031-2022; Dayan, Michael/G-4760-2016; Molinari, Marco/A-9624-2010; Olivito, Giusy/J-8733-2018; Clausi, Silvia/T-8443-2017	Leggio, Maria G/0000-0003-3750-2760; Dayan, Michael/0000-0002-2666-0969; Molinari, Marco/0000-0001-9808-9688; Olivito, Giusy/0000-0001-5832-8402; Clausi, Silvia/0000-0001-8721-1799; Cercignani, Mara/0000-0002-4550-2456; Bozzali, Marco/0000-0002-0568-2026	Ministry of Education, Universities and Research (MIUR) [C26A1329AR]; Ministry of Health [RF-2011-02348213]	Ministry of Education, Universities and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health	This work was supported by the Ministry of Education, Universities and Research (MIUR) - (Grant Number C26A1329AR) and Ministry of Health (Grant Number RF-2011-02348213) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi AK, 1998, FUNCTIONAL NEUROANAT, P730; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Andersson J., 2008, 14 ANN M ORG HUM BRA, P15; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beldarrain MG, 1997, EUR NEUROL, V37, P82; BONI S, 1992, NUCL MED COMMUN, V13, P824, DOI 10.1097/00006231-199211000-00009; BROICH K, 1987, NEUROSCI LETT, V83, P7, DOI 10.1016/0304-3940(87)90207-2; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Clausi S, 2009, NEUROSCIENCE, V162, P827, DOI 10.1016/j.neuroscience.2009.02.001; Cook PA, 2006, 14TH SCIENTIFIC MEET; Dayan M, 2016, FUNCT NEUROL, V31, P239; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Della Nave R, 2008, NEUROIMAGE, V40, P19, DOI 10.1016/j.neuroimage.2007.11.050; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Ferrucci R, 2016, CEREBELLUM, V15, P43, DOI 10.1007/s12311-015-0737-x; Gaudinski MR, 2008, STROKE, V39, P2765, DOI 10.1161/STROKEAHA.107.512269; Grimaldi G, 2014, CEREBELLUM, V13, P121, DOI 10.1007/s12311-013-0514-7; Grimaldi G, 2016, NEUROSCIENTIST, V22, P83, DOI 10.1177/1073858414559409; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Harris AD, 2009, MAGN RESON IMAGING C, V17, P291, DOI 10.1016/j.mric.2009.02.001; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jissendi P, 2008, J NEURORADIOLOGY, V35, P42, DOI 10.1016/j.neurad.2007.11.001; Kamali A, 2010, J MAGN RESON IMAGING, V32, P809, DOI 10.1002/jmri.22330; Komaba Y, 2000, ACTA NEUROL SCAND, V101, P8, DOI 10.1034/j.1600-0404.2000.00002.x; Manto M, 2006, CEREBELLUM, V5, P187, DOI 10.1080/14734220600925075; Marek M, 2015, J NEUROL, V262, P54, DOI 10.1007/s00415-014-7503-8; Mendoza J. E., 2007, CLINICAL NEUROANATOM; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Middleton FA, 2001, J NEUROSCI, V31, P236; Molinari M, 2002, NEUROSCIENCE, V111, P863, DOI 10.1016/S0306-4522(02)00024-6; Nolte J., 2002, THE HUMAN BRAIN AN I, P650; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Saito M., 1922, ARBEITEN NEUROLOGISC, P74; Salamon N, 2007, J NEURORADIOLOGY, V34, P115, DOI 10.1016/j.neurad.2007.03.002; Salamon N, 2005, NEURORADIOLOGY, V47, P895, DOI 10.1007/s00234-005-1439-8; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shereen A, 2001, J CEREB BLOOD FLOW M, V31, P1155; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; SONMEZOGLU K, 1993, ACTA NEUROL SCAND, V87, P275; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Suzuki Y, 2003, NMR BIOMED, V16, P257, DOI 10.1002/nbm.848; Taib NOulad Ben, 2008, BRAIN RES, V1204, P59; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van Baarsen KM, 2016, NEUROIMAGE, V124, P724, DOI 10.1016/j.neuroimage.2015.09.014	59	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180439	10.1371/journal.pone.0180439	http://dx.doi.org/10.1371/journal.pone.0180439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692678	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000405544800040
J	Wang, MT; Wang, YH; Chang, HA; Tsai, CL; Yang, YS; Lin, CW; Kuo, CC; Hsu, YJ				Wang, Meng-Ting; Wang, Yun-Han; Chang, Hsin-An; Tsai, Chen-Liang; Yang, Ya-Sung; Lin, Chen Wei; Kuo, Cheng-Chin; Hsu, Yu-Juei			Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: A population-based nested casecontrol study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; QUALITY-OF-LIFE; OLDER-PEOPLE; MORTALITY; INSOMNIA; DIAZEPAM; ANXIETY; ADULTS; METAANALYSIS; MEDICATIONS	Background Concerns were raised about pneumonia development from benzodiazepines (BZDs) and Zdrugs, but direct evidence is limited, conflicting and without examining the highly susceptible patients with chronic kidney disease (CKD) nor specifying the risk for different drug utilizations. This study aimed to investigate whether use of BZDs and Z-drugs was each associated with an increased risk of pneumonia in a CKD population. Methods We performed a nested case-control study of 36,880 CKD patients analyzing the Taiwan National Health Insurance Database between 01/1/2000 and 12/31/2011. Among the study cohort, we identified 4,533 cases of pneumonia based on validated disease codes, chest xray examination, and prescriptions of respiratory antibiotics, and randomly selected 16,388 controls from risk sets, matched by sex, age, and number of CKD-related hospitalizations. All prescription filling records of BZDs and Z-drugs in the year before the event/index date were analyzed for cases and controls. Conditional logistic regressions were performed to estimate the odds ratios (ORs). Results Current use of BZDs was associated with a 1.31-fold (95% CI, 1.18-1.26) increased risk of pneumonia compared to nonuse, but not for recent and past use. The risk from current BZD use was confined to new initiation (adjusted OR, 2.47; 95% CI, 2.02-3.03) or use for <= 30 days, and elevated to 2.88-fold (95% CI, 1.87-4.42) with parenteral administration. New initiation and current short-term use of Z-drugs was associated with a 2.94-fold (95% CI, 1.65-5.26) and 1.75-fold (95% CI, 1.13-2.72) increased risk of pneumonia, respectively. The findings were robust to adoption of a case-crossover study that analyzed cases only. Conclusions Use of BZRAs is associated with an increased risk of pneumonia in CKD patients, especially for patients newly initiating BZDs or Z-drugs or those injected with BZDs. Physicians should exercise cautions for signs of pneumonia when prescribing BZDs or Z-drugs to CKD patients.	[Wang, Meng-Ting; Wang, Yun-Han; Lin, Chen Wei] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Chang, Hsin-An] Natl Def Med Ctr, Dept Psychiat, Triserv Gen Hosp, Taipei, Taiwan; [Tsai, Chen-Liang] Natl Def Med Ctr, Div Pulm & Crit Care, Triserv Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Ya-Sung] Natl Def Med Ctr, Div Infect Dis & Trop Med, Triserv Gen Hosp, Dept Med, Taipei, Taiwan; [Kuo, Cheng-Chin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Kuo, Cheng-Chin] Natl Def Med Ctr, Grad Inst Life Sci & Biochem, Taipei, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Metabol Res Ctr, China Med Univ Hosp, Taichung, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Triserv Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Hsu, YJ (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.; Hsu, YJ (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Hsu, YJ (corresponding author), Natl Def Med Ctr, Grad Inst Biochem, Taipei, Taiwan.	yujuei@mail2000.com.tw	Lin, Chen/GRR-2799-2022	Wang, Yun-Han/0000-0002-7673-7098; Tsai, Chen-Liang/0000-0001-9783-5423; Chang, Hsin-An/0000-0001-5572-7109	National Science Council [102-2314-B-016-006-MY3]; Tri-Service General Hospital [C103-117]; Ministry of National Defense-Medical Affairs Bureau [104-046]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Ministry of National Defense-Medical Affairs Bureau	This work was supported by National Science Council 102-2314-B-016-006-MY3 (YJH); Tri-Service General Hospital-C103-117 (YJH); Ministry of National Defense-Medical Affairs Bureau-104-046 (YJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; [Anonymous], 2015, GUID ATC CLASS DDD A; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Bjerre LM, 2000, BRIT MED J, V320, P503, DOI 10.1136/bmj.320.7233.503; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001110; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P919, DOI 10.2215/CJN.00820207; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Dublin S, 2011, J AM GERIATR SOC, V59, P1899, DOI 10.1111/j.1532-5415.2011.03586.x; FERRARESE C, 1993, PSYCHONEUROENDOCRINO, V18, P3, DOI 10.1016/0306-4530(93)90051-L; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; FINNERTY M, 1991, IMMUNOPHARMACOLOGY, V22, P185, DOI 10.1016/0162-3109(91)90043-X; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Galley HF, 1998, ANESTH ANALG, V86, P1289, DOI 10.1097/00000539-199806000-00030; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Huemer HP, 2010, VACCINE, V28, P6152, DOI 10.1016/j.vaccine.2010.07.032; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; Maeda T, 2016, INT J GERIATR PSYCH, V31, P186, DOI 10.1002/gps.4310; Massoco C, 2003, VET IMMUNOL IMMUNOP, V95, P11, DOI 10.1016/S0165-2427(03)00097-7; Morisaki H, 1989, Masui, V38, P1588; National health Insurance Administration Ministry of Health and Welfare, ENR STAT ALT TERM FI; Nose M, 2015, PHARMACOEPIDEM DR S, V24, P812, DOI 10.1002/pds.3804; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; PASINI FL, 1987, IMMUNOPHARM IMMUNOT, V9, P101, DOI 10.3109/08923978709035204; Sanders RD, 2013, CRIT CARE MED, V41, P1627, DOI 10.1097/CCM.0b013e31827c0c8d; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1532; Stein MB, 2015, NEW ENGL J MED, V373, P2059, DOI 10.1056/NEJMcp1502514; Taiwan National Health Insurance Research Database, INTR NAT HLTH INS RE; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Viasus D, 2011, NEPHROL DIAL TRANSPL, V26, P2899, DOI 10.1093/ndt/gfq798; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Wheeler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017152; Winkelman JW, 2015, NEW ENGL J MED, V373, P1437, DOI 10.1056/NEJMcp1412740; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; ZAVALA F, 1990, J PHARMACOL EXP THER, V255, P442	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179472	10.1371/journal.pone.0179472	http://dx.doi.org/10.1371/journal.pone.0179472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692645	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800010
J	Balazik, MT; Farrae, DJ; Darden, TL; Garman, GC				Balazik, Matthew T.; Farrae, Daniel J.; Darden, Tanya L.; Garman, Greg C.			Genetic differentiation of spring-spawning and fall-spawning male Atlantic sturgeon in the James River, Virginia	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS-OXYRINCHUS; NORTH-AMERICA; MANAGEMENT; SOFTWARE	Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus, Acipenseridae) populations are currently at severely depleted levels due to historic overfishing, habitat loss, and pollution. The importance of biologically correct stock structure for effective conservation and management efforts is well known. Recent improvements in our understanding of Atlantic sturgeon migrations, movement, and the occurrence of putative dual spawning groups leads to questions regarding the true stock structure of this endangered species. In the James River, VA specifically, captures of spawning Atlantic sturgeon and accompanying telemetry data suggest there are two discrete spawning groups of Atlantic sturgeon. The two putative spawning groups were genetically evaluated using a powerful microsatellite marker suite to determine if they are genetically distinct. Specifically, this study evaluates the genetic structure, characterizes the genetic diversity, estimates effective population size, and measures inbreeding of Atlantic sturgeon in the James River. The results indicate that fall and spring spawning James River Atlantic sturgeon groups are genetically distinct (overall F-ST = 0.048, F'(ST) = 0.181) with little admixture between the groups. The observed levels of genetic diversity and effective population sizes along with the lack of detected inbreeding all indicated that the James River has two genetically healthy populations of Atlantic sturgeon. The study also demonstrates that samples from adult Atlantic sturgeon, with proper sample selection criteria, can be informative when creating reference population databases. The presence of two genetically-distinct spawning groups of Atlantic sturgeon within the James River raises concerns about the current genetic assignment used by managers. Other nearby rivers may also have dual spawning groups that either are not accounted for or are pooled in reference databases. Our results represent the second documentation of genetically distinct dual spawning groups of Atlantic sturgeon in river systems along the U.S. Atlantic coast, suggesting that current reference population database should be updated to incorporate both new samples and our increased understanding of Atlantic sturgeon life history.	[Balazik, Matthew T.; Garman, Greg C.] Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Farrae, Daniel J.; Darden, Tanya L.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Hollings Marine Lab, Charleston, SC 29412 USA	Virginia Commonwealth University	Balazik, MT (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, Med Coll Virginia Campus, Richmond, VA 23284 USA.	balazikmt@vcu.edu	Darden, Tanya/B-6915-2019	Darden, Tanya/0000-0001-7295-7360; Farrae, Daniel/0000-0002-6632-3705	NOAA Section 6 grant [NA13NMF4720037]; Virginia Department of Game and Inland Fisheries Award [NA13NMF4720037]; National Marine Fisheries Service	NOAA Section 6 grant; Virginia Department of Game and Inland Fisheries Award; National Marine Fisheries Service	Tis work was supported by NOAA Section 6 grant #NA13NMF4720037, The Virginia Department of Game and Inland Fisheries Award number NA13NMF4720037, and the National Marine Fisheries Service.	ASMFC (Atlantic States Marine Fisheries Commission), 1998, 31 ASMFC; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Balazik MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128234; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Balazik MT, 2010, BIOL LETTERS, V6, P708, DOI 10.1098/rsbl.2010.0144; BIRSTEIN VJ, 1993, CONSERV BIOL, V7, P773, DOI 10.1046/j.1523-1739.1993.740773.x; Boreman J, 1997, ENVIRON BIOL FISH, V48, P399, DOI 10.1023/A:1007345806559; Cobb J.N., 1900, REPORT COMMISSIONER, V25, P369; Collins MR, 2000, T AM FISH SOC, V129, P982, DOI 10.1577/1548-8659(2000)129&lt;0982:HUABCO&gt;2.3.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farrae DJ, 2017, CONSERV GENET, V18, P1; Goode G. B., 1887, GEOGRAPHICAL REV FIS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hilton EJ, 2016, J APPL ICHTHYOL, V32, P30, DOI 10.1111/jai.13242; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; McCord JW, 2007, AM FISH S S, V56, P397; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5880; O'Leary SJ, 2014, CONSERV GENET, V15, P1173, DOI 10.1007/s10592-014-0609-9; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryder J. A., 1890, B US FISH COMM, V8, P231; Scott W.B., 1988, CANADIAN B FISHERIES, V219, pxxx; Secor DH, 2002, AM FISH S S, V28, P89; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; USA Federal Register, 2012, US FED REG, V77, P5914; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	34	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179661	10.1371/journal.pone.0179661	http://dx.doi.org/10.1371/journal.pone.0179661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686610	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100019
J	Dendoncker, K; Timmermans, S; Van Looveren, K; De Cauwer, L; De Bosscher, K; Libert, C				Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; De Cauwer, Lode; De Bosscher, Karolien; Libert, Claude			The nature of the GRE influences the screening for GR-activity enhancing modulators	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GLUCOCORTICOID-RECEPTOR AGONIST; DOWN-REGULATION; CLASS-I; ACETYLATION; COMPLEXES; CHROMATIN; COACTIVATOR; ACTIVATION; RESISTANCE	Glucocorticoid resistance (GCR), i.e. unresponsiveness to the beneficial anti-inflammatory activities of the glucocorticoid receptor (GR), poses a serious problem in the treatment of inflammatory diseases. One possible solution to try and overcome GCR, is to identify molecules that prevent or revert GCR by hyper-stimulating the biological activity of the GR. To this purpose, we screened for compounds that potentiate the dexamethasone (Dex)induced transcriptional activity of GR. To monitor GR transcriptional activity, the screen was performed using the lung epithelial cell line A549 in which a glucocorticoid responsive element (GRE) coupled to a luciferase reporter gene construct was stably integrated. Histone deacetylase inhibitors (HDACi) such as Vorinostat and Belinostat are two broad-spectrum HDACi that strongly increased the Dex-induced luciferase expression in our screening system. In sharp contrast herewith, results from a genome-wide transcriptome analysis of Dexinduced transcripts using RNAseq, revealed that Belinostat impairs the ability of GR to transactivate target genes. The stimulatory effect of Belinostat in the luciferase screen further depends on the nature of the reporter construct. In conclusion, a profound discrepancy was observed between HDACi effects on two different synthetic promoter-luciferase reporter systems. The favorable effect of HDACi on gene expression should be evaluated with care, when considering them as potential therapeutic agents. GEO accession number GSE96649.	[Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; Libert, Claude] VIB Ctr Inflammat Res, Mouse Genet Inflammat, Ghent, Belgium; [Dendoncker, Karen; Timmermans, Steven; Van Looveren, Kelly; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Cauwer, Lode; De Bosscher, Karolien] VIB, Med Biotechnol Ctr, Ghent, Belgium; [De Cauwer, Lode; De Bosscher, Karolien] Univ Ghent, Dept Biochem, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Libert, C (corresponding author), VIB Ctr Inflammat Res, Mouse Genet Inflammat, Ghent, Belgium.; Libert, C (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	Claude.Libert@ugent.be		Dendoncker, Karen/0000-0003-0688-0312; De Cauwer, Lode/0000-0002-6928-8271; De Bosscher, Karolien/0000-0001-5059-9718	Research Foundation Flanders (FWO Vlaanderen); Research Council of Ghent University GOA program; Interuniversity Attraction Poles of the Belgian Science Policy; VIB Nucleomics Core facility	Research Foundation Flanders (FWO Vlaanderen)(FWO); Research Council of Ghent University GOA program; Interuniversity Attraction Poles of the Belgian Science Policy; VIB Nucleomics Core facility	This work was supported by the Research Foundation Flanders (FWO Vlaanderen, http://www.fwo.be/)KD, The Research Council of Ghent University GOA programCL, Interuniversity Attraction Poles of the Belgian Science Policy (IAP-VI-18, http://www.belspo.be/IAP)CL, VIB Nucleomics Core facility (http://www.vib.be/en/research/services/Pages/VIB-Nucleomics-Core.aspx)ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arlt A, 2016, EXPERT OPINION INVES, P1; Bannister AJ, 2011, CELL RES; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes Peter J, 2009, Ther Adv Respir Dis, V3, P235, DOI 10.1177/1753465809348648; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; Blind RD, 2012, BIOCHEM BIOPH RES CO, V420, P839, DOI 10.1016/j.bbrc.2012.03.084; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Buttgereit F, 2015, CLIN EXP RHEUMATOL, V33, pS29; Cain DW, 2015, BEST PRACT RES CL EN, V29, P545, DOI 10.1016/j.beem.2015.04.007; Carafa V, 2013, EXPERT OPIN THER PAT, V23, P1, DOI 10.1517/13543776.2013.736493; Chakrabarti A, 2016, FUTURE MED CHEM, V8, P1609, DOI 10.4155/fmc-2016-0117; Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2016, TRENDS PHARMACOL SCI, V37, P4, DOI 10.1016/j.tips.2015.09.002; Dejager L, 2014, CYTOKINE GROWTH F R, V25, P21, DOI 10.1016/j.cytogfr.2013.12.006; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Dekker FJ, 2014, DRUG DISCOV TODAY, V19, P654, DOI 10.1016/j.drudis.2013.11.012; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Garrett LA, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0267-2; Gillette TG, 2015, CIRC RES, V116, P1245, DOI 10.1161/CIRCRESAHA.116.303630; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Guerrero J, 2013, CRIT CARE, V17, DOI 10.1186/cc12774; Hsieh IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.133; Huang LL, 2006, J CELL PHYSIOL, V209, P611, DOI 10.1002/jcp.20781; Irwin MH, 2016, DRUG DEVELOP RES, V77, P109, DOI 10.1002/ddr.21294; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kadiyala V, 2013, J BIOL CHEM, V288, P28900, DOI 10.1074/jbc.M113.505115; Kim BK, 2014, CURR TOP MED CHEM, V14, P2759, DOI 10.2174/1568026615666141208105614; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Lee HZ, 2015, CLIN CANCER RES, V21, P2666, DOI 10.1158/1078-0432.CCR-14-3119; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leus NGJ, 2016, CURR OPIN CHEM BIOL, V33, P160, DOI 10.1016/j.cbpa.2016.06.019; Li Y., 2016, COLD SPRING HARB PER, V6; Li YQ, 2012, SURGERY, V152, P455, DOI 10.1016/j.surg.2012.06.036; Libert C, 2014, CELL REP, V7, P938, DOI 10.1016/j.celrep.2014.04.041; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nixon M, 2013, STEROIDS, V78, P59, DOI 10.1016/j.steroids.2012.09.013; Payne, 2015, GENSTAT REFERENCE MA; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Qiu XY, 2017, PROG NEURO-PSYCHOPH, V72, P60, DOI 10.1016/j.pnpbp.2016.09.002; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Regna NL, 2014, CLIN IMMUNOL, V151, P29, DOI 10.1016/j.clim.2014.01.002; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Roche J, 2016, EUR J MED CHEM, V121, P451, DOI 10.1016/j.ejmech.2016.05.047; Rodriguez JM, 2016, STEROIDS, V115, P182, DOI 10.1016/j.steroids.2016.09.010; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Sharma S, 2016, PHARMACOL RES, V113, P320, DOI 10.1016/j.phrs.2016.09.009; Spinelli SL, 2014, EXP EYE RES, V127, P290, DOI 10.1016/j.exer.2014.07.013; Van Bogaert T, 2011, J BIOL CHEM, V286, P26555, DOI 10.1074/jbc.M110.212365; van den Akker ELT, 2009, INTENS CARE MED, V35, P1247, DOI 10.1007/s00134-009-1468-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wang JG, 2007, J BIOL CHEM, V282, P28408, DOI 10.1074/jbc.M703586200; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wu DF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-212; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Zhang JZ, 2009, MOL VIS, V15, P2606; Zhao T, 2013, SURGERY, V154, P206, DOI 10.1016/j.surg.2013.04.003; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	78	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181101	10.1371/journal.pone.0181101	http://dx.doi.org/10.1371/journal.pone.0181101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686666	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100133
J	Hamel-Cote, G; Gendron, D; Rola-Pleszczynski, M; Stankova, J				Hamel-Cote, Genevieve; Gendron, Daniel; Rola-Pleszczynski, Marek; Stankova, Jana			Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway	PLOS ONE			English	Article							INTERLEUKIN-6 MESSENGER-RNA; MUSCLE-CELL PROLIFERATION; TUMOR-NECROSIS-FACTOR; IN-GEL ASSAY; FACTOR RECEPTOR; KAPPA-B; SIGNALING PATHWAYS; GENE-EXPRESSION; NUCLEAR-FACTOR; ATHEROSCLEROSIS	Atherosclerosis is a pro-inflammatory condition underlying many cardiovascular diseases. Platelet-activating factor (PAF) and interleukin 6 (IL-6) are actively involved in the onset and progression of atherosclerotic plaques. The involvement of monocyte-derived macrophages is well characterized in the installation of inflammatory conditions in the plaque, but less is known about the contribution of monocyte-derived dendritic cells (Mo-DCs). In the same way, the involvement of calcium, phospholipase C and A2 in PAF-induced IL-6 production, in different cells types, has been shown; however, the importance of the Jak/STAT pathway and its regulation by protein-tyrosine phosphatases in this response have not been addressed. In this study, we report that PAF stimulates PTP1B activity via Jak2, thereby modulating PAF-induced IL-6 production. Using HEK 293 cells stably transfected with the PAF receptor in order to discriminate the pathway components, our results suggest that Jak2 modulates PAF-induced IL-6 production via both positive and negative pathways. Jak2 kinase activity was necessary for maximal transactivation of the IL-6 promoter, as seen by luciferase assays, whereas the same kinase also downregulated this promoter transactivation through the activation of a calcium/calpain/PTP1B pathway. The same pathways were operational in monocyte-derived dendritic cells, since PAF-induced PTP1B activation negatively regulated PAF-induced IL-6 mRNA production and, in addition, Jak2 activated calpain, one of the components involved in PAF-induced PTP1B activation. Results obtained in this study indicate that Jak2 activation is important for maximal IL-6 promoter transactivation by PAF and that PTP1B is involved in the negative regulation of this transactivation. However, PTP1B does not directly regulate Jak2 activ-ation, but rather Jak2 regulates PAF-induced PTP1B activation.	[Hamel-Cote, Genevieve; Gendron, Daniel; Rola-Pleszczynski, Marek; Stankova, Jana] Univ Sherbrooke, Immunol Div, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada	University of Sherbrooke	Stankova, J (corresponding author), Univ Sherbrooke, Immunol Div, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada.	jana.stankova@usherbrooke.ca	Hamel-Côté, Geneviève/AAQ-3949-2021	Stankova, Jana/0000-0002-4127-8506	Canadian Institutes of Health Research [MT-6822]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant (#MT-6822) from the Canadian Institutes of Health Research to MR-Pand JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Akbarali HI, 2010, NEUROGASTROENT MOTIL, V22, P1045, DOI 10.1111/j.1365-2982.2010.01560.x; Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Brown SL, 2006, J IMMUNOL, V177, P3242, DOI 10.4049/jimmunol.177.5.3242; Burdon KP, 2006, DIABETES, V55, P651, DOI 10.2337/diabetes.55.03.06.db05-0058; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Carroll CJ, 2013, J INTERF CYTOK RES, V33, P542, DOI 10.1089/jir.2012.0165; CHAO W, 1992, BIOCHEM J, V288, P777, DOI 10.1042/bj2880777; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen ZG, 2003, CELL SIGNAL, V15, P843, DOI 10.1016/S0898-6568(03)00056-1; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Demopoulos CA, 2003, EUR J LIPID SCI TECH, V105, P705, DOI 10.1002/ejlt.200300845; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Dichmann S, 2000, J CELL PHYSIOL, V185, P394, DOI 10.1002/1097-4652(200012)185:3<394::AID-JCP9>3.3.CO;2-Q; Drolet AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/913802; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Garcia-Ramirez M, 2011, CELL SIGNAL, V23, P1596, DOI 10.1016/j.cellsig.2011.05.011; Gaumond F, 1997, J CARDIOVASC PHARM, V30, P169, DOI 10.1097/00005344-199708000-00004; Gulati P, 2004, EMBO REP, V5, P812, DOI 10.1038/sj.embor.7400190; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Ibe BO, 2008, CELL PROLIFERAT, V41, P208, DOI 10.1111/j.1365-2184.2008.00517.x; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Kawashima T, 1950, J IMMUNOL BALTIM MD, V167, P3652; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Ko HM, 2005, FEBS LETT, V579, P6451, DOI 10.1016/j.febslet.2005.10.027; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Lacasse C, 1997, INFLAMMATION, V21, P145, DOI 10.1023/A:1027314103063; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Leon MLA, 2005, INFLAMM RES, V54, P395, DOI 10.1007/s00011-005-1377-2; Lu DP, 2003, BIOL REPROD, V69, P106, DOI 10.1095/biolreprod.102.014696; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Lukashova V, 1950, J IMMUNOL BALTIM MD, V171, P3794; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Majumder A, 2011, BIOCHEMISTRY-US, V50, P7774, DOI 10.1021/bi200847n; Marriott I, 1998, J CELL PHYSIOL, V177, P232, DOI 10.1002/(SICI)1097-4652(199811)177:2<232::AID-JCP5>3.0.CO;2-O; McAvoy Thomas, 2010, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1818s92; Mellado M, 1950, J IMMUNOL BALTIM MD, V161, P805; Meng TC, 2005, METHODS, V35, P28, DOI 10.1016/j.ymeth.2004.07.005; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakata M, 2005, DIABETES RES CLIN PR, V70, P209, DOI 10.1016/j.diabres.2005.03.036; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Row BW, 2004, J NEUROCHEM, V89, P189, DOI 10.1111/j.1471-4159.2004.02352.x; Sattayaprasert P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-11; SCHMAIER AH, 1990, BLOOD, V75, P1273; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Smith AW, 2011, J NEUROIMMUNOL, V232, P179, DOI 10.1016/j.jneuroim.2010.09.030; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Southall MD, 2001, J BIOL CHEM, V276, P45548, DOI 10.1074/jbc.M105978200; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; THIVIERGE M, 1992, J ALLERGY CLIN IMMUN, V90, P796, DOI 10.1016/0091-6749(92)90104-A; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; Trumpler A, 2009, FEBS J, V276, P5622, DOI 10.1111/j.1742-4658.2009.07255.x; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Wang H, 2001, BRIT J PHARMACOL, V133, P713, DOI 10.1038/sj.bjp.0704102; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Zhou WL, 2007, AM J PHYSIOL-HEART C, V292, pH2773, DOI 10.1152/ajpheart.01018.2006; Zhou X, 2011, ATHEROSCLEROSIS, V218, P147, DOI 10.1016/j.atherosclerosis.2011.05.021; Zhuang D, 2008, AM J PHYSIOL-HEART C, V295, pH163, DOI 10.1152/ajpheart.01105.2007	72	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180336	10.1371/journal.pone.0180336	http://dx.doi.org/10.1371/journal.pone.0180336			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686728	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100052
J	Piovezan, RD; Hirotsu, C; Feres, MC; Cintra, FD; Andersen, ML; Tufik, S; Poyares, D				Piovezan, Ronaldo D.; Hirotsu, Camila; Feres, Marcia C.; Cintra, Fatima D.; Andersen, Monica L.; Tufik, Sergio; Poyares, Dalva			Obstructive sleep apnea and objective short sleep duration are independently associated with the risk of serum vitamin D deficiency	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ADULTS; POPULATION; SEVERITY	'Background Studies demonstrate an association between vitamin D (25(OH) D) deficiency and sleep disturbances, such as obstructive sleep apnea (OSA) and short sleep duration. However, to date, no studies have concurrently and objectively evaluated the effect of these factors on 25(OH) D. Objectives To evaluate whether OSA and objective short sleep duration are independently associated with reduced 25(OH) D in an adult population sample. Methods A cross-sectional study included 657 individuals from the city of Sao Paulo, Brazil, as part of the ERA project. Participants fulfilled questionnaires and underwent clinical evaluation, polysomnography and blood sample collection for 25(OH) D quantification. OSA was classified into three categories (mild, moderate and severe). The risk of 25(OH) D deficiency was considered as levels<30 ng/mL. Short sleep duration was defined as total sleep time<6 hours. Results The risk of 25(OH) D deficiency was observed in 59.5% of the sample, affecting more individuals of the female gender, obese, with African American ethnicity, and those that were smokers, sedentary and presented hypertension and diabetes. In the final logistic model adjusted for age, gender, ethnicity, obesity, smoking, hypertension, diabetes, sedentary lifestyle, seasonality and creatinine serum levels, both OSA and short sleep duration showed significant independent associations with the risk of 25(OH) D deficiency (moderate OSA: OR for 25(OH) D<30 = 2.21, 95% CI: 1.35-3.64, p<0.01; severe OSA: OR for 25(OH) D<30 = 1.78, 95% CI: 1.06-3.00, p = 0.03; short sleep duration: OR for 25(OH) D<30 = 1.61, 95% CI: 1.15-2.26, p = 0.01). After a subgroup analysis, similar results were observed only in participants >= 50 years. Conclusion OSA and short sleep duration are independently associated with the risk of 25(OH) D deficiency in an adult population. Age-related changes in vitamin D metabolism and the frequency of sleep disorders may be involved in these associations. Future studies exploring whether 25(OH) D levels may modulate OSA and sleep curtailment-related outcomes are needed.	[Piovezan, Ronaldo D.; Hirotsu, Camila; Feres, Marcia C.; Andersen, Monica L.; Tufik, Sergio; Poyares, Dalva] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil; [Cintra, Fatima D.] Univ Fed Sao Paulo, Dept Med, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Piovezan, RD (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil.	rdpiovezan@gmail.com	Cintra, Fatima Dumas/T-8276-2019; Piovezan, Ronaldo/AAY-4017-2020	Piovezan, Ronaldo/0000-0003-2537-8766; Hirotsu, Camila/0000-0002-6760-0663; Dumas Cintra, Fatima/0000-0002-3361-7061	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/15259-2, 98/14303-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The support of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2014/15259-2 to CH) was a personal PhD fellowships, and the #98/14303-3 is already finished. Associacao Fundo de Incentivo a Pesquisa (AFIP) is a private philanthropic non-profitable organization that has purchased reagents for the performance of the study. The sponsors had no role in the study design, data collection, and analysis, or in the manuscript writing.	Ahmad Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067548; Allan Rechtschaffen, 1968, MANUAL STANDARDIZED; Andersen ML, 2012, J CLIN SLEEP MED; Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P675, DOI 10.1007/s00198-011-1606-1; Bauters F, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0556-z; Bertisch SM, 2015, SLEEP; Bozkurt NC, 2012, ENDOCRINE, V41, P518, DOI 10.1007/s12020-012-9595-1; Brouwer-Brolsma EM, 2015, J STEROID BIOCHEM, p[S0960, 30045]; Dashti HS, 2015, ADV NUTR, V6, P648, DOI 10.3945/an.115.008623; de Oliveira DL, 2015, J CLIN SLEEP MED, V11, P1345, DOI 10.5664/jcsm.5206; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Evatt ML, 2015, SLEEP; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Iber C., 2007, AASM MANUAL SCORING; Itani O, 2016, SLEEP MED; Kerley CP, 2016, SLEEP, V39, P293, DOI 10.5665/sleep.5430; Kim JH, 2014, J AM GERIATR SOC, V62, P2327, DOI 10.1111/jgs.13148; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Koivula MK, 2013, CLIN LAB, V59, P397, DOI 10.7754/Clin.Lab.2012.120527; Liguori C, 2015, J CLIN SLEEP MED; Liguori C, 2017, SLEEP MED, V29, P81, DOI 10.1016/j.sleep.2016.08.022; Massa J, 2015, SLEEP; McCarty DE, 2014, SLEEP MED REV, V18, P311, DOI 10.1016/j.smrv.2013.07.001; Moraes W, 2014, SLEEP MED, V15, P401, DOI 10.1016/j.sleep.2013.11.791; Nakashima A, 2016, WORLD J DIABETES, V7, P89, DOI 10.4239/wjd.v7.i5.89; Pande RU, 2009, LOW SERUM VITAMIN S, V32, pA136; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Piovezan RD, 2015, AGEING RES REV, V23, P210, DOI 10.1016/j.arr.2015.07.003; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Puckrin R, 2015, INT UROL NEPHROL, V47, P1839, DOI 10.1007/s11255-015-1113-y; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Sanders KM, 2014, CURR OSTEOPOROS REP, V12, P74, DOI 10.1007/s11914-014-0193-4; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Unnikrishnan D, 2015, REV ENDOCR METAB DIS, V16, P25, DOI 10.1007/s11154-014-9304-x; Upala S, 2015, J CLIN SLEEP MED, V11, P1347, DOI 10.5664/jcsm.5208; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024	38	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180901	10.1371/journal.pone.0180901	http://dx.doi.org/10.1371/journal.pone.0180901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686746	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100120
J	Quintana, AM; Hernandez, JA; Gonzalez, CG				Quintana, Anita M.; Hernandez, Jose A.; Gonzalez, Cesar G.			Functional analysis of the zebrafish ortholog of HMGCS1 reveals independent functions for cholesterol and isoprenoids in craniofacial development	PLOS ONE			English	Article							NEURAL CREST CELLS; SONIC HEDGEHOG; TREACHER-COLLINS; GENE; BIOSYNTHESIS; INHIBITION; EXPRESSION; DIFFERENTIATION; INACTIVATION; REQUIREMENTS	There are 8 different human syndromes caused by mutations in the cholesterol synthesis pathway. A subset of these disorders such as Smith-Lemli-Opitz disorder, are associated with facial dysmorphia. However, the molecular and cellular mechanisms underlying such facial deficits are not fully understood, primarily because of the diverse functions associated with the cholesterol synthesis pathway. Recent evidence has demonstrated that mutation of the zebrafish ortholog of HMGCR results in orofacial clefts. Here we sought to expand upon these data, by deciphering the cholesterol dependent functions of the cholesterol synthesis pathway from the cholesterol independent functions. Moreover, we utilized loss of function analysis and pharmacological inhibition to determine the extent of sonic hedgehog (Shh) signaling in animals with aberrant cholesterol and/or isoprenoid synthesis. Our analysis confirmed that mutation of hmgcs1, which encodes the first enzyme in the cholesterol synthesis pathway, results in craniofacial abnormalities via defects in cranial neural crest cell differentiation. Furthermore targeted pharmacological inhibition of the cholesterol synthesis pathway revealed a novel function for isoprenoid synthesis during vertebrate craniofacial development. Mutation of hmgcs1 had no effect on Shh signaling at 2 and 3 days post fertilization (dpf), but did result in a decrease in the expression of gli1, a known Shh target gene, at 4 dpf, after morphological deficits in craniofacial development and chondrocyte differentiation were observed in hmgcs1 mutants. These data raise the possibility that deficiencies in cholesterol modulate chondrocyte differentiation by a combination of Shh independent and Shh dependent mechanisms. Moreover, our results describe a novel function for isoprenoids in facial development and collectively suggest that cholesterol regulates craniofacial development through versatile mechanisms.	[Quintana, Anita M.; Hernandez, Jose A.; Gonzalez, Cesar G.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Quintana, Anita M.] Univ Texas El Paso, Border Biomed Res Ctr, NeuroModulat Cluster, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Quintana, AM (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.; Quintana, AM (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, NeuroModulat Cluster, El Paso, TX 79968 USA.	aquintana8@utep.edu		Gonzalez, Cesar/0000-0003-3513-1716; Quintana, Anita/0000-0002-3596-1587	NIMH [2G12MD007592, T32MH015442]; University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up; NIGMS linked awards [RL5GM118969, TL4GM118971, UL1GM118970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL5GM118969, UL1GM118970, TL4GM118971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015442] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up; NIGMS linked awards; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for this project was obtained from NIMH Grant no. 2G12MD007592 to the University of Texas El Paso, University of Texas El Paso Office of Research and Sponsored Projects New Investigator start-up funding, NIGMS linked awards RL5GM118969, TL4GM118971, UL1GM118970 and the NIMH Grant no. T32MH015442 to the University of Colorado School of Medicine, Department of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; Bhatt S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008326; Bianconi SE, 2015, EXPERT OPIN ORPHAN D, V3, P267, DOI 10.1517/21678707.2015.1014472; Blasky AJ, 2014, DEV DYNAM, V243, P1511, DOI 10.1002/dvdy.24172; Blassberg R, 2016, HUM MOL GENET, V25, P693, DOI 10.1093/hmg/ddv507; Callahan BP, 2015, CANCERS, V7, P2037, DOI 10.3390/cancers7040875; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Cretnik M, 2007, INT J MOL MED, V19, P875; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Hammond KL, 2009, EVOL DEV, V11, P27, DOI 10.1111/j.1525-142X.2008.00300.x; Herman GE, 2000, BBA-MOL CELL BIOL L, V1529, P357, DOI 10.1016/S1388-1981(00)00160-8; Hudish LI, 2016, DEVELOPMENT, V143, P2292, DOI 10.1242/dev.137844; Hudish LI, 2013, DEV CELL, V27, P387, DOI 10.1016/j.devcel.2013.10.015; Jindal GA, 2015, DIS MODEL MECH, V8, P769, DOI 10.1242/dmm.020339; Kadakia S, 2014, INT J PEDIATR OTORHI, V78, P893, DOI 10.1016/j.ijporl.2014.03.006; Kavalipati Narasaraju, 2015, Indian J Endocrinol Metab, V19, P554, DOI 10.4103/2230-8210.163106; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Koleva MV, 2015, MOL MEMBR BIOL, V32, P65, DOI 10.3109/09687688.2015.1066895; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kurosaka H, 2014, J CLIN INVEST, V124, P1660, DOI 10.1172/JCI72688; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lanthaler B, 2015, CLIN GENET, V88, P149, DOI 10.1111/cge.12454; Liu Y, 2013, DEV BIOL, V383, P239, DOI 10.1016/j.ydbio.2013.09.013; Mathews ES, 2016, J NEUROSCI, V36, P7628, DOI 10.1523/JNEUROSCI.0726-16.2016; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Mejia-Pous C, 2011, CELL PROLIFERAT, V44, P441, DOI 10.1111/j.1365-2184.2011.00771.x; Morand OH, 1997, J LIPID RES, V38, P373; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Palsuledesai CC, 2015, ACS CHEM BIOL, V10, P51, DOI 10.1021/cb500791f; Pelluard-Nehme F, 2005, ANN PATHOL, V25, P318, DOI 10.1016/S0242-6498(05)80136-1; Porter FD, 2003, CURR OPIN PEDIATR, V15, P607, DOI 10.1097/00008480-200312000-00011; Quintana AM, 2014, DEV BIOL, V396, P94, DOI 10.1016/j.ydbio.2014.09.026; Quintana AM, 2014, DIS MODEL MECH, V7, P265, DOI 10.1242/dmm.012526; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Signore IA, 2016, BIRTH DEFECTS RES A, V106, P814, DOI 10.1002/bdra.23546; Stathopoulou A, 2016, DEV BIOL, V409, P392, DOI 10.1016/j.ydbio.2015.11.023; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian H, 2005, DEVELOPMENT, V132, P133, DOI 10.1242/dev.01563; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Xavier GM, 2016, DEV BIOL; Zhang DC, 2014, BIRTH DEFECTS RES C, V102, P275, DOI 10.1002/bdrc.21081	50	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180856	10.1371/journal.pone.0180856	http://dx.doi.org/10.1371/journal.pone.0180856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686747	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100116
J	Smith, HF; Hutchison, JH; Townsend, KEB; Adrian, B; Jager, D				Smith, Heather F.; Hutchison, J. Howard; Townsend, K. E. Beth; Adrian, Brent; Jager, Daniel			Morphological variation, phylogenetic relationships, and geographic distribution of the Baenidae (Testudines), based on new specimens from the Uinta Formation (Uinta Basin), Utah (USA)	PLOS ONE			English	Article							TURTLES; ANATOMY; MEXICO	We described newly discovered baenid specimens from the Uintan North American Land Mammal Age (NALMA), in the Uinta Formation, Uinta Basin, Utah. These specimens include a partial skull and several previously undescribed postcranial elements of Baena arenosa, and numerous well-preserved shells of B. arenosa and Chisternon undatum. Baenids from the Uintan NALMA (46.5-40 Ma) are critical in that they provide valuable insight into the morphology and evolution of the diverse and speciose baenid family near the end of its extensive radiation, just prior to the disappearance of this clade from the fossil record. These Uintan specimens greatly increase the known variation in these late-surviving taxa and indicate that several characters thought to define these species should be reassessed. The partial cranium of B. arenosa, including portions of the basicranium, neurocranium, face, and lower jaw, was recently recovered from Uinta B sediments. While its morphology is consistent with known specimens of B. arenosa, we observed several distinct differences: a crescent-shaped condylus occipitalis that is concave dorsally, tuberculum basioccipitale that flare out laterally, and a distinct frontal-nasal suture. The current sample of plastral and carapacial morphology considerably expands the documented variation in the hypodigms of B. arenosa and C. undatum. Novel shell characters observed include sigmoidal extragularhumeral sulci, and small, subtriangular gular scutes. Subadult specimens reveal ontogenetic processes in both taxa, and demonstrate that diagnostic morphological differences between them were present from an early developmental age.	[Smith, Heather F.; Townsend, K. E. Beth; Adrian, Brent; Jager, Daniel] Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA; [Smith, Heather F.; Townsend, K. E. Beth] Midwestern Univ, Coll Vet Med, Glendale, AZ 85308 USA; [Smith, Heather F.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Hutchison, J. Howard] Univ Calif Berkeley, Univ Calif Museum Paleontol, Berkeley, CA 94720 USA	Midwestern University; Midwestern University; Arizona State University; Arizona State University-Tempe; University of California System; University of California Berkeley	Smith, HF (corresponding author), Midwestern Univ, Dept Anat, Glendale, AZ 85308 USA.; Smith, HF (corresponding author), Midwestern Univ, Coll Vet Med, Glendale, AZ 85308 USA.; Smith, HF (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	hsmith@midwestern.edu	Smith, Heather F./ABG-5436-2020	Smith, Heather F./0000-0002-3738-0903; Adrian, Brent/0000-0002-6167-838X	Midwestern University	Midwestern University	The authors were funded by intramural research funds from Midwestern University (HFS, KET).; Funding for this research was provided by Midwestern University faculty intramural funds (to HFS and KET). We thank Jessica Cundiff (Museum of Comparative Zoology) and Amy Henrici (Carnegie Museum of Natural History) for the loans of relevant comparative fossil material. We also thank Carrie-Levitt Bussian (UMNH) and Steve Sroka (FHM) for permission to study specimens under their care. We also wish to acknowledge the hard work of the Uinta Basin field crew over many productive field seasons, including Penny Higgins, Pat Holroyd, Karen McCormick, Laura Stroik, Jeffrey Westgate, and Jim Westgate. We would like to thank Walter Joyce and Adan Perez-Garcia for their insightful comments and suggestions on this manuscript, which greatly improved it.	Adrian B, 2016, J VERT PALEONTOL, V36S, P86; Andersen DW, 1972, UTAH GEOLOGICAL MINE, V97, P1; Anquetin J, 2012, J SYST PALAEONTOL, V10, P3, DOI 10.1080/14772019.2011.558928; AUFFENBERG WALTER, 1958, BULL FLORIDA STATE MUS BIOL SER, V3, P53; Barbieri R, 2003, GREENHOUSE ICEHOUSE, P452; Batsch JGC, 1788, VERSUCH ANLEITUNG KE; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Brinkman D.B., 1991, Journal of Vertebrate Paleontology, V11, P302; Brinkman DB, 2003, J VERTEBR PALEONTOL, V23, P146, DOI 10.1671/0272-4634(2003)23[146:AASOPA]2.0.CO;2; Bryant B, 1989, USGS B J, P1787; Bury BR, 1979, US FISH WILDLIFE SER, V219, P1; Chamberlain CP, 2012, AM J SCI, V312, P213, DOI 10.2475/02.2012.05; CLARK JOHN, 1932, ANN CARNEGIE MUS, V21, P131; Cope E.D., 1882, P AM PHILOS SOC, V10, P139; Davis SJ, 2008, EARTH PLANET SC LETT, V275, P258, DOI 10.1016/j.epsl.2008.08.009; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; GAFFNEY E S, 1975, Bulletin of the American Museum of Natural History, V155, P387; Gaffney E.S., 1982, American Museum Novitates, P1; Gaffney E.S., 1982, American Museum Novitates, P1; GAFFNEY E S, 1979, Bulletin of the American Museum of Natural History, V164, P69; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; Gaffney E. S., 1972, B AM MUS NAT HIST, V147, P243; GILMORE C.W., 1916, MEM CARNEGIE MUS, V7, P101; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gunnell G.F., 2009, PAPERS GEOLOGY VERTE, V65, P279; Hay OP, 1904, AM J SCI, V18, P261, DOI 10.2475/ajs.s4-18.106.261; Hay OP, 1908, CARNEGIE I WASH PUBL, P1; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Hurley John V., 2003, P223; Hutchison J. Howard, 2001, Paleobios, V21, P12; Hutchison J. Howard, 1992, P451; HUTCHISON JH, 1982, PALAEOGEOGR PALAEOCL, V37, P149, DOI 10.1016/0031-0182(82)90037-2; Hutchison JH, 1996, GUIDE UINTA TURTLES; Hutchison JH, 1987, J VERT PALEONTOL, V3, P148; Jager DM, 2016, J VERT PALEONTOL, V36S, P160; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2015, B PEABODY MUS NAT HI, V56, P147, DOI 10.3374/014.056.0203; Larson D. W., 2012, MORPHOLOGY EVOLUTION, P389; Leidy J., 1872, P ACAD NAT SCI PHILA, P162; Leidy J, 1870, P ACAD NAT SCI PHILA, V1870, P123; LEIDY J., 1871, P ACAD NAT SCI PHILA, V23, P228; Leidy J., 1873, REPORTS US GEOLOGICA, V1, P14, DOI [10.5962/bhl.title.61805, DOI 10.5962/BHL.TITLE.61805]; Lyson TR, 2016, J PALEONTOL, V90, P305, DOI 10.1017/jpa.2016.47; Lyson TR, 2011, J PALEONTOL, V85, P789, DOI 10.1666/10-081.1; Lyson TR, 2010, J VERTEBR PALEONTOL, V30, P394, DOI 10.1080/02724631003618389; Lyson TR, 2009, J PALEONTOL, V83, P833, DOI 10.1666/09-035.1; Lyson TR, 2009, J PALEONTOL, V83, P457, DOI 10.1666/08-172.1; Methner K, 2016, EARTH PLANET SC LETT, V450, P132, DOI 10.1016/j.epsl.2016.05.053; MILSTEAD WW, 1967, COPEIA, P180; Milstead WW, 1969, FLORIDA ST MUS B, V14, P1; Nelson A. B, 2000, RESTORATION MANAGEME; Osborn H. F., 1895, Bulletin of the American Museum, Vvii, P71; Osborn H. F., 1929, US GEOLOGICAL SURVEY, V1, P1, DOI [10.5962/bhl.title.36431, DOI 10.5962/BHL.TITLE.36431]; Prothero D.R., 1996, TERRESTRIAL EOCENE O, P75; Rasmussen D. T., 1999, VERTEBRATE PALEONTOL, P402; Rasmussen DT, 1995, J VERTEBR PALEONTOL, V15, p49A; Rasmussen DT, 1996, J HUM EVOL, V31, P75; Russell D.A., 1975, GEOL ASSOC CAN SPEC, P119; RYDER RT, 1976, GEOL SOC AM BULL, V87, P496, DOI 10.1130/0016-7606(1976)87<496:ETSITW>2.0.CO;2; SCHUMACHER G. H., 1956, ANAT ANZ, V103, P1; Schumaker G-H, 1954, MITTEILUNG WISS Z MN, P457; Schumaker G-H, 1955, MITTEILUNG WISS Z MN, P501; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Sterli J, 2013, J SYST PALAEONTOL, V11, P835, DOI 10.1080/14772019.2012.708674; Townsend K. E., 2004, THESIS; Townsend KEB, 2010, PALAEOGEOGR PALAEOCL, V297, P144, DOI 10.1016/j.palaeo.2010.07.024; Townsend KEB, 2006, MOUNTAIN GEOL, V43, P115; Werneburg I, 2013, BIOL OPEN, V2, P1103, DOI 10.1242/bio.20135439; Werneburg L, 2014, J EXPT ZOOLOGY B, V324B, P230; Williams EE, 1950, B AM MUS NAT HIST, V94, P511; Wood HE, 1941, BULL GEOL SOC AM, V52, P1; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	73	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180574	10.1371/journal.pone.0180574	http://dx.doi.org/10.1371/journal.pone.0180574			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686718	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100077
J	Tanaka, H; Kataoka, M; Isobe, S; Yamamoto, T; Shirakawa, K; Endo, J; Satoh, T; Hakamata, Y; Kobayashi, E; Sano, M; Fukuda, K				Tanaka, Hiroaki; Kataoka, Masaharu; Isobe, Sarasa; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Endo, Jin; Satoh, Toru; Hakamata, Yoji; Kobayashi, Eiji; Sano, Motoaki; Fukuda, Keiichi			Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; INHIBITION; MACITENTAN; REGISTRY; DISEASE; CELLS	Background Pulmonary hypertension (PH), caused by elevated pulmonary vascular resistance, leads to right heart failure and ultimately death. Vitamin D deficiency can predispose individuals to hypertension and left ventricular dysfunction; however, it remains unknown how serum vitamin D level is related to PH and right ventricular (RV) dysfunction. Methods Serum 25-hydroxyvitamin D [25(OH) D] levels were assessed in PH patients for an association with disease severity. To examine whether vitamin D supplementation could prevent the development of pulmonary vascular remodeling and RV dysfunction in PH, a rat model of PH was fed either normal chow or a high vitamin D diet. Results The majority (95.1%) of PH patients had 25(OH) D levels in the insufficiency range, which is associated with increased mean pulmonary artery pressure, increased pulmonary vascular resistance, and decreased cardiac output in PH patients. Vitamin D supplementation significantly increased serum 25(OH) D levels and improved survival in PH rats. Interestingly, while the supplemented rats retained the typical increases in medial thickness of the muscular pulmonary arteries and RV systolic pressure, RV cardiomyocyte hypertrophy and B-type natriuretic peptide expression was significantly attenuated. Conclusions Vitamin D deficiency is frequently seen in patients diagnosed with PH and low serum levels of 25(OH) D are associated with severity of PH and RV dysfunction. Vitamin D supplementation in PH rats improved survival via ameliorating pathological RV hypertrophy. These findings suggest an insufficient intake of vitamin D might potentially accelerate RV dysfunction, leading to a crucial clinical impact of vitamin D supplementation in PH.	[Tanaka, Hiroaki; Kataoka, Masaharu; Isobe, Sarasa; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Endo, Jin; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Tanaka, Hiroaki] Actelion Pharmaceut Japan Ltd, Tokyo, Japan; [Satoh, Toru] Kyorin Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Hakamata, Yoji] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Basic Sci, Fac Vet Sci, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan	Keio University; Kyorin University; Nippon Veterinary & Life Science University; Keio University	Kataoka, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.	m.kataoka09@keio.jp	Hakamata, Yoji/AAF-7759-2020; Sano, Motoaki/L-3405-2013; Isobe, Sarasa/F-8480-2014	Hakamata, Yoji/0000-0002-0138-6692; Yamamoto, Tsunehisa/0000-0002-5241-9482	Health and Labour Sciences Research Grant - Ministry of Health, Labour, and Welfare of Japan; Actelion Pharmaceuticals Japan Ltd	Health and Labour Sciences Research Grant - Ministry of Health, Labour, and Welfare of Japan; Actelion Pharmaceuticals Japan Ltd	This study was financed by the Health and Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan, and Actelion Pharmaceuticals Japan Ltd. provided support in the form of salaries for an author [HT], but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Demir M, 2013, Prague Med Rep, V114, P154; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Jiang BH, 2016, AM J RESP CELL MOL, V54, P461, DOI 10.1165/rcmb.2014-0488OC; Kuwano K, 2008, J PHARMACOL EXP THER, V326, P691, DOI 10.1124/jpet.108.138305; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; McLaughlin VV, 2009, J AM COLL CARDIOL, V54, pS97, DOI 10.1016/j.jacc.2009.04.007; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; Muscogiuri G, 2017, ARCH TOXICOL, V91, P97, DOI 10.1007/s00204-016-1804-x; Nakamura K, 2015, BONE, V74, P10, DOI 10.1016/j.bone.2014.12.064; Perros F, 2015, CIRCULATION, V132, P834, DOI 10.1161/CIRCULATIONAHA.115.014207; Pilz S, 2016, NAT REV CARDIOL, V13, P404, DOI 10.1038/nrcardio.2016.73; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184; Witte KK, 2016, J AM COLL CARDIOL, V67, P2593, DOI 10.1016/j.jacc.2016.03.508; Yung LM, 2016, AM J RESP CRIT CARE, V194, P1140, DOI 10.1164/rccm.201510-1955OC	21	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180615	10.1371/journal.pone.0180615	http://dx.doi.org/10.1371/journal.pone.0180615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686688	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100082
J	Yano, F; Omura, N; Tsuboi, K; Hoshino, M; Yamamoto, S; Akimoto, S; Masuda, T; Kashiwagi, H; Yanaga, K				Yano, Fumiaki; Omura, Nobuo; Tsuboi, Kazuto; Hoshino, Masato; Yamamoto, Seryung; Akimoto, Shunsuke; Masuda, Takahiro; Kashiwagi, Hideyuki; Yanaga, Katsuhiko			Learning curve for laparoscopic Heller myotomy and Dor fundoplication for achalasia	PLOS ONE			English	Article							ORAL ENDOSCOPIC MYOTOMY; ESOPHAGEAL ACHALASIA; SURGERY; OUTCOMES	Purpose Although laparoscopic Heller myotomy and Dor fundoplication (LHD) is widely performed to address achalasia, little is known about the learning curve for this technique. We assessed the learning curve for performing LHD. Methods Of the 514 cases with LHD performed between August 1994 and March 2016, the surgical outcomes of 463 cases were evaluated after excluding 50 cases with reduced port surgery and one case with the simultaneous performance of laparoscopic distal partial gastrectomy. A receiver operating characteristic (ROC) curve analysis was used to identify the cut-off value for the number of surgical experiences necessary to become proficient with LHD, which was defined as the completion of the learning curve. Results We defined the completion of the learning curve when the following 3 conditions were satisfied. 1) The operation time was less than 165 minutes. 2) There was no blood loss. 3) There was no intraoperative complication. In order to establish the appropriate number of surgical experiences required to complete the learning curve, the cut-off value was evaluated by using a ROC curve (AUC 0.717, p < 0.001). Finally, we identified the cut-off value as 16 surgical cases (sensitivity 0.706, specificity 0.646). Conclusion Learning curve seems to complete after performing 16 cases.	[Yano, Fumiaki; Omura, Nobuo; Tsuboi, Kazuto; Hoshino, Masato; Yamamoto, Seryung; Akimoto, Shunsuke; Masuda, Takahiro; Kashiwagi, Hideyuki; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Jikei University	Yano, F (corresponding author), Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan.	yano@jikei.ac.jp	Tsuboi, Kazuto/AAN-4313-2021; Yanaga, Katsuhiko/Y-6290-2019	Yanaga, Katsuhiko/0000-0001-8918-4720				[Anonymous], 2016, NIHON GEKA GAKKAI ZA, V21, P689; Bencini L, 2016, WORLD J GASTRO SURG, V8, P52, DOI 10.4240/wjgs.v8.i1.52; Bloomston Mark, 2002, JSLS, V6, P41; Boeckxstaens GE, 2014, LANCET, V383, P83, DOI 10.1016/S0140-6736(13)60651-0; Calhoun JT, 2014, JSLS-J SOC LAPAROEND, V18, P55, DOI 10.4293/108680813X13693422520431; El Zein M, 2016, ENDOSC INT OPEN, V4, pE577, DOI 10.1055/s-0042-104113; Grotenhuis BA, 2008, WORLD J SURG, V32, P1689, DOI 10.1007/s00268-008-9622-9; Hungness ES, 2016, ANN SURG, V264, P508, DOI 10.1097/SLA.0000000000001870; Japanese Society for Esophageal Disease, 2012, DESCR RUL ACH ES; Kurian AA, 2013, GASTROINTEST ENDOSC, V77, P719, DOI 10.1016/j.gie.2012.12.006; Leggett P L, 2002, Surg Endosc, V16, P362, DOI 10.1007/s00464-001-4109-x; Lynch KL, 2012, AM J GASTROENTEROL, V107, P1817, DOI 10.1038/ajg.2012.332; Omura N, 2015, SURG TODAY, V45, P1139, DOI 10.1007/s00595-014-1109-8; Osaka K, 2015, INT J UROL, V22, P1000, DOI 10.1111/iju.12893; Patel KS, 2015, GASTROINTEST ENDOSC, V81, P1181, DOI 10.1016/j.gie.2014.10.002; Pescarus Radu, 2014, Curr Gastroenterol Rep, V16, P369, DOI 10.1007/s11894-013-0369-6; Ricci C, 2015, SURG TODAY, V45, P50, DOI 10.1007/s00595-014-0872-x; Ross SB, 2013, AM SURGEON, V79, P837; Tsuboi K, 2016, SURG ENDOSC, V30, P706, DOI 10.1007/s00464-015-4264-0; Tsuboi K, 2015, WORLD J GASTROENTERO, V21, P10830, DOI 10.3748/wjg.v21.i38.10830; Tsuboi K, 2009, DIS ESOPHAGUS, V22, P169, DOI 10.1111/j.1442-2050.2008.00891.x; Yamakawa T., 2013, BH SURG, V3, P6; Yano Fumiaki, 2008, Int J Surg, V6, P490, DOI 10.1016/j.ijsu.2006.07.007; Zaninotto G, 2014, J GASTROINTEST SURG, V18, P98	24	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180515	10.1371/journal.pone.0180515	http://dx.doi.org/10.1371/journal.pone.0180515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686640	gold, Green Published			2022-12-27	WOS:000405464100073
J	Suktitipat, B; Sathirareuangchai, S; Roothumnong, E; Thongnoppakhun, W; Wangkiratikant, P; Vorasan, N; Krittayaphong, R; Pithukpakorn, M; Boonyapisit, W				Suktitipat, Bhoom; Sathirareuangchai, Sakda; Roothumnong, Ekkapong; Thongnoppakhun, Wanna; Wangkiratikant, Purin; Vorasan, Nutchavadee; Krittayaphong, Rungroj; Pithukpakorn, Manop; Boonyapisit, Warangkna			Molecular investigation by whole exome sequencing revealed a high proportion of pathogenic variants among Thai victims of sudden unexpected death syndrome	PLOS ONE			English	Article							CHINESE HAN POPULATION; UNEXPLAINED DEATH; CARDIAC DEATH; AUTOPSY; MEN; DISEASES; GENES; SNPS	Introduction Sudden unexpected death syndrome (SUDS) is an important cause of death in young healthy adults with a high incident rate in Southeast Asia; however, there are no molecular autopsy reports about these victims. We performed a combination of both a detailed autopsy and a molecular autopsy by whole exome sequencing (WES) to investigate the cause of SUDS in Thai sudden death victims. Materials and methods A detailed forensic autopsy was performed to identify the cause of death, followed by a molecular autopsy, in 42 sudden death victims who died between January 2015 and August 2015. The coding sequences of 98 SUDS-related genes were sequenced using WES. Potentially causative variants were filtered based on the variant functions annotated in the dbNSFP database. Variants with inconclusive clinical significance evidence in ClinVar were resolved with a variant prediction algorithm, metaSVM, and the frequency data of the variants found in public databases, such as the 1000 Genome Project, ESP6500 project, and the Exome Aggregation Consortium (ExAc) project. Results Combining both autopsy and molecular autopsy enabled the potential identification of cause of death in 81% of the cases. Among the 25 victims with WES data, 72% (18/25) were found to have potentially causative SUDS mutations. The majority of the victims had at a mutation in the TTN gene (8/18 = 44%), and only one victim had an SCN5A mutation. Conclusions WES can help to identify the genetic causes in victims of SUDS and may help to further guide investigations into their relatives to prevent additional SUDS victims.	[Suktitipat, Bhoom] Mahidol Univ, Fac Med, Dept Biochem, Siriraj Hosp, Bangkok, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Integrat Computat BioSci Ctr ICBS, Bangkok, Thailand; [Sathirareuangchai, Sakda] Mahidol Univ, Fac Med, Dept Forens Med, Siriraj Hosp, Bangkok, Thailand; [Roothumnong, Ekkapong; Krittayaphong, Rungroj; Pithukpakorn, Manop; Boonyapisit, Warangkna] Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand; [Thongnoppakhun, Wanna] Mahidol Univ, Fac Med, Dept Res & Dev, Siriraj Hosp, Bangkok, Thailand; [Wangkiratikant, Purin; Vorasan, Nutchavadee] Mahidol Univ, Fac Med, Res Div, Siriraj Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Boonyapisit, W (corresponding author), Mahidol Univ, Fac Med, Dept Med, Siriraj Hosp, Bangkok, Thailand.	waran_byps@yahoo.com	Pithukpakorn, Manop/K-9825-2013; Suktitipat, Bhoom/H-4239-2019	Pithukpakorn, Manop/0000-0003-3611-5718; Suktitipat, Bhoom/0000-0001-8034-7757; Sathirareuangchai, Sakda/0000-0002-0585-6874; Boonyapisit, Warangkna/0000-0002-5278-0091	Mahidol University [R015837002]; Siriraj Core Research Facility (SiCRF); Siriraj Chalermphrakiat; Crown Property Bureau Foundation Grant; Thanapat Fund [D003752]; Faculty of Medicine Siriraj Hospital, Mahidol University [R015734003]	Mahidol University; Siriraj Core Research Facility (SiCRF); Siriraj Chalermphrakiat; Crown Property Bureau Foundation Grant; Thanapat Fund; Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by Mahidol University (Grant R015837002 to WB); Siriraj Core Research Facility (SiCRF) Grant to MP; Siriraj Chalermphrakiat Grant to BS, SS, WT, WB, MP and RK; the Crown Property Bureau Foundation Grant to BS; Thanapat Fund (D003752) to MP, Faculty of Medicine Siriraj Hospital, Mahidol University, Grant Number (IO) R015734003 to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RC, 1983, LANCET, V1, P764; Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Campuzano O, 2015, INT J MOL SCI, V16, P25773, DOI 10.3390/ijms161025773; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Chanavirut R, 2017, INT J CARDIOL, V226, P87, DOI 10.1016/j.ijcard.2016.10.001; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Hertz CL, 2015, EUROPACE, V17, P350, DOI 10.1093/europace/euu210; Huang L, 2014, FORENSIC SCI INT, V235, P14, DOI 10.1016/j.forsciint.2013.12.007; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Liu C, 2014, FORENSIC SCI INT, V236, P38, DOI 10.1016/j.forsciint.2013.12.033; Liu C, 2013, FORENSIC SCI INT, V231, P82, DOI 10.1016/j.forsciint.2013.04.020; Lombardi R, 2013, CURR OPIN CARDIOL, V28, P272, DOI 10.1097/HCO.0b013e32835fb7f3; LUCAS S, 2005, GUIDELINES AUTOPSY P; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; Pithukpakorn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128481; Sanchez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167358; Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581; Tang YY, 2014, CARDIOVASC PATHOL, V23, P1, DOI 10.1016/j.carpath.2013.09.002; TATSANAVIVAT P, 1992, INT J EPIDEMIOL, V21, P904, DOI 10.1093/ije/21.5.904; Torkamani A, 2016, JAMA-J AM MED ASSOC, V316, P1492, DOI 10.1001/jama.2016.11445; TUNGSANGA K, 1993, INT J EPIDEMIOL, V22, P81, DOI 10.1093/ije/22.1.81; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Wang C, 2015, FORENSIC SCI INT, V257, pE20, DOI 10.1016/j.forsciint.2015.08.022; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180056	10.1371/journal.pone.0180056	http://dx.doi.org/10.1371/journal.pone.0180056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704380	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700024
J	Szafran, AT; Stossi, F; Mancini, MG; Walker, CL; Mancini, MA				Szafran, Adam T.; Stossi, Fabio; Mancini, Maureen G.; Walker, Cheryl L.; Mancini, Michael A.			Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis	PLOS ONE			English	Article							RECEPTOR-ALPHA; CHEMICALS; TRANSCRIPTION; MECHANISMS	Animal studies have linked the estrogenic properties of bisphenol A (BPA) to adverse effects on the endocrine system. Because of concerns for similar effects in humans, there is a desire to replace BPA in consumer products, and a search for BPA replacements that lack endocrine-disrupting bioactivity is ongoing. We used multiple cell-based models, including an established multi-parametric, high throughput microscopy-based platform that incorporates engineered HeLa cell lines with visible ER alpha- or ER beta-regulated transcription loci, to discriminate the estrogen-like and androgen-like properties of previously uncharacterized substituted bisphenol derivatives and hydroquinone. As expected, BPA induced 70-80% of the estrogen-like activity via ER alpha and ER beta compared to E2 in the HeLa prolactin array cell line. 2,2' BPA, Bisguaiacol F, CHDM 4-hydroxybuyl acrylate, hydroquinone, and TM modified variants of BPF showed very limited estrogen-like or androgen-like activity (< 10% of that observed with the control compounds). Interestingly, TM-BFP and CHDM 4-hydroxybuyl acrylate, but not their derivatives, demonstrated evidence of anti-estrogenic and anti-androgenic activity. Our findings indicate that Bisguaiacol F, TM-BFP-ER and TM-BPFDGE demonstrate low potential for affecting estrogenic or androgenic endocrine activity. This suggest that the tested compounds could be suitable commercially viable alternatives to BPA.	[Szafran, Adam T.; Stossi, Fabio; Mancini, Maureen G.; Walker, Cheryl L.; Mancini, Michael A.] Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA; [Mancini, Michael A.] DeepBio Inc, Houston, TX 77046 USA	Baylor College of Medicine	Mancini, MA (corresponding author), Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA.; Mancini, MA (corresponding author), DeepBio Inc, Houston, TX 77046 USA.	mancini@bcm.edu			Integrated Microscopy Core at Baylor College of Medicine; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Dan L. Duncan Cancer Center [NIH P30CA125123]; NIH [HD007495, DK56338, K12DK0083014]; multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded; NIEHS [R01 (1R01ES023206-01), P30 (ES023512-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007495, P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, K12DK083014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES027704, P30ES023512, R01ES023206] Funding Source: NIH RePORTER	Integrated Microscopy Core at Baylor College of Medicine; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Dan L. Duncan Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS grants NIEHS R01 (1R01ES023206-01; Cheryl L. Walker, Bert W. OMalley, M.A.M. and Mark T. Bedford) and NIEHS P30 (ES023512-01; Center of Excellence in Environmental Health, C.L.W.). Further support was provided by the Integrated Microscopy Core at Baylor College of Medicine with funding from the John S. Dunn Gulf Coast Consortium for Chemical Genomics, the Dan L. Duncan Cancer Center (NIH P30CA125123), and the NIH (HD007495, and DK56338). ATS is a K12 Scholar supported by NIH grant K12DK0083014, the multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded to Dr. Dolores J. Lamb. DeepBio, Inc received funds and material support from the Valspar Corporation. Funders do not have scientific or editorial control over the design, conduct, analysis, or interpretation of the data, nor were they involved in the decision to publish or producing this manuscript. DeepBio, Inc provided support in the form of materials and consulting fees for A.T.S., F.S., and M.G.M. and provided salary for M.A.M. The specific roles of these authors are articulated in the author contributions section. M.A.M participated in in study design, data interpretation, and final manuscript review, however, DeepBio, Inc did not have editorial control nor was involved in the decision to publish.	Ashcroft FJ, 2011, GENE, V477, P42, DOI 10.1016/j.gene.2011.01.009; Berno V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002286; Bolt MJ, 2013, NUCLEIC ACIDS RES, V41, P4036, DOI 10.1093/nar/gkt100; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P1239, DOI 10.1289/ehp.1408258; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Colleta SJ, 2015, ENV TOXICOL; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Jiang SM, 2006, MOL ENDOCRINOL, V20, P311, DOI 10.1210/me.2005-0100; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Karmakar S, 2013, J BIOL CHEM, V288, P24020, DOI 10.1074/jbc.M113.473819; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Odian, PRINCIPLES POLYM; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Rehan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138438; Rivas A, 2002, J STEROID BIOCHEM, V82, P45, DOI 10.1016/S0960-0760(02)00146-2; Robertson G.L., 2006, PACKAG TECHNOL SCI; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rosenmai AK, 2014, TOXICOL SCI, V139, P35, DOI 10.1093/toxsci/kfu030; Sharp ZD, 2006, J CELL SCI, V119, P4365, DOI 10.1242/jcs.03264; Soto AM, 2017, ENVIRON SCI TECHNOL, V51, P1718, DOI 10.1021/acs.est.6b04704; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stossi F, 2016, ONCOTARGET; Stossi F, 2014, CHEM BIOL, V21, P743, DOI 10.1016/j.chembiol.2014.03.013; Stoye E, 2014, CHEM WORLD; Szafran AT, 2014, ASSAY DRUG DEV TECHN, V12, P87, DOI 10.1089/adt.2013.532; Weiss B, 2012, NEUROTOXICOLOGY, V33, P1410, DOI 10.1016/j.neuro.2012.05.014; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Wu J, 2015, TOXICOL IND HLTH	31	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180141	10.1371/journal.pone.0180141	http://dx.doi.org/10.1371/journal.pone.0180141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704378	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700029
J	Horio, Y; Ichiyasu, H; Kojima, K; Saita, N; Migiyama, Y; Iriki, T; Fujii, K; Niki, T; Hirashima, M; Kohrogi, H				Horio, Yuko; Ichiyasu, Hidenori; Kojima, Keisuke; Saita, Naoki; Migiyama, Yohei; Iriki, Toyohisa; Fujii, Kazuhiko; Niki, Toshiro; Hirashima, Mitsuomi; Kohrogi, Hirotsugu			Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; CONNECTIVE-TISSUE BREAKDOWN; SMOKE-INDUCED EMPHYSEMA; NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE; POLYMORPHONUCLEAR NEUTROPHILS; OXIDATIVE STRESS; T-CELLS; MICE	Purpose Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow obstruction and pulmonary emphysema. Persistent inflammation and remodeling of the lungs and airways result in reduced lung function and a lower quality of life. Galectin (Gal)-9 plays a crucial role as an immune modulator in various diseases. However, its role in the pathogenesis of pulmonary emphysema is unknown. This study investigates whether Gal-9 is involved in pulmonary inflammation and changes in emphysema in a porcine pancreatic elastase (PPE)-induced emphysema model. Materials and methods Gal-9 was administered to mice subcutaneously once daily from 1 day before PPE instillation to day 5. During the development of emphysema, lung tissue and bronchoalveolar lavage fluid (BALF) were collected. Histological and cytological findings, concentrations of chemokines and matrix metalloproteinases (MMPs) in the BALF, and the influence of Gal-9 treatment on neutrophils were analyzed. Results Gal-9 suppressed the pathological changes of PPE-induced emphysema. The mean linear intercept (Lm) of Gal-9-treated emphysema mice was significantly lower than that of PBStreated emphysema mice (66.1 +/- 3.3 mu m vs. 118.8 +/- 14.8 ae m, respectively; p < 0.01). Gal-9 decreased the number of neutrophils and levels of MMP-9, MMP-2 and tissue inhibitor of metalloproteinases (TIMP)-1 in the BALF. The number of neutrophils in the BALF correlated significantly with MMPs levels. Interestingly, Gal-9 pretreatment in vitro inhibited the chemotactic activity of neutrophils and MMP-9 production from neutrophils. Furthermore, in Gal-9deficient mice, PPE-induced emphysema progressed significantly compared with that in wild-type (WT) mice (108.7 +/- 6.58 mu m vs. 77.19 +/- 6.97 ae m, respectively; p < 0.01). Conclusions These results suggest that Gal-9 protects PPE-induced inflammation and emphysema by inhibiting the infiltration of neutrophils and decreasing MMPs levels. Exogenous Gal-9 could be a potential therapeutic agent for COPD.	[Horio, Yuko; Ichiyasu, Hidenori; Kojima, Keisuke; Saita, Naoki; Migiyama, Yohei; Iriki, Toyohisa; Fujii, Kazuhiko; Kohrogi, Hirotsugu] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Dept Immunol & Immunopathol, Takamatsu, Kagawa, Japan	Kumamoto University; Kagawa University	Kohrogi, H (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan.	kohrogi@kumamoto-u.ac.jp		Ichiyasu, Hidenori/0000-0003-1773-8485				Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Antunes MA, 2011, AN ACAD BRAS CIENC, V83, P1385, DOI 10.1590/S0001-37652011005000039; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Baila B, 2012, BIOL PHARM BULL, V35, P494, DOI 10.1248/bpb.35.494; BARON EJ, 1982, J IMMUNOL METHODS, V49, P305, DOI 10.1016/0022-1759(82)90130-2; Baseras B, 2012, IMMUNOBIOLOGY, V217, P83, DOI 10.1016/j.imbio.2011.07.031; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Cheng SL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-115; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Dentener MA, 2008, RESPIRATION, V76, P275, DOI 10.1159/000117386; Dhami R, 2000, AM J RESP CELL MOL, V22, P244, DOI 10.1165/ajrcmb.22.2.3809; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Horio Y, 2016, ERS INT C LOND UK; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; John S, 2016, J BIOSCIENCES, V41, P507, DOI 10.1007/s12038-016-9616-y; Kadowaki T, 2013, CRIT CARE, V17, DOI 10.1186/cc13147; KAPLAN PD, 1973, J LAB CLIN MED, V82, P349; Kojima K, 2011, AM J RESP CRIT CARE, V184, P328, DOI 10.1164/rccm.201010-1566OC; Koo HK, 2016, INT J CHRONIC OBSTR, V11, P1129, DOI 10.2147/COPD.S103281; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Leskela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123938; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; Ma DW, 2006, J MED CHEM, V49, P456, DOI 10.1021/jm051101g; Mackarel AJ, 1999, AM J RESP CELL MOL, V20, P1209; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Mikko M, 2013, IMMUNOBIOLOGY, V218, P225, DOI 10.1016/j.imbio.2012.04.012; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Ofulue AF, 1999, AM J PHYSIOL-LUNG C, V277, pL97, DOI 10.1152/ajplung.1999.277.1.L97; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sakao S, 2001, AM J RESP CRIT CARE, V163, P420, DOI 10.1164/ajrccm.163.2.2006031; Seemungal TAR, 2015, AM J RESP CRIT CARE, V192, P1036, DOI 10.1164/rccm.201503-0534UP; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Steichen AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123573; Taguchi L, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0233-3; Tsai WC, 2004, AM J RESP CRIT CARE, V170, P1331, DOI 10.1164/rccm.200402-200OC; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	51	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180742	10.1371/journal.pone.0180742	http://dx.doi.org/10.1371/journal.pone.0180742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704475	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600047
J	Zarkoob, H; Lewinsky, S; Almgren, P; Melander, O; Fakhrai-Rad, H				Zarkoob, Hadi; Lewinsky, Sarah; Almgren, Peter; Melander, Olle; Fakhrai-Rad, Hossein			Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; SUSCEPTIBILITY LOCI; VARIANTS; MELLITUS; METAANALYSIS; KCNQ1; CONSUMPTION; GLUCOSE; HEALTH	The aim of this study was to measure the impact of genetic data in improving the prediction of type 2 diabetes (T2D) in the Malmo Diet and Cancer Study cohort. The current study was performed in 3,426 Swedish individuals and utilizes of a set of genetic and environmental risk data. We first validated our environmental risk model by comparing it to both the Finnish Diabetes Risk Score and the T2D risk model derived from the Framingham Offspring Study. The area under the curve (AUC) for our environmental model was 0.72 [95% CI, 0.69-0.74], which was significantly better than both the Finnish (0.64 [95% CI, 0.61-0.66], p-value < 1 x 10(-4)) and Framingham (0.69 [95% CI, 0.66-0.71], p-value = 0.0017) risk scores. We then verified that the genetic data has a statistically significant positive correlation with incidence of T2D in the studied population. We also verified that adding genetic data slightly but statistically increased the AUC of a model based only on environmental risk factors (RFs, AUC shift + 1.0% from 0.72 to 0.73, p-value = 0.042). To study the dependence of the results on the environmental RFs, we divided the population into two equally sized risk groups based only on their environmental risk and repeated the same analysis within each subpopulation. While there is a statistically significant positive correlation between the genetic data and incidence of T2D in both environmental risk categories, the positive shift in the AUC remains statistically significant only in the category with the lower environmental risk. These results demonstrate that genetic data can be used to increase the accuracy of T2D prediction. Also, the data suggests that genetic data is more valuable in improving T2D prediction in populations with lower environmental risk. This suggests that the impact of genetic data depends on the environmental risk of the studied population and thus genetic association studies should be performed in light of the underlying environmental risk of the population.	[Zarkoob, Hadi; Lewinsky, Sarah; Fakhrai-Rad, Hossein] BaseHealth Inc, Sunnyvale, CA 94086 USA; [Almgren, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University	Fakhrai-Rad, H (corresponding author), BaseHealth Inc, Sunnyvale, CA 94086 USA.	rad@basehealth.com		Melander, Olle/0000-0002-2581-484X	Novo Nordisk Fonden [NNF17OC0026936, NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Al Safar HS, 2013, ANN HUM GENET, V77, P488, DOI 10.1111/ahg.12036; [Anonymous], 2013, DIABETOLOGIA, V56, P47, DOI [10.1007/s00125-012-2718-7, DOI 10.1007/S00125-012-2718-7]; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Conen D, 2007, EUROPEAN HEART J; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Enhorning S, 2013, INT J OBESITY, V37, P598, DOI 10.1038/ijo.2012.88; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Lindholm E, 2001, EUR J EPIDEMIOL, V17, P983, DOI 10.1023/A:1020036805655; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; National Board of Health and Welfare, 2003, PHARMACOEPIDEMIOLOGY; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rich SS, 2009, HORM RES, V71, P17, DOI 10.1159/000178031; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tabassum R, 2012, DIABETES; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Talmud PJ, 2014, DIABETES; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO, 2016, GLOB REP PSOR; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zarkoob H, 2016, INT J MED TECHNOLOGY, V23; Zarkoob H, 2015, INT J MED TECHNOLOGY, V23; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180180	10.1371/journal.pone.0180180	http://dx.doi.org/10.1371/journal.pone.0180180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700623	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600021
J	Bodine, TJ; Evangelista, MA; Chang, HT; Ayoub, CA; Samuel, BS; Sucgang, R; Zechiedrich, L				Bodine, Truston J.; Evangelista, Michael A.; Chang, Huan Ting; Ayoub, Christopher A.; Samuel, Buck S.; Sucgang, Richard; Zechiedrich, Lynn			Escherichia coli DNA ligase B may mitigate damage from oxidative stress	PLOS ONE			English	Article							GENE-EXPRESSION; EXCISION-REPAIR; MUTATION; DEATH; MECHANISMS; RESPONSES; PROTEINS; CADMIUM; PATHWAY	Escherichia coli encodes two DNA ligases, ligase A, which is essential under normal laboratory growth conditions, and ligase B, which is not. Here we report potential functions of ligase B. We found that across the entire Enterobacteriaceae family, ligase B is highly conserved in both amino acid identity and synteny with genes associated with oxidative stress. Deletion of ligB sensitized E. coli to specific DNA damaging agents and antibiotics resulted in a weak mutator phenotype, and decreased biofilm formation. Overexpression of ligB caused a dramatic extension of lag phase that eventually resumed normal growth. The ligase function of ligase B was not required to mediate the extended lag phase, as overexpression of a ligase-deficient ligB mutant also blocked growth. Overexpression of ligB during logarithmic growth caused an immediate block of cell growth and DNA replication, and death of about half of cells. These data support a potential role for ligase B in the base excision repair pathway or the mismatch repair pathway.	[Bodine, Truston J.; Zechiedrich, Lynn] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bodine, Truston J.; Evangelista, Michael A.; Chang, Huan Ting; Ayoub, Christopher A.; Samuel, Buck S.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Bodine, Truston J.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Evangelista, Michael A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chang, Huan Ting] Rice Univ, Dept Biosci, Houston, TX USA; [Samuel, Buck S.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Chang, Huan Ting] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zechiedrich, L (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Samuel, Buck/I-3837-2019	Samuel, Buck/0000-0002-4347-3997; Zechiedrich, Lynn/0000-0003-0533-1637; Ayoub, Christopher/0000-0003-0694-1058	National Institutes of Health (NIH) [RO1 AI054830, R56 AI054830, R01 GM115501];  [T32GM088129];  [T32GM007330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants RO1 AI054830, R56 AI054830, R01 GM115501 (to LZ), and in part by T32GM088129 and T32GM007330 (to TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NUCLEIC ACIDS RES, V42, P13228; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Brotz-Oesterhelt H, 2003, J BIOL CHEM, V278, P39435, DOI 10.1074/jbc.M306479200; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Deibler RW, 2001, GENE DEV, V15, P748, DOI 10.1101/gad.872301; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Elbing Karen, 2002, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0101s59; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harcum SW, 2006, J IND MICROBIOL BIOT, V33, P801, DOI 10.1007/s10295-006-0122-3; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Horst JP, 1999, TRENDS MICROBIOL, V7, P29, DOI 10.1016/S0966-842X(98)01424-3; Inokuchi H, 2013, J BIOL CHEM, V288, P32952, DOI 10.1074/jbc.M113.507772; Ito A, 2008, BIOTECHNOL BIOENG, V99, P1462, DOI 10.1002/bit.21695; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOW YW, 1994, ANN NY ACAD SCI, V726, P178, DOI 10.1111/j.1749-6632.1994.tb52812.x; Krishna S, 2007, PLOS COMPUT BIOL, V3, P451, DOI 10.1371/journal.pcbi.0030041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Long HA, 2016, P NATL ACAD SCI USA, V113, pE2498, DOI 10.1073/pnas.1601208113; Lopez CR, 2005, MOL MICROBIOL, V58, P80, DOI 10.1111/j.1365-2958.2005.04812.x; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; MITRA RS, 1978, J BACTERIOL, V133, P75, DOI 10.1128/JB.133.1.75-80.1978; MITRA RS, 1975, J BACTERIOL, V121, P1180, DOI 10.1128/JB.121.3.1180-1188.1975; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; Moore SD, 2011, METHODS MOL BIOL, V765, P155, DOI 10.1007/978-1-61779-197-0_10; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Price A., 2012, 2012 IEEE Symposium on Biological Data Visualization (BioVis 2012), P57, DOI 10.1109/BioVis.2012.6378593; Quan S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002444; Riehle MM, 2003, PHYSIOL GENOMICS, V14, P47, DOI 10.1152/physiolgenomics.00034.2002; Rodriguez-Verdugo A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-50; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Rotman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; Swick MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065961; Tamayo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-69; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wei Y, 2001, J BACTERIOL, V183, P2259, DOI 10.1128/JB.183.7.2259-2264.2001; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; Worden CR, 2009, FEMS MICROBIOL LETT, V293, P58, DOI 10.1111/j.1574-6968.2009.01508.x; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948	60	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180800	10.1371/journal.pone.0180800	http://dx.doi.org/10.1371/journal.pone.0180800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700629	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649400018
J	Begum, A; Ewachiw, T; Jung, C; Huang, A; Norberg, KJ; Marchionni, L; McMillan, R; Penchev, V; Rajeshkumar, NV; Maitra, A; Wood, L; Wang, CG; Wolfgang, C; DeJesus-Acosta, A; Laheru, D; Shapiro, IM; Padval, M; Pachter, JA; Weaver, DT; Rasheed, ZA; Matsui, W				Begum, Asma; Ewachiw, Theodore; Jung, Clinton; Huang, Ally; Norberg, K. Jessica; Marchionni, Luigi; McMillan, Ross; Penchev, Vesselin; Rajeshkumar, N. V.; Maitra, Anirban; Wood, Laura; Wang, Chenguang; Wolfgang, Christopher; DeJesus-Acosta, Ana; Laheru, Daniel; Shapiro, Irina M.; Padval, Mahesh; Pachter, Jonathan A.; Weaver, David T.; Rasheed, Zeshaan A.; Matsui, William			The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							I COLLAGEN; MALIGNANT PHENOTYPE; EPITHELIAL CANCER; OVARIAN-CARCINOMA; MULTIPLE-MYELOMA; BREAST-CANCER; SELF-RENEWAL; TUMOR-GROWTH; TGF-BETA; FAK	Cancer stem cells (CSCs) play an important role in the clonogenic growth and metastasis of pancreatic ductal adenocarcinoma (PDAC). A hallmark of PDAC is the desmoplastic reaction, but the impact of the tumor microenvironment (TME) on CSCs is unknown. In order to better understand the mechanisms, we examined the impact of extracellular matrix (ECM) proteins on PDAC CSCs. We quantified the effect of ECM proteins, beta 1-integrin, and focal adhesion kinase (FAK) on clonogenic PDAC growth and migration in vitro and tumor initiation, growth, and metastasis in vivo in nude mice using shRNA and overexpression constructs as well as small molecule FAK inhibitors. Type I collagen increased PDAC tumor initiating potential, self-renewal, and the frequency of CSCs through the activation of FAK. FAK overexpression increased tumor initiation, whereas a dominant negative FAK mutant or FAK kinase inhibitors reduced clonogenic PDAC growth in vitro and in vivo. Moreover, the FAK inhibitor VS-4718 extended the anti-tumor response to gemcitabine and nab-paclitaxel in patient-derived PDAC xenografts, and the loss of FAK expression limited metastatic dissemination of orthotopic xenografts. Type I collagen enhances PDAC CSCs, and both kinase-dependent and independent activities of FAK impact PDAC tumor initiation, selfrenewal, and metastasis. The anti-tumor impact of FAK inhibitors in combination with standard chemotherapy support the clinical testing of this combination.	[Begum, Asma; Ewachiw, Theodore; Jung, Clinton; Huang, Ally; Norberg, K. Jessica; Marchionni, Luigi; McMillan, Ross; Penchev, Vesselin; Rajeshkumar, N. V.; Wang, Chenguang; DeJesus-Acosta, Ana; Laheru, Daniel; Rasheed, Zeshaan A.; Matsui, William] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wood, Laura] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wolfgang, Christopher] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Shapiro, Irina M.; Padval, Mahesh; Pachter, Jonathan A.; Weaver, David T.] Verastem Inc, Needham, MA USA; [Rasheed, Zeshaan A.] One Medimmune Way, Gaithersburg, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University	Matsui, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	matsuwi@jhmi.edu	Marchionni, Luigi/S-6774-2017; Wolfgang, Christopher/HGD-0863-2022	Marchionni, Luigi/0000-0002-7336-8071; 	Pancreatic Cancer Action Network-AACR Pathway; Tempur-Pedic Retailers [10-70-25-RASH]; V Foundation V Scholar Award; National Cancer Institute [R01 CA150142, R01 CA193887]; Lustgarten Foundation; Verastem Inc; NATIONAL CANCER INSTITUTE [K24CA198315, R01CA193887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-AACR Pathway; Tempur-Pedic Retailers; V Foundation V Scholar Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation; Verastem Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the following grants: 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant, supported by Tempur-Pedic Retailers, Grant Number 10-70-25-RASH, V Foundation 2013 V Scholar Award (ZAR), National Cancer Institute R01 CA150142, R01CA193887 (WM), and Lustgarten Foundation (WM). Verastem Inc. provided support in the form of salaries for authors (MP, JP, DW, IS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Cance WG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004021; Conti JA, 2008, CLIN CANCER RES, V14, P6405, DOI 10.1158/1078-0432.CCR-08-0816; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Gogate PN, 2014, CANCER LETT, V353, P281, DOI 10.1016/j.canlet.2014.07.032; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Gurler H, 2015, INT J MOL SCI, V16, P3419, DOI 10.3390/ijms16023419; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Infante JR, 2012, J CLIN ONCOL, V30, P1527, DOI 10.1200/JCO.2011.38.9346; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kurenova E, 2013, ONCOTARGET, V4, P1632, DOI 10.18632/oncotarget.1365; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lu J, 2014, BRIT J CANCER, V110, P409, DOI 10.1038/bjc.2013.706; Luo M, 2013, CANCER RES, V73, P5591, DOI 10.1158/0008-5472.CAN-13-1351; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Moen I, 2015, CLIN EXP METASTAS, V32, P799, DOI 10.1007/s10585-015-9752-z; MOLLENHAUER J, 1987, Pancreas, V2, P14, DOI 10.1097/00006676-198701000-00003; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Ou JJ, 2013, STEM CELL RES, V11, P820, DOI 10.1016/j.scr.2013.05.009; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Penchev VR, 2012, CLIN CANCER RES, V18, P4277, DOI 10.1158/1078-0432.CCR-11-3112; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rasheed Z, 2010, JOURNAL OF VISUALIZE; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rognoni E, 2014, NAT MED, V20, P350, DOI 10.1038/nm.3490; Sainz B, 2015, GUT, V64, P1921, DOI 10.1136/gutjnl-2014-308935; Sainz B, 2014, CANCER RES, V74, P7309, DOI 10.1158/0008-5472.CAN-14-1354; Schmitt-Graeff AH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/347270; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tanno T, 2014, BLOOD, V123, P725, DOI 10.1182/blood-2013-08-524025; Vaquero EC, 2003, GASTROENTEROLOGY, V125, P1188, DOI 10.1016/S0016-5085(03)01203-4; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Waghray M, 2013, CURR OPIN GASTROEN, V29, P537, DOI 10.1097/MOG.0b013e328363affe; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x; Zhang JL, 2014, CELL CYCLE, V13, P3143, DOI 10.4161/15384101.2014.949550; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang Y, 2014, BLOOD, V124, P2675, DOI 10.1182/blood-2014-03-563981	71	51	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180181	10.1371/journal.pone.0180181	http://dx.doi.org/10.1371/journal.pone.0180181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692661	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800028
J	Gissi, E; Menegon, S; Sarretta, A; Appiotti, F; Maragno, D; Vianello, A; Depellegrin, D; Venier, C; Barbanti, A				Gissi, Elena; Menegon, Stefano; Sarretta, Alessandro; Appiotti, Federica; Maragno, Denis; Vianello, Andrea; Depellegrin, Daniel; Venier, Chiara; Barbanti, Andrea			Addressing uncertainty in modelling cumulative impacts within maritime spatial planning in the Adriatic and Ionian region	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; HUMAN PRESSURES; SEA; BIODIVERSITY; ECOSYSTEM; CONSERVATION; VULNERABILITY; INFORMATION; ASSUMPTIONS; SCIENTISTS	Maritime spatial planning (MSP) is envisaged as a tool to apply an ecosystem-based approach to the marine and coastal realms, aiming at ensuring that the collective pressure of human activities is kept within acceptable limits. Cumulative impacts (CI) assessment can support science-based MSP, in order to understand the existing and potential impacts of human uses on the marine environment. A CI assessment includes several sources of uncertainty that can hinder the correct interpretation of its results if not explicitly incorporated in the decision-making process. This study proposes a three-level methodology to perform a general uncertainty analysis integrated with the CI assessment for MSP, applied to the Adriatic and Ionian Region (AIR). We describe the nature and level of uncertainty with the help of expert judgement and elicitation to include all of the possible sources of uncertainty related to the CI model with assumptions and gaps related to the case-based MSP process in the AIR. Next, we use the results to tailor the global uncertainty analysis to spatially describe the uncertainty distribution and variations of the CI scores dependent on the CI model factors. The results show the variability of the uncertainty in the AIR, with only limited portions robustly identified as the most or the least impacted areas under multiple model factors hypothesis. The results are discussed for the level and type of reliable information and insights they provide to decision-making. The most significant uncertainty factors are identified to facilitate the adaptive MSP process and to establish research priorities to fill knowledge gaps for subsequent planning cycles. The method aims to depict the potential CI effects, as well as the extent and spatial variation of the data and scientific uncertainty; therefore, this method constitutes a suitable tool to inform the potential establishment of the precautionary principle in MSP.	[Gissi, Elena; Appiotti, Federica; Maragno, Denis] Univ Iuav Venezia, Dept Design & Planning Complex Environm, Venice, Italy; [Menegon, Stefano; Sarretta, Alessandro; Vianello, Andrea; Depellegrin, Daniel; Venier, Chiara; Barbanti, Andrea] CNR, Inst Marine Sci, Venice, Italy; [Vianello, Andrea] EURAC Res, Inst Appl Remote Sensing, Bolzano, Italy	IUAV University Venice; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); European Academy of Bozen-Bolzano	Gissi, E (corresponding author), Univ Iuav Venezia, Dept Design & Planning Complex Environm, Venice, Italy.	egissi@iuav.it	Gissi, Elena/T-1108-2019; Menegon, Stefano/AAK-4256-2021; Venier, Chiara/ABB-1251-2020; Barbanti, Andrea/AAL-1470-2021; Sarretta, Alessandro/AAV-9739-2020; Depellegrin, Daniel/E-4788-2012	Gissi, Elena/0000-0002-1666-8772; Menegon, Stefano/0000-0003-4488-8745; Venier, Chiara/0000-0001-6880-2745; Depellegrin, Daniel/0000-0002-6493-9506; Sarretta, Alessandro/0000-0002-1475-8686; Barbanti, Andrea/0000-0002-4871-7874	ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project; co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries, [SI2.666717, MARE/2012/25]; SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project; European Commission, Executive Agency for Small and Medium-sized Enterprises [SI2.742087, EASME/EMFF/2015/1.2.1.3/01]; Flagship Project RITMARED Italian Research; Italian Ministry of Education, University and Research within the National Research Program	ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project; co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries,; SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project; European Commission, Executive Agency for Small and Medium-sized Enterprises(European CommissionEuropean Commission Joint Research Centre); Flagship Project RITMARED Italian Research; Italian Ministry of Education, University and Research within the National Research Program(Ministry of Education, Universities and Research (MIUR))	This research was supported by the ADRIPLAN (ADRiaticIonianmaritimespatial PLANning) project, co-financed by European Commission, Directorate-General for Maritime Affairs and Fisheries, SI2.666717 call MARE/2012/25,by the SUPREME (SUpporting maritime spatial Planning in the Eastern Mediterranean) project,co-Financed by European Commission, Executive Agency for Small and Medium-sized Enterprises, SI2.742087,call for proposals EASME/EMFF/2015/1.2.1.3/01,and by the the Flagship Project RITMARED Italian Research for the Sea, coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013.The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Andersen J.H., 2013, 18 DCE AARHUS U; [Anonymous], 2004, RIVM MNP GUIDANCE UN; Ansong J, 2017, OCEAN COAST MANAGE, V141, P65, DOI 10.1016/j.ocecoaman.2017.03.005; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barbanti A., 2015, DEV MARITIME SPATIAL; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Cameron A, 2011, EUSEAMAP FINAL REPOR; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chiles J.P, 2009, GEOSTATISTICS MODELI, V497; COM, 2000, COMMUNICATION; Costantino G, 2010, CHEM ECOL, V26, P91, DOI 10.1080/02757541003705484; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dankel DJ, 2012, ICES J MAR SCI, V69, P3, DOI 10.1093/icesjms/fsr179; Ehler C, 2009, IOC MANUAL GUIDES N; Falco P, 2000, J PHYS OCEANOGR, V30, P2055, DOI 10.1175/1520-0485(2000)030<2055:TPITAS>2.0.CO;2; Fraschetti S, 2011, AQUAT CONSERV, V21, P299, DOI 10.1002/aqc.1185; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Gissi E, 2016, MAR POLICY, V74, P43, DOI 10.1016/j.marpol.2016.09.016; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00181.1; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; INSPIRE Thematic Working Group Coordinate reference systems and Geographical grid systems, 2010, D2 8 1 2 INSPIRE SPE; Judd AD, 2015, ENVIRON SCI POLICY, V54, P254, DOI 10.1016/j.envsci.2015.07.008; Kelly RP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0276; Korpinen S, 2013, MAR POLLUT BULL, V74, P311, DOI 10.1016/j.marpolbul.2013.06.036; Korpinen S, 2012, ECOL INDIC, V15, P105, DOI 10.1016/j.ecolind.2011.09.023; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Levin N, 2014, MAR ECOL PROG SER, V508, P261, DOI 10.3354/meps10857; Lilburne L, 2009, INT J GEOGR INF SCI, V23, P151, DOI 10.1080/13658810802094995; Liquete C, 2016, ECOL INDIC, V63, P249, DOI 10.1016/j.ecolind.2015.11.058; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; McKinney F.K., 2007, NO ADRIATIC ECOSYSTE; Menegon S, 2016, PEERJ PREPRINTS, V4; Menegon S, CUMULATIVE IN PRESS; Peifer H., 2011, EEA REFERENCE GRID E; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; Poulain PM, 2001, J MARINE SYST, V29, P3, DOI 10.1016/S0924-7963(01)00007-0; Rudd MA, 2015, GLOBAL ENVIRON CHANG, V33, P44, DOI 10.1016/j.gloenvcha.2015.04.006; Ruggeri P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153061; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Shucksmith RJ, 2014, MAR POLICY, V50, P27, DOI 10.1016/j.marpol.2014.05.006; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Souvermezoglou E, 1999, NATO ASI 2, V51, P475; Speranza F, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009475; Spruijt P, 2014, ENVIRON SCI POLICY, V40, P16, DOI 10.1016/j.envsci.2014.03.002; Stelzenmuller V, 2015, MAR POLICY, V51, P151, DOI 10.1016/j.marpol.2014.08.001; Stock A, 2016, GLOBAL ECOL BIOGEOGR, V25, P1321, DOI 10.1111/geb.12493; Tang T, 2006, HYDROL EARTH SYST SC, V3, P3333, DOI [DOI 10.5194/hessd-3-3333-2006, 10.5194/hessd-3-3333-2006, DOI 10.5194/HESSD-3-3333-2006]; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Telesca Luca, 2015, SCI REPORTS; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; van der Sluijs J, 2005, WATER SCI TECHNOL, V52, P87, DOI 10.2166/wst.2005.0155; Walker W.E., 2003, INTEGR ASSESS, V4, P5; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	65	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180501	10.1371/journal.pone.0180501	http://dx.doi.org/10.1371/journal.pone.0180501			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692688	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800048
J	Laggner, M; Pollreisz, A; Schmidinger, G; Schmidt-Erfurth, U; Chen, YT				Laggner, Maria; Pollreisz, Andreas; Schmidinger, Gerald; Schmidt-Erfurth, Ursula; Chen, Ying-Ting			Autophagy mediates cell cycle response by regulating nucleocytoplasmic transport of PAX6 in limbal stem cells under ultraviolet-A stress	PLOS ONE			English	Article							EPITHELIAL-CELLS; DOWN-REGULATION; PROLIFERATION; DIFFERENTIATION; APOPTOSIS; GROWTH; MODEL; PREVALENCE; EXPRESSION; PTERYGIUM	Limbal stem cells (LSC) account for homeostasis and regeneration of corneal epithelium. Solar ultraviolet A (UVA) is the major source causing oxidative damage in the ocular surface. Autophagy, a lysosomal degradation mechanism, is essential for physiologic function and stress defense of stem cells. PAX6, a master transcription factor governing corneal homeostasis by regulating cell cycle and cell fate of LSC, responds to oxidative stress by nucleocytoplasmic shuttling. Impaired autophagy and deregulated PAX6 have been reported in oxidative stress-related ocular surface disorders. We hypothesize a functional role for autophagy and PAX6 in LSC's stress response to UVA. Therefore, human LSC colonies were irradiated with a sub-lethal dose of UVA and autophagic activity and intracellular reactive oxygen species (ROS) were measured by CYTO-ID assay and CM-H(2)DCFDA live staining, respectively. Following UVA irradiation, the percentage of autophagic cells significantly increased in LSC colonies while intracellular ROS levels remained unaffected. siRNA-mediated knockdown (KD) of ATG7 abolished UVA-induced autophagy and led to an excessive accumulation of ROS. Upon UVA exposure, LSCs displayed nuclear-to-cytoplasmic translocation of PAX6, while ATG7KD or antioxidant pretreatment largely attenuated the intracellular trafficking event. Immunofluorescence showing downregulation of proliferative marker PCNA and induction of cell cycle regulator p21 indicates cell cycle arrest in UVA-irradiated LSC. Abolishing autophagy, adenoviral-assisted restoration of nuclear PAX6 or antioxidant pretreatment abrogated the UVA-induced cell cycle arrest. Adenoviral expression of an ectopic PAX gene, PAX7, did not affect UVA cell cycle response. Furthermore, knocking down PAX6 attenuated the cell cycle progression of irradiated ATG7KD LSC by de-repressing p21 expression. Collectively, our data suggest a crosstalk between autophagy and PAX6 in regulating cell cycle response of ocular progenitors under UVA stress. Autophagy deficiency leads to impaired intracellular trafficking of PAX6, perturbed redox balance and uncurbed cell cycle progression in UVA-stressed LSCs. The coupling of autophagic machinery and PAX6 in cell cycle regulation represents an attractive therapeutic target for hyperproliferative ocular surface disorders associated with solar radiation.	[Laggner, Maria; Pollreisz, Andreas; Schmidinger, Gerald; Schmidt-Erfurth, Ursula; Chen, Ying-Ting] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Medical University of Vienna	Chen, YT (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	ying-ting.chen@meduniwien.ac.at	Pollreisz, Andreas/AAJ-1538-2021	Schmidt-Erfurth, Ursula/0000-0002-7788-7311; Chen, Ying-Ting/0000-0002-8606-2418	internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien [MUW 2015/2016]	internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien	This study was supported by internal research funding of Univ.-Klinik fur Augenheilkunde & Optometrie, Medizinische Universitat Wien (MUW 2015/2016). There was no additional external funding received for this study.	Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Bai HQ, 2010, HISTOCHEM CELL BIOL, V134, P527, DOI 10.1007/s00418-010-0751-5; Carmona FD, 2010, J ANAT, V217, P488, DOI 10.1111/j.1469-7580.2010.01299.x; Chan CML, 2002, CORNEA, V21, P38, DOI 10.1097/00003226-200201000-00009; Chen YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077286; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Choi W, 2016, CURR EYE RES, V41, P1143, DOI 10.3109/02713683.2015.1098707; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Garg A, 2007, J AM ACAD DERMATOL, V57, P177, DOI 10.1016/j.jaad.2007.03.037; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Huang SL, 2001, CANCER RES, V61, P3373; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kimura T, 2016, J CELL SCI, V129, P881, DOI 10.1242/jcs.163758; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Korthagen NM, 2015, BRIT J OPHTHALMOL, V99, P700, DOI 10.1136/bjophthalmol-2014-306309; Lesaffre B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-2; Li J, 2016, INVEST OPHTH VIS SCI, V57, P444, DOI 10.1167/iovs.15-17519; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li YW, 2014, DIGEST DIS SCI, V59, P598, DOI 10.1007/s10620-013-2929-x; Liu GY, 2015, ACTA PHARMACOL SIN, V36, P1473, DOI 10.1038/aps.2015.101; McNamara NA, 2014, INVEST OPHTHALMOL VI; Meng YB, 2015, MOL MED REP, V11, P379, DOI 10.3892/mmr.2014.2684; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Parisi I, 2012, INT J DEV BIOL, V56, P341, DOI 10.1387/ijdb.113406ip; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Rasband WS, 2014, IMAGEJ; Sailaja GS, 2013, INT J ONCOL, V42, P188, DOI 10.3892/ijo.2012.1678; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shubham K, 2012, MOL VIS, V18, P951; Tsubota K, 2011, CORNEA, V30, pS1, DOI 10.1097/ICO.0b013e3182284b69; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Willmann G, 2015, HIGH ALT MED BIOL, V16, P277, DOI 10.1089/ham.2015.0109; Wong TY, 2001, AM J OPHTHALMOL, V131, P176, DOI 10.1016/S0002-9394(00)00703-0; Zhang XB, 2015, HUM MUTAT, V36, P1164, DOI 10.1002/humu.22907; Zhao X, 2014, MATH PROBL ENG, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0108020; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26; Zhou WP, 2016, MOL MED REP, V14, P3, DOI 10.3892/mmr.2016.5223	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180868	10.1371/journal.pone.0180868	http://dx.doi.org/10.1371/journal.pone.0180868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700649	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800089
J	Lin, CJ; Adolphs, R; Alvarez, RM				Lin, Chujun; Adolphs, Ralph; Alvarez, R. Michael			Cultural effects on the association between election outcomes and face-based trait inferences	PLOS ONE			English	Article							ELECTORAL SUCCESS; FACIAL APPEARANCE; EMOTIONAL EXPRESSIONS; CANDIDATE APPEARANCE; SOCIAL ATTRIBUTIONS; POLITICAL ELECTIONS; COMPETENCE; IMPRESSIONS; JUDGMENTS; LOOKING	How competent a politician looks, as assessed in the laboratory, is correlated with whether the politician wins in real elections. This finding has led many to investigate whether the association between candidate appearances and election outcomes transcends cultures. However, these studies have largely focused on European countries and Caucasian candidates. To the best of our knowledge, there are only four cross-cultural studies that have directly investigated how face-based trait inferences correlate with election outcomes across Caucasian and Asian cultures. These prior studies have provided some initial evidence regarding cultural differences, but methodological problems and inconsistent findings have complicated our understanding of how culture mediates the effects of candidate appearances on election outcomes. Additionally, these four past studies have focused on positive traits, with a relative neglect of negative traits, resulting in an incomplete picture of how culture may impact a broader range of trait inferences. To study Caucasian-Asian cultural effects with a more balanced experimental design, and to explore a more complete profile of traits, here we compared how Caucasian and Korean participants' inferences of positive and negative traits correlated with U.S. and Korean election outcomes. Contrary to previous reports, we found that inferences of competence (made by participants from both cultures) correlated with both U.S. and Korean election outcomes. Inferences of open-mindedness and threat, two traits neglected in previous cross-cultural studies, were correlated with Korean but not U.S. election outcomes. This differential effect was found in trait judgments made by both Caucasian and Korean participants. Interestingly, the faster the participants made face-based trait inferences, the more strongly those inferences were correlated with real election outcomes. These findings provide new insights into cultural effects and the difficult question of causality underlying the association between facial inferences and election outcomes. We also discuss the implications for political science and cognitive psychology.	[Lin, Chujun; Adolphs, Ralph; Alvarez, R. Michael] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lin, CJ (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	clin7@caltech.edu		Lin, Chujun/0000-0002-7605-6508	Discretionary Caltech research funds; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Discretionary Caltech research funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Discretionary Caltech research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahler DJ, 2016, FACE VALUE EXPT EVID, P1; Albright L, 1997, J PERS SOC PSYCHOL, V72, P558, DOI 10.1037/0022-3514.72.3.558; Alvarez R., 1998, INFORM ELECTIONS; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Atkinson MD, 2009, Q J POLIT SCI, V4, P229, DOI 10.1561/100.00008062; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Banducci SA, 2008, POLIT PSYCHOL, V29, P903, DOI 10.1111/j.1467-9221.2008.00672.x; Bartels LM, 2002, IMPACT CANDIDATE TRA, P44; Berggren N, 2017, J PUBLIC ECON, V146, P79, DOI 10.1016/j.jpubeco.2016.12.008; Berggren N, 2010, J PUBLIC ECON, V94, P8, DOI 10.1016/j.jpubeco.2009.11.002; Buckley Fiona., 2007, POLITICS, V27, P174, DOI [DOI 10.1111/J.1467-9256.2007.00297.X, 10.1111/j.1467-9256.2007.00297.x]; Carpinella CM, 2016, SOC PERSONAL PSYCHOL, V10, P281, DOI 10.1111/spc3.12249; Castelli L, 2009, J EXP SOC PSYCHOL, V45, P1152, DOI 10.1016/j.jesp.2009.06.018; Chen FF, 2014, J EXP SOC PSYCHOL, V51, P27, DOI 10.1016/j.jesp.2013.10.008; Chen FF, 2012, J EXP SOC PSYCHOL, V48, P1350, DOI 10.1016/j.jesp.2012.07.006; Chen FF, 2016, SOCIAL PSYCHOL PERSO, V28; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; Costa P, 2015, WEST EUR POLIT, V38, P1226, DOI 10.1080/01402382.2015.1004231; Ensari N, 2003, ORGAN BEHAV HUM DEC, V92, P52, DOI 10.1016/S0749-5978(03)00066-9; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; GERSTNER CR, 1994, LEADERSHIP QUART, V5, P121, DOI 10.1016/1048-9843(94)90024-8; Glasgow G, 2000, AM POLIT QUART, V28, P26, DOI 10.1177/1532673X00028001002; Guo S., 2006, POLITICAL EC ASIAN T; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Horiuchi Y, 2012, POLIT PSYCHOL, V33, P925, DOI 10.1111/j.1467-9221.2012.00917.x; Kahneman D., 2011, THINKING FAST SLOW; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; King A, 2009, KYKLOS, V62, P579, DOI 10.1111/j.1467-6435.2009.00452.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lau Richard R., 2006, VOTERS DECIDE INFORM; Laustsen L, 2014, POLIT BEHAV, V36, P777, DOI 10.1007/s11109-013-9253-1; Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195; Lenz GS, 2011, AM J POLIT SCI, V55, P574, DOI 10.1111/j.1540-5907.2011.00511.x; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Lutz G, 2010, SWISS POLIT SCI REV, V16, P457, DOI 10.1002/j.1662-6370.2010.tb00437.x; MARTIN DS, 1978, AUST J PSYCHOL, V30, P255, DOI 10.1080/00049537808256378; Mattes K, 2014, ELECT STUD, V34, P177, DOI 10.1016/j.electstud.2013.11.004; Mattes K, 2010, POLIT PSYCHOL, V31, P41, DOI 10.1111/j.1467-9221.2009.00745.x; Miller AH, 1998, LEADER POPULARITY PA; Miller W.E., 1996, NEW AM VOTER; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Na J, 2015, PSYCHOL SCI, V8; Newman B. I., 1999, J MENTAL CHANGES, V5, P7; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Olivola CY, 2014, LEADERSHIP QUART, V25, P817, DOI 10.1016/j.leaqua.2014.06.002; Olivola CY, 2012, SOC PSYCHOL PERS SCI, V3, P605, DOI 10.1177/1948550611432770; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Poutvaara P, 2009, J EXP SOC PSYCHOL, V45, P1132, DOI 10.1016/j.jesp.2009.06.007; Rosar U, 2008, EUR J POLIT RES, V47, P64, DOI 10.1111/j.1475-6765.2007.00720.x; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P1, DOI 10.1037/a0017673; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Spezio ML, 2012, POLIT PSYCHOL, V33, P331, DOI 10.1111/j.1467-9221.2012.00897.x; Spezio ML, 2008, SOC COGN AFFECT NEUR, V3, P344, DOI 10.1093/scan/nsn040; Stockemer D, 2017, BRIT J POLIT INT REL, V8; Sussman AB, 2013, J EXP SOC PSYCHOL, V49, P771, DOI 10.1016/j.jesp.2013.02.003; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tsai JL, 2016, EMOTION, V16, P183, DOI 10.1037/emo0000133; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wong SH, 2016, EVIDENCE CHINA SOCIA; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990	64	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180837	10.1371/journal.pone.0180837	http://dx.doi.org/10.1371/journal.pone.0180837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700647	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800084
J	Link, D; Hoernig, M				Link, Daniel; Hoernig, Martin			Individual ball possession in soccer	PLOS ONE			English	Article							ELITE SOCCER; PERFORMANCE ANALYSIS; FUTURE-RESEARCH; TEAM; FOOTBALL; SUCCESS; GAME	This paper describes models for detecting individual and team ball possession in soccer based on position data. The types of ball possession are classified as Individual Ball Possession (IBC), Individual Ball Action (IBA), Individual Ball Control (IBC), Team Ball Possession (TBP), Team Ball Control (TBC) und Team Playmaking (TPM) according to different starting points and endpoints and the type of ball control involved. The machine learning approach used is able to determine how long the ball spends in the sphere of influence of a player based on the distance between the players and the ball together with their direction of motion, speed and the acceleration of the ball. The degree of ball control exhibited during this phase is classified based on the spatio-temporal configuration of the player controlling the ball, the ball itself and opposing players using a Bayesian network. The evaluation and application of this approach uses data from 60 matches in the German Bundesliga season of 2013/ 14, including 69,667 IBA intervals. The identification rate was F =.88 for IBA and F =.83 for IBP, and the classification rate for IBC was. K=.67. Match analysis showed the following mean values per match: TBP 56: 04 +/- 5: 12 min, TPM 50: 01 +/- 7: 05 min and TBC 17: 49 +/- 8: 13 min. There were 836 +/- 424 IBC intervals per match and their number was significantly reduced by -5.1% from the 1st to 2nd half. The analysis of ball possession at the player level indicates shortest accumulated IBC times for the central forwards (0: 49 +/- 0: 43 min) and the longest for goalkeepers (1: 38 +/- 0: 58 min), central defenders (1: 38 +/- 1: 09 min) and central midfielders (1: 27 +/- 1: 08 min). The results could improve performance analysis in soccer, help to detect match events automatically, and allow discernment of higher value tactical structures, which is based on individual ball possession.	[Link, Daniel] Tech Univ Munich, Dept Exercise Sci & Sport Informat, Munich, Germany; [Hoernig, Martin] Tech Univ Munich, Dept Comp Sci, Munich, Germany	Technical University of Munich; Technical University of Munich	Link, D (corresponding author), Tech Univ Munich, Dept Exercise Sci & Sport Informat, Munich, Germany.	daniel.link@tum.de		Link, Daniel/0000-0003-3606-2986	German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing (websites: www.tum.de; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Yates RA, 1999, MODERN INFORM RETRIE; Bate R, 1988, SCI FOOTBALL, P293; Beetz M., 2009, INT J COMPUTER SCI S, V8, P1; Bialkowski A, 2014, P 14 IEEE INT C DAT; Bloomfield JR., 2005, J SPORT SCI, V23, P192, DOI DOI 10.1080/02640410512331334413; Carling C, 2010, J SPORT SCI, V28, P319, DOI 10.1080/02640410903473851; Carling C, 2014, J SPORT SCI, V32, P2, DOI 10.1080/02640414.2013.807352; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Collet C, 2013, J SPORT SCI, V31, P123, DOI 10.1080/02640414.2012.727455; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Di Salvo V, 2013, INT J SPORTS MED, V34, P526, DOI 10.1055/s-0032-1327660; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Fonseca S, 2012, HUM MOVEMENT SCI, V31, P1652, DOI 10.1016/j.humov.2012.04.006; Frencken W, 2012, J SPORT SCI, V30, P1207, DOI 10.1080/02640414.2012.703783; Gama J, 2014, INT J PERF ANAL SPOR, V14, P692, DOI 10.1080/24748668.2014.11868752; Grant A., 1999, J SPORTS SCI, V17, P827, DOI [10.1080/026404199365524, DOI 10.1080/026404199365524]; Grunz A, 2012, HUM MOVEMENT SCI, V31, P334, DOI 10.1016/j.humov.2011.02.008; Gudmundsson J, 2012, P 20 INT C ADV GEOGR, P566; Harper LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110995; Harrop K, 2014, INT J PERF ANAL SPOR, V14, P907, DOI 10.1080/24748668.2014.11868767; Hughes M, 2005, J SPORT SCI, V23, P509, DOI 10.1080/02640410410001716779; JONES PD, 2004, INT J PERF ANAL SPOR, V4, P98, DOI DOI 10.1080/02640410; Kang Ch, 2006, P 6 INT C DAT MIN WO; Lago C, 2007, J SPORT SCI, V25, P969, DOI 10.1080/02640410600944626; Lago-Ballesteros J, 2010, J HUM KINET, V25, P85, DOI 10.2478/v10078-010-0035-0; Lago-Penas C, 2010, J HUMAN KINETICS, V25; Lames M., 2007, INT J PERF ANAL SPOR, V7, P62, DOI [10.1080/24748668.2007.11868388, DOI 10.1080/24748668.2007.11868388, https://doi.org/10.1080/24748668.2007.11868388]; Le Hoang M, 2017, P 11 MIT SLOAN SPORT; LINK D, 2016, PLOS ONE, V11; Mackenzie R, 2013, J SPORT SCI, V31, P639, DOI 10.1080/02640414.2012.746720; Paul DJ, 2015, INT J SPORT PHYSIOL, V10, P516, DOI 10.1123/IJSPP.2015-0029; Qing W, 2015, P 21 ACM SIGKDD INT, P2197; Rein R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3108-2; Ribeiro J.C.V., 2017, SPORTS MED AUCKLAND, P1, DOI DOI 10.1007/S40279-017-0695-1; Sarkka S., 2013, BAYESIAN FILTERING S, V3rd ed.; Siegle M, 2012, J SPORT SCI, V30, P619, DOI 10.1080/02640414.2012.667877; Spearman W., 2017, P 11 MIT SLOAN SPORT; Volossovitch A., 2012, OPEN SPORT SCI J, V5, P193, DOI [10.2174/1875399X01205010193, DOI 10.2174/1875399X01205010193]	39	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179953	10.1371/journal.pone.0179953	http://dx.doi.org/10.1371/journal.pone.0179953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692649	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800021
J	Moretti, ML; Alarcon-Reverte, R; Pearce, S; Morran, S; Hanson, BD				Moretti, Marcelo L.; Alarcon-Reverte, Rocio; Pearce, Stephen; Morran, Sarah; Hanson, Bradley D.			Transcription of putative tonoplast transporters in response to glyphosate and paraquat stress in Conyza bonariensis and Conyza canadensis and selection of reference genes for qRT-PCR	PLOS ONE			English	Article							REAL-TIME PCR; VACUOLAR SEQUESTRATION; QUANTITATIVE PCR; INTERNAL CONTROL; ABC TRANSPORTER; MIQE GUIDELINES; RT-PCR; RESISTANCE; HORSEWEED; ARABIDOPSIS	Herbicide resistance is a challenge for modern agriculture further complicated by cases of resistance to multiple herbicides. Conyza bonariensis and Conyza canadensis are invasive weeds of field crops, orchards, and non-cropped areas in many parts of the world. In California, USA, Conyza populations resistant to the herbicides glyphosate and paraquat have recently been described. Although the mechanism conferring resistance to glyphosate and paraquat in these species was not elucidated, reduced translocation of these herbicides was observed under experimental conditions in both species. Glyphosate and paraquat resistance associated with reduced translocation are hypothesized to be a result of sequestration of herbicides into the vacuole, with the possible involvement of over-expression of genes encoding tonoplast transporters of ABC-transporter families in cases of glyphosate resistance or cationic amino acid transporters (CAT) in cases of paraquat resistance. However, gene expression in response to herbicide treatment has not been studied in glyphosate and paraquat resistant populations. In the current study, we evaluated the transcript levels of genes possibly involved in resistance using real-time PCR. First, we evaluated eight candidate reference genes following herbicide treatment and selected three genes that exhibited stable expression profiles; ACTIN, HEAT-SHOCK-PROTEIN-70, and CYCLOPHILIN. The reference genes identified here can be used for further studies related to plant-herbicide interactions. We used these reference genes to assay the transcript levels of EPSPS, ABC transporters, and CAT in response to herbicide treatment in susceptible and resistant Conyza spp. lines. No transcription changes were observed in EPSPS or CAT genes after glyphosate or paraquat treatment, suggesting that these genes are not involved in the resistance mechanism. Transcription of the two ABC transporter genes increased following glyphosate treatment in all Conyza spp. lines. Transcription of ABC transporters also increased after paraquat treatment in all three lines of C. bonariensis. However, in C. canadensis, paraquat treatment increased transcription of only one ABC transporter gene in the susceptible line. The increase in transcription of ABC transporters after herbicide treatment is likely a stress response based on similar response observed across all Conyza lines regardless of resistance or sensitivity to glyphosate or paraquat, thus these genes do not appear to be directly involved in the mechanism of resistance in Conyza spp.	[Moretti, Marcelo L.; Alarcon-Reverte, Rocio; Morran, Sarah; Hanson, Bradley D.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Moretti, Marcelo L.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Pearce, Stephen] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Oregon State University; Colorado State University	Moretti, ML (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Moretti, ML (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	marcelo.moretti@oregonstate.edu	Pearce, Stephen/HHS-1613-2022	Hanson, Bradley/0000-0003-4462-5339	USDA-NIFA-AFRI [2010-85320-20415]; Almond Board of California	USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); Almond Board of California	Funding for this research was provided by USDA-NIFA-AFRI Award No. 2010-85320-20415 and by the Almond Board of California.	An J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099940; Benbrook CM, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-016-0070-0; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Faus I, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0378-0; Fujita M, 2014, PLANT CELL PHYSIOL, V55, P855, DOI 10.1093/pcp/pcu032; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Gaines TA, 2014, PLANT J, V78, P865, DOI 10.1111/tpj.12514; Ge X, 2014, PLANT PHYSIOL, V166, P1255, DOI 10.1104/pp.114.247197; Gianessi LP, 2013, PEST MANAG SCI, V69, P1099, DOI 10.1002/ps.3598; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Green JM, 2012, PEST MANAG SCI, V68, P1323, DOI 10.1002/ps.3374; HART JJ, 1992, PLANT PHYSIOL, V99, P1400, DOI 10.1104/pp.99.4.1400; HART JJ, 1994, WEED SCI, V42, P277, DOI 10.1017/S0043174500080395; Hawkes TR, 2014, PEST MANAG SCI, V70, P1316, DOI 10.1002/ps.3699; Heap I, INT SURVEY HERBICIDE; Heap I., 2014, INTEGRATED PEST MANA, DOI [10.1007/978-94-007-7796-5_12, DOI 10.1007/978-94-007-7796-5_12]; Holm L., 1997, WORLD WEEDS NATURAL; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jori B, 2007, PESTIC BIOCHEM PHYS, V88, P57, DOI 10.1016/j.pestbp.2006.08.013; Karlsson LM, 2007, WEED RES, V47, P433, DOI 10.1111/j.1365-3180.2007.00576.x; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kitts PA, 2016, NUCLEIC ACIDS RES, V44, pD73, DOI 10.1093/nar/gkv1226; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lasat MM, 1997, PHYSIOL PLANTARUM, V99, P255, DOI 10.1034/j.1399-3054.1997.990207.x; Li JY, 2013, PLANT PHYSIOL, V162, P470, DOI 10.1104/pp.113.213892; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moretti ML, 2017, WEED RES, V57, P25, DOI 10.1111/wre.12230; Moretti ML, 2016, WEED SCI, V64, P339, DOI 10.1614/WS-D-15-00174.1; Nol N, 2012, WEED RES, V52, P233, DOI 10.1111/j.1365-3180.2012.00911.x; Peng YH, 2014, PLANT PHYSIOL, V166, P1241, DOI 10.1104/pp.114.247668; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Petit Cecile, 2012, BMC Res Notes, V5, P18, DOI 10.1186/1756-0500-5-18; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Saha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106308; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoham J., 2013, Outlooks on Pest Management, V24, P64, DOI 10.1564/v24_apr_05; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Tani E, 2015, PLANT MOL BIOL REP, V33, p1 ; Tani E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040342; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Yang HY, 2014, J PLANT PHYSIOL, V171, P594, DOI 10.1016/j.jplph.2013.11.012; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu Q, 2010, PESTIC BIOCHEM PHYS, V98, P104, DOI 10.1016/j.pestbp.2010.05.007	60	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180794	10.1371/journal.pone.0180794	http://dx.doi.org/10.1371/journal.pone.0180794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700644	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800078
J	Sabol, I; Gasperov, NM; Matovina, M; Bozinovic, K; Grubisic, G; Fistonic, I; Belci, D; Alemany, L; Dzebro, S; Dominis, M; Sekerija, M; Tous, S; de Sanjose, S; Grce, M				Sabol, Ivan; Gasperov, Nina Milutin; Matovina, Mihaela; Bozinovic, Ksenija; Grubisic, Goran; Fistonic, Ivan; Belci, Dragan; Alemany, Laia; Dzebro, Sonja; Dominis, Mara; Sekerija, Mario; Tous, Sara; de Sanjose, Silvia; Grce, Magdalena			Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; POLYMERASE-CHAIN-REACTION; YOUNG-WOMEN; CANCER; RISK; CLASSIFICATION; NEOPLASIA; GENOTYPES; CYTOLOGY; COMMON	The main etiological factor of precancerous lesion and invasive cervical cancer are oncogenic human papillomaviruses types (HPVs). The objective of this study was to establish the distribution of the most common HPVs in different cervical lesions and cancer prior to the implementation of organized population-based cervical screening and HPV vaccination in Croatia. In this study, 4,432 cervical specimens, collected through a 16-year period, were tested for the presence of HPV-DNA by polymerase chain reaction (PCR) with three sets of broad-spectrum primers and type-specific primers for most common low-risk (LR) types (HPV-6, 11) and the most common high-risk (HR) types (HPV-16, 18, 31, 33, 45, 52, 58). Additional 35 archival formalin-fixed, paraffin embedded tissue of cervical cancer specimens were analyzed using LiPA25 assay. The highest age-specific HPV-prevalence was in the group 18-24 years, which decreased continuously with age (P< 0.0001) regardless of the cytological diagnosis. The prevalence of HR-HPV types significantly increased (P< 0.0001) with the severity of cervical lesions. HPV-16 was the most common type found with a prevalence (with or without another HPV-type) of 6.9% in normal cytology, 15.5% in atypical squamous cells of undetermined significance, 14.4% in low-grade squamous intraepithelial lesions, 33.3% in high-grade squamous intraepithelial lesions, and 60.9% in cervical cancer specimens (P< 0.0001). This study provides comprehensive and extensive data on the distribution of the most common HPV types among Croatian women, which will enable to predict and to monitor the impact of HPV-vaccination and to design effective screening strategies in Croatia.	[Sabol, Ivan; Gasperov, Nina Milutin; Matovina, Mihaela; Bozinovic, Ksenija; Grce, Magdalena] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Grubisic, Goran] Univ Hosp Sisters Mercy, Clin Obstet & Gynaecol, Zagreb, Croatia; [Fistonic, Ivan] Obstet Gynecol & Menopause Clin, Zagreb, Croatia; [Belci, Dragan] Gen Hosp Pula, Dept Gynecol & Obstet, Pula, Croatia; [Alemany, Laia; Tous, Sara; de Sanjose, Silvia] Catalan Inst Oncol, Unit Infect & Canc, Canc Epidemiol Res Program, Barcelona, Spain; [Alemany, Laia; de Sanjose, Silvia] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Dzebro, Sonja; Dominis, Mara] Univ Zagreb, Univ Hosp Merkur, Sch Med, Dept Pathol & Cytol, Zagreb, Croatia; [Sekerija, Mario] Croatian Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Sekerija, Mario] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Zagreb, Croatia	Rudjer Boskovic Institute; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Zagreb; University of Zagreb	Gasperov, NM (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia.	nmilutin@irb.hr	Fistonic, Ivan/V-7013-2017; Sabol, Ivan/B-7455-2012; Alemany, Laia/G-9643-2015; GRCE, MAGDALENA/ABD-2768-2020; Sekerija, Mario/W-8550-2019; Matovina, Mihaela/P-7426-2019; Tous, Sara/G-5052-2015	Fistonic, Ivan/0000-0003-3295-9390; Sabol, Ivan/0000-0002-5753-8528; Alemany, Laia/0000-0003-0945-6015; Sekerija, Mario/0000-0001-7508-1501; Matovina, Mihaela/0000-0001-7647-3339; Grce, Magdalena/0000-0001-6178-8418; Tous, Sara/0000-0002-5423-7092	Croatian Ministry of Science, Education and Sports [098-09824642 510]; international project Retrospective International Survey; HPV Time Trends Study Group"	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); international project Retrospective International Survey; HPV Time Trends Study Group"	This research has been partially supported by the Croatian Ministry of Science, Education and Sports (grantno.098-09824642 510,URL:zprojekti.mzos.hr), and partially by the international project Retrospective International Survey and HPV Time Trends Study Group" (URL: ico.gencat.cat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agodi A, 2009, INT J GYNECOL CANCER, V19, P1094, DOI 10.1111/IGC.0b013e3181a83c9d; [Anonymous], 2007, MON EV CARC RISKS HU; Arbyn M, 2009, CANCER EPIDEM BIOMAR, V18, P321, DOI 10.1158/1055-9965.EPI-08-0510; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Blanks RG, 2009, BRIT J CANCER, V100, P1832, DOI 10.1038/sj.bjc.6605069; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; CHAN SY, 1995, J VIROL, V69, P3074, DOI 10.1128/JVI.69.5.3074-3083.1995; Clifford GM, 2009, LANCET, V374, P1948, DOI 10.1016/S0140-6736(09)61789-X; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; Croatian National Cancer Registry, 2016, CANC INC MORT CROAT; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; De Vuyst H, 2009, EUR J CANCER, V45, P2632, DOI 10.1016/j.ejca.2009.07.019; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Grce M, 1997, EUR J EPIDEMIOL, V13, P645, DOI 10.1023/A:1007323405069; Grce M, 2001, ANTICANCER RES, V21, P579; Grce M, 2009, EXPERT REV MOL DIAGN, V9, P851, DOI [10.1586/erm.09.64, 10.1586/ERM.09.64]; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hadzisejdic I, 2006, COLLEGIUM ANTROPOL, V30, P879; Howell-Jones R, 2012, VACCINE, V30, P3867, DOI 10.1016/j.vaccine.2012.04.006; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kovacs K, 2008, J MED VIROL, V80, P1814, DOI 10.1002/jmv.21282; Ljubjoevic N., 2001, GYNAECOL PERINATOL, V10, P85; Maver PJ, 2013, ACTA DERMATOVEN ALP, V21, P7, DOI 10.2478/v10162-012-0025-0; Milutin-Gagperov N, 2007, COLLEGIUM ANTROPOL, V31, P89; Moore RA, 2009, CANCER CAUSE CONTROL, V20, P1387, DOI 10.1007/s10552-009-9365-4; Nicula FA, 2009, EUR J CANCER, V45, P2679, DOI 10.1016/j.ejca.2009.07.025; OVANINRAKIC A, 2003, GYNAECOL PERINATOL, V12, P148; Poljak M, 2013, VACCINE, V31, pH59, DOI 10.1016/j.vaccine.2013.03.029; Ronco G, 2005, EUR J CANCER, V41, P297, DOI 10.1016/j.ejca.2004.07.005; Sabol I, 2008, J CLIN MICROBIOL, V46, P1606, DOI 10.1128/JCM.02328-07; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Seme K, 2013, ACTA DERMATOVEN ALP, V21, P21, DOI 10.2478/v10162-012-0026-z; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; SPAVENTI R, 1994, EUR J CANCER, V30A, P419, DOI 10.1016/0959-8049(94)90277-1; Tachezy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079156; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180480	10.1371/journal.pone.0180480	http://dx.doi.org/10.1371/journal.pone.0180480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692681	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000405544800047
J	Leong, SH; Ong, SH				Leong, Siow Hoo; Ong, Seng Huat			Similarity measure and domain adaptation in multiple mixture model clustering: An application to image processing	PLOS ONE			English	Article							LARGE DATA SETS; SIMULATING DATA; SEGMENTATION; CLASSIFICATION; PERFORMANCE; REDUCTION; ALGORITHM; DATASETS	This paper considers three crucial issues in processing scaled down image, the representation of partial image, similarity measure and domain adaptation. Two Gaussian mixture model based algorithms are proposed to effectively preserve image details and avoids image degradation. Multiple partial images are clustered separately through Gaussian mixture model clustering with a scan and select procedure to enhance the inclusion of small image details. The local image features, represented by maximum likelihood estimates of the mixture components, are classified by using the modified Bayes factor (MBF) as a similarity measure. The detection of novel local features from MBF will suggest domain adaptation, which is changing the number of components of the Gaussian mixture model. The performance of the proposed algorithms are evaluated with simulated data and real images and it is shown to perform much better than existing Gaussian mixture model based algorithms in reproducing images with higher structural similarity index.	[Leong, Siow Hoo] Univ Teknol MARA, Fac Comp & Math Sci, Kota Samarahan, Sarawak, Malaysia; [Ong, Seng Huat] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; Universiti Malaya	Leong, SH (corresponding author), Univ Teknol MARA, Fac Comp & Math Sci, Kota Samarahan, Sarawak, Malaysia.; Ong, SH (corresponding author), Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia.	ongsh@um.edu.my; leongsh@sarawak.uitm.edu.my	Leong, Siow Hoo/AAW-8938-2020; ONG, Seng Huat/B-9454-2010	ONG, Seng Huat/0000-0002-4288-7637; Leong, Siow Hoo/0000-0002-0325-0115	Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [FP045-2015A]	Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia	Funded by Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia [FP045-2015A] OSH.	Asuncion A, 2007, UCI MACHINE LEARNING; Banda JM, 2013, SOL PHYS, V288, P435, DOI 10.1007/s11207-013-0304-x; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; BROWNING JD, 1982, PATTERN RECOGN, V15, P1, DOI 10.1016/0031-3203(82)90055-3; Chang PC, 2012, APPL SOFT COMPUT, V12, P3165, DOI 10.1016/j.asoc.2012.06.004; Constantinopoulos C, 2007, LECT NOTES COMPUT SC, V4673, P596; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dong FF, 2014, J VIS COMMUN IMAGE R, V25, P827, DOI 10.1016/j.jvcir.2014.01.014; Duan Lixin, 2012, IEEE Trans Neural Netw Learn Syst, V23, P504, DOI 10.1109/TNNLS.2011.2178556; Fayyad U, 1996, P WORKSH MASS DAT SE, P129; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2005, J COMPUTATIONAL GRAP, V14, P1; Fraley C, 2012, 597 U WASH; Gan L, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P403; Gong BQ, 2014, INT J COMPUT VISION, V109, P3, DOI 10.1007/s11263-014-0718-4; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jeffreys H., 1935, P CAMBR PHIL SOC, P201; Ji ZX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168449; Jiang XP, 2017, NEUROCOMPUTING, V220, P191, DOI 10.1016/j.neucom.2016.04.062; Jin HD, 2005, IEEE T PATTERN ANAL, V27, P1710, DOI 10.1109/TPAMI.2005.226; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kosmidis I, 2010, SUPERVISED SAMPLING; Maitra R, 2010, J COMPUT GRAPH STAT, V19, P354, DOI 10.1198/jcgs.2009.08054; Mandal B, 2012, COMM COM INF SC, V311, P482; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Masmoudi A, 2015, SIGNAL IMAGE VIDEO P, V9, P1021, DOI 10.1007/s11760-013-0531-5; Melnykov V, 2012, J STAT SOFTW, V51, P1; Meng T, 2011, INT J MULTIMED DATA, V2, P54, DOI 10.4018/jmdem.2011040104; Naim I, 2014, CYTOM PART A, V85, P408, DOI 10.1002/cyto.a.22446; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Pinto RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139931; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scrucca L, 2016, R J, V8, P289; Shoyaib M, 2012, INT J APPROX REASON, V53, P636, DOI 10.1016/j.ijar.2012.01.003; Singh S, 2007, DIGIT SIGNAL PROCESS, V17, P225, DOI 10.1016/j.dsp.2005.08.003; SMITH AFM, 1980, J ROY STAT SOC B MET, V42, P213; Solomon C, 2011, FUNDAMENTALS DIGITAL, V1st, DOI 10.1002/9780470689776; Sonka M., 2014, J ELECTRON IMAGING, Vxix; Steiner PM, 2007, COMPUT STAT DATA AN, V51, P5416, DOI 10.1016/j.csda.2006.09.014; Tan KS, 2013, APPL SOFT COMPUT, V13, P2017, DOI 10.1016/j.asoc.2012.11.038; Tang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165664; Triantafyllidis GA, 2002, IEEE T CIRC SYST VID, V12, P877, DOI 10.1109/TCSVT.2002.804880; Tuia D, 2011, REMOTE SENS ENVIRON, V115, P2232, DOI 10.1016/j.rse.2011.04.022; van den Oord A, 2014, J MACH LEARN RES, V15, P2061; Vatsavai R. R., 2011, PROC 2 INT C COMPUTI, P1, DOI [10.1145/1999320.1999331, DOI 10.1145/1999320.1999331]; Vatsavi RR, 2009, LECT NOTES COMPUT SC, V5545, P375, DOI 10.1007/978-3-642-01973-9_42; Wang LA, 2011, PATTERN RECOGN, V44, P222, DOI 10.1016/j.patcog.2010.08.005; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091315; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, SSIM INDEX IMAGE QUA; Wehrens R, 2004, J CLASSIF, V21, P231, DOI 10.1007/s00357-004-0018-8; Wolfe JH, 1971, TECHNICAL B STB; Yang J, P ACM INT C; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	57	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180307	10.1371/journal.pone.0180307	http://dx.doi.org/10.1371/journal.pone.0180307			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686634	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100049
J	Fukuhara, K; Ida, H; Ogata, T; Ishii, M; Higuchi, T				Fukuhara, Kazunobu; Ida, Hirofumi; Ogata, Takahiro; Ishii, Motonobu; Higuchi, Takahiro			The role of proximal body information on anticipatory judgment in tennis using graphical information richness	PLOS ONE			English	Article							BIOLOGICAL MOTION; PERCEPTION; SKILL; PERFORMANCE; EXPERTISE; PATTERNS; CUES	Objective Recent studies have reported that skilled tennis players are likely to use proximal body information for anticipating the direction of their opponent's forehand shot. However, in these studies, the visual stimuli did not include visual information about the ball. Skilled players may have used proximal information owing to the lack of distal information. To address this issue, we developed a novel methodological approach using computer graphics (CG) images in which the entire body was presented by a combination of point-light display (i.e., poor graphical information, PLD) and polygons (i.e., rich graphical information). Using our novel methodological approach, we examined whether skilled tennis players use proximal body information when anticipating shot directions. Methods and results Fifteen skilled tennis players and fifteen novice players tried to anticipate shot directions by observing four CG forehand strokes (ALPOL: all body parts were represented with polygon; RAPLD: racket and arm were represented with PLD; BOPLD: body parts without racket and arm were represented with PLD; and ALPLD: all body parts were represented with PLD). Our intention in creating CG models with such combinations (i.e., RAPLD and BOPLD) was that because of the richer graphical information provided by polygons compared to PLD, the participant's anticipatory judgment would be influenced more by body parts expressed with polygons. The results showed that for skilled players, anticipatory judgment was more accurate when they observed RAPLD than when they observed BOPLD and ALPLD. In contrast, for novice players, there were no differences in the accuracy of anticipatory judgments with the four CG models. Conclusions Only skilled players made more accurate anticipatory judgments when body regions were expressed with rich graphical information, and the racket and arm were expressed with poor graphical information. These suggest that skilled players used proximal information to effectively anticipate shot directions.	[Fukuhara, Kazunobu; Higuchi, Takahiro] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Grad Sch Human Hlth Sci, Hachioji, Tokyo, Japan; [Ida, Hirofumi] Jobu Univ, Dept Sports & Hlth Management, Toyazuka Machi, Isesaki, Gunma, Japan; [Ogata, Takahiro] Teikyo Univ, Dept Sport & Med Sci, Hachioji, Tokyo, Japan; [Ishii, Motonobu] Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, Tokyo, Japan	Tokyo Metropolitan University; Teikyo University; Tokyo Institute of Technology	Fukuhara, K (corresponding author), Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Grad Sch Human Hlth Sci, Hachioji, Tokyo, Japan.	fukuhara-k@tmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25750294]; Yamaha Motor Foundation for Sports; Casio Science Promotion Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamaha Motor Foundation for Sports; Casio Science Promotion Foundation	This work was supported by the Japan Society for the Promotion of Science (JSPS, 25750294), Yamaha Motor Foundation for Sports (http://www.ymfs.jp/), and Casio Science Promotion Foundation (http://casiozaidan.org/). KF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, J SPORT EXERCISE PSY, V9, P326, DOI 10.1123/jsp.9.4.326; Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bruland R, 2011, HUM MOVEMENT SCI, V30, P495, DOI [10.1016/j.humov, DOI 10.1016/J.HUMOV]; Bruland R, 2009, J MOTOR BEHAV, V41, P158; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Farrow D, 2003, PERCEPTION, V32, P1127, DOI 10.1068/p3323; Fukuhara K., 2009, INT J SPORT HLTH SCI, V7, P12, DOI DOI 10.5432/IJSHS.IJSHS20090015; Hodgins JK, 1998, IEEE T VIS COMPUT GR, V4, P307, DOI 10.1109/2945.765325; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; Ida H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033879; Ida H, 2011, BEHAV RES METHODS, V43, P781, DOI 10.3758/s13428-011-0084-x; Jackson RC, 2007, J MOTOR BEHAV, V39, P341, DOI 10.3200/JMBR.39.5.341-352; Johansson G, 1973, PERCEPT PSYCHOPHYS, V2, P201; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Loffing F, 2011, PERCEPTION, V40, P1447, DOI 10.1068/p7035; Muller S, 2012, RES Q EXERCISE SPORT, V83, P175; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Ward P, 2002, RES Q EXERCISE SPORT, V73, P107, DOI 10.1080/02701367.2002.10608997; Williams AM, 2009, HUM MOVEMENT SCI, V28, P362, DOI 10.1016/j.humov.2008.10.006; Williams AM, 2002, J EXP PSYCHOL-APPL, V8, P259, DOI 10.1037/1076-898X.8.4.259	23	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180985	10.1371/journal.pone.0180985	http://dx.doi.org/10.1371/journal.pone.0180985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704485	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700069
J	Puolakkainen, T; Rummukainen, P; Lehto, J; Ritvos, O; Hiltunen, A; Saamanen, AM; Kiviranta, R				Puolakkainen, Tero; Rummukainen, Petri; Lehto, Jemina; Ritvos, Olli; Hiltunen, Ari; Saamanen, Anna-Marja; Kiviranta, Riku			Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFLAMMATORY RESPONSE; GROWTH-FACTORS; BONE; BISPHOSPHONATES; MYOSTATIN; PROTEIN; REGENERATION; OSTEOPOROSIS; FOLLISTATIN	Fractures still present a significant burden to patients due to pain and periods of unproductivity. Numerous growth factors have been identified to regulate bone remodeling. However, to date, only the bone morphogenetic proteins (BMPs) are used to enhance fracture healing in clinical settings. Activins are pleiotropic growth factors belonging to the TGF-beta superfamily. We and others have recently shown that treatment with recombinant fusion proteins of activin receptors greatly increases bone mass in different animal models by trapping activins and other ligands thus inhibiting their signaling pathways. However, their effects on fracture healing are less known. Twelve-week old male C57Bl mice were subjected to a standardized, closed tibial fracture model. Animals were divided into control and treatment groups and were administered either PBS control or a soluble activin type IIB receptor (ActRIIB-Fc) intraperitoneally once a week for a duration of two or four weeks. There were no significant differences between the groups at two weeks but we observed a significant increase in callus mineralization in ActRIIB-Fc-treated animals by microcomputed tomography imaging at four weeks. Bone volume per tissue volume was 60%, trabecular number 55% and bone mineral density 60% higher in the 4-week calluses of the ActRIIB-Fc-treated mice (p< 0.05 in all). Biomechanical strength of 4-week calluses was also significantly improved by ActRIIBFc treatment as stiffness increased by 64% and maximum force by 45% (p< 0.05) compared to the PBS-injected controls. These results demonstrate that ActRIIB-Fc treatment significantly improves healing of closed long bone fractures. Our findings support the previous reports of activin receptors increasing bone mass but also demonstrate a novel approach for using ActRIIB-Fc to enhance fracture healing.	[Puolakkainen, Tero; Rummukainen, Petri; Lehto, Jemina; Saamanen, Anna-Marja; Kiviranta, Riku] Univ Turku, Inst Biomed, Turku, Finland; [Ritvos, Olli] Univ Helsinki, Dept Physiol, Helsinki, Finland; [Hiltunen, Ari] Terveystalo Pulssi, Turku, Finland; [Kiviranta, Riku] Turku Univ Hosp, Div Endocrinol, Turku, Finland	University of Turku; University of Helsinki; University of Turku	Kiviranta, R (corresponding author), Univ Turku, Inst Biomed, Turku, Finland.; Kiviranta, R (corresponding author), Turku Univ Hosp, Div Endocrinol, Turku, Finland.	Riku.kiviranta@utu.fi	Ritvos, Olli/GWC-2442-2022	Lehto, Jemina/0000-0002-2827-5749; Saamanen, Anna-Marja/0000-0003-3963-6324; Ritvos, Olli/0000-0001-7017-6931	Academy of Finland [132962, 139165, 298535]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation; Terveystalo Pulssi	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Terveystalo Pulssi	The work was supported by the following: RK: Academy of Finland-Grants 132962, 139165, 298535, http://webfocus.aka.fi/ibi_apps/WFServlet?IBIF_ex=x_HakKuvaus & Sigrid Juselius Foundation; Emil Aaltonen Foundation; and Finnish Cultural Foundation. Regarding the employer of Dr. Ari Hiltunen, the funder, Terveystalo Pulssi, provided support in the form of salaries for author AH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the "author contributions" section.	Bialek P, 2014, BONE, V60, P162, DOI 10.1016/j.bone.2013.12.002; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Bray N, 2015, NAT REV DRUG DISCOV, V14, P677, DOI 10.1038/nrd4745; Canalis E, 2010, J CLIN ENDOCR METAB, V95, P1496, DOI 10.1210/jc.2009-2677; Chen YG, 2006, EXP BIOL MED, V231, P534; Crawford Charles H 3rd, 2009, Am J Orthop (Belle Mead NJ), V38, P567; DiGirolamo DJ, 2015, BONE RES, V3, DOI 10.1038/boneres.2014.42; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fisher DM, 2013, CURR STEM CELL RES T, V8, P260; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Goldhahn J, 2012, CALCIFIED TISSUE INT, V90, P343, DOI 10.1007/s00223-012-9587-4; Hardy CL, 2015, CLIN EXP ALLERGY, V45, P1510, DOI 10.1111/cea.12561; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Khojasteh A, 2013, OR SURG OR MED OR PA, V116, pE405, DOI 10.1016/j.oooo.2012.01.044; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Kuklo TR, 2008, J BONE JOINT SURG BR, V90B, P1068, DOI 10.1302/0301-620X.90B8.20349; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Li YT, 2015, OSTEOPOROSIS INT, V26, P431, DOI 10.1007/s00198-014-2903-2; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Lowery JW, 2015, J CELL SCI, V128, P1308, DOI 10.1242/jcs.156737; Marino FE, 2014, MOL HUM REPROD, V20, P1223, DOI 10.1093/molehr/gau074; Morse A, 2015, J ORTHOPAEDIC RES OF; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nagamine T, 1998, J ORTHOPAED RES, V16, P314, DOI 10.1002/jor.1100160307; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Sattui SE, 2014, NAT REV ENDOCRINOL, V10, P592, DOI 10.1038/nrendo.2014.125; Shintaku Y, 2011, CELLS TISSUES ORGANS, V194, P38, DOI 10.1159/000322557; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tanko LB, 2016, CALCIFIED TISSUE INT, V99, P310, DOI 10.1007/s00223-016-0148-0; Williamson RD, 2015, CYTOKINE, V71, P360, DOI 10.1016/j.cyto.2014.11.017	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180593	10.1371/journal.pone.0180593	http://dx.doi.org/10.1371/journal.pone.0180593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704409	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700043
J	Simino, J; Wang, ZY; Bressler, J; Chouraki, V; Yang, Q; Younkin, SG; Seshadri, S; Fornage, M; Boerwinkle, E; Mosley, TH				Simino, Jeannette; Wang, Zhiying; Bressler, Jan; Chouraki, Vincent; Yang, Qiong; Younkin, Steven G.; Seshadri, Sudha; Fornage, Myriam; Boerwinkle, Eric; Mosley, Thomas H., Jr.			Whole exome sequence-based association analyses of plasma amyloid-beta in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-AGE INTERACTIONS; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DECLINE; PRECURSOR PROTEIN; BLOOD-PRESSURE; ABNORMAL-BEHAVIOR; THP-1 MACROPHAGES; CONTACT SYSTEM	Objective We performed single-variant and gene-based association analyses of plasma amyloid-beta (a beta) concentrations using whole exome sequence from 1,414 African and European Americans. Our goal was to identify genes that influence plasma a beta(42) concentrations and a beta(42): a beta(40) ratios in late middle age (mean = 59 years), old age (mean = 77 years), or change over time (mean = 18 years). Methods Plasma a beta measures were linearly regressed onto age, gender, APOE epsilon 4 carrier status, and time elapsed between visits (fold-changes only) separately by race. Following inverse normal transformation of the residuals, seqMeta was used to conduct race-specific single-variant and gene-based association tests while adjusting for population structure. Linear regression models were fit on autosomal variants with minor allele frequencies (MAF)>= 1%. T5 burden and Sequence Kernel Association (SKAT) gene-based tests assessed functional variants with MAF <= 5%. Cross-race fixed effects meta-analyses were Bonferroni-corrected for the number of variants or genes tested. Results Seven genes were associated with a beta in late middle age or change over time; no associations were identified in old age. Single variants in KLKB1 (rs3733402; p = 4.33x10(-10)) and F12 (rs1801020; p = 3.89x10(-8)) were significantly associated with midlife a beta(42) levels through cross-race meta-analysis; the KLKB1 variant replicated internally using 1,014 additional participants with exome chip. ITPRIP, PLIN2, and TSPAN18 were associated with the midlife a beta(42): a beta(40) ratio via the T5 test; TSPAN18 was significant via the cross-race meta-analysis, whereas ITPRIP and PLIN2 were European American-specific. NCOA1 and NT5C3B were associated with the midlife a beta(42): a beta(40) ratio and the fold-change in a beta(42), respectively, via SKAT in African Americans. No associations replicated externally (N = 725). Conclusion We discovered age-dependent genetic effects, established associations between vascularrelated genes (KLKB1, F12, PLIN2) and midlife plasma a beta levels, and identified a plausible Alzheimer's Disease candidate gene (ITPRIP) influencing cell death. Plasma a beta concentrations may have dynamic biological determinants across the lifespan; plasma a beta study designs or analyses must consider age.	[Simino, Jeannette; Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Gertrude C Ford MIND Ctr, Jackson, MS 39216 USA; [Simino, Jeannette] Univ Mississippi, Med Ctr, Dept Data Sci, John D Bower Sch Populat Hlth, Jackson, MS 39216 USA; [Wang, Zhiying; Bressler, Jan; Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Chouraki, Vincent] Lille Univ, Inst Pasteur Lille, CHU Lille, Inserm,U1167,RID AGE Risk Factors & Mol Determina, Lille, France; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Yang, Qiong; Seshadri, Sudha] NHLBI, Framingham Heart Study, Framingham, MA USA; [Younkin, Steven G.] Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Res Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MA USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; Boston University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Mississippi; University of Mississippi Medical Center	Simino, J (corresponding author), Univ Mississippi, Med Ctr, Gertrude C Ford MIND Ctr, Jackson, MS 39216 USA.; Simino, J (corresponding author), Univ Mississippi, Med Ctr, Dept Data Sci, John D Bower Sch Populat Hlth, Jackson, MS 39216 USA.	jsimino@umc.edu		Chouraki, Vincent/0000-0002-4698-1794; Seshadri, Sudha/0000-0001-6135-2622	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01 HL70825]; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Deafness and Other Communication Disorders [U01 HL096812, HL096814, HL096899, HL096902, HL096917]; Framingham Heart Study (NHLBI/NIH) [HHSN268201500001I]; National Institute on Aging [R01 AG008122, R01 AG054076, R01 AG049607, R01 AG033193, U01 AG049505, U01 AG052409]; National Institute of Neurological Disorders and Stroke [NS017950, UH2 NS100605]; National Institutes of Health through American Recovery and Reinvestment Act (ARRA) [5RC2HL102419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096899, U01HL096812, U01HL096814, U01HL096917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Framingham Heart Study (NHLBI/NIH); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health through American Recovery and Reinvestment Act (ARRA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). ARIC Neurocognitive data was collected through the joint support of the National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; National Institute on Aging; and the National Institute on Deafness and Other Communication Disorders (U01 HL096812, HL096814, HL096899, HL096902, HL096917), with previous brain MRI examinations funded by R01 HL70825 from the National Heart, Lung, and Blood Institute. This work was supported by the Framingham Heart Study (NHLBI/NIH contract HHSN268201500001I to the Boston University School of Medicine) and by grants from the National Institute on Aging (R01 AG008122, R01 AG054076, R01 AG049607, R01 AG033193, U01 AG049505, U01 AG052409) and the National Institute of Neurological Disorders and Stroke (NS017950 and UH2 NS100605). Funding support for Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium was provided by the National Institutes of Health through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Sequencing for both studies was carried out at the Baylor College of Medicine Human Genome Sequencing Center (U54 HG003273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Ashby EL, 2012, NEUROBIOL AGING, V33, P1345, DOI 10.1016/j.neurobiolaging.2010.09.024; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002093-199806000-00008; Bergamaschini L, 2001, NEUROBIOL AGING, V22, P63, DOI 10.1016/S0197-4580(00)00174-3; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Biswas N, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0283-5; Calero M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00138; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chen FL, 2010, MOL CELL BIOCHEM, V337, P193, DOI 10.1007/s11010-009-0299-7; Cho SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20185; Chou CT, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0222-x; Chouraki V, 2014, MOL PSYCHIATR, V19, P1326, DOI 10.1038/mp.2013.185; Chouraki V, 2015, ALZHEIMERS DEMENT, V11, P249, DOI 10.1016/j.jalz.2014.07.001; Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001; De Meyer GRY, 2002, CIRC RES, V90, P1197, DOI 10.1161/01.RES.0000020017.84398.61; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Glahn DC, 2014, AM J MED GENET B, V165, P122, DOI 10.1002/ajmg.b.32221; Gomez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Gronewold J, 2016, MOL NEUROBIOL, V53, P3136, DOI 10.1007/s12035-015-9218-y; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Guella I, 2011, THROMB HAEMOSTASIS, V106, P655, DOI 10.1160/TH11-04-0247; Gupta A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00115; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Huang HM, 1998, LIFE SCI, V63, P195, DOI 10.1016/S0024-3205(98)00260-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jakobsdottir J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006327; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Jawaid A, 2015, J AM GERIATR SOC, V63, P419, DOI 10.1111/jgs.13262; Jensen LE, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00036; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Kanaji T, 1998, BLOOD, V91, P2010, DOI 10.1182/blood.V91.6.2010.2010_2010_2014; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Katsuda I, 2007, EUR J HAEMATOL, V79, P59, DOI 10.1111/j.1600-0609.2007.00871.x; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Knopman David S, 2016, Alzheimers Dement (Amst), V2, P1; Koyama A, 2012, ARCH NEUROL-CHICAGO, V69, P824, DOI 10.1001/archneurol.2011.1841; Kunkle BW, 2015, ALZHEIMERS DEMENTIA; Kyratzi E, 2014, NEUROBIOL AGING, V35, P2053, DOI 10.1016/j.neurobiolaging.2014.03.019; Lachno DR, 2012, J ALZHEIMERS DIS, V32, P905, DOI 10.3233/JAD-2012-121075; Lai AY, 2012, FUTUR NEUROL, V7, P165, DOI 10.2217/FNL.12.6; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018536; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lord J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00369; Lu XF, 2007, HUM GENET, V121, P327, DOI 10.1007/s00439-007-0340-4; Magne J, 2013, FASEB J OFFICIAL PUB, P27; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; Musani SK, 2015, CIRC-CARDIOVASC GENE, V8, P122, DOI 10.1161/CIRCGENETICS.114.000900; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Najt CP, 2014, BIOCHEMISTRY-US, V53, P7051, DOI 10.1021/bi500918m; Nitsch RM, 1998, NEUROCHEM RES, V23, P807, DOI 10.1023/A:1022423813362; Oien DB, 2008, FREE RADICAL BIO MED, V45, P193, DOI 10.1016/j.freeradbiomed.2008.04.003; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Poljak A, 2017, EXPERT REV NEUROTHER, V17, P3, DOI 10.1080/14737175.2016.1217156; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramirez A, 2014, HUM MOL GENET, V23, P6644, DOI 10.1093/hmg/ddu372; Reitz C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.005; Rembach A, 2014, ALZHEIMERS DEMENT, V10, P53, DOI 10.1016/j.jalz.2012.12.006; Santamaria A, 2004, STROKE, V35, P1795, DOI 10.1161/01.STR.0000133127.68041.a3; Scholz CJ, 2010, AM J MED GENET B, V153B, P967, DOI 10.1002/ajmg.b.31057; Schupf N, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.020; Seipold L, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2016.00149, 10.3389/fnmol.2015.00013]; Shen C, 2015, J MOL NEUROSCI, V56, P89, DOI 10.1007/s12031-014-0470-9; Shi G, 2009, HYPERTENSION, V53, P35, DOI 10.1161/HYPERTENSIONAHA.108.120071; Shibayama Y, 1999, CLIN IMMUNOL, V90, P89, DOI 10.1006/clim.1998.4621; Shie FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134531; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Siegerink B, 2014, J THROMB HAEMOST, V12, P606, DOI 10.1111/jth.12531; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Simino J, 2014, ATHEROSCLEROSIS, V235, P84, DOI 10.1016/j.atherosclerosis.2014.04.008; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Swaminathan Shanker, 2014, Alzheimers Dement, V10, pe9, DOI 10.1016/j.jalz.2013.01.007; The ARIC Investigators, 1989, AM J EPIDEMIOL, V129, P687; Toledo JB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt162; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Tzen KY, 2014, ACS CHEM NEUROSCI, V5, P830, DOI 10.1021/cn500101j; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Verweij N, 2013, HYPERTENSION, V61, P602, DOI 10.1161/HYPERTENSIONAHA.111.203117; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QB, 2002, CHINESE MED J-PEKING, V115, P884; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995; YASUHARA O, 1994, BRAIN RES, V654, P234, DOI 10.1016/0006-8993(94)90484-7; Yuan JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058785; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zamolodchikov D, 2015, P NATL ACAD SCI USA, V112, P4068, DOI 10.1073/pnas.1423764112; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762; Zinser EG, 2007, BBA-BIOMEMBRANES, V1768, P1991, DOI 10.1016/j.bbamem.2007.02.014; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	104	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180046	10.1371/journal.pone.0180046	http://dx.doi.org/10.1371/journal.pone.0180046			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704393	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700023
J	Mukaida, H; Hayashida, M; Matsushita, S; Yamamoto, M; Nakamura, A; Amano, A				Mukaida, Hiroshi; Hayashida, Masakazu; Matsushita, Satoshi; Yamamoto, Makiko; Nakamura, Atsushi; Amano, Atsushi			Brain natriuretic peptide (BNP) may play a major role in risk stratification based on cerebral oxygen saturation by near-infrared spectroscopy in patients undergoing major cardiovascular surgery	PLOS ONE			English	Article							PUMP CARDIAC-SURGERY; HEMOGLOBIN CONCENTRATION; MITRAL REGURGITATION; COGNITIVE FUNCTION; HEART-FAILURE; DESATURATION; DYSFUNCTION; SEVOFLURANE; ANESTHESIA; EUROSCORE	Purpose A previous study reported that low baseline cerebral oxygen saturation (ScO2) (<= 50%) measured with near-infrared spectroscopy was predictive of poor clinical outcomes after cardiac surgery. However, such findings have not been reconfirmed by others. We conducted the current study to evaluate whether the previous findings would be reproducible, and to explore mechanisms underlying the ScO2-based outcome prediction. Methods We retrospectively investigated 573 consecutive patients, aged 20 to 91 (mean +/- standard deviation, 67.1 +/- 12.8) years, who underwent major cardiovascular surgery. Preanesthetic baseline ScO2, lowest intraoperative ScO2, various clinical variables, and hospital mortality were examined. Results Bivariate regression analyses revealed that baseline ScO2 correlated significantly with plasma brain natriuretic peptide concentration (BNP), hemoglobin concentration (Hgb), estimated glomerular filtration rate (eGFR), and left ventricular ejection fraction (LVEF) (p < 0.0001 for each). Baseline ScO2 correlated with BNP in an exponential manner, and BNP was the most significant factor influencing ScO2. Logistic regression analyses revealed that baseline and lowest intraoperative ScO2 values, but not relative ScO2 decrements, were significantly associated with hospital mortality (p < 0.05), independent of the EuroSCORE (p < 0.01). Receiver operating curve analysis of ScO2 values and hospital mortality revealed an area under the curve (AUC) of 0.715 (p < 0.01) and a cutoff value of <= 50.5% for the baseline and ScO2, and an AUC of 0.718 (p < 0.05) and a cutoff value of <= 35% for the lowest intraoperative ScO2. Low baseline ScO2 (<= 50%) was associated with increases in intubation time, intensive care unit stay, hospital stay, and hospital mortality. Conclusion Baseline ScO2 was reflective of severity of systemic comorbidities and was predictive of clinical outcomes after major cardiovascular surgery. ScO2 correlated most significantly with BNP in an exponential manner, suggesting that BNP plays a major role in the ScO2-based outcome prediction.	[Mukaida, Hiroshi; Matsushita, Satoshi; Amano, Atsushi] Juntendo Univ, Fac Med, Dept Cardiovasc Surg, Tokyo, Japan; [Mukaida, Hiroshi] Juntendo Univ Hosp, Dept Clin Engn, Tokyo, Japan; [Hayashida, Masakazu; Yamamoto, Makiko] Juntendo Univ, Fac Med, Dept Anesthesiol & Pain Med, Tokyo, Japan; [Nakamura, Atsushi] Kyorin Univ, Fac Hlth Sci, Dept Clin Engn, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Kyorin University	Mukaida, H (corresponding author), Juntendo Univ, Fac Med, Dept Cardiovasc Surg, Tokyo, Japan.; Mukaida, H (corresponding author), Juntendo Univ Hosp, Dept Clin Engn, Tokyo, Japan.	me-da@juntendo.ac.jp						Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Tournay-Jette E, 2011, J CARDIOTHOR VASC AN, V25, P95, DOI 10.1053/j.jvca.2010.03.019; Edmonds HL, 2005, ANN NY ACAD SCI, V1053, P12, DOI 10.1196/annals.1344.002; El-Saed Aiman, 2009, Clin Cardiol, V32, pE33, DOI 10.1002/clc.20490; Ewald B, 2008, INTERN MED J, V38, P101, DOI 10.1111/j.1445-5994.2007.01454.x; Forfia PR, 2005, J AM COLL CARDIOL, V45, P1667, DOI 10.1016/j.jacc.2005.01.046; Greenberg S, 2016, CAN J ANESTH, V63, P24, DOI 10.1007/s12630-015-0451-7; Heringlake M, 2011, ANESTHESIOLOGY, V114, P58, DOI 10.1097/ALN.0b013e3181fef34e; Hong SW, 2008, EUR J CARDIO-THORAC, V33, P560, DOI 10.1016/j.ejcts.2008.01.012; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Ito K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117474; Jungbauer CG, 2012, BIOMARK MED, V6, P789, DOI [10.2217/BMM.12.67, 10.2217/bmm.12.67]; Kainuma S, 2015, J CARDIOL, V66, P279, DOI 10.1016/j.jjcc.2015.02.015; Klaar U, 2011, EUR J HEART FAIL, V13, P163, DOI 10.1093/eurjhf/hfq189; Kobayashi K, 2017, J ARTIF ORGANS, V20, P110, DOI 10.1007/s10047-016-0941-6; Madsen PL, 2000, CLIN PHYSIOL, V20, P158; Maeder MT, 2010, HYPERTENSION, V56, P682, DOI 10.1161/HYPERTENSIONAHA.110.156547; Maries L, 2013, CARDIOVASC J AFR, V24, P286, DOI 10.5830/CVJA-2013-055; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Paquet C, 2008, J CARDIOTHOR VASC AN, V22, P840, DOI 10.1053/j.jvca.2008.02.013; Reents W, 2002, ANN THORAC SURG, V74, P109, DOI 10.1016/S0003-4975(02)03618-4; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Schoen J, 2011, CRIT CARE, V15, DOI 10.1186/cc10454; Skhirtladze K, 2009, CRIT CARE MED, V37, P471, DOI 10.1097/CCM.0b013e3181953d4c; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; Steppan J, 2014, BEST PRACT RES-CLIN, V28, P429, DOI 10.1016/j.bpa.2014.09.002; Thavasothy M, 2002, ANAESTHESIA, V57, P999, DOI 10.1046/j.1365-2044.2002.02826.x; Yao FSF, 2004, J CARDIOTHOR VASC AN, V18, P552, DOI 10.1053/j.jvca.2004.07.007; Yoshitani K, 2005, BRIT J ANAESTH, V94, P341, DOI 10.1093/bja/aei046; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Zheng F, 2013, ANESTH ANALG, V116, P663, DOI 10.1213/ANE.0b013e318277a255	35	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181154	10.1371/journal.pone.0181154	http://dx.doi.org/10.1371/journal.pone.0181154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704502	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600063
J	Vesterinen, HM; Morello-Frosch, R; Sen, S; Zeise, L; Woodruff, TJ				Vesterinen, Hanna M.; Morello-Frosch, Rachel; Sen, Saunak; Zeise, Lauren; Woodruff, Tracey J.			Cumulative effects of prenatal- exposure to exogenous chemicals and psychosocial stress on fetal growth: Systematic-review of the human and animal evidence	PLOS ONE			English	Review							LOW-BIRTH-WEIGHT; PERFLUOROOCTANE SULFONATE PFOS; INDUCED DEVELOPMENTAL TOXICITY; MATERNAL CIGARETTE-SMOKING; EVIDENCE-BASED MEDICINE; AMBIENT AIR-POLLUTION; POSTNATAL-DEVELOPMENT; RESTRAINT STRESS; PRETERM BIRTH; SOCIOECONOMIC-STATUS	Background Adverse effects of prenatal stress or environmental chemical exposures on fetal growth are well described, yet their combined effect remains unclear. Objectives To conduct a systematic review on the combined impact and interaction of prenatal exposure to stress and chemicals on developmental outcomes. Methods We used the first three steps of the Navigation Guide systematic review. We wrote a protocol, performed a robust literature search to identify relevant animal and human studies and extracted data on developmental outcomes. For the most common outcome (fetal growth), we evaluated risk of bias, calculated effect sizes for main effects of individual and combined exposures, and performed a random effects meta-analysis of those studies reporting on odds of low birthweight (LBW) by smoking and socioeconomic status (SES). Results We identified 17 human-and 22 animal-studies of combined chemical and stress exposures and fetal growth. Human studies tended to have a lower risk of bias across nine domains. Generally, we found stronger effects for chemicals than stress, and these exposures were associated with reduced fetal growth in the low-stress group and the association was often greater in high stress groups, with limited evidence of effect modification. We found smoking associated with significantly increased odds of LBW, with a greater effect for high stress (low SES; OR 4.75 (2.46 -9.16)) compared to low stress (high SES; OR 1.95 (95% CI 1.53 -2.48)). Animal studies generally had a high risk of bias with no significant combined effect or effect modification. Conclusions We found that despite concern for the combined effects of environmental chemicals and stress, this is still an under-studied topic, though limited available human studies indicate chemical exposures exert stronger effects than stress, and this effect is generally larger in the presence of stress.	[Vesterinen, Hanna M.; Woodruff, Tracey J.] Univ Calif San Francisco, Program Reprod Hlth & Environm, San Francisco, CA 94143 USA; [Morello-Frosch, Rachel] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Morello-Frosch, Rachel] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sen, Saunak] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Zeise, Lauren] Calif Environm Protect Agcy, Off Environm Hlth Hazard Assessment, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Health Science Center; California Environmental Protection Agency	Woodruff, TJ (corresponding author), Univ Calif San Francisco, Program Reprod Hlth & Environm, San Francisco, CA 94143 USA.	tracey.woodruff@ucsf.edu		Woodruff, Tracey/0000-0003-3622-1297	California Environmental Protection Agency Office of Environmental Health Hazard Assessment [14-E0015]; Passport Foundation; Forsythia Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022841] Funding Source: NIH RePORTER	California Environmental Protection Agency Office of Environmental Health Hazard Assessment; Passport Foundation; Forsythia Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	TW received funding from the California Environmental Protection Agency Office of Environmental Health Hazard Assessment (grant number 14-E0015), the Passport Foundation and Forsythia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2003, J EPIDEMIOL COMMUN H, V57, P606, DOI 10.1136/jech.57.8.606; Albina ML, 2003, EXP BIOL MED, V228, P1072, DOI 10.1177/153537020322800914; Albina ML, 2002, EXP BIOL MED, V227, P779, DOI 10.1177/153537020222700909; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P1118, DOI 10.1289/ehp.9759; BELLINGER D, 1988, NEUROTOXICOL TERATOL, V10, P497, DOI 10.1016/0892-0362(88)90084-0; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Bolton JL, 2013, ENVIRON HEALTH PERSP, V121, P1075, DOI 10.1289/ehp.1306560; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Chen D, 2000, OCCUP ENVIRON MED, V57, P661, DOI 10.1136/oem.57.10.661; Colomina M. T., 1997, Teratology, V56, P388; Colomina MT, 1998, NEUROTOXICOL TERATOL, V20, P651, DOI 10.1016/S0892-0362(98)00025-7; Colomina MT, 1997, PHYSIOL BEHAV, V61, P455, DOI 10.1016/S0031-9384(96)00462-3; Colomina MT, 2005, NEUROTOXICOL TERATOL, V27, P565, DOI 10.1016/j.ntt.2005.06.014; Colomina MT, 1997, RES COMMUN ALCOHOL S, V18, P71; COLOMINA MT, 1995, PHYSIOL BEHAV, V58, P979, DOI 10.1016/0031-9384(95)00140-E; Colomina MT, 1999, PSYCHOBIOLOGY, V27, P521; Committee on Environmental Justice IoM, 1999, ENV JUST RES ED HLTH; COMSTOCK GW, 1971, AM J OBSTET GYNECOL, V111, P53, DOI 10.1016/0002-9378(71)90926-4; Cory-Slechta DA, 2004, ENVIRON HEALTH PERSP, V112, P717, DOI 10.1289/ehp.6481; Cory-Slechta DA, 2013, TOXICOL SCI, V131, P194, DOI 10.1093/toxsci/kfs260; DASILVA AAM, 1992, REV SAUDE PUBL, V26, P150, DOI 10.1590/S0034-89101992000300004; Davidson PW, 1999, NEUROTOXICOLOGY, V20, P833; DIETRICH KN, 1987, PEDIATRICS, V80, P721; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; EVANS DR, 1979, BRIT MED J, V2, P171, DOI 10.1136/bmj.2.6183.171; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fink NS, 2012, J PERINAT NEONAT NUR, V26, P296, DOI 10.1097/JPN.0b013e31823f565b; Fuentes S, 2007, TOXICOL LETT, V171, P162, DOI 10.1016/j.toxlet.2007.05.006; Fuentes S, 2007, TOXICOL SCI, V98, P589, DOI 10.1093/toxsci/kfm121; Fuentes S, 2006, TOXICOL LETT, V164, P81, DOI 10.1016/j.toxlet.2005.11.013; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Gonzalez-Alzaga B., 2013, TOXICOL LETT; Gyllstrom ME, 2011, MATERN CHILD HLTH J, V15, P198, DOI 10.1007/s10995-009-0558-y; Higgins JPT, 2008, COCHRANE HDB SYSTEMA, Vxxi, DOI DOI 10.1002/9780470712184; Hodek JM, 2010, ACTA PAEDIATR, V99, P98; Hofhuis W, 2003, ARCH DIS CHILD, V88, P1086, DOI 10.1136/adc.88.12.1086; HOOK EB, 1988, AM J HUM GENET, V42, P482; Hougaard KS, 2005, NEUROTOXICOL TERATOL, V27, P153, DOI 10.1016/j.ntt.2004.08.001; Hougaard KS, 2003, PHARMACOL TOXICOL, V92, P148, DOI 10.1034/j.1600-0773.2003.920308.x; Huijbregts SCJ, 2006, INFANT CHILD DEV, V15, P593, DOI 10.1002/icd.480; Huijbregts SCJ, 2008, DEV PSYCHOPATHOL, V20, P437, DOI 10.1017/S0954579408000217; Hunter SK, 2011, SCHIZOPHRENIA BULL, V37, P1200, DOI 10.1093/schbul/sbq036; Ihrig MM, 1998, EPIDEMIOLOGY, V9, P290, DOI 10.1097/00001648-199805000-00013; Irgens A, 1998, AM J IND MED, V34, P431, DOI 10.1002/(SICI)1097-0274(199811)34:5<431::AID-AJIM3>3.0.CO;2-T; Johnson PI, 2016, ENVIRON INT, V92-93, P716, DOI 10.1016/j.envint.2016.03.009; Johnson PI, 2013, NAVIGATION GUI UNPUB; Kabir Z, 2011, PEDIATRICS, V128, P263, DOI 10.1542/peds.2011-0023; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; KLEINMAN JC, 1988, AM J EPIDEMIOL, V127, P274, DOI 10.1093/oxfordjournals.aje.a114803; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Koustas E, 2013, NAVIGATION IN PRESS; Koustas E, 2014, ENVIRON HEALTH PERSP, V122, P1015, DOI 10.1289/ehp.1307177; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Ladefoged O, 2004, BASIC CLIN PHARMACOL, V94, P169; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Li Zhu-ying, 2008, Zhonghua Yufang Yixue Zazhi, V42, P717; LUMLEY J, 1985, AUST NZ J OBSTET GYN, V25, P33, DOI 10.1111/j.1479-828X.1985.tb00599.x; Martin JA, 2013, NAT VITAL STAT REP, V62; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; MILLER HC, 1987, YALE J BIOL MED, V60, P221; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; Morello-Frosch R, 2011, HEALTH AFFAIR, V30, P879, DOI 10.1377/hlthaff.2011.0153; Morello-Frosch R, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-44; MORRA M, 1969, J GENET PSYCHOL, V114, P77, DOI 10.1080/00221325.1969.10533839; Mortensen LH, 2009, HUM REPROD, V24, P2629, DOI 10.1093/humrep/dep211; Murray RL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1062; Nepomnyaschy L, 2006, AM J PUBLIC HEALTH, V96, P1604, DOI 10.2105/AJPH.2005.079400; NEWTON RW, 1984, BRIT MED J, V288, P1191, DOI 10.1136/bmj.288.6425.1191; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Orr ST, 1996, AM J PREV MED, V12, P459, DOI 10.1016/S0749-3797(18)30268-X; Pampel FC, 2004, J HEALTH SOC BEHAV, V45, P306, DOI 10.1177/002214650404500305; Pennington JS, 2002, ALCOHOL CLIN EXP RES, V26, P848, DOI 10.1097/00000374-200206000-00015; Phung H, 2003, EUR J EPIDEMIOL, V18, P235, DOI 10.1023/A:1023384213536; Ponce NA, 2005, AM J EPIDEMIOL, V162, P140, DOI 10.1093/aje/kwi173; RASCO JF, 1994, REPROD TOXICOL, V8, P49, DOI 10.1016/0890-6238(94)90066-3; Ribes D, 2010, TOXICOL APPL PHARM, V243, P13, DOI 10.1016/j.taap.2009.11.001; Roberts AD, 2004, NEUROTOXICOL TERATOL, V26, P169, DOI 10.1016/j.ntt.2003.12.003; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; RUSH D, 1983, J EPIDEMIOL COMMUN H, V37, P249, DOI 10.1136/jech.37.4.249; Sanchez D. J., 1997, Teratology, V56, P388; Sanchez DJ, 2006, TOXICOLOGY, V228, P323, DOI 10.1016/j.tox.2006.09.017; Schaaf JM, 2013, AM J PERINAT, V30, P433, DOI 10.1055/s-0032-1326988; Schneider ML, 2001, ALCOHOL CLIN EXP RES, V25, P1383; Shankardass K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-96; Sharma AJ, 2008, AM J EPIDEMIOL, V168, P995, DOI 10.1093/aje/kwn223; Smith SH, 2011, BRAIN BEHAV IMMUN, V25, pS230; Solomon GM, 2016, ANNU REV PUBL HEALTH, V37, P83, DOI 10.1146/annurev-publhealth-032315-021807; SPINILLO A, 1995, INT J GYNECOL OBSTET, V51, P15, DOI 10.1016/0020-7292(95)80003-U; Torrente M, 2002, NEUROTOXICOL TERATOL, V24, P219, DOI 10.1016/S0892-0362(02)00188-5; Virgolini MB, 2008, NEUROTOXICOLOGY, V29, P812, DOI 10.1016/j.neuro.2008.03.003; WARD GR, 1989, PHYSIOL BEHAV, V45, P541, DOI 10.1016/0031-9384(89)90071-1; WARD GR, 1989, PHYSIOL BEHAV, V45, P533, DOI 10.1016/0031-9384(89)90070-X; WARD IL, 1994, BEHAV NEUROSCI, V108, P1188, DOI 10.1037/0735-7044.108.6.1188; Ward IL, 1996, BEHAV NEUROSCI, V110, P1469, DOI 10.1037/0735-7044.110.6.1469; Ward OB, 2002, HORM BEHAV, V41, P229, DOI 10.1006/hbeh.2001.1746; Wehby GL, 2011, J HUM CAPITAL, V5, P207, DOI 10.1086/660885; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Woodruff TJ, 2011, HEALTH AFFAIR, V30, P931, DOI 10.1377/hlthaff.2010.1219; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Yi O, 2010, ENVIRON RES, V110, P55, DOI 10.1016/j.envres.2009.10.004; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60	104	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							0176331	10.1371/journal.pone.0176331	http://dx.doi.org/10.1371/journal.pone.0176331			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700705	gold, Green Published			2022-12-27	WOS:000405649600001
J	Zhang, XZ; Wu, X; Chen, WB; Zhang, YW; Jiang, YM; Meng, QX; Zhou, ZM				Zhang, Xinzhuang; Wu, Xin; Chen, Wanbao; Zhang, Yawei; Jiang, Yuming; Meng, Qingxiang; Zhou, Zhenming			Growth performance and development of internal organ, and gastrointestinal tract of calf supplementation with calcium propionate at various stages of growth period	PLOS ONE			English	Article							RUMEN EPITHELIUM; ENERGY; FERMENTATION; DIGESTIBILITY; EXPRESSION; INSULIN; CALVES; FIBER; FEED	To investigate the effects of calcium propionate (CaP) supplementation on performance, the development of the internal organ, and gastrointestinal tract of calves at various stages of growth period, 54 male Jersey calves ( age = 7 +/- 1 d, body weight(BW) = 23.1 +/- 1.2 kg) were randomly allocated to three treatment groups. While control calves were fed basis dietary with no additives (0CaP), other treatment calves were fed basis dietary supplementation with CaP at 50 (5CaP) or 100 (10CaP) g kg(- 1) dry matter. The experiment lasted 160 d and was divided into three feeding stages: Stage 1 (d 0 to 30), Stage 2 (d 31 to 90), and Stage 3 (d 91 to160). Six calves from each group were randomly selected and slaughtered on days 30, 90, and 160 when at the conclusion of each experimental feeding stage. The BW of calves increased with 10CaP after feeding 90 d, whereas it increased with 5CaP and 10CaP at feeding 120d and 160d compared to 0CaP. The 10CaP group improved average daily gain (ADG) of calves at stage 2, and d120-160 of stage 3 compared with the 0CaP group. The ADG of 5CaP was greater than the 0CaP group only at 120-160 d of stage 3 compared with the 0CaP group. The results of feed efficiency were in agreed with ADG as no dry matter intake difference at all stages of growth period. The 10CaP treatment exhibited the greatest spleen weight among the treatment at the end of the experiment; the liver weight of the 5CaP and 10CaP calves at feeding 90 d and of the 10CaP calves at feeding 160 d and were greater than those of the 0CaP animals. The CaP at the tested doses increased the rumen weight after feeding 90d of Jersey calves, and also improved the development of intestine. In conclusion, dietary supplementation with calcium propionate at the tested doses caused a beneficial effect in the growth performance and gastrointestinal tract traits of Jersey calves, thus to add 10% CaP before feeding 90 days was better and 5% CaP supplementation was expected at the period for feeding 90 to160 d.	[Zhang, Xinzhuang; Wu, Xin; Chen, Wanbao; Zhang, Yawei; Jiang, Yuming; Meng, Qingxiang; Zhou, Zhenming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	China Agricultural University	Meng, QX; Zhou, ZM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	qxmeng@cau.edu.cn; zhouzm@cau.edu.cn	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383	National Natural Science foundation of China [31372335, 31672449]; China Agricultural Research System [CARS-38]; special fund for agro-scientific research in the public interest [201503134]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System; special fund for agro-scientific research in the public interest	National Natural Science foundation of China (No:31372335 and 31672449), the China Agricultural Research System (CARS-38), and the special fund for agro-scientific research in the public interest (No:201503134).	Abeni F, 2000, J DAIRY SCI, V83, P1468, DOI 10.3168/jds.S0022-0302(00)75019-3; Alam S, 2014, FOOD ADDIT CONTAM A, V31, P1896, DOI 10.1080/19440049.2014.963699; Alam S, 2010, J FOOD SCI, V75, pM61, DOI 10.1111/j.1750-3841.2009.01462.x; AOAC, 1990, ASS OFF AN CHEM, V15th; Bergman E., 1975, DIGESTION METABOLISM, P292; Berry BA, 2004, J ANIM SCI, V82, P837; Brown EG, 2005, J DAIRY SCI, V88, P585, DOI 10.3168/jds.S0022-0302(05)72722-3; Bunting LD, 2000, J DAIRY SCI, V83, P2491, DOI 10.3168/jds.S0022-0302(00)75141-1; Cao YuJuan, 2014, Chinese Journal of Animal Nutrition, V26, P90; Fluharty FL, 1999, J ANIM SCI, V77, P816; GILLILAND RL, 1962, J DAIRY SCI, V45, P1211, DOI 10.3168/jds.S0022-0302(62)89598-8; He LW, 2015, POULTRY SCI, V94, P2464, DOI 10.3382/ps/pev237; HUNTINGTON GB, 1990, REPROD NUTR DEV, V30, P35, DOI 10.1051/rnd:19900103; Lane MA, 1997, J DAIRY SCI, V80, P740, DOI 10.3168/jds.S0022-0302(97)75993-9; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee-Rangel HA, 2012, ANIM FEED SCI TECH, V177, P237, DOI 10.1016/j.anifeedsci.2012.08.012; Liu Q, 2010, J ANIM PHYSIOL AN N, V94, P605, DOI 10.1111/j.1439-0396.2009.00945.x; Liu Q, 2009, J AGR SCI-CAMBRIDGE, V147, P201, DOI 10.1017/S0021859609008429; Malhi M, 2013, J DAIRY SCI, V96, P7603, DOI 10.3168/jds.2013-6700; Martin-Diana AB, 2007, TRENDS FOOD SCI TECH, V18, P210, DOI 10.1016/j.tifs.2006.11.027; NRC, 2000, NAT AC; PETERS JP, 1990, J ANIM SCI, V68, P3905; SAKATA T, 1979, J DAIRY SCI, V62, P49, DOI 10.3168/jds.S0022-0302(79)83200-2; SAKATA T, 1980, BRIT J NUTR, V44, P325, DOI 10.1079/BJN19800047; SANO H, 1995, J ANIM SCI, V73, P191; Shen ZM, 2004, J NUTR, V134, P11, DOI 10.1093/jn/134.1.11; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang A, 2012, J DAIRY SCI, V95, P1371, DOI 10.3168/jds.2011-4886; Xie XX, 2013, J ANIM SCI, V91, P4315, DOI 10.2527/jas.2012-5731; Zhang XZ, 2015, J ANIM FEED SCI, V24, P100, DOI 10.22358/jafs/65634/2015	30	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0179940	http://dx.doi.org/10.1371/journal.pone.0179940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692656	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800020
J	Matyushenko, V; Isakova-Sivak, I; Smolonogina, T; Dubrovina, I; Tretiak, T; Rudenko, L				Matyushenko, Victoria; Isakova-Sivak, Irina; Smolonogina, Tatiana; Dubrovina, Irina; Tretiak, Tatiana; Rudenko, Larisa			Genotyping assay for differentiation of wildtype and vaccine viruses in subjects immunized with live attenuated influenza vaccine	PLOS ONE			English	Article							YOUNG-CHILDREN; DOUBLE-BLIND; B VIRUS; SAFETY; IMMUNOGENICITY; AMPLIFICATION; STABILITY; SET	Live attenuated influenza vaccines (LAIVs) are considered as safe and effective tool to control influenza in different age groups, especially in young children. An important part of the LAIV safety evaluation is the detection of vaccine virus replication in the nasopharynx of the vaccinees, with special attention to a potential virus transmission to the unvaccinated close contacts. Conducting LAIV clinical trials in some geographical regions with year-round circulation of influenza viruses warrants the development of robust and reliable tools for differentiating vaccine viruses from wild-type influenza viruses in nasal pharyngeal wash (NPW) specimens of vaccinated subjects. Here we report the development of genotyping assay for the detection of wild-type and vaccine-type influenza virus genes in NPW specimens of young children immunized with Russian-backbone seasonal trivalent LAIV using Sanger sequencing from newly designed universal primers. The new primer set allowed amplification and sequencing of short fragments of viral genes in NPW specimens and appeared to be more sensitive than conventional real-time RT-PCR protocols routinely used for the detection and typing/subtyping of influenza virus in humans. Furthermore, the new assay is capable of defining the origin of wild-type influenza virus through BLAST search with the generated sequences of viral genes fragments.	[Matyushenko, Victoria; Isakova-Sivak, Irina; Smolonogina, Tatiana; Dubrovina, Irina; Tretiak, Tatiana; Rudenko, Larisa] Inst Expt Med, Dept Virol, St Petersburg, Russia	Institute of Experimental Medicine	Isakova-Sivak, I (corresponding author), Inst Expt Med, Dept Virol, St Petersburg, Russia.	isakova.sivak@gmail.com	Isakova-Sivak, Irina/C-1034-2014; Rudenko, Larisa/AAN-9226-2020; Matyushenko, Victoria/AAN-9986-2020; Kotomina, Tatiana S/U-8669-2018	Isakova-Sivak, Irina/0000-0002-2801-1508; Rudenko, Larisa/0000-0002-0107-9959; Kotomina, Tatiana S/0000-0001-9999-089X; Matyushenko, Victoria/0000-0002-4698-6085	PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh); Russian Scientific Foundation [14-15-00034]	PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh); Russian Scientific Foundation(Russian Science Foundation (RSF))	The study was supported by PATH (LAIV-specific testing of influenza-positive post-vaccination shedding specimens from LAIV clinical study in Bangladesh) and Russian Scientific Foundation grant No 14-15-00034 (the development of the assay and genotyping of influenza viruses of various subtypes).	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P389, DOI 10.1111/j.1750-2659.2011.00243.x; Barr I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037568; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Block SL, 2008, VACCINE, V26, P4940, DOI 10.1016/j.vaccine.2008.07.013; Brooks W.A., 2016, LANCET GLOB HLTH; Brooks WA, 2016, LANCET GLOB HEALTH, V4, pE946, DOI [10.1016/s2214-109x(16)30200-5, 10.1016/S2214-109X(16)30200-5]; Coelingh KL, 2014, EXPERT REV VACCINES, V13, P855, DOI 10.1586/14760584.2014.922417; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Inoue E, 2010, MICROBIOL IMMUNOL, V54, P129, DOI 10.1111/j.1348-0421.2009.00193.x; Isakova-Sivak I, 2015, EXPERT REV VACCINES, V14, P1313, DOI 10.1586/14760584.2015.1075883; Isakova-Sivak I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102339; Karkishchenko N N, 2010, MANUAL LAB ANIMALS A; Kiseleva IV, 2011, MOL GENET MICROBIOL+, V26, P174, DOI 10.3103/S0891416811040045; Kiseleva IV, 2012, VOP VIRUSOL RUSSIAN, V57, P45; KLIMOV AI, 1995, J VIROL METHODS, V52, P41, DOI 10.1016/0166-0934(94)00133-2; Kulkarni PS, 2014, HUM VACCIN IMMUNOTHE, V10; Mallory RM, 2011, VACCINE, V29, P4322, DOI 10.1016/j.vaccine.2011.04.022; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ortiz JR, 2015, VACCINE; Ortiz JR, 2015, VACCINE, V33, P3415, DOI 10.1016/j.vaccine.2015.04.048; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Shcherbik SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092580; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; World Health Organization, 2012, WHO INF MOL DIAGN IN; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180497	10.1371/journal.pone.0180497	http://dx.doi.org/10.1371/journal.pone.0180497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686625	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100070
J	Tashima, Y; Banno, F; Kita, T; Matsuda, Y; Yanamoto, H; Miyata, T				Tashima, Yuko; Banno, Fumiaki; Kita, Toshiyuki; Matsuda, Yasuyuki; Yanamoto, Hiroji; Miyata, Toshiyuki			Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; LIGNEOUS CONJUNCTIVITIS; MOLECULAR ABNORMALITY; CEREBRAL-ISCHEMIA; DEFICIENT MICE; HUMAN-DISEASE; ACTIVE-SITE; MUTATION; GENE; SYSTEM	Plasminogen (Plg) is a precursor of plasmin that degrades fibrin. A race-specific A620T mutation in Plg, also known as Plg-Tochigi, originally identified in a patient with recurrent venous thromboembolism, causes dysplasminogenemia with reduced plasmin activity. The Plg-A620T mutation is present in 3 - 4% of individuals in East Asian populations, and as many as 50,000 Japanese are estimated to be homozygous for the mutant 620T allele. In the present study, to understand the changes of thrombotic phenotypes in individuals with the mutant 620T allele, we generated knock-in mice carrying the homozygous Plg-A622T mutation (Plg(T/T)), an equivalent to the A620T mutation in human Plg. Plg(T/T) mice grew normally but showed severely reduced plasmin activity activated by urokinase, equivalent to similar to 8% of that in wild-type mice. In vitro fibrin clot lysis in plasma was significantly slower in Plg T/T mice than in wild-type mice. However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between Plg T/T mice and wild-type mice. Protein S-K196E mutation (Pros1 E/E) is a race-specific genetic risk factor for venous thromboembolism. Coexistence in mice of Plg(T/T) and Pros1 (E/E) did not affect pulmonary embolism symptoms, compared with those in Pros1 (E/E) mice. Hence, the present study showed that the Plg-A622T mutation, which confers similar to 8% plasmin activity, does not increase the risk of thrombotic diseases in mice under experimental thrombotic conditions and does not modify the thrombotic phenotype observed in Pros1 (E/E) mice. Plg (T/T) mice can be used to investigate the potential pathophysiological impact of the Plg-A620T mutation.	[Tashima, Yuko; Banno, Fumiaki; Kita, Toshiyuki; Matsuda, Yasuyuki; Yanamoto, Hiroji; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Lab Neurol & Neurosurg, Suita, Osaka, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Tashima, Yuko] Nagoya Univ, Sch Med, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan; [Banno, Fumiaki] Koriyama Womens Univ, Dept Food & Nutr, Koriyama, Fukushima, Japan; [Matsuda, Yasuyuki] Asahikawa Med Univ, Dept Microbiol & Immunochem, Asahikawa, Hokkaido, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Nagoya University; Asahikawa Medical College	Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.; Miyata, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan.	miyata@ncvc.go.jp	Yanamoto, Hiroji/ABF-7320-2020; yanamoto, hiroji/ABB-3923-2020		Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Japan Cardiovascular Research Foundation; Uehara Memorial Foundation; Takeda Scientific Foundation; Intramural Research Fund; Grants-in-Aid for Scientific Research [16K14696, 16K19045, 16K09834] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Intramural Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science; the Japan Cardiovascular Research Foundation; the Uehara Memorial Foundation; the Takeda Scientific Foundation; and the Intramural Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI N, 1978, J CLIN INVEST, V61, P1186, DOI 10.1172/JCI109034; Banno F, 2004, J BIOL CHEM, V279, P30896, DOI 10.1074/jbc.M314184200; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Banno F, 2015, BLOOD, V126, P2247, DOI 10.1182/blood-2015-06-653162; Barrios M, 2009, THROMB RES, V124, P338, DOI 10.1016/j.thromres.2008.11.001; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Das R, 2014, BLOOD, V124, P679, DOI 10.1182/blood-2014-01-549659; Diaz JA, 2013, THROMB HAEMOSTASIS, V109, P1158, DOI 10.1160/TH12-09-0711; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; ICHINOSE A, 1991, P NATL ACAD SCI USA, V88, P115, DOI 10.1073/pnas.88.1.115; Iwaki T, 2010, J THROMB HAEMOST, V8, P2341, DOI 10.1111/j.1538-7836.2010.03995.x; Kawao N, 2010, J THROMB HAEMOST, V8, P1555, DOI 10.1111/j.1538-7836.2010.03870.x; Kimura R, 2006, BLOOD, V107, P1737, DOI 10.1182/blood-2005-09-3892; Kita T, 2012, J THROMB HAEMOST, V10, P1453, DOI 10.1111/j.1538-7836.2012.04776.x; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MIYATA T, 1982, P NATL ACAD SCI-BIOL, V79, P6132, DOI 10.1073/pnas.79.20.6132; Miyata T, 2006, INT J HEMATOL, V83, P217, DOI 10.1532/IJH97.A20514; Miyata T, 2016, INT J HEMATOL, V104, P223, DOI 10.1007/s12185-016-2021-3; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; NAGAYAMA T, 1993, STROKE, V24, P2104, DOI 10.1161/01.STR.24.12.2104; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Ooe A, 1999, THROMB HAEMOSTASIS, V82, P1342; Parker AC, 2004, CIRCULATION, V110, P3594, DOI 10.1161/01.CIR.0000148781.87906.C0; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKATA Y, 1980, J BIOL CHEM, V255, P5442; Schuster V, 2007, J THROMB HAEMOST, V5, P2315, DOI 10.1111/j.1538-7836.2007.02776.x; Schuster V, 1997, BLOOD, V90, P958, DOI 10.1182/blood.V90.3.958.958_958_966; Singh S, 2016, J THROMB HAEMOST; Tashima Y, 2015, THROMB HAEMOSTASIS, V114, P206, DOI 10.1160/TH14-08-0656; Tefs K, 2006, BLOOD, V108, P3021, DOI 10.1182/blood-2006-04-017350; Vercauteren E, 2011, BLOOD, V117, P4615, DOI 10.1182/blood-2010-08-303677; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu CL, 2003, THROMB HAEMOSTASIS, V90, P414, DOI 10.1160/TH02-09-0104; Yamamoto H, 2011, J BIOL CHEM, V286, P26158, DOI 10.1074/jbc.M111.256446; Yang D, 2014, EUR NEUROL, V71, P4, DOI 10.1159/000356048; Zeng B, 2002, THROMB HAEMOSTASIS, V88, P805, DOI 10.1055/s-0037-1613306	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180981	10.1371/journal.pone.0180981	http://dx.doi.org/10.1371/journal.pone.0180981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686706	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100126
J	Bai, XF; Ewins, D; Crocombe, AD; Xu, W				Bai, Xuefei; Ewins, David; Crocombe, Andrew D.; Xu, Wei			Kinematic and biomimetic assessment of a hydraulic ankle/foot in level ground and camber walking	PLOS ONE			English	Article							PROSTHETIC ANKLE; PARKINSONS-DISEASE; GAIT ASYMMETRY; AMPUTEE GAIT; FOOT; SYMMETRY; LOCOMOTION; BIOMECHANICS; AMPUTATIONS; MECHANISM	Improved walking comfort has been linked with better bio-mimicking of the prosthetic ankle. This study investigated if a hydraulic ankle/foot can provide enough motion in both the sagittal and frontal planes during level and camber walking and if the hydraulic ankle/foot better mimics the biological ankle moment pattern compared with a fixed ankle/foot device. Five active male unilateral trans-femoral amputees performed level ground walking at normal and fast speeds and 2.5 E camber walking in both directions using their own prostheses fitted with an "Echelon" hydraulic ankle/foot and an "Esprit" fixed ankle/foot. Ankle angles and the Trend Symmetry Index of the ankle moments were compared between prostheses and walking conditions. Significant differences between prostheses were found in the stance plantarflexion and dorsiflexion peaks with a greater range of motion being reached with the Echelon foot. The Echelon foot also showed significantly improved bio-mimicry of the ankle resistance moment in all walking conditions, either compared with the intact side of the same subject or with the "normal" mean curve from non-amputees. During camber walking, both types of ankle/foot devices showed similar changes in the frontal plane ankle angles. Results from a questionnaire showed the subjects were more satisfied with Echelon foot.	[Bai, Xuefei; Ewins, David; Crocombe, Andrew D.; Xu, Wei] Univ Surrey, Dept Mech Engn Sci, Guildford, Surrey, England; [Ewins, David] Queen Marys Hosp, Gait Lab, London, England	University of Surrey; University of London; Queen Mary University London	Xu, W (corresponding author), Univ Surrey, Dept Mech Engn Sci, Guildford, Surrey, England.	w.xu@surrey.ac.uk			Henry Lester Trust Ltd	Henry Lester Trust Ltd	Xuefei Bai was supported by Henry Lester Trust Ltd. for her doctoral research and publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Blatchford & Sons Ltd. for supplying the two types of prosthetic ankles/feet used in this research and for providing prosthetists to help with the fitting of the prosthetic ankles/feet to the subjects. Blatchford & Sons Ltd. did not participant in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins TD, 2009, GAIT POSTURE, V30, P173, DOI 10.1016/j.gaitpost.2009.04.004; Crenshaw SJ, 2006, GAIT POSTURE, V24, P515, DOI 10.1016/j.gaitpost.2005.12.002; Goldberg EJ, 2008, J BIOMECH, V41, P695, DOI 10.1016/j.jbiomech.2007.10.002; Gouwanda D, 2011, J BIOMECH, V44, P972, DOI 10.1016/j.jbiomech.2010.12.013; Grant JCV, 2015, J BIOENGINEERING BIO; HALE SA, 1990, PROSTHET ORTHOT INT, V14, P125; Hansen AH, 2004, J BIOMECH, V37, P1467, DOI 10.1016/j.jbiomech.2004.01.017; Hekmatfard M, 2013, GAIT POSTURE, V37, P78, DOI 10.1016/j.gaitpost.2012.06.010; Hurwitz DE, 2001, CELLS TISSUES ORGANS, V169, P201, DOI 10.1159/000047883; Kaufman KR, 2012, CLIN BIOMECH, V27, P460, DOI 10.1016/j.clinbiomech.2011.11.011; Kulkarni J, 1998, CLIN REHABIL, V12, P348, DOI 10.1191/026921598672367610; Llikavainio T, 2007, KNEE, V14, P231, DOI 10.1016/j.knee.2007.03.001; Lusardi MM., 2012, ORTHOTICS PROSTHETIC, V3rd edn; Mcnealy LL, 2008, PROSTHET ORTHOT INT, V32, P111, DOI 10.1080/02699200701847244; Nickel E, 2014, J REHABIL RES DEV, V51, P803, DOI 10.1682/JRRD.2013.08.0177; Park K, 2016, CLIN BIOMECH, V33, P92, DOI 10.1016/j.clinbiomech.2016.02.012; Pitkin Mark R, 1997, J Prosthet Orthot, V9, P113, DOI 10.1097/00008526-199700930-00005; Pitkin Mark R, 1995, J Prosthet Orthot, V7, P114, DOI 10.1097/00008526-199507040-00003; Pitkin MR, 2010, BIOMECHANICS OF LOWER LIMB PROSTHETICS, P1, DOI 10.1007/978-3-642-03016-1; Pitkin MR, 1996, PROSTHET ORTHOT INT, V20, P159; Portnoy S, 2012, GAIT POSTURE, V35, P121, DOI 10.1016/j.gaitpost.2011.08.021; Prince F., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P247, DOI 10.1109/86.340873; Sadeghi H, 2003, GAIT POSTURE, V17, P197, DOI 10.1016/S0966-6362(02)00089-9; Sagawa Y, 2011, GAIT POSTURE, V33, P511, DOI 10.1016/j.gaitpost.2011.02.003; Sant'Anna A, 2011, IEEE T BIO-MED ENG, V58, P2127, DOI 10.1109/TBME.2011.2149521; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Shorter KA, 2008, CLIN BIOMECH, V23, P459, DOI 10.1016/j.clinbiomech.2007.11.009; Silva MPT, 2004, GAIT POSTURE, V19, P35, DOI 10.1016/S0966-6362(03)00013-4; Simon J, 2007, GAIT POSTURE, V26, P11; Sinitski EH, 2015, GAIT POSTURE, V41, P568, DOI 10.1016/j.gaitpost.2014.12.016; Struchkov V, 2016, CLIN BIOMECH, V32, P164, DOI 10.1016/j.clinbiomech.2015.11.015; Tulchin K, 2010, JPO J PROSTHETICS OR, V22, P53; van der Linden ML, 1999, J BIOMECH, V32, P877, DOI 10.1016/S0021-9290(99)00086-X; Versluys R, 2009, DISABIL REHABIL-ASSI, V4, P65, DOI 10.1080/17483100802715092; Villa C, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P175; Villa C, 2016, ARCH PHYS MED REHABI; Villa C, 2015, C INT SOC BIOM 12 16, P1256; Villa C, 2015, CLIN BIOMECH, V30, P623, DOI 10.1016/j.clinbiomech.2015.03.022; Vogt L, 2002, CLIN BIOMECH, V17, P162, DOI 10.1016/S0268-0033(01)00111-5; WIRTA RW, 1991, J REHABIL RES DEV, V28, P13, DOI 10.1682/JRRD.1991.04.0013; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	42	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180836	10.1371/journal.pone.0180836	http://dx.doi.org/10.1371/journal.pone.0180836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704428	Green Published, gold			2022-12-27	WOS:000405649700053
J	Chen, RJ; Gifford, DK				Chen, Rujian; Gifford, David K.			Differential chromatin profiles partially determine transcription factor binding	PLOS ONE			English	Article							IN-VIVO	We characterize how genomic variants that alter chromatin accessibility influence regulatory factor binding with a new method called DeltaBind that predicts condition specific factor binding more accurately than other methods based on DNase-seq data. Using DeltaBind and DNase-seq experiments we predicted the differential binding of 18 factors in K562 and GM12878 cells with an average precision of 28% at 10% recall, with the prediction of individual factors ranging from 5% to 65% precision. We further found that genome variants that alter chromatin accessibility are not necessarily predictive of altering proximal factor binding. Taken together these findings suggest that DNase-seq or ATAC-seq Quantitative Trait Loci (dsQTLs), while important, must be considered in a broader context to establish causality for phenotypic changes.	[Chen, Rujian; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institute of Health [U01HG007037]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health under grant U01HG007037 to D.G.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; MacQuarrie KL, 2013, MOL CELL BIOL, V33, P773, DOI 10.1128/MCB.00916-12; Mahony S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003501; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Teif VB, 2014, GENOME RES, V24, P1285, DOI 10.1101/gr.164418.113	11	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179411	10.1371/journal.pone.0179411	http://dx.doi.org/10.1371/journal.pone.0179411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704389	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700010
J	Gleason, RJ; Vora, M; Li, Y; Kane, NS; Liao, K; Padgett, RW				Gleason, Ryan J.; Vora, Mehul; Li, Ying; Kane, Nanci S.; Liao, Kelvin; Padgett, Richard W.			C-elegans SMA-10 regulates BMP receptor trafficking	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; TGF-BETA; I RECEPTOR; SIGNALING PATHWAY; TRANSGENIC LINES; FAMILY; GENOME; LRIG1; UBIQUITINATION; ACTIVATION	Signal transduction of the conserved transforming growth factor-beta(TGF beta) family signaling pathway functions through two distinct serine/ threonine transmembrane receptors, the type I and type II receptors. Endocytosis orchestrates the assembly of signaling complexes by coordinating the entry of receptors with their downstream signaling mediators. Recently, we showed that the C. elegans type I bone morphogenetic protein (BMP) receptor SMA-6, part of the TGF beta family, is recycled through the retromer complex while the type II receptor, DAF-4 is recycled in a retromer-independent, ARF-6 dependent manner. From genetic screens in C. elegans aimed at identifying new modifiers of BMP signaling, we reported on SMA-10, a conserved LRIG (leucine-rich and immunoglobulin-like domains) transmembrane protein. It is a positive regulator of BMP signaling that binds to the SMA-6 receptor. Here we show that the loss of sma-10 leads to aberrant endocytic trafficking of SMA-6, resulting in its accumulation in distinct intracellular endosomes including the early endosome, multivesicular bodies (MVB), and the late endosome with a reduction in signaling strength. Our studies show that trafficking defects caused by the loss of sma-10 are not universal, but affect only a limited set of receptors. Likewise, in Drosophila, we find that the fly homolog of sma-10, lambik (lbk), reduces signaling strength of the BMP pathway, consistent with its function in C. elegans and suggesting evolutionary conservation of function. Loss of sma-10 results in reduced ubiquitination of the type I receptor SMA-6, suggesting a possible mechanism for its regulation of BMP signaling.	[Gleason, Ryan J.; Vora, Mehul; Li, Ying; Kane, Nanci S.; Liao, Kelvin; Padgett, Richard W.] Rutgers State Univ, Canc Inst New Jersey, Dept Mol Biol & Biochem, Waksman Inst, Piscataway, NJ 08854 USA; [Gleason, Ryan J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Li, Ying] Chongqing Med Univ, Life Sci Inst, Chongqing, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Johns Hopkins University; Chongqing Medical University	Padgett, RW (corresponding author), Rutgers State Univ, Canc Inst New Jersey, Dept Mol Biol & Biochem, Waksman Inst, Piscataway, NJ 08854 USA.	padgett@waksman.rutgers.edu	Vora, Mehul/P-4848-2016	Vora, Mehul/0000-0002-1239-6458; Padgett, Richard/0000-0002-5740-3324	 [GM103995]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by GM103995 (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; BRENNER S, 1974, GENETICS, V77, P71; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cendrowski J, 2016, CYTOKINE GROWTH F R, V32, P63, DOI 10.1016/j.cytogfr.2016.07.002; Chen CL, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0229-4; de Leon N, 2016, CURR GENET, V62, P765, DOI 10.1007/s00294-016-0605-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Elderbroom JL, 2014, MOL BIOL CELL, V25, P2320, DOI 10.1091/mbc.E13-09-0524; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gleason RJ, 2014, P NATL ACAD SCI US; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gudey SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004207; Gumienny TL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000963; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gupta Bhagwati P, 2012, WormBook, P1, DOI 10.1895/wormbook.1.152.1; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Heldin C. H., 2016, COLD SPRING HARB PER, V8; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herhaus L, 2014, CELL SIGNAL, V26, P2186, DOI 10.1016/j.cellsig.2014.06.012; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Liu ZY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005221; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McLean S, 2010, BIOCHEM J, V429, P137, DOI 10.1042/BJ20091598; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; O'Brien CE, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0065-0; Padgett RW, 1999, CANCER METAST REV, V18, P247, DOI 10.1023/A:1006325408261; Padgett RW, 2008, TGFBETA SIGNALING NE, P527; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Praitis V, 2001, GENETICS, V157, P1217; Praitis Vida, 2006, V351, P93; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sato Ken, 2014, WormBook, P1, DOI 10.1895/wormbook.1.77.2; Savage-Dunn C, 2017, COLD SPRING HARB PER; Savage-Dunn C., 2005, TGF BETA SIGNALING; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; Schweinsberg Peter J, 2013, WormBook, P1, DOI 10.1895/wormbook.1.166.1; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Simion C, 2014, ENDOCR-RELAT CANCER, V21, pR431, DOI 10.1530/ERC-14-0179; Skorobogata O, 2016, MOL BIOL CELL; Skorobogata O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036489; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tian CX, 2010, DEVELOPMENT, V137, P2375, DOI 10.1242/dev.051615; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Upadhyay A, 2017, COLD SPRING HARB PER; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Wang L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006568; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xu P, 2016, COLD SPRING HARB PER; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Zhang Jing, 2012, Cell Logist, V2, P161	78	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180681	10.1371/journal.pone.0180681	http://dx.doi.org/10.1371/journal.pone.0180681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704415	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700046
J	Paulone, S; Ardizzoni, A; Tavanti, A; Piccinelli, S; Rizzato, C; Lupetti, A; Colombari, B; Pericolini, E; Polonelli, L; Magliani, W; Conti, S; Posteraro, B; Cermelli, C; Blasi, E; Peppoloni, S				Paulone, Simona; Ardizzoni, Andrea; Tavanti, Arianna; Piccinelli, Serena; Rizzato, Cosmeri; Lupetti, Antonella; Colombari, Bruna; Pericolini, Eva; Polonelli, Luciano; Magliani, Walter; Conti, Stefania; Posteraro, Brunella; Cermelli, Claudio; Blasi, Elisabetta; Peppoloni, Samuele			The synthetic killer peptide KP impairs Candida albicans biofilm in vitro	PLOS ONE			English	Article							ANTIFUNGAL SUSCEPTIBILITY; AMPHOTERICIN-B; RESISTANCE; FUNGAL; INFECTIONS; MECHANISMS	Candida albicans is a commensal organism, commonly inhabiting mucosal surfaces of healthy individuals, as a part of the resident microbiota. However, in susceptible hosts, especially hospitalized and/or immunocompromised patients, it may cause a wide range of infections. The presence of abiotic substrates, such as central venous or urinary catheters, provides an additional niche for Candida attachment and persistence, particularly via biofilm development. Furthermore, Candida biofilm is poorly susceptible to most antifungals, including azoles. Here we investigated the effects of a synthetic killer peptide (KP), known to be active in vitro, ex vivo and/or in vivo against different pathogens, on C. albicans biofilm. Together with a scrambled peptide used as a negative control, KP was tested against Candida biofilm at different stages of development. A reference strain, two fluconazole-resistant and two fluconazole-susceptible C. albicans clinical isolates were used. KP-induced C. albicans oxidative stress response and membrane permeability were also analysed. Moreover, the effect of KP on transcriptional profiles of C. albicans genes involved in different stages of biofilm development, such as cell adhesion, hyphal development and extracellular matrix production, was evaluated. Our results clearly show that the treatment with KP strongly affected the capacity of C. albicans to form biofilm and significantly impairs preformed mature biofilm. KP treatment resulted in an increase in C. albicans oxidative stress response and membrane permeability; also, biofilm-related genes expression was significantly reduced. Comparable inhibitory effects were observed in all the strains employed, irrespective of their resistance or susceptibility to fluconazole. Finally, KP-mediated inhibitory effects were observed also against a catheter-associated C. albicans biofilm. This study provides the first evidence on the KP effectiveness against C. albicans biofilm, suggesting that KP may be considered as a potential novel tool for treatment and prevention of biofilm-related C. albicans infections.	[Paulone, Simona; Ardizzoni, Andrea; Piccinelli, Serena; Colombari, Bruna; Pericolini, Eva; Cermelli, Claudio; Blasi, Elisabetta; Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Tavanti, Arianna] Univ Pisa, Dept Biol, Pisa, Italy; [Rizzato, Cosmeri; Lupetti, Antonella] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Polonelli, Luciano; Magliani, Walter; Conti, Stefania] Univ Parma, Dept Med & Surg, Parma, Italy; [Posteraro, Brunella] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Publ Hlth, Rome, Italy	Universita di Modena e Reggio Emilia; University of Pisa; University of Pisa; University of Parma; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Blasi, E (corresponding author), Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy.	elisabetta.blasi@unimore.it	Rizzato, Cosmeri/AAI-1261-2020; Posteraro, Brunella/K-8499-2018; Pericolini, Eva/AAZ-5848-2021; ardizzoni, andrea/AAC-4337-2021; Blasi, Elisabetta/F-5870-2015; Cermelli, Claudio/L-1501-2016; Conti, Stefania/N-3558-2015; Ardizzoni, Andrea/G-2976-2015	Posteraro, Brunella/0000-0002-1663-7546; ardizzoni, andrea/0000-0003-2678-0714; Blasi, Elisabetta/0000-0002-4202-8293; Cermelli, Claudio/0000-0003-3396-0000; Conti, Stefania/0000-0001-9973-8352; Ardizzoni, Andrea/0000-0001-9845-7399; Tavanti, Arianna/0000-0001-5791-686X; Pericolini, Eva/0000-0002-5299-8197				Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414; Mesa-Arango AC, 2014, ANTIMICROB AGENTS CH, V58, P6627, DOI 10.1128/AAC.03570-14; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; De Brucker K, 2014, ANTIMICROB AGENTS CH, V58, P5395, DOI 10.1128/AAC.03045-14; Delattin N, 2017, CURR TOP MED CHEM, V17, P604, DOI 10.2174/1568026616666160713142228; Deorukhkar SC, 2016, INTERDISCIPLINARY PE, V2016, P5; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Gulati M, 2016, MICROBES INFECT, V18, P310, DOI 10.1016/j.micinf.2016.01.002; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Hirota K, 2017, J APPL MICROBIOL, V122, P321, DOI 10.1111/jam.13330; Hua J, 2010, MOL ORAL MICROBIOL, V25, P418, DOI 10.1111/j.2041-1014.2010.00590.x; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kucharikova S, 2015, JOVE-J VIS EXP, DOI 10.3791/52239; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lupetti A, 2002, ANTIMICROB AGENTS CH, V46, P1634, DOI 10.1128/AAC.46.6.1634-1639.2002; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Magliani W, 2011, FUTURE MED CHEM, V3, P1209, DOI [10.4155/fmc.11.71, 10.4155/FMC.11.71]; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Mazaheritehrani E, 2014, VIRUS RES, V179, P153, DOI 10.1016/j.virusres.2013.10.018; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; Moreno MG, 2017, CURR TOP MED CHEM; Morici P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167470; Niimi K, 2010, J ANTIMICROB CHEMOTH, V65, P842, DOI 10.1093/jac/dkq073; Pierce Christopher G, 2010, J Vis Exp, DOI 10.3791/2287; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35018; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramirez-Zavala B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003696; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2016, ANTIMICROB AGENTS CH, V60, P229, DOI 10.1128/AAC.02157-15; Scorzoni L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00036; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Vriens K, 2016, PEPTIDES, V75, P71, DOI 10.1016/j.peptides.2015.11.001; Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117; Zhao L-P, 2013, PLOS ONE, V8	47	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181278	10.1371/journal.pone.0181278	http://dx.doi.org/10.1371/journal.pone.0181278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704490	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700118
J	Rosenberg, M; Steele, KM				Rosenberg, Michael; Steele, Katherine M.			Simulated impacts of ankle foot orthoses on muscle demand and recruitment in typically-developing children and children with cerebral palsy and crouch gait	PLOS ONE			English	Article							SINGLE-LIMB STANCE; FLEXED-KNEE STANCE; HUMAN WALKING; ENERGY-COST; AUTONOMOUS EXOSKELETON; DYNAMIC SIMULATIONS; LOWER-EXTREMITY; METABOLIC COST; FORCE; MODEL	Passive ankle foot orthoses (AFOs) are often prescribed for children with cerebral palsy (CP) to assist locomotion, but predicting how specific device designs will impact energetic demand during gait remains challenging. Powered AFOs have been shown to reduce energy costs of walking in unimpaired adults more than passive AFOs, but have not been tested in children with CP. The goal of this study was to investigate the potential impact of powered and passive AFOs on muscle demand and recruitment in children with CP and crouch gait. We simulated gait for nine children with crouch gait and three typically-developing children with powered and passive AFOs. For each AFO design, we computed reductions in muscle demand compared to unassisted gait. Powered AFOs reduced muscle demand 15-44% compared to unassisted walking, 1-14% more than passive AFOs. A slower walking speed was associated with smaller reductions in absolute muscle demand for all AFOs (r(2) = 0.60-0.70). However, reductions in muscle demand were only moderately correlated with crouch severity (r(2) = 0.40-0.43). The ankle plantarflexor muscles were most heavily impacted by the AFOs, with gastrocnemius recruitment decreasing 13-73% and correlating with increasing knee flexor moments (r(2) = 0.29-0.91). These findings support the potential use of powered AFOs for children with crouch gait, and highlight how subject-specific kinematics and kinetics may influence muscle demand and recruitment to inform AFO design.	[Rosenberg, Michael; Steele, Katherine M.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rosenberg, M (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	mcrosenb@uw.edu	Steele, Katherine/GYE-0887-2022; Rosenberg, Michael/AAD-6682-2020	Steele, Katherine/0000-0002-4128-9387; 	National Science Foundation [CBET-1452646]; Institute for Translational Health Sciences, National Institutes of Health - National Center for Advancing Translational Sciences [TL1TR000422]; Directorate For Engineering [1452646] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Translational Health Sciences, National Institutes of Health - National Center for Advancing Translational Sciences; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding was provided to KMS by the National Science Foundation (https://www.nsf.gov/) grant CBET-1452646 and to MR by the Institute for Translational Health Sciences (https://www.iths.org/) as part of National Institutes of Health - National Center for Advancing Translational Sciences (https://ncats.nih.gov/) grant number TL1TR000422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Arnold AS, 2006, J BIOMECH, V39, P1498, DOI 10.1016/j.jbiomech.2005.03.026; Arnold EM, 2013, J EXP BIOL, V216, P2150, DOI 10.1242/jeb.075697; Bregman DJJ, 2009, GAIT POSTURE, V30, P144, DOI 10.1016/j.gaitpost.2009.05.012; Brehm MA, 2008, J REHABIL MED, V40, P529, DOI 10.2340/16501977-0209; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Fowler EG, 2010, DEV MED CHILD NEUROL, V52, P264, DOI 10.1111/j.1469-8749.2009.03586.x; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Harlaar J, 2010, PROSTHET ORTHOT INT, V34, P327, DOI 10.3109/03093646.2010.504977; HARRINGTON ED, 1983, ORTHOTICS PROSTHET, V37, P34; Hegarty AK, 2016, J BIOMECHANICAL ENG; Hicks J, 2006, GAIT POSTURE, V24, pS99; Hicks JL, 2008, J BIOMECH, V41, P960, DOI 10.1016/j.jbiomech.2008.01.002; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Hoang HX, 2012, GAIT POSTURE, V36, P405, DOI 10.1016/j.gaitpost.2012.03.020; HOF AL, 1996, GAIT POSTURE, V4, P222; HSU AT, 1993, CLIN ORTHOP RELAT R, P254; Kerkum YL, 2016, GAIT POSTURE, V46, P104, DOI 10.1016/j.gaitpost.2016.03.001; Kerkum YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142878; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Maltais D, 2001, MED SCI SPORT EXER, V33, P320; Meyns P, 2017, FRONT HUM NEUROSCI, P11; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; PERRY J, 1975, J BONE JOINT SURG AM, V57, P961, DOI 10.2106/00004623-197557070-00014; Ries AJ, 2015, PM&R, V7, P922, DOI 10.1016/j.pmrj.2015.03.005; Ries AJ, 2014, GAIT POSTURE, V40, P539, DOI 10.1016/j.gaitpost.2014.06.011; ROSE J, 1989, J PEDIATR ORTHOPED, V9, P276; Royer TD, 2005, MED SCI SPORT EXER, V37, P649, DOI 10.1249/01.MSS.0000159007.56083.96; Sawicki GS, 2016, IEEE T BIO-MED ENG, V63, P914, DOI 10.1109/TBME.2015.2491224; Schwartz MH, 2004, J PEDIATR ORTHOPED, V24, P45, DOI 10.1097/01241398-200401000-00009; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Steele KM, 2013, GAIT POSTURE, V38, P86, DOI 10.1016/j.gaitpost.2012.10.019; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Summa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151792; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; TURNER DL, 1991, J EXP BIOL, V160, P309; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018; Wren TAL, 2015, PEDIATR PHYS THER, V27, P218, DOI 10.1097/PEP.0000000000000153	54	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180219	10.1371/journal.pone.0180219	http://dx.doi.org/10.1371/journal.pone.0180219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704464	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700032
J	Vassiliou, VS; Flynn, PD; Raphael, CE; Newsome, S; Khan, T; Ali, A; Halliday, B; Bruengger, AS; Malley, T; Sharma, P; Selvendran, S; Aggarwal, N; Sri, A; Berry, H; Donovan, J; Lam, W; Auger, D; Cook, SA; Pennell, DJ; Prasad, SK				Vassiliou, Vassilios S.; Flynn, Paul D.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Berry, Helen; Donovan, Jackie; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.			Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance	PLOS ONE			English	Article							MYOCARDIAL FIBROSIS; VALVE STENOSIS; ELEVATED LIPOPROTEIN(A); PROGNOSTIC-SIGNIFICANCE; RAISED LIPOPROTEIN(A); PLASMINOGEN-ACTIVATOR; REFRACTORY ANGINA; MIDWALL FIBROSIS; DISEASE; CARDIOMYOPATHY	Background Aortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patients with aortic stenosis. Although mechanistic pathways could link Lipoprotein(a) with myocardial fibrosis, whether the two are related has not been previously explored. In this study, we investigated whether elevated Lipoprotein(a) was associated with the presence of myocardial replacement fibrosis. Methods A total of 110 patients with mild, moderate and severe aortic stenosis were assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance to identify fibrosis. Mann Whitney U tests were used to assess for evidence of an association between Lp(a) and the presence or absence of myocardial fibrosis and aortic stenosis severity and compared to controls. Univariable and multivariable linear regression analysis were undertaken to identify possible predictors of Lp(a). Results Thirty-six patients (32.7%) had no LGE enhancement, 38 (34.6%) had midwall enhancement suggestive of midwall fibrosis and 36 (32.7%) patients had subendocardial myocardial fibrosis, typical of infarction. The aortic stenosis patients had higher Lp(a) values than controls, however, there was no significant difference between the Lp(a) level in mild, moderate or severe aortic stenosis. No association was observed between midwall or infarction pattern fibrosis and Lipoprotein(a), in the mild/moderate stenosis (p = 0.91) or severe stenosis patients (p = 0.42). Conclusion There is no evidence to suggest that higher Lipoprotein(a) leads to increased myocardial midwall or infarction pattern fibrosis in patients with aortic stenosis.	[Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, CMR Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, NIHR Biomed Res Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Harefield Hosp, NIHR Biomed Res Unit, London, England; [Vassiliou, Vassilios S.; Raphael, Claire E.; Newsome, Simon; Khan, Tina; Ali, Aamir; Halliday, Brian; Bruengger, Annina Studer; Malley, Tamir; Sharma, Pranev; Selvendran, Subothini; Aggarwal, Nikhil; Sri, Anita; Lam, Willis; Auger, Dominique; Cook, Stuart A.; Pennell, Dudley J.; Prasad, Sanjay K.] Imperial Coll London, London, England; [Vassiliou, Vassilios S.] Univ East Anglia, Norwich Med Sch, Bob Champion Res & Educ Bldg, Norwich, Norfolk, England; [Flynn, Paul D.] UK & Univ Cambridge, Cambridge Univ Fdn NHS Trust, Addenbrookes Hosp, Lipid Clin, Cambridge, England; [Newsome, Simon] London Sch Hyg & Trop Med, Dept Stat, London, England; [Bruengger, Annina Studer] Stadtspital Triemli, Clin Cardiol, Zurich, Switzerland; [Berry, Helen; Donovan, Jackie] Royal Brompton & Harefield NHS Trust, Dept Biochem, London, England; [Cook, Stuart A.] Duke Natl Univ Hosp, Singapore, Singapore; [Cook, Stuart A.] Imperial Coll London, MRC London Inst Med Sci, Cardiovasc Magnet Resonance Imaging & Genet, Hammersmith Hosp Campus, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; University of East Anglia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Triemli Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Vassiliou, VS (corresponding author), Royal Brompton Hosp, CMR Unit, London, England.; Vassiliou, VS (corresponding author), Royal Brompton Hosp, NIHR Biomed Res Unit, London, England.; Vassiliou, VS (corresponding author), Harefield Hosp, NIHR Biomed Res Unit, London, England.; Vassiliou, VS (corresponding author), Imperial Coll London, London, England.; Vassiliou, VS (corresponding author), Univ East Anglia, Norwich Med Sch, Bob Champion Res & Educ Bldg, Norwich, Norfolk, England.	v.vassiliou@rbht.nhs.uk; b.halliday@rbht.nhs.uk	Halliday, Brian/R-5634-2019; Vassiliou, Vass/AAZ-7358-2020; Auger, Dominique/AAG-3819-2020	Vassiliou, Vass/0000-0002-4005-7752; Halliday, Brian/0000-0002-5876-1748; Pennell, Dudley/0000-0001-5523-1314	Rosetrees Charity Trust, London, UK; NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK; British Heart Foundation Clinical Research Training fellowship [FS/14/13/30619, FS/15/29/31492]; Medical Research Council, UK; MRC [MR/M003191/1, MC_U120085815] Funding Source: UKRI; British Heart Foundation [FS/15/29/31492, FS/14/13/30619] Funding Source: researchfish; Medical Research Council [MC_U120085815, MR/M003191/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10089] Funding Source: researchfish; Rosetrees Trust [M189-F1] Funding Source: researchfish	Rosetrees Charity Trust, London, UK; NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK; British Heart Foundation Clinical Research Training fellowship; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	The authors would like to acknowledge financial support from Rosetrees Charity Trust (VSV, SKP), London, UK, and the NIHR Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, UK (TK, DJP, SKP). CR and BH were supported by a British Heart Foundation Clinical Research Training fellowship (FS/14/13/30619 and FS/15/29/31492). SAC was supported by the Medical Research Council, UK.	Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P369, DOI 10.1016/0009-3084(94)90159-7; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Barone-Rochette G, 2014, J AM COLL CARDIOL, V64, P144, DOI 10.1016/j.jacc.2014.02.612; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Bouchareb R, 2015, CIRCULATION, V132, P677, DOI 10.1161/CIRCULATIONAHA.115.016757; BROWN MS, 1987, NATURE, V330, P113, DOI 10.1038/330113a0; Capoulade R, 2015, J AM COLL CARDIOL, V66, P1236, DOI 10.1016/j.jacc.2015.07.020; Chin CW, 2014, EXPERT REV CARDIOVAS, V12, P901, DOI 10.1586/14779072.2014.923307; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Dube JB, 2012, CURR OPIN LIPIDOL, V23, P133, DOI 10.1097/MOL.0b013e32835111d8; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hung MY, 2014, CURR OPIN LIPIDOL, V25, P423, DOI 10.1097/MOL.0000000000000131; Kamstrup PR, 2014, J AM COLL CARDIOL, V63, P470, DOI 10.1016/j.jacc.2013.09.038; Khan TZ, 2017, EUR HEART J, V38, P1561, DOI 10.1093/eurheartj/ehx178; Khan TZ, 2015, ATHEROSCLEROSIS SUPP, V18, P103, DOI 10.1016/j.atherosclerosissup.2015.02.019; Kostner KM, 2013, EUR HEART J, V34, P3268, DOI 10.1093/eurheartj/eht053; Kotar K, 2015, EARLY AORTIC VALVE L; Lee SP, 2015, RADIOLOGY, V274, P359, DOI 10.1148/radiol.14141120; Lippi G, 2012, J CLIN PHARM THER, V37, P1, DOI 10.1111/j.1365-2710.2011.01244.x; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Nordestgaard BG, 2015, J AM COLL CARDIOL, V66, P1247, DOI 10.1016/j.jacc.2015.07.045; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sabatine MS, 2015, NEW ENGL J MED, V372; SIMON DI, 1991, BIOCHEMISTRY-US, V30, P6671, DOI 10.1021/bi00241a006; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Vassiliou V, 2017, MAGMA IN PRESS; Vassiliou VS, 2017, J AM COLL CARDIOL, V69, P1755, DOI 10.1016/j.jacc.2017.01.034; Vassiliou VS, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0275-9; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181077	10.1371/journal.pone.0181077	http://dx.doi.org/10.1371/journal.pone.0181077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704465	Green Accepted, Green Published, gold			2022-12-27	WOS:000405649700089
J	Wang, J; Fan, H; Xiong, KC; Liu, YH				Wang, Jia; Fan, Huan; Xiong, Ke-Cai; Liu, Ying-Hong			Transcriptomic and metabolomic profiles of Chinese citrus fly, Bactrocera minax (Diptera: Tephritidae), along with pupal development provide insight into diapause program	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; INSECT DIAPAUSE; GENE-EXPRESSION; SARCOPHAGA-CRASSIPALPIS; COLD-HARDINESS; GC-MS; TREHALOSE; STRESS; TERMINATION; CALCIUM	The Chinese citrus fly, Bactrocera minax (Enderlein), is a devastating citrus pest in Asia. This univoltine insect enters obligatory pupal diapause in each generation, while little is known about the course and the molecular mechanisms of diapause. In this study, the course of diapause was determined by measuring the respiratory rate throughout the pupal stage. In addition, the variation of transcriptomic and metabolomic profiles of pupae at five developmental stages (pre-, early-, middle-, late-, and post-diapause) were evaluated by next-generation sequencing technology and H-1 nuclear magnetic resonance spectroscopy (NMR), respectively. A total of 4,808 genes were significantly altered in ten pairwise comparisons, representing major shifts in metabolism and signal transduction as well as endocrine system and digestive system. Gene expression profiles were validated by qRT-PCR analysis. In addition, 48 metabolites were identified and quantified by H-1 NMR. Nine of which significantly contributed to the variation in the metabolomic profiles, especially proline and trehalose. Moreover, the samples collected within diapause maintenance (early-, middle-, and late- diapause) only exhibited marginal transcriptomic and metabolomic variation with each other. These findings greatly improve our understanding of B. minax diapause and lay the foundation for further pertinent studies.	[Wang, Jia; Fan, Huan; Xiong, Ke-Cai; Liu, Ying-Hong] Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China	Southwest University - China	Wang, J (corresponding author), Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China.	aimarjia@126.com	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022	Wang, Jia/0000-0002-5803-5113	National Natural Science Foundation of China [31401742]; China Postdoctoral Science Foundation [2014M552307]; Chongqing Research program of Basic Research and Frontier Technology [cstc2016jcyjA0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Research program of Basic Research and Frontier Technology	This study was financially supported by the National Natural Science Foundation of China (31401742), the China Postdoctoral Science Foundation (2014M552307), and the Chongqing Research program of Basic Research and Frontier Technology (cstc2016jcyjA0203). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bi ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090435; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Bround MJ, 2013, J BIOL CHEM, V288, P18975, DOI 10.1074/jbc.M112.427062; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen EH, 2012, FLA ENTOMOL, V95, P593, DOI 10.1653/024.095.0309; CHURCHILL TA, 1989, J INSECT PHYSIOL, V35, P579, DOI 10.1016/0022-1910(89)90147-9; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Dong YC, 2014, J PEST SCI, V87, P647, DOI 10.1007/s10340-014-0605-3; Dong YC, 2014, INT J BIOL SCI, V10, P1051, DOI 10.7150/ijbs.9438; Dorji C, 2006, B ENTOMOL RES, V96, P531, DOI 10.1079/BER2006455; Drew RAI, 2006, J ECON ENTOMOL, V99, P1651, DOI 10.1603/0022-0493-99.5.1651; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Farag MA, 2012, PHYTOCHEMISTRY, V76, P60, DOI 10.1016/j.phytochem.2011.12.010; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gao Li-zhi, 2013, Scientia Agricultura Sinica, V46, P3285; Guo Q, 2015, GENE, V565, P106, DOI 10.1016/j.gene.2015.03.070; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Han P, 2011, J PEST SCI, V84, P289, DOI 10.1007/s10340-011-0363-4; Hounoum BM, 2015, ANAL BIOANAL CHEM, V407, P8861, DOI 10.1007/s00216-015-9047-x; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020; Kankofer M, 2001, PLACENTA, V22, P466, DOI 10.1053/plac.2001.0650; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Li YP, 2001, J INSECT PHYSIOL, V47, P1181, DOI 10.1016/S0022-1910(01)00099-3; Lu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099948; Lv J.X., 2010, J HUAZHONG AGR U SOC, V6, P46; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ragland GJ, 2011, J EXP BIOL, V214, P3948, DOI 10.1242/jeb.061085; Ragland GJ, 2009, J INSECT PHYSIOL, V55, P344, DOI 10.1016/j.jinsphys.2008.12.013; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santulli G, 2015, CURR MOL PHARMACOL, V8, P206, DOI 10.2174/1874467208666150507105105; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Tredwell GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016286; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157656; Wang Jia, 2014, Acta Entomologica Sinica, V57, P1375; Wang J, 2014, J ECON ENTOMOL, V107, P1519, DOI 10.1603/EC13539; Wang J, 2014, ARCH INSECT BIOCHEM, V85, P216, DOI 10.1002/arch.21155; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100558; Zhang Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-751; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d; Zhang Y., 2005, B AGR SCI TECH, V2, P22	75	12	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181033	10.1371/journal.pone.0181033	http://dx.doi.org/10.1371/journal.pone.0181033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704500	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600054
J	Yoshida, K; Shimizu, Y; Yoshimoto, J; Takamura, M; Okada, G; Okamoto, Y; Yamawaki, S; Doya, K				Yoshida, Kosuke; Shimizu, Yu; Yoshimoto, Junichiro; Takamura, Masahiro; Okada, Go; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Prediction of clinical depression scores and detection of changes in whole-brain using resting-state functional MRI data with partial least squares regression	PLOS ONE			English	Article							MAJOR DEPRESSION; REGIONAL HOMOGENEITY; HEAD MOTION; CONNECTIVITY; METAANALYSIS; CEREBELLUM; ACTIVATION; DISORDER; PATTERN; ENDOPHENOTYPES	In diagnostic applications of statistical machine learning methods to brain imaging data, common problems include data high-dimensionality and co-linearity, which often cause over-fitting and instability. To overcome these problems, we applied partial least squares (PLS) regression to resting-state functional magnetic resonance imaging (rs-fMRI) data, creating a low-dimensional representation that relates symptoms to brain activity and that predicts clinical measures. Our experimental results, based upon data from clinically depressed patients and healthy controls, demonstrated that PLS and its kernel variants provided significantly better prediction of clinical measures than ordinary linear regression. Subsequent classification using predicted clinical scores distinguished depressed patients from healthy controls with 80% accuracy. Moreover, loading vectors for latent variables enabled us to identify brain regions relevant to depression, including the default mode network, the right superior frontal gyrus, and the superior motor area.	[Yoshida, Kosuke] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Yoshida, Kosuke; Doya, Kenji] Okinawa Inst Sci & Technol Grad Univ, Neural Computat Unit, Onna, Okinawa, Japan; [Shimizu, Yu] Okinawa Inst Sci & Technol Grad Univ, Integrated Open Syst Unit, Onna, Okinawa, Japan; [Yoshimoto, Junichiro] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara, Japan; [Takamura, Masahiro; Okada, Go; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University; Nara Institute of Science & Technology; Hiroshima University	Yoshida, K (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.; Yoshida, K (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Neural Computat Unit, Onna, Okinawa, Japan.	kosuke.yoshida@oist.jp; yamawaki@hiroshima-u.ac.jp	Takamura, Masahiro/AEJ-6059-2022; Yoshimoto, Junichiro/B-5884-2015; Yoshimoto, Junichiro/ABI-8028-2020	Takamura, Masahiro/0000-0001-9742-152X; Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimoto, Junichiro/0000-0001-7995-0321	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED	Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This research is supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED (http://www.amed.go.jp/en). All authors of this study are supported by this program. This program does not have a grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Chen KW, 2009, NEUROIMAGE, V47, P602, DOI 10.1016/j.neuroimage.2009.04.053; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Embrechts M.J., 2003, NATO SCI SER SUBSER, V190, P227; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Giessing C, 2007, J COGNITIVE NEUROSCI, V19, P658, DOI 10.1162/jocn.2007.19.4.658; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haldane M, 2008, J PSYCHOPHARMACOLOGY; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Iwabuchi SJ, 2015, NEUROSCI BIOBEHAV R, V51, P77, DOI 10.1016/j.neubiorev.2015.01.006; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Katona CLE, 1995, REV CLIN GERONTOLOGY, V5, P427, DOI DOI 10.1017/S095925980000486X; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; MANNE R, 1987, CHEMOMETR INTELL LAB, V2, P187, DOI 10.1016/0169-7439(87)80096-5; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nestor PG, 2002, SCHIZOPHR RES, V53, P57, DOI 10.1016/S0920-9964(00)00171-7; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price JC, 2004, IEEE NUCL SCI CONF R, P3161; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Rosipal R, 2002, J MACH LEARN RES, V2, P97, DOI 10.1162/15324430260185556; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Shimizu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123524; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wold H., 1975, PERSPECTIVES PROBABI, P520; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yahata N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11254; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yoshida K, 2015, IEEE INT C BIOINFORM, P1078, DOI 10.1109/BIBM.2015.7359831; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	51	34	34	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179638	10.1371/journal.pone.0179638	http://dx.doi.org/10.1371/journal.pone.0179638			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700672	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600010
J	Li, H; Jiang, CX; Wu, DW; Shi, SP; Liao, MT; Wang, J; Li, YW; Xu, ZH				Li, Hui; Jiang, Chunxiang; Wu, Dongwen; Shi, Shupeng; Liao, Mengting; Wang, Jing; Li, Yanwen; Xu, Zihao			The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; EMMPRIN	Objective The prognostic significance of CD147 expression in esophageal cancer patients remains controversial. Using a meta-analysis, we investigated the prognostic and clinicopathologic characteristics of CD147 in esophageal cancer. Methods A comprehensive literature search of the PubMed (1966-2016), EMBASE (1980-2016), Cochrane Library (1996-2016), Web of Science (1945-2016), China National Knowledge Infrastructure (1982-2016), and Wanfang databases (1988-2016) was performed to identify studies of all esophageal cancer subtypes. Correlations between CD147 expression and survival outcomes and clinicopathological features were analyzed using meta-analysis methods. Results Seventeen studies were included. High CD147 expression reduced the 3-year survival rate (OR = 3.26, 95% CI = (1.53, 6.93), p = 0.02) and 5-year survival rate(OR = 4.35, 95% CI = (2.13, 8.90), p < 0.0001). High CD147 expression reduced overall survival in esophageal cancer (HR = 1.60, 95% CI = (1.19, 2.15), p = 0.02). Additionally, higher CD147 expression was detected in esophageal cancer tissues than noncancerous tissues (OR = 9.45, 95% CI = (5.39, 16.59), p < 0.00001), normal tissues (OR = 12.73, 95% CI = (3.49, 46.46), p = 0.0001), para-carcinoma tissues (OR = 12.80, 95% CI = (6.57, 24.92), p < 0.00001), and hyperplastic tissues (OR = 3.27, 95% CI = (1.47, 7.29), p = 0.004). CD147 expression was associated with TNM stage (OR = 3.66, 95% CI = (2.20, 6.09), p < 0.00001), tumor depth (OR = 7.97, 95% CI = (4.13, 15.38), p < 0.00001), and lymph node status (OR = 5.14, 95% CI = (2.03,13.01), p = 0.0005), but not with tumor differentiation, age, or sex. Conclusion Our meta-analysis suggests that CD147 is an efficient prognostic factor in esophageal cancer. High CD147 expression in patients with esophageal cancer was associated with worse survival outcomes and common clinicopathological indicators of poor prognosis.	[Li, Hui] Cent S Univ, Xiangya Hosp, Reprod Dept, Changsha, Hunan, Peoples R China; [Jiang, Chunxiang; Wu, Dongwen; Shi, Shupeng; Wang, Jing; Li, Yanwen; Xu, Zihao] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Liao, Mengting] Cent S Univ, Xiangya Hosp, Oncol Dept, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Li, H (corresponding author), Cent S Univ, Xiangya Hosp, Reprod Dept, Changsha, Hunan, Peoples R China.	HUILI257@hotmail.com	Liao, Mengting/GSJ-2298-2022					Abdel-Latif MMM, 2015, EUR J CANCER, V51, P464, DOI 10.1016/j.ejca.2014.11.014; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Cheng MF, 2006, DIS ESOPHAGUS, V19, P482, DOI 10.1111/j.1442-2050.2006.00613.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; ELLIS SM, 1989, CANCER RES, V49, P3385; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Guang MA, 2009, J NEW MED, V19, P12; Haiming L, 2010, CHINA FOREIGN MED TR, V29, P3; Hemdan T, 2015, J UROLOGY, V194, P1575, DOI 10.1016/j.juro.2015.06.085; Huang L, 2015, INT J CLIN EXP PATHO, V8, P1929; Huang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0651-3; Ishibashi Y, 2004, CANCER-AM CANCER SOC, V101, P1994, DOI 10.1002/cncr.20593; Jiang LY, 2015, CANCER LETT, V357, P69, DOI 10.1016/j.canlet.2014.11.045; Jin-xu C, 2009, CANC RES PREVENTION, V07, P596; LI Chang-xiu, 2013, LAB MED CLIN, V10, P129; Li H, 2017, ONCOTARGET; Li H, 2017, J NEUROONCOL; Li-na X, 2011, CLIN FOCUS, V01, P20; Ling X, 2008, J INT ONCOLOGY, V35, P156; Peng F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163678; Qi B, 2008, YI XUE XIN XI, V21, P886; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; Siegel R, 2014, CA CANC J CLIN, V64; Song-bai X, 2007, PROGR MODERN BIOMEDI, V01, P42; Tang WR, 2014, ASIAN PAC J CANCER P, V15, P6929, DOI 10.7314/APJCP.2014.15.16.6929; Wan Yong, 2012, Zhonghua Zhong Liu Za Zhi, V34, P44; Wang CY, 2015, ONCOTARGET, V6, P18674, DOI 10.18632/oncotarget.4367; Wang Q, 2015, GENET MOL RES, V14, P6844, DOI 10.4238/2015.June.18.27; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Xiao X., 2011, CLIN RES RELATIONSHI, V05, P58; [张惠忠 ZHANG Huizhong], 2006, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V23, P1248; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; [赵建华 Zhao Jianhua], 2004, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V24, P621; Zhao J, 2015, ONCOL REP, V34, P67, DOI 10.3892/or.2015.3999; Zhu S, 2011, DIG DIS SCI, V56; Zhu S, 2011, CHINESE J CELLULAR M, V07, P784; Zhu SJ, 2011, DIGEST DIS SCI, V56, P3569, DOI 10.1007/s10620-011-1812-x	37	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180271	10.1371/journal.pone.0180271	http://dx.doi.org/10.1371/journal.pone.0180271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700599	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400010
J	Kato, S; Chinen, K; Shinoura, S; Kikuchi, K				Kato, Shin; Chinen, Kenji; Shinoura, Susumu; Kikuchi, Kaoru			Predictors for bile duct stone recurrence after endoscopic extraction for naive major duodenal papilla: A cohort study	PLOS ONE			English	Article							LARGE BALLOON DILATION; TERM-FOLLOW-UP; RISK-FACTORS; PERIAMPULLARY DIVERTICULA; SPHINCTEROTOMY; CHOLEDOCHOLITHIASIS; SIZE; ASSOCIATION; DIAMETER; SUCCESS	Background Predictors for bile duct stone recurrence after endoscopic stone extraction have not yet been clearly defined and a study investigating naive major duodenal papilla is warranted because studies focusing only on naive major duodenal papilla are rare. The aim of this study was to observe the long-term outcomes of endoscopic bile duct stone extraction for naive major duodenal papilla and to assess the predictors for recurrence. Methods This was a retrospective cohort study that consisted of 384 patients with naive papilla who underwent initial endoscopic bile duct stone extraction. Patients were followed up in outpatient department subsequent to complete stone clearance. Recurrence was defined as symptomatic repeated stone formation observed at least three months after the procedure. Stone recurrence, predictors of recurrence, and the recurrence rate, depending on each endoscopic treatment for major duodenal papilla, were examined. Results In this study, 34 patients (8.9%) developed stone recurrence. The median time to recurrence was 439 days. Periampullary diverticulum and multiple stones were strong predictors of bile duct stone recurrence (RR, 5.065; 95% CI, 2.435-10.539 and RR: 2.4401; 95% CI: 1.0946-5.4396, respectively). The above two factors were independent predictors of stone recurrence as per logistic regression analysis adjusted for confounders (Periampullary diverticulum: OR, 7.768; 95% CI, 3.27-18.471; multiple stones: OR, 4.144; 95% CI, 1.33-12.915). No recurrence was observed after endoscopic papillary large balloon dilatation (0/20), whereas recurrence was observed in 7 patients after endoscopic papillary balloon dilatation (7/45) and in 27 patients after endoscopic sphincterotomy (27/319). However, these differences were not statistically significant (p = 0.105). Conclusions We determined that the presence of periampullary diverticulum and multiple stones are strong predictors for recurrence after endoscopic stone extraction. Moreover, endoscopic papillary large balloon dilatation tended to be correlated with non-recurrence of bile duct stone.	[Kato, Shin; Chinen, Kenji; Shinoura, Susumu; Kikuchi, Kaoru] Okinawa Prefectural Chubu Hosp, Dept Gastroenterol, Uruma, Okinawa, Japan		Kato, S (corresponding author), Okinawa Prefectural Chubu Hosp, Dept Gastroenterol, Uruma, Okinawa, Japan.	shinchan1231@gmail.com		Kato, Shin/0000-0003-4792-9397				Ando T, 2003, GUT, V52, P116, DOI 10.1136/gut.52.1.116; BENATTAR JM, 1993, DIGEST DIS SCI, V38, P2225, DOI 10.1007/BF01299900; Chang JH, 2014, TURK J GASTROENTEROL, V25, P518, DOI 10.5152/tjg.2014.6457; Costamagna G, 2002, ENDOSCOPY, V34, P273, DOI 10.1055/s-2002-23632; Itokawa F, 2015, J GASTROEN HEPATOL, V30, P223, DOI 10.1111/jgh.12675; Keizman D, 2006, GASTROINTEST ENDOSC, V64, P60, DOI 10.1016/j.gie.2006.01.022; Kim CW, 2013, J GASTROEN HEPATOL, V28, P893, DOI 10.1111/jgh.12184; Kim DI, 2001, GASTROINTEST ENDOSC, V54, P42, DOI 10.1067/mge.2001.115335; Kim KH, 2012, GUT LIVER, V6, P107, DOI 10.5009/gnl.2012.6.1.107; Kim MH, 1998, ENDOSCOPY, V30, P601, DOI 10.1055/s-2007-1001363; KUBOTA Y, 1993, ABDOM IMAGING, V18, P145; Lai KH, 1997, GUT, V41, P399, DOI 10.1136/gut.41.3.399; LAURI A, 1993, GUT, V34, P1718, DOI 10.1136/gut.34.12.1718; Li X, 2012, WORLD J SURG, V36, P2666, DOI 10.1007/s00268-012-1716-8; MIYAZAWA Y, 1995, INT SURG, V80, P120; Oak JH, 2012, GASTROENT RES PRACT, V2012; Pereira-Lima JC, 1998, GASTROINTEST ENDOSC, V48, P457, DOI 10.1016/S0016-5107(98)70085-9; Saito M, 2000, GASTROINTEST ENDOSC, V51, P540, DOI 10.1016/S0016-5107(00)70286-0; Sugiyama M, 2004, GUT, V53, P1856, DOI 10.1136/gut.2004.041020; Sugiyama M, 2001, SCAND J GASTROENTERO, V36, P994, DOI 10.1080/003655201750305549; Sun Z, 2016, GASTROENTEROLOGY RES, V2016; Tanaka M, 1998, GASTROINTEST ENDOSC, V48, P465, DOI 10.1016/S0016-5107(98)70086-0; Tham TCK, 2004, ENDOSCOPY, V36, P1050, DOI 10.1055/s-2004-826043; Wan XJ, 2011, HEPATOB PANCREAT DIS, V10, P403, DOI 10.1016/S1499-3872(11)60068-4; Wojtun S, 1997, ENDOSCOPY, V29, P258, DOI 10.1055/s-2007-1004186; Yasuda I, 2010, GASTROINTEST ENDOSC, V72, P1185, DOI 10.1016/j.gie.2010.07.006	26	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180536	10.1371/journal.pone.0180536	http://dx.doi.org/10.1371/journal.pone.0180536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692706	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800051
J	Naumann, P; Liermann, J; Fortunato, F; Schmid, TE; Weber, KJ; Debus, J; Combs, SE				Naumann, Patrick; Liermann, Jakob; Fortunato, Franco; Schmid, Thomas E.; Weber, Klaus-Josef; Debus, Juergen; Combs, Stephanie E.			Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; OXIDATIVE STRESS; NEOADJUVANT CHEMORADIATION; GAMMA-H2AX; ARREST; CHEMOTHERAPY; RADIATION; APOPTOSIS; PATHWAYS; PHASE	Background Sulforaphane (SFN), an herbal isothiocyanate enriched in cruciferous vegetables like broccoli and cauliflower, has gained popularity for its antitumor effects in cell lines such as pancreatic cancer. Antiproliferative as well as radiosensitizing properties were reported for head and neck cancer but little is known about its effects in pancreatic cancer cells in combination with irradiation (RT). Methods In four established pancreatic cancer cell lines we investigated clonogenic survival, analyzed cell cycle distribution and compared DNA damage via flow cytometry and western blot after treatment with SFN and RT. Results Both SFN and RT show a strong and dose dependent survival reduction in clonogenic assays, an induction of a G2/M cell cycle arrest and an increase in.H2AX protein level indicating DNA damage. Effects were more pronounced in combined treatment and both cell cycle perturbation and DNA damage persisted for a longer period than after SFN or RT alone. Moreover, SFN induced a loss of DNA repair proteins Ku 70, Ku 80 and XRCC4. Conclusion Our results suggest that combination of SFN and RT exerts a more distinct DNA damage and growth inhibition than each treatment alone. SFN seems to be a viable option to improve treatment efficacy of chemoradiation with hopefully higher rates of secondary resectability after neoadjuvant treatment for pancreatic cancer.	[Naumann, Patrick; Liermann, Jakob; Weber, Klaus-Josef; Debus, Juergen] Univ Clin Heidelberg, Dept Radiat Oncol, Heidelberg, Germany; [Fortunato, Franco] Univ Clin Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Schmid, Thomas E.; Combs, Stephanie E.] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany; [Combs, Stephanie E.] Helmholtz Zentrum Munchen, DRS, Inst Innovat Radiotherapy iRT, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Naumann, P (corresponding author), Univ Clin Heidelberg, Dept Radiat Oncol, Heidelberg, Germany.	patrick.naumann@med.uni-heidelberg.de		Schmid, Thomas/0000-0002-8894-8087				Adiseshaiah PP, 2016, NAT REV CLIN ONCOL, V13, P750, DOI 10.1038/nrclinonc.2016.119; Akasaka H, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0729-0; Appari M, 2014, INT J ONCOL, V45, P1391, DOI 10.3892/ijo.2014.2539; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brunner T, 2012, STRAHLENTHER ONKOL, V188, P366, DOI 10.1007/s00066-012-0079-2; Brunner TB, 2016, BEST PRACT RES CL GA, V30, P617, DOI 10.1016/j.bpg.2016.08.001; Chang CC, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-41; Forster T, 2014, ONCOTARGET, V5, P1621, DOI 10.18632/oncotarget.1764; Ganai SA, 2016, ANTICANCER AGENTS ME; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Habermehl D, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-28; Harrabi SB, 2016, J RADIAT RES, V57, P110, DOI 10.1093/jrr/rrv097; Kotowski U, 2011, STRAHLENTHER ONKOL, V187, P575, DOI 10.1007/s00066-011-2218-6; Kuo LJ, 2008, IN VIVO, V22, P305; Li YY, 2012, J NUTR BIOCHEM, V23, P1617, DOI 10.1016/j.jnutbio.2011.11.004; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lozanovski VJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-204; Naumann P, 2013, STRAHLENTHER ONKOL, V189, P745, DOI 10.1007/s00066-013-0393-3; Naumann P, 2011, INT J ONCOL, V39, P101, DOI 10.3892/ijo.2011.1025; Pham NA, 2004, MOL CANCER THER, V3, P1239; RADFORD IR, 1985, INT J RADIAT BIOL, V48, P45, DOI 10.1080/09553008514551051; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sawai Y, 2013, ONCOL REP, V29, P941, DOI 10.3892/or.2012.2195; Schlaich F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-260; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Song JY, 2003, J BIOL CHEM, V278, P36676, DOI 10.1074/jbc.M303692200; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Stewart FA, 2009, INT J RADIAT BIOL, V85, P574, DOI 10.1080/09553000902985136	34	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180940	10.1371/journal.pone.0180940	http://dx.doi.org/10.1371/journal.pone.0180940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700650	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800102
J	Yasuga, H; Inoue, K; Kawano, R; Takinoue, M; Osaki, T; Kamiya, K; Miki, N; Takeuchi, S				Yasuga, Hiroki; Inoue, Kosuke; Kawano, Ryuji; Takinoue, Masahiro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji			Serial DNA relay in DNA logic gates by electrical fusion and mechanical splitting of droplets	PLOS ONE			English	Article							MICROFLUIDIC MIXER; BILAYER FORMATION; NANOPORE; ACID; DISCRIMINATION; OPERATIONS; MOLECULES; CIRCUITS; PLATFORM	DNA logic circuits utilizing DNA hybridization and/or enzymatic reactions have drawn increasing attention for their potential applications in the diagnosis and treatment of cellular diseases. The compartmentalization of such a system into a microdroplet considerably helps to precisely regulate local interactions and reactions between molecules. In this study, we introduced a relay approach for enabling the transfer of DNA from one droplet to another to implement multi-step sequential logic operations. We proposed electrical fusion and mechanical splitting of droplets to facilitate the DNA flow at the inputs, logic operation, output, and serial connection between two logic gates. We developed Negative-OR operations integrated by a serial connection of the OR gate and NOT gate incorporated in a series of droplets. The four types of input defined by the presence/absence of DNA in the input droplet pair were correctly reflected in the readout at the Negative-OR gate. The proposed approach potentially allows for serial and parallel logic operations that could be used for complex diagnostic applications.	[Yasuga, Hiroki; Inoue, Kosuke; Kawano, Ryuji; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji] Kanagawa Inst Ind Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan; [Yasuga, Hiroki; Inoue, Kosuke; Miki, Norihisa] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa, Japan; [Kawano, Ryuji] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa, Japan	Kanagawa Academy Science & Technology; Keio University; Tokyo University of Agriculture & Technology; Tokyo Institute of Technology; University of Tokyo; Keio University	Takeuchi, S (corresponding author), Kanagawa Inst Ind Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takinoue, Masahiro/AAI-6179-2020; Takeuchi, Shoji/J-5349-2019; Takinoue, Masahiro/A-1490-2014; Kawano, Ryuji/A-3177-2011; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Kamiya, Koki/F-9889-2018; Kamiya, Koki/AAL-6950-2020; Yasuga, Hiroki/AGZ-6419-2022	Takinoue, Masahiro/0000-0002-3874-2670; Takinoue, Masahiro/0000-0002-3874-2670; Kawano, Ryuji/0000-0001-6523-0649; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Yasuga, Hiroki/0000-0003-2040-9017; Takeuchi, Shoji/0000-0001-6946-0409	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25246017];  [24104002];  [15H00803];  [16H06043]	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (No. 24104002, 15H00803 and 16H06043) to MT and RK; the Regional Innovation Strategy Support Program to ST and TO; a Grant- in-Aid for Scientific Research (A) (No. 25246017) to ST of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Ayukawa S, 2011, ACCOUNTS CHEM RES, V44, P1369, DOI 10.1021/ar200128b; Barlow NE, 2016, LAB CHIP, V16, P4653, DOI 10.1039/c6lc01011c; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Feng LY, 2015, ANGEW CHEM INT EDIT, V54, P7693, DOI 10.1002/anie.201502315; Frezza BM, 2007, J AM CHEM SOC, V129, P14875, DOI 10.1021/ja0710149; Fu LM, 2005, ELECTROPHORESIS, V26, P1814, DOI 10.1002/elps.200410222; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Hiratani M, 2017, ANAL CHEM, V89, P2312, DOI 10.1021/acs.analchem.6b03830; Huang YY, 2015, ANAL CHIM ACTA, V870, P92, DOI 10.1016/j.aca.2015.02.026; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Kawano R, 2009, LANGMUIR, V25, P1233, DOI 10.1021/la803556p; Kim J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100099; Li Y, 2014, ANAL CHEM, V86, P4333, DOI 10.1021/ac500112d; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Nishimura T, 2012, MICROFLUID NANOFLUID, V13, P1, DOI 10.1007/s10404-012-0934-6; Ohara M, 2017, ACS SYNTH BIOL; Osaki T, 2017, ANAL CHEM, V89, P216, DOI 10.1021/acs.analchem.6b04744; Paik P, 2003, LAB CHIP, V3, P253, DOI 10.1039/b307628h; Park KS, 2012, SMALL, V8, P2203, DOI 10.1002/smll.201102758; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Yasuga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149667; You MX, 2015, J AM CHEM SOC, V137, P667, DOI 10.1021/ja509263k; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2010, NUCLEIC ACIDS RES, V38, P4182, DOI 10.1093/nar/gkq088	37	4	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180876	10.1371/journal.pone.0180876	http://dx.doi.org/10.1371/journal.pone.0180876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700641	gold, Green Published			2022-12-27	WOS:000405544800090
J	Leow, LA; Marinovic, W; Riek, S; Carroll, TJ				Leow, Li-Ann; Marinovic, Welber; Riek, Stephan; Carroll, Timothy J.			Cerebellar anodal tDCS increases implicit learning when strategic re-aiming is suppressed in sensorimotor adaptation	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; SENSORY PREDICTION ERRORS; PRISM ADAPTATION; VISUOMOTOR ADAPTATION; OLDER-ADULTS; EXPLICIT STRATEGY; MOVEMENT PREPARATION; INTERNAL-MODELS; MOTOR MEMORIES; DEGENERATION	Neurophysiological and neuroimaging work suggests that the cerebellum is critically involved in sensorimotor adaptation. Changes in cerebellar function alter behaviour when compensating for sensorimotor perturbations, as shown by non-invasive stimulation of the cerebellum and studies involving patients with cerebellar degeneration. It is known, however, that behavioural responses to sensorimotor perturbations reflect both explicit processes (such as volitional aiming to one side of a target to counteract a rotation of visual feedback) and implicit, error-driven updating of sensorimotor maps. The contribution of the cerebellum to these explicit and implicit processes remains unclear. Here, we examined the role of the cerebellum in sensorimotor adaptation to a 30 E rotation of visual feedback of hand position during target-reaching, when the capacity to use explicit processes was manipulated by controlling movement preparation times. Explicit re-aiming was suppressed in one condition by requiring subjects to initiate their movements within 300ms of target presentation, and permitted in another condition by requiring subjects to wait approximately 1050ms after target presentation before movement initiation. Similar to previous work, applying anodal transcranial direct current stimulation (]tDCS; 1.5mA) to the right cerebellum during adaptation resulted in faster compensation for errors imposed by the rotation. After exposure to the rotation, we evaluated implicit remapping in no-feedback trials after providing participants with explicit knowledge that the rotation had been removed. Crucially, movements were more adapted in these no-feedback trials following cerebellar anodal tDCS than after sham stimulation in both long and short preparation groups. Thus, cerebellar anodal tDCS increased implicit remapping during sensorimotor adaptation, irrespective of preparation time constraints. The results are consistent with the possibility that the cerebellum contributes to the formation of new visuomotor maps that correct perturbations in sensory feedback, even when explicit processes are suppressed during sensorimotor adaptation.	[Leow, Li-Ann; Marinovic, Welber; Riek, Stephan; Carroll, Timothy J.] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Bldg 26B, Brisbane, Qld, Australia; [Marinovic, Welber] Curtin Univ, Sch Psychol & Speech Pathol, Bldg 401, Perth, WA, Australia	University of Queensland; Curtin University	Leow, LA (corresponding author), Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement & Nutr Sci, Bldg 26B, Brisbane, Qld, Australia.	l.leow@uq.edu.au	Carroll, Timothy/C-3513-2008; Riek, Stephan/A-1506-2010; Leow, Li-Ann/D-1051-2016; Marinovic, Welber/F-1755-2010	Carroll, Timothy/0000-0003-0761-1819; Riek, Stephan/0000-0002-8355-8426; Leow, Li-Ann/0000-0002-9655-3181; Marinovic, Welber/0000-0002-2472-7955				Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bernard JA, 2013, FRONTIERS HUMAN NEUR; Bernard JA, 2014, NEUROSCI BIOBEHAV R, V42, P193, DOI 10.1016/j.neubiorev.2014.02.011; Block H, 2013, CEREBELLUM, V12, P781, DOI 10.1007/s12311-013-0486-7; Bock O, 2002, NEUROSCI BIOBEHAV R, V26, P761, DOI 10.1016/S0149-7634(02)00063-5; Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Brooks JX, 2015, NATURE NEUROSCIENCE; Bruijn SM, 2012, J NEUROPHYSIOL, V108, P1149, DOI 10.1152/jn.00018.2012; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Christou AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36633; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Clower DM, 2001, JNEUROSCI, V21, P6283; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; Fernandez-Ruiz J, 2011, BEHAV BRAIN RES, V219, P8, DOI 10.1016/j.bbr.2010.11.060; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Galea JM, 2009, J NEUROSCI, V29, P9115, DOI 10.1523/JNEUROSCI.2184-09.2009; Gibo TL, 2013, J NEUROPHYSIOL, V110, P322, DOI 10.1152/jn.00745.2012; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Haith AM, 2015, J NEUROSCI, V35, P5109, DOI 10.1523/JNEUROSCI.3869-14.2015; Hanajima R, 2015, J NEUROPHYSIOL, V114, P2460, DOI 10.1152/jn.00145.2015; Hardwick RM, 2014, NEUROBIOL AGING, V35, P2217, DOI 10.1016/j.neurobiolaging.2014.03.030; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Herzfeld DJ, 2014, NEUROIMAGE, V98, P147, DOI 10.1016/j.neuroimage.2014.04.076; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, ACTA PSYCHOL, V127, P369, DOI 10.1016/j.actpsy.2007.07.006; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hulst T, 2017, J NEUROPHYSIOLOGY; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; Jalali R, 2017, J NEUROPHYSIOLOGY; Jamil A., 2016, J PHYSL; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Kitago T, 2013, FRONTIERS HUMAN NEUR; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Kuper M, 2014, HUM BRAIN MAPP, V35, P1574, DOI 10.1002/hbm.22274; Leow L-A, 2016, BIORXIV; Luaute J, 2006, NEUROLOGY, V66, P1859, DOI 10.1212/01.wnl.0000219614.33171.01; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Marinovic W, 2008, EXP BRAIN RES, V188, P275, DOI 10.1007/s00221-008-1360-6; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDougle SD, 2016, P NATL ACAD SCI USA, V113, P6797, DOI 10.1073/pnas.1523669113; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Morehead J. R., 2015, NEURAL CONTROL MOVEM; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Panouilleres MTN, 2015, J PHYSIOL-LONDON, V593, P3645, DOI 10.1113/JP270484; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; REDDING GM, 1985, PERCEPT PSYCHOPHYS, V37, P225, DOI 10.3758/BF03207568; Saijo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009399; Schlerf J, 2012, J NEUROSCI, V32, P4913, DOI 10.1523/JNEUROSCI.4504-11.2012; Schlerf JE, 2013, J NEUROPHYSIOL, V109, P1164, DOI 10.1152/jn.00654.2011; SCHOUTEN JF, 1967, ACTA PSYCHOL, V27, P143, DOI 10.1016/0001-6918(67)90054-6; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2010, CEREBELLUM, V9, P580, DOI 10.1007/s12311-010-0201-x; Therrien AS, 2015, BRAIN; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; UHLARIK JJ, 1973, J EXP PSYCHOL, V98, P223, DOI 10.1037/h0034364; Vindras P, 2008, ERROR PARSING VISUOM, P1212; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Werner S, 2010, EXP BRAIN RES, V201, P429, DOI 10.1007/s00221-009-2052-6; Werner S, 2009, EXP BRAIN RES, V193, P189, DOI 10.1007/s00221-008-1607-2; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yavari F, 2015, EXP BRAIN RES; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	80	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179977	10.1371/journal.pone.0179977	http://dx.doi.org/10.1371/journal.pone.0179977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686607	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100028
J	Li, S; Zuo, Q; Wang, XY; Ma, WW; Jin, XX; Shi, JC; Ben-Gal, A				Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu; Ben-Gal, Alon			Characterizing roots and water uptake in a ground cover rice production system	PLOS ONE			English	Article							DRY-MATTER PRODUCTION; ORYZA-SATIVA L.; USE EFFICIENCY; GRAIN-YIELD; HYDRAULIC CONDUCTIVITY; SIGNAL-TRANSDUCTION; NUTRIENT-UPTAKE; NITROGEN MASS; WINTER-WHEAT; GROWTH	Background and aims Water-saving ground cover rice production systems (GCRPS) are gaining popularity in many parts of the world. We aimed to describe the characteristics of root growth, morphology, distribution, and water uptake for a GCRPS. Methods A traditional paddy rice production system (TPRPS) was compared with GCRPS in greenhouse and field experiments. In the greenhouse, GCRPS where root zone average soil water content was kept near saturation (GCRPS(sat)), field capacity (GCRPS(fwc)) and 80% field capacity (GCRPS(80%)), were evaluated. In a two-year field experiment, GCRPSsat and GCRPS(80%) were applied. Results Similar results were found in greenhouse and field experiments. Before mid-tillering the upper soil temperature was higher for GCRPS, leading to enhanced root dry weight, length, surface area, specific root length, and smaller diameter of roots but lower water uptake rate per root length compared to TPRPS. In subsequent growth stages, the reduced soil water content under GCRPS caused that the preponderance of root growth under GCRPS(sat) disappeared in comparison to TPRPS. Under other GCRPS treatments (GCRPS(fwc) and GCRPS(80%)), significant limitation on root growth, bigger root diameter and higher water uptake rate per root length were found. Conclusions Discrepancies in soil water and temperature between TPRPS and GCRPS caused adjustments to root growth, morphology, distribution and function. Even though drought stress was inevitable after mid-tillering under GCRPS, especially GCRPS(80%), similar or even enhanced root water uptake capacity in comparison to TPRPS might promote allocation of photosynthetic products to shoots and increase water productivity.	[Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] China Agr Univ, Dept Soil & Water Sci, Beijing, Peoples R China; [Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] Minist Educ, Key Lab Plant Soil Interact, Beijing, Peoples R China; [Li, Sen; Zuo, Qiang; Wang, Xiaoyu; Ma, Wenwen; Jin, Xinxin; Shi, Jianchu] Minist Agr, Key Lab Arable Land Conservat North China, Beijing, Peoples R China; [Ben-Gal, Alon] Agr Res Org, Soil Water & Environm Sci, Gilat Res Ctr, Negev, Israel	China Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, JC (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing, Peoples R China.; Shi, JC (corresponding author), Minist Educ, Key Lab Plant Soil Interact, Beijing, Peoples R China.; Shi, JC (corresponding author), Minist Agr, Key Lab Arable Land Conservat North China, Beijing, Peoples R China.	shijianchu@cau.edu.cn	Ben-Gal, Alon/F-5190-2013; , 李森/K-2019-2019	Ben-Gal, Alon/0000-0003-4105-7807; 	National Natural Science Foundation of China ( [51139006, 51621061]; Construction Special for First-class University [4572-18101510]	National Natural Science Foundation of China ((National Natural Science Foundation of China (NSFC)); Construction Special for First-class University	This research was supported partly by the National Natural Science Foundation of China (51139006 and 51621061) and the Construction Special for First-class University (4572-18101510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseng S, 1997, PLANT SOIL, V190, P267, DOI 10.1023/A:1004228201299; Asseng S, 1998, PLANT SOIL, V201, P265, DOI 10.1023/A:1004317523264; Azhiri-Sigari Tahere, 2000, Plant Production Science, V3, P180; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; [蔡昆争 CAI KunZheng], 2006, [生态学报, Acta Ecologica Sinica], V26, P1903; Chu G, 2014, FIELD CROP RES, V162, P108, DOI 10.1016/j.fcr.2013.11.006; Ding L, 2015, PLANT SCI, V234, P14, DOI 10.1016/j.plantsci.2015.01.016; Dirksen C., 1993, Water flow and solute transport in soils: developments and applications., P99; Feddes R. A., 1978, SIMULATION FIELD WAT; FEDDES RA, 1976, J HYDROL, V31, P13, DOI 10.1016/0022-1694(76)90017-2; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gao SY, 1998, AGRON J, V90, P505, DOI 10.2134/agronj1998.00021962009000040011x; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; HASEGAWA T, 2001, P 6 S INT SOC ROOT R, P520; He HB, 2014, J ANIM PLANT SCI, V24, P290; HENRY A, 2012, J EXP BOT, V63, P4751, DOI DOI 10.1093/jxb/ers150; Henry A, 2015, J EXP BOT, V66, P1787, DOI 10.1093/jxb/eru506; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jabran K, 2015, J AGRON CROP SCI, V201, P389, DOI 10.1111/jac.12099; Jabran K, 2015, INT J AGRIC BIOL, V17, P920, DOI 10.17957/IJAB/15.0019; Jiang Y, 2009, J ENVIRON MANAGE, V90, P3185, DOI 10.1016/j.jenvman.2009.04.016; Jin XX, 2016, J HYDROL, V540, P220, DOI 10.1016/j.jhydrol.2016.06.018; Ju CX, 2015, FIELD CROP RES, V175, P47, DOI 10.1016/j.fcr.2015.02.007; Kano-Nakatal M, 2011, PLANT PROD SCI, V14, P307, DOI 10.1626/pps.14.307; Kato Y, 2011, ANN BOT-LONDON, V108, P575, DOI 10.1093/aob/mcr184; Kato Y, 2010, FIELD CROP RES, V117, P9, DOI 10.1016/j.fcr.2009.12.003; Kreye C, 2007, NUTR CYCL AGROECOSYS, V77, P293, DOI 10.1007/s10705-006-9068-0; Kuwagata T, 2007, PLANT CELL PHYSIOL, V48, pS239; Kuwagata T, 2012, PLANT CELL PHYSIOL, V53, P1418, DOI 10.1093/pcp/pcs087; Lin S, WATER WISE RICE PROD; Liu MJ, 2014, FIELD CROP RES, V164, P74, DOI 10.1016/j.fcr.2014.05.018; Liu MJ, 2013, FIELD CROP RES, V150, P19, DOI 10.1016/j.fcr.2013.06.005; Matsuo N, 2009, PLANT SOIL, V316, P25, DOI 10.1007/s11104-008-9755-5; MEYER WS, 1990, AUST J AGR RES, V41, P253, DOI 10.1071/AR9900253; Nagasuga K, 2011, PLANT PROD SCI, V14, P22, DOI 10.1626/pps.14.22; North GB, 2000, ANN BOT-LONDON, V85, P247, DOI 10.1006/anbo.1999.1026; Ojha CSP, 1996, J IRRIG DRAIN ENG, V122, P198, DOI 10.1061/(ASCE)0733-9437(1996)122:4(198); Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Phogat V, 2010, PADDY WATER ENVIRON, V8, P333, DOI 10.1007/s10333-010-0213-7; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Poorter H, 2015, NEW PHYTOL, V206, P1188, DOI 10.1111/nph.13438; PRASAD R, 1988, J HYDROL, V99, P297, DOI 10.1016/0022-1694(88)90055-8; Qu H, 2012, AGRON J, V104, P1399, DOI 10.2134/agronj2011.0419; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Shi JC, 2015, J HYDROL, V522, P285, DOI 10.1016/j.jhydrol.2014.12.045; Shi JC, 2014, AGR WATER MANAGE, V146, P163, DOI 10.1016/j.agwat.2014.08.006; Shi JC, 2013, PLANT SOIL, V363, P139, DOI 10.1007/s11104-012-1299-z; Shi JC, 2009, SOIL SCI SOC AM J, V73, P1764, DOI 10.2136/sssaj2009.0002; Singh R, 2006, AGR WATER MANAGE, V82, P253, DOI 10.1016/j.agwat.2005.07.027; Singh R., 2003, WATER PRODUCTIVITY I, P41; Taleisnik E, 1999, ANN BOT-LONDON, V83, P19, DOI 10.1006/anbo.1998.0781; Tan XZ, 2015, AGR WATER MANAGE, V150, P67, DOI 10.1016/j.agwat.2014.12.005; Tao YY, 2015, EUR J AGRON, V68, P13, DOI 10.1016/j.eja.2015.04.002; Tao YY, 2014, FIELD CROP RES, V168, P101, DOI 10.1016/j.fcr.2014.08.014; VANGENUCHTEN MT, 1987, 121 USDAARS US SAL L; Wang LC, 2012, AGR WATER MANAGE, V104, P142, DOI 10.1016/j.agwat.2011.12.008; Wu JQ, 1999, PLANT SOIL, V215, P7, DOI 10.1023/A:1004702807951; Wu WG, 1998, J ANHUI AGR SCI, V3, P4043; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu W, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1892-x; Xue Q, 2003, PLANT SOIL, V257, P151, DOI 10.1023/A:1026230527597; Yadav Gulab Singh, 2011, Indian Journal of Agronomy, V56, P365; YAMAUCHI A, 1987, JPN J CROP SCI, V56, P608; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang ZC, 2008, FIELD CROP RES, V108, P71, DOI 10.1016/j.fcr.2008.03.004; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zuo Q, 2013, ADV AGR SYST MODEL, V4, P93, DOI 10.2134/advagricsystmodel4.c5	70	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180713	10.1371/journal.pone.0180713	http://dx.doi.org/10.1371/journal.pone.0180713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686687	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100094
J	Michel, AL; Lane, EP; De Klerk-Lorist, LM; Hofmeyr, M; van der Heijden, EMDL; Botha, L; van Helden, P; Miller, M; Buss, P				Michel, Anita L.; Lane, Emily P.; De Klerk-Lorist, Lin-Mari; Hofmeyr, Markus; van der Heijden, Elisabeth M. D. L.; Botha, Louise; van Helden, Paul; Miller, Michele; Buss, Peter			Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; GAMMA IFN-GAMMA; BLACK RHINOCEROS; SOUTH-AFRICA; PULMONARY TUBERCULOSIS; AMPLIFICATION; DIAGNOSIS; WILDLIFE; ASSAY	Tuberculosis caused by Mycobacterium bovis is endemic in the African buffalo (Syncerus caffer) population in the Kruger National Park and other conservation areas in South Africa. The disease has been diagnosed in a total of 21 free ranging or semi-free ranging wildlife species in the country with highly variable presentations in terms of clinical signs as well as severity and distribution of tuberculous lesions. Most species are spillover or dead-end hosts without significant role in the epidemiology of the disease. White rhinoceroses (Ceratotherium simum) are translocated from the Kruger National Park in substantial numbers every year and a clear understanding of their risk to manifest overt tuberculosis disease and to serve as source of infection to other species is required. We report the findings of experimental infection of three white rhinoceroses with a moderately low dose of a virulent field isolate of Mycobacterium bovis. None of the animals developed clinical signs or disseminated disease. The susceptibility of the white rhinoceros to bovine tuberculosis was confirmed by successful experimental infection based on the ante mortem isolation of M. bovis from the respiratory tract of one rhinoceros, the presence of acid-fast organisms and necrotizing granulomatous lesions in the tracheobronchial lymph nodes and the detection of M. bovis genetic material by PCR in the lungs of two animals.	[Michel, Anita L.; van der Heijden, Elisabeth M. D. L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Onderstepoort, South Africa; [Michel, Anita L.] Natl Zool Gardens South Africa, Pretoria, South Africa; [Lane, Emily P.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [De Klerk-Lorist, Lin-Mari] State Vet Off, Dept Agr Forestry & Fisheries, Kruger Natl Pk, Skukuza, South Africa; [Hofmeyr, Markus; Buss, Peter] South African Natl Parks, Vet Wildlife Serv, Kruger Natl Pk, Skukuza, South Africa; [van der Heijden, Elisabeth M. D. L.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Botha, Louise; van Helden, Paul; Miller, Michele] Stellenbosch Univ, Fac Med & Hlth Sci, MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB,Div Mol Biol & H, Cape Town, South Africa	University of Pretoria; National Research Foundation - South Africa; National Zoological Gardens of South Africa; National Research Foundation - South Africa; National Zoological Gardens of South Africa; Utrecht University; National Research Foundation - South Africa; Stellenbosch University	Michel, AL (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Onderstepoort, South Africa.; Michel, AL (corresponding author), Natl Zool Gardens South Africa, Pretoria, South Africa.	anita.michel@up.ac.za	Miller, Michele/ABA-1332-2020; Michel, Anita/N-8996-2014	Michel, Anita/0000-0001-9240-2653; van der Heijden, Elisabeth Margaretha Diana Louise/0000-0002-8444-6928; Miller, Michele/0000-0002-5883-6076	NRF and South African MRC; National Research Foundation	NRF and South African MRC; National Research Foundation	Authors acknowledge funding support from the NRF and South African MRC. Processing of the pathology sections was funded by a core grant of the National Research Foundation to Dr E Lane at the NZG. SANParks provided funding relating to the animal experiment (capture, care, housing, veterinary procedures). All participating co-authors provided financial support for their respective activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2016, EMERG MICROBES INF; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bengis Roy G., 1999, P101; De Klerk L, 2006, ONDERSTEPOORT J VET, V73, P293; de Klerk LM, 2010, VET IMMUNOL IMMUNOP, V137, P84, DOI 10.1016/j.vetimm.2010.04.013; Duncan AE, 2009, J ZOO WILDLIFE MED, V40, P781, DOI 10.1638/2009-0044.1; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Espie IW, 2009, J WILDLIFE DIS, V45, P1187, DOI 10.7589/0090-3558-45.4.1187; GRIFFIN JFT, 1995, TRENDS MICROBIOL, V3, P418, DOI 10.1016/S0966-842X(00)88994-5; Harmsen D, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-26; Hlokwe TM, 2014, PREV VET MED, V115, P10, DOI 10.1016/j.prevetmed.2014.03.011; Hlokwe TM, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0813-6; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Katale BZ, 2015, TRANSBOUND EMERG DIS, V10; Landolfi JA, 2015, VET PATHOL, V52, P535, DOI 10.1177/0300985814548517; Mathebula N, 2012, J ZOO WILDLIFE MED, V43, P530, DOI 10.1638/2011-0259R.1; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Michel AL, 2014, 12 SAVEPM C PORT EL; Michel AL, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, P365, DOI 10.1079/9781780643960.0365; Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304; Miller M, 2016, TRANSBOUND EMERG DIS; Miller M, 2016, J WILDLIFE DIS, V52, pS78, DOI 10.7589/52.2S.S85; Miller M, 2015, J WILDLIFE DIS, V51, P916, DOI 10.7589/2015-03-081; Miller M, 2015, J WILDLIFE DIS, V51, P493, DOI 10.7589/2014-07-170; Miller MA, 2017, EMERG INFECT DIS, V23, P557, DOI 10.3201/eid2303.161622; Miller MA, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, P277, DOI 10.1079/9781780643960.0277; Miller MA, 2015, J ZOO WILDLIFE MED, V46, P100, DOI 10.1638/2014-0172R1.1; Morar D, 2007, VET IMMUNOL IMMUNOP, V115, P146, DOI 10.1016/j.vetimm.2006.10.016; Morar D, 2013, TRANSBOUND EMERG DIS, V60, P60, DOI 10.1111/tbed.12132; MORRIS CDW, 1989, Q J MED, V73, P1151; Murakami PS, 2012, J ZOO WILDLIFE MED, V43, P872, DOI 10.1638/2010-0108R.1; Okamura K, 2013, INTERNAL MED, V52, P439, DOI 10.2169/internalmedicine.52.8158; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Pavlik I, 2004, VET MED-CZECH, V49, P427, DOI 10.17221/5733-VETMED; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Pesciaroli M, 2014, RES VET SCI, V97, pS78, DOI 10.1016/j.rvsc.2014.05.015; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Roussos A, 2001, RESP MED, V95, P187, DOI 10.1053/rmed.2000.1019; Stetter MD, 1995, J AM VET MED ASSOC, V207, P1618; Yaranal PJ, 2013, INTERJ HLTH REHAB SC, V2, P50; [No title captured]	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179943	10.1371/journal.pone.0179943	http://dx.doi.org/10.1371/journal.pone.0179943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686714	Green Published, gold			2022-12-27	WOS:000405464100027
J	Savi, E; Incorvaia, C; Boni, E; Mauro, M; Peveri, S; Pravettoni, V; Quercia, O; Reccardini, F; Montagni, M; Pessina, L; Ridolo, E				Savi, Eleonora; Incorvaia, Cristoforo; Boni, Elisa; Mauro, Marina; Peveri, Silvia; Pravettoni, Valerio; Quercia, Oliviero; Reccardini, Federico; Montagni, Marcello; Pessina, Laura; Ridolo, Erminia			Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study	PLOS ONE			English	Article							HYMENOPTERA VENOM; WASP VENOM; DIAGNOSIS	Background Venom immunotherapy (VIT) is highly effective in preventing allergic reactions to insect stings, but the appropriate venom must be used to achieve clinical protection. In patients with multiple positive results to venoms, molecular allergy diagnostics or CAP-inhibition may identify the causative venom. Concerning allergy to venom from Polistes spp. it has been proposed that only the European species P. dominulus should be used for VIT. However, this recommendation is not present in any international guideline. Using both laboratory and clinical data, we aimed to evaluate the reliability of this proposal. Methods We performed an in vitro study using CAP-inhibition to determine sensitization of 19 patients allergic to Polistes venom. The clinical study included 191 patients with positive tests to Polistes treated with VIT, 102 were treated with P. dominulus and 89 were treated with a mix of American Polistes (mAP). Results The difference in% of inhibition was significant concerning inhibition of P. dominulus sIgE by P. dominulus venom (79.8%) compared with inhibition by mAP venom (64.2%) and not significant concerning the inhibition of mAP sIgE by P. dominulus venom (80.1%) and by mAP venom (73.6%). Instead, the clinical protection from stings was not statistically different between the two kinds of venom. Conclusion The data from CAP inhibition would suggest that the choice of either P. dominulus venom or mAP venom for VIT is appropriate in patients with CAP inhibition higher than 70%, but the clinical data show the same odds of protection from stings using for VIT P. dominulus or mAP venom.	[Savi, Eleonora; Peveri, Silvia; Montagni, Marcello] AUSL, Allergy Dept Unit, G Da Saliceto Hosp, Piacenza, Italy; [Incorvaia, Cristoforo; Pessina, Laura] ASST Gaetano Pini CTO, Cardiac Pulm Rehabil, Milan, Italy; [Boni, Elisa; Mauro, Marina] St Anna Hosp, ASST Lariana, Allergy Unit, Como, Italy; [Pravettoni, Valerio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Allergy & Immunol Unit, Milan, Italy; [Quercia, Oliviero] Osped Faenza RA, Unit Alta Specializzaz Allergol, Faenza, Italy; [Reccardini, Federico] Azienda Sanitaria Univ Integrata Udine, SOC Pneumol Fisiopatol Resp, Udine, Italy; [Ridolo, Erminia] Univ Parma, Dept Med & Surg, Parma, Italy	Guglielmo da Saliceto Hospital; ASST Gaetano Pini CTO; University of Ferrara; Arcispedale Sant'Anna; IRCCS Ca Granda Ospedale Maggiore Policlinico; Hospital Santa Maria della Misericordia; University of Parma	Ridolo, E (corresponding author), Univ Parma, Dept Med & Surg, Parma, Italy.	erminia.ridolo@unipr.it						Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Boyle RJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008838.pub2; Caruso B, 2007, ALLERGY, V62, P561, DOI 10.1111/j.1398-9995.2007.01353.x; CASCONE O, 1995, TOXICON, V33, P659, DOI 10.1016/0041-0101(95)00001-3; Ebo DG, 2014, EXPERT REV CLIN IMMU, V10, P375, DOI 10.1586/1744666X.2014.881252; Galindo-Bonilla PA, 2015, ALLERGOL IMMUNOPATH, V43, P398, DOI 10.1016/j.aller.2014.05.004; Golden DBK, 2015, IMMUNOL ALLERGY CLIN, V35, P287, DOI 10.1016/j.iac.2015.01.007; HAMILTON RG, 1993, J ALLERGY CLIN IMMUN, V92, P651, DOI 10.1016/0091-6749(93)90007-3; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; HOFFMAN DR, 1982, ANN ALLERGY, V48, P82; KING TP, 1984, ARCH BIOCHEM BIOPHYS, V230, P1, DOI 10.1016/0003-9861(84)90080-8; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Martinez-Canavate A, 2010, ALLERGOL IMMUNOPATH, V38, P259, DOI 10.1016/j.aller.2010.02.004; MULLER U, 1992, J ALLERGY CLIN IMMUN, V89, P529, DOI 10.1016/0091-6749(92)90319-W; Pantera B, 2003, BBA-GEN SUBJECTS, V1623, P72, DOI 10.1016/j.bbagen.2003.07.001; Pesek RD, 2014, CURR OPIN ALLERGY CL, V14, P340, DOI 10.1097/ACI.0000000000000073; Rueff F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063233; Savi Eleonora, 2016, Clin Mol Allergy, V14, P3, DOI 10.1186/s12948-016-0040-5; Severino M, 2009, ALLERGY, V64, P1229, DOI 10.1111/j.1398-9995.2009.02030.x; Severino MG, 2006, ALLERGY, V61, P860, DOI 10.1111/j.1398-9995.2006.01077.x; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Straumann F, 2000, INT ARCH ALLERGY IMM, V123, P268, DOI 10.1159/000024453; Tibbetts EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028173; Vinzon SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041351	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180270	10.1371/journal.pone.0180270	http://dx.doi.org/10.1371/journal.pone.0180270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686638	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100046
J	Watson, AM; Rose, AH; Gibson, GA; Gardner, CL; Sun, CQ; Reed, DS; Lam, LKM; Croix, CMS; Strick, PL; Klimstra, WB; Watkins, SC				Watson, Alan M.; Rose, Annika H.; Gibson, Gregory A.; Gardner, Christina L.; Sun, Chengqun; Reed, Douglas S.; Lam, L. K. Metthew; Croix, Claudette M. St.; Strick, Peter L.; Klimstra, William B.; Watkins, Simon C.			Ribbon scanning confocal for high-speed high-resolution volume imaging of brain	PLOS ONE			English	Article							WHOLE-BRAIN	Whole-brain imaging is becoming a fundamental means of experimental insight; however, achieving subcellular resolution imagery in a reasonable time window has not been possible. We describe the first application of multicolor ribbon scanning confocal methods to collect high- resolution volume images of chemically cleared brains. We demonstrate that ribbon scanning collects images over ten times faster than conventional high speed confocal systems but with equivalent spectral and spatial resolution. Further, using this technology, we reconstruct large volumes of mouse brain infected with encephalitic alphaviruses and demonstrate that regions of the brain with abundant viral replication were inaccessible to vascular perfusion. This reveals that the destruction or collapse of large regions of brain micro vasculature may contribute to the severe disease caused by Venezuelan equine encephalitis virus. Visualization of this fundamental impact of infection would not be possible without sampling at subcellular resolution within large brain volumes.	[Watson, Alan M.; Gardner, Christina L.; Sun, Chengqun; Reed, Douglas S.; Lam, L. K. Metthew; Klimstra, William B.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Watson, Alan M.; Gardner, Christina L.; Sun, Chengqun; Lam, L. K. Metthew; Klimstra, William B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Rose, Annika H.; Strick, Peter L.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Gibson, Gregory A.; Croix, Claudette M. St.; Watkins, Simon C.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15260 USA; [Gibson, Gregory A.; Croix, Claudette M. St.; Watkins, Simon C.] Univ Pittsburgh, Dept Cellular Biol, Pittsburgh, PA 15260 USA; [Reed, Douglas S.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Klimstra, WB (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Klimstra, WB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.; Watkins, SC (corresponding author), Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15260 USA.; Watkins, SC (corresponding author), Univ Pittsburgh, Dept Cellular Biol, Pittsburgh, PA 15260 USA.	klimstra@pitt.edu; simon.watkins@pitt.edu	Watkins, Simon/ABG-2590-2021; Reed, Douglas/AAA-2587-2020	Watkins, Simon/0000-0003-4092-1552; Reed, Douglas/0000-0003-0076-9023; Watson, Alan/0000-0003-0632-8296	Defense Threat Reduction Agency [HDTRA1-15-1-0047]; NIAID [R01 AI09543605]; NINDS [R01 NS24328, P30 NS076405]; NIH Office of the Director [P40 OD010996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095436] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010996] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the: Defense Threat Reduction Agency, HDTRA1-15-1-0047; NIAID, R01 AI09543605; NINDS, R01 NS24328, P30 NS076405; and NIH Office of the Director, P40 OD010996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Raux H, 1997, J GEN VIROL, V78, P119, DOI 10.1099/0022-1317-78-1-119; Reed DS, 2014, PATHOG DIS, V71, P225, DOI 10.1111/2049-632X.12157; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042	13	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180486	10.1371/journal.pone.0180486	http://dx.doi.org/10.1371/journal.pone.0180486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686653	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100068
J	Azizi, H; Romao, TP; Charret, KS; Padmanabhan, PK; Neto, OPD; Muller-McNicoll, M; Papadopoulou, B				Azizi, Hiva; Romao, Tatiany P.; Charret, Karen Santos; Padmanabhan, Prasad K.; de Melo Neto, Osvaldo P.; Mueller-McNicoll, Michaela; Papadopoulou, Barbara			RNA secondary structure and nucleotide composition of the conserved hallmark sequence of Leishmania SIDER2 retroposons are essential for endonucleolytic cleavage and mRNA degradation	PLOS ONE			English	Article							GENE-EXPRESSION; DEVELOPMENTAL REGULATION; DECAY; RECOGNITION; ELEMENTS; REGION; TRYPANOSOMATIDS; DEADENYLATION; AMASTIGOTES; TRANSLATION	We have reported previously that Short Interspersed Degenerate Retroposons of the SIDER2 subfamily, largely located within 3'UTRs of Leishmania transcripts, promote rapid turnover of mRNAs through endonucleolytic cleavage within the highly conserved second tandem 79-nt hallmark sequence (79-nt SII). Here, we used site-directed mutagenesis and in silico RNA structural studies to delineate the cis-acting requirements within 79-nt SII for cleavage and mRNA degradation. The putative cleavage site(s) and other nucleotides predicted to alter the RNA secondary structure of 79-nt SII were either deleted or mutated and their effect on mRNA turnover was monitored using a gene reporter system. We found that short deletions of 8-nt spanning the two predicted cleavage sites block degradation of SIDER2-containing transcripts, leading to mRNA accumulation. Furthermore, single or double substitutions of the dinucleotides targeted for cleavage as well as mutations altering the predicted RNA secondary structure encompassing both cleavage sites also prevent mRNA degradation, confirming that these dinucleotides are the bona fide cleavage sites. In line with these results, we show that stage-regulated SIDER2 inactivation correlates with the absence of endonucleolytic cleavage. Overall, these data demonstrate that both cleavage sites within the conserved 79-nt SII as well as RNA folding in this region are essential for SIDER2-mediated mRNA decay, and further support that SIDER2-harboring transcripts are targeted for degradation by endonucleolytic cleavage.	[Azizi, Hiva; Padmanabhan, Prasad K.; Papadopoulou, Barbara] Univ Laval, CHU Quebec, Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada; [Azizi, Hiva; Padmanabhan, Prasad K.; Papadopoulou, Barbara] Univ Laval, Fac Med, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada; [Romao, Tatiany P.; de Melo Neto, Osvaldo P.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil; [Charret, Karen Santos] Fundacao Oswaldo Cruz, FIOCRUZ, Rio De Janeiro, Brazil; [Mueller-McNicoll, Michaela] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Cluster Excellence Macromol Complexes, RNA Regulat Grp, Frankfurt, Germany	Laval University; Laval University; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Goethe University Frankfurt	Papadopoulou, B (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada.; Papadopoulou, B (corresponding author), Univ Laval, Fac Med, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada.	barbara.papadopoulou@crchul.ulaval.ca	Müller-McNicoll, Michaela/AAC-6125-2019; Romão, Tatiany Patrícia/F-6957-2015; de Melo Neto, Osvaldo P/B-1366-2015	Müller-McNicoll, Michaela/0000-0002-7174-8310; Romão, Tatiany Patrícia/0000-0002-5296-0543; de Melo Neto, Osvaldo P/0000-0001-5402-7346	Canadian Institutes of Health Research (CIHR) Strategic Training Program [STP-53924]; Centre for Host-Parasite Interactions (CHPI); National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil; German Research Counsel [CEF-MC, SFB902]; Canadian Institutes of Health Research [MOP-12182]	Canadian Institutes of Health Research (CIHR) Strategic Training Program(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions (CHPI); National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil; German Research Counsel; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	HA was supported by a PhD studentship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program STP-53924 and the Centre for Host-Parasite Interactions (CHPI). TPR and KSC were supported by fellowships from the National Council for Scientific and Technological Development (CNPq) 'Science without Borders Scholarship Program' from Brazil, respectively. MMM was supported by the German Research Counsel (CEF-MC and SFB902). This work was supported by the Canadian Institutes of Health Research operating grant MOP-12182 awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi H, 2017, INT J PARASITOL, V47, P305, DOI 10.1016/j.ijpara.2017.02.001; Boucher N, 2002, J BIOL CHEM, V277, P19511, DOI 10.1074/jbc.M200500200; Bringaud F, 2008, MICROBES INFECT, V10, P575, DOI 10.1016/j.micinf.2008.02.009; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dupe A, 2014, MOL MICROBIOL, V91, P548, DOI 10.1111/mmi.12478; Geraldo MV, 2005, FEMS MICROBIOL LETT, V242, P275, DOI 10.1016/j.femsle.2004.11.030; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haile S, 2008, NUCLEIC ACIDS RES, V36, P1634, DOI 10.1093/nar/gkn019; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Sanchez-Luque FJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-340; Kligun E, 2015, RNA BIOL, V12, P720, DOI 10.1080/15476286.2015.1040977; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Muller M, 2010, NUCLEIC ACIDS RES, V38, P5867, DOI 10.1093/nar/gkq349; Muller M, 2010, MOL MICROBIOL, V77, P471, DOI 10.1111/j.1365-2958.2010.07226.x; Muller M, 2010, MOL BIOCHEM PARASIT, V170, P17, DOI 10.1016/j.molbiopara.2009.11.009; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; Smith M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-240; SOGIN ML, 1993, NATURE, V362, P795, DOI 10.1038/362795a0; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180678	10.1371/journal.pone.0180678	http://dx.doi.org/10.1371/journal.pone.0180678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704426	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700045
J	Beninca, E; van Boven, M; Hagenaars, T; van der Hoek, W				Beninca, Elisa; van Boven, Michiel; Hagenaars, Thomas; van der Hoek, Wim			Space-time analysis of pneumonia hospitalisations in the Netherlands	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; WAVELET ANALYSIS; RESPIRATORY SYMPTOMS; PRIMARY-CARE; SERIES; EPIDEMICS; MORTALITY; DYNAMICS; CLUSTERS; FARMS	Community acquired pneumonia is a major global public health problem. In the Netherlands there are 40,000-50,000 hospital admissions for pneumonia per year. In the large majority of these hospital admissions the etiologic agent is not determined and a real-time surveillance system is lacking. Localised and temporal increases in hospital admissions for pneumonia are therefore only detected retrospectively and the etiologic agents remain unknown. Here, we perform spatio-temporal analyses of pneumonia hospital admission data in the Netherlands. To this end, we scanned for spatial clusters on yearly and seasonal basis, and applied wavelet cluster analysis on the time series of five main regions. The pneumonia hospital admissions show strong clustering in space and time superimposed on a regular yearly cycle with high incidence in winter and low incidence in summer. Cluster analysis reveals a heterogeneous pattern, with most significant clusters occurring in the western, highly urbanised, and in the eastern, intensively farmed, part of the Netherlands. Quantitatively, the relative risk (RR) of the significant clusters for the age-standardised incidence varies from a minimum of 1.2 to a maximum of 2.2. We discuss possible underlying causes for the patterns observed, such as variations in air pollution.	[Beninca, Elisa; van Boven, Michiel; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Beninca, Elisa; Hagenaars, Thomas] Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Beninca, E (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.; Beninca, E (corresponding author), Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.	elisa.beninca@rivm.nl			ZonMw [522001001]; Netherlands Organization for Scientific Research (NWO)	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of E.B., W.v.d.H., T.H. and M.v.B. is supported by a ZonMw grant (project number 522001001) from the Netherlands Organization for Scientific Research (NWO)	Ben-Ari T, 2012, P NATL ACAD SCI USA, V109, P8196, DOI 10.1073/pnas.1110585109; Beninca E, 2015, P NATL ACAD SCI USA, V112, P6389, DOI 10.1073/pnas.1421968112; Beninca E, 2009, ECOL LETT, V12, P1367, DOI 10.1111/j.1461-0248.2009.01391.x; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Crighton EJ, 2008, GEOSPATIAL HEALTH, V2, P191, DOI 10.4081/gh.2008.243; Curtin L.R., 2000, HLTH PEOPLE 2000 STA, V1995, P1; Freidl GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174796; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Maassen K, 2016, 20160058 RIVM; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755; Malcolm BL, 2014, SPAT SPATIO-TEMPORAL, V8, P35, DOI 10.1016/j.sste.2014.01.001; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; Quan TP, 2016, THORAX, V71, P535, DOI 10.1136/thoraxjnl-2015-207688; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Rouyer T, 2008, MAR ECOL PROG SER, V359, P11, DOI 10.3354/meps07330; Schenker MB, 1998, AM J RESP CRITICAL C, V158; Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Smit LAM, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0027-0; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Snijders BEP, 2013, PRIM CARE RESP J, V22, P400, DOI 10.4104/pcrj.2013.00085; Teirlinck AC vAL, 2015, 20150042 RIVM; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; van Gageldonk-Lafeber AB, 2009, EPIDEMIOL INFECT, V137, P1472, DOI 10.1017/S0950268809002258	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180797	10.1371/journal.pone.0180797	http://dx.doi.org/10.1371/journal.pone.0180797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704495	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700051
J	Evangelista, KV; Lourdault, K; Matsunaga, J; Haake, DA				Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.			Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis	PLOS ONE			English	Article							BORGPETERSENII SEROVAR HARDJO; OUTER-MEMBRANE PROTEINS; IMMUNOGLOBULIN-LIKE; PROTECTIVE IMMUNITY; PATHOGENIC LEPTOSPIRA; RENAL COLONIZATION; CONSERVED REGION; LETHAL INFECTION; BOVIS INFECTION; DNA VACCINE	Leptospirosis is the most widespread zoonosis and is considered a major public health problem worldwide. Currently, there is no widely available vaccine against leptospirosis for use in humans. A purified, recombinant subunit vaccine that includes the last six immunoglobulin-like (Ig-like) domains of the leptospiral protein LigA (LigA7'-13) protects against lethal infection but not renal colonization after challenge by Leptospira interrogans. In this study, we examined whether the addition of the first seven Ig-like domains of LigB (LigB0-7) to LigA7'-13, can enhance immune protection and confer sterilizing immunity in the Golden Syrian hamster model of acute leptospirosis. Hamsters were subcutaneously immunized with soluble, recombinant LigA7'-13, LigB0-7, or a combination of LigA7'-13 and LigB0-7 in Freund's adjuvant. Immunization with Lig proteins generated a strong humoral immune response with high titers of IgG that recognized homologous protein, and cross-reacted with the heterologous protein as assessed by ELISA. LigA7'-13 alone, or in combination with LigB0-7, protected all hamsters from intraperitoneal challenge with a lethal dose of L. interrogans serovar Copenhageni strain Fiocruz L1-130. However, bacteria were recovered from the kidneys of all animals. Of eight animals immunized with LigB0-7, only three survived Leptospira challenge, one of which lacked renal colonization and had antibodies to native LigB by immuno-blot. In addition, sera from two of the three LigB0-7 immunized survivors cross-reacted with LigA11-13, a region of LigA that is sufficient for protection. In summary, we confirmed that LigA7'-13 protects hamsters from death but not infection, and immunization with LigB0-7, either alone or in combination with LigA7'-13, did not confer sterilizing immunity.	[Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Evangelista, Karen V.; Lourdault, Kristel; Matsunaga, James; Haake, David A.] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Haake, David A.] UCLA, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Haake, David A.] UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Evangelista, KV (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.; Evangelista, KV (corresponding author), UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	karen.evangelista@gmail.com		lourdault, kristel/0000-0003-2875-5918	Veterans Affairs Merit Award; National Institutes of Health [R01 AI 034431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI128560, R01AI034431] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Veterans Affairs Merit Award to DAH, and National Institutes of Health grant R01 AI 034431 to DAH.	ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977; Adler B., 2014, LEPTOSPIRA LEPTOSPIR; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002; BOLIN CA, 1991, AM J VET RES, V52, P1639; BOLIN CA, 1989, AM J VET RES, V50, P2004; Bolin CA, 2001, AM J VET RES, V62, P995, DOI 10.2460/ajvr.2001.62.995; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Breda LCD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004192; Brown RA, 2003, VACCINE, V21, P4448, DOI 10.1016/S0264-410X(03)00439-0; Cao YG, 2011, VACCINE, V29, P7379, DOI 10.1016/j.vaccine.2011.07.070; Castiblanco-Valencia MM, 2016, IMMUNOL LETT, V173, P61, DOI 10.1016/j.imlet.2016.03.005; Castiblanco-Valencia MM, 2016, IMMUNOBIOLOGY, V221, P679, DOI 10.1016/j.imbio.2016.01.001; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Choy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041566; Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879; Conrad NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005441; Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307; Coutinho ML, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001422; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Forster KM, 2015, MEM I OSWALDO CRUZ, V110, P989, DOI 10.1590/0074-02760150222; Forster KM, 2013, CLIN VACCINE IMMUNOL, V20, P725, DOI 10.1128/CVI.00601-12; Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; Goris MGA., 2005, LEPTOSPIROSIS SERODI; Haake DA, 1999, INFECT IMMUN, V67, P6572; Haake DA, 2006, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc12-02s02, DOI 10.1002/9780471729259.MC12-02S02]; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hartwig DD, 2014, CURR MICROBIOL, V68, P524, DOI 10.1007/s00284-013-0505-4; Hsieh CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004974; Humphryes PC, 2014, CLIN VACCINE IMMUNOL, V21, P546, DOI 10.1128/CVI.00719-13; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2005, J Postgrad Med, V51, P210; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin XA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-21; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2011, MOL MICROBIOL, V79, P1063, DOI 10.1111/j.1365-2958.2010.07510.x; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Martinez Sanchez R, 1998, Rev Cubana Med Trop, V50, P159; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2012, APPL ENVIRON MICROB, V78, P5699, DOI 10.1128/AEM.00713-12; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Monaris D, 2015, CLIN VACCINE IMMUNOL, V22, P965, DOI 10.1128/CVI.00285-15; Murray GL, 2013, VACCINE, V31, P495, DOI 10.1016/j.vaccine.2012.11.028; Naiman BM, 2001, INFECT IMMUN, V69, P7550, DOI 10.1128/IAI.69.12.7550-7558.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P7888, DOI 10.1128/AEM.02202-15; Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127; Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17; Truccolo J, 2002, ANTIMICROB AGENTS CH, V46, P848, DOI 10.1128/AAC.46.3.848-853.2002; Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618	69	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180004	10.1371/journal.pone.0180004	http://dx.doi.org/10.1371/journal.pone.0180004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704385	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700022
J	Keddis, MT; El-Zoghby, Z; Kaplan, B; Meeusen, JW; Donato, LJ; Cosio, FG; Steidley, DE				Keddis, Mira T.; El-Zoghby, Ziad; Kaplan, Bruce; Meeusen, Jeffrey W.; Donato, Leslie J.; Cosio, Fernando G.; Steidley, D. Eric			Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE; CONSENSUS PANEL; HEMODIALYSIS-PATIENTS; PROGNOSTIC VALUE; ALL-CAUSE; BIOMARKERS; DEATH	Background Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure. We assessed the association of sST2 with the composite outcome of CVE and/or mortality compared to cTnT in kidney transplant candidates. Methods 200 kidney transplant candidates between 2010 and 2013 were included. Elevated sST2 was defined as >= 30ng/ml, cTnT >= 0.01 ng/ml. Results Median age 53 (interquartile range (IQR) 42-61) years, 59.7% male and 82.0% white. 33.5% had history of CVE, 42.5% left ventricular hypertrophy (LVH) and 15.6% positive cardiac stress test. Elevated sST2 correlated with male gender, history of prior-transplants, CVE, positive stress test, LVH, elevated cTnT, anemia, hyperphosphatemia, increased CRP and non-transplanted status. Male gender, history of CVE and LVH were independent determinants of sST2. During 28 months (IQR 25.3-30), 7.5% died, 13.0% developed CVE and 19.0% developed the composite outcome. Elevated sST2 was associated with the composite outcome (hazard ratio = 1.76, CI 1.06-2.73, p = 0.029) on univariate analysis but not after adjusting for age, diabetes and cTnT (p = 0.068). sST2 did not change the risk prediction model for composite outcome after including age, diabetes, prior history of CVE and elevated cTnT. Conclusions Increased sST2 level is significantly associated with variables associated with CVE in kidney transplant candidates. sST2 was associated with increased risk of the composite outcome of CVE and/or death but not independent of cTnT. Larger studies are needed to confirm these findings and determine whether sST2 has added value in CV risk stratification in this cohort of patients.	[Keddis, Mira T.; Kaplan, Bruce] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA; [El-Zoghby, Ziad; Cosio, Fernando G.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA; [Meeusen, Jeffrey W.; Donato, Leslie J.] Mayo Clin, Div Renal Lab, Dept Lab Med & Pathol, Rochester, MN USA; [Steidley, D. Eric] Mayo Clin, Div Cardiol, Dept Med, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Keddis, MT (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA.	keddis.mira@mayo.edu	Zoghby, Ziad M./O-5181-2019; Keddis, Mira/Y-2129-2019	Zoghby, Ziad M./0000-0002-8734-9699; 				Apple FS, 2004, CLIN CHEM, V50, P2279, DOI 10.1373/clinchem.2004.035741; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Bao YS, 2012, J CLIN IMMUNOL, V32, P587, DOI 10.1007/s10875-011-9622-7; Boisot S, 2008, J CARD FAIL, V14, P732, DOI 10.1016/j.cardfail.2008.06.415; Daniels LB, 2014, FUTUR CARDIOL, V10, P525, DOI [10.2217/FCA.14.36, 10.2217/fca.14.36]; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Dieplinger B, 2009, CLIN CHIM ACTA, V409, P33, DOI 10.1016/j.cca.2009.08.010; Dispenzieri A, 2015, AM J HEMATOL, V90, P524, DOI 10.1002/ajh.24001; Dubin RF, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-229; Gaggin HK, 2014, JACC-HEART FAIL, V2, P65, DOI 10.1016/j.jchf.2013.10.005; Gaggin HK, 2013, CIRC-HEART FAIL, V6, P1206, DOI 10.1161/CIRCHEARTFAILURE.113.000457; Gruson D, 2014, INT J CARDIOL, V172, pE250, DOI 10.1016/j.ijcard.2013.12.101; Hickson LJ, 2008, AM J TRANSPLANT, V8, P2352, DOI 10.1111/j.1600-6143.2008.02395.x; Hickson LTJ, 2009, AM J TRANSPLANT, V9, P1354, DOI 10.1111/j.1600-6143.2009.02636.x; Ishii J, 2001, CLIN CHIM ACTA, V312, P69, DOI 10.1016/S0009-8981(01)00592-7; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; Januzzi JL, 2015, AM J CARDIOL, V115, p70B, DOI 10.1016/j.amjcard.2015.01.044; Januzzi JL, 2015, AM J CARDIOL, V115, p26B, DOI 10.1016/j.amjcard.2015.01.037; Keddis MT, 2012, AM J TRANSPLANT; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Mueller T, 2015, CLIN BIOCHEM, V48, P1163, DOI 10.1016/j.clinbiochem.2015.07.031; Pascual-Figal DA, 2015, AM J CARDIOL, V115, p3B, DOI 10.1016/j.amjcard.2015.01.034; Pascual-Figal DA, 2011, EUR J HEART FAIL, V13, P718, DOI 10.1093/eurjhf/hfr047; Pascual-Figal DA, 2009, J AM COLL CARDIOL, V54, P2174, DOI 10.1016/j.jacc.2009.07.041; Smith K, 2013, AM J KIDNEY DIS, V61, P67, DOI 10.1053/j.ajkd.2012.06.022; Sommerer C, 2007, CLIN NEPHROL, V68, P392; Sommerer C, 2007, NEPHRON CLIN PRACT, V107, pC77, DOI 10.1159/000108647; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	30	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181123	10.1371/journal.pone.0181123	http://dx.doi.org/10.1371/journal.pone.0181123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704488	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649700094
J	Mameli, C; Krakauer, JC; Krakauer, NY; Bosetti, A; Ferrari, CM; Schneider, L; Borsani, B; Arrigoni, S; Pendezza, E; Zuccotti, GV				Mameli, Chiara; Krakauer, Jesse C.; Krakauer, Nir Y.; Bosetti, Alessandra; Ferrari, Chiara Matilde; Schneider, Laura; Borsani, Barbara; Arrigoni, Sara; Pendezza, Erica; Zuccotti, Gian Vincenzo			Effects of a multidisciplinary weight loss intervention in overweight and obese children and adolescents: 11 years of experience	PLOS ONE			English	Article							PEDIATRIC OBESITY; CHILDHOOD OBESITY; PREVENTION; MANAGEMENT	Aims To evaluate the effects of an outpatient multidisciplinary weight loss intervention in reducing body mass index (BMI) in children and adolescents suffering overweight and obesity, changes in A Body Shape Index (ABSI, waist circumference normalized to height and weight) and Hip Index (HI, normalized hip circumference) during treatment and correlation between the ABSI and HI with change in BMI z score. Methods We analyze anthropometric data from pediatric patients affected by overweight and obesity aged 2 to 18 years old who entered our multidisciplinary weight loss intervention, which included medical, psychological and nutritional sessions, from January 1(st) 2006 to December 31(st) 2016. Lifestyle modification counselling was delivered. Follow-up visits were planned every month for 3 months and subsequently every 2-4 months. BMI, ABSI, and HI were converted to z scores using age and sex specific population normals. Results 864 patients entered our intervention. 453 patients (208 males), mean age 11.2 +/- 3.1 years, 392 with obesity (86%, z-BMI 2.90 +/- 0.80 SD) and 61 patients with overweight (z-BMI 1.73 +/- 0.21 SD) attended at least 1 follow-up visit. The mean number of visits was 3.5 (+/- 1.8 SD) in overweight subjects and 3.9 (+/- 2.2 SD) in ones with obesity. At the last attended follow-up visit (at 16 +/- 12 months SD) we observed a reduction in mean z-BMI in patients with obesity (to 2.52 +/- 0.71 SD) and patients with overweight (to 1.46 +/- 0.5 SD). Most patients (80.8%) reduced their BMI z scores. Mean ABSI and HI z scores showed no significant change. 78/ 392 patients (19.8%) recovered from obese to overweight, 5/392 (1.2%) from obese to normal weight. The recovery rate from overweight to normal weight was 13.1%. In a multivariate model, initial BMI z score and number of follow-up visits were significant predictors of weight change, while age, sex, ABSI, and HI were not significant predictors. Conclusions Patients affected by overweight and obesity involved in a multidisciplinary weight loss intervention reduced their mean BMI z score, while ABSI and HI were stable. Weight loss was not predicted by initial ABSI or HI. More visits predict more weight loss, but dropout rates are high. The great majority of patients leave the weight management program before having normalized their BMI.	[Mameli, Chiara; Bosetti, Alessandra; Ferrari, Chiara Matilde; Schneider, Laura; Borsani, Barbara; Arrigoni, Sara; Pendezza, Erica; Zuccotti, Gian Vincenzo] Univ Milan, V Buzzi Childrens Hosp, Dept Pediat, Milan, Italy; [Krakauer, Jesse C.] Metro Detroit Diabet & Endocrinol, Southfield, MI USA; [Krakauer, Nir Y.] CUNY City Coll, Dept Civil Engn, New York, NY 10031 USA	University of Milan; City University of New York (CUNY) System; City College of New York (CUNY)	Mameli, C (corresponding author), Univ Milan, V Buzzi Childrens Hosp, Dept Pediat, Milan, Italy.	chiara.mameli@unimi.it	Krakauer, Jesse/AAV-2692-2021	Pendezza, Erica/0000-0002-4966-7389				Aschbrenner KA, 2015, TRANSL BEHAV MED, V5, P277, DOI 10.1007/s13142-015-0313-4; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Danielsson P, 2016, ACTA PAEDIATR, V105, P1181, DOI 10.1111/apa.13360; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Kirk S, 2005, OBES RES, V13, P876, DOI 10.1038/oby.2005.101; Krakauer NY, 2016, J OBES, V2016, DOI 10.1155/2016/8094275; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Mameli C, 2016, PEDIAT OBES; Mameli C, 2017, PHARMACOL RES, V119, P99, DOI 10.1016/j.phrs.2017.01.017; Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838; McGovern L, 2008, J CLIN ENDOCR METAB, V93, P4600, DOI 10.1210/jc.2006-2409; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Resnicow K, 2006, J AM DIET ASSOC, V106, P2024, DOI 10.1016/j.jada.2006.09.015; Styne DM, 2017, J CLIN ENDOCR METAB, V102, P709, DOI 10.1210/jc.2016-2573; Tate EB, 2013, TRANSL BEHAV MED, V3, P406, DOI 10.1007/s13142-013-0222-3; Woolford SJ, 2011, CLIN PEDIATR, V50, P187, DOI 10.1177/0009922810384845; World Health Organization Expert Committee on Physical Status, 1995, TECHNICAL REPORT SER, V854; Xu Y, 2015, ANN HUM BIOL, V42, P70, DOI 10.3109/03014460.2014.903998	22	28	30	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181095	10.1371/journal.pone.0181095	http://dx.doi.org/10.1371/journal.pone.0181095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704494	Green Published, gold			2022-12-27	WOS:000405649700090
J	Sprenger, M; Mettler, T; Osma, J				Sprenger, Michaela; Mettler, Tobias; Osma, Jorge			Health professionals' perspective on the promotion of e-mental health apps in the context of maternal depression	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; WEB-BASED INTERVENTION; POSTNATAL DEPRESSION; POSTPARTUM DEPRESSION; POSITIVE PSYCHOLOGY; PLANNED BEHAVIOR; PRIMARY-CARE; SELF-HELP; WOMEN; IMPLEMENTATION	Objective Our study focuses on exploring (1) the intention of health professionals to use and recommend e-mental health applications, (2) how this intention of health professionals might be influenced, (3) which group of health professionals might be most accessible to promote emental health applications for maternal depression, and (4) for which tasks they rate them to be most useful. Materials and methods Based on a questionnaire informed by the theory of planned behavior, we collected 131 responses of U.S., Spanish, and Swiss health professionals in the field of pregnancy and maternal care (including psychologists, psychiatrists, midwives, and doctors) by means of an online survey. We analyzed the gathered data applying a structured equation model. Results Our study reveals that health professionals would in general intend to recommend and use e-mental health applications. However, their attitude towards e-mental health applications varies regarding the respective use cases and also differs among health professions. Conclusion We offer three alternative propositions for private or public organizations, associations, or any other entity whose purpose is service to the community for introducing e-mental health applications into practice.	[Sprenger, Michaela] Univ St Gallen, Inst Informat Management, St Gallen, Switzerland; [Mettler, Tobias] Univ Lausanne, Swiss Grad Sch Publ Adm, Lausanne, Switzerland; [Osma, Jorge] Univ Zaragoza, Dept Psychol & Sociol, Teruel, Spain	University of St Gallen; University of Lausanne; University of Zaragoza	Mettler, T (corresponding author), Univ Lausanne, Swiss Grad Sch Publ Adm, Lausanne, Switzerland.	tobias.mettler@unil.ch	Osma Lopez, Jorge Javier/F-9221-2011; Mettler, Tobias/A-9581-2015	Osma Lopez, Jorge Javier/0000-0002-7293-318X; Mettler, Tobias/0000-0002-7895-7545	Universidad de Zaragoza; Gobiernode Aragon; Fondo Social Europeo; Fundacion Bancaria Ibercaja; Fundacion CAI- [CH-21/16]; Swiss National Science Foundation [IZK0Z1_171209]	Universidad de Zaragoza; Gobiernode Aragon(Gobierno de Aragon); Fondo Social Europeo(European Social Fund (ESF)European Commission); Fundacion Bancaria Ibercaja; Fundacion CAI-; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partially supported by the Universidad de Zaragoza, Gobiernode Aragon, Fondo Social Europeo, Fundacion Bancaria Ibercaja, and Fundacion CAI- (CH-21/16) and the Swiss National Science Foundation (grant no. IZK0Z1_171209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2005, PERINATAL DEPRESSION; Austin M-P, 2004, Arch Womens Ment Health, V7, P1, DOI 10.1007/s00737-003-0034-4; Barlow DH, 2013, ANNU REV CLIN PSYCHO, V9, P1, DOI 10.1146/annurev-clinpsy-050212-185629; Barrera Alinne Z, 2015, Internet Interv, V2, P257, DOI 10.1016/j.invent.2015.06.002; Berg M, 2003, METHOD INFORM MED, V42, P297; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Byatt N, 2012, J REPROD INFANT PSYC, V30, P436, DOI 10.1080/02646838.2012.743000; Bygholm A, 2012, STUD HEALTH TECHNOL, V180, P934, DOI 10.3233/978-1-61499-101-4-934; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Chau PYK, 2002, INFORM MANAGE-AMSTER, V39, P297, DOI 10.1016/S0378-7206(01)00098-2; Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7; Chin W.W., 2010, HDB PARTIAL LEAST SQ, DOI DOI 10.1007/978-3-540-32827-8_29; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; Christensen Helen, 2003, Evid Based Ment Health, V6, P66; Christensen LarsRune., 2021, INFRAHEALTH 2021 P 8; Conner M., 2005, PREDICTING HLTH BEHA, P1; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Danaher BG, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2329; Emmelkamp PMG, 2005, PSYCHOTHER PSYCHOSOM, V74, P336, DOI 10.1159/000087780; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Fleming ML, 2014, RES SOC ADMIN PHARM, V10, P285, DOI 10.1016/j.sapharm.2013.05.009; Gefen D, 2011, MIS QUART, V35, pIII; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Haga SM, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2659; Hagger MS, 2015, HEALTH PSYCHOL REV, V9, P125, DOI 10.1080/17437199.2015.1034470; Hair J. F., 2017, ADV ISSUES PARTIAL L; Heneghan AM, 2007, CHILD CARE HLTH DEV, V33, P333, DOI 10.1111/j.1365-2214.2006.00648.x; Hewitt CE, 2009, BJOG-INT J OBSTET GY, V116, P1019, DOI 10.1111/j.1471-0528.2009.02148.x; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; Lal S, 2014, PSYCHIAT SERV, V65, P24, DOI 10.1176/appi.ps.201300009; Mair FS, 2012, B WORLD HEALTH ORGAN, V90, P357, DOI 10.2471/BLT.11.099424; Maloni JA, 2013, ARCH PSYCHIAT NURS, V27, P90, DOI 10.1016/j.apnu.2012.12.001; Meinel C, 2011, UNDERST INNOV, pXIII; Mettler T, 2011, INFORM HEALTH SOC CA, V36, P220, DOI 10.3109/17538157.2011.554931; Meurk C, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4827; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Munoz RF, 2012, AM PSYCHOL, V67, P285, DOI 10.1037/a0027666; Murray E, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-6; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; O'Mahen HA, 2013, J AFFECT DISORDERS, V150, P814, DOI 10.1016/j.jad.2013.03.005; Osma J, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P547, DOI 10.1109/BHI.2014.6864423; Osma J, 2016, CYBERPSYCH BEH SOC N, V19, P412, DOI 10.1089/cyber.2015.0549; Penate W, 2012, INT J CLIN HLTH PSYC, V12, P475; Petrou S, 2002, BRIT J PSYCHIAT, V181, P505, DOI 10.1192/bjp.181.6.505; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Ragaban Nouran, 2012, Stud Health Technol Inform, V178, P186; Reynolds J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4200; Santoro, 2010, IDENTIFYING TREATING; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Sockol LE, 2015, J AFFECT DISORDERS, V177, P7, DOI 10.1016/j.jad.2015.01.052; Staemmler M, 2011, STUD HEALTH TECHNOL, V169, P537, DOI 10.3233/978-1-60750-806-9-537; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Venkatesh V., 2012, EUR C INF SYST ECIS; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Vis Christiaan, 2015, Internet Interventions, V2, P399, DOI 10.1016/j.invent.2015.10.002; Warmerdam L, 2012, STUD HEALTH TECHNOL, V181, P339, DOI 10.3233/978-1-61499-121-2-339; Wykes T, 2016, J MENT HEALTH, V25, P1, DOI 10.3109/09638237.2015.1124406; [No title captured]	67	28	28	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180867	10.1371/journal.pone.0180867	http://dx.doi.org/10.1371/journal.pone.0180867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28704442	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600051
J	Haupt-Jorgensen, M; Nielsen, E; Engkilde, K; Lerche, M; Larsen, J; Buschard, K				Haupt-Jorgensen, Martin; Nielsen, Erik; Engkilde, Kare; Lerche, Mia; Larsen, Jesper; Buschard, Karsten			Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study	PLOS ONE			English	Article							GLUTEN-FREE; NOD MICE; INSULIN; DIET; MELLITUS	Intranasal administration of gliadin prevents autoimmune diabetes in non-obese diabetic mice. The current study was designed to investigate if bakers are intranasally exposed to gluten during work and whether occupation as baker is inversely associated with type 1 diabetes. Gliadin was measured in nasal swabs from eight bakers and butchers. The odds ratio of type 1 diabetes in selected profession groups was analysed in a registry-based case-control study with data from 1980 to 2010 derived from Statistics Denmark. The cohort included 1,210,017 Danish individuals, thereof 15,451 with type 1 diabetes (1.28%). Average nasal gliadin swab content after full working days was 6.3 mu g (confidence interval (CI): 2.8 to 9.7) among bakers, while no nasal gliadin was detected among butchers. The odds ratio of type 1 diabetes was lower among bakers (OR = 0.57; CI: 0.52 to 0.62) and agriculture workers occupied with production of grains (OR = 0.65; CI: 0.56 to 0.75). Bakers had a lower odds ratio of type 1 diabetes, which potentially could be attributed to exposure of nasal mucosal gluten during work, as observed in this study. If other studies confirm the present observations, intranasal gliadin administration could possibly be an easy and safe approach for the prevention of type 1 diabetes in high-risk individuals or prediabetic subjects.	[Haupt-Jorgensen, Martin; Nielsen, Erik; Engkilde, Kare; Lerche, Mia; Larsen, Jesper; Buschard, Karsten] Rigshosp, Bartholin Inst, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Haupt-Jorgensen, M (corresponding author), Rigshosp, Bartholin Inst, Copenhagen, Denmark.	martin.haupt-joergensen@regionh.dk	Haupt-Jorgensen, Martin/K-7424-2019	Haupt-Jorgensen, Martin/0000-0003-4088-5862; Buschard, Karsten/0000-0002-0126-7423	Kirsten and Freddy Johannsen Foundation	Kirsten and Freddy Johannsen Foundation	This study was supported by Kirsten and Freddy Johannsen Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094530; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Hansen D, 2001, ACTA PAEDIATR, V90, P1238, DOI 10.1080/080352501317130254; Harrison LC, 2013, CURR DIABETES REP, V13, P616, DOI 10.1007/s11892-013-0415-7; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; Ostman J, 2008, J INTERN MED, V263, P386, DOI 10.1111/j.1365-2796.2007.01896.x; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Sildorf S. M., 2012, BMJ CASE REP, V2012; Svensson J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2641-3; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	16	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e.0181143	10.1371/journal.pone.0181143	http://dx.doi.org/10.1371/journal.pone.0181143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700675	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400034
J	Grellet, S; Tzelepi, K; Roskamp, M; Williams, P; Sharif, A; Slade-Carter, R; Goldie, P; Whilde, N; Smialek, MA; Mason, NJ; Golding, JP				Grellet, Sophie; Tzelepi, Konstantina; Roskamp, Meike; Williams, Phil; Sharif, Aquila; Slade-Carter, Richard; Goldie, Peter; Whilde, Nicky; Smialek, Malgorzata A.; Mason, Nigel J.; Golding, Jon P.			Cancer-selective, single agent chemoradiosensitising gold nanoparticles	PLOS ONE			English	Article							RADIATION-THERAPY; CELLS; RADIOSENSITIZATION; ENHANCEMENT; RESONANCE; SIZE	Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50: 50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics.	[Grellet, Sophie; Tzelepi, Konstantina; Golding, Jon P.] Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England; [Roskamp, Meike; Williams, Phil] Midatech Pharma, Milton Pk, Abingdon, Oxon, England; [Sharif, Aquila; Slade-Carter, Richard] Milton Keynes Med Ctr, GenesisCare, Milton Keynes, Bucks, England; [Goldie, Peter; Whilde, Nicky] Northampton Gen Hosp NHS Trust, Radiotherapy Dept, Northampton, England; [Smialek, Malgorzata A.] Gdansk Univ Technol, Fac Ocean Engn & Ship Technol, Dept Control & Power Engn, Gdansk, Poland; [Smialek, Malgorzata A.; Mason, Nigel J.] Open Univ, Sch Phys Sci, Walton Hall, Milton Keynes, Bucks, England	Open University - UK; Fahrenheit Universities; Gdansk University of Technology; Open University - UK	Golding, JP (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England.	Jon.Golding@open.ac.uk	Golding, Jon/L-2700-2017; Smialek, Malgorzata A./G-1577-2011; Śmiałek-Telega, Małgorzata/GYJ-5849-2022	Golding, Jon/0000-0002-7910-7382; Smialek, Malgorzata A./0000-0003-2624-3716; 				Alric C, 2013, NANOSCALE, V5, P5930, DOI 10.1039/c3nr00012e; Beddoes CM, 2015, ADV COLLOID INTERFAC, V218, P48, DOI 10.1016/j.cis.2015.01.007; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Butterworth KT, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/29/295101; Chhour P, 2017, BIOCONJUGATE CHEM, V28, P260, DOI 10.1021/acs.bioconjchem.6b00566; Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; COLLINS AK, 1994, MED PHYS, V21, P1741, DOI 10.1118/1.597275; Fratoddi I, 2015, NANO RES, V8, P1771, DOI 10.1007/s12274-014-0697-3; Geng F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285101; Gilles M, 2014, COLLOID SURFACE B, V123, P770, DOI 10.1016/j.colsurfb.2014.10.028; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hau H, 2016, BIOENG TRANSL MED, V1, P94, DOI 10.1002/btm2.10007; Haume Kaspar, 2016, Cancer Nanotechnol, V7, P8, DOI 10.1186/s12645-016-0021-x; Hong R, 2006, GLUTATHIONE MEDIATED; Hostetler MJ, 1998, ALKANETHIOLATE GOLD; Irure A, 2013, BIOMATER SCI-UK, V1, P658, DOI 10.1039/c3bm60032g; Jain S, 2011, INT J RADIAT ONCOL, V79, P531, DOI 10.1016/j.ijrobp.2010.08.044; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Kelts JL, 2015, ALTERED CYTOTOXICITY, V4, P269; Khoshgard K, 2014, PHYS MED BIOL, V59, P2249, DOI 10.1088/0031-9155/59/9/2249; Kwatra D, 2013, TRANSL CANCER RES, V2, P330, DOI 10.3978/j.issn.2218-676X.2013.08.06; Lee K, 2011, BIOMATERIALS, V32, P2556, DOI 10.1016/j.biomaterials.2010.11.072; Liu CJ, 2010, PHYS MED BIOL, V55, P931, DOI 10.1088/0031-9155/55/4/002; Liu CJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295104; Luchette M, 2014, NANOMED-NANOTECHNOL, V10, P1751, DOI 10.1016/j.nano.2014.06.004; Lund T, 2011, BIOMATERIALS, V32, P9776, DOI 10.1016/j.biomaterials.2011.09.018; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; McMahon SJ, 2016, NANOSCALE, V8, P581, DOI 10.1039/c5nr07089a; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Page P, 2010, ANTICANCER RES, V30, P3675; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pottier A, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150171; Qian HF, 2012, P NATL ACAD SCI USA, V109, P696, DOI 10.1073/pnas.1115307109; Rahman WN, 2009, NANOMED-NANOTECHNOL, V5, P136, DOI 10.1016/j.nano.2009.01.014; Sancey L, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140134; Schaaff GT, 2001, PROPERTIES UBIQUITOU; Xiao FX, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/46/465101; Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047; Zhang XJ, 2008, CLIN INVEST MED, V31, pE160, DOI 10.25011/cim.v31i3.3473; Zhu CD, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0129-x	43	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0181103	http://dx.doi.org/10.1371/journal.pone.0181103			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700660	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000405544800121
J	Lee, LW; Lin, CM; Li, HC; Hsiao, PL; Chung, AC; Hsieh, CJ; Wu, PC; Hsu, SF				Lee, Li-Wen; Lin, Chieh-Mo; Li, Hung-Chou; Hsiao, Pei-Lin; Chung, An-Chi; Hsieh, Chu-Jung; Wu, Pi-Chi; Hsu, Shu-Feng			Body composition changes in male patients with chronic obstructive pulmonary disease: Aging or disease process?	PLOS ONE			English	Article							YOUNG-ADULTS; COPD; AGE; CACHEXIA; PREVALENCE; MECHANISMS; SAMPLE; COHORT; MASS; DXA	Background Chronic obstructive pulmonary disease (COPD) mainly affects middle-age and elderly adults. It is unclear if the presence of muscle wasting and fat accumulation in patients with COPD is age or disease-related. This study investigated the effect of age and COPD disease severity on body composition with the aim of identifying a biomarker(s) for COPD. Methods Healthy subjects and patients with COPD of different severity were recruited. Dual-energy X-ray absorptiometry was used to analyze total and segmental body composition. Subjects included in the analysis were classified into four groups: healthy young (aged 20-45 years) (n = 35), healthy old (aged >= 60 years) (n = 37), moderate COPD (n = 40), and severe COPD (n = 14). Results In healthy old adults, leg and limb lean masses were lower by 10.6% and 8.5%, respectively, compared with healthy young adults (P < 0.05). Appendicular lean outcomes were significantly lower in the moderate COPD compared to the healthy old group and were significant lower in subjects with severe COPD compared to those with moderate COPD. All fat depots were similar for both young and old healthy subjects and subjects with moderate COPD, but significantly decreased in patients with severe COPD. Conclusions This study examined the changes in total and segmental body composition with aging and COPD severity. It found that aging and COPD altered the body composition differently, and the effect was most pronounced in leg lean mass. Remarkably, differences in appendicular lean masses were seen in mild COPD although no changes in body weight or BMI were apparent compared with healthy young adults. In contrast, fat depot changes were only observed in severe COPD. Aging and COPD processes are multifactorial and additional longitudinal studies are required to explore both the quantitative and qualitative changes in body composition with aging and disease process.	[Lee, Li-Wen; Li, Hung-Chou; Hsiao, Pei-Lin; Hsieh, Chu-Jung] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Lee, Li-Wen; Lin, Chieh-Mo] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Lin, Chieh-Mo] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Chieh-Mo] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chung, An-Chi] Chang Gung Mem Hosp, Dept Resp Therapy, Chiayi, Taiwan; [Wu, Pi-Chi; Hsu, Shu-Feng] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsu, SF (corresponding author), Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan.	koala7138@cgmh.org.tw	Lee, Li-Wen/AAY-3542-2021	Lee, Li-Wen/0000-0001-8019-1772	Chang Gung Medical Foundation (Chang Gung Memorial Hospital) [CMRPG6D0262, CMRPG6D0271]	Chang Gung Medical Foundation (Chang Gung Memorial Hospital)	This study was funded by the Chang Gung Medical Foundation (Chang Gung Memorial Hospital), grant number CMRPG6D0262 to SFH and CMRPG6D0271 (https://www.cgmh.org.tw/) to HCL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazmi M, 2007, CAN RESPIR J, V14, P221, DOI 10.1155/2007/987249; Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; [Anonymous], 2004, PRACT GUID BON DENS; Atlantis E, 2008, AM J CLIN NUTR, V88, P95; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Cerveri I, 2001, EUR RESPIR J, V18, P85, DOI 10.1183/09031936.01.00087101; Charlier R, 2015, ARCH GERONTOL GERIAT, V61, P161, DOI 10.1016/j.archger.2015.06.009; Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Ding JZ, 2007, AM J CLIN NUTR, V85, P405; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Franssen FME, 2002, MED SCI SPORT EXER, V34, P1570, DOI 10.1097/00005768-200210000-00007; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOBAL STRATEGY DIAG; Hart NH, 2015, J SPORT SCI MED, V14, P620; Heymsfield SB, 2000, EUR J CLIN NUTR, V54, pS26, DOI 10.1038/sj.ejcn.1601022; HIMES JH, 1979, MONOGR SOC RES CHILD, V44, P28, DOI 10.2307/1165884; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Joppa P, 2016, J AM MED DIR ASSOC, V17, P712, DOI 10.1016/j.jamda.2016.03.020; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; National health and nutrition examination survey (NHANES), 2013, BOD COMP PROC MAN; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Polkey MI, 2002, CHEST, V121, p131S, DOI 10.1378/chest.121.5_suppl.131S; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Romme EAPM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0192-8; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Sanders KJC, 2016, J CACHEXIA SARCOPENI, V7, P5, DOI 10.1002/jcsm.12062; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Sun SMS, 2012, AM J HUM BIOL, V24, P506, DOI 10.1002/ajhb.22256; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180928	10.1371/journal.pone.0180928	http://dx.doi.org/10.1371/journal.pone.0180928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700654	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800101
J	Nakajima, A; Nakatani, A; Hasegawa, S; Irie, J; Ozawa, K; Tsujimoto, G; Suganami, T; Itoh, H; Kimura, I				Nakajima, Akira; Nakatani, Akiho; Hasegawa, Sae; Irie, Junichiro; Ozawa, Kentaro; Tsujimoto, Gozoh; Suganami, Takayoshi; Itoh, Hiroshi; Kimura, Ikuo			The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GUT MICROBIOTA; INSULIN SENSITIVITY; MICE DEFICIENT; TNF-ALPHA; OBESITY; ACCUMULATION; ADIPOCYTES; PROPIONATE; EXPRESSION	The regulation of inflammatory responses within adipose tissue by various types of immune cells is closely related to tissue homeostasis and progression of metabolic disorders such as obesity and type 2 diabetes. G-protein-coupled receptor 43 (GPR43), which is activated by short-chain fatty acids (SCFAs), is known to be most abundantly expressed in white adipose tissue and to modulate metabolic processes. Although GPR43 is also expressed in a wide variety of immune cells, whether and how GPR43 in adipose tissue immune cells regulates the inflammatory responses and metabolic homeostasis remains unknown. In this study, we investigated the role of GPR43 in adipose tissue macrophages by using Gpr43deficient mice and transgenic mice with adipose- tissue-specific overexpression of GPR43. We found that GPR43 activation bySCFA resulted in induction of the pro-inflammatory cytokine tumor necrosis factor-a (TNF-a) in anti-inflammatory M2-type macrophages within adipose tissue. By contrast, this effect was not noted in inflammatory M1-type macrophages, suggesting that GPR43 plays distinct functions depending on macrophage types. Local TNF-a signaling derived from steady-state adipose tissue is associated with proper tissue remodeling as well as suppression of fat accumulation. Thus, GPR43-involving mechanism that we have identified supports maintenance of adipose tissue homeostasis and increase in metabolic activity. This newly identified facet of GPR43 in macrophages may have clinical implications for immune-metabolism related episodes.	[Nakajima, Akira; Nakatani, Akiho; Hasegawa, Sae; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Irie, Junichiro] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Ozawa, Kentaro] Nara Med Univ, Sch Med, Dept Pharmacol, Nara, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Shimoadachi Cho, Kyoto, Japan; [Suganami, Takayoshi] Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Tokyo University of Agriculture & Technology; Keio University; Nara Medical University; Kyoto University; Nagoya University	Nakajima, A; Kimura, I (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.	anakajima@mol.f.u-tokyo.ac.jp; ikimura@cc.tuat.ac.jp	Kimura, Ikuo/B-4193-2015; Irie, Junichiro/H-7795-2019	Irie, Junichiro/0000-0003-2662-4121	Japan Society for the Promotion of Science [JP15H05344]; Ministry of Education, Culture, Sports, Science and Technology [JP16H01355]; Takeda Science Foundation; Cell Science Research Foundation; Uehara Memorial Foundation; Yakult Bioscience Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [16H01355] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Yakult Bioscience Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JP15H05344, Dr. Ikuo Kimura); Ministry of Education, Culture, Sports, Science and Technology (JP16H01355, Dr. IkuoKimura); Takeda Science Foundation (Dr. IkuoKimura); Cell Science Research Foundation (Dr. IkuoKimura); Uehara Memorial Foundation (Dr.IkuoKimura); Yakult Bioscience Research Foundation (Dr. Akira Nakajima); and Tojuro Iijima Foundation for Food Science and Technology (Dr. IkuoKimura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Liu LS, 1998, DIABETES, V47, P515, DOI 10.2337/diabetes.47.4.515; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Sivaprakasam S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.38; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	44	64	69	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179696	10.1371/journal.pone.0179696	http://dx.doi.org/10.1371/journal.pone.0179696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692672	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800013
J	Sundberg, JP; Dadras, SS; Silva, KA; Kennedy, VE; Garland, G; Murray, SA; Sundberg, BA; Schofield, PN; Pratt, CH				Sundberg, John P.; Dadras, Soheil S.; Silva, Kathleen A.; Kennedy, Victoria E.; Garland, Gaven; Murray, Stephen A.; Sundberg, Beth A.; Schofield, Paul N.; Pratt, C. Herbert			Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program	PLOS ONE			English	Article							GENE-FUNCTION; GENOME-WIDE; AKR/J MICE; HISTOPATHOLOGY; DISEASE; EXPRESSION; GENERATION; PHENOTYPES; MUTATIONS; PATHOLOGY	The International Knockout Mouse Consortium was formed in 2007 to inactivate ("knockout") all protein-coding genes in the mouse genome in embryonic stem cells. Production and characterization of these mice, now underway, has generated and phenotyped 3,100 strains with knockout alleles. Skin and adnexa diseases are best defined at the gross clinical level and by histopathology. Representative retired breeders had skin collected from the back, abdomen, eyelids, muzzle, ears, tail, and lower limbs including the nails. To date, 169 novel mutant lines were reviewed and of these, only one was found to have a relatively minor sebaceous gland abnormality associated with follicular dystrophy. The B6N(Cg)Far2 (tm2b(KOMP) Wtsi)/2J strain, had lesions affecting sebaceous glands with what appeared to be a secondary follicular dystrophy. A second line, B6N(Cg)-Ppp1r9b(tm1.1(KOMP)Vlcg)/J, had follicular dystrophy limited to many but not all mystacial vibrissae in heterozygous but not homozygous mutant mice, suggesting that this was a nonspecific background lesion. We discuss potential reasons for the low frequency of skin and adnexal phenotypes in mice from this project in comparison to those seen in human Mendelian diseases, and suggest alternative approaches to identification of human disease-relevant models.	[Sundberg, John P.; Silva, Kathleen A.; Kennedy, Victoria E.; Garland, Gaven; Murray, Stephen A.; Sundberg, Beth A.; Schofield, Paul N.; Pratt, C. Herbert] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Dadras, Soheil S.] Univ Connecticut, Dept Dermatol, Farmington, CT USA; [Dadras, Soheil S.] Univ Connecticut, Dept Pathol, Farmington, CT USA; [Schofield, Paul N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Jackson Laboratory; University of Connecticut; University of Connecticut; University of Cambridge	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org		Schofield, Paul/0000-0002-5111-7263	National Institutes of Health [R21-AR063781, U42-OD011185]; National Cancer Institute Core Grant [P30-CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UM1OD023222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (R21-AR063781 and U42-OD011185). Shared services at The Jackson Laboratory are subsidized by a National Cancer Institute Core Grant (P30-CA034196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Adissu HA, 2014, DIS MODEL MECH, V7, P515, DOI 10.1242/dmm.015263; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Carroll JM, 2002, J INVEST DERMATOL, V119, P392, DOI 10.1046/j.1523-1747.2002.01811.x; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DiTommaso T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004705; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Giehl KA, 2009, CLIN EXP DERMATOL, V34, P509, DOI 10.1111/j.1365-2230.2008.03135.x; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Qin Wenning, 2016, Curr Protoc Mouse Biol, V6, P39, DOI 10.1002/9780470942390.mo150178; Schofield PN, 2012, DIS MODEL MECH, V5, P19, DOI 10.1242/dmm.008334; Schofield PN, 2011, TOXICOL PATHOL, V39, P559, DOI 10.1177/0192623311399789; Silva K, 2012, LAB MOUSE, P779; Simon MM, 2015, MAMM GENOME, V26, P486, DOI 10.1007/s00335-015-9603-x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stenn KS, 1999, ARCH DERMATOL, V135, P973, DOI 10.1001/archderm.135.8.973; Sundberg JP, 2011, VET PATHOL, V48, P513, DOI 10.1177/0300985810379431; Sundberg J. P., 2012, COMP ANATOMY HISTOLO, P433; Sundberg JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113582; Taylor DK, 2012, VET PATHOL, V49, P146, DOI 10.1177/0300985811430511; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vogel P, 2015, VET PATHOL, V52, P224, DOI 10.1177/0300985814528218; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Ward JM, 2017, LAB ANIMAL, V46, P146, DOI 10.1038/laban.1214; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wolf JC, 2017, ENVIRON TOXICOL CHEM, V36, P601, DOI 10.1002/etc.3695; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180682	10.1371/journal.pone.0180682	http://dx.doi.org/10.1371/journal.pone.0180682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700664	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800065
J	Zubala, A; MacGillivray, S; Frost, H; Kroll, T; Skelton, DA; Gavine, A; Gray, NM; Toma, M; Morris, J				Zubala, Ania; MacGillivray, Stephen; Frost, Helen; Kroll, Thilo; Skelton, Dawn A.; Gavine, Anna; Gray, Nicola M.; Toma, Madalina; Morris, Jacqui			Promotion of physical activity interventions for community dwelling older adults: A systematic review of reviews	PLOS ONE			English	Review							BEHAVIOR-CHANGE TECHNIQUES; DEPRESSIVE SYMPTOMS; HARVEST PLOT; HEALTH; EXERCISE; PEOPLE; METAANALYSIS; MAINTENANCE; RETIREMENT; CHALLENGES	Objectives While there is strong evidence that regular participation in physical activity (PA) brings numerous health benefits to older adults, and interventions to effectively promote PA are being developed and tested, the characteristics and components of the most effective interventions remain unclear. This systematically conducted review of systematic reviews evaluated the effects and characteristics of PA promotion interventions aimed at community dwelling people over 50 years old. Methods Major databases were searched for reviews from January 1990 to May 2015. TIDieR guidelines aided data extraction and the ROBIS tool was used to assess the risk of bias. Primary outcomes were objective and self-reported levels of PA. Indicators of psychological wellbeing and participation rates were secondary outcomes. Results Of 1284 records identified, 19 reviews met inclusion criteria and eight included meta-analyses. Interventions typically incorporated behaviour change techniques (BCTs) and were delivered as face-to-face, remote, group, individual or as combined interventions. Despite their heterogeneity, interventions often resulted in sustained improvements in PA over the study period, typically at 12 months, and led to improvements in general wellbeing. However, ways to ensure effective maintenance beyond one year are unclear. Certain intervention components were more clearly associated with positive effects (e.g. tailoring promotion strategy with combination of cognitive and behavioural elements, low to moderate intensity activity recommended). We found no evidence that certain other intervention characteristics were superior in achieving positive outcomes (e.g. mode of delivery, setting, professional background of the intervention provider, type of PA recommended). Conclusion The evidence suggests that interventions to promote PA among older adults are generally effective but there is uncertainty around the most beneficial intervention components. There are indications that purely cognitive strategies and BCTs might be less suitable for older adults than motivators more meaningful to them, including social and environmental support, and enjoyment coming from being physically active. A whole system-oriented approach is required that is tailored to meet the needs of older adults and aligned with social, individual and environmental factors.	[Zubala, Ania; Gray, Nicola M.; Toma, Madalina] Univ Dundee, Scottish Improvement Sci Collaborating Ctr, Sch Nursing & Hlth Sci, Dundee, Scotland; [MacGillivray, Stephen; Gavine, Anna] Univ Dundee, Sch Nursing & Hlth Sci, Evidence Synth Training & Res Grp STAR Grp, Dundee, Scotland; [Frost, Helen] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Kroll, Thilo] Univ Coll Dublin, Sch Nursing Midwifery & Hlth Syst, Dublin, Ireland; [Skelton, Dawn A.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Inst Appl Hlth Res, Glasgow, Lanark, Scotland; [Morris, Jacqui] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow, Lanark, Scotland	University of Dundee; University of Dundee; University of Stirling; University College Dublin; Glasgow Caledonian University; Glasgow Caledonian University	Zubala, A (corresponding author), Univ Dundee, Scottish Improvement Sci Collaborating Ctr, Sch Nursing & Hlth Sci, Dundee, Scotland.	a.zubala@dundee.ac.uk	Zubala, Ania/AAG-8065-2019; Skelton, Dawn A/B-7552-2013	Zubala, Ania/0000-0001-8061-6777; Skelton, Dawn A/0000-0001-6223-9840; MacGillivray, Stephen/0000-0002-1933-6431; Frost, Helen/0000-0001-9241-8970; Kroll, Thilo/0000-0003-2082-5117; Morris, Jacqui/0000-0002-9130-686X	Scottish Funding Council, Chief Scientist's Office, NHS Education for Scotland; Health Foundation; Scottish Funding Council (SFC) [242343290]; Chief Scientist Office [CZH/4/554] Funding Source: researchfish	Scottish Funding Council, Chief Scientist's Office, NHS Education for Scotland; Health Foundation; Scottish Funding Council (SFC); Chief Scientist Office	This work was undertaken by and on behalf of The Scottish Improvement Science Collaborating Centre (SISCC). The Scottish Improvement Science Collaborating Centre (SISCC) is funded by the Scottish Funding Council, Chief Scientists Office, NHS Education for Scotland, and The Health Foundation, with substantial additional investment from partner organisations. The grant reference number is 242343290. This reference number was received from Scottish Funding Council (SFC) on behalf of the funders listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbesman M, 2012, AM J OCCUP THER, V66, P277, DOI 10.5014/ajot.2012.003327; Baker PRA, 2014, J PUBLIC HEALTH-UK, V36, P517, DOI 10.1093/pubmed/fdu050; Baker PRA, 2015, COCHRANE DB SYST REV; Baker RP, 2011, CLIN PRACTICE GUIDEL, P1; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bauman A, 2016, GERONTOLOGIST, V56, pS268, DOI 10.1093/geront/gnw031; Baxter S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0336-3; Belza B., 2007, PRC HAN PHYS ACT C P; Bromley C., 2012, SCOTTISH HLTH SURVEY, V1; Chase JAD, 2015, GERONTOLOGIST, V55, P706, DOI 10.1093/geront/gnu090; Colley RC, 2011, HLTH REPORTS, V22; Conn VS, 2003, J AM GERIATR SOC, V51, P1159, DOI 10.1046/j.1532-5415.2003.51365.x; Conn VS, 2002, ANN BEHAV MED, V24, P190, DOI 10.1207/S15324796ABM2403_04; Cooper H, 2012, AM PSYCHOL, V67, P446, DOI 10.1037/a0027119; Costa EF, 2015, PREV MED, V81, P114, DOI 10.1016/j.ypmed.2015.08.007; Crowther M, 2011, RES SYNTH METHODS, V2, P79, DOI 10.1002/jrsm.37; Department of Health, 2011, START ACT STAY ACT R; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Elg M, 2012, J SERV MANAGE, V23, P328, DOI 10.1108/09564231211248435; Finegood DT, 2012, NESTLE NUTR WORKS SE, V73, P123, DOI 10.1159/000341308; Foster C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010395.pub2; Franco MR, 2015, BR J SPORTS MED, V49; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; Galvagno M, 2014, MANAG SERV QUAL, V24, P643, DOI 10.1108/MSQ-09-2013-0187; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Geraedts H, 2013, PATIENT EDUC COUNS, V91, P14, DOI 10.1016/j.pec.2012.10.018; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Hardy S, 2009, J HEALTH PSYCHOL, V14, P1036, DOI 10.1177/1359105309342298; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Hawley-Hague H, 2014, GERONTOLOGIST, V54, P599, DOI 10.1093/geront/gnt075; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hillsdon M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003180.pub.2; Hillsdon M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0260-y; Hobbs N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-75; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Kassavou A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-18; King AC, 1998, AM J PREV MED, V15, P316, DOI 10.1016/S0749-3797(98)00085-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lehne G, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0472-4; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; McCluskey A, 2005, BMC MED ED, V5; McGowan LJ, 2017, SYSTEMATIC REV META; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Mochcovitch MD, 2016, REV BRAS PSIQUIATR, V38, P255, DOI 10.1590/1516-4446-2015-1893; Moore M, 2016, J AGING PHYS ACTIV, V24, P158, DOI 10.1123/japa.2014-0218; Muller AM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-35; National Institute for Health and Clinical Excellence, 2008, MENT WELLB 65S OCC T; National Records of Scotland, 2015, SCOTL POP 2015 REG G; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; NHS Choices, 2015, PHYS ACT GUID OLD AD; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; O'Brien N, 2015, HEALTH PSYCHOL REV, V9, P417, DOI 10.1080/17437199.2015.1012177; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Office for National Statistics, 2016, OV UK POP FEBR 2016; Ogilvie D, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-8; Olanrewaju O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168614; Oliveira JS, 2017, BR J SPORTS MED; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Ory M, 2003, AM J PREV MED, V25, P164, DOI 10.1016/S0749-3797(03)00181-8; Ostrander RE, 2014, J GERONTOL NURS, V40, P36, DOI 10.3928/00989134-20140324-03; Park SH, 2014, APPL NURS RES, V27, P219, DOI 10.1016/j.apnr.2014.01.004; Patterson I., 2007, AUSTR J VOLUNTEERING, V12, P37; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rhyner KT, 2016, J AGING PHYS ACTIV, V24, P234, DOI 10.1123/japa.2015-0146; Richards J, 2013, COCHRANE LIB; Richards J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010392.pub2; Rosenberg DE, 2012, J AGING PHYS ACTIV, V20, P379, DOI 10.1123/japa.20.3.379; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sanchez A, 2015, PREV MED, V76, pS56, DOI 10.1016/j.ypmed.2014.09.012; Scholes S, 2012, HLTH SURV ENGL 2012, V1; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Stevens Z, 2014, PRIM HEALTH CARE RES, V15, P190, DOI 10.1017/S1463423613000017; Tang J, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2857; Thomson D, 2010, RES SYNTH METHODS, V1, P198, DOI 10.1002/jrsm.30; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; van der Deijl M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1301; van Stralen MM, 2009, HEALTH PSYCHOL REV, V3, P147, DOI 10.1080/17437190903229462; van Stralen MM, 2010, ANN BEHAV MED, V39, P139, DOI 10.1007/s12160-010-9166-8; Vogel T, 2009, INT J CLIN PRACT, V63, P303, DOI 10.1111/j.1742-1241.2008.01957.x; Warner LM, 2016, PSYCHOL HEALTH, V31, P1145, DOI 10.1080/08870446.2016.1185523; Watson KB, 2016, MMWR-MORBID MORTAL W, V65, P954, DOI 10.15585/mmwr.mm6536a3; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Windle G, 2010, AGING MENT HEALTH, V14, P652, DOI 10.1080/13607861003713232; World Health Organization, 2016, PHYS ACT OLD AD REC	88	139	140	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180902	10.1371/journal.pone.0180902	http://dx.doi.org/10.1371/journal.pone.0180902			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700754	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800097
J	Banfi, C; Kemeny, F; Gangl, M; Schulte-Korne, G; Moll, K; Landerl, K				Banfi, Chiara; Kemeny, Ferenc; Gangl, Melanie; Schulte-Koerne, Gerd; Moll, Kristina; Landerl, Karin			Visuo-spatial cueing in children with differential reading and spelling profiles	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; DEVELOPMENTAL DYSLEXIA; DEFICITS; ADULTS; INHIBITION; DIRECTION; RETURN; DISSOCIATION; INFORMATION; ACQUISITION	Dyslexia has been claimed to be causally related to deficits in visuo-spatial attention. In particular, inefficient shifting of visual attention during spatial cueing paradigms is assumed to be associated with problems in graphemic parsing during sublexical reading. The current study investigated visuo-spatial attention performance in an exogenous cueing paradigm in a large sample (N = 191) of third and fourth graders with different reading and spelling profiles (controls, isolated reading deficit, isolated spelling deficit, combined deficit in reading and spelling). Once individual variability in reaction times was taken into account by means of z-transformation, a cueing deficit (i.e. no significant difference between valid and invalid trials) was found for children with combined deficits in reading and spelling. However, poor readers without spelling problems showed a cueing effect comparable to controls, but exhibited a particularly strong right-over-left advantage (position effect). Isolated poor spellers showed a significant cueing effect, but no position effect. While we replicated earlier findings of a reduced cueing effect among poor nonword readers (indicating deficits in sublexical processing), we also found a reduced cueing effect among children with particularly poor orthographic spelling (indicating deficits in lexical processing). Thus, earlier claims of a specific association with nonword reading could not be confirmed. Controlling for ADHD-symptoms reported in a parental questionnaire did not impact on the statistical analysis, indicating that cueing deficits are not caused by more general attentional limitations. Between 31 and 48% of participants in the three reading and/or spelling deficit groups as well as 32% of the control group showed reduced spatial cueing. These findings indicate a significant, but moderate association between certain aspects of visuo-spatial attention and subcomponents of written language processing, the causal status of which is yet unclear.	[Banfi, Chiara; Kemeny, Ferenc; Gangl, Melanie; Landerl, Karin] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Schulte-Koerne, Gerd; Moll, Kristina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	University of Graz; University of Munich	Banfi, C (corresponding author), Karl Franzens Univ Graz, Inst Psychol, Graz, Austria.	chiara.banfi@uni-graz.at	Schulte-Körne, Gerd/AAI-4828-2021; Moll, Kristina/AAZ-1087-2021; Kemény, Ferenc/L-8685-2015	Schulte-Körne, Gerd/0000-0002-9960-1572; Kemény, Ferenc/0000-0003-2961-3014; Landerl, Karin/0000-0003-4074-0233	German Research Foundation [MO 2569/2-1]; Austrian Science Fund [I 1658-G22]; Austrian Science Fund; German Research Foundation	German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG))	This research was supported by grants from the German Research Foundation http://www.dfg.de/en/ (grant number MO 2569/2-1) and the Austrian Science Fund https://www.fwf.ac.at/en/ (grant number I 1658-G22). CB, MG, KL were funded by the Austrian Science Fund, KM and GS were funded by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico A, 2016, ACTA PSYCHOL, V171, P85, DOI 10.1016/j.actpsy.2016.10.003; BRANNAN JR, 1987, PERCEPT PSYCHOPHYS, V41, P23, DOI 10.3758/BF03208209; Buchholz J, 2005, BRAIN COGNITION, V57, P30, DOI 10.1016/j.bandc.2004.08.017; Buchholz J, 2008, DYSLEXIA, V14, P247, DOI 10.1002/dys.356; Carroll JM, 2016, J CHILD PSYCHOL PSYC, V57, P750, DOI 10.1111/jcpp.12488; Cassim R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106191; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Dopfner M., 2008, DISYPS II DIAGNOSTIK; EVIATAR Z, 1995, BRAIN COGNITION, V29, P137, DOI 10.1006/brcg.1995.1273; Facoetti A, 2000, COGNITIVE BRAIN RES, V10, P185, DOI 10.1016/S0926-6410(00)00031-8; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2001, NEUROPSYCHOLOGIA, V39, P352, DOI 10.1016/S0028-3932(00)00138-X; Facoetti A, 2000, NEUROSCI LETT, V290, P216, DOI 10.1016/S0304-3940(00)01354-9; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Goldfarb L, 2013, NEUROPSYCHOLOGY, V27, P725, DOI 10.1037/a0034422; Gorissen S.H.M., 2015, CEREB CORTEX, P1; Goswami U, 2015, NAT REV NEUROSCI, V16, P43, DOI 10.1038/nrn3836; Grainger J, 2016, TRENDS COGN SCI, V20, P171, DOI 10.1016/j.tics.2015.12.008; Grund M., 2004, DRT 4 DIAGNOSTISCHER; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hari R, 2001, BRAIN, V124, P1373, DOI 10.1093/brain/124.7.1373; Hilchey MD, 2014, J EXP PSYCHOL HUMAN, V40, P1603, DOI 10.1037/a0036859; Judge J, 2013, DYSLEXIA, V19, P55, DOI 10.1002/dys.1452; Kinsey K, 2004, NEUROREPORT, V15, P2215, DOI 10.1097/00001756-200410050-00014; Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Mayringer H., 2014, SLS 2 9 SALZBURGER L; Mele S, 2012, ACTA PSYCHOL, V141, P281, DOI 10.1016/j.actpsy.2012.09.012; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Moll K., 2010, SLRT II LESE RECHTSC; Moll K, 2016, J LEARN DISABIL-US, V49, P272, DOI 10.1177/0022219414547221; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Moores E, 2015, VISION RES, V111, P55, DOI 10.1016/j.visres.2015.03.019; Muller R., 2004, DRT 3 DIAGNOSTISCHER; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perry C, 2007, PSYCHOL REV, V114, P273, DOI 10.1037/0033-295X.114.2.273; Perry C, 2010, COGNITIVE PSYCHOL, V61, P106, DOI 10.1016/j.cogpsych.2010.04.001; Petermann F., 2011, WISC IV WECHSLER INT; Peterson RL, 2015, ANNU REV CLIN PSYCHO, V11, P283, DOI 10.1146/annurev-clinpsy-032814-112842; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Poynter W, 2010, BRAIN COGNITION, V72, P355, DOI 10.1016/j.bandc.2009.10.014; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Roach NW, 2007, BRAIN, V130, P771, DOI 10.1093/brain/awl353; Roach NW, 2004, PSYCHOL SCI, V15, P650, DOI 10.1111/j.0956-7976.2004.00735.x; Ruffino M., 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/fnhum.2013.00507, DOI 10.3389/fnhum.2014.00331]; Sexton CC, 2012, J LEARN DISABIL-US, V45, P538, DOI 10.1177/0022219411407772; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Skoyles J, 2004, BRAIN LANG, V88, P79, DOI 10.1016/S0093-934X(03)00162-7; Smigasiewicz K, 2010, NEUROPSYCHOLOGIA, V48, P2852, DOI 10.1016/j.neuropsychologia.2010.05.027; Spalek TM, 2005, PSYCHOL SCI, V16, P15, DOI 10.1111/j.0956-7976.2005.00774.x; Wei&beta; R.H., 2006, CFT 20 R GRUNDINTELL; Willburger E, 2010, DYSLEXIA, V16, P175, DOI 10.1002/dys.404; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	60	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180358	10.1371/journal.pone.0180358	http://dx.doi.org/10.1371/journal.pone.0180358			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686635	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100053
J	Bruni, GO; Battle, B; Kelly, B; Zhang, ZG; Wang, P				Bruni, Gillian O.; Battle, Blake; Kelly, Ben; Zhang, Zhengguang; Wang, Ping			Comparative proteomic analysis of Gib2 validating its adaptor function in Cryptococcus neoformans	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; CRYSTAL-STRUCTURE; MAMMALIAN RACK1; CYCLIC-AMP; PROTEIN; HOMOLOG; VIRULENCE; SUBUNIT; MENINGITIS; GPA1	Cryptococcus neoformans causes often-fatal fungal meningoencephalitis in immunocom-promised individuals. While the exact disease mechanisms remain elusive, signal transduction pathways mediated by key elements such as G-protein a subunit Gpa1, small GTPase Ras1, and atypical G beta-like/RACK1 protein Gib2 are known to play important roles in C. neoformans virulence. Gib2 is important for normal growth, differentiation, and pathogenicity, and it also positively regulates cAMP levels in conjunction with Gpa1. Interestingly, Gib2 displays a scaffold protein property by interacting with a wide variety of cellular proteins. To explore Gib2 global regulatory functions, we performed two-dimensional differential gel electrophoresis (DIGE) analysis and found that GIB2 disruption results in an increased expression of 304 protein spots (43.4%) and a decreased expression of 396 protein spots (56.6%). Analysis of 96 proteins whose expression changes were deemed significant (>= +/1.5-fold) revealed that 75 proteins belong to at least 12 functional protein groups. Among them, eight groups have the statistical stringency of p <= 0.05, and four groups, including Hsp70/71 heat shock protein homologs and ribosomal proteins, survived the Bonferroni correction. This finding is consistent with earlier established roles for the human G beta-like/RACK1 and the budding yeast Saccharomyces cerevisiae Asc1. It suggests that Gib2 could also be part of the complex affecting ribosomal biogenesis and protein translation in C. neoformans. Since eukaryotic Hsp70/71 proteins are involved in the facilitation of nascent protein folding, processing, and protection of cells against stress, we also propose that Gib2regulated stress responses are linked to fungal virulence. Collectively, our study supports a conserved role of G beta-like/RACK/Gib2 proteins in the essential cellular process of ribosomal biogenesis and protein translation. Our study also highlights a multifaceted regulatory role of Gib2 in the growth and pathogenicity of C. neoformans.	[Bruni, Gillian O.; Kelly, Ben; Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Battle, Blake] Loyola Univ, Coll Arts & Sci, New Orleans, LA 70118 USA; [Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wang, P (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.; Wang, P (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA.	pwang@lsuhsc.edu		Bruni, Gillian/0000-0002-5856-3274	USNIH [AI121460, AI121451]; Natural Science Foundation of China [31530063, 31325022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI121460, R21AI121451] Funding Source: NIH RePORTER	USNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by USNIH grants AI121460 and AI121451 and Natural Science Foundation of China grants 31530063 and 31325022 Z.Z. Zhang is also supported by an especially appointed professorship from Jiangsu, China	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casadevall A., 1998, CRYPTOCOCCUS NEOFORM, P1; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Choudhury K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020710; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Doyle S, 2011, FEMS MICROBIOL LETT, V321, P1, DOI 10.1111/j.1574-6968.2011.02292.x; Eastman AJ, 2015, J IMMUNOL, V194, P5999, DOI 10.4049/jimmunol.1402719; Ero R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08688; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gong JJ, 2014, EUKARYOT CELL, V13, P1290, DOI 10.1128/EC.00109-14; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Kim YN, 2007, PROTEOM CLIN APPL, V1, P1625, DOI 10.1002/prca.200700034; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1980, AM J PATHOL, V101, P177; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Sharma D, 2009, PROTEIN PEPTIDE LETT, V16, P571, DOI 10.2174/092986609788490230; Shen G, 2010, MOL MICROBIOL, V76, P662, DOI 10.1111/j.1365-2958.2010.07121.x; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wang P, 2005, EVOL GENET, P321; Wang YL, 2014, J BIOL CHEM, V289, P12202, DOI 10.1074/jbc.M113.537183; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036023; Zhang SR, 2006, MOL MICROBIOL, V62, P1090, DOI 10.1111/j.1365-2958.2006.05422.x	34	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180243	10.1371/journal.pone.0180243	http://dx.doi.org/10.1371/journal.pone.0180243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686685	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100044
J	Choi, SY; Ryu, HM; Oh, EJ; Choi, JY; Cho, JH; Kim, CD; Kim, YL; Park, SH				Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee			Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells	PLOS ONE			English	Article							ARTERIAL MEDIAL CALCIFICATION; RUNX2 GENE-EXPRESSION; OXIDATIVE STRESS; OSTEOBLASTIC DIFFERENTIATION; UREMIC RATS; PHOSPHATIDYLINOSITOL 3-KINASE; IN-VITRO; PHOSPHATE; CATENIN; AKT	Although dipeptidyl peptidase-4 inhibitors, a class of antidiabetic drugs, have various pleiotropic effects, it remains undetermined whether gemigliptin has a beneficial effect on vascular calcification. Therefore, this study was performed to evaluate the effect of gemigliptin on vascular calcification in a rat model of adenine-induced chronic kidney disease and in cultured vascular smooth muscle cells. Gemigliptin attenuated calcification of abdominal aorta and expression of RUNX2 in adenine-induced chronic kidney disease rats. In cultured vascular smooth muscle cells, phosphate-induced increase in calcium content was reduced by gemigliptin. Gemigliptin reduced phosphate-induced PiT-1 mRNA expression, reactive oxygen species generation, and NADPH oxidase mRNA expression (p22(phox) and NOX4). The reduction of oxidative stress by gemigliptin was associated with the downregulation of phospho-PI3K/AKT expression. High phosphate increased the expression of frizzled-3 (FDZ3) and decreased the expression of dickkopf-related protein-1 (DKK-1) in the Wnt pathway. These changes were attenuated by gemigliptin treatment. Gemigliptin restored the decreased expression of vascular smooth muscle cells markers (alpha-SMA and SM22 alpha) and increased expression of osteogenic makers (CBFA1, OSX, E11, and SOST) induced by phosphate. In conclusion, gemigliptin attenuated vascular calcification and osteogenic trans-differentiation in vascular smooth muscle cells via multiple steps including downregulation of PiT-1 expression and suppression of reactive oxygen species generation, phospho-PI3K/AKT, and the Wnt signaling pathway.	[Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Sch Med, Div Nephrol, Daegu, South Korea; [Choi, Soon-Youn; Ryu, Hye-Myung; Oh, Eun-Joo; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Soon-Youn; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Biomed Sci, Plus Biomed Convergence Program BK21, Daegu, South Korea; [Choi, Soon-Youn; Ryu, Hye-Myung; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Park, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Div Nephrol, Daegu, South Korea.; Park, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.; Park, SH (corresponding author), Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea.	sh-park@knu.ac.kr	Park, Sun/GSD-9620-2022; Cho, Jang-hee/ABD-3534-2020; Choi, Soon Youn/AHC-8865-2022	Cho, Jang-hee/0000-0002-7031-5214; 	Korea Health Technology R & D Project through Korea Health Industry Development Institute (KHIDI) [HI15C0001, HI13C1232]; Ministry of Health & Welfare, Republic of Korea	Korea Health Technology R & D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) (HI15C0001; HI13C1232), funded by the Ministry of Health & Welfare, Republic of Korea (www.khidi.or.kr) (YLK, CDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2011, KIDNEY INT, V79, P1044, DOI 10.1038/ki.2010.548; Barbieri M, 2013, ATHEROSCLEROSIS, V227, P349, DOI 10.1016/j.atherosclerosis.2012.12.018; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cai T, 2016, EXP CELL RES, V345, P206, DOI 10.1016/j.yexcr.2016.06.007; Chinda K, 2013, INT J CARDIOL, V167, P451, DOI 10.1016/j.ijcard.2012.01.011; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Hwang HJ, 2015, MOL CELL ENDOCRINOL, V405, P25, DOI 10.1016/j.mce.2015.01.025; Hwang HJ, 2014, MOL CELL ENDOCRINOL, V392, P1, DOI 10.1016/j.mce.2014.04.017; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kim SH, 2016, EUR J PHARMACOL, V788, P54, DOI 10.1016/j.ejphar.2016.06.016; Koska J, 2015, DIABETES VASC DIS RE, V12, P154, DOI 10.1177/1479164114562411; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035007; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manivannan J, 2013, MOL CELL BIOCHEM, V378, P9, DOI 10.1007/s11010-013-1588-8; Manrique C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0414-5; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; Min HS, 2014, LAB INVEST, V94, P598, DOI 10.1038/labinvest.2014.50; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Picatoste B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078330; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Rong S, 2014, CELL PHYSIOL BIOCHEM, V34, P2049, DOI 10.1159/000366400; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shah Z, 2011, VASC PHARMACOL, V55, P2, DOI 10.1016/j.vph.2011.03.001; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967; Sutra T, 2008, FREE RADICAL RES, V42, P789, DOI 10.1080/10715760802400766; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Terawaki Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0154-3; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Vittone F, 2012, DIABETOLOGIA, V55, P2267, DOI 10.1007/s00125-012-2582-5; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093447; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Yao L, 2015, AM J NEPHROL, V41, P28, DOI 10.1159/000370250; Yoshida T, 2013, J VASC RES, V50, P512, DOI 10.1159/000355263; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhan JK, 2015, INT J CARDIOL, V189, P188, DOI 10.1016/j.ijcard.2015.04.086; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Zhu DX, 2015, J CELL MOL MED, V19, P165, DOI 10.1111/jcmm.12373; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180393	10.1371/journal.pone.0180393	http://dx.doi.org/10.1371/journal.pone.0180393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686724	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100059
J	Hayes, MA; Adams, RA				Hayes, Mark A.; Adams, Rick A.			Simulated bat populations erode when exposed to climate change projections for western North America	PLOS ONE			English	Article							FRINGED MYOTIS; WATER HOLES; RESOURCE; RISK	Recent research has demonstrated that temperature and precipitation conditions correlate with successful reproduction in some insectivorous bat species that live in arid and semiarid regions, and that hot and dry conditions correlate with reduced lactation and reproductive output by females of some species. However, the potential long-term impacts of climate-induced reproductive declines on bat populations in western North America are not well understood. We combined results from long-term field monitoring and experiments in our study area with information on vital rates to develop stochastic age-structured population dynamics models and analyzed how simulated fringed myotis (Myotis thysanodes) populations changed under projected future climate conditions in our study area near Boulder, Colorado (Boulder Models) and throughout western North America (General Models). Each simulation consisted of an initial population of 2,000 females and an approximately stable age distribution at the beginning of the simulation. We allowed each population to be influenced by the mean annual temperature and annual precipitation for our study area and a generalized range-wide model projected through year 2086, for each of four carbon emission scenarios (representative concentration pathways RCP2.6, RCP4.5, RCP6.0, RCP8.5). Each population simulation was repeated 10,000 times. Of the 8 Boulder Model simulations, 1 increased (+29.10%), 3 stayed approximately stable (+2.45%, +0.05%, -0.03%), and 4 simulations decreased substantially (-44.10%, -44.70%, -44.95%, -78.85%). All General Model simulations for western North America decreased by >90% (-93.75%, -96.70%, -96.70%, -98.75%). These results suggest that a changing climate in western North America has the potential to quickly erode some forest bat populations including species of conservation concern, such as fringed myotis.	[Hayes, Mark A.; Adams, Rick A.] Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Hayes, Mark A.] Cherokee Nation Technol, Ft Collins, CO 80521 USA	University of Northern Colorado	Hayes, MA (corresponding author), Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA.; Hayes, MA (corresponding author), Cherokee Nation Technol, Ft Collins, CO 80521 USA.				University of Northern Colorado's School of Biological Sciences; Colorado Wildlife Conservation Grant program	University of Northern Colorado's School of Biological Sciences; Colorado Wildlife Conservation Grant program	This study was supported by the University of Northern Colorado's School of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Colorado Wildlife Conservation Grant program, administered cooperatively by Colorado Parks and Wildlife and U.S. Fish and Wildlife Service, and Bureau of Land Management, were generous in supporting the field research described in this paper. The City of Boulder Open Space and Mountain Parks department also was generous in funding, support, and access to their properties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2006, J ZOOL, V270, P466, DOI 10.1111/j.1469-7998.2006.00152.x; Adams R.A., 2003, BATS ROCKY MOUNTAIN; Adams R. A., 2000, ONTOGENY FUNCTIONAL; Adams RA, 2003, J ZOOL, V260, P189, DOI 10.1017/S0952836903003613; Adams RA, 2002, ACTA CHIROPTEROL, V4, P195, DOI 10.3161/001.004.0211; Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Adams Rick A., 2000, P275, DOI 10.1017/CBO9780511541872.009; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Caswell, 2000, MATRIX POPULATION MO; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Cook ER, 2009, J QUATERNARY SCI; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Duffy PB, 2014, REG CLIM STUD, P167, DOI 10.1007/978-3-319-03768-4_4; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Ghanem SJ, 2012, ADV STUD BEHAV, V44, P279, DOI 10.1016/B978-0-12-394288-3.00007-1; Hallam Thomas G., 2009, P177; Hayes MA., 2011, THESIS; Hayes MA, 2014, WEST N AM NATURALIST, V74, P446, DOI 10.3398/064.074.0410; Hayes MA, 2015, WEST N AM NATURALIST, V75, P460, DOI 10.3398/064.075.0404; Heideman Paul D., 2000, P469, DOI 10.1016/B978-012195670-7/50012-6; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Jones G, 2015, BAT EVOLUTION ECOLOG, P457; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kang B, 2007, J HYDROL ENG, V12, P63, DOI 10.1061/(ASCE)1084-0699(2007)12:1(63); Korine C, 2015, BATS ANTHROPOCENE CO, P215; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; KURTA A, 1989, CAN J ZOOL, V67, P2468, DOI 10.1139/z89-348; Lande R., 2003, OXFORD SERIES ECOLOG; Loeb SC, 2015, SRS208 USDA; Lucan RK, 2013, J ZOOL, V290, P151, DOI 10.1111/jzo.12021; Lukas J., 2014, CLIMATE CHANGE COLOR; Maine JJ, 2015, P NATL ACAD SCI USA, V112, P12438, DOI 10.1073/pnas.1505413112; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Murray JD, 2001, MATH BIOL; O'Donnell Colin F.J., 2009, P158; O'Shea Thomas J., 2004, P297; O'Shea TJ, 2011, J MAMMAL, V92, P433, DOI 10.1644/10-MAMM-A-162.1; O'Shea TJ, 2003, WILDLIFE SOC B, V31, P16; Pachauri RK, 2014, SYNTHESIS REPORT; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Racey P.A., 1987, Symposia of the Zoological Society of London, P107; Sherwin H. A., 2012, MAMM REV, DOI 10.1111/j.1365-2907.2012.00214.x; Speakman JR, 2003, BAT ECOLOGY, P430; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Studier E.H., 1980, Proceedings International Bat Research Conference, V5, P415; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; TUTTLE MD, 1976, ECOLOGY, V57, P587, DOI 10.2307/1936443; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Voight C.C., 2016, BATS ANTHROPOCENE CO, DOI 10.1007/978-3-319-25220-9; Wilson D. E., 2005, MAMMAL SPECIES WORLD	54	14	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180693	10.1371/journal.pone.0180693	http://dx.doi.org/10.1371/journal.pone.0180693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686737	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100091
J	Jing, X; Cui, XR; Liang, HP; Hao, CH; Han, CY				Jing, Xuan; Cui, Xiangrong; Liang, Hongping; Hao, Chonghua; Han, Chongyang			Diagnostic accuracy of ELISA for detecting serum Midkine in cancer patients	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; BIOMARKER; EXPRESSION; GENE; MICRORNAS; HETEROGENEITY; PLEIOTROPHIN; METAANALYSIS	Midkine (MK) has been reported as the potential novel diagnostic biomarker for cancer in several studies, but their results were controversial. Therefore, we performed a diagnostic meta-analysis to assess the diagnostic value of serum MK in cancer patients. A systematic electronic and manual search was performed for relevant literatures through several data-bases up to June 1, 2017. The quality of the studies included in the meta-analysis was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. All analyses were conducted using stata12.0 software. Ten studies collectively included 1119 cancer patients and 1441 controls met the eligible criteria. The summary estimates were: sensitivity 0.78 (95% CI = 0.68-0.85), specificity 0.83 (95% CI = 0.72-0.90), positive likelihood ratio 4,54 (95% CI = 2.64-7.80), negative likelihood 0.27 (95% CI = 0.18-0.40), diagnostic odds ratio 16.79 (95% CI = 7.17-39.33), and area under the curve 0.87 (95% CI = 0.84-0.89). Publication bias was suggested by Deeks' funnel plot asymmetry test (P = 0.92). According to our results, serum MK has greater diagnostic value in diagnosing cancer, however, more reliable studies in larger cohort should be conducted to evaluate the diagnostic accuracy of serum MK.	[Jing, Xuan; Liang, Hongping; Hao, Chonghua] Shanxi Med Univ, Shanxi Prov Peoples Hosp, Dept Clin Lab, Taiyuan, Peoples R China; [Cui, Xiangrong] Shanxi Med Univ, Reprod Med Ctr, Childrens Hosp Shanxi & Women Hlth Ctr Shanxi, Taiyuan, Shanxi, Peoples R China; [Han, Chongyang] Shanxi Med Univ, Dept Nephrol, Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University; Shanxi Medical University; Shanxi People's Hospital	Jing, X (corresponding author), Shanxi Med Univ, Shanxi Prov Peoples Hosp, Dept Clin Lab, Taiyuan, Peoples R China.	jx05070103@163.com			National Natural Science Foundation of China [81670270]; Scientific Research Project of Shanxi Provincial Department of Health [201601070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shanxi Provincial Department of Health	This work was supported by the National Natural Science Foundation of China (81670270) and Scientific Research Project of Shanxi Provincial Department of Health (201601070).	Navarro SA, 2016, EXPERT OPIN THER PAT, V26, P1095, DOI 10.1080/13543776.2016.1211640; ARIDOME K, 1995, JPN J CANCER RES, V86, P655, DOI 10.1111/j.1349-7006.1995.tb02449.x; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bray F., 2015, CANC DIS CONTROL PRI, V3; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Cui X, 2017, ONCOTARGET; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; GARVER RI, 1994, CANCER, V74, P1584, DOI 10.1002/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO;2-V; GARVER RI, 1993, AM J RESP CELL MOL, V9, P463, DOI 10.1165/ajrcmb/9.5.463; Global Burden of Disease Cancer Collaboration, 2017, JAMA Oncol, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Iwamoto H, 2014, INT J ONCOL, V44, P53, DOI 10.3892/ijo.2013.2169; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Konishi N, 1999, ONCOLOGY-BASEL, V57, P253, DOI 10.1159/000012039; Krzystek-Korpacka M, 2013, CYTOKINE, V64, P158, DOI 10.1016/j.cyto.2013.07.008; Li Haojie, 2017, Zhonghua Wei Chang Wai Ke Za Zhi, V20, P195; Lucas S, 2009, J PEDIAT HEMATOL ONC, V31, P713, DOI 10.1097/MPH.0b013e3181b6db9f; Ma R, 2017, ONCOTARGET; Meng ZW, 2015, LIFE SCI, V130, P18, DOI 10.1016/j.lfs.2015.02.028; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P811, DOI 10.1111/bph.12571; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Rawnaq T, 2014, MOL CANCER RES, V12, P670, DOI 10.1158/1541-7786.MCR-13-0467; Shaheen KYA, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/146389; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Shimada H, 2003, CANCER SCI, V94, P628, DOI 10.1111/j.1349-7006.2003.tb01494.x; Shin JH, 2017, ULTRASONOGRAPHY, V36, P103, DOI 10.14366/usg.16048; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun C, 2015, GUANGDONG MED J, P768; Tanaka IB, 2017, RADIAT RES; TOMOMURA M, 1990, BIOCHEM BIOPH RES CO, V171, P603, DOI 10.1016/0006-291X(90)91189-Y; Vongsuvanh R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155800; Wan C, 2012, ARCH MED SCI, V8, P749, DOI 10.5114/aoms.2012.31609; Wang J, 2012, SURG ONCOL, V21, P119, DOI 10.1016/j.suronc.2010.12.004; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xia X, 2016, ONCOTARGET, V7, P87462, DOI 10.18632/oncotarget.13865; Yamashita T, 2016, CANCER MED-US, V5, P415, DOI 10.1002/cam4.600; Zhang Y, 2014, TUMOR BIOL, V35, P9343, DOI 10.1007/s13277-014-2209-1; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	43	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180511	10.1371/journal.pone.0180511	http://dx.doi.org/10.1371/journal.pone.0180511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686647	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100071
J	Knafl, D; Thalhammer, F; Vossen, MG				Knafl, Daniela; Thalhammer, Florian; Vossen, Matthias G.			In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin D layer (PRF) D a laboratory evaluation of a modern, autologous wound treatment	PLOS ONE			English	Article							CHRONIC LEG ULCERS; HUMAN BETA-DEFENSIN-2	Objectives Platelet rich fibrin (PRF) is an autologous fibrin glue, produced from patients' blood, which, besides intraoperative use, has applications in the treatment of infected wounds. The combination with antimicrobial agents results in a prolonged antibacterial effect allowing for wound dressing change intervals of seven days even in infected wounds. The aim of this study was to evaluate release kinetics of amikacin, teicoplanin or polyhexanide from a PRF- layer. Methods PRF mixed with teicoplanin, amikacin or polyhexanide was sprayed on a silicon gauze patch and put on a colombia agar with bacteria with known minimal inhibitory concentration (MIC) and incubated for 24 hours and afterwards transferred to another agar with the same bacterial strain. Inhibition zones were measured every 24 hours. This was repeated on 7 consecutive days. Antibiotic concentrations were calculated by interpolation. Results More than 1000 mg/L teicoplanin were released within the first 24 hours and 28.22 mg/L after 168 hours. Amikacin release was above 10,000 mg/L within the first 24 hours and still 120.8 mg/L after 120 hours. A release of polyhexanide could be verified for the first 24 hours only. Consequently teicoplanin and amikacin released from PRF showed antimicrobial invitro effects for almost a week, whereas an antimicrobial effect of polyhexanide could only be verified for the first 24 hours. Conclusions Our Results show that a weekly dressing regimen may be justified in wounds treated with PRF plus amikacin or teicoplanin, since bacteria will be eradicated over a considerable period of time after a single application of PRF.	[Knafl, Daniela; Thalhammer, Florian; Vossen, Matthias G.] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	Medical University of Vienna	Vossen, MG (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	matthias.vossen@meduniwien.ac.at	Vossen, Matthias Gerhard/H-8761-2019		Vivostat A/S	Vivostat A/S	F.T. and M.G.V. received an unrestricted research grant from Vivostat A/S. D.K. did not receive any grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.vivostat.com/.	[Anonymous], 2008, WOUND REPAIR REGENER, V16, P356; Bayer A, 2016, EXP DERMATOL, V25, P460, DOI 10.1111/exd.12966; Carter Marissa J, 2011, Eplasty, V11, pe38; EUCAST, 2020, EUR COMM ANT SUSC TE; Giamarellos-Bourboulis EJ, 2005, DIAGN MICR INFEC DIS, V51, P113, DOI 10.1016/j.diagmicrobio.2004.09.004; Hurd T, 2008, INT WOUND J, V5, P296, DOI 10.1111/j.1742-481X.2008.00484.x; Jockenhofer F, 2014, J DTSCH DERMATOL GES, V12, P1121, DOI 10.1111/ddg.12540; Korber A, 2011, J DTSCH DERMATOL GES, V9, P116, DOI 10.1111/j.1610-0387.2010.07535.x; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; O'Meara S, 2000, Health Technol Assess, V4, P1; Ruttermann M, 2013, DTSCH ARZTEBL INT, V110, P25, DOI 10.3238/arztebl.2013.0025; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Steenvoorde P, 2008, J Wound Care, V17, P60; Tohidnezhad M, 2011, HISTOCHEM CELL BIOL, V135, P453, DOI 10.1007/s00418-011-0808-0; Tohidnezhad M, 2012, PLATELETS, V23, P217, DOI 10.3109/09537104.2011.610908; Tohidnezhad M, 2011, INJURY, V42, P682, DOI 10.1016/j.injury.2010.12.010	16	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181090	10.1371/journal.pone.0181090	http://dx.doi.org/10.1371/journal.pone.0181090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686663	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100131
J	Landi, D; Albanese, M; Buttari, F; Monteleone, F; Boffa, L; Rossi, S; Motta, C; Puma, E; Centonze, D				Landi, Doriana; Albanese, Maria; Buttari, Fabio; Monteleone, Fabrizia; Boffa, Laura; Rossi, Silvia; Motta, Caterina; Puma, Elisa; Centonze, Diego			Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study	PLOS ONE			English	Article							SYMPTOMS; IBUPROFEN	Background Flu-like syndrome (FLS) is a common adverse event experienced by patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon beta (IFN beta). FLS can lead to poor treatment adherence and early IFN beta discontinuation. The involvement of interleukin-6 (IL-6) in the occurrence of FLS has been suggested. We hypothesized that cetirizine, a second-generation histamine H1 receptor antagonist able to reduce the levels of IL-6, might improve IFN beta-induced FLS. Methods We conducted a pilot, cross-over, randomized, placebo-controlled, double-blind study to evaluate the efficacy of cetirizine 10 mg added after each IFN beta injection to the standard of care for FLS (acetaminophen or nonsteroidal anti-inflammatory drugs) on FLS in patients with RRMS treated with IFN beta. Patients were randomized to two treatment sequences: 1) 4week treatment with placebo added to the standard treatment for FLS, followed by 4-week treatment with cetirizine added to the standard of care, and 2) first addition of cetirizine, then of placebo. The primary efficacy endpoint was the mean change of FLS severity [11-point visual analog scale (VAS)] after 4 weeks of treatment within each sequence. Results Forty-five patients (71.1% female, mean age 39.1 years, mean time from RRMS diagnosis 5.8 years) were randomized to treatment sequences 1 and 2. The differences between cetirizine and placebo in the intensity of FLS were not statistically significant: total mean VAS scores at 4 hours from IFN beta injection were 3.57 and 3.42 for cetirizine and placebo, respectively (difference-0.15; 95% confidence interval: from -0.74 to 0.44; p = 0.6029). The two treatments were similar also with regard to other efficacy measures considered and to the safety/tolerability profile. Conclusions The addition of cetirizine to the standard of care for IFN beta-induced FLS in patients with RRMS does not seem to provide significant benefits compared with placebo. Further effort is required to understand the mechanisms underlying IFN beta-induced FLS.	[Landi, Doriana; Albanese, Maria; Buttari, Fabio; Monteleone, Fabrizia; Boffa, Laura; Motta, Caterina; Centonze, Diego] Tor Vergata Univ, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy; [Landi, Doriana; Albanese, Maria; Buttari, Fabio; Centonze, Diego] IRCCS, INM Neuromed, Pozzilli, Is, Italy; [Rossi, Silvia] IRCCS, Fdn Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy; [Puma, Elisa] Biogen Italy, Med Dept, Milan, Italy	University of Rome Tor Vergata; IRCCS Neuromed; IRCCS Istituto Neurologico Besta	Landi, D (corresponding author), Tor Vergata Univ, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy.; Landi, D (corresponding author), IRCCS, INM Neuromed, Pozzilli, Is, Italy.	doriana.landi@gmail.com	Landi, Doriana/AAK-7105-2021; Motta, Caterina/L-1513-2018; Albanese, Maria/K-7232-2016; Centonze, Diego/J-7767-2016	Landi, Doriana/0000-0002-3309-8417; Centonze, Diego/0000-0002-8390-8545	Biogen	Biogen(Biogen)	This study was sponsored by Biogen (http://www.biogen.com/). The sponsor monitored clinical data collection, reviewed and provided feedback on the manuscript to the authors, who had full editorial control of the manuscript and provided their final approval of all content.	Abdelaziz MM, 2000, ALLERGY, V55, P425, DOI 10.1034/j.1398-9995.2000.00114.x; Armitage P., 2002, STAT METHODS MED RES; Bertoli D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135441; Brandes DW, 2007, CURR MED RES OPIN, V23, P1667, DOI 10.1185/030079907X210741; Brod SA, 1996, NEUROLOGY, V46, P1633, DOI 10.1212/WNL.46.6.1633; Ciprandi G, 1997, ANN ALLERG ASTHMA IM, V79, P507, DOI 10.1016/S1081-1206(10)63057-8; Curran MP, 2004, DRUGS, V64, P523, DOI 10.2165/00003495-200464050-00008; Fox Robert J, 2013, Int J MS Care, V15, P194, DOI 10.7224/1537-2073.2012-034; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Hegen H, 2015, EXPERT OPIN DRUG MET, V11, P1803, DOI 10.1517/17425255.2015.1094055; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kumpfel T, 2007, MULT SCLER J, V13, P1138, DOI 10.1177/1352458507078685; Martinez-Caceres EM, 1998, ANN NEUROL, V44, P682, DOI 10.1002/ana.410440415; Montalban X, 2000, J NEUROL, V247, P259, DOI 10.1007/s004150050580; Moses H, 2008, CURR MED RES OPIN, V24, P2679, DOI [10.1185/03007990802329959, 10.1185/03007990802329959 ]; Nadjar Y, 2011, CLIN NEUROL NEUROSUR, V113, P316, DOI 10.1016/j.clineuro.2010.12.013; Patti F, 2010, PATIENT PREFER ADHER, V4, P1; Plosker GL, 2011, CNS DRUGS, V25, P67, DOI 10.2165/11206430-000000000-00000; Portaccio E, 2009, CNS DRUGS, V23, P453, DOI 10.2165/00023210-200923060-00001; Poulos C, 2016, PATIENT, V9, P171, DOI 10.1007/s40271-015-0136-x; Reess J, 2002, MULT SCLER, V8, P15; Rice GPA, 1999, NEUROLOGY, V52, P1893, DOI 10.1212/WNL.52.9.1893; Rio J, 1998, NEUROLOGY, V50, P1910, DOI 10.1212/WNL.50.6.1910; Scolding N, 2015, PRACT NEUROL, P1; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Vignatelli L, 2003, NEUROL SCI, V23, P295, DOI 10.1007/s100720300004	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0165415	10.1371/journal.pone.0165415	http://dx.doi.org/10.1371/journal.pone.0165415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686675	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100001
J	Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A				Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Neureiter, Daniel; Klieser, Eckhard; Gampenrieder, Simon; Moser, Gerhard; Gaggl, Alexander; Greil, Richard; Egle, Alexander			Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; C-REACTIVE PROTEIN; OPEN-LABEL; HUMAN-PAPILLOMAVIRUS; LYMPHOCYTE RATIO; PLUS CETUXIMAB; CISPLATIN; FLUOROURACIL; MULTICENTER; DOCETAXEL	Despite modern treatment approaches, survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) remains low and it is difficult to identify patients who derive optimal benefit from treatment. We therefore analyzed which commonly available laboratory and clinical parameters may help improve the prognostication in this patient group. This retrospective monocenter analysis includes 128 patients with recurrent or metastatic SCCHN treated with cetuximab alone or in combination with polychemotherapy as first line therapy. Factors with independent prognostic power in the multivariate analysis were used to build up a score separating patient groups with different survival. Patients had a median age of 61 years and 103 patients were treated with polychemotherapy plus cetuximab. An ECOG score above 1, high CRP and leukocyte levels, less intensive treatment and a time below 12 months from primary diagnosis to relapse remained as independent negative prognostic factors in multivariate analysis. Patients with 0 to 1 risk factors had a median OS of 13.6 months compared to a median OS of less than one month for patients 4 to 5 risk factors (p< 0.001). This study identifies 5 clinical and serum values that influence survival of patients with recurrent or metastatic SCCHN treated with cetuximab. By combining these factors to create a score for OS, it is possible to distinguish a group of patients with significantly improved survival and define those most likely to have no benefit from cetuximab treatment.	[Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Paracelsus Med Univ, Med Dept 3, Salzburg, Austria; [Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Salzburg Canc Res Inst, Salzburg, Austria; [Magnes, Teresa; Melchardt, Thomas; Weiss, Lukas; Mittermair, Christof; Gampenrieder, Simon; Greil, Richard; Egle, Alexander] Canc Cluster Salzburg, Salzburg, Austria; [Neureiter, Daniel; Klieser, Eckhard] Paracelsus Med Univ, Inst Pathol, Salzburg, Austria; [Moser, Gerhard] Paracelsus Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Salzburg, Austria; [Gaggl, Alexander] Paracelsus Med Univ, Dept Oral & Maxillofacial Surg, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Egle, A (corresponding author), Paracelsus Med Univ, Med Dept 3, Salzburg, Austria.; Egle, A (corresponding author), Salzburg Canc Res Inst, Salzburg, Austria.; Egle, A (corresponding author), Canc Cluster Salzburg, Salzburg, Austria.	a.egle@salk.at	Gampenrieder, Simon Peter/AFM-7798-2022; Egle, Alexander/AAC-3787-2020; Moser, Gerhard/N-7402-2013	Egle, Alexander/0000-0003-0648-4416; Weiss, Lukas/0000-0002-2174-5613; Moser, Gerhard/0000-0003-4916-5490	PMU Research Fund- PMU FFF [R-16/02/081-MAM]; province of Salzburg; company Merck	PMU Research Fund- PMU FFF; province of Salzburg; company Merck	This work was supported by the PMU Research Fund- PMU FFF [grant number: R-16/02/081-MAM] and the province of Salzburg. The author Thomas Melchardt received an unrestricted grant from the company Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2004, CANCER, V101, P2222, DOI 10.1002/cncr.20640; Argiris A, 2014, ANN ONCOL, V25, P1410, DOI 10.1093/annonc/mdu167; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bektas-Kayhan K, 2012, ORAL DIS, V18, P55, DOI 10.1111/j.1601-0825.2011.01843.x; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; de Mello RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086697; Fang HY, 2013, LARYNGOSCOPE, V123, P2690, DOI 10.1002/lary.24105; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Guo Y, 2015, HEAD NECK-J SCI SPEC, V37, P1081, DOI 10.1002/hed.23707; Jalali MM, 2011, ASIAN PAC J CANCER P, V12, P1731; Keil F, 2013, EUR J CANCER, V49, P352, DOI 10.1016/j.ejca.2012.08.004; Khandavilli SD, 2009, ORAL ONCOL, V45, P912, DOI 10.1016/j.oraloncology.2009.03.015; Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853; Lynggaard CD, 2015, ACTA ONCOL, V54, P1071, DOI 10.3109/0284186X.2014.964308; Melchardt T, 2015, J NATL COMPR CANC NE, V13, P1501, DOI 10.6004/jnccn.2015.0178; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Misiukiewicz K, 2014, ANN ONCOL, V25, P1667, DOI 10.1093/annonc/mdu194; Nakayama M, 2015, HEAD NECK-J SCI SPEC, V37, P1745, DOI 10.1002/hed.23823; Perisanidis C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0334-5; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Purdue MP, 2013, BLOOD, V122, P951, DOI 10.1182/blood-2013-01-481077; Ramsey S, 2006, BRIT J CANCER, V95, P1076, DOI 10.1038/sj.bjc.6603387; Rischin D, 2010, J CLIN ONCOL, V28, P4142, DOI 10.1200/JCO.2010.29.2904; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Selzer E, 2015, STRAHLENTHER ONKOL, V191, P486, DOI 10.1007/s00066-014-0803-1; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Troppan KT, 2014, BRIT J CANCER, V111, P55, DOI 10.1038/bjc.2014.277; Ueda M, 2010, AURIS NASUS LARYNX, V37, P488, DOI 10.1016/j.anl.2009.11.012; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vermorken JB, 2013, LANCET ONCOL, V14, P697, DOI 10.1016/S1470-2045(13)70181-5	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180995	10.1371/journal.pone.0180995	http://dx.doi.org/10.1371/journal.pone.0180995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686697	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100130
J	Snow, KJ; Richards, AH; Kinner, SA				Snow, Kathryn J.; Richards, Alun H.; Kinner, Stuart A.			Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort study	PLOS ONE			English	Article							VIRUS-INFECTION; INJECT DRUGS; VALIDITY; PEOPLE	Hepatitis C is a major cause of preventable morbidity and mortality. Prisoners are a key population for hepatitis C control programs, and with the advent of highly effective therapies, prisons are increasingly important sites for hepatitis C diagnosis and treatment. Accurate estimates of hepatitis C prevalence among prisoners are needed in order to plan and resource service provision, however many prevalence estimates are based on surveys compromised by limited and potentially biased participation. We aimed to compare estimates derived from three different data sources, and to assess whether the use of selfreport as a supplementary data source may help researchers assess the risk of selection bias. We used three data sources to estimate the prevalence of hepatitis C antibodies in a large cohort of Australian prisoners-prison medical records, self-reported status during a face-to-face interview prior to release from prison, and data from a statewide notifiable conditions surveillance system. Of 1,315 participants, 33.8% had at least one indicator of hepatitis C seropositivity, however less than one third of these (9.5% of the entire cohort) were identified by all three data sources. Among participants of known status, self-report had a sensitivity of 80.1% and a positive predictive value of 97.8%. Any one data source used in isolation would have under-estimated the prevalence of hepatitis C in this cohort. Using multiple data sources in studies of hepatitis C seroprevalence among prisoners may improve case detection and help researchers assess the risk of selection bias due to non-participation in serological testing.	[Snow, Kathryn J.; Kinner, Stuart A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Snow, Kathryn J.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Australia; [Snow, Kathryn J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Australia; [Richards, Alun H.] Queensland Govt, Prevent Div, Communicable Dis Branch, Dept Hlth, Brisbane, Qld, Australia; [Kinner, Stuart A.] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Kinner, Stuart A.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Queensland Health; Griffith University; Mater Research; University of Queensland; Monash University; Murdoch Children's Research Institute	Snow, KJ (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Snow, KJ (corresponding author), Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Australia.; Snow, KJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Australia.	kathryn.snow@unimelb.edu.au; s.kinner@unimelb.edu.au		Snow, Kathryn J/0000-0002-6625-5175	NHMRC Strategic Award [409966]; NHMRC Project Grant [1002463]	NHMRC Strategic Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by NHMRC Strategic Award #409966 and NHMRC Project Grant #1002463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2014, PRISONERS AUSTR; Brameld KJ, 1999, AUST NZ J PUBL HEAL, V23, P464, DOI 10.1111/j.1467-842X.1999.tb01299.x; Butler T, 2015, NATL PRISON ENTRANTS; Craine N, 2014, EUR J PUBLIC HEALTH; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Fisher DG, 2007, SEX TRANSM DIS, V34, P389, DOI 10.1097/01.olq.0000245916.45429.ec; Guirgis M, 2012, INTERN MED J, V42, P497, DOI 10.1111/j.1445-5994.2011.02440.x; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Kinner SA, 2013, CONTEMP CLIN TRIALS, V36, P198, DOI 10.1016/j.cct.2013.07.001; Kinner SA, 2012, DRUG ALCOHOL DEPEN, V126, P156, DOI 10.1016/j.drugalcdep.2012.05.008; Martin NK, 2016, HEPATOLOGY, V63, P1796, DOI 10.1002/hep.28497; Mina MM, 2014, MED J AUSTRALIA, V200, P15, DOI 10.5694/mja13.10654; O'Keefe D, 2013, DRUG ALCOHOL REV, V32, P208, DOI 10.1111/j.1465-3362.2012.00502.x; Queensland Health, 2012, HEP C QUEENSL HLTH G; Reekie JM, 2014, MED J AUSTRALIA, V200, P277, DOI 10.5694/mja13.11062; Rowe S, 2012, VICTORIAN INFECT DIS, V15; Rumble C, 2015, EUR J PUBLIC HEALTH; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Topp L, 2009, DRUG ALCOHOL REV, V28, P669, DOI 10.1111/j.1465-3362.2009.00060.x; Treloar C, 2012, DRUG ALCOHOL REV, V31, P918, DOI 10.1111/j.1465-3362.2012.00468.x; van Gamert CB I, 2011, EVALUATION HEPATITIS; WHO, 2016, MYANM NATL SIMPL TRE; World Health Organization, 2012, GUID PREV VIR HEP B	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180646	10.1371/journal.pone.0180646	http://dx.doi.org/10.1371/journal.pone.0180646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686715	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100086
J	Tweya, H; Feldacker, C; Heller, T; Gugsa, S; Ng'ambi, W; Nthala, O; Kalulu, M; Chiwoko, J; Banda, R; Makwinja, A; Phiri, S				Tweya, Hannock; Feldacker, Caryl; Heller, Tom; Gugsa, Salem; Ng'ambi, Wingston; Nthala, Omisher; Kalulu, Mike; Chiwoko, Jane; Banda, Rabecca; Makwinja, Agness; Phiri, Sam			Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study	PLOS ONE			English	Article							AIDS; MORTALITY; RECOVERY; AGE	Objective To estimate patients enrolling on antiretroviral therapy (ART) over time; describe trends in baseline characteristics; and compare immunological response, loss to follow-up (LTFU), and mortality by three age groups (25-39, 40-49 and >= 50 years). Design A retrospective observation cohort study. Methods This study used routine ART data from two public clinics in Lilongwe, Malawi. All HIVinfected individuals, except pregnant or breastfeeding women, aged >= 25 years at ART initiation between 2006 and 2015 were included. Poisson regression models estimated risk of mortality, stratified by age groups. Results Of 37,378 ART patients, 3,406 were >= 50 years old. Patients aged >= 50 years initiated ART with more advanced WHO clinical stage and lower CD4 cell count than their younger counterparts. Older patients had a significantly slower immunological response to ART in the first 18 months on ART compared to patients aged 25-39 years (p = 0.04). Overall mortality rates were 2.3 (95% confidence Interval (CI) 2.2-2.4), 2.9 (95% CI 2.7-3.2) and 4.6 (95% CI 4.2-5.1) per 100 person-years in patients aged 25-39 years, 40-49 years and 50 years and older, respectively. Overall LTFU rates were 6.3 (95% CI 6.1-6.5), 4.5 (95% CI 4.2-4.7), and 5.6 (95% CI 5.1-6.1) per 100 person years among increasing age cohorts. The proportion of patients aged >= 50 years and newly enrolling into ART care remained stable at 9% while the proportion of active ART patients aged >= 50 years increased from 10% in 2006 to 15% in 2015. Conclusion Older people had slower immunological response and higher mortality. Malawi appears to be undergoing a demographic shift in people living with HIV. Increased consideration of long-term ART-related problems, drug-drug interactions and age-related non-communicable diseases is warranted.	[Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Heller, Tom; Gugsa, Salem; Ng'ambi, Wingston; Nthala, Omisher; Kalulu, Mike; Chiwoko, Jane; Banda, Rabecca; Makwinja, Agness; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Feldacker, Caryl; Gugsa, Salem] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Phiri, Sam] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.; Tweya, H (corresponding author), Lighthouse Trust, Lilongwe, Malawi.	h_tweya@lighthouse.org.mw		Feldacker, Caryl/0000-0002-8152-6754; Gugsa, Salem/0000-0003-3545-3117	Department for International Development (DFD), UK	Department for International Development (DFD), UK	We thank the Department for International Development (DFD), UK, for funding the Global Operational Research Fellowship Programme at the International Union Against Tuberculosis and Lung Disease (The Union), Paris, France in which Dr Hannock Tweya works as a senior operational research fellow.	Aboderin IAG, 2015, LANCET, V385, pE9, DOI 10.1016/S0140-6736(14)61602-0; [Anonymous], HIV ATT AW TEST OLD; Center for Disease control and prevention (CDC), 2008, HIV PEOPL AG 50; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2015, LANCET HIV, V2, pE368, DOI 10.1016/S2352-3018(15)00113-7; Cuzin L, 2007, CLIN INFECT DIS, V45, P654, DOI 10.1086/520652; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Eduardo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103864; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Feldacker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050871; FERRO S, 1992, J ACQ IMMUN DEF SYND, V5, P348; Gaeta TJ, J EMERG MED, V14, P19; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Lacerda HR, 2008, INT J STD AIDS, V19, P450, DOI 10.1258/ijsa.2008.007317; Malawi Ministry of Health, 2008, TREATM AIDS GUID US; Malawi Ministry of Health, 2014, CLIN MAN HIV CHILDR; Martin CP, 2008, AM J MED, V121, P1032, DOI 10.1016/j.amjmed.2008.08.009; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; Maskew Mhairi, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P57, DOI 10.1177/1545109711421641; Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39; Navarro G, 2008, J INFECTION, V57, P64, DOI 10.1016/j.jinf.2008.05.003; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Semeere AS, 2014, JAIDS-J ACQ IMM DEF, V67, P382, DOI 10.1097/QAI.0000000000000330; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; Williams J., HIV RISK RECENT SEXU	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180232	10.1371/journal.pone.0180232	http://dx.doi.org/10.1371/journal.pone.0180232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686636	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100043
J	Yin, WX; Zhang, C; Zhu, HY; Zhao, YR; He, Y				Yin, Wenxin; Zhang, Chu; Zhu, Hongyan; Zhao, Yanru; He, Yong			Application of near-infrared hyperspectral imaging to discriminate different geographical origins of Chinese wolfberries	PLOS ONE			English	Article							SPECTROSCOPY; CLASSIFICATION; WAVELENGTHS; TECHNOLOGY; FEATURES; SPECTRA	Near-infrared (874-1734 nm) hyperspectral imaging (NIR-HSI) technique combined with chemometric methods was used to trace origins of 1200 Chinese wolfberry samples, which from Ningxia, Inner Mongolia, Sinkiang and Qinghai in China. Two approaches, named pixel-wise and object-wise, were investigated to discriminative the origin of these Chinese wolfberries. The pixel-wise classification assigned a class to each pixel from individual Chinese wolfberries, and with this approach, the differences in the Chinese wolfberries from four origins were reflected intuitively. Object-wise classification was performed using mean spectra. The average spectral information of all pixels of each sample in the hyperspectral image was extracted as the representative spectrum of a sample, and then discriminant analysis models of the origins of Chinese wolfberries were established based on these average spectra. Specifically, the spectral curves of all samples were collected, and after removal of obvious noise, the spectra of 972-1609 nm were viewed as the spectra of wolfberry. Then, the spectral curves were pretreated with moving average smoothing (MA), and discriminant analysis models including support vector machine (SVM), neural network with radial basis function (NN-RBF) and extreme learning machine (ELM) were established based on the full-band spectra, the extracted characteristic wavelengths from loadings of principal component analysis (PCA) and 2nd derivative spectra, respectively. Among these models, the recognition accuracies of the calibration set and prediction set of the ELM model based on extracted characteristic wavelengths from loadings of PCA were higher than 90%. The model not only ensured a high recognition rate but also simplified the model and was conducive to future rapid on-line testing. The results revealed that NIR-HSI combined with PCA loadings-ELM could rapidly trace the origins of Chinese wolfberries.	[Yin, Wenxin; Zhang, Chu; Zhu, Hongyan; Zhao, Yanru; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010; Zhang, Chu/J-7191-2017	He, Yong/0000-0001-6752-1757; Zhang, Chu/0000-0001-6760-3154	Key Projects in the National Science & Technology Pillar Program [2015BAD19B03]	Key Projects in the National Science & Technology Pillar Program	This study was supported by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (Project No. 2015BAD19B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello F, 2015, INT J REMOTE SENS, V36, P645, DOI 10.1080/01431161.2014.999882; Bagnasco L, 2015, TALANTA, V144, P1225, DOI 10.1016/j.talanta.2015.07.071; Boyaci IH, 2014, FOOD CHEM, V148, P37, DOI 10.1016/j.foodchem.2013.10.006; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Chen J, 2013, J CEREAL SCI, V58, P241, DOI 10.1016/j.jcs.2013.07.002; Cynkar W, 2009, FOOD RES INT, V42, P653, DOI 10.1016/j.foodres.2009.02.002; Delwiche SR, 2013, BIOSYST ENG, V115, P260, DOI 10.1016/j.biosystemseng.2013.03.015; Devos O, 2009, CHEMOMETR INTELL LAB, V96, P27, DOI 10.1016/j.chemolab.2008.11.005; Feng YZ, 2013, FOOD CHEM, V138, P1829, DOI 10.1016/j.foodchem.2012.11.040; Gao JF, 2013, COMPUT ELECTRON AGR, V99, P186, DOI 10.1016/j.compag.2013.09.011; Hajati S, 2014, J IND ENG CHEM, V20, P2421, DOI 10.1016/j.jiec.2013.10.022; He NW, 2012, FOOD CHEM, V133, P978, DOI 10.1016/j.foodchem.2012.02.018; Huang M, 2013, J FOOD ENG, V116, P45, DOI 10.1016/j.jfoodeng.2012.11.014; Ishii K., 2014, OPTICS PHOTONICS J, V4, P271, DOI DOI 10.4236/OPJ.2014.410026; Kafle GK, 2016, POSTHARVEST BIOL TEC, V120, P188, DOI 10.1016/j.postharvbio.2016.06.013; Langeron Y, 2007, ENG APPL ARTIF INTEL, V20, P415, DOI 10.1016/j.engappai.2006.07.001; Li H, 2007, ANAL BIOANAL CHEM, V389, P2313, DOI 10.1007/s00216-007-1624-1; Li Q, 2017, INT J FOOD IN PRESS; Li SX, 2014, LASER PHYS LETT, V11, DOI 10.1088/1612-2011/11/6/065603; Li XT, 2012, MODERN FOOD SCI TECH, V9; Li YH, 2017, FOOD ANAL METHOD, V10, P1034, DOI 10.1007/s12161-016-0666-4; Li Z, 2016, SPECTROSC SPECT ANAL, V36, P720, DOI 10.3964/j.issn.1000-0593(2016)03-0720-04; Lu WY, 2014, J AGR FOOD CHEM, V62, P9073, DOI 10.1021/jf502156n; Ma J, 2016, FOOD CHEM, V197, P848, DOI 10.1016/j.foodchem.2015.11.023; Manley M, 2012, TALANTA, V89, P223, DOI 10.1016/j.talanta.2011.11.086; Nagao R, 2015, ADV BIOMED ENG, V4, P158, DOI 10.14326/abe.4.158; Nagao R, 2015, OPT REV, V22, P329, DOI 10.1007/s10043-015-0035-3; Qiao J, 2007, J FOOD ENG, V83, P10, DOI 10.1016/j.jfoodeng.2007.02.038; Santos AAP, 2014, MARIT ECON LOGIST, V16, P72, DOI 10.1057/mel.2013.20; Shen TT, 2016, FOOD ANAL METHOD, V9, P68, DOI 10.1007/s12161-015-0175-x; Tabasi SH, 2009, INT J PHARMACEUT, V382, P1, DOI 10.1016/j.ijpharm.2009.07.029; van der Meijde M, 2013, INT J APPL EARTH OBS, V23, P384, DOI 10.1016/j.jag.2012.11.001; Wang J, 2011, LWT-FOOD SCI TECHNOL, V44, P1119, DOI 10.1016/j.lwt.2010.11.012; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Wang YG, 2016, FOOD ANAL METHOD, V9, P131, DOI 10.1007/s12161-015-0178-7; Williams PJ, 2016, FOOD CHEM, V209, P131, DOI 10.1016/j.foodchem.2016.04.044; Wu D, 2008, ANAL CHIM ACTA, V610, P232, DOI 10.1016/j.aca.2008.01.056; Yan Y.L., 2005, BASICS APPL NEAR INF; Yu KQ, 2014, FOOD BIOPROCESS TECH, V7, P3077, DOI 10.1007/s11947-014-1357-z; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234; Zhao LQ, 2013, IND CROP PROD, V47, P51, DOI 10.1016/j.indcrop.2013.02.008	41	46	47	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180534	10.1371/journal.pone.0180534	http://dx.doi.org/10.1371/journal.pone.0180534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704423	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700042
J	Nejdl, L; Kudr, J; Moulick, A; Hegerova, D; Ruttkay-Nedecky, B; Gumulec, J; Cihalova, K; Smerkova, K; Dostalova, S; Krizkova, S; Novotna, M; Kopel, P; Adam, V				Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Gumulec, Jaromir; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech			Platinum nanoparticles induce damage to DNA and inhibit DNA replication	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; CANCER-CELLS; SUPEROXIDE ANION; BACTERIAL GHOSTS; POLYMERASE-BETA; SILVER(I) IONS; CROSS-LINKS; COMPLEXES; RESISTANCE; CISPLATIN	Sparsely tested group of platinum nanoparticles (PtNPs) may have a comparable effect as complex platinum compounds. The aim of this study was to observe the effect of PtNPs in in vitro amplification of DNA fragment of phage., on the bacterial cultures (Staphylococcus aureus), human foreskin fibroblasts and erythrocytes. In vitro synthesized PtNPs were characterized by dynamic light scattering (PtNPs size range 4.8-11.7 nm), zeta potential measurements (-15 mV at pH 7.4), X-ray fluorescence, UV/vis spectrophotometry and atomic absorption spectrometry. The PtNPs inhibited the DNA replication and affected the secondary structure of DNA at higher concentrations, which was confirmed by polymerase chain reaction, DNA sequencing and DNA denaturation experiments. Further, cisplatin (CisPt), as traditional chemotherapy agent, was used in all parallel experiments. Moreover, the encapsulation of PtNPs in liposomes (LipoPtNPs) caused an approximately 2.4x higher of DNA damage in comparison with CisPt, LipoCisPt and PtNPs. The encapsulation of PtNPs in liposomes also increased their antibacterial, cytostatic and cytotoxic effect, which was determined by the method of growth curves on S. aureus and HFF cells. In addition, both the bare and encapsulated PtNPs caused lower oxidative stress (determined by GSH/GSSG ratio) in the human erythrocytes compared to the bare and encapsulated CisPt. CisPt was used in all parallel experiments as traditional chemotherapy agent.	[Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Nejdl, Lukas; Kudr, Jiri; Moulick, Amitava; Hegerova, Dagmar; Ruttkay-Nedecky, Branislav; Gumulec, Jaromir; Cihalova, Kristyna; Smerkova, Kristyna; Dostalova, Simona; Krizkova, Sona; Novotna, Marie; Kopel, Pavel; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Gumulec, Jaromir] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic	Mendel University in Brno; Brno University of Technology; Masaryk University Brno	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.	vojtech.adam@mendelu.cz	Chudobová, Dagmar/J-7030-2012; Adam, Vojtech/D-7686-2012; Nejdl, Lukas/E-8438-2012; Kudr, Jiri/D-1921-2013; Kopel, Pavel/E-5711-2012; Rex, Simona/D-4951-2013; Moulick, Amitava/I-9677-2016; Gumulec, Jaromir/D-7638-2012; Smerkova, Kristyna/F-3892-2012; Dolezelikova, Kristyna/H-4517-2018; Krizkova, Sona/E-9617-2012	Chudobová, Dagmar/0000-0003-0826-234X; Adam, Vojtech/0000-0002-8527-286X; Nejdl, Lukas/0000-0001-6332-8917; Kudr, Jiri/0000-0002-2058-4563; Kopel, Pavel/0000-0003-4216-9544; Rex, Simona/0000-0003-0737-3144; Moulick, Amitava/0000-0001-5769-6748; Gumulec, Jaromir/0000-0002-9658-3444; Smerkova, Kristyna/0000-0002-1667-7660; Dolezelikova, Kristyna/0000-0001-8661-0763; Krizkova, Sona/0000-0002-0479-8369	Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II [CEITEC 2020 (LQ1601)]; AZV [15-28334A]; CIISB research infrastructure - MEYS CR [LM2015043]	Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II; AZV; CIISB research infrastructure - MEYS CR	This research was carried out under the project CEITEC 2020 (LQ1601) with financial support from the Ministry of Education, Youth and Sports of the Czech Republic under the National Sustainability Programme II. The financial support from AZV project no. 15-28334A is also highly acknowledged. Moreover, authors acknowledge the CF CEITEC - Cryo-electron Microscopy and Tomography supported by the CIISB research infrastructure (LM2015043 funded by MEYS CR) for their support with obtaining scientific data presented in this paper.	Ali I, 2013, ANTI-CANCER AGENT ME, V13, P296, DOI 10.2174/1871520611313020016; Asharani PV, 2010, NANOMEDICINE-UK, V5, P51, DOI [10.2217/nnm.09.85, 10.2217/NNM.09.85]; Barabas R, 2013, CHEM PAP, V67, P1414, DOI 10.2478/s11696-013-0409-6; Bednarski PJ, 2013, PHILOS T R SOC A, V371, P1; Boulikas T, 2004, ONCOL REP, V12, P3; Boulikas T, 2003, ONCOL REP, V10, P1663; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Brabec V, 2002, DRUG RESIST UPDATE, V5, P147, DOI 10.1016/S1368-7646(02)00047-X; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chang CL, 2012, BIOPOLYMERS, V97, P807, DOI 10.1002/bip.22077; Chudobova D, 2015, MICROBIOL RES, V170, P147, DOI 10.1016/j.micres.2014.08.003; Chudobova D, 2014, INT J ENV RES PUB HE, V11, P3233, DOI 10.3390/ijerph110303233; Chudobova D, 2013, INT J MOL SCI, V14, P13592, DOI 10.3390/ijms140713592; Chudobova D, 2013, INT J ELECTROCHEM SC, V8, P4422; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Conlin AK, 2010, CLIN BREAST CANCER, V10, P281, DOI 10.3816/CBC.2010.n.036; Edwards KA, 2012, CURR OPIN CHEM BIOL, V16, P444, DOI 10.1016/j.cbpa.2012.05.182; Fan J, 2011, BIOMATERIALS, V32, P1611, DOI 10.1016/j.biomaterials.2010.11.004; Fenske AE, 2012, CANCER LETT, V324, P171, DOI 10.1016/j.canlet.2012.05.009; Fikrova P, 2013, NEOPLASMA, V60, P413, DOI 10.4149/neo_2013_053; Gao JH, 2007, J AM CHEM SOC, V129, P1428, DOI 10.1021/ja067785e; Gehrke H, 2011, ARCH TOXICOL, V85, P799, DOI 10.1007/s00204-010-0636-3; Gopal J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01260; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Ho YP, 2003, MED RES REV, V23, P633, DOI 10.1002/med.10038; Hrabeta J, 2016, ANTI-CANCER AGENT ME, V16, P686, DOI 10.2174/1871520616666151120122611; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679; Kim WK, 2012, EXP MOL MED, V44, P432, DOI 10.3858/emm.2012.44.7.048; Konieczny P, 2013, INT J NANOMED, V8, P3963, DOI 10.2147/IJN.S49612; Kosmider B, 2004, MUTAT RES-GEN TOX EN, V558, P93, DOI 10.1016/j.mrgentox.2003.11.006; Kunjachan S, 2012, EUR J PHARM SCI, V45, P421, DOI 10.1016/j.ejps.2011.08.028; Li Y, 2012, MUTAT RES-GEN TOX EN, V745, P4, DOI 10.1016/j.mrgentox.2011.11.010; Manikandan M, 2013, BIOMATERIALS, V34, P5833, DOI 10.1016/j.biomaterials.2013.03.077; Mayr UB, 2005, ADV DRUG DELIVER REV, V57, P1381, DOI 10.1016/j.addr.2005.01.027; Melnik M, 2013, MAIN GROUP MET CHEM, V36, P1, DOI 10.1515/mgmc-2012-0062; Mitchell C, 2007, MOL PHARMACOL, V72, P704, DOI 10.1124/mol.107.038406; Mouron SA, 2001, MUTAT RES-GEN TOX EN, V498, P47, DOI 10.1016/S1383-5718(01)00266-2; Nejdl L, 2014, ELECTROPHORESIS, V35, P393, DOI 10.1002/elps.201300197; Oehlsen ME, 2005, J BIOL INORG CHEM, V10, P433, DOI 10.1007/s00775-005-0009-1; Oh JG, 2013, CURR APPL PHYS, V13, P130, DOI 10.1016/j.cap.2012.06.025; Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015; Palchoudhury S, 2013, IEEE T MAGN, V49, P373, DOI 10.1109/TMAG.2012.2223660; Paraskar A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075103; Paraskar A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265101; Paraskar AS, 2010, P NATL ACAD SCI USA, V107, P12435, DOI 10.1073/pnas.1007026107; Park EJ, 2010, ARCH PHARM RES, V33, P727, DOI 10.1007/s12272-010-0512-y; Paukner S, 2003, J DRUG TARGET, V11, P151, DOI 10.1080/10611860310001593366; Pekarik V, 2013, CURR MED CHEM, V20, P534; Pelka J, 2009, CHEM RES TOXICOL, V22, P649, DOI 10.1021/tx800354g; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; POPENOE EA, 1979, ARCH BIOCHEM BIOPHYS, V196, P109, DOI 10.1016/0003-9861(79)90557-5; Rehman MU, 2012, INFLAMM RES, V61, P1177, DOI 10.1007/s00011-012-0512-0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; Sgarbossa P, 2012, ORGANOMETALLICS, V31, P1257, DOI 10.1021/om200953z; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Skladanka J, 2012, INT J ENV RES PUB HE, V9, P3789, DOI 10.3390/ijerph9113789; Smerkova K, 2013, CHROMATOGRAPHIA, V76, P329, DOI 10.1007/s10337-012-2326-1; Stathopoulos GP, 2006, ANTICANCER RES, V26, P1489; Summa N, 2007, INORG CHEM, V46, P2094, DOI 10.1021/ic061990d; Takamiya M, 2012, NEUROSCIENCE, V221, P47, DOI 10.1016/j.neuroscience.2012.06.060; Takamiya M, 2011, J NEUROSCI RES, V89, P1125, DOI 10.1002/jnr.22622; Theile D, 2012, J PHARMACOL EXP THER, V341, P51, DOI 10.1124/jpet.111.189621; Vavrova M, 2003, RADIAT ONCOL, P1; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Williams JW, 2007, INORG CHEM, V46, P5820, DOI 10.1021/ic700410y; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Zhang LB, 2010, NANO LETT, V10, P219, DOI 10.1021/nl903313r; ZOLOTOV YA, 1983, ANAL CHIM ACTA, V148, P135, DOI 10.1016/S0003-2670(00)85160-0	73	43	44	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180798	10.1371/journal.pone.0180798	http://dx.doi.org/10.1371/journal.pone.0180798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704436	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600050
J	Cui, YB; Zhu, CC; Ming, Z; Cao, JM; Yan, YL; Zhao, P; Pang, GC; Deng, ZX; Yao, Y; Chen, QS				Cui, Yongbo; Zhu, Chenchen; Ming, Zhu; Cao, Jiangming; Yan, Yali; Zhao, Pei; Pang, Guangchang; Deng, Zixin; Yao, Yi; Chen, Qingsen			Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; BOVINE GLYCOMACROPEPTIDE; TGF-BETA; HUMAN MONOCYTES; CROHNS-DISEASE; COLONIC-MUCOSA; EXPRESSION; PATHOGENESIS; TGF-BETA-1	Objectives The aim of this study was to elucidate the molecular mechanisms by which food-derived casein glycomacropeptide (CGMP) maintains internal homeostasis in the intestinal mucosa and to investigate the effects of CGMP on the intestinal mucosal immunological barrier and related signal transduction pathways. Methods In this study, a famoxadone (OXZ)-induced mouse experimental ulcerative colitis (UC) model was built. The experimental UC mice were intragastrically administered milk-derived CGMP for four consecutive days. The molecular mechanisms by which milk-derived CGMP improved and restored the inflammatory status in UC symptoms were elucidated by H&E staining, immunohistochemical staining and western blotting. Results The results indicated that CGMP (50 mg/(kg bw center dot d)) could significantly improve morphological injury to intestinal mucosa in OXZ-induced UC mice to the same extent that did sulfasalazine (SASP, 40 mg/(kg bw center dot d)), a medicine used to treat UC, in the control group. The study found that CGMP could significantly reduce the expression of Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1), Cluster of differentiation 4 (CD4) and Cluster of differentiation 8 (CD8) in the lamina propria of the intestinal mucosa and significantly stimulate the secretion of sIgA to increase intestinal immunity. Furthermore, CGMP was found to be directly involved in inhibiting the MAPK pathway and activating the TGF-beta 1/Smad signal transduction cascade, which could maintain immunological regulation of the intestinal mucosa and protect the functions of the intestinal mucosal barrier. Conclusions This study elucidated the molecular mechanisms by which CGMP maintained homeostasis of the intestinal mucosa and further confirmed its pharmaceutical value as a food-derived functional component with promising potential for further exploration/utilization.	[Cui, Yongbo; Deng, Zixin] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China; [Zhu, Chenchen; Ming, Zhu; Cao, Jiangming; Yan, Yali; Zhao, Pei; Pang, Guangchang; Chen, Qingsen] Tianjin Univ Commerce, Tianjin Key Lab Food Biotechnol, Coll Biotechnol & Food Sci, Tianjin, Peoples R China; [Yao, Yi] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Wuhan University; Tianjin University of Commerce; Yale University	Deng, ZX (corresponding author), Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China.; Chen, QS (corresponding author), Tianjin Univ Commerce, Tianjin Key Lab Food Biotechnol, Coll Biotechnol & Food Sci, Tianjin, Peoples R China.; Yao, Y (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	zxdeng@sjtu.edu.cn; yi.yao@yale.edu; chqsen@tjcu.edu.cn	Ming, Zhu/ABD-8589-2021		National Natural Science Foundation of China [31071522]; National Natural Fund Training Project of Tianjin University of Commerce [160120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Fund Training Project of Tianjin University of Commerce	This work was supported by the National Natural Science Foundation of China [No. 31071522] and National Natural Fund Training Project of Tianjin University of Commerce [No. 160120]. Prof Qingsen Chen had the main role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Balmus IM, 2016, SAUDI J GASTROENTERO, V22, P3, DOI 10.4103/1319-3767.173753; Biasi F, 2007, GENES NUTR, V2, P233, DOI 10.1007/s12263-007-0053-2; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Brandhorst G, 2013, CLIN CHIM ACTA, V421, P31, DOI 10.1016/j.cca.2013.02.016; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; Daddaoua A, 2005, J NUTR, V135, P1164, DOI 10.1093/jn/135.5.1164; Dolan K.T., 2016, MOL NUTR FOOD RES; Dosani T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.32; Ekstrom GM, 1998, SCAND J GASTROENTERO, V33, P174, DOI 10.1080/00365529850166914; ElSalam MHA, 1996, INT DAIRY J, V6, P327, DOI 10.1016/0958-6946(95)00026-7; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Fujimori H, 2002, GASTROENTEROLOGY, V122, P734, DOI 10.1053/gast.2002.31899; Ghosh S, 2000, BMJ-BRIT MED J, V320, P1119, DOI 10.1136/bmj.320.7242.1119; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; HARPAZ N, 1994, HUM PATHOL, V25, P1069, DOI 10.1016/0046-8177(94)90067-1; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hozumi H, 2013, INT J COLORECTAL DIS, V28, P1049, DOI 10.1007/s00384-013-1654-4; Hvas CL, 2016, EUR J CLIN INVEST, V46, P555, DOI 10.1111/eci.12634; Kaetzel CS, 2014, IMMUNOL LETT, V162, P10, DOI 10.1016/j.imlet.2014.05.008; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Leal MC, 2015, INFLAMM BOWEL DIS, V21, P2936, DOI 10.1097/MIB.0000000000000511; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li Fang, 2010, Chinese Journal of Pathology, V39, P19, DOI 10.3760/cma.j.issn.0529-5807.2010.01.006; Li Guohua, 2012, Gastroenterol Res Pract, V2012, P404752, DOI 10.1155/2012/404752; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Marion-Letellier R, 2016, J CROHNS COLITIS, V10, P1351, DOI 10.1093/ecco-jcc/jjw106; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Ming Z, 2015, FOOD AGR IMMUNOL, V26, P1; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Montufar-Solis D, 2007, IMMUNOL REV, V215, P189, DOI 10.1111/j.1600-065X.2006.00471.x; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Neurath Markus F., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P81; Ortega-Gonzalez M, 2014, BRIT J NUTR, V111, P1202, DOI 10.1017/S0007114513003590; Pang G., 2014, FOOD SCI HUM WELL, V3, P51, DOI [10.1016/j.fshw.2014.04.001, DOI 10.1016/J.FSHW.2014.04.001]; Pang G., 2012, FOOD SCI HUM WELL, V1, P26, DOI DOI 10.1016/J.FSHW.2012.10.001; Requena P, 2008, BRIT J PHARMACOL, V154, P825, DOI 10.1038/bjp.2008.138; Requena P, 2009, BRIT J PHARMACOL, V157, P1232, DOI 10.1111/j.1476-5381.2009.00195.x; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; Rong YL, 2015, ANIM NUTR, V1, P54, DOI 10.1016/j.aninu.2015.05.006; Sales-Campos H, 2015, BRAZ J MED BIOL RES, V48, P96, DOI [10.1590/1414-431X20143774, 10.1590/1414-431x20143774]; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Ueno E, 2011, HISTOL HISTOPATHOL, V26, P1317, DOI 10.14670/HH-26.1317; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; WOLF HM, 1994, BLOOD, V83, P1278; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yu CG, 2013, J DIGEST DIS, V14, P513, DOI 10.1111/1751-2980.12087; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	54	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181075	10.1371/journal.pone.0181075	http://dx.doi.org/10.1371/journal.pone.0181075			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700735	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800118
J	Magee, MJ; Sun, YV; Brust, JCM; Shah, NS; Ning, YM; Allana, S; Campbell, A; Hui, Q; Mlisana, K; Moodley, P; Gandhi, NR				Magee, Matthew J.; Sun, Yan V.; Brust, James C. M.; Shah, N. Sarita; Ning, Yuming; Allana, Salim; Campbell, Angela; Hui, Qin; Mlisana, Koleka; Moodley, Pravi; Gandhi, Neel R.			Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrugresistant tuberculosis patients in South Africa	PLOS ONE			English	Article							HIGH-DOSE VITAMIN-D-3; PULMONARY TUBERCULOSIS; DOUBLE-BLIND; SUPPLEMENTATION	Background Vitamin D modulates the inflammatory and immune response to tuberculosis (TB) and also mediates the induction of the antimicrobial peptide cathelicidin. Deficiency of 25-hydroxyvitamin D and single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene may increase the risk of TB disease and decrease culture conversion rates in drug susceptible TB. Whether these VDR SNPs are found in African populations or impact multidrugresistant (MDR) TB treatment has not been established. We aimed to determine if SNPs in the VDR gene were associated with sputum culture conversion among a cohort of MDR TB patients in South Africa. Methods We conducted a prospective cohort study of adult MDR TB patients receiving second-line TB treatment in KwaZulu-Natal province. Subjects had monthly sputum cultures performed. In a subset of participants, whole blood samples were obtained for genomic analyses. Genomic DNA was extracted and genotyped with Affymetrix Axiom Pan-African Array. Cox proportional models were used to determine the association between VDR SNPs and rate of culture conversion. Results Genomic analyses were performed on 91 MDR TB subjects enrolled in the sub-study; 60% were female and median age was 35 years (interquartile range [IQR] 29-42). Smoking was reported by 21% of subjects and most subjects had HIV (80%), were smear negative (57%), and had cavitary disease (55%). Overall, 87 (96%) subjects initially converted cultures to negative, with median time to culture conversion of 57 days (IQR 17-114). Of 121 VDR SNPs examined, 10 were significantly associated (p<0.01) with rate of sputum conversion in multivariable analyses. Each additional risk allele on SNP rs74085240 delayed culture conversion significantly (adjusted hazard ratio 0.30, 95% confidence interval 0.14-0.67). Conclusions Polymorphisms in the VDR gene were associated with rate of sputum culture conversion in MDR TB patients in this high HIV prevalence setting in South Africa.	[Magee, Matthew J.] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA; [Sun, Yan V.; Allana, Salim; Campbell, Angela; Hui, Qin; Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Brust, James C. M.; Ning, Yuming] Albert Einstein Coll Med, Div Gen Internal Med & Infect Dis, Bronx, NY 10467 USA; [Shah, N. Sarita] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Mlisana, Koleka; Moodley, Pravi] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Gandhi, Neel R.] Emory Univ, Emory Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; Yeshiva University; Albert Einstein College of Medicine; Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; Emory University; Emory University; Rollins School Public Health	Magee, MJ (corresponding author), Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA.	mjmagee@gsu.edu	Magee, Matthew/W-1169-2019; Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268; Campbell, Angela/0000-0003-3990-3656; Moodley, Pravi/0000-0002-9946-8783	US National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [R01AI087465, R01AI089349]; NIH/NIAID [K23AI083088, K24AI114444]; Emory Center for AIDS Research (CFAR) [P30AI050409]; Einstein CFAR [P30AI051519]; Einstein/Montefiore Institute for Clinical and Translational Research (ICTR) [UL1TR001073]; Atlanta Clinical Translational Science Institute (ACTSI) [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI114444, R01AI087465, P30AI050409] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory Center for AIDS Research (CFAR); Einstein CFAR; Einstein/Montefiore Institute for Clinical and Translational Research (ICTR); Atlanta Clinical Translational Science Institute (ACTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH www.nih.gov): R01AI087465 and R01AI089349 (both to NRG). It was also supported in part by NIH/NIAID grants: K23AI083088 (to JCMB), K24AI114444 (to NRG), Emory Center for AIDS Research (CFAR www.cfar.emory.edu) P30AI050409, Einstein CFAR (www.einstein.yu.edu/centers/erc-center-for-aids-research) P30AI051519, Einstein/Montefiore Institute for Clinical and Translational Research (ICTR http://www.einstein.yu.edu/centers/ictr) UL1TR001073 and the Atlanta Clinical Translational Science Institute (ACTSI www.actsi.org) UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb C, 2007, TUBERCULOSIS, V87, P295, DOI 10.1016/j.tube.2007.03.001; Bruns H, 2014, FUTURE MICROBIOL, V9, P327, DOI 10.2217/fmb.13.164; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Cegielski P, 2015, LANCET INFECT DIS, V15, P489, DOI 10.1016/S1473-3099(15)70163-5; Coussens AK, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/903680; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Daley P, 2015, LANCET INFECT DIS, V15, P528, DOI 10.1016/S1473-3099(15)70053-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Ndjecka N, 2014, MULTIDRUG RESISTANT; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Rathored J, 2012, INT J TUBERC LUNG D, V16, P1522, DOI 10.5588/ijtld.12.0122; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Scientific ATF, AX GEN WID POP OPT H; Shisana O., 2012, INCIDENCE BEHAV SURV INCIDENCE BEHAV SURV; Sutaria N, 2014, J CLIN TRANSL ENDOCR, V1, P151, DOI 10.1016/j.jcte.2014.08.001; Tukvadze N, 2015, AM J CLIN NUTR, V102, P1059, DOI 10.3945/ajcn.115.113886; WHO, 2016, GLOB TUB REP; World Health Organization, 2015, GLOB TUB REP 2015	25	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180916	10.1371/journal.pone.0180916	http://dx.doi.org/10.1371/journal.pone.0180916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700743	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800099
J	Marco-Jimenez, F; Vicente, JS				Marco-Jimenez, Francisco; Salvador Vicente, Jose			Overweight in young males reduce fertility in rabbit model	PLOS ONE			English	Article							BODY-MASS INDEX; REPRODUCTIVE HORMONE-LEVELS; DIET-INDUCED OBESITY; SEMEN QUALITY; WAIST CIRCUMFERENCE; MALE PARTNERS; PARAMETERS; ASSOCIATION; IMPACT; CHOLESTEROL	Semen quality has certainly declined over the past few decades, possibly owing to modern lifestyle factors. In this sense, the role of overweight and obesity in the development of subfertility in males has generated a considerable amount of interest in recent years. However, there is no consensus on whether overweight or obesity impaired sperm quality. Thus, based on the ongoing debate about risk factors for subfertility associated with overweight and obesity in men, this study was designed to investigate the effect of overweight on sperm quality parameters and fertility success in randomized controlled trial in a rabbit model. Fourteen male rabbits were randomly assigned to a control group in which nutritional requirements were satisfied or a group fed to satiety from 12 to 32 weeks of age. At 24 weeks of age, semen samples were analysed weekly by conventional semen analysis for 8 weeks. In addition, during the trial female rabbits were artificially inseminated by each male to assess the fertility success and the number of offspring. Young males fed to satiety were associated with a significant increase in body weight (13.6% overweight) and perirenal fat thickness (5%). Male overweight presented a significant decrease in sperm concentration. There were no differences in the remaining sperm parameters. However, male overweight showed a clear and significant decrease in fertility success (control group, 64 +/- 8.9% versus fed to satiety group, 35 +/- 9.2%), but not in the number of offspring. Taken together, our findings provide new evidence on the loss of fertility induced by overweight in males.	[Marco-Jimenez, Francisco; Salvador Vicente, Jose] Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012	Jiménez, Francisco Marco/0000-0002-5226-4118	Spanish Research project Comision Interministerial de Ciencia y Tecnologia [AGL2014-5 3405-C2-1-P]	Spanish Research project Comision Interministerial de Ciencia y Tecnologia	This research was supported by the projects: Spanish Research project AGL2014-5 3405-C2-1-P Comision Interministerial de Ciencia y Tecnologia (FMJ, JSV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Mormandi EA, 2013, ENDOCRINOL NUTR, V60, P303, DOI 10.1016/j.endonu.2013.01.006; Alshahrani S, 2016, ANDROLOGIA, V48, P1125, DOI 10.1111/and.12549; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bataineh HN, 2005, SAUDI MED J, V26, P398; Belloc S, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1212; Bieniek Jared M, 2016, F1000Res, V5, P2756; Bjorndahl L, 2011, HUM FERTIL, V14, P179, DOI 10.3109/14647273.2011.580823; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Duits FH, 2010, FERTIL STERIL, V94, P1356, DOI 10.1016/j.fertnstert.2009.05.075; Ehala-Aleksejev K, 2015, ANDROLOGY-US, V3, P225, DOI 10.1111/andr.12002; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; ESTANY J, 1992, GENET SEL EVOL, V24, P527, DOI 10.1051/gse:19920604; Ewuola EO, 2010, REPRODUCTION, V139, P439, DOI 10.1530/REP-09-0077; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; GARNER DL, 1994, J ANDROL, V15, P620; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Guney AI, 2012, GENET MOL RES, V11, P1039, DOI 10.4238/2012.April.27.2; Guo D, 2017, ONCOTARGET IN PRESS; GUPTA RS, 1988, Z ERNAHRUNGSWISS, V27, P236, DOI 10.1007/BF02019512; Gurunath S, 2011, HUM REPROD UPDATE, V17, P575, DOI 10.1093/humupd/dmr015; Gutorova NV, 2014, B EXP BIOL MED+, V157, P95, DOI 10.1007/s10517-014-2500-6; Hajshafiha M, 2013, INT J GEN MED, V6, P447, DOI 10.2147/IJGM.S41341; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Kumar Naina, 2015, J Hum Reprod Sci, V8, P191, DOI 10.4103/0974-1208.170370; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lancellotti TES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052386; Leisegang K, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-34; Littell RC, 1998, J ANIM SCI, V76, P1216; Lu JC, 2015, ANDROLOGIA, V47, P1047, DOI 10.1111/and.12376; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; McPherson NO, 2015, ASIAN J ANDROL, V17, P450, DOI 10.4103/1008-682X.148076; Mendiola J, 2009, FERTIL STERIL, V91, P812, DOI 10.1016/j.fertnstert.2008.01.020; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43475; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Pascual JJ, 2000, ANIM SCI, V70, P435, DOI 10.1017/S135772980005178X; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Petersen GL, 2013, FERTIL STERIL, V99, P1654, DOI 10.1016/j.fertnstert.2013.01.092; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Rato L, 2014, OBES REV, V15, P996, DOI 10.1111/obr.12226; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Soubry A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0217-2; Thomsen L, 2014, ASIAN J ANDROL, V16, P749, DOI 10.4103/1008-682X.125398; Tsao CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119458; Virtanen HE, 2017, NAT REV UROL, V14, P120, DOI 10.1038/nrurol.2016.261; Wang EY, 2017, ASIAN J ANDROL, V19, P234, DOI 10.4103/1008-682X.169996; WHO, 2016, OBESITY SITUATION AN; Xiccato G, 2010, NUTRITION OF THE RABBIT, 2ND EDITION, P83, DOI 10.1079/9781845936693.0083; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516	62	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180679	10.1371/journal.pone.0180679	http://dx.doi.org/10.1371/journal.pone.0180679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700645	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800064
J	Molparia, B; Nichani, E; Torkamani, A				Molparia, Bhuvan; Nichani, Eshaan; Torkamani, Ali			Assessment of circulating copy number variant detection for cancer screening	PLOS ONE			English	Article							TUMOR DNA; PROSTATE-CANCER; LANDSCAPE; CLASSIFICATION; IDENTIFICATION; ALLELES	Current high-sensitivity cancer screening methods, largely utilizing correlative biomarkers, suffer from false positive rates that lead to unnecessary medical procedures and debatable public health benefit overall. Detection of circulating tumor DNA (ctDNA), a causal biomarker, has the potential to revolutionize cancer screening. Thus far, the majority of ctDNA studies have focused on detection of tumor-specific point mutations after cancer diagnosis for the purpose of post-treatment surveillance. However, ctDNA point mutation detection methods developed to date likely lack either the scope or analytical sensitivity necessary to be useful for cancer screening, due to the low (< 1%) ctDNA fraction derived from early stage tumors. On the other hand, tumor-derived copy number variant (CNV) detection is hypothetically a superior means of ctDNA-based cancer screening for many tumor types, given that, relative to point mutations, each individual tumor CNV contributes a much larger number of ctDNA fragments to the overall pool of circulating free DNA (cfDNA). A small number of studies have demonstrated the potential of ctDNA CNV-based screening in select cancer types. Here we perform an in silico assessment of the potential for ctDNA CNVbased cancer screening across many common cancers, and suggest ctDNA CNV detection shows promise as a broad cancer screening methodology.	[Molparia, Bhuvan; Torkamani, Ali] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Molparia, Bhuvan; Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Nichani, Eshaan] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Torkamani, Ali] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Hlth, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Scripps Research Institute	Torkamani, A (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Hlth, La Jolla, CA 92037 USA.	atorkama@scripps.edu			Scripps Translational Science Institute pilot award from Scripps Genomic Medicine [5 UL1 TR001114]; NIH-NCATS Clinical and Translational Science Award (CTSA) [5 UL1 RR025774]; NHGRI Genome Sequencing Informatics Tools (GS-IT) Program [NIH U01 HG006476]	Scripps Translational Science Institute pilot award from Scripps Genomic Medicine; NIH-NCATS Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI Genome Sequencing Informatics Tools (GS-IT) Program	This work is supported by a Scripps Translational Science Institute pilot award (5 UL1 TR001114) from Scripps Genomic Medicine, a NIH-NCATS Clinical and Translational Science Award (CTSA; 5 UL1 RR025774) to STSI. Further support is provided by NHGRI Genome Sequencing Informatics Tools (GS-IT) Program via grant NIH U01 HG006476.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amant F, 2015, JAMA ONCOL, V1, P814, DOI 10.1001/jamaoncol.2015.1883; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bianchi DW, 2015, JAMA-J AM MED ASSOC, V314, P162, DOI 10.1001/jama.2015.7120; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borrell B, 2011, NAT MED, V17, P1329, DOI 10.1038/nm1111-1329a; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Erikson GA, 2014, GENETICS MED OFFICIA; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Heidary M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0421-y; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kirkizlar E, 2015, TRANSL ONCOL, V8, P407, DOI 10.1016/j.tranon.2015.08.004; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Lefkowitz RB, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin J., 2003, SIGMOD; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Rousseeuw PJ, 2011, WIRES DATA MIN KNOWL, V1, P73, DOI 10.1002/widm.2; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	42	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180647	10.1371/journal.pone.0180647	http://dx.doi.org/10.1371/journal.pone.0180647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686671	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100087
J	Sawada, T; Arai, D; Jing, XF; Miyajima, M; Frank, SJ; Sakaguchi, K				Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Miyajima, Masayasu; Frank, Stuart J.; Sakaguchi, Kazushige			Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B	PLOS ONE			English	Article							JAK2 TYROSINE KINASE; ASSOCIATION; DOMAINS; EPHRINS; PHOSPHORYLATION; DETERMINANTS; MEMBRANE; STAT5B; ROLES; MOUSE	We previously reported that EphA4, a member of the Eph family of receptor tyrosine kinases, is an important modulator of growth hormone (GH) signaling, leading to augmented synthesis of insulin-like growth factor 1 (IGF1) for postnatal body growth. In the present study, we report the molecular interactions of EphA4, GH receptor (GHR), Janus kinase 2 (JAK2), and signal transducer and activator of transcription 5B (STAT5B). EphA4 binds to GHR at both its extracellular and intracellular domains and phosphorylates GHR when stimulated with a ligand. The cytoplasmic domain of EphA4 binds to the carboxy-terminus of JAK2 in contrast to the known binding of GHR to the amino-terminus. STAT5B binds to the amino-terminal kinase domain of EphA4. Ligand-activated EphA4 and JAK2 phosphorylate each other and STAT5B, but JAK2 does not appear to phosphorylate EphA4-bound STAT5B. Ligand-activated EphA4 induces the nuclear translocation of STAT5B in a JAK2-independent manner. GHR expression is required for the activation of STAT5B signaling, even via the JAK2-independent pathway. Various ephrins that have affinity for EphA4 induce STAT5B phosphorylation. These findings suggest the molecular mechanisms by which ephrin/EphA4 signaling enhances the canonical GH-IGF1 axis.	[Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Frank, Stuart J.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL USA; [Frank, Stuart J.] Birmingham VA Med Ctr, Birmingham, AL USA	Wakayama Medical University; Wakayama Medical University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Sakaguchi, K (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan.	ksaka@wakayama-med.ac.jp			Research Grant on Priority Areas from Wakayama Medical University; Naito Foundation; Uehara Foundation; Takeda Science Foundation; JSPS KAKENHI [JP26860709, JP25461394]; NIH [R01 DK107441]; VA Merit Review Grant; Veterans Affairs [I01BX003718] Funding Source: NIH RePORTER	Research Grant on Priority Areas from Wakayama Medical University; Naito Foundation(Naito Memorial Foundation); Uehara Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Research Grant on Priority Areas from Wakayama Medical University (K.S.), a Research Grant from the Naito Foundation (K.S.), a Research Grant from the Uehara Foundation (T.S.), a Research Grant from the Takeda Science Foundation (T.S.), JSPS KAKENHI Grant Numbers JP26860709 (D.A.) and JP25461394 (X.J.), NIH R01 DK107441 (S.J.F.), and a VA Merit Review Grant (S.J.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Birzniece V, 2009, REV ENDOCR METAB DIS, V10, P145, DOI 10.1007/s11154-008-9089-x; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; FRANK SJ, 1995, J BIOL CHEM, V270, P14776, DOI 10.1074/jbc.270.24.14776; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Jing XF, 2012, CELL REP, V2, P652, DOI 10.1016/j.celrep.2012.08.021; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Liu Y, 2014, MOL ENDOCRINOL, V28, P1807, DOI 10.1210/me.2014-1153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rotwein P, 2012, TRENDS ENDOCRIN MET, V23, P186, DOI 10.1016/j.tem.2012.01.001; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Sayeski PP, 2001, J BIOL CHEM, V276, P10556, DOI 10.1074/jbc.M008856200; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; Waters MJ, 2015, BIOCHEM J, V466, P1, DOI 10.1042/BJ20141293; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu BXC, 1996, J BIOL CHEM, V271, P19768, DOI 10.1074/jbc.271.33.19768; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang J, 2006, J PATHOL, V208, P453, DOI 10.1002/path.1937; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180785	10.1371/journal.pone.0180785	http://dx.doi.org/10.1371/journal.pone.0180785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686668	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100104
J	Wang, HP; Ba, HJ; Yang, C; Zhang, JQ; Tai, YC				Wang, Huipin; Ba, Huajie; Yang, Chun; Zhang, Jianqiu; Tai, Yunchun			Inner and inter population structure construction of Chinese Jiangsu Han population based on Y23 STR system	PLOS ONE			English	Article							MODERN HUMAN-ORIGIN; Y-CHROMOSOME; DEVELOPMENTAL VALIDATION; MINORITY POPULATION; SEQUENCE VARIATION; GENETIC-ANALYSIS; HAPLOTYPE DATA; PLUS KIT; LOCI; MULTIPLEX	In this study, we analyzed the genetic polymorphisms of 23 Y-STR loci from PowerPlex (R) Y23 system in 916 unrelated healthy male individuals from Chinese Jiangsu Han, and observed 912 different haplotypes including 908 unique haplotypes and 4 duplicate haplotypes. The haplotype diversity reached 0.99999 and the discrimination capacity and match probability were 0.9956 and 0.0011, respectively. The gene diversity values ranged from 0.3942 at DYS438 to 0.9607 at DYS385a/b. Population differentiation within 10 Jiangsu Han subpopulations were evaluated by RST values and visualized in Neighbor-Joining trees and Multi-Dimensional Scaling plots as well as population relationships between the Jiangsu Han population and other 18 Eastern Asian populations. Such results indicated that the 23 Y-STR loci were highly polymorphic in Jiangsu Han population and played crucial roles in forensic application as well as population genetics. For the first time, we reported the genetic diversity of male lineages in Jiangsu Han population at a high-resolution level of 23 Y-STR set and consequently contributed to familial searching, offender tracking, and anthropology analysis of Jiangsu Han population.	[Wang, Huipin] Zhongshan City Peoples Hosp, Zhongshan, Guangdong, Peoples R China; [Ba, Huajie] Publ Secur Bur Changzhou, DNA Lab, Changzhou, Jiangsu, Peoples R China; [Yang, Chun] 102 Hosp Peoples Liberat Army, Psychiat Ctr Chinese Peoples Liberat Army, Dept Psychiat, Changzhou, Jiangsu, Peoples R China; [Zhang, Jianqiu] Publ Secur Bur Yangzhou, DNA Lab, Yangzhou, Jiangsu, Peoples R China; [Tai, Yunchun] Southern Med Univ, Sch Forens Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Tai, YC (corresponding author), Southern Med Univ, Sch Forens Med, Guangzhou, Guangdong, Peoples R China.	yunchun_tai@163.com			Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province) [2015A030310080]	Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province)	This project was supported by the Natural Science Foundation of Guangdong Province, China (NSF of Guangdong Province, No. 2015A030310080).	Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Cann R L, 1982, Prog Clin Biol Res, V103 Pt A, P157; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coble MD, 2013, FORENSIC SCI INT-GEN, V7, pE66, DOI 10.1016/j.fsigen.2013.03.006; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fulmer PM, PROMEGA APPL NOTES; Gao TZ, 2016, INT J LEGAL MED, V130, P1509, DOI 10.1007/s00414-016-1433-1; Gao TZ, 2015, FORENSIC SCI INT-GEN, V19, P130, DOI 10.1016/j.fsigen.2015.07.006; Gopinath S, 2016, FORENSIC SCI INT-GEN, V24, P164, DOI 10.1016/j.fsigen.2016.07.006; Hasan MM, 2016, INT J LEGAL MED, V130, P1493, DOI 10.1007/s00414-016-1367-7; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; Jiang WB, 2017, INT J LEGAL MED, V131, P115, DOI 10.1007/s00414-016-1411-7; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Jung JY, 2016, LEGAL MED-TOKYO, V23, P17, DOI 10.1016/j.legalmed.2016.09.001; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kwon SY, 2016, FORENSIC SCI INT-GEN, V25, P132, DOI 10.1016/j.fsigen.2016.08.010; Lacerenza D, 2017, FORENSIC SCI INT-GEN, V27, P172, DOI 10.1016/j.fsigen.2016.12.009; Li LM, 2016, FORENSIC SCI INT-GEN, V20, P101, DOI 10.1016/j.fsigen.2015.10.007; Luo HB, 2015, INT J LEGAL MED, V129, P737, DOI 10.1007/s00414-015-1175-5; Meng ZY, 2012, SCI GEOGRAPHICA SINI, V32, P8; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Olofsson JK, 2015, FORENSIC SCI INT-GEN, V16, P232, DOI 10.1016/j.fsigen.2015.02.006; Ottaviani E, 2015, INT J LEGAL MED, V129, P729, DOI 10.1007/s00414-014-1078-x; Petit E, 2002, TRENDS ECOL EVOL, V17, P28, DOI 10.1016/S0169-5347(01)02356-4; Provine WB, 2004, GENETICS, V167, P1041; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Rapone C, 2016, FORENSIC SCI INT-GEN, V21, pE1, DOI 10.1016/j.fsigen.2015.11.006; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schneider PM, 2007, FORENSIC SCI INT, V165, P238, DOI 10.1016/j.forsciint.2006.06.067; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Siegert S, 2015, FORENSIC SCI INT-GEN, V16, P216, DOI 10.1016/j.fsigen.2015.02.001; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JM, 2013, FORENSIC SCI INT-GEN, V7, P240, DOI 10.1016/j.fsigen.2012.10.013; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Toscanini U, 2016, FORENSIC SCI INT-GEN, V20, P1, DOI 10.1016/j.fsigen.2015.09.002; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang H, 2016, INT J LEGAL MED; Wang Y, 2016, INT J LEGAL MED, V130, P689, DOI 10.1007/s00414-015-1301-4; Yang M, 2016, INT J LEGAL MED, V130, P1195, DOI 10.1007/s00414-016-1332-5; Yao J, 2016, FORENSIC SCI INT-GEN, V24, P112, DOI 10.1016/j.fsigen.2016.06.015; Yao J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160415; Yin CY, 2015, FORENSIC SCI INT-GEN, V14, P108, DOI 10.1016/j.fsigen.2014.09.015; Zeng ZS, 2014, FORENSIC SCI INT-GEN, V12, P100, DOI 10.1016/j.fsigen.2014.05.004; Zhang XF, 2017, FORENSIC SCI INT-GEN, V28, pE30, DOI 10.1016/j.fsigen.2017.02.006	56	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180921	10.1371/journal.pone.0180921	http://dx.doi.org/10.1371/journal.pone.0180921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704439	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700060
J	Kuribayashi, T; Abe, T; Montani, S				Kuribayashi, Takanori; Abe, Tsuyoshi; Montani, Shigeru			Historical delta(15) N records of Saccharina specimens from oligotrophic waters of Japan Sea (Hokkaido)	PLOS ONE			English	Article							NITROGEN ISOTOPE RATIO; N-15 NATURAL-ABUNDANCE; FOOD-CHAINS; DELTA-N-15; PACIFIC; MARINE; CARBON; INDICATORS; ENRICHMENT; SALMON	Historically Saccharina spp. beds occurred along the west coast of Hokkaido, an oligotrophic area, and were commercially exploited. Currently extensive commercial Saccharina spp. beds do not form due to nutrient limitations. Here, we postulate that nutrients assimilated by paleo-Saccharina spp. beds may have been derived from spawning herrings (Clupea pallasii) acting as organisms that formed a vector from their feeding grounds (Okhotsk Sea and Pacific Ocean) to their spawning area (west coast of Hokkaido, Japan Sea). To test this hypothesis we examined stable nitrogen isotope ratios (delta N-15) of 100-to 135-year-old Saccharina specimens preserved at the Herbarium (Hokkaido University Museum). delta(15) N values of the paleo-Saccharina specimens collected from this region were in the range of 10%, which is significantly higher than the current 3-7% in freshly sampled Saccharina spp. This high delta(15) N indicates that spawning herring (Clupea pallasii) had potentially been a significant source of dissolved inorganic nitrogen (DIN) absorbed by Saccharina, acting as an organism forming a vector for transporting nutrients from eutrophic to oligotrophic coastal ecosystems. Our findings support the hypothesis of so-called "herring-derived nutrients."	[Kuribayashi, Takanori; Montani, Shigeru] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan; [Kuribayashi, Takanori] Hokkaido Nucl Energy Environm Res Ctr, Sect Fisheries Res, Iwanai, Hokkaido, Japan; [Abe, Tsuyoshi] Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Abe, Tsuyoshi] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan; [Montani, Shigeru] Hokkaido Univ, Grad Sch Fisheries Sci, Div Marine Bioresource & Environm Sci, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Kuribayashi, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.; Kuribayashi, T (corresponding author), Hokkaido Nucl Energy Environm Res Ctr, Sect Fisheries Res, Iwanai, Hokkaido, Japan.	kuribayashi-takanori@hro.or.jp	Kuribayashi, Takanori/AAK-6924-2020	Kuribayashi, Takanori/0000-0001-8885-4219	Hokkaido Research Organization; Hokkaido Government; Hokkaido University	Hokkaido Research Organization; Hokkaido Government; Hokkaido University	This work was funded by the Hokkaido Research Organization, Hokkaido Government, and Hokkaido University. The funders had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agatsuma Y, 2014, J APPL PHYCOL, V26, P1845, DOI 10.1007/s10811-013-0196-z; Akaike S., 1998, AQUAC SCI, V46, P57; Akaike Shoichi, 2002, Scientific Reports of Hokkaido Fisheries Experimental Station, V63, P41; Baker DM, 2010, GLOBAL CHANGE BIOL, V16, P2701, DOI 10.1111/j.1365-2486.2010.02167.x; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; BROWDER RG, 1994, T AM FISH SOC, V123, P993, DOI 10.1577/1548-8659(1994)123<0993:IACIAT>2.3.CO;2; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Cole ML, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003269; Costanzo SD, 2001, MAR POLLUT BULL, V42, P149, DOI 10.1016/S0025-326X(00)00125-9; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dotsu K, 1999, NIPPON SUISAN GAKK, V65, P216; DURBIN AG, 1979, ECOLOGY, V60, P8, DOI 10.2307/1936461; Fong P, 1998, J EXP MAR BIOL ECOL, V231, P63, DOI 10.1016/S0022-0981(98)00085-9; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; HAY DE, 1983, CAN J FISH AQUAT SCI, V40, P109, DOI 10.1139/f83-019; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hokkaido Prefectural Government, 1960, HOKK SUIS GENS; Ishida T, 1952, FISHERIES SCIS SERIE; Jones AB, 2001, ESTUAR COAST SHELF S, V52, P91, DOI 10.1006/ecss.2000.0729; KLINE TC, 1990, CAN J FISH AQUAT SCI, V47, P136, DOI 10.1139/f90-014; Kobayashi Tokimasa, 2002, Scientific Reports of Hokkaido Fisheries Experimental Station, V62, P1; Kobayashi Tokimasa, 1993, Bulletin of the National Research Institute of Far Seas Fisheries, V30, P1; Kondo H., 1965, SCI REPORTS HOKKAIDO, V3, P1; Kuribayashi T, 2014, B COASTAL OCEANOGRAP, V52, P75; Kuribayashi T, 2014, FISHEREIS ENG, V51, P47; Kuribayashi T, 2016, ALGAL RESOURCES, V9, P1; MacAvoy SE, 2000, OECOLOGIA, V122, P568, DOI 10.1007/s004420050980; MacAvoy SE, 2009, FISH B-NOAA, V107, P165; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; McClelland JW, 1998, MAR ECOL PROG SER, V168, P259, DOI 10.3354/meps168259; McClelland JW, 1997, LIMNOL OCEANOGR, V42, P930, DOI 10.4319/lo.1997.42.5.0930; McKinney RA, 1999, HYDROBIOLOGIA, V412, P17, DOI 10.1023/A:1003887913402; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minagawa M, 2001, J OCEANOGR, V57, P285, DOI DOI 10.1023/A:1012430512137; MIYAKE Y, 1967, Records of Oceanographic Works in Japan, V9, P37; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; Nagasawa K, 2001, PROG OCEANOGR, V49, P551, DOI 10.1016/S0079-6611(01)00040-4; Nakano S, 1999, ECOLOGY, V80, P2435; North W. J., 1982, SYNTHETIC DEGRADATIV, P247; Oba T, 1991, PALEOCEANOGRAPHY, V6, P499, DOI 10.1029/91PA00560; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; SAINO T, 1980, NATURE, V283, P752, DOI 10.1038/283752a0; SAINO T, 1987, DEEP-SEA RES, V34, P807, DOI 10.1016/0198-0149(87)90038-0; Seto M, 2001, P CIV ENG OC, V17, P123; SEUNG YH, 1995, J OCEANOGR, V51, P421; SUDO H, 1986, PROG OCEANOGR, V17, P313, DOI 10.1016/0079-6611(86)90052-2; Torii S, 1987, J HOKKAIDO FISHERIES, V44, P275; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; Wiley AE, 2013, P NATL ACAD SCI USA, V110, P8972, DOI 10.1073/pnas.1300213110	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180760	10.1371/journal.pone.0180760	http://dx.doi.org/10.1371/journal.pone.0180760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704453	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649600048
J	Lee, S; Seo, DH; Kim, KM; Lee, EY; Kim, HC; Kim, CO; Youm, Y; Rhee, Y				Lee, Seungwon; Seo, Da Hea; Kim, Kyoung Min; Lee, Eun Young; Kim, Hyeon Chang; Kim, Chang Oh; Youm, Yoosik; Rhee, Yumie			Contingent association between the size of the social support network and osteoporosis among Korean elderly women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; NATIONAL-HEALTH; HIP FRACTURE; PREVALENCE; OLDER; MEN; RECIPROCITY; AWARENESS; OUTCOMES; FRIENDS	Objective To investigate the association between the number of personal ties (or the size of the social support network) and the incidence of osteoporosis among older women in Korea. Methods Data from the Korean Urban Rural Elderly Study were used. Bone density was measured by dual-energy X-ray absorptiometry at the lumbar spine (L1-L4) and femur neck. T-score, the standardized bone density compared with what is normally expected in a healthy young adult, was measured and the presence of osteoporosis was determined, if the T-score was < -2.5. The social support network size was measured by self-responses (number of confidants and spouse). Results Of the 1,846 participants, 44.9% were diagnosed with osteoporosis. The association between the social support network size and the incidence of osteoporosis was curvilinear in both bivariate and multivariate analyses. Having more people in one's social support network size was associated with lower risk of osteoporosis until it reached around four. Increasing the social support network size beyond four, in contrast, was associated with a higher risk of osteoporosis. This association was contingent on the average intimacy level of the social network. At the highest average intimacy level (''extremely close''), increasing the number of social support network members from one to six was associated with linear decrease in the predicted probability of osteoporosis from 45% to 30%. However, at the lowest average intimacy level (''not very close''), the predicted probability of osteoporosis dramatically increased from 48% to 80% as the size of the social network increased from one to six. Conclusion Our results show that maintaining a large and intimate social support network is associated with a lower risk of osteoporosis among elderly Korean women, while a large but less-intimate social relationship is associated with a higher risk.	[Lee, Seungwon; Youm, Yoosik] Yonsei Univ, Dept Sociol, Seoul, South Korea; [Seo, Da Hea] Inha Univ, Sch Med, Dept Endocrinol & Metab, Incheon, South Korea; [Kim, Kyoung Min] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lee, Eun Young] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Kim, Hyeon Chang; Kim, Chang Oh; Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Inha University; Seoul National University (SNU); Catholic University of Korea; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System	Youm, Y (corresponding author), Yonsei Univ, Dept Sociol, Seoul, South Korea.; Rhee, Y (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	yoosik@yonsei.ac.kr; yumie@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Rhee, Yumie/0000-0003-4227-5638; Kim, Chang Oh/0000-0002-0773-5443; Kim, Hyeon Chang/0000-0001-7867-1240; Kim, Kyoung Min/0000-0001-8150-0266				Antonucci TC, 1998, FAM RELAT, V47, P379, DOI 10.2307/585268; ANTONUCCI TC, 1990, J SOC PERS RELAT, V7, P519, DOI 10.1177/0265407590074008; Baek J, 2016, J GERIATR CARDIOL, V13, P580, DOI 10.11909/j.issn.1671-5411.2016.07.005; BERKMAN L, 2003, NEIGHBORHOODS HLTH, P288; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Boudou L, 2011, OSTEOPOROSIS INT, V22, P2099, DOI 10.1007/s00198-011-1638-6; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Choi YJ, 2012, J BONE MINER RES, V27, P1879, DOI 10.1002/jbmr.1635; Cornwell B, 2009, J GERONTOL B-PSYCHOL, V64, pI47, DOI 10.1093/geronb/gbp042; Davis JA, 1991, NORC GEN SOCIAL SURV; Deelstra JT, 2003, J APPL PSYCHOL, V88, P324, DOI 10.1037/0021-9010.88.2.324; Falci C, 2009, SOC FORCES, V87, P2031; Farahmand BY, 2000, OSTEOPOROSIS INT, V11, P803, DOI 10.1007/s001980070060; Fink HA, 2014, OSTEOPOROSIS INT, V25, P2833, DOI 10.1007/s00198-014-2853-8; Gaipa J.J.L., 1990, PERSONAL RELATIONSHI, P122; Ganda K, 2013, OSTEOPOROSIS INT, V24, P393, DOI 10.1007/s00198-012-2090-y; Ganesan K, 2005, J NATL MED ASSOC, V97, P329; Gowen M, 1983, INTERLEUKIN 1 FACTOR; Haines VA, 2008, SEX ROLES, V59, P164, DOI 10.1007/s11199-008-9441-3; Hall A., 1985, SOCIAL SUPPORT HLTH, P23; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; KAPLAN RM, 1987, HEALTH PSYCHOL, V6, P387, DOI 10.1037/0278-6133.6.5.387; Kim Y, 2015, J KOREAN ACAD NURS, V45, P293, DOI 10.4040/jkan.2015.45.2.293; Lee EY, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-33; Lindstrom M, 2000, SCAND J PUBLIC HEALT, V28, P200, DOI 10.1177/14034948000280030901; Ma L, 2015, PLOS ONE, V10; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Mezuk B, 2008, OSTEOPOROSIS INT, V19, P1, DOI 10.1007/s00198-007-0449-2; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Miller-Martinez D, 2014, OSTEOPOROSIS INT, V25, P1327, DOI 10.1007/s00198-013-2602-4; Moriwaki K, 2016, OSTEOPOROSIS INT, P1; Nabipour I, 2011, OSTEOPOROSIS INT, V22, P1343, DOI 10.1007/s00198-010-1332-0; Organization WH, 1994, ASS FRACT RISK ITS A; Portes A., 2000, KNOWLEDGE SOCIAL CAP, P43, DOI DOI 10.1016/B978-0-7506-7222-1.50006-4; Resnick Barbara, 2002, Clin Nurs Res, V11, P52, DOI 10.1177/1054773802011001005; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; RUEHLMAN LS, 1988, J PERS SOC PSYCHOL, V55, P293, DOI 10.1037/0022-3514.55.2.293; SCHUSTER TL, 1990, AM J COMMUN PSYCHOL, V18, P423, DOI 10.1007/BF00938116; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; UEHARA ES, 1995, J SOC PERS RELAT, V12, P483, DOI 10.1177/0265407595124001; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR, P87; Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001; Wortman CamilleB., 1985, SOCIAL SUPPORT THEOR; Youm Y, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-102	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180017	10.1371/journal.pone.0180017	http://dx.doi.org/10.1371/journal.pone.0180017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700637	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649600014
J	Mailankody, S; Dangeti, GV; Soundravally, R; Joseph, NM; Mandal, J; Dutta, TK; Kadhiravan, T				Mailankody, Sharada; Dangeti, Gurukiran V.; Soundravally, Rajendiran; Joseph, Noyal M.; Mandal, Jharna; Dutta, Tarun K.; Kadhiravan, Tamilarasu			Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DEXAMETHASONE; ADULTS; INCREASE; THERAPY	Objectives Tuberculous meningitis is characterized by elevated levels of matrix metalloproteinase 9 (MMP9) in the cerebrospinal fluid (CSF). However, it is unclear whether elevated MMP9 levels are associated with poor treatment outcome. We tested the hypothesis that pretreatment MMP9 levels in the CSF would be higher in tuberculous meningitis patients experiencing a poor treatment outcome. Methods We prospectively assessed the treatment outcome in a consecutive sample of human immunodeficiency virus-negative patients with tuberculous meningitis. We defined good outcome as survival without severe neurological disability (modified Rankin scale scores 0-2). We estimated levels of MMP9 and its tissue inhibitor (TIMP1) on pretreatment CSF samples. We used albumin index to assess blood-brain barrier permeability. Results We studied 40 patients (23 males [58%]) with tuberculous meningitis. Sixteen patients (40%) had stage 3 disease. On follow-up, 18 (45%) patients had a poor treatment outcome D 15 patients died and 3 had severe neurological disability. Pretreatment MMP9 levels were not associated with treatment outcome (median [interquartile range], 254 [115-389] vs. 192 [60-383] ng/mL in good vs. poor outcome groups; P = 0.693). MMP9 levels did not correlate with the albumin index (Spearman's rho = 0.142; P = 0.381). However, MMP9 levels significantly correlated with CSF glucose levels (rho = -0.419; P = 0.007) and admission Glasgow coma scale score (rho = 0.324; P = 0.032). Likewise, TIMP1 levels also did not differ by treatment outcome (1239 [889-1511] vs. 1522 [934-1949] ng/mL; P = 0.201). MMP9/TIMP1 ratio that reflects net proteolytic activity was also not different between the two groups (0.191 [0.107-0.250] vs. 0.163 [0.067-0.34]; P = 0.625). Conclusion Our findings do not support the hypothesis that pretreatment levels of MMP9 would be higher in tuberculous meningitis patients experiencing a poor treatment outcome. Further, MMP9 levels in the CSF did not correlate with blood-brain barrier permeability in patients with tuberculous meningitis.	[Mailankody, Sharada; Dangeti, Gurukiran V.; Dutta, Tarun K.; Kadhiravan, Tamilarasu] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Pondicherry, India; [Soundravally, Rajendiran] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem, Pondicherry, India; [Joseph, Noyal M.; Mandal, Jharna] Jawaharlal Inst Postgrad Med Educ & Res, Dept Microbiol, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Kadhiravan, T (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Pondicherry, India.	kadhir@jipmer.edu.in	Mailankody, Sharada/AAF-7935-2021; Kadhiravan, Tamilarasu/AAU-8104-2020; Mandal, Jharna/AAF-5908-2020; Joseph, Noyal Mariya/AAW-2061-2020	Joseph, Noyal Mariya/0000-0001-6586-2742; Kadhiravan, Tamilarasu/0000-0002-4676-743X	Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India [Edn.7(1)/2013/25]	Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India	This work was supported by an intramural research grant (No. Edn.7(1)/2013/25) to TK and SM from the Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the authors (SM, GVD, TK) used personal funds to procure Xpert MTB/RIF cartridges for this study.	Brilha S, 2015, J INFECTION, V71, P683, DOI 10.1016/j.jinf.2015.09.020; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Donald PR, 2010, TUBERCULOSIS, V90, P279, DOI 10.1016/j.tube.2010.07.002; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Erdem H, 2015, J NEUROL, V262, P890, DOI 10.1007/s00415-015-7651-5; Green JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007277; Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062; Lee KY, 2004, J NEUROL SCI, V220, P73, DOI 10.1016/j.jns.2004.02.008; LINCOLN EM, 1960, J PEDIATR-US, V57, P807, DOI 10.1016/S0022-3476(60)80132-1; LINK H, 1977, SCAND J CLIN LAB INV, V37, P391, DOI 10.3109/00365517709091497; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; Nagarathna S, 2008, INT J TUBERC LUNG D, V12, P105; PERRY TL, 1950, PEDIATRICS, V5, P988; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Price NM, 2001, J IMMUNOL, V166, P4223, DOI 10.4049/jimmunol.166.6.4223; Rai D, 2014, ANN INDIAN ACAD NEUR, V17, P171, DOI 10.4103/0972-2327.132617; Salgame P, 2011, J CLIN INVEST, V121, P1686, DOI 10.1172/JCI57423; Simmons CP, 2005, J IMMUNOL, V175, P579, DOI 10.4049/jimmunol.175.1.579; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Walker NF, 2012, AM J RESP CRIT CARE, V185, P989, DOI 10.1164/rccm.201110-1769OC; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Yasar KK, 2010, INT J TUBERC LUNG D, V14, P1330	27	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181262	10.1371/journal.pone.0181262	http://dx.doi.org/10.1371/journal.pone.0181262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704492	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600068
J	Tosetti, V; Sassone, J; Ferri, ALM; Taiana, M; Bedini, G; Nava, S; Brenna, G; Di Resta, C; Pareyson, D; Di Giulio, AM; Carelli, S; Parati, EA; Gorio, A				Tosetti, Valentina; Sassone, Jenny; Ferri, Anna L. M.; Taiana, Michela; Bedini, Gloria; Nava, Sara; Brenna, Greta; Di Resta, Chiara; Pareyson, Davide; Di Giulio, Anna Maria; Carelli, Stephana; Parati, Eugenio A.; Gorio, Alfredo			Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis	PLOS ONE			English	Article							MESSENGER-RNA; ACTIVE CHROMATIN; GENE-EXPRESSION; ENHANCER RNAS; NEURONS ARISE; STEM-CELLS; BICALUTAMIDE; TESTOSTERONE; BINDING; REVEALS	The complex architecture of adult brain derives from tightly regulated migration and differentiation of precursor cells generated during embryonic neurogenesis. Changes at transcriptional level of genes that regulate migration and differentiation may lead to neurodevelopmental disorders. Androgen receptor (AR) is a transcription factor that is already expressed during early embryonic days. However, AR role in the regulation of gene expression at early embryonic stage is yet to be determinate. Long non-coding RNA (lncRNA) Sox2 overlapping transcript (Sox2OT) plays a crucial role in gene expression control during development but its transcriptional regulation is still to be clearly defined. Here, using Bicalutamide in order to pharmacologically inactivated AR, we investigated whether AR participates in the regulation of the transcription of the lncRNASox2OTat early embryonic stage. We identified a new DNA binding region upstream of Sox2 locus containing three androgen response elements (ARE), and found that AR binds such a sequence in embryonic neural stem cells and in mouse embryonic brain. Our data suggest that through this binding, AR can promote the RNA polymerase II dependent transcription of Sox2OT. Our findings also suggest that AR participates in embryonic neurogenesis through transcriptional control of the long non-coding RNA Sox2OT.	[Tosetti, Valentina; Ferri, Anna L. M.; Bedini, Gloria; Parati, Eugenio A.] Fdn IRCCS Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy; [Tosetti, Valentina; Di Giulio, Anna Maria; Carelli, Stephana; Gorio, Alfredo] Univ Milan, Dept Hlth Sci, Lab Pharmacol, Milan, Italy; [Sassone, Jenny] Vita Salute Univ & San Raffaele Sci Inst, Div Neurosci, Milan, Italy; [Taiana, Michela] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy; [Nava, Sara] Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit, Cerebrovasc Unit, Lab Cellular Neurobiol, Milan, Italy; [Nava, Sara] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurooncol, Milan, Italy; [Brenna, Greta] Fdn IRCCS Ist Neurol Carlo Besta, Biostatistician Serv Clin Res, Sci Dept, Milan, Italy; [Di Resta, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Di Resta, Chiara] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Pareyson, Davide] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Neurol Rare Dis Adulthood Unit, Milan, Italy; [Di Giulio, Anna Maria] Univ Milan, Pediat Clin Res Ctr Fdn Romeo & Enrica Invernizzi, Milan, Italy	IRCCS Istituto Neurologico Besta; University of Milan; Vita-Salute San Raffaele University; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; University of Milan	Tosetti, V (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Milan, Italy.; Tosetti, V (corresponding author), Univ Milan, Dept Hlth Sci, Lab Pharmacol, Milan, Italy.	tosettivalentina@gmail.com	Taiana, Michela/AAB-8846-2019; Parati, Eugenio Agostino/AAN-5893-2021; Nava, Sara/J-8740-2016; Carelli, Stephana/AAB-2365-2021; Ferri, Luca Angelo/AAC-5890-2022; Di Resta, Chiara/J-3627-2018; Pareyson, Davide/K-5890-2016	Parati, Eugenio Agostino/0000-0001-5020-6523; Nava, Sara/0000-0001-9912-8255; Carelli, Stephana/0000-0003-4603-396X; Ferri, Luca Angelo/0000-0001-9031-6284; Pareyson, Davide/0000-0001-6854-765X; DI RESTA, Chiara/0000-0003-2880-6631				Altwein JE, 2013, MOL BIOL PROSTATE CA; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Askarian-Amiri ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102140; AYUB M, 1989, J STEROID BIOCHEM, V33, P251, DOI 10.1016/0022-4731(89)90301-4; Chuang HC, AUTISMRES, V20158, P412; CLAESSENS F, 1993, ANN NY ACAD SCI, V684, P199, DOI 10.1111/j.1749-6632.1993.tb32283.x; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P1256, DOI 10.1210/me.11.9.1256; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Cockshott ID, 2004, CLIN PHARMACOKINET, V43, P855, DOI 10.2165/00003088-200443130-00003; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FELDMAN SC, 1978, ENDOCRINOLOGY, V102, P999, DOI 10.1210/endo-102-4-999; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Furr BJA, 1996, EUR UROL, V29, P83; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Giorgetti E, 2015, HUM MOL GENET, V24, P64, DOI 10.1093/hmg/ddu419; Godsave SF, 2002, J COMP NEUROL, V453, P57, DOI 10.1002/cne.10391; Gorelick DA, 2008, DEV DYNAM, V237, P2987, DOI 10.1002/dvdy.21700; Gravina GL, 2009, UROLOGY, V74, P452, DOI 10.1016/j.urology.2009.01.018; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; HEINLEIN CA, 2002, ENDOCR REV, V23, P175, DOI DOI 10.1210/ER.23.2.175; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Lee DK, 2003, J STEROID BIOCHEM, V84, P41, DOI 10.1016/S0960-0760(03)00005-0; Ling Guoyu, 2013, Methods Mol Biol, V977, P21, DOI 10.1007/978-1-62703-284-1_3; Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4; Luo SQ, 1997, UROLOGY, V50, P913, DOI 10.1016/S0090-4295(97)00393-2; MacLean HE, 2008, PHYSIOL GENOMICS, V33, P133, DOI 10.1152/physiolgenomics.00260.2007; Malkowicz SB, 1996, UROLOGY, V47, P29, DOI 10.1016/S0090-4295(96)80005-7; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001; Mora GR, 1999, STEROIDS, V64, P587, DOI 10.1016/S0039-128X(99)00037-9; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOUMURA T, 1966, ENDOCRINOLOGY, V78, P245, DOI 10.1210/endo-78-2-245; Orom UA, 2013, CELL, V143, P46; PARKER MG, 1977, CELL, V12, P401, DOI 10.1016/0092-8674(77)90116-7; Perets R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046467; Prensner JR, 2014, ONCOTARGET, V5, P1434, DOI 10.18632/oncotarget.1846; Rangasamy S, 2013, NEUROTHERAPEUTICS, V10, P742, DOI 10.1007/s13311-013-0227-0; Ransome Mark I, 2015, Front Cell Neurosci, V9, P253, DOI 10.3389/fncel.2015.00253; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Ronen D, 2014, CELL REP, V8, P923, DOI 10.1016/j.celrep.2014.07.013; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Sheflin LG, 2004, BIOCHEM BIOPH RES CO, V322, P644, DOI 10.1016/j.bbrc.2004.07.173; Sheppard KM, 2011, J NEUROENDOCRINOL, V23, P401, DOI 10.1111/j.1365-2826.2011.02126.x; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; SRIDARAN R, 1983, ENDOCRINOLOGY, V112, P1770, DOI 10.1210/endo-112-5-1770; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; TEUTSCH G, 1994, J STEROID BIOCHEM, V48, P111, DOI 10.1016/0960-0760(94)90257-7; TOOLE JJ, 1979, CELL, V17, P441, DOI 10.1016/0092-8674(79)90170-3; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WARREN DW, 1973, BIOL REPROD, V8, P560, DOI 10.1093/biolreprod/8.5.560; WATSON G, 1990, MOL CELL ENDOCRINOL, V68, P67, DOI 10.1016/0303-7207(90)90171-4; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wood CE, 2008, NEUROSCI LETT, V439, P153, DOI 10.1016/j.neulet.2008.05.008; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yu IC, 2013, DIABETES, V62, P411, DOI 10.2337/db12-0135; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhao Y, 2016, CELL REP, V15, P599, DOI 10.1016/j.celrep.2016.03.038	87	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180579	10.1371/journal.pone.0180579	http://dx.doi.org/10.1371/journal.pone.0180579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704421	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600036
J	Balakrishnan, P; Beaty, T; Young, JH; Colantuoni, E; Matsushita, K				Balakrishnan, Poojitha; Beaty, Terri; Young, J. Hunter; Colantuoni, Elizabeth; Matsushita, Kunihiro			Methods to estimate underlying blood pressure: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; HYPERTENSION; ADULTS; TRENDS	Antihypertensive medications complicate studies of blood pressure (BP) natural history; BP if untreated ("underlying BP") needs to be estimated. Our objectives were to compare validity of five missing data imputation methods to estimate underlying BP and longitudinal associations of underlying BP and age. We simulated BP treatment in untreated hypertensive participants from Atherosclerosis Risk in Communities (ARIC) in visits 1-5 (1987-2013) using matched treated hypertensive participants. The underlying BP was imputed: #1, set as missing; #2, add 10 mmHg for systolic, 5 mmHg for diastolic; #3, add medication class-specific constant; #4, truncated normal regression; and #5, truncated normal regression including prior visit data. Longitudinal associations were estimated using linear mixed models of imputed underlying BP for simulated treated and measured BP for untreated participants. Method 3 was the best-performing for systolic BP; lowest relative bias (5.3% for intercept at age 50, 0% for age coefficient) and average deviation from expected (0.04 to -1.79). Method 2 performed best for diastolic BP; lowest relative bias (0.6% intercept at age 50, 33.3% age <60, 9.1% age 60+) and average deviation (-1.25 to -1.68). Methods 4 and 5 were comparable or slightly inferior. In conclusion, constant addition methods yielded valid and precise underlying BP and longitudinal associations.	[Balakrishnan, Poojitha] Columbia Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Beaty, Terri; Young, J. Hunter; Matsushita, Kunihiro] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beaty, Terri; Colantuoni, Elizabeth] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Beaty, Terri; Young, J. Hunter; Matsushita, Kunihiro] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Young, J. Hunter] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Balakrishnan, P (corresponding author), Columbia Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	pbalakr2@jhu.edu	Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER; NHLBI NIH HHS [HHSN268201100005I, HHSN268201100009C, HHSN268201100005C, HHSN268201100007I, HHSN268201100012C, HHSN268201100009I, HHSN268201100010C, HHSN268201100008C, HHSN268201100005G, HHSN268201100008I, HHSN268201100007C, HHSN268201100011I, HHSN268201100011C, T32 HL007024, HHSN268201100006C] Funding Source: Medline; NIEHS NIH HHS [T32 ES007141] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; ARIC Coordinating Center, ATHEROSCLEROSIS RISK; ARIC Coordinating Center, HOM FIELD CTR PROC A; Cook NR, 1997, STAT MED, V16, P2713, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2713::AID-SIM705>3.0.CO;2-S; Fang J, 2013, MMWR-MORBID MORTAL W, V62, P237; Frohlich E D, 1993, Heart Dis Stroke, V2, P459; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hindorff L., 2014, CATALOG PUBLISHED GE; Jorgensen NW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-81; Kang T, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S43; McClelland RL, 2008, STAT MED, V27, P5039, DOI 10.1002/sim.3341; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Pogue VA, 1996, HYPERTENSION, V28, P713, DOI 10.1161/01.HYP.28.5.713; R Core Team, 2016, R LANG ENV STAT COMP; Sun WJ, 2014, STAT MED, V33, P1288, DOI 10.1002/sim.6037; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vaitsiakhovich Tatsiana, 2014, BMC Proc, V8, pS83, DOI 10.1186/1753-6561-8-S1-S83; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu J, 2005, AM J HYPERTENS, V18, P935, DOI 10.1016/j.amjhyper.2005.01.011	25	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179234	10.1371/journal.pone.0179234	http://dx.doi.org/10.1371/journal.pone.0179234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700596	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400002
J	Chen, X; Li, SJ; Ojcius, DM; Sun, AH; Hu, WL; Lin, X; Yan, J				Chen, Xu; Li, Shi-Jun; Ojcius, David M.; Sun, Ai-Hua; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie			Mononuclear-macrophages but not neutrophils act as major infiltrating antileptospiral phagocytes during leptospirosis	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; PHAGOSOME MATURATION; ESCHERICHIA-COLI; DENDRITIC CELLS; MICE; INTERROGANS; DISEASE; INFECTION; MODEL; LIPOPOLYSACCHARIDE	Objective To identify the major infiltrating phagocytes during leptospirosis and examine the killing mechanism used by the host to eliminate Leptospira interrogans. Methods Major infiltrating phagocytes in Leptospira-infected C3H/HeJ mice were detected by immunohistochemistry. Chemokines and vascular endothelial cell adhesion molecules (VECAMs) of Leptospira-infected mice and leptospirosis patients were detected by microarray and immunohistochemistry. Leptospira-phagocytosing and -killing abilities of human or mouse macrophages and neutrophils, and the roles of intracellular ROS, NO and [Ca2+]i in Leptospira-killing process were evaluated by confocal microscopy and spectrofluorimetry. Results Peripheral blood mononuclear-macrophages rather than neutrophils were the main infiltrating phagocytes in the lungs, liver and kidneys of infected mice. Levels of macrophage-but not neutrophil-specific chemokines and VECAMs were significantly increased in the samples from infected mice and patients. All macrophages tested had a higher ability than neutrophils to phagocytose and kill leptospires. Higher ROS and NO levels and [Ca2+] i in the macrophages were involved in killing leptospires. Human macrophages displayed more phagolysosome formation and a stronger leptospire-killing ability to than mouse macrophages. Conclusions Mononuclear-macrophages but not neutrophils represent the main infiltrating and anti-leptospiral phagocytes during leptospirosis. A lower level of phagosome-lysosome fusion may be responsible for the lower Leptospira-killing ability of human macrophages.	[Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou, Zhejiang, Peoples R China; [Chen, Xu; Hu, Wei-Lin; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Div Basic Med Microbiol,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, Shi-Jun] Guizhou Prov Ctr Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Ojcius, David M.] Univ Pacific, Dept Biomed Sci, Arthur Dugoni Sch Dent, San Francisco, CA USA; [Sun, Ai-Hua] Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University; University of the Pacific; Hangzhou Medical College	Lin, X; Yan, J (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Lin, X; Yan, J (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou, Zhejiang, Peoples R China.; Lin, X; Yan, J (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Div Basic Med Microbiol,Sch Med, Hangzhou, Zhejiang, Peoples R China.	lxai122@163.com; Med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81471907, 81671974, 81260250]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [J20111845/2013-032]; National Natural Science Foundation of Zhejiang Province, China [LQ14H190001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China; National Natural Science Foundation of Zhejiang Province, China	This work was supported by grants from the National Natural Science Foundation of China (81471907, 81671974 and 81260250), the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China (J20111845/2013-032) and the National Natural Science Foundation of Zhejiang Province, China (LQ14H190001).	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; AREAN VM, 1962, AM J PATHOL, V40, P393; Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; da Silva JB, 2009, MICROB PATHOGENESIS, V47, P87, DOI 10.1016/j.micpath.2009.05.002; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Eisele NA, 2011, AM J PATHOL, V178, P1190, DOI 10.1016/j.ajpath.2010.11.067; Forbes AE, 2012, QJM-INT J MED, V105, P1151, DOI 10.1093/qjmed/hcs145; Ghanem ENB, 2015, J IMMUNOL, V194, P1090, DOI 10.4049/jimmunol.1402401; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Goswami RP, 2014, T ROY SOC TROP MED H, V108, P791, DOI 10.1093/trstmh/tru144; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Harding MG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004379; Hu WL, 2014, CURR OPIN INFECT DIS, V27, P432, DOI 10.1097/QCO.0000000000000097; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Kassegne K, 2014, J INFECT DIS, V209, P1105, DOI 10.1093/infdis/jit659; Kaufmann SHE, 2016, IMMUNITY, V44, P476, DOI 10.1016/j.immuni.2016.02.014; Kern B, 2015, CELL MICROBIOL, V17, P1811, DOI 10.1111/cmi.12474; Kolonko M, 2014, CELL MICROBIOL, V16, P232, DOI 10.1111/cmi.12217; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Komi KK, 2015, MICROBES INFECT, V17, P34, DOI 10.1016/j.micinf.2014.10.010; Landes MB, 2015, J LEUKOCYTE BIOL, V97, P1111, DOI 10.1189/jlb.3A1114-557R; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Lau CL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0982-0; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Luz RA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/102160; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McGuinness WA, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010032; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miraglia F, 2013, DIAGN MICR INFEC DIS, V77, P195, DOI 10.1016/j.diagmicrobio.2013.08.003; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nakashima K, 2002, NITRIC OXIDE-BIOL CH, V6, P61, DOI 10.1006/niox.2001.0384; Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005; Nizet V, 2010, J INNATE IMMUN, V2, P505, DOI 10.1159/000320473; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3; Podgorny PJ, 2016, BIOL BLOOD MARROW TR, V22, P37, DOI 10.1016/j.bbmt.2015.09.003; Popova TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129860; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; Scharrig E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003927; SITPRIJA V, 1980, KIDNEY INT, V17, P827, DOI 10.1038/ki.1980.95; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Toma C, 2011, CELL MICROBIOL, V13, P1783, DOI 10.1111/j.1462-5822.2011.01660.x; Traxler RM, 2014, EMERG INFECT DIS, V20, P1273, DOI 10.3201/eid2008.130450; Vadia S, 2014, INFECT IMMUN, V82, P1084, DOI 10.1128/IAI.01067-13; Vedel-Krogh S, 2017, CLIN CHEM, V63, P823, DOI 10.1373/clinchem.2016.267450; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Visvalingam J, 2013, FOOD MICROBIOL, V34, P95, DOI 10.1016/j.fm.2012.11.021; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042266; Wang SH, 2015, MOL NEUROBIOL, V51, P718, DOI 10.1007/s12035-014-8755-0; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Xu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28802; Zeng QO, 2010, BIOMATERIALS, V31, P5772, DOI 10.1016/j.biomaterials.2010.04.022; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang L, 2012, MOL MICROBIOL, V83, P1006, DOI 10.1111/j.1365-2958.2012.07985.x; Zhao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075652; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhu XW, 2012, CIRC RES, V111, P1398, DOI 10.1161/CIRCRESAHA.112.269043	72	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181014	10.1371/journal.pone.0181014	http://dx.doi.org/10.1371/journal.pone.0181014			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700741	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649400028
J	Nagayoshi, Y; Miyazaki, T; Shimamura, S; Nakayama, H; Minematsu, A; Yamauchi, S; Takazono, T; Nakamura, S; Yanagihara, K; Kohno, S; Mukae, H; Izumikawa, K				Nagayoshi, Yohsuke; Miyazaki, Taiga; Shimamura, Shintaro; Nakayama, Hironobu; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Yanagihara, Katsunori; Kohno, Shigeru; Mukae, Hiroshi; Izumikawa, Koichi			Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species	PLOS ONE			English	Article							FLUCONAZOLE RESISTANCE; ECHINOCANDIN SUSCEPTIBILITY; OPPORTUNISTIC YEAST; MONOAMINE-OXIDASE; DRUG-RESISTANCE; ALBICANS; EFFLUX; GENE; SPHINGOLIPIDS; CASPOFUNGIN	The pathogenic fungus Candida glabrata is often resistant to azole antifungal agents. Drug efflux through azole transporters, such as Cdr1 and Cdr2, is a key mechanism of azole resistance and these genes are under the control of the transcription factor Pdr1. Recently, the monoamine oxidase A (MAO-A) inhibitor clorgyline was shown to inhibit the azole efflux pumps, leading to increased azole susceptibility in C. glabrata. In the present study, we have evaluated the effects of clorgyline on susceptibility of C. glabrata to not only azoles, but also to micafungin and amphotericin B, using wild-type and several mutant strains. The addition of clorgyline to the culture media increased fluconazole susceptibility of a C. glabrata wild-type strain, whereas micafungin and amphotericin B susceptibilities were markedly decreased. These phenomena were also observed in other medically important Candida species, including Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida krusei. Expression levels of CDR1, CDR2 and PDR1 mRNAs and an amount of Cdr1 protein in the C. glabrata wild-type strain were highly increased in response to the treatment with clorgyline. However, loss of Cdr1, Cdr2, Pdr1, and a putative clorgyline target (Fms1), which is an ortholog of human MAO-A, or overexpression of CDR1 did not affect the decreased susceptibility to micafungin and amphotericin B in the presence of clorgyline. The presence of other azole efflux pump inhibitors including milbemycin A4 oxime and carbonyl cyanide 3chlorophenylhydrazone also decreased micafungin susceptibility in C. glabrata wild-type,.cdr1,.cdr2, and.pdr1 strains. These findings suggest that azole efflux pump inhibitors increase azole susceptibility but concurrently induce decreased susceptibility to other classes of antifungals independent of azole transporter functions.	[Nagayoshi, Yohsuke; Miyazaki, Taiga; Takazono, Takahiro; Izumikawa, Koichi] Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan; [Nagayoshi, Yohsuke; Miyazaki, Taiga; Shimamura, Shintaro; Minematsu, Asuka; Yamauchi, Shunsuke; Takazono, Takahiro; Nakamura, Shigeki; Kohno, Shigeru; Mukae, Hiroshi] Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan; [Nakayama, Hironobu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Minematsu, Asuka; Mukae, Hiroshi] Nagasaki Univ, Dept Resp Med, Grad Sch Biomed Sci, Nagasaki, Japan; [Yamauchi, Shunsuke; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Nakamura, Shigeki] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; National Institute of Infectious Diseases (NIID)	Miyazaki, T (corresponding author), Nagasaki Univ, Dept Infect Dis, Grad Sch Biomed Sci, Nagasaki, Japan.; Miyazaki, T (corresponding author), Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan.	taiga-m@nagasaki-u.ac.jp		Takazono, Takahiro/0000-0002-0696-5386	Japanese Ministry of Education, Culture, Sports, Science and Technology [24791027, 21390305]; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15K09573] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Grant-in-Aid for Scientific Research (no. 24791027 to TM and no. 21390305 to SK) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann SP, 2002, J CLIN MICROBIOL, V40, P2228, DOI 10.1128/JCM.40.6.2228-2230.2002; Basso LR, 2010, EUKARYOT CELL, V9, P960, DOI 10.1128/EC.00355-09; Bennett JE, 2004, ANTIMICROB AGENTS CH, V48, P1773, DOI 10.1128/AAC.48.5.1773-1777.2004; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cormack BP, 1999, GENETICS, V151, P979; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Flamand V, 2010, J CANCER RES CLIN, V136, P1761, DOI 10.1007/s00432-010-0835-6; Guinea J, 2006, MED MYCOL, V44, P575, DOI 10.1080/13693780600561544; Healey KR, 2015, ANTIMICROB AGENTS CH, V59, P3377, DOI 10.1128/AAC.04667-14; Healey KR, 2012, MOL MICROBIOL, V86, P303, DOI 10.1111/j.1365-2958.2012.08194.x; Holmes AR, 2012, ANTIMICROB AGENTS CH, V56, P1508, DOI 10.1128/AAC.05706-11; Joets J, 1996, CURR GENET, V30, P115, DOI 10.1007/s002940050109; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; KAISER C, 1994, LAB COURSE MANUAL ME; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; MALLOY PJ, 1993, P NATL ACAD SCI USA, V90, P1902, DOI 10.1073/pnas.90.5.1902; Miyazaki H, 1998, ANTIMICROB AGENTS CH, V42, P1695, DOI 10.1128/AAC.42.7.1695; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Miyazaki T, 2010, ANTIMICROB AGENTS CH, V54, P1639, DOI 10.1128/AAC.01364-09; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Niimi K, 2006, ANTIMICROB AGENTS CH, V50, P1148, DOI 10.1128/AAC.50.4.1148-1155.2006; Mario DAN, 2012, MEM I OSWALDO CRUZ, V107, P433, DOI 10.1590/S0074-02762012000300022; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Silva ATPE, 2009, FEMS YEAST RES, V9, P626, DOI 10.1111/j.1567-1364.2009.00508.x; Posteraro B, 2006, J ANTIMICROB CHEMOTH, V58, P458, DOI 10.1093/jac/dkl237; Pudencio C, 2000, CYTOMETRY, V39, P26, DOI 10.1002/(SICI)1097-0320(20000101)39:1<26::AID-CYTO5>3.0.CO;2-C; Richards TS, 2008, J ANTIMICROB CHEMOTH, V62, P349, DOI 10.1093/jac/dkn156; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Schuetzer-Muehlbauer M, 2003, MOL MICROBIOL, V48, P225, DOI 10.1046/j.1365-2958.2003.03430.x; Silva LV, 2013, ANTIMICROB AGENTS CH, V57, P873, DOI 10.1128/AAC.02040-12; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06	41	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7								10.1371/journal.pone.0180990	http://dx.doi.org/10.1371/journal.pone.0180990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700656	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400025
J	Jinushi, M; Morita, T; Xu, ZH; Kinoshita, I; Dosaka-Akita, H; Yagita, H; Kawakami, Y				Jinushi, Masahisa; Morita, Tomoko; Xu, Zhihang; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Yagita, Hideo; Kawakami, Yutaka			Autophagy-dependent regulation of tumor metastasis by myeloid cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; GROWTH; INFLAMMATION; TUMORIGENESIS; MECHANISMS; BLOCKADE; IMMUNITY; DISEASE	Autophagy is a vital process controlling the lysosomal degradation of cellular organelles and thereby regulating tissue homeostasis in an environment-dependent fashion. Recent studies have unveiled the critical role of tumor cell-derived autophagy in regulating pro-tumor and anti-tumor processes depending on different stages and tumor microenvironments. However, the precise mechanism whereby autophagy regulates tumor progression remains largely unclear. Since myeloid cells contribute to tumor progression and metastasis, we evaluated the role of myeloid cell-specific autophagy in the regulation of tumor progression. We found that the number and size of metastatic lesions were smaller in myeloid cell-specific autophagy-deficient mice. Furthermore, autophagy-mediated regulation of TGF-beta in myeloid cells was associated with the induction of epithelial-mesenchymal transition (EMT), which increases the invasive and metastatic potentials of tumor cells. Myeloid-derived autophagy also plays a critical role in impairing antitumor immune responses and promoting the survival and accumulation of M2 macrophages in tumor tissues in a CSF-1 and TGF-beta-dependent manner. Taken together, our findings elucidate previously unrecognized mechanisms by which myeloid cells promote tumor progression through autophagy-mediated regulation of malignancy and immune tolerance.	[Jinushi, Masahisa; Xu, Zhihang; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Morita, Tomoko] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan; [Xu, Zhihang] Univ Tradit Chinese Med, Acupuncture & Moxibust Coll Tianjin, Tianjin, Peoples R China; [Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan	Keio University; Hokkaido University; Hokkaido University; Juntendo University	Jinushi, M (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan.	jinushi@keio.jp		Xu, Zhifang/0000-0002-0576-163X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26670183]; Ministry of Health, Labor and Welfare [H24-B-008]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study is partially supported by a Grant-in-Aid (26670183) for Scientific Research for Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/en/) and the Ministry of Health, Labor and Welfare (Grant number: H24-B-008 to MJ; http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chaffer CL, 2001, SCIENCE, V331, P1559; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lock R, 2014, CANCER DISCOV, V4, P466, DOI 10.1158/2159-8290.CD-13-0841; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Ogunjimi AA, 2012, CELL SIGNAL, V24, P476, DOI 10.1016/j.cellsig.2011.09.027; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yan HYH, 2015, CANCER RES, V75, P5283, DOI 10.1158/0008-5472.CAN-15-2282-T; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhao XD, 2013, INT J CANCER, V132, P1, DOI 10.1002/ijc.27664	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179357	10.1371/journal.pone.0179357	http://dx.doi.org/10.1371/journal.pone.0179357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686632	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100015
J	Kim, J; Lee, DY; Park, SE; Park, CY; Lee, WY; Oh, KW; Park, SW; Rhee, EJ				Kim, Jihyun; Lee, Da Young; Park, Se Eun; Park, Cheol-Young; Lee, Won-Young; Oh, Ki-Won; Park, Sung-Woo; Rhee, Eun-Jung			Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; SUBCLINICAL ATHEROSCLEROSIS; INSULIN-RESISTANCE; PREVALENCE; ASSOCIATION; OBESITY; GLUCOSE; ADULTS	Background Recent studies have suggested the importance of non-alcoholic fatty liver disease (NAFLD) and systemic inflammation in the development of atherosclerosis. The aim of this study was to compare the risk for coronary artery calcification (CAC) development according to the status of NAFLD and inflammation over four years of follow-up in subjects without baseline CAC. Methods A total of 1,575 participants in a health screening program were divided into four groups according to baseline NAFLD state and high-sensitivity C-reactive protein (hs-CRP) (median 0.06 mg/L) levels as follows: no NAFLD and hs-CRP < 0.06 mg/L, no NAFLD and hs-CRP >= 0.06 mg/L, NAFLD and hs-CRP < 0.06 mg/L, and NAFLD and hs-CRP >= 0.06 mg/ L. Coronary artery calcium score (CACS) was repeatedly measured by multi-detector computed tomography at four-year intervals and CAC development during those intervals was monitored in subjects with baseline CACS = 0. Results Over four years, 148 subjects (9.4%) developed CAC. The proportion of subjects who developed CAC was significantly higher in subjects with NAFLD at baseline compared with those without NAFLD at baseline (6.8 vs. 12.4%, p< 0.01), and it was also higher in subjects with hs-CRP >= 0.06 mg/L compared with those with hs-CRP < 0.06 mg/L (7.2 vs. 11.5%, p< 0.01). In addition, the proportion of subjects who developed CAC was highest in subjects with NAFLD and hs-CRP >= 0.06 mg/dL, followed by subjects with NAFLD, subjects without NAFLD and hs-CRP >= 0.06 mg/L, and subjects without NALFD and hs-CRP < 0.05 mg/L at baseline, in that order (13.7, 10.0, 8.3, and 5.8%, respectively; p for trend< 0.01). The odds ratio for CAC development was highest in subjects with NAFLD and hs-CRP >= 0.06 mg/L (1.67, 95% CI 1.01 - 2.77), though it was attenuated after adjustment for body mass index. Conclusions The concomitant presence of NAFLD and systemic inflammation as assessed by hs-CRP increases the risk of CAC development over four years.	[Kim, Jihyun; Lee, Da Young; Park, Se Eun; Park, Cheol-Young; Lee, Won-Young; Oh, Ki-Won; Park, Sung-Woo; Rhee, Eun-Jung] Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, EJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea.	hongsiri@hanmail.net	, Da Young Lee/AAA-1843-2021; Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	, Da Young Lee/0000-0002-8211-2393; Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592				Al Rifai M, 2015, ATHEROSCLEROSIS, V239, P629, DOI 10.1016/j.atherosclerosis.2015.02.011; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Blankstein R, 2017, ENDOCRINOL METAB, V32, P47, DOI 10.3803/EnM.2017.32.1.47; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Chen CH, 2010, DIGEST DIS SCI, V55, P1752, DOI 10.1007/s10620-009-0935-9; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kovacic JC, 2012, ATHEROSCLEROSIS, V221, P176, DOI 10.1016/j.atherosclerosis.2011.11.020; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Lee JI, 2016, ENDOCRINOL METAB, V31, P86, DOI 10.3803/EnM.2016.31.1.86; Lee MK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0253-9; Liu H, 2014, WORLD J GASTROENTERO, V20, P8407, DOI 10.3748/wjg.v20.i26.8407; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; Oni ET, 2015, AM J CARDIOL, V115, P34, DOI 10.1016/j.amjcard.2014.09.044; Park HE, 2016, J CLIN ENDOCR METAB, V101, P3134, DOI 10.1210/jc.2016-1525; Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x; Povero D, 2016, DIABETES METAB J, V40, P1, DOI 10.4093/dmj.2016.40.1.1; QUINN SF, 1985, AM J ROENTGENOL, V145, P753, DOI 10.2214/ajr.145.4.753; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sinn DH, 2017, GUT, V66, P323, DOI 10.1136/gutjnl-2016-311854; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; VanWagner LB, 2014, ATHEROSCLEROSIS, V235, P599, DOI 10.1016/j.atherosclerosis.2014.05.962; Yoon HJ, 2014, WORLD J HEPATOL, V6, P800, DOI 10.4254/wjh.v6.i11.800; Younossi ZM, 2002, HEPATOLOGY, V35, P746, DOI 10.1053/jhep.2002.32483	31	17	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180118	10.1371/journal.pone.0180118	http://dx.doi.org/10.1371/journal.pone.0180118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686633	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100036
J	Zhalyalov, AS; Panteleev, MA; Gracheva, MA; Ataullakhanov, FI; Shibeko, AM				Zhalyalov, Ansar S.; Panteleev, Mikhail A.; Gracheva, Marina A.; Ataullakhanov, Fazoil I.; Shibeko, Alexey M.			Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; MASSIVE PULMONARY-EMBOLISM; FACTOR-VII ACTIVATION; RANDOMIZED-TRIAL; MODELING FIBRINOLYSIS; THROMBOLYTIC THERAPY; CONFOCAL MICROSCOPY; ENDOTHELIAL-CELLS; POSITIVE FEEDBACK	Fibrinolysis is a cascade of proteolytic reactions occurring in blood and soft tissues, which functions to disintegrate fibrin clots when they are no more needed. In order to elucidate its regulation in space and time, fibrinolysis was investigated using an in vitro reaction-diffusion experimental model of blood clot formation and dissolution. Clotting was activated by a surface with immobilized tissue factor in a thin layer of recalcified blood plasma supplemented with tissue plasminogen activator (TPA), urokinase plasminogen activator or streptokinase. Formation and dissolution of fibrin clot was monitored by videomicroscopy. Computer systems biology model of clot formation and lysis was developed for data analysis and experimental planning. Fibrin clot front propagated in space from tissue factor, followed by a front of clot dissolution propagating from the same source. Velocity of lysis front propagation linearly depended on the velocity clotting front propagation (correlation r(2) = 0.91). Computer model revealed that fibrin formation was indeed the rate-limiting step in the fibrinolysis front propagation. The phenomenon of two fronts which switched the state of blood plasma from liquid to solid and then back to liquid did not depend on the fibrinolysis activator. Interestingly, TPA at high concentrations began to increase lysis onset time and to decrease lysis propagation velocity, presumably due to plasminogen depletion. Spatially non-uniform lysis occurred simultaneously with clot formation and detached the clot from the procoagulant surface. These patterns of spatial fibrinolysis provide insights into its regulation and might explain clinical phenomena associated with thrombolytic therapy.	[Zhalyalov, Ansar S.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.; Shibeko, Alexey M.] Ctr Theoret Problems Physicochem Pharmacol RAS, Moscow, Russia; [Panteleev, Mikhail A.; Gracheva, Marina A.; Ataullakhanov, Fazoil I.] Natl Sci & Pract Ctr Pediat Hematol, Oncol & Immunol, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia	Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Shibeko, AM (corresponding author), Ctr Theoret Problems Physicochem Pharmacol RAS, Moscow, Russia.	alshibeko@gmail.com	Ataullakhanov, Fazoil/J-8076-2012; Panteleev, Mikhail A/H-5491-2012; Ataullakhanov, Fazoil/O-3458-2019; Gracheva, Marina/A-8559-2014; Shibeko, Alexey/A-9447-2014	Panteleev, Mikhail A/0000-0002-8128-7757; Shibeko, Alexey/0000-0003-1494-3125; Gracheva, Marina/0000-0002-7522-168X	Russian Foundation for Basic Research [15-51-15008, 17-04-01309]; Russian Academy of Sciences; President of Russian Federation Grant [MK-9245.2016.4, MD-229.2017.4]; Russian Science Foundation [16-14-00-224]; Russian Science Foundation [16-14-00224] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); President of Russian Federation Grant; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The project was supported by Russian Foundation for Basic Research grants 15-51-15008 and 17-04-01309 to MAP; by Russian Academy of Sciences grants to FIA (Molecular and Cellular Biology, Basic Research for Development of Biomedical Technologies, Molecular Mechanisms of Physiologic Functions) and to MAP (Basic Science for Medicine); by Grant of President of Russian Federation MK-9245.2016.4 to AMS and MD-229.2017.4 to MAP. Theoretical modelling was supported by grant from Russian Science Foundation 16-14-00-224 to FIA (sections Computational model of fibrin clot growth and lysis and Computer simulation of spatial clot growth and lysis; Figures 6 and 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1970, JAMA-J AM MED ASSOC, V214, p2163/2172; Balandina AN, 2011, BIOPHYS J, V101, P1816, DOI 10.1016/j.bpj.2011.08.034; Bannish BE, 2014, MATH MED BIOL, V31, P17, DOI 10.1093/imammb/dqs029; Bannish BE, 2014, MATH MED BIOL, V31, P45, DOI 10.1093/imammb/dqs030; Bizjak N, 2014, THROMB RES, V133, P908, DOI 10.1016/j.thromres.2014.02.008; Bode C, 1996, CIRCULATION, V94, P891, DOI 10.1161/01.CIR.94.5.891; Bucay I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116350; CALIFF RM, 1991, CIRCULATION, V83, P1543, DOI 10.1161/01.CIR.83.5.1543; Campbell RA, 2008, ARTERIOSCL THROM VAS, V28, P2247, DOI 10.1161/ATVBAHA.108.176008; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Campbell RA, 2009, BLOOD, V114, P4886, DOI 10.1182/blood-2009-06-228940; CARR ME, 1978, MACROMOLECULES, V11, P46, DOI 10.1021/ma60061a009; Chernysh IN, 2015, J THROMB HAEMOST, V13, P601, DOI 10.1111/jth.12857; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; Collet JP, 2003, J BIOL CHEM, V278, P21331, DOI 10.1074/jbc.M212734200; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; DIAMOND SL, 1993, BIOPHYS J, V65, P2622, DOI 10.1016/S0006-3495(93)81314-6; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; GEMMILL JD, 1991, BRIT J CLIN PHARMACO, V31, P143, DOI 10.1111/j.1365-2125.1991.tb05502.x; KRUITHOF EKO, 1987, BLOOD, V70, P1645; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; Lindahl TL, 2015, THROMB RES, V135, P544, DOI 10.1016/j.thromres.2014.12.019; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; LIU JN, 1991, J CLIN INVEST, V88, P2012, DOI 10.1172/JCI115528; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Meneveau N, 1997, EUR HEART J, V18, P1141; MEYER G, 1992, J AM COLL CARDIOL, V19, P239, DOI 10.1016/0735-1097(92)90472-Y; Meyerovitz MF, 1995, J VASC INTERV RADIOL, V6, P775, DOI 10.1016/S1051-0443(95)71184-8; Michels HR, 1999, J THROMB THROMBOLYS, V8, P213, DOI 10.1023/A:1008914321384; Mutch NJ, 2007, J THROMB HAEMOST, V5, P812, DOI 10.1111/j.1538-7836.2007.02430.x; Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x; Ovanesov MV, 2003, THROMB HAEMOSTASIS, V89, P235; Ovanesov MV, 2002, BBA-GEN SUBJECTS, V1572, P45, DOI 10.1016/S0304-4165(02)00278-7; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Panteleev MA, 2004, BIOCHEM J, V381, P779, DOI 10.1042/BJ20031748; Panteleev MA, 2015, THROMB RES, V136, P699, DOI 10.1016/j.thromres.2015.07.025; Panteleev MA, 2010, BIOPHYS J, V98, P1751, DOI 10.1016/j.bpj.2010.01.027; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; ROSSI E, 1988, THROMB RES, V52, P453, DOI 10.1016/0049-3848(88)90029-1; Ruiz-Bailen M, 2002, MED SCI MONITOR, V8, pI85; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; SEIFRIED E, 1989, THROMB HAEMOSTASIS, V61, P497; Sharifi M, 2013, CARDIOVASC INTER RAD, V36, P1586, DOI 10.1007/s00270-013-0569-3; Shibeko AM, 2016, BRIEF BIOINFORM, V17, P429, DOI 10.1093/bib/bbv040; Shibeko AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-5; Soshitova NP, 2012, BLOOD COAGUL FIBRIN, V23, P498, DOI 10.1097/MBC.0b013e328352e90e; Takahashi K, 1998, AM J PHYSIOL-LUNG C, V275, pL47, DOI 10.1152/ajplung.1998.275.1.L47; TANSWELL P, 1992, J AM COLL CARDIOL, V19, P1071, DOI 10.1016/0735-1097(92)90297-Z; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; TORR SR, 1992, J AM COLL CARDIOL, V19, P1085, DOI 10.1016/0735-1097(92)90300-C; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Welsh JD, 2014, BLOOD, V124, P1808, DOI 10.1182/blood-2014-01-550335; WIMAN B, 1978, EUR J BIOCHEM, V87, P143, DOI 10.1111/j.1432-1033.1978.tb12360.x; Wootton DM, 2002, BIOTECHNOL BIOENG, V77, P405, DOI 10.1002/bit.10127	59	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180668	10.1371/journal.pone.0180668	http://dx.doi.org/10.1371/journal.pone.0180668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686711	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100089
J	Erku, DA; Mersha, AG				Erku, Daniel Asfaw; Mersha, Amanual Getnet			Involvement of community pharmacists in public health priorities: A multi-center descriptive survey in Ethiopia	PLOS ONE			English	Article							DISEASE PREVENTION; EDUCATION	Located in the heart of the community and widely distributed geographically, community pharmacies provide a platform for a more proactive involvement in public health services. So far, little information has been gathered in Ethiopia on community pharmacists' level of involvement in public health services. The aim of the present study was, therefore, to document the level of involvement of community pharmacy professionals in the provision of public health services and the barriers to such involvement. This study employed a selfadministered questionnaire based survey, which asked participants to indicate their frequency and level of involvement in providing public health services and their perceived barriers in providing such services. Surveys were undertaken from May to July, 2016 with 472 community pharmacy professionals working in community pharmacies in six cities of Amhara regional state of Ethiopia: Debre Markos, Gondar, Dessie, Bahir Dar, Woldya and Debre Birhan. Among 472 community pharmacy professionals approached, 412 (233 pharmacists and 179 pharmacy technicians) completed the survey with a response rate of 87.3%. Most respondents reported as being either ''not at all involved'' or ''little involved'' in counselling on smoking cessation (79.3%), and screening for hypertension (86.9%), diabetes (89.5%), and dyslipidemia (88.9%). On the other hand, they reported a higher level of involvement in the management and screening of infectious diseases (72.8%) and counseling with partners when initiating treatment for sexually transmitted diseases (68.9%). Lack of knowledge or clinical skills and lack of personnel or resources were the most commonly reported barrier for expanding such services. This survey revealed a low level of involvement of community pharmacists in public health services. In order to better integrate community pharmacies into future public health programs and optimize the contribution of community pharmacy professionals, interventions should focus on overcoming the identified barriers.	[Erku, Daniel Asfaw] Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia; [Mersha, Amanual Getnet] Univ Gondar, Sch Med, Dept Gynecol & Obstet, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Erku, DA (corresponding author), Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia.	staymotivated015@gmail.com	Erku, Daniel/AAC-1508-2020	Erku, Daniel/0000-0002-8878-0317; Mersha, Amanual Getnet/0000-0002-1183-8517				Amsler M R, 2001, J Am Pharm Assoc (Wash), V41, P850; Anderson C, 2007, CONTRIBUTION COMMUNI; [Anonymous], 2016, INTERDISCIP PERSPECT, V2016; [Anonymous], INT J PHARM PRACTICE, V14, P171; [Anonymous], INT J IMPOT RES SUPP, V16; Canadian Pharmacists Association, PHARMACISTS AND PRIM; Central Statistical Agency, 2008, SUMM STAT REP 2007 P; Dent LA, 2009, ANN PHARMACOTHER, V43, P194, DOI 10.1345/aph.1L556; Dhippayom T, 2013, J PUBLIC HEALTH-UK, V35, P262, DOI 10.1093/pubmed/fds078; Eades CE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-582; Hassell KE, 2001, BRIT MED J, V323, P146, DOI 10.1136/bmj.323.7305.146; Hess KM, 2010, J AM PHARM ASSOC, V50, P174, DOI 10.1331/JAPhA.2010.09204; Krska J, 2010, J PHARM HEALTH SERV, V1, P33, DOI 10.1211/jphsr/01.01.0013; Laliberte MC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-192; Maguire T. A., 2001, Addiction, V96, P325, DOI 10.1046/j.1360-0443.2001.96232516.x; Mangum Stacy A, 2003, J Am Pharm Assoc (Wash), V43, P50, DOI 10.1331/10865800360467042; Nimpitakpong P, 2010, J COMMUN HEALTH, V35, P554, DOI 10.1007/s10900-010-9242-9; O'Loughlin J, 1999, PREV MED, V28, P324, DOI 10.1006/pmed.1998.0436; PALUCK EC, 1994, CAN J PUBLIC HEALTH, V85, P389; Puspitasari HP, 2011, TROP MED INT HEALTH, V16, P840, DOI 10.1111/j.1365-3156.2011.02782.x; Scott David M., 2016, Pharmacy Pract (Granada), V14, P836, DOI [10.18549/PharmPract.2016.04.836, 10.18549/pharmpract.2016.04.836]; Snella KA, 2006, J AM PHARM ASSOC, V46, P370, DOI 10.1331/154434506777069598; Soyemi O. I., 2015, Journal of Public Health and Epidemiology, V7, P15; Suleman S, 2009, RES SOC ADMIN PHARM, V5, P76, DOI 10.1016/j.sapharm.2008.04.002; Thananithisak C, 2008, NICOTINE TOB RES, V10, P921, DOI 10.1080/14622200802027115; United-Kingdom Department of Health, CHOOS HLTH PHARM PRO; Watson L, 2003, J PUBLIC HEALTH MED, P2513; World Health Organization, 2004, GLOB STRAT DIET PHYS	28	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180943	10.1371/journal.pone.0180943	http://dx.doi.org/10.1371/journal.pone.0180943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704478	Green Published, gold			2022-12-27	WOS:000405649700064
J	Klose, D; Woitok, M; Niesen, J; Beerli, RR; Grawunder, U; Fischer, R; Barth, S; Fendel, R; Nachreiner, T				Klose, Diana; Woitok, Mira; Niesen, Judith; Beerli, Roger R.; Grawunder, Ulf; Fischer, Rainer; Barth, Stefan; Fendel, Rolf; Nachreiner, Thomas			Generation of an artificial human B cell line test system using Transpo-mAb (TM) technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins	PLOS ONE			English	Article							HUMAN GRANZYME-B; PIGGYBAC TRANSPOSON SYSTEM; PHASE-I TRIAL; LYMPHOMA-CELLS; GENE-TRANSFER; LUPUS; IMMUNOTOXIN; VITRO; ANTIBODIES; LEUKEMIA	The antigen-specific targeting of autoreactive B cells via their unique B cell receptors (BCRs) is a novel and promising alternative to the systemic suppression of humoral immunity. We generated and characterized cytolytic fusion proteins based on an existing immunotoxin comprising tetanus toxoid fragment C (TTC) as the targeting component and the modified Pseudomonas aeruginosa exotoxin A (ETA') as the cytotoxic component. The immunotoxin was reconfigured to replace ETA' with either the granzyme B mutant R201K or MAPTau as human effector domains. The novel cytolytic fusion proteins were characterized with a recombinant human lymphocytic cell line developed using Transpo-mAb (TM) technology. Genes encoding a chimeric TTC-reactive immunoglobulin G were successfully integrated into the genome of the precursor B cell line REH so that the cells could present TTC-reactive BCRs on their surface. These cells were used to investigate the specific cytotoxicity of GrB(R201K)-TTC and TTC-MAPTau, revealing that the serpin proteinase inhibitor 9-resistant granzyme B R201K mutant induced apoptosis specifically in the lymphocytic cell line. Our data confirm that antigen-based fusion proteins containing granzyme B (R201K) are suitable candidates for the depletion of autoreactive B cells.	[Klose, Diana; Woitok, Mira; Niesen, Judith; Fischer, Rainer; Fendel, Rolf] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Klose, Diana; Barth, Stefan; Nachreiner, Thomas] Univ Hosp RWTH Aachen, Inst Appl Med Engn, Dept Expt Med & Immunotherapy, Aachen, Germany; [Woitok, Mira; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol Biol 7, Aachen, Germany; [Beerli, Roger R.; Grawunder, Ulf] NBE Therapeut AG, Basel, Switzerland; [Barth, Stefan] Univ Cape Town, Inst Infect Dis & Mol Med IDM, South African Res Chair Canc Biotechnol, Dept Integrat Biomed Sci,Fac Hlth Sci, Cape Town, South Africa	Fraunhofer Gesellschaft; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; University of Cape Town	Fendel, R (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	rolf.fendel@ime.fraunhofer.de	Barth, Stefan/F-7301-2012; Fendel, Rolf/K-3985-2013	Barth, Stefan/0000-0001-9589-653X; Fendel, Rolf/0000-0003-4716-0311	NBE-Therapeutics AG	NBE-Therapeutics AG	The company NBE-Therapeutics AG provided support in the form of salaries for authors RRB and UG as well as study material (cell line REH, expression vectors pPB-EGFP-LC-Ac10/pPB-EGFP-HC-Ac10 and pcDNA3.1-hy-mPB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijon Lana M, 2014, DRUGS TARGETING B CE, P65; Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062; Bialon Magdalena, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P369, DOI 10.1089/mab.2014.0044; Brehm H, 2015, CANCER LETT, V365, P149, DOI 10.1016/j.canlet.2015.04.004; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Cremer C, 2015, J IMMUNOTHER, V38, P85, DOI 10.1097/CJI.0000000000000053; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Di Matteo M, 2014, MOL THER, V22, P1614, DOI 10.1038/mt.2014.131; Dorner T, 2015, AUTOIMMUN REV, V14, P1079, DOI 10.1016/j.autrev.2015.07.013; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel P, 2011, PHARMACOL REV, V63, P127, DOI 10.1124/pr.109.002006; Fitzsimmons SP, 2000, VACCINE, V19, P114, DOI 10.1016/S0264-410X(00)00115-8; GODING JW, 1980, J IMMUNOL METHODS, V39, P285, DOI 10.1016/0022-1759(80)90230-6; Grawunder U, 2014, TRANSPOSITION MEDIAT; Hampe CS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/215308; Hehmann-Titt G, 2013, ANTIBODIES, V2, P19, DOI 10.3390/antib2010019; Horlick RA, 2013, J BIOL CHEM, V288, P19861, DOI 10.1074/jbc.M113.452482; Hostmann A, 2008, LUPUS, V17, P1064, DOI 10.1177/0961203308095138; Hoyer BF, 2015, Z RHEUMATOL, V74, P206, DOI 10.1007/s00393-014-1458-0; Hristodorov D, 2013, BRIT J CANCER, V109, P1570, DOI 10.1038/bjc.2013.457; Hristodorov D, 2014, MOL CANCER THER, V13, P2194, DOI 10.1158/1535-7163.MCT-13-0781; Hristodorov D, 2014, BRIT J HAEMATOL, V164, P251, DOI 10.1111/bjh.12626; Jabulowsky RA, 2012, BIOCONJUGATE CHEM, V23, P1567, DOI 10.1021/bc3000657; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Kamen DL, 2016, RHEUM DIS CLIN N AM, V42, P63, DOI 10.1016/j.rdc.2015.08.008; Kampmeier F, 2009, BIOCONJUGATE CHEM, V20, P1010, DOI 10.1021/bc9000257; Kapelski S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0577-7; Kapelski S, 2015, ANTIMICROB AGENTS CH, V59, P669, DOI 10.1128/AAC.04190-14; Klose D, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0249-x; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kreitman RJ, 2009, J CLIN ONCOL, V27, P2983, DOI 10.1200/JCO.2008.20.2630; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Losasso V, 2012, PROTEINS, V80, P2514, DOI 10.1002/prot.24133; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Mathew M, 2009, CANCER SCI, V100, P1359, DOI 10.1111/j.1349-7006.2009.01192.x; Mirabelli G, 2015, CLIN EXP RHEUMATOL, V33, P414; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nachreiner T, 2008, J NEUROIMMUNOL, V195, P28, DOI 10.1016/j.jneuroim.2008.01.001; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Niesen J, 2015, J CANCER RES CLIN, V141, P2079, DOI 10.1007/s00432-015-1975-5; Niesen J, 2015, J CANCER RES CLIN, V141, P1049, DOI 10.1007/s00432-014-1884-z; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Saha S, 2015, NUCLEIC ACIDS RES, V43, P1770, DOI 10.1093/nar/gkv017; Saha S, 2012, JOVE-J VIS EXP, DOI 10.3791/4235; Schiffer S, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.4; Schiffer S, 2014, INT J CANCER, V135, P1497, DOI 10.1002/ijc.28786; Schiffer S, 2013, CANCER LETT, V341, P178, DOI 10.1016/j.canlet.2013.08.005; Sciascia S, 2015, INT IMMUNOPHARMACOL, V27, P189, DOI 10.1016/j.intimp.2015.04.049; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Skipper KA, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-92; Stahnke B, 2008, MOL CANCER THER, V7, P2924, DOI 10.1158/1535-7163.MCT-08-0554; Stepanov A, 2016, BIOTECHNOL LETT; Stocker M, 2003, PROTEIN EXPRES PURIF, V28, P211, DOI 10.1016/S1046-5928(02)00709-X; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Tarlinton DM, 2015, NAT IMMUNOL, V16, P685, DOI 10.1038/ni.3209; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Waldmeier L, 2016, MABS-AUSTIN, V8, P726, DOI 10.1080/19420862.2016.1160990; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Wayne AS, 2014, BLOOD, V123, P2470, DOI 10.1182/blood-2014-01-492256; Weidle UH, 2012, CANCER GENOM PROTEOM, V9, P119; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Yildirim-Toruner C, 2011, J ALLERGY CLIN IMMUN, V127, P303, DOI 10.1016/j.jaci.2010.12.1087; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	77	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180305	10.1371/journal.pone.0180305	http://dx.doi.org/10.1371/journal.pone.0180305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704435	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700036
J	Lacomba, JA; Lagos, F; Perote, J				Lacomba, Juan A.; Lagos, Francisco; Perote, Javier			The Lazarillo's game: Sharing resources with asymmetric conditions	PLOS ONE			English	Article							PUBLIC-GOODS GAME; ULTIMATUM GAMES; DILEMMAS; COOPERATION; INFORMATION; COORDINATION; PAYOFFS	The Lazarillo of Tormes' picaresque novel introduces a story where two subjects sequentially extract (one, two or three) tokens from a common pool in an asymmetric information framework (the first player cannot observe her partners' actions). By introducing a reward for both subjects in case that in every period at least one subject had taken one single token, we define an interesting coordination game. We conduct an experiment with 120 undergraduate students to study their behavior in this framework. We find that if the second player is allowed to take more tokens than her partner, then the frequency of cooperators does not seem to be affected by the informational asymmetry. Nevertheless, this asymmetry (i) incentives the second player to use her 'power of extraction' while the social externality is still available, (ii) yields to more asymmetric profit distributions when subjects win the social externality and (iii) delays the breach period in case of coordination failure. Furthermore, the first choice of the first player is determinant for getting the reward.	[Lacomba, Juan A.; Lagos, Francisco] Univ Granada, Dept Theory & Econ Hist, Granada, Spain; [Perote, Javier] Univ Salamanca, Dept Econ & Econ Hist, Salamanca, Spain; [Perote, Javier] Univ Salamanca, IME, Salamanca, Spain	University of Granada; University of Salamanca; University of Salamanca	Perote, J (corresponding author), Univ Salamanca, Dept Econ & Econ Hist, Salamanca, Spain.; Perote, J (corresponding author), Univ Salamanca, IME, Salamanca, Spain.	perote@usal.es	Lagos, Francis/AAT-6192-2020; Perote, Javier/E-6235-2016	Perote, Javier/0000-0002-9122-4370; Lagos Garcia, Francisco Miguel/0000-0003-1945-3272	Spanish Ministry of Economics and Competitiveness [ECO2012-36695, ECO2013-44483-P, ECO2015-66657, ECO2016-75631-P]; Junta de Castilla y Leon [SA072U16]; Juntade Andalucia [P12-SEJ-1436]	Spanish Ministry of Economics and Competitiveness(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Juntade Andalucia(Junta de Andalucia)	Financial support from the Spanish Ministry of Economics and Competitiveness through the Projects ECO2012-36695, ECO2013-44483-P, ECO2015-66657 and ECO2016-75631-P, Junta de Castilla y Leon (SA072U16) and Juntade Andalucia (P12-SEJ-1436) is gratefully acknowledged	Ahn TK, 2007, PUBLIC CHOICE, V132, P353, DOI 10.1007/s11127-007-9158-9; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; BANKS J, 1994, GAME ECON BEHAV, V6, P1, DOI 10.1006/game.1994.1001; Bone JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155773; Bone JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117183; Brandt G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052763; Budescu DV, 2002, J BEHAV DECIS MAKING, V15, P37, DOI 10.1002/bdm.402; BUDESCU DV, 1990, EUR J SOC PSYCHOL, V20, P475; CAMERER C, 1989, J POLIT ECON, V97, P1232, DOI 10.1086/261651; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FORSYTHE R, 1991, AM ECON REV, V81, P253; HACKETT S, 1994, J ENVIRON ECON MANAG, V27, P99, DOI 10.1006/jeem.1994.1029; Howe EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158940; Janssen MA, 2012, AGR SYST, V109, P65, DOI 10.1016/j.agsy.2012.03.004; Janssen MA, 2011, EXP ECON, V14, P547, DOI 10.1007/s10683-011-9281-9; Kagel JH, 1996, GAME ECON BEHAV, V13, P100, DOI 10.1006/game.1996.0026; MITZKEWITZ M, 1993, INT J GAME THEORY, V22, P171, DOI 10.1007/BF01243649; Myerson RB, 1986, UNCERTAINTY INFORM C, V3; Neugebauer T, 2008, EXP ECON, V11, P190, DOI 10.1007/s10683-007-9166-0; Neugebauer T, 2009, J ECON PSYCHOL, V30, P52, DOI 10.1016/j.joep.2008.04.005; Ozono H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154321; Rapoport A, 1997, INT J GAME THEORY, V26, P113, DOI 10.1007/s001820050021; VANDIJK E, 1995, J EXP SOC PSYCHOL, V31, P1, DOI 10.1006/jesp.1995.1001; Wang CJ, 2017, APPL MATH COMPUT, V293, P18, DOI 10.1016/j.amc.2016.06.026; Wang JG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006269	26	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180421	10.1371/journal.pone.0180421	http://dx.doi.org/10.1371/journal.pone.0180421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704408	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700038
J	Lang, RL; Xiao, H; Li, Z; Yu, LH				Lang, Rongling; Xiao, Hong; Li, Zi; Yu, Lihong			A anti-jamming method for satellite navigation system based on multi-objective optimization technique	PLOS ONE			English	Article								In this paper, an anti-jamming method, which turns the single objective optimization problem into a multi-objective optimization problem by utilizing 2-norm, is proposed. The proposed jamming suppression method can reduce the wide nulls and wrong nulls problems, which are generated by the common adaptive nulling methods. Therefore a better signal-noiseratio (SNR) can be achieved, especially when the jammers are close to satellite signals. It can also improve the robustness of the algorithm. The effectiveness of the proposed method is evaluated by simulation and practical outdoor experiments with the GPS L1 band C/A signals. The experimental results show that with the dedicated method, the nulls targeting at the corresponding jammers become narrower and the wrong nulls can be eliminated.	[Lang, Rongling; Xiao, Hong; Yu, Lihong] Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Li, Zi] Huaiyin Inst Technol, Dept Foreign Language, Huaian, Jiangsu, Peoples R China	Beihang University; Huaiyin Institute of Technology	Lang, RL (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	ronglinglang@163.com						AGEE BG, 1990, P IEEE, V78, P753, DOI 10.1109/5.54812; Ahmad Z.S., 2015, IEEE INT SEM WORKSH, DOI [10.1109/DIPED.2015.7324263, DOI 10.1109/DIPED.2015.7324263]; Borio Daniele, 2012, 2012 6 ESA WORKSH S, P1, DOI [10.1109/NAVITEC.2012.6423048., DOI 10.1109/NAVITEC.2012.6423048]; Brown A., 2001, P 14 INT TECHN M SAT, P894; COMPTON RT, 1979, IEEE T AERO ELEC SYS, V15, P803, DOI 10.1109/TAES.1979.308765; Frost O.L., 1970, ADAPTIVE LEAST SQUAR; Gao G. X., 2016, P IEEE MAY 30; GUPTA IJ, 1984, IEEE T ANTENN PROPAG, V32, P933, DOI 10.1109/TAP.1984.1143448; Han Q., 2014, 2014 IEEE ION POS LO, P5, DOI DOI 10.1109/PLANS.2014.6851474; Karsi M. F., 2002, IEEE T COMMUN, V48, P886; Lu D, 2006, PIERS 2006 CAMBRIDGE: PROGRESS IN ELECTROMAGNETICS RESEARCH SYMPOSIUM, PROCEEDINGS, P357; Lu Y, 2001, 2001 CIE INTERNATIONAL CONFERENCE ON RADAR PROCEEDINGS, P1190, DOI 10.1109/ICR.2001.984923; Meng Dawei, 2008, Tsinghua Science and Technology, V13, P796, DOI 10.1016/S1007-0214(08)72202-8; Omata K., 2002, TRANSM DISTR C EXH O, DOI [10.1109/TDC.2002.1178388, DOI 10.1109/TDC.2002.1178388]; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Tsui B., 2005, FUNDAMENTALS GLOBAL, P129; Wang WY, 2015, IET RADAR SONAR NAV, V9, P852, DOI 10.1049/iet-rsn.2014.0258; Yu L. H., 2016, J BEIJING U AERONAUT, V41, P1747	18	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180893	10.1371/journal.pone.0180893	http://dx.doi.org/10.1371/journal.pone.0180893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704483	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700058
J	Maiga, S; Allain, G; Hauet, T; Roumy, J; Baulier, E; Scepi, M; Dierick, M; Van Hoorebeke, L; Hannaert, P; Guy, F; Favreau, F				Maiga, Souleymane; Allain, Geraldine; Hauet, Thierry; Roumy, Jerome; Baulier, Edouard; Scepi, Michel; Dierick, Manuel; Van Hoorebeke, Luc; Hannaert, Patrick; Guy, Franck; Favreau, Frederic			Renal auto-transplantation promotes cortical microvascular network remodeling in a preclinical porcine model	PLOS ONE			English	Article							LONG-TERM; COLD ISCHEMIA/REPERFUSION; ENDOTHELIAL INJURY; KIDNEY; DYSFUNCTION; MICROCIRCULATION; MECHANISMS; REJECTION; ISCHEMIA; DAMAGE	The vascular network is a major target of ischemia-reperfusion, but has been poorly investigated in renal transplantation. The aim of this study was to characterize the remodeling of the renal vascular network that follows ischemia-reperfusion along with the most highly affected cortex section in a preclinical renal transplantation model. There were two experimental groups. The first was a grafted kidney group consisting of large white pigs for which the left kidney was harvested, cold flushed, preserved for 24 h in the University of Wisconsin's preservation solution, and then auto-transplanted (n = 5); the right kidney was removed to mimic the situation of human kidney transplantation. The second group (uni-nephrectomized kidney group) consisted of animals that underwent only right nephrectomy, but not left renal transplantation (n = 5). Three months after autotransplantation, the kidneys were studied by X-ray microcomputed tomography. Vessel morphology and density and tortuosity of the network were analyzed using a 3D image analysis method. Cortical blood flow was determined by laser doppler analysis and renal function and tissue injury assessed by plasma creatinine levels and histological analysis. Renal ischemia-reperfusion led to decreased vascular segment volume associated with fewer vessels of less than 30 mu m, particularly in the inner cortex: 0.79 +/- 0.54% in grafted kidneys vs. 7.06 +/- 1.44% in uni-nephrectomized kidneys, p < 0.05. Vessels showed higher connectivity throughout the cortex (the arborescence factor of the whole cortex was less in grafted than uni-nephrectomized kidneys 0.90 +/- 0.04 vs. 1.07 +/- 0.05, p < 0.05, with an increase in the number of bifurcations). Furthermore, cortical blood flow decreased early in kidney grafts and remained low three months after autotransplantation. The decrease in microvasculature correlated with a deterioration of renal function, proteinuria, and tubular dysfunction, and was associated with the development of fibrous tissue. This work provides new evidence concerning the impact of ischemia-reperfusion injuries on the spectrum of renal vascular diseases and could potentially guide future therapy to preserve microvessels in transplantation ischemia-reperfusion injury.	[Maiga, Souleymane; Allain, Geraldine; Hauet, Thierry; Roumy, Jerome; Baulier, Edouard; Scepi, Michel; Hannaert, Patrick; Favreau, Frederic] INSERM, U1082, Poitiers, France; [Maiga, Souleymane; Hauet, Thierry; Scepi, Michel; Favreau, Frederic] Univ Poitiers, Fac Med & Pharm, Poitiers, France; [Maiga, Souleymane] Ctr Hosp Univ Bordeaux, Grp Hosp Pellegrin, Serv Imagerie Diagnost & Intervent Adulte, Bordeaux, France; [Allain, Geraldine] CHU Poitiers, Serv Chirurg Cardiothorac, Poitiers, France; [Hauet, Thierry; Favreau, Frederic] CHU Poitiers, Lab Biochim, Poitiers, France; [Hauet, Thierry] INRA, GenESI UE1372, Plateforme IBISA, Surgeres, France; [Hauet, Thierry] CHU La Miletrie, Federat Hosp Univ Transplantat, SUrvival oPtimizat ORgan Transplantat SUPORT, Poitiers, France; [Dierick, Manuel; Van Hoorebeke, Luc] Univ Ghent, UGCT Dept Phys & Astron, Fac Sci, Proeftuinstr 86, Ghent, Belgium; [Guy, Franck] CNRS, IPHEP Inst Paleoprimatol & Paleontol Humaine Evol, INEE,UMR 7262, Poitiers, France; [Guy, Franck] Univ Poitiers, Fac Sci, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Bordeaux; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; INRAE; CHU Poitiers; Universite de Poitiers; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Universite de Poitiers	Hauet, T (corresponding author), INSERM, U1082, Poitiers, France.; Hauet, T (corresponding author), Univ Poitiers, Fac Med & Pharm, Poitiers, France.; Hauet, T (corresponding author), CHU Poitiers, Lab Biochim, Poitiers, France.; Hauet, T (corresponding author), INRA, GenESI UE1372, Plateforme IBISA, Surgeres, France.; Hauet, T (corresponding author), CHU La Miletrie, Federat Hosp Univ Transplantat, SUrvival oPtimizat ORgan Transplantat SUPORT, Poitiers, France.	thierry.hauet@gmail.com	Hauet, Thierry/AAC-9277-2021; raphael, thuillier/P-5709-2016	Hauet, Thierry/0000-0002-0117-071X; GUY, Franck/0000-0001-7032-7963; raphael, thuillier/0000-0002-7482-0031	Inserm; University of Poitiers	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Poitiers	This study was supported by funding from Inserm (http://www.inserm.fr) and University of Poitiers (http://www.univ-poitiers.fr). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Professor T Hauet and F Favreau received a salary from University of Poitiers, but they worked independently from University of Poitiers in this research study.	Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bentley MD, 2002, KIDNEY INT, V61, P1056, DOI 10.1046/j.1523-1755.2002.00211.x; Bentley MD, 2002, AM J PHYSIOL-REG I, V282, pR1267, DOI 10.1152/ajpregu.00560.2001; BISHOP GA, 1989, TRANSPLANTATION, V48, P408, DOI 10.1097/00007890-198909000-00011; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Brenner BM, 1999, BRENNER RECTORS KIDN; Chade AR, 2004, AM J PHYSIOL-RENAL, V286, pF1079, DOI 10.1152/ajprenal.00385.2003; Chade AR, 2003, ARTERIOSCL THROM VAS, V23, P1295, DOI 10.1161/01.ATV.0000077477.40824.52; Cicco G, 2005, ADV EXP MED BIOL, V566, P363; CLARK RL, 1977, INVEST RADIOL, V12, P62, DOI 10.1097/00004424-197701000-00014; Eirin A, 2011, AM J PHYSIOL-RENAL, V300, pF1394, DOI 10.1152/ajprenal.00697.2010; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Hauet T, 2002, KIDNEY INT, V62, P654, DOI 10.1046/j.1523-1755.2002.00473.x; Hauet T, 2000, J AM SOC NEPHROL, V11, P138, DOI 10.1681/ASN.V111138; Jochmans I, 2011, ANN SURG, V254, P784, DOI 10.1097/SLA.0b013e3182368fa7; Kline TL, 2010, ANN BIOMED ENG, V38, P2851, DOI 10.1007/s10439-010-0058-7; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; MCNAY JL, 1970, CIRC RES, V27, P571, DOI 10.1161/01.RES.27.4.571; Menger MD, 2000, MICROCIRCULATION, V7, P291, DOI 10.1038/sj.mn.7300117; Mikhalski D, 2008, TRANSPLANTATION, V85, pS3, DOI 10.1097/TP.0b013e318169c29e; Minnich B, 2000, SCANNING, V22, P173, DOI 10.1002/sca.4950220305; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Nankivell BJ, 2001, TRANSPLANTATION, V71, P515, DOI 10.1097/00007890-200102270-00006; Navar LG, 1996, PHYSIOL REV, V76, P425, DOI 10.1152/physrev.1996.76.2.425; Pereira-Sampaio MA, 2004, J UROLOGY, V172, P2077, DOI 10.1097/01.ju.0000138085.19352.b5; Persy V, 2006, ARTERIOSCL THROM VAS, V26, P2110, DOI 10.1161/01.ATV.0000236200.02726.f7; Pober J, 1998, TRANSPLANTATION P; Reffelmann T, 2003, CIRCULATION, V108, P2911, DOI 10.1161/01.CIR.0000101917.80668.E1; Reinders MEJ, 2006, J AM SOC NEPHROL, V17, P932, DOI 10.1681/ASN.2005121250; Ren Y, 2007, KIDNEY INT, V71, P1116, DOI 10.1038/sj.ki.5002190; Sato M, 2000, COMP GRAPH APPL 2000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skov K, 1999, KIDNEY INT, V55, P1462, DOI 10.1046/j.1523-1755.1999.00398.x; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Vodenicharov A, 1998, ANAT HISTOL EMBRYOL, V27, P257, DOI 10.1111/j.1439-0264.1998.tb00190.x; WARE RW, 1975, INT REV CYTOL, V40, P325, DOI 10.1016/S0074-7696(08)60956-0; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhu XY, 2004, ARTERIOSCL THROM VAS, V24, P1854, DOI 10.1161/01.ATV.0000142443.52606.81	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181067	10.1371/journal.pone.0181067	http://dx.doi.org/10.1371/journal.pone.0181067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704481	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700086
J	Priya, GB; Nagaleekar, VK; Milton, AAP; Saminathan, M; Kumar, A; Sahoo, AR; Wani, SA; Kumar, A; Gupta, SK; Sahoo, AP; Tiwari, AK; Agarwal, RK; Gandham, RK				Priya, G. Bhuvana; Nagaleekar, Viswas Konasagara; Milton, A. Arun Prince; Saminathan, M.; Kumar, Amod; Sahoo, Amit Ranjan; Wani, Sajad Ahmad; Kumar, Amit; Gupta, S. K.; Sahoo, Aditya P.; Tiwari, A. K.; Agarwal, R. K.; Gandham, Ravi Kumar			Genome wide host gene expression analysis in mice experimentally infected with Pasteurella multocida	PLOS ONE			English	Article							BACTERIAL PEPTIDOGLYCAN; DEFICIENT MICE; APOPTOSIS; SEPSIS; INNATE; PATHOGENESIS; INFLAMMATION; RECOGNITION; ENVIRONMENT; RECEPTORS	Pasteurella multocida causes acute septicemic and respiratory diseases, including haemorrhagic septicaemia, in cattle and buffalo with case fatality of 100%. In the present study, mice were infected with P. multocida (1.6 x 10 (3) cfu, intraperitoneal) to evaluate host gene expression profile at early and late stages of infection using high throughput microarray transcriptome analyses. Several differentially expressed genes (DEGs) at both the time points were identified in P. multocida infected spleen, liver and lungs. Functional annotation of these DEGs showed enrichment of key pathways such as TLR, NF-.B, MAPK, TNF, JAKSTAT and NOD like receptor signaling pathways. Several DEGs overlapped across different KEGG pathways indicating a crosstalk between them. The predicted protein D protein interaction among these DEGs suggested, that the recognition of P. multocida LPS or outer membrane components by TLR4 and CD14, results in intracellular signaling via MyD88, IRAKs and/or TRAF6 leading to activation of NF kappa B and MAPK pathways and associated cytokines.	[Priya, G. Bhuvana; Nagaleekar, Viswas Konasagara; Agarwal, R. K.] ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India; [Milton, A. Arun Prince] ICAR Indian Vet Res Inst, Div Vet Publ Hlth, Bareilly, Uttar Pradesh, India; [Saminathan, M.] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India; [Kumar, Amod] ICAR Indian Vet Res Inst, Div Anim Genet, Bareilly, Uttar Pradesh, India; [Sahoo, Amit Ranjan; Wani, Sajad Ahmad; Kumar, Amit; Sahoo, Aditya P.; Gandham, Ravi Kumar] ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India; [Gupta, S. K.] ICAR RCER, Div Livestock & Fishery Management, Patna, Bihar, India; [Tiwari, A. K.] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for Eastern Region; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Nagaleekar, VK; Agarwal, RK (corresponding author), ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India.; Gandham, RK (corresponding author), ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.	vkn111@gmail.com; grace_bly@yahoo.com; gandham71@gmail.com	MILTON, AROCKIASAMY ARUN PRINCE/M-5350-2019; Kumar, Amod/AAB-3464-2019	MILTON, AROCKIASAMY ARUN PRINCE/0000-0002-0436-6582; M, Saminathan/0000-0003-0557-7194; Kumar, Amod/0000-0002-7531-574X; WANI, SAJAD/0000-0002-7593-1825; Nagaleekar, Viswas K./0000-0003-4873-0857; KUMAR, AMIT/0000-0002-4423-7881	Network projecton Hemorrhagic Septicemia [AS/8/1/2014/ASR-IV]	Network projecton Hemorrhagic Septicemia	Funded by Network projecton Hemorrhagic Septicemia- F.No. AS/8/1/2014/ASR-IV, dated November 2014.	Boyce JD, 2006, CURR OPIN MICROBIOL, V9, P117, DOI 10.1016/j.mib.2005.12.005; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brogaard L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1557-6; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Harrison DA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011205; Horadagoda NU, 2001, MICROB PATHOGENESIS, V30, P171, DOI 10.1006/mpat.2000.0423; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Jaeger A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0178-z; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; OKERMAN L, 1979, J COMP PATHOL, V89, P51, DOI 10.1016/0021-9975(79)90008-2; Peschon JJ, 1998, J IMMUNOL, V160, P943; Praveena PE, 2010, RES VET SCI, V89, P332, DOI 10.1016/j.rvsc.2010.04.012; Quinn PJ, 2011, VET MICROBIOLOGY MIC, V27, P300; RAMDANI, 1990, IMMUNOL CELL BIOL, V68, P57, DOI 10.1038/icb.1990.8; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Saminathan M, 2016, J EXP BIOL AGRIC SCI, V4, P338, DOI 10.18006/2016.4(3S).338.367; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; VOGEL SN, 1990, IMMUNOPHYSIOLOGY ROL, P238; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Xie F, 2010, AM J REPROD IMMUNOL, V63, P7, DOI 10.1111/j.1600-0897.2009.00745.x	43	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179420	10.1371/journal.pone.0179420	http://dx.doi.org/10.1371/journal.pone.0179420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704394	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700011
J	Mihoubi, W; Sahli, E; Gargouri, A; Amiel, C				Mihoubi, Wafa; Sahli, Emna; Gargouri, Ali; Amiel, Caroline			FTIR spectroscopy of whole cells for the monitoring of yeast apoptosis mediated by p53 over-expression and its suppression by Nigella sativa extracts	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; RADIATION-INDUCED APOPTOSIS; SACCHAROMYCES-CEREVISIAE; IR SPECTROSCOPY; FATTY-ACID; HL60 CELLS; MICROSPECTROSCOPY; DEATH; STRESS; IDENTIFICATION	p53 over expression in yeast results in cell death with typical markers of apoptosis such as DNA fragmentation and phosphatidylserine externalization. We aimed to substitute/ supplement classical fluorescent techniques (TUNEL, Annexin V, ROS detection) usually used to detect biochemical changes occurring during yeast apoptosis mediated by p53 over expression and the effect of anti-apoptotic purified molecules from Nigel (Nigella sativa) extracts on these same yeasts by the label free technique of FTIR spectroscopy. The comparison of the entire IR spectra highlighted clear modifications between apoptotic p53-expressing yeasts and normal ones. More precisely, DNA damage was detected by the decrease of band intensities at 1079 and 1048 cm(-1). While phosphatidylserine exposure was followed by the increase of.sCH(2) and.asCH(2) bands of unsaturated fatty acids that were exhibited at 2855 and 2926 cm(-1), and the appearance of the C = O ester functional group band at 1740 cm(-1). In a second step, this FTIR approach was used to estimate the effect of a purified fraction of the Nigel extract. The modulation of band intensities specific to DNA and membrane status was in agreement with apoptosis supression in presence of the Nigel extracts. FTIR spectroscopy is thus proven to be a very reliable technique to monitor the apoptotic cell death in yeast and to be used as a means of evaluating the biomolecules effect on yeast survival.	[Mihoubi, Wafa; Sahli, Emna; Gargouri, Ali] Ctr Biotechnol Sfax, Lab Biotechnol Mol Eucaryotes, Sfax, Tunisia; [Amiel, Caroline] Univ Caen Normandie, Unite Rech Aliments Bioproc Toxicol Environm, EA 4651, Blvd Marechal Juin, Caen, France	Centre de Biotechnologie de Sfax; Universite de Sfax; Universite de Caen Normandie	Mihoubi, W (corresponding author), Ctr Biotechnol Sfax, Lab Biotechnol Mol Eucaryotes, Sfax, Tunisia.	fafani.mihoubi@yahoo.fr						Abbott GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049070; Amiel C, 2000, LAIT, V80, P445, DOI 10.1051/lait:2000137; Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Bellisola G, 2012, AM J CANCER RES, V2, P1; BENEDETTI E, 1986, APPL SPECTROSC, V40, P39, DOI 10.1366/0003702864815565; BENEDETTI E, 1990, APPL SPECTROSC, V44, P1276, DOI 10.1366/000370290789619621; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Cheung HY, 1999, MICROBIOL-SGM, V145, P1043, DOI 10.1099/13500872-145-5-1043; CHOO LP, 1993, BIOCHIM BIOPHYS ACTA, V1182, P333, DOI 10.1016/0925-4439(93)90078-F; Corte L, 2010, ANAL CHIM ACTA, V659, P258, DOI 10.1016/j.aca.2009.11.035; CULLIN C, 1988, GENE, V65, P203, DOI 10.1016/0378-1119(88)90457-X; Diem M, 1999, APPL SPECTROSC, V53, p148A, DOI 10.1366/0003702991946712; Dixit VM, 1996, ADV EXP MED BIOL, V406, P113; Dogan A, 2007, APPL SPECTROSC, V61, P199, DOI 10.1366/000370207779947459; Erukhimovitch V, 2009, BIOPOLYMERS, V91, P61, DOI 10.1002/bip.21082; Ferreira P, 2014, FEMS YEAST RES, V14, P1006, DOI 10.1111/1567-1364.12189; Gao YF, 2015, MOL MED REP, V11, P2585, DOI 10.3892/mmr.2014.3088; Gasparri F, 2003, BIOCHEM J, V369, P239, DOI 10.1042/BJ20021021; Gaudenzi AS, 2004, CELL APOPTOSIS SPECI, V18, P415; Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1; Gautam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045521; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Griffiths P., 1986, FOURIER TRANSFORM IN; Guibet M, 2006, CARBOHYD RES, V341, P1859, DOI 10.1016/j.carres.2006.04.018; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kamnev AA, 2005, J TRACE ELEM MED BIO, V19, P91, DOI 10.1016/j.jtemb.2005.03.002; Kendall C, 2009, ANALYST, V134, P1029, DOI 10.1039/b822130h; Lasch P, 2008, BIOMEDICAL VIBRATION, P79; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Liu KZ, 2007, BRIT J HAEMATOL, V136, P713, DOI 10.1111/j.1365-2141.2006.06474.x; Liu KZ, 2005, BLOOD CELL MOL DIS, V35, P404, DOI 10.1016/j.bcmd.2005.06.009; Liu KZ, 2001, J MOL STRUCT, V565, P299, DOI 10.1016/S0022-2860(00)00817-6; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mahmood MS, 2003, PHYTOTHER RES, V17, P921, DOI 10.1002/ptr.1251; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Mantsch HH, 2002, VIB SPECTROSC, V30, P31, DOI 10.1016/S0924-2031(02)00036-X; Mecozzi M, 2007, VIB SPECTROSC, V44, P228, DOI 10.1016/j.vibspec.2006.11.006; Melin AM, 2001, ARCH BIOCHEM BIOPHYS, V394, P265, DOI 10.1006/abbi.2001.2533; Moen B, 2005, APPL ENVIRON MICROB, V71, P2086, DOI 10.1128/AEM.71.4.2086-2094.2005; Mokdad-Gargouri R, 2001, NUCLEIC ACIDS RES, V29, P1222, DOI 10.1093/nar/29.5.1222; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Perromat A, 2003, BIOPOLYMERS, V72, P207, DOI 10.1002/bip.10381; Portenier I, 2005, J ENDODONT, V31, P380, DOI 10.1097/01.don.0000145421.84121.c8; Pozzi D, 2007, RADIAT RES, V168, P698, DOI 10.1667/RR0991.1; Ryser S, 1999, CURR GENET, V36, P21, DOI 10.1007/s002940050468; Saharan RK, 2011, VIB SPECTROSC, V55, P85, DOI 10.1016/j.vibspec.2010.08.003; Sajbidor J, 1995, FOLIA MICROBIOL, V40, P508, DOI 10.1007/BF02814733; Sambrook J., MOL CLONING LAB MANU; Saulou C, 2010, ANAL BIOANAL CHEM, V396, P1441, DOI 10.1007/s00216-009-3316-5; Schultz CP, 1998, ONCOL RES, V10, P277; Scott CE, 1999, J CELL PHYSIOL, V181, P147, DOI 10.1002/(SICI)1097-4652(199910)181:1<147::AID-JCP15>3.0.CO;2-M; Singh JK, 1996, BBA-LIPID LIPID MET, V1304, P171, DOI 10.1016/S0005-2760(96)00134-8; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Szeghalmi A, 2007, ANAL BIOANAL CHEM, V387, P1779, DOI 10.1007/s00216-006-0850-2; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toyran N, 2005, INT J RADIAT BIOL, V81, P911, DOI 10.1080/09553000600571022; van den Driesche S, 2013, SENSOR ACTUAT B-CHEM, V179, P150, DOI 10.1016/j.snb.2012.10.139; Wu B., 2015, DISCRETE DYN NAT SOC, V2015, P1, DOI DOI 10.1186/S12967-015-0468-2; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yacoubi-Hadj Amor I, 2008, FEMS YEAST RES, V8, P1, DOI DOI 10.1111/J.1567-1364.2008.00445; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026; ZEROUAL W, 1995, PATHOL BIOL, V43, P300; Zhou JB, 2001, BIOTECHNOL APPL BIOC, V33, P127, DOI 10.1042/BA20000074	73	43	44	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180680	10.1371/journal.pone.0180680	http://dx.doi.org/10.1371/journal.pone.0180680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704406	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600042
J	Tang, JJ; He, HM; Chen, C; Fu, S; Xue, FS				Tang, Jianjun; He, Haimin; Chen, Chao; Fu, Shu; Xue, Fangsen			Latitudinal cogradient variation of development time and growth rate and a negative latitudinal body weight cline in a widely distributed cabbage beetle	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; STRIDER AQUARIUS-REMIGIS; LIFE-HISTORY RESPONSES; COLAPHELLUS-BOWRINGI; PHENOTYPIC PLASTICITY; GEOGRAPHIC-VARIATION; COUNTERGRADIENT VARIATION; EVOLUTIONARY SIGNIFICANCE; DIAPAUSE INCIDENCE; TEMPERATURE-CHANGE	The evolutionary and phenotypic responses to environmental gradients are often assumed to be the same, a phenomenon known as "cogradientvariation" .However, only a few insect species display cogradient variation in physiological traits along a latitudinal gradient. We found evidence for such a response in the examination of the life history traits of the cabbage beetle Colaphellus bowringi from 6 different geographical populations at 16, 19, 22, 24, 26 and 28 degrees C. Our results showed that larval and pupal development times significantly decreased as rearing temperature increased, and that growth rates were positively correlated with temperature. Body weight tended to decrease with increasing temperature, consistent with the general pattern in ectothermic animals. Larval development time was positively correlated with latitude, whereas the growth rate decreased as latitude increased, showing an example of latitudinal cogradient variation. Body weight significantly decreased with increasing latitude in a stepwise manner, showing a negative latitudinal body weight cline. Females were significantly larger than males, consistent with the female biased sex dimorphism in insects. Body weight tended to decrease with increasing rearing temperature, whereas the differences in sexual size dimorphism (SSD) tended to decrease with increasing body weight, which biased our results toward acceptance of Rensch's rule. We found that weight loss was an important regulator of SSD, and because male pupae lost significantly more weight at metamorphosis than female pupae, SSD was greater in adults than in pupae. Overall, our data provide a new example that a latitudinal cogradient variation in physiological traits is associated with a negative latitudinal body weight cline.	[Tang, Jianjun] Jiangxi Agr Univ, Coll Comp & Informat Engn, Nanchang, Jiangxi, Peoples R China; [He, Haimin; Fu, Shu; Xue, Fangsen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Chen, Chao] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Jiangxi Agricultural University; Jiangxi Agricultural University; State University System of Florida; University of Florida	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com		Xue, Fangsen/0000-0002-7609-7414	National Natural Science Foundation of the People's Republic of China [31260430]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	The research was supported by a grant from National Natural Science Foundation of the People's Republic of China to FSX (31260430). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Arendt JD, 1999, ECOLOGY, V80, P2793, DOI 10.1890/0012-9658(1999)080[2793:CSFRGI]2.0.CO;2; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Barton M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095258; Bidau CJ, 2007, B ENTOMOL RES, V97, P69, DOI 10.1017/S0007485307004749; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; BLANCKENHORN WU, 1995, J EVOLUTION BIOL, V8, P21, DOI 10.1046/j.1420-9101.1995.8010021.x; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; De Block M, 2008, ECOGRAPHY, V31, P115, DOI 10.1111/j.2007.0906-7590.05313.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fischer K, 2000, OIKOS, V90, P372, DOI 10.1034/j.1600-0706.2000.900218.x; Fu DM, 2016, J THERM BIOL, V61, P115, DOI 10.1016/j.jtherbio.2016.09.006; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hirst AG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2475; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Kivela SM, 2012, J EVOLUTION BIOL, V25, P881, DOI 10.1111/j.1420-9101.2012.02478.x; Kivela SM, 2011, J ANIM ECOL, V80, P1184, DOI 10.1111/j.1365-2656.2011.01864.x; Lai XT, 2008, ENTOMOL EXP APPL, V129, P117, DOI 10.1111/j.1570-7458.2008.00749.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; PARK O, 1949, PHYSIOL ZOOL, V22, P359, DOI 10.1086/physzool.22.4.30152061; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; Poykko H, 2010, J EVOLUTION BIOL, V23, P1278, DOI 10.1111/j.1420-9101.2010.01990.x; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Schutze MK, 2008, GLOBAL ECOL BIOGEOGR, V17, P424, DOI 10.1111/j.1466-8238.2007.00374.x; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Stillwell RC, 2009, OIKOS, V118, P703, DOI 10.1111/j.1600-0706.2008.17327.x; Tang JJ, 2016, ENTOMOL RES, V46, P337, DOI 10.1111/1748-5967.12184; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Valimaki P, 2013, J EVOLUTION BIOL, V26, P118, DOI 10.1111/jeb.12033; Winterhalter Wade E., 2008, Journal of Orthoptera Research, V17, P347, DOI 10.1665/1082-6467-17.2.347; Xiao L, 2016, ECOL EVOL, V6, P5129, DOI 10.1002/ece3.2275; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; Yang D, 2007, J INSECT PHYSIOL, V53, P900, DOI 10.1016/j.jinsphys.2007.02.015	51	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181030	10.1371/journal.pone.0181030	http://dx.doi.org/10.1371/journal.pone.0181030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704496	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600053
J	Price, A; Gibas, C				Price, Adam; Gibas, Cynthia			The quantitative impact of read mapping to non-native reference genomes in comparative RNA-Seq studies	PLOS ONE			English	Article							ALIGNMENT; SEQUENCE	Sequence read alignment to a reference genome is a fundamental step in many genomics studies. Accuracy in this fundamental step is crucial for correct interpretation of biological data. In cases where two or more closely related bacterial strains are being studied, a common approach is to simply map reads from all strains to a common reference genome, whether because there is no closed reference for some strains or for ease of comparison. The assumption is that the differences between bacterial strains are insignificant enough that the results of differential expression analysis will not be influenced by choice of reference. Genes that are common among the strains under study are used for differential expression analysis, while the remaining genes, which may fail to express in one sample or the other because they are simply absent, are analyzed separately. In this study, we investigate the practice of using a common reference in transcriptomic analysis. We analyze two multi-strain transcriptomic data sets that were initially presented in the literature as comparisons based on a common reference, but which have available closed genomic sequence for all strains, allowing a detailed examination of the impact of reference choice. We provide a method for identifying regions that are most affected by non-native alignments, leading to false positives in differential expression analysis, and perform an in depth analysis identifying the extent of expression loss. We also simulate several data sets to identify best practices for non-native reference use.	[Price, Adam; Gibas, Cynthia] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Gibas, C (corresponding author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu	Price, Adam/AAA-3128-2019	Price, Adam/0000-0001-6114-6298; Gibas, Cynthia/0000-0002-1288-9543	Charlotte Research Institute; Lucille P. and Edward C. Giles Dissertation-Year Fellowship	Charlotte Research Institute; Lucille P. and Edward C. Giles Dissertation-Year Fellowship	This work was supported by the Charlotte Research Institute and the Lucille P. and Edward C. Giles Dissertation-Year Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fraser-Liggett CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/gr.3724205; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Gama-Castro S., 2016, NUCL ACIDS RES, V44; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Price A., 2017, BIOINFORMATICS; Vital M, 2015, ISME J, V9, P1130, DOI 10.1038/ismej.2014.204; Williams T. C., 2014, PLOS ONE, V9	14	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180904	10.1371/journal.pone.0180904	http://dx.doi.org/10.1371/journal.pone.0180904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700635	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400022
J	Villegas-Negrete, N; Robleto, EA; Obregon-Herrera, A; Yasbin, RE; Pedraza-Reyes, M				Villegas-Negrete, Norberto; Robleto, Eduardo A.; Obregon-Herrera, Armando; Yasbin, Ronald E.; Pedraza-Reyes, Mario			Implementation of a loss-of-function system to determine growth and stress-associated mutagenesis in Bacillus subtilis	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; THYMIDYLATE SYNTHASE; ADAPTIVE EVOLUTION; ESCHERICHIA-COLI; RNA-POLYMERASE; REPAIR SYSTEM; DNA-DAMAGE; CELLS; TRANSCRIPTION; MUTANTS	A forward mutagenesis system based on the acquisition of mutations that inactivate the thymidylate synthase gene (TMS) and confer a trimethoprim resistant (Tmp(r)) phenotype was developed and utilized to study transcription-mediated mutagenesis (TMM). In addition to thyA, Bacillus subtilis possesses thyB, whose expression occurs under conditions of cell stress; therefore, we generated a thyB(-) thyA(+) mutant strain. Tmp(r) colonies of this strain were produced with a spontaneous mutation frequency of similar to 1.4 x 10(-9). Genetic disruption of the canonical mismatch (MMR) and guanine oxidized (GO) repair pathways increased the Tmp(r) frequency of mutation by similar to 2-3 orders of magnitude. A wide spectrum of base substitutions as well as insertion and deletions in the ORF of thyA were found to confer a Tmp(r) phenotype. Stationary-phase-associated mutagenesis (SPM) assays revealed that colonies with a Tmpr phenotype, accumulated over a period of ten days with a frequency of similar to 60 x 10(-7). The Tmp(r) system was further modified to study TMM by constructing a Delta thyA Delta thyB strain carrying an IPTG-inducible Pspac-thyA cassette. In conditions of transcriptional induction of thyA, the generation of Tmp(r) colonies increased similar to 3-fold compared to conditions of transcriptional repression. Further, the Mfd and GreA factors were necessary for the generation of Tmpr colonies in the presence of IPTG in B. subtilis. Because GreA and Mfd facilitate transcription-coupled repair, our results suggest that TMM is a mechanim to produce genetic diversity in highly transcribed regions in growth-limited B. subtilis cells.	[Villegas-Negrete, Norberto; Obregon-Herrera, Armando; Pedraza-Reyes, Mario] Univ Guanajuato, Dept Biol, Div Nat & Exact Sci, Guanajuato, Mexico; [Robleto, Eduardo A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Yasbin, Ronald E.] Univ Missouri St Louis, Coll Arts & Sci, St Louis, MO 63121 USA	Universidad de Guanajuato; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Missouri System; University of Missouri Saint Louis	Pedraza-Reyes, M (corresponding author), Univ Guanajuato, Dept Biol, Div Nat & Exact Sci, Guanajuato, Mexico.	pedrama@ugto.mx			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110624] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016464] Funding Source: Medline; NIGMS NIH HHS [R15 GM110624] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambriz-Avina V, 2016, CURR MICROBIOL, V73, P721, DOI 10.1007/s00284-016-1122-9; Behe MJ, 2010, Q REV BIOL, V85, P419, DOI 10.1086/656902; BOYLAN RJ, 1972, J BACTERIOL, V110, P281, DOI 10.1128/JB.110.1.281-290.1972; Bridges BA, 1998, MUTAT RES-DNA REPAIR, V408, P1, DOI 10.1016/S0921-8777(98)00008-1; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Castellanos-Juarez FX, 2006, J BACTERIOL, V188, P2285, DOI 10.1128/JB.188.6.2285-2289.2006; Cohen SE, 2010, CURR BIOL, V20, P80, DOI 10.1016/j.cub.2009.11.039; Cutting S., 1990, MOL BIOL METHODS BAC; Debora BN, 2011, J BACTERIOL, V193, P236, DOI 10.1128/JB.00940-10; Barajas-Ornelas RD, 2014, J BACTERIOL, V196, P3012, DOI 10.1128/JB.01681-14; FARMER JL, 1965, J BACTERIOL, V89, P262, DOI 10.1128/JB.89.1.262-263.1965; Fox KM, 1999, PROTEIN SCI, V8, P538; Fukushima T, 2003, J BIOCHEM, V133, P475, DOI 10.1093/jb/mvg062; Gomez-Marroquin M, 2015, J BACTERIOL, V197, P1963, DOI 10.1128/JB.00147-15; Halas A, 2002, CURR GENET, V42, P140, DOI 10.1007/s00294-002-0334-7; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Ishikawa S, 2010, J BACTERIOL, V192, P5778, DOI 10.1128/JB.00489-10; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Kamarthapu V, 2015, CURR OPIN MICROBIOL, V24, P15, DOI 10.1016/j.mib.2014.12.005; Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134; Kusuya Y, 2011, J BACTERIOL, V193, P3090, DOI 10.1128/JB.00086-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; NEUHARD J, 1978, P NATL ACAD SCI USA, V75, P1194, DOI 10.1073/pnas.75.3.1194; OKADA T, 1962, J BACTERIOL, V84, P602, DOI 10.1128/JB.84.3.602-603.1962; OKADA T, 1960, NATURE, V188, P340, DOI 10.1038/188340a0; OLLINGTON JF, 1981, J BACTERIOL, V147, P432, DOI 10.1128/JB.147.2.432-442.1981; Pedraza-Reyes M, 2004, J BACTERIOL, V186, P6485, DOI 10.1128/JB.186.19.6485-6491.2004; Pybus C, 2010, J BACTERIOL, V192, P3321, DOI 10.1128/JB.00354-10; Quinlivan EP, 2000, FASEB J, V14, P2519, DOI 10.1096/fj.99-1037com; Robleto EA, 2007, CRIT REV BIOCHEM MOL, V42, P327, DOI 10.1080/10409230701597717; Rosenberg SM, 1998, GENETICS, V148, P1559; Ross C, 2006, J BACTERIOL, V188, P7512, DOI 10.1128/JB.00980-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sankar TS, 2016, NATURE, V535, P178, DOI 10.1038/nature18316; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Sung HM, 2002, J BACTERIOL, V184, P5641, DOI 10.1128/JB.184.20.5641-5653.2002; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Vidales LE, 2009, J BACTERIOL, V191, P506, DOI 10.1128/JB.01210-08; WILSON MC, 1966, J BACTERIOL, V92, P186, DOI 10.1128/JB.92.1.186-196.1966; YASBIN RE, 1980, GENE, V12, P155, DOI 10.1016/0378-1119(80)90026-8	42	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0179625	10.1371/journal.pone.0179625	http://dx.doi.org/10.1371/journal.pone.0179625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700593	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400004
J	Bin Naser, I; Hoque, MM; Abdullah, A; Bari, SMN; Ghosh, AN; Faruque, SM				Bin Naser, Iftekhar; Hoque, M. Mozammel; Abdullah, Ahmed; Bari, S. M. Nayeemul; Ghosh, Amar N.; Faruque, Shah M.			Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: Potential relevance in cholera epidemiology	PLOS ONE			English	Article							PHAGE; BACTERIA; INFECTIVITY; RESISTANCE; ENHANCE; WATER	In cholera-endemic areas, toxigenic Vibrio cholerae persist in the aquatic ecosystem mostly in a biofilm-associated state in which the bacteria remain embedded in an exopolysaccharide matrix. The biofilm-associated cells often enter into a dormant form referred to as conditionally viable environmental cells (CVEC), which resist cultivation on routine bacteriological media. However, these cells can naturally resuscitate into the active planktonic form through various mechanisms, multiply, and cause epidemics of cholera. This study was conducted to study possible effects of environmental bacteriophages on the prevalence and distribution of the pathogen between the biofilm associated state, and the planktonic form.	[Bin Naser, Iftekhar; Hoque, M. Mozammel; Abdullah, Ahmed; Bari, S. M. Nayeemul; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh; [Ghosh, Amar N.] Natl Inst Cholera & Enter Dis, Kolkata, W Bengal, India	International Centre for Diarrhoeal Disease Research (ICDDR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Faruque, SM (corresponding author), Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh.	faruque@icddrb.org		Hoque, Md Mozammel/0000-0002-6014-6955; Faruque, Shah/0000-0002-7006-622X	Wellcome Trust through a senior investigator [WT-105927/Z/14/Z]; Swedish International Development Cooperation Agency (Sida) under International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb); Governments of Bangladesh, Canada, Sweden; UK	Wellcome Trust through a senior investigator; Swedish International Development Cooperation Agency (Sida) under International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb); Governments of Bangladesh, Canada, Sweden; UK	This research was funded by the Wellcome Trust through a senior investigator award WT-105927/Z/14/Z to Shah Faruque, and the Swedish International Development Cooperation Agency (Sida) under an agreement with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb). The icddreb receives core support from the Governments of Bangladesh, Canada, Sweden and the UK. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ACKERMANN HW, 1987, MICROBIOL SCI, V4, P214; Albert MJ, 1996, J CLIN MICROBIOL, V34, P1843, DOI 10.1128/JCM.34.7.1843-1845.1996; Bari SMN, 2013, P NATL ACAD SCI USA, V110, P9926, DOI 10.1073/pnas.1307697110; Colwell Rita R., 1994, P117; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Faruque SM, 2012, VIRULENCE, V3, P556, DOI 10.4161/viru.22351; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Faruque SM, 2003, EMERG INFECT DIS, V9, P1116; Faruque SM, 2000, INFECT IMMUN, V68, P4795, DOI 10.1128/IAI.68.8.4795-4801.2000; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoque MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37956; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107; KHAN MU, 1984, TROP GEOGR MED, V36, P335; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Maniatis T., 1982, MOL CLONING; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Seed KD, 2011, MBIO, V2, DOI 10.1128/mBio.00334-10; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	30	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180838	10.1371/journal.pone.0180838	http://dx.doi.org/10.1371/journal.pone.0180838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700707	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800085
J	Liu, PF; Hu, YC; Kang, BH; Tseng, YK; Wu, PC; Liang, CC; Hou, YY; Fu, TY; Liou, HH; Hsieh, IC; Ger, LP; Shu, CW				Liu, Pei-Feng; Hu, Yu-Chang; Kang, Bor-Hwang; Tseng, Yu-Kai; Wu, Pi-Chuang; Liang, Chi-Chuang; Hou, Yu-Yi; Fu, Ting-Ying; Liou, Huei-Han; Hsieh, I-Chien; Ger, Luo-Ping; Shu, Chih-Wen			Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma	PLOS ONE			English	Article							CANCER-CELLS; PROTEIN EXPRESSION; BLADDER-CANCER; APOPTOSIS; ACTIVATION; REPOPULATION; INSTABILITY; RECURRENCE; PATHWAYS; DISEASE	Apoptosis plays a dual role in cancer development and malignancy. The role of apoptosisrelated caspases in cancer remains controversial, particularly in oral tongue squamous cell carcinoma (OTSCC). In this study, we examined the protein levels of cleaved caspase-3, caspase-3, caspase-8, and caspase-9 on tissue microarrays consisting of samples from 246 OTSCC patients by immunohistochemistry. Wilcoxon signed-rank test indicated that the protein levels of cleaved caspase-3, caspase-3, caspase-8, and caspase-9 in tumor tissues were significantly higher compared to those in adjacent normal tissues (all p<0.001). The expression level of caspase-8 in tumors was elevated in patients with lymph node invasion. Moreover, positive expression of cleaved caspase-3 was associated with shorter disease-free survival (DFS) in OTSCC patients with moderate differentiation and lymph node invasion. Combination of either positive cleaved caspase-3 or higher caspase-3 expression or both was associated with poor DFS. Interestingly, stratification analysis showed that coexpression levels of positive cleaved caspase-3 or/and higher caspase-3 were associated with better disease-specific survival in patients with advanced stages of the disease, such as large tumor size and lymph node invasion, whereas it was associated with poor DFS in OTSCC patients with moderate cell differentiation and small tumor size. Taken together, cleaved caspase-3 and caspase-3/8/9 could be biomarkers for tumorigenesis in OTSCC patients. The co-expression level of cleaved caspase-3 and caspase-3 might be a prognostic biomarker for OTSCC patients, particular in those patients with certain tumor stages and cell differentiation status.	[Liu, Pei-Feng; Liou, Huei-Han; Ger, Luo-Ping; Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Hu, Yu-Chang] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Kang, Bor-Hwang; Hou, Yu-Yi] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Kang, Bor-Hwang] Natl Def Med Ctr, Sch Med, Dept Otorhinolaryngol, Taipei, Taiwan; [Tseng, Yu-Kai] Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan; [Tseng, Yu-Kai] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Wu, Pi-Chuang; Liang, Chi-Chuang] Kaohsiung Vet Gen Hosp, Dept Nutr, Kaohsiung, Taiwan; [Fu, Ting-Ying; Hsieh, I-Chien] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Ger, Luo-Ping] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; Show Chwan Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University	Ger, LP; Shu, CW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.; Ger, LP (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.	lpger@vghks.gov.tw; cwshu@vghks.gov.tw	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002; Liu, Pei-Feng/0000-0002-7849-8940	Kaohsiung Veterans General Hospital in Taiwan, ROC [VGHKS 102-037, VGHKS102-080, VGHKS105-024, VGHKS106-154, VGHKS106-020]	Kaohsiung Veterans General Hospital in Taiwan, ROC	This study was supported by a research grant from the Kaohsiung Veterans General Hospital (VGHKS 102-037, VGHKS102-080, VGHKS105-024, VGHKS106-154, and VGHKS106-020) in Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andressakis D, 2008, J LARYNGOL OTOL, V122, P1213, DOI 10.1017/S0022215108002636; Coutinho-Camillo CM, 2011, HEAD NECK-J SCI SPEC, V33, P1191, DOI 10.1002/hed.21602; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; de Heer P, 2007, CLIN CANCER RES, V13, P5810, DOI 10.1158/1078-0432.CCR-07-0343; Fan CF, 2011, FOLIA HISTOCHEM CYTO, V49, P231, DOI 10.5603/FHC.2011.0032; Fujikawa K, 2000, ANTICANCER RES, V20, P1927; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Fulda S, 2009, CANCER LETT, V281, P128, DOI 10.1016/j.canlet.2008.11.023; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Jakubowska K, 2016, ONCOL LETT, V11, P1879, DOI 10.3892/ol.2016.4125; Kumar S, 1999, CLIN EXP PHARMACOL P, V26, P295, DOI 10.1046/j.1440-1681.1999.03031.x; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Li S, 2014, J CLIN ENDOCR METAB, V99, pE2298, DOI 10.1210/jc.2014-1779; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Loro LL, 2005, ORAL DIS, V11, P274, DOI 10.1111/j.1601-0825.2005.01117.x; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mukai M, 2005, CANCER RES, V65, P9121, DOI 10.1158/0008-5472.CAN-04-4344; Nagaraj NS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-38; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Noble P, 2013, BRIT J CANCER, V108, P2097, DOI 10.1038/bjc.2013.166; O'Donovan N, 2003, CLIN CANCER RES, V9, P738; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Satoh K, 2000, PANCREAS, V21, P352, DOI 10.1097/00006676-200011000-00005; Tormanen-Napankangas U, 2001, INT J CANCER, V93, P192, DOI 10.1002/ijc.1315; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; Wang JW, 2014, WORLD J UROL, V32, P1477, DOI 10.1007/s00345-014-1246-0; Winter RN, 2001, CANCER RES, V61, P1227; Xia B, 2005, WORLD J GASTROENTERO, V11, P415, DOI 10.3748/wjg.v11.i3.415; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	35	48	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180620	10.1371/journal.pone.0180620	http://dx.doi.org/10.1371/journal.pone.0180620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700659	gold, Green Submitted, Green Published			2022-12-27	WOS:000405544800058
J	Sanchez-Tejada, L; Sanchez-Ortiga, R; Lamas, C; Camara, R; Riesgo, P; Fajardo, C; Aranda, FI; Pico, A				Sanchez-Tejada, Laura; Sanchez-Ortiga, Ruth; Lamas, Cristina; Camara, Rosa; Riesgo, Pedro; Fajardo, Carmen; Ignacio Aranda, Francisco; Pico, Antonio			Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas	PLOS ONE			English	Article							SILENT CORTICOTROPH ADENOMAS; PROLACTIN GENE-EXPRESSION; CLINICOPATHOLOGICAL CLASSIFICATION; GROWTH-HORMONE; MANAGEMENT; SECRETION; PATHOLOGY	Aim The WHO Classification of Tumours of Endocrine Organs considers the inmunohistochemical characterization of pituitary adenomas (PA) as mandatory for patient diagnosis. Recent advances in the knowledge of the molecular patterns of these tumours could complement this classification with gene expression profiling. Methods Within the context of the Spanish Molecular Registry of Pituitary Adenomas (REMAH), a multicentre clinical- basic research project, we analysed the molecular phenotype of 142 PAs with complete IHC and clinical information. Gene expression levels of all pituitary hormones, type 1 corticotrophin- releasing hormone receptor, dopamine receptors and arginine vasopressin receptor 1b were measured by quantitative real- time polymerase chain reaction. In addition, we used three housekeeping genes for normalization and a pool of nine healthy pituitary glands from autopsies as calibration reference standard. Results Based on the clinically functioning PA (FPA: somatotroph, corticotroph, thyrotroph and lactotroph adenomas), we established the interquartile range of relative expression for all genes studied in each PA subtype. That allowed molecularly the different PA subtypes, including the clinically non- functioning PA (NFPA). Afterwards, we estimated the concordance of the molecular and immunohistochemical classification with clinical diagnosis in FPA and between them in NFPA. The kappa values were higher in molecular than in immunohistochemical classification in FPA and showed a bad concordance in all NFPA subtypes. Conclusions According to these results, the molecular characterization of the PA complements the IHC analysis, allowing a better typification of the NFPA.	[Sanchez-Tejada, Laura] Hosp Gen Univ Alicante, Isabial Fisabio Fdn, Inst Hlth & Biomed Res, Res Unit, Alicante, Spain; [Sanchez-Ortiga, Ruth; Pico, Antonio] Hosp Gen Univ Alicante, Endocrinol Dept, Alicante, Spain; [Lamas, Cristina] Hosp Gen Univ Albacete, Endocrinol Dept, Albacete, Spain; [Camara, Rosa] Hosp Univ Politecn La Fe, Endocrinol Dept, Valencia, Spain; [Riesgo, Pedro] Hosp La Ribera, Neurosurg Dept, Valencia, Spain; [Fajardo, Carmen] Hosp La Ribera, Endocrinol Dept, Alzira, Spain; [Ignacio Aranda, Francisco] Hosp Gen Univ Alicante, Pathol Dept, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Hospital Universitari i Politecnic La Fe; General University Hospital of Alicante	Pico, A (corresponding author), Hosp Gen Univ Alicante, Endocrinol Dept, Alicante, Spain.	antonio.pico@umh.es	pico, antonio/B-6439-2018; pico, antonio/E-9061-2011; SANCHEZ-TEJADA, LAURA/B-6336-2015; ARANDA, FRANCISCO I/L-5525-2015	pico, antonio/0000-0002-7549-7563; pico, antonio/0000-0002-7549-7563; SANCHEZ-TEJADA, LAURA/0000-0001-5563-8923; ARANDA, FRANCISCO I/0000-0003-2338-2286; Fajardo-Montanana, Carmen/0000-0002-0784-0761; Lamas Oliveira, Cristina/0000-0003-4622-9508	Spanish Society of Endocrinology and Nutrition (SEEN) - Novartis Oncology	Spanish Society of Endocrinology and Nutrition (SEEN) - Novartis Oncology	This work is the result of analysis of the REMAH project in its Alicante node, sponsored by the Spanish Society of Endocrinology and Nutrition (SEEN) and funded by Novartis Oncology. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Brahim NYY, 2006, J CLIN PATHOL, V59, P1245, DOI 10.1136/jcp.2005.031187; Asa SL, 2008, ARCH PATHOL LAB MED, V132, P1231, DOI 10.1043/1543-2165(2008)132[1231:PPPWDT]2.0.CO;2; Baldeweg SE, 2005, BRIT J NEUROSURG, V19, P38, DOI 10.1080/02688690500081230; Chanson P, 2015, ANN ENDOCRINOL-PARIS, V76, P239, DOI 10.1016/j.ando.2015.04.002; Cho HY, 2010, CLIN ENDOCRINOL, V72, P648, DOI 10.1111/j.1365-2265.2009.03673.x; Cooper O, 2012, BEST PRACT RES CL EN, V26, P447, DOI 10.1016/j.beem.2012.01.002; de Keyzer Y, 1998, CLIN ENDOCRINOL, V49, P475, DOI 10.1046/j.1365-2265.1998.00560.x; Ezzat S, 2004, CANCER-AM CANCER SOC, V101, P613, DOI 10.1002/cncr.20412; Gomez-Hernandez Karen, 2015, Turk Patoloji Derg, V31 Suppl 1, P4, DOI 10.5146/tjpath.2015.01311; Greenman Y, 2009, BEST PRACT RES CL EN, V23, P625, DOI 10.1016/j.beem.2009.05.005; Gruszka A, 2007, ENDOCRINOLOGY, V148, P6107, DOI 10.1210/en.2007-0378; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; HORVATH E, 1980, AM J PATHOL, V98, P617; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Lloyd R. V, 2004, WHO CLASSIFICATION T, P10; Luque RM, 2016, ENDOCRINOL NUTR, V63, P274, DOI 10.1016/j.endonu.2016.03.001; Mahta A, 2007, FOLIA NEUROPATHOL, V45, P72; Ohta S, 2002, Pituitary, V5, P221, DOI 10.1023/A:1025321731790; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petrus M, 1996, ARCH PEDIATRIE, V3, P245, DOI 10.1016/0929-693X(96)81302-9; Raverot G, 2014, EUR J ENDOCRINOL, V170, pR121, DOI 10.1530/EJE-13-1031; Raverot G, 2010, EUR J ENDOCRINOL, V163, P35, DOI 10.1530/EJE-10-0076; Sanchez-Ortiga R, 2013, PITUITARY, V16, P370, DOI 10.1007/s11102-012-0434-4; Sepulveda AR, 2017, AM J CLIN PATHOL, V147, P221, DOI 10.1093/ajcp/aqw209; Sugimoto K, 2007, BRAIN RES BULL, V74, P142, DOI 10.1016/j.brainresbull.2007.06.004; Tateno T, 2007, EUR J ENDOCRINOL, V157, P717, DOI 10.1530/EJE-07-0428; Tateno T, 2007, ENDOCR J, V54, P777, DOI 10.1507/endocrj.K07-059; Trouillas J, 2014, ENDOCR PATHOL, V25, P124, DOI 10.1007/s12022-014-9322-y; Trouillas J, 2013, ACTA NEUROPATHOL, V126, P123, DOI 10.1007/s00401-013-1084-y; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Vezina J L, 1975, Arq Neuropsiquiatr, V33, P119; Yamakita N, 1999, ENDOCR J, V46, P563, DOI 10.1507/endocrj.46.563	33	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180039	10.1371/journal.pone.0180039	http://dx.doi.org/10.1371/journal.pone.0180039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692683	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800023
J	Tuitert, I; Bootsma, RJ; Schoemaker, MM; Otten, E; Mouton, LJ; Bongers, RM				Tuitert, Inge; Bootsma, Reinoud J.; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.			Does practicing a wide range of joint angle configurations lead to higher flexibility in a manual obstacle-avoidance target-pointing task?	PLOS ONE			English	Article							UNCONTROLLED MANIFOLD ANALYSIS; MOTOR ABUNDANCE; EFFECT SIZE; VARIABILITY; COORDINATION; ADAPTATION; STATISTICS; REDUNDANCY; MOVEMENTS; ELBOW	Flexibility in motor actions can be defined as variability in the use of degrees of freedom (e.g., joint angles in the arm) over repetitions while keeping performance (e.g., fingertip position) stabilized. We examined whether flexibility can be increased through enlarging the joint angle range during practice in a manual obstacle-avoidance target-pointing task. To establish differences in flexibility we partitioned the variability in joint angles over repetitions in variability within (GEV) and variability outside the solution space (NGEV). More GEV than NGEV reflects flexibility; when the ratio of the GEV and NGEV is higher, flexibility is higher. The pretest and posttest consisted of 30 repetitions of manual pointing to a target while moving over a 10 cm high obstacle. To enlarge the joint angle range during practice participants performed 600 target-pointing movements while moving over obstacles of different heights (5-9 cm, 11-15 cm). The results indicated that practicing movements over obstacles of different heights led participants to use enlarged range of joint angles compared to the range of joint angles used in movements over the 10 cm obstacle in the pretest. However, for each individual obstacle neither joint angle variance nor flexibility were higher during practice. We also did not find more flexibility after practice. In the posttest, joint angle variance was in fact smaller than before practice, primarily in GEV. The potential influences of learning effects and the task used that could underlie the results obtained are discussed. We conclude that with this specific type of practice in this specific task, enlarging the range of joint angles does not lead to more flexibility.	[Tuitert, Inge; Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Tuitert, Inge; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Groningen	Tuitert, I (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France.; Tuitert, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	i.tuitert@umcg.nl	Bootsma, Reinoud/B-1254-2008; Bongers, Raoul/C-1094-2012	Bootsma, Reinoud/0000-0002-3719-7586; Mouton, Leonora/0000-0001-8389-2013; Bongers, Raoul/0000-0002-3518-7464	Excellence Initiative of Aix-Marseille University - A*MIDEX, a French "Investissements d'Avenir" programme	Excellence Initiative of Aix-Marseille University - A*MIDEX, a French "Investissements d'Avenir" programme(French National Research Agency (ANR))	The project leading to this publication has received funding from Excellence Initiative of Aix-Marseille University - A*MIDEX, a French Investissements dAvenir programme.	Alberts JL, 2002, EXP BRAIN RES, V143, P417, DOI 10.1007/s00221-002-1005-0; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bernstein N, 1967, COORDINATION REGULAT; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Borbely BJ, 2014, EXP BRAIN RES, V232, P889, DOI 10.1007/s00221-013-3801-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Freitas SMSF, 2007, NEUROSCI LETT, V417, P66, DOI 10.1016/j.neulet.2007.02.037; Domkin D, 2005, EXP BRAIN RES, V163, P44, DOI 10.1007/s00221-004-2137-1; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gelfand I M, 1998, Motor Control, V2, P306; Gera G, 2010, MOTOR CONTROL, V14, P83, DOI 10.1123/mcj.14.1.83; Greve C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127017; Jacquier-Bret J, 2009, MOTOR CONTROL, V13, P342, DOI 10.1123/mcj.13.3.342; Klous M, 2010, EXP BRAIN RES, V202, P457, DOI 10.1007/s00221-009-2153-2; Kruger M, 2012, HUM MOVEMENT SCI, V31, P1071, DOI 10.1016/j.humov.2011.12.002; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Latash ML, 2002, EXP BRAIN RES, V146, P345, DOI 10.1007/s00221-002-1189-3; Mattos DJS, 2011, J NEUROPHYSIOL, V106, P1424, DOI 10.1152/jn.00163.2011; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Park J, 2013, CLIN NEUROPHYSIOL, V124, P991, DOI 10.1016/j.clinph.2012.10.021; Park J, 2012, J NEUROPHYSIOL, V108, P915, DOI 10.1152/jn.00043.2012; Saling M, 1998, EXP BRAIN RES, V118, P251, DOI 10.1007/s002210050279; Scholz JP, 2003, EXP BRAIN RES, V153, P45, DOI 10.1007/s00221-003-1580-8; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tuitert I, 2014, EXP BRAIN RES, V232, P3211, DOI 10.1007/s00221-014-4009-7; Valk TA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00826; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; Verrel J, 2010, J NEUROSCI METH, V191, P166, DOI 10.1016/j.jneumeth.2010.06.016; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/454021; Wu YH, 2013, EXP BRAIN RES, V226, P273, DOI 10.1007/s00221-013-3433-4; Wu YH, 2012, J MOTOR BEHAV, V44, P471, DOI 10.1080/00222895.2012.740101; Yang JF, 2007, EXP BRAIN RES, V176, P54, DOI 10.1007/s00221-006-0602-8; Yang JF, 2005, EXP BRAIN RES, V163, P137, DOI 10.1007/s00221-004-2149-x; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007; Zhang W, 2009, MOTOR CONTROL, V13, P251, DOI 10.1123/mcj.13.3.251	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181041	10.1371/journal.pone.0181041	http://dx.doi.org/10.1371/journal.pone.0181041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700695	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800116
J	Aydin, CI; Ozkaynak, B; Rodriguez-Labajos, B; Yenilmez, T				Aydin, Cem Iskender; Ozkaynak, Begum; Rodriguez-Labajos, Beatriz; Yenilmez, Taylan			Network effects in environmental justice struggles: An investigation of conflicts between mining companies and civil society organizations from a network perspective	PLOS ONE			English	Article							SOCIAL-MOVEMENTS; COMMUNITY-ACTION; GLOBAL PATTERNS; RISK	This paper examines conflicts that occur between mining companies and civil society organizations (CSOs) around the world and offers an innovative analysis of mining conflicts from a social network perspective. The analysis showed that, as the number of CSOs involved in a conflict increased, its outcome was more likely to be perceived as a success in terms of environmental justice (EJ); if a CSO was connected to other central CSOs, the average perception of EJ success was likely to increase; and as network distance between two conflicts increased (or decreased), they were more likely to lead to different (or similar) EJ outcomes. Such network effects in mining conflicts have policy implications for EJ movements. It would be a strategic move on the part of successful CSOs to become involved in other major conflicts and disseminate information about how they achieved greater EJ success.	[Aydin, Cem Iskender] UVSQ Univ Paris Saclay, REEDS Ctr Res Ecol Econ Ecoinnovat & Tool Dev Sus, Guyancourt, France; [Ozkaynak, Begum] Bogazici Univ, Dept Econ, Istanbul, Turkey; [Rodriguez-Labajos, Beatriz] Autonomous Univ Barcelona, Inst Environm Sci & Technol ICTA, Barcelona, Spain	UDICE-French Research Universities; Universite Paris Saclay; Bogazici University; Autonomous University of Barcelona	Ozkaynak, B (corresponding author), Bogazici Univ, Dept Econ, Istanbul, Turkey.	begum.ozkaynak@boun.edu.tr	Rodriguez-Labajos, Beatriz/I-6257-2015; Yenilmez, Taylan/AAZ-8290-2020; AYDIN, Cem İskender/AAQ-7473-2021; Ozkaynak, Begum/AAC-1412-2020	Rodriguez-Labajos, Beatriz/0000-0002-0559-910X; AYDIN, Cem İskender/0000-0002-8071-8789; Ozkaynak, Begum/0000-0003-0526-8543	project Environmental Justice Organisations, Liabilities and Trade (EJOLT); European Union's 7th Framework programme (FP7-Science in Society-2010-1) [266642, 289374]	project Environmental Justice Organisations, Liabilities and Trade (EJOLT); European Union's 7th Framework programme (FP7-Science in Society-2010-1)	We acknowledge financial support from the project Environmental Justice Organisations, Liabilities and Trade (EJOLT) which received funding from the European Unions 7th Framework programme (FP7-Science in Society-2010-1) for research, technological development and demonstration under grant agreement no: 266642 and 289374. The funders had no role in study to design, data collection and analysis, decision to publish preparation of the manuscript. Authors who received the funding: BRL, BO, CIA. URL of funder's website: http://ec.europa.eu/research/participants/portal/desktop/en/home.html.	Acemoglu D, 2015, AM ECON REV, V105, P564, DOI 10.1257/aer.20130456; Ackland R, 2011, SOC NETWORKS, V33, P177, DOI 10.1016/j.socnet.2011.03.001; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured]; Avc o D., 2015, GEOFORUM; Avci D, 2010, ECOL ECON, V70, P228, DOI 10.1016/j.ecolecon.2010.05.009; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Banks N, 2015, WORLD DEV, V66, P707, DOI 10.1016/j.worlddev.2014.09.028; Bebbington A, 2008, WORLD DEV, V36, P2888, DOI 10.1016/j.worlddev.2007.11.016; Bebbington A, 2008, DEV CHANGE, V39, P887, DOI 10.1111/j.1467-7660.2008.00517.x; Bebbington A, 2008, MT RES DEV, V28, P190, DOI 10.1659/mrd.1039; Bebbington AJ, 2009, P NATL ACAD SCI USA, V106, P17296, DOI 10.1073/pnas.0906057106; Bian YJ, 2015, SOC NETWORKS, V40, P129, DOI 10.1016/j.socnet.2014.09.003; Bridge G, 2004, PROF GEOGR, V56, P406; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Broadbent Jeffrey, 2003, SOCIAL MOVEMENTS NET; Brown K, 2014, PROG HUM GEOG, V38, P107, DOI [10.1177/0361684313496549, 10.1177/0309132513498837]; Bustos Beatriz, 2016, GEOFORUM; Delgado A, 2010, PUBLIC UNDERST SCI, V19, P562, DOI 10.1177/0963662508098578; DeNardo J., 2014, POWER NUMBERS POLITI; Diani, 1999, SOCIAL MOVEMENTS INT; DIANI M, 1992, SOCIOL REV, V40, P1, DOI 10.1111/j.1467-954X.1992.tb02943.x; Diani Mario, 1995, GREEN NETWORKS STRUC; Franks DM, 2014, P NATL ACAD SCI USA, V111, P7576, DOI 10.1073/pnas.1405135111; Garibay Claudio, 2015, 14 EJOLT; Giljum S, 2014, RESOURCES-BASEL, V3, P319, DOI 10.3390/resources3010319; Giugni MG, 1998, ANNU REV SOCIOL, V24, P371, DOI 10.1146/annurev.soc.24.1.371; Haldane AG., 2009, RETHINKING FINANCIAL; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Klimek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038924; Leenders RTAJ, 2002, SOC NETWORKS, V24, P21, DOI 10.1016/S0378-8733(01)00049-1; Malinick TE, 2013, SOC NETWORKS, V35, P148, DOI 10.1016/j.socnet.2011.10.005; Markose S, 2012, J ECON BEHAV ORGAN, V83, P627, DOI 10.1016/j.jebo.2012.05.016; Martinez-Alier J, 2001, J HAZARD MATER, V86, P153, DOI 10.1016/S0304-3894(01)00252-7; McAdam Dough, 1996, COMP PERSPECTIVES SO; Ozkaynak B., 2012, 7 EJOLT; Passy F, 2001, SOCIOL FORUM, V16, P123, DOI 10.1023/A:1007613403970; Pegg S, 2006, J CLEAN PROD, V14, P376, DOI 10.1016/j.jclepro.2004.06.006; Pellow DN, 2001, SOCIOL QUART, V42, P47, DOI 10.1525/tsq.2001.42.1.47; Pena AM, 2016, MOBILIZATION, V21, P506; Rivera C., 2016, REV CIENCIAS SOCIALE, V17, P231; Rootes C., 2008, ACTING LOCALLY LOCAL, P2; Rootes C., 1999, ENVIRON POLIT, V8, P1, DOI [10.1080/09644019908414435, DOI 10.1080/09644019908414435]; Rootes Chris, 1999, ENVIRON POLIT, V8, P290, DOI DOI 10.1080/09644019908414448; Saltoglu B, 2015, QUANT FINANC, V15, P1933, DOI 10.1080/14697688.2015.1043331; Sanyal P, 2006, NONPROF VOLUNT SEC Q, V35, P66, DOI 10.1177/0899764005282480; Schaffartzik A, 2016, ECOL ECON, V122, P101, DOI 10.1016/j.ecolecon.2015.12.007; Schlosberg D, 2009, DEFINING ENV JUSTICE; Schlosberg David., 1999, ENVIRON POLIT, V6, P122, DOI [10.1080/09644019908414441, DOI 10.1080/09644019908414441]; Sikor T, 2014, GEOFORUM, V54, P151, DOI 10.1016/j.geoforum.2014.04.009; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Steinberger JK, 2010, ECOL ECON, V69, P1148, DOI 10.1016/j.ecolecon.2009.12.009; Swain A., 2010, STRUGGLE STATE, P49; Temper L, 2015, J POLIT ECOL, V22, P255, DOI 10.2458/v22i1.21108; Temper L, 2013, ECOL ECON, V96, P79, DOI 10.1016/j.ecolecon.2013.09.011; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Urkidi L, 2011, GEOFORUM, V42, P683, DOI 10.1016/j.geoforum.2011.06.003; Urkidi L, 2011, J AGRAR CHANGE, V11, P556, DOI 10.1111/j.1471-0366.2011.00326.x; Urkidi L, 2010, ECOL ECON, V70, P219, DOI 10.1016/j.ecolecon.2010.05.004; Van Der Heijden H. A., 1997, ENVIRON POLIT, V6, P25, DOI DOI 10.1080/09644019708414357; Velicu I, 2015, GEOFORUM; Ventresca M, 2013, SOC NETWORKS, V35, P75, DOI 10.1016/j.socnet.2013.01.002; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Walter M., 2014, POLITICAL ECOLOGY MI; Walter M, 2010, CAN J DEV STUD, V30, P281, DOI 10.1080/02255189.2010.9669292; Wollenberg E, 2006, INT FOREST REV, V8, P265, DOI 10.1505/ifor.8.2.265; Zhou M, 2016, SOC NETWORKS, V44, P9, DOI 10.1016/j.socnet.2015.07.006	67	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180494	10.1371/journal.pone.0180494	http://dx.doi.org/10.1371/journal.pone.0180494			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686618	gold, Green Submitted, Green Published			2022-12-27	WOS:000405464100069
J	Silva, SL; Albuquerque, A; Amaral, AJ; Li, QZ; Mota, C; Cheynier, R; Victorino, RMM; Pereira-Santos, MC; Sousa, AE				Silva, Susana L.; Albuquerque, Adriana; Amaral, Andreia J.; Li, Quan-Zhen; Mota, Catarina; Cheynier, Remi; Victorino, Rui M. M.; Conceicao Pereira-Santos, M.; Sousa, Ana E.			Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy	PLOS ONE			English	Article							REGULATORY T-CELLS; NEONATAL THYMECTOMY; IMMUNE FUNCTION; COMPARTMENT; RISK	The contribution of the decline in thymic activity for the emergence of autoimmunity is still debatable. Immune-competent adults submitted to complete thymectomy early in life provide a unique model to address this question. We applied here strict criteria to identify adults lacking thymic activity based on sjTREC levels, to exclude thymic rebound and/or ectopic thymuses. In agreement, they featured severe naive CD4 T-cell depletion and contraction of T-cell receptor diversity. Notwithstanding this, there was neither increased incidence of autoimmune disease in comparison with age-matched controls nor significant changes in their IgG/IgA/IgM/IgE autoreactivity profiles, as assessed through extensive arrays. We reasoned that the observed relative preservation of the regulatory T-cell compartment, including maintenance of naive regulatory CD4 T-cells, may contribute to limit the emergence of autoimmunity upon thymectomy. Our findings have implications in other clinical settings with impaired thymic activity, and are particularly relevant to studies of autoimmunity in ageing.	[Silva, Susana L.; Albuquerque, Adriana; Amaral, Andreia J.; Mota, Catarina; Victorino, Rui M. M.; Conceicao Pereira-Santos, M.; Sousa, Ana E.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Silva, Susana L.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Clin Univ Imunoalergol, Lisbon, Portugal; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA; [Mota, Catarina; Victorino, Rui M. M.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Clin Univ Med 2, Lisbon, Portugal; [Cheynier, Remi] Inst Cochin, INSERM, Cytokines & Viral Infect, Immunol Infect & Inflammat Dept,U1016, Paris, France; [Cheynier, Remi] CNRS, UMR8104, Paris, France; [Cheynier, Remi] Univ Paris 05, Paris, France	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Lisboa; Hospital Santa Maria; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Sousa, AE (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	asousa@medicina.ulisboa.pt	Cheynier, Remi/E-9921-2010; Sousa, Ana E./L-2642-2014; Amaral, Andreia/O-8168-2015	Cheynier, Remi/0000-0003-1146-660X; Albuquerque, Adriana/0000-0003-3391-0396; Sousa, Ana E./0000-0002-4618-9799; Amaral, Andreia/0000-0003-0958-5570	Fundacco para a Ciencia e Tecnologia (FCT) [POCI2010/IC/83068/2007, PTDC/SAU-MIC/109786/2009]; Gulbenkian Foundation [P132532/2013]; EMBO long-term fellowship [ALT-33-2010]; Marie Curie European Integration [PERG-GA-2009-256595]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-MIC/109786/2009, PIC/IC/83068/2007] Funding Source: FCT	Fundacco para a Ciencia e Tecnologia (FCT); Gulbenkian Foundation; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie European Integration; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacco para a Ciencia e Tecnologia (FCT; POCI2010/IC/83068/2007 to RMMV; PTDC/SAU-MIC/109786/2009 to AES), and Gulbenkian Foundation (P132532/2013 to AES). SLS, ASA and AJA received FCT scholarships. AJA was supported by an EMBO long-term fellowship (ALT-33-2010) and a Marie Curie European Integration Grant (PERG-GA-2009-256595).	Appay V, 2010, AGING-US, V2, P78, DOI 10.18632/aging.100122; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; BREARLEY S, 1987, CLIN EXP IMMUNOL, V70, P322; Caramalho I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00395; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Czaja AJ, 2003, J CLIN GASTROENTEROL, V37, P315, DOI 10.1097/00004836-200310000-00011; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Eysteinsdottir JH, 2004, CLIN EXP IMMUNOL, V136, P349, DOI 10.1111/j.1365-2249.2004.02437.x; Gudmundsdottir J, 2016, J ALLERGY CLIN IMMUN; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Halnon NJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/915864; Halnon NJ, 2005, PEDIATR RES, V57, P42, DOI 10.1203/01.PDR.0000147735.19342.DE; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Merayo-Chalico J, 2016, HUM IMMUNOL, V77, P921, DOI 10.1016/j.humimm.2016.06.016; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanei Behnam, 2015, Adv Biomed Res, V4, P18, DOI 10.4103/2277-9175.149849; Sanjuan MA, 2016, J ALLERGY CLIN IMMUN, V137, P1651, DOI 10.1016/j.jaci.2016.04.007; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schadenberg AWL, 2014, J ALLERGY CLIN IMMUN, V133, P277, DOI 10.1016/j.jaci.2013.08.030; Silva SL, 2016, ONCOTARGET; Silva SL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00020; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Team. RDC, 2007, R LANG ENV STAT COMP; Torfadottir H, 2006, CLIN EXP IMMUNOL, V145, P407, DOI 10.1111/j.1365-2249.2006.03139.x; van den Broek T, 2016, J CLIN INVEST, V126, P1126, DOI 10.1172/JCI84997; van Gent R, 2011, BLOOD, V118, P627, DOI 10.1182/blood-2011-03-341396; Wandstrat AE, 2006, J AUTOIMMUN, V27, P153, DOI 10.1016/j.jaut.2006.09.001; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Zhu HL, 2015, GENOM PROTEOM BIOINF, V13, P210, DOI 10.1016/j.gpb.2015.09.001	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180385	10.1371/journal.pone.0180385	http://dx.doi.org/10.1371/journal.pone.0180385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686710	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100058
J	Sonnleitner, E; Prindl, K; Blasi, U				Sonnleitner, Elisabeth; Prindl, Konstantin; Blaesi, Udo			The Pseudomonas aeruginosa CrcZ RNA interferes with Hfq-mediated riboregulation	PLOS ONE			English	Article							ESCHERICHIA-COLI-HFQ; CARBON CATABOLITE REPRESSION; MESSENGER-RNA; INTERACTION SURFACES; BINDING; GENE; IRON; IDENTIFICATION; COMPETITION; REGULATOR	The RNA chaperone Hfq regulates virulence and metabolism in the opportunistic pathogen Pseudomonas aeruginosa. During carbon catabolite repression (CCR) Hfq together with the catabolite repression control protein Crc can act as a translational repressor of catabolic genes. Upon relief of CCR, the level of the Hfq-titrating RNA CrcZ is increasing, which in turn abrogates Hfq-mediated translational repression. As the interdependence of Hfq-mediated and RNA based control mechanisms is poorly understood, we explored the possibility whether the regulatory RNA CrcZ can interfere with riboregulation. We first substantiate that the P. aeruginosa Hfq is proficient and required for riboregulation of the transcriptional activator gene antR by the small RNA PrrF1-2. Our studies further revealed that CrcZ can interfere with PrrF1-2/Hfq-mediated regulation of antR. The competition for Hfq can be rationalized by the higher affinity of Hfq for CrcZ than for antR mRNA.	[Sonnleitner, Elisabeth; Prindl, Konstantin; Blaesi, Udo] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Ctr Mol Biol,Vienna Bioctr VBC, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Sonnleitner, E (corresponding author), Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Ctr Mol Biol,Vienna Bioctr VBC, Vienna, Austria.	elisabeth.sonnleitner@univie.ac.at		Sonnleitner, Elisabeth/0000-0002-6961-9536	Austrian Science Fund [P28711-B22]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by grant P28711-B22 (UB, ES) from the Austrian Science Fund (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bossi L, 2016, NAT REV MICROBIOL, V14, P775, DOI 10.1038/nrmicro.2016.129; DREYFUS M, 1988, J MOL BIOL, V204, P79, DOI 10.1016/0022-2836(88)90601-8; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Ellis MJ, 2015, MOL MICROBIOL, V96, P633, DOI 10.1111/mmi.12961; Ferrara S, 2015, ENVIRON MICROBIOL, V17, P199, DOI 10.1111/1462-2920.12590; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lu P, 2016, MOL MICROBIOL, V102, P244, DOI 10.1111/mmi.13458; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Moll I, 2003, EMBO REP, V4, P284, DOI 10.1038/sj.embor.embor772; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Osborne J, 2014, MICROBIOLOGYOPEN, V3, P950, DOI 10.1002/mbo3.220; Panja S, 2013, NUCLEIC ACIDS RES, V41, P7536, DOI 10.1093/nar/gkt521; Ribeiro ED, 2012, NUCLEIC ACIDS RES, V40, P8072, DOI 10.1093/nar/gks510; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sonnleitner E, 2002, MICROBIOL-SGM, V148, P883, DOI 10.1099/00221287-148-3-883; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sterzenbach T, 2013, EMBO J, V32, P2872, DOI 10.1038/emboj.2013.206; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zhan YH, 2016, P NATL ACAD SCI USA, V113, pE4348, DOI 10.1073/pnas.1604514113; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006; Zheng A, 2016, J MOL BIOL, V428, P2259, DOI 10.1016/j.jmb.2016.03.027	37	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180887	10.1371/journal.pone.0180887	http://dx.doi.org/10.1371/journal.pone.0180887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686727	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100118
J	Chen, SY; Sun, YK; Neoh, KH; Chen, AQ; Li, WJ; Yang, XR; Han, RPS				Chen, Shuiyu; Sun, Yukun; Neoh, Kuang Hong; Chen, Anqi; Li, Weiju; Yang, Xiaorui; Han, Ray P. S.			Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris	PLOS ONE			English	Article							STABLE ANGINA; GROWTH-FACTOR; MANAGEMENT; IDENTIFICATION; ENUMERATION; GUIDELINES; BINDING; MARKER; PLAQUE; CD146	Background Circulating endothelial cells (CECs) are widely reported as a promising biomarker of endothelial damage/dysfunction in coronary artery disease (CAD). The two popular methods of CEC quantification include the use of immunomagnetic beads separation (IB) and flow cytometry analysis (FC); however, they suffer from two main shortcomings that affect their diagnostic and prognostic responses: non-specific bindings of magnetic beads to non-target cells and a high degree of variability in rare cell identification, respectively. We designed a microfluidic chip with spatially staggered micropillars for the efficient harvesting of CECs with intact cellular morphology in an attempt to revisit the diagnostic goal of CEC counts in CAD patients with angina pectoris. Methods A label-free microfluidic assay that involved an in-situ enumeration and immunofluorescent identification (DAPI(+)/CD146(+)/VEGFR1(+)/CD45(-)) of CECs was carried out to assess the CEC count in human peripheral blood samples. A total of 55 CAD patients with angina pectoris [16 with chronic stable angina (CSA) and 39 with unstable angina (UA)], together with 15 heathy controls (HCs) were enrolled in the study. Results CEC counts are significantly higher in both CSA and UA groups compared to the HC group [respective medians of 6.9, 10.0 and 1.5 cells/ml (p < 0.01)]. Further, a significant elevation of CEC count was observed in the three UA subgroups [low risk (5.3) vs. intermediate risk (10.8) vs. high risk (18.0) cells/ml, p < 0.001) classified in accordance to the TIMI NSTEMI/UA risk score system. From the receiver-operating characteristic curve analysis, the AUCs for distinguishing CSA and UA from HC were 0.867 and 0.938, respectively. The corresponding sensitivities were 87.5% and 84.6% and the specificities were 66.7% and 86.7%, respectively. Conclusions Our microfluidic assay system is efficient and stable for CEC capture and enumeration. The results showed that the CEC count has the potential to be a promising clinical biomarker for the assessment of endothelial damage/dysfunction in CAD patients with angina pectoris.	[Chen, Shuiyu; Sun, Yukun; Neoh, Kuang Hong; Chen, Anqi; Han, Ray P. S.] Peking Univ, Coll Engn, Beijing, Peoples R China; [Li, Weiju; Yang, Xiaorui] Peking Univ Hosp, Beijing, Peoples R China	Peking University; Peking University	Han, RPS (corresponding author), Peking Univ, Coll Engn, Beijing, Peoples R China.; Yang, XR (corresponding author), Peking Univ Hosp, Beijing, Peoples R China.	xryang@pku.edu.cn; ray-han@pku.edu.cn		Han, Ray/0000-0002-3551-4795	Peking University startup funds	Peking University startup funds	This work was carried out entirely using internal funds provided by Peking University startup funds. There were no external funds for the project as our "discovery" of the CECs was inadvertently made during the course of our research on CTC capture from the peripheral blood.	Anderson JL, 2007, CIRCULATION, V116, P803, DOI 10.1161/CIRCULATIONAHA.107.185752; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; Boos CJ, 2007, EUR HEART J, V28, P1092, DOI 10.1093/eurheartj/ehm070; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Chalmers JJ, 2010, BIOTECHNOL BIOENG, V105, P1078, DOI 10.1002/bit.22635; Chen J, 2012, LAB CHIP, V12, P1753, DOI 10.1039/c2lc21273k; Chen KC, 2011, CLIN CHEM, V57, P586, DOI 10.1373/clinchem.2010.157404; Clarke LA, 2008, J THROMB HAEMOST, V6, P1025, DOI 10.1111/j.1538-7836.2008.02953.x; Damani S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003451; Duda DG, 2006, J CLIN ONCOL, V24, P1449, DOI 10.1200/JCO.2005.04.2861; Elshal MF, 2005, BLOOD, V106, P2923, DOI 10.1182/blood-2005-06-2307; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fraker Theodore D Jr, 2007, Circulation, V116, P2762, DOI 10.1161/CIRCULATIONAHA.107.187930; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; FUSTER V, 1995, AM J CARDIOL, V76, pC24, DOI 10.1016/S0002-9149(99)80467-6; Hong B, 2013, THERANOSTICS, V3, P377, DOI 10.7150/thno.5195; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Lv PT, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4808456; Magbanua MJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141166; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mann JM, 1996, CIRCULATION, V94, P928, DOI 10.1161/01.CIR.94.5.928; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Mutin M, 1999, BLOOD, V93, P2951; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Quilici J, 2004, CIRCULATION, V110, P1586, DOI 10.1161/01.CIR.0000142295.85740.98; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x	36	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181249	10.1371/journal.pone.0181249	http://dx.doi.org/10.1371/journal.pone.0181249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704506	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700116
J	Dalgard, O; Weiland, O; Noraberg, G; Karlsen, L; Heggelund, L; Farkkila, M; Balslev, U; Belard, E; Ovrehus, A; Kjaer, MS; Krarup, H; Roge, BT; Hallager, S; Madsen, LG; Laursen, AL; Lagging, M; Weis, N				Dalgard, Olav; Weiland, Ola; Noraberg, Geir; Karlsen, Lars; Heggelund, Lars; Farkkila, Martti; Balslev, Ulla; Belard, Erika; Ovrehus, Anne; Kjaer, Mette Skalshoi; Krarup, Henrik; Roge, Birgit Thorup; Hallager, Sofie; Madsen, Lone G.; Laursen, Alex Lund; Lagging, Martin; Weis, Nina			Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study	PLOS ONE			English	Article							ADVANCED LIVER-DISEASE; DECOMPENSATED CIRRHOSIS; PHASE-III; HCV; VIRUS; DACLATASVIR; RIBAVIRIN; EPIDEMIOLOGY; VELPATASVIR; LEDIPASVIR	Background and aims Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of HCV genotype 3 infections in a real life setting in Scandinavia. Methods Consecutive patients with chronic HCV genotype 3 infection were enrolled at 16 treatment centers in Denmark, Sweden, Norway and Finland. Patients who had received a SOF containing regimen were included. The fibrosis stage was evaluated by liver biopsy or transient liver elastography. The following treatments were given according availability and local guidelines: 1) SOF + ribavirin (RBV) for 24 weeks, 2) SOF + daclatasvir (DCV) +/-RBV for 12-24 weeks, 3) SOF + pegylated interferon alpha (peg-IFN-a) + RBV for 12 weeks or 4) SOF/ledipasvir (LDV) + RBV for 12-16 weeks. The primary endpoint was sustained virological response (SVR) assessed at week 12 (SVR12) after end of treatment. Results We included 316 patients with a mean age of 55 years (range 24-79), 70% men, 49% treatment experienced, 58% with compensated cirrhosis and 12% with decompensated cirrhosis. In the modified intention to treat (mITT) population SVR12 was achieved in 284/311 91%) patients. Among 26 treatment failures, five had non-response, 3 breakthrough and 18 relapse. Five patients were not included in the mITT population. Three patients died from reasons unrelated to treatment and two were lost to follow-up. The SVR12 rate was similar for all treatment regimens, but lower in men (p = 0.042), and in patients with decompensated liver disease (p = 0.004). Conclusion We found that sofosbuvir based treatment in a real-life setting could offer SVR rates exceeding 90% in patients with HCV genotype 3 infection and advanced liver disease.	[Dalgard, Olav] Akershus Univ Hosp, Lorenskog, Norway; [Dalgard, Olav] Univ Oslo, Inst Clin Med, Oslo, Norway; [Weiland, Ola] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Stockholm, Sweden; [Noraberg, Geir] Sorlandet Sykehus, Arendal, Norway; [Karlsen, Lars] Stavanger Univ Hosp, Stavanger, Norway; [Heggelund, Lars] Vestre Viken, HF, Drammen, Norway; [Farkkila, Martti] Helsinki Univ Hosp, Helsinki, Finland; [Balslev, Ulla; Belard, Erika] Copenhagen Univ Hosp, Herlev, Denmark; [Ovrehus, Anne] Odense Univ Hosp, Odense, Denmark; [Kjaer, Mette Skalshoi] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Aalborg, Denmark; [Roge, Birgit Thorup] Kolding Cty Hosp, Kolding, Denmark; [Hallager, Sofie; Weis, Nina] Copenhagen Univ Hosp, Hvidovre, Denmark; [Madsen, Lone G.] Koge Hosp, Koge, Denmark; [Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Lagging, Martin] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Stavanger University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital; Kolding Hospital; University of Copenhagen; Aarhus University; University of Gothenburg; University of Copenhagen	Dalgard, O (corresponding author), Akershus Univ Hosp, Lorenskog, Norway.; Dalgard, O (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	odalgard@medisin.uio.no	Färkkilä, Martti/AAG-6970-2021; Weis, Nina/GLT-4232-2022; Heggelund, Lars/GSN-0026-2022	Färkkilä, Martti/0000-0002-0250-8559; Ovrehus, Anne Lindebo Holm/0000-0002-2594-6500; Krarup, Henrik/0000-0001-5294-2428; Weis, Nina/0000-0002-3133-2724; Laursen, Alex Lund/0000-0002-1206-156X				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Kanwal F, 2014, HEPATOLOGY, V60, P98, DOI 10.1002/hep.27095; Lawitz E, 2015, HEPATOLOGY, V61, P769, DOI 10.1002/hep.27567; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Leroy V, 2016, HEPATOLOGY, V63, P1430, DOI 10.1002/hep.28473; Lindh M, 2005, J CLIN VIROL, V34, P108, DOI 10.1016/j.jcv.2005.02.002; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Wang CF, 2013, ANTIMICROB AGENTS CH, V57, P611, DOI 10.1128/AAC.01874-12; Welzel TM, 2016, GUT, V65, P2060, DOI 10.1136/gutjnl-2016-312444corr1; Young J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2106-x; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	23	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7								10.1371/journal.pone.0179764	http://dx.doi.org/10.1371/journal.pone.0179764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704381	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700018
J	Liu, JG; Liu, XL; Guo, Q; Han, JT				Liu, Jian-Guo; Liu, Xiao-Lu; Guo, Qiang; Han, Jing-Ti			Identifying the perceptive users for online social systems	PLOS ONE			English	Article							HEAVY TAILS; REPUTATION; DYNAMICS; BOOTSTRAP; EMERGENCE; NETWORKS; BIAS	In this paper, the perceptive user, who could identify the high-quality objects in their initial lifespan, is presented. By tracking the ratings given to the rewarded objects, we present a method to identify the user perceptibility, which is defined as the capability that a user can identify these objects at their early lifespan. Moreover, we investigate the behavior patterns of the perceptive users from three dimensions: User activity, correlation characteristics of user rating series and user reputation. The experimental results for the empirical networks indicate that high perceptibility users show significantly different behavior patterns with the others: Having larger degree, stronger correlation of rating series and higher reputation. Furthermore, in view of the hysteresis in finding the rewarded objects, we present a general framework for identifying the high perceptibility users based on user behavior patterns. The experimental results show that this work is helpful for deeply understanding the collective behavior patterns for online users.	[Liu, Jian-Guo; Han, Jing-Ti] Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China; [Liu, Xiao-Lu; Guo, Qiang] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai 200093, Peoples R China; [Liu, Jian-Guo] Fribourg Univ, Dept Phys, CH-1700 Fribourg, Switzerland	Shanghai University of Finance & Economics; University of Shanghai for Science & Technology	Liu, JG (corresponding author), Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China.; Liu, JG (corresponding author), Fribourg Univ, Dept Phys, CH-1700 Fribourg, Switzerland.	liujg004@ustc.edu.cn	Liu, Jianguo/B-4492-2012; Guo, Qiang/B-2635-2014; liu, xiaolu/AAC-6908-2020	Liu, Jianguo/0000-0002-5641-0266; 	National Natural Science Foundation of China [71271126, 61374177, 71371125]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shuguang Program Project of Shanghai Educational Committee [14SG42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shuguang Program Project of Shanghai Educational Committee	This work is supported by the National Natural Science Foundation of China (Grant Nos. 71271126,61374177,71371125), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the Shuguang Program Project of Shanghai Educational Committee (Grant No. 14SG42)	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ATHREYA KB, 1987, ANN STAT, V15, P724, DOI 10.1214/aos/1176350371; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B., 1992, BOOTSTRAP METHODS AN; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gao J, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/28003; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Han XP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073010; Hou L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06560; Ji L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121105; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kurant M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026103; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097146; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21380; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep18653; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu XL, 2017, PHYSICA A, V467, P508, DOI 10.1016/j.physa.2016.10.031; Liu XL, 2015, PHYSICA A, V436, P629, DOI 10.1016/j.physa.2015.05.043; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Medo M, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/48004; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Ni J, 2014, PHYSICA A, V402, P134, DOI 10.1016/j.physa.2014.01.046; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vazquez A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.248701; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Yang ZM, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/68002; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624; Zhang YL, 2015, PHYSICA A, V417, P261, DOI 10.1016/j.physa.2014.09.012; Zhao ZD, 2013, SCI REP-UK, V3, DOI 10.1038/srep03472; Zhou YB, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48002	51	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0178118	10.1371/journal.pone.0178118	http://dx.doi.org/10.1371/journal.pone.0178118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704382	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700006
J	Sano, H; Goto, R; Hamashima, C				Sano, Hiroshi; Goto, Rei; Hamashima, Chisato			Does lack of resources impair access to breast and cervical cancer screening in Japan?	PLOS ONE			English	Article							TAILORED INTERVENTIONS; SOCIOECONOMIC-STATUS; COST-EFFECTIVENESS; COLLECTED SAMPLES; GEOGRAPHIC ACCESS; HEALTH-EDUCATION; CLINICAL-TRIAL; OLDER WOMEN; MAMMOGRAPHY; METAANALYSIS	Objectives To assess the impact of the quantity of resources for breast and cervical cancer screening on the participation rates in screening in clinical settings in municipalities, as well as to clarify whether lack of resources impairs access to cancer screening in Japan. Methods Of the 1,746 municipalities in 2010, 1,443 (82.6%) and 1,469 (84.1%) were included in the analyses for breast and cervical cancer screening, respectively. In order to estimate the effects of the number of mammography units and of gynecologists on the participation rates in breast and cervical cancer screening in clinical settings, multiple regression analyses were performed using the interaction term for urban municipalities. Results The average participation rate in screening in clinical settings was 6.01% for breast cancer, and was 8.93% for cervical cancer. The marginal effect of the number of mammography units per 1,000 women was significantly positive in urban municipalities (8.20 percent point). The marginal effect of the number of gynecologists per 1,000 women was significantly positive in all municipalities (2.54 percent point) and rural municipalities (3.68 percent point). Conclusions Lack of mammography units in urban areas and of gynecologists particularly in rural areas impaired access to breast and cervical cancer screening. Strategies are required that quickly improve access for the residents and increase their participation rates in cancer screening.	[Sano, Hiroshi] Shiga Univ, Fac Econ, Hikone, Shiga, Japan; [Goto, Rei] Keio Univ, Grad Sch Business Adm, Yokohama, Kanagawa, Japan; [Hamashima, Chisato] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Canc Screening Assessment & Management, Chuo Ku, Tokyo, Japan	Shiga University; Keio University; National Cancer Center - Japan	Sano, H (corresponding author), Shiga Univ, Fac Econ, Hikone, Shiga, Japan.	hi-sano@biwako.shiga-u.ac.jp	Hamashima, Chisato/AAI-3061-2021		Ministry of Health, Labour and Welfare of Japan [008]; Center for Risk Research, Faculty of Economics, Shiga University, Japan [1304]; Grants-in-Aid for Scientific Research [17H03589] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Center for Risk Research, Faculty of Economics, Shiga University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for H26-Research for Promotion of Cancer Control from the Ministry of Health, Labour and Welfare of Japan (Grant number: general study-008; URL: http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo/09.html), and the Center for Risk Research, Faculty of Economics, Shiga University, Japan (Grant number: 1304; URL: http://www.econ.shiga-u.ac.jp/main.cgi?c=10/2/6:28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Autier P, 2008, BRIT J CANCER, V99, P1185, DOI 10.1038/sj.bjc.6604657; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Baron RC, 2008, AM J PREV MED, V35, pS56, DOI 10.1016/j.amepre.2008.04.001; Blumenthal DS, 2010, CANCER-AM CANCER SOC, V116, P922, DOI 10.1002/cncr.24842; Champion V, 2003, PREV MED, V36, P150, DOI 10.1016/S0091-7435(02)00038-5; Crosby RA, 2015, SEX TRANSM DIS, V42, P607, DOI 10.1097/OLQ.0000000000000365; Dolan NC, 1999, ARCH INTERN MED, V159, P393, DOI 10.1001/archinte.159.4.393; Duport N, 2012, REV EPIDEMIOL SANTE, V60, P421, DOI 10.1016/j.respe.2012.05.006; Eguchi N, 2014, 331 JAP MED ASS RES, P331; Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb; Elting LS, 2009, AM J PREV MED, V37, P102, DOI 10.1016/j.amepre.2009.03.017; Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x; Fukuda Y, 2005, PUBLIC HEALTH, V119, P875, DOI 10.1016/j.puhe.2005.03.013; Fukuda Yoshiharu, 2007, Environmental Health and Preventive Medicine, V12, P90, DOI 10.1007/BF02898155; Giordano L, 2012, EUR J PUBLIC HEALTH, V22, P413, DOI 10.1093/eurpub/ckr090; Greene WH, 2000, ECONOMETRIC ANAL, P652; Hamashima C, 2010, JPN J CLIN ONCOL, V40, P485, DOI 10.1093/jjco/hyq036; Hashimoto S, 2008, CALCULATION METHODS; Ho SSM, 2014, PUBLIC HEALTH, V128, P1009, DOI 10.1016/j.puhe.2014.09.001; Kuroki H, 2012, J OBSTET GYNAECOL RE, V38, P35, DOI 10.1111/j.1447-0756.2011.01672.x; Lee FH, 2011, CANCER NURS, V34, P464, DOI 10.1097/NCC.0b013e31820b7866; Leung J, 2014, RURAL REMOTE HEALTH, V14; Maddala GS, 1983, LTD DEPENDENT QUALIT, P149; Ministry of Health Labour and Welfare, 2014, RES SURV REG IMPL CA; Ministry of Health Labour and Welfare, 2015, REP REG PUBL HLTH SE; National Cancer Center, 2014, JAP GUID BREAST CANC; National Cancer Center, 2009, JAP GUID CERV CANC S; New Medicine in Japan (Monthly), 2012, DAT BOOK MED DEV SYS; OECD, 2013, GYN OBST MIDW HLTH G; Okamoto N, 2014, J HLTH WELF STAT, V61, P13; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Racey CS, 2016, J WOMENS HEALTH, V25, P1; Reuben DB, 2002, AM J ROENTGENOL, V179, P1509, DOI 10.2214/ajr.179.6.1791509; RIMER BK, 1992, PUBLIC HEALTH REP, V107, P369; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009; Sano H, 2014, ASIAN PAC J CANCER P, V15, P2607, DOI 10.7314/APJCP.2014.15.6.2607; Saywell RM, 2003, AM J MANAG CARE, V9, P33; Saywell RM, 2004, J WOMENS HEALTH, V13, P909, DOI 10.1089/jwh.2004.13.909; Shariff-Marco S, 2013, AM J MANAG CARE, V19, P205; Shimada T, 2010, J GASTROENTEROLOGICA, V48, P655; Soneji S, 2013, REV PANAM SALUD PUBL, V33, P174, DOI 10.1590/S1020-49892013000300003; St-Jacques S, 2013, J EPIDEMIOL COMMUN H, V67, P861, DOI 10.1136/jech-2013-202614; Tabuchi T, 2013, INT J CANCER, V133, P972, DOI 10.1002/ijc.28095; Takaku R, 2011, J HLTH CARE MED COMM, V21, P121; Teo A, 2007, MED EDUC, V41, P302, DOI 10.1111/j.1365-2929.2007.02691.x; Tsunematsu M, 2013, ASIAN PAC J CANCER P, V14, P6041, DOI 10.7314/APJCP.2013.14.10.6041; Watanabe R., 2003, MED SOC, V13, P113, DOI [10.4091/iken.13.2_113, DOI 10.4091/IKEN.13.2_113]; Yoshida M, 2012, J MED INVESTIG, V59, P127, DOI 10.2152/jmi.59.127	49	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180819	10.1371/journal.pone.0180819	http://dx.doi.org/10.1371/journal.pone.0180819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704430	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700052
J	Kaufmann, B; Wang, BC; Zhong, SY; Laschinger, M; Patil, P; Lu, M; Assfalg, V; Cheng, ZJ; Friess, H; Huser, N; von Figura, G; Hartmann, D				Kaufmann, Benedikt; Wang, Baocai; Zhong, Suyang; Laschinger, Melanie; Patil, Pranali; Lu, Miao; Assfalg, Volker; Cheng, Zhangjun; Friess, Helmut; Hueser, Norbert; von Figura, Guido; Hartmann, Daniel			BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness	PLOS ONE			English	Article							CELL-CYCLE; HEPATOCELLULAR-CARCINOMA; RETINOBLASTOMA PROTEIN; MUTATIONAL LANDSCAPE; SWI/SNF COMPLEX; EXPRESSION; COMPONENT	The chromatin remodeler complex SWI/SNF plays an important role in physiological and pathological processes. Brahma related gene 1(BRG1), a catalytic subunit of the SWI/SNF complex, is known to be mutated in hepatocellular carcinoma (HCC). However, its role in HCC remains unclear. Here, we investigate the role of BRG1 on cell growth and invasiveness as well as its effect on the expression of putative target genes. Expression of BRG1 was examined in human liver tissue samples and in HCC cell lines. In addition, BRG1 was silenced in human HCC cell lines to analyse cell growth and invasiveness by growth curves, colony formation assay, invasion assay and the expression of putative target genes. BRG1 was found to be significantly increased in HCC samples compared to non-HCC samples. In addition, a declined proliferation rate of BRG1-silenced human HCC cell lines was associated with a decrease of expression of cyclin family members. In line with a decreased invasiveness of BRG1-siRNA-treated human HCC cell lines, down-regulation of MMP7 was detected. These results support the hypothesis that overexpression of BRG1 increases cell growth and invasiveness in HCC. Furthermore, the data highlight cyclin B, E and MMP7 to be associated with BRG1 during hepatocarcinogenesis.	[Kaufmann, Benedikt; Wang, Baocai; Laschinger, Melanie; Patil, Pranali; Assfalg, Volker; Friess, Helmut; Hueser, Norbert; Hartmann, Daniel] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Zhong, Suyang; von Figura, Guido] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany; [Lu, Miao; Cheng, Zhangjun] Southeast Univ, Zhongda Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Southeast University - China	Hartmann, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany.; von Figura, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany.	gvfigura@tum.de; daniel.hartmann@tum.de						Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059772; Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Endo M, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12005; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Karnezis AN, 2016, J PATHOL, V238, P389, DOI 10.1002/path.4633; Lee JS, 2015, CLIN MOL HEPATOL, V21, P220, DOI 10.3350/cmh.2015.21.3.220; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Ma ZD, 2004, J BIOL CHEM, V279, P46326, DOI 10.1074/jbc.M405438200; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; REMMELE W, 1987, PATHOLOGE, V8, P138; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shanahan F., 2013, PLOS ONE, V8; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Torkamandi S, 2014, IRAN J BASIC MED SCI, V17, P912; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong AKC, 2000, CANCER RES, V60, P6171; Wu Q, 2015, J CELL PHYSIOL, V230, P2683, DOI 10.1002/jcp.24991; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608	35	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180225	10.1371/journal.pone.0180225	http://dx.doi.org/10.1371/journal.pone.0180225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700662	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649600023
J	Lima, JJP; Buitink, J; Lalanne, D; Rossi, RF; Pelletier, S; da Silva, EAA; Leprince, O				Pereira Lima, Juliana Joice; Buitink, Julia; Lalanne, David; Rossi, Rubiana Falopa; Pelletier, Sandra; Amaral da Silva, Edvaldo Aparecido; Leprince, Olivier			Molecular characterization of the acquisition of longevity during seed maturation in soybean	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GLYCINE-MAX; 3 GENOTYPES; GERMINATION; VIGOR; EXPRESSION; ACCUMULATION; GALACTINOL; RAFFINOSE; ESTABLISHMENT	Seed longevity, defined as the ability to remain alive during storage, is an important agronomic factor. Poor longevity negatively impacts seedling establishment and consequently crop yield. This is particularly problematic for soybean as seeds have a short lifespan. While the economic importance of soybean has fueled a large number of transcriptome studies during embryogenesis and seed filling, the mechanisms regulating seed longevity during late maturation remain poorly understood. Here, a detailed physiological and molecular characterization of late seed maturation was performed in soybean to obtain a comprehensive overview of the regulatory genes that are potentially involved in longevity. Longevity appeared at physiological maturity at the end of seed filling before maturation drying and progressively doubled until the seeds reached the dry state. The increase in longevity was associated with the expression of genes encoding protective chaperones such as heat shock proteins and the repression of nuclear and chloroplast genes involved in a range of chloroplast activities, including photosynthesis. An increase in the raffinose family oligosaccharides (RFO)/sucrose ratio together with changes in RFO metabolism genes was also associated with longevity. A gene co-expression network analysis revealed 27 transcription factors whose expression profiles were highly correlated with longevity. Eight of them were previously identified in the longevity network of Medicago truncatula, including homologues of ERF110, HSF6AB, NFXL1 and members of the DREB2 family. The network also contained several transcription factors associated with auxin and developmental cell fate during flowering, organ growth and differentiation. A transcriptional transition occurred concomitant with seed chlorophyll loss and detachment from the mother plant, suggesting the activation of a post-abscission program. This transition was enriched with AP2/EREBP and WRKY transcription factors and genes associated with growth, germination and post-transcriptional processes, suggesting that this program prepares the seed for the dry quiescent state and germination.	[Pereira Lima, Juliana Joice; Rossi, Rubiana Falopa; Amaral da Silva, Edvaldo Aparecido] Univ Estadual Paulista, Fac Ciencias Agron, Botucatu, SP, Brazil; [Pereira Lima, Juliana Joice; Buitink, Julia; Lalanne, David; Rossi, Rubiana Falopa; Pelletier, Sandra; Leprince, Olivier] Univ Angers, SFR QUASAV, Agrocampus Ouest, Inst Rech Hort & Semences,INRA, Beaucouze, France	Universidade Estadual Paulista; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	da Silva, EAA (corresponding author), Univ Estadual Paulista, Fac Ciencias Agron, Botucatu, SP, Brazil.; Leprince, O (corresponding author), Univ Angers, SFR QUASAV, Agrocampus Ouest, Inst Rech Hort & Semences,INRA, Beaucouze, France.	amaraldasilva@fca.unesp.br; olivier.leprince@agrocampus-ouest.fr	Amaral da Silva, Edvaldo/AAY-4481-2021; Buitink, Julia/AAR-2872-2020; Pelletier, Sandra/A-3852-2013	Amaral da Silva, Edvaldo/0000-0001-6454-1488; Buitink, Julia/0000-0002-1457-764X; Pelletier, Sandra/0000-0001-7582-2939; Leprince, Olivier/0000-0003-1414-8690				Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; Ballesteros D, 2011, PLANT J, V68, P607, DOI 10.1111/j.1365-313X.2011.04711.x; Benson, 1985, SPECIAL REPORT, P1; Bilyeu KD, 2016, J AGR FOOD CHEM, V64, P1071, DOI 10.1021/acs.jafc.5b04779; Boca S, 2014, PLANT CELL ENVIRON, V37, P368, DOI 10.1111/pce.12159; Buitink J, 2000, P NATL ACAD SCI USA, V97, P2385, DOI 10.1073/pnas.040554797; Capella M, 2015, NEW PHYTOL, V207, P669, DOI 10.1111/nph.13401; Chatelain E, 2012, PLANT CELL ENVIRON, V35, P1440, DOI 10.1111/j.1365-3040.2012.02501.x; Cheng MC, 2012, PLANT PHYSIOL, V158, P363, DOI 10.1104/pp.111.189738; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duplan V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00042; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Finch-Savage WE, 2016, J EXP BOT, V67, P567, DOI 10.1093/jxb/erv490; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Gillen AM, 2012, CROP SCI, V52, P2757, DOI 10.2135/cropsci2011.10.0566; Hay FR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot030; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005833; Hundertmark M, 2011, SEED SCI RES, V21, P165, DOI 10.1017/S0960258511000079; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kaur H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00713; KUENEMAN EA, 1983, CROP SCI, V23, P5, DOI 10.2135/cropsci1983.0011183X002300010002x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leprince O, 2017, J EXP BOT, V68, P827, DOI 10.1093/jxb/erw363; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; Li L, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S9; Lisso J, 2006, FEBS LETT, V580, P4851, DOI 10.1016/j.febslet.2006.07.079; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LOWELL CA, 1989, CROP SCI, V29, P459, DOI 10.2135/cropsci1989.0011183X002900020044x; Marcos-Filho J., 2016, SEED PHYSIOLOGY OF C; Nagel M, 2015, PLANT CELL ENVIRON, V38, P1011, DOI 10.1111/pce.12474; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakajima S, 2012, PLANT PHYSIOL, V160, P261, DOI 10.1104/pp.112.196881; Niedzielski M, 2009, SEED SCI RES, V19, P213, DOI 10.1017/S0960258509990110; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Obendorf RL, 2009, CROP SCI, V49, P329, DOI 10.2135/cropsci2008.06.0370; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Pádua Gilda Pizzolante de, 2007, Rev. bras. sementes, V29, P128, DOI 10.1590/S0101-31222007000300015; Righetti K, 2015, PLANT CELL, V27, P2692, DOI 10.1105/tpc.15.00632; ROBERTS EH, 1989, ANN BOT-LONDON, V63, P39, DOI 10.1093/oxfordjournals.aob.a087727; Rosnoblet C, 2007, PLANT J, V51, P47, DOI 10.1111/j.1365-313X.2007.03116.x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Salvi P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35088; Sano N, 2016, PLANT CELL PHYSIOL, V57, P660, DOI 10.1093/pcp/pcv186; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuster C, 2015, DEVELOPMENT, V142, P3343, DOI 10.1242/dev.120444; Schwember AR, 2010, J EXP BOT, V61, P4423, DOI 10.1093/jxb/erq248; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Teixeira RN, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0729-0; Tejedor-Cano J, 2010, PLANT CELL ENVIRON, V33, P1408, DOI 10.1111/j.1365-3040.2010.02159.x; Verdier J, 2013, PLANT PHYSIOL, V163, P757, DOI 10.1104/pp.113.222380; VERTUCCI CW, 1984, PLANT PHYSIOL, V75, P114, DOI 10.1104/pp.75.1.114; Vidigal DD, 2016, PLANT SCI, V246, P112, DOI 10.1016/j.plantsci.2016.02.015; Walters C, 2005, SEED SCI RES, V15, P1, DOI 10.1079/SSR2004195; Walters C, 2010, PLANT SCI, V179, P565, DOI 10.1016/j.plantsci.2010.06.016; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Waterworth WM, 2010, PLANT J, V63, P848, DOI 10.1111/j.1365-313X.2010.04285.x; Yamaguchi N, 2016, PLANT PHYSIOL, V170, P283, DOI 10.1104/pp.15.00969; ZANAKIS GN, 1994, EXP AGR, V30, P157, DOI 10.1017/S0014479700024108; ZANAKIS GN, 1994, EXP AGR, V30, P139, DOI 10.1017/S0014479700024091; Zhang YY, 2015, PLANT CELL, V27, P620, DOI 10.1105/tpc.114.135368; Zinsmeister J, 2016, PLANT CELL, V28, P2735, DOI 10.1105/tpc.16.00470	71	45	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180282	10.1371/journal.pone.0180282	http://dx.doi.org/10.1371/journal.pone.0180282			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700604	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600025
J	Kubota, JT; Peiso, J; Marcum, K; Cloutier, J				Kubota, Jennifer T.; Peiso, Jaelyn; Marcum, Kori; Cloutier, Jasmin			Intergroup contact throughout the lifespan modulates implicit racial biases across perceivers' racial group	PLOS ONE			English	Article							INTERRACIAL INTERACTIONS; IMPROVING IMPLICIT; METAANALYTIC TEST; IMAGINED CONTACT; REDUCE PREJUDICE; ASSOCIATION TEST; ATTITUDES; EXPLICIT; HYPOTHESIS; PREDICTORS	Few researchers have investigated how contact across the lifespan influences racial bias and whether diversity of contact is beneficial regardless of the race of the perceiver. This research aims to address these gaps in the literature with a focus on how diversity in childhood and current contact shapes implicit racial bias across perceivers' racial group. In two investigations, participants completed an Implicit Association Test and a self- report measure of the racial diversity of their current and childhood contact. In both studies, increased contact with Black compared with White individuals, both in childhood (Study 2) and currently (Studies 1 and 2), was associated with reduced implicit pro- White racial bias. For Black individuals (Study 2) more contact with Black compared with White individuals also was associated with reduced implicit pro- White racial bias. These findings suggest that diversity in contact across the lifespan may be related to reductions in implicit racial biases and that this relationship may generalize across racial groups.	[Kubota, Jennifer T.; Peiso, Jaelyn; Marcum, Kori; Cloutier, Jasmin] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Kubota, Jennifer T.] Univ Chicago, Ctr Study Race Polit & Culture, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kubota, JT (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.; Kubota, JT (corresponding author), Univ Chicago, Ctr Study Race Polit & Culture, Chicago, IL 60637 USA.	jtkubota@uchicago.edu						Aberson CL, 2007, GROUP PROCESS INTERG, V10, P179, DOI 10.1177/1368430207074726; Aberson CL, 2004, J SOC PSYCHOL, V144, P335, DOI 10.3200/SOCP.144.3.335-347; Binder J, 2009, J PERS SOC PSYCHOL, V96, P843, DOI 10.1037/a0013470; Cloutier J, 2016, CEREB CORTX, P1; Cloutier J, 2014, J COGNITIVE NEUROSCI, V26, P1992, DOI 10.1162/jocn_a_00605; Crisp RJ, 2009, SOC PERSONAL PSYCHOL, V3, P1, DOI 10.1111/j.1751-9004.2008.00155.x; Dasgupta N, 2008, SOC COGNITION, V26, P112, DOI 10.1521/soco.2008.26.1.112; Davis DE, 2016, J PERS SOC PSYCHOL, V110, pE23, DOI 10.1037/pspp0000056; Dhont K, 2011, GROUP PROCESS INTERG, V14, P223, DOI 10.1177/1368430210391121; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Dunham Y, 2013, PSYCHOL SCI, V24, P860, DOI 10.1177/0956797612463081; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Gehring WJ, 2003, NAT NEUROSCI, V6, P1241, DOI 10.1038/nn1203-1241; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Henry PJ, 2006, PSYCHOL SCI, V17, P862, DOI 10.1111/j.1467-9280.2006.01795.x; Kawakami K, 2007, J PERS SOC PSYCHOL, V92, P957, DOI 10.1037/0022-3514.92.6.957; Killen M, 2007, INT J BEHAV DEV, V31, P491, DOI 10.1177/0165025407081478; Kubota JT, 2012, NAT NEUROSCI, V15, P940, DOI 10.1038/nn.3136; Livingston RW, 2002, J EXP SOC PSYCHOL, V38, P405, DOI 10.1016/S0022-1031(02)00002-1; MacInnis CC, 2015, PERSPECT PSYCHOL SCI, V10, P307, DOI 10.1177/1745691614568482; Mahonen TA, 2011, GROUP PROCESS INTERG, V14, P19, DOI 10.1177/1368430210378300; Miles E, 2014, GROUP PROCESS INTERG, V17, P3, DOI 10.1177/1368430213510573; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Pagotto L, 2013, GROUP PROCESS INTERG, V16, P209, DOI 10.1177/1368430212450057; Pettigrew T. F., 2000, REDUCING PREJUDICE D, V93, P114; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 1997, PERS SOC PSYCHOL B, V23, P173, DOI 10.1177/0146167297232006; Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Plant EA, 2009, J EXP SOC PSYCHOL, V45, P961, DOI 10.1016/j.jesp.2009.04.018; POWERS DA, 1995, SOC FORCES, V74, P205, DOI 10.2307/2580629; Prestwich A, 2008, BRIT J SOC PSYCHOL, V47, P575, DOI 10.1348/014466607X267470; Rae JR, 2015, SOC PSYCHOL PERS SCI, V6, P535, DOI 10.1177/1948550614567357; Rudman LA, 2004, CURR DIR PSYCHOL SCI, V13, P79, DOI 10.1111/j.0963-7214.2004.00279.x; Rudman LA, 2002, SOC COGNITION, V20, P294, DOI 10.1521/soco.20.4.294.19908; Tumer RN, 2007, J PERS SOC PSYCHOL, V93, P369, DOI 10.1037/0022-3514.93.3.369; Turner RN, 2013, J APPL SOC PSYCHOL, V43, pE196, DOI 10.1111/jasp.12019; Turner RN, 2010, BRIT J SOC PSYCHOL, V49, P129, DOI 10.1348/014466609X419901; Vezzali L, 2012, GROUP PROCESS INTERG, V15, P203, DOI 10.1177/1368430211424920; Weisbuch M, 2009, SCIENCE, V326, P1711, DOI 10.1126/science.1178358; White FA, 2009, INT J INTERCULT REL, V33, P524, DOI 10.1016/j.ijintrel.2009.06.008	42	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180440	10.1371/journal.pone.0180440	http://dx.doi.org/10.1371/journal.pone.0180440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700624	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400013
J	Stervbo, U; Pohlmann, D; Baron, U; Bozzetti, C; Jurchott, K; Malzer, JN; Nienen, M; Olek, S; Roch, T; Schulz, AR; Warth, S; Neumann, A; Thiel, A; Grutzkau, A; Babel, N				Stervbo, Ulrik; Pohlmann, Dominika; Baron, Udo; Bozzetti, Cecilia; Juerchott, Karsten; Maelzer, Julia Nora; Nienen, Mikalai; Olek, Sven; Roch, Toralf; Schulz, Axel Ronald; Warth, Sarah; Neumann, Avidan; Thiel, Andreas; Gruetzkau, Andreas; Babel, Nina			Age dependent differences in the kinetics of Y delta T cells after influenza vaccination	PLOS ONE			English	Article							PROFESSIONAL ANTIGEN-PRESENTATION; B-CELLS; A VIRUSES; ACTIVATION; INFECTION; RESPONSES; CYTOMEGALOVIRUS; NEUTRALIZATION; CYTOTOXICITY; LYMPHOCYTES	Immunosenescence is a hallmark of the aging immune system and is considered the main cause of a reduced vaccine efficacy in the elderly. Although Y delta T cells can become activated by recombinant influenza hemagglutinin, their age-related immunocompetence during a virus-induced immune response has so far not been investigated. In this study we evaluate the kinetics of Y delta T cells after vaccination with the trivalent 2011/2012 northern hemisphere seasonal influenza vaccine. We applied multi-parametric flow cytometry to a cohort of 21 young (19-30 years) and 23 elderly (53-67 years) healthy individuals. Activated and proliferating Y delta T cells, as identified by CD38 and Ki67 expression, were quantified on the days 0, 3, 7, 10, 14, 17, and 21. We observed a significantly lower number of activated and proliferating Y delta T cells at baseline and following vaccination in elderly as compared to young individuals. The kinetics changes of activated Upsilon delta T cells were much stronger in the young, while corresponding changes in the elderly occurred slower. In addition, we observed an association between day 21 HAI titers of influenza A and the frequencies of Ki67(+) Y delta T cells at day 7 in the young. In conclusion, aging induces alterations of the Upsilon delta T cell response that might have negative implications for vaccination efficacy.	[Stervbo, Ulrik; Pohlmann, Dominika; Bozzetti, Cecilia; Juerchott, Karsten; Maelzer, Julia Nora; Schulz, Axel Ronald; Warth, Sarah; Neumann, Avidan; Thiel, Andreas; Babel, Nina] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, Berlin, Germany; [Stervbo, Ulrik; Nienen, Mikalai; Babel, Nina] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Clin 1,Ctr Translat Med, Holkeskampring 40, Herne, Germany; [Baron, Udo; Olek, Sven] Epiontis GmbH, Rudower Chaussee 29, Berlin, Germany; [Roch, Toralf] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Inst Biomat Sci, Kantstr 55, Teltow, Germany; [Roch, Toralf] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Berlin Brandenburg Ctr Regenerat Therapies, Kantstr 55, Teltow, Germany; [Schulz, Axel Ronald; Gruetzkau, Andreas] Deutsch Rheuma Forschungszentrum Berlin, Leibniz Inst, Charitepl 1, Berlin, Germany; [Pohlmann, Dominika] Charite, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany; [Neumann, Avidan] Helmholtz Ctr Munich, Chair & Inst Environm Med, UNIKA T, Neusaesser Str 47, Augsburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; St. Marien Hospital; Epiontis GmbH; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stervbo, U (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, Berlin, Germany.; Stervbo, U (corresponding author), Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Clin 1,Ctr Translat Med, Holkeskampring 40, Herne, Germany.	ulrik.stervbo-kristensen@charite.de	Thiel, Andreas/F-1539-2013; Babel, Nina/AAK-2034-2021; Stervbo, Ulrik/AAV-1561-2020; Roch, Toralf/AAQ-7480-2021	Stervbo, Ulrik/0000-0002-2831-8868; Jurchott, Karsten/0000-0003-1589-0037; Roch, Toralf/0000-0003-2948-8700; Nienen, Mikalai/0000-0002-5678-1956; Babel, Nina/0000-0003-3673-712X; Baron, Udo/0000-0001-7432-3601; Schulz, Axel Ronald/0000-0002-5106-0148; Thiel, Andreas/0000-0002-5515-4002; Pohlmann, Dominika/0000-0002-9866-0431	Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE	Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE	This work was supported by the following Bundesministerium fur Bildung und Forschung (BMBF) Gerontosys Program PRIMAGE. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. Epiontis GmbH provided support in the form of salaries for authors (UB, SO), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Bauvois B, 1999, J INTERF CYTOK RES, V19, P1059, DOI 10.1089/107999099313299; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bissel SJ, 2014, J VIROL, V88, P3077, DOI 10.1128/JVI.01840-13; Born WK, 2011, CELL MOL LIFE SCI, V68, P2335, DOI 10.1007/s00018-011-0697-3; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P1, DOI 10.1038/cmi.2012.73; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Ernst IMA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00259; Fisher JPH, 2014, CLIN CANCER RES, V20, P5720, DOI 10.1158/1078-0432.CCR-13-3464; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Fujishima N, 2007, CLIN EXP IMMUNOL, V149, P70, DOI 10.1111/j.1365-2249.2007.03388.x; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Himoudi N, 2012, J IMMUNOL, V188, P1708, DOI 10.4049/jimmunol.1102654; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; Hou LF, 2015, INT IMMUNOPHARMACOL, V28, P887, DOI 10.1016/j.intimp.2015.03.038; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Iwasaki M, 2011, EUR J IMMUNOL, V41, P345, DOI 10.1002/eji.201040959; Jurchott K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150812; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Lafont V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00622; Langer JC, 2006, J GERONTOL A-BIOL, V61, P568, DOI 10.1093/gerona/61.6.568; Lee N, 2012, J GERONTOL A-BIOL, V67, P254, DOI 10.1093/gerona/glr237; Li H, 2013, CELL MOL IMMUNOL, V10, P159, DOI 10.1038/cmi.2012.70; Lu YL, 2013, CELL MOL IMMUNOL, V10, P463, DOI 10.1038/cmi.2013.26; Meuter S, 2010, P NATL ACAD SCI USA, V107, P8730, DOI 10.1073/pnas.1002769107; Motamedi M, 2016, J IMMUNOL METHODS, V437, P43, DOI 10.1016/j.jim.2016.08.002; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Petrasca A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00650; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; R Core Team, 2012, R LANG ENV STAT COMP; Rambal V, 2014, MED MICROBIOL IMMUN, V203, P35, DOI 10.1007/s00430-013-0312-3; Roux A, 2013, J IMMUNOL, V191, P1300, DOI 10.4049/jimmunol.1202940; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Tseng CTK, 2001, HEPATOLOGY, V33, P1312, DOI 10.1053/jhep.2001.24269; Tuero I, 2016, J IMMUNOL, V197, P4686, DOI 10.4049/jimmunol.1600579; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; WHO, 2011, RELEVE EPIDEMIOLOGIQ, V86, P86; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wistuba-Hamprecht K, 2014, CYTOM PART A, V85A, P522, DOI 10.1002/cyto.a.22470; Wistuba-Hamprecht K, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-26; Wu YL, 2014, INT J BIOL SCI, V10, P119, DOI 10.7150/ijbs.7823; Yin WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26296	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181161	10.1371/journal.pone.0181161	http://dx.doi.org/10.1371/journal.pone.0181161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700738	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400035
J	Minges, A; Groth, G				Minges, Alexander; Groth, Georg			Small-molecule inhibition of pyruvate phosphate dikinase targeting the nucleotide binding site	PLOS ONE			English	Article							PROTEIN-KINASE-C; SWIVELING-DOMAIN MECHANISM; BUNDLE SHEATH-CELLS; ORTHOPHOSPHATE DIKINASE; C-4 PHOTOSYNTHESIS; REVERSIBLE PHOSPHORYLATION; INACTIVATION; ACTIVATION; DESIGN; CANCER	Pyruvate phosphate dikinase (PPDK) is an essential enzyme of C4 photosynthesis in plants, catalyzing the ATP-driven conversion of pyruvate to phosphoenolpyruvate ( PEP). It is further used by some bacteria and unicellular protists in the reverse, ATP-forming direction. Many weed species use C4 photosynthesis in contrast to world's major crops, which are C3 plants. Hence inhibitors of PPDK may be used as C4-specific herbicides. By screening a library of 80 commercially available kinase inhibitors, we identified compounds derived from bisindolylmaleimide (bisindolylmaleimide IV, IC50 = 0.76 +/- 0.13 mu M) and indirubin (indirubin3'- monoxime, IC50 = 4.2 +/- 0.9 mu M) that showed high inhibitory potency towards PPDK and are among the most effective PPDK inhibitors described today. Physiological studies on leaf tissues of a C4 model plant confirmed in vivo inhibition of C4-driven photosynthesis by these substances. Moreover, comparative docking studies of non-inhibitory bisindolylmaleimide derivatives suggest that the selectivity towards PPDK may be increased by addition of functional groups to the core structure.	[Minges, Alexander; Groth, Georg] Heinrich Heine Univ, Inst Biochem Plant Physiol, Cluster Excellence Plant Sci CEPLAS, D-40204 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Cologne	Groth, G (corresponding author), Heinrich Heine Univ, Inst Biochem Plant Physiol, Cluster Excellence Plant Sci CEPLAS, D-40204 Dusseldorf, Germany.	georg.groth@hhu.de		Minges, Alexander/0000-0001-7760-2753	Heinrich Heine University Dusseldorf within iGRASPseed-Graduate Cluster	Heinrich Heine University Dusseldorf within iGRASPseed-Graduate Cluster	This work was supported by Heinrich Heine University Dusseldorf (scholarships within the iGRASPseed-Graduate Cluster for AM) (http://igrasp.hhu.de/).	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert DH, 2006, MOL CANCER THER, V5, P995, DOI 10.1158/1535-7163.MCT-05-0410; [Anonymous], 2016, RDKIT OPEN SOURCE CH; Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO;2-0; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ASHTON AR, 1984, ARCH BIOCHEM BIOPHYS, V230, P492, DOI 10.1016/0003-9861(84)90429-6; Astley HM, 2011, PLANT J, V68, P1070, DOI 10.1111/j.1365-313X.2011.04759.x; BURNELL JN, 1988, ARCH BIOCHEM BIOPHYS, V260, P177, DOI 10.1016/0003-9861(88)90439-0; CHAPMAN KSR, 1981, ARCH BIOCHEM BIOPHYS, V210, P82, DOI 10.1016/0003-9861(81)90166-1; Chastain CJ, 2011, J EXP BOT, V62, P3083, DOI 10.1093/jxb/err058; Chastain CJ, 2003, PLANT PHYSIOL BIOCH, V41, P523, DOI 10.1016/S0981-9428(03)00065-2; Chen YB, 2014, PLANT PHYSIOL, V165, P534, DOI 10.1104/pp.113.231993; Cosenza LW, 2002, J MOL BIOL, V318, P1417, DOI 10.1016/S0022-2836(02)00113-4; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; Doyle JR, 2005, J BIOMOL SCREEN, V10, P67, DOI 10.1177/1087057104269978; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Ghannoum O, 2011, ADV PHOTOSYNTH RESP, V32, P129; Greaves B, 1996, US Patent, Patent No. [5,587,109, 5587109]; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Haines DS, 2005, J AGR FOOD CHEM, V53, P3856, DOI 10.1021/jf048010x; Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Holm LG, 1977, THE WORLDS WORST WEE; Jiang L, 2016, PLANT PHYSIOL, V170, P732, DOI 10.1104/pp.15.01709; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Kopriva S, 2011, ADV PHOTOSYNTH RESP, V32, P109; LAWYER AL, 1987, Z NATURFORSCH C, V42, P834; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lim K, 2007, BIOCHEMISTRY-US, V46, P14845, DOI 10.1021/bi701848w; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Minges A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45389; MOORE R, 1979, PLANT PHYSIOL, V64, P309, DOI 10.1104/pp.64.2.309; Motti CA, 2007, MOLECULES, V12, P1376, DOI 10.3390/12071376; Motti CA, 2007, APPL ENVIRON MICROB, V73, P1921, DOI 10.1128/AEM.02479-06; Nakanishi T, 2005, BIOCHEMISTRY-US, V44, P1136, DOI 10.1021/bi0484522; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2004, R FOUNDATION FOR STA; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; SALAHAS G, 1990, PHOTOSYNTH RES, V24, P183, DOI 10.1007/BF00032598; Schrodinger LLC, 2015, THE PYMOL MOLECULAR; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Tanaka M, 2004, BIOORG MED CHEM LETT, V14, P5171, DOI 10.1016/j.bmcl.2004.07.061; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu C, 2013, J ORG CHEM, V78, P1910, DOI 10.1021/jo3018473; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	51	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181139	10.1371/journal.pone.0181139	http://dx.doi.org/10.1371/journal.pone.0181139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700696	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800126
J	Serinolli, MI; Novaretti, MCZ				Serinolli, Mario Ivo; Zago Novaretti, Marcia Cristina			A cross-sectional study of sociodemographic factors and their influence on quality of life in medical students at Sao Paulo, Brazil	PLOS ONE			English	Article							BODY-MASS INDEX; WHOQOL-BREF; PORTUGUESE VERSION; MENTAL-HEALTH; OBESITY; SPIRITUALITY; ASSOCIATION; OVERWEIGHT; BEHAVIORS; EDUCATION	Background Various sociodemographic factors can affect the quality of life of medical students and interfere in their ability to study. A deeper understanding of these factors may facilitate improvements in learning and retention of medical students. Methods We conducted a cross-sectional study of 405 medical students, representing 65.3% of the total student body (years 1-6), at a private medical school in Sao Paulo, Brazil. Among the entire study group, 177 students (43.7%) were male, and 228 (56.3%) were female. The mean age was 23.55 years (SD = 3.98 years, range: 18-40). The World Health Organization Quality of Life-Biomedical Research and Education Facility (WHOQOL-BREF) scale was used to evaluate the following sociodemographic factors: age, sex, academic year, daily traveling time, housing conditions, smoking, weight, height, participant's and his/her parents' education background, students who had a degree or not and religious beliefs. The reliability of the WHOQOL-BREF was evaluated using Cronbach's analysis, and the association of sociodemographic factors with quality of life was examined using multivariate regression analysis. Main Results Quality of life was significantly higher in medical students with religious beliefs (beta 0.14 for psychological domain; beta 0.11 for environmental domain) when compared with that in those with no religious beliefs. BMI was negative associated with QOL in medical students (beta-0.11 for physical domain; beta-18.9 for the psychological domain). In both male and female students, longer daily traveling time was negative related to QOL (beta-0.11 for environmental domain). Having at least one parent who was a doctor was associated with a better quality of life (beta 0.17 for environmental domain). Male students presented with significantly higher mean scores for three of the four domains evaluated (beta 0.20 for physical domain; beta 0.25 for psychological domain; beta 0.14 for social domain). Conclusion This study has provided novel insights into the effects of sociodemographic factors, physical traits, and religious beliefs on the quality of life of medical students. These findings may facilitate improvements in physical, psychological, and social support for medical students at a critical stage in their training, thereby providing tools for student better adjustment to medical school.	[Serinolli, Mario Ivo; Zago Novaretti, Marcia Cristina] Univ Nove Julho, Hlth Adm Grad Dept, Sao Paulo, SP, Brazil	Universidade Nove de Julho	Novaretti, MCZ (corresponding author), Univ Nove Julho, Hlth Adm Grad Dept, Sao Paulo, SP, Brazil.	marcianovaretti@uni9.pro.br	Novaretti, Marcia C Z/L-6624-2013	Novaretti, Marcia C Z/0000-0002-4802-8446				[Anonymous], 2015, STAT WOM AC MED PIP; Bertsias G, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-3; Bonelli RM, 2013, J RELIG HEALTH, V52, P657, DOI 10.1007/s10943-013-9691-4; Cruess RL, 2014, ACAD MED, V89, P1446, DOI 10.1097/ACM.0000000000000427; Curlin FA, 2006, MED CARE, V44, P446, DOI 10.1097/01.mlr.0000207434.12450.ef; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; Domantay JAA, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014545459; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2010, ACAD MED, V85, P94, DOI 10.1097/ACM.0b013e3181c46aad; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Farooqi Y.N., 2012, INT J PSYCHOL BEHAV, V2, P38, DOI DOI 10.5923/J.IJPBS.20120202.06; Fleck MP, 2006, REV SAUDE PUBL, V40, P785, DOI 10.1590/S0034-89102006000600007; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Henning MA, 2013, J RELIG HLTH, V54, P3; Jalali-Farahani S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0434-6; Jamali A, 2013, MED EDUC, V47, P1001, DOI 10.1111/medu.12247; Jefferson L, 2015, BRIT MED BULL, V114, P5, DOI 10.1093/bmb/ldv007; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Khan Zeeshan Nasir, 2016, Indian J Endocrinol Metab, V20, P206, DOI 10.4103/2230-8210.176357; Kim Bomi, 2014, Korean J Med Educ, V26, P53, DOI 10.3946/kjme.2014.26.1.53; Kjeldstadli Kari, 2006, BMC Med Educ, V6, P48, DOI 10.1186/1472-6920-6-48; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Krageloh CU, 2015, ACAD PSYCHIATR, V39, P85, DOI 10.1007/s40596-014-0158-z; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lavalle FJ, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0216-4; Leahy CM, 2010, AUST NZ J PSYCHIAT, V44, P608, DOI 10.3109/00048671003649052; Lucchetti G, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-85; Macy Jr J, 2008, REVISITING MED SCH E; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P267, DOI 10.1590/1809-4503201400050021; Neto ANF, 2012, REV BRAS MED, V69, P219; O'Connell KA, 2006, SOC SCI MED, V62, P1486, DOI 10.1016/j.socscimed.2005.08.001; Paro César Augusto, 2013, Rev. bras. educ. med., V37, P365, DOI 10.1590/S0100-55022013000300009; Paro HBMS, 2010, MED EDUC, V44, P227, DOI 10.1111/j.1365-2923.2009.03587.x; Phelan SM, 2015, J GEN INTERN MED, V30, P1251, DOI 10.1007/s11606-015-3266-x; Portney LG, 2009, FDN CLIN RES APPL PR, P607; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Chazan ACS, 2015, CIENC SAUDE COLETIVA, V20, P547, DOI 10.1590/1413-81232015202.05182014; Shareef MA, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0476-1; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Taylor VH, 2013, BEST PRACT RES CL EN, V27, P139, DOI 10.1016/j.beem.2013.04.004; Tempski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131535; Ul-Haq Z, 2014, PSYCHOL MED, V44, P2231, DOI 10.1017/S0033291713002833; WALLERSTEIN N, 1988, HEALTH EDUC QUART, V15, P379, DOI 10.1177/109019818801500402; World Health Organization, 2006, STAT D GROUP WOM MED; World Health Organization, 2018, OB OV FACT SHEET 311; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	47	10	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180009	10.1371/journal.pone.0180009	http://dx.doi.org/10.1371/journal.pone.0180009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28692676	Green Published, gold			2022-12-27	WOS:000405544800022
J	Yang, LS; Craviso, GL; Vernier, PT; Chatterjee, I; Leblanc, N				Yang, Lisha; Craviso, Gale L.; Vernier, P. Thomas; Chatterjee, Indira; Leblanc, Normand			Nanosecond electric pulses differentially affect inward and outward currents in patch clamped adrenal chromaffin cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PERMEABILIZATION; GATED SODIUM-CHANNELS; INTRACELLULAR CA2+; ION CHANNELS; PHOSPHATIDYLSERINE TRANSLOCATION; CALCIUM-CHANNELS; SALT-BRIDGE; FIELD NSPEF; IN-VITRO; INHIBITION	This study examined the effect of 5 ns electric pulses on macroscopic ionic currents in whole-cell voltage-clamped adrenal chromaffin cells. Current-voltage (I-V) relationships first established that the early peak inward current was primarily composed of a fast voltage-dependent Na+ current (I-Na), whereas the late outward current was composed of at least three ionic currents: a voltage-gated Ca2+ current (I-Ca), a Ca2+-activated K+ current (I-K(Ca)), and a sustained voltage-dependent delayed rectifier K+ current (I-KV). A constant-voltage step protocol was next used to monitor peak inward and late outward currents before and after cell exposure to a 5 ns pulse. A single pulse applied at an electric (E)-field amplitude of 5 MV/m resulted in an instantaneous decrease of similar to 4% in peak INa that then declined exponentially to a level that was similar to 85% of the initial level after 10 min. Increasing the E-field amplitude to 8 or 10 MV/m caused a twofold greater inhibitory effect on peak INa. The decrease in INa was not due to a change in either the steady-state inactivation or activation of the Na+ channel but instead was associated with a decrease in maximal Na+ conductance. Late outward current was not affected by a pulse applied at 5 MV/m. However, for a pulse applied at the higher E-field amplitudes of 8 and 10 MV/m, late outward current in some cells underwent a progressive similar to 22% decline over the course of the first 20 s following pulse exposure, with no further decline. The effect was most likely concentrated on ICa and IK(Ca) as IKV was not affected. The results of this study indicate that in whole-cell patch clamped adrenal chromaffin cells, a 5 ns pulse differentially inhibits specific voltage-gated ionic currents in a manner that can be manipulated by tuning E-field amplitude.	[Yang, Lisha; Craviso, Gale L.; Leblanc, Normand] Univ Nevada, Dept Pharmacol, Reno Sch Med, Reno, NV 89557 USA; [Vernier, P. Thomas] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Chatterjee, Indira] Univ Nevada, Dept Elect & Biomed Engn, Coll Engn, Reno, NV 89557 USA; [Leblanc, Normand] Univ Nevada, Ctr Cardiovasc Res, Reno Sch Med, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Old Dominion University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Leblanc, N (corresponding author), Univ Nevada, Dept Pharmacol, Reno Sch Med, Reno, NV 89557 USA.; Leblanc, N (corresponding author), Univ Nevada, Ctr Cardiovasc Res, Reno Sch Med, Reno, NV 89557 USA.	nleblanc@unr.edu	YANG, LISHA/AAA-1663-2019; Vernier, P. Thomas/D-7926-2016	YANG, LISHA/0000-0001-6318-4298; Vernier, P. Thomas/0000-0003-2335-1500; Leblanc, Normand/0000-0002-1090-9432	Air Force Office of Scientific Research [FA9550-14-1-0018, FA9550-14-1-0123]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by grants FA9550-14-1-0018 (GLC) and FA9550-14-1-0123 (PTV) from the Air Force Office of Scientific Research (http://www.afosr.af.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Barry PH, 2013, EUR BIOPHYS J BIOPHY, V42, P631, DOI 10.1007/s00249-013-0911-3; Blanchard MG, 2012, BRIT J PHARMACOL, V165, P2167, DOI 10.1111/j.1476-5381.2011.01674.x; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Cain SM, 2012, JASPER S BASIC MECH, P1; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Catterall WA, 2014, EXP PHYSIOL, V99, P1; Chen W, 2004, BIOELECTROCHEMISTRY, V62, P47, DOI 10.1016/j.bioelechem.2003.10.006; Chen W, 2006, BURNS, V32, P52, DOI 10.1016/j.burns.2005.08.008; Craviso GL, 2015, BIOELECTROCHEMISTRY, V103, P98, DOI 10.1016/j.bioelechem.2014.08.006; Craviso GL, 2012, BIOELECTROCHEMISTRY, V87, P244, DOI 10.1016/j.bioelechem.2011.11.016; Craviso GL, 2010, CELL MOL NEUROBIOL, V30, P1259, DOI 10.1007/s10571-010-9573-1; Craviso GL, 2009, IEEE T DIELECT EL IN, V16, P1294, DOI 10.1109/TDEI.2009.5293941; Craviso GL, 2004, J NEUROSCI METH, V137, P275, DOI 10.1016/j.jneumeth.2004.02.031; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Dworakowska B, 2000, ACTA BIOCHIM POL, V47, P685, DOI 10.18388/abp.2000_3989; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; GRIMES JA, 1995, FEBS LETT, V369, P290, DOI 10.1016/0014-5793(95)00772-2; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; ISLASSUAREZ L, 1994, J NEUROPHYSIOL, V72, P1938, DOI 10.1152/jn.1994.72.4.1938; Jiang N, 2011, BIOELECTROMAGNETICS, V32, P148, DOI 10.1002/bem.20620; Lee S, 2013, CURR NEUROPHARMACOL, V11, P606, DOI 10.2174/1570159X11311060005; MALECOT CO, 1988, PFLUG ARCH EUR J PHY, V411, P235, DOI 10.1007/BF00585109; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MEECH RW, 1975, J PHYSIOL-LONDON, V249, P211, DOI 10.1113/jphysiol.1975.sp011012; Muratori C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36835; Neely A, 1992, THE JOURNAL OF PHYSI; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P443, DOI 10.1002/bem.21703; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; Romeo S, 2013, BBA-BIOMEMBRANES, V1828, P1715, DOI 10.1016/j.bbamem.2013.03.007; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; Semenov I, 2013, CELL CALCIUM, V54, P145, DOI 10.1016/j.ceca.2013.05.008; Semenov I, 2013, BBA-BIOMEMBRANES, V1828, P981, DOI 10.1016/j.bbamem.2012.11.032; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Shao XM, 2007, J NEUROSCI METH, V159, P108, DOI 10.1016/j.jneumeth.2006.07.001; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tolstykh GP, 2013, BIOELECTROCHEMISTRY, V94, P23, DOI 10.1016/j.bioelechem.2013.05.002; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Wada A, 2008, ACTA PHYSIOL, V192, P221, DOI 10.1111/j.1748-1716.2007.01810.x; Wu YH, 2012, BIOPHYS J, V102, p190A, DOI 10.1016/j.bpj.2011.11.1035; Yoon J, 2016, J MEMBRANE BIOL, V249, P633, DOI 10.1007/s00232-016-9902-5	57	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181002	10.1371/journal.pone.0181002	http://dx.doi.org/10.1371/journal.pone.0181002			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700658	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800114
J	Meyer, AJ; Atuheire, C; Worodria, W; Kizito, S; Katamba, A; Sanyu, I; Andama, A; Ayakaka, I; Cattamanchi, A; Bwanga, F; Huang, L; Davis, JL				Meyer, Amanda J.; Atuheire, Collins; Worodria, William; Kizito, Samuel; Katamba, Achilles; Sanyu, Ingvar; Andama, Alfred; Ayakaka, Irene; Cattamanchi, Adithya; Bwanga, Freddie; Huang, Laurence; Davis, J. Lucian			Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; XPERT MTB/RIF; MICROSCOPY; IMPACT; ASSAY	Background Introduction of GeneXpert MTB/RIF (Xpert) assay has constituted a major breakthrough for tuberculosis (TB) diagnostics. Several patient factors may influence diagnostic performance of Xpert including sputum quality. Objective We carried out a prospective, observational, cross-sectional study to determine the effect of sputum quality on diagnostic performance of Xpert among presumed TB patients in Uganda. Methods We collected clinical and demographic information and two sputum samples from participants. Staff recorded sputum quality and performed LED fluorescence microscopy and mycobacterial culture on each sample. If both smear examinations were negative, Xpert testing was performed. We calculated diagnostic yield, sensitivity, specificity, and other indicators for Xpert for each stratum of sputum quality in reference to a standard of mycobacterial culture. Results Patients with salivary sputum showed a trend towards a substantially higher proportion of samples that were Xpert-positive (54/286, 19%, 95% CI 15-24) compared with those with all other sputum sample types (221/1496, 15%, 95% CI 13-17). Blood-stained sputum produced the lowest sensitivity (28%; 95% CI 12-49) and salivary sputum the highest (66%; 95% CI 53-77). Specificity didn't vary meaningfully by sample types. Salivary sputum was significantly more sensitive than mucoid sputum (+ 13%, 95% CI + 1 to + 26), while bloodstained sputum was significantly less sensitive (-24%, 95% CI -42 to -5). Conclusions Our findings demonstrate the need to exercise caution in collecting sputum for Xpert and in interpreting results because sputum quality may impact test yield and sensitivity. In particular, it may be wise to pursue additional testing should blood-stained sputum test negative while salivary sputum should be readily accepted for Xpert testing given its higher sensitivity and potentially higher yield than other sample types. These findings challenge conventional recommendations against collecting salivary sputum for TB diagnosis and could inform new standards for sputum quality.	[Meyer, Amanda J.; Davis, J. Lucian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Atuheire, Collins] Africa Renewal Univ, Dept Hlth Sci & Special Educ, Kampala, Uganda; [Worodria, William; Andama, Alfred] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Kizito, Samuel; Katamba, Achilles] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda; [Sanyu, Ingvar; Andama, Alfred; Ayakaka, Irene] Mulago Hosp, Infect Dis Res Collaborat, Kampala, Uganda; [Cattamanchi, Adithya; Huang, Laurence] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Bwanga, Freddie] Makerere Univ, Dept Microbiol, Kampala, Uganda; [Huang, Laurence] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Davis, J. Lucian] Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT USA	Yale University; Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; Yale University	Davis, JL (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.; Davis, JL (corresponding author), Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT USA.	lucian.davis@yale.edu	Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAZ-7120-2021; Samuel, Kizito/AAE-5463-2020; Huang, Laurence/AAE-1590-2019; Kizito, Samuel/GVU-3763-2022	Davis, J. Lucian/0000-0002-8629-9992; Huang, Laurence/0000-0003-3888-2195; Gupta, Amanda J/0000-0003-2318-1783; Kizito, Samuel/0000-0003-2413-0398	National Institutes of Health [R01HL090335, U01HL098964, R01HL128156, K23AI080147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, K24HL087713, R01HL128156, U01HL098964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health, through the following grants: R01HL090335 (LH), U01HL098964 (LH), R01HL128156 (LH), and K23AI080147 (JLD). In addition, the training and mentoring support provided by D43TW009607 (CA, SK, AK, JLD) and K24HL087713 (LH) were critical to the study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hanrahan CF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw068; Ho J, 2016, INT J TUBERC LUNG D, V20, P319, DOI 10.5588/ijtld.15.0620; Ho J, 2015, INT J TUBERC LUNG D, V19, P537, DOI 10.5588/ijtld.14.0798; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kalema N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038888; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kyeyune R, 1999, J ACQ IMMUN DEF SYND, V55, P446; ORINA F, 2014, AFRICAN J HLTH SCI, V27, P446; Sharma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141011; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Stop TB Partnership Geneva Global Laboratory Initiative, 2013, HDB STOP TB PARTN; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walusimbi S, 2013, INT J MYCOBACT, V2, P148, DOI 10.1016/j.ijmyco.2013.06.001; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210; Yoon SH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-172	28	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180572	10.1371/journal.pone.0180572	http://dx.doi.org/10.1371/journal.pone.0180572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686705	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100076
J	Raffray, L; Giry, C; Thirapathi, Y; Reboux, AH; Jaffar-Bandjee, MC; Gasque, P				Raffray, Loic; Giry, Claude; Thirapathi, Yoga; Reboux, Anne-Helene; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe			Increased levels of soluble forms of E-selectin and ICAM-1 adhesion molecules during human leptospirosis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ACTIVATION; SEPSIS; BIOMARKERS; FAILURE; DISEASE; MARKERS	Leptospirosis is a multisystemic zoonotic disease with infiltration of visceral organs by Leptospira. The capacity of the vascular endothelium to grant immune cell recruitment and activation in target organs during the disease course remains poorly characterized. We ascertained the levels of expression of several soluble cell adhesion molecules (CAM) notably expressed by endothelial cells in human leptospirosis. We prospectively enrolled 20 hospitalized patients and compared them to 10 healthy controls. Disease severity was defined by one or more organ failures, or death. Plasmatic concentrations of soluble CAM were assessed by multiplex bead assay at the time of patient presentation (M0) and 1 month after hospital discharge. The levels of soluble E-selectin (sCD62E) and soluble intercellular adhesion molecule 1 (sICAM-1, sCD53) were significantly increased in patients compared to controls (p< 0.0001) and at 1 month (p< 0.0001) with median values at 978 ng/ml (interquartile ranges 787-1164; sCD62E) and 1021 ng/ml (690-1428; sCD53). At M0, Soluble P-selectin level (sCD62P) was found to be decreased with levels at 60 ng/ml (0-631) versus 711 ng/ml (343-1113) for healthy controls (p< 0.05). Levels of sICAM-3 (sCD50), sVCAM-1 (vascular cell adhesion molecule, sCD106) and sPECAM-1 (platelet endothelial cell adhesion molecule, sCD31) were not different from healthy subjects at M0. This study shows that two adhesion molecules, shed as soluble forms, are elevated during the acute phase of leptospirosis: E-selectin and s-ICAM1. These molecules may interfere with the process of immune cell recruitment to clear Leptospira at tissue levels.	[Raffray, Loic; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] Univ La Reunion, CHU La Reunion, UMR PIMIT, CNRS 9192,INSERM,U1187,IRD 249,CYROI, St Clotilde, Reunion, France; [Raffray, Loic; Gasque, Philippe] CHU La Reunion, Lab Biol, Site Felix Guyon, St Denis, Reunion, France; [Raffray, Loic] CHU La Reunion, Internal Med Unit, Site Felix Guyon, St Denis, Reunion, France; [Giry, Claude; Jaffar-Bandjee, Marie-Christine] CHU La Reunion, Microbiol Virol Lab, Site Felix Guyon, St Denis, Reunion, France; [Thirapathi, Yoga] GHER Hosp, Internal Med Unit, St Benoit, Reunion, France; [Reboux, Anne-Helene] CHU La Reunion, Nephrol Dialysis & Transplantat Unit, Site Felix Guyon, St Denis, Reunion, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Raffray, L; Gasque, P (corresponding author), Univ La Reunion, CHU La Reunion, UMR PIMIT, CNRS 9192,INSERM,U1187,IRD 249,CYROI, St Clotilde, Reunion, France.; Raffray, L; Gasque, P (corresponding author), CHU La Reunion, Lab Biol, Site Felix Guyon, St Denis, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion, Internal Med Unit, Site Felix Guyon, St Denis, Reunion, France.	loic.raffray@chu-reunion.fr; philippe.gasque@chu-reunion.fr						Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Connolly-Andersen AM, 2015, J INFECT DIS, V212, P1061, DOI 10.1093/infdis/jiv161; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Evangelista K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002672; Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569; Goeijenbier M, 2015, J INFECTION, V71, P437, DOI 10.1016/j.jinf.2015.05.016; Gomez RM, 2008, MICROB PATHOGENESIS, V45, P315, DOI 10.1016/j.micpath.2008.08.004; Hashimoto VL, 2013, MICROB PATHOGENESIS, V61-62, P29, DOI 10.1016/j.micpath.2013.04.011; Hochedez P, 2015, EMERG INFECT DIS, V21, P2221, DOI 10.3201/eid2112.141099; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liborio AB, 2015, AM J TROP MED HYG, V92, P611, DOI 10.4269/ajtmh.14-0232; Lukasz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087490; Martinez-Lopez DG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000918; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x; Raffray L, 2015, MICROBES INFECT, V17, P451, DOI 10.1016/j.micinf.2015.04.001; Smith CW, 1997, CIRCULATION, V95, P1986; Tantitanawat Sompong, 2003, J Med Assoc Thai, V86, P925; Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991; Vieira ML, 2007, FEMS MICROBIOL LETT, V276, P172, DOI 10.1111/j.1574-6968.2007.00924.x; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180474	10.1371/journal.pone.0180474	http://dx.doi.org/10.1371/journal.pone.0180474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686648	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100066
J	Rao, K; Sethi, K; Ischia, J; Gibson, L; Galea, L; Xiao, L; Yim, M; Chang, M; Papa, N; Bolton, D; Shulkes, A; Baldwin, GS; Patel, O				Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Galea, Laurence; Xiao, Lin; Yim, Mildred; Chang, Mike; Papa, Nathan; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel			Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; RAT-KIDNEY; GENE-EXPRESSION; FAILURE; COBALT; CELLS; ACTIVATION; INDUCTION; GASTRIN; MODEL	Objectives Ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury and chronic kidney disease. Two promising preconditioning methods for the kidney, intermittent arterial clamping (IC) and treatment with the hypoxia mimetic cobalt chloride, have never been directly compared. Furthermore, the protective efficacy of the chemically related transition metal Zn (2+) against renal IRI is unclear. Although Co (2+) ions have been shown to protect the kidney via hypoxia inducible factor (HIF), the effect of Zn 2+ ions on the induction of HIF1 alpha, HIF2 alpha and HIF3 alpha has not been investigated previously. Materials and methods The efficacy of different preconditioning techniques was assessed using a Sprague-Dawley rat model of renal IRI. Induction of HIF proteins following Zn (2+) treatment of the human kidney cell lines HK-2 (immortalized normal tubular cells) and ACHN (renal cancer) was measured using Western Blot. Results Following 40 minutes of renal ischemia in rats, cobalt preconditioning offered greater protection against renal IRI than IC as evidenced by lower peak serum creatinine and urea concentrations. ZnCl2 (10 mg/kg) significantly lowered the creatinine and urea concentrations compared to saline-treated control rats following a clinically relevant 60 minutes of ischemia. Zn (2+) induced expression of HIF1 alpha and HIF2 alpha but not HIF3 alpha in HK-2 and ACHN cells. Conclusion ZnCl2 preconditioning protects against renal IRI in a dose-dependent manner. Further studies are warranted to determine the possible mechanisms involved, and to assess the benefit of ZnCl2 preconditioning for clinical applications.	[Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Xiao, Lin; Yim, Mildred; Chang, Mike; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel] Univ Melbourne Victoria, Dept Surg, Melbourne, Vic, Australia; [Rao, Kenny; Sethi, Kapil; Ischia, Joseph; Gibson, Luke; Papa, Nathan; Bolton, Damien] Austin Hlth, Dept Urol, Heidelberg, Vic, Australia; [Galea, Laurence] Austin Hlth, Dept Anat Pathol, Heidelberg, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Patel, O (corresponding author), Univ Melbourne Victoria, Dept Surg, Melbourne, Vic, Australia.	patelo@unimelb.edu.au	Papa, Nathan/GLV-0589-2022; Sethi, Kapil/AAF-7908-2020	Sethi, Kapil/0000-0002-6037-8895; Papa, Nathan/0000-0002-3188-1803	Austin Health Medical Research Foundation; Foundation for Surgery Research Scholarship from Australasian Urological Foundation; National Health and Medical Research Council of Australia [1020983]	Austin Health Medical Research Foundation; Foundation for Surgery Research Scholarship from Australasian Urological Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was in part supported by the Austin Health Medical Research Foundation (www.austinmrf.org.au). Dr Kapil Sethi was supported by a Foundation for Surgery Research Scholarship from the Australasian Urological Foundation (www.usanz.org.au/auf). Prof Graham Baldwin is supported by a Senior Research Fellowship (1020983) from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). All the authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babula P, 2012, METALLOMICS, V4, P739, DOI 10.1039/c2mt20081c; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Becker F, 2009, EUR UROL, V56, P625, DOI 10.1016/j.eururo.2009.07.016; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; HEGENAUER J, 1991, Journal of Trace Elements in Experimental Medicine, V4, P103; Islam CF, 1997, BRIT J UROL, V79, P842, DOI 10.1046/j.1464-410X.1997.00209.x; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Li DD, 2011, EXP NEUROL, V230, P302, DOI 10.1016/j.expneurol.2011.05.009; Li PF, 1997, CIRCULATION, V96, P3602; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Mecinovic J, 2008, CHEMMEDCHEM, V3, P569, DOI 10.1002/cmdc.200700233; Michels C, 2009, WORLD J UROL, V27, P817, DOI 10.1007/s00345-009-0415-z; Morris SD, 1997, J AM COLL CARDIOL, V29, P1599, DOI 10.1016/S0735-1097(97)00087-9; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Ogawa T, 1999, AM J NEPHROL, V19, P609, DOI 10.1159/000013529; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Patel SG, 2012, J UROLOGY, V187, P816, DOI 10.1016/j.juro.2011.10.173; Schanz M, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0503-z; Simonsen LO, 2012, SCI TOTAL ENVIRON, V432, P210, DOI 10.1016/j.scitotenv.2012.06.009; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Toosy N, 1999, BJU INT, V84, P489; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; Viswanath K, 2011, BIOMETALS, V24, P171, DOI 10.1007/s10534-010-9371-8; Wang HJ, 2012, RENAL FAILURE, V34, P1324, DOI 10.3109/0886022X.2012.725292; Westwood DA, 2014, BBA-MOL CELL RES, V1843, P2471, DOI 10.1016/j.bbamcr.2014.06.016; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Xiao L, 2014, J MOL ENDOCRINOL, V52, P29, DOI 10.1530/JME-13-0162; Xiao L, 2012, ENDOCRINOLOGY, V153, P3006, DOI 10.1210/en.2011-2069; Xu ZL, 2013, BIOMETALS, V26, P863, DOI 10.1007/s10534-013-9671-x; ZAGER RA, 1984, KIDNEY INT, V26, P689, DOI 10.1038/ki.1984.204; Zhang L, 2016, J CRIT CARE, V33, P224, DOI 10.1016/j.jcrc.2016.01.026	35	32	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180028	10.1371/journal.pone.0180028	http://dx.doi.org/10.1371/journal.pone.0180028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686686	Green Published, gold			2022-12-27	WOS:000405464100032
J	Sanderson, M; Arbuthnott, K; Kovats, S; Hajat, S; Falloon, P				Sanderson, Michael; Arbuthnott, Katherine; Kovats, Sari; Hajat, Shakoor; Falloon, Pete			The use of climate information to estimate future mortality from high ambient temperature: A systematic literature review	PLOS ONE			English	Review							HEAT-RELATED MORTALITY; COLD-RELATED MORTALITY; HUMAN HEALTH; PUBLIC-HEALTH; PART II; UNCERTAINTY ANALYSIS; SUMMER TEMPERATURE; CHANGING CLIMATE; WARNING SYSTEMS; WAVE MORTALITY	Background and objectives Heat related mortality is of great concern for public health, and estimates of future mortality under a warming climate are important for planning of resources and possible adaptation measures. Papers providing projections of future heat-related mortality were critically reviewed with a focus on the use of climate model data. Some best practice guidelines are proposed for future research. Methods The electronic databases Web of Science and PubMed/Medline were searched for papers containing a quantitative estimate of future heat-related mortality. The search was limited to papers published in English in peer-reviewed journals up to the end of March 2017. Reference lists of relevant papers and the citing literature were also examined. The wide range of locations studied and climate data used prevented a meta-analysis. Results A total of 608 articles were identified after removal of duplicate entries, of which 63 were found to contain a quantitative estimate of future mortality from hot days or heat waves. A wide range of mortality models and climate model data have been used to estimate future mortality. Temperatures in the climate simulations used in these studies were projected to increase. Consequently, all the papers indicated that mortality from high temperatures would increase under a warming climate. The spread in projections of future climate by models adds substantial uncertainty to estimates of future heat-related mortality. However, many studies either did not consider this source of uncertainty, or only used results from a small number of climate models. Other studies showed that uncertainty from changes in populations and demographics, and the methods for adaptation to warmer temperatures were at least as important as climate model uncertainty. Some inconsistencies in the use of climate data (for example, using global mean temperature changes instead of changes for specific locations) and interpretation of the effects on mortality were apparent. Some factors which have not been considered when estimating future mortality are summarised. Conclusions Most studies have used climate data generated using scenarios with medium and high emissions of greenhouse gases. More estimates of future mortality using climate information from the mitigation scenario RCP2.6 are needed, as this scenario is the only one under which the Paris Agreement to limit global warming to 2 degrees C or less could be realised. Many of the methods used to combine modelled data with local climate observations are simplistic. Quantile-based methods might offer an improved approach, especially for temperatures at the ends of the distributions. The modelling of adaptation to warmer temperatures in mortality models is generally arbitrary and simplistic, and more research is needed to better quantify adaptation. Only a small number of studies included possible changes in population and demographics in their estimates of future mortality, meaning many estimates of mortality could be biased low. Uncertainty originating from establishing a mortality baseline, climate projections, adaptation and population changes is important and should be considered when estimating future mortality.	[Sanderson, Michael; Falloon, Pete] Met Off, Exeter, Devon, England; [Arbuthnott, Katherine; Kovats, Sari; Hajat, Shakoor] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Arbuthnott, Katherine] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England	Met Office - UK; University of London; London School of Hygiene & Tropical Medicine; Public Health England	Sanderson, M (corresponding author), Met Off, Exeter, Devon, England.	michael.sanderson@metoffice.gov.uk		Kovats, Sari/0000-0002-4823-8099	NIHR Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health; London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE); University of Exeter, University College London; Met Office	NIHR Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health; London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE); University of Exeter, University College London; Met Office	This work was funded under the NIHR Health Protection Research Unit (NIHR HPRU) in Environmental Change and Health, led by the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE), and in collaboration with the University of Exeter, University College London, and the Met Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailliot P, 2015, STOCHASTIC WEATHER G; Akhtar R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P451; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Anderson GB, 2016, CLIM CHANGE; Ando M, 1996, CLIMATE CHANGE 1995; Arbuthnott K, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0102-7; Argueso D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117066; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baaghideh M, 2017, IRAN J PUBLIC HEALTH, V46, P396; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Baker DJ, 2016, GLOBAL CHANGE BIOL, V22, P2392, DOI 10.1111/gcb.13273; Ballester J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1360; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Barreca AI, 2012, J ENVIRON ECON MANAG, V63, P19, DOI 10.1016/j.jeem.2011.07.004; Bassil KL, 2010, INT J ENV RES PUB HE, V7, P991, DOI 10.3390/ijerph7030991; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Benmarhnia T, 2014, ENVIRON HEALTH PERSP, V122, P1293, DOI 10.1289/ehp.1306954; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Brekke L, 2013, DOWNSCALES CMIP3 CMI; Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147; Cheng CS, 2008, AIR QUAL ATMOS HLTH, V1, P223, DOI 10.1007/s11869-009-0026-2; Cheng J, 2014, INT J BIOMETEOROL, V58, P2011, DOI 10.1007/s00484-014-0797-5; Clark RT, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043898; Collins M., 2013, CLIMATE CHANGE 2013; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Confalonieri U, 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013; Cubash U., 2013, CLIMATE CHANGE 2013, P119, DOI DOI 10.1017/CBO9781107415324.007; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis RE, 2003, ENVIRON HEALTH PERSP, V111, P1712, DOI 10.1289/ehp.6336; Davis RE, 2016, ENVIRON HEALTH PERSP, V124, P795, DOI 10.1289/ehp.1509946; de' Donato FK, 2015, INT J ENV RES PUB HE, V12, P15567, DOI 10.3390/ijerph121215006; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dessai S, 2003, INT J BIOMETEOROL, V48, P37, DOI 10.1007/s00484-003-0180-4; Dixon KW, 2016, CLIMATIC CHANGE, V135, P395, DOI 10.1007/s10584-016-1598-0; Dousset B, 2011, INT J CLIMATOL, V31, P313, DOI 10.1002/joc.2222; Doyon B, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-23; El-Fadel M, 2013, REG ENVIRON CHANGE, V13, P1059, DOI 10.1007/s10113-013-0415-9; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Flato G., 2013, CLIMATE CHANGE 2013, P741; Garrett AT, 2012, EUR J APPL PHYSIOL, V112, P1827, DOI 10.1007/s00421-011-2153-3; Gasparrini A, 2015, ENVIRON HEALTH PERSP, V123, P1200, DOI 10.1289/ehp.1409070; Giorgi F, 2015, ANNU REV ENV RESOUR, V40, P467, DOI 10.1146/annurev-environ-102014-021217; Gosling S. N., 2016, ENV HLTH PE IN PRESS; Gosling SN, 2012, CLIMATIC CHANGE, V112, P217, DOI 10.1007/s10584-011-0211-9; Gosling SN, 2009, CLIMATIC CHANGE, V92, P299, DOI [10.1007/s10584-008-9441-x, 10.1007/S10584-008-9441-X]; Gosling S, 2009, INT J BIOMETEOROL, V53, P31, DOI 10.1007/s00484-008-0189-9; GOVER MARY, 1938, PUBL HEALTH REPTS, V53, P1122, DOI 10.2307/4582590; Greene S, 2011, WEATHER CLIM SOC, V3, P281, DOI 10.1175/WCAS-D-11-00055.1; Guest CS, 1999, CLIMATE RES, V13, P1, DOI 10.3354/cr013001; Guo YM, 2016, ENVIRON POLLUT, V208, P66, DOI 10.1016/j.envpol.2015.09.041; Ha J, 2011, ENVIRON HEALTH PERSP, V119, P542, DOI 10.1289/ehp.1002080; Hajat S, 2002, J EPIDEMIOL COMMUN H, V56, P367, DOI 10.1136/jech.56.5.367; Hajat S, 2014, J EPIDEMIOL COMMUN H, V68, P641, DOI 10.1136/jech-2013-202449; Hajat S, 2010, AM J PUBLIC HEALTH, V100, P1137, DOI 10.2105/AJPH.2009.169748; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hayhoe K, 2010, J GREAT LAKES RES, V36, P65, DOI 10.1016/j.jglr.2009.12.009; Heaviside C, 2016, SCI TOTAL ENVIRON, V569, P627, DOI 10.1016/j.scitotenv.2016.06.138; Heaviside C, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0100-9; Honda Y, 2014, ENVIRON HEALTH PREV, V19, P56, DOI 10.1007/s12199-013-0354-6; Hondula DM, 2014, SCI TOTAL ENVIRON, V490, P538, DOI 10.1016/j.scitotenv.2014.04.130; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Huynen MMTE, 2015, INT J ENV RES PUB HE, V12, P13295, DOI 10.3390/ijerph121013295; Jackson JE, 2010, CLIMATIC CHANGE, V102, P159, DOI 10.1007/s10584-010-9852-3; Jenkins K, 2014, CLIMATIC CHANGE, V124, P105, DOI 10.1007/s10584-014-1105-4; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.1289/ehp.9710584; KALKSTEIN LS, 1993, LANCET, V342, P1397, DOI 10.1016/0140-6736(93)92757-K; KALKSTEIN LS, 1993, EXPERIENTIA, V49, P969, DOI 10.1007/BF02125644; Kalkstein LS, 1988, PUBLICATIONS CLIMATO, V41; Kim DW, 2016, NAT HAZARDS, V80, P623, DOI 10.1007/s11069-015-1987-0; Kim YM, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00003; Kingsley SL, 2016, ENVIRON HEALTH PERSP, V124, P460, DOI 10.1289/ehp.1408826; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Lee JY, 2016, ENVIRON INT, V94, P489, DOI 10.1016/j.envint.2016.06.007; Leggett J, 1992, EMISSIONS SCENARIOS; Li T, 2016, SCI REPS, V6, P21861; Li TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep11441; Li TT, 2013, NAT CLIM CHANGE, V3, P717, DOI [10.1038/nclimate1902, 10.1038/NCLIMATE1902]; Linares C, 2014, ENVIRON HEALTH PERSP, V122, pA118, DOI 10.1289/ehp.1308042; Lowe D, 2011, INT J ENV RES PUB HE, V8, P4623, DOI 10.3390/ijerph8124623; Martens WJM, 1998, SOC SCI MED, V46, P331, DOI 10.1016/S0277-9536(97)00162-7; Martin SL, 2012, INT J BIOMETEOROL, V56, P605, DOI 10.1007/s00484-011-0449-y; Martinez GS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3077-y; McSweeney CF, 2015, CLIM DYNAM, V44, P3237, DOI 10.1007/s00382-014-2418-8; Mearns LO, 2013, CLIMATIC CHANGE, V120, P965, DOI 10.1007/s10584-013-0831-3; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mills D, 2015, CLIMATIC CHANGE, V131, P83, DOI 10.1007/s10584-014-1154-8; Morabito M, 2012, SCI TOTAL ENVIRON, V441, P28, DOI 10.1016/j.scitotenv.2012.09.056; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Murari KK, 2015, REG ENVIRON CHANGE, V15, P569, DOI 10.1007/s10113-014-0660-6; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Muthers S, 2010, INT J ENV RES PUB HE, V7, P2965, DOI 10.3390/ijerph7072965; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ostro B, 2012, INT J BIOMETEOROL, V56, P1135, DOI 10.1007/s00484-012-0529-7; Ostro B, 2011, ENVIRON RES, V111, P1258, DOI 10.1016/j.envres.2011.08.013; Pascal Mathilde, 2012, PLoS Curr, V4, pRRN1307, DOI 10.1371/currents.RRN1307; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Petkova EP, 2017, ENVIRON HEALTH PERSP, V125, P47, DOI 10.1289/EHP166; Petkova EP, 2014, INT J ENV RES PUB HE, V11, P11371, DOI 10.3390/ijerph111111371; Petkova EP, 2013, INT J ENV RES PUB HE, V10, P6734, DOI 10.3390/ijerph10126734; Raisanen J, 2013, CLIM DYNAM, V41, P1553, DOI 10.1007/s00382-012-1515-9; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; Roldan E, 2016, STOCH ENV RES RISK A, V30, P831, DOI 10.1007/s00477-015-1068-7; Rouviere C, 1990, CLIMATE CHANGE: THE IPCC IMPACTS ASSESSMENT; Schwartz Joel D, 2015, Environ Health, V14, P85, DOI 10.1186/s12940-015-0071-2; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Sexton DMH, 2012, CLIM DYNAM, V38, P2513, DOI 10.1007/s00382-011-1208-9; Sheridan SC, 2012, CLIMATIC CHANGE, V115, P311, DOI 10.1007/s10584-012-0437-1; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Stafoggia M, 2009, EPIDEMIOLOGY, V20, P575, DOI 10.1097/EDE.0b013e31819ecdf0; Stocker T. F., 2010, M INT PAN CLIM CHANG; Takahashi K, 2007, J RISK RES, V10, P339, DOI 10.1080/13669870701217375; Tawatsupa B, 2014, INT J BIOMETEOROL, V58, P203, DOI 10.1007/s00484-012-0597-8; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; UK Health Security Agency, 2022, TB ACTION PLAN ENGLA; United Nations, 2014, STESASERA352 UN; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; Vardoulakis S, 2014, ENVIRON HEALTH PERSP, V122, P1285, DOI 10.1289/ehp.1307524; Vautard R, 2013, CLIM DYNAM, V41, P2555, DOI 10.1007/s00382-013-1714-z; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y; Watkins R., 2002, Building Services Engineering Research & Technology, V23, P97, DOI 10.1191/0143624402bt031oa; Watkiss P, 2012, CLIMATIC CHANGE, V112, P101, DOI 10.1007/s10584-011-0342-z; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Wu JY, 2014, ENVIRON HEALTH PERSP, V122, P10, DOI [10.1289/ehp.1306670, 10.1289/ehp.1307701]; Xu ZW, 2016, ENVIRON INT, V89-90, P193, DOI 10.1016/j.envint.2016.02.007; Zacharias S, 2015, CLIMATE, V3, P100, DOI 10.3390/cli3010100; Zhang J, 2014, BIOMED ENVIRON SCI, V27, P485, DOI 10.3967/bes2014.080; Zhou JW, 2012, J AGR BIOL ENVIR ST, V17, P377, DOI 10.1007/s13253-012-0105-y	129	46	46	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180369	10.1371/journal.pone.0180369	http://dx.doi.org/10.1371/journal.pone.0180369			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686743	gold, Green Published, Green Accepted			2022-12-27	WOS:000405464100056
J	Schaefer, HL; Brandes, H; Ulber, B; Becker, HC; Vidal, S				Schaefer, Heike L.; Brandes, Haiko; Ulber, Bernd; Becker, Heiko C.; Vidal, Stefan			Evaluation of nine genotypes of oilseed rape (Brassica napus L.) for larval infestation and performance of rape stem weevil (Ceutorhynchus napi Gyll.)	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; CABBAGE SEEDPOD WEEVIL; MELIGETHES-AENEUS; POLLEN BEETLE; COLEOPTERA-CHRYSOMELIDAE; EUROPEAN POPULATIONS; PLANT-DAMAGE; RESISTANCE; OVIPOSITION; LEPIDOPTERA	The rape stem weevil, Ceutorhynchus napi Gyll., is a serious pest of winter oilseed rape (Brassica napus L.) crops in Europe causing severe yield loss. In currently used oilseed rape cultivars no resistance to C. napi has been identified. Resynthesized lines of B. napus have potential to broaden the genetic variability and may improve resistance to insect pests. In this study, the susceptibility to C. napi of three cultivars, one breeding line and five resynthesized lines of oilseed rape was compared in a semi-field plot experiment under multichoice conditions. Plant acceptance for oviposition was estimated by counting the number of C. napi larvae in stems. The larval instar index and the dry body mass were assessed as indicators of larval performance. The extent of larval feeding within stems was determined by the stem injury coefficient. Morphological stem traits and stem contents of glucosinolates were assessed as potential mediators of resistance. The resynthesized line S30 had significantly fewer larvae than the cultivars Express617 and Visby and the resynthesized lines L122 and L16. The low level of larval infestation in S30 was associated with a low larval instar and stem injury index. Low numbers of larvae were not correlated with the length or diameter of stems, and the level of stem glucosinolates. As indicated by the low larval infestation and slow larval development the resistance of S30 to C. napi is based on both antixenotic and antibiotic properties of the genotypes. The resynthesized line S30 should therefore be introduced into B. napus breeding programs to enhance resistance against C. napi.	[Schaefer, Heike L.; Ulber, Bernd; Vidal, Stefan] Georg August Univ, Sect Agr Entomol, Dept Crop Sci, Div Plant Pathol & Plant Protect, Gottingen, Germany; [Brandes, Haiko; Becker, Heiko C.] Georg August Univ, Sect Plant Breeding, Dept Crop Sci, Gottingen, Germany	University of Gottingen; University of Gottingen	Schaefer, HL (corresponding author), Georg August Univ, Sect Agr Entomol, Dept Crop Sci, Div Plant Pathol & Plant Protect, Gottingen, Germany.	heike.schaefer@gmx.com	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) [313-06.01-28-1-45.071-10]; Board of support for Private Plant Breeding in Germany (GFP) [OE 137/10 IF]	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV); Board of support for Private Plant Breeding in Germany (GFP)	The study was funded by German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV; 313-06.01-28-1-45.071-10) and coordinated by the Board of support for Private Plant Breeding in Germany (GFP; OE 137/10 IF; http://www.bdp-online.de/de/GFPi/Abteilungen_Projekte/Abteilung_Oel-_und_Eiweisspflanzen/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alford David V., 2003, P9, DOI 10.1002/9780470750988.ch2; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Ballanger Y, 1987, PHYTOMA, V384, P35; Barari H, 2005, BIOCONTROL, V50, P69, DOI 10.1007/s10526-004-0895-0; Barari Hassan, 2004, IOBC-WPRS Bulletin, V27, P263; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bartlet E., 1999, Bulletin OILB/SROP, V22, P13; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baur R, 1998, CHEMOECOLOGY, V8, P163, DOI 10.1007/s000490050021; BODNARYK RP, 1992, PHYTOCHEMISTRY, V31, P2671, DOI 10.1016/0031-9422(92)83609-3; Buchi R, 1996, ANZ SCHADLINGSKD PFL, V69, P136, DOI 10.1007/BF01904715; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; BUCHI R, 1988, MITT SCHWEIZ LANDWIR, V35, P110; Cleemput S, 2012, GENET RESOUR CROP EV, V59, P539, DOI 10.1007/s10722-011-9701-x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Dechert G, 2004, AGR FOREST ENTOMOL, V6, P193, DOI 10.1111/j.1461-9555.2004.00220.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Diederichsen E, 1991, P 8 RAP C JUL 9 11 S; Eickerman M, 2014, EUR J ENTOMOL, V111, P243, DOI 10.14411/eje.2014.018; Eickermann M, 2011, B ENTOMOL RES, V101, P287, DOI 10.1017/S0007485310000489; Eickermann M, 2010, J APPL ENTOMOL, V134, P542, DOI 10.1111/j.1439-0418.2009.01449.x; Ferguson AW, 2003, AGR ECOSYST ENVIRON, V95, P509, DOI 10.1016/S0167-8809(02)00200-1; Ferguson AW, 1995, P 9 INT RAP C JUL 4; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; GIAMOUSTARIS A, 1995, ANN APPL BIOL, V126, P347, DOI 10.1111/j.1744-7348.1995.tb05371.x; Girke A., 2002, THESIS; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gunthart E., 1949, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V22, P441; Herve MR, 2014, ARTHROPOD-PLANT INTE, V8, P383, DOI 10.1007/s11829-014-9321-4; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; KOGAN M, 1978, Bulletin of the Entomological Society of America, V24, P175; Kovacs G, 2017, BIOCONTROL, V62, P29, DOI 10.1007/s10526-016-9765-9; Kowalski B. R., 1986, ANAL CHIM ACTA, V185, P17, DOI DOI 10.1016/0003-2670(86)80028-9; Kurtz B, 2010, ENVIRON ENTOMOL, V39, P1532, DOI 10.1603/EN10025; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Lee RWH, 2014, THEOR APPL GENET, V127, P419, DOI 10.1007/s00122-013-2228-0; LERIN J, 1993, IOBC WPRS B, V16, P160; Moyes CL, 2001, P ROY SOC B-BIOL SCI, V268, P1567, DOI 10.1098/rspb.2001.1685; Nauen R, 2012, PESTIC BIOCHEM PHYS, V103, P173, DOI 10.1016/j.pestbp.2012.04.012; Nilsson C, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P305, DOI 10.1007/978-90-481-3983-5_11; Nilsson Christer, 2004, IOBC-WPRS Bulletin, V27, P215; Nuss H., 2004, THESIS; Olsson G., 1980, Brassica crops and wild allies. [II]., P167; Renwick JAA, 2002, ENTOMOL EXP APPL, V104, P35, DOI 10.1023/A:1021231732022; RigginBucci TM, 1996, J ECON ENTOMOL, V89, P891, DOI 10.1093/jee/89.4.891; Rojas JC, 1999, ENVIRON ENTOMOL, V28, P588, DOI 10.1093/ee/28.4.588; Rygulla W, 2007, PHYTOPATHOLOGY, V97, P1391, DOI 10.1094/PHYTO-97-11-1391; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Siemens DH, 1996, ENVIRON ENTOMOL, V25, P1344, DOI 10.1093/ee/25.6.1344; Tansey JA, 2011, P 13 INT RAP C 2011; THIES W, 1977, Z PFLANZENZUCHT, V79, P331; Ulmer BJ, 2006, ENTOMOL EXP APPL, V121, P203, DOI [10.1111/j.1570-8703.2006.00480.x, 10.1111/j.1570-7458.2006.00480.x]; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5_1; Zimmer CT, 2014, ENTOMOL EXP APPL, V150, P279, DOI 10.1111/eea.12162	56	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180807	10.1371/journal.pone.0180807	http://dx.doi.org/10.1371/journal.pone.0180807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686731	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100109
J	Cheng, HM; Ning, YZ; Ma, XK; Liu, X; Zhang, ZY				Cheng, Hui-Min; Ning, Yi-Zi; Ma, Xiaoke; Liu, Xin; Zhang, Zhong-Yuan			Effectiveness of rapid rail transit system in Beijing	PLOS ONE			English	Article							TRANSPORTATION NETWORK; COMMUNITY STRUCTURE; CENTRALITY	The effectiveness of rapid rail transit system is analyzed using tools of complex network for the first time. We evaluated the effectiveness of the system in Beijing quantitatively from different perspectives, including descriptive statistics analysis, bridging property, centrality property, ability of connecting different part of the system and ability of disease spreading. The results showed that the public transport of Beijing does benefit from the rapid rail transit lines, and the benefit of different regions from RRTS is gradually decreased from the north to the south. The paper concluded with some policy suggestions regarding how to promote the system. This study offered significant insight that can help understand the public transportation better. The methodology can be easily applied to analyze other urban public systems, such as electricity grid, water system, to develop more livable cities.	[Cheng, Hui-Min; Ning, Yi-Zi; Liu, Xin; Zhang, Zhong-Yuan] Cent Univ Finance & Econ, Sch Stat & Math, Beijing, Peoples R China; [Ma, Xiaoke] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China	Central University of Finance & Economics; Xidian University	Zhang, ZY (corresponding author), Cent Univ Finance & Econ, Sch Stat & Math, Beijing, Peoples R China.	zhyuanzh@gmail.com			Program for Innovation Research in Central University of Finance and Economics; Young Elite Teacher Project of Central University of Finance and Economics; Disciplinary funding of Central University of Finance and Economics; National Natural Science Foundation of China [61203295]; NSFC [61502363, 61672406]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JQ6044]	Program for Innovation Research in Central University of Finance and Economics; Young Elite Teacher Project of Central University of Finance and Economics; Disciplinary funding of Central University of Finance and Economics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China	This study was supported by the Program for Innovation Research in Central University of Finance and Economics (Dr. Zhong-Yuan Zhang); Young Elite Teacher Project of Central University of Finance and Economics (Dr. Zhong-Yuan Zhang); Disciplinary funding of Central University of Finance and Economics (Dr. Zhong-Yuan Zhang); National Natural Science Foundation of China under Grant No. 61203295 to Dr. Zhong-Yuan Zhang; NSFC (Grant No. 61502363,61672406) to Dr. Xiaoke Ma; and the Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2016JQ6044) to Dr. Xiaoke Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bavelas A., 1950, J ACOUSTICAL SOC AM; Chen Q, 2016, J ADV TRANSPORT, V50, P949, DOI 10.1002/atr.1382; Chen Q, 2016, IEEE INTEL TRANSP SY, V8, P43, DOI 10.1109/MITS.2016.2549979; Cho SB, 2001, J REGIONAL SCI, V41, P39, DOI 10.1111/0022-4146.00206; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; De Leo V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042810; Derrible S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040575; Derrible S, 2010, PHYSICA A, V389, P3678, DOI 10.1016/j.physa.2010.04.008; Dong WH, 2014, SUSTAINABILITY-BASEL, V6, P7334, DOI 10.3390/su6107334; Easley D, 2010, NETWORKS CROWDS MARK; ERDdS P, 1959, PUBL MATH-DEBRECEN, V6, P290; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Jarboui S, 2012, PUBLIC TRANSPORT, V4, P101, DOI 10.1007/s12469-012-0055-3; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li W, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046106; Liu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162618; Nematzadeh A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.088701; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nicolaides C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040961; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang H, 2015, DISCRETE DYNAMICS NA, V2015; Zhou D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066103	32	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180075	10.1371/journal.pone.0180075	http://dx.doi.org/10.1371/journal.pone.0180075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704376	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700027
J	Idh, J; Andersson, B; Lerm, M; Raffetseder, J; Eklund, D; Woksepp, H; Werngren, J; Mansjo, M; Sundqvist, T; Stendahl, O; Schon, T				Idh, Jonna; Andersson, Blanka; Lerm, Maria; Raffetseder, Johanna; Eklund, Daniel; Woksepp, Hanna; Werngren, Jim; Mansjo, Mikael; Sundqvist, Tommy; Stendahl, Olle; Schon, Thomas			Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISONIAZID ACTIVATION; IN-VITRO; RESISTANCE; HOMEOSTASIS; INFECTION; REDUCTASE; DONORS; OXYGEN; KATG	Background Drugs such as isoniazid (INH) and pretomanid (PRT), used against Mycobacterium tuberculosis are active partly through generation of reactive nitrogen species (RNS). The aim of this study was to explore variability in intracellular susceptibility to nitric oxide (NO) in clinical strains of M. tuberculosis. Method Luciferase-expressing clinical M. tuberculosis strains with or without INH resistance were exposed to RNS donors (DETA/NO and SIN-1) in broth cultures and bacterial survival was analysed by luminometry. NO-dependent intracellular killing in a selection of strains was assessed in interferon gamma/lipopolysaccharide-activated murine macrophages using the NO inhibitor L-NMMA. Results When M. tuberculosis H37Rv was compared to six clinical isolates and CDC1551, three isolates with inhA mediated INH resistance showed significantly reduced NO-susceptibility in broth culture. All strains showed a variable but dose-dependent susceptibility to RNS donors. Two clinical isolates with increased susceptibility to NO exposure in broth compared to H37Rv were significantly inhibited by activated macrophages whereas there was no effect on growth inhibition when activated macrophages were infected by clinical strains with higher survival to NO exposure in broth. Furthermore, the most NO-tolerant clinical isolate showed increased resistance to PRT both in broth culture and the macrophage model compared to H37Rv in the absence of mutational resistance in genes associated to reduced susceptibility against PRT or NO. Conclusion In a limited number of clinical M. tuberculosis isolates we found a significant difference in susceptibility to NO between clinical isolates, both in broth cultures and in macrophages. Our results indicate that mycobacterial susceptibility to cellular host defence mechanisms such as NO need to be taken into consideration when designing new therapeutic strategies.	[Idh, Jonna; Andersson, Blanka; Lerm, Maria; Raffetseder, Johanna; Eklund, Daniel; Sundqvist, Tommy; Stendahl, Olle; Schon, Thomas] Linkoping Univ, Dept Clin & Expt Med, Div Microbiol & Mol Med, Linkoping, Sweden; [Lerm, Maria] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Woksepp, Hanna; Schon, Thomas] Linneaus Univ, Dept Optometry & Med, Kalmar, Sweden; [Woksepp, Hanna; Schon, Thomas] Kalmar Cty Hosp, Dept Infect Dis & Clin Microbiol, Kalmar, Sweden; [Werngren, Jim; Mansjo, Mikael] Publ Hlth Agcy Sweden, Dept Microbiol, Unit Lab Surveillance Bacterial Pathogens, Solna, Sweden	Linkoping University; Karolinska Institutet; Linnaeus University; Public Health Agency of Sweden	Schon, T (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Microbiol & Mol Med, Linkoping, Sweden.; Schon, T (corresponding author), Linneaus Univ, Dept Optometry & Med, Kalmar, Sweden.; Schon, T (corresponding author), Kalmar Cty Hosp, Dept Infect Dis & Clin Microbiol, Kalmar, Sweden.	tschon@hotmail.com	Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Woksepp, Hanna/0000-0002-1707-2655; Eklund, Daniel/0000-0002-6045-4800; Raffetseder, Johanna/0000-0001-8871-2560	Research Council of South East of Sweden; Swedish Heart and Lung Foundation; Swedish Research Council	Research Council of South East of Sweden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was financially supported by the Research Council of South East of Sweden (TSc; FORSS, http://www.fou.nu/is/forss), the Swedish Heart and Lung Foundation (OS, TSc; https://www3.hjart-lungfonden.se, (Oscar II Jubilee Foundation) and the Swedish Research Council (TSc, OS; http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Attarian R, 2009, FEBS LETT, V583, P3215, DOI 10.1016/j.febslet.2009.09.007; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Firmani MA, 2002, INFECT IMMUN, V70, P3965, DOI 10.1128/IAI.70.7.3965-3968.2002; Flynn JL, 1998, J IMMUNOL, V160, P1796; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; Idh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039891; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Liu YC, 2016, J EXP MED, V213, P809, DOI 10.1084/jem.20151248; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Martin-Romero FJ, 2004, J FLUORESC, V14, P17, DOI 10.1023/B:JOFL.0000014655.89256.bd; Miranda KM EM, 2010, NITRIC OXIDE; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2008, SCIENCE, V322, P1337, DOI 10.1126/science.1167452; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Schon T, 2004, INT J TUBERC LUNG D, V8, P1134; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shi SP, 2006, INFECT IMMUN, V74, P56, DOI 10.1128/IAI.74.1.56-63.2006; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timmins GS, 2004, J BACTERIOL, V186, P5427, DOI 10.1128/JB.186.16.5427-5431.2004; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181221	10.1371/journal.pone.0181221	http://dx.doi.org/10.1371/journal.pone.0181221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704501	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700109
J	Matthews, GJ; Thiruvathukal, GK; Luetkemeier, MP; Brophy, JK				Matthews, Gregory J.; Thiruvathukal, George K.; Luetkemeier, Maxwell P.; Brophy, Juliet K.			Examining the use of Amazon's Mechanical Turk for edge extraction of the occlusal surface of fossilized bovid teeth	PLOS ONE			English	Article							GAUTENG PROVINCE; PLOVERS LAKE	In order to reconstruct environments associated with Plio-Pleistocene hominins in southern Africa, researchers frequently rely upon the animals associated with the hominins, in particular, animals in the Family Bovidae. Bovids in southern Africa are typically identified by their teeth. However, identifying the taxon of a bovid tooth is challenging due to various biasing factors. Furthermore, inaccurate identification of fossil bovids can have significant consequences on the reconstructed paleoenvironment. Recent research on the classification of bovid fossil teeth has relied on using elliptical Fourier analysis to summarize the shape of the outline of the occlusal surface of the tooth and the resulting harmonic amplitudes. Currently, an expert in the field must manually place landmarks around the edges of each tooth which is slow and time consuming. This study tests whether it is possible to crowdsource this task, while maintaining the necessary level of quality needed to perform a statistical analysis on each tooth. Amazon Mechanical Turk workers place landmarks on the edge of the tooth which is compared to the performance of an expert in the field. The results suggest that crowdsourcing the digitization process is reliable and replicable. With the technical aspects of digitization managed, researchers can concentrate on analyzing and interpreting the data.	[Matthews, Gregory J.; Luetkemeier, Maxwell P.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Thiruvathukal, George K.] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA; [Brophy, Juliet K.] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA	Loyola University Chicago; Loyola University Chicago; Louisiana State University System; Louisiana State University	Matthews, GJ (corresponding author), Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA.	gmatthews1@luc.edu						Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bright JA, 2014, J PALEONTOL, V88, P760, DOI 10.1666/13-090; Brophy JK, 2011, RECONSTRUCTING HABIT; Brophy JK, 2014, J ARCHAEOL SCI, V41, P376, DOI 10.1016/j.jas.2013.08.005; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cooke HBS, 1956, FOSSIL BOVIDAE LIMEW; de Ruiter DJ, 2008, J HUM EVOL, V55, P1102, DOI 10.1016/j.jhevol.2008.07.011; Drake AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08299; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Kendall DG, 1982, B LOND MATH SOC, V16, P81; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LESTREL P E, 1989, American Journal of Human Biology, V1, P149, DOI 10.1002/ajhb.1310010204; Lindeberg T, 1998, INT J COMPUT VISION, V30, P117, DOI 10.1023/A:1008097225773; Matthews GJ, 2016, COMP MACHINE LEARNIN; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Polly PD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111225; R Core Team, 2021, R LANGUAGE ENV STAT; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Rouse SV, 2015, COMPUT HUM BEHAV, V43, P304, DOI 10.1016/j.chb.2014.11.004; Sorokin A., 2008, P 1 IEEE WORKSH INT, V08, P1, DOI DOI 10.1109/CVPRW.2008.4562953; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; The GIMP Development Team, 2016, GMU IM MAN PROGR GIM; Vittayakorn S, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.109; Vrba ES, 1995, FOSSIL RECORD AFRICA; Wolfe CA, 1999, EFF23 2 D 3 D ELLIPT	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179757	10.1371/journal.pone.0179757	http://dx.doi.org/10.1371/journal.pone.0179757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704414	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700017
J	Nyoka, R; Foote, AD; Woods, E; Lokey, H; O'Reilly, CE; Magumba, F; Okello, P; Mintz, ED; Marano, N; Morris, JF				Nyoka, Raymond; Foote, Andrew D.; Woods, Emily; Lokey, Hana; O'Reilly, Ciara E.; Magumba, Fred; Okello, Patrick; Mintz, Eric D.; Marano, Nina; Morris, Jamae F.			Sanitation practices and perceptions in Kakuma refugee camp, Kenya: Comparing the status quo with a novel service-based approach	PLOS ONE			English	Article							HYGIENE; DISEASE; AFRICA; WATER; SUDAN	Globally, an estimated 2.5 billion people lack access to improved sanitation. Unimproved sanitation increases the risk of morbidity and mortality, especially in protracted refugee situations where sanitation is based on pit latrine use. Once the pit is full, waste remains in the pit, necessitating the construction of a new latrine, straining available land and funding resources. A viable, sustainable solution is needed. This study used qualitative and quantitative methods to design, implement, and pilot a novel sanitation system in Kakuma refugee camp, Kenya. An initial round of 12 pre-implementation focus group discussions (FGDs) were conducted with Dinka and Somali residents to understand sanitation practices, perceptions, and needs. FGDs and a supplementary pre-implementation survey informed the development of an innovative sanitation management system that incorporated the provision of urine and liquid-diverting toilets, which separate urine and fecal waste, and a servicebased sanitation system that included weekly waste collection. The new system was implemented on a pilot scale for 6 weeks. During the implementation, bi-weekly surveys were administered in each study household to monitor user perceptions and challenges. At the end of the pilot, the sanitation system was assessed using a second round of four postimplementation FGDs. Those who piloted the new sanitation system reported high levels of user satisfaction. Reported benefits included odor reduction, insect/pest reduction, the sitting design, the appropriateness for special populations, and waste collection. However, urine and liquid diversion presented a challenge for users who perform anal washing and for women who had experienced female genital mutilation. Refugee populations are often culturally and ethnically diverse. Using residents' input to inform the development of sanitation solutions can increase user acceptability and provide opportunities to improve sanitation system designs based on specific needs.	[Nyoka, Raymond; Marano, Nina] CDC Kenya, Nairobi, Kenya; [Foote, Andrew D.; Woods, Emily; Lokey, Hana] Sanivat LLC, Naivasha, Kenya; [O'Reilly, Ciara E.; Mintz, Eric D.; Morris, Jamae F.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Magumba, Fred; Okello, Patrick] Norwegian Refugee Council, Nairobi, Kenya; [Morris, Jamae F.] Georgia State Univ, African Amer Studies, Atlanta, GA 30303 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University	Morris, JF (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.; Morris, JF (corresponding author), Georgia State Univ, African Amer Studies, Atlanta, GA 30303 USA.	jmorris60@gsu.edu			CDC through the CDC KEMRI Cooperative Agreement	CDC through the CDC KEMRI Cooperative Agreement	The study was entirely funded by CDC in part through the CDC KEMRI Cooperative Agreement and in part through salary and travel support for CDC co-authors. The funder (CDC) provided support in the form of salaries for authors employed by the CDC [RN, CO, EM, NM, JM], and provided support to Sanivation for implementation of the study. CDC co-authors had a direct role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Biran A, 2012, TROP MED INT HEALTH, V17, P1133, DOI 10.1111/j.1365-3156.2012.03045.x; Byler R, 2015, PROCEEDINGS OF THE FIFTH IEEE GLOBAL HUMANITARIAN TECHNOLOGY CONFERENCE GHTC 2015, P123; Clasen TF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub3; Corcoran E., 2010, SICK WATER CENTRAL R, P85; Cronin AA, 2008, J WATER HEALTH, V6, P1, DOI 10.2166/wh.2007.019; Cronin AA, 2009, J WATER HEALTH, V7, P557, DOI 10.2166/wh.2009.089; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Galan DI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-527; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Kalipeni E, 1998, SOC SCI MED, V46, P1637, DOI 10.1016/S0277-9536(97)10129-0; Kwan CML, 2011, ASIAN AM J PSYCHOL, V2, P115, DOI 10.1037/a0024184; Mahamud AS, 2012, J INFECT DEV COUNTR, V6, P234, DOI 10.3855/jidc.1966; Majorin F, 2014, COCHRANE DATABASE SY; Moller KA, 2012, ENVIRON URBAN, V24, P305, DOI 10.1177/0956247811434259; Munch E, 2006, WATER SUPPLY, P506; Murphy JL, 2014, 2014 WAT HLTH C SCI; Mwase H., 2006, POTENTIAL ECOSAN PRO; Ngala P, 2014, 37 WEDC INT C HAN VI; Shultz A, 2009, AM J TROP MED HYG, V80, P640, DOI 10.4269/ajtmh.2009.80.640; The Sphere Project, 2012, SPHER HDB HUM CHART; Thomson K, 2013, MMWR-MORBID MORTAL W, V62, P581; Toole M. J., 1992, Journal of Refugee Studies, V5, P313, DOI 10.1093/jrs/5.3-4.313; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; UN Water, 2014, PROGR DRINK WAT SAN, P1; UNHCR,, 2006, HUMAN INTELLIGENCE; UNHCR, 2012, KEN CAMP SEES INFL S; UNHCR, 2015, GLOB APP 2015 UPD; UNHCR, 2014, SIT REP 2014 KAK KEN; Unicef and World Health Organization, 2015, PROGR SAN DRINK WAT, P50; Unicef and World Health Organization, 2012, PROGR DRINK WAT SAN; United Nations High Commissioner for Refugees, 2015, IMPR SAN REF CAMPS; United Nations High Commissioner for Refugees UC of L and IRC, 2012, SENS NUTR SURV REP K; Wasonga J., 2015, Waterlines, V34, P174, DOI 10.3362/1756-3488.2015.016; WHO, FACT SHEETS ENV SAN	34	14	14	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180864	10.1371/journal.pone.0180864	http://dx.doi.org/10.1371/journal.pone.0180864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704504	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700057
J	Zhao, J; Bi, HY; Coltheart, M				Zhao, Jing; Bi, Hong-Yan; Coltheart, Max			Different relationship of magnocellular-dorsal function and reading-related skills between Chinese developing and skilled readers	PLOS ONE			English	Article							PHONOLOGICAL AWARENESS; DEVELOPMENTAL DYSLEXIA; FMRI EVIDENCE; CHILDREN; DEFICITS; PATHWAY; ATTENTION; DYSFUNCTION; STREAM; SENSITIVITY	Previous studies have indicated that the relationship between magnocellular-dorsal (M-D) function and reading-related skills may vary with reading development in readers of alphabetic languages. Since this relationship could be affected by the orthographic depth of writing systems, the present study explored the relationship between M-D function and readingrelated skills in Chinese, a writing system with a deeper orthography than alphabetic languages. Thirty-seven primary school students and fifty-one undergraduate students participated. Orthographic and phonological awareness tests were adopted as reading-related skill measurements. A steady-pedestal paradigm was used to assess the low-spatial-frequency contrast thresholds of M-D function. Results showed that M-D function was only correlated with orthographic awareness for adults, revealing an enhancement with reading development; while being related to phonological awareness only for children revealing a developmental decrement. It suggested that the mechanism responsible for the relationship between M-D activity and reading-related skills was affected by the characteristics of literacy development in Chinese.	[Zhao, Jing; Bi, Hong-Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Ctr Brain Sci & Learning Difficulties, Beijing, Peoples R China; [Zhao, Jing; Bi, Hong-Yan] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Coltheart, Max] Macquarie Univ, Ctr Cognit & Its Disorders, Sydney, NSW, Australia	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Macquarie University	Bi, HY (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Ctr Brain Sci & Learning Difficulties, Beijing, Peoples R China.; Bi, HY (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.	bihy@psych.ac.cn	zhao, jing/B-3868-2019	Coltheart, Max/0000-0002-6580-0047	National Natural Science Foundation of China [31371044, 31671155, 31500903]; Beijing Advanced Innovation Center for Imaging Technology [BAICIT-2016018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Advanced Innovation Center for Imaging Technology	This research is supported by National Natural Science Foundation of China (grant numbers: 31371044, 31671155, 31500903), and Beijing Advanced Innovation Center for Imaging Technology (grant numbers: BAICIT-2016018). The website for National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The funders had a role in data collection of the manuscript.	Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar-Kochva I, 2013, READ WRIT, V26, P1417, DOI 10.1007/s11145-012-9414-3; Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Boden C, 2009, BRAIN COGNITION, V69, P580, DOI 10.1016/j.bandc.2008.12.002; Boden C, 2007, PSYCHOL BULL, V133, P346, DOI 10.1037/0033-2909.133.2.346; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Cao F, 2011, NEUROIMAGE, V57, P750, DOI 10.1016/j.neuroimage.2010.09.047; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Chung KKH, 2008, ANN DYSLEXIA, V58, P15, DOI 10.1007/s11881-008-0015-4; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Danelli L, 2013, HUM BRAIN MAPP, V34, P2669, DOI 10.1002/hbm.22098; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Giraldo-Chica M, 2015, NEUROIMAGE-CLIN, V7, P830, DOI 10.1016/j.nicl.2015.03.011; Goodbourn PT, 2012, P ROY SOC B-BIOL SCI, V279, P4263, DOI 10.1098/rspb.2012.1430; Gori S, 2016, CEREB CORTEX, V26, P4356, DOI 10.1093/cercor/bhv206; Gori S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00460; Gori S, 2014, VISION RES, V99, P78, DOI 10.1016/j.visres.2013.11.011; Grainger J, 2012, COGNITION, V123, P280, DOI 10.1016/j.cognition.2012.01.003; Heim S, 2014, BRAIN STRUCT FUNCT, V219, P461, DOI 10.1007/s00429-013-0509-7; Heim S, 2010, DYSLEXIA, V16, P258, DOI 10.1002/dys.409; Horie S, 2012, NEUROIMAGE, V63, P979, DOI 10.1016/j.neuroimage.2012.03.046; HUANG HS, 1995, COGNITION, V54, P73, DOI 10.1016/0010-0277(94)00641-W; Jednorog K, 2011, DEVELOPMENTAL SCI, V14, P873, DOI 10.1111/j.1467-7687.2011.01037.x; Kevan A, 2008, NEUROREPORT, V19, P467, DOI 10.1097/WNR.0b013e3282f5f7ad; Kevan A, 2009, NEUROPSYCHOLOGIA, V47, P3174, DOI 10.1016/j.neuropsychologia.2009.07.016; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1494, DOI 10.1016/j.neubiorev.2008.06.002; Levy T, 2010, VISION RES, V50, P883, DOI 10.1016/j.visres.2010.02.019; Luo YC, 2013, SCI STUD READ, V17, P22, DOI 10.1080/10888438.2012.689790; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; McBride-Chang C, 2011, J CHILD PSYCHOL PSYC, V52, P204, DOI 10.1111/j.1469-7610.2010.02299.x; McLean GMT, 2011, J EXP PSYCHOL HUMAN, V37, P1957, DOI 10.1037/a0024668; Meng XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108274; Meng XZ, 2011, ANN DYSLEXIA, V61, P161, DOI 10.1007/s11881-010-0049-2; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Olulade OA, 2013, NEURON, V79, P180, DOI 10.1016/j.neuron.2013.05.002; Pammer K, 2007, SCI STUD READ, V11, P33; Peng DS, 2004, COGNITIVE BRAIN RES, V20, P156, DOI 10.1016/j.cogbrainres.2004.02.006; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Pokorny J, 2011, J VISION, V11, DOI 10.1167/11.5.7; Qian Y, 2016, BRAIN LANG, V160, P42, DOI 10.1016/j.bandl.2016.07.007; Qian Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01529; Qian Y, 2015, NEUROPSYCHOLOGIA, V71, P84, DOI 10.1016/j.neuropsychologia.2015.03.024; Qian Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00692; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Ruffino M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00331; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Stein J., 2012, VISUAL ASPECTS DYSLE, P405; Stein John, 2014, Curr Dev Disord Rep, V1, P267; Tholen N, 2011, DYSLEXIA, V17, P268, DOI 10.1002/dys.434; Wang JJ, 2010, NEUROPSYCHOLOGIA, V48, P3627, DOI 10.1016/j.neuropsychologia.2010.08.015; Wang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044848; Wang ZK, 2014, DYSLEXIA, V20, P280, DOI 10.1002/dys.1475; Wei TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096240; X C Guo, 2000, PSYCHOL SCI, V23, P576; Xu GF, 2012, NEUROPSYCHOLOGIA, V50, P862, DOI 10.1016/j.neuropsychologia.2012.01.026; Zhao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07068; Zhao J, 2013, PROG BIOCHEM BIOPHYS, V40, P141, DOI 10.3724/SP.J.1206.2012.00262; Zhou W, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00495	67	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179712	10.1371/journal.pone.0179712	http://dx.doi.org/10.1371/journal.pone.0179712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704422	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700014
J	Doyle, RM; Harris, K; Kamiza, S; Harjunmaa, U; Ashorn, U; Nkhoma, M; Dewey, KG; Maleta, K; Ashorn, P; Klein, N				Doyle, Ronan M.; Harris, Kathryn; Kamiza, Steve; Harjunmaa, Ulla; Ashorn, Ulla; Nkhoma, Minyanga; Dewey, Kathryn G.; Maleta, Kenneth; Ashorn, Per; Klein, Nigel			Bacterial communities found in placental tissues are associated with severe chorioamnionitis and adverse birth outcomes	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; PREGNANT-WOMEN; PRETERM LABOR; FETAL MEMBRANES; INFECTION; ANTIBIOTICS; PREVALENCE; DIVERSITY; DELIVERY; MALAWI	Preterm birth is a major cause of neonatal mortality and morbidity worldwide. Bacterial infection and the subsequent inflammatory response are recognised as an important cause of preterm birth. It is hypothesised that these organisms ascend the cervical canal, colonise placental tissues, cause chorioamnionitis and in severe cases infect amniotic fluid and the foetus. However, the presence of bacteria within the intrauterine cavity does not always precede chorioamnionitis or preterm birth. Whereas previous studies observing the types of bacteria present have been limited in size and the specificity of a few predetermined organisms, in this study we characterised bacteria found in placental tissues from a cohort of 1391 women in rural Malawi using 16S ribosomal RNA gene sequencing. We found that specific bacteria found concurrently on placental tissues associate with chorioamnionitis and delivery of a smaller newborn. Severe chorioamnionitis was associated with a distinct difference in community members, a higher bacterial load and lower species richness. Furthermore, Sneathia sanguinengens and Peptostreptococcus anaerobius found in both matched participant vaginal and placental samples were associated with a lower newborn length-for-age Z-score. This is the largest study to date to examine the placental microbiome and its impact of birth outcomes. Our results provide data on the role of the vaginal microbiome as a source of placental infection as well as the possibility of therapeutic interventions against targeted organisms during pregnancy.	[Doyle, Ronan M.; Klein, Nigel] UCL, UCL Great Ormond St Inst Child Hlth, London, England; [Doyle, Ronan M.; Harris, Kathryn] Great Ormond St Hosp NHS Fdn Trust, Dept Microbiol Virol & Infect Control, London, England; [Kamiza, Steve] Univ Malawi, Coll Med, Dept Pathol, Blantyre, Malawi; [Harjunmaa, Ulla] Univ Tampere, Fac Med & Life Sci, Ctr Child Hlth Res, Tampere, Finland; [Harjunmaa, Ulla] Tampere Univ Hosp, Tampere, Finland; [Ashorn, Ulla; Nkhoma, Minyanga; Ashorn, Per] Univ Tampere, Sch Med, Dept Int Hlth, Tampere, Finland; [Dewey, Kathryn G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Maleta, Kenneth] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Ashorn, Per] Univ Tampere, Sch Med, Dept Paediat, Tampere, Finland; [Ashorn, Per] Tampere Univ Hosp, Dept Paediat, Tampere, Finland	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Malawi; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of California System; University of California Davis; University of Malawi; Tampere University; Tampere University; Tampere University Hospital	Doyle, RM (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, London, England.; Doyle, RM (corresponding author), Great Ormond St Hosp NHS Fdn Trust, Dept Microbiol Virol & Infect Control, London, England.	ronan.doyle.10@ucl.ac.uk	Doyle, Ronan/L-8091-2019; Maleta, Ken M/J-2821-2016	Doyle, Ronan/0000-0001-5001-1945; Maleta, Ken M/0000-0002-2536-3938; Klein, Nigel/0000-0003-3925-9258; Harris, Kathryn/0000-0003-3807-9749; Ashorn, Per/0000-0003-2311-2593	Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) through the Food and Nutrition Technical Assistance III Project (FANTA) [AID-OAA-A-12-00005]; Bill & Melinda Gates Foundation; Academy of Finland [252075]; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9S001]; Great Ormond Street Hospital Childrens Charity [W1068] Funding Source: researchfish	Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) through the Food and Nutrition Technical Assistance III Project (FANTA)(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Academy of Finland(Academy of Finland); Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Great Ormond Street Hospital Childrens Charity	This publication is based on research funded by a grant to the University of California, Davis from the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development (USAID) under terms of Cooperative Agreement No. AID-OAA-A-12-00005, through the Food and Nutrition Technical Assistance III Project (FANTA), managed by FHI 360. Additional support was provided by the Bill & Melinda Gates Foundation through a grant to the University of California Davis, the Academy of Finland (Grant 252075), and the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (Grant 9S001). The findings and conclusions contained within the article are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation, USAID, the US government, or the other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ashorn, 2017, FHI 360FOOD NUTR TEC, P148; Ashorn P, 2015, AM J CLIN NUTR  0201; Ashorn P, 2017, ASS NUTR STRESS IN 2; Ashorn P, 2017, PATHWAYS LEADING A 3; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P1, DOI 10.1007/BF02718272; Cheung YB., 2013, STAT ANAL HUMAN GROW; da Mota VQ, 2013, J CLIN PATHOL, V66, P243, DOI 10.1136/jclinpath-2012-201124; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; DiGiulio DB, 2015, P NATL ACAD SCI; Doyle RM, 2014, PLACENTA, V35, P1099, DOI 10.1016/j.placenta.2014.10.007; Fall CHD, 2009, FOOD NUTR BULL, V30, pS533, DOI 10.1177/15648265090304S408; Fettweis JM, 2014, MICROBIOL READ  0729; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1065, DOI 10.1016/j.ajog.2006.05.046; Gonzales-Marin C, 2012, J MED MICROBIOL; Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Harjunmaa U, 2015, TROP MED INT HLTH; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schmiedel D, 2014, CLIN MICROBIOL INFEC, V20, pO538, DOI 10.1111/1469-0691.12526; Sebire N J, 2001, J Obstet Gynaecol, V21, P242; Shaw L, 2016, APPL ENVIRON MICROB, V82, P6057, DOI 10.1128/AEM.01756-16; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; van den Broek NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090128; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoon BH, 1998, AM J OBSTET GYNECOL, V179, P1254, DOI 10.1016/S0002-9378(98)70142-5	48	68	73	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180167	10.1371/journal.pone.0180167	http://dx.doi.org/10.1371/journal.pone.0180167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700642	Green Published, gold, Green Accepted			2022-12-27	WOS:000405649600019
J	Lu, CL; Chu, A; Li, ZH; Shen, J; Subramanian, S; Hill, K				Lu, Chunling; Chu, Annie; Li, Zhihui; Shen, Jian; Subramanian, Subu; Hill, Kenneth			Assessing development assistance for child survival between 2000 and 2014: A multisectoral perspective	PLOS ONE			English	Article							OFFICIAL DEVELOPMENT ASSISTANCE; MATERNAL EDUCATION; NEWBORN BABIES; HEALTH; INTERVENTIONS; COUNTDOWN; MORTALITY; LIFE	Background The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on aid targeting reproductive, maternal, newborn, and child health (RMNCH). We take a multi-sectoral approach and extend the estimation to the four sectors that determine child survival: health (RMNCH and non-RMNCH), education, water and sanitation, and food and humanitarian assistance (Food/HA). Methods and findings Using donor reported data, obtained mainly from the OECD Creditor Reporting System and Development Assistance Committee, we tracked the level and trends of aid (in grants or loans) disbursed to each of the four sectors at the global, regional, and country levels. We performed detailed analyses on missing data and conducted imputation with various methods. To identify aid projects for RMNCH, we developed an identification strategy that combined keyword searches and manual coding. To quantify aid for RMNCH in projects with multiple purposes, we adopted an integrated approach and produced the lower and upper bounds of estimates for RMNCH, so as to avoid making assumptions or using weak evidence for allocation. We checked the sensitivity of trends to the estimation methods and compared our estimates to that produced by other studies. Our study yielded time-series and recipient-specific annual estimates of aid disbursed to each sector, as well as their lower- and upper-bounds in 134 countries between 2000 and 2014, with a specific focus on Countdown countries. We found that the upper-bound estimates of total aid disbursed to the four sectors in 134 countries rose from US$ 22.62 billion in 2000 to US$ 59.29 billion in 2014, with the increase occurring in all income groups and regions with sub-Saharan Africa receiving the largest sum. Aid to RMNCH has experienced the fastest growth (12.4%), followed by aid to Food/HA (9.4%), education (5.1%), and water and sanitation (5.0%). With the exception of RMNCH, the average per capita aid disbursed to each sector in the 74 Countdown countries was smaller than in non-Countdown countries. While countries with a large number of child deaths tend to receive the largest amount of disbursements, non-Countdown countries with small populations usually received the highest level of per capita aid for child survival among all 134 countries. Compared to other Countdown countries, those that met MDG 4 with a high reliance on health aid received much higher per capita aid across all sectors. These findings are robust to estimation methods. Conclusions The study suggests that to improve child survival, better targeted investments should be made in the four sectors, and aid to non-health sectors could be a possible contributor to child mortality reduction. We recommend that future studies on tracking aid for child survival go beyond the health sector and include other sectors that directly affect child survival. Investigation should also be made about the link between aid to each of the four sectors and child mortality reduction.	[Lu, Chunling] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Lu, Chunling; Chu, Annie; Li, Zhihui; Hill, Kenneth] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Lu, Chunling] Univ Witwatersrand, Ctr Excellence Human Dev, DST NRF, Johannesburg, South Africa; [Lu, Chunling] Univ Witwatersrand, Ctr Excellence Human Dev, DST NRF, Boston, MA USA; [Shen, Jian] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Subramanian, Subu] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Research Foundation - South Africa; University of Witwatersrand; University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health	Lu, CL (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Lu, CL (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Lu, CL (corresponding author), Univ Witwatersrand, Ctr Excellence Human Dev, DST NRF, Johannesburg, South Africa.; Lu, CL (corresponding author), Univ Witwatersrand, Ctr Excellence Human Dev, DST NRF, Boston, MA USA.	chunling_lu@hms.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD071929] Funding Source: NIH RePORTER; NICHD NIH HHS [K01 HD071929] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Asztalos EV, 2013, JAMA PEDIATR, V167, P1102, DOI 10.1001/jamapediatrics.2013.2764; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Britto P., WHY EARLY CHILDHOOD; Centers for Disease Control and Prevention (CDC), GLOB WAT SAN HYG WAS; DAC, LIST CRS PURP COD; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Easterly W, 1999, J ECON GROWTH, V4, P239, DOI 10.1023/A:1009882702130; Galiani S, 2005, J POLIT ECON, V113, P83, DOI 10.1086/426041; GAVI, DAT COMM APPR DISB; GFATM, DISB; Gilbert BJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001834; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Grepin KA, 2015, J HEALTH ECON, V44, P97, DOI 10.1016/j.jhealeco.2015.08.003; HILL K, 1989, POPUL DEV REV, V15, P657, DOI 10.2307/1972594; Hill K, 2003, B WORLD HEALTH ORGAN, V81, P138; Hsu J, 2013, LANCET, V381, P1772, DOI 10.1016/S0140-6736(13)60762-X; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S4; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; OECD, DAC TABL 2A AID ODA; OECD, TECHNICAL GUIDE TO T; OECD, DAC TABL 5 AID ODA S; Partnership for Maternal Newborn & Child Health, GLOB STRAT HAV YOU M; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Schaferhoff M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000305; The Partnership for Maternal Newborn & Child Health, 2014, THE PMNCH 2014 ACCOU; UNICEF, 2016, UNICEF PHILIPS FDN T; WHO, MDG 4 RED CHILD MORT; Wolpin K.I, 1997, HDB POPULATION FAMIL, V1, P483	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0178887	10.1371/journal.pone.0178887	http://dx.doi.org/10.1371/journal.pone.0178887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700612	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649400001
J	Abeyrathne, PD; Grigorieff, N				Abeyrathne, Priyanka D.; Grigorieff, Nikolaus			Expression, purification, and contaminant detection for structural studies of Ralstonia metallidurance ClC protein rm1	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CHLORIDE CHANNEL; CYTOPLASMIC DOMAIN; ACRB CONTAMINATION; ION-CHANNEL; CRYSTALLIZATION; OVEREXPRESSION; TRANSPORTER; DETERGENTS; OPTIMIZATION	Single-particle electron cryo-microscopy (cryo-EM) has become a popular method for highresolution study of the structural and functional properties of proteins. However, sufficient expression and purification of membrane proteins holds many challenges. We describe methods to overcome these obstacles using ClC-rm1, a prokaryotic chloride channel (ClC) family protein from Ralstonia metallidurans, overexpressed in Escherichia coli (E. coli) BL21(DE3) strain. Mass spectrometry and electron microscopy analyses of purified samples revealed multiple contaminants that can obfuscate results of subsequent high-resolution structural analysis. Here we describe the systematic optimization of sample preparation procedures, including expression systems, solubilization techniques, purification protocols, and contamination detection. We found that expressing ClC-rm1 in E. coli BL21(DE3) and using n-dodecyl-beta-D-maltopyranoside as a detergent for solubilization and purification steps resulted in the highest quality samples of those we tested. However, although protein yield, sample stability, and the resolution of structural detail were improved following these changes, we still detected contaminants including Acriflavine resistant protein AcrB. AcrB was particularly difficult to remove as it co-purified with ClC-rm1 due to four intrinsic histidine residues at its C-terminus that bind to affinity resins. We were able to obtain properly folded pure ClC-rm1 by adding eGFP to the C-terminus and overexpressing the protein in the Delta acrB variant of the JW0451-2 E. coli strain.	[Abeyrathne, Priyanka D.; Grigorieff, Nikolaus] Howard Hughes Med Inst, Janelia Res Campus,Helix Dr, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Abeyrathne, PD (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,Helix Dr, Ashburn, VA 20147 USA.	abeyrathnep@janelia.hhmi.org		Grigorieff, Nikolaus/0000-0002-1506-909X	Howard Hughes Medical Institute Internal	Howard Hughes Medical Institute Internal	This work was supported by Howard Hughes Medical Institute Internal to Priyanka D Abeyrathne and Nikolaus Grigorieff.	Abeyrathne PD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 1: BIOPHYSICAL TECHNIQUES FOR STRUCTURAL CHARACTERIZATION OF MACROMOLECULES, P277, DOI 10.1016/B978-0-12-374920-8.00119-3; Abeyrathne PD, 2016, BIOCHIMIE, V128, P154, DOI 10.1016/j.biochi.2016.08.008; Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bell SP, 2006, BIOCHEMISTRY-US, V45, P6773, DOI 10.1021/bi0523815; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2007, FEBS LETT, V581, P2839, DOI 10.1016/j.febslet.2007.04.016; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kalbermatter D, 2015, J STRUCT BIOL, V191, P376, DOI 10.1016/j.jsb.2015.08.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KUHLBRANDT W, 1988, Q REV BIOPHYS, V21, P429, DOI 10.1017/S0033583500004625; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Psakis G, 2009, J STRUCT BIOL, V166, P107, DOI 10.1016/j.jsb.2008.12.007; Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Schlegel S, 2014, BBA-MOL CELL RES, V1843, P1739, DOI 10.1016/j.bbamcr.2013.10.023; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Wiseman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114864; Yang ZR, 2014, PROTEIN SCI, V23, P769, DOI 10.1002/pro.2460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	41	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180163	10.1371/journal.pone.0180163	http://dx.doi.org/10.1371/journal.pone.0180163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692650	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800027
J	Blount, RJ; Daly, KR; Fong, S; Chang, E; Grieco, K; Greene, M; Stone, S; Balmes, J; Miller, RF; Walzer, PD; Huang, L				Blount, Robert J.; Daly, Kieran R.; Fong, Serena; Chang, Emily; Grieco, Katherine; Greene, Meredith; Stone, Stephen; Balmes, John; Miller, Robert F.; Walzer, Peter D.; Huang, Laurence			Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV plus patients	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; CARINII-PNEUMONIA; NITROGEN-DIOXIDE; SEROLOGIC RESPONSES; INFECTED PATIENTS; ACUTE EXPOSURE; LAVAGE FLUID; MICE; OZONE; IMMUNIZATION	Background Humoral immunity plays an important role against Pneumocystis jirovecii infection, yet clinical and environmental factors that impact bronchoalveolar antibody responses to P. jirovecii remain uncertain. Methods From October 2008 D December 2011 we enrolled consecutive HIV-infected adults admitted to San Francisco General Hospital (SFGH) who underwent bronchoscopy for suspected Pneumocystis pneumonia ( PCP). We used local air quality monitoring data to assign ozone, nitrogen dioxide, and fine particulate matter exposures within 14 days prior to hospital admission. We quantified serum and bronchoalveolar lavage fluid (BALF) antibody responses to P. jirovecii major surface glycoprotein (Msg) recombinant constructs using ELISA. We then fit linear regression models to determine whether PCP and ambient air pollutants were associated with bronchoalveolar antibody responses to Msg. Results Of 81 HIV- infected patients enrolled, 47 (58%) were diagnosed with current PCP and 9 (11%) had a prior history of PCP. The median CD4+ count was 51 cells/mu l (IQR 15 -129) and 44% were current smokers. Serum antibody responses to Msg were statistically significantly predictive of BALF antibody responses, with the exception of IgG responses to MsgC8 and MsgC9. Prior PCP was associated with increased BALF IgA responses to Msg and current PCP was associated with decreased IgA responses. For instance, among patients without current PCP, those with prior PCP had a median 73.2 U (IQR 19.2 -169) IgA response to MsgC1 compared to a 5.00 U (3.52 - 12.6) response among those without prior PCP. Additionally, current PCP predicted a 22.5 U (95% CI - 39.2, -5.82) lower IgA response to MsgC1. Ambient ozone within the two weeks prior to hospital admission was associated with decreased BALF IgA responses to Msg while nitrogen dioxide was associated with increased IgA responses. Conclusions PCP and ambient air pollutants were associated with BALF IgA responses to P. jirovecii in HIV-infected patients evaluated for suspected PCP.	[Blount, Robert J.; Balmes, John; Huang, Laurence] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Blount, Robert J.] Univ Calif San Francisco, Div Pediat Pulmonol, San Francisco, CA 94143 USA; [Daly, Kieran R.; Walzer, Peter D.] Univ Cincinnati, Div Infect Dis, Cincinnati, OH USA; [Daly, Kieran R.; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Fong, Serena; Chang, Emily; Grieco, Katherine; Greene, Meredith; Stone, Stephen; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Balmes, John] Univ Calif Berkeley, Environm Hlth Sci, Berkeley, CA 94720 USA; [Miller, Robert F.] UCL, Inst Epidemiol & Healthcare, Res Dept Infect & Populat Hlth, London, England; [Miller, Robert F.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Blount, RJ (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.; Blount, RJ (corresponding author), Univ Calif San Francisco, Div Pediat Pulmonol, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAE-1590-2019; blount, robert/ABI-5978-2020; Huang, Laurence/AAZ-7120-2021; Balmes, John/L-6281-2019	Huang, Laurence/0000-0003-3888-2195; Miller, Robert/0000-0003-2067-4291; Blount, Robert/0000-0001-6177-7436; Fong, Serena/0000-0002-9803-3016	National Institute of Environmental Health Science (NIEHS) [F32ES022582, K23ES025807]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007185, K24HL087713, R01HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL128156, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: the National Institute of Environmental Health Science (NIEHS), www.niehs.nih.gov, F32ES022582 (Blount) and K23ES025807 (Blount); and the National Heart, Lung, and Blood Institute (NHLBI), www.nhlbi.nih.gov, T32HL007185 (Blount), K24HL087713 (Huang), and R01HL090335 (Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALA, 2016, STAT AIR REP AM LUNG; Alibrahim A, 1998, J ALLERGY CLIN IMMUN, V101, P552, DOI 10.1016/S0091-6749(98)70363-X; Alvaro-Meca A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19906; Arjomandi M, 2015, AM J PHYSIOL-HEART C, V308, pH1499, DOI 10.1152/ajpheart.00849.2014; BALCHUM OJ, 1965, ARCH ENVIRON HEALTH, V10, P274, DOI 10.1080/00039896.1965.10663995; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Blount RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080795; Blount RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051545; CDC, 2010, TOB SMOK CAUS DIS BI, V3; Cetin E, 2007, PEDIATR RADIOL, V37, P329, DOI 10.1007/s00247-006-0375-z; CHANEY S, 1981, ARCH ENVIRON HEALTH, V36, P53, DOI 10.1080/00039896.1981.10667607; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Davis JL, 2008, THORAX, V63, P329, DOI 10.1136/thx.2007.088104; Dittrich AM, 2003, EUR J PEDIATR, V162, P432, DOI 10.1007/s00431-003-1200-4; Djawe K, 2013, CLIN INFECT DIS, V56, P74, DOI 10.1093/cid/cis841; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; Djawe K, 2010, INT J INFECT DIS, V14, pE1060, DOI 10.1016/j.ijid.2010.07.003; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; EHRLICH R, 1975, ENVIRON RES, V10, P217, DOI 10.1016/0013-9351(75)90085-7; Empey KM, 2004, INFECT IMMUN, V72, P6211, DOI 10.1128/IAI.72.11.6211-6220.2004; Esteves F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.11.025; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; FUJIMAKI H, 1981, ENVIRON RES, V26, P490, DOI 10.1016/0013-9351(81)90224-3; FURUTA T, 1985, INFECT IMMUN, V47, P544, DOI 10.1128/IAI.47.2.544-548.1985; GAJDUSEK DC, 1957, PEDIATRICS, V19, P543; Gigliotti F, 1997, J INFECT DIS, V176, P1322, DOI 10.1086/514128; Gigliotti F, 2002, INFECT IMMUN, V70, P1069, DOI 10.1128/IAI.70.3.1069-1074.2002; HARMSEN AG, 1991, J PROTOZOOL, V38, pS44; Hashmi H, 2016, AM J RESP CRIT CARE, V193; HIDEKAZU F, 1981, ARCH ENVIRON HEALTH, V36, P114, DOI 10.1080/00039896.1981.10667614; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; Jalil A, 2000, INFECT IMMUN, V68, P1054, DOI 10.1128/IAI.68.3.1054-1060.2000; Kelly MN, 2010, FUTURE MICROBIOL, V5, P43, DOI [10.2217/fmb.09.116, 10.2217/FMB.09.116]; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; LAURSEN AL, 1994, EUR RESPIR J, V7, P679, DOI 10.1183/09031936.94.07040679; Marcotte H, 1996, J INFECT DIS, V173, P1034, DOI 10.1093/infdis/173.4.1034; Mei Q, 1998, INFECT IMMUN, V66, P4268; Skalski JH, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov046; Steele C, 2005, MED MYCOL, V43, P1, DOI 10.1080/13693780400015360; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Tomas AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36287; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; WALZER PD, 1981, J LAB CLIN MED, V97, P820; Ward WO, 2015, INHAL TOXICOL, V27, P80, DOI 10.3109/08958378.2014.954172; Wells J, 2006, INFECT IMMUN, V74, P2446, DOI 10.1128/IAI.74.4.2446-2448.2006; Wells J, 2006, INFECT IMMUN, V74, P390, DOI 10.1128/IAI.74.1.390-393.2006; Zheng MQ, 2001, J CLIN INVEST, V108, P1469, DOI 10.1172/JCI13826	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180212	10.1371/journal.pone.0180212	http://dx.doi.org/10.1371/journal.pone.0180212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692651	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000405544800031
J	Chidori, K; Yamamoto, Y				Chidori, Kazuhiro; Yamamoto, Yuji			Effects of the lateral amplitude and regularity of upper body fluctuation on step time variability evaluated using return map analysis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; OLDER-ADULTS; TRUNK ACCELEROMETRY; CLUSTER-ANALYSIS; ACCELERATION PATTERNS; GAIT VARIABILITY; LEVEL WALKING; HEALTHY; FALLS; RISK	The aim of this study was to evaluate the effects of the lateral amplitude and regularity of upper body fluctuation on step time variability. Return map analysis was used to clarify the relationship between step time variability and a history of falling. Eleven healthy, community-dwelling older adults and twelve younger adults participated in the study. All of the subjects walked 25 m at a comfortable speed. Trunk acceleration was measured using triaxial accelerometers attached to the third lumbar vertebrae (L3) and the seventh cervical vertebrae (C7). The normalized average magnitude of acceleration, the coefficient of determination ($R<^>2$) of the return map, and the step time variabilities, were calculated. Cluster analysis using the average fluctuation and the regularity of C7 fluctuation identified four walking patterns in the mediolateral (ML) direction. The participants with higher fluctuation and lower regularity showed significantly greater step time variability compared with the others. Additionally, elderly participants who had fallen in the past year had higher amplitude and a lower regularity of fluctuation during walking. In conclusion, by focusing on the time evolution of each step, it is possible to understand the cause of stride and/or step time variability that is associated with a risk of falls.	[Chidori, Kazuhiro] Chubu Gakuin Univ, Fac Nursing, 2-1 Kirigaoka, Seki, Gifu, Japan; [Chidori, Kazuhiro] Chubu Gakuin Univ, Rehabil Dept, Phys Therapy, 2-1 Kirigaoka, Seki, Gifu, Japan; [Chidori, Kazuhiro; Yamamoto, Yuji] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan; [Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Chidori, K (corresponding author), Chubu Gakuin Univ, Fac Nursing, 2-1 Kirigaoka, Seki, Gifu, Japan.; Chidori, K (corresponding author), Chubu Gakuin Univ, Rehabil Dept, Phys Therapy, 2-1 Kirigaoka, Seki, Gifu, Japan.; Chidori, K (corresponding author), Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan.	chidori@chubu-gu.ac.jp			Koshiyama Science and Technology Foundation; MEXT, Japan [24240085]	Koshiyama Science and Technology Foundation; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Koshiyama Science and Technology Foundation. This work was partially supported by a Grant-in-Aid for Scientific Research (A) no. 24240085 from MEXT, Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin M, 2015, GAIT POSTURE, V42, P545, DOI 10.1016/j.gaitpost.2015.08.011; Asai T, 2013, GAIT POSTURE, V38, P830, DOI 10.1016/j.gaitpost.2013.04.005; Auvinet B, 2002, GAIT POSTURE, V16, P124, DOI 10.1016/S0966-6362(01)00203-X; Bernstein N, 1967, COORDINATION REGULAT; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; CAPPOZZO A, 1982, J BIOMECH, V15, P599, DOI 10.1016/0021-9290(82)90071-9; Descatoire A., 2009, Annals of Physical and Rehabilitation Medicine, V52, P319, DOI 10.1016/j.rehab.2009.02.004; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Giacomozzi C, 2009, GAIT POSTURE, V29, P220, DOI 10.1016/j.gaitpost.2008.08.004; Gibson M.J., 1990, IMPROVING HLTH OLDER, P296, DOI https://doi.org/10.2307/3342511; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Mazza C, 2009, GAIT POSTURE, V29, P300, DOI 10.1016/j.gaitpost.2008.09.013; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Nakamura T, 1996, GERONTOLOGY, V42, P108, DOI 10.1159/000213780; Niino N, 2000, J Epidemiol, V10, pS90; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Skurvydas A, 2012, HOMO, V63, P114, DOI 10.1016/j.jchb.2012.02.003; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Terrier P, 2015, GAIT POSTURE, V41, P170, DOI 10.1016/j.gaitpost.2014.09.024; Toro B, 2007, GAIT POSTURE, V25, P157, DOI 10.1016/j.gaitpost.2006.02.004; Yamamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072436	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e010898	10.1371/journal.pone.0180898	http://dx.doi.org/10.1371/journal.pone.0180898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700633	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800095
J	Chou, CL; Lin, H; Chen, JS; Fang, TC				Chou, Chu-Lin; Lin, Heng; Chen, Jin-Shuen; Fang, Te-Chao			Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; HYPERINSULINEMIA-INDUCED HYPERTENSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; TYPE-1 RECEPTOR; BLOOD-PRESSURE; CARDIOVASCULAR CHANGES; VASCULAR DYSFUNCTION; ALISKIREN; EXPRESSION	Renin-angiotensin system in visceral fat plays a crucial role in the pathogenesis of metabolic syndrome in fructose-fed rats. However, the effects of renin inhibition on visceral adiposity in metabolic syndrome are not fully investigated. We investigated the effects of renin inhibition on visceral adiposity in fructose-fed rats. Male Wistar-Kyoto rats were divided into 4 groups for 8-week experiments: Group Con (standard chow diet), Group Fru (high-fructose diet; 60% fructose), Group FruA (high-fructose diet and concurrent aliskiren treatment; 100 mg/kg body weight [BW] per day), and Group FruB (high-fructose diet and subsequent, i.e. 4 weeks after initiating high-fructose feeding, aliskiren treatment; 100 mg/kg BW per day). The high-fructose diet induced metabolic syndrome, increased visceral fat weights and adipocyte sizes, and augmented angiotensin II (Ang II), NADPH oxidase (NOX) isoforms expressions, oxidative stress, and dysregulated production of adipocytokines from visceral adipose tissues. Concurrent and subsequent aliskiren administration ameliorated metabolic syndrome, dysregulated adipocytokines, and visceral adiposity in high fructose-fed hypertensive rats, and was associated with reducing Ang II levels, NOX isoforms expressions and oxidative stress in visceral fat tissues. Therefore, this study demonstrates renin inhibition could improve metabolic syndrome, and reduce Ang II levels and oxidative stress in visceral fat tissue in fructose-fed rats, and suggests that visceral adipose Ang II plays a crucial role in the pathogenesis of metabolic syndrome in fructose-fed rats.	[Chou, Chu-Lin; Chen, Jin-Shuen] Natl Def Med Ctr, Div Nephrol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan; [Chou, Chu-Lin; Fang, Te-Chao] Taipei Med Univ, Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chou, Chu-Lin; Fang, Te-Chao] Taipei Med Univ, Sch Med, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Lin, Heng] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Fang, TC (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Fang, TC (corresponding author), Taipei Med Univ, Sch Med, Div Nephrol, Dept Internal Med, Taipei, Taiwan.; Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	fangtechao@yahoo.com.tw	Fang, Te-Chao/V-7731-2017	Fang, Te-Chao/0000-0002-5577-9280; Chou, Chu-Lin/0000-0002-9695-1067	Ministry of Science and Technology, Taiwan [MOST101-2314-B-303-013-MY3]; Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan [WFH104-11]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan (https://www. most.gov.tw; MOST101-2314-B-303-013-MY3; Funds for Te-Chao Fang) and Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan (http:// wfh.tmu.edu.tw; WFH104-11; Funds for Te-Chao Fang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamendi A, 2009, ENDOCRINE, V35, P227, DOI 10.1007/s12020-008-9143-1; Buczko W, 2008, PHARMACOL REP, V60, P623; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; Caminhotto Rde O, 2016, BRAZ J MED BIOL RES, V49; Castro MC, 2015, LIFE SCI, V137, P1, DOI 10.1016/j.lfs.2015.07.010; Chang L, 2012, AM J MED SCI, V343, P220, DOI 10.1097/MAJ.0b013e31822993ff; Chou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119843; Chou CL, 2013, HYPERTENS RES, V36, P123, DOI 10.1038/hr.2012.124; Chou CL, 2011, ARCH MED SCI, V7, P882, DOI 10.5114/aoms.2011.25566; Fang TC, 1998, HYPERTENSION, V32, P235, DOI 10.1161/01.HYP.32.2.235; Fang TC, 1998, J HYPERTENS, V16, P1767, DOI 10.1097/00004872-199816120-00009; Ferder L, 2010, CURR HYPERTENS REP, V12, P105, DOI 10.1007/s11906-010-0097-3; Fukui T, 1997, CIRC RES, V80, P45, DOI 10.1161/01.RES.80.1.45; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Galinier A, 2006, J BIOL CHEM, V281, P12682, DOI 10.1074/jbc.M506949200; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Guo Q, 2012, HYPERTENS RES, V35, P48, DOI 10.1038/hr.2011.140; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Habibi J, 2008, ENDOCRINOLOGY, V149, P5643, DOI 10.1210/en.2008-0070; Hayashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116163; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Iwai M, 2010, J HYPERTENS, V28, P1471, DOI 10.1097/HJH.0b013e32833bc420; Kalupahana NS, 2012, OBESITY, V20, P48, DOI 10.1038/oby.2011.299; Kubota Y, 2006, BIOL PHARM BULL, V29, P1756, DOI 10.1248/bpb.29.1756; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lastra G, 2009, ENDOCRINOLOGY, V150, P2561, DOI 10.1210/en.2008-1391; Lee KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18899; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miatello R, 2005, AM J HYPERTENS, V18, P864, DOI 10.1016/j.amjhyper.2004.12.012; Miatello R, 2003, CELL MOL BIOL, V49, P945; Miatello R, 2002, AM J HYPERTENS, V15, P872, DOI 10.1016/S0895-7061(02)02983-7; Miatello Roberto, 2004, Current Vascular Pharmacology, V2, P371, DOI 10.2174/1570161043385510; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Nagai Y, 2009, EXP PHYSIOL, V94, P1016, DOI 10.1113/expphysiol.2009.048108; Nyby MD, 2007, HYPERTENS RES, V30, P451, DOI 10.1291/hypres.30.451; Oudot C, 2013, KIDNEY INT, V83, P674, DOI 10.1038/ki.2012.478; Farina JP, 2013, CLIN SCI, V125, P87, DOI 10.1042/CS20120470; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Rabie EM, 2015, EUR J PHARMACOL, V760, P145, DOI 10.1016/j.ejphar.2015.04.019; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rashikh A, 2011, HUM EXP TOXICOL, V30, P102, DOI 10.1177/0960327110369819; Rebolledo A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-65; Risler NR, 2005, THESCIENTIFICWORLDJO, V5, P959, DOI 10.1100/tsw.2005.122; Shinozaki K, 2004, HYPERTENSION, V43, P255, DOI 10.1161/01.HYP.0000111136.86976.26; Stucchi P, 2009, BRIT J PHARMACOL, V158, P771, DOI 10.1111/j.1476-5381.2009.00355.x; Sugimoto M, 2009, ATHEROSCLEROSIS, V204, P388, DOI 10.1016/j.atherosclerosis.2008.10.021; Tamura Y, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.34; Umeda M, 2003, HYPERTENS RES, V26, P485, DOI 10.1291/hypres.26.485; Vazquez-Prieto MA, 2011, AM J HYPERTENS, V24, P234, DOI 10.1038/ajh.2010.214; Wood JM, 2005, J HYPERTENS, V23, P417, DOI 10.1097/00004872-200502000-00025; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yarows SA, 2008, ADV THER, V25, P1288, DOI 10.1007/s12325-008-0123-x	54	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180712	10.1371/journal.pone.0180712	http://dx.doi.org/10.1371/journal.pone.0180712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700686	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800068
J	Figueiredo, AS; Kouril, T; Esser, D; Haferkamp, P; Wieloch, P; Schomburg, D; Ruoff, P; Siebers, B; Schaber, J				Figueiredo, Ana Sofia; Kouril, Theresa; Esser, Dominik; Haferkamp, Patrick; Wieloch, Patricia; Schomburg, Dietmar; Ruoff, Peter; Siebers, Bettina; Schaber, Joerg			Systems biology of the modified branched Entner-Doudoroff pathway in Sulfolobus solfataricus	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; GLUCOSE-DEHYDROGENASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; KINETIC CHARACTERIZATION; YEAST GLYCOLYSIS; KEY-ENZYME; ROBUSTNESS; MODEL; PROMISCUITY; DEGRADATION	Sulfolobus solfataricus is a thermoacidophilic Archaeon that thrives in terrestrial hot springs (solfatares) with optimal growth at 80 degrees C and pH 2-4. It catabolizes specific carbon sources, such as D-glucose, to pyruvate via the modified Entner-Doudoroff(ED) pathway. This pathway has two parallel branches, the semi-phosphorylative and the non-phosphorylative. However, the strategy of S. solfataricus to endure in such an extreme environment in terms of robustness and adaptation is not yet completely understood. Here, we present the first dynamic mathematical model of the ED pathway parameterized with quantitative experimental data. These data consist of enzyme activities of the branched pathway at 70 E C and 80 E C and of metabolomics data at the same temperatures for the wild type and for a metabolic engineered knockout of the semi-phosphorylative branch. We use the validated model to address two questions: 1. Is this system more robust to perturbations at its optimal growth temperature? 2. Is the ED robust to deletion and perturbations? We employed a systems biology approach to answer these questions and to gain further knowledge on the emergent properties of this biological system. Specifically, we applied deterministic and stochastic approaches to study the sensitivity and robustness of the system, respectively. The mathematical model we present here, shows that: 1. Steady state metabolite concentrations of the ED pathway are consistently more robust to stochastic internal perturbations at 80 E C than at 70 E C; 2. These metabolite concentrations are highly robust when faced with the knockout of either branch. Connected with this observation, these two branches show different properties at the level of metabolite production and flux control. These new results reveal how enzyme kinetics and metabolomics synergizes with mathematical modelling to unveil new systemic properties of the ED pathway in S. solfataricus in terms of its adaptation and robustness.	[Figueiredo, Ana Sofia; Schaber, Joerg] Otto von Guericke Univ, Med Fac, Inst Expt Internal Med, Magdeburg, Germany; [Kouril, Theresa; Esser, Dominik; Haferkamp, Patrick; Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Ctr Water & Environm Res, Biofilm Ctr,Mol Enzyme Technol & Biochem,MEB,CWE, Essen, Germany; [Wieloch, Patricia; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Bioinformat & Biochem, Braunschweig, Germany; [Ruoff, Peter] Univ Stavanger, CORE, Ctr Organelle Res, Stavanger, Norway; [Figueiredo, Ana Sofia] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Surg Intens Care Med, Heidelberg, Germany; [Kouril, Theresa] Univ Stellenbosch, Dept Biochem, Stellenbosch, South Africa	Otto von Guericke University; University of Duisburg Essen; Braunschweig University of Technology; Universitetet i Stavanger; Ruprecht Karls University Heidelberg; Stellenbosch University	Figueiredo, AS (corresponding author), Otto von Guericke Univ, Med Fac, Inst Expt Internal Med, Magdeburg, Germany.; Figueiredo, AS (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol & Surg Intens Care Med, Heidelberg, Germany.	sofia.figueiredo@medma.uni-heidelberg.de	Figueiredo, Ana/GWU-6748-2022	Siebers, Bettina/0000-0002-9905-541X	BMBF; DFG [0316188E, 0315004A, 0316188A, 0315004B, 0316188B, SI 642/10-1]	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was performed within the e:Bio SulfoSYSBIOTEC consortium from the Federal Ministry of Education and Research (BMBF), Germany. The authors acknowledge the BMBF and DFG for financial support: ASF (0316188E), TK, PH, BS (0315004A, 0316188A), PW, DS (0315004B, 0316188B), DE (SI 642/10-1), JS (0316188E).	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; Albers SV, 2009, BIOCHEM SOC T, V37, P58, DOI 10.1042/BST0370058; ANDREESEN JR, 1969, ARCH MIKROBIOL, V69, P160, DOI 10.1007/BF00409760; Barnard D, 2010, ENVIRON TECHNOL, V31, P871, DOI 10.1080/09593331003710236; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; BUDGEN N, 1986, FEBS LETT, V196, P207, DOI 10.1016/0014-5793(86)80247-2; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; ELZAINY TA, 1973, J BACTERIOL, V114, P457, DOI 10.1128/JB.114.1.457-459.1973; ENTNER N, 1952, J BIOL CHEM, V196, P853; Ettema TJG, 2008, EXTREMOPHILES, V12, P75, DOI 10.1007/s00792-007-0082-1; EYZAGUIRRE J, 1982, ARCH MICROBIOL, V132, P67, DOI 10.1007/BF00690820; Figueiredo AS, 2011, MATH MODELS IL 10 RE; GIARDINA P, 1986, BIOCHEM J, V239, P517, DOI 10.1042/bj2390517; Haferkamp P, 2011, BIOCH STUDIES ENZYME; Haferkamp P, 2011, BIOCHEM SOC T, V39, P77, DOI 10.1042/BST0390077; Hammerstein Peter, 2006, Biological Theory, V1, P90, DOI 10.1162/biot.2006.1.1.90; Isupov MN, 1999, J MOL BIOL, V291, P651, DOI 10.1006/jmbi.1999.3003; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Kardinahl S, 1999, EUR J BIOCHEM, V260, P540, DOI 10.1046/j.1432-1327.1999.00201.x; Kartal O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008001; Kim S, 2006, BIOSCI BIOTECH BIOCH, V70, P1308, DOI 10.1271/bbb.50566; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kouril T, 2012, CHALLENGING METABOLI; Kouril T, 2013, FEBS J, V280, P4666, DOI 10.1111/febs.12438; Kouril T, 2013, FEBS J, V280, P1126, DOI 10.1111/febs.12106; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Liebermeister W, 2005, IEE P SYST BIOL, V152, P97, DOI 10.1049/ip-syb:20045033; Lin L, 2013, BIOTECHNOL ADV, V31, P827, DOI 10.1016/j.biotechadv.2013.03.003; Mastascusa V, 2014, ORIGINS LIFE EVOL B, V44, P231, DOI 10.1007/s11084-014-9397-y; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Penkler G, 2015, FEBS J, V282, P1481, DOI 10.1111/febs.13237; Saa P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004195; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Warburg O, 1941, NATURWISSENSCHAFTEN, V29, P589, DOI 10.1007/BF01482279; Westerhoff HV, 2009, J MATH BIOL, V58, P7, DOI 10.1007/s00285-008-0160-8; Wieloch P, 2012, METABOLOMANALYSE HYP; Wolf J, 2000, BIOPHYS J, V78, P1145, DOI 10.1016/S0006-3495(00)76672-0; Wolstencroft K, 2011, METHOD ENZYMOL, V500, P629, DOI 10.1016/B978-0-12-385118-5.00029-3; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886	55	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180331	10.1371/journal.pone.0180331	http://dx.doi.org/10.1371/journal.pone.0180331			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692669	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800034
J	Sun, Q; Zhu, JJ; Cao, FW; Chen, FJ				Sun, Qi; Zhu, Jiajin; Cao, Feiwei; Chen, Fengjia			Anti-inflammatory properties of extracts from Chimonanthus nitens Oliv. leaf	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BIOACTIVE COMPOUNDS; PHENOLIC-COMPOUNDS; COMPREHENSIVE CHARACTERIZATION; ANTIOXIDANT ACTIVITY; IMMUNE-RESPONSES; ZEBRAFISH LARVAE; INFLAMMATION; MODEL; IDENTIFICATION	Chimonanthus nitens Oliv. (CN) is a species in the family Calycanthaceae. Its leaf is widely used to make traditional herbal tea in southern China and has a wide range of therapeutic effects. The profile of the ethanol extracts from CN leaves was identified by UPLC-QTOFMS/ MS. Forty seven compounds were determined including organic acids, phenolic acids and derivatives, flavonoids, coumarins, fatty acids and other compounds. The effect of the CN extracts on the inflammatory damage in zebrafish and in RAW 264.7 cells was investigated. The extracts demonstrated a strong ability to inhibit the recruitment of neutrophils in LPS-stimulated zebrafish, but macrophage migration was not significantly affected. Proinflammatory cytokines (i.e., TNF-alpha, IL-6 and IL-1 beta) were also determined by q-PCR. The extracts strongly reduced mRNA expression of TNF-alpha, IL-6 but not IL-1 beta in zebrafish model, while significantly inhibited the production of the factors in the RAW 264.7 cells. Therefore, our results suggest that the ethanol extracts of CN leaves may serve as a source of nutraceutical compounds with anti-inflammatory properties.	[Sun, Qi; Zhu, Jiajin; Cao, Feiwei; Chen, Fengjia] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang Engn Ctr Food Technol & Equipment, Fuli Inst Food Sci,Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhu, JJ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Zhejiang Engn Ctr Food Technol & Equipment, Fuli Inst Food Sci,Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.	jjzhu@zju.edu.cn	朱, 加进/HHS-3257-2022		National High-tech Research and Development Program of China (863 Program) [2011AA100804]; Research Fund of Fuli Institute of Food Science Zhejiang University [KY201403]	National High-tech Research and Development Program of China (863 Program); Research Fund of Fuli Institute of Food Science Zhejiang University	This research was funded by National High-tech Research and Development Program of China (863 Program) (No. 2011AA100804) (http://program.most.gov.cn/) and Research Fund of Fuli Institute of Food Science Zhejiang University (No. KY201403) (http://fifs.zju.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Chen H, 2016, PLOS ONE, V11, P14; Chen L, 2014, MODERN FOOD SCI TECH, V30, P13; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; Chyau CC, 2015, J FUNCT FOODS, V18, P159, DOI 10.1016/j.jff.2015.06.025; [Commission CP. Pharmacopoeia of the People's Republic of China. Health PCoMo], 1977, PHARMACOPOEIA OF THE; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Cruz FF, 2017, COMP BIOCHEM PHYS C, V194, P28, DOI 10.1016/j.cbpc.2017.01.007; Cadiz-Gurrea MD, 2014, INT J MOL SCI, V15, P20382, DOI 10.3390/ijms151120382; Cadiz-Gurrea MD, 2013, FOOD RES INT, V50, P197, DOI 10.1016/j.foodres.2012.09.038; Debnath T, 2013, MOLECULES, V18, P7253, DOI 10.3390/molecules18067253; Ding ZQ, 2008, PHARM BIOL, V46, P854, DOI 10.1080/13880200802367155; DuPont MS, 2000, J AGR FOOD CHEM, V48, P3957, DOI 10.1021/jf0002387; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Farag MA, 2013, PHYTOCHEM ANALYSIS, V24, P277, DOI 10.1002/pca.2408; FINGER A, 1991, PHYTOCHEMISTRY, V30, P2057, DOI 10.1016/0031-9422(91)85066-9; Fylaktakidou KC, 2004, CURR PHARM DESIGN, V10, P3813, DOI 10.2174/1381612043382710; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Hall JE, 2011, GUYTON AND HALL TEXT; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang J, 2016, IND CROP PROD, V91, P302, DOI 10.1016/j.indcrop.2016.07.033; Iswaldi I, 2013, FOOD RES INT, V50, P77, DOI 10.1016/j.foodres.2012.09.030; Kawabata K, 2015, FOOD FUNCT, V6, P1399, DOI [10.1039/C4FO01178C, 10.1039/c4fo01178c]; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim SM, 2012, BIOMED CHROMATOGR, V26, P199, DOI 10.1002/bmc.1646; Kitajima M, 2006, TETRAHEDRON LETT, V47, P3199, DOI 10.1016/j.tetlet.2006.03.047; Kupeli E, 2007, J ETHNOPHARMACOL, V114, P234, DOI 10.1016/j.jep.2007.08.005; Kwon JH, 2011, ARCH PHARM RES, V34, P1459, DOI 10.1007/s12272-011-0907-4; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li CQ, 2007, J ETHNOPHARMACOL, V114, P212, DOI 10.1016/j.jep.2007.08.002; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Li Z, 2010, J AGR FOOD CHEM, V58, P6503, DOI 10.1021/jf1006962; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lim D, 2015, J DERMATOL SCI, V79, P288, DOI 10.1016/j.jdermsci.2015.06.012; Lima A, 2014, ZEBRAFISH, V11, P434, DOI 10.1089/zeb.2014.1001; Liu ZZ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789263; Lv HP, 2015, J FUNCT FOODS, V19, P194, DOI 10.1016/j.jff.2015.09.047; Marcon M, 2016, PSYCHOPHARMACOLOGY, V233, P3815, DOI 10.1007/s00213-016-4408-5; Meier SM, 2015, PLOS ONE, V10, P16; Mena P, 2014, IUBMB LIFE, V66, P745, DOI 10.1002/iub.1332; Mullen W, 2004, J CHROMATOGR A, V1058, P163, DOI 10.1016/j.chroma.2004.08.117; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Ni SM, 2010, J CHROMATOGR B, V878, P2741, DOI 10.1016/j.jchromb.2010.08.014; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Qing LS, 2012, J CHROMATOGR A, V1249, P130, DOI 10.1016/j.chroma.2012.06.013; Riveiro ME, 2010, CURR MED CHEM, V17, P1325, DOI 10.2174/092986710790936284; Ryu HW, 2015, J FUNCT FOODS, V17, P774, DOI 10.1016/j.jff.2015.06.036; Sanz M, 2010, J AGR FOOD CHEM, V58, P9631, DOI 10.1021/jf102718t; Shelembe JS, 2012, INT J FOOD SCI TECH, V47, P648, DOI 10.1111/j.1365-2621.2011.02889.x; Stankovic MS, 2017, IND CROP PROD, V95, P493, DOI 10.1016/j.indcrop.2016.09.070; Sun Y, 2015, J FUNCT FOODS, V18, P300, DOI 10.1016/j.jff.2015.07.009; Uddin MN, 2016, INT J FOOD PROP, V19, P911, DOI 10.1080/10942912.2015.1048355; [王凌云 Wang Lingyun], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P3103; Wang WX, 2011, PHYTOCHEM LETT, V4, P271, DOI 10.1016/j.phytol.2011.04.012; Wang XJ, 2005, BIOL PHARM BULL, V28, P1106, DOI 10.1248/bpb.28.1106; Xu W, 2016, J ZHEJIANG UNIV-SC B, V17, P425, DOI 10.1631/jzus.B1500213; Yan B, 2014, J IMMUNOL, V192, P5998, DOI 10.4049/jimmunol.1301645; Yang LL, 2014, MOLECULES, V19, P2390, DOI 10.3390/molecules19022390; Yen CT, 2009, CHEM PHARM BULL, V57, P280, DOI 10.1248/cpb.57.280; Zhang CN, 2017, ECOTOX ENVIRON SAFE, V138, P1, DOI 10.1016/j.ecoenv.2016.12.016; Zhao J, 2013, J CHROMATOGR A, V1313, P2, DOI 10.1016/j.chroma.2013.07.039; Zhou L, 2008, J PHARMACEUT BIOMED, V47, P39, DOI 10.1016/j.jpba.2007.12.009; Zhou Y, 2010, J SEP SCI, V33, P3675, DOI 10.1002/jssc.201000452; Zhu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096576; Zon LI, 1999, GENOME RES, V9, P99	71	27	32	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181094	10.1371/journal.pone.0181094	http://dx.doi.org/10.1371/journal.pone.0181094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700722	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800120
J	Wang, WW; Li, Z; Lv, ZP; Zhang, BB; Lv, H; Guo, YM				Wang, Weiwei; Li, Zhui; Lv, Zengpeng; Zhang, Beibei; Lv, Hong; Guo, Yuming			Effects of Kluyveromyces marxianus supplementation on immune responses, intestinal structure and microbiota in broiler chickens	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST CULTURE; IN-VITRO; PERFORMANCE; GROWTH; PROTEIN; DIETS; PARAMETERS; EXPRESSION; BOULARDII	To investigate the effects of Kluyveromyces marxianus on immune responses, intestinal structure and microbiota in broilers, 840 1-d-old broiler chicks were randomly divided into seven groups (eight replicates) and were fed basal diets without or with 0.25, 0.50, 1.0, 1.5, 2.0, and 2.5 g/kg of K. marxianus (2.0x10(10) CFU/g). Serum and intestine samples were collected at 21 d of age. The results showed that increasing K. marxianus addition linearly reduced feed conversion ratio but linearly elevated relative thymus weight, as well as quadratically increased serum lysozyme and IgG levels, with the medium dose (1.0 g/kg) being the most effective. The ratio of villus height to crypt depth of jejunum and ileum, ileal villus height and sucrase activity, as well as the mRNA expression of ileal mucin-2, claudin-1 and sodium glucose cotransporter 1 linearly responded to the increasing K. marxianus addition. Supplemental K. marxianus at low (0.5 g/kg), medium (1.5 g/kg) and high (2.5 g/kg) dose all decreased the abundance of phylum Cyanobacteria, increased the abundance of phylum Firmicutes and genus Lactobacillus in ileum. The high dose of K. marxianus addition also reduced the abundance of order Rickettsiales and Pseudomonadales along with species Acinetobacter junii. Ileal bacterial communities between K. marxianus-treated and untreated groups formed distinctly different clusters. In summary, K. marxianus supplementation benefits feed efficiency and immune function, as well as intestinal structure in broilers, which might be attributed to the improved ileal microbial structure. Supplemental K. marxianus at high dose (2.5 g/kg) was more effective for feed efficiency and intestinal health of broilers, while the innate immunity was optimized at a medium dose (1.0 g/kg).	[Wang, Weiwei; Li, Zhui; Lv, Zengpeng; Zhang, Beibei; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Lv, Hong] Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, Shanghai, Peoples R China	China Agricultural University; Fudan University	Guo, YM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	guoyum@cau.edu.cn		Wang, Weiwei/0000-0002-1886-6748	Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China); China Agricultural Research System program [CARS-42]	Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China); China Agricultural Research System program	This work was financially supported by Shanghai Engineering Research Center of Industrial Microorganisms, College of Life Sciences, Fudan University (Shanghai, China) and China Agricultural Research System program (CARS-42). The authors received nos pecific funding for this work.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; BALLARD ST, 1995, ANNU REV NUTR, V15, P35, DOI 10.1146/annurev.nu.15.070195.000343; Bolla PA, 2013, ANAEROBE, V21, P28, DOI 10.1016/j.anaerobe.2013.03.010; Bontempo V, 2006, ANIM FEED SCI TECH, V129, P224, DOI 10.1016/j.anifeedsci.2005.12.015; Breves G, 2000, J ANIM PHYSIOL AN N, V84, P9, DOI 10.1046/j.1439-0396.2000.00277.x; Broniek G, 2014, INFECTION, V42, P1051, DOI 10.1007/s15010-014-0647-8; De Maesschalck C, 2015, APPL ENVIRON MICROB, V81, P5880, DOI 10.1128/AEM.01616-15; Fasina YO, 2004, POULTRY SCI, V83, P1559, DOI 10.1093/ps/83.9.1559; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Funari E, 2008, CRIT REV TOXICOL, V38, P97, DOI 10.1080/10408440701749454; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Gao J, 2009, POULTRY SCI, V88, P2141, DOI 10.3382/ps.2009-00151; Goyer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149159; Greig SL, 2016, DRUGS, V76, P1467, DOI 10.1007/s40265-016-0636-6; Haldar S, 2011, ANIM FEED SCI TECH, V168, P61, DOI 10.1016/j.anifeedsci.2011.03.007; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Heckert RA, 2002, POULTRY SCI, V81, P451, DOI 10.1093/ps/81.4.451; Jahromi MF, 2016, INT J BIOMETEOROL, V60, P1099, DOI 10.1007/s00484-015-1103-x; Jang YD, 2013, LIVEST SCI, V152, P167, DOI 10.1016/j.livsci.2012.12.022; Kourelis A, 2010, J APPL MICROBIOL, V109, P260, DOI 10.1111/j.1365-2672.2009.04651.x; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Lane MM, 2011, ANTON LEEUW INT J G, V100, P507, DOI 10.1007/s10482-011-9606-x; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Milewski S, 2013, ACTA VET BRNO, V82, P147, DOI 10.2754/avb201382020147; Moran AW, 2010, BRIT J NUTR, V104, P647, DOI 10.1017/S0007114510000954; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Prakash UNS, 2010, BRIT J NUTR, V104, P31, DOI 10.1017/S0007114510000334; Rajput IR, 2013, POULTRY SCI, V92, P956, DOI 10.3382/ps.2012-02845; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; Romanin D, 2010, INT J FOOD MICROBIOL, V140, P102, DOI 10.1016/j.ijfoodmicro.2010.04.014; Rymuszka A, 2010, ENVIRON TOXICOL CHEM, V29, P569, DOI 10.1002/etc.87; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Sugiharto S., 2016, Journal of the Saudi Society of Agricultural Sciences, V15, P99, DOI 10.1016/j.jssas.2014.06.001; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Tripathi MK, 2011, LIVEST SCI, V135, P17, DOI 10.1016/j.livsci.2010.06.007; Tripathi MK, 2010, ANIM FEED SCI TECH, V155, P163, DOI 10.1016/j.anifeedsci.2009.11.007; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valbuena G, 2009, THROMB HAEMOSTASIS, V102, P1071, DOI 10.1160/TH09-03-0186; van Heugten E, 2003, J ANIM SCI, V81, P1004; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078507; Zanello G, 2013, VET IMMUNOL IMMUNOP, V152, P20, DOI 10.1016/j.vetimm.2012.09.023; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	56	13	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180884	10.1371/journal.pone.0180884	http://dx.doi.org/10.1371/journal.pone.0180884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700666	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800092
J	Duthu, RC; Bradley, TH				Duthu, Ray C.; Bradley, Thomas H.			A road damage and life-cycle greenhouse gas comparison of trucking and pipeline water delivery systems for hydraulically fractured oil and gas field development in Colorado	PLOS ONE			English	Article							EMISSIONS; IMPACTS	The process of hydraulic fracturing for recovery of oil and natural gas uses large amounts of fresh water and produces a comparable amount of wastewater, much of which is typically transported by truck. Truck transport of water is an expensive and energy-intensive process with significant external costs including roads damages, and pollution. The integrated development plan (IDP) is the industry nomenclature for an integrated oil and gas infrastructure system incorporating pipeline-based transport of water and wastewater, centralized water treatment, and high rates of wastewater recycling. These IDP have been proposed as an alternative to truck transport systems so as to mitigate many of the economic and environmental problems associated with natural gas production, but the economic and environmental performance of these systems have not been analyzed to date. This study presents a quantification of lifecycle greenhouse gas (GHG) emissions and road damages of a generic oil and gas field, and of an oil and gas development sited in the Denver-Julesburg basin in the northern Colorado region of the US. Results demonstrate that a reduction in economic and environmental externalities can be derived from the development of these IDP-based pipeline water transportation systems. IDPs have marginal utility in reducing GHG emissions and road damage when they are used to replace in-field water transport, but can reduce GHG emissions and road damage by factors of as much as 6 and 7 respectively, when used to replace fresh water transport and waste-disposal routes for exemplar Northern Colorado oil and gas fields.	[Duthu, Ray C.; Bradley, Thomas H.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA	Colorado State University	Bradley, TH (corresponding author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.	Thomas.Bradley@ColoState.Edu	Bradley, Thomas/ABF-5356-2021; Bradley, Thomas/AAD-9244-2022	Bradley, Thomas/0000-0003-3533-293X; 	Research Partnership to Secure Energy for America Unconventional Resources Program [11122-55]	Research Partnership to Secure Energy for America Unconventional Resources Program	This work is supported by the Research Partnership to Secure Energy for America 2011 Unconventional Resources Program under project number 11122-55.	Abramzon S, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000203; American Association of State Highway and Transportation Officials, 1993, GUID DES PAV STRUCT; Argonne National Laboratory, 2014, GREET 1 2014; Ariaratnam ST, 2009, J GREEN BUILD, V4, P126, DOI 10.3992/jgb.4.2.126; Bai B, 2015, J UNCONV OIL GAS RES, V12, P1, DOI 10.1016/j.juogr.2015.07.001; Bai B, 2013, J PETROL SCI ENG, V108, P383, DOI 10.1016/j.petrol.2013.05.003; Bai Y, 2009, ESTIMATING HIGHWAY P; Bissoli DD, 2016, J PETROL SCI ENG, V139, P13, DOI 10.1016/j.petrol.2015.12.009; Boschee P., 2012, OIL GAS FACIL, V1, P22; Boudet H, 2014, ENERG POLICY, V65, P57, DOI 10.1016/j.enpol.2013.10.017; Christopherson S., 2011, J TOWN CITY MANAGEME, V2, P350; Clark C., 2012, ANLEVSR125; Clark C. E, 2009, ANLEVSR0911021721007; Colorado Division of Water Resources Colorado Water Conservation Board & Colorado Oil and Gas Conservation Commission, 2015, WAT SOURC DEM HYDR F; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dale AT, 2013, ENVIRON SCI TECHNOL, V47, P5459, DOI 10.1021/es304414q; Etkin D. S, 2009, AM PETROLEUM I PUBLI, P356; Felsburg Holt & Ullevig and BBC Research and Consulting, 2013, 1210901 FHU; Gaines L, 2006, 062567 ARG NAT LAB C; Gaines L., 1998, AIR WAST MAN ASS ANN; Goodwin S., 2013, Journal of Water Resource and Protection, V5, P1262; Goodwin S, 2014, THESIS; Jiang M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034014; Litovitz A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014017; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Piratla KR, 2012, J MANAGE ENG, V28, P22, DOI 10.1061/(ASCE)ME.1943-5479.0000069; Prozzi J., 2011, IMPACTS ENERGY DEV T; Stephenson T, 2011, ENVIRON SCI TECHNOL, V45, P10757, DOI 10.1021/es2024115; U.S. Department of Transportation Federal High Administration, 2015, FLEX HIGHW DES; U.S. Department of Transportation Pipeline and Hazardous Materials Safety Administration, 2010, BUILD STAT COMM PIP; U.S. Energy Information Administration, 2015, ANN EN OUTL; Ziemkiewicz PF, 2014, J NAT GAS SCI ENG, V16, P77, DOI 10.1016/j.jngse.2013.11.003	32	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180587	10.1371/journal.pone.0180587	http://dx.doi.org/10.1371/journal.pone.0180587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686682	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100079
J	Vetsch, JR; Betts, DC; Muller, R; Hofmann, S				Vetsch, Jolanda Rita; Betts, Duncan Colin; Mueller, Ralph; Hofmann, Sandra			Flow velocity-driven differentiation of human mesenchymal stromal cells in silk fibroin scaffolds: A combined experimental and computational approach	PLOS ONE			English	Article							MINERALIZED MATRIX DEPOSITION; MICRO-COMPUTED TOMOGRAPHY; 3D PERFUSION CULTURE; SHEAR-STRESS; IN-VITRO; STEM-CELLS; BONE; CONSTRUCTS; MECHANOTRANSDUCTION; QUANTIFICATION	Mechanical loading plays a major role in bone remodeling and fracture healing. Mimicking the concept of mechanical loading of bone has been widely studied in bone tissue engineering by perfusion cultures. Nevertheless, there is still debate regarding the in-vitro mechanical stimulation regime. This study aims at investigating the effect of two different flow rates (v(low) = 0.001m/s and v(high) = 0.061m/s) on the growth of mineralized tissue produced by human mesenchymal stromal cells cultured on 3-D silk fibroin scaffolds. The flow rates applied were chosen to mimic the mechanical environment during early fracture healing or during bone remodeling, respectively. Scaffolds cultured under static conditions served as a control. Time-lapsed micro-computed tomography showed that mineralized extracellular matrix formation was completely inhibited at v(low) compared to v(high) and the static group. Biochemical assays and histology confirmed these results and showed enhanced osteogenic differentiation at v(high) whereas the amount of DNA was increased at v(low). The biological response at v(low) might correspond to the early stage of fracture healing, where cell proliferation and matrix production is prominent. Visual mapping of shear stresses, simulated by computational fluid dynamics, to 3-D micro-computed tomography data revealed that shear stresses up to 0.39mPa induced a higher DNA amount and shear stresses between 0.55mPa and 24mPa induced osteogenic differentiation. This study demonstrates the feasibility to drive cell behavior of human mesenchymal stromal cells by the flow velocity applied in agreement with mechanical loading mimicking early fracture healing (v(low)) or bone remodeling (v(high)). These results can be used in the future to tightly control the behavior of human mesenchymal stromal cells towards proliferation or differentiation. Additionally, the combination of experiment and simulation presented is a strong tool to link biological responses to mechanical stimulation and can be applied to various in-vitro cultures to improve the understanding of the cause-effect relationship of mechanical loading.	[Vetsch, Jolanda Rita; Betts, Duncan Colin; Mueller, Ralph; Hofmann, Sandra] Swiss Fed Inst Technol Zurich, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Eindhoven University of Technology	Hofmann, S (corresponding author), Swiss Fed Inst Technol Zurich, Inst Biomech, Zurich, Switzerland.; Hofmann, S (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands.; Hofmann, S (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.	S.Hofmann.Boss@tue.nl	Hofmann, Sandra/F-2832-2010; Müller, Ralph/A-1198-2008	Hofmann, Sandra/0000-0002-2568-8388; Müller, Ralph/0000-0002-5811-7725; Vetsch, Jolanda Rita/0000-0003-4134-2691	European Union's Seventh Framework Programme (FP) [FP7-NMP-2010-LARGE-4]; BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration; REMOTE [ERC-2013-StG]	European Union's Seventh Framework Programme (FP); BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration; REMOTE	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP/2007-2013): FP7-NMP-2010-LARGE-4: BIODESIGN - Rational Bioactive Materials Design for Tissue Regeneration (JRV, DCB, RM, SH) and ERC-2013-StG: REMOTE - Real-time monitoring of load induced remodeling in tissue-engineered bone (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107; Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740; de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Fan J, 2015, J TISSUE ENG REGEN M, V9, pE210, DOI 10.1002/term.1701; Gardel LS, 2013, J BIOMED MATER RES B, V101, P1377, DOI 10.1002/jbm.b.32955; Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5; Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075; Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251; Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]; Jungreuthmayer C, 2009, TISSUE ENG PT A, V15, P1141, DOI 10.1089/ten.tea.2008.0204; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Maes F, 2012, J BIOMECH, V45, P1586, DOI 10.1016/j.jbiomech.2012.04.015; Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109; Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10; McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117; Mullender M, 2004, MED BIOL ENG COMPUT, V42, P14, DOI 10.1007/BF02351006; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Ochoa I, 2009, J BIOMECH, V42, P257, DOI 10.1016/j.jbiomech.2008.10.030; Partap S, 2010, J MATER SCI-MATER M, V21, P2325, DOI 10.1007/s10856-009-3966-z; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017; Zermatten E, 2014, ANN BIOMED ENG, V42, P1085, DOI 10.1007/s10439-014-0981-0; Zermatten E, 2011, J GLACIOL, V57, P811, DOI 10.3189/002214311798043799; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184	42	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180781	10.1371/journal.pone.0180781	http://dx.doi.org/10.1371/journal.pone.0180781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686698	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100103
J	Newell-Fugate, AE; Lenz, K; Skenandore, C; Nowak, RA; White, BA; Braundmeier-Fleming, A				Newell-Fugate, Annie E.; Lenz, Katherine; Skenandore, Cassandra; Nowak, Romana A.; White, Bryan A.; Braundmeier-Fleming, Andrea			Effects of coconut oil on glycemia, inflammation, and urogenital microbial parameters in female Ossabaw mini-pigs	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TRANS-FATTY-ACIDS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MINIATURE SWINE; GUT MICROBIOTA; RISK-FACTORS; OBESITY; LIPIDS; RATS	Forty percent of American women are obese and at risk for type II diabetes, impaired immune function, and altered microbiome diversity, thus impacting overall health. We investigated whether obesity induced by an excess calorie, high fat diet containing hydrogenated fats, fructose, and coconut oil (HFD) altered glucose homeostasis, peripheral immunity, and urogenital microbial dynamics. We hypothesized that HFD would cause hyperglycemia, increase peripheral inflammation, and alter urogenital microbiota to favor bacterial taxonomy associated with inflammation. We utilized female Ossabaw mini-pigs to model a ` thrifty' metabolic phenotype associated with increased white adipose tissue mass. Pigs were fed HFD (similar to 4570 kcal/pig/day) or lean (similar to 2000 kcal/pig/day) diet for a total of 9 estrous cycles (similar to 6 months). To determine the effect of cycle stage on cytokines and the microbiome, animals had samples collected during cycles 7 and 9 on certain days of the cycle: D1, 4, 8, 12, 16, 18. Vaginal swabs or cervical flushes assessed urogenital microbiota. Systemic fatty acids, insulin, glucose, and cytokines were analyzed. Pig weights and morphometric measurements were taken weekly. Obese pigs had increased body weight, length, heart and belly girth but similar glucose concentrations. Obese pigs had decreased cytokine levels (IL-1 beta, TNF-alpha, IL-4, IL-10), arachidonic acid and plasma insulin, but increased levels of vaccenic acid. Obese pigs had greater urogenital bacterial diversity, including several taxa known for anti-inflammatory properties. Overall, induction of obesity did not induce inflammation but shifted the microbial communities within the urogenital tract to an anti-inflammatory phenotype. We postulate that the coconut oil in the HFD oil may have supported normal glucose homeostasis and modulated the immune response, possibly through regulation of microbial community dynamics and fatty acid metabolism. This animal model holds promise for the study of how different types of obesity and high fat diets may affect metabolism, immune phenotype, and microbial dynamics.	[Newell-Fugate, Annie E.; Skenandore, Cassandra] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Newell-Fugate, Annie E.; Nowak, Romana A.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Lenz, Katherine; Braundmeier-Fleming, Andrea] Southern Illinois Univ, Sch Med, Dept Med Microbiol & Immunol, Springfield, IL 62702 USA; [White, Bryan A.; Braundmeier-Fleming, Andrea] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Braundmeier-Fleming, Andrea] Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University; University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University	Newell-Fugate, AE (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.; Newell-Fugate, AE (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Braundmeier-Fleming, A (corresponding author), Southern Illinois Univ, Sch Med, Dept Med Microbiol & Immunol, Springfield, IL 62702 USA.; Braundmeier-Fleming, A (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Braundmeier-Fleming, A (corresponding author), Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA.	ANewell-Fugate@cvm.tamu.edu; abraundmeier88@siumed.edu	Newell-Fugate, Anne/AAD-5499-2019; Skenandore, Cassandra S/B-7251-2017; Braundmeier-Fleming, Andrea/AAQ-4014-2020	Newell-Fugate, Anne/0000-0002-1878-5892; Skenandore, Cassandra S/0000-0002-9337-7602; Braundmeier-Fleming, Andrea/0000-0001-7136-9567	NIH [NIH K01 RR031274-01A21]; USDA ILLU [USDA ILLU 538-370]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ILLU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: 1) NIH K01 RR031274-01A21 (ANF); http://dpcpsi.nih.gov/orip/index; 2) USDA ILLU 538-370 (RAN); https://nifa.usda.gov/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Archibeque SL, 2005, J ANIM SCI, V83, P1153; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Deol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132672; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; HALL JA, 1993, DOMEST ANIM ENDOCRIN, V10, P141, DOI 10.1016/0739-7240(93)90019-8; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Intahphuak S, 2010, PHARM BIOL, V48, P151, DOI 10.3109/13880200903062614; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kongmun P, 2010, LIVEST SCI, V127, P38, DOI 10.1016/j.livsci.2009.08.008; Kotzampassi Katerina, 2014, ISRN Obes, V2014, P651895, DOI 10.1155/2014/651895; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Machmuller A, 1999, CAN J ANIM SCI, V79, P65, DOI 10.4141/A98-079; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Moreno JJ., 2016, EUR J PHARM; MORRISON WR, 1964, J LIPID RES, V5, P600; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Narayanankutty A, 2016, J FOOD SCI TECH MYS, V53, P895, DOI 10.1007/s13197-015-2040-8; Naziroglu M, 2004, CLIN CHIM ACTA, V344, P63, DOI 10.1016/j.cccn.2004.01.031; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Newell-Fugate AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128749; Newell-Fugate AE, 2014, COMPARATIVE MED, V64, P44; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; PANEPINTO LM, 1983, LAB ANIM SCI, V33, P95; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sadeghi S, 1999, IMMUNOLOGY, V96, P404, DOI 10.1046/j.1365-2567.1999.00701.x; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; TUOMANEN E, 1985, J INFECT DIS, V151, P535, DOI 10.1093/infdis/151.3.535; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; Vickers SP, 2011, BRIT J PHARMACOL, V164, P1248, DOI 10.1111/j.1476-5381.2011.01245.x; WANG LL, 1992, APPL ENVIRON MICROB, V58, P624, DOI 10.1128/AEM.58.2.624-629.1992; Wang Y, 2008, J NUTR, V138, P2117, DOI 10.3945/jn.108.091009; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; Xu X, 2003, GRAEF ARCH CLIN EXP, V241, P56, DOI 10.1007/s00417-002-0575-7	62	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179542	10.1371/journal.pone.0179542	http://dx.doi.org/10.1371/journal.pone.0179542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704429	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700012
J	Payr, S; Tichy, B; Atteneder, C; Michel, M; Tiefenboeck, T; Lang, N; Nuernberger, S; Hajdu, S; Rosado-Balmayor, E; Marlovits, S; Albrecht, C				Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Rosado-Balmayor, Elizabeth; Marlovits, Stefan; Albrecht, Christian			Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; CHONDROGENIC DIFFERENTIATION; CARTILAGE REPAIR; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; IN-VITRO; ALGINATE; CULTURES; MARKERS	Melanoma inhibitory activity (MIA) affects the differentiation to hyaline cartilage and can inhibit the osteogenic potential of bone morphogenetic protein (BMP)-2 in mesenchymal stem cells (MSC). The aim of this study was to investigate if MIA also inhibits the osteogenic potential of BMP-2 in human articular chondrocytes during redifferentiation, which may lead to a higher grade of differentiation without calcification. HAC of four female patients (mean age: 73.75 +/- 6.98) were seeded into 3D culture for 28 days; after adding the recombinant proteins, four groups were formed (Control, BMP-2, MIA, BMP-2+ MIA). Samples were analysed for gene expression, glycosaminoglycan (GAG) content and histology on day 0, 14 and 28. Collagen type 2 (COL2A1) was significantly increased in the BMP-2 containing groups on day 28; BMP-2 (100-fold, p = 0.001), BMP-2+ MIA (65-fold, p = 0.009) and similar to the level of native cartilage. Higher aggrecan (Agg) levels were present in the BMP-2 (3fold, p = 0.007) and BMP-2+ MIA (4-fold, p = 0.002) group after 14 days and in the BMP-2 (9fold, p = 0.001) group after 28 days. Collagen type 10 (COL10A1) was increased in the BMP-2 containing groups (6-fold, p = 0.006) but these levels were significantly below native cartilage. Alkaline phosphatase (ALP), collagen type 1 (COL1A1) and the glycosaminoglycan (GAG) content did not reveal any relevant differences between groups. BMP-2 is a potent inducer for differentiation of HAC. A significant enhancement of this effect in combination with MIA could not be observed. Furthermore no significant reduction of osteogenic markers during re-differentiation of chondrocytes was present combining BMP-2 and MIA.	[Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Marlovits, Stefan; Albrecht, Christian] Med Univ Vienna, Gen Hosp, Dept Trauma Surg, Vienna, Austria; [Payr, Stephan; Tichy, Brigitte; Atteneder, Clemens; Michel, Marc; Tiefenboeck, Thomas; Lang, Nikolaus; Nuernberger, Sylvia; Hajdu, Stefan; Marlovits, Stefan; Albrecht, Christian] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Rosado-Balmayor, Elizabeth] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, Munich, Germany	Medical University of Vienna; Technical University of Munich	Payr, S (corresponding author), Med Univ Vienna, Gen Hosp, Dept Trauma Surg, Vienna, Austria.; Payr, S (corresponding author), Austrian Cluster Tissue Regenerat, Vienna, Austria.	stephan.payr@meduniwien.ac.at	Balmayor, E. R./N-9283-2015	Balmayor, E. R./0000-0002-0484-4847; Nurnberger, Sylvia/0000-0002-5175-5118; Albrecht, Christian/0000-0001-8022-1417; Tiefenboeck, Thomas/0000-0002-8698-8341	medical scientific fund of the mayor of the city of Vienna [15002]	medical scientific fund of the mayor of the city of Vienna	Study was funded by the medical scientific fund of the mayor of the city of Vienna (C.A.); project number 15002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, J TISSUE ENG REGEN M, V4, P233, DOI 10.1002/term.235; Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Albrecht C, 2014, AM J SPORT MED, V42, P59, DOI 10.1177/0363546513507543; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Ashraf S, 2015, OSTEOARTHRITIS CARTI; Ashraf S., 2016, J TISSUE ENG REGEN M; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015; Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Claus S, 2010, J CELL BIOCHEM, V111, P1642, DOI 10.1002/jcb.22897; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Krawczak DA, 2009, TISSUE ENG PT A, V15, P1247, DOI 10.1089/ten.tea.2008.0249; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; Marlovits S, 2004, INT J MOL MED, V13, P281; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Martin I, 2000, BIORHEOLOGY, V37, P141; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701; O'Connell G.D., 2015, J TISSUE ENG REGEN M; Rackwitz L, 2014, OSTEOARTHR CARTILAGE, V22, P1148, DOI 10.1016/j.joca.2014.05.019; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Schubert T, 2010, EXP MOL MED, V42, P166, DOI 10.3858/emm.2010.42.3.017; Steinert A, 2003, J ORTHOP RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179729	10.1371/journal.pone.0179729	http://dx.doi.org/10.1371/journal.pone.0179729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704392	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700015
J	Lori, M; Symnaczik, S; Mader, P; De Deyn, G; Gattinger, A				Lori, Martina; Symnaczik, Sarah; Maeder, Paul; De Deyn, Gerlinde; Gattinger, Andreas			Organic farming enhances soil microbial abundance and activity-A meta-analysis and meta-regression	PLOS ONE			English	Article							LONG-TERM; COMMUNITY STRUCTURE; PUBLICATION BIAS; AGRICULTURAL MANAGEMENT; CONVENTIONAL MANAGEMENT; BIOLOGICAL-CONTROL; TILLAGE SYSTEMS; MATTER DYNAMICS; CROP DIVERSITY; BIOMASS	Population growth and climate change challenge our food and farming systems and provide arguments for an increased intensification of agriculture. A promising option is eco-functional intensification through organic farming, an approach based on using and enhancing internal natural resources and processes to secure and improve agricultural productivity, while minimizing negative environmental impacts. In this concept an active soil microbiota plays an important role for various soil based ecosystem services such as nutrient cycling, erosion control and pest and disease regulation. Several studies have reported a positive effect of organic farming on soil health and quality including microbial community traits. However, so far no systematic quantification of whether organic farming systems comprise larger and more active soil microbial communities compared to conventional farming systems was performed on a global scale. Therefore, we conducted a meta-analysis on current literature to quantify possible differences in key indicators for soil microbial abundance and activity in organic and conventional cropping systems. All together we integrated data from 56 mainly peer-reviewed papers into our analysis, including 149 pairwise comparisons originating from different climatic zones and experimental duration ranging from 3 to more than 100 years. Overall, we found that organic systems had 32% to 84% greater microbial biomass carbon, microbial biomass nitrogen, total phospholipid fatty-acids, and dehydrogenase, urease and protease activities than conventional systems. Exclusively the metabolic quotient as an indicator for stresses on microbial communities remained unaffected by the farming systems. Categorical subgroup analysis revealed that crop rotation, the inclusion of legumes in the crop rotation and organic inputs are important farming practices affecting soil microbial community size and activity. Furthermore, we show that differences in microbial size and activity between organic and conventional farming systems vary as a function of land use (arable, orchards, and grassland), plant life cycle (annual and perennial) and climatic zone. In summary, this study shows that overall organic farming enhances total microbial abundance and activity in agricultural soils on a global scale.	[Lori, Martina; Symnaczik, Sarah; Maeder, Paul; Gattinger, Andreas] Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland; [Lori, Martina; Gattinger, Andreas] Justus Liebig Univ Giessen, Karl Glockner Str 21 C, Giessen, Germany; [De Deyn, Gerlinde] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands	Justus Liebig University Giessen; Wageningen University & Research	Lori, M (corresponding author), Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland.; Lori, M (corresponding author), Justus Liebig Univ Giessen, Karl Glockner Str 21 C, Giessen, Germany.	martina.lori@fibl.org	De Deyn, Gerlinde/AFI-8702-2022; De Deyn, Gerlinde B/C-1593-2009	De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde B/0000-0003-4823-6912				Aciego P. J. C., 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI DOI 10.1016/J.S0ILBI0.2008.03.020; Adamtey N, 2016, AGR ECOSYST ENVIRON, V235, P61, DOI 10.1016/j.agee.2016.10.001; Affaires PD, 2014, INT ASSESSMENT AGR K; Alef K., 1995, METHODS APPL SOIL MI, DOI DOI 10.1016/B978-0-12-513840-6.X5014-9; ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G; Aparna K, 2014, ECOL ENG, V71, P268, DOI 10.1016/j.ecoleng.2014.07.016; Appl M., 2011, ULLMANNS ENCY IND CH, DOI DOI 10.1002/14356007.O02_O11; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bahlai CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011250; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Borenstein M, 2009, INTRO METAANALYSIS, V20; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1; Bunemann EK, 2006, AUST J SOIL RES, V44, P379, DOI 10.1071/SR05125; Burger M, 2005, BIOL FERT SOILS, V42, P109, DOI 10.1007/s00374-005-0007-z; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Cooper J, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0354-1; COPELAND PJ, 1992, AGRON J, V84, P503, DOI 10.2134/agronj1992.00021962008400030028x; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; Debosz K, 1999, APPL SOIL ECOL, V13, P209, DOI 10.1016/S0929-1393(99)00034-7; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dickersin K., 2006, PUBLICATION BIAS MET, P9, DOI [10.1002/0470870168.ch2, DOI 10.1002/0470870168.CH2]; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Emmerling C, 2002, J PLANT NUTR SOIL SC, V165, P408, DOI 10.1002/1522-2624(200208)165:4<408::AID-JPLN408>3.0.CO;2-3; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; FAUCI MF, 1994, SOIL SCI SOC AM J, V58, P801, DOI 10.2136/sssaj1994.03615995005800030023x; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; Forster D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081039; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Fu R., 2013, HANDLING CONTINUOUS; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gattinger A, 2003, ACTA BIOTECHNOL, V23, P21, DOI 10.1002/abio.200390003; Gattinger A, 2012, P NATL ACAD SCI USA, V109, P18226, DOI 10.1073/pnas.1209429109; Ge TD, 2013, EUR J SOIL BIOL, V58, P122, DOI 10.1016/j.ejsobi.2013.07.005; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; Hartmann M., 2006, THESIS; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Heinze S, 2010, PLANT SOIL, V328, P203, DOI 10.1007/s11104-009-0102-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IFOAM OI, 2016, FUT CONS ANN REP IF, P24; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; KILLHAM K, 1985, ENVIRON POLLUT A, V38, P283, DOI 10.1016/0143-1471(85)90133-3; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Lagomarsino A, 2009, ECOL INDIC, V9, P518, DOI 10.1016/j.ecolind.2008.07.003; Lal R., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P303, DOI 10.1007/s11027-006-9036-7; Larsen E, 2014, SOIL TILL RES, V139, P37, DOI 10.1016/j.still.2014.02.002; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Liu B, 2007, APPL SOIL ECOL, V37, P202, DOI 10.1016/j.apsoil.2007.06.007; Lorenz K, 2016, ADV AGRON, V139, P99, DOI 10.1016/bs.agron.2016.05.003; Lotter DW, 2003, AM J ALTERNATIVE AGR, V18, P146, DOI 10.1079/AJAA200345; Luan JW, 2012, SOIL BIOL BIOCHEM, V44, P143, DOI 10.1016/j.soilbio.2011.08.012; Lynch J. M., 1985, Advances in Soil Science, USA, V2, P133; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mader P, 2012, RENEW AGR FOOD SYST, V27, P7, DOI 10.1017/S1742170511000470; McDaniel MD, 2014, ECOL APPL, V24, P560, DOI 10.1890/13-0616.1; McKnight T., 2000, PHYS GEOGRAPHY LANDS, V6th ed., P205; McLauchlan K, 2006, ECOSYSTEMS, V9, P1364, DOI 10.1007/s10021-005-0135-1; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Nickel JL., 1972, S AGR ENT DEV COUNTR; Nielsen UN, 2015, ANNU REV ENV RESOUR, V40, P63, DOI 10.1146/annurev-environ-102014-021257; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Petersen SO, 1997, GEODERMA, V78, P181, DOI 10.1016/S0016-7061(97)00032-3; Pulleman M, 2003, SOIL USE MANAGE, V19, P157, DOI 10.1079/SUM2003186; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Reeve JR, 2016, ADV AGRON, V137, P319, DOI 10.1016/bs.agron.2015.12.003; Reganold J. P., 1988, American Journal of Alternative Agriculture, V3, P144, DOI 10.1017/S0889189300002423; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Romaniuk R, 2011, ECOL INDIC, V11, P1345, DOI 10.1016/j.ecolind.2011.02.008; Schneider M, 2017, EXP AGR, V53, P351, DOI 10.1017/S0014479716000417; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Siegrist S, 1998, AGR ECOSYST ENVIRON, V69, P253, DOI 10.1016/S0167-8809(98)00113-3; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Skinner C, 2014, SCI TOTAL ENVIRON, V468, P553, DOI 10.1016/j.scitotenv.2013.08.098; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Sun HY, 2016, APPL SOIL ECOL, V108, P16, DOI 10.1016/j.apsoil.2016.07.014; Tebrugge F, 1999, SOIL TILL RES, V53, P15, DOI 10.1016/S0167-1987(99)00073-2; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Venter ZS, 2016, PEDOBIOLOGIA, V59, P215, DOI 10.1016/j.pedobi.2016.04.001; Vian JF, 2009, SOIL USE MANAGE, V25, P1, DOI 10.1111/j.1475-2743.2008.00176.x; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; WANDER MM, 1995, PLANT SOIL, V170, P87, DOI 10.1007/BF02183057; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Xue K, 2013, APPL ENVIRON MICROB, V79, P1284, DOI 10.1128/AEM.03393-12; Yeates GW, 1997, J APPL ECOL, V34, P453, DOI 10.2307/2404890; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; ZELLES L, 1993, SOIL BIOL BIOCHEM, V25, P495, DOI 10.1016/0038-0717(93)90075-M; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zuber SM, 2016, SOIL BIOL BIOCHEM, V97, P176, DOI 10.1016/j.soilbio.2016.03.011	106	186	189	19	235	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180442	10.1371/journal.pone.0180442	http://dx.doi.org/10.1371/journal.pone.0180442			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700609	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600030
J	Sholts, SB; Gingerich, JAM; Schlager, S; Stanford, DJ; Warmlander, SKTS				Sholts, Sabrina B.; Gingerich, Joseph A. M.; Schlager, Stefan; Stanford, Dennis J.; Warmlander, Sebastian K. T. S.			Tracing social interactions in Pleistocene North America via 3D model analysis of stone tool asymmetry	PLOS ONE			English	Article							CULTURAL TRANSMISSION; SEXUAL-DIMORPHISM; CLOVIS; SYMMETRY; AGE; MORPHOMETRICS; EVOLUTION; AFFINITY; CONTEXT; SURFACE	Stone tools, often the sole remnant of prehistoric hunter-gatherer behavior, are frequently used as evidence of ancient human mobility, resource use, and environmental adaptation. In North America, studies of morphological variation in projectile points have provided important insights into migration and interactions of human groups as early as 12-13 kya. Using new approaches to 3D imaging and morphometric analysis, we here quantify bifacial asymmetry among early North American projectile point styles to better understand changes in knapping technique and cultural transmission. Using a sample of 100 fluted bifaces of Clovis and post-Clovis styles in the eastern United States ca. 13,100-9,000 cal BP (i.e., Clovis, Debert-Vail, Bull Brook, Michaud-Neponset/Barnes, and Crowfield), we employed two different approaches for statistical shape analysis: our previously presented method for analysis of 2D flake scar contours, and a new approach for 3D surface analysis using spherical harmonics (SPHARM). Whereas bifacial asymmetry in point shape does not vary significantly across this stylistic sequence, our measure of asymmetric flake scar patterning shows temporal variation that may signify the beginning of regionalization among early New World colonists.	[Sholts, Sabrina B.; Gingerich, Joseph A. M.; Stanford, Dennis J.] Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Gingerich, Joseph A. M.] Ohio Univ, Dept Sociol & Anthropol, Athens, OH 45701 USA; [Schlager, Stefan] Albert Ludwigs Univ Freiburg, Med Fak, Dept Anthropol, Freiburg, Germany; [Warmlander, Sebastian K. T. S.] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Warmlander, Sebastian K. T. S.] Univ Calif Los Angeles, Cotsen Inst Archaeol, UCLA Getty Conservat Programme, Los Angeles, CA 90095 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; Ohio University; University of Freiburg; Stockholm University; University of California System; University of California Los Angeles	Warmlander, SKTS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Warmlander, SKTS (corresponding author), Univ Calif Los Angeles, Cotsen Inst Archaeol, UCLA Getty Conservat Programme, Los Angeles, CA 90095 USA.	seb@dbb.su.se		Sholts, Sabrina/0000-0003-4168-0578; Schlager, Stefan/0000-0001-6493-9250				Amberg B, 2011, EDITING FACES VIDEOS; ANDERSON D.G., 2015, PALEOAMERICA, V1, P7, DOI DOI 10.1179/2055556314Z.00000000012; Anderson D.G., 2010, ARCHAEOLOGY E N AM, V38, P63; Bettinger RL, 1999, AM ANTIQUITY, V64, P231, DOI 10.2307/2694276; Bodenhofer U, 2008, MATHWARE SOFT COMPUT, V15, P5; Boisvert RA, 2008, NEW HAMPSHIRE ARCHAE, V47, P57; Boisvert RA, E FLUTED POINT TRADI, VII; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bradley BA, 2010, INT MONOGRAPHS PREHI; Bradley J. W., 2008, ARCHAEOLOGY E N AM, V36, P119; Buchanan B, 2015, J ARCHAEOL SCI-REP, V3, P11, DOI 10.1016/j.jasrep.2015.05.011; Buchanan B, 2014, ARCHAEOL ANTHROP SCI, V6, P145, DOI 10.1007/s12520-013-0168-x; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Buchanan B, 2009, AM ANTIQUITY, V74, P279, DOI 10.1017/S0002731600048605; Bulut O, 2016, FORENSIC SCI INT, V261, DOI 10.1016/j.forsciint.2016.01.028; CHRISTENSON AL, 1986, PLAINS ANTHROPOL, V31, P109, DOI 10.1080/2052546.1986.11909324; Eerkens JW, 2007, J ARCHAEOL RES, V15, P239, DOI 10.1007/s10814-007-9013-z; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Ellis C, 2011, J ANTHROPOL ARCHAEOL, V30, P385, DOI 10.1016/j.jaa.2011.05.001; Eren MI, 2015, J HUM EVOL, V80, P159, DOI 10.1016/j.jhevol.2015.01.002; Gingerich JAM, 2014, WORLD ARCHAEOL, V46, P101, DOI 10.1080/00438243.2014.892437; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Graham JH, 1998, BIOL J LINN SOC, V64, P1, DOI 10.1111/j.1095-8312.1998.tb01530.x; Gunn J., 1977, STUDIES VARIABILITY, P167; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; Haynes C.Vance., 1992, ICE AGE HUNTERS ROCK, P83; Haynes G, 2007, SCIENCE, V317, DOI 10.1126/science.1141960; HOLM S, 1979, SCAND J STAT, V6, P65; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lipo CP, 2012, AM ANTIQUITY, V77, P774, DOI 10.7183/0002-7316.77.4.774; Lothrop JC, 2011, QUATERN INT, V242, P546, DOI 10.1016/j.quaint.2011.04.015; McAvoy, 2015, NOTTAWAY RIVER SUR 2; Miller D. Shane, 2013, E FLUTED POINT TRADI, P9; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Morrow JE, 1999, AM ANTIQUITY, V64, P215, DOI 10.2307/2694275; MOSHFEGHI M, 1994, IEEE T IMAGE PROCESS, V3, P128, DOI 10.1109/83.277895; Nain D, 2007, BIOM IM NAN MACR 200; Neiss M, 2016, ARCHAEOL ANTHROP SCI, V8, P651, DOI 10.1007/s12520-014-0200-9; Newby P, 2005, QUATERNARY SCI REV, V24, P141, DOI 10.1016/j.quascirev.2004.04.010; Newby P, 2007, CURRENT RES PLEISTOC, V24, P16; O'Brien MJ, 2015, REPLACE NEANDERTHAL, P121, DOI 10.1007/978-4-431-55363-2_9; O'Brien MJ, 2014, J ANTHROPOL ARCHAEOL, V34, P100, DOI 10.1016/j.jaa.2014.03.001; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Petaros A, 2015, CLIN ANAT, V28, P593, DOI 10.1002/ca.22545; Prasciunas MM, 2011, AM ANTIQUITY, V76, P107, DOI 10.7183/0002-7316.76.1.107; Prasciunas MM, 2014, CLOVIS EDGE NEW UNDE, P21; Sanchez G, 2014, P NATL ACAD SCI USA, V111, P10972, DOI 10.1073/pnas.1404546111; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schlager S, 2014, RVCG MANIPULATIONS T; Schlager S, 2017, ANAT REC, V300, P226, DOI 10.1002/ar.23450; Schlager S, 2015, AM J PHYS ANTHROPOL, V156, P278; Shearer BM, 2012, FORENSIC SCI INT, V222, DOI 10.1016/j.forsciint.2012.06.013; Sholts SB, 2012, J ARCHAEOL SCI, V39, P3018, DOI 10.1016/j.jas.2012.04.049; Sholts SB, 2012, FORENSIC SCI INT, V217, DOI 10.1016/j.forsciint.2011.11.016; Sholts SB, 2011, J FORENSIC SCI, V56, P333, DOI 10.1111/j.1556-4029.2011.01701.x; Sholts SB, 2010, J FORENSIC SCI, V55, P871, DOI 10.1111/j.1556-4029.2010.01380.x; Taylor RE, 1996, ANTIQUITY, V70, P515, DOI 10.1017/S0003598X00083678; Wagemans J, 1997, TRENDS COGN SCI, V1, P346, DOI 10.1016/S1364-6613(97)01105-4; Warmlander SKTS, 2011, ENVIRON HEALTH PERSP, V119, P1203, DOI 10.1289/ehp.1103478; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149	64	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0179933	10.1371/journal.pone.0179933	http://dx.doi.org/10.1371/journal.pone.0179933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FA7TK	28700598	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600012
J	Yu, D; Lin, QY; Chiu, APY; He, DH				Yu, Duo; Lin, Qianying; Chiu, Alice P. Y.; He, Daihai			Effects of reactive social distancing on the 1918 influenza pandemic	PLOS ONE			English	Article							PUBLIC-HEALTH MEASURES; TIME-SERIES; DYNAMICS; TRANSMISSION; IMMUNITY; DISEASE; MODELS; MORTALITY; INFERENCE; EPIDEMIC	The 1918 influenza pandemic was characterized by multiple epidemic waves. We investigated reactive social distancing, a form of behavioral response where individuals avoid potentially infectious contacts in response to available information on an ongoing epidemic or pandemic. We modelled its effects on the three influenza waves in the United Kingdom. In previous studies, human behavioral response was modelled by a Power function of the proportion of recent influenza mortality in a population, and by a Hill function, which is a function of the number of recent influenza mortality. Using a simple epidemic model with a Power function and one common set of parameters, we provided a good model fit for the observed multiple epidemic waves in London boroughs, Birmingham and Liverpool. We further applied the model parameters from these three cities to all 334 administrative units in England and Wales and including the population sizes of individual administrative units. We computed the Pearson's correlation between the observed and simulated for each administrative unit. We found a median correlation of 0.636, indicating that our model predictions are performing reasonably well. Our modelling approach is an improvement from previous studies where separate models are fitted to each city. With the reduced number of model parameters used, we achieved computational efficiency gain without over-fitting the model. We also showed the importance of reactive behavioral distancing as a potential non-pharmaceutical intervention during an influenza pandemic. Our work has both scientific and public health significance.	[Yu, Duo; Lin, Qianying; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China; [Yu, Duo] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA	Hong Kong Polytechnic University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Kowloon, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	Lin, Qianying/ABD-8415-2021; He, Daihai/AAT-8735-2021	He, Daihai/0000-0003-3253-654X	General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council [PolyU 251001/14M]; Hong Kong Polytechnic University	General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	DH was supported by General Research Fund (Early Career Scheme) from Hong Kong Research Grants Council (PolyU 251001/14M) and Start-up Fund for New Recruits from Hong Kong Polytechnic University.	Barry John M, 2004, J Transl Med, V2, P3, DOI 10.1186/1479-5876-2-3; Bhadra A, 2010, J R STAT SOC B, V72, P314, DOI [DOI 10.1111/J.1467-9868.2009.00736.X, 10.1111/j.1467-9868.2009.00736.x]; Bhadra A, 2011, J AM STAT ASSOC, V106, P440, DOI 10.1198/jasa.2011.ap10323; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P9595, DOI 10.1073/pnas.1220908110; Blake IM, 2014, P NATL ACAD SCI USA, V111, P10604, DOI 10.1073/pnas.1323688111; Bolton KJ, 2014, EPIDEMICS-NETH, V8, P18, DOI 10.1016/j.epidem.2014.07.004; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Breto C, 2014, STAT PROBABIL LETT, V91, P20, DOI 10.1016/j.spl.2014.04.003; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Camacho A, 2011, P ROY SOC B-BIOL SCI, V278, P3635, DOI 10.1098/rspb.2011.0300; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Gani R, 2005, EMERG INFECT DIS, V11, P1355; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886; Ionides EL, 2011, STAT SCI, V26, P49, DOI 10.1214/11-STS345C; Johnson N, 2011, SN4350 UK DAT SERV; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Lavine JS, 2012, EXPERT REV VACCINES, V11, P1319, DOI [10.1586/ERV.12.109, 10.1586/erv.12.109]; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Zhou J, 2013, STAT PROBABIL LETT, V83, P1448, DOI 10.1016/j.spl.2013.01.032	42	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180545	10.1371/journal.pone.0180545	http://dx.doi.org/10.1371/journal.pone.0180545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704460	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649600033
J	Zhou, HF; Liu, J; Li, JH; Duan, WC				Zhou, HongFang; Liu, Jie; Li, JunHuai; Duan, WenCong			A density-based approach for detecting complexes in weighted PPI networks by semantic similarity	PLOS ONE			English	Article							OVERLAPPING PROTEIN COMPLEXES; ALGORITHM; IDENTIFICATION; INFORMATION	Protein complex detection in PPI networks plays an important role in analyzing biological processes. A new algorithm-DBGPWN-is proposed for predicting complexes in PPI networks. Firstly, a method based on gene ontology is used to measure semantic similarities between interacted proteins, and the similarity values are used as their weights. Then, a density-based graph partitioning algorithm is developed to find clusters in the weighted PPI networks, and the identified ones are considered to be dense and similar. Experimental results demonstrate that our approach achieves good performance as compared with such algorithms as MCL, CMC, MCODE, RNSC, CORE, ClusterOne and FGN.	[Zhou, HongFang; Liu, Jie; Li, JunHuai; Duan, WenCong] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Peoples R China	Xi'an University of Technology	Zhou, HF (corresponding author), Xian Univ Technol, Sch Comp Sci & Engn, Xian, Peoples R China.	zhouhf@xaut.edu.cn			National Natural Science Foundation of China [61402363]; Education Department of Shaanxi Province Key Laboratory Project [15JS079]; Xi'an Science Program Project [CXY1509(7)]; Beilin district of Xi'an Science and Technology Project [GX1625]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Shaanxi Province Key Laboratory Project; Xi'an Science Program Project; Beilin district of Xi'an Science and Technology Project	This research is supported by the National Natural Science Foundation of China (61402363), Education Department of Shaanxi Province Key Laboratory Project (15JS079), Xian Science Program Project (CXY1509(7)), and Beilin district of Xian Science and Technology Project (GX1625).	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hanna EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144163; He T, 2016, IEEE ACM TRANS COMPU, P1, DOI DOI 10.1109/TCBB.2016.264210728029628; Hu AL, 2013, IEEE ACM T COMPUT BI, V10, P780, DOI 10.1109/TCBB.2013.37; Hu LX, 2015, BMC GENOMICS, V16, DOI [10.1186/s12859-015-0583-3, 10.1186/s12864-015-1799-3]; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Leung HCM, 2009, J COMPUT BIOL, V16, P133, DOI 10.1089/cmb.2008.01TT; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Peng W, 2015, IEEE ACM T COMPUT BI, V12, P179, DOI 10.1109/TCBB.2014.2343954; Satuluri V, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P737; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wang JD, 2012, J NANOMATER, V2012, DOI 10.1155/2012/129041; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Yanai I, 2002, TRENDS GENET, V18, P176, DOI 10.1016/S0168-9525(01)02621-X; Zaki N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-163; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]; Zhao BH, 2014, IEEE ACM T COMPUT BI, V11, P486, DOI 10.1109/TCBB.2013.2297915; Zhou H.F., 2016, SPRINGERPLUS, V5, P1, DOI DOI 10.1186/S40064-015-1659-2; Zhou HF, 2016, COMPUTATIONAL INTELL, P1; Zhou HF, 2017, PHYSICA A, V469, P551, DOI 10.1016/j.physa.2016.11.015; Zhou HF, 2014, KNOWL-BASED SYST, V56, P79, DOI 10.1016/j.knosys.2013.10.024	29	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180570	10.1371/journal.pone.0180570	http://dx.doi.org/10.1371/journal.pone.0180570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704455	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600035
J	Holmes, MJ; Robertson, FC; Little, F; Randall, SR; Cotton, MF; van der Kouwe, AJW; Laughton, B; Meintjes, EM				Holmes, Martha J.; Robertson, Frances C.; Little, Francesca; Randall, Steven R.; Cotton, Mark F.; van der Kouwe, Andre J. W.; Laughton, Barbara; Meintjes, Ernesta M.			Longitudinal increases of brain metabolite levels in 5-10 year old children	PLOS ONE			English	Article							ABSOLUTE QUANTITATION; SOCIOECONOMIC-STATUS; SYNAPSE ELIMINATION; MR SPECTROSCOPY; BASAL GANGLIA; WHITE-MATTER; PROTON; CHILDHOOD; CORTEX; MATURATION	Longitudinal magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) studies reveal significant changes in brain structure and structural networks that occur together with cognitive and behavioral maturation in childhood. However, the underlying cellular changes accompanying brain maturation are less understood. Examining regional agerelated changes in metabolite levels provides insight into the physiology of neurodevelopment. Magnetic resonance spectroscopy (MRS) measures localize brain metabolism. The majority of neuroimaging studies of healthy development are from the developed world. In a longitudinal MRS study of 64 South African children aged 5 to 10 years old (29 female; 29 HIV exposed, uninfected), we examined the age-related trajectories of creatine (Cr +PCr), N-acetyl-aspartate (NAA), the combined NAA+N-acetyl-aspartyl-glutamate (NAAG), choline (GPC+PCh), glutamate (Glu) and the combined Glu+glutamine (Glu +Gln) in voxels within gray and white matter, as well as subcortically in the basal ganglia (BG). In frontal gray matter, we found age-related increases in Cr+PCr, NAA, NAA+NAAG and Glu+Gln levels pointing to synaptic activity likely related to learning. In the BG we observed increased levels of Glu, Glu+Gln and NAA+NAAG with age that point to subcortical synaptic reorganization. In white matter, we found increased levels of Cr+PCr, NAA, NAA+NAAG, Glu and Glu+Gln with age, implicating these metabolites in ongoing myelination. We observed no sex-age or HIV exposure-age interactions, indicating that physiological changes are independent of sex during this time period. The metabolite trajectories presented, therefore, provide a critical benchmark of normal cellular growth for a low socioeconomic pediatric population in the developing world against which pathology and abnormal development may be compared.	[Holmes, Martha J.; Robertson, Frances C.; Meintjes, Ernesta M.] Univ Cape Town, Fac Hlth Sci, Div Biomed Engn, MRC UCT Med Imaging Res Unit, Cape Town, South Africa; [Holmes, Martha J.; Robertson, Frances C.; Randall, Steven R.; Meintjes, Ernesta M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Cape Town, South Africa; [Little, Francesca] Univ Cape Town, Fac Sci, Dept Stat Sci, Cape Town, South Africa; [Cotton, Mark F.; Laughton, Barbara] Stellenbosch Univ, Childrens Infect Dis Clin Res Unit, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [van der Kouwe, Andre J. W.] Massachusetts Gen Hosp, Dept Radiol, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [van der Kouwe, Andre J. W.] Harvard Med Sch, Dept Radiol, Boston, MA USA	University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Holmes, MJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Biomed Engn, MRC UCT Med Imaging Res Unit, Cape Town, South Africa.; Holmes, MJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Cape Town, South Africa.	martha.j.holmes@gmail.com	Laughton, Barbara/AAR-5427-2020; Meintjes, Ernesta/ABD-8771-2020; Cotton, Mark/AAQ-9936-2020	Laughton, Barbara/0000-0001-7260-7723; Meintjes, Ernesta/0000-0002-0781-3632; Cotton, Mark/0000-0003-2559-6034; Holmes, Martha/0000-0001-5873-2405; Little, Francesca/0000-0002-5917-9928; Randall, Steven Ronald/0000-0002-5029-2174	National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network [U19 AI53217]; National Institutes of Health (NIH) [R01HD071664, R21MH096559, R21MH108346]; NRF [CPR20110614000019421]; Medical Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH108346] Funding Source: NIH RePORTER	National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRF; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study was provided by the National Research Foundation (NRF)/Department of Science and Technology (DST) South African Research Chairs Initiative; US National Institute of Allergy and Infectious Diseases (NIAID) through the CIPRA network, Grant U19 AI53217; National Institutes of Health (NIH) grants R01HD071664 (PIs: AJWvdK, EMM, BL; https://www.fic.nih.gov/Grants/Search/Pages/brain-R01HD071664.aspx), R21MH096559 (PIs: AJWvdK, EMM, BL) and R21MH108346 (PI: EMM; https://www.fic.nih.gov/Grants/Search/Pages/brain-R21MH108346.aspx); NRF grant CPR20110614000019421 (PI Ernesta Meintjes), and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agarwal N, 2012, AM J NEURORADIOL, V33, P595, DOI 10.3174/ajnr.A2587; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Ben Bashat D, 2005, J MAGN RESON IMAGING, V21, P503, DOI 10.1002/jmri.20281; Benarroch EE, 2005, BASIC NEUROSCIENCES; Benjamini Y, 2001, ANN STAT, V29, P1165; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Graybiel AM, 2004, PARKINSONISM RELAT D, V10, P293, DOI 10.1016/j.parkreldis.2004.03.007; HASHIMOTO T, 1995, DEV MED CHILD NEUROL, V37, P398; Hess AT, 2011, MAGN RESON MED, V66, P314, DOI 10.1002/mrm.22805; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Keller MA, 2004, NEUROLOGY, V62, P1810, DOI 10.1212/01.WNL.0000125492.57419.25; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; R-Core-Team, 2015, LANG ENV STAT COMP; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; UNAIDS, 2014, UND FAST TRACK ACC A; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072	46	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180973	10.1371/journal.pone.0180973	http://dx.doi.org/10.1371/journal.pone.0180973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700727	gold, Green Published			2022-12-27	WOS:000405649400024
J	Jin, QY; Grama, I; Liu, QS				Jin, Qiyu; Grama, Ion; Liu, Quansheng			Optimal Weights Mixed Filter for removing mixture of Gaussian and impulse noises	PLOS ONE			English	Article							ANISOTROPIC 2ND; MEDIAN FILTERS; IMAGE; ALGORITHM; MODEL	In this paper we consider the problem of restoration of a image contaminated by a mixture of Gaussian and impulse noises. We propose a new statistic called ROADGI which improves the well-known Rank-Ordered Absolute Differences (ROAD) statistic for detecting points contaminated with the impulse noise in this context. Combining ROADGI statistic with the method of weights optimization we obtain a new algorithm called Optimal Weights Mixed Filter (OWMF) to deal with the mixed noise. Our simulation results show that the proposed filter is effective for mixed noises, as well as for single impulse noise and for single Gaussian noise.	[Jin, Qiyu] Inner Mongolia Univ, Sch Math Sci, 235 Daxue West Rd, Hohhot 010021, Peoples R China; [Grama, Ion; Liu, Quansheng] Univ Bretagne Sud, Lab Math Bretagne Atlantique, UMR 6205, Campus Tohaninic,BP 573, F-56017 Vannes, France; [Liu, Quansheng] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China	Inner Mongolia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Nanjing University of Information Science & Technology	Liu, QS (corresponding author), Univ Bretagne Sud, Lab Math Bretagne Atlantique, UMR 6205, Campus Tohaninic,BP 573, F-56017 Vannes, France.; Liu, QS (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China.	quansheng.liu@univ-ubs.fr	Jin, Qiyu/HGD-8010-2022	Jin, Qiyu/0000-0001-8639-233X	National Natural Science Foundation of China [61661039, 11571052, 11401590]; Natural Science Fund of Inner Mongolia Autonomous Region [2016MS0107]; Scientific Research Projection of Higher Schools of Inner Mongolia [NJZY16017]; Hunan Provincial Natural Science Foundation [2017JJ2271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Inner Mongolia Autonomous Region; Scientific Research Projection of Higher Schools of Inner Mongolia; Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	Jin and Liu have been partially supported by the National Natural Science Foundation of China (Grants No. 61661039, No. 11571052 and No. 11401590), the Natural Science Fund of Inner Mongolia Autonomous Region (Grant No. 2016MS0107), the Scientific Research Projection of Higher Schools of Inner Mongolia (Grant No. NJZY16017), and Hunan Provincial Natural Science Foundation (Grant no. 2017JJ2271).	Abreu E, 1996, IEEE T IMAGE PROCESS, V5, P1012, DOI 10.1109/83.503916; Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Bouboulis P, 2010, IEEE T IMAGE PROCESS, V19, P1465, DOI 10.1109/TIP.2010.2042995; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Cai JF, 2008, INVERSE PROBL IMAG, V2, P187; Chan RH, 2004, IEEE SIGNAL PROC LET, V11, P921, DOI 10.1109/LSP.2004.838190; Chen T, 1999, IEEE T IMAGE PROCESS, V8, P1834, DOI 10.1109/83.806630; Chen T, 2001, IEEE SIGNAL PROC LET, V8, P1, DOI 10.1109/97.889633; Chen T, 2001, IEEE T CIRCUITS-II, V48, P784, DOI 10.1109/82.959870; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Crnojevic V, 2004, IEEE SIGNAL PROC LET, V11, P589, DOI 10.1109/LSP.2004.830117; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Delon J, 2016, PARIGI PATCH BASED A, V5, P130; Delon J, 2013, SIAM J IMAGING SCI, V6, P1140, DOI 10.1137/120885000; Dong YQ, 2007, IEEE T IMAGE PROCESS, V16, P1112, DOI 10.1109/TIP.2006.891348; Foi A, P 6 IMA INT C MATH S, P79; Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261; Hammond DK, 2008, IEEE T IMAGE PROCESS, V17, P2089, DOI 10.1109/TIP.2008.2004796; Hirakawa K, 2006, IEEE T IMAGE PROCESS, V15, P2730, DOI 10.1109/TIP.2006.877352; Hu HJ, 2016, J SCI COMPUT, V67, P103, DOI 10.1007/s10915-015-0073-9; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Jin Q, 2017, SIAM J IMAGING SCI; Jin QY, 2014, J SCI COMPUT, V58, P548, DOI 10.1007/s10915-013-9743-7; Katkovnik Vladimir, 2004, 2004 12th European Signal Processing Conference (EUSIPCO), P101; Katkovnik V, 2010, INT J COMPUT VISION, V86, P1, DOI 10.1007/s11263-009-0272-7; Kervrann C, 2008, INT J COMPUT VISION, V79, P45, DOI 10.1007/s11263-007-0096-2; Kervrann C, 2006, IEEE T IMAGE PROCESS, V15, P2866, DOI 10.1109/TIP.2006.877529; Li B, 2010, SCI CHINA SER F, V54, P1; Lien CY, 2013, IEEE T COMPUT, V62, P631, DOI 10.1109/TC.2011.256; Lou YF, 2010, J SCI COMPUT, V42, P185, DOI 10.1007/s10915-009-9320-2; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; Luo WB, 2005, IEICE T FUND ELECTR, VE88A, P2579, DOI 10.1093/ietfec/e88-a.10.2579; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Polzehl J, 2000, J R STAT SOC B, V62, P335, DOI 10.1111/1467-9868.00235; Roth S, 2009, INT J COMPUT VISION, V82, P205, DOI 10.1007/s11263-008-0197-6; SUN T, 1994, PATTERN RECOGN LETT, V15, P341, DOI 10.1016/0167-8655(94)90082-5; Wang HB, 2012, COMPUT SCI INF SYST, V9, P1493, DOI 10.2298/CSIS120219060W; Wang Y, 2011, ELECTRON LETT, V47, P592, DOI 10.1049/el.2010.3505; Wang YQ, 2013, SIGNAL PROCESS, V93, P2548, DOI 10.1016/j.sigpro.2013.02.020; Wang YQ, 2013, COMPUT MATH APPL, V66, P1729, DOI 10.1016/j.camwa.2013.08.034; Wang Z, 1999, IEEE T CIRCUITS-II, V46, P78, DOI 10.1109/82.749102; Xiao Y, 2011, PATTEEN RECOGN; Xiong B, 2012, IEEE T IMAGE PROCESS, V21, P1663, DOI 10.1109/TIP.2011.2172804; Yu HC, 2008, IEEE SIGNAL PROC LET, V15, P922, DOI 10.1109/LSP.2008.2005051	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179051	10.1371/journal.pone.0179051	http://dx.doi.org/10.1371/journal.pone.0179051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692667	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800007
J	Lv, M; Li, Y; Kou, B; Zhou, ZL				Lv, Ming; Li, Yi; Kou, Bo; Zhou, Zhili			Integer programming for improving radiotherapy treatment efficiency	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; WAITING TIME; MODEL; OPTIMIZATION	Background and purpose Patients received by radiotherapy departments are diverse and may be diagnosed with different cancers. Therefore, they need different radiotherapy treatment plans and thus have different needs for medical resources. This research aims to explore the best method of scheduling the admission of patients receiving radiotherapy so as to reduce patient loss and maximize the usage efficiency of service resources. Materials and methods A mix integer programming (MIP) model integrated with special features of radiotherapy is constructed. The data used here is based on the historical data collected and we propose an exact method to solve the MIP model. Results Compared with the traditional First Come First Served (FCFS) method, the new method has boosted patient admission as well as the usage of linear accelerators (LINAC) and beds. Conclusions The integer programming model can be used to describe the complex problem of scheduling radio-receiving patients, to identify the bottleneck resources that hinder patient admission, and to obtain the optimal LINAC-bed radio under the current data conditions. Different management strategies can be implemented by adjusting the settings of the MIP model. The computational results can serve as a reference for the policy-makers in decision making.	[Lv, Ming; Zhou, Zhili] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China; [Li, Yi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China; [Kou, Bo] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiac Surg, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, Y (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China.	flinglee@sina.com						Buchanan R., 2002, ROYAL COLL RADIOLOGI, P1; Ceschia S, 2011, COMPUT OPER RES, V38, P1452, DOI 10.1016/j.cor.2011.01.007; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Claudio D., 2014, IIE T HEALTHC SYST E, V4, P16, DOI [10.1080/19488300.2013.879459, DOI 10.1080/19488300.2013.879459]; Conforti D, 2008, 4OR-Q J OPER RES, V6, P263, DOI 10.1007/S10288-007-0050-8; Conforti D, 2010, EUR J OPER RES, V201, P289, DOI 10.1016/j.ejor.2009.02.016; D'Souza DP, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-3; Danjoux C, 2006, SUPPORT CARE CANCER, V14, P38, DOI 10.1007/s00520-005-0822-7; Delaney G, 2002, CLIN ONCOL-UK, V14, P406, DOI 10.1053/clon.2002.0141; Faria SL, 2006, AM J CLIN ONCOL-CANC, V29, P463, DOI 10.1097/01.coc.0000225919.35003.88; Garg L, 2010, HEALTH CARE MANAG SC, V13, P155, DOI 10.1007/s10729-009-9120-0; Gemmel P, 1999, INT J OPER PROD MAN, V19, P863, DOI 10.1108/01443579910280188; Hahn-Goldberg S, 2014, HEALTH CARE MANAG SC, V17, P379, DOI 10.1007/s10729-014-9268-0; Han Y, 2005, JPN J CLIN ONCOL, V35, P470, DOI 10.1093/jjco/hyi129; Herbert C E, 2000, Australas Radiol, V44, P444, DOI 10.1046/j.1440-1673.2000.00851.x; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; KOLESAR P, 1970, MANAGE SCI B-APPL, V16, pB384; Mackillop WJ, 2007, RADIOTHER ONCOL, V84, P1, DOI 10.1016/j.radonc.2007.05.006; MACKILLOP WJ, 1994, INT J RADIAT ONCOL, V30, P221, DOI 10.1016/0360-3016(94)90538-X; Matta Marie E, 2007, Health Care Manag Sci, V10, P173, DOI 10.1007/s10729-007-9010-2; Sadki A, 2013, DECIS SUPPORT SYST, V55, P640, DOI 10.1016/j.dss.2012.10.020; Saure A, 2012, EUR J OPER RES, V223, P573, DOI 10.1016/j.ejor.2012.06.046; Schafer C, 2005, STRAHLENTHER ONKOL, V181, P9, DOI 10.1007/s00066-005-1252-7; Seel Matthew, 2002, Australas Radiol, V46, P275, DOI 10.1046/j.1440-1673.2002.01059.x; Turkcan Ayten, 2012, IIE Transactions on Healthcare Systems Engineering, V2, P31, DOI 10.1080/19488300.2012.665155; Verellen D, 2002, RADIOTHER ONCOL, V63, P27, DOI 10.1016/S0167-8140(02)00030-0; Winston WL, 2004, OPERATIONS RES APPL	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180564	10.1371/journal.pone.0180564	http://dx.doi.org/10.1371/journal.pone.0180564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700726	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800054
J	Lytvynchuk, L; Sergienko, A; Savytska, I; Albert, R; Glittenberg, C; Binder, S; Petrovski, G				Lytvynchuk, Lyubomyr; Sergienko, Andrij; Savytska, Iryna; Albert, Reka; Glittenberg, Carl; Binder, Susanne; Petrovski, Goran			Comparative cyto-histological study of needle tip aspirates and entry sites after intravitreal injection using different needle types	PLOS ONE			English	Article							ANTI-VEGF INJECTIONS; MACULAR DEGENERATION; ENDOPHTHALMITIS; CONTAMINATION; BEVACIZUMAB; INFECTION; THERAPY; MODEL	A comparison of the cellular content of needle tip aspirates and entry sites after transconjunctival intravitreal injection (IVI) using different needle types was performed. White outbred rats and human cadaver eyes were used for IVI by hypodermic 27 gauge (G) and 30G needles, and spinal anesthesia Pencan 27G needles. Aspiration of vitreous for quantitative morphological and cell cultivation analysis, as well as cyto-histological analysis of aspirates and entry sites were carried out. The most common cells in the aspirates from all needle types were conjunctival epithelial-, ciliary body non-pigmented epithelial-and sclerocyte-like cells and granular proteins. Crystallized vitreous specimens were present in each aspirate. The entry sites of hypodermic needles showed marked trauma in all wall layers of rat and human eyes accompanied by cellular destruction and hemorrhages. Pencan 27G needle caused less tissue trauma with partial reposition of sclerocytes. Transconjunctival IVIs with hypodermic 27G and 30G, and Pencan 27G needles result in trauma of all layers of the eyeball. The possible consequences of cellular content being cut and injected into the eye, as well as the entry site wound shape deserve future consideration and improvements.	[Lytvynchuk, Lyubomyr] Justus Liebig Univ Giessen, Univ Hosp Giessen, Dept Ophthalmol, Eye Clin, Campus Giessen, Giessen, Germany; [Lytvynchuk, Lyubomyr] Marburg GmbH, Campus Giessen, Giessen, Germany; [Lytvynchuk, Lyubomyr; Sergienko, Andrij] Prof Sergienko Eye Clin, Vinnycia, Ukraine; [Lytvynchuk, Lyubomyr; Glittenberg, Carl; Binder, Susanne] Karl Landsteiner Inst Retinal Res & Imaging, Vienna, Austria; [Lytvynchuk, Lyubomyr; Albert, Reka; Petrovski, Goran] Univ Szeged, Dept Ophthalmol, Albert Szent Gyorgyi Clin Ctr, Fac Med,Stem Cells & Eye Res Lab, Szeged, Hungary; [Savytska, Iryna] Natl Acad Med Sci Ukraine, AA Shalimov Natl Inst Surg & Transplantol, Dept Expt Surg, Kiev, Ukraine; [Glittenberg, Carl; Binder, Susanne] Rudolf Fdn Clin, Dept Ophthalmol, Vienna, Austria; [Petrovski, Goran] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Petrovski, Goran] Univ Oslo, Oslo, Norway	Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; Szeged University; National Academy of Medical Sciences of Ukraine; Shalimov National Institute of Surgery & Transplantology of the National Academy of Medical Sciences of Ukraine; University of Oslo; University of Oslo	Petrovski, G (corresponding author), Univ Szeged, Dept Ophthalmol, Albert Szent Gyorgyi Clin Ctr, Fac Med,Stem Cells & Eye Res Lab, Szeged, Hungary.; Petrovski, G (corresponding author), Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway.; Petrovski, G (corresponding author), Univ Oslo, Oslo, Norway.	goran.petrovski@med.u-szeged.hu		Petrovski, Goran/0000-0003-2905-9252				Apiliogullari S, 2010, PEDIATR ANESTH, V20, P177, DOI 10.1111/j.1460-9592.2009.03236.x; Avery Robert L, 2014, Retina, V34 Suppl 12, pS1, DOI 10.1097/IAE.0000000000000399; Bhatt SS, 2011, RETINA-J RET VIT DIS, V31, P2032, DOI 10.1097/IAE.0b013e31820f4b4f; Brodie FL, 2014, RETINA-J RET VIT DIS, V34, P1473, DOI 10.1097/IAE.0000000000000098; Cheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014; De Caro JJ, 2008, RETINA-J RET VIT DIS, V28, P877, DOI 10.1097/IAE.0b013e31816b3180; De Stefano VS, 2011, CLIN EXP OPHTHALMOL, V39, P236, DOI 10.1111/j.1442-9071.2010.02447.x; Diago T, 2009, RETINA-J RET VIT DIS, V29, P601, DOI 10.1097/IAE.0b013e31819d2591; Fagan XJ, 2013, CLIN EXP OPHTHALMOL, V41, P500, DOI 10.1111/ceo.12026; Fintak DR, 2008, RETINA-J RET VIT DIS, V28, P1395, DOI 10.1097/IAE.0b013e3181884fd2; FORRESTER JV, 1986, INVEST OPHTH VIS SCI, V27, P1085; Friedman DA, 2014, RETINA-J RET VIT DIS, V34, P929, DOI 10.1097/IAE.0000000000000067; Goldberg RA, 2014, AM J OPHTHALMOL, V158, P733, DOI 10.1016/j.ajo.2014.06.019; Hubschman JP, 2010, RETINA-J RET VIT DIS, V30, P167, DOI 10.1097/IAE.0b013e3181b094cf; Jeganathan VSE, 2009, CURR OPIN OPHTHALMOL, V20, P223, DOI 10.1097/ICU.0b013e328329b656; Jonas JB, 2007, J OCUL PHARMACOL TH, V23, P240, DOI 10.1089/jop.2006.0146; Karcioglu ZA, 2002, RETINA-J RET VIT DIS, V22, P707, DOI 10.1097/00006982-200212000-00004; Klein KS, 2009, OPHTHALMOLOGY, V116, P1225, DOI 10.1016/j.ophtha.2009.02.031; Kucklick T.R., 2006, INTRO NEEDLES CANNUL, P33487; Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Pulido JS, 2007, EYE, V21, P1210, DOI 10.1038/sj.eye.6702577; Rodrigues EB, 2011, J OCUL PHARMACOL TH, V27, P197, DOI 10.1089/jop.2010.0082; Ruiz-Moreno JM, 2015, RETINA-J RET VIT DIS, V35, P2450, DOI 10.1097/IAE.0000000000000632; Scott AW, 2013, CURR OPIN OPHTHALMOL, V24, P190, DOI 10.1097/ICU.0b013e32835fefee; Sigford DK, 2015, CLIN OPHTHALMOL, V9, P773, DOI 10.2147/OPTH.S77067; Smith DG, 2001, DISSECTION GUIDE ATL; Van Asten F, 2015, RETINA-J RET VIT DIS, V35, P1778, DOI 10.1097/IAE.0000000000000550; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; WALKER WF, 1998, ANATOMY DISSECTION R	30	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0174467	10.1371/journal.pone.0174467	http://dx.doi.org/10.1371/journal.pone.0174467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692684	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000405544800001
J	Nguyen, PH; Sanghvi, T; Kim, SS; Tran, LM; Afsana, K; Mahmud, Z; Aktar, B; Menon, P				Nguyen, Phuong H.; Sanghvi, Tina; Kim, Sunny S.; Tran, Lan M.; Afsana, Kaosar; Mahmud, Zeba; Aktar, Bachera; Menon, Purnima			Factors influencing maternal nutrition practices in a large scale maternal, newborn and child health program in Bangladesh	PLOS ONE			English	Article							FOLIC ACID SUPPLEMENTATION; CALCIUM SUPPLEMENTATION; IRON SUPPLEMENTATION; PREGNANCY; WOMEN; DETERMINANTS; COUNTRIES; ANEMIA; UNDERNUTRITION; DEFICIENCY	Improving maternal nutrition practices during pregnancy is essential to save lives and improve health outcomes for both mothers and babies. This paper examines the maternal, household, and health service factors influencing maternal nutrition practices in the context of a large scale maternal, newborn, and child health (MNCH) program in Bangladesh. Data were from a household survey of pregnant (n = 600) and recently delivered women (n = 2,000). Multivariate linear and logistic regression analyses were used to examine the determinants of three outcomes: consumption of iron and folic acid (IFA) tablets, calcium tablets, and diverse diets. Women consumed 94 +/- 68 IFA and 82 +/- 66 calcium tablets ( out of 180 as recommended) during pregnancy, and only half of them consumed an adequately diverse diet. Good nutrition knowledge was the key maternal factor associated with higher consumption of IFA (beta = 32.5, 95% CI: 19.5, 45.6) and calcium tablets (beta similar to 31.9, 95% CI: 20.9, 43.0) and diverse diet (OR = 1.8, 95% CI: 1.0 - 3.1), compared to poor knowledge. Women's self- efficacy in achieving the recommended practices and perception of enabling social norms were significantly associated with dietary diversity. At the household level, women who reported a high level of husband's support were more likely to consume IFA (beta = 25.0, 95% CI: 18.0, 32.1) and calcium ( beta = 26.6, 95% CI: 19.4, 33.7) tablets and diverse diet (OR = 1.9, 95% CI: 1.2, 3.3), compared to those who received low support. Health service factors associated with higher intakes of IFA and calcium tablets were early and more prenatal care visits and receipt of free supplements. Combined exposure to several of these factors was attributed to the consumption of an additional 46 IFA and 53 calcium tablets and 17% higher proportions of women consuming diverse diets. Our study shows that improving knowledge, self-efficacy and perceptions of social norms among pregnant women, and increasing husbands' support, early registration in prenatal care, and provision of free supplements will largely improve maternal nutrition practices.	[Nguyen, Phuong H.; Kim, Sunny S.; Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Sanghvi, Tina; Tran, Lan M.; Mahmud, Zeba] Alive & Thr, Washington, DC USA; [Afsana, Kaosar; Aktar, Bachera] BRAC, Dhaka, Bangladesh	CGIAR; International Food Policy Research Institute (IFPRI); Bangladesh Rural Advancement Committee BRAC	Nguyen, PH (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	P.H.Nguyen@cgiar.org	Aktar, Bachera/AFS-4218-2022	Aktar, Bachera/0000-0003-0242-1792; Nguyen, Phuong H/0000-0003-3418-1674; Afsana, Kaosar/0000-0002-5197-8151	Canadian Department of Foreign Affairs, Trade and Development [7060808]	Canadian Department of Foreign Affairs, Trade and Development	This work was supported by the Canadian Department of Foreign Affairs, Trade and Development, Grant No 7060808, managed by FHI 360. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn Eric, 2006, BMC Pregnancy Childbirth, V6, P10, DOI 10.1186/1471-2393-6-10; Alam A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1697-2; [Anonymous], [No title captured]; Bendich A, 2001, NUTRITION, V17, P46, DOI 10.1016/S0899-9007(00)00482-2; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Branca F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4173; Coates J, 2007, FOOD NUTR TECHNICAL, V3; COOK JD, 1991, AM J CLIN NUTR, V53, P106, DOI 10.1093/ajcn/53.1.106; *FAO, 1998, JOINT FAO WHO EXP CO; FAO FHI360, 2016, MIN DIETR DIV WOM GU; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Hashima-e-Nasreen Ahmed SM, 2010, RES MONOGRAPH SERIES; Hofmeyr GJ, 2014, BJOG-INT J OBSTET GY, V121, P951, DOI 10.1111/1471-0528.12613; Hyder SMZ, 2004, PUBLIC HEALTH NUTR, V7, P1065, DOI 10.1079/PHN2004645; ICN, 2014, 2 INT C NUTR C OUTC; Islam MZ, 2003, EUR J CLIN NUTR, V57, P674, DOI 10.1038/sj.ejcn.1601597; Klemm RW, 2011, CROSS COUNTRY COMPAR; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Lunet N, 2008, CAD SAUDE PUBLICA, V24, P1151, DOI 10.1590/S0102-311X2008000500022; Maina-Gathigi L, 2013, MATERN CHILD HLTH J, V17, P1236, DOI 10.1007/s10995-012-1120-x; Martin SL, 2017, J NUTR; Martin-Prevel Y, 2015, FAO REPORT MOVING FO; Nagata JM, 2012, MATERN CHILD NUTR, V8, P1, DOI 10.1111/j.1740-8709.2011.00338.x; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nguyen P.H., 2015, ASSESSING OPERATIONA; NIPORT, 2011, MITR ASS ICF INT BAN; NIPORT (National Institute of Population Research and Training), 2015, MITR ASS ICF INT BAN; Rashid M, 2010, BANGLADESH MEDICAL J, V39; Shaw A, 2012, INT J NONPROFIT VOLU, V17, P325, DOI 10.1002/nvsm.1438; StataCorp, 2021, STATA STAT SOFTWARE; Stevens GA, 2013, LANCET, V1, P16, DOI DOI 10.1016/S2214-109X(13)70001-9; Sununtnasuk C, 2016, PUBLIC HEALTH NUTR, V19, P732, DOI 10.1017/S1368980015001652; Tinago CB, 2016, MATERN CHILD NUTR; Victora CG, 2012, FOOD NUTR BULL, V33, pS6, DOI 10.1177/15648265120332S102; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wendt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120404; World Health . Organization, 2013, GUID CALC SUPPL PREG	43	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0179873	http://dx.doi.org/10.1371/journal.pone.0179873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692689	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800018
J	Sjogren, V; Bystrom, B; Renlund, H; Svensson, PJ; Oldgren, J; Norrving, B; Sjalander, A				Sjogren, Vilhelm; Bystrom, Bjorn; Renlund, Henrik; Svensson, Peter J.; Oldgren, Jonas; Norrving, Bo; Sjalander, Anders			Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study	PLOS ONE			English	Article							NORMALIZED RATIO CONTROL; ATRIAL-FIBRILLATION; EFFICACY; SAFETY; QUALITY; METAANALYSIS; VALIDATION; DABIGATRAN; INPATIENT; APIXABAN	Background For patients with atrial fibrillation, non-vitamin K oral anticoagulants, or NOACs (dabigatran, rivaroxaban, edoxaban, and apixaban) have been proven non-inferior or superior to warfarin in preventing stroke and systemic embolism, and in risk of haemorrhage. In the pivotal NOAC studies, quality of warfarin treatment was poor with mean time in therapeutic range (TTR) 55-65%, compared with >= 70% in Swedish clinical practice. Methods We compared NOACs (as a group) to warfarin in non-valvular atrial fibrillation, studying all 12,694 patients starting NOAC treatment within the Swedish clinical register and dosing system Auricula, from July 1, 2011 to December 31, 2014, and matching them to 36,317 patients starting warfarin using propensity scoring. Endpoints were thromboembolic events and major bleedings that were fatal or required hospital care. Outcome data were collected from validated Swedish hospital administrative and clinical registers. Results Mean age was 72.2 vs 72.3 years, proportion of males 58.2% vs 57.0%, and mean follow-up time 299 vs 283 days for NOACs and warfarin. Distribution of NOACs was: dabigatran 40.3%, rivaroxaban 31.2%, and apixaban 28.5%. Mean TTR was 70%. There were no significant differences in rates of thromboembolic/thrombotic events or gastrointestinal bleeding. NOAC treated patients had lower rates of major bleeding overall, hazard ratio 0.78 (95% confidence interval 0.67-0.92), intracranial bleeding 0.59 (0.40-0.87), haemorrhagic stroke 0.49 (0.28-0.86), and other major bleeding 0.71 (0.57-0.89). Conclusion For patients with atrial fibrillation, NOACs are as effective for stroke prevention as well-managed warfarin but cause fewer major bleedings.	[Sjogren, Vilhelm; Bystrom, Bjorn; Sjalander, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Renlund, Henrik] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Svensson, Peter J.] Lund Univ, Dept Translat Med, Clin Coagulat Res Unit, Skane Univ Hosp, Malmo, Sweden; [Oldgren, Jonas] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Oldgren, Jonas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Norrving, Bo] Lund Hosp, Dept Clin Sci Lund, Neurol, Skane Univ Hosp, Lund, Sweden	Umea University; Uppsala University; Lund University; Skane University Hospital; Uppsala University; Uppsala University; Lund University; Skane University Hospital	Sjogren, V (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	vilhelm.sjogren.md@gmail.com	Sjögren, Vilhelm/N-5150-2016	Sjögren, Vilhelm/0000-0003-0282-8648; Renlund, Henrik/0000-0002-2141-6086	Swedish Heart-Lung Foundation [20150435]; Swedish Association of Local Authorities and Regions; Northern Swedish Stroke fund	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association of Local Authorities and Regions; Northern Swedish Stroke fund	This work was supported by The Swedish Heart-Lung Foundation, grant number 20150435, https://www3.hjart-lungfonden.se/ViewPublicReport.aspx (AS); The Swedish Association of Local Authorities and Regions, http://kvalitetsregister.se/englishpages/findaregistry/registerarkivenglish/nationalqualityregistryforatrialfibrillationandanticoagulationauricula.2145.html; and The Northern Swedish Stroke fund, http://www.umu.se/om-universitetet/aktuellt/nyheter/nyhetsvisning//bidrag-ska-framja-strokeforskning.cid258571 (AS).	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Austin PC, 2015, STAT MED, V34, P3949, DOI 10.1002/sim.6602; Bjorck F, 2016, JAMA CARDIOL, V1, P172, DOI 10.1001/jamacardio.2016.0199; Bjorck F, 2015, THROMB RES, V136, P216, DOI 10.1016/j.thromres.2015.04.016; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Kirchhof P., 2016, EUR HEART J; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ming KW, 2000, BIOMETRICS, V56, P118, DOI 10.1111/j.0006-341X.2000.00118.x; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sjogren V, 2015, THROMB HAEMOSTASIS, V113, P1370, DOI 10.1160/TH14-10-0859; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Therneau TM, 2000, GRAMBSCH PM MODELING, Vxiii; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725	26	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181000	10.1371/journal.pone.0181000	http://dx.doi.org/10.1371/journal.pone.0181000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700711	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800113
J	Szostak, N; Synak, J; Borowski, M; Wasik, S; Blazewicz, J				Szostak, Natalia; Synak, Jaroslaw; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek			Simulating the origins of life: The dual role of RNA replicases as an obstacle to evolution	PLOS ONE			English	Article							SYSTEMS BIOLOGY; GROUP SELECTION; HYPERCYCLES; POLYMERIZATION; PARASITES; RIBOZYME; COMPLEX; MODEL	Despite years of study, it is still not clear how life emerged from inanimate matter and evolved into the complex forms that we observe today. One of the most recognized hypotheses for the origins of life, the RNA World hypothesis, assumes that life was sparked by prebiotic replicating RNA chains. In this paper, we address the problems caused by the interplay between hypothetical prebiotic RNA replicases and RNA parasitic species. We consider the coexistence of parasite RNAs and RNA replicases as well as the impact of parasites on the further evolution of replicases. For these purposes, we used multi-agent modeling techniques that allow for realistic assumptions regarding the movement and spatial interactions of modeled species. The general model used in this study is based on work by Takeuchi and Hogeweg. Our results confirm that the coexistence of parasite RNAs and replicases is possible in a spatially extended system, even if we take into consideration more realistic assumptions than Takeuchi and Hogeweg. However, we also showed that the presence of trade-off that takes into the account an RNA folding process could still pose a serious obstacle to the evolution of replication. We conclude that this might be a cause for one of the greatest transitions in life that took place early in evolution-the separation of the function between DNA templates and protein enzymes, with a central role for RNA species.	[Szostak, Natalia; Synak, Jaroslaw; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Szostak, Natalia; Wasik, Szymon; Blazewicz, Jacek] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Szostak, Natalia; Borowski, Marcin; Wasik, Szymon; Blazewicz, Jacek] European Ctr Bioinformat & Genom, Poznan, Poland	Poznan University of Technology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Wasik, S (corresponding author), Poznan Univ Tech, Inst Comp Sci, Poznan, Poland.; Wasik, S (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.; Wasik, S (corresponding author), European Ctr Bioinformat & Genom, Poznan, Poland.	szymon.wasik@cs.put.poznan.pl	Borowski, Marcin/F-9278-2013; Szostak, Natalia/H-1331-2015; Wasik, Szymon/F-7677-2014; Synak, Jaroslaw/AAI-3858-2021; Szostak, Natalia/GPX-0551-2022; Blazewicz, Jacek/L-5597-2014	Borowski, Marcin/0000-0003-2116-8761; Szostak, Natalia/0000-0001-9933-0496; Wasik, Szymon/0000-0002-2753-2862; Szostak, Natalia/0000-0001-9933-0496; Blazewicz, Jacek/0000-0001-8326-1094	Poznan University of Technology [09/91/DSPB/0600]; Etiuda grant from National Science Center, Poland [2016/20/T/ST6/00395]	Poznan University of Technology; Etiuda grant from National Science Center, Poland	This work was supported by Poznan University of Technology (www.put.edu.pl) grant [09/91/DSPB/0600]. Additionally NS was supported by Etiuda grant from National Science Center (www.ncn.gov.pl), Poland [2016/20/T/ST6/00395]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber MS, 2003, IMA VOL MATH APPL, V134, P1; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bartel DP., 1999, COLD SPRING HARBOR M, V37, P143; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; BOERLIJST MC, 1991, SFI STUD SCI COMPLEX, P255; BRESCH C, 1980, J THEOR BIOL, V85, P399, DOI 10.1016/0022-5193(80)90314-8; Colizzi ES, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004902; Costanzo G, 2009, J BIOL CHEM, V284, P33206, DOI 10.1074/jbc.M109.041905; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRONHJORT MB, 1995, ORIGINS LIFE EVOL B, V25, P227, DOI 10.1007/BF01581586; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; DAMUTH J, 1988, BIOL PHILOS, V3, P407, DOI 10.1007/BF00647962; Domingo E, 2015, CURRENT TOPICS IN MI, P1; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1982, DISEQUILIBRIUM SELF, P169; Eigen M., 1979, THE HYPERCYCLE A PRI; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Gesteland R. F., 2005, RNA WORLD; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Horning DP, 2016, P NATL ACAD SCI USA, V113, P9786, DOI 10.1073/pnas.1610103113; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Klann M, 2012, INT J MOL SCI, V13, P7798, DOI 10.3390/ijms13067798; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Knuth DE., 1981, THE ART OF COMPUTER, V2, P133; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Leigh E. G., 1995, EVOLUTION, V49, P1302; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035454; MAY RM, 1991, NATURE, V353, P607, DOI 10.1038/353607a0; McCaskill JS, 2001, BIOL CHEM, V382, P1343, DOI 10.1515/BC.2001.167; Merelli E, 2007, BRIEF BIOINFORM, V8, P45, DOI 10.1093/bib/bbl014; NUNNEY L, 1985, AM NAT, V126, P212, DOI 10.1086/284410; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Prejzendanc T, 2016, CURR BIOINFORM, V11, P551, DOI 10.2174/1574893610666150928193510; Rybarczyk A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0718-6; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Scheuring I., 2001, AVOIDING CATCH 22 OF, V1, P135; Sczepanski JT, 2014, NATURE, V515, P440, DOI 10.1038/nature13900; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2015, P NATL ACAD SCI USA, V112, P10104, DOI 10.1073/pnas.1421398112; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Szostak N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004853; Szostak N, 2014, RNA BIOL, V11, P836, DOI 10.4161/rna.29305; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Takeuchi N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002024; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vodovotz Y, 2015, TRANSLATIONAL SYSTEM, P111, DOI [10.1016/b978-0-12-397884-4.00014-8, DOI 10.1016/B978-0-12-397884-4.00014-8]; von Kiedrowski G., 2001, SELECTION, V1, P173, DOI DOI 10.1556/SELECT.1.2000.1-3.17; Wasik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145557; Wasik S, 2014, ARTIF INTELL MED, V60, P123, DOI 10.1016/j.artmed.2013.11.001; Wasik S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/320715; Wasik S, 2010, COMPUT MATH METHOD M, V11, P185, DOI 10.1080/17486700903170712; WEIMAR JR, 1994, PHYS REV E, V49, P1749, DOI 10.1103/PhysRevE.49.1749; Woese C., 1967, THE GENETIC CODE THE; Wojciechowski P, 2016, FOUND COMPUT DECIS S, V41, P123, DOI 10.1515/fcds-2016-0007	73	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180827	10.1371/journal.pone.0180827	http://dx.doi.org/10.1371/journal.pone.0180827			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700697	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800083
J	Jin, B; Liu, R; Hao, SY; Li, Z; Zhu, CQ; Zhou, X; Chen, P; Fu, TY; Hu, ZK; Wu, Q; Liu, W; Liu, DW; Yu, YX; Zhang, Y; McElhinney, DB; Li, YM; Culver, DS; Alfreds, ST; Stearns, F; Sylvester, KG; Widen, E; Ling, XFB				Jin, Bo; Liu, Rui; Hao, Shiying; Li, Zhen; Zhu, Chunqing; Zhou, Xin; Chen, Pei; Fu, Tianyun; Hu, Zhongkai; Wu, Qian; Liu, Wei; Liu, Daowei; Yu, Yunxian; Zhang, Yan; McElhinney, Doff B.; Li, Yu-Ming; Culver, Devore S.; Alfreds, Shaun T.; Stearns, Frank; Sylvester, Karl G.; Widen, Eric; Ling, Xuefeng B.			Defining and characterizing the critical transition state prior to the type 2 diabetes disease	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING BIOMOLECULAR NETWORKS; IMPAIRED GLUCOSE-TOLERANCE; EPILEPTIC SEIZURES; COMPLEX DISEASES; BETA-BLOCKERS; LIFE-STYLE; RISK; METAANALYSIS; ANTIBIOTICS	Background Type 2 diabetes mellitus (T2DM), with increased risk of serious long-term complications, currently represents 8.3% of the adult population. We hypothesized that a critical transition state prior to the new onset T2DM can be revealed through the longitudinal electronic medical record (EMR) analysis. Method We applied the transition-based network entropy methodology which previously identified a dynamic driver network (DDN) underlying the critical T2DM transition at the tissue molecular biological level. To profile pre-disease phenotypical changes that indicated a critical transition state, a cohort of 7,334 patients was assembled from the Maine State Health Information Exchange (HIE). These patients all had their first confirmative diagnosis of T2DM between January 1, 2013 and June 30, 2013. The cohort's EMRs from the 24 months preceding their date of first T2DM diagnosis were extracted. Results Analysis of these patients' pre-disease clinical history identified a dynamic driver network (DDN) and an associated critical transition state six months prior to their first confirmative T2DM state. Conclusions This 6-month window before the disease state provides an early warning of the impending T2DM, warranting an opportunity to apply proactive interventions to prevent or delay the new onset of T2DM.	[Jin, Bo; Zhu, Chunqing; Fu, Tianyun; Stearns, Frank; Widen, Eric] HBI Solut Inc, Palo Alto, CA USA; [Liu, Rui; Hao, Shiying; Li, Zhen; Hu, Zhongkai; Zhang, Yan; McElhinney, Doff B.; Sylvester, Karl G.; Ling, Xuefeng B.] Stanford Univ, Stanford, CA 94305 USA; [Liu, Rui] South China Univ Technol, Sch Math, Guangzhou, Guangdong, Peoples R China; [Hao, Shiying; McElhinney, Doff B.; Ling, Xuefeng B.] Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Stanford, CA 94304 USA; [Li, Zhen] Southeast Univ, Sch Elect Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Xin; Li, Yu-Ming] Pingjin Hosp, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Heart Ctr, Tianjin, Peoples R China; [Chen, Pei] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Qian; Liu, Wei; Liu, Daowei] China Elect Power Res Inst, Beijing, Peoples R China; [Yu, Yunxian] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yan] First Hosp Shijiazhuang, Dept Oncol, Shijiazhuang, Hebei, Peoples R China; [Culver, Devore S.; Alfreds, Shaun T.] HealthInfoNet, Portland, ME USA; [Ling, Xuefeng B.] Zhejiang Univ, Sch Publ Hlth, Hlth Care Big Data Ctr, Hangzhou, Zhejiang, Peoples R China	Stanford University; South China University of Technology; Lucile Packard Children's Hospital (LPCH); Southeast University - China; South China University of Technology; Zhejiang University; Zhejiang University	Ling, XFB (corresponding author), Stanford Univ, Stanford, CA 94305 USA.; Ling, XFB (corresponding author), Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Stanford, CA 94304 USA.; Ling, XFB (corresponding author), Zhejiang Univ, Sch Publ Hlth, Hlth Care Big Data Ctr, Hangzhou, Zhejiang, Peoples R China.	bxling@stanford.edu	Liu, Rui/AAK-8178-2020	Liu, Rui/0000-0002-4547-8695; Hao, Shiying/0000-0002-7527-2460; McElhinney, Doff/0000-0001-7242-0934; Ling, Bruce/0000-0002-5386-3884; Sylvester, Karl G./0000-0002-8559-0155	HBI	HBI	The authors received no public funding for this work. HBI Solutions, Inc. (HBI) is a private commercial company, and several authors are employed by HBI. HBI provided funding in the form of salaries to the authors employed by HBI: BJ, TF, CZ, FS and EW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Gilmore R., 1993, CATASTROPHE THEORY S, Vxvii; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Hao SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140271; Hao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112944; He DN, 2012, J MOL CELL BIOL, V4, P140, DOI 10.1093/jmcb/mjs011; Hu ZK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4976; Hu ZK, 2015, INTERACT J MED RES, V4, P39, DOI 10.2196/ijmr.4022; Inzucchi SE, 2012, NEW ENGL J MED, V367, P542, DOI 10.1056/NEJMcp1103643; JIN B, 2016, BMC EMERG MED, V16, DOI DOI 10.HTTPS://D0I.0RG/10.1186/S12873-016-0074-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Li MY, 2014, BRIEF BIOINFORM, V15, P229, DOI 10.1093/bib/bbt027; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Liu R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00813; Liu XP, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S8; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P3633, DOI 10.1210/jc.2015-2696; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Paek SH, 2005, CANCER-AM CANCER SOC, V104, P580, DOI 10.1002/cncr.21190; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shen L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6745; Tan Z, 2015, METHODS, V83, P36, DOI 10.1016/j.ymeth.2015.05.004; Telfer SJ, 2014, MED HYPOTHESES, V83, P263, DOI 10.1016/j.mehy.2014.05.013; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Wang Y, 2015, INT J MED INFORM, V84, P1039, DOI 10.1016/j.ijmedinf.2015.06.007; WHO, 2016, GLOB REP PSOR; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Zheng L, 2016, JMIR MED INF, V4, P38, DOI 10.2196/medinform.6328	35	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180937	10.1371/journal.pone.0180937	http://dx.doi.org/10.1371/journal.pone.0180937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686739	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100122
J	Wang, LC; Zhou, KH; Zhao, HP; Wang, JH; Zheng, HC; Yu, Y; Chen, W				Wang, Linchuan; Zhou, Kai-Hua; Zhao, He-Ping; Wang, Ji-Han; Zheng, Hai-Chao; Yu, Yan; Chen, Wei			The characteristics of screening and confirmatory test results for HIV in Xi'an, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; COMBINED P24 ANTIGEN; WESTERN-BLOT; AG/AB COMBO; ANTIBODY; INFECTION; ASSAY; DIAGNOSIS; SEROCONVERSION; PERFORMANCE	Objectives Individuals with recent or acute HIV infection are more infectious than those with established infection. Our objective was to analyze the characteristics of detection among HIV infections in Xi'an. Methods A 4(th) -generation kit (Architect HIV Ag/Ab Combo) and three 3(rd) -generationEIA kits (WanTai, XinChuang and Livzon) were used for HIV screening. Overall, 665 individuals were identified as positive and were tested by western blotting (WB). The characteristics of the screening and confirmatory tests were analyzed, including the band patterns, the early detection performance and the false-positive rates. Results In total, 561 of the 665 patients were confirmed as having HIV-1 infection, and no HIV-2 specific band was observed. Among these 561 WB-positive cases, reactivity to greater than or equal to 9 antigens was the most commonly observed pattern (83.18%), and the absence of reactivity to p17, p31 and gp41 was detected in 6.44%, 5.9% and 2.86% of the cases, respectively. Two cases were positive by the 4 (th) -generation assay but negative by the 3(rd)-generation assay for HIV screening and had seroconversion. The false-positive rate of the Architect HIV Ag/Ab Combo (22.01%) was significantly higher than those of WanTai (9.88%), XinChuang (10.87%) and Livzon (8.93%), p< 0.05. Conclusion HIV infection in Xi'an is mainly caused by HIV-1, and individuals are rarely identified at the early phase. Although the false-positive rate of the 4(th) -generation assay was higher than that of the 3 (rd) -generation assay, it is still recommended for use as the initial HIV screening test for high-risk individuals. In Xi'an, a 3rd-generation assay for screening could be considered.	[Wang, Linchuan; Chen, Wei] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China; [Zhou, Kai-Hua] Hosp Xian Jiaotong Univ, Xian, Shaanxi Provinc, Peoples R China; [Zhao, He-Ping; Wang, Ji-Han; Yu, Yan] Xi An Jiao Tong Univ, Honghui Hosp, Xian, Shaanxi Provinc, Peoples R China; [Zheng, Hai-Chao] Xian Ctr Dis Control & Prevent, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Chen, W (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China.; Yu, Y (corresponding author), Xi An Jiao Tong Univ, Honghui Hosp, Xian, Shaanxi Provinc, Peoples R China.	yu.yan74@163.com; 568646799@qq.com	Wang, Linchuan/AAH-8711-2020					Alexander TS, 2016, CLIN VACCINE IMMUNOL, V23, P249, DOI 10.1128/CVI.00053-16; Chavez P, 2011, J CLIN VIROL, V52, pS51, DOI 10.1016/j.jcv.2011.09.010; Chen JM, 2002, J INFECT DIS, V186, P321, DOI 10.1086/341661; Dubravac T, 2013, J CLIN VIROL, V58, pE76, DOI 10.1016/j.jcv.2013.10.020; Duri K, 2011, Z BMC INFECT DIS, V11, P1; Erickson CP, 2006, NEW ENGL J MED, V354, P1422, DOI 10.1056/NEJMc053417; Everett DB, 1969, TROP MED INT HEALTH, V12, P1323; Fanmi AN, 2013, EUR J CLIN MICROBIOL, V32, P425, DOI 10.1007/s10096-012-1760-1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Goldenberg S, 2007, J MED VIROL, V79, pS23, DOI 10.1002/jmv.20964; Grusky O, 2006, AIDS PATIENT CARE ST, V20, P620, DOI 10.1089/apc.2006.20.620; Guan M, 2007, CLIN VACCINE IMMUNOL, V14, P649, DOI 10.1128/CVI.00393-06; Jensen TO, 2015, J CLIN MICROBIOL, V53, P1709, DOI 10.1128/JCM.03583-14; Kim S, 2010, CLIN VACCINE IMMUNOL, V17, P1642, DOI 10.1128/CVI.00258-10; Lee K, 2013, ANN LAB MED, V33, P420, DOI 10.3343/alm.2013.33.6.420; Ly TD, 2000, J CLIN MICROBIOL, V38, P2459; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Mahajan VS, 2010, CLIN CHEM, V56, P1523, DOI 10.1373/clinchem.2009.139535; Mitchell EO, 2013, J CLIN VIROL, V58, pE79, DOI 10.1016/j.jcv.2013.08.009; Pandori M, 2009, ANTIMICROB AGENTS CH, V53, P4032, DOI 10.1128/AAC.00406-09; Rickman LS., 1981, MMWR-MORBID MORTAL W, V30, P250; SAAH AJ, 1987, J CLIN MICROBIOL, V25, P1605, DOI 10.1128/JCM.25.9.1605-1610.1987; Salmona M, 2014, J CLIN MICROBIOL, V52, P103, DOI 10.1128/JCM.02460-13; Schappert J, 2006, CLIN CHIM ACTA, V372, P158, DOI 10.1016/j.cca.2006.04.017; Shaw GM, 2012, COLD SPRING HARB PER, V2, P705; Shima-Sano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009382; Stekler J, 2007, CLIN INFECT DIS, V44, P459, DOI 10.1086/510747; Talha SM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-325; Talha SM, 2011, J VIROL METHODS, V173, P24, DOI 10.1016/j.jviromet.2011.01.001; Wang Ji-bao, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P998; Wang LC, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22015; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weber B, 2002, J CLIN MICROBIOL, V40, P1420, DOI 10.1128/JCM.40.4.1420-1426.2002	33	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180071	10.1371/journal.pone.0180071	http://dx.doi.org/10.1371/journal.pone.0180071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686629	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100034
J	Onyedum, CC; Alobu, I; Ukwaja, KN				Onyedum, Cajetan C.; Alobu, Isaac; Ukwaja, Kingsley Nnanna			Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and metaanalysis	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANCE; RISK-FACTORS; RIFAMPICIN	Background Drug-resistant tuberculosis TB) undermines control efforts and its burden is poorly understood in resource-limited settings. We performed a systematic review and meta-analysis to provide an up-to-date summary of the extent of drug-resistant TB in Nigeria. Methods We searched PubMed, Scopus, Embase, HINARI, AJOL, the Cochrane library, Web of Science, and Google Scholar for reports published before January 31 2017, that included any resistance, mono-resistance or multidrug resistance to anti-TB drugs in Nigeria. Summary estimates were calculated using random effects models. Results We identified 34 anti-TB drug resistance surveys with 8002 adult TB patients consisting of 2982 new and 5020 previously-treated cases. The prevalence rate of any drug resistance among new TB cases was 32.0% 95% CI 24.0 -40.0%; 734/ 2892) and among previouslytreated cases, the rate was 53.0% 95% CI 35.0 -71.0%; 1467/ 5020). Furthermore, multidrug resistance among new and previously-treated cases was 6.0% 95% CI 4.0 -8.0%; 161/ 2502) and 32.0% 95% CI 20.0 -44.0; 357/ 949), respectively. There was significant heterogeneity between the studies p< 0.001, I 2 tests). The prevalence of drug-resistant TB varied according to methods of drug susceptibility testing and geographic region of Nigeria. Conclusion The burden of drug-resistant TB in Nigeria is high. We recommend that a national anti-TB drug resistance survey be carried out, and strategies for case detection and programmatic management of drug-resistant TB in Nigeria need to be strengthened.	[Onyedum, Cajetan C.] Univ Nigeria, Dept Med, Coll Med, Enugu Campus, Enugu, Nigeria; [Alobu, Isaac] Minist Hlth, Natl TB & Leprosy Control Programme, Abakaliki, Ebonyi State, Nigeria; [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria	University of Nigeria	Ukwaja, KN (corresponding author), Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.	ukwajakingsley@yahoo.co.uk	Onyedum, Cajetan/AAF-3862-2020; Ukwaja, Kingsley N./A-7794-2013	Ukwaja, Kingsley N./0000-0002-1974-8735				Adamu A. U., 2015, The Journal of American Science, V11, P293; Aghaji MN, 2010, NIGER J CLIN PRACT, V13, P58; Aliyu Gambo, 2013, Tuberc Res Treat, V2013, P650561, DOI 10.1155/2013/650561; Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3; Ani AE, 2009, T ROY SOC TROP MED H, V103, P67, DOI 10.1016/j.trstmh.2008.08.004; Antunes ML, 2000, INT J TUBERC LUNG D, V4, P223; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bello LA, 2014, INT J RES MED SCI, V2, P1134; Berhan A, 2013, ETHIOP J HEALTH SCI, V23, P271, DOI 10.4314/ejhs.v23i3.10; Blondal K, 2007, BULL WORLD HEALTH OR, V85; Daniel O, 2011, AFR J RESPIR MED, V6, P18; Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6; Deutschendorf C, 2012, BRAZ J INFECT DIS, V16, P142, DOI [10.1590/S1413-86702012000200006, 10.1016/S1413-8670(12)70295-7]; Dosumu EA, 2008, AFR J RESP MED, V4, P22; Duan QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148041; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egbe K, 2016, SCI J PUBLIC HLTH, V4, P214; Eltayeb O, J PULMON RESP MED S, VS6; FAWCETT IW, 1976, TUBERCLE, V57, P71, DOI 10.1016/0041-3879(76)90020-9; Federal Ministry of Health, 2015, NATIONAL TUBERCULOSI; Gehre F, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0704-5; Halilu TB, 2013, J PHARM COSMET SCI, V1, P45; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; IDIGBE EO, 1992, J TROP MED HYG, V95, P186; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Kehinde A O, 2013, Niger J Physiol Sci, V28, P187; Kehinde AO, 2007, J NATL MED ASSOC, V99, P1185; Kehinde AO, 2012, J MED MICROB DIAGN S, VS3; Kolo I, 1991, THESIS; Lawson L, 2011, TROP MED INT HEALTH, V16, P974, DOI 10.1111/j.1365-3156.2011.02792.x; Lawson L, 2010, ANN AFR MED, V9, P184, DOI 10.4103/1596-3519.68355; Lukoye D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1614-8; Mawak JD, 2006, NIG J EXP APPL BIOL, V7, P128; Mustapha G., 2015, SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, V12, P1; Nasiri MJ, 2014, AM J INFECT CONTROL, V42, P1212, DOI 10.1016/j.ajic.2014.07.017; Nwachukwu NO, 2016, J INFEC DIS TREAT, V2, P1; Nwofor AC, 2015, CURR HIV RES, V13, P308, DOI 10.2174/1570162X13666150407143147; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Okodua M, 2012, INT J BASIC APPL INN, V1, P48; Oluwaseun E., 2013, AM J RES COMMUN, V1, P224; Otu A, 2013, NIGERIA PULM MED, V2013; Pokam BT, 2013, INT J MYCOBACT, V2, P89, DOI 10.1016/j.ijmyco.2013.03.002; Rasaki SO, 2014, J INFECT DIS THER, V2, P3; Rikoto JA, 2015, THESIS; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Sogaolu OM, 2012, AM J RESP CRIT CARE, V185, pA3257; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; The Joanna Briggs Institute, 2014, JOANNA BRIGGS INSTIT; Ukaegbu CO, 2016, BR J PHARM RES, V9, P1; Ukoli C, 2012, JOS J MED, V6, P26; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P860; Uzoewulu NG, 2014, J MED MICROB DIAGN, V3, P2, DOI DOI 10.4172/2161-0703.1000141; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; Weldegebreal S, 2017, INT J TUBERC LUNG D, V21, P18, DOI 10.5588/ijtld.16.0286; World Health Organization, 2016, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GUIDELINES FOR SURVE; Zhao P, 2012, J INT MED RES, V40, P436, DOI 10.1177/147323001204000205	58	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							0180996	10.1371/journal.pone.0180996	http://dx.doi.org/10.1371/journal.pone.0180996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704459	Green Submitted, gold, Green Published			2022-12-27	WOS:000405649700071
J	Wang, JX; Gronalt, M; Sun, Y				Wang, Jiaxi; Gronalt, Manfred; Sun, Yan			A two-stage approach to the depot shunting driver assignment problem with workload balance considerations	PLOS ONE			English	Article							PASSENGER TRAIN UNITS; MODEL; OPTIMIZATION; VEHICLE; ALGORITHM	Due to its environmentally sustainable and energy-saving characteristics, railway transportation nowadays plays a fundamental role in delivering passengers and goods. Emerged in the area of transportation planning, the crew (workforce) sizing problem and the crew scheduling problem have been attached great importance by the railway industry and the scientific community. In this paper, we aim to solve the two problems by proposing a novel two-stage optimization approach in the context of the electric multiple units (EMU) depot shunting driver assignment problem. Given a predefined depot shunting schedule, the first stage of the approach focuses on determining an optimal size of shunting drivers. While the second stage is formulated as a bi-objective optimization model, in which we comprehensively consider the objectives of minimizing the total walking distance and maximizing the workload balance. Then we combine the normalized normal constraint method with a modified Pareto filter algorithm to obtain Pareto solutions for the bi-objective optimization problem. Furthermore, we conduct a series of numerical experiments to demonstrate the proposed approach. Based on the computational results, the regression analysis yield a driver size predictor and the sensitivity analysis give some interesting insights that are useful for decision makers.	[Wang, Jiaxi] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Gronalt, Manfred] Univ Nat Resources & Life Sci, Vienna BOKU, Inst Prod & Logist, Vienna, Austria; [Sun, Yan] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China	Beijing Jiaotong University; University of Natural Resources & Life Sciences, Vienna; Shandong University of Finance & Economics	Wang, JX (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	wangjiaxi@bjtu.edu.cn			Austrian Federal Ministry of Science, Research and Economy within the EURASIA PACIFIC UNINET scholarship framework [ICM-2016-04321]	Austrian Federal Ministry of Science, Research and Economy within the EURASIA PACIFIC UNINET scholarship framework	This work is partially financed by the Austrian Federal Ministry of Science, Research and Economy (http://www.en.bmwfw.gv.at/Seiten/default.aspx) within the EURASIA PACIFIC UNINET scholarship framework (Reference No.: ICM-2016-04321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RK, 2005, TRANSPORT SCI, V39, P503, DOI 10.1287/trsc.1050.0115; [Anonymous], 1986, MANAGING HUMAN RESOU; Azadeh A, 2013, APPL SOFT COMPUT, V13, P158, DOI 10.1016/j.asoc.2012.08.012; Bai Q, 2015, COMPUT-AIDED CIV INF, V30, P163, DOI 10.1111/mice.12079; Beasley JE, 1996, EUR J OPER RES, V94, P517, DOI 10.1016/0377-2217(95)00093-3; BEAUJON GJ, 1991, TRANSPORT SCI, V25, P19, DOI 10.1287/trsc.25.1.19; Borndorfer R, 2011, OASICS OPENACCESS SE; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; Engels B, 2015, NETWORKS, V66, P33, DOI 10.1002/net.21603; Florian M., 1976, INFOR. Canadian Journal of Operational Research and Information Processing, V14, P121; Freling R, 2005, TRANSPORT SCI, V39, P261, DOI 10.1287/trsc.1030.0076; Freling R, 2004, ANN OPER RES, V127, P203, DOI 10.1023/B:ANOR.0000019090.39650.32; Giacco GL, 2014, J INTELL TRANSPORT S, V18, P95, DOI 10.1080/15472450.2013.801712; Haase K, 2001, TRANSPORT SCI, V35, P286, DOI 10.1287/trsc.35.3.286.10153; Hanafi R, 2014, COMPUT IND ENG, V70, P11, DOI 10.1016/j.cie.2014.01.002; Huisman D, 2005, TRANSPORT SCI, V39, P491, DOI 10.1287/trsc.1040.0104; Ighravwe DE, 2014, INT J PROD ECON, V150, P204, DOI 10.1016/j.ijpe.2014.01.004; Jacobsen PM, 2011, FLEX SERV MANUF J, V23, P156, DOI 10.1007/s10696-011-9096-1; JORDAN WC, 1983, TRANSPORT SCI, V17, P123, DOI 10.1287/trsc.17.2.123; Jutte S, 2012, EUR J OPER RES, V219, P214, DOI 10.1016/j.ejor.2011.12.038; Jutte S, 2011, INTERFACES, V41, P109, DOI 10.1287/inte.1100.0549; Kroon LG, 2008, TRANSPORT SCI, V42, P436, DOI 10.1287/trsc.1080.0243; Lai YC, 2015, COMPUT IND ENG, V85, P284, DOI 10.1016/j.cie.2015.03.016; Li YJ, 2007, ANN OPER RES, V155, P361, DOI 10.1007/s10479-007-0215-z; Mansouri SA, 2015, TRANSPORT RES E-LOG, V78, P3, DOI 10.1016/j.tre.2015.01.012; Messac A, 2003, STRUCT MULTIDISCIP O, V25, P86, DOI 10.1007/s00158-002-0276-1; Milenkovic M, 2013, TRANSPORT RES C-EMER, V33, P107, DOI 10.1016/j.trc.2013.05.003; Narisetty AK, 2008, INTERFACES, V38, P89, DOI 10.1287/inte.1070.0330; Piu F, 2015, TRANSPORT RES E-LOG, V82, P217, DOI 10.1016/j.tre.2015.07.003; Shiftan Y, 1995, COMPUTER AIDED SCHED, P248; Sun Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080762; VERBEEK PJ, 1991, EUR J OPER RES, V55, P368, DOI 10.1016/0377-2217(91)90206-B; Wang JX, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/5804626; Zak J, 2008, J ADV TRANSPORT, V42, P379, DOI 10.1002/atr.5670420402; Zak J, 2011, J ADV TRANSPORT, V45, P1, DOI 10.1002/atr.108	35	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181165	10.1371/journal.pone.0181165	http://dx.doi.org/10.1371/journal.pone.0181165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704489	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700102
J	Carmona-Antonanzas, G; Bekaert, M; Humble, JL; Boyd, S; Roy, W; Bassett, DI; Houston, RD; Gharbi, K; Bron, JE; Sturm, A				Carmona-Antonanzas, Greta; Bekaert, Michael; Humble, Joseph L.; Boyd, Sally; Roy, William; Bassett, David I.; Houston, Ross D.; Gharbi, Karim; Bron, James E.; Sturm, Armin			Maternal inheritance of deltamethrin resistance in the salmon louse Lepeophtheirus salmonis (Kroyer) is associated with unique mtDNA haplotypes	PLOS ONE			English	Article							INSECT SODIUM-CHANNELS; SEA LICE; EMAMECTIN BENZOATE; PYRETHROID RESISTANCE; MOLECULAR-BIOLOGY; CALIGUS-ROGERCRESSEYI; DRUG-RESISTANCE; P-GLYCOPROTEIN; COMPLEX I; GENE	Parasitic infections by the salmon louse, Lepeophtheirus salmonis (Kroyer), cause huge economic damage in salmon farming in the northern hemisphere, with combined treatment costs and production losses in 2014 having been estimated at US$ 350 million for Norway (annual production 1.25 million tonnes). The control of L. salmonis relies significantly on medicinal treatments, supplemented by non-pharmacological approaches. However, efficacy losses have been reported for several delousing agents, including the pyrethroid deltamethrin. The aim of the present study was to analyse the genetic basis of deltamethrin resistance in L. salmonis. Deltamethrin median effective concentrations (EC50) were 0.28 mu g L (-1) in the drug susceptible L. salmonis strain IoA-00 and 40.1 mu g L (-1) in the pyrethroid resistant strain IoA-02. IoA-00 and IoA-02 were crossed to produce families spanning one parental and three filial generations (P0, F1-F3). In three families derived from P0 crosses between an IoA-00 sire and an IoA-02 dam, 98.8% of F2 parasites (n = 173) were resistant, i.e. remained unaffected after exposure to 2.0 mu g L (-1) deltamethrin. F3 parasites from these crosses showed a deltamethrin EC50 of 9.66 mu g L (-1).(.) In two families of the inverse orientation at P0 (IoA-02 sire x IoA-00 dam), 16.7% of F2 parasites were resistant (n = 84), while the deltamethrin EC50 in F3 animals was 0.26 mu g L (-1). The results revealed a predominantly maternal inheritance of deltamethrin resistance. The 15,947-nt mitochondrial genome was sequenced and compared among six unrelated L. salmonis strains and parasites sampled from wild salmon in 2010. IoA-02 and three further deltamethrin resistant strains, established from isolates originating from different regions of Scotland, showed almost identical mitochondrial haplotypes. In contrast, the mitochondrial genome was variable among susceptible strains and L. salmonis from wild hosts. Deltamethrin caused toxicity and depletion of whole body ATP levels in IoA-00 but not IoA-02 parasites. The maternal inheritance of deltamethrin resistance and its association with mitochondrial haplotypes suggests that pyrethroid toxicity in L. salmonis may involve molecular targets encoded by mitochondrial genes.	[Carmona-Antonanzas, Greta; Bekaert, Michael; Humble, Joseph L.; Boyd, Sally; Roy, William; Bassett, David I.; Bron, James E.; Sturm, Armin] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Houston, Ross D.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Houston, Ross D.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Gharbi, Karim] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Stirling; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Sturm, A (corresponding author), Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland.	armin.sturm@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Roy, William/0000-0001-9493-5795; Sturm, Armin/0000-0003-2632-1999; Bassett, David/0000-0002-7529-0829; Bekaert, Michael/0000-0002-1206-7654; Houston, Ross/0000-0003-1805-0762	Biotechnology and Biological Sciences Research Council [BB/L022923/1, BBS/E/D/20002173, BB/L024004/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211553] Funding Source: Medline; BBSRC [BB/L024004/1, BB/L022923/1, BBS/E/D/20211553, BBS/E/D/20002173] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Anand SS, 2006, TOXICOL APPL PHARM, V212, P156, DOI 10.1016/j.taap.2005.07.021; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Blanquer A., 1990, PHYLOGEOGRAPHIE INTR; Braguini WL, 2004, TOXICOL LETT, V152, P191, DOI 10.1016/j.toxlet.2004.03.017; Brooker R.J., 2012, GENETICS ANAL PRINCI; Carmichael SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077832; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Carmona-Antonanzas G, 2016, AQUACULTURE, V464, P570, DOI 10.1016/j.aquaculture.2016.08.007; CASIDA JE, 1980, ENVIRON HEALTH PERSP, V34, P189, DOI 10.2307/3428960; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Chen D, 2007, J APPL TOXICOL, V27, P368, DOI 10.1002/jat.1215; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; ELLIOTT M, 1974, NATURE, V248, P710, DOI 10.1038/248710a0; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Fast MD, 2007, LEPEOPHTHEIRUS SALMO, V5000, P179; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gassner B, 1997, J PHARMACOL EXP THER, V281, P855; Godin SJ, 2006, DRUG METAB DISPOS, V34, P1764, DOI 10.1124/dmd.106.010058; Gong MQ, 2005, ARCH BIOCHEM BIOPHYS, V438, P53, DOI 10.1016/j.abb.2005.03.021; Carcamo JG, 2011, AQUACULTURE, V321, P207, DOI 10.1016/j.aquaculture.2011.09.012; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Helgesen KO, 2015, MONITORING DRUG RESI; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Heumann J, 2014, AQUACULTURE, V424, P207, DOI 10.1016/j.aquaculture.2013.12.015; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Igboeli OO, 2012, AQUACULTURE, V344, P40, DOI 10.1016/j.aquaculture.2012.03.026; ISHAAYA I, 1993, ARCH INSECT BIOCHEM, V22, P263, DOI 10.1002/arch.940220119; Iversen A., 2015, KOSTNADSDRIVERE LAKS; Jackson D, 2012, AQUACULTURE, V364, P118, DOI 10.1016/j.aquaculture.2012.08.003; Johnson SC, 2004, ZOOL STUD, V43, P229; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nardini L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-229; Nilsen F, 2015, Method for detection of pyrethroid resistance in crustaceans and oligonucleotide sequences useful in detection of pyrethroid resistance. Can Pat Appl, Patent No. [CA 2920588: A1, 2920588]; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Perlman SJ, 2015, P NATL ACAD SCI USA, V112, P10162, DOI 10.1073/pnas.1421391112; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Salama NKG, 2013, J FISH DIS, V36, P323, DOI 10.1111/jfd.12065; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2005, AQUACULTURE, V244, P19, DOI 10.1016/j.aquaculture.2004.11.009; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skern-Mauritzen R, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-44; Soderlund DM, 2015, PEST MANAG SCI, V71, P801, DOI 10.1002/ps.3881; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014; Stien LH, 2016, AQUACULTURE, V458, P29, DOI 10.1016/j.aquaculture.2016.02.014; Sutherland BJG, 2015, EVOL APPL, V8, P133, DOI 10.1111/eva.12237; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Tjensvoll K, 2006, DIS AQUAT ORGAN, V68, P251, DOI 10.3354/dao068251; Tjensvoll K, 2005, GENE, V353, P218, DOI 10.1016/j.gene.2005.04.033; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Valenzuela-Miranda D, 2016, AQUACULTURE, V465, P65, DOI 10.1016/j.aquaculture.2016.08.027; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2006, INSECT BIOCHEM MOLEC, V36, P869, DOI 10.1016/j.ibmb.2006.08.005; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Westcott JD, 2008, DIS AQUAT ORGAN, V79, P119, DOI 10.3354/dao01887; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Zhang SY, 2007, ENDOCRINOLOGY, V148, P3941, DOI 10.1210/en.2006-1497; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	76	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180625	10.1371/journal.pone.0180625	http://dx.doi.org/10.1371/journal.pone.0180625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704444	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600037
J	Pradhan, S; Kant, C; Verma, S; Bhatia, S				Pradhan, Seema; Kant, Chandra; Verma, Subodh; Bhatia, Sabhyata			Genome-wide analysis of the CCCH zinc finger family identifies tissue specific and stress responsive candidates in chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							RNA-BINDING PROTEINS; AU-RICH ELEMENTS; MESSENGER-RNA; GENE FAMILY; ABSCISIC-ACID; ARABIDOPSIS; SEED; EVOLUTION; SEQUENCE; TRISTETRAPROLIN	The CCCH zinc finger is a group of proteins characterised by a typical motif consisting of three cysteine residues and one histidine residue. These proteins have been reported to play important roles in regulation of plant growth, developmental processes and environmental responses. In the present study, genome wide analysis of the CCCH zinc finger gene family was carried out in the available chickpea genome. Various bioinformatics tools were employed to predict 58 CCCH zinc finger genes in chickpea (designated CarC3H158), which were analysed for their physio-chemical properties. Phylogenetic analysis classified the proteins into 12 groups in which members of a particular group had similar structural organization. Further, the numbers as well as the types of CCCH motifs present in the CarC3H proteins were compared with those from Arabidopsis and Medicago truncatula. Synteny analysis revealed valuable information regarding the evolution of this gene family. Tandem and segmental duplication events were identified and their Ka/Ks values revealed that the CarC3H gene family in chickpea had undergone purifying selection. Digital, as well as real time qRT-PCR expression analysis was performed which helped in identification of several CarC3H members that expressed preferentially in specific chickpea tissues as well as during abiotic stresses (desiccation, cold, salinity). Moreover, molecular characterization of an important member CarC3H45 was carried out. This study provides comprehensive genomic information about the important CCCH zinc finger gene family in chickpea. The identified tissue specific and abiotic stress specific CCCH genes could be potential candidates for further characterization to delineate their functional roles in development and stress.	[Pradhan, Seema; Kant, Chandra; Verma, Subodh; Bhatia, Sabhyata] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	sabhyatabhatia@nipgr.ac.in	Verma, Subodh/X-3993-2019	Verma, Subodh/0000-0001-9071-037X; Bhatia, Sabhyata/0000-0003-0811-219X	Department of Biotechnology (DBT), Ministry of Science and Technology, India [BT/AGR/CG-Phase II/01/2014]; Department of Biotechnology (DBT); Council for Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT), Ministry of Science and Technology, India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by grant (BT/AGR/CG-Phase II/01/2014) from the Department of Biotechnology (DBT), Ministry of Science and Technology, India (http://www.dbtindia.nic.in). SP and SV acknowledge the award of research fellowship from the Department of Biotechnology (DBT) and CK acknowledges the award of research fellowship from Council for Scientific and Industrial Research (CSIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bogamuwa SP, 2014, PLANT AND CELL PHYSI; Bogamuwa S, 2013, PLANT CELL ENVIRON, V36, P1507, DOI 10.1111/pce.12084; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Carranco RT, 2004, PLANT MOL BIOL, V55, P221, DOI 10.1007/s11103-004-0512-8; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Doyle J. J., 1987, PHYTOCHEM B, P11; Duran Chris, 2009, V513, P41, DOI 10.1007/978-1-59745-427-8_3; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Garg R, 2014, PLANT MOL BIOL REP; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kim DH, 2008, PLANT CELL, V20, P1260, DOI 10.1105/tpc.108.058859; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Koornneef M, 1994, COLD SPRING HARB MON, V27, P313; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; LI WH, 1983, MOL BIOL EVOL, V1, P94; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Liu SR, 2014, MOL GENET GENOMICS, V289, P855, DOI 10.1007/s00438-014-0858-9; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; MCCARTY DR, 1995, ANNU REV PLANT PHYS, V46, P71, DOI 10.1146/annurev.pp.46.060195.000443; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Nandi S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-116; Ouwerkerk P B, 2001, CURR PROTOC MOL BIOL, P12; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Pradhan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00698; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Soderman EM, 2000, PLANT PHYSIOL, V124, P1752, DOI 10.1104/pp.124.4.1752; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wagner A, 2002, GENOME BIOL, V3; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003521; Wang XL, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0019; Zhang CQ, 2013, PLANT CELL REP, V32, P1543, DOI 10.1007/s00299-013-1466-6	70	22	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180469	10.1371/journal.pone.0180469	http://dx.doi.org/10.1371/journal.pone.0180469			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704400	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600032
J	Chaisawang, P; Sirichoat, A; Chaijaroonkhanarak, W; Pannangrong, W; Sripanidkulchai, B; Wigmore, P; Welbat, JU				Chaisawang, Pornthip; Sirichoat, Apiwat; Chaijaroonkhanarak, Wunnee; Pannangrong, Wanassanun; Sripanidkulchai, Bungorn; Wigmore, Peter; Welbat, Jariya Umka			Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; ADULT NEUROGENESIS; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; PENTACYCLIC TRITERPENE; THYMIDYLATE SYNTHASE; CENTELLA-ASIATICA; NEWBORN NEURONS; MOUSE MODEL; EXPRESSION	The chemotherapy drug, 5-fluorouracil (5-FU), has been reported to cause cognitive impairments in cancer patients. The drug also reduces cell proliferation and survival in the brain. Asiatic acid (AA) is a triterpene compound found in Centella asiatica that can protect against reduction of neurogenesis in the hippocampus and memory deficits induced by valproic acid (VPA). In the present study, we investigated the preventive effects of AA on the deficits in spatial working memory and cell proliferation and survival caused by 5-FU chemotherapy in a rat model. Male Sprague Dawley rats received 5-FU (5 i.v. injections, 25 mg/kg) on day 8, 11, 14, 17 and 20 of the study. This was co-administered with AA (30 mg/kg, oral gavage tube) either 20 days before receiving 5-FU (preventive), after receiving 5-FU (recovery), or for the entire period of the experiment (throughout). Spatial working memory was determined using the novel object location (NOL) test and hippocampal cell proliferation and survival of dividing cells were quantified using immunohistochemistry. Rats in the 5-FU alone and recovery groups showed memory deficits in the NOL test and reductions in cell proliferation and cell survival in the subgranular zone (SGZ) of the hippocampal dentate gyrus. Rats in the control, AA alone, and both preventive and throughout co-administration groups, however, did not exhibit these characteristics. The results showed that 5-FU chemotherapy impaired memory and reduced cell proliferation and cell survival in the SGZ of the hippocampal dentate gyrus. However, these impairments in the animals receiving 5-FU chemotherapy were restored to control levels when AA was co-administered before and during 5-FU treatment. These data demonstrate that AA can prevent the spatial working memory and hippocampal neurogenesis impairments caused by 5-FU chemotherapy.	[Chaisawang, Pornthip; Sirichoat, Apiwat; Chaijaroonkhanarak, Wunnee; Pannangrong, Wanassanun; Welbat, Jariya Umka] Khon Kaen Univ, Dept Anat, Fac Med, Khon Kaen, Thailand; [Pannangrong, Wanassanun; Sripanidkulchai, Bungorn; Welbat, Jariya Umka] Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen, Thailand; [Wigmore, Peter] Univ Nottingham, Med Sch, Sch Life Sci, Queens Med Ctr, Nottingham, England; [Welbat, Jariya Umka] Khon Kaen Univ, Neurosci Res & Dev Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; University of Nottingham; Khon Kaen University	Welbat, JU (corresponding author), Khon Kaen Univ, Dept Anat, Fac Med, Khon Kaen, Thailand.; Welbat, JU (corresponding author), Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen, Thailand.; Welbat, JU (corresponding author), Khon Kaen Univ, Neurosci Res & Dev Grp, Khon Kaen, Thailand.	jariya@kku.ac.th			The Thailand Research Fund [TRG5780086]; Invitation Research of the Faculty of Medicine [IN59312]; Neuroscience Research and Development Group at Khon Kaen University	The Thailand Research Fund(Thailand Research Fund (TRF)); Invitation Research of the Faculty of Medicine; Neuroscience Research and Development Group at Khon Kaen University	The Thailand Research Fund (TRG5780086), Invitation Research of the Faculty of Medicine (grant number: IN59312), and the Neuroscience Research and Development Group at Khon Kaen University funded this project.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ATKINS JN, 1991, AM J CLIN ONCOL-CANC, V14, P526, DOI 10.1097/00000421-199112000-00012; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Chiou SH, 2006, BIOCHEM BIOPH RES CO, V343, P391, DOI 10.1016/j.bbrc.2006.02.180; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Crupi R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-7; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; ELBeltagy M, 2012, BRAIN RES BULL, V88, P514, DOI 10.1016/j.brainresbull.2012.05.005; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Falleti MG, 2005, BRAIN COGNITION, V59, P60, DOI 10.1016/j.bandc.2005.05.001; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Foley JJ, 2008, PSYCHOPHARMACOLOGY, V199, P527, DOI 10.1007/s00213-008-1175-y; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; Imayoshi I, 2009, DEV GROWTH DIFFER, V51, P379, DOI 10.1111/j.1440-169X.2009.01094.x; Khotimah H, 2015, J PSYCHOL, V2, P22; Kreukels BPC, 2008, CLIN BREAST CANCER, V8, P80, DOI 10.3816/CBC.2008.n.006; Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee MK, 2000, RES COMMUN MOL PATH, V108, P75; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Lyons L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030010; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MOORE DH, 1990, GYNECOL ONCOL, V36, P152, DOI 10.1016/0090-8258(90)90127-7; Mustafa S, 2008, EUR J NEUROSCI, V28, P323, DOI 10.1111/j.1460-9568.2008.06325.x; Nasir MN, 2011, J ETHNOPHARMACOL, V134, P203, DOI 10.1016/j.jep.2010.12.010; ORHAN IE, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/946259; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rustum YM, 2004, FRONT BIOSCI-LANDMRK, V9, P2467, DOI 10.2741/1408; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Shukla A, 1999, J ETHNOPHARMACOL, V65, P1, DOI 10.1016/S0378-8741(98)00141-X; Sirichoat A, 2015, NUTRIENTS, V7, P8413, DOI 10.3390/nu7105401; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Umka Welbat J, 2016, NUTRIENTS, V8; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Wakabayashi T, 2008, NEUROSCI LETT, V442, P249, DOI 10.1016/j.neulet.2008.07.030; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Welbat JU, 2016, ANN ANAT, V206, P7, DOI 10.1016/j.aanat.2016.04.029; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Xu MF, 2012, ACTA PHARMACOL SIN, V33, P578, DOI 10.1038/aps.2012.3; Yeh Kun-Huei, 1994, Journal of the Formosan Medical Association, V93, P721; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	62	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180650	10.1371/journal.pone.0180650	http://dx.doi.org/10.1371/journal.pone.0180650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700628	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800062
J	Cheng, A; Chuang, YC; Sun, HY; Yang, CJ; Chang, HT; Yang, JL; Sheng, WH; Chen, YC; Chang, SC				Cheng, Aristine; Chuang, Yu-Chung; Sun, Hsin-Yun; Yang, Chia-Jui; Chang, Hou-Tai; Yang, Jia-Ling; Sheng, Wang-Huei; Chen, Yee-Chun; Chang, Shan-Chwen			Should we treat patients with only one set of positive blood cultures for extensively drugresistant Acinetobacter baumannii the same as multiple sets?	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; NOSOCOMIAL BACTEREMIA; CLINICAL-SIGNIFICANCE; PROGNOSTIC-FACTORS; STREAM INFECTIONS; RISK-FACTORS; MORTALITY; EPIDEMIOLOGY; THERAPY; OUTCOMES	Acinetobacter species are not considered skin commensals and under-treatment is an overriding concern when caring for critically-ill patients who are mostly at risk of extensively drug-resistant Acinetobacter baumannii (XDRAB) infections. Hence even a single blood culture yielding XDRAB will tend to prompt intervention. However, field observations suggest that patients with single-positive blood cultures had milder disease and were more likely to be recruited in interventional studies than those with multiple-positive blood cultures, yet no distinction is made in current clinical or trial recruitment practices. To our knowledge, this is the first study to compare the clinical characteristics and outcomes of patients with singlepositive versus multiple-positive blood cultures for XDRAB. In this multicenter prospective cohort study of XDRAB bacteremic patients from July 2010 to June 2015, only patients with at least two simultaneously drawn blood cultures were included. The patients were classified as having single-positive or multiple-positive blood cultures according to the number of positive blood cultures yielding XDRAB. The primary end-point was the 28-day mortality. Of a total of 155 patients enrolled, 69 had a single-positive and 86 had multiple-positive blood cultures. Leukopenia (37.2% vs. 16.2%; P = 0.004), thrombocytopenia (56.0% vs. 26.5%; P < 0.001), higher Pitt bacteremia scores (6.6 vs. 5.5, P = 0.03) and higher 28-day mortality rates (70.9% vs. 43.5%; P = 0.001) distinguished patients with multiple-positive from those with single-positive cultures. Multivariate logistic regression showed that multi-positivity independently predicted 28-day mortality (adjusted odds ratio, 2.34; 95% confidence interval (CI), 1.03 - 5.28; P = 0.04) and the Cox regression confirmed that multi-positivity (adjusted hazard ratio, 1.80; 95% CI, 1.13 - 2.85; P = 0.01) predicted rapid mortality. Patients with multiple versus single positive blood cultures yielding XDRAB had greater morbidity and mortality. Investigators and clinicians should be aware that the blood culture positivity rate impacts outcomes of XDRAB bacteremia.	[Cheng, Aristine; Chuang, Yu-Chung; Sun, Hsin-Yun; Sheng, Wang-Huei; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Main Branch, Dept Internal Med, Taipei, Taiwan; [Cheng, Aristine; Chuang, Yu-Chung; Sun, Hsin-Yun; Sheng, Wang-Huei; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chuang, Yu-Chung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Yang, Chia-Jui; Chang, Hou-Tai] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Yang, Jia-Ling] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Internal Med, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chuang, YC (corresponding author), Natl Taiwan Univ Hosp, Main Branch, Dept Internal Med, Taipei, Taiwan.; Chuang, YC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Chuang, YC (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	weischuang@gmail.com	houtai, chang/AAB-1479-2019; Chen, Yee-Chun/AGW-7535-2022; CHUANG, YU-CHUNG/F-4627-2016	Chen, Yee-Chun/0000-0002-1816-9010; SUN, HSIN-YUN/0000-0003-0074-7721; SHENG, WANG-HUEI/0000-0002-5605-7853; Cheng, Aristine/0000-0002-1182-7375; CHANG, SHAN-CHWEN/0000-0001-6505-4139; CHUANG, YU-CHUNG/0000-0003-3094-8276	Ministry of Science and Technology, Taiwan [MOST-104-2314-B-002-109-MY3]; Ministry of Health and Welfare, Taiwan [MOHW106-TDU-B-211-113002]; National Taiwan University Hospital [NTUH104- M2926]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare, Taiwan; National Taiwan University Hospital(National Taiwan University)	This study was supported partially by the Ministry of Science and Technology, Taiwan (MOST-104-2314-B-002-109-MY3), the Ministry of Health and Welfare, Taiwan (MOHW106-TDU-B-211-113002) and the National Taiwan University Hospital (NTUH104- M2926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; CHANDRASEKAR PH, 1994, ARCH INTERN MED, V154, P841, DOI 10.1001/archinte.154.8.841; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2003, INFECTION, V31, P331, DOI 10.1007/s15010-003-3223-1; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Cheng A, 2015, CRIT CARE MED, V43, P1194, DOI 10.1097/CCM.0000000000000933; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Chuang YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014133; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Claeys KC, 2016, AM J INFECT CONTROL, V44, P47, DOI 10.1016/j.ajic.2015.08.002; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Falagas ME, 2006, CLIN INFECT DIS, V43, P389, DOI 10.1086/505599; Favre B, 2005, INFECT CONT HOSP EP, V26, P697, DOI 10.1086/502605; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; FLOURNOY DJ, 1987, J NATL MED ASSOC, V79, P816; FLOURNOY DJ, 1983, ZBL BAKT-INT J MED M, V255, P336, DOI 10.1016/S0174-3031(83)80174-7; Garcia-Garmendia JL, 2001, CLIN INFECT DIS, V33, P939, DOI 10.1086/322584; Gomez J, 1999, EUR J CLIN MICROBIOL, V18, P358, DOI 10.1007/PL00015019; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jindai K, 2014, EUR J CLIN MICROBIOL, V33, P1995, DOI 10.1007/s10096-014-2167-y; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lee YT, 2012, CLIN INFECT DIS, V55, P209, DOI 10.1093/cid/cis385; MACGREGOR RR, 1972, ARCH INTERN MED, V130, P84, DOI 10.1001/archinte.130.1.84; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Munoz-Price LS, 2010, INFECT CONT HOSP EP, V31, P1057, DOI 10.1086/656247; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P313, DOI 10.1016/j.cmi.2015.01.003; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Pfaller MA, 1998, ANTIMICROB AGENTS CH, V42, P1762, DOI 10.1128/AAC.42.7.1762; Poutanen SM, 1997, EUR J CLIN MICROBIOL, V16, P737, DOI 10.1007/BF01709254; Savithri MB, 2011, CRIT CARE RESUSC, V13, P103; SCHONHEYDER HC, 1995, SCAND J INFECT DIS, V27, P19, DOI 10.3109/00365549509018967; SEIFERT H, 1995, MEDICINE, V74, P340, DOI 10.1097/00005792-199511000-00004; Souvenir D, 1998, J CLIN MICROBIOL, V36, P1923, DOI 10.1128/JCM.36.7.1923-1926.1998; Spellberg B, 2012, CLIN INFECT DIS, V55, P1031, DOI 10.1093/cid/cis688; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	41	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180967	10.1371/journal.pone.0180967	http://dx.doi.org/10.1371/journal.pone.0180967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686744	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100123
J	Moore, ER; Bullington, BS; Weisberg, AJ; Jiang, Y; Chang, J; Halsey, KH				Moore, Eric R.; Bullington, Briana S.; Weisberg, Alexandra J.; Jiang, Yuan; Chang, Jeff; Halsey, Kimberly H.			Morphological and transcriptomic evidence for ammonium induction of sexual reproduction in Thalassiosira pseudonana and other centric diatoms	PLOS ONE			English	Article							CELL-CYCLE; VEGETATIVE CELL; GENOME REVEALS; LIFE-CYCLES; EVOLUTIONARY; BACILLARIOPHYCEAE; SILICA; LIGHT; SPERMATOGENESIS; IDENTIFICATION	The reproductive strategy of diatoms includes asexual and sexual phases, but in many species, including the model centric diatom Thalassiosira pseudonana, sexual reproduction has never been observed. Furthermore, the environmental factors that trigger sexual reproduction in diatoms are not understood. Although genome sequences of a few diatoms are available, little is known about the molecular basis for sexual reproduction. Here we show that ammonium reliably induces the key sexual morphologies, including oogonia, auxospores, and spermatogonia, in two strains of T. pseudonana, T. weissflogii, and Cyclotella cryptica. RNA sequencing revealed 1,274 genes whose expression patterns changed when T. pseudonana was induced into sexual reproduction by ammonium. Some of the induced genes are linked to meiosis or encode flagellar structures of heterokont and cryptophyte algae. The identification of ammonium as an environmental trigger suggests an unexpected link between diatom bloom dynamics and strategies for enhancing population genetic diversity.	[Moore, Eric R.; Bullington, Briana S.; Halsey, Kimberly H.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Weisberg, Alexandra J.; Halsey, Kimberly H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Jiang, Yuan] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Halsey, KH (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	halseyk@science.oregonstate.edu		Moore, Eric/0000-0001-5834-8753; Halsey, Kimberly/0000-0002-1407-0777; Weisberg, Alexandra/0000-0002-0045-1368; Chang, Jeff/0000-0002-1833-0695; Jiang, Yuan/0000-0001-6409-9159				Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 1999, APPL ENVIRON MICROB, V65, P3121; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ARMBRUST EV, 1990, J PHYCOL, V26, P470, DOI 10.1111/j.0022-3646.1990.00470.x; Assmy P, 2006, J PHYCOL, V42, P1002, DOI 10.1111/j.1529-8817.2006.00260.x; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bernstein H, 2010, BIOSCIENCE, V60, P498, DOI 10.1525/bio.2010.60.7.5; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chen G, 2016, LIMNOL OCEANOGR, V61, P2165, DOI 10.1002/lno.10361; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2008, BIOESSAYS, V30, P692, DOI 10.1002/bies.20773; Chepurnov VA, 2006, J PHYCOL, V42, P845, DOI 10.1111/j.1529-8817.2006.00244.x; Chepurnov VA, 2011, CELL ORIG LIFE EXTRE, V19, P167, DOI 10.1007/978-94-007-1327-7_7; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Collos Y, 2014, MAR POLLUT BULL, V80, P8, DOI 10.1016/j.marpolbul.2014.01.006; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edlund MB, 1997, J PHYCOL, V33, P897, DOI 10.1111/j.0022-3646.1997.00897.x; EDLUND MB, 1991, J PHYCOL, V27, P780, DOI 10.1111/j.0022-3646.1991.00780.x; Ezzati J., 2011, TRENDS ANAL CHEM, V30, P9; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; FRENCH FW, 1985, J PHYCOL, V21, P477; GALLAGHER JC, 1983, J PHYCOL, V19, P539, DOI 10.1111/j.0022-3646.1983.00539.x; Geitler L, 1932, ARCH PROTISTENKD, V78, P1; Gillard J, 2008, PLANT PHYSIOL, V148, P1394, DOI 10.1104/pp.108.122176; Godhe A, 2014, PROTIST, V165, P401, DOI 10.1016/j.protis.2014.04.006; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Holtermann KE, 2010, J PHYCOL, V46, P41, DOI 10.1111/j.1529-8817.2009.00792.x; Honda D, 2007, PROTIST, V158, P77, DOI 10.1016/j.protis.2006.08.004; HOOPS HJ, 1979, PHYCOLOGIA, V18, P424, DOI 10.2216/i0031-8884-18-4-424.1; Huysman MJJ, 2014, J EXP BOT, V65, P2573, DOI 10.1093/jxb/ert387; Idei M, 2015, J PHYCOL, V51, P144, DOI 10.1111/jpy.12261; Idei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041890; JEWSON DH, 1992, PHILOS T ROY SOC B, V336, P191, DOI 10.1098/rstb.1992.0056; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koester JA, 2007, EUR J PHYCOL, V42, P351, DOI 10.1080/09670260701562100; Kroth P, 2007, ADV EXP MED BIOL, V616, P23; LEWIS WM, 1984, AM NAT, V123, P73, DOI 10.1086/284187; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Mann D. G., 1988, ALGAE AQUATIC ENV, P384; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; Moeys S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19252; Mouget JL, 2009, FEMS MICROBIOL ECOL, V69, P194, DOI 10.1111/j.1574-6941.2009.00700.x; Nagai S, 1995, PHYCOLOGIA, V34, P533, DOI 10.2216/i0031-8884-34-6-533.1; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Patil S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1983-5; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Round F. E., 1972, NOVA HEDWIGIA, V23, P291; Sabbe K, 2004, EUR J PHYCOL, V39, P327, DOI 10.1080/0967026042000236445; Shirokawa Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0503; SIMONSEN R, 1979, Bacillaria, V2, P9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; VAULOT D, 1987, J PLANKTON RES, V9, P345, DOI 10.1093/plankt/9.2.345; von Dassow P, 2011, J PLANKTON RES, V33, P3, DOI 10.1093/plankt/fbq137; Werner D, 1977, BOTANICAL MONOGRAPHS, V13, P250; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424, DOI 10.4319/lo.2006.51.1_part_2.0424; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	76	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0181098	10.1371/journal.pone.0181098	http://dx.doi.org/10.1371/journal.pone.0181098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686696	gold, Green Submitted, Green Published			2022-12-27	WOS:000405464100132
J	Nicol, S; Chades, I				Nicol, Sam; Chades, Iadine			A preliminary approach to quantifying the overall environmental risks posed by development projects during environmental impact assessment	PLOS ONE			English	Article							BAYESIAN BELIEF NETWORKS; ECOLOGICAL RISK; DIAGNOSIS; KNOWLEDGE	Environmental impact assessment (EIA) is used globally to manage the impacts of development projects on the environment, so there is an imperative to demonstrate that it can effectively identify risky projects. However, despite the widespread use of quantitative predictive risk models in areas such as toxicology, ecosystem modelling and water quality, the use of predictive risk tools to assess the overall expected environmental impacts of major construction and development proposals is comparatively rare. A risk-based approach has many potential advantages, including improved prediction and attribution of cause and effect; sensitivity analysis; continual learning; and optimal resource allocation. In this paper we investigate the feasibility of using a Bayesian belief network (BBN) to quantify the likelihood and consequence of non-compliance of new projects based on the occurrence probabilities of a set of expert-defined features. The BBN incorporates expert knowledge and continually improves its predictions based on new data as it is collected. We use simulation to explore the trade-off between the number of data points and the prediction accuracy of the BBN, and find that the BBN could predict risk with 90% accuracy using approximately 1000 data points. Although a further pilot test with real project data is required, our results suggest that a BBN is a promising method to monitor overall risks posed by development within an existing EIA process given a modest investment in data collection.	[Nicol, Sam; Chades, Iadine] CSIRO Land & Water, Dutton Pk, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nicol, S (corresponding author), CSIRO Land & Water, Dutton Pk, Qld, Australia.	sam.nicol@csiro.au	Chades, iadine/A-4052-2011; Nicol, Sam/I-1074-2012	Chades, iadine/0000-0002-7442-2850; Nicol, Sam/0000-0002-1160-7444	Australian Department of Environment (DoE)	Australian Department of Environment (DoE)	SN and IC received funding from the Australian Department of Environment (DoE; http://www.environment.gov.au). DoE staff provided indicator categories and initial weightings for the pilot study. The study was designed and the manuscript prepared and written by the authors and does not represent the views of the DoE.	Ahammed AKMR, 2006, ENVIRON IMPACT ASSES, V26, P426, DOI 10.1016/j.eiar.2005.09.002; Al-Rashdan D, 1999, EUR J OPER RES, V118, P30, DOI 10.1016/S0377-2217(97)00079-9; Alexander C, 2000, DISCUSSION PAPERS FI; [Anonymous], 2009, RISK ANAL WATER POLL; Arts J., 2001, IMPACT ASSESS PROJ A, V19, P175, DOI [10.3152/147154601781767014, DOI 10.3152/147154601781767014]; Australian National Audit Office, 2014, MAN COMPL ENV PROT B; Banko M, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P26, DOI 10.3115/1073012.1073017; Bennett ND, 2013, ENVIRON MODELL SOFTW, V40, P1, DOI 10.1016/j.envsoft.2012.09.011; Bermudez L, 2008, INSUR MATH ECON, V42, P779, DOI 10.1016/j.insmatheco.2007.08.002; Biedermann A, 2005, FORENSIC SCI INT, V147, P49, DOI 10.1016/j.forsciint.2004.04.014; Bouissou M, 1999, REL MAINT S 1999 P A; BURGMAN M, 2005, RISKS DECISIONS CONS, P42; Cain J, 2001, PLANNING IMPROVEMENT; Cardenas IC, 2013, RISK ANAL, V33, P92, DOI 10.1111/j.1539-6924.2012.01829.x; Cowell RG, 2007, J RISK INSUR, V74, P795, DOI 10.1111/j.1539-6975.2007.00235.x; Deb K., 2014, SEARCH METHODOLOGIES, P403, DOI DOI 10.1007/978-1-4614-6940-7_15; Evett IW, 2002, J FORENSIC SCI, V47, P520; Fenton N., 2000, MATH TODAY SOUTHEND, V36, P180, DOI [https://doi.org/10.1111/cogs.12004, DOI 10.1111/COGS.12004]; Fenton N., 2013, RISK ASSESSMENT DECI; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Hallowell MR, 2010, J CONSTR ENG M, V136, P99, DOI 10.1061/(ASCE)CO.1943-7862.0000137; Harding R., 1998, ENV DECISION MAKING; HILDEN J, 1984, COMPUT BIOL MED, V14, P429, DOI 10.1016/0010-4825(84)90043-X; Howes AL, 2010, CONSERV BIOL, V24, P974, DOI 10.1111/j.1523-1739.2010.01451.x; Jalava K, 2015, IMPACT ASSESS PROJ A, V33, P255, DOI 10.1080/14615517.2015.1069997; Kahn CE, 1997, COMPUT BIOL MED, V27, P19, DOI 10.1016/S0010-4825(96)00039-X; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kynn M, 2008, J ROY STAT SOC A STA, V171, P239; Langseth H, 2007, RELIAB ENG SYST SAFE, V92, P92, DOI 10.1016/j.ress.2005.11.037; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Morrison-Saunders A, 2003, IMPACT ASSESS PROJ A, V21, P43, DOI DOI 10.3152/147154603781766527; Ngai EWT, 2011, DECIS SUPPORT SYST, V50, P559, DOI 10.1016/j.dss.2010.08.006; Nicol S, 2015, RISK CALCULATOR SUPP; Nicol S, 2014, DEV RISK BASED APPRO; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; NOAA, 2015, DEEPW HOR OIL SPILL; Norsys Software Corp, NET TUT; Norsys Software Corp, 2010, NET J REF MAN; Nyberg JB, 2006, CAN J FOREST RES, V36, P3104, DOI 10.1139/X06-108; Petts Judith, 1999, P3; Pollino CA, 2007, ENVIRON MODELL SOFTW, V22, P1140, DOI 10.1016/j.envsoft.2006.03.006; Pradhan M, 1996, ARTIFICIAL INTELLIGE, V85, P363; Renooij S, 2001, KNOWL ENG REV, V16, P255, DOI 10.1017/S0269888901000145; Standards Australia/ Standards New Zealand, 2009, 310002009 ASNZS; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; Suter Glenn W. III, 2008, Integrated Environmental Assessment and Management, V4, P285, DOI 10.1897/IEAM_2007-062; SUTER GW, 1992, ENVIRON SCI TECHNOL, V26, P432, DOI 10.1021/es00027a001; Suter GWI, 2006, ECOLOGICAL RISK ASSE; WAGENAAR WA, 1988, LAW HUMAN BEHAV, V12, P499, DOI 10.1007/BF01044630; Wang Y, 2003, ENVIRON IMPACT ASSES, V23, P543, DOI DOI 10.1016/S0195-9255(03)00071-4	51	6	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180982	10.1371/journal.pone.0180982	http://dx.doi.org/10.1371/journal.pone.0180982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686651	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100127
J	Brigham, EP; Matsui, EC; Appel, LJ; Bull, DA; Curtin-Brosnan, J; Zhai, SY; White, K; Charleston, JB; Hansel, NN; Diette, GB; McCormack, MC				Brigham, Emily P.; Matsui, Elizabeth C.; Appel, Lawrence J.; Bull, Deborah A.; Curtin-Brosnan, Jean; Zhai, Shuyan; White, Karen; Charleston, Jeanne B.; Hansel, Nadia N.; Diette, Gregory B.; McCormack, Meredith C.			A pilot feeding study for adults with asthma: The healthy eating better breathing trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; MACRONUTRIENT INTAKE TRIAL; MEDITERRANEAN DIET; BLOOD-PRESSURE; QUESTIONNAIRE; VALIDITY; RESPONSIVENESS; RELIABILITY; VALIDATION; OMNIHEART	Rationale Evidence from observational studies and to a lesser extent clinical trials suggest that a healthy diet may improve symptoms and lung function in patients with asthma. We conducted a pilot study to determine the feasibility of conducting a larger scale dietary trial and to provide preliminary evidence on the impact of a healthy diet on asthma outcomes. Methods In a randomized, two period cross-over trial, participants with asthma received a 4-week dietary intervention followed by a usual diet (or vice versa), separated by a 4-week washout. The dietary intervention was a healthy diet rich in unsaturated fat. During the dietary intervention, participants ate three meals per week on site at the Johns Hopkins ProHealth Research Center. All remaining meals and snacks were provided for participants to consume off-site. During the control diet, participants were instructed to continue their usual dietary intake. Relevant biomarkers and asthma clinical outcomes were assessed at 0, 2, and 4 weeks after starting each arm of the study. Results Eleven participants were randomized, and seven completed the full study protocol. Among these seven participants, average age was 42 years, six were female, and six were African American. Participant self-report of dietary intake revealed significant increases in fruit, vegetable, and omega-3 fatty acid intake with the dietary intervention compared to usual diet. Serum carotenoids (eg. lutein and beta-cryptoxanthin) increased in the intervention versus control. Total cholesterol decreased in the intervention versus control diet. There was no consistent effect on asthma outcomes. Conclusions The findings suggest that a feeding trial in participants with asthma is feasible. Larger trials are needed to definitively assess the potential benefits of dietary interventions on pulmonary symptoms and function in patients with asthma.	[Brigham, Emily P.; Matsui, Elizabeth C.; Appel, Lawrence J.; Bull, Deborah A.; Curtin-Brosnan, Jean; Zhai, Shuyan; White, Karen; Charleston, Jeanne B.; Hansel, Nadia N.; Diette, Gregory B.; McCormack, Meredith C.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Matsui, Elizabeth C.; Appel, Lawrence J.; Hansel, Nadia N.; Diette, Gregory B.; McCormack, Meredith C.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	McCormack, MC (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; McCormack, MC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	mmccor16@jhmi.edu	Appel, Larry/GLT-2608-2022	Ayers, Andrew/0000-0001-5305-7156; McCormack, Meredith/0000-0003-1702-3201; Matsui, Elizabeth/0000-0001-8134-5593; Pham, Hewlett/0000-0003-0330-6104; Koehl, Rachelle/0000-0002-7797-7456	National Institute of Environmental Health Sciences - Environmental Protection Agency [P50ES018176, RD83615201]; National Institute of Environmental Health Sciences [K23ES016819];  [4KL2TR001077]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES018176] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences - Environmental Protection Agency(United States Environmental Protection AgencyUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: National Institute of Environmental Health Sciences P50ES018176/Environmental Protection Agency RD83615201 (Nadia Hansel); 4KL2TR001077-04 (Emily Brigham); National Institute of Environmental Health Sciences P01ES018176/Environmental Protection Agency RD83451001 (Greg Diette); National Institute of Environmental Health Sciences K23ES016819 (McCormack).	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Apfelbacher CJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-97; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Brigham EP, 2015, ANN ALLERG ASTHMA IM, V114, P273, DOI 10.1016/j.anai.2014.11.003; Carey VJ, 2005, CLIN TRIALS, V2, P529, DOI 10.1191/1740774505cn123oa; Forno E, 2012, AM J RESP CRIT CARE, V185, P1033, DOI 10.1164/rccm.201202-0350ED; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Lv N, 2014, J ASTHMA ALLERGY, V7, P105, DOI 10.2147/JAA.S49960; Ma J, 2016, EUR RESPIR J, V47, P122, DOI 10.1183/13993003.00591-2015; Ma J, 2013, CONTEMP CLIN TRIALS, V35, P55, DOI 10.1016/j.cct.2013.04.008; MARKS GB, 1993, J CLIN EPIDEMIOL, V46, P1103, DOI 10.1016/0895-4356(93)90109-E; MARKS GB, 1992, J CLIN EPIDEMIOL, V45, P461, DOI 10.1016/0895-4356(92)90095-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Molitor J, 2014, HYPERTENSION, V64, P1198, DOI 10.1161/HYPERTENSIONAHA.114.03799; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Rice JL, 2015, LUNG, V193, P893, DOI 10.1007/s00408-015-9792-9; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Sexton P, 2013, J ASTHMA, V50, P75, DOI 10.3109/02770903.2012.740120; Swain JF, 2008, J AM DIET ASSOC, V108, P257, DOI 10.1016/j.jada.2007.10.040; Wang J, 2011, CURR OPIN ALLERGY CL, V11, P249, DOI 10.1097/ACI.0b013e3283464c8e; Wood LG, 2012, AM J CLIN NUTR, V96, P534, DOI 10.3945/ajcn.111.032623; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036	28	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180068	10.1371/journal.pone.0180068	http://dx.doi.org/10.1371/journal.pone.0180068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704419	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700026
J	Kadison, E; Brandt, M; Nemeth, R; Martens, J; Blondeau, J; Smith, T				Kadison, Elizabeth; Brandt, Marilyn; Nemeth, Richard; Martens, Justin; Blondeau, Jeremiah; Smith, Tyler			Abundance of commercially important reef fish indicates different levels of over-exploitation across shelves of the US Virgin Islands	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PROTECTED AREAS; GROUPERS PISCES; FLORIDA; RETENTION; FISHERIES; RECRUITMENT; POPULATION; SERRANIDAE; DENSITY	The United States Virgin Islands are comprised of two separate insular platforms separated by the deep water Anegada Passage. Although managed by the same regulations, as one fishery, several physical and spatial differences exist between the two northern shelf islands, St. Thomas and St. John, and isolated St. Croix. Based on two long-term fisheries independent datasets, collected by the U.S. Virgin Islands Territorial Coral Reef Monitoring Program and the National Oceanographic and Atmospheric Administration Center for Coastal Monitoring and Assessment, there were significant differences between the northern USVI and St. Croix in both the occurrence and size of several species of large and commercially important reef fishes. These fishes are primarily apex piscivores and generally the first species over-exploited in small-scale fisheries. The disparities between the fish communities on the two island shelves cannot be explained solely by differences in habitat (coral cover, rugosity) or fisheries management, such as relative amount of marine protected area in local waters. They are instead probably caused by a combination of several other interrelated factors including water depth, fishing methodology, fishable area, and the presence or absence of viable fish spawning areas. This study considers those aspects, and illustrates the need for management of island artisanal fisheries that is tailored to the physical and spatial constraints imposed by insular platforms.	[Kadison, Elizabeth; Brandt, Marilyn; Nemeth, Richard; Smith, Tyler] Univ Virgin Isl, Ctr Marine & Environm Studies, USVI, St Thomas, VI 00802 USA; [Martens, Justin] US Fish & Wildlife Serv, Alpine, AZ USA; [Blondeau, Jeremiah] NOAA, Southwest Fisheries Sci Ctr, 75 Virginia Beach Dr, Miami, FL USA	University of the Virgin Islands; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA	Kadison, E (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, USVI, St Thomas, VI 00802 USA.	ekadiso@live.uvi.edu			Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration [233041]	Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration	This work was supported by the Coral Reef Conservation Program, National Oceanographic and Atmospheric Administration, coralreef.noaa.gov, Award Number 233041, Recipient: TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DAT USVI TRIP TICK A; [Anonymous], 2006, TITL 50 WILDL FISH P, P216; Appeldoorn R, 1992, 304 NOAA NMFSSEFSC; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Ault JS, 2005, B MAR SCI, V76, P595; Ault JS, 2005, ICES J MAR SCI, V62, P417, DOI 10.1016/j.icesjms.2004.12.001; Beets J, 1999, ENVIRON BIOL FISH, V55, P91, DOI 10.1023/A:1007404421518; Beets J, 1996, 5 VINP; BROCK RE, 1982, B MAR SCI, V32, P269; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; CLARO R, 1991, Tropical Ecology, V32, P36; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Friedlander A.M., 2008, 70 NOAA NOS NCCOS; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garrison VH, 1998, REV BIOL TROP, V46, P41; Gillett R, 2006, FAO FISHCODE REV; Gladfelter EH, 1977, ENV STUDIES BUCK ISL; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Kadison Elizabeth, 2006, Rev. biol. trop, V54, P69; Kendall MS, 2001, METHODS USED MAP BEN; KIMMEL JJ, 1985, ENVIRON BIOL FISH, V12, P23, DOI 10.1007/BF00007707; Kojis BL, 2006, P 10 INT COR REEF S, V1326, P1334; KOSLOW JA, 1988, MAR ECOL PROG SER, V43, P201, DOI 10.3354/meps043201; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; MCCLANAHAN TR, 1988, HYDROBIOLOGIA, V166, P269, DOI 10.1007/BF00008136; Mohammed E., 2003, MEXICO BRAZIL CENTRA, P11; Monaco M.E., 2008, 71 NOAA NOS NCCOS; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Munro JL, 1983, CARIBBEAN CORAL REEF; Nemeth R. S., 2006, P GULF CARIBBEAN FIS, V57, P543; Nemeth RS, 2008, 3349 CAR FISH MAN CO; Nevill J, 2006, IMPACTS SPEARFISHING; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Oakley SG, 1984, P S COR REEF ENV RED, P341; Olsen D. A., 1979, P GULF CARIB FISH I, V31, P130; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Quinn NJ, 2011, P 64 GULF CAR FISH I, P135; Randall J.E., 1962, P GULF CARIBBEAN FIS, V14, P201; RANDALL JOHN E., 1963, CARIBBEAN J SCI, V3, P31; Richards WJ, 1990, LARGE MARINE ECOSYST; Rogers C.S., 1985, P 5 INT COR REEF C T, V6, P491; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; Rogers CS, 1982, MARINE ENV BREWERS B; Ruttenberg BI, 2001, CONSERV BIOL, V15, P1691, DOI 10.1046/j.1523-1739.2001.99556.x; Sadovy Y, 2001, J FISH BIOL, V59, P90, DOI 10.1006/jfbi.2001.1760; Sluka R, 1996, NATURE CONSERVANCY; Sluka RD, 1998, FISH B-NOAA, V96, P388; Smith TB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00107.1; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Tobias W, 1988, 26 BIOSPH RES; Tobias W, 2000, US VIRGIN ISLANDS NA; Tyler EHM, 2009, BIOL CONSERV, V142, P652, DOI 10.1016/j.biocon.2008.11.017; Warner RR, 2002, B MAR SCI, V70, P245; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; [No title captured]	70	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180063	10.1371/journal.pone.0180063	http://dx.doi.org/10.1371/journal.pone.0180063			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704387	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700025
J	Korner, M; Luzay, L; Plewnia, A; Becker, S; Rundel, M; Zimmermann, L; Muller, C				Koerner, Mirjam; Luzay, Leonie; Plewnia, Anne; Becker, Sonja; Rundel, Manfred; Zimmermann, Linda; Mueller, Christian			A cluster-randomized controlled study to evaluate a team coaching concept for improving teamwork and patient-centeredness in rehabilitation teams	PLOS ONE			English	Article							SHARED DECISION-MAKING; CARE; SCALE	Purpose Although the relevance of interprofessional teamwork in the delivery of patient-centered care is well known, there is a lack of interventions for improving team interaction in the context of rehabilitation in Germany. The aim of the present study is to evaluate whether a specially developed team coaching concept (TCC) could improve both teamwork and patient-centeredness. Method A multicenter, cluster-randomized controlled intervention study was conducted with both staff and patient questionnaires. Data was collected at ten German rehabilitation clinics (five clusters) of different indication fields before (t1) and after (t2) the intervention. Intervention clinics received the TCC, while control clinics did not receive any treatment. Staff questionnaires were used to measure internal participation and other aspects of teamwork, such as team organization, while patient questionnaires assessed patient-centeredness. A multivariate analysis of variance was applied for data analysis. Results In order to analyze the effect of TCC on internal participation and teamwork, 305 questionnaires were included for t1 and 213 for t2 in the staff survey. In the patient survey, 523 questionnaires were included for t1 and 545 for t2. The TCC improved team organization, willingness to accept responsibility and knowledge integration according to staff, with small effect sizes (univariate:eta(2)=.010-.017), whereas other parameters including internal participation, team leadership and cohesion did not improve due to the intervention. The patient survey did not show any improvements on the assessed dimensions. Conclusion The TCC improved dimensions that were addressed directly by the approach and were linked to the clinics' needs, such as restructured team meetings and better exchange of information. The TCC can be used to improve team organization, willingness to accept responsibility, and knowledge integration in rehabilitation practice, but some further evaluation is needed to understand contextual factors and processes regarding the implementation of the intervention.	[Koerner, Mirjam; Luzay, Leonie; Plewnia, Anne; Becker, Sonja] Albert Ludwigs Univ, Med Fac, Med Psychol & Med Sociol, Freiburg, Germany; [Rundel, Manfred] Celenus Kliniken GmbH, Offenburg, Germany; [Zimmermann, Linda] Moving Concept, Freiburg, Germany; [Mueller, Christian] Saarland Univ Cooperat Educ Hlth Care & Welf, Saarbrucken, Germany	University of Freiburg	Korner, M (corresponding author), Albert Ludwigs Univ, Med Fac, Med Psychol & Med Sociol, Freiburg, Germany.	mirjam.koerner@mps.uni-freiburg.de			Bundesministerium fur Bildung und Forschung; Deutsche RentenversicherungBund [01GX1024]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche RentenversicherungBund	This study was supported by Bundesministerium fur Bildung und Forschung, https://www.bmbf.de/; Deutsche RentenversicherungBund, http://www.deutsche-rentenversicherung.de/Bund/de/Navigation/0_Home/home_node.html, grant number: 01GX1024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni CH, 2010, Z EVIDENZ FORTBILD Q, V104, P18, DOI 10.1016/j.zefq.2009.12.027; Becker S, DEV PILOT TEST UNPUB; Bieber C, 2006, Z MED PSYCHOL, V15, P53; Bieber C, 2008, J PSYCHOSOM RES, V64, P13, DOI 10.1016/j.jpsychores.2007.05.009; Bleich C., 2010, PATIENTENORIENTIERUN, P275; Bleses H., 2005, THESIS; Bortz J., 2009, FORSCHUNGSMETHODEN E; Buljac-Samardzic M, 2010, HEALTH POLICY, V94, P183, DOI 10.1016/j.healthpol.2009.09.015; Cott CA, 2006, DISABIL REHABIL, V28, P1387, DOI 10.1080/09638280600638398; Dinius J, 2016, MANUAL PATIENTENORIE; Eppich W, 2011, SIMUL HEALTHC S, V6, P9; Gaba DM, 2010, BRIT J ANAESTH, V105, P3, DOI 10.1093/bja/aeq124; Gillespie Brigid M, 2010, AORN J, V92, P642, DOI 10.1016/j.aorn.2010.02.015; Grant AM., 2006, INT COACH PSYCHOL RE, V1, P14; Gray D, 2016, QUAL HEALTH RES, V26, P1434, DOI 10.1177/1049732315604589; Hackman JR, 2005, ACAD MANAGE REV, V30, P269, DOI [10.5465/AMR.2005.16387885, 10.2307/20159119]; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kauffeld S., 2004, FAT FRAGEBOGEN ARBEI; Kibble S, 2014, BMJ QUALITY IMPROVEM, V3; Klein C, 2009, SMALL GROUP RES; Kockert S, 2011, REHABILITATION, V19, P30; Korner M, 2009, REHABILITATION, V48, P160, DOI 10.1055/s-0029-1220748; Korner M, 2016, J INTERPROF CARE, V30, P15, DOI 10.3109/13561820.2015.1051616; Korner M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-374; Korner M, CLIN REHABI IN PRESS; Korner M., 2013, HLTH IRVINE CALIF, V5, P48, DOI [10.4236/HEALTH.2013.56A2008, DOI 10.4236/HEALTH.2013.56A2008]; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Loh A, 2007, PATIENT EDUC COUNS, V67, P324, DOI 10.1016/j.pec.2007.03.023; Maynard M Travis, 2012, Adv Health Care Manag, V13, P59; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mickan Sharon M, 2005, J Interprof Care, V19, P358, DOI 10.1080/13561820500165142; Muller C, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0413-3; Muller C, 2014, REHABILITATION, V53, P390, DOI 10.1055/s-0034-1375639; O'Leary KJ, 2012, J HOSP MED, V7, P48, DOI 10.1002/jhm.970; O'Leary M., 2012, MULTITEAM SYSTEMS OR, P141; Ottevanger N, 2013, J EVAL CLIN PRACT, V19, P1035, DOI 10.1111/jep.12022; Papadimitriou C, 2015, DISABIL REHABIL, V37, P1135, DOI 10.3109/09638288.2014.955138; Quaschning K, 2013, PATIENT EDUC COUNS, V91, P167, DOI 10.1016/j.pec.2012.12.007; Reeves S, 2010, J INTERPROF CARE, V24, P230, DOI 10.3109/13561820903163405; Roberts, 2011, HDB ADV MULTILEVEL A, DOI 10.4324/9780203848852; Robinson JH, 2008, J AM ACAD NURSE PRAC, V20, P600, DOI 10.1111/j.1745-7599.2008.00360.x; Scholl I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107828; Steinheider B, 2009, Z ARB ORGAN, V53, P121, DOI 10.1026/0932-4089.53.3.121; Stewart M, 2003, PATIENT CENTERED MED; Sullivan MD, 2010, CLIN J PAIN, V26, P512, DOI 10.1097/AJP.0b013e3181dc7adc; Wiedemann J, 2001, TEAMPULS INTERNETGES; Zwarenstein M., 2009, INTERPROFESSIONAL CO	48	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180171	10.1371/journal.pone.0180171	http://dx.doi.org/10.1371/journal.pone.0180171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704377	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700030
J	Kosten, IJ; van de Ven, R; Thon, M; Gibbs, S; de Gruijl, TD				Kosten, Ilona Jennifer; van de Ven, Rieneke; Thon, Maria; Gibbs, Susan; de Gruijl, Tanja D.			Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin	PLOS ONE			English	Article							LANGERHANS CELLS; T-CELLS; IMMUNOLOGICAL MECHANISMS; SUBLINGUAL IMMUNOTHERAPY; IRRITANT EXPOSURE; CUTTING EDGE; IN-VITRO; TOLERANCE; MATURATION; EPIDERMIS	Antigen exposure to oral mucosa is generally thought to lead to immune tolerance induction. However, very little is known about the subset composition and function of dendritic cells (DC) migrating from human oral mucosa. Here we show that migratory DC from healthy human gingival explants consist of the same phenotypic subsets in the same frequency distribution as DC migrating from human skin. The gingival CD1a(+) Langerhans cell and interstitial DC subsets lacked CXCR4 expression in contrast to their cutaneous counterparts, pointing to different migration mechanisms, consistent with previous observations in constructed skin and gingival equivalents. Remarkably, without any exogenous conditioning, gingival explants released higher levels of inflammatory cytokines than human skin explants, resulting in higher DC migration rates and a superior ability of migrated DC to prime allogeneic T cells and to induce type-1 effector T cell differentiation. From these observations we conclude that rather than an intrinsic ability to induce T cell tolerance, DC migrating from oral mucosa may have a propensity to induce effector T cell immunity and maintain a high state of alert against possible pathogenic intruders in the steady state. These findings may have implications for oral immunization strategies.	[Kosten, Ilona Jennifer; Thon, Maria; Gibbs, Susan] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [van de Ven, Rieneke; de Gruijl, Tanja D.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Gibbs, Susan] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [Gibbs, Susan] Vrije Univ Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	de Gruijl, TD (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	td.degruijl@vumc.nl		Thon, Maria/0000-0003-2380-7846	VU Universit medical center-Cancer Center Amsterdam, Amsterdam, the Netherlands	VU Universit medical center-Cancer Center Amsterdam, Amsterdam, the Netherlands	This study was financed by the VU Universit medical center-Cancer Center Amsterdam, Amsterdam, the Netherlands.	Ahlfors E, 1996, CLIN EXP IMMUNOL, V104, P297, DOI 10.1046/j.1365-2249.1996.967659.x; Allam JP, 2008, ALLERGY, V63, P720, DOI 10.1111/j.1398-9995.2007.01611.x; Allam JP, 2009, CURR OPIN ALLERGY CL, V9, P554, DOI 10.1097/ACI.0b013e32833239a9; Allam JP, 2011, CURR OPIN ALLERGY CL, V11, P571, DOI 10.1097/ACI.0b013e32834cbaab; Allam Jean-Pierre, 2009, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V96, P237; Barrett AW, 1996, CRIT REV ORAL BIOL M, V7, P36, DOI 10.1177/10454411960070010301; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; CRUCHLEY AT, 1989, J ORAL PATHOL MED, V18, P510, DOI 10.1111/j.1600-0714.1989.tb01353.x; Cutler CW, 2006, J DENT RES, V85, P678, DOI 10.1177/154405910608500801; Hasseus B, 2004, CLIN EXP IMMUNOL, V136, P483, DOI 10.1111/j.1365-2249.2004.02469.x; Hovav AH, 2014, MUCOSAL IMMUNOL, V7, P27, DOI 10.1038/mi.2013.42; Jotwani R, 2003, J DENT RES, V82, P736, DOI 10.1177/154405910308200915; Jotwani R, 2001, J IMMUNOL, V167, P4693, DOI 10.4049/jimmunol.167.8.4693; Kosten IJ, ALTEX 2016; Kosten IJ, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/627125; Kosten IJ, 2015, TOXICOL APPL PHARM, V287, P35, DOI 10.1016/j.taap.2015.05.017; Lin CL, 1998, EUR J IMMUNOL, V28, P4114, DOI 10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Novak N, 2011, ALLERGY, V66, P22, DOI 10.1111/j.1398-9995.2011.02626.x; Novak N, 2011, ALLERGY, V66, P733, DOI 10.1111/j.1398-9995.2010.02535.x; Novak N, 2008, TRENDS MOL MED, V14, P191, DOI 10.1016/j.molmed.2008.03.001; Ouwehand K, 2011, J INVEST DERMATOL, V131, P418, DOI 10.1038/jid.2010.336; Ouwehand K, 2010, EUR J IMMUNOL, V40, P2026, DOI 10.1002/eji.200940150; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Reinartz SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154409; Rescigno M, 2011, CELL MICROBIOL, V13, P1312, DOI 10.1111/j.1462-5822.2011.01626.x; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Wang J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2402; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wray D, 2000, QJM-MON J ASSOC PHYS, V93, P507, DOI 10.1093/qjmed/93.8.507	41	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180333	10.1371/journal.pone.0180333	http://dx.doi.org/10.1371/journal.pone.0180333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704477	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700037
J	Nilsson, T; Wahlstrom, J; Burstrom, L				Nilsson, Tohr; Wahlstrom, Jens; Burstrom, Lage			Hand-arm vibration and the risk of vascular and neurological diseases - A systematic review and meta-analysis	PLOS ONE			English	Review							INDUCED WHITE FINGER; THERMAL PERCEPTION THRESHOLDS; DOSE-RESPONSE RELATION; CARPAL-TUNNEL-SYNDROME; TRANSMITTED VIBRATION; RAYNAUDS-PHENOMENON; FORESTRY WORKERS; COLD RESPONSE; EXPOSURE; PREVALENCE	Background Increased occurrence of Raynaud's phenomenon, neurosensory injury and carpal tunnel syndrome has been reported for more than 100 years in association with work with vibrating machines. The current risk prediction modelling (ISO-5349) for "Raynaud's phenomenon" is based on a few studies published 70 to 40 years ago. There are no corresponding risk prediction models for neurosensory injury or carpal tunnel syndrome, nor any systematic reviews comprising a statistical synthesis (meta-analysis) of the evidence. Objectives Our aim was to provide a systematic review of the literature on the association between Raynaud's phenomenon, neurosensory injuries and carpal tunnel syndrome and hand-arm vibration (HAV) exposure. Moreover the aim was to estimate the magnitude of such an association using meta-analysis. Methods This systematic review covers the scientific literature up to January 2016. The databases used for the literature search were PubMed and Science Direct. We found a total of 4,335 abstracts, which were read and whose validity was assessed according to pre-established criteria. 294 articles were examined in their entirety to determine whether each article met the inclusion criteria. The possible risk of bias was assessed for each article. 52 articles finally met the pre-established criteria for inclusion in the systematic review. Results The results show that workers who are exposed to HAV have an increased risk of vascular and neurological diseases compared to non-vibration exposed groups. The crude estimate of the risk increase is approximately 4-5 fold. The estimated effect size (odds ratio) is 6.9 for the studies of Raynaud's phenomenon when including only the studies judged to have a low risk of bias. The corresponding risk of neurosensory injury is 7.4 and the equivalent of carpal tunnel syndrome is 2.9. Conclusion At equal exposures, neurosensory injury occurs with a 3-time factor shorter latency than Raynaud's phenomenon. Which is why preventive measures should address this vibration health hazard with greater attention.	[Nilsson, Tohr; Wahlstrom, Jens; Burstrom, Lage] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden	Umea University	Nilsson, T (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden.	Tohr.Nilsson@envmed.umu.se		Nilsson, Tohr/0000-0003-2789-6321	Swedish AFA Insurance [090326]	Swedish AFA Insurance	The financial support of the Swedish AFA Insurance is gratefully acknowledged (Dnr: part of project 090326 https://www.afaforsakring.se/forskning/projektkatalog/Projekt/3889/ and supplied through Occupational and Environmental medicine, https://gupea.ub.gu.se/handle/2077/42452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2012, J OCCUP HEALTH, V54, P96, DOI 10.1539/joh.11-0058-OA; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 2001, 53491 ISO; Anttonen H, 1994, Arctic Med Res, V53 Suppl 3, P19; Barregard L, 2003, OCCUP ENVIRON MED, V60, P287, DOI 10.1136/oem.60.4.287; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M., 2009, INTRO METAANALYSIS; BOVENZI M, 1980, INT ARCH OCC ENV HEA, V46, P251, DOI 10.1007/BF00380015; Bovenzi M, 1998, INT ARCH OCC ENV HEA, V71, P493, DOI 10.1007/s004200050311; Bovenzi M, 2000, INT ARCH OCC ENV HEA, V73, P519, DOI 10.1007/s004200000177; Bovenzi M, 2005, INT ARCH OCC ENV HEA, V78, P303, DOI 10.1007/s00420-004-0574-6; BOVENZI M, 1985, BRIT J IND MED, V42, P253; BOVENZI M, 1995, OCCUP ENVIRON MED, V52, P722, DOI 10.1136/oem.52.11.722; BOVENZI M, 1994, OCCUP ENVIRON MED, V51, P603, DOI 10.1136/oem.51.9.603; Bovenzi M, 2010, OCCUP ENVIRON MED, V67, P38, DOI 10.1136/oem.2009.046128; BOVENZI M, 1988, INT ARCH OCC ENV HEA, V61, P25, DOI 10.1007/BF00381604; Bovenzi M, 1998, SCAND J WORK ENV HEA, V24, P138, DOI 10.5271/sjweh.291; Bovenzi M, 2008, INT ARCH OCC ENV HEA, V81, P613, DOI 10.1007/s00420-007-0255-3; Bovenzi M, 2008, INT ARCH OCC ENV HEA, V81, P401, DOI 10.1007/s00420-007-0225-9; Bovenzi M, 2011, SCAND J WORK ENV HEA, V37, P244, DOI 10.5271/sjweh.3129; Bovenzi M, 2011, INT ARCH OCC ENV HEA, V84, P325, DOI 10.1007/s00420-010-0549-8; Bovenzi M, 2010, INT ARCH OCC ENV HEA, V83, P259, DOI 10.1007/s00420-009-0461-2; BRAMMER AJ, 1986, SCAND J WORK ENV HEA, V12, P284, DOI 10.5271/sjweh.2139; BRAMMER AJ, 1987, SCAND J WORK ENV HEA, V13, P279, DOI 10.5271/sjweh.2050; Brubaker R, 1985, J LOW FREQ NOISE VIB, V4, P66; BRUBAKER RL, 1987, SCAND J WORK ENV HEA, V13, P305, DOI 10.5271/sjweh.2035; BURDORF A, 1991, ANN OCCUP HYG, V35, P287, DOI 10.1093/annhyg/35.3.287; Burstrom L, 2010, SCAND J WORK ENV HEA, V36, P509, DOI 10.5271/sjweh.3072; Carmeli Y, 1999, ARCH INTERN MED, V159, P2461, DOI 10.1001/archinte.159.20.2461; CHATTERJEE DS, 1978, BRIT J IND MED, V35, P208; Cherniack M, 2004, AM J IND MED, V45, P500, DOI 10.1002/ajim.20019; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edlund M, 2013, SCAND J WORK ENV HLT; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Futatsuka M, 2005, J OCCUP HEALTH, V47, P165, DOI 10.1539/joh.47.165; FUTATSUKA M, 1985, J OCCUP ENVIRON MED, V27, P257; GEMNE G, 1987, SCAND J WORK ENV HEA, V13, P275, DOI 10.5271/sjweh.2038; Gerhardsson L, 2005, APPL ERGON, V36, P55, DOI 10.1016/j.apergo.2004.09.001; Hagberg Mats, 2008, J Occup Med Toxicol, V3, P13, DOI 10.1186/1745-6673-3-13; Hamilton A., 1918, US BUREAU LABOUR STA, P53; Hamilton A., 1943, EXPLORING DANGEROUS; Harazin B, 1996, Cent Eur J Public Health, V4, P130; Hewitt S, 2015, CRITICAL REV EVIDENC; HO ST, 1986, INT ARCH OCC ENV HEA, V58, P259, DOI 10.1007/BF00377883; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jang JY, 2002, AIHAJ, V63, P305, DOI 10.1080/15428110208984718; KOSKIMIES K, 1992, INT ARCH OCC ENV HEA, V64, P251, DOI 10.1007/BF00378282; Lawson IJ, 2010, HUNTER'S DISEASES OF OCCUPATIONS, 10TH EDITION, P489; LETZ R, 1992, BRIT J IND MED, V49, P53; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Loriga G., 1911, BOLL INSPETT LAVORO, V2, P35; Lundstrom R, 1999, AM J IND MED, V35, P456, DOI 10.1002/(SICI)1097-0274(199905)35:5<456::AID-AJIM2>3.0.CO;2-#; Malchaire J, 2001, ANN OCCUP HYG, V45, P479, DOI 10.1016/S0003-4878(00)00084-3; Matsumoto T, 1995, Cent Eur J Public Health, V3 Suppl, P93; MIRBOD SM, 1994, INT ARCH OCC ENV HEA, V66, P13; MIRBOD SM, 1992, INT ARCH OCC ENV HEA, V64, P93, DOI 10.1007/BF00381475; Mirbod SM, 1999, IND HEALTH, V37, P415, DOI 10.2486/indhealth.37.415; MUSSON Y, 1989, ANN OCCUP HYG, V33, P85, DOI 10.1093/annhyg/33.1.85; Nilsson T, 2008, INT ARCH OCC ENV HEA, V81, P519, DOI 10.1007/s00420-007-0258-0; NILSSON T, 1994, SCAND J WORK ENV HEA, V20, P189, DOI 10.5271/sjweh.1409; Nilsson T, 2002, INT ARCH OCC ENV HEA, V75, P55; Nilsson T, 2001, OCCUP ENVIRON MED, V58, P472, DOI 10.1136/oem.58.7.472; NILSSON T, 1989, INT ARCH OCC ENV HEA, V61, P473, DOI 10.1007/BF00386482; Palmer K, 1998, OCCUP ENVIRON MED, V55, P716, DOI 10.1136/oem.55.10.716; Palmer KT, 2011, BEST PRACT RES CL RH, V25, P15, DOI 10.1016/j.berh.2011.01.014; Pelmear PL, 1998, HAND ARM VIBRATION, P1; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Sanden H, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-21; Seyring M, 1931, B HYGIENE, V6; Su AT, 2013, OCCUP ENVIRON MED, V70, P498, DOI 10.1136/oemed-2012-101321; Tominaga Y, 1994, Nagoya J Med Sci, V57 Suppl, P235; van Rijn RM, 2009, SCAND J WORK ENV HEA, V35, P19, DOI 10.5271/sjweh.1306; Virokannas H, 1995, Cent Eur J Public Health, V3 Suppl, P109; WALKER DD, 1985, BRIT J IND MED, V42, P672; Yamada S, 1995, Nagoya J Med Sci, V58, P1	75	54	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180795	10.1371/journal.pone.0180795	http://dx.doi.org/10.1371/journal.pone.0180795			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704466	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700050
J	Pinsof, D; Haselton, MG				Pinsof, David; Haselton, Martie G.			The effect of the promiscuity stereotype on opposition to gay rights	PLOS ONE			English	Article							MATING STRATEGIES; SEX; RELIGIOSITY; ATTITUDES; MARRIAGE; STATES; ORIENTATION; IDEOLOGY; VALUES	Opposition to gay rights is prevalent in countries around the world. Recent correlational research suggests that opposition to gay rights may be driven by an interaction between one's own short-term mating orientation (i.e. willingness to engage in casual sex) and representations of gay people as sexually promiscuous. Here, we experimentally manipulated representations of gay men by randomly assigning participants to read one of two versions of a fictitious newspaper article, one of which contained faux scientific evidence confirming the stereotype that gay men are promiscuous, and the other containing faux scientific evidence refuting the stereotype. We found that the manipulation interacted with short-term mating orientation (STMO) to predict opposition to gay rights, such that low-STMO individuals (i.e. more averse to casual sex) exhibited more support for gay rights when assigned to read the stereotype-refuting article compared to the stereotype-confirming article, whereas high-STMO individuals (i.e. less averse to casual sex) were not significantly influenced by the manipulation. We discuss the implications of these findings for the study of antigay attitudes, as well as for recent societal changes in acceptance of homosexuality.	[Pinsof, David; Haselton, Martie G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Pinsof, D (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	david.pinsof@gmail.com						Al-Shawaf L, 2015, EVOL HUM BEHAV, V36, P199, DOI 10.1016/j.evolhumbehav.2014.11.003; Apostolou M, 2016, ADAPT HUM BEHAV PHYS, V3, P1; Atunji BO, 2008, J RES PERS, V42, P1364, DOI 10.1016/j.jrp.2008.04.001; Brody S, 1996, J PSYCHOL, V130, P615, DOI 10.1080/00223980.1996.9915035; Brumbaugh SM, 2008, J MARRIAGE FAM, V70, P345, DOI 10.1111/j.1741-3737.2008.00486.x; Cahn Naomi R., 2010, RED FAMILIES BLUE FA; Chambers JR, 2013, PSYCHOL SCI, V24, P140, DOI 10.1177/0956797612447820; Cosmides L., 2006, HEURISTICS LAW, P182; Craig SC, 2005, POLIT RES QUART, V58, P5, DOI 10.1177/106591290505800101; Doherty Carroll, 2015, NEGATIVE VIEWS SUPRE; Francis AM, 2013, ARCH SEX BEHAV, V42, P5, DOI 10.1007/s10508-012-0018-4; Gates G, 2011, MANY PEOPLE ARE LESB; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hayford SR, 2008, SOC FORCES, V86, P1163, DOI 10.1353/sof.0.0000; Hodson G, 2009, EUR J SOC PSYCHOL, V39, P509, DOI 10.1002/ejsp.558; Jackson JJ, 2007, EVOL HUM BEHAV, V28, P382, DOI 10.1016/j.evolhumbehav.2007.04.005; Kurzban R, 2010, P ROY SOC B-BIOL SCI, V277, P3501, DOI 10.1098/rspb.2010.0608; McVeigh R, 2009, AM SOCIOL REV, V74, P891, DOI 10.1177/000312240907400603; Monson RA, 2011, SOCIOL QUART, V52, P244, DOI 10.1111/j.1533-8525.2011.01203.x; Moss JH, 2016, PERS SOC PSYCHOL B, V42, P72, DOI 10.1177/0146167215612744; Pedersen F A, 1991, Hum Nat, V2, P271, DOI 10.1007/BF02692189; Pinsof D, 2016, PSYCHOL SCI, V27, P435, DOI 10.1177/0956797615621719; Price ME, 2014, ARCH SEX BEHAV, V43, P1289, DOI 10.1007/s10508-014-0320-4; Reyna C, 2014, J APPL SOC PSYCHOL, V44, P289, DOI 10.1111/jasp.12226; Rowatt WC, 2003, J SCI STUD RELIG, V42, P455, DOI 10.1111/1468-5906.00194; Smith TW, 2008, 53 GSS NAT OP RES CT; Smith TW, 1994, SEXUALITY LIFE COURS, P63; Stewart N, 2015, JUDGM DECIS MAK, V10, P479; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099; Swift A, 2015, MOST AMERICANS SAY S; Tybur JM, 2015, EVOL HUM BEHAV, V36, P489, DOI 10.1016/j.evolhumbehav.2015.01.006; Weeden J., 2014, HIDDEN AGENDA POLITI, DOI 10.1515/9781400851966; Weeden J, 2003, THESIS; Weeden J, 2008, EVOL HUM BEHAV, V29, P327, DOI 10.1016/j.evolhumbehav.2008.03.004; Weeden J, 2013, EVOL HUM BEHAV, V34, P440, DOI 10.1016/j.evolhumbehav.2013.08.006; Whitley BE, 2009, INT J PSYCHOL RELIG, V19, P21, DOI 10.1080/10508610802471104	37	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0178534	10.1371/journal.pone.0178534	http://dx.doi.org/10.1371/journal.pone.0178534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704375	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700008
J	Siew, CT; Mazzucchelli, TG; Rooney, R; Girdler, S				Siew, Choo Ting; Mazzucchelli, Trevor G.; Rooney, Rosanna; Girdler, Sonya			A specialist peer mentoring program for university students on the autism spectrum: A pilot study	PLOS ONE			English	Article							ASPERGER SYNDROME; ADULTS; DISORDERS; LIFE; INDIVIDUALS; SUPPORT; TRANSITION; COMMUNITY; ANXIETY; IMPACT	Introduction The provision of peer mentoring may improve tertiary education outcomes of students with autism spectrum disorder (ASD). This study evaluated the pilot year of the Curtin Specialist Mentoring Program (CSMP), a specialised peer mentoring program for university students with ASD aimed at improving self-reported well-being, academic success and retention in university studies. Methods A single group pre-test, post-test design was employed. Quantitative and qualitative evaluations were undertaken with 10 young adults with ASD to explore the effectiveness and acceptability of the CSMP program. Students completed a battery of questionnaires focused on general anxiety, state communication apprehension, perceived communication competence, and communication apprehension both prior to, and five months after commencing enrolment in the CSMP. Information regarding academic success and retention was also obtained. Interviews with participants provided further insight into their experience of the program. Results Students enrolled in the CSMP showed significant improvement in social support and general communication apprehension assessment scores. Interviews revealed key features of the CSMP that may have contributed to these positive outcomes. Conclusions The current study provides preliminary evidence that a specialised peer mentoring program can improve the well-being of students with ASD, and highlights the importance of interventions which are individualised, flexible, based on a social model, and target environmental factors such as social support.	[Siew, Choo Ting; Mazzucchelli, Trevor G.; Rooney, Rosanna] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA, Australia; [Siew, Choo Ting; Mazzucchelli, Trevor G.; Girdler, Sonya] Cooperat Res Ctr Living Autism Spectrum Disorders, Brisbane, Qld, Australia; [Girdler, Sonya] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia	Curtin University; Curtin University	Mazzucchelli, TG (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA, Australia.; Mazzucchelli, TG (corresponding author), Cooperat Res Ctr Living Autism Spectrum Disorders, Brisbane, Qld, Australia.	trevor.mazzucchelli@curtin.edu.au	Girdler, Sonya/ABC-9629-2021; Mazzucchelli, Trevor/AAC-5853-2019	Mazzucchelli, Trevor/0000-0002-8306-3917; Girdler, Sonya/0000-0001-7992-0800; Rooney, Rosanna/0000-0003-2549-4169	Speech Pathology Research Allocation Fund [RAF-2014-22]; Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC) [3.032RS]; Australian Government's Cooperative Research Centres Program	Speech Pathology Research Allocation Fund; Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was supported by a grant awarded to Dr Rosanna Rooney, Dr Trevor Mazzucchelli, and Ms Choo Ting Siew from the School of Psychology and Speech Pathology Research Allocation Fund [grant number RAF-2014-22] and the support of the Cooperative Research Centre for Living with Autism Spectrum Disorders (Autism CRC) [project number 3.032RS], established and supported under the Australian Government's Cooperative Research Centres Program. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. However, the funder approved the decision to publish	Ahlstrom Britt H, 2014, Int J Qual Stud Health Well-being, V9, P23376, DOI 10.3402/qhw.v9.23376; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2010, DIAGN STAT MAN MENT; Ames M, 2010, INT M AUT RES 2010 M; [Anonymous], 2015, NAT STAT ETH COND HU; Asgari S, 2016, SOC TEACHING PSYCHOL, V43; Autism Spectrum Australia, 2012, WE BEL INV EXP ASP N; Balfe Myles, 2010, BMC Res Notes, V3, P300, DOI 10.1186/1756-0500-3-300; Beardon L., 2007, ASPECT CONSULTANCY R; Bebko JM, 2011, MENTORING PROGRAM ST; Bene K, 2014, REV J AUTISM DEV DIS, V1, P135, DOI 10.1007/s40489-014-0014-9; Berry S, 2007, HDB RES ELECT SURVEY, P376; Blandford E, 2011, EQUALITY HIGHER ED S; Blumberg SJ, 2013, NATL HLTH STAT REPOR, V1-11; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Cai RY, 2016, J AUTISM DEV DISORD, V46, P31, DOI 10.1007/s10803-015-2535-1; Collings R, 2014, HIGH EDUC, V68, P927, DOI 10.1007/s10734-014-9752-y; Crisp G, 2010, REV HIGH EDUC, V34, P39; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; Fleischer AS, 2012, SCAND J DISABIL RES, V14, P177, DOI 10.1080/15017419.2011.558236; Friedman NDB, 2013, NEUROPSYCHIATRY-LOND, V3, P181, DOI 10.2217/NPY.13.13; Glennon Tara J., 2001, Work, V17, P183; Hamilton J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153204; Hancock LN, 2009, CAN PSYCH ASS C 2009; Hastwell J, 2013, ASPERGER SYNDROME ST; Hastwell J, 2012, GOOD AUTISM PRACT, V13, P56; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2013, J AM ACAD CHILD PSY, V52, P572, DOI 10.1016/j.jaac.2013.02.017; Howlin P, 2012, CAN J PSYCHIAT, V57, P275, DOI 10.1177/070674371205700502; IBM Corp, 2013, IBM SPSS STAT WINDOW; Kasari C, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0512-6; Klienert H, 2012, TEACHING EXCEPTIONAL, V44, P26; Knott F, 2014, INT J INCLUSIVE EDUC, V18, P411, DOI 10.1080/13603116.2013.781236; KRAM KE, 1985, ACAD MANAGE J, V28, P110, DOI 10.2307/256064; KRAM KE, 1983, ACAD MANAGE J, V26, P608, DOI 10.2307/255910; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Leonard H, 2010, RES AUTISM SPECT DIS, V4, P548, DOI 10.1016/j.rasd.2010.01.003; Levy A, 2011, RES AUTISM SPECT DIS, V5, P1271, DOI 10.1016/j.rasd.2011.01.023; Lowe PA, 2013, CAN J SCH PSYCHOL, V28, P277, DOI 10.1177/0829573513497907; MacLeod A, 2009, STUD HIGH EDUC, V34, P631, DOI 10.1080/03075070802590643; Madriaga M, 2008, PROJECT REPORT; Madriaga M, 2010, CHILD GEOGR, V8, P39, DOI 10.1080/14733280903500166; Madriaga M, 2010, INT J INCLUSIVE EDUC, V14, P115, DOI 10.1080/13603110802504168; Matthews NL, 2015, J AUTISM DEV DISORDE; McCroskey J.C., 1988, COMMUN RES REP, V5, P108, DOI [DOI 10.1080/08824098809359810, https://doi.org/10.1080/08824098809359810]; McCroskey J.C., 1982, INTRO RHETORICAL COM; McCroskey JC, 1982, PERSONAL REPORT COMM; Measurement Instrument Database for the Social Science, SELF PERC COMM COMP; Nicpon MF, 2006, J COLL STUD RETENT-R, V8, P345, DOI 10.2190/A465-356M-7652-783R; Orsmond GI, 2004, J AUTISM DEV DISORD, V34, P245, DOI 10.1023/B:JADD.0000029547.96610.df; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Piven J, 2011, J AM GERIATR SOC, V59, P2151, DOI 10.1111/j.1532-5415.2011.03632.x; Pohlert, 2003, J COLL STUDENT RETEN, V5, P255, DOI [https://doi.org/10.2190/C0T7-YX50-F71V-00CW, DOI 10.2190/C0T7-YX50-F71V-00CW]; Quintrell N., 1994, HIGHER ED RES DEV, V13, P49, DOI DOI 10.1080/0729436940130105; Renty J, 2006, AUTISM, V10, P511, DOI 10.1177/1362361306066604; Reynolds C.R., 2003, ADULT MANIFEST ANXIE; Richmond, 1978, HUMAN COMMUNICATION, V4, P338, DOI [10.1111/j.1468-2958.1978.tb00720.x, DOI 10.1111/J.1468-2958.1978.TB00720.X]; Rodger, 2003, CANADIAN JOURNAL OF, V33, P1; Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958; Taylor JL, 2011, J AUTISM DEV DISORD, V41, P566, DOI 10.1007/s10803-010-1070-3; THILE EL, 1995, J MULTICULT COUNS D, V23, P116, DOI 10.1002/j.2161-1912.1995.tb00605.x; Wazana A, 2007, J AM ACAD CHILD PSY, V46, P721, DOI 10.1097/chi.0b013e31804a7f3b; White SW, 2011, AUTISM, V15, P683, DOI 10.1177/1362361310393363; Wilcox P, 2005, STUD HIGH EDUC, V30, P707, DOI 10.1080/03075070500340036; Wolf Lorraine E, 2009, STUDENTS ASPERGER SY	66	41	41	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180854	10.1371/journal.pone.0180854	http://dx.doi.org/10.1371/journal.pone.0180854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704446	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700055
J	Staron, R; Lipinski, P; Lenartowicz, M; Bednarz, A; Gajowiak, A; Smuda, E; Krzeptowski, W; Pieszka, M; Korolonek, T; Hamza, I; Swinkels, DW; Van Swelm, RPL; Starzynski, RR				Staron, Robert; Lipinski, Pawel; Lenartowicz, Malgorzata; Bednarz, Aleksandra; Gajowiak, Anna; Smuda, Ewa; Krzeptowski, Wojciech; Pieszka, Marek; Korolonek, Tamara; Hamza, Iqbal; Swinkels, Dorine W.; Van Swelm, Rachel P. L.; Starzynski, Rafal R.			Dietary hemoglobin rescues young piglets from severe iron deficiency anemia: Duodenal expression profile of genes involved in heme iron absorption	PLOS ONE			English	Article							INTESTINAL BRUSH-BORDER; REGULATORY PROTEINS; METABOLISM; TRANSPORTER; IDENTIFICATION; HOMEOSTASIS; RECEPTOR; MICE; SUPPLEMENTATION; FERROPORTIN	Heme is an efficient source of iron in the diet, and heme preparations are used to prevent and cure iron deficiency anemia in humans and animals. However, the molecular mechanisms responsible for heme absorption remain only partially characterized. Here, we employed young iron-deficient piglets as a convenient animal model to determine the efficacy of oral heme iron supplementation and investigate the pathways of heme iron absorption. The use of bovine hemoglobin as a dietary source of heme iron was found to efficiently counteract the development of iron deficiency anemia in piglets, although it did not fully rebalance their iron status. Our results revealed a concerted increase in the expression of genes responsible for apical and basolateral heme transport in the duodenum of piglets fed a heme-enriched diet. In these animals the catalytic activity of heme oxygenase 1 contributed to the release of elemental iron from the protoporphyrin ring of heme within enterocytes, which may then be transported by the strongly expressed ferroportin across the basolateral membrane to the circulation. We hypothesize that the well-recognized high bioavailability of heme iron may depend on a split pathway mediating the transport of heme derived elemental iron and intact heme from the interior of duodenal enterocytes to the bloodstream.	[Staron, Robert; Lipinski, Pawel; Gajowiak, Anna; Smuda, Ewa; Starzynski, Rafal R.] Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland; [Lenartowicz, Malgorzata; Bednarz, Aleksandra; Krzeptowski, Wojciech] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, Krakow, Poland; [Pieszka, Marek] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Krakow, Poland; [Korolonek, Tamara; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Korolonek, Tamara; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Swinkels, Dorine W.; Van Swelm, Rachel P. L.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med LGEM 830, Nijmegen, Netherlands	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University; National Research Institute of Animal Production; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Radboud University Nijmegen	Lipinski, P; Starzynski, RR (corresponding author), Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl; r.starzynski@ighz.pl	van Swelm, Rachel PL/P-6063-2015	, Rafal/0000-0002-7470-0507; Hamza, Iqbal/0000-0003-0045-0610; Bednarz, Aleksandra/0000-0003-2256-2998	National Science Centre [2012/05/E/NZ5/02126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085035] Funding Source: NIH RePORTER	National Science Centre(National Science Centre, Poland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Science Centre, grant no. 2012/05/E/NZ5/02126 (https://ncn.gov.pl/). RRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2005, BIOMETALS, V18, P339, DOI 10.1007/s10534-005-3708-8; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Blachier F, 2007, CAN J PHYSIOL PHARM, V85, P185, DOI 10.1139/Y07-007; BONI RE, 1993, PHARMACOLOGY, V47, P318, DOI 10.1159/000139113; Canonne-Hergaux F, 2000, BLOOD, V96, P3964; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Delaby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042199; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Egeli AK, 1998, ACTA VET SCAND, V39, P381; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Fiorito V, 2015, ANTIOXID REDOX SIGN, V23, P1410, DOI 10.1089/ars.2014.6216; Fiorito V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068146; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gonzalez-Rosendo G, 2010, J FOOD SCI, V75, pH73, DOI 10.1111/j.1750-3841.2010.01523.x; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; GRASBECK R, 1979, SCAND J HAEMATOL, V23, P5; GRASBECK R, 1982, BIOCHIM BIOPHYS ACTA, V700, P137, DOI 10.1016/0167-4838(82)90089-9; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Khan AA, 2013, MOL ASPECTS MED, V34, P669, DOI 10.1016/j.mam.2012.07.013; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Laftah AH, 2009, BRIT J NUTR, V101, P1150, DOI 10.1017/S0007114508066762; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Le Blanc S, 2012, AM J PHYSIOL-CELL PH, V302, pC1780, DOI 10.1152/ajpcell.00080.2012; Lin YW, 2013, J INORG BIOCHEM, V129, P162, DOI 10.1016/j.jinorgbio.2013.07.023; Lipinski P, 2010, AM J PATHOL, V177, P1233, DOI 10.2353/ajpath.2010.091020; Maes D, 2011, VET REC, V168, P188, DOI 10.1136/vr.c7033; Moretti D, 2015, BLOOD, V126, P1981, DOI 10.1182/blood-2015-05-642223; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Quintero-Gutierrez AG, 2008, INT J BIOL SCI, V4, P58; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rincker MJ, 2005, J ANIM SCI, V83, P2137; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Staron R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136695; Starzynski RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064022; Starzynski RR, 2013, BIOCHEM J, V449, P69, DOI 10.1042/BJ20121139; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; Svoboda M., 2005, Folia Veterinaria, V49, P104; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Vinchi F, 2014, GASTROENTEROLOGY, V146, P1325, DOI 10.1053/j.gastro.2014.01.053; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; WALSH R J, 1955, Australas Ann Med, V4, P272; WEINTRAUB LR, 1968, J CLIN INVEST, V47, P531, DOI 10.1172/JCI105749; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; West AR, 2008, J GASTROEN HEPATOL, V23, P150, DOI 10.1111/j.1440-1746.2007.05047.x; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Young MF, 2010, J NUTR, V140, P2162, DOI 10.3945/jn.110.127209	62	30	30	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181117	10.1371/journal.pone.0181117	http://dx.doi.org/10.1371/journal.pone.0181117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704474	Green Submitted, Green Published, gold			2022-12-27	WOS:000405649700092
J	Wu, MC; Xu, X; Chen, SM; Tyan, YS; Chiou, JY; Wang, YH; Lin, LC; Chen, CM; Wei, JCC				Wu, Ming-Chi; Xu, Xun; Chen, Shan-Ming; Tyan, Yeu-Sheng; Chiou, Jeng-Yuan; Wang, Yu-Hsun; Lin, Li-Chi; Chen, Chyong-Mei; Wei, James Cheng-Chung			Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INCREASED RISK; MANIFESTATION; GENDER; COHORT; AGE	Objective To investigate whether Sjogren's syndrome would have an influence on the development of Parkinson's disease. Methods A population-based case-control study was conducted. Participants consisted of 7716 subjects with newly diagnosed Parkinson's disease and a population of 75129 matched control subjects between 2000 and 2010. We measured the risk of Parkinson's disease in association with Sjogren's syndrome by using adjusted odds ratios. Results A total of 143 Parkinson's disease subjects (1.9%) and 893 control subjects (1.2%) suffered from Sjogren's syndrome (p < 0.001). The crude odds ratio for Parkinson's disease among subjects with Sjogren's syndrome was 1.56 (95% CI 1.30- 1.86; p < 0.01). After adjustment for potential confounders which have been proposed that would increase the risk of development of Parkinson's disease, Sjogren's syndrome was found to be significantly associated with the risk of Parkinson's disease with an odds ratio of 1.37 (95% CI 1.15-1.65; p < 0.01). Conclusion This study preliminarily proposed that Sjogren's syndrome was significant associated with an increased risk of Parkinson's disease.	[Wu, Ming-Chi; Chen, Shan-Ming; Tyan, Yeu-Sheng; Wei, James Cheng-Chung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Chi; Xu, Xun; Tyan, Yeu-Sheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Wu, Ming-Chi] Chung Shan Med Univ, Dept Med Informat, Taichung, Taiwan; [Xu, Xun] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Chen, Shan-Ming] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Chiou, Jeng-Yuan] Chung Shan Med Univ, Sch Hlth Policy & Management, Taichung, Taiwan; [Wang, Yu-Hsun] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Li-Chi; Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Li-Chi] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Chen, Chyong-Mei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Chyong-Mei] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Nanjing Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Oklahoma State University System; Oklahoma State University - Stillwater; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University	Wei, JCC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	jccwei@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679				ALEXANDER EL, 1993, RHEUM DIS CLIN N AM, V19, P869; Brocks DR, 1999, J PHARM PHARM SCI, V2, P39; Chambers Mark S, 2004, ORL Head Neck Nurs, V22, P22; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Fabiani G, 2002, MOVEMENT DISORD, V17, P601, DOI 10.1002/mds.10029; Garcia-Carrasco M, 2006, ARCH MED RES, V37, P921, DOI 10.1016/j.arcmed.2006.08.002; Garcia-Moreno JM, 2002, MOVEMENT DISORD, V17, P1329, DOI 10.1002/mds.10288; Hassin-Baer S, 2007, CLIN RHEUMATOL, V26, P743, DOI 10.1007/s10067-006-0398-8; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kchaou M, 2015, CASE REP MED, V2015, P1; Kogure T, 2008, JCR-J CLIN RHEUMATOL, V14, P192, DOI 10.1097/RHU.0B013E318178825f; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Mavragani CP, 2007, CLIN REV ALLERG IMMU, V32, P284, DOI 10.1007/s12016-007-8008-3; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; MIYOSHI Y, 1993, LUPUS, V2, P199, DOI 10.1177/096120339300200314; Mochizuki H, 1997, Rinsho Shinkeigaku, V37, P57; MOLL JWB, 1993, NEUROLOGY, V43, P2574, DOI 10.1212/WNL.43.12.2574; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Rugbjerg K, 2009, NEUROLOGY, V73, P1462, DOI 10.1212/WNL.0b013e3181c06635; Rugbjerg K, 2010, MOVEMENT DISORD, V25, P2355, DOI 10.1002/mds.23274; Shahar E, 1998, PEDIATR NEUROL, V18, P456, DOI 10.1016/S0887-8994(97)00229-4; Sheu JJ, 2013, J AM ACAD DERMATOL, V68, P992, DOI 10.1016/j.jaad.2012.12.961; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van der Hooft CS, 2004, J AM COLL CARDIOL, V44, P2117, DOI 10.1016/j.jacc.2004.08.053; Walker RH, 1999, MOVEMENT DISORD, V14, P262, DOI 10.1002/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6; Wang IK, 2014, NEUROEPIDEMIOLOGY, V42, P204, DOI 10.1159/000358921; Zhang P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/729194	32	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0175836	10.1371/journal.pone.0175836	http://dx.doi.org/10.1371/journal.pone.0175836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704397	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700002
J	Gomez-Gonzalez, S; Paula, S; Cavieres, LA; Pausas, JG				Gomez-Gonzalez, Susana; Paula, Susana; Cavieres, Lohengrin A.; Pausas, Juli G.			Postfire responses of the woody flora of Central Chile: Insights from a germination experiment	PLOS ONE			English	Article							SEED-GERMINATION; EVOLUTIONARY ECOLOGY; FIRE REGIMES; SMOKE; HEAT; LIGNOTUBERS; VEGETATION; EMERGENCE; INVASIONS; DYNAMICS	Fire is a selective agent shaping plant traits and community assembly in fire-prone ecosystems. However, in ecosystems with no fire history, it can be a cause of land degradation when it is suddenly introduced by humans, as plant species may not be able to respond to such novel disturbance. Unlike other Mediterranean-type ecosystems (MTE) of the world, natural fires have not been frequent during the Quaternary in the matorral of Central Chile, and thus, plant adaptive responses are expected to be uncommon. We evaluated the effect of heat shock on seed survival and germination of 21 native woody plants of the Chilean matorral and compiled information on smoke-stimulation and resprouting, to evaluate the importance of fire-adaptive responses in the context of the other MTE. We found that in the Chilean woody flora negative seed responses to fire cues were more frequent than positive responses. Although resprouting is a relatively widespread trait, fire-stimulated germination is not as common in the Chilean matorral as in other MTE. The seeds of seven endemic species were strongly damaged by fire cues and this should be considered in post-fire restoration planning. However, our results also showed that many species were resistant to elevated doses of heat shock and in some, germination was even stimulated. Thus, future research should focus on the evolutionary causes of these responses. These findings could help to develop strategies for fire management in the Chilean matorral. In addition, they will improve our understanding of the evolutionary forces that shaped this plant community and to better frame this region among the other MTE worldwide.	[Gomez-Gonzalez, Susana] Univ Cadiz, IVAGRO, Dept Biol, Puerto Real, Spain; [Gomez-Gonzalez, Susana] Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile; [Paula, Susana] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Cavieres, Lohengrin A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, ECOBIOSIS, Dept Bot, Concepcion, Chile; [Cavieres, Lohengrin A.] IEB, Santiago, Chile; [Pausas, Juli G.] CSIC, Ctr Invest Desertificac CIDE, Valencia, Spain	Universidad de Cadiz; Universidad de Chile; Universidad Austral de Chile; Universidad de Concepcion; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Gomez-Gonzalez, S (corresponding author), Univ Cadiz, IVAGRO, Dept Biol, Puerto Real, Spain.; Gomez-Gonzalez, S (corresponding author), Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile.	susana.gomez@uca.es	Gómez-González, Susana/AAL-2631-2021; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Pausas, Juli/C-5794-2008	Gómez-González, Susana/0000-0002-3779-8701; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Pausas, Juli/0000-0003-3533-5786; Paula, Susana/0000-0001-5405-6155	Comision Nacional de Investigacion Cientifica y Tecnologica (Chile) [CONICYT/FONDECYT-INICIACION 11121264, CONICYT/FONDAP 1511009]	Comision Nacional de Investigacion Cientifica y Tecnologica (Chile)	SGG was funded by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT-INICIACION 11121264 and CONICYT/FONDAP 1511009, Chile); SGG, SP, LAC and JGP were funded by Consejo Superior de Investigaciones Cientificas (ilink0556, Spain); and JGP was funded by Generalitat Valenciana (PROMETEO/2016/021, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua AM, 2016, PALAEOGEOGR PALAEOCL, V459, P76, DOI 10.1016/j.palaeo.2016.06.036; ACEITUNO P, 1988, MON WEATHER REV, V116, P505, DOI 10.1175/1520-0493(1988)116<0505:OTFOTS>2.0.CO;2; Aravena JC, 2003, ECOL STU AN, V160, P343; Armesto J., 2009, FIRE EFFECTS SOILS R, P537; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BROWN NAC, 1993, NEW PHYTOL, V123, P575, DOI 10.1111/j.1469-8137.1993.tb03770.x; BUSTAMANTE RO, 1993, ACTA OECOL, V14, P739; D'Antonio C.M., 2000, INVASIVE SPECIES CHA, P65; Daniau AL, 2007, QUATERNARY SCI REV, V26, P1369, DOI 10.1016/j.quascirev.2007.02.005; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; DUBAR M, 1995, CR ACAD SCI II, V320, P873; Figueroa JA, 2004, REV CHIL HIST NAT, V77, P201; Figueroa JA, 2012, REV CHIL HIST NAT, V85, P101, DOI 10.4067/S0716-078X2012000100008; Figueroa JA, 2009, ACTA OECOL, V35, P335, DOI 10.1016/j.actao.2008.12.004; Fuentes N., 2014, PLANTAS INVASORAS CT; Garcia RA, 2010, REV CHIL HIST NAT, V83, P443; Gomez-Gonzalez S, 2008, FOREST ECOL MANAG, V255, P1510, DOI 10.1016/j.foreco.2007.11.006; Gomez-Gonzalez S, 2017, OPEN SCIENCE FR 0214; Gomez-Gonzalez S., 2008, THESIS; Gomez-Gonzalez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159655; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, GAYANA BOT, V68, P86, DOI 10.4067/S0717-66432011000100007; Gomez-Gonzalez S, 2009, INT J WILDLAND FIRE, V18, P213, DOI 10.1071/WF07074; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hart SC, 2005, FOREST ECOL MANAG, V220, P166, DOI 10.1016/j.foreco.2005.08.012; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; Keeley J. E., 2000, Seeds: the ecology of regeneration in plant communities, P311, DOI 10.1079/9780851994321.0311; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 1998, ECOLOGY, V79, P2320, DOI 10.1890/0012-9658(1998)079[2320:SISGIC]2.0.CO;2; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; KEELEY SC, 1977, AM MIDL NAT, V97, P120, DOI 10.2307/2424690; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; Lamont BB, 2011, PLANT ECOL, V212, P1945, DOI 10.1007/s11258-011-9982-3; Lloret F, 1998, J VEG SCI, V9, P417, DOI 10.2307/3237106; Montenegro G, 2004, REV CHIL HIST NAT, V77, P455, DOI 10.4067/S0716-078X2004000300005; MONTENEGRO G, 1983, CAN J BOT, V61, P1804, DOI 10.1139/b83-189; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Moreira B, 2016, S AFRICAN J BOT; MUNOZ MR, 1989, OIKOS, V56, P177, DOI 10.2307/3565333; Ojeda F, 2010, OECOLOGIA, V163, P729, DOI 10.1007/s00442-009-1550-3; Pauchard A, 2008, BIOL INVASIONS, V10, P547, DOI 10.1007/s10530-007-9151-8; Paula S, 2008, J ECOL, V96, P543, DOI 10.1111/j.1365-2745.2008.01359.x; Paula S, 2016, PLANT ECOL, V217, P661, DOI 10.1007/s11258-015-0538-9; Pausas JG, 2006, J ECOL, V94, P31, DOI 10.1111/j.1365-2745.2005.01092.x; Pausas JG, 2015, FUNCT ECOL, V29, P315, DOI 10.1111/1365-2435.12372; Pausas JG, 2014, NEW PHYTOL, V204, P55, DOI 10.1111/nph.12921; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; PLISCOFF P., 2006, SINOPSIS BIOCLIMATIC; Quintanilla P?rez V., 1998, SERIE GEOGRAFICA, V7, P147; Quintanilla Perez Victor, 1996, Pirineos, V147-148, P97; Segura AM, 1998, PLANT ECOL, V139, P259, DOI 10.1023/A:1009715328868; Taylor KT, 2017, ECOLOGY, V98, P678, DOI 10.1002/ecy.1673; Trabaud L., 1991, Biogeography of mediterranean invasions., P179, DOI 10.1017/CBO9780511525544.017; van Staden Johannes, 2000, Plant Species Biology, V15, P167, DOI 10.1046/j.1442-1984.2000.00037.x; Venier P, 2012, S AFR J BOT, V79, P19, DOI 10.1016/j.sajb.2011.11.005; Villa-Martinez R, 2003, QUATERNARY RES, V60, P284, DOI 10.1016/j.yqres.2003.07.007; WICKLOW DT, 1988, P ROY SOC EDINB B, V94, P87, DOI 10.1017/S0269727000007168; Williams R. J., 2003, FIRE TROPICAL SAVANN; Zouhar K, 2008, RMRSGTR42 DEP AGR FO, V6; Zuloaga FO., 2008, MONOGR SYST BOT MISS, V107, P136; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1111/J.1472-4642.2010.00728.X	69	17	20	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180661	10.1371/journal.pone.0180661	http://dx.doi.org/10.1371/journal.pone.0180661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704449	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600040
J	Nava, A; Bondioli, L; Coppa, A; Dean, C; Rossi, PF; Zanolli, C				Nava, Alessia; Bondioli, Luca; Coppa, Alfredo; Dean, Christopher; Rossi, Paola Francesca; Zanolli, Clement			New regression formula to estimate the prenatal crown formation time of human deciduous central incisors derived from a Roman Imperial sample (Velia, Salerno, Italy, I-II cent. CE)	PLOS ONE			English	Article							SKELETAL REMAINS; ENAMEL GROWTH; DENTAL REMAINS; NEONATAL LINE; PRIMARY TEETH; HARD TISSUES; PERIODICITY; AGE; THICKNESS; HISTOLOGY	The characterization and quantification of human dental enamel microstructure, in both permanent and deciduous teeth, allows us to document crucial growth parameters and to identify stressful events, thus contributing to the reconstruction of the past life history of an individual. Most studies to date have focused on the more accessible post-natal portion of the deciduous dental enamel, even though the analysis of prenatal enamel is pivotal in understanding fetal growth, and reveals information about the mother's health status during pregnancy. This contribution reports new data describing the prenatal enamel development of 18 central deciduous incisors from the Imperial Roman necropolis of Velia (I-II century CE, Salerno, Italy). Histomorphometrical analysis was performed to collect data on prenatal crown formation times, daily secretion rates and enamel extension rates. Results for the Velia sample allowed us to derive a new regression formula, using a robust statistical approach, that describes the average rates of deciduous enamel formation. This can now be used as a reference for pre-industrial populations. The same regression formula, even when daily incremental markings are difficult to visualize, may provide a clue to predicting the proportion of infants born full term and pre-term in an archaeological series.	[Nava, Alessia; Coppa, Alfredo] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Nava, Alessia; Bondioli, Luca; Rossi, Paola Francesca] Museo Nazl Preistor Etnog Luigi Pigorini, Museo Civilta, Sect Bioarchaeol, Rome, Italy; [Dean, Christopher] UCL, Dept Cell & Dev Biol, London, England; [Zanolli, Clement] Univ Toulouse III, Lab AMIS, UMR 5288, Toulouse, France	Sapienza University Rome; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nava, A (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	alessia.nava@uniroma1.it	Nava, Alessia/AAH-1754-2019	Nava, Alessia/0000-0002-6319-0425	Environmental Biology Doctoral School of Sapienza University of Rome (AN); Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR).	Environmental Biology Doctoral School of Sapienza University of Rome (AN); Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR).	Funded by Environmental Biology Doctoral School of Sapienza University of Rome (AN) and Italian Ministry of Cultural Heritage and Tourism (AN,LB,PFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Birch W, 2014, J FORENSIC LEG MED, V22, P127, DOI 10.1016/j.jflm.2013.12.002; Birch W, 2011, THESIS; Birch W, 2009, FRONT ORAL BIOL, V13, P116, DOI 10.1159/000242402; Bondioli L., 2016, ACTA IMEKO, V5, P19, DOI [DOI 10.1002/ajpa.10130, DOI 10.21014/ACTA_IMEKO.V5I2.333]; BOYDE A, 1990, MG PRIMATOL, V14, P229; BOYDE A, 1963, EXCERPTA MED INT C S, V80, P36; Boyde A., 1964, THESIS; Caropreso S, 2000, J MICROSC-OXFORD, V199, P244, DOI 10.1046/j.1365-2818.2000.00731.x; Cleveland W.S., 1993, STAT METHODS S, P309; Craig OE, 2009, AM J PHYS ANTHROPOL, V139, P572, DOI 10.1002/ajpa.21021; Cunningham C., 2016, DEV JUV OST 2 ED; Dean C, 2004, J HUM EVOL, V46, P633, DOI 10.1016/j.jhevol.2004.03.001; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean M Christopher, 2012, Methods Mol Biol, V915, P89, DOI 10.1007/978-1-61779-977-8_5; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, FRONT ORAL BIOL, V13, P68, DOI 10.1159/000242394; DEAN MC, 1987, J HUM EVOL, V16, P157, DOI 10.1016/0047-2484(87)90074-1; Fazekas Istvan G., 1978, FORENSIC FETAL OSTEO; Fiammenghi C.A., 2003, QUADERNI CTR STUDI M, V1, P49; FitzGerald C, 2009, FRONT ORAL BIOL, V13, P178, DOI 10.1159/000242414; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Guatelli Steinberg D., 2016, WHAT TEETH REVEAL AB; Guatelli-Steinberg D, 2012, J HUM EVOL, V63, P475, DOI 10.1016/j.jhevol.2012.05.006; Gustafson G., 1967, STRUCTURAL CHEM ORG, P135; Gysi A., 1939, DENT DIG, V37, P661; Hillson S., 2014, TOOTH DEVELOPMENT IN; Huda T, 1994, INT J OSTEOARCHAEOL, V4, P49; Janardhanan Mahija, 2011, J Forensic Dent Sci, V3, P8, DOI 10.4103/0975-1475.85284; Kajiyama S., 1965, NIHON U DENT J, V39, P77; Katzenberg MA, 2005, INT J OSTEOARCHAEOL, V15, P61, DOI 10.1002/oa.748; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lacruz RS, 2016, DEVELOPMENTAL APPROACHES TO HUMAN EVOLUTION, P61; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Le Cabec A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123019; Leeuwenhoek A, 1665, PHIL T ROYAL SOC, V12, P1002; Lewis S. J., 1999, CURRENT RECENT RES O, P54; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Mahoney P, 2015, AM J PHYS ANTHROPOL, V156, P407, DOI 10.1002/ajpa.22666; Mahoney P, 2012, AM J PHYS ANTHROPOL, V147, P637, DOI 10.1002/ajpa.22029; Mahoney P, 2011, AM J PHYS ANTHROPOL, V144, P204, DOI 10.1002/ajpa.21386; Maresh M. M., 1970, HUMAN GROWTH DEV, P157; NOREN JG, 1983, ACTA ODONTOL SCAND, V41, P355, DOI 10.3109/00016358309162347; Pickerill HP, 1912, THE PREVENTION OF DE; Preiswerk G., 1895, BEITRAGE ZUR KENNTNI; R Core Team, 2017, R A LANGUAGE AND ENV; Retzius A., 1837, ARCH ANAT PHYSL, V1837, P486; RISNES S, 1986, SCAND J DENT RES, V94, P394; Rythen M, 2008, INT J PAEDIATR DENT, V18, P397, DOI 10.1111/j.1365-263X.2008.00928.x; Sabel N, 2008, ARCH ORAL BIOL, V53, P954, DOI 10.1016/j.archoralbio.2008.05.003; SCHOUR I., 1940, JOUR AMER DENTAL ASSOC, V27, P1918; SCHOUR ISAAC, 1936, JOUR AMER DENTAL ASSOC, V23, P1946; Schwartz JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009177; Seow WK, 2005, PEDIATR DENT, V27, P374; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Simpson Scott W., 1999, HUMAN GROWTH STUDIES, P241; SKINNER M, 1993, J FORENSIC SCI, V38, P1383; SKINNER M, 1991, J FORENSIC SCI, V36, P939; Smith P, 2005, J ARCHAEOL SCI, V32, P83, DOI 10.1016/j.jas.2004.06.008; Smith TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118118; Smith TM, 2011, VERTEBR PALEOBIOL PA, P155, DOI 10.1007/978-94-007-0492-3_13; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Takiguchi H, 1966, NIHON U DENT, V40, P391; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; Wissler H., 1916, FESTIGKEIBERECHUNG R; Witzel C, 2008, AM J PHYS ANTHROPOL, V136, P400, DOI 10.1002/ajpa.20822; Witzel C, 2014, ANTHROPOL ANZ, V71, P87, DOI 10.1127/0003-5548/2014/0386; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zanolli C, 2016, CR PALEVOL, V15, P209, DOI 10.1016/j.crpv.2015.02.001; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2011, HUM BIOL, V83, P695, DOI 10.3378/027.083.0603; Zheng L, 2014, EXP CELL RES, V325, P83, DOI 10.1016/j.yexcr.2014.02.007; Zheng L, 2013, BONE, V55, P158, DOI 10.1016/j.bone.2013.02.011	78	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180104	10.1371/journal.pone.0180104	http://dx.doi.org/10.1371/journal.pone.0180104			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700601	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000405649600017
J	Tangri, N; Ferguson, TW; Whitlock, RH; Rigatto, C; Jassal, DS; Kass, M; Toleva, O; Komenda, P				Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Jassal, Davinder S.; Kass, Malek; Toleva, Olga; Komenda, Paul			Long term health outcomes in patients with a history of myocardial infarction: A population based cohort study	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; POSTMYOCARDIAL INFARCTION; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; CORONARY; RISK; GUIDELINE; DISEASE; METAANALYSIS; OUTPATIENTS	Background Myocardial infarction (MI) is associated with high morbidity and mortality, particularly in the first 12 months post-event. Interventions such as dual antiplatelet therapy can reduce the risk of major adverse cardiovascular events (MACE), but the duration of the high-risk time interval and the optimal prescription time frame for these interventions remains unknown. Design, setting, participants, and measurements We performed a retrospective cohort study using data from medical services and hospitalizations in Manitoba, Canada for patients admitted with a MI between April 2006 and March 2010, and followed until Nov 30, 2014. We used survival analysis to determine the cumulative incidence of death, subsequent MI, or stroke, and used Cox proportional hazards models to assess factors associated with these endpoints. Results There were 8,493 patients in Manitoba admitted to hospital for a MI during the study period. Of those, 6,749 (79.5%) survived for at least 1 year without a recurrent MI or stroke. In the following year, this population remained at high risk, with 372 (5.5%) of the remaining patients dying in the next twelve months (48.1% cardiovascular deaths), 244 (3.6%) having a recurrent MI, and 74 (1.1%) having a stroke. Older age, male sex, diabetes, prior stroke, prior heart failure, prior unstable angina, and absence of revascularization were associated with worse long-term prognosis. Conclusions The risk of MACE remains elevated among post-MI patients after the first year. Interventions to more intensively monitor, evaluate, and treat these patients should be considered beyond the first year following myocardial infarction.	[Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Jassal, Davinder S.; Kass, Malek; Toleva, Olga; Komenda, Paul] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Tangri, Navdeep; Ferguson, Thomas W.; Whitlock, Reid H.; Rigatto, Claudio; Komenda, Paul] Univ Manitoba, Seven Oaks Hosp Chron Dis Innovat Ctr, Winnipeg, MB, Canada; [Jassal, Davinder S.; Kass, Malek; Toleva, Olga] St Boniface Gen Hosp, Dept Cardiac Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Tangri, N (corresponding author), Univ Manitoba, Dept Med, Winnipeg, MB, Canada.; Tangri, N (corresponding author), Univ Manitoba, Seven Oaks Hosp Chron Dis Innovat Ctr, Winnipeg, MB, Canada.	ntangri@sogh.mb.ca		Jassal, Davinder/0000-0002-3639-9047				Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Rapsomaniki E, 2014, EUR HEART J, V35, P844, DOI 10.1093/eurheartj/eht533; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Yang E, 2016, CARDIOVASC THER; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003	17	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180010	10.1371/journal.pone.0180010	http://dx.doi.org/10.1371/journal.pone.0180010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700669	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600013
J	Cho, JH				Cho, Jun Ho			The association between electronic-cigarette use and self-reported oral symptoms including cracked or broken teeth and tongue and/or inside-cheek pain among adolescents: A cross-sectional study	PLOS ONE			English	Article							NICOTINE DELIVERY; SMOKING; NICKEL; HEALTH; CANCER; AREAS	Background Little is known about oral health related to electronic-cigarette (EC) use, even though EC use is increasing rapidly. The aim of this study is to assess the relationship between EC use and oral health, including 'gingival pain and/or bleeding', 'tongue and/or inside-cheek pain', and 'cracked or broken teeth' among adolescents. Methods A total of 65,528 students in 2016 were included in this cross-sectional study. Results For EC use, 0.5% (n = 297) students were daily users, 1.9% (n = 1259) were '1 to 29 days past month users', and 5.9% (n = 3848) were former users. Overall, 18.5% students reported they had experienced 'gingival pain and/or bleeding', 11.0% reported 'tongue and/or inside-cheek pain', and 11.4% reported a 'cracked or broken tooth' within the past 12 months. When comparing 'daily EC users', '1 to 29 days past month EC users', and 'former EC users' with 'never EC users', the adjusted ORs for 'cracked or broken tooth' were 1.65 (95% CI: 1.19-2.27), 1.26 (95% CI: 1.06-1.51), and 1.16 (95% CI: 1.04-1.30), respectively. Comparing 'daily EC users' with ` never EC users', the adjusted OR for 'tongue and/or inside-cheek pain' was 1.54 (1.05-2.26). However, EC use among adolescents was not associated with 'gingival pain and/or bleeding' when adjusted for the potential confounders. Conclusions Based on the results, the odds of cracked or broken teeth among daily, '1 to 29 days past month', and former EC users were significantly higher than those among never EC users. The odds of tongue and/or inside-cheek pain among daily EC users were significantly higher than those among never EC users. In conclusion, the results suggest that daily EC use among adolescents may be a risk factor for cracked or broken teeth and tongue and/or inside-cheek pain.	[Cho, Jun Ho] Hanyang Womens Univ, Dept Publ Hlth Adm, Seoul, South Korea		Cho, JH (corresponding author), Hanyang Womens Univ, Dept Publ Hlth Adm, Seoul, South Korea.	cjhjunho@hanmail.net		CHO, JUN HO/0000-0002-6936-9055	2016-2nd semester Hanyang Women's University Research Fund [2016-2-034]	2016-2nd semester Hanyang Women's University Research Fund	The study was supported by the 2016-2nd semester Hanyang Women's University Research Fund (2016-2-034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avezov K, 2014, TOXICOL IN VITRO, V28, P485, DOI 10.1016/j.tiv.2014.01.004; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Cho JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151022; Cooper Maria, 2016, Tob Regul Sci, V2, P278; Dawkins LE, 2016, PSYCHOPHARMACOLOGY, V233, P2933, DOI 10.1007/s00213-016-4338-2; Do D, 2013, BIOMATERIALS, V34, P8650, DOI 10.1016/j.biomaterials.2013.07.090; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084; Giroud C, 2015, INT J ENV RES PUB HE, V12, P9988, DOI 10.3390/ijerph120809988; Goniewicz ML, 2014, J ADOLESCENT HEALTH, V55, P713, DOI 10.1016/j.jadohealth.2014.07.015; Huang LL, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150564; Huang RJ, 2012, EUR J ORAL SCI, V120, P319, DOI 10.1111/j.1600-0722.2012.00971.x; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Javed F, 2017, ORAL DIS; Ji EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154447; Jin LJ, 2016, ORAL DIS, V22, P609, DOI 10.1111/odi.12428; Kahler B, 2003, J BIOMECH, V36, P229, DOI 10.1016/S0021-9290(02)00327-5; Khlystov A, 2016, ENVIRON SCI TECHNOL, V50, P13080, DOI 10.1021/acs.est.6b05145; King BA, 2015, NICOTINE TOB RES, V17, P219, DOI 10.1093/ntr/ntu191; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; Korea Centers for Disease Control and Prevention, STAT AD HLTH REL BEH; Krause MJ, 2015, WASTE MANAGE, V39, P57, DOI 10.1016/j.wasman.2015.02.005; Lee CP, 2016, J CANCER, V7, P1724, DOI 10.7150/jca.15441; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee Sungkyu, 2011, J Prev Med Public Health, V44, P235, DOI 10.3961/jpmph.2011.44.6.235; Lopez AA, 2016, NICOTINE TOB RES, V18, P720, DOI 10.1093/ntr/ntv182; Maida CA, 2015, QUAL LIFE RES, V24, P2739, DOI 10.1007/s11136-015-1015-6; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; Manuela R, 2015, LIFE SCI, V135, P49, DOI 10.1016/j.lfs.2015.04.027; Meo SA, 2014, EUR REV MED PHARMACO, V18, P3315; Miech R, 2016, TOB CONTROL; Moran-Martinez J, 2013, GENET MOL RES, V12, P3178, DOI 10.4238/2013.August.29.1; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Ogunwale MA, 2017, ACS OMEGA, V2, P1207, DOI 10.1021/acsomega.6b00489; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; PERCIVAL RS, 1994, J DENT RES, V73, P1416, DOI 10.1177/00220345940730080401; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Soares TR, 2016, DENT TRAUMATOL; Su CC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-67; Sundar IK, 2016, ONCOTARGET, V7, P77196, DOI 10.18632/oncotarget.12857; The Network for Public Health Law, IMPR OR HLTH CAR ACA; Tomar SL, 2015, J AM DENT ASSOC, V146, P651, DOI 10.1016/j.adaj.2015.07.002; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; U.S. Department of Health and Human Services, 2014, REP SURG GEN; Varlet V, 2015, INT J ENV RES PUB HE, V12, P4796, DOI 10.3390/ijerph120504796; Vasiliou A, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0284-y; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Yahyazadehfar M, 2014, APPL MECH REV, V66, DOI 10.1115/1.4027431; Yanagita M, 2008, J ENDODONT, V34, P1061, DOI 10.1016/j.joen.2008.06.005; Yu V, 2016, ORAL ONCOL, V52, P58, DOI 10.1016/j.oraloncology.2015.10.018	53	27	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180506	10.1371/journal.pone.0180506	http://dx.doi.org/10.1371/journal.pone.0180506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TI	28700729	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649400014
J	Teodoro, GR; Gontijo, AVL; Borges, AC; Tanaka, MH; Lima, GDG; Salvador, MJ; Koga-Ito, CY				Teodoro, Guilherme Rodrigues; Lacerda Gontijo, Aline Vidal; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Salvador, Marcos Jose; Koga-Ito, Cristiane Yumi			Gallicacid/hydroxypropyl-beta-cyclodextrin complex: Improving solubility for application on in vitro/in vivo Candida albicans biofilms	PLOS ONE			English	Article							GALLIC ACID; ANTIFUNGAL ACTIVITY; INCLUSION COMPLEX; ORAL CANDIDIASIS; GROWTH; MODEL; FORMULATIONS; ANTIOXIDANT; INFECTION; EXTRACTS	The aim of this study was to increase the solubility of gallic acid (GA) for the treatment of Candida albicans biofilm, which is very difficult to treat and requires high drug concentrations. Cyclodextrins (CDs) were used for this purpose. Complexes were evaluated by phase-solubility studies, prepared by spray drying and characterized by drug loading, scanning electron microscopy (SEM) and differential scanning calorimetry (DSC). The complexes were tested on C. albicans biofilm using in vitro and in vivo models. HP beta CD formed soluble inclusion complexes with GA. The percentage of GA in GA/HP beta CD was 10.8 +/- 0.01%. The SEM and DSC analyses confirmed the formation of inclusion complexes. GA/HP beta CD maintained the antimicrobial activity of the pure GA. GA/HP beta CD was effective on C. albicans biofilms of 24 and 48h. The in vivo results showed an anti-inflammatory activity of GA/HP beta CD with no difference in invading hypha counting among the groups. This study encourages the development of new antifungal agents.	[Teodoro, Guilherme Rodrigues; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Oral Biopathol Grad Program, Sao Jose Dos Campos, SP, Brazil; [Lacerda Gontijo, Aline Vidal; Borges, Aline Chiodi; Tanaka, Marcia Hiromi; Gouvea Lima, Gabriela de Morais; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Dept Environm Engn, Sao Jose Dos Campos, SP, Brazil; [Lacerda Gontijo, Aline Vidal; Salvador, Marcos Jose] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Koga-Ito, CY (corresponding author), Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Oral Biopathol Grad Program, Sao Jose Dos Campos, SP, Brazil.; Koga-Ito, CY (corresponding author), Univ Estadual Paulista, UNESP, Sao Jose dos Campos Inst Sci & Technol, Dept Environm Engn, Sao Jose Dos Campos, SP, Brazil.	cristiane@ict.unesp.br	Salvador, Marcos/V-3129-2019; Tanaka, Marcia Hiromi/J-7804-2012; Koga-Ito, Cristiane/ABC-6537-2020; Koga-Ito, Cristiane Y/D-7999-2012; Borges, Aline/AAH-7429-2021; Lima, Gabriela M G/I-5491-2012; Gontijo, Aline/G-9909-2013	Salvador, Marcos/0000-0002-3839-5445; Tanaka, Marcia Hiromi/0000-0002-6594-2301; Koga-Ito, Cristiane Y/0000-0002-2416-2173; Gontijo, Aline/0000-0002-4122-7610	Sao Paulo Research Foundation (FAPESP) [2013/00037-1]; GR Teodoro [2012/16805-5]; AVL Gontijo [2014/09666-4]; AC Borges [2014/02354-7]; MH Tanaka [2014/13469-0]; GMG Lima [2015/03470-3]; FAPESP	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); GR Teodoro; AVL Gontijo; AC Borges; MH Tanaka; GMG Lima; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grant #2013/00037-1, Sao Paulo Research Foundation (FAPESP). GR Teodoro (#2012/16805-5), AVL Gontijo (#2014/09666-4), AC Borges, (#2014/02354-7), MH Tanaka (#2014/13469-0) and GMG Lima (#2015/03470-3) are supported by FAPESP. The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the article for publication.	Alnuaimi AD, 2013, FEMS YEAST RES, V13, P689, DOI 10.1111/1567-1364.12068; Alves CT, 2014, FUTURE MICROBIOL, V9, P139, DOI 10.2217/fmb.13.147; Aytac Z, 2016, MAT SCI ENG C-MATER, V63, P231, DOI 10.1016/j.msec.2016.02.063; Boniface PK, 2016, J ETHNOPHARMACOLOGY; Bouzidi A, 2016, PAK J PHARM SCI, V29, P1299; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Cheng L, 2011, CARIES RES, V45, P87, DOI 10.1159/000324084; Crastechini E, 2009, 21 C IN CIENT UNESP; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Ge X, 2012, CARBOHYD POLYM, V89, P208, DOI 10.1016/j.carbpol.2012.02.072; Girardot M, 2016, FUTURE MICROBIOL, V11, P69, DOI 10.2217/fmb.15.118; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Jug M, 2011, J PHARMACEUT BIOMED, V54, P1030, DOI 10.1016/j.jpba.2010.12.009; Junqueira JC, 2005, MICROBIOL IMMUNOL, V49, P199, DOI 10.1111/j.1348-0421.2005.tb03721.x; Loftsson T, 2005, INT J PHARMACEUT, V302, P18, DOI 10.1016/j.ijpharm.2005.05.042; Loftsson T, 2007, J INCL PHENOM MACRO, V57, P545, DOI 10.1007/s10847-006-9247-2; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Lyu X, 2016, DRUG DES DEV THER, V10, P1161, DOI 10.2147/DDDT.S100795; Macaev F, 2013, CURR TOP MED CHEM, V13, P2677, DOI 10.2174/15680266113136660194; Vila TVM, 2015, ANTIMICROB AGENTS CH, V59, P7611, DOI 10.1128/AAC.01890-15; National Committee for Clinical Laboratory Standards, 2008, M27A3 NCCLS; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Okada M, 2013, ARCH ORAL BIOL, V58, P444, DOI 10.1016/j.archoralbio.2012.09.014; Olga G, 2015, FOOD CHEM, V185, P33, DOI 10.1016/j.foodchem.2015.03.058; Petronilho S, 2012, IND CROP PROD, V40, P1, DOI 10.1016/j.indcrop.2012.02.041; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rosales P, 2012, PLOS ONE, V7; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Spampinato C., 2013, BIOMED RES INT, V2013; Srinivas K, 2010, J CHEM ENG DATA, V55, P3101, DOI 10.1021/je901097n; Tang PX, 2016, CARBOHYD POLYM, V142, P16, DOI 10.1016/j.carbpol.2016.01.042; Teodoro GR, 2015, FUTURE MICROBIOL, V10, P917, DOI [10.2217/FMB.15.20, 10.2217/fmb.15.20]; Tewes F, 2008, J CONTROL RELEASE, V129, P93, DOI 10.1016/j.jconrel.2008.04.007; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Veiga MD, 2005, J INCL PHENOM MACRO, V53, P77, DOI 10.1007/s10847-005-1047-6; Veiga MD, 2002, J THERM ANAL CALORIM, V68, P511, DOI 10.1023/A:1016091803317; Williams DW, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22434; Yao YS, 2014, CARBOHYD POLYM, V110, P329, DOI 10.1016/j.carbpol.2014.04.006	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181199	10.1371/journal.pone.0181199	http://dx.doi.org/10.1371/journal.pone.0181199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700692	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649400038
J	Alvarado, C; Nachtigal, D; Slack, JP; Green, BG				Alvarado, Cynthia; Nachtigal, Danielle; Slack, Jay P.; Green, Barry G.			Differential modulation of the lactisole 'Sweet Water Taste' by sweeteners	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ALLOSTERIC MODULATORS; MOLECULAR-MECHANISM; TRANSMEMBRANE DOMAIN; ACTIVATION MECHANISM; ENDOCYTOSIS; ADAPTATION; CHALLENGES; MAGNITUDE	Pre-exposure to taste stimuli and certain chemicals can cause water to have a taste. Here we studied further the 'sweet water taste' (SWT) perceived after exposure to the sweet taste inhibitor lactisole. Experiment 1 investigated an incidental observation that presenting lactisole in mixture with sucrose reduced the intensity of the SWT. The results confirmed this observation and also showed that rinsing with sucrose after lactisole could completely eliminate the SWT. The generalizability of these findings was investigated in experiment 2 by presenting 5 additional sweeteners before, during, or after exposure to lactisole. The results found with sucrose were replicated with fructose and cyclamate, but the 3 other sweeteners were less effective suppressors of the SWT, and the 2 sweeteners having the highest potency initially enhanced it. A third experiment investigated these interactions on the tongue tip and found that the lactisole SWT was perceived only when water was actively flowed across the tongue. The same experiment yielded evidence against the possibility that suppression of the SWT following exposure to sweeteners is an aftereffect of receptor activation while providing additional support for a role of sweetener potency. Collectively these results provide new evidence that complex inhibitory and excitatory interactions occur between lactisole and agonists of the sweet taste receptor TAS1R2-TAS1R3. Receptor mechanisms that may be responsible for these interactions are discussed in the context of the current model of the SWT and the possible contribution of allosteric modulation.	[Alvarado, Cynthia; Nachtigal, Danielle; Green, Barry G.] John B Pierce Lab, New Haven, CT 06519 USA; [Slack, Jay P.] Givaudan Flavors Corp, Dept Sci Technol, Cincinnati, OH USA; [Green, Barry G.] Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA; [Alvarado, Cynthia] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Yale University; The John B Pierce Laboratory, Inc; Givaudan SA; Yale University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Green, BG (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; Green, BG (corresponding author), Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA.	green@jbpierce.org			National Institute on Deafness and Other Communication Disorders [RO1 DC05002]; Givaudan Flavors Corp	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Givaudan Flavors Corp	This work was supported by the National Institute on Deafness and Other Communication Disorders, Award Number RO1 DC05002 to BGG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Givaudan Flavors Corp. provided support in the form of salary for author JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section	Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; BARTOSHUK LM, 1968, PERCEPT PSYCHOPHYS, V3, P69, DOI 10.3758/BF03212715; BARTOSHUK LM, 1964, SCIENCE, V143, P967, DOI 10.1126/science.143.3609.967; Bartoshuk LM, 2003, FOOD QUAL PREFER, V14, P125, DOI 10.1016/S0950-3293(02)00077-0; BARTOSHUK LM, 1974, PHYSIOL BEHAV, V12, P449, DOI 10.1016/0031-9384(74)90122-X; BARTOSHUK LM, 1972, SCIENCE, V178, P988, DOI 10.1126/science.178.4064.988; Bradley PJ, 2010, EUR MAN MED, P333, DOI 10.1007/978-3-540-68940-9_36; Campa VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122604; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; D'Angelo L. L., 1999, DUBOIS SELECTIVE SWE; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; DuBois GE, 2004, P NATL ACAD SCI USA, V101, P13972, DOI 10.1073/pnas.0405991101; DuBois GE, 2016, PHYSIOL BEHAV, V164, P453, DOI 10.1016/j.physbeh.2016.03.015; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; Green BG, 2015, CHEM SENSES, V40, P391, DOI 10.1093/chemse/bjv021; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Kenakin T, 2004, RECEPTOR CHANNEL, V10, P51, DOI 10.1080/10606820490464316; Kenakin T, 2017, CHEM REV, V117, P4, DOI 10.1021/acs.chemrev.5b00561; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; LINDLEY MG, 1991, ACS SYM SER, V450, P251; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; MCBURNEY DH, 1971, PERCEPT PSYCHOPHYS, V10, P249, DOI 10.3758/BF03212815; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Miyano M, 2010, J AGR FOOD CHEM, V58, P11870, DOI 10.1021/jf102573w; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Schiffman SS, 1999, CHEM SENSES, V24, P439, DOI 10.1093/chemse/24.4.439; Servant G, 2011, TRENDS PHARMACOL SCI, V32, P631, DOI 10.1016/j.tips.2011.06.007; Servant G, 2010, P NATL ACAD SCI USA, V107, P4746, DOI 10.1073/pnas.0911670107; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuga H, 1998, J BIOCHEM-TOKYO, V124, P863, DOI 10.1093/oxfordjournals.jbchem.a022191; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107	48	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180787	10.1371/journal.pone.0180787	http://dx.doi.org/10.1371/journal.pone.0180787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700634	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800075
J	Gonen, T; Gazit, T; Korn, A; Kirschner, A; Perry, D; Hendler, T; Ram, Z				Gonen, Tal; Gazit, Tomer; Korn, Akiva; Kirschner, Adi; Perry, Daniella; Hendler, Talma; Ram, Zvi			Intra-operative multi-site stimulation: Expanding methodology for cortical brain mapping of language functions	PLOS ONE			English	Article							AWAKE CRANIOTOMY; NETWORKS; CONNECTIVITY; RESECTION; ORGANIZATION; SYSTEMS; SPEECH; TUMORS; FMRI	Direct cortical stimulation (DCS) is considered the gold-standard for functional cortical mapping during awake surgery for brain tumor resection. DCS is performed by stimulating one local cortical area at a time. We present a feasibility study using an intra-operative technique aimed at improving our ability to map brain functions which rely on activity in distributed cortical regions. Following standard DCS, Multi-Site Stimulation (MSS) was performed in 15 patients by applying simultaneous cortical stimulations at multiple locations. Language functioning was chosen as a case-cognitive domain due to its relatively well-known cortical organization. MSS, performed at sites that did not produce disruption when applied in a single stimulation point, revealed additional language dysfunction in 73% of the patients. Functional regions identified by this technique were presumed to be significant to language circuitry and were spared during surgery. No new neurological deficits were observed in any of the patients following surgery. Though the neuro-electrical effects of MSS need further investigation, this feasibility study may provide a first step towards sophistication of intraoperative cortical mapping.	[Gonen, Tal; Korn, Akiva; Ram, Zvi] Tel Aviv Med Ctr & Sch Med, Dept Neurosurg, Tel Aviv, Israel; [Gonen, Tal; Gazit, Tomer; Kirschner, Adi; Perry, Daniella; Hendler, Talma] Tel Aviv Med Ctr & Sch Med, Tel Aviv Ctr Brain Funct, Tel Aviv, Israel; [Gonen, Tal; Hendler, Talma] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel; [Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hendler, Talma; Ram, Zvi] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Ram, Z (corresponding author), Tel Aviv Med Ctr & Sch Med, Dept Neurosurg, Tel Aviv, Israel.; Ram, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	zviram@tasmc.health.gov.il			European Union ACTIVE grant [FP7-ICT-2009-270460]; Israel Cancer Association; BRAIN division grant TLVMC	European Union ACTIVE grant; Israel Cancer Association; BRAIN division grant TLVMC	This research has been partly supported by the European Union ACTIVE grant (FP7-ICT-2009-270460), the Israel Cancer Association and by the BRAIN division grant TLVMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER MS, 1992, STEREOT FUNCT NEUROS, V58, P153, DOI 10.1159/000098989; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005; De Benedictis A, 2010, NEUROSURGERY, V66, P1074, DOI 10.1227/01.NEU.0000369514.74284.78; Duffau H., 2013, BRAIN LANGUAGE; Eickhoff SB, 2009, PHILOS T R SOC A, V367, P2399, DOI 10.1098/rsta.2008.0287; Gazit T, 2016, J NEUROSURG, P1; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Gonen T, 2017, WORLD NEUROSURG, V99, P674, DOI 10.1016/j.wneu.2016.12.081; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kombos T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09141; Nathan SS, 1993, CLIN NEUROPHYSIOL, V86, P183, DOI [10.1016/0013-4694(93)90006-H, DOI 10.1016/0013-4694(93)90006-H]; Nossek E, 2013, J NEUROSURG, V118, P243, DOI 10.3171/2012.10.JNS12511; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Ojemann GA, 1979, SCIENCE; Penfield W., 1937, BRAIN J NEUROLOGY; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Saur D, 2010, NEUROIMAGE, V49, P3187, DOI 10.1016/j.neuroimage.2009.11.009; Shetreet E, 2009, NEUROIMAGE, V48, P707, DOI 10.1016/j.neuroimage.2009.07.001; Sole RV, 2010, COMPLEXITY, V15, P20, DOI 10.1002/cplx.20305; Souffache B, 2010, J APPL GEOPHYS, V71, P6, DOI 10.1016/j.jappgeo.2010.01.009; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180740	10.1371/journal.pone.0180740	http://dx.doi.org/10.1371/journal.pone.0180740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700619	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800071
J	Krol, ME; Krol, M				Krol, Magdalena Ewa; Krol, Michal			The trickle-down effect of predictability: Secondary task performance benefits from predictability in the primary task	PLOS ONE			English	Article							VISUAL-SEARCH; ATTENTIONAL CONTROL; CAPTURE ATTENTION; MEMORY; VISION; EXPERTISE; STIMULI; REPRESENTATIONS; REGULARITIES; PERCEPTION	Predictions optimize processing by reducing attentional resources allocation to expected or predictable sensory data. Our study demonstrates that these saved processing resources can be then used on concurrent stimuli, and in consequence improve their processing and encoding. We illustrate this ''trickle-down'' effect with a dual task, where the primary task varied in terms of predictability. The primary task involved detection of a pre-specified symbol that appeared at some point of a short video of a dot moving along a random, semipredictable or predictable trajectory. The concurrent secondary task involved memorization of photographs representing either emotionally neutral or non-neutral (social or threatening) content. Performance in the secondary task was measured by a memory test. We found that participants allocated more attention to unpredictable (random and semi-predictable) stimuli than to predictable stimuli. Additionally, when the stimuli in the primary task were more predictable, participants performed better in the secondary task, as evidenced by higher sensitivity in the memory test. Finally, social or threatening stimuli were allocated more ''looking time'' and a larger number of saccades than neutral stimuli. This effect was stronger for the threatening stimuli than social stimuli. Thus, predictability of environmental input is used in optimizing the allocation of attentional resources, which trickles-down and benefits the processing of concurrent stimuli.	[Krol, Magdalena Ewa] SWPS Univ Social Sci & Human Wroclaw, Wroclaw Fac Psychol, Wroclaw, Poland; [Krol, Michal] Univ Manchester, Sch Social Sci, Dept Econ, Manchester, Lancs, England	SWPS University of Social Sciences & Humanities; University of Manchester	Krol, ME (corresponding author), SWPS Univ Social Sci & Human Wroclaw, Wroclaw Fac Psychol, Wroclaw, Poland.	mkrol1@swps.edu.pl	Król, Magdalena E/G-2412-2018; Krol, Michal/AAH-7963-2020	Król, Magdalena E/0000-0002-7951-1537; Krol, Michal/0000-0002-5512-214X	National Science Centrein Poland [2013/11/D/HS6/04683]	National Science Centrein Poland	This work was supported by the National Science Centrein Poland (https://www.ncn.gov.pl/) under Grant 2013/11/D/HS6/04683 (awarded to MEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Becker MW, 2007, J EXP PSYCHOL HUMAN, V33, P20, DOI 10.1037/0096-1523.33.1.20; Beilock SL, 2004, PSYCHON B REV, V11, P373, DOI 10.3758/BF03196585; Beilock SL, 2002, Q J EXP PSYCHOL-A, V55, P1211, DOI 10.1080/02724980244000170; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; Castelhano MS, 2007, J EXP PSYCHOL HUMAN, V33, P753, DOI 10.1037/0096-1523.33.4.753; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Cole GG, 2004, J EXP PSYCHOL HUMAN, V30, P464, DOI 10.1037/0096-1523.30.3.464; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Donaldson MJ, 2016, ATTEN PERCEPT PSYCHO, V78, P1901, DOI 10.3758/s13414-016-1185-5; Downing PE, 2004, COGNITION, V93, pB27, DOI 10.1016/j.cognition.2003.10.010; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Egloff B, 2003, PERS INDIV DIFFER, V35, P475, DOI 10.1016/S0191-8869(02)00265-9; Findlay J.M., 2003, PSYCHOL LOOKING SEEI; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; GIBSON JJ, 1966, THE SENSES CONSIDERE; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hutchinson JB, 2012, TRENDS COGN SCI, V16, P576, DOI 10.1016/j.tics.2012.10.003; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; JOHNSTON WA, 1990, J EXP PSYCHOL GEN, V119, P397, DOI 10.1037/0096-3445.119.4.397; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krol M, 2017, COGN PROCESS, P1; Lang P.J., 2008, TECHNICAL REPORT; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Ludwig CJH, 2003, PERCEPT PSYCHOPHYS, V65, P1243, DOI 10.3758/BF03194849; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Neider MB, 2006, VISION RES, V46, P614, DOI 10.1016/j.visres.2005.08.025; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pratt J, 2010, PSYCHOL SCI, V21, P1724, DOI 10.1177/0956797610387440; Schwarz KA, 2016, TRENDS COGN SCI, V20, P469, DOI 10.1016/j.tics.2016.04.001; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TSOTSOS JK, 1990, BEHAV BRAIN SCI, V13, P423, DOI 10.1017/S0140525X00079577; Tsotsos JK, 1997, CONSCIOUS COGN, V6, P429, DOI 10.1006/ccog.1997.0302; Umemoto A, 2010, J EXP PSYCHOL HUMAN, V36, P1419, DOI 10.1037/a0019324; Van Damme S, 2008, EMOTION, V8, P820, DOI 10.1037/a0014149; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zhao JY, 2013, PSYCHOL SCI, V24, P667, DOI 10.1177/0956797612460407	47	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180573	10.1371/journal.pone.0180573	http://dx.doi.org/10.1371/journal.pone.0180573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700673	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800055
J	McDonnell, C; Leanez, S; Pol, O				McDonnell, Christina; Leanez, Sergi; Pol, Olga			The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice	PLOS ONE			English	Article							MEDIATES MECHANICAL ALLODYNIA; IMPROVES INSULIN SENSITIVITY; SPINAL NITRIC-OXIDE; HEME OXYGENASE 1; NEUROPATHIC PAIN; MOUSE MODEL; KEAP1-NRF2 SYSTEM; RATS; ACTIVATION; MELLITUS	The involvement of heme oxygenase 1 (HO-1) in the modulation of the antinociceptive effects of opioids in type 1 diabetes has been demonstrated but the role played by the transcription factor Nrf2 in the regulation of painful neuropathy and in the effects and expression of d-opioid receptors (DOR) in type 2 diabetes, has not been studied. In male BKS. Cg-m+/+Leprdb/J (db/db) mice, the anti-allodynic effects produced by a Nrf2 transcription factor activator, sulforaphane (SFN) administered alone and combined with two DOR agonists, [dPen( 2), d-Pen(5)]-Enkephalin (DPDPE) and (+)-4-[(aR)-a-((2S, 5R)-4-Allyl-2,5-dimethyl-1piperazinyl)-3-methoxybenzyl]-N, N diethylbenzamide (SNC-80), were evaluated. The effects of SFN on glucose levels and body weight as well as on the proteins levels of Nrf2, HO-1, NAD(P) H: quinone oxidoreductase 1 (NQO1), MAPKs (JNK) and DOR in sciatic nerve from db/db mice were also assessed. This study showed that the administration of SFN dose dependently reversed mechanical allodynia, reduced hyperglycemia and body weight gain associated to type 2 diabetes and significantly increased the anti-allodynic effects of DPDPE and SNC-80 in db/db mice. This treatment normalized the down regulation of Nrf2 and NQO1 and enhanced the protein levels of HO-1 in db/db mice. Moreover, the administration of SFN also inhibited the JNK phosphorylation and DOR down-regulation in the sciatic nerve of diabetic mice. Our data indicated that SFN treatment is effective in reversing mechanical allodynia and enhancing DOR antinociceptive effects in db/db mice which effects might be mediated by activating Nrf2 signaling, reducing hyperglycemia, inhibiting JNK phosphorylation and avoiding DOR down-regulation in the sciatic nerve of these animals. These results propose SFN, alone and/or combined with DOR agonists, as interesting approaches for the treatment of painful diabetic neuropathy associated to type 2 diabetes in mice.	[McDonnell, Christina; Leanez, Sergi; Pol, Olga] Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, Barcelona, Spain; [McDonnell, Christina; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain	Autonomous University of Barcelona	Pol, O (corresponding author), Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, Barcelona, Spain.; Pol, O (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain.	opol@santpau.es	Pol, Olga/O-2146-2019	Pol, Olga/0000-0002-4621-8457	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER); Union Europea [PI1400927]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER); Union Europea	This work was supported by Ministerio de Economia y Competitividad, Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Union Europea [Grant: PI1400927]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine T, 2015, J PHARMACOL EXP THER, V354, P65, DOI 10.1124/jpet.115.223891; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Carcole M, 2014, J PHARMACOL EXP THER, V351, P224, DOI 10.1124/jpet.114.215681; Castany S, 2016, NEUROSCI LETT, V614, P49, DOI 10.1016/j.neulet.2015.12.059; Castany S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146427; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2003, ANESTHESIOLOGY, V98, P217, DOI 10.1097/00000542-200301000-00033; Cheng HT, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-28; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Courteix C, 1998, J PHARMACOL EXP THER, V285, P63; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Gou G, 2014, EUR J PHARMACOL, V737, P41, DOI 10.1016/j.ejphar.2014.05.004; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; KAMEI J, 1992, BRAIN RES, V571, P199, DOI 10.1016/0006-8993(92)90655-S; Khan GM, 2002, J PHARMACOL EXP THER, V303, P1021, DOI 10.1124/jpet.102.040865; Kiguchi N, 2017, BBA-MOL BASIS DIS, V1863, P274, DOI 10.1016/j.bbadis.2016.10.007; Kong Q, 2012, NEURAL REGEN RES, V7, P2305, DOI 10.3969/j.issn.1673-5374.2012.29.010; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Li M, 2007, CELL CYCLE, V6, P567, DOI 10.4161/cc.6.5.3917; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; Ndisang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087936; Negi G, 2011, CURR NEUROVASC RES, V8, P294, DOI 10.2174/156720211798120972; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohsawa M, 2000, EUR J PHARMACOL, V401, P55, DOI 10.1016/S0014-2999(00)00408-8; Patrick BA, 2012, FREE RADICAL BIO MED, V53, P1886, DOI 10.1016/j.freeradbiomed.2012.08.584; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Saito T, 2015, ANESTHESIOLOGY, V123, P1420, DOI 10.1097/ALN.0000000000000892; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Shen Y, 2015, NEUROBIOL DIS, V79, P100, DOI 10.1016/j.nbd.2015.04.012; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Tian RF, 2016, EUR J PHARMACOL, V771, P84, DOI 10.1016/j.ejphar.2015.12.021; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Xu X, 2014, NEUROSCI BULL, V30, P53, DOI 10.1007/s12264-013-1387-y; Yeo SH, 2013, TOXICOL LETT, V219, P35, DOI 10.1016/j.toxlet.2013.02.013; Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005; Zhou JY, 2014, MOL NEUROBIOL, V49, P536, DOI 10.1007/s12035-013-8537-0	42	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180998	10.1371/journal.pone.0180998	http://dx.doi.org/10.1371/journal.pone.0180998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700700	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800111
J	Peng, XY; Jiang, LP; Chen, C; Qin, Y; Yuan, T; Wang, O; Xing, XP; Li, XM; Nie, M; Chen, LM				Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Yuan, Tao; Wang, Ou; Xing, Xiaoping; Li, Xuemei; Nie, Min; Chen, Limeng			Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome	PLOS ONE			English	Article							CYCLOOXYGENASE-2; PATHOPHYSIOLOGY; INHIBITION; PHENOTYPE	Background Gitelman syndrome (GS), an inherited autosomal recessive salt-losing renal tubulopathy caused by mutations in SLC12A3 gene, has been associated with normal prostaglandin E2 (PGE2) levels since 1995 by a study involving 11 clinically diagnosed patients. However, it is difficult to explain why cyclooxygenase-2 (COX2) inhibitors, which pharmacologically reduce PGE2 synthesis, are helpful to patients with GS, and few studies performed in the last 20 years have measured PGE2 levels. The relationships between the clinical manifestations and PGE2 levels were never thoroughly analyzed. Methods This study involved 39 GS patients diagnosed by SLC12A3 gene sequencing. Plasma and 24-h urine samples as well as the clinical data were collected at admission. PGE2 and PGEM levels were detected in plasma and urine samples by enzyme immunoassays. The in vivo function of the sodium-chloride co-transporter (NCC) in GS patients was evaluated using a modified thiazide test. The association among PGE2 levels, clinical manifestations and the function of NCC in GS patients were analyzed. Results Significantly higher levels of urinary and plasma PGEM were observed in GS patients than in the healthy volunteers. Higher urinary PGEM levels indicated more severe clinical manifestations and NCC dysfunction estimated by the increase of Cl- clearance. A higher PGEM level was found in male GS patients, who showed earlier onset age and more severe hypokalemia, hypochloremia and metabolic alkalosis than female GS patients. No relationship between renin angiotensin aldosterone system activation and PGEM level was observed. Conclusions Higher urinary PGEM levels indicated more severe clinical manifestations and NCC dysfunction in GS patients. COX2 inhibition might be a potential therapeutic target in GS patients with elevated PGEM levels.	[Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Li, Xuemei; Chen, Limeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China; [Peng, Xiaoyan; Jiang, Lanping; Chen, Chen; Qin, Yan; Yuan, Tao; Wang, Ou; Xing, Xiaoping; Li, Xuemei; Nie, Min; Chen, Limeng] Peking Union Med Coll, Beijing, Peoples R China; [Chen, Chen] Cent South Univ, Xiangya Hosp, Dept Pediat, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Yuan, Tao; Wang, Ou; Xing, Xiaoping; Nie, Min] Chinese Acad Med Sci, Peking Union Med Coll, Natl Hlth & Family Planning Commiss, Dept Endocrinol, Beijing, Peoples R China; [Yuan, Tao; Wang, Ou; Xing, Xiaoping; Nie, Min] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Key Lab Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, LM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China.; Chen, LM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	chenlimeng@pumch.cn			Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2016-I2M-2-004]; Xiehe Scholar Professor grant of Peking Union Medical College; National Natural Scientific Foundation, China [81470937, 81641024]; Capital Specialized Clinical Application Project [Z121107001012139]	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; Xiehe Scholar Professor grant of Peking Union Medical College; National Natural Scientific Foundation, China(National Natural Science Foundation of China (NSFC)); Capital Specialized Clinical Application Project	This work was partly supported by (1) Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-2-004 to CL), URL: http://english.cams.cn/index.html; (2) Xiehe Scholar Professor grant of Peking Union Medical College (to CL), URL: http://english.cams.cn/index.html; (3) National Natural Scientific Foundation, China (81470937, 81641024 to CL), URL: http://www.nsfc.gov.cn/publish/portal1/; (4) the Capital Specialized Clinical Application Project (Z121107001012139 to CL), URL: http://www.bjkw.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Shibli Amar, 2015, World J Methodol, V5, P55, DOI 10.5662/wjm.v5.i2.55; Arai Y, 2014, INFLAMM BOWEL DIS, V20, P1208, DOI 10.1097/MIB.0000000000000062; Blanchard A, 2017, KIDNEY INT, V91, P24, DOI 10.1016/j.kint.2016.09.046; Blanchard A, 2015, J AM SOC NEPHROL, V26, P468, DOI 10.1681/ASN.2014030293; Deschenes G, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/396209; DUNN MJ, 1981, KIDNEY INT, V19, P86, DOI 10.1038/ki.1981.12; Grill A, 2016, ACTA PHYSL; Jeck N, 2005, AM J PHYSIOL-REG I, V288, pR782, DOI 10.1152/ajpregu.00600.2004; Jiang LP, 2015, ENDOCR PRACT, V21, P1017, DOI 10.4158/EP14432.OR; Jiang LP, 2014, AM J NEPHROL, V39, P357, DOI 10.1159/000360773; Kammerl MC, 2001, KIDNEY INT, V60, P1684, DOI 10.1046/j.1523-1755.2001.00988.x; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Komhoff M, 2004, PEDIATR RES, V55, P261, DOI 10.1203/01.PDR.0000101747.09626.6B; Larkins N, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu029; Lauridsen TG, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-28; Liaw LCT, 1999, ARCH DIS CHILD, V81, P508, DOI 10.1136/adc.81.6.508; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; LUTHY C, 1995, AM J KIDNEY DIS, V25, P824, DOI 10.1016/0272-6386(95)90563-4; Martin-Miguel V, 2014, Semergen, V40, pe95, DOI 10.1016/j.semerg.2013.03.003; Nasrallah R, 2015, LAB INVEST, V95, P1044, DOI 10.1038/labinvest.2015.79; NIVET H, 1978, LANCET, V1, P333; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Onem Y, 2008, RENAL FAILURE, V30, P691, DOI 10.1080/08860220802212718; Peng Xiao-yan, 2016, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V38, P275, DOI 10.3881/j.issn.1000-503X.2016.03.006; Peters M, 2002, AM J MED, V112, P183, DOI 10.1016/S0002-9343(01)01086-5; Peti-Peterdi J, 2013, PFLUG ARCH EUR J PHY, V465, P53, DOI 10.1007/s00424-012-1130-y; Qu Ling, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P432; Seyberth HW, 2016, PEDIATR NEPHROL, V31, P407, DOI 10.1007/s00467-015-3143-1; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Seys E, 2017, J AM SOC NEPHROL; Soleimani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159804; Tseng MH, 2012, J CLIN ENDOCR METAB, V97, pE1478, DOI 10.1210/jc.2012-1707; Tuhta GA, 2010, J NEPHROL, V23, P617; Wang F, 2016, CLIN EXP NEPHROL; Yang Guo-qing, 2006, Zhonghua Nei Ke Za Zhi, V45, P650; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118004	36	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180811	10.1371/journal.pone.0180811	http://dx.doi.org/10.1371/journal.pone.0180811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700713	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800081
J	Huang, YH; Yeh, CH; Cheng, NM; Lin, CY; Wang, HM; Ko, SF; Toh, CH; Yen, TC; Liao, CT; Ng, SH				Huang, Yu-Han; Yeh, Chih-Hua; Cheng, Nai-Ming; Lin, Chien-Yu; Wang, Hung-Ming; Ko, Sheung-Fat; Toh, Cheng-Hong; Yen, Tzu-Chen; Liao, Chun-Ta; Ng, Shu-Hang			Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC DENSITY; CISPLATIN-BASED CHEMOTHERAPY; NECK-CANCER; LYMPH-NODES; HEAD; AREA; EXPRESSION; SURVIVAL; TAIWAN	Objectives We investigated the relationships of cystic nodal metastasis, human papillomavirus (HPV) status, and treatment failure patterns in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with chemoradiotherapy. Methods We retrospectively reviewed pretreatment MRI and clinical courses of patients with OPSCC whose tumors were tested for HPV-induced p16 expression via immunohistochemistry and who completed chemoradiotherapy. Cervical cystic nodal metastasis and necrotic nodal metastasis were classified on MRI. Results Of 98 patients eligible for analysis, 33 were p16-positive. Cystic nodal metastasis was significantly more prevalent in p16-positive than in p16-negative patients (39.4% versus 18.5%, respectively; p = 0.025). Necrotic nodal metastasis was significantly more prevalent in p16-negative than in p16-positive patients (73.8% versus 51.5%, respectively; p = 0.027). On multivariate analysis, necrotic nodal metastasis (odds ratio [OR] = 7.310, p = 0.011) was an independent predictor of regional failure, while advanced nodal stage (OR = 4.119, p = 0.022) and cystic nodal metastases (OR = 0.087, p = 0.026) were independent positive and negative predictors of distant failure, respectively. Conclusions Cervical cystic and necrotic nodal metastases are associated with HPV-induced p16-positive and p16-negative OPSCC, respectively. Patients with necrotic nodal metastasis at presentation have an increased risk of regional failure. Distant failure is directly and inversely correlated with advanced nodal stage and cystic nodal metastasis, respectively.	[Huang, Yu-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, Taipei, Taiwan; [Yeh, Chih-Hua; Cheng, Nai-Ming; Toh, Cheng-Hong; Yen, Tzu-Chen; Ng, Shu-Hang] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan; [Yeh, Chih-Hua; Ko, Sheung-Fat; Toh, Cheng-Hong; Ng, Shu-Hang] Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Cheng, Nai-Ming; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Lin, Chien-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Liao, Chun-Ta] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan	Taipei Medical University; Shuang Ho Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Ng, SH (corresponding author), Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan.; Ng, SH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan.	shuhangng@gmail.com	Yeh, Chih-Hua/N-5165-2018	Yeh, Chih-Hua/0000-0001-6988-8739; Toh, Cheng Hong/0000-0002-8871-5101; Ng, Shu-Hang/0000-0002-1842-6179	National Science Council-Taiwan [NSC102-2314-B-182A-098-MY2]	National Science Council-Taiwan(Ministry of Science and Technology, Taiwan)	This study was partially supported by a grant from the National Science Council-Taiwan (NSC102-2314-B-182A-098-MY2).	Amin MB, 2017, AJCC CANC STAGING MA; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Cantrell SC, 2013, AM J NEURORADIOL, V34, P2005, DOI 10.3174/ajnr.A3524; Chien CY, 2008, ORAL ONCOL, V44, P174, DOI 10.1016/j.oraloncology.2007.01.018; Corey A, 2013, NEUROIMAG CLIN N AM, V23, P47, DOI 10.1016/j.nic.2012.08.005; El-Naggar AK, 2012, HEAD NECK-J SCI SPEC, V34, P459, DOI 10.1002/hed.21974; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Goldenberg D, 2008, HEAD NECK-J SCI SPEC, V30, P898, DOI 10.1002/hed.20796; Ho PS, 2002, J ORAL PATHOL MED, V31, P213, DOI 10.1034/j.1600-0714.2002.310404.x; Jaju S, 2014, J CANCER RES THER, V10, P284, DOI 10.4103/0973-1482.136566; JANOT F, 1993, HEAD NECK-J SCI SPEC, V15, P222, DOI 10.1002/hed.2880150309; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Mirghani H, 2014, ORAL ONCOL, V50, P1, DOI 10.1016/j.oraloncology.2013.10.008; Mokhtari S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-6; Morani AC, 2013, J COMPUT ASSIST TOMO, V37, P343, DOI 10.1097/RCT.0b013e318282d7c3; MUNCK JN, 1991, J NATL CANCER I, V83, P569, DOI 10.1093/jnci/83.8.569; Okami K, 2016, INT J CLIN ONCOLOGY; Regauer S, 1999, BRIT J CANCER, V79, P1437, DOI 10.1038/sj.bjc.6690229; Regauer S, 2000, HUM PATHOL, V31, P1096, DOI 10.1053/hupa.2000.6279; Thompson LDR, 1998, CANCER, V82, P944, DOI 10.1002/(SICI)1097-0142(19980301)82:5<944::AID-CNCR21>3.0.CO;2-#; Vergeer MR, 2006, RADIOTHER ONCOL, V79, P39, DOI 10.1016/j.radonc.2006.03.008; VERMAN K, 1995, ACTA CYTOL, V39, P478; Wang HM, 1996, CANCER, V78, P1972, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1972::AID-CNCR19>3.0.CO;2-V; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wilson L, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-19	26	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180779	10.1371/journal.pone.0180779	http://dx.doi.org/10.1371/journal.pone.0180779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686646	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100102
J	Murphy, SF; Stallard, RF; Scholl, MA; Gonzalez, G; Torres-Sanchez, AJ				Murphy, Sheila F.; Stallard, Robert F.; Scholl, Martha A.; Gonzalez, Grizelle; Torres-Sanchez, Angel J.			Reassessing rainfall in the Luquillo Mountains, Puerto Rico: Local and global ecohydrological implications	PLOS ONE			English	Article							EXPERIMENTAL FOREST; LONG-TERM; OROGRAPHIC PRECIPITATION; CLIMATE-CHANGE; SOUTHERN ALPS; LAND-COVER; WATER; EVAPOTRANSPIRATION; STREAMFLOW; GRADIENTS	Mountains receive a greater proportion of precipitation than other environments, and thus make a disproportionate contribution to the world's water supply. The Luquillo Mountains receive the highest rainfall on the island of Puerto Rico and serve as a critical source of water to surrounding communities. The area's role as a long-term research site has generated numerous hydrological, ecological, and geological investigations that have been included in regional and global overviews that compare tropical forests to other ecosystems. Most of the forest-and watershed-wide estimates of precipitation (and evapotranspiration, as inferred by a water balance) have assumed that precipitation increases consistently with elevation. However, in this new analysis of all known current and historical rain gages in the region, we find that similar to other mountainous islands in the trade wind latitudes, leeward (western) watersheds in the Luquillo Mountains receive lower mean annual precipitation than windward (eastern) watersheds. Previous studies in the Luquillo Mountains have therefore overestimated precipitation in leeward watersheds by up to 40%. The Icacos watershed, however, despite being located at elevations 200 - 400 m below the tallest peaks and to the lee of the first major orographic barrier, receives some of the highest precipitation. Such lee-side enhancement has been observed in other island mountains of similar height and width, and may be caused by several mechanisms. Thus, the long-reported discrepancy of unrealistically low rates of evapotranspiration in the Icacos watershed is likely caused by previous underestimation of precipitation, perhaps by as much as 20%. Rainfall/runoff ratios in several previous studies suggested either runoff excess or runoff deficiency in Luquillo watersheds, but this analysis suggests that in fact they are similar to other tropical watersheds. Because the Luquillo Mountains often serve as a wet tropical archetype in global assessments of basic ecohydrological processes, these revised estimates are relevant to regional and global assessments of runoff efficiency, hydrologic effects of reforestation, geomorphic processes, and climate change.	[Murphy, Sheila F.; Stallard, Robert F.] US Geol Survey, Boulder, CO 80303 USA; [Scholl, Martha A.] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA; [Gonzalez, Grizelle] US Forest Serv, USDA, Int Inst Forestry, Rio Piedras, PR USA; [Torres-Sanchez, Angel J.] US Geol Survey, Guaynabo, PR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey	Murphy, SF (corresponding author), US Geol Survey, Boulder, CO 80303 USA.	sfmurphy@usgs.gov		Murphy, Sheila/0000-0002-5481-3635; Gonzalez, Grizelle/0000-0003-3007-5540	United States Geological Survey National Research Program; United States Geological Survey Climate Mission Area's Research and Development Program; National Science Foundation [DEB-0218039, 1239764, EAR-1331841]; Division Of Earth Sciences [1331841] Funding Source: National Science Foundation; Division Of Environmental Biology [1546686] Funding Source: National Science Foundation	United States Geological Survey National Research Program; United States Geological Survey Climate Mission Area's Research and Development Program(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States Geological Survey National Research Program, https://www.usgs.gov/ (SFM, RFS, MAS); United States Geological Survey Climate Mission Areas Research and Development Program, https://www.usgs.gov/ (SFM, RFS, MAS, AJT); National Science Foundation grants to the Luquillo Long-Term Ecological Research Site DEB-0218039 and 1239764 (GG); National Science Foundation grant to the Luquillo Critical Zone Observatory EAR-1331841 (GG, MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; [Anonymous], THESIS; [Anonymous], 2003, INT J CLIMATOLOGY, V23, P1359; ASBURY CE, 1994, ATMOS ENVIRON, V28, P1773, DOI 10.1016/1352-2310(94)90139-2; Austin GL, 2006, ENCY HYDROLOGICAL SC, V3, P1; Baldocchi DD, 2011, ECOL STUD-ANAL SYNTH, V216, P101, DOI 10.1007/978-94-007-1363-5_5; Barker BS, 2015, ECOGRAPHY, V38, P769, DOI 10.1111/ecog.01327; Bassiouni M, 2017, AGR FOREST METEOROL, V243, P100, DOI 10.1016/j.agrformet.2017.04.010; Bawiec W., 1999, 9838 US GEOL SURV; Beck HE, 2013, HYDROL EARTH SYST SC, V17, P2613, DOI 10.5194/hess-17-2613-2013; Beck HE, 2013, WATER RESOUR RES, V49, P7843, DOI 10.1002/2013WR013918; Bogart DB, 1964, US GEOLOGICAL SURVEY, V4; Briscoe C., 1966, ITF3 USDA FOR SERV I; Brocard GY, 2016, J GEOPHYS RES-EARTH, V121, P1182, DOI 10.1002/2015JF003678; Brocard GY, 2015, APPL GEOCHEM, V63, P586, DOI 10.1016/j.apgeochem.2015.04.001; Brokaw N., 2012, CARIBBEAN FOREST TAP, DOI 10.1093/acprof:osobl/9780195334692.001.0001; Brown S., 1983, SO44 USDA FOR SERV S; Browning K. A., 1981, Weather, V36, P326, DOI 10.1002/j.1477-8696.1981.tb05354.x; Bruijnzeel LA, 2011, HYDROL PROCESS, V25, P465, DOI 10.1002/hyp.7974; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Calvesbert RJ, 1970, CLIMATE PUERTO RICO; Chater AM, 1998, INT J CLIMATOL, V18, P77, DOI 10.1002/(SICI)1097-0088(199801)18:1<77::AID-JOC218>3.0.CO;2-M; Colle B.A., 2013, MOUNTAIN WEAR RES, P291, DOI [DOI 10.1007/978-94-007-4098-3_6, https://doi.org/10.1007/978-94-007-4098-3_6]; Comarazamy DE, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015414; Crook KE, 2004, IITFGTR34 USDA FOR S; Daley R., 1991, ATMOSPHERIC DATA ANA; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2017, INT J CLIMATOLOGY; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Ewel J.J., 1973, ECOLOGICAL LIFE ZONE; Falcone J.A., 2011, GAGES 2 GEOSPATIAL A, DOI [10.3133/70046617, DOI 10.3133/70046617]; Farrick KK, 2013, HYDROL PROCESS, V27, P3254, DOI 10.1002/hyp.9935; Ferguson PR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008431; Funk C, 2004, J APPL METEOROL, V43, P1366, DOI 10.1175/JAM2138.1; Garcia-Martino A.R., 1996, CARIBB J SCI, V32, P413; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; GIUSTI E V, 1967, Caribbean Journal of Science, V7, P87; Giusti EV, 1978, 1012 US GEOL SURV; GLM Engineering, MEAN ANN RAINF MAP P; Gonzalez G., 2013, ECOLOGICAL GRADIENT; Gould WA, 2008, PUERTO RICO GAP ANAL; Harmsen E.W., 2008, INT J SYST APPL ENG, V2, P91; Harris N.L., 2012, LUQUILLO EXPT FOREST; Hayhoe K., 2013, QUNTIFYING KEY DRIVE; Heartsill-Scalley T, 2007, J HYDROL, V333, P472, DOI 10.1016/j.jhydrol.2006.09.019; Helsel D, 2002, A3 US GEOL SURV, VA3; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Holben B, 1979, CEERT40 U PUERT RIC, P57; Holwerda F, 2006, J HYDROL, V327, P592, DOI 10.1016/j.jhydrol.2005.12.014; Holwerda F, 2012, J HYDROL, V414, P1, DOI 10.1016/j.jhydrol.2011.07.033; Houze RA, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000365; Hovind, 1964, J APPL METEOROL, V3, P235; Karmalkar AV, 2013, ATMOSFERA, V26, P283, DOI 10.1016/S0187-6236(13)71076-2; Khalyani AH, 2016, J APPL METEOROL CLIM, V55, P265, DOI 10.1175/JAMC-D-15-0182.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Kurtz AC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009853; LARSEN MC, 1998, 3 INT S WAT RES K CA, P199; Luquillo Critical Zone Observatory, LUQ MOUNT SPAT DAT; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; MCDOWELL WH, 1994, LIMNOL OCEANOGR, V39, P111, DOI 10.4319/lo.1994.39.1.0111; Meyerhoff HA, 1931, SCI SURVEY PORTO R 3, VII, P201; Moore S, 2013, NATURE, V493, P660, DOI 10.1038/nature11818; Murphy S.F, 2006, STATE WATERSHED WATE; Murphy SF, 1998, GEOCHIM COSMOCHIM AC, V62, P227, DOI 10.1016/S0016-7037(97)00336-0; Murphy SF, 2012, US GEOLOGICAL SURVEY, V1789, P292; Murphy SF, 2012, WATER QUALITY LANDSC, P48; Murphy SF, 2003, COMPREHENSIVE WATER, P5; National Aeronautics and Space Administration, TROP RAINF MEAS MISS; National Aeronautics and Space Administration, ADV SPAC THERM EM RE; National Oceanic and Atmospheric Administration National Weather Service, ADV HYDR PRED SERV; National Weather Service, 2016, MEAN ANN RAINF PUERT; Odum H. T., 1970, TROPICAL RAIN FOREST; Odum HT, 1970, TROPICAL RAIN FOREST, pB347; Ohte N, 2011, ECOL STUD-ANAL SYNTH, V216, P261, DOI 10.1007/978-94-007-1363-5_12; Padron RS, 2015, J HYDROMETEOROL, V16, P985, DOI 10.1175/JHM-D-14-0135.1; Peters NE, 2006, SCI TOTAL ENVIRON, V358, P221, DOI 10.1016/j.scitotenv.2005.04.044; Porder S, 2015, GEODERMA, V249, P100, DOI 10.1016/j.geoderma.2015.03.002; Post DA, 2001, ADV WATER RESOUR, V24, P1195, DOI 10.1016/S0309-1708(01)00036-7; Puerto Rico Climate Change Council, 2013, STAT PUERT RIC CLIM; Ralph FM, 2003, J HYDROMETEOROL, V4, P1243, DOI 10.1175/1525-7541(2003)004<1243:TIOAPR>2.0.CO;2; Ramirez-Beltran Nazario D., 2008, WSEAS Transactions on Systems, V7, P1016; Ramseyer CA, 2016, CLIM DYNAM, V47, P2515, DOI 10.1007/s00382-016-2980-3; Rauber RM, 2007, B AM METEOROL SOC, V88, P1912, DOI 10.1175/BAMS-88-12-1912; ROBERTS JM, 2005, INT HYDROL SER, P287; Roberts JM, 2009, FORESTS FOREST PLANT; Robinson M., 2005, ENCY HYDROLOGICAL SC, P537, DOI DOI 10.1002/0470848944.HSA039; Roe GH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001521; Rollenbeck R, 2007, J ATMOS OCEAN TECH, V24, P156, DOI 10.1175/JTECH1970.1; Rossi MW, 2016, J GEOPHYS RES-EARTH, V121, P128, DOI 10.1002/2015JF003446; Ryu Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2011GB004053; Scalley TH, 2012, J TROP ECOL, V28, P127, DOI 10.1017/S0266467411000733; Scatena F. N., 1990, Tropical hydrology and Caribbean water resources. Proceedings of the International symposium on tropical hydrology and Fourth Caribbean Islands Water Resources Congress., P237; Schellekens J, 2000, WATER RESOUR RES, V36, P2183, DOI 10.1029/2000WR900074; Schellekens J, 2000, PHYS CHEM EARTH PT B, V25, P659, DOI 10.1016/S1464-1909(00)00081-2; Schellekens J, 1998, PORTRAIT AM JEWISH C, P29; Scholl MA, 2014, WATER RESOUR RES, V50, P4305, DOI 10.1002/2013WR014413; Sevruk B., 2005, ENCY HYDROLOGICAL SC, P1; Sharples JJ, 2005, J APPL METEOROL, V44, P1850, DOI 10.1175/JAM2289.1; Sinclair MR, 1997, J APPL METEOROL, V36, P428, DOI 10.1175/1520-0450(1997)036<0428:FATDAS>2.0.CO;2; Smith RB, 2012, B AM METEOROL SOC, V93, P1567, DOI 10.1175/BAMS-D-11-00194.1; Snyder N. F. R., 1987, PARROTS LUQUILLO NAT; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; STALLARD RF, 1995, ANNU REV EARTH PL SC, V23, P11, DOI 10.1146/annurev.ea.23.050195.000303; Stocks G, 2008, BIOTROPICA, V40, P397, DOI 10.1111/j.1744-7429.2007.00393.x; Taylor MA, 2013, INT J CLIMATOL, V33, P784, DOI 10.1002/joc.3461; U. S. Geological Survey, USGS WAT DAT NAT; U. S. Geological Survey, USGS NAT EL DAT NED; University of Hawaii at Manoa, SHOR IM HAW ISL 2016; Van Beusekom AE, 2017, ATMOSPHERIC CHEM PHY; Van Beusekom AE, 2016, INT J CLIMATOL, V36, P3370, DOI 10.1002/joc.4560; Van Beusekom AE, 2014, J AM WATER RESOUR AS, V50, P1575, DOI 10.1111/jawr.12227; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; Wadsworth FH, 1970, TROPICAL RAINFOREST; Wang HQ, 2003, FOREST ECOL MANAG, V179, P69, DOI 10.1016/S0378-1127(02)00489-9; Weaver P. L., 1972, CARIBB J SCI, V12, P129; WEAVER P. L., 2012, IITFGTR44 USDA FOR S; WEAVER PL, 1991, INTERCIENCIA, V16, P142; Weaver PL, 2000, INTERCIENCIA, V25, P254; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; White AF, 1998, GEOCHIM COSMOCHIM AC, V62, P209, DOI 10.1016/S0016-7037(97)00335-9; Whiteman C.D., 2000, MOUNTAIN METEOROLOGY; Wilson AM, 2014, J ATMOS SCI, V71, P1783, DOI 10.1175/JAS-D-13-0228.1; Wu W, 2006, J HYDROL, V328, P733, DOI 10.1016/j.jhydrol.2006.01.020; Wu W, 2007, HYDROL PROCESS, V21, P2944, DOI 10.1002/hyp.6515; Y-L Lin, 2007, MESOSCALE DYNAMICS; Yu C.-K., 2000, MONTHLY WEATHER REV, V136, P497, DOI DOI 10.1175/2007MWR2129.1	130	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180987	10.1371/journal.pone.0180987	http://dx.doi.org/10.1371/journal.pone.0180987			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686734	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100128
J	Yordanov, YS; Ma, C; Yordanova, E; Meilan, R; Strauss, SH; Busov, VB				Yordanov, Yordan S.; Ma, Cathleen; Yordanova, Elena; Meilan, Richard; Strauss, Steven H.; Busov, Victor B.			BIG LEAF is a regulator of organ size and adventitious root formation in poplar	PLOS ONE			English	Article							GENETIC-CONTROL; GROWTH; AINTEGUMENTA; TRANSFORMATION; SYSTEM; DNA; DIVISION; TRAITS; KEY	Here we report the discovery through activation tagging and subsequent characterization of the BIG LEAF (BL) gene from poplar. In poplar, BL regulates leaf size via positively affecting cell proliferation. Up and downregulation of the gene led to increased and decreased leaf size, respectively, and these phenotypes corresponded to increased and decreased cell numbers. BL function encompasses the early stages of leaf development as native BL expression was specific to the shoot apical meristem and leaf primordia and was absent from the later stages of leaf development and other organs. Consistently, BL downregulation reduced leaf size at the earliest stages of leaf development. Ectopic expression in mature leaves resulted in continued growth most probably via sustained cell proliferation and thus the increased leaf size. In contrast to the positive effect on leaf growth, ectopic BL expression in stems interfered with and significantly reduced stem thickening, suggesting that BL is a highly specific activator of growth. In addition, stem cuttings from BL overexpressing plants developed roots, whereas the wild type was difficult to root, demonstrating that BL is a positive regulator of adventitious rooting. Large transcriptomic changes in plants that over-expressed BL indicated that BL may have a broad integrative role, encompassing many genes linked to organ growth. We conclude that BL plays a fundamental role in control of leaf size and thus may be a useful tool for modifying plant biomass productivity and adventitious rooting.	[Yordanov, Yordan S.; Yordanova, Elena; Busov, Victor B.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Yordanov, Yordan S.; Yordanova, Elena] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Ma, Cathleen; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Meilan, Richard] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Michigan Technological University; Eastern Illinois University; Oregon State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Busov, VB (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	vbusov@mtu.edu	Meilan, Richard/T-9269-2017	Meilan, Richard/0000-0002-8680-1110	Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy [DE-FG02-06ER64185, DE-FG02-05ER64113, DES C0008462]; U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program [2003-04345]; Consortium for Plant Biotechnology Research, Inc [GO12026-203A]; USDA Biotechnology Risk Assessment Research Grants Program [2004-35300-14687]; USDA McIntire-Stennis Fund [1001498]; USDA National Institute of Food Agriculture [MICW-2011-04378]; Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program; Consortium for Plant Biotechnology Research, Inc; USDA Biotechnology Risk Assessment Research Grants Program; USDA McIntire-Stennis Fund(United States Department of Agriculture (USDA)); USDA National Institute of Food Agriculture; Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	This research was supported, in part, by grants from the Office of Science Biological and Environmental Research (BER) program at the U.S. Department of Energy (Grants DE-FG02-06ER64185, DE-FG02-05ER64113, and DES C0008462); U.S. Department of Agriculture (USDA) National Resources Inventory Plant Genome Program (Grant 2003-04345); Consortium for Plant Biotechnology Research, Inc. (Grant GO12026-203A); USDA Biotechnology Risk Assessment Research Grants Program (Grant 2004-35300-14687); USDA McIntire-Stennis Fund (Grant 1001498); USDA National Institute of Food Agriculture (MICW-2011-04378); and industrial members of the Tree Biosafety and Genomics Research Cooperative based at Oreg on State University	Alvarez-Buylla Elena R, 2010, Arabidopsis Book, V8, pe0127, DOI 10.1199/tab.0127; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Busov VB, 2005, NEW PHYTOL, V167, P9, DOI 10.1111/j.1469-8137.2005.01412.x; Busov VB, 2009, ADVENTITIOUS ROOT FO, P85; Busov V, 2011, TREE GENET GENOMES, V7, P91, DOI 10.1007/s11295-010-0317-7; Byzova MV, 1999, GENE DEV, V13, P1002, DOI 10.1101/gad.13.8.1002; Chen YH, 2013, PLANT CELL REP, V32, P219, DOI 10.1007/s00299-012-1356-3; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Cnops G, 2004, J EXP BOT, V55, P1529, DOI 10.1093/jxb/erh165; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hisanaga T, 2015, J EXP BOT, V66, P1055, DOI 10.1093/jxb/erv028; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Horstman A, 2014, TRENDS PLANT SCI, V19, P146, DOI 10.1016/j.tplants.2013.10.010; Ichihashi Y, 2015, FRONTIERS PLANT SCI, V6; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karlberg A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002361; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; Kraus D., 2014, MED WRIT, V23, P25, DOI DOI 10.1179/2047480613Z.000000000181; Krizek BA, 2000, PLANT CELL, V12, P1357, DOI 10.1105/tpc.12.8.1357; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Krizek BA, 2009, CURR OPIN PLANT BIOL, V12, P17, DOI 10.1016/j.pbi.2008.09.006; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; LARSON PR, 1980, ANN BOT-LONDON, V46, P757, DOI 10.1093/oxfordjournals.aob.a085973; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Legue V, 2014, PHYSIOL PLANTARUM, V151, P192, DOI 10.1111/ppl.12197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui K, 2010, PLANT J, V61, P570, DOI 10.1111/j.1365-313X.2009.04081.x; Meilan R., 2007, AGROBACTERIUM PROTOC, V2, P143; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Russo G, 2015, IFOREST, V8, P547, DOI 10.3832/ifor1104-007; Sabaghian E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17617; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sicard A, 2016, P NATL ACAD SCI; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stieger PA, 2004, PLANT PHYSIOL, V135, P1798, DOI 10.1104/pp.104.040899; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai C. J., 2011, Genetics, genomics and breeding of poplar, P112; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P372, DOI 10.1093/pcp/pcf051; Tsukaya Hirokazu, 2013, Arabidopsis Book, V11, pe0163, DOI [10.1199/tab.0072, 10.1199/tab.0163]; Wang ZB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11192; Wei HR, 2013, NEW PHYTOL, V200, P483, DOI 10.1111/nph.12375; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yordanov YS, 2014, P NATL ACAD SCI USA, V111, P10001, DOI 10.1073/pnas.1405621111; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634	60	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180527	10.1371/journal.pone.0180527	http://dx.doi.org/10.1371/journal.pone.0180527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686626	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100074
J	Lau, JK; Chow, V; Brown, A; Kritharides, L; Ng, ACC				Lau, Jerrett K.; Chow, Vincent; Brown, Alex; Kritharides, Leonard; Ng, Austin C. C.			Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; HYPONATREMIA; INDEX; EPIDEMIOLOGY; METAANALYSIS; DIAGNOSIS; SEVERITY; OUTCOMES	Background Pulmonary embolism continues to be a significant cause of death. The aim was to derive and validate a risk prediction model for in-hospital death after acute pulmonary embolism to identify low risk patients suitable for outpatient management. Methods A confirmed acute pulmonary embolism database of 1,426 consecutive patients admitted to a tertiary-center (2000-2012) was analyzed, with odd and even years as derivation and validation cohorts respectively. Risk stratification for in-hospital death was performed using multivariable logistic-regression modelling. Models were compared using receiver-operating characteristic-curve and decision curve analyses. Results In-hospital mortality was 3.6% in the derivation cohort (n = 693). Adding day-1 sodium and bicarbonate to simplified Pulmonary Embolism Severity Index (sPESI) significantly increased the C-statistic for predicting in-hospital death (0.71 to 0.86, P = 0.001). The validation cohort yielded similar results (n = 733, C-statistic 0.85). The new model was associated with a net reclassification improvement of 0.613, and an integrated discrimination improvement of 0.067. The new model also increased the C-statistic for predicting 30-day mortality compared to sPESI alone (0.74 to 0.83, P = 0.002). Decision curve analysis demonstrated superior clinical benefit with the use of the new model to guide admission for pulmonary embolism, resulting in 43 fewer admissions per 100 presentations based on a risk threshold for admission of 2%. Conclusions A risk model incorporating sodium, bicarbonate, and the sPESI provides accurate risk prediction of acute in-hospital mortality after pulmonary embolism. Our novel model identifies patients with pulmonary embolism who are at low risk and who may be suitable for outpatient management.	[Lau, Jerrett K.; Chow, Vincent; Kritharides, Leonard; Ng, Austin C. C.] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia; [Brown, Alex] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Concord Repatriation General Hospital; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Ng, ACC (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia.	chin.ng@sydney.edu.au	Ng, Austin Chin Chwan/AAQ-3192-2021; Kritharides, Leonard/AAQ-2720-2020	Brown, Alex/0000-0003-2112-3918	NHMRC/National Heart Foundation of Australia Postgraduate Scholarship [1094384]; Viertel Senior Medical Research Fellowship; NHMRC Program grant [1037903]	NHMRC/National Heart Foundation of Australia Postgraduate Scholarship; Viertel Senior Medical Research Fellowship; NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia)	Dr J.K. Lau is supported by a NHMRC/National Heart Foundation of Australia Postgraduate Scholarship (1094384). Professor A. Brown is supported by a Viertel Senior Medical Research Fellowship. Professor L. Kritharides is supported by NHMRC Program grant (1037903). No sponsors had a role in the study design, data collection, data analysis, data interpretation, or writing of the report. There was no additional external funding received for this study.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Ng ACC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061966; Becattini C, 2001, THROMB RES, V103, pV239, DOI 10.1016/S0049-3848(01)00291-2; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Berend K, 2014, NEW ENGL J MED, V371, P1434, DOI 10.1056/NEJMra1003327; Binder L, 2005, CIRCULATION, V112, P1573, DOI 10.1161/CIRCULATIONAHA.105.552216; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forfia PR, 2008, AM J RESP CRIT CARE, V177, P1364, DOI 10.1164/rccm.200712-1876OC; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Haley H, 2010, AM J MED SCI, V340, P42, DOI 10.1097/MAJ.0b013e3181e5939e; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2008, AM J RESP CRIT CARE, V178, P425, DOI 10.1164/rccm.200803-459OC; Marini C, 2010, INTERN EMERG MED, V5, P235, DOI 10.1007/s11739-010-0354-0; Moutzouris JP, 2014, J AM GERIATR SOC, V62, P2004, DOI 10.1111/jgs.13063; Murin S, 2002, THROMB HAEMOSTASIS, V88, P407; National Research Council, 2008, INSTR CLASS UND CAUS, P20001; Ng ACC, 2011, CIRC-CARDIOVASC QUAL, V4, P122, DOI 10.1161/CIRCOUTCOMES.110.958397; Scherz N, 2010, AM J RESP CRIT CARE, V182, P1178, DOI 10.1164/rccm.201003-0481OC; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	25	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179755	10.1371/journal.pone.0179755	http://dx.doi.org/10.1371/journal.pone.0179755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704383	Green Published, gold			2022-12-27	WOS:000405649700016
J	Sausville, LN; Jones, CC; Aldrich, MC; Blot, WJ; Pozzi, A; Williams, SM				Sausville, Lindsay N.; Jones, Carissa C.; Aldrich, Melinda C.; Blot, William J.; Pozzi, Ambra; Williams, Scott M.			Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival	PLOS ONE			English	Article							SOUTHERN COMMUNITY COHORT; ACTIVATED RECEPTOR-ALPHA; PROGNOSTIC-SIGNIFICANCE; FEMALE GENDER; GROWTH-FACTOR; EXPRESSION; 15-LIPOXYGENASE-2; OVEREXPRESSION; INHIBITION; CLONING	Globally, lung cancer results in more deaths worldwide than any other cancer, indicating a need for better treatments. Members of the eicosanoid metabolism pathway represent promising therapeutic targets, as several enzymes involved in the generation of these lipids are dysregulated in many cancers and their inhibition reduces lung cancer growth in mouse models. However, genetic variation of enzymes involved in eicosanoid metabolism has not been adequately examined for association with lung cancer. The goal of this study was to determine whether germline genetic variation altering eicosanoid producing enzyme function and/or expression are associated with differences in lung cancer survival. We examined the association of genetic variation with mortality within eicosanoid metabolism genes in 395 non-small-cell lung cancer (NSCLC) cases from the Southern Community Cohort Study (SCCS). A total of 108 SNPs, both common and rare, in 19 genes, were examined for association. No common or rare variants were associated with lung cancer survival across the entire study population. However, rare variants in ALOX15B (arachidonate 15-lipoxygenase, type B) and the common variant rs12529 in AKR1C3 (prostaglandin F synthase) were associated with NSCLC mortality in women and African Americans, respectively. Rare variants in ALOX15B were associated with greater mortality in women (HR = 2.10, 95% CI = 1.25-3.54, p-value = 0.005). The major allele of rs12529 in AKCR1C3 associated with improved survival in African Americans (HR = 0.74, 95% CI = 0.59-0.92, p-value = 0.008). The lack of genetic associations among all NSCLC cases and the association among women only for rare variants in ALOX15B may, in part, explain the better NSCLC survival observed among women. These results raise the possibility that some subgroups within the NSCLC population may benefit from drugs targeting eicosanoid metabolism.	[Sausville, Lindsay N.; Williams, Scott M.] Dartmouth Coll, Dept Genet, Geisel Sch Med, Hanover, NH 03755 USA; [Sausville, Lindsay N.; Williams, Scott M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Jones, Carissa C.; Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Jones, Carissa C.; Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.; Blot, William J.] Vanderbilt Univ, Sch Med, Div Epidemiol, Nashville, TN 37212 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Pozzi, Ambra] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Pozzi, Ambra] Vet Affairs Hosp, Dept Med, Nashville, TN 37212 USA	Dartmouth College; Case Western Reserve University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Williams, SM (corresponding author), Dartmouth Coll, Dept Genet, Geisel Sch Med, Hanover, NH 03755 USA.; Williams, SM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.; Pozzi, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.; Pozzi, A (corresponding author), Vet Affairs Hosp, Dept Med, Nashville, TN 37212 USA.	ambra.pozzi@vanderbilt.edu; smw154@case.edu	Williams, Scott/Q-4812-2019	Williams, Scott/0000-0002-4835-9544	National Cancer Institute of the National Institutes of Health, USDA [R01CA092447, R01CA162433]; NATIONAL CANCER INSTITUTE [R01CA162433, K07CA172294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health, USDA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Cancer Institute of the National Institutes of Health, USDA numbers R01CA092447 and R01CA162433 (https://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript	ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632; Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Aldrich MC, 2013, J THORAC ONCOL, V8, P1248, DOI 10.1097/JTO.0b013e3182a406f6; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Araujo JM, 2016, ONCOTARGET; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batevik R, 2005, LUNG CANCER, V47, P173, DOI 10.1016/j.lungcan.2004.08.014; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Brabender J, 2002, ANN SURG, V235, P440, DOI 10.1097/00000658-200203000-00017; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Chang J, 2015, PLOS ONE, V10; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howlader N, 2013, SEER CANC STAT REV 1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Keightley MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-488; Keightley MC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-8; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MY, 2012, CURR CANCER DRUG TAR, V12, P597; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Nakamura H, 2011, ANN THORAC CARDIOVAS, V17, P469, DOI 10.5761/atcs.oa.10.01637; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Sales KJ, 2005, CANCER RES, V65, P7707, DOI 10.1158/0008-5472.CAN-05-0101; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Skrypnyk N, 2014, CANCER RES, V74, P621, DOI 10.1158/0008-5472.CAN-13-1928; Society AC, 2013, CANC FACTS FIG 2015; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Soumya SJ, 2013, BIOCHEM CELL BIOL, V91, P498, DOI 10.1139/bcb-2013-0037; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Wallace AE, 2011, MOL CELL ENDOCRINOL, V331, P129, DOI 10.1016/j.mce.2010.08.018; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wheatley-Price P, 2010, ANN ONCOL, V21, P2023, DOI 10.1093/annonc/mdq067; Yarla NS, 2016, SEMINARS CANC BIOL; Yuan HL, 2010, THORAX, V65, P321, DOI 10.1136/thx.2009.122747; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	62	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180471	10.1371/journal.pone.0180471	http://dx.doi.org/10.1371/journal.pone.0180471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704416	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700040
J	Gamell, A; Luwanda, LB; Kalinjuma, AV; Samson, L; Ntamatungiro, AJ; Weisser, M; Gingo, W; Tanner, M; Hatz, C; Letang, E; Battegay, M				Gamell, Anna; Luwanda, Lameck Bonaventure; Kalinjuma, Aneth Vedastus; Samson, Leila; Ntamatungiro, Alex John; Weisser, Maja; Gingo, Winfrid; Tanner, Marcel; Hatz, Christoph; Letang, Emilio; Battegay, Manuel		KIULARCO Study Grp	Prevention of mother-to-child transmission of HIV Option B plus cascade in rural Tanzania: The One Stop Clinic model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; PREGNANCY; RETENTION	Background Strategies to improve the uptake of Prevention of Mother-To-Child Transmission of HIV (PMTCT) are needed. We integrated HIV and maternal, newborn and child health services in a One Stop Clinic to improve the PMTCT cascade in a rural Tanzanian setting. Methods The One Stop Clinic of Ifakara offers integral care to HIV-infected pregnant women and their families at one single place and time. All pregnant women and HIV-exposed infants attended during the first year of Option B+ implementation (04/2014-03/2015) were included. PMTCT was assessed at the antenatal clinic (ANC), HIV care and labour ward, and compared with the pre-B+ period. We also characterised HIV-infected pregnant women and evaluated the MTCT rate. Results 1,579 women attended the ANC. Seven (0.4%) were known to be HIV-infected. Of the remainder, 98.5% (1,548/1,572) were offered an HIV test, 94% (1,456/1,548) accepted and 38 (2.6%) tested HIV-positive. 51 were re-screened for HIV during late pregnancy and one had seroconverted. The HIV prevalence at the ANC was 3.1% (46/1,463). Of the 39 newly diagnosed women, 35 (90%) were linked to care. HIV test was offered to >98% of ANC clients during both the pre-and post-B+ periods. During the post-B+ period, test acceptance (94% versus 90.5%, p<0.0001) and linkage to care (90% versus 26%, p<0.0001) increased. Ten additional women diagnosed outside the ANC were linked to care. 82% (37/ 45) of these newly-enrolled women started antiretroviral treatment (ART). After a median time of 17 months, 27% (12/45) were lost to follow-up. 79 women under HIV care became pregnant and all received ART. After a median follow-up time of 19 months, 6% (5/79) had been lost. 5,727 women delivered at the hospital, 20% (1,155/5,727) had unknown HIV serostatus. Of these, 30% (345/1,155) were tested for HIV, and 18/345 (5.2%) were HIV-positive. Compared to the pre-B+ period more women were tested during labour (30% versus 2.4%, p<0.0001). During the study, the MTCT rate was 2.2%. Conclusions The implementation of Option B+through an integrated service delivery model resulted in universal HIV testing in the ANC, high rates of linkage to care, and MTCT below the elimination threshold. However, HIV testing in late pregnancy and labour, and retention during early ART need to be improved.	[Gamell, Anna; Luwanda, Lameck Bonaventure; Kalinjuma, Aneth Vedastus; Samson, Leila; Ntamatungiro, Alex John; Weisser, Maja; Letang, Emilio] United Republ Tanzania, Ifakara Hlth Inst, Ifakara, Tanzania; [Gamell, Anna; Weisser, Maja; Tanner, Marcel; Hatz, Christoph; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gamell, Anna; Weisser, Maja; Tanner, Marcel; Hatz, Christoph; Letang, Emilio; Battegay, Manuel] Univ Basel, Basel, Switzerland; [Gingo, Winfrid] St Francis Referral Hosp, Ifakara, Tanzania; [Letang, Emilio] Hosp Clin Univ Barcelona, ISGlobal, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Basel	Gamell, A (corresponding author), United Republ Tanzania, Ifakara Hlth Inst, Ifakara, Tanzania.; Gamell, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Gamell, A (corresponding author), Univ Basel, Basel, Switzerland.	anna.gamell@unibas.ch		Ntamatungiro, Alex/0000-0002-3134-3992; Weisser, Maja/0000-0002-0134-1929; Kalinjuma, Aneth Vedastus/0000-0001-5862-9264	Ministry of Health and Social Welfare of Tanzania; Swiss Tropical and Public Health Institute; Ifakara Health Institute; Government of the Canton of Basel; USAID through the local implementer TUNAJALI-Deloitte; Merck for Mothers Global Giving Program [10937]	Ministry of Health and Social Welfare of Tanzania; Swiss Tropical and Public Health Institute; Ifakara Health Institute; Government of the Canton of Basel; USAID through the local implementer TUNAJALI-Deloitte(United States Agency for International Development (USAID)); Merck for Mothers Global Giving Program	The funders of our clinic are: the Ministry of Health and Social Welfare of Tanzania, the Swiss Tropical and Public Health Institute, the Ifakara Health Institute, the Government of the Canton of Basel, USAID through the local implementer TUNAJALI-Deloitte, and the Merck for Mothers Global Giving Program (grant number 10937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, AIDS, V27, pS235, DOI 10.1097/QAD.0000000000000099; Aliyu MH, 2016, LANCET HIV, V3, pE202, DOI 10.1016/S2352-3018(16)00018-7; [Anonymous], 2016, CHILDR HIV FACTSH JU; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Chan AK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20672; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Gamell A, 2016, JAIDS-J ACQ IMM DEF, V73, pE67, DOI 10.1097/QAI.0000000000001178; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123275; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Letang E, 2017, SWISS MED W IN PRESS; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Ministry of Health and Social Welfare (MoHSW), 2013, NAT GUID COMPR CAR S; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Muri L, 2016, AIDS LOND ENGL; Ramirez-Mena A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw162; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; Tanzanian MoHSW, 2015, NAT GUID MAN HIV AID; Tanzanian NBS, 2012, POP HOUS CENS 2012 M; Tenthani L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-140; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2016, CONGUID UANT DRU; WHO, 2004, US ANT DRUGS TREAT P; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Health Organization, 2014, GLOB GUID CRIT PROC; Wudineh F, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/3262746	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181096	10.1371/journal.pone.0181096	http://dx.doi.org/10.1371/journal.pone.0181096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704472	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000405649600059
J	Goto, A; Tanaka, M; Yoshida, M; Umakoshi, M; Nanjo, H; Shiraishi, K; Saito, M; Kohno, T; Kuriyama, S; Konno, H; Imai, K; Saito, H; Minamiya, Y; Maeda, D				Goto, Akiteru; Tanaka, Masamitsu; Yoshida, Makoto; Umakoshi, Michinobu; Nanjo, Hiroshi; Shiraishi, Kouya; Saito, Motonobu; Kohno, Takashi; Kuriyama, Sei; Konno, Hayato; Imai, Kazuhiro; Saito, Hajime; Minamiya, Yoshihiro; Maeda, Daichi			The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; MICRORNA-451 INCREASES; UP-REGULATION; STEM-CELLS; ADENOCARCINOMA; CARCINOMA; CHEMORESISTANCE; PROLIFERATION; SENSITIVITY; APOPTOSIS	Purpose miR-451 is a tumor suppressive microRNA with several target genes, including Macrophage migration inhibitory factor (MIF). As little is known about the expression and clinicopathological significance of mir-451 in NSCLC, we performed a clinicopathological study of 370 NSCLC cases to clarify them. Cell biological experiments were also performed on NSCLC cell lines to confirm the tumor-suppressive role of miR-451 and whether or not MIF is targeted by miR-451. Methods We analyzed 370 NSCLC cases for the miR-451 expression by quantitative real-time polymerase chain reaction and the MIF expression by immunohistochemistry. Eighty-four background lung tissue samples were also evaluated for the miR-451 expression. The clinicopathological and genetic factors surveyed were the disease-free survival, smoking status, histological type, disease stage, EGFR gene mutations and ALK rearrangements. In 286 adenocarcinoma cases, the invasive status (adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma) was also evaluated. Five NSCLC cell lines (H23, H441, H522, H1703, and H1975) were cultured and evaluated for their miR-451 and MIF expression. The cell lines with lower miR-451 and higher MIF expressions were then selected and transfected with miR-451-mimic to observe its effects on MIF expression, Akt and Erk status, cell proliferation, and cell migration. Results The miR-451 expression was down-regulated in cancer tissues compared with background lung tissues (P<0.0001). Factors such as advanced disease stage, positive pleural invasion and nodal status and being a smoker were significantly correlated with a lower expression of miR-451 (P<0.05 each), while EGFR gene mutations and ALK rearrangements were not. In adenocarcinoma, invasive and minimally invasive adenocarcinoma showed lower expression of miR-451 than adenocarcinoma in situ (P<0.0005, respectively). A survival analysis showed that a lower expression of miR-451 was an independent predictor of a poor prognosis for NSCLC (P<0.05). The MIF expression was inversely correlated with the miR-451 expression. Out of 5 NSCLC cell lines examined, H441 and H1975 showed higher MIF and lower miR-451 expressions. After the transfection of miR-451-mimic, the MIF expression and phosphorylated Akt expression of these cell lines was suppressed, as were cell proliferation and cell migration. Conclusion This clinicopathological study of 370 NSCLC cases and the cell biological studies of NSCLC cell lines clarified the tumor-suppressive role of miR-451 and its prognostic value. We also validated MIF as a target of miR-451 in NSCLC.	[Goto, Akiteru; Yoshida, Makoto; Umakoshi, Michinobu; Maeda, Daichi] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita, Japan; [Tanaka, Masamitsu; Kuriyama, Sei] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita, Japan; [Nanjo, Hiroshi] Akita Univ Hosp, Dept Clin Pathol, Akita, Japan; [Shiraishi, Kouya; Saito, Motonobu; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Tokyo, Japan; [Konno, Hayato; Imai, Kazuhiro; Saito, Hajime; Minamiya, Yoshihiro] Akita Univ Hosp, Dept Thorac Surg, Akita, Japan	Akita University; Akita University; Akita University; National Cancer Center - Japan; Akita University	Goto, A (corresponding author), Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita, Japan.	akigoto@med.akita-u.ac.jp	Goto, Akiteru/P-5775-2014; Kuriyama, Sei/AAV-2368-2020; Saito, Motonobu/AAQ-3633-2021	Kuriyama, Sei/0000-0002-5502-7177; Saito, Motonobu/0000-0001-5072-3520; Goto, Akiteru/0000-0001-8776-9004	Japan Society for the Promotion of Science [C25460431]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [17K19579] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science C25460431 (http://www.jsps.go.jp/english/) and the Smoking Research Foundation (http://www.srf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen DQ, 2014, EUR J CANCER, V50, P3050, DOI 10.1016/j.ejca.2014.09.008; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Goto A, 2016, HUM PATHOL, V56, P1, DOI 10.1016/j.humpath.2016.04.011; Huang JY, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.82; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Liu N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-123; Liu W, 2017, BIOMED PHARMACOTHER, V87, P621, DOI 10.1016/j.biopha.2016.12.121; Nakaoku T, 2014, CLIN CANCER RES, V20, P3087, DOI 10.1158/1078-0432.CCR-14-0107; Nobre CC, 2016, PATHOL ONCOL RES; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; The Japan Lung Cancer Society, 2017, GEN RUL CLIN PATH RE, V8th; Tian F, 2016, THORAC CANCER, V7, P226, DOI 10.1111/1759-7714.12318; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; von der Thusen JH, 2013, J THORAC ONCOL, V8, P37, DOI 10.1097/JTO.0b013e318276274e; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Warth A, 2015, AM J SURG PATHOL, V39, P793, DOI 10.1097/PAS.0000000000000409; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; White ES, 2003, CLIN CANCER RES, V9, P853; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yokouchi H, 2016, ONCOTARGET; Zhao JW, 2016, J BIOL CHEM, V291, P27343, DOI 10.1074/jbc.M116.740084	32	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181270	10.1371/journal.pone.0181270	http://dx.doi.org/10.1371/journal.pone.0181270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704499	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600069
J	Song, YS; Ha, S; Hsu, H; Ting, LH; Liu, CK				Song, Yun Seong; Ha, Sehoon; Hsu, Hsiang; Ting, Lena H.; Liu, C. Karen			Stair negotiation made easier using novel interactive energy-recycling assistive stairs	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; GENERATING ELECTRICITY; HUMAN WALKING; DESCENT; ASCENT; ADULTS; FORCE; WORK; TASK; GAIT	Here we show that novel, energy-recycling stairs reduce the amount of work required for humans to both ascend and descend stairs. Our low-power, interactive, and modular steps can be placed on existing staircases, storing energy during stair descent and returning that energy to the user during stair ascent. Energy is recycled through event-triggered latching and unlatching of passive springs without the use of powered actuators. When ascending the energy-recycling stairs, naive users generated 17.4 +/- 6.9% less positive work with their leading legs compared to conventional stairs, with the knee joint positive work reduced by 37.7 +/- 10.5%. Users also generated 21.9 +/- 17.8% less negative work with their trailing legs during stair descent, with ankle joint negative work reduced by 26.0 +/- 15.9%. Our low-power energy-recycling stairs have the potential to assist people with mobility impairments during stair negotiation on existing staircases.	[Song, Yun Seong] Missouri Univ Sci & Technol, Dept Mech Engn, Rolla, MO USA; [Ha, Sehoon] Disney Res, Pittsburgh, PA USA; [Hsu, Hsiang] Georgia Inst Technol, Dept Mech Engn, Atlanta, GA 30332 USA; [Ting, Lena H.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Ting, Lena H.] Emory Univ, Atlanta, GA 30322 USA; [Ting, Lena H.] Emory Univ, Div Phys Therapy, Dept Rehabil Med, Atlanta, GA 30322 USA; [Liu, C. Karen] Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA	University of Missouri System; Missouri University of Science & Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Liu, CK (corresponding author), Georgia Inst Technol, Sch Interact Comp, Atlanta, GA 30332 USA.	karenliu@cc.gatech.edu		Song, Yun Seong/0000-0003-1826-586X	National Science Foundation (NSF) [EFRI-1137229]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR016151] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Science Foundation (NSF), Grant EFRI-1137229.	[Anonymous], 2011, US ENERGY INFORM ADM; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Dolbow DR, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0826; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Firth S, 2008, ENERG BUILDINGS, V40, P926, DOI 10.1016/j.enbuild.2007.07.005; Granstrom J, 2007, SMART MATER STRUCT, V16, P1810, DOI 10.1088/0964-1726/16/5/036; Hall M, 2016, HIP BIOMECHANICS STA; Hayashida J. Y., 2000, UNOBTRUSIVE INTEGRAT; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; LaStayo PC, 2003, J ORTHOP SPORT PHYS, V33, P557, DOI 10.2519/jospt.2003.33.10.557; LaStayo PC, 2003, J GERONTOL A-BIOL, V58, P419, DOI 10.1093/gerona/58.5.M419; Liu C. Karen, 2012, GITGVU15011 SCH INT; MCFADYEN BJ, 1988, J BIOMECH, V21, P733, DOI 10.1016/0021-9290(88)90282-5; McLaughlin P, 2013, CLIN BIOMECH, V28, P672, DOI 10.1016/j.clinbiomech.2013.05.008; Morlock M, 2001, J BIOMECH, V34, P873, DOI 10.1016/S0021-9290(01)00035-5; Nadeau S, 2003, CLIN BIOMECH, V18, P950, DOI 10.1016/S0268-0033(03)00179-7; Niu P, 2004, IEEE POWER ELECTRON, P2100, DOI 10.1109/PESC.2004.1355442; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Preece SJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1209-2; Pynoos J, 2009, GENERATIONS, V33, P26; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Riemer R, 2010, 1 INT C APPL BION BI, P14; Riemer R, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-22; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Routson RL, 2010, EFFECTS VARYING SPEE; Schertzer E, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0023-7; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Startzell J, 2000, J AM GERIATRICS SOC, V48; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Williamson JD, 1996, J AM GERIATR SOC, V44, P1429, DOI 10.1111/j.1532-5415.1996.tb04066.x	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e179637	10.1371/journal.pone.0179637	http://dx.doi.org/10.1371/journal.pone.0179637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28700719	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600009
J	Kember, G; Ardell, JL; Shivkumar, K; Armour, JA				Kember, Guy; Ardell, Jeffrey L.; Shivkumar, Kalyanam; Armour, J. Andrew			Recurrent myocardial infarction: Mechanisms of free-floating adaptation and autonomic derangement in networked cardiac neural control	PLOS ONE			English	Article							CENTRAL COMMAND; NERVOUS-SYSTEM; HEART-FAILURE; EXERCISE; DEATH; TRANSPLANTATION; COMPENSATION; INTERMEDIATE; DENERVATION; ARRHYTHMIAS	The cardiac nervous system continuously controls cardiac function whether or not pathology is present. While myocardial infarction typically has a major and catastrophic impact, population studies have shown that longer-term risk for recurrent myocardial infarction and the related potential for sudden cardiac death depends mainly upon standard atherosclerotic variables and autonomic nervous system maladaptations. Investigative neurocardiology has demonstrated that autonomic control of cardiac function includes local circuit neurons for networked control within the peripheral nervous system. The structural and adaptive characteristics of such networked interactions define the dynamics and a new normal for cardiac control that results in the aftermath of recurrent myocardial infarction and/or unstable angina that may or may not precipitate autonomic derangement. These features are explored here via a mathematical model of cardiac regulation. A main observation is that the control environment during pathology is an extrapolation to a setting outside prior experience. Although global bounds guarantee stability, the resulting closed-loop dynamics exhibited while the network adapts during pathology are aptly described as 'free-floating' in order to emphasize their dependence upon details of the network structure. The totality of the results provide a mechanistic reasoning that validates the clinical practice of reducing sympathetic efferent neuronal tone while aggressively targeting autonomic derangement in the treatment of ischemic heart disease.	[Kember, Guy] Dalhousie Univ, Fac Engn, Dept Engn Math & Internetworking, Halifax, NS, Canada; [Ardell, Jeffrey L.; Shivkumar, Kalyanam; Armour, J. Andrew] Univ Calif Los Angeles, David Geffen Sch Med, Cardiac Arrhythmia Ctr, Los Angeles, CA 90095 USA	Dalhousie University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kember, G (corresponding author), Dalhousie Univ, Fac Engn, Dept Engn Math & Internetworking, Halifax, NS, Canada.	guy.kember@dal.ca	Shivkumar, Kalyanam/AAI-1085-2019	Shivkumar, Kalyanam/0000-0002-4121-1766	National Sciences and Engineering Research Council (NSERC) Discovery Grant [43354]; NIH SPARC [U18EB021799, 1OT2OD023848]	National Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH SPARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Sciences and Engineering Research Council (NSERC) Discovery Grant 43354. (remaining three authors) JLA KS JAA: NIH SPARC U18EB021799 and 1OT2OD023848.	Ajijola OA, 2015, HEART RHYTHM, V12, P1027, DOI 10.1016/j.hrthm.2015.01.045; Ardell JL, 2016, J PHYSIOL-LONDON, V594, P3877, DOI 10.1113/JP271869; Ardell JL, 2016, COMPR PHYSIOL, V6, P1635, DOI 10.1002/cphy.c150046; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Arora, 2000, Curr Interv Cardiol Rep, V2, P188; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Buckley Una, 2015, Curr Heart Fail Rep, V12, P284, DOI 10.1007/s11897-015-0263-7; Cardinal R, 2009, AUTON NEUROSCI-BASIC, V145, P55, DOI 10.1016/j.autneu.2008.11.007; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Fukuda K, 2015, CIRC RES, V116, P2005, DOI 10.1161/CIRCRESAHA.116.304679; Gibbons DD, 2012, AM J PHYSIOL-REG I, V302, pR357, DOI 10.1152/ajpregu.00535.2011; GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979; Guyenet PG, 2014, COMPR PHYSIOL, V4, P1511, DOI 10.1002/cphy.c140004; Habecker BA, 2016, J PHYSL, P1; Hardiman K, 2014, THESIS; Jokhadar M, 2004, AM J EPIDEMIOL, V159, P1040, DOI 10.1093/aje/kwh147; Kember G, 2013, PHYSIOL GENOMICS, V45, P638, DOI 10.1152/physiolgenomics.00027.2013; Kember G, 2011, J THEOR BIOL, V277, P41, DOI 10.1016/j.jtbi.2011.02.013; Kember G, 2014, PLOS ONE, P1; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2015, CURR OPIN NEUROBIOL, V31, P156, DOI 10.1016/j.conb.2014.10.012; Murphy DA, 2000, ANN THORAC SURG, V69, P1769, DOI 10.1016/S0003-4975(00)01240-6; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; Potts JT, 1998, AM J PHYSIOL-HEART C, V275, pH2000, DOI 10.1152/ajpheart.1998.275.6.H2000; Rajendran PS, 2016, J PHYSIOL-LONDON, V594, P321, DOI 10.1113/JP271165; Salavatian S, 2016, AM J PHYSL HEART CIR; Shivkumar K, 2016, J PHYSL, P1; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Vaseghi M, 2008, J AM COLL CARDIOL, V51, P2241, DOI 10.1016/j.jacc.2008.02.065; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Wang HJ, 2014, HYPERTENSION, V64, P745, DOI 10.1161/HYPERTENSIONAHA.114.03699; Williamson JW, 2015, AUTON NEUROSCI-BASIC, V188, P3, DOI 10.1016/j.autneu.2014.10.011; Williamson JW, 2010, EXP PHYSIOL, V95, P1043, DOI 10.1113/expphysiol.2009.051870; Zucker IH, 2012, HEART FAIL CLIN, V8, P87, DOI 10.1016/j.hfc.2011.08.007	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180194	10.1371/journal.pone.0180194	http://dx.doi.org/10.1371/journal.pone.0180194			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692680	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800029
J	Kraft, LJ; Kopco, J; Harmon, JP; Oliver, KM				Kraft, Laura J.; Kopco, James; Harmon, Jason P.; Oliver, Kerry M.			Aphid symbionts and endogenous resistance traits mediate competition between rival parasitoids	PLOS ONE			English	Article							PRAON-PEQUODORUM HYMENOPTERA; PEA APHID; CONFERRED RESISTANCE; EVOLUTIONARY ECOLOGY; BACTERIAL SYMBIONTS; HOST-RESISTANCE; SUSCEPTIBILITY; COVARIATION; VARIABILITY; PROTECTION	Insects use endogenous mechanisms and infection with protective symbionts to thwart attacks from natural enemies. Defenses that target specific enemies, however, potentially mediate competition between rivals and thereby impact community composition. Following its introduction to North America to control pea aphids (Acyrthosiphon pisum), the parasitoid Aphidius ervi competitively displaced other parasitoids, except for the native Praon pequodorum. The pea aphid exhibits tremendous clonal variation in resistance to A. ervi, primarily through infection with the heritable bacterial symbiont Hamiltonella defensa, although some symbiont-free aphid genotypes encode endogenous resistance. Interestingly, H. defensa strains and aphid genotypes that protect against A. ervi, provide no protection against the closely related, P. pequodorum. Given the specificity of aphid defenses, we hypothesized that aphid resistance traits may contribute to the continued persistence of P. pequodorum. We conducted multiparasitism assays to determine whether aphid resistance traits mediate internal competition between these two solitary parasitoid species, but found this was not the case; P. pequodorum was the successful internal competitor across lines varying in susceptibility to A. ervi. Next, to determine whether resistance traits influence competitive interactions resulting in the stable persistence of P. pequodorum, we established replicated cages varying in the proportion of resistant aphids and recorded successful parasitism for each wasp species over time. As expected, A. ervi outcompeted P. pequodorum in cages containing only susceptible aphids. However, P. pequodorum not only persisted, but was the superior competitor in populations containing any proportion (20-100%) of resistant aphids (20-100%). Smaller scale, better replicated competition cage studies corroborated this finding, and no-competition and behavioral assays provide insight into the processes mediating competition. Genetic variation, including that acquired via infection with protective symbionts, may provide a supply of hosts susceptible only to particular enemies, mediating competition with effects on community richness and stability.	[Kraft, Laura J.; Oliver, Kerry M.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Kopco, James; Harmon, Jason P.] North Dakota State Univ, Dept Entomol, Fargo, ND USA	University System of Georgia; University of Georgia; North Dakota State University Fargo	Oliver, KM (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kmoliver@uga.edu	Harmon, Jason/AAW-3036-2021; Oliver, Kerry/H-4498-2017	Harmon, Jason/0000-0002-2533-5005; Oliver, Kerry/0000-0002-2835-4017	National Science Foundation Dimensions in Biodiversity awards [1240804, 1241031]; Division Of Environmental Biology [1240804] Funding Source: National Science Foundation	National Science Foundation Dimensions in Biodiversity awards; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Dimensions in Biodiversity awards 1240804 (KMO) and 1241031 (JPH).	Asplen MK, 2014, ECOL ENTOMOL, V39, P736, DOI 10.1111/een.12153; Auld SKJR, 2013, J EVOLUTION BIOL, V26, P2479, DOI 10.1111/jeb.12243; CHOW FJ, 1985, CAN ENTOMOL, V117, P133, DOI 10.4039/Ent117133-1; CHOW FJ, 1984, CAN ENTOMOL, V116, P1097, DOI 10.4039/Ent1161097-8; Colares F, 2015, BIOL CONTROL, V90, P16, DOI 10.1016/j.biocontrol.2015.05.009; Danyk TP, 1996, BIOL CONTROL, V7, P67, DOI 10.1006/bcon.1996.0066; Danyk TP, 1992, THESIS; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Dion E, 2011, J EVOLUTION BIOL, V24, P741, DOI 10.1111/j.1420-9101.2010.02207.x; Dion E, 2011, BIOL LETTERS, V7, P743, DOI 10.1098/rsbl.2011.0249; Doremus MR, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.03276-16, 10.1128/aem.03276-16]; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gruner DS, 2009, ECOLOGY, V90, P1721, DOI 10.1890/08-1616.1; Hare J.D., 1992, P278; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; HENTER HJ, 1995, EVOLUTION, V49, P427, DOI [10.1111/j.1558-5646.1995.tb02275.x, 10.2307/2410267]; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; Ives AR, 1999, AM NAT, V154, P652, DOI 10.1086/303269; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Mackauer M., 1973, Bulletin ent Soc NZ, V2, P20; Martinez AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154670; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; McLean A. H., 2016, FUNCTIONAL ECOLOGY; McLean AHC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0977; Meisner M, 2007, POPUL ECOL, V49, P347, DOI 10.1007/s10144-007-0054-4; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2014, CURR OPIN INSECT SCI, V4, P1, DOI 10.1016/j.cois.2014.08.001; Oliver KM, 2014, FUNCT ECOL, V28, P341, DOI 10.1111/1365-2435.12133; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Poirie M, 2011, ISJ-INVERT SURVIV J, V8, P247; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; Rouchet R, 2014, EVOLUTION, V68, P1607, DOI 10.1111/evo.12377; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schellhorn NA, 2002, ECOLOGY, V83, P2745, DOI 10.1890/0012-9658(2002)083[2745:CBNAIP]2.0.CO;2; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; SEQUEIRA R, 1987, ENTOMOL GEN, V12, P259; von Burg S, 2008, P ROY SOC B-BIOL SCI, V275, P1089, DOI 10.1098/rspb.2008.0018; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Vorburger C, 2014, INSECT SCI, V21, P251, DOI 10.1111/1744-7917.12067; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642	54	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180729	10.1371/journal.pone.0180729	http://dx.doi.org/10.1371/journal.pone.0180729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700614	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800070
J	Mikami, K; Shiraishi, M; Kawasaki, T; Kamo, T				Mikami, Kyohei; Shiraishi, Makoto; Kawasaki, Tsubasa; Kamo, Tsutomu			Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position	PLOS ONE			English	Article							PROGRESSION; IMPAIRMENT; POSTURE	Purpose No method has been established to evaluate the dissociation between subjective and objective vertical positions with respect to the self-awareness of postural deformity in patients with Parkinson's disease (PD). The purpose of this study was to demonstrate, from the relationship between an assessment of the dissociation of subjective and objective vertical positions of PD patients and an assessment based on established PD clinical evaluation scales, that the dissociation regarding vertical position is a factor in the severity of the forward flexion of trunk (FFT). Methods Subjects were 39 PD patients and 15 age-matched healthy individuals (control group). Posture was evaluated with measurement of FFT angle during static standing and the subjective vertical position (SV) of the patient. For evaluation of motor function, the Modified Hoehn & Yahr scale, Unified Parkinson's Disease Rating Scale (UPDRS), 3-m Timed Up and Go Test ( TUG), and Functional Reach Test (FRT) were used. Results In PD patients, FFT angle in the 3rd tertile of patients was 13.8 +/- 9.7 E, significantly greater than those in the control group and the 1st and 2nd tertiles of PD patients ( control group vs 3rd tertile, p = 0.008; 1st tertile vs 3rd tertile, p< 0.001; 2nd vs 3rd tertile, p = 0.008). In multiple regression analysis for factors in the FFT angle, significant factors were SV, disease duration, and the standard deviation of each SV angle measurement. Conclusion The dissociation between SV and objective vertical position affects the FFT of PD patients, suggesting an involvement of non-basal ganglia pathologies.	[Mikami, Kyohei] Noborito Neurol Clin, Dept Rehabil, Kawasaki, Kanagawa, Japan; [Shiraishi, Makoto] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kawasaki, Tsubasa] Ryotokuji Univ, Fac Hlth Sci, Dept Phys Therapy, 5-8-1 Akemi, Urayasu, Chiba, Japan; [Kamo, Tsutomu] Noborito Neurol Clin, Dept Neurol, Kawasaki, Kanagawa, Japan; [Mikami, Kyohei] Noborito Neurol Clin, Tama Ku, 434 Nobotitoshinmachi, Kawasaki, Kanagawa, Japan; [Shiraishi, Makoto] St Marianna Univ, Sch Med, Div Neurol, Miyamae Ku, 2-16-1Sugao, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Mikami, K (corresponding author), Noborito Neurol Clin, Dept Rehabil, Kawasaki, Kanagawa, Japan.; Mikami, K (corresponding author), Noborito Neurol Clin, Tama Ku, 434 Nobotitoshinmachi, Kawasaki, Kanagawa, Japan.	kyo.mikami@gmail.com						[Anonymous], 1995, JPN J REHABIL MED, V32, P208; Azher SN, 2005, NEUROLOGY, V65, P355, DOI 10.1212/01.wnl.0000171857.09079.9f; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Benninger F, 2015, GAIT POSTURE, V42, P263, DOI 10.1016/j.gaitpost.2015.05.015; Bergmann J, 2015, ATTEN PERCEPT PSYCHO, V77, P953, DOI 10.3758/s13414-014-0815-z; BONNET AM, 1987, NEUROLOGY, V37, P1539, DOI 10.1212/WNL.37.9.1539; Broussolle E, 2007, MOVEMENT DISORD, V22, P909, DOI 10.1002/mds.21484; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; DIETZ V, 1988, ANN NEUROL, V24, P660, DOI 10.1002/ana.410240511; Djaldetti R, 2004, MOVEMENT DISORD, V19, P1325, DOI 10.1002/mds.20187; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; DUVOISIN RC, 1975, J NEUROL NEUROSUR PS, V38, P787, DOI 10.1136/jnnp.38.8.787; EKBOM K, 1972, Z NEUROL, V202, P94, DOI 10.1007/BF00316159; GOETZ CG, 1987, NEUROLOGY, V37, P695, DOI 10.1212/WNL.37.4.695; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; HUBER SJ, 1988, J NEUROL NEUROSUR PS, V51, P855, DOI 10.1136/jnnp.51.6.855; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Karnath HO, 2000, NEUROLOGY, V55, P1298, DOI 10.1212/WNL.55.9.1298; Khlebtovsky A, 2017, J NEUROL, V264, P675, DOI 10.1007/s00415-017-8402-6; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Ninomiya S, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/462143; Poewe WH, 1998, ANN NEUROL, V44, pS1, DOI 10.1002/ana.410440703; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; Shiraishi M., 2016, ADV PARKINSONS DIS, V5, P7, DOI [10.4236/apd.2016.52002, DOI 10.4236/APD.2016.52002]; Tagliabue M, 2009, NEUROSCIENCE, V158, P1206, DOI 10.1016/j.neuroscience.2008.12.007; Umapathi T, 2003, J NEUROL NEUROSUR PS, V74, P692; Uzawa A, 2009, MOVEMENT DISORD, V24, P2408, DOI 10.1002/mds.22779; Vaugoyeau M, 2010, J NEUROL SCI, V289, P66, DOI 10.1016/j.jns.2009.08.019	28	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181210	10.1371/journal.pone.0181210	http://dx.doi.org/10.1371/journal.pone.0181210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700731	gold, Green Submitted, Green Published			2022-12-27	WOS:000405544800130
J	Reimer, A; Schmitt, A; Ehrmann, D; Kulzer, B; Hermanns, N				Reimer, Andre; Schmitt, Andreas; Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert			Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study	PLOS ONE			English	Article							EUROPEAN DEPRESSION; PROBLEM AREAS; SELF-CARE; TYPE-1; ADULTS; INTERVENTION; INDIVIDUALS; PREVALENCE; PEOPLE; SCALE	Objective Depressive symptoms in people with diabetes are associated with increased risk of adverse outcomes. Although successful psychosocial treatment options are available, little is known about factors that facilitate treatment response for depression in diabetes. This prospective study aims to examine the impact of known risk factors on improvement of depressive symptoms with a special interest in the role of diabetes-related distress. Methods 181 people with diabetes participated in a randomized controlled trial. Diabetes-related distress was assessed using the Problem Areas In Diabetes (PAID) scale; depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. Multiple logistic and linear regression analyses were used to assess associations between risk factors for depression (independent variables) and improvement of depressive symptoms (dependent variable). Reliable change indices were established as criteria of meaningful reductions in diabetes distress and depressive symptoms. Results A reliable reduction of diabetes-related distress (15.43 points in the PAID) was significantly associated with fourfold increased odds for reliable improvement of depressive symptoms (OR = 4.25, 95% CI: 2.05-8.79; P<0.001). This result was corroborated using continuous measures of diabetes distress and depressive symptoms, showing that greater reduction of diabetes-related distress independently predicted greater improvement in depressive symptoms (beta = -0.40; P<0.001). Higher age had a positive (Odds Ratio = 2.04, 95% CI: 1.21-3.43; P<0.01) and type 2 diabetes had a negative effect on the meaningful reduction of depressive symptoms (Odds Ratio = 0.12, 95% CI: 0.04-0.35; P<0.001). Conclusions The reduction of diabetes distress is a statistical predictor of improvement of depressive symptoms. Diabetes patients with comorbid depressive symptomatology might benefit from treatments to reduce diabetes-related distress.	[Reimer, Andre; Schmitt, Andreas; Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany; [Reimer, Andre; Schmitt, Andreas; Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Diabet Ctr Mergentheim DZM, Bad Mergentheim, Germany; [Reimer, Andre; Schmitt, Andreas; Kulzer, Bernhard; Hermanns, Norbert] German Ctr Diabet Res DZD, Munich, Germany; [Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Otto Friedrich Univ Bamberg, Dept Psychol, Bamberg, Germany	Otto Friedrich University Bamberg	Reimer, A (corresponding author), Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.; Reimer, A (corresponding author), Diabet Ctr Mergentheim DZM, Bad Mergentheim, Germany.; Reimer, A (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	reimer@diabetes-zentrum.de	Hermanns, Norbert/AAG-7060-2020; Schmitt, Andreas/AAY-7704-2020	Hermanns, Norbert/0000-0002-2903-2677; Schmitt, Andreas/0000-0002-5913-1457; Ehrmann, Dominic/0000-0002-5794-5596; Reimer, Andre/0000-0003-4601-8559	German Center for Diabetes Research (DZD) [82DZD01101]	German Center for Diabetes Research (DZD)	This work was supported by grants funded by the German Center for Diabetes Research (DZD) (grant number 82DZD01101; URL:http://www.dzd-ev.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Burns RJ, 2015, DIABETIC MED, V32, P1272, DOI 10.1111/dme.12860; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Ehrmann D, 2015, DIABETIC MED, V32, P1264, DOI 10.1111/dme.12861; Evans CE., 1998, EVID-BASED MENT HEAL, V1, P70, DOI [10.1136/ebmh.1.3.70, DOI 10.1136/EBMH.1.3.70]; Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572; Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117; Hautzinger M, 2012, ALLGEMEINE DEPRESSIO, V2nd; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Hermanns N, 2015, DIABETES CARE, DOI DOI 10.2337/DC14-1416; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Judd LL, 2002, AM J GERIAT PSYCHIAT, V10, P233, DOI 10.1176/appi.ajgp.10.3.233; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Kulzer B, 2013, DIABETOL STOFFWECHS, V8, P198, DOI 10.1055/s-0033-1335785; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x; Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; Neupert SD, 2007, J GERONTOL B-PSYCHOL, V62, pP216, DOI 10.1093/geronb/62.4.P216; Nobis S, 2015, DIABETES CARE, V38, P776, DOI 10.2337/dc14-1728; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Petrak F, 2015, LANCET DIABETES ENDO, V3, P472, DOI 10.1016/S2213-8587(15)00045-5; Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448; Pibernik-Okanovic M, 2008, J DIABETES COMPLICAT, V22, P246, DOI 10.1016/j.jdiacomp.2007.03.002; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004; Rondags SMPA, 2016, DIABETES CARE, V39, P2190, DOI 10.2337/dc16-1614; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Schmitt A, 2016, DIABETIC MED, V33, P835, DOI 10.1111/dme.12887; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Snoek FJ, 2015, LANCET DIABETES ENDO, V3, P450, DOI 10.1016/S2213-8587(15)00135-7; Sperl-Hillen J, 2013, AM J MANAG CARE, V19, P104; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011; Young-Hyman D, 2016, DIABETES CARE, V39, P2126, DOI 10.2337/dc16-2053	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181218	10.1371/journal.pone.0181218	http://dx.doi.org/10.1371/journal.pone.0181218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA6HV	28700718	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800131
J	Sarkar, O; Li, Y; Anand-Srivastava, MB				Sarkar, Oli; Li, Yuan; Anand-Srivastava, Madhu B.			Nitric oxide attenuates overexpression of Gia proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; PEPTIDE RECEPTOR-C; NUCLEOTIDE REGULATORY PROTEIN; ENHANCED OXIDATIVE STRESS; GROWTH-FACTOR RECEPTOR; ADENYLYL-CYCLASE; ANGIOTENSIN-II; ALPHA PROTEINS; BLOOD-PRESSURE; ALTERED EXPRESSION	Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit decreased levels of nitric oxide (NO) that may be responsible for the overexpression of Gia proteins that has been shown as a contributing factor for the pathogenesis of hypertension in SHR. The present study was undertaken to investigate if increasing the intracellular levels of NO by NO donor S-Nitroso-N-acetyl-DL-penicillamine (SNAP) could attenuate the enhanced expression of Gia proteins in VSMC from SHR and explore the underlying mechanisms responsible for this response. The expression of Gia proteins and phosphorylation of ERK1/2, growth factor receptors and c-Src was determined by Western blotting using specific antibodies. Treatment of VSMC from SHR with SNAP for 24 hrs decreased the enhanced expression of Gia-2 and Gia-3 proteins and hyperproliferation that was not reversed by 1H (1, 2, 4) oxadiazole (4, 3-a) quinoxalin-1-one (ODQ), an inhibitor of soluble guanylyl cyclase, however, PD98059, a MEK inhibitor restored the SNAP-induced decreased expression of Gia proteins towards control levels. In addition, the increased production of superoxide anion, NAD(P) H oxidase activity, overexpression of AT1 receptor, Nox4, p22 phox and p47 phox proteins, enhanced levels of TBARS and protein carbonyl, increased phosphorylation of PDGF-R, EGF-R, c-Src and ERK1/2 in VSMC from SHR were all decreased to control levels by SNAP treatment. These results suggest that NO decreased the enhanced expression of Gia-2/3 proteins and hyperproliferation of VSMC from SHR by cGMP-independent mechanism and involves ROS and ROS-mediated transactivation of EGF-R/PDGF-R and MAP kinase signaling pathways.	[Sarkar, Oli; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada.	madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-53074]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MBAS was funded by a grant from the Canadian Institutes of Health Research (CIHR) (MOP-53074).	ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P72, DOI 10.1093/ajh/6.1.72; ANANDSRIVASTAVA MB, 1992, BIOCHEM J, V288, P79, DOI 10.1042/bj2880079; ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; Arejian M, 2009, AM J PHYSIOL-HEART C, V296, pH1859, DOI 10.1152/ajpheart.01108.2008; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Bassil M, 2008, AM J PHYSIOL-HEART C, V294, pH775, DOI 10.1152/ajpheart.00841.2007; Bassil M, 2007, CELL BIOCHEM BIOPHYS, V47, P99, DOI 10.1385/CBB:47:1:99; Bassil M, 2006, FREE RADICAL BIO MED, V41, P1162, DOI 10.1016/j.freeradbiomed.2006.07.004; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Blanco-Rivero J, 2011, EXP PHYSIOL, V96, P275, DOI 10.1113/expphysiol.2010.055822; BOHM M, 1992, HYPERTENSION, V20, P103, DOI 10.1161/01.HYP.20.1.103; Bou Daou G, 2015, CANADIAN J PHYSL PHA, P1; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; CAHILL PA, 1995, EUR J PHARM-MOLEC PH, V288, P219, DOI 10.1016/0922-4106(95)90197-3; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Di Fusco F, 2000, J HYPERTENS, V18, P1081; DUBEY RK, 1995, J CLIN INVEST, V96, P141, DOI 10.1172/JCI118014; El Andalousi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076183; FLEMING JW, 1992, CIRCULATION, V85, P420, DOI 10.1161/01.CIR.85.2.420; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; FUKUDA N, 1991, JPN CIRC J, V55, P721, DOI 10.1253/jcj.55.721; Ge C, 2006, CAN J PHYSIOL PHARM, V84, P739, DOI 10.1139/Y05-123; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; Gusan S, 2013, AM J PHYSIOL-CELL PH, V304, pC1198, DOI 10.1152/ajpcell.00269.2012; Hashim S, 2004, J HYPERTENS, V22, P181, DOI 10.1097/00004872-200401000-00028; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; ITOH H, 1988, J BIOL CHEM, V263, P6656; Kim SO, 2000, BIOCHIMICA ET BIOPHY, V1496, P2; Lahteenmaki T, 1998, BRIT J PHARMACOL, V125, P402, DOI 10.1038/sj.bjp.0702076; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lane P, 1999, SEMIN NEPHROL, V19, P215; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; LEE RMKW, 1983, BLOOD VESSELS, V20, P72; Li Y, 2002, CIRC RES, V91, P247, DOI 10.1161/01.RES.0000029969.39875.4B; Li Y, 2007, AM J PHYSIOL-HEART C, V292, pH1922, DOI 10.1152/ajpheart.01166.2006; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; LIAU G, 1989, J BIOL CHEM, V264, P10315; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lu MH, 2003, CLIN EXP HYPERTENS, V25, P413, DOI 10.1081/CEH-120024985; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; Marcil J, 1998, CARDIOVASC RES, V39, P492, DOI 10.1016/S0008-6363(98)00111-4; Marcil J, 1997, J MOL CELL CARDIOL, V29, P1009, DOI 10.1006/jmcc.1996.0343; McKillop IH, 1999, EUR J GASTROEN HEPAT, V11, P761, DOI 10.1097/00042737-199907000-00014; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; Nakamura A, 1996, J BIOCHEM, V119, P768; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; RODBELL M, 1971, J BIOL CHEM, V246, P1872; Saha S, 2008, CAN J PHYSIOL PHARM, V86, P190, DOI 10.1139/Y08-012; Saha S, 2008, J MOL CELL CARDIOL, V44, P336, DOI 10.1016/j.yjmcc.2007.11.003; Sandoval YHG, 2011, CELL SIGNAL, V23, P1716, DOI 10.1016/j.cellsig.2011.06.006; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089; Stotz WH, 2004, J VASC RES, V41, P211, DOI 10.1159/000077577; Sun JZ, 2001, AM J PHYSIOL-LUNG C, V281, pL155, DOI 10.1152/ajplung.2001.281.1.L155; THIBAULT C, 1992, FEBS LETT, V313, P160, DOI 10.1016/0014-5793(92)81435-O; Tonelli AR, 2013, PULM CIRC, V3, P20, DOI 10.4103/2045-8932.109911; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3	61	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179301	10.1371/journal.pone.0179301	http://dx.doi.org/10.1371/journal.pone.0179301			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692698	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800009
J	Christiansen, MK; Larsen, SB; Nyegaard, M; Neergaard-Petersen, S; Ajjan, R; Wurtz, M; Grove, EL; Hvas, AM; Jensen, HK; Kristensen, SD				Christiansen, Morten Krogh; Larsen, Sanne Bojet; Nyegaard, Mette; Neergaard-Petersen, Sos; Ajjan, Ramzi; Wurtz, Morten; Grove, Erik Lerkevang; Hvas, Anne-Mette; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby			Coronary artery disease-associated genetic variants and biomarkers of inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION; MYELOID-RELATED PROTEIN-14; HEART-DISEASE; MYOCARDIAL-INFARCTION; LDL-CHOLESTEROL; RISK SCORES; LOCI; APOE; MYELOID-RELATED-PROTEIN-8/14	Introduction Genetic constitution and inflammation both contribute to development of coronary artery disease (CAD). Several CAD-associated single-nucleotide polymorphisms (SNPs) have recently been identified, but their functions are largely unknown. We investigated the associations between CAD-associated SNPs and five CAD-related inflammatory biomarkers. Methods We genotyped 45 CAD-associated SNPs in 701 stable CAD patients in whom levels of highsensitivity C-reactive protein (hsRCP), interleukin-6, calprotectin, fibrinogen and complement component 3 levels had previously been measured. A genetic risk score was calculated to assess the combined risk associated with all the genetic variants. A multiple linear regression model was used to assess associations between the genetic risk score, single SNPs, and the five inflammatory biomarkers. Results The minor allele (G) (CAD risk allele) of rs2075650 (TOMM40/APOE) was associated with lower levels of high-sensitivity C-reactive protein (effect per risk allele: -0.37 mg/l [95% CI -0.56 to -0.18 mg/l]). The inflammatory markers tested showed no association with the remaining 44 SNPs or with the genetic risk score. Conclusions In stable CAD patients, the risk allele of a common CAD-associated marker at the TOMM40/APOE locus was associated with lower hsCRP levels. No other genetic variants or the combined effect of all variants were associated with the five inflammatory biomarkers.	[Christiansen, Morten Krogh; Larsen, Sanne Bojet; Neergaard-Petersen, Sos; Wurtz, Morten; Grove, Erik Lerkevang; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Christiansen, Morten Krogh; Larsen, Sanne Bojet; Grove, Erik Lerkevang; Hvas, Anne-Mette; Jensen, Henrik Kjaerulf; Kristensen, Steen Dalby] Aarhus Univ, Inst Clin Med, Fac Hlth, Aarhus, Denmark; [Nyegaard, Mette] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ajjan, Ramzi] Univ Leeds, Leeds Inst Cardiovasc & Metab Med LICAMM, Leeds, W Yorkshire, England; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Leeds; Aarhus University	Christiansen, MK (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark.; Christiansen, MK (corresponding author), Aarhus Univ, Inst Clin Med, Fac Hlth, Aarhus, Denmark.	mkc@dadlnet.dk	Jensen, Henrik/A-7980-2018; Nyegaard, Mette/M-3379-2019	Jensen, Henrik/0000-0003-1802-4302; Nyegaard, Mette/0000-0003-4973-8543; Christiansen, Morten Krogh/0000-0002-3894-888X	Novo Nordic Foundation [NNF14OC0008817]; Pfizer [WS2632086]; Novo Nordisk Fonden [NNF14OC0008817] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Pfizer(Pfizer); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was received from the Novo Nordic Foundation (grant no. NNF14OC0008817 to SDK) and Pfizer (unrestricted research grant no. WS2632086 to HKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; Christiansen MK, 2017, INT J CARDIOL, P1; Christiansen MK, 2017, ATHEROSCLEROSIS, V257, P172, DOI 10.1016/j.atherosclerosis.2017.01.010; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dorajoo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067650; Ganna A, 2013, ARTERIOSCL THROM VAS, V33, P2267, DOI 10.1161/ATVBAHA.113.301218; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Jensen LJN, 2010, J INTERV CARDIOL, V23, P123, DOI 10.1111/j.1540-8183.2010.00532.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kocarnik JM, 2014, CIRC-CARDIOVASC GENE, V7, P178, DOI 10.1161/CIRCGENETICS.113.000173; Larsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126767; Larsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125992; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; McPherson R., 2014, CURR GENET MED REP, V2, P1, DOI [10.1007/s40142-014-0033-y, DOI 10.1007/S40142-014-0033-Y]; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Neergaard-Petersen S, 2014, THROMB HAEMOSTASIS, V112, P1142, DOI 10.1160/TH14-05-0468; Neergaard-Petersen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071150; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shah T, 2013, CIRC-CARDIOVASC GENE, V6, P163, DOI 10.1161/CIRCGENETICS.112.964254; Vaara S, 2016, CIRC-CARDIOVASC GENE, V9, P172, DOI 10.1161/CIRCGENETICS.115.001271; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yang XB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002916	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180365	10.1371/journal.pone.0180365	http://dx.doi.org/10.1371/journal.pone.0180365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686695	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100054
J	Dorph, A; McDonald, PG				Dorph, Annalie; McDonald, Paul G.			The acoustic repertoire and behavioural context of the vocalisations of a nocturnal dasyurid, the eastern quoll (Dasyurus viverrinus)	PLOS ONE			English	Article							RED DEER; NORTHERN QUOLL; BIRD; COMMUNICATION; HEARING; COMMON; SIZE	Defining an acoustic repertoire is essential to understanding vocal signalling and communicative interactions within a species. Currently, quantitative and statistical definition is lacking for the vocalisations of many dasyurids, an important group of small to medium-sized marsupials from Australasia that includes the eastern quoll (Dasyurus viverrinus), a species of conservation concern. Beyond generating a better understanding of this species' social interactions, determining an acoustic repertoire will further improve detection rates and inference of vocalisations gathered by automated bioacoustic recorders. Hence, this study investigated eastern quoll vocalisations using objective signal processing techniques to quantitatively analyse spectrograms recorded from 15 different individuals. Recordings were collected in conjunction with observations of the behaviours associated with each vocalisation to develop an acoustic-based behavioural repertoire for the species. Analysis of recordings produced a putative classification of five vocalisation types: Bark, Growl, Hiss, Cp-cp, and Chuck. These were most frequently observed during agonistic encounters between conspecifics, most likely as a graded sequence from Hisses occurring in a warning context through to Growls and finally Barks being given prior to, or during, physical confrontations between individuals. Quantitative and statistical methods were used to objectively establish the accuracy of these five putative call types. A multinomial logistic regression indicated a 97.27% correlation with the perceptual classification, demonstrating support for the five different vocalisation types. This putative classification was further supported by hierarchical cluster analysis and silhouette information that determined the optimal number of clusters to be five. Minor disparity between the objective and perceptual classifications was potentially the result of gradation between vocalisations, or subtle differences present within vocalisations not discernible to the human ear. The implication of these different vocalisations and their given context is discussed in relation to the ecology of the species and the potential application of passive acoustic monitoring techniques.	[Dorph, Annalie; McDonald, Paul G.] Univ New England, Sch Environm & Rural Sci, Ctr Behav & Physiol Ecol, Zool, Armidale, NSW, Australia	University of New England	McDonald, PG (corresponding author), Univ New England, Sch Environm & Rural Sci, Ctr Behav & Physiol Ecol, Zool, Armidale, NSW, Australia.	paul.mcdonald@une.edu.au	McDonald, Paul G/A-5928-2010	McDonald, Paul/0000-0002-9541-3304; Dorph, Annalie/0000-0001-8133-080X	University of New England student research funds	University of New England student research funds	This research was supported by University of New England student research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin L, 1996, J EXP ZOOL, V276, P394, DOI 10.1002/(SICI)1097-010X(19961215)276:6<394::AID-JEZ3>3.0.CO;2-I; AITKIN LM, 1994, J COMP NEUROL, V349, P377, DOI 10.1002/cne.903490305; Alexander CH, 1997, P SOC STAT SECT AM S; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bishop Nicolas, 1995, Australian Mammalogy, V18, P99; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boersma P., 2014, PRAAT DOING PHONETIC; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; CONNER DA, 1982, J MAMMAL, V63, P48, DOI 10.2307/1380670; Croft D.B., 1982, P291; Croissant Y., 2013, MLOGIT MULTINOMIAL L; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; Dempster Edith R., 1995, Australian Mammalogy, V18, P27; EISENBERG J F, 1975, Zeitschrift fuer Tierpsychologie, V37, P379; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129420; Fancourt BA, 2013, AUST MAMMAL, V35, P195, DOI 10.1071/AM13004; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; FLEAY D. H., 1935, JOUR MAMMAL, V16, P10, DOI 10.2307/1374524; FLEAY DAVID, 1932, VICTORIAN NAT, V49, P63; Garcia M, 2016, ETHOLOGY, V122, P329, DOI 10.1111/eth.12472; Glen AS, 2006, J ZOOL, V268, P347, DOI 10.1111/j.1469-7998.2006.00064.x; Godsell J., 1982, P199; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; Harrell FE, 2016, HARRELL MISCELLANEOU; Hasan A, 2015, MNLOGIT MULTINOMIAL; Haselmayer J, 2000, CONDOR, V102, P887, DOI 10.1650/0010-5422(2000)102[0887:ACOPCA]2.0.CO;2; Hobson KA, 2002, WILDLIFE SOC B, V30, P709; Ippi S, 2011, IBIS, V153, P789, DOI 10.1111/j.1474-919X.2011.01165.x; Izrael D., 2009, 2009 SAS GLOB FOR CA; Jones M, 1996, NATURE AUSTR, V25, P46; Jones Menna E., 2001, Mammalian Species, V677, P1, DOI 10.1644/1545-1410(2001)677<0001:DV>2.0.CO;2; Kish Leslie., 1992, J OFF STAT, V8, P183; Kortner G, 2004, WILDLIFE RES, V31, P475, DOI 10.1071/WR03041; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Le Roux A, 2009, NATURWISSENSCHAFTEN, V96, P575, DOI 10.1007/s00114-008-0506-5; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2014, SURVEY ANAL COMPLEX; Maechler M., 2016, CLUSTER CLUSTERANALY; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; Marler P., 1976, GROWING POINTS ETHOL, P239; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON SR, 1978, AUST WILDLIFE RES, V5, P163; Naimi B, 2021, RTS RATER TIME SERIE; Negus VE., 1962, COMP ANATOMY PHYSL L; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Novomestky F, 2015, MOMENTS CUMULANTS SK; PEMBERTON D, 1993, AUST J ZOOL, V41, P507, DOI 10.1071/ZO9930507; Potter F., 1990, P SURV RES METH SECT, P225; R Core Team, 2021, R LANGUAGE ENV STAT; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Robbins RL, 2000, BEHAVIOUR, V137, P1271, DOI 10.1163/156853900501926; Rogers TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052542; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Slocombe KE, 2009, ANIM COGN, V12, P441, DOI 10.1007/s10071-008-0204-x; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; TITZE IR, 1987, J SPEECH HEAR RES, V30, P252, DOI 10.1044/jshr.3002.252; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilson E.O., 1975, P1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	69	2	2	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179337	10.1371/journal.pone.0179337	http://dx.doi.org/10.1371/journal.pone.0179337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686679	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100013
J	Iangrai, B; Pattanayak, A; Khongwir, DEA; Pale, G; Gatphoh, EM; Das, A; Chrungoo, NK				Iangrai, Banshanlang; Pattanayak, Arunava; Khongwir, D. Evanoreen Ann; Pale, Gratify; Gatphoh, Emica Mary; Das, Alpana; Chrungoo, Nikhil Kumar			Development and characterization of a new set of genomic microsatellite markers in rice bean (Vigna umbellata (Thunb.) Ohwi and Ohashi) and their utilization in genetic diversity analysis of collections from North East India	PLOS ONE			English	Article							SEQUENCE REPEATS; LINKAGE MAP; SSR-MARKERS; GERMPLASM; IDENTIFICATION; POLYMORPHISMS; HYBRIDIZATION; CONSTRUCTION; SELECTION; SOFTWARE	Rice bean [Vigna umbellate (Thumb.) Ohwi and Ohashi] is an underutilized crop believed to be domesticated in the Myanmar-Thailand region of Asia. In India, rice bean is mainly cultivated in the North-Eastern Hills, which is a hotspot for biological diversity. A 5' anchored PCR was used to develop microsatellite markers in rice bean. Twenty-eight specific primer pairs were designed and employed to characterize sixty five ricebean accessions collected from North East India. A total of 179 alleles were amplified with an average of 6.393 alleles per locus. The gene diversity was high (mean 0.534) in the accessions collected from Darjeeling, Nagaland and Manipur, which are bordering areas with East Nepal and Myanmar, respectively. Exceptionally high outcrossing rate was observed in the entire population. Population structure analysis identified three distinct clusters in which accessions collected from areas bordering Myanmar and East Nepal grouped separately. Using a combination of STRUCTURE and Principal Coordinate Analysis, relative affinity of the intermediate accessions could be established. However, differences in allelic counts among populations were non-significant. The results showed that there is a high level of genetic diversity within the accessions, with high outcrossing rate.	[Iangrai, Banshanlang; Pattanayak, Arunava; Khongwir, D. Evanoreen Ann; Pale, Gratify; Gatphoh, Emica Mary; Das, Alpana] ICAR Res Complex, Ctr Biotechnol, Res Complex NEH Reg, Umiam, Meghalaya, India; [Chrungoo, Nikhil Kumar] North Eastern Hill Univ, Dept Bot, Shillong, Meghalaya, India; [Pattanayak, Arunava] ICAR Vivekananda Parvatiya Krishi Anusandhan Sans, Almora, Uttarakhand, India; [Das, Alpana] CPCRI, Reg Ctr, Gauhati, Assam, India	Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; North Eastern Hill University; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Indian Council of Agricultural Research (ICAR); ICAR - Central Plantation Crops Research Institute	Pattanayak, A (corresponding author), ICAR Res Complex, Ctr Biotechnol, Res Complex NEH Reg, Umiam, Meghalaya, India.; Pattanayak, A (corresponding author), ICAR Vivekananda Parvatiya Krishi Anusandhan Sans, Almora, Uttarakhand, India.	apat.icarneh@gmail.com		Pattanayak, Arunava/0000-0002-8397-9466				ARORA RK, 1980, ECON BOT, V34, P260, DOI 10.1007/BF02858644; Bajracharya J, 2010, 7 BANG U COLL NAT SC; Chen HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0383-5; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Gante HF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0392-3; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Gupta S, 2009, J AGR SCI-CAMBRIDGE, V147, P581, DOI 10.1017/S0021859609008715; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Kaga A, 1996, THEOR APPL GENET, V93, P658, DOI 10.1007/BF00224059; KANDPAL RP, 1994, P NATL ACAD SCI USA, V91, P88, DOI 10.1073/pnas.91.1.88; Khate P, 2009, PLANT CELL REP, V29, P1423; KIJAS JMH, 1994, BIOTECHNIQUES, V16, P656; Lewis PO, 2001, GENETIC DATA ANAL GD; Ling LP, 2011, J GENET, V90, pE101; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Muthusamy S, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-8; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PITCHARD JK, 2000, GENETICS, V155, P945; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Qin Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144108; Roy S, 2015, PLOS ONE, V10, P1; Seehalak W, 2006, GENET RESOUR CROP EV, V53, P1043, DOI 10.1007/s10722-004-7939-2; Shirasawa K, 2013, BREEDING SCI, V63, P21, DOI 10.1270/jsbbs.63.21; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian J, 2013, GENOME, V56, P717, DOI 10.1139/gen-2013-0118; Tiwari KK, 2015, PLANT BREEDING, V134, P164, DOI 10.1111/pbr.12252; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Toomaka N, 2006, PLANT GENOME BIODIVE, P87; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang LX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0259-8; Wang LX, 2016, CROP J, V4, P40, DOI 10.1016/j.cj.2015.09.004; WANG Z, 1994, THEOR APPL GENET, V88, P1, DOI 10.1007/BF00222386; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Yang MH, 2016, CONSERVATION GENET R	44	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179801	10.1371/journal.pone.0179801	http://dx.doi.org/10.1371/journal.pone.0179801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686712	Green Submitted, gold, Green Published			2022-12-27	WOS:000405464100020
J	Blooi, M; Laking, AE; Martel, A; Haesebrouck, F; Jocque, M; Brown, T; Green, S; Vences, M; Bletz, MC; Pasmans, F				Blooi, Mark; Laking, Alexandra E.; Martel, An; Haesebrouck, Freddy; Jocque, Merlijn; Brown, Tom; Green, Stephen; Vences, Miguel; Bletz, Molly C.; Pasmans, Frank			Host niche may determine disease-driven extinction risk	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; PICADOS BROMELIAD TREEFROG; FUNGAL PATHOGEN; POPULATION DECLINES; AMPHIBIAN PATHOGEN; EMERGING DISEASE; PROTECTED AREAS; CHYTRIDIOMYCOSIS; BIODIVERSITY; TEMPERATURE	The fungal pathogen Batrachochytrium dendrobatidis (Bd) drives declines and extinctions in amphibian communities. However, not all regions and species are equally affected. Here, we show that association with amphibian aquatic habitat types (bromeliad phytotelmata versus stream) across Central America results in the odds of being threatened by Bd being five times higher in stream microhabitats. This differential threat of Bd was supported in our study by a significantly lower prevalence of Bd in bromeliad-associated amphibian species compared to riparian species in Honduran cloud forests. Evidence that the bromeliad environment is less favorable for Bd transmission is exemplified by significantly less suitable physicochemical conditions and higher abundance of Bd-ingesting micro-eukaryotes present in bromeliad water. These factors may inhibit aquatic Bd zoospore survival and the development of an environmental reservoir of the pathogen. Bromeliad phytotelmata thus may act as environmental refuges from Bd, which contribute to protecting associated amphibian communities against chytridiomycosis-driven amphibian declines that threaten the nearby riparian communities.	[Blooi, Mark; Laking, Alexandra E.; Martel, An; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Laking, Alexandra E.; Jocque, Merlijn; Brown, Tom; Green, Stephen] Operat Wallacea, Hope House, Old Bolingbroke, Lincs, England; [Jocque, Merlijn] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Green, Stephen] Cornwall Coll Newquay, Ctr Appl Zool, Newquay, Cornwall, England; [Vences, Miguel; Bletz, Molly C.] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Braunschweig, Germany	Ghent University; Stanford University; Braunschweig University of Technology	Pasmans, F (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium.	Frank.Pasmans@UGent.be	Haesebrouck, Freddy/M-3857-2014; Bletz, Molly/Q-2817-2018; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; Bletz, Molly/0000-0003-4120-9356; Laking, Alexandra Elizabeth/0000-0003-4410-7195; Vences, Miguel/0000-0003-0747-0817; Brown, Tom/0000-0003-2333-7127				Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; AmphibiaWeb, INF AMPH DECL NAT HI; Bacigalupe LD, 2017, GLOBAL CHANGE BIOL, V23, P3543, DOI 10.1111/gcb.13610; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Blooi M, 2013, FUNGAL BIOL-UK, V117, P156, DOI 10.1016/j.funbio.2013.01.004; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley PW, 2015, CONSERV BIOL, V29, P1347, DOI 10.1111/cobi.12566; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foissner W, 1996, FRESHWATER BIOL, V35, P375; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Green S, 2012, CUSUCO NATL PARK HON; Hamilton PT, 2012, ECOL EVOL, V2, P2450, DOI 10.1002/ece3.369; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jocque M., 2012, International Journal of Plant Physiology and Biochemistry, V4, P59; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kohler G., 2011, AMPHIBIANS CENTRAL A; Kolby JE, 2011, FROGLOG, V96, P26; Kolby JE, 2010, DIS AQUAT ORGAN, V92, P245, DOI 10.3354/dao02055; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lindquist Erik D., 2011, Herpetological Review, V42, P205; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; R Core Team, 2021, R LANGUAGE ENV STAT; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Ron SR, 2003, J HERPETOL, V37, P116, DOI 10.1670/0022-1511(2003)037[0116:PDOTJT]2.0.CO;2; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Lopez LCS, 2009, HYDROBIOLOGIA, V625, P151, DOI 10.1007/s10750-009-9704-1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Strauss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076035; Stuckert Adam M. M., 2009, Phyllomedusa, V8, P125; The IUCN Red List of Threatened Species, IUCN RED LIST THREAT; Van Rooij P, 2011, ECOHEALTH, V8, P237, DOI 10.1007/s10393-011-0704-z; Vences M, 2016, CONSERV GENET RESOUR, V8, P323, DOI 10.1007/s12686-016-0550-y; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2007, DIS AQUAT ORGAN, V77, P105, DOI 10.3354/dao01850; Witty LM, 2004, PRACTICAL GUIDE TO I; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	67	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181051	10.1371/journal.pone.0181051	http://dx.doi.org/10.1371/journal.pone.0181051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704480	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700083
J	Jimenez, E; Arroyo, R; Cardenas, N; Marin, M; Serrano, P; Fernandez, L; Rodriguez, JM				Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia; Marin, Maria; Serrano, Pilar; Fernandez, Leonides; Rodriguez, Juan M.			Mammary candidiasis: A medical condition without scientific evidence?	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; BREAST-FEEDING WOMEN; INFECTIOUS MASTITIS; BACTERIAL DIVERSITY; LACTATION MASTITIS; CLINICAL SYMPTOMS; HUMAN-MILK; ALBICANS; PAIN; IDENTIFICATION	Many physicians, midwives and lactation consultants still believe that yeasts (particularly Candida spp.) play an important role as an agent of nipple and breast pain despite the absolute absence of scientific proofs to establish such association. In this context, the objective of this study was to investigate the microorganisms involved in sore nipples and/or painful ''shooting'' breastfeeding by using a variety of microscopy techniques, as well as culturedependent and-independent identification methods. Initially, 60 women (30 diagnosed as suffering ''mammary candidiasis'' and 30 with no painful breastfeeding) were recruited to elucidate the role of their pumps on the milk microbial profiles. After realizing the bias introduced by using such devices, manual expression was selected as the collection method for the microbiological analysis of milk samples provided by 529 women with symptoms compatible with ''mammary candidiasis''. Nipple swabs and nipple biopsy samples were also collected from the participating women. Results showed that the role played by yeasts in breast and nipple pain is, if any, marginal. In contrast, our results strongly support that coagulasenegative staphylococci and streptococci (mainly from the mitis and salivarius groups) are the agents responsible for such cases. As a consequence, and following the recommendations of the US Library of Medicine for the nomenclature of infectious diseases, the term ''mammary candidiasis'' or ''nipple thrush'' should be avoided when referring to such condition and replaced by ''subacute mastitis''.	[Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia; Marin, Maria; Fernandez, Leonides; Rodriguez, Juan M.] Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain; [Serrano, Pilar] Hosp Virgen del Rocio, Unidadde Endocrinol & Nutr, Seville, Spain; [Jimenez, Esther; Arroyo, Rebeca; Cardenas, Nivia] Probisearch, Madrid, Spain	Complutense University of Madrid; Virgen del Rocio University Hospital	Rodriguez, JM (corresponding author), Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain.	jmrodrig@ucm.es	Rodriguez, Juan Miguel/ABB-6650-2020; Fernández, Leonides/N-7521-2019	Rodriguez, Juan Miguel/0000-0002-1285-9686; Fernández, Leonides/0000-0003-2380-0767	Ministerio de Economia y Competitividad (Spain) [AGL2016-75476-R]	Ministerio de Economia y Competitividad (Spain)	This work was supported by project AGL2016-75476-R from the Ministerio de Economia y Competitividad (Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir L H, 1991, J Hum Lact, V7, P177, DOI 10.1177/089033449100700414; Amir LH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002351; Andrews JI, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.053; Arroyo R, 2011, ACTA PEDIATR ESP, V69, P276; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Barrett ME, 2013, DERMATOL THER, V26, P331, DOI 10.1111/dth.12071; Beaussart A, 2013, NANOSCALE, V5, P10894, DOI 10.1039/c3nr03272h; Betzold CM, 2012, J MIDWIFERY WOM HEAL, V57, P353, DOI 10.1111/j.1542-2011.2011.00136.x; Brent NB, 2001, CLIN PEDIATR, V40, P503, DOI 10.1177/000992280104000905; Brown SL, 2005, J HUM LACT, V21, P169, DOI 10.1177/0890334405275445; Carmichael AR, 2002, BREAST, V11, P88, DOI 10.1054/brst.2001.0313; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delgado S, 2015, PROCEDURES IN CLINIC, V54; Delgado S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-51; Dixon JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d396; Eglash A, 2006, J HUM LACT, V22, P429, DOI 10.1177/0890334406293431; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Fernandez L, 2016, CLIN INFECT DIS, V62, P568, DOI 10.1093/cid/civ974; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Francis-Morrill J, 2004, J HUM LACT, V20, P288, DOI 10.1177/0890334404267226; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Graves Stephen, 2003, Aust Fam Physician, V32, P570; Hale TW, 2009, BREASTFEED MED, V4, P57, DOI 10.1089/bfm.2008.0144; Heinig M J, 1999, J Hum Lact, V15, P281; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jarvinen KM, 2002, PEDIAT ALLERG IMM-UK, V13, P243, DOI 10.1034/j.1399-3038.2002.00087.x; Jimenez E, 2008, APPL ENVIRON MICROB, V74, P4650, DOI 10.1128/AEM.02599-07; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Johnstone H A, 1990, J Obstet Gynecol Neonatal Nurs, V19, P171, DOI 10.1111/j.1552-6909.1990.tb01636.x; Marin ML, 2009, J PEDIATR GASTR NUTR, V49, P343, DOI 10.1097/MPG.0b013e31818cf53d; MATHESON I, 1988, ACTA OBSTET GYN SCAN, V67, P723, DOI 10.3109/00016349809004296; Mediano P, 2017, J HUM LACT, V33, P309, DOI 10.1177/0890334417692968; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Morrill JF, 2003, J CLIN MICROBIOL, V41, P475, DOI 10.1128/JCM.41.1.475-478.2003; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Park JY, 2011, VET MICROBIOL, V147, P149, DOI 10.1016/j.vetmic.2010.06.021; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Renfrew M, 2012, PREVENTING DIS SAVIN; Schoenfelder SMK, 2010, INT J MED MICROBIOL, V300, P380, DOI 10.1016/j.ijmm.2010.04.011; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shin JH, 1997, J CLIN MICROBIOL, V35, P1454, DOI 10.1128/JCM.35.6.1454-1459.1997; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Thomassen P, 1998, GYNECOL OBSTET INVES, V46, P73, DOI 10.1159/000010004; THOMSEN AC, 1985, ACTA OBSTET GYN SCAN, V64, P163, DOI 10.3109/00016348509154711; Thorberg BM, 2009, J DAIRY SCI, V92, P4962, DOI 10.3168/jds.2009-2184; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACT SU; Walker M, 2008, J PERINAT NEONAT NUR, V22, P267, DOI 10.1097/01.JPN.0000341356.45446.23; Witt A, 2014, BREASTFEED MED, V9, P29, DOI 10.1089/bfm.2013.0012; Zhang SL, 2000, INFECT IMMUN, V68, P1102, DOI 10.1128/IAI.68.3.1102-1108.2000	50	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0181071	10.1371/journal.pone.0181071	http://dx.doi.org/10.1371/journal.pone.0181071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704470	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700087
J	Song, YK; Kilburn, D; Song, JH; Cheng, YL; Saeui, CT; Cheung, DG; Croce, CM; Yarema, KJ; Meltzer, SJ; Liu, KJ; Wang, TH				Song, Yunke; Kilburn, Duncan; Song, Jee Hoon; Cheng, Yulan; Saeui, Christopher T.; Cheung, Douglas G.; Croce, Carlo M.; Yarema, Kevin J.; Meltzer, Stephen J.; Liu, Kelvin J.; Wang, Tza-Huei			Determination of absolute expression profiles using multiplexed miRNA analysis	PLOS ONE			English	Article							DROPLET DIGITAL PCR; DOWN-REGULATION; CELL-CYCLE; RT-PCR; CANCER; QUANTIFICATION; MICRORNAS; GENERATION; MIR-15A; IDENTIFICATION	Accurate measurement of miRNA expression is critical to understanding their role in gene expression as well as their application as disease biomarkers. Correct identification of changes in miRNA expression rests on reliable normalization to account for biological and technological variance between samples. Ligo-miR is a multiplex assay designed to rapidly measure absolute miRNA copy numbers, thus reducing dependence on biological controls. It uses a simple 2-step ligation process to generate length coded products that can be quantified using a variety of DNA sizing methods. We demonstrate Ligo-miR's ability to quantify miRNA expression down to 20 copies per cell sensitivity, accurately discriminate between closely related miRNA, and reliably measure differential changes as small as 1.2-fold. Then, benchmarking studies were performed to show the high correlation between Ligo-miR, microarray, and TaqMan qRT-PCR. Finally, Ligo-miR was used to determine copy number profiles in a number of breast, esophageal, and pancreatic cell lines and to demonstrate the utility of copy number analysis for providing layered insight into expression profile changes.	[Song, Yunke; Saeui, Christopher T.; Yarema, Kevin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Kilburn, Duncan; Liu, Kelvin J.] Circulomics Inc, Baltimore, MD 21202 USA; [Song, Jee Hoon; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA; [Song, Jee Hoon; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Cheung, Douglas G.; Croce, Carlo M.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Liu, Kelvin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Wang, Tza-Huei] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Wang, Tza-Huei] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Wang, TH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Kilburn, D (corresponding author), Circulomics Inc, Baltimore, MD 21202 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Wang, TH (corresponding author), Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA.	dkilburn@circulomics.com; thwang@jhu.edu	Young, Richard A/F-6495-2012; Liu, Kelvin/F-5432-2010	Young, Richard A/0000-0001-8855-8647; Liu, Kelvin/0000-0002-1164-582X; Wang, Tza-Huei/0000-0002-3540-9354	National Institute of Health [1R43GM103360, 2R44GM103360, F31CA192767, 5R21CA191715, T32-GM086252, P30 CA006973, CA190040, CA211457, R21CA173390, R21CA186809]; Johns Hopkins University[JHU Synergy Award]; OSU/HHMI Medin to Grad Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM103360, T32GM086252, R43GM103360] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021567] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University[JHU Synergy Award]; OSU/HHMI Medin to Grad Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health [grant numbers 1R43GM103360, 2R44GM103360, F31CA192767, 5R21CA191715, T32-GM086252 to DGC, P30 CA006973, CA190040, CA211457, R21CA173390, R21CA186809]; Johns Hopkins University[JHU Synergy Award]; OSU/HHMI	Amin M, 2015, EXP MOL PATHOL, V98, P411, DOI 10.1016/j.yexmp.2015.03.002; Ayers D, 2015, COMPUT STRUCT BIOTEC, V13, P307, DOI 10.1016/j.csbj.2015.04.003; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cappella P, 2001, INT J CANCER, V93, P401, DOI 10.1002/ijc.1351.abs; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; HUANG P, 1995, SEMIN ONCOL, V22, P19; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kestens C, 2016, WORLD J GASTROENTERO, V22, P1, DOI 10.3748/wjg.v22.i1.1; Kilburn D, 2017, METHODS MOL BIOL, V1509, P185, DOI 10.1007/978-1-4939-6524-3_17; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu KJ, 2011, J AM CHEM SOC, V133, P6898, DOI 10.1021/ja200279y; Lohman GJS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv898; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; Luo QF, 2013, INT J ONCOL, V43, P1212, DOI 10.3892/ijo.2013.2034; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Roberts TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089237; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shinden Y, 2015, ANTICANCER RES, V35, P123; Showalter AK, 2006, CHEM REV, V106, P340, DOI 10.1021/cr040487k; Song Y, 2015, NAT PUBL GR, V5, P1; Song YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089725; Sorbara L, 2014, CANC RES, V69; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Veigaard C, 2014, GENOMICS, V104, P271, DOI 10.1016/j.ygeno.2014.08.002; Vigneron N, 2016, MOL ONCOL, V10, P981, DOI 10.1016/j.molonc.2016.03.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Wu HL, 2009, EXPERT OPIN THER TAR, V13, P1439, DOI 10.1517/14728220903338777; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199	59	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180988	10.1371/journal.pone.0180988	http://dx.doi.org/10.1371/journal.pone.0180988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704432	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649700070
J	Sorensen, M; Gong, YY; Bjarnason, F; Vasanth, GK; Dahle, D; Huntley, M; Kiron, V				Sorensen, Mette; Gong, Yangyang; Bjarnason, Fridrik; Vasanth, Ghana K.; Dahle, Dalia; Huntley, Mark; Kiron, Viswanath			Nannochloropsis oceania-derived defatted meal as an alternative to fishmeal in Atlantic salmon feeds	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; SALAR FED DIETS; ONCORHYNCHUS-MYKISS; GROWTH-PERFORMANCE; NUTRIENT DIGESTIBILITY; PARTIAL REPLACEMENT; MARINE MICROALGAE; DISTAL INTESTINE; PHYSICAL QUALITY; PRIMARY DEFENSE	Defatted microalgal biomass derived from biorefinery can be potential feed ingredients for carnivorous fish. The present study investigated the growth, feed intake: gain and health parameters in Atlantic salmon fed for 84 days with defatted Nannochloropsis oceania as a fishmeal replacer. Fish fed feeds containing the algal biomass (at 10 and 20% inclusion, alga groups) were compared with groups that consumed alga-devoid feeds (control group). The fish that received 20% alga tended to have reduced weight gain and specific growth rate. Condition factor, feed conversion ratio and feed intake of this fish group were significantly different when compared with the control group. Hepatosomatic and viscerosomatic indices, whole body and fillet proximate composition were not affected by the dietary treatments. Digestibility of dry matter, protein, lipid, ash and energy, as well as retention of lipid and energy of the fish that received feed with 20% alga meal were also significantly different from those of the control group. Serum superoxide dismutase activity of the 10% alga-fed fish was significantly higher compared with the control fish. Although alga feeding did not cause any distal intestinal inflammation, the intestinal proteins that were altered upon feeding 20% algal meal might be pointing to systemic physiological disturbances. In conclusion, feeds with 20% alga had a negative effect on feed intake, FCR, lipid and energy retention and health of the fish. The defatted Nannochloropsis oceania can be used at modest inclusion levels, around 10%, without negative effects on the performance of Atlantic salmon.	[Sorensen, Mette; Gong, Yangyang; Bjarnason, Fridrik; Vasanth, Ghana K.; Dahle, Dalia; Kiron, Viswanath] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Gong, Yangyang] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Huntley, Mark] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Huntley, Mark] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	Nord University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Cornell University; Duke University	Sorensen, M (corresponding author), Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway.	mette.sorensen@nord.no		Sorensen, Mette/0000-0003-3557-3768	US Department of Energy [DE-EE0003371]; China Scholarship Council; East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences	US Department of Energy(United States Department of Energy (DOE)); China Scholarship Council(China Scholarship Council); East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences	This study was a part of the project Large-scale production of fuels and feed from marine microalgae funded by the US Department of Energy (Grant DE-EE0003371). Yangyang Gong was financially supported by a fellowship from the China Scholarship Council as well as the funding from East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences. The funding agencies had no role in the design, analyses or writing of this article.	ABIODUN PO, 1985, EUR J PEDIATR, V144, P368, DOI 10.1007/BF00441779; Alne H, 2011, AQUAC RES, V42, P248, DOI 10.1111/j.1365-2109.2010.02618.x; Arguelles S, 2011, MECH AGEING DEV, V132, P55, DOI 10.1016/j.mad.2010.12.002; AUSTRENG E, 1978, AQUACULTURE, V13, P265, DOI 10.1016/0044-8486(78)90008-X; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke A., 2011, AV NUTR AC 11 MEM DE; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Becker W., 2004, Handbook of microalgal culture: biotechnology and applied phycology, P312; Berge GM, 2013, AQUACULT NUTR, V19, P110, DOI 10.1111/anu.12092; Cho C. Y., 1979, Finfish nutrition and fishfeed technology. Volume 2, P239; Concha MI, 2003, FISH SHELLFISH IMMUN, V14, P259, DOI 10.1006/fsim.2002.0435; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Einen O, 1997, AQUACULT NUTR, V3, P115, DOI 10.1046/j.1365-2095.1997.00084.x; Gatrell SK, 2015, J AGR FOOD CHEM, V63, P9315, DOI 10.1021/acs.jafc.5b03137; Ghosh A, 2016, ENERG CONVERS MANAGE, V113, P104, DOI 10.1016/j.enconman.2016.01.050; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Gong Y, 2017, AQUACULT NUTR; GrisdaleHelland B, 1997, AQUACULTURE, V152, P167, DOI 10.1016/S0044-8486(97)00003-3; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hatlen B, 2012, AQUACULTURE, V364, P39, DOI 10.1016/j.aquaculture.2012.07.005; HEMRE GI, 1989, AQUACULTURE, V80, P261, DOI 10.1016/0044-8486(89)90174-9; Hulatt CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170440; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntley ME, 2015, ALGAL RES, V10, P249, DOI 10.1016/j.algal.2015.04.016; Irvin S, 2015, AQUACULT NUTR; Justet C, 2015, CELL TISSUE RES, V362, P557, DOI 10.1007/s00441-015-2223-7; Kenney Justin W., 2014, Advances in Biological Regulation, V55, P15, DOI 10.1016/j.jbior.2014.04.003; Kim SS, 2013, TURK J FISH AQUAT SC, V13, P197, DOI 10.4194/1303-2712-v13_2_01; Kiron V, 2012, AQUACULT NUTR, V18, P521, DOI 10.1111/j.1365-2095.2011.00923.x; Kiron V, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00067; Kiron V, 2016, DEV COMP IMMUNOL, V56, P57, DOI 10.1016/j.dci.2015.11.007; Kissinger KR, 2016, AQUACULTURE, V452, P37, DOI 10.1016/j.aquaculture.2015.10.022; Knudsen D, 2007, J AGR FOOD CHEM, V55, P2261, DOI 10.1021/jf0626967; Kousoulaki K, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.14; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Krogdahl A, 2004, AQUACULTURE, V229, P335, DOI 10.1016/S0044-8486(03)00396-X; Krogdahl A, 2005, AQUACULT NUTR, V11, P103, DOI 10.1111/j.1365-2095.2004.00327.x; Lang IK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-124; Lekva A, 2010, AQUACULTURE, V300, P169, DOI 10.1016/j.aquaculture.2010.01.001; Moazami N, 2012, BIOMASS BIOENERG, V39, P449, DOI 10.1016/j.biombioe.2012.01.046; Moldal T, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-60; NAKAGAWA H, 1986, B JPN SOC SCI FISH, V52, P1887; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124042; Palmegiano GB, 2005, AQUAC RES, V36, P188, DOI 10.1111/j.1365-2109.2005.01209.x; Patterson D, 2013, AQUACULTURE, V416, P92, DOI 10.1016/j.aquaculture.2013.08.033; Refstie S, 1998, AQUACULTURE, V162, P301, DOI 10.1016/S0044-8486(98)00222-1; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; SHEARER KD, 1994, AQUACULTURE, V119, P63, DOI 10.1016/0044-8486(94)90444-8; Skrede A, 2011, J ANIM FEED SCI, V20, P131, DOI 10.22358/jafs/66164/2011; Sorensen M, 2005, AQUACULT NUTR, V11, P251, DOI 10.1111/j.1365-2095.2005.00347.x; Sorensen M, 2011, AQUACULT NUTR, V17, pE326, DOI 10.1111/j.1365-2095.2010.00767.x; Sorensen M, 2002, AQUACULTURE, V211, P215, DOI 10.1016/S0044-8486(01)00887-0; Sorensen M, 2016, AQUACULTURE, V460, P116, DOI 10.1016/j.aquaculture.2016.04.010; Sorensen M, 2011, AQUACULTURE, V314, P145, DOI 10.1016/j.aquaculture.2011.02.013; Sorensen M, 2010, AQUAC RES, V41, P419, DOI 10.1111/j.1365-2109.2009.02346.x; Sprague M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21892; Tibaldi E, 2015, AQUACULTURE, V440, P60, DOI 10.1016/j.aquaculture.2015.02.002; Vasanth G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00409; Villarroel F, 2007, FISH SHELLFISH IMMUN, V23, P197, DOI 10.1016/j.fsi.2006.10.008; VIRCA GD, 1984, EUR J BIOCHEM, V144, P1, DOI 10.1111/j.1432-1033.1984.tb08423.x; Walker AB, 2011, N AM J AQUACULT, V73, P76, DOI 10.1080/15222055.2010.549030; Wei JG, 2015, FISH SHELLFISH IMMUN, V43, P396, DOI 10.1016/j.fsi.2015.01.006; Yi Young-Ho, 1994, Bulletin of the Korean Fisheries Society, V27, P69; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	65	55	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179907	10.1371/journal.pone.0179907	http://dx.doi.org/10.1371/journal.pone.0179907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704386	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000405649700019
J	Tapio, I; Fischer, D; Blasco, L; Tapio, M; Wallace, RJ; Bayat, AR; Ventto, L; Kahala, M; Negussie, E; Shingfield, KJ; Vilkki, J				Tapio, Ilma; Fischer, Daniel; Blasco, Lucia; Tapio, Miika; Wallace, R. John; Bayat, Ali R.; Ventto, Laura; Kahala, Minna; Negussie, Enyew; Shingfield, Kevin J.; Vilkki, Johanna			Taxon abundance, diversity, co-occurrence and network analysis of the ruminal microbiota in response to dietary changes in dairy cows	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RUMEN BACTERIAL; PHYLUM NEOCALLIMASTIGOMYCOTA; CELLULOLYTIC BACTERIA; METHANOGENIC ARCHAEA; FUNGAL DIVERSITY; COMMUNITY; OIL; DEGRADATION; POPULATIONS	The ruminal microbiome, comprising large numbers of bacteria, ciliate protozoa, archaea and fungi, responds to diet and dietary additives in a complex way. The aim of this study was to investigate the benefits of increasing the depth of the community analysis in describing and explaining responses to dietary changes. Quantitative PCR, ssu rRNA amplicon based taxa composition, diversity and co-occurrence network analyses were applied to ruminal digesta samples obtained from four multiparous Nordic Red dairy cows fitted with rumen cannulae. The cows received diets with forage: concentrate ratio either 35: 65 (diet H) or 65: 35 (L), supplemented or not with sunflower oil (SO) (0 or 50 g/kg diet dry matter), supplied in a 4 x 4 Latin square design with a 2 x 2 factorial arrangement of treatments and four 35-day periods. Digesta samples were collected on days 22 and 24 and combined. QPCR provided a broad picture in which a large fall in the abundance of fungi was seen with SO in the H but not the L diet. Amplicon sequencing showed higher community diversity indices in L as compared to H diets and revealed diet specific taxa abundance changes, highlighting large differences in protozoal and fungal composition. Methanobrevibacter ruminantium and Mbb. gottschalkii dominated archaeal communities, and their abundance correlated negatively with each other. Co-occurrence network analysis provided evidence that no microbial domain played a more central role in network formation, that some minor-abundance taxa were at nodes of highest centrality, and that microbial interactions were diet specific. Networks added new dimensions to our understanding of the diet effect on rumen microbial community interactions.	[Tapio, Ilma; Fischer, Daniel; Tapio, Miika; Bayat, Ali R.; Ventto, Laura; Negussie, Enyew; Shingfield, Kevin J.; Vilkki, Johanna] Nat Resources Inst Finland, Green Technol, Jokioinen, Finland; [Blasco, Lucia; Kahala, Minna] Nat Resources Inst Finland, Biobased Business & Ind, Jokioinen, Finland; [Wallace, R. John] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Shingfield, Kevin J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Aberdeen; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Tapio, I (corresponding author), Nat Resources Inst Finland, Green Technol, Jokioinen, Finland.	ilma.tapio@luke.fi	Tapio, Miika/AAA-7043-2020; Kahala, Minna/AAQ-1743-2020; Fischer, Daniel/C-8791-2017; Bayat, Ali-Reza/O-5769-2016	Fischer, Daniel/0000-0002-7513-683X; Bayat, Ali-Reza/0000-0002-4894-0662; Tapio, Ilma/0000-0002-0752-9551; Kahala, Minna/0000-0003-0679-3729; Negussie, Enyew/0000-0003-4892-9938	Finnish Ministry of Agriculture and Forestry, GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production) [2908234]; BBSRC [BB/J016608/1] Funding Source: UKRI	Finnish Ministry of Agriculture and Forestry, GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Study was funded by the Finnish Ministry of Agriculture and Forestry as part of the GreenDairy Project (Developing Genetic and Nutritional Tools to Mitigate the Environmental Impact of Milk Production; Project No. 2908234). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldassano SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26087; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bates D., 2016, MATRIX SPARSE DENSE; Bayat AR, 2015, J DAIRY SCI, V98, P3166, DOI 10.3168/jds.2014-7976; Belanche A, 2012, J ANIM SCI, V90, P4495, DOI 10.2527/jas.2012-5118; Belanche A, 2012, J NUTR, V142, P1684, DOI 10.3945/jn.112.159574; Belenguer A, 2010, J DAIRY SCI, V93, P3275, DOI 10.3168/jds.2010-3101; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Boots B, 2013, J APPL MICROBIOL, V114, P626, DOI 10.1111/jam.12067; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DEMEYER DI, 1981, AGR ENVIRON, V6, P295, DOI 10.1016/0304-1131(81)90020-5; Denman SE, 2008, LETT APPL MICROBIOL, V47, P492, DOI 10.1111/j.1472-765X.2008.02449.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Forsberg Cecil W., 1997, P319; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Hristov AN, 2012, J ANIM SCI, V90, P4449, DOI 10.2527/jas.2011-4624; Huhtanen P, 2013, AGR FOOD SCI, V22, P35, DOI 10.23986/afsci.6632; Huws SA, 2015, MICROB BIOTECHNOL, V8, P331, DOI 10.1111/1751-7915.12164; Ivan M, 2001, SMALL RUMINANT RES, V41, P215, DOI 10.1016/S0921-4488(01)00220-6; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Joblin KN, 2002, CURR MICROBIOL, V45, P46, DOI 10.1007/s00284-001-0078-5; Kim M, 2011, FOLIA MICROBIOL, V56, P453, DOI 10.1007/s12223-011-0066-5; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kittelmann Sandra, 2013, PLoS One, V8, pe47879, DOI 10.1371/journal.pone.0047879; Koetschan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091928; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oksanen J., **DATA OBJECT**; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Popova M, 2011, ANIM FEED SCI TECH, V166-67, P113, DOI 10.1016/j.anifeedsci.2011.04.060; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2016, R LANG ENV STAT COMP; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Shingfield KJ, 2013, ANIMAL, V7, P132, DOI 10.1017/S1751731112001681; Tapio I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151220; Taxis TM, 2015, NUCLEIC ACIDS RES, V43, P9600, DOI 10.1093/nar/gkv973; Ventto L, 2017, BRIT J NUTR, V117, P364, DOI [10.1017/S0007114517000010, 10.1017/s0007114517000010]; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	57	51	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180260	10.1371/journal.pone.0180260	http://dx.doi.org/10.1371/journal.pone.0180260			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704445	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700033
J	Zhao, WQ; Gong, CX; Ouyang, ZH; Wang, PF; Wang, J; Zhou, PP; Zheng, NG; Gong, ZF				Zhao, Weiqiao; Gong, Caixia; Ouyang, Zhenhuan; Wang, Pengfei; Wang, Jie; Zhou, Peipei; Zheng, Nenggan; Gong, Zhefeng			Turns with multiple and single head cast mediate Drosophila larval light avoidance	PLOS ONE			English	Article							GENETIC-ANALYSIS; DECISION-MAKING; NEURONS; PHOTOBEHAVIOR; THERMOTAXIS; LOCOMOTION; DISSECTION; PREFERENCE; PHOTOTAXIS; BEHAVIOR	Drosophila larvae exhibit klinotaxis when placed in a gradient of temperature, chemicals, or light. The larva samples environmental stimuli by casting its head from side to side. By comparing the results of two consecutive samples, it decides the direction of movement, appearing as a turn proceeded by one or more head casts. Here by analyzing larval behavior in a light-spot-based phototaxis assay, we showed that, in addition to turns with a single cast (1cast), turns with multiple head casts (n-cast) helped to improve the success of light avoidance. Upon entering the light spot, the probability of escape from light after the first head cast was only similar to 30%. As the number of head casts increased, the chance of successful light avoidance increased and the overall chance of escaping from light increased to >70%. The amplitudes of first head casts that failed in light avoidance were significantly smaller in n cast turns than those in 1-cast events, indicating that n-cast turns might be planned before completion of the first head cast. In n-casts, the amplitude of the second head cast was generally larger than that of the first head cast, suggesting that larvae tried harder in later attempts to improve the efficacy of light avoidance. We propose that both 1-cast turns and n-cast turns contribute to successful larval light avoidance, and both can be initiated at the first head cast.	[Zhao, Weiqiao; Gong, Caixia; Wang, Jie; Zhou, Peipei; Gong, Zhefeng] Zhejiang Univ, Sch Med, Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou, Zhejiang, Peoples R China; [Ouyang, Zhenhuan; Wang, Pengfei; Zheng, Nenggan] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gong, ZF (corresponding author), Zhejiang Univ, Sch Med, Key Lab Neurobiol, Dept Neurobiol,Key Lab Med Neurobiol,Minist Hlth, Hangzhou, Zhejiang, Peoples R China.; Zheng, NG (corresponding author), Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China.	zng@cs.zju.edu.cn; zfgong@zju.edu.cn		ZHOU, Peipei/0000-0002-1798-3344	National Basic Research Program of China (973 Program) [2013CB945603]; National Natural Science Foundation of China [31070944, 31271147, 31471063, 31671074, 61572433]; Natural Science Foundation of Zhejiang Province [LR13C090001, LZ14F020002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Basic Research Program of China (973 Program 2013CB945603), the National Natural Science Foundation of China (31070944, 31271147, 31471063, 31671074, and 61572433), and the Natural Science Foundation of Zhejiang Province (LR13C090001 and LZ14F020002).	Busto M, 1999, J NEUROSCI, V19, P3337; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Davies A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004606; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gong ZF, 2010, SCIENCE, V330, P499, DOI 10.1126/science.1195993; Gong ZF, 2009, BIOCHEM BIOPH RES CO, V382, P395, DOI 10.1016/j.bbrc.2009.03.033; Hassan J, 2000, BEHAV GENET, V30, P59, DOI 10.1023/A:1002090627601; Hernandez-Nunez L, 2015, ELIFE, V4, DOI 10.7554/eLife.06225; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; Klein M, 2015, P NATL ACAD SCI USA, V112, pE220, DOI 10.1073/pnas.1416212112; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schulze A, 2015, ELIFE, V4, DOI 10.7554/eLife.06694; Tastekin I, 2015, CURR BIOL, V25, P1448, DOI 10.1016/j.cub.2015.04.016; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210	24	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0181193	10.1371/journal.pone.0181193	http://dx.doi.org/10.1371/journal.pone.0181193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700684	gold, Green Submitted, Green Published			2022-12-27	WOS:000405649400037
J	Fang, WF; Chen, YM; Lin, CY; Huang, KT; Kao, HC; Fang, YT; Huang, CH; Chang, YT; Wang, YH; Wang, CC; Lin, MC				Fang, Wen-Feng; Chen, Yu-Mu; Lin, Chiung-Yu; Huang, Kuo-Tung; Kao, Hsu-Ching; Fang, Ying-Tang; Huang, Chi-Han; Chang, Ya-Ting; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih			Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LUNG-CANCER; FEBRILE NEUTROPENIA; LEVELS CORRELATE; DR EXPRESSION; HLA-DR; PLACE; DEATH; IMMUNOTHERAPY; INTERLEUKIN-6	Background Immunoparalysis was observed in both patients with cancer and sepsis. In cancer patients, Cytotoxic T lymphocyte antigen-4 and programmed cell death protein 1/programmed deathligand 1 axis are two key components of immunoparalysis. Several emerging therapies against these two axes gained significant clinical benefit. In severe sepsis patients, immunoparalysis was known as compensatory anti- inflammatory response syndrome and this has been suggested as an important cause of death in patients with sepsis. It would be interesting to see if immune status was different in severe sepsis patients with or without active cancer. The aim of this study was to assess the differences in immune profiles, and clinical outcomes between severe sepsis patients with or without cancer admitted to ICU. Methods A combined retrospective and prospective observational study from a cohort of adult sepsis patients admitted to three medical ICUs at Kaohsiung Chang Gung Memorial Hospital in Taiwan between August 2013 and June 2016. Results Of the 2744 patients admitted to the ICU, 532 patients with sepsis were included. Patients were divided into those with or without active cancer according to their medical history. Of the 532 patients, 95 (17.9%) patients had active cancer, and 437 (82.1%) patients had no active cancer history. Patients with active cancer were younger (p = 0.001) and were less likely to have diabetes mellitus (p< 0.001), hypertension (p< 0.001), coronary artery disease (p = 0.004), chronic obstructive pulmonary disease (p = 0.002) or stroke ( p = 0.002) compared to patients without active cancer. Patients with active cancer also exhibited higher baseline lactate levels (p = 0.038), and higher baseline plasma interleukin (IL)- 10 levels ( p = 0.040), higher trend of granulocyte colony-stimulating factor (G-CSF) ( p = 0.004) compared to patients without active cancer. The 14-day, 28-day and 90-day mortality rates were higher for patients with active cancer than those without active cancer (P < 0.001 for all intervals). Conclusions Among patients admitted to the ICU with sepsis, those with underling active cancer had higher baseline levels of plasma IL-10, higher trend of G-CSF and higher mortality rate than those without active cancer.	[Fang, Wen-Feng; Chen, Yu-Mu; Lin, Chiung-Yu; Huang, Kuo-Tung; Kao, Hsu-Ching; Fang, Ying-Tang; Huang, Chi-Han; Chang, Ya-Ting; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Internal Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Fang, WF; Lin, MC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Internal Med,Div Pulm & Critical Care Med, Kaohsiung, Taiwan.; Fang, WF; Lin, MC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.; Fang, WF (corresponding author), Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan.	wenfeng@cgmh.org.tw; mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021	Fang, Wen-Feng/0000-0003-0350-9059; Huang, Chi-Han/0000-0002-3393-1587	Chang Gung Memorial Hospital Grant [CMRPG8B1061, CMRPG8B1062, CMRPG8B1063, CMRPG8C0551, CMRPG8C0052, CMRPG8B1071, CMRPG8B1081]; Taiwan Ministry of Science and Technology [MOST 104-2314-B-182A-123-]	Chang Gung Memorial Hospital Grant(Chang Gung Memorial Hospital); Taiwan Ministry of Science and Technology	The work is supported in part by grants from the Chang Gung Memorial Hospital Grant (CMRPG8B1061, CMRPG8B1062, CMRPG8B1063, CMRPG8C0551, and CMRPG8C0052 to WF Fang; CMRPG8B1071 to 73 to YH Wang; CMRPG8B1081 to 83 to CCWang) and a grant from Taiwan Ministry of Science and Technology (MOST 104-2314-B-182A-123-) to WF Fang.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Allareddy Veerasathpurush, 2015, J Mass Dent Soc, V64, P38; Arens C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1233-5; Bird GT, 2012, BRIT J ANAESTH, V108, P452, DOI 10.1093/bja/aer449; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cohen J, 2015, BRIT J CANCER, V113, P1397, DOI 10.1038/bjc.2015.312; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Hawari FI, 2016, CRIT CARE MED, V44, P548, DOI 10.1097/CCM.0000000000001429; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Jarosek SL, 2016, J AM GERIATR SOC, V64, P1815, DOI 10.1111/jgs.14269; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kumar S, 2010, INDIAN J PATHOL MICR, V53, P494, DOI 10.4103/0377-4929.68290; Landy R, 2016, BR J CANC; Lee LC, 2014, AM J HOSP PALLIAT ME, V31, P300, DOI 10.1177/1049909113487427; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lim GH, 2012, SINGAP MED J, V53, P3; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mhaskar R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003039.pub2; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2014, CRIT CARE, V18, DOI 10.1186/cc13179; Murphy CC, 2016, CLIN GASTROENTEROL H; O'Dowd EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161399; Obeng-Nkrumah Noah, 2015, BMC Res Notes, V8, P742, DOI 10.1186/s13104-015-1701-z; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Reilly JP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1398-y; Samuels S, 2016, INT J GYNECOL CANCER, V26, P1503, DOI 10.1097/IGC.0000000000000783; Santegoets SJAM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030029; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Sundar KM, 2013, INDIAN J CRIT CARE M, V17, P162, DOI 10.4103/0972-5229.117054; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Urbonas V, 2012, CYTOKINE, V57, P313, DOI 10.1016/j.cyto.2011.11.012; VandenBerk JMM, 1997, TRANSPLANTATION, V63, P1846, DOI 10.1097/00007890-199706270-00026; Vanska M, 2012, CYTOKINE, V60, P787, DOI 10.1016/j.cyto.2012.07.023; Wittayachamnankul B, 2016, J CRIT CARE, V36, P223, DOI 10.1016/j.jcrc.2016.08.002; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Xiao LH, 2016, ASIAN J ANDROL; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Young KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157164	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0179749	10.1371/journal.pone.0179749	http://dx.doi.org/10.1371/journal.pone.0179749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692671	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800015
J	Bai, YJ; Li, XQ				Bai, Yunjun; Li, Xiaoqiang			Late Miocene Pseudolarix amabilis bract-scale complex from Zhejiang, East China	PLOS ONE			English	Article							NICHE STABILITY; CLIMATE-CHANGE; RAIN-FOREST; EOCENE; EVOLUTION; RESPONSES; DYNAMICS; GERMANY; FLORAS; SHIFTS	Previously, the identification of fossil Pseudolarix at the species level has been based on the morphology of the bract-scale complex of the seed cone. The morphological consistence of fossils through most of the Cenozoic with extant P. amabilis has led them to be considered conspecific, suggesting that P. amabilis is an extraordinary example of morphological stasis. However, the lack of cuticular evidence, especially for the leaf-homologous bract, reduces the accuracy of fossil identification based on morphology, thus weakening the evidence for morphological stasis in P. amabilis. For the first time, we provide cuticular evidence of the bract-scale of fossil P. amabilis based on the bract-scale complex from the late Miocene Shengxian Formation, Zhejiang, East China, which improves the identification accuracy and reinforces the concept of morphological stasis in this species. Second, we preliminarily reveal the niche stability of P. amabilis, which corresponds to its morphological stasis. Finally, we infer that the late Miocene forest containing P. amabilis in Zhejiang was an evergreen sclerophyllous broad-leaved or mixed mesophytic forest, which combined with the evergreen broad-leaved forest suggested by previous megafossil studies, indicates the occurrence of vertical vegetation zonation.	[Bai, Yunjun; Li, Xiaoqiang] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Li, XQ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	lixiaoqiang@ivpp.ac.cn			National Natural Science Foundation of China [41602188]; National Basic Research Program of China [2015CB953803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (grant no. 41602188, YB [http://www.nsfc.gov.cn/]) and the National Basic Research Program of China (grant no. 2015CB953803, XL [http://www.nsfc.gov.cn/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axsmith BJ, 1998, AM J BOT, V85, P704, DOI 10.2307/2446541; Brown CJ, 2016, GLOBAL CHANGE BIOL, V22, P1548, DOI 10.1111/gcb.13184; Cai RH, 1988, J HANGZHOU U, V15, P344; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dillhoff RM, 2013, BOTANY, V91, P514, DOI 10.1139/cjb-2012-0313; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; ELDREDGE N, 1989, MACROEVOLUTIONARY DY; Farjon A, 1990, PINACEAE; Farjon Aljos, 2002, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V124, P129, DOI 10.1127/0006-8152/2002/0124-0129; FLORIN R, 1954, BIOL REV, V29, P367, DOI 10.1111/j.1469-185X.1954.tb01515.x; FLORSCHUTZ F, 1925, REC TRAV BOT NEERL, V22, P269; Fu L., 1999, FLORA CHINA, V4, P11, DOI DOI 10.1038/35093166.PMID:11557970; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; GOOCH NL, 1992, PALEOBIOS, V14, P13; Greenwood DR, 2010, GEOLOGY, V38, P15, DOI 10.1130/G30218.1; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Hills L, 1967, B CAN PETROL GEOL, V15, P138; Ho KS, 2003, CHEM GEOL, V197, P287, DOI 10.1016/S0009-2541(02)00399-6; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Keller AM, 1997, PALAIOS, V12, P282, DOI 10.2307/3515428; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Laurent L, 1923, MEDED RIJKS GEOL DIE, V1, P1; LEPAGE BA, 1995, INT J PLANT SCI, V156, P910, DOI 10.1086/297313; Li HM, 1982, ATLAS PALEONTOLOGY E, P280; Li HM, 1984, PALAEOBOTANY PALAEOZ, V2, P461; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Mai D.H., 2000, RANDGEBIETEALTENBURG, V13, P1; Mai DH., 1995, TERTI RE VEGETATIONS; Mai DH, 1991, ABH STAATL MUS MIN G, V38, P1; Malizia RW, 2011, PALAEOGEOGR PALAEOCL, V311, P154, DOI 10.1016/j.palaeo.2011.08.017; Mili S., 1957, Journal of the Institute of Polytechnics, Osaka City University, Osaka Ser. D., P221; Reid C, 1915, MEMOIRS GOVT I GEOLO, V6, P1, DOI DOI 10.5962/BHL.TITLE.57075; Roth-Nebelsick A, 2004, PALAEOGEOGR PALAEOCL, V205, P43, DOI 10.1016/j.palaeo.2003.11.014; Stigall AL, 2014, ECOGRAPHY, V37, P1123, DOI 10.1111/ecog.00719; Stigall AL, 2012, J BIOGEOGR, V39, P772, DOI 10.1111/j.1365-2699.2011.02651.x; Stigall Alycia L., 2011, Memoir of the Association of Australasian Palaeontologists, V41, P229; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; van der Hammen T, 1971, LATE CENOZOIC GLACIA, P391; Walls BJ, 2011, PALAEOGEOGR PALAEOCL, V299, P15, DOI 10.1016/j.palaeo.2010.10.024; Wang CW, 1961, FORESTS CHINA SURVEY, V5; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WOLFE JA, 1978, AM SCI, V66, P694; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2; Wu Z.Y., 1999, FLORA CHINA, V4; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zanni M, 2007, REV PALAEOBOT PALYNO, V145, P35, DOI 10.1016/j.revpalbo.2006.08.004; 杨永, 2001, 植物分类学报, V39, P169	48	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180979	10.1371/journal.pone.0180979	http://dx.doi.org/10.1371/journal.pone.0180979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686672	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100124
J	Rendon, JC; Cortes-Mancera, F; Restrepo-Gutierrez, JC; Hoyos, S; Navas, MC				Cesar Rendon, Julio; Cortes-Mancera, Fabian; Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio; Navas, Maria-Cristina			Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia	PLOS ONE			English	Article							SURFACE-ANTIGEN VARIANTS; HBSAG-NEGATIVE PATIENTS; BASAL CORE PROMOTER; HBV INFECTION; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; C-VIRUS; ISOLATED ANTIBODIES; FUNCTIONAL-ANALYSIS; GENETIC-VARIATION	Background Hepatitis B virus (HBV) occult infection (OBI) is a risk factor to be taken into account in transfusion, hemodialysis and organ transplantation. The aim of this study was to identify and characterize at the molecular level OBI cases in patients with end-stage liver disease. Methods Sixty-six liver samples were obtained from patients with diagnosis of end-stage liver disease submitted to liver transplantation in Medellin (North West, Colombia). Samples obtained from patients who were negative for the surface antigen of HBV (n = 50) were tested for viral DNA detection by nested PCR for ORFs S, C, and X and confirmed by Southern-Blot. OBI cases were analyzed by sequencing the viral genome to determine the genotype and mutations; additionally, viral genome integration events were examined by the AluPCR technique. Results In five cases out of 50 patients (10%) the criteria for OBI was confirmed. HBV genotype F (subgenotypes F1 and F3), genotype A and genotype D were characterized in liver samples. Three integration events in chromosomes 5q14.1, 16p13 and 20q12 affecting Receptortype tyrosine-protein phosphatase T, Ras Protein Specific Guanine Nucleotide Releasing Factor 2, and the zinc finger 263 genes were identified in two OBI cases. Sequence analysis of the viral genome of the 5 OBI cases showed several punctual missense and nonsense mutations affecting ORFs S, P, Core and X. Conclusions This is the first characterization of OBI in patients with end-stage liver disease in Colombia. The OBI cases were identified in patients with HCV infection or cryptogenic cirrhosis. The integration events (5q14.1, 16p13 and 20q12) described in this study have not been previously reported. Further studies are required to validate the role of mutations and integration events in OBI pathogenesis.	[Cesar Rendon, Julio; Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio; Navas, Maria-Cristina] Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [Cortes-Mancera, Fabian] ITM, Fac Ciencias Exactas & Aplicadas, GI2B, Medellin, Colombia; [Carlos Restrepo-Gutierrez, Juan; Hoyos, Sergio] Hosp Pablo Tobon Uribe, Unidad Hepatol & Trasplante Hepat, Medellin, Colombia	Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022	Rendon, Julio Cesar/0000-0002-4054-3582; Restrepo-Gutierrez, Juan Carlos/0000-0002-1793-5756; Navas, Maria Cristina/0000-0003-2610-9306	Vicerrectoria de Investigacion,Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM)	Vicerrectoria de Investigacion,Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM)	The study was funded by Vicerrectoria de Investigacion, Universidad de Antioquia (Proyecto Mediana Cuantoa,) and Instituto Tecnologico Metropolitano (ITM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2011, HEPAT RES TREAT, V2011; Alencar RSM, 2008, BRAZ J MED BIOL RES, V41, P235, DOI 10.1590/S0100-879X2006005000197; Rios-Ocampo WA, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0206-z; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; [Anonymous], 2015, 2015 B EPIDEMIOLOGIC, V52; [Anonymous], 2016, DAT GLOB DON TRANSPL; [Anonymous], 2016, SCI REG TRANSPL REC; Arroyave J, 2011, REV HECH MICROBIOL, P22; BAGINSKI I, 1992, TRANSFUSION, V32, P215, DOI 10.1046/j.1537-2995.1992.32392213803.x; Barros GM, 2008, REV SOC BRAS MED TRO, V41, P596, DOI 10.1590/S0037-86822008000600010; Bautista H, 2012, REV COL GASTROENTERO, V27; Bautista-Amorocho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114272; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Beltran M, 2011, BIOMEDICA, V31, P580, DOI 10.1590/S0120-41572011000400013; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottecchia M, 2008, J ANTIMICROB CHEMOTH, V62, P626, DOI 10.1093/jac/dkn207; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Castellanos YZ, 2013, REV HECH MICROBIOL, P17; Chan HLY, 2002, AM J GASTROENTEROL, V97, P1211, DOI 10.1111/j.1572-0241.2002.05706.x; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; Cheung CKY, 2010, LIVER TRANSPLANT, V16, P1314, DOI 10.1002/lt.22169; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; Coffin CS, 2004, HEPATOLOGY, V40, P1053, DOI 10.1002/hep.20419; Coppola N, 2015, WORLD J GASTROENTERO, V21, P11931, DOI 10.3748/wjg.v21.i42.11931; Cortes-Mancera F, 2011, HEPAT RES TREAT, V2011; De Feo TM, 2005, TRANSPL P, V37, P1238, DOI 10.1016/j.transproceed.2004.12.041; Deny P, 2010, PATHOL BIOL, V58, P245, DOI 10.1016/j.patbio.2010.05.002; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; Di Stefano M, 2009, J NEPHROL, V22, P381; Dickson RC, 1997, GASTROENTEROLOGY, V113, P1668, DOI 10.1053/gast.1997.v113.pm9352871; Dong QM, 2008, BIOCHEM BIOPH RES CO, V374, P773, DOI 10.1016/j.bbrc.2008.07.115; Duque-Jaramillo A, 2016, REV COLOMB GASTROENT, V31, P7; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Ferrari TCA, 2014, BRAZ J MED BIOL RES, V47, P990, DOI 10.1590/1414-431X20143782; Freitas N, 2014, J VIROL, V88, P5742, DOI 10.1128/JVI.00430-14; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Gerstenkorn C, 2000, LIVER, V20, P425; Ghisetti V, 2004, LIVER TRANSPLANT, V10, P356, DOI 10.1002/LT.20093; Gouas DA, 2012, CARCINOGENESIS, P33; Gujar SA, 2009, J VIROL, V83, P3861, DOI 10.1128/JVI.02521-08; GUNTHER S, 1995, J VIROL, V69, P5437; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han ZG, 2015, CLIN CHIM ACTA, V438, P266, DOI 10.1016/j.cca.2014.09.007; Hassan ZK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-90; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hu KQ, 2002, J VIRAL HEPATITIS, V9, P243, DOI 10.1046/j.1365-2893.2002.00344.x; Hu XL, 2000, P NATL ACAD SCI USA, V97, P1661, DOI 10.1073/pnas.97.4.1661; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kannangai R, 2004, J VIRAL HEPATITIS, V11, P297, DOI 10.1111/j.1365-2893.2004.00502.x; Kao JH, 2002, J CLIN MICROBIOL, V40, P4068, DOI 10.1128/JCM.40.11.4068-4071.2002; Kim H, 2015, INT J MOL SCI, V16, P13595, DOI 10.3390/ijms160613595; Kim H, 2015, WORLD J GASTROENTERO, V21, P1794, DOI 10.3748/wjg.v21.i6.1794; Kimbi GC, 2005, WORLD J GASTROENTERO, V11, P6416, DOI 10.3748/wjg.v11.i41.6416; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Krajden Mel, 2005, Can J Infect Dis Med Microbiol, V16, P65; Kumar V, 2004, HANDB EXP PHARM, V166, P377; Lee YS, 2012, J GASTROEN HEPATOL, V27, P300, DOI 10.1111/j.1440-1746.2011.06853.x; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; LIANG TJ, 1991, HEPATOLOGY, V13, P1044, DOI 10.1002/hep.1840130607; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Mahboobi N, 2012, TRANSPL INFECT DIS, V14, P445, DOI 10.1111/j.1399-3062.2012.00782.x; Marzano A, 2003, TRANSPL P, V35, P1020, DOI 10.1016/S0041-1345(03)00253-7; Mazzolla R, 2002, FEMS IMMUNOL MED MIC, P32; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Michailidis E, 2012, INT J BIOCHEM CELL B, V44, P1060, DOI 10.1016/j.biocel.2012.04.006; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Minuk GY, 2004, HEPATOLOGY, V40, P1072, DOI 10.1002/hep.20435; Munoz SJ, 2002, LIVER TRANSPLANT, V8, pS82, DOI 10.1053/jlts.2002.35783; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Niu YJ, 2014, CLIN RES HEPATOL GAS, V38, P475, DOI 10.1016/j.clinre.2014.03.016; Nunez M, 2002, AIDS, V16, P2099, DOI 10.1097/00002030-200210180-00024; Ocana S, 2011, WORLD J GASTROENTERO, V17, P1553, DOI 10.3748/wjg.v17.i12.1553; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; PATERLINI P, 1993, HEPATOLOGY, V17, P20, DOI 10.1016/0270-9139(93)90186-Q; PATERLINI P, 1990, NEW ENGL J MED, V323, P80, DOI 10.1056/NEJM199007123230202; Pollicino T, 2009, ANTIVIR THER, V14, P649; Polo P, 2009, INFECTIO, V14, P39; Ponde RA, 2015, EUR J CLIN MICROBIOL; Pult I, 2001, J VIROL, V75, P9623, DOI 10.1128/JVI.75.20.9623-9632.2001; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Raimondo Giovanni, 2005, Ann Hepatol, V4, P100; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Ramírez Sánchez Isabel Cristina, 2008, Iatreia, V21, ps10; Ríos Patiño David, 2015, Rev. colomb. Gastroenterol., V30, P11; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Santos EA, 2003, EUR J CLIN MICROBIOL, V22, P92, DOI 10.1007/s10096-002-0868-0; Schaefer S, 2003, J CLIN VIROL, V27, P30, DOI 10.1016/S1386-6532(02)00108-7; Seigneres B, 2001, J HEPATOL, V34, P114, DOI 10.1016/S0168-8278(00)00074-X; Shetty K, 2008, LIVER TRANSPLANT, V14, P534, DOI 10.1002/lt.21284; Squadrito G, 2006, CANCER-AM CANCER SOC, V106, P1326, DOI 10.1002/cncr.21702; Strasser SI, 1999, BLOOD, V93, P1127, DOI 10.1182/blood.V93.4.1127.404k01_1127_1136; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; TABOR E, 1979, TRANSFUSION, V19, P725, DOI 10.1046/j.1537-2995.1979.19680104098.x; TAKADA S, 1990, P NATL ACAD SCI USA, V87, P5628, DOI 10.1073/pnas.87.15.5628; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SP, 2005, J CLIN VIROL, V34, pS134, DOI 10.1016/S1386-6532(05)80023-X; Toniutto P, 2009, CLIN TRANSPLANT, V23, P184, DOI 10.1111/j.1399-0012.2009.00964.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Tsui JI, 2007, CLIN INFECT DIS, V45, P736, DOI 10.1086/520989; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Wakil SM, 2002, J MED VIROL, V68, P311, DOI 10.1002/jmv.10205; Weizmann_Institute_of_Science, 2016, RASGRF2 GEN; Weizmann Institute of Science, 2016, PTPRT GEN; WHO, 2015, HEP B; Wong DKH, 2011, HEPATOLOGY, V54, P829, DOI 10.1002/hep.24551; Zeng GB, 2004, WORLD J GASTROENTERO, V10, P3132; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhang ZH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0464-z; Zhang ZH, 2015, J MED VIROL, V87, P1890, DOI 10.1002/jmv.24245; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12; Zhong YW, 2012, ANTIVIR RES, V93, P185, DOI 10.1016/j.antiviral.2011.11.012; Zhu HL, 2016, WORLD J GASTROENTERO, V22, P3531, DOI 10.3748/wjg.v22.i13.3531; Zoulim F, 2004, ANTIVIR RES, V64, P1, DOI [10.1016/j.antiviral.2004.07.003, 10.1016/S0166-3542(04)00162-7]	126	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180447	10.1371/journal.pone.0180447	http://dx.doi.org/10.1371/journal.pone.0180447			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686707	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100064
J	Kwan, MMS; Kondalsamy-Chennakesavan, S; Ranmuthugala, G; Toombs, MR; Nicholson, GC				Kwan, Marcella M. S.; Kondalsamy-Chennakesavan, Srinivas; Ranmuthugala, Geetha; Toombs, Maree R.; Nicholson, Geoffrey C.			The rural pipeline to longer-term rural practice: General practitioners and specialists	PLOS ONE			English	Article							MEDICAL WORKFORCE; HEALTH-WORKERS; RETENTION; RECRUITMENT; EDUCATION; SCHOOL; PHYSICIANS; UNIVERSITY; AUSTRALIA; INCREASE	Background Rural medical workforce shortage contributes to health disadvantage experienced by rural communities worldwide. This study aimed to determine the regional results of an Australian Government sponsored national program to enhance the Australian rural medical workforce by recruiting rural background students and establishing rural clinical schools (RCS). In particular, we wished to determine predictors of graduates' longer-term rural practice and whether the predictors differ between general practitioners (GPs) and specialists. Methods A cross-sectional cohort study, conducted in 2012, of 729 medical graduates of The University of Queensland 2002-2011. The outcome of interest was primary place of graduates' practice categorised as rural for at least 50% of time since graduation ('Longer-term Rural Practice', LTRP) among GPs and medical specialists. The main exposures were rural background (RB) or metropolitan background (MB), and attendance at a metropolitan clinical school (MCS) or the Rural Clinical School for one year (RCS-1) or two years (RCS-2). Results Independent predictors of LTRP (odds ratio [95% confidence interval]) were RB (2.10 [1.37-3.20]), RCS-1 (2.85 [1.77-4.58]), RCS-2 (5.38 [3.15-9.20]), GP (3.40 [2.13-5.43]), and bonded scholarship (2.11 [1.19-3.76]). Compared to being single, having a metropolitan background partner was a negative predictor (0.34 [0.21-0.57]). The effects of RB and RCS were additive D compared to MB and MCS (Reference group): RB and RCS-1 (6.58 [3.32-13.04]), RB and RCS-2 (10.36[4.89-21.93]). Although specialists were less likely than GPs to be in LTRP, the pattern of the effects of rural exposures was similar, although some significant differences in the effects of the duration of RCS attendance, bonded scholarships and partner's background were apparent. Conclusions Among both specialists and GPs, rural background and rural clinical school attendance are independent, duration-dependent, and additive, predictors of longer-term rural practice. Metropolitan-based medical schools can enhance both specialist and GP rural medical workforce by enrolling rural background medical students and providing them with long-term rural undergraduate clinical training. Policy settings to achieve optimum rural workforce outcomes may differ between specialists and GPs.	[Kwan, Marcella M. S.; Kondalsamy-Chennakesavan, Srinivas; Ranmuthugala, Geetha; Toombs, Maree R.; Nicholson, Geoffrey C.] Univ Queensland, Rural Clin Sch, Toowoomba, Qld, Australia; [Ranmuthugala, Geetha] Univ New England, Sch Rural Med, Armidale, NSW, Australia	University of Queensland; University of New England	Nicholson, GC (corresponding author), Univ Queensland, Rural Clin Sch, Toowoomba, Qld, Australia.	geoff.nicholson@uq.edu.au	Ranmuthugala, Geetha/P-5041-2019; Kondalsamy-Chennakesavan, Srinivas/F-4845-2010; Nicholson, Geoffrey C/F-1901-2010; Toombs, Maree/F-4704-2010; Kwan, Marcella Mun-San/J-3555-2013	Ranmuthugala, Geetha/0000-0002-4893-5775; Kondalsamy-Chennakesavan, Srinivas/0000-0002-1333-374X; Nicholson, Geoffrey C/0000-0002-0152-1153; Toombs, Maree/0000-0002-7481-167X; Kwan, Marcella Mun-San/0000-0002-3317-5056	Australian Government Department of Health and Ageing under Rural Clinical Training and Support program	Australian Government Department of Health and Ageing under Rural Clinical Training and Support program(Australian GovernmentDepartment of Health & Ageing)	The study was funded by the Australian Government Department of Health and Ageing under the Rural Clinical Training and Support program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2003, NAT HLTH LAB FORC SE; Australian Institute of Health and Welfare (AIHW), 2015, AUSTR BURD DIS STUD, V2; Australian Institute of Health and Welfare (AIHW), 2014, MORT IN AUSTR 2009 2, V124; Australian Institute of Health and Welfare (AIHW), 2014, NAT HLTH WORKF SER, V8; Buchan J, 2013, B WORLD HEALTH ORGAN, V91, P834, DOI 10.2471/BLT.13.119008; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; Easterbrook M, 1999, CAN MED ASSOC J, V160, P1159; Ferrer RL, 2005, ANN INTERN MED, V142, P691, DOI 10.7326/0003-4819-142-8-200504190-00037; Greenhill JA, 2015, RURAL REMOTE HEALTH, V15; Grobler L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub3; Kondalsamy-Chennakesavan S, 2015, MED J AUSTRALIA, V202, P41, DOI 10.5694/mja14.00236; Laven Gillian, 2003, Aust J Rural Health, V11, P277, DOI 10.1111/j.1440-1584.2003.00534.x; Lee DM, 2014, INT J HEALTH CARE Q, V27, P642, DOI 10.1108/IJHCQA-04-2014-0042; Manusov EG, 2010, FAM MED, V42, P732; Matsumoto M, 2010, J RURAL HEALTH, V26, P234, DOI 10.1111/j.1748-0361.2010.00286.x; McGrail MR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-63; Medical Training Review Panel (MTRP), 2013, 16 MTRP; Norris TE, 2009, ACAD MED, V84, P902, DOI 10.1097/ACM.0b013e3181a85776; Owen JA, 2007, J RURAL HEALTH, V23, P133, DOI 10.1111/j.1748-0361.2007.00080.x; Playford DE, 2014, MED J AUSTRALIA, V200, P104, DOI 10.5694/mja13.11082; Rabinowitz HK, 1999, JAMA-J AM MED ASSOC, V281, P255, DOI 10.1001/jama.281.3.255; Rabinowitz HK, 2008, ACAD MED, V83, P235, DOI 10.1097/ACM.0b013e318163789b; Rourke J, 2008, CAN MED ASSOC J, V178, P322, DOI 10.1503/cmaj.070293; Rourke J, 2010, B WORLD HEALTH ORGAN, V88, P395, DOI 10.2471/BLT.09.073072; Rourke JTB, 2005, CAN J RURAL MED, V10, P231; Sen Gupta T, 2014, RURAL REMOTE HEALTH, V14; Sen Gupta TK, 2013, RURAL REMOTE HEALTH, V13; Soles J, 2015, CAN J RURAL MED, V20, P5; Strasser Sarah, 2007, Cah Sociol Demogr Med, V47, P469; VERBY JE, 1991, JAMA-J AM MED ASSOC, V266, P110, DOI 10.1001/jama.266.1.110; Viscomi M, 2013, CAN J RURAL MED, V18, P13; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Wilkinson D, 2000, MED J AUSTRALIA, V173, P137, DOI 10.5694/j.1326-5377.2000.tb125568.x; Wilson DR, 1998, CAN MED ASSOC J, V158, P351; Wilson NW, 2009, RURAL REMOTE HEALTH, V9; Zink T, 2010, ACAD MED, V85, P599, DOI 10.1097/ACM.0b013e3181d2b537	37	39	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180394	10.1371/journal.pone.0180394	http://dx.doi.org/10.1371/journal.pone.0180394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686628	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100060
J	Shino, MY; Weigt, SS; Li, N; Palchevskiy, V; Derhovanessian, A; Saggar, R; Sayah, DM; Huynh, RH; Gregson, AL; Fishbein, MC; Ardehali, A; Ross, DJ; Lynch, JP; Elashoff, RM; Belperio, JA				Shino, Michael Y.; Weigt, S. Samuel; Li, Ning; Palchevskiy, Vyacheslav; Derhovanessian, Ariss; Saggar, Rajan; Sayah, David M.; Huynh, Richard H.; Gregson, Aric L.; Fishbein, Michael C.; Ardehali, Abbas; Ross, David J.; Lynch, Joseph P., III; Elashoff, Robert M.; Belperio, John A.			The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; ACUTE CELLULAR REJECTION; MINIMAL ACUTE REJECTION; WORKING FORMULATION; RETROSPECTIVE ANALYSIS; PULMONARY ALLOGRAFT; STANDARDIZATION; NOMENCLATURE; PATHOGENESIS; SURVIVAL	Rationale Since the pathogenesis of chronic lung allograft dysfunction (CLAD) remains poorly defined with no known effective therapies, the identification and study of key events which increase CLAD risk is a critical step towards improving outcomes. We hypothesized that bronchoalveolar lavage fluid (BALF) CXCR3 ligand concentrations would be augmented during organizing pneumonia (OP) and that episodes of OP with marked chemokine elevations would be associated with significantly higher CLAD risk. Methods All transbronchial biopsies (TBBX) from patients who received lung transplantation between 2000 to 2010 were reviewed. BALF concentrations of the CXCR3 ligands (CXCL9, CXCL10 and CXCL11) were compared between episodes of OP and "healthy" biopsies using linear mixed-effects models. The association between CXCR3 ligand concentrations during OP and CLAD risk was evaluated using proportional hazards models with time-dependent covariates. Results There were 1894 bronchoscopies with TBBX evaluated from 441 lung transplant recipients with 169 (9%) episodes of OP and 907 (49%) non-OP histopathologic injuries. 62 (37%) episodes of OP were observed during routine surveillance bronchoscopy. Eight hundred thirtyeight (44%) TBBXs had no histopathology and were classified as "healthy" biopsies. There were marked elevations in BALF CXCR3 ligand concentrations during OP compared with "healthy" biopsies. In multivariable models adjusted for other injury patterns, OP did not significantly increase the risk of CLAD when BAL CXCR3 chemokine concentrations were not taken into account. However, OP with elevated CXCR3 ligands markedly increased CLAD risk in a dose-response manner. An episode of OP with CXCR3 concentrations greater than the 25th, 50th and 75th percentiles had HRs for CLAD of 1.5 (95% CI 1.0-2.3), 1.9 ( 95% CI 1.2-2.8) and 2.2 ( 95% CI 1.4-3.4), respectively. Conclusions This study identifies OP, a relatively uncommon histopathologic finding after lung transplantation, as a major risk factor for CLAD development when considered in the context of increased allograft expression of interferon-.inducible ELR-CXC chemokines. We further demonstrate for the first time, the prognostic importance of BALF CXCR3 ligand concentrations during OP on subsequent CLAD risk.	[Shino, Michael Y.; Weigt, S. Samuel; Palchevskiy, Vyacheslav; Derhovanessian, Ariss; Saggar, Rajan; Sayah, David M.; Huynh, Richard H.; Ross, David J.; Lynch, Joseph P., III; Belperio, John A.] UCLA, David Geffen Sch Med, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90095 USA; [Li, Ning; Elashoff, Robert M.; Belperio, John A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Gregson, Aric L.] UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Fishbein, Michael C.] UCLA, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ardehali, Abbas] UCLA, David Geffen Sch Med, Dept Surg, Div Cardiothorac Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shino, MY (corresponding author), UCLA, David Geffen Sch Med, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90095 USA.	mshino@mednet.ucla.edu			NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI [UL1TR000124, 5U01AI113315-02, R01HL112990-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL138256] Funding Source: NIH RePORTER	NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	There search described was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLACTSI Grant Number UL1TR000124 (MYS), 5U01AI113315-02 (SW +JAB) and R01HL112990-01 (JAB).	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Belperio JA, 2003, J IMMUNOL, V171, P4844, DOI 10.4049/jimmunol.171.9.4844; Belperio JA, 2002, J IMMUNOL, V169, P1037, DOI 10.4049/jimmunol.169.2.1037; Burton CM, 2008, TRANSPLANTATION, V86, P811, DOI 10.1097/TP.0b013e3181852f02; Burton CM, 2008, TRANSPLANTATION, V85, P547, DOI 10.1097/TP.0b013e3181641df9; Burton CM, 2009, J HEART LUNG TRANSPL, V28, P888, DOI 10.1016/j.healun.2009.04.022; Christie JD, 2011, J HEART LUNG TRANSPL, V30, P1104, DOI 10.1016/j.healun.2011.08.004; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Crespo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117618; Davis WA, 2012, AM J TRANSPLANT, V12, P745, DOI 10.1111/j.1600-6143.2011.03849.x; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200; Glanville AR, 2008, AM J RESP CRIT CARE, V177, P1033, DOI 10.1164/rccm.200706-951OC; Hachem RR, 2005, TRANSPLANTATION, V80, P1406, DOI 10.1097/01.tp.0000181161.60638.fa; Heng D, 1998, J HEART LUNG TRANSPL, V17, P1255; Hopkins PM, 2004, AM J RESP CRIT CARE, V170, P1022, DOI 10.1164/rccm.200302-165oc; Husain AN, 1999, AM J RESP CRIT CARE, V159, P829, DOI 10.1164/ajrccm.159.3.9607099; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Kroshus TJ, 1997, J THORAC CARDIOV SUR, V114, P195, DOI 10.1016/S0022-5223(97)70144-2; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Paraskeva M, 2013, AM J RESP CRIT CARE, V187, P1360, DOI 10.1164/rccm.201210-1831OC; Sato M, 2012, J HEART LUNG TRANSPL; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Sato MS T., 2013, ISHLT 33 ANN M SCI S; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Shino MY, 2013, AM J RESP CRIT CARE, V188, P1117, DOI 10.1164/rccm.201305-0861OC; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Todd JL, 2014, AM J RESP CRIT CARE, V189, P159, DOI 10.1164/rccm.201306-1155OC; Verleden GM, 2011, TRANSPLANTATION, V92, P703, DOI 10.1097/TP.0b013e31822bf790; Verleden SE, 2013, TRANSPLANTATION, V95, P1167, DOI 10.1097/TP.0b013e318286e076; Weigt SS, 2009, AM J TRANSPLANT, V9, P1903, DOI 10.1111/j.1600-6143.2009.02635.x; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; YOUSEM SA, 1993, AM J SURG PATHOL, V17, P491, DOI 10.1097/00000478-199305000-00008	35	16	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180281	10.1371/journal.pone.0180281	http://dx.doi.org/10.1371/journal.pone.0180281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686641	gold, Green Published			2022-12-27	WOS:000405464100048
J	Yang, SS; Flores, B; Magal, R; Harris, K; Gross, J; Ewbank, A; Davenport, S; Ormachea, P; Nasser, W; Le, WD; Peacock, WF; Katz, Y; Eagleman, DM				Yang, Suosuo; Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Le, Weidong; Peacock, W. Frank; Katz, Yael; Eagleman, David M.			Diagnostic accuracy of tablet-based software for the detection of concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; RAPID SCREEN; SENSITIVITY; PERFORMANCE; CHILDREN; TESTS; IDENTIFICATION; SPECIFICITY	Despite the high prevalence of traumatic brain injuries (TBI), there are few rapid and straightforward tests to improve its assessment. To this end, we developed a tablet-based software battery ("BrainCheck") for concussion detection that is well suited to sports, emergency department, and clinical settings. This article is a study of the diagnostic accuracy of BrainCheck. We administered BrainCheck to 30 TBI patients and 30 pain-matched controls at a hospital Emergency Department (ED), and 538 healthy individuals at 10 control test sites. We compared the results of the tablet-based assessment against physician diagnoses derived from brain scans, clinical examination, and the SCAT3 test, a traditional measure of TBI. We found consistent distributions of normative data and high test-retest reliability. Based on these assessments, we defined a composite score that distinguishes TBI from non-TBI individuals with high sensitivity (83%) and specificity (87%). We conclude that our testing application provides a rapid, portable testing method for TBI.	[Yang, Suosuo; Le, Weidong] Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China; [Yang, Suosuo; Peacock, W. Frank] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Flores, Benjamin; Magal, Rotem; Harris, Kyrsti; Gross, Jonathan; Ewbank, Amy; Davenport, Sasha; Ormachea, Pablo; Nasser, Waleed; Katz, Yael; Eagleman, David M.] BrainCheck Inc, Houston, TX 77021 USA; [Davenport, Sasha] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA USA	Dalian Medical University; Baylor College of Medicine; Baylor College of Medicine; Stanford University	Le, WD (corresponding author), Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China.; Katz, Y (corresponding author), BrainCheck Inc, Houston, TX 77021 USA.	wdle@sibs.ac.cn; yael@braincheck.com			Brain Check, Inc	Brain Check, Inc	Brain Check, Inc, provided support in the form of salaries for authors DE, YK, BF, RM, KH, AE, SD, WN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of some of the authors' salaries and research materials (the software battery of tests) Nothing about this funding alters our adherence to PLOSONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Berg DB, 2011, J SURG EDUC, V68, P10, DOI 10.1016/j.jsurg.2010.08.005; BOONE KB, 1990, DEV NEUROPSYCHOL, V6, P215, DOI 10.1080/87565649009540462; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Control CfD, 2011, MMWR-MORBID MORTAL W, V60, P1337; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Miller P, 2015, EMERG MED AUSTRALAS, V27, P225, DOI 10.1111/1742-6723.12369; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Ortega E, 2003, EXERC IMMUNOL REV, V9, P70; Ricard C, 2013, SANTE PUBLIQUE, V25, P711, DOI 10.3917/spub.136.0711; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Strauss E, 2006, COMPENDIUM NEUROPSYC; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e.0179352	10.1371/journal.pone.0179352	http://dx.doi.org/10.1371/journal.pone.0179352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686616	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100014
J	Prabhu, KS; Siveen, KS; Kuttikrishnan, S; Iskandarani, A; Tsakou, M; Achkar, IW; Therachiyil, L; Krishnankutty, R; Parray, A; Kulinski, M; Merhi, M; Dermime, S; Mohammad, RM; Uddin, S				Prabhu, Kirti S.; Siveen, Kodappully S.; Kuttikrishnan, Shilpa; Iskandarani, Ahmad; Tsakou, Magdalini; Achkar, Iman W.; Therachiyil, Lubna; Krishnankutty, Roopesh; Parray, Aijaz; Kulinski, Michal; Merhi, Maysaloun; Dermime, Said; Mohammad, Ramzi M.; Uddin, Shahab			Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells	PLOS ONE			English	Article							XIAP EXPRESSION; DOWN-REGULATION; PROGNOSTIC-SIGNIFICANCE; THERAPEUTIC TARGET; CANCER-CELLS; AKT ACTIVITY; PATHWAY; RESISTANCE; CARCINOMA; RECEPTOR	The X-linked inhibitor of apoptosis (XIAP) is a viable molecular target for anticancer drugs that overcome apoptosis-resistance of malignant cells. XIAP is an inhibitor of apoptosis, mediating through its association with BIR3 domain of caspase 9. Embelin, a quinone derivative isolated from the Embelia ribes plant, has been shown to exhibit chemopreventive, anti-inflammatory, and apoptotic activities via inhibiting XIAP activity. In this study, we found that embelin causes a dose-dependent suppression of proliferation in leukemic cell lines K562 and U937. Embelin mediated inhibition of proliferation correlates with induction of apoptosis. Furthermore, embelin treatment causes loss of mitochondrial membrane potential and release of cytochrome c, resulting in subsequent activation of caspase-3 followed by polyadenosin-5'-diphosphate-ribose polymerase (PARP) cleavage. In addition, embelin treatment of leukemic cells results in a decrease of constitutive phosphorylations/activation level of AKT and downregulation of XIAP. Gene silencing of XIAP and AKT expression showed a link between XIAP expression and activated AKT in leukemic cells. Interestingly, targeting of XIAP and PI3-kinase/AKT signaling augmented inhibition of proliferation and induction of apoptosis in leukemic cells. Altogether these findings raise the possibility that embelin alone or in combination with inhibitors of PI3-kinase/AKT pathway may have therapeutic usage in leukemia and possibly other malignancies with up-regulated XIAP pathway.	[Prabhu, Kirti S.; Siveen, Kodappully S.; Kuttikrishnan, Shilpa; Iskandarani, Ahmad; Tsakou, Magdalini; Achkar, Iman W.; Therachiyil, Lubna; Krishnankutty, Roopesh; Parray, Aijaz; Kulinski, Michal; Mohammad, Ramzi M.; Uddin, Shahab] Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar; [Merhi, Maysaloun; Dermime, Said] Hamad Med Corp, NCCCR, Translat Canc Res Facil, Doha, Qatar	Hamad Medical Corporation; Hamad Medical Corporation	Uddin, S (corresponding author), Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha, Qatar.	SKhan34@hamad.qa	Dermime, Said/P-2448-2019; Krishnankutty, Roopesh/M-5836-2015	Dermime, Said/0000-0002-5526-7496; Achkar, Iman/0000-0003-3197-7108; Uddin, Shahab/0000-0003-1886-6710; Krishnankutty, Roopesh/0000-0002-1496-6135	Medical Research Center, Hamad Medical Corporation, Doha, Qatar [16102/16]	Medical Research Center, Hamad Medical Corporation, Doha, Qatar	This study was supported by a grant from the Medical Research Center, Hamad Medical Corporation, Doha, Qatar (Grant # 16102/16).	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Asselin E, 2001, CANCER RES, V61, P1862; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Carter BZ, 2003, LEUKEMIA, V17, P2081, DOI 10.1038/sj.leu.2403113; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Dai Y, 2014, MOL CANCER THER, V13, P1206, DOI 10.1158/1535-7163.MCT-13-0378; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Dean EJ, 2007, EXPERT OPIN THER TAR, V11, P1459, DOI 10.1517/14728222.11.11.1459; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gagnon V, 2003, INT J ONCOL, V23, P803; Guo HR, 2015, INT J MOL SCI, V16, P22989, DOI 10.3390/ijms160922989; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2015, J CLIN ENDOCR METAB, V100, pE974, DOI 10.1210/jc.2014-4356; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; Iskandarani A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0823-y; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Ma YH, 2016, ONCOL REP, V36, P49, DOI 10.3892/or.2016.4820; Maghsoudi N., 2012, Experimental Oncology, V34, P146; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Park N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134760; Pazhang Y, 2016, J CANCER RES THER, V12, P155, DOI 10.4103/0973-1482.150407; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sasaki H, 2000, CANCER RES, V60, P5659; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Siveen KS, 2014, ONCOTARGET, V5, P634, DOI 10.18632/oncotarget.1596; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Yang S, 2016, ONCOL LETT, V11, P4167, DOI 10.3892/ol.2016.4522; Yang TX, 2015, CELL BIOCHEM BIOPHYS, V71, P291, DOI 10.1007/s12013-014-0197-9; Zhou SN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-288; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	52	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180895	10.1371/journal.pone.0180895	http://dx.doi.org/10.1371/journal.pone.0180895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704451	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649700059
J	Siffredi, V; Barrouillet, P; Spencer-Smith, M; Vaessen, M; Anderson, V; Vuilleumier, P				Siffredi, Vanessa; Barrouillet, Pierre; Spencer-Smith, Megan; Vaessen, Maarten; Anderson, Vicki; Vuilleumier, Patrik			Examining distinct working memory processes in children and adolescents using fMRI: Results and validation of a modified Brown-Peterson paradigm	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORD FORM AREA; N-BACK TASK; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; DEVELOPMENTAL-CHANGES; NATIONAL CURRICULUM; HUMAN BRAIN; CAPACITY; ATTENTION	Verbal working memory (WM) comprises different processes (encoding, maintenance, retrieval) that are often compromised in brain diseases, but their neural correlates have not yet been examined in childhood and adolescence. To probe WM processes and associated neural correlates in developmental samples, and obtain comparable effects across different ages and populations, we designed an adapted Brown-Peterson task (verbal encoding and retrieval combined with verbal and visual concurrent tasks during maintenance) to implement during functional magnetic resonance imaging (fMRI). In a sample of typically developing children and adolescents (n = 16), aged 8 to 16 years, our paradigm successfully identified distinct patterns of activation for encoding, maintenance, and retrieval. While encoding activated perceptual systems in posterior and ventral visual regions, retrieval activated fronto-parietal regions associated with executive control and attention. We found a different impact of verbal versus visual concurrent processing during WM maintenance: at retrieval, the former condition evoked greater activations in visual cortex, as opposed to selective involvement of language-related areas in left temporal cortex in the latter condition. These results are in accord with WM models, suggesting greater competition for processing resources when retrieval follows within-domain compared with cross-domain interference. This pattern was found regardless of age. Our study provides a novel paradigm to investigate distinct WM brain systems with reliable results across a wide age range in developmental populations, and suitable for participants with different WM capacities.	[Siffredi, Vanessa; Barrouillet, Pierre; Vaessen, Maarten; Vuilleumier, Patrik] Univ Geneva, Geneva, Switzerland; [Siffredi, Vanessa; Spencer-Smith, Megan; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Siffredi, Vanessa; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia; [Spencer-Smith, Megan] Monash Univ, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia	University of Geneva; Murdoch Children's Research Institute; University of Melbourne; Monash University; Royal Children's Hospital Melbourne	Siffredi, V (corresponding author), Univ Geneva, Geneva, Switzerland.; Siffredi, V (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Siffredi, V (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	vanessa.siffredi@gmail.com	Vuilleumier, Patrik/AAJ-1839-2021; Siffredi, Vanessa/AAA-4866-2020	Vuilleumier, Patrik/0000-0002-8198-9214; Siffredi, Vanessa/0000-0002-9137-0730; Spencer-Smith, Megan/0000-0002-1047-0829	Victorian Government's Operational Infrastructure Support Program; Murdoch Childrens Research Institute; Swiss National Science Foundation Doc.CH scholarship; Australian National Health and Medical Research Council Senior Practitioner Fellowship	Victorian Government's Operational Infrastructure Support Program; Murdoch Childrens Research Institute; Swiss National Science Foundation Doc.CH scholarship; Australian National Health and Medical Research Council Senior Practitioner Fellowship	This study was supported by Victorian Governments Operational Infrastructure Support Program, the Murdoch Childrens Research Institute. VS was supported by the Swiss National Science Foundation Doc.CH scholarship. VA was supported by Australian National Health and Medical Research Council Senior Practitioner Fellowship.	Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A., 1986, WORKING MEMORY, pxi,; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley AD, 2011, NEUROPSYCHOLOGIA, V49, P1393, DOI 10.1016/j.neuropsychologia.2010.12.042; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Barrouillet P, 2001, J MEM LANG, V45, P1, DOI 10.1006/jmla.2001.2767; Barrouillet P, 2010, COGNITIVE DEV WORKIN, pxiv; Barrouillet P., 2015, WORKING MEMORY LOSS; Barrouillet P, 2008, PSYCHON B REV, V15, P528, DOI 10.3758/PBR.15.3.528; Barrouillet P, 2009, DEV PSYCHOL, V45, P477, DOI 10.1037/a0014615; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Brahmbhatt SB, 2010, BRAIN RES, V1354, P140, DOI 10.1016/j.brainres.2010.07.055; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Camos V, 2009, J MEM LANG, V61, P457, DOI 10.1016/j.jml.2009.06.002; Camos V, 2011, DEV PSYCHOL, V47, P898, DOI 10.1037/a0023193; Ciesielski KT, 2006, NEUROIMAGE, V33, P980, DOI 10.1016/j.neuroimage.2006.07.028; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2009, DEV MEMORY INFANCY C, pxii; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Darki F, 2014, CEREB CORTEX; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dehaene S, 2010, NEUROIMAGE, V49, P1837, DOI 10.1016/j.neuroimage.2009.09.024; Delogu F, 2012, COGN PROCESS, V13, P267, DOI 10.1007/s10339-012-0442-3; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Finn AS, 2010, J NEUROSCI, V30, P11062, DOI 10.1523/JNEUROSCI.6266-09.2010; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Garrett AS, 2000, NEUROIMAGE, V11, P111, DOI 10.1006/nimg.1999.0528; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Groen MA, 2012, BRAIN BEHAV, V2, P256, DOI 10.1002/brb3.56; IBM C, 2013, IBM SPSS STAT WIND V; Jolles DD, 2011, DEVELOPMENTAL SCI, V14, P713, DOI 10.1111/j.1467-7687.2010.01016.x; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Libertus ME, 2009, NEUROIMAGE, V44, P1404, DOI 10.1016/j.neuroimage.2008.10.027; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Murner-Lavanchy I, 2014, DEV COGN NEUROS-NETH, V9, P106, DOI 10.1016/j.dcn.2014.02.004; Nagel BJ, 2005, J CLIN EXP NEUROPSYC, V27, P823, DOI 10.1080/13803390490919038; O'Hare ED, 2008, NEUROIMAGE, V42, P1678, DOI 10.1016/j.neuroimage.2008.05.057; Oberauer K, 2012, J EXP PSYCHOL LEARN, V38, P665, DOI 10.1037/a0026337; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Reber PJ, 2002, J NEUROSCI, V22, P9541; Savage R, 2006, BRIT J PSYCHOL, V97, P365, DOI 10.1348/000712605X81370; Schweinsburg AD, 2005, J INT NEUROPSYCH SOC, V11, P631, DOI 10.1017/S1355617705050757; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spencer-Smith M, 2013, DEV NEUROPSYCHOL, V38, P236, DOI 10.1080/87565641.2013.784321; Spencer-Smith MM, 2013, DEV NEUROPS IN PRESS; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Vergauwe E, 2014, J EXP PSYCHOL LEARN, V40, P1072, DOI 10.1037/a0035779; Vuontela V, 2009, BRAIN COGNITION, V69, P56, DOI 10.1016/j.bandc.2008.05.010; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WILHELM O, 2013, FRONT PSYCHOL, V4	77	12	12	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179959	10.1371/journal.pone.0179959	http://dx.doi.org/10.1371/journal.pone.0179959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704424	gold, Green Published			2022-12-27	WOS:000405649700021
J	Arellano-Llamas, R; Alfaro-Ruiz, L; Canon, CA; Rosshandler, II; Cruz-Lagunas, A; Zuniga, J; Vega, RR; Wong, CW; Maurer-Stroh, S; Cordoba, SR; Liu, ET; Hidalgo-Miranda, A; Vazquez-Perez, JA				Arellano-Llamas, Rocio; Alfaro-Ruiz, Luis; Arriaga Canon, Cristian; Imaz Rosshandler, Ivan; Cruz-Lagunas, Alfredo; Zuniga, Joaquin; Rebollar Vega, Rosa; Wong, Christopher W.; Maurer-Stroh, Sebastian; Romero Cordoba, Sandra; Liu, Edison T.; Hidalgo-Miranda, Alfredo; Vazquez-Perez, Joel A.			Molecular features of influenza A (H1N1) pdm09 prevalent in Mexico during winter seasons 2012-2014	PLOS ONE			English	Article							INCREASED VIRULENCE; STRUCTURAL BASIS; BINDING-SITE; VIRUS; SWINE; IDENTIFICATION; MUTATIONS; PROTEIN; NS1; HEMAGGLUTININ	Since the emergence of the pandemic H1N1pdm09 virus in Mexico and California, biannual increases in the number of cases have been detected in Mexico. As observed in previous seasons, pandemic A/H1N1 09 virus was detected in severe cases during the 2011-2012 winter season and finally, during the 2013-2014 winter season it became the most prevalent influenza virus. Molecular and phylogenetic analyses of the whole viral genome are necessary to determine the antigenic and pathogenic characteristics of influenza viruses that cause severe outcomes of the disease. In this paper, we analyzed the evolution, antigenic and genetic drift of Mexican isolates from 2009, at the beginning of the pandemic, to 2014. We found a clear variation of the virus in Mexico from the 2011-2014 season due to different markers and in accordance with previous reports. In this study, we identified 13 novel substitutions with important biological effects, including virulence, T cell epitope presented by MHC and host specificity shift and some others substitutions might have more than one biological function. The systematic monitoring of mutations on whole genome of influenza A pH1N1 (2009) virus circulating at INER in Mexico City might provide valuable information to predict the emergence of new pathogenic influenza virus	[Arellano-Llamas, Rocio; Alfaro-Ruiz, Luis; Imaz Rosshandler, Ivan; Rebollar Vega, Rosa; Romero Cordoba, Sandra; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Arriaga Canon, Cristian] Inst Nacl Cancerol, CONACYT, Mexico City, DF, Mexico; [Cruz-Lagunas, Alfredo; Zuniga, Joaquin; Vazquez-Perez, Joel A.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Wong, Christopher W.] Genome Insitute Singapore, Singapore, Singapore; [Maurer-Stroh, Sebastian] Bioinformat Inst Singapore, Singapore, Singapore; [Liu, Edison T.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Instituto Nacional de Medicina Genomica; Instituto Nacional de Cancerologia (INCAN); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Jackson Laboratory	Hidalgo-Miranda, A (corresponding author), Inst Nacl Med Genom, Mexico City, DF, Mexico.; Vazquez-Perez, JA (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico.	ahidalgo@inmegen.gob.mx; joevazpe@gmail.com	Vazquez-Perez, Joel/F-3476-2019; Romero, Sandra/A-2246-2014; Romero-Cordoba, Sandra/AAY-2625-2020; Hidalgo-Miranda, Alfredo/B-2123-2010; Maurer-Stroh, Sebastian/Q-9476-2019	Vazquez-Perez, Joel/0000-0002-8508-3698; Romero, Sandra/0000-0002-5591-696X; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Maurer-Stroh, Sebastian/0000-0003-0813-9640; CRUZ-LAGUNAS, ALFREDO/0000-0001-5487-5919; ARRIAGA, CRISTIAN/0000-0002-4866-9067; Zuniga, Joaquin/0000-0002-7143-0281; REBOLLAR VEGA, ROSA GLORIA/0000-0002-9293-5959; Imaz Rosshandler, Ivan/0000-0001-5975-0138	Mexican National Council of Science and Technology [127004]; CONACYT [CVU 389997]	Mexican National Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Mexican National Council of Science and Technology, grant number 127004, granted to AHM. There was no additional external funding received for this study. This work was submitted in partial fulfillment of the requirements to obtain the Ph.D. degree for Rocio Arellano-Llamas at Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) who also received a PhD fellowship from CONACYT (CVU 389997).	Ahn JK, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/340717; Babakir-Mina M, 2009, ARCH VIROL, V154, P1349, DOI 10.1007/s00705-009-0438-1; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Chowell G, 2012, PLOS CURRENTS; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elderfield RA, 2014, J VIROL, V88, P13269, DOI 10.1128/JVI.01636-14; Escalera-Zamudio M, 2012, VIROLOGY, V433, P176, DOI 10.1016/j.virol.2012.08.003; Garten R, 2012, NIH PUBLIC ACCESS, V325, P197; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hayashi T, 2015, J VIROL, V89, P8042, DOI 10.1128/JVI.00901-15; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Kerry PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017946; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Lapinsky S., 2010, EPIDEMIC VIRAL PNEUM, P139; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mishel P., 2009, GENOME ANNOUNC, V2015, P3, DOI DOI 10.1128/GEN0MEA.00676-15; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Shinde V, 2009, TRIPLE REASSORTANT S, P1; Shinya Y, 2010, PLOS PATHOG, V6, P15; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Su YCF, 2015, NATURE COMMUNICATION, V6, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; Wang WJ, 2012, VACCINE, V30, P872, DOI 10.1016/j.vaccine.2011.11.101; WHO, 2012, FLUNET CHARTS; Wong CW, 2004, TRACKING EVOLUTION S, P398; Yang H, 2014, J VIROL, V88, P4828, DOI 10.1128/JVI.02278-13; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zepeda HM, 2010, J CLIN VIROL, V48, P36, DOI 10.1016/j.jcv.2010.02.008; Zhang CY, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-88; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7								10.1371/journal.pone.0180419	http://dx.doi.org/10.1371/journal.pone.0180419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692701	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800038
J	Saha, B; Parks, RJ				Saha, Bratati; Parks, Robin J.			Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells	PLOS ONE			English	Article							TERMINAL PROTEIN; PRETERMINAL PROTEIN; IN-VIVO; 55-KILODALTON PROTEIN; TRANSCRIPTION UNIT; ESCHERICHIA-COLI; BINDING PROTEIN; GENE-THERAPY; POLYMERASE; ACTIVATION	Adenovirus (Ad) vectors deleted of the early region 1 (E1) are widely used for transgene delivery in preclinical and clinical gene therapy studies. Although proteins encoded within the E1 region are required for efficient virus replication, previous studies have suggested that certain viral or cellular proteins can functionally compensate for E1, leading to expression of the early region 2 (E2)-encoded replicative proteins and subsequent virus replication. We have generated a series of E1-encoding and E1-deficient Ad vectors containing a FLAG-epitope tag on each of the E2-encoded proteins: DNA-binding protein (DBP), terminal protein (TP) and DNA polymerase (Pol). Using these constructs, we show that for the replication-competent virus, the expression level of each E2-encoded protein declines with increasing distance from the E2 promoter, with E2A-encoded DBP expression being similar to 800-fold higher than E2B-encoded TP. Pol was expressed at extremely low levels in infected cells, and immunoprecipitation from cell lysates was required prior to its detection by immunoblot. We further show that DBP was expressed 200-to 400-fold less efficiently from an E1-deficient virus compared to a replication-competent virus in A549 and HepG2 cells, which was accompanied by a very small increase in genome copy number. For the E1-deficient virus, late gene expression (a marker of virus replication) was only observed at very high multiplicities of infection. These data show that E1-deleted Ad gives rise to limited expression of the E2-encoded genes and replication in infected cells, but highlight the importance of considering viral dose-dependent effects in gene therapy studies.	[Saha, Bratati; Parks, Robin J.] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Saha, Bratati; Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Saha, Bratati; Parks, Robin J.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Parks, RJ (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.	rparks@ohri.ca			Canadian Institutes of Health Research (CIHR); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC) of Canada; Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government	This study was supported by grants to RJP from the Canadian Institutes of Health Research (CIHR), the Cancer Research Society (Canada), and the National Sciences and Engineering Research Council (NSERC) of Canada. BS was supported by an Ontario Graduate Scholarship (OGS) from the Ontario Provincial Government.	Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; Bramson JL, 2004, HUM GENE THER, V15, P179, DOI 10.1089/104303404772679986; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caravokyri C, 1996, VIRUS GENES, V12, P65, DOI 10.1007/BF00370002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CHEN M, 1990, J BIOL CHEM, V265, P18634; de Jong RN, 2003, NUCLEIC ACIDS RES, V31, P3274, DOI 10.1093/nar/gkg405; DESIDERIO SV, 1981, J MOL BIOL, V145, P319, DOI 10.1016/0022-2836(81)90208-4; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; FRIEFELD BR, 1985, P NATL ACAD SCI USA, V82, P2652, DOI 10.1073/pnas.82.9.2652; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; GATTONI R, 1986, J MOL BIOL, V187, P379, DOI 10.1016/0022-2836(86)90440-7; Giberson AN, 2012, NUCLEIC ACIDS RES, V40, P2369, DOI 10.1093/nar/gkr1076; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Gorziglia MI, 1996, J VIROL, V70, P4173, DOI 10.1128/JVI.70.6.4173-4178.1996; Goulet BB, 2013, BIOCHEM CELL BIOL, V91, P252, DOI 10.1139/bcb-2012-0094; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hoke CH, 2013, VACCINE, V31, P1623, DOI 10.1016/j.vaccine.2012.12.029; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Huang JH, 2010, MOL THER, V18, P264, DOI 10.1038/mt.2009.205; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; KUSUKAWA J, 1994, J BIOL CHEM, V269, P2189; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; Lind SB, 2012, VIROLOGY, V433, P253, DOI 10.1016/j.virol.2012.08.012; Mangel WF, 2014, VIRUSES-BASEL, V6, P4536, DOI 10.3390/v6114536; MCKINNON RD, 1982, GENE, V19, P33, DOI 10.1016/0378-1119(82)90186-X; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; Nakai M, 2007, HUM GENE THER, V18, P925, DOI 10.1089/hum.2007.085; Nash LA, 2016, THERAPEUTIC APPL ADE, P1; Nelson JE, 1997, J VIROL, V71, P8902, DOI 10.1128/JVI.71.11.8902-8907.1997; O'Connor RJ, 2000, J VIROL, V74, P5819, DOI 10.1128/JVI.74.13.5819-5824.2000; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Parker EJ, 1998, NUCLEIC ACIDS RES, V26, P1240, DOI 10.1093/nar/26.5.1240; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Parks RJ, 2005, MOL THER, V11, P19, DOI 10.1016/j.ymthe.2004.09.018; Poulin KL, 2011, VIROLOGY, V420, P146, DOI 10.1016/j.virol.2011.09.004; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; REICHEL R, 1989, J VIROL, V63, P3643, DOI 10.1128/JVI.63.9.3643-3650.1989; ROOVERS DJ, 1991, VIROLOGY, V180, P273, DOI 10.1016/0042-6822(91)90032-7; ROOVERS DJ, 1993, J VIROL, V67, P265, DOI 10.1128/JVI.67.1.265-276.1993; Ross PJ, 2011, J VIROL, V85, P3950, DOI 10.1128/JVI.01787-10; Ruzindana-Umunyana A, 2002, VIRUS RES, V89, P41, DOI 10.1016/S0168-1702(02)00111-9; Saha B, 2014, VIRUSES-BASEL, V6, P3563, DOI 10.3390/v6093563; Sargent KL, 2004, J VIROL, V78, P5032, DOI 10.1128/JVI.78.10.5032-5037.2004; SCHAACK J, 1995, J VIROL, V69, P4079, DOI 10.1128/JVI.69.7.4079-4085.1995; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; Swaminathan S, 1996, J MOL BIOL, V258, P736, DOI 10.1006/jmbi.1996.0283; Swaminathan S, 1995, MOL REPERTOIRE ADE 3, V199/3, P177; Tollefson AE, 2007, J VIROL, V81, P12918, DOI 10.1128/JVI.01531-07; TSERNOGLOU D, 1985, FEBS LETT, V188, P248, DOI 10.1016/0014-5793(85)80381-1; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; VOS HL, 1989, VIROLOGY, V172, P634, DOI 10.1016/0042-6822(89)90206-7; Webster A, 1997, J VIROL, V71, P6381, DOI 10.1128/JVI.71.9.6381-6389.1997; WEBSTER A, 1994, J VIROL, V68, P7292, DOI 10.1128/JVI.68.11.7292-7300.1994; Weitzman MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1106, DOI 10.2741/1604; Ying BL, 2010, J VIROL, V84, P11470, DOI 10.1128/JVI.01338-10	60	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181012	10.1371/journal.pone.0181012	http://dx.doi.org/10.1371/journal.pone.0181012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700677	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800115
J	Savolainen, O; Fagerberg, B; Lind, MV; Sandberg, AS; Ross, AB; Bergstrom, G				Savolainen, Otto; Fagerberg, Bjom; Lind, Mads Vendelbo; Sandberg, Ann-Sofie; Ross, Alastair B.; Bergstrom, Goran			Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPONECTIN LEVELS; RISK; ACID	Aim The aim was to determine if metabolomics could be used to build a predictive model for type 2 diabetes (T2D) risk that would improve prediction of T2D over current risk markers. Methods Gas chromatography-tandem mass spectrometry metabolomics was used in a nested casecontrol study based on a screening sample of 64-year-old Caucasian women (n = 629). Candidate metabolic markers of T2D were identified in plasma obtained at baseline and the power to predict diabetes was tested in 69 incident cases occurring during 5.5 years followup. The metabolomics results were used as a standalone prediction model and in combination with established T2D predictive biomarkers for building eight T2D prediction models that were compared with each other based on their sensitivity and selectivity for predicting T2D. Results Established markers of T2D (impaired fasting glucose, impaired glucose tolerance, insulin resistance (HOMA), smoking, serum adiponectin)) alone, and in combination with metabolomics had the largest areas under the curve (AUC) (0.794 (95% confidence interval [0.738-0.850]) and 0.808 [0.749-0.867] respectively), with the standalone metabolomics model based on nine fasting plasma markers having a lower predictive power (0.657 [0.577-0.736]). Prediction based on non-blood based measures was 0.638 [0.565-0.711]). Conclusions Established measures of T2D risk remain the best predictor of T2D risk in this population. Additional markers detected using metabolomics are likely related to these measures as they did not enhance the overall prediction in a combined model.	[Savolainen, Otto; Lind, Mads Vendelbo; Sandberg, Ann-Sofie; Ross, Alastair B.] Chalmers Univ Technol, Div Food & Nutr Sci, Dept Biol & Biol Engn, Gothenburg, Sweden; [Fagerberg, Bjom] Gothenburg Univ, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Wallenberg Lab Cardiovascular Res,Inst Med, Gothenburg, Sweden; [Lind, Mads Vendelbo] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Frederiksberg, Denmark; [Bergstrom, Goran] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg; University of Copenhagen; University of Gothenburg; Sahlgrenska University Hospital	Savolainen, O (corresponding author), Chalmers Univ Technol, Div Food & Nutr Sci, Dept Biol & Biol Engn, Gothenburg, Sweden.	otto.savolainen@chalmers.se	sandberg, ann-sofie/B-6857-2016; Lind, Mads Vendelbo/L-7387-2014	sandberg, ann-sofie/0000-0002-9681-3342; Lind, Mads Vendelbo/0000-0002-4999-1218; Bergstrom, Goran/0000-0003-4289-5722; Ross, Alastair/0000-0002-9585-0141	Chalmers area of advance life science engineering; Swedish Heart and Lung Foundation; Vastra Gotalandsregionen	Chalmers area of advance life science engineering; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vastra Gotalandsregionen	The work was supported by Chalmers area of advance life science engineering, by grants from the Swedish Heart and Lung Foundation and the LUA-ALF grants from Vastra Gotalandsregionen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bailes Barbara K, 2002, AORN J, V76, P266; Bro R, 2015, METABOLOMICS, V11, P1376, DOI 10.1007/s11306-015-0793-8; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Brunius C., 2015, CURR NUTR REP, V4, P348, DOI [10.1007/s13668-015-0144-4, DOI 10.1007/S13668-015-0144-4]; Calcagno V, 2010, J STAT SOFTW, V34, P1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fagerberg B, 2011, J INTERN MED, V269, P636, DOI 10.1111/j.1365-2796.2010.02336.x; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Hochberg Y, 1995, J ROYAL STAT SOC B; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lind MV, 2016, EUR J EPIDEMIOL, V31, P717, DOI 10.1007/s10654-016-0166-2; Lorenzi M., 2007, J DIABETES RES, V2007, P1; Magnusson M, 2015, DIABETES, V64, P3010, DOI 10.2337/db14-1863; Meiss E, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0958-0; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Oates PJ, 2002, POLYOL PATHWAY DIABE, P325; Palmer ND, 2014, J CLIN ENDOCRINOLOGY, V100, pE463; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Savolainen OI, 2016, J PROTEOME RES, V15, P259, DOI 10.1021/acs.jproteome.5b00790; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Yaghootkar H, 2013, DIABETES, V62, P3589, DOI 10.2337/db13-0128	32	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0177738	10.1371/journal.pone.0177738	http://dx.doi.org/10.1371/journal.pone.0177738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692646	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800003
J	Strom, JB; Kramer, DB; Wang, Y; Shen, CY; Wasfy, JH; Landon, BE; Wilker, EH; Yeh, RW				Strom, Jordan B.; Kramer, Daniel B.; Wang, Yun; Shen, Changyu; Wasfy, Jason H.; Landon, Bruce E.; Wilker, Elissa H.; Yeh, Robert W.			Short-term rehospitalization across the spectrum of age and insurance types in the United States	PLOS ONE			English	Article							READMISSIONS REDUCTION PROGRAM; DIAGNOSES	Few studies have examined rates and causes of short-term readmissions among adults across age and insurance types. We compared rates, characteristics, and costs of 30-day readmission after all-cause hospitalizations across insurance types in the US. We retrospectively evaluated alive patients >= 18 years old, discharged for any cause, 1/1/13-11/31/13, 2006 non-federal hospitals in 21 states in the Nationwide Readmissions Database. The primary stratification variable of interest was primary insurance. Comorbid conditions were assessed based on Elixhauser comorbidities, as defined by administrative billing codes. Additional measures included diagnoses for index hospitalizations leading to rehospitalization. Hierarchical multivariable logistic regression models, with hospital site as a random effect, were used to calculate the adjusted odds of 30-day readmissions by age group and insurance categories. Cost and discharge estimates were weighted per NRD procedures to reflect a nationally representative sample. Diagnoses for index hospitalizations leading to rehospitalization were determined. Among 12,533,551 discharges, 1,818,093 (14.5%) resulted in readmission within 30 days. Medicaid insurance was associated with the highest adjusted odds ratio (AOR) for readmission both in those >= 65 years old (AOR 1.12, 95% CI 1.10-1.14; p < 0.001), and 45-64 (AOR 1.67, 95% CI 1.66-1.69; p < 0.001), and Medicare in the 18-44 group (Medicare vs. private insurance: AOR 1.99, 95% CI 1.96-2.01; p < 0.001). Discharges for psychiatric or substance abuse disorders, septicemia, and heart failure accounted for the largest numbers of readmissions, with readmission rates of 24.0%, 17.9%, 22.9% respectively. Total costs for readmissions were 50.7 billion USD, highest for Medicare (29.6 billion USD), with non-Medicare costs exceeding 21 billion USD. While Medicare readmissions account for more than half of the total burden of readmissions, costs of non-Medicare readmissions are nonetheless substantial. Medicaid patients have the highest odds of readmission in individuals older than age 44, commonly due to hospitalizations for psychiatric illness and substance abuse disorders. Medicaid patients represent a population at uniquely high risk for readmission.	[Strom, Jordan B.; Kramer, Daniel B.; Shen, Changyu; Wilker, Elissa H.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Cardiovasc Outcomes, Boston, MA 02215 USA; [Wang, Yun] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Wasfy, Jason H.] Massachusetts Gen Hosp, Div Cardiovasc Med, Boston, MA 02114 USA; [Landon, Bruce E.] Harvard Med Sch, Dept Healthcare Policy, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Cardiovasc Outcomes, Boston, MA 02215 USA.	ryeh@bidmc.harvard.edu	Yeh, Robert/AAJ-3463-2020	Strom, Jordan/0000-0002-6592-6141	National Heart, Lung, and Blood Institute [K23HL118138, 5T32HL007374-37]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by K23HL118138 (RWY) National Heart, Lung, and Blood Institute; 5T32HL007374-37 (JBS) National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Association, 2015, RETH HOSP READM RED; [Anonymous], 2015, BLUEPR CMS MEAS MAN; [Anonymous], SIGN MED SPEC COND; [Anonymous], 2014, MANAGEMENT STRATEGIE; [Anonymous], 2015, COST CHARG RAT FIL 2; [Anonymous], 2016, FACTS MED SPENDING F; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Brown D, 2014, CONSIDERATIONS INTEG; Carnahan RM, 2011, MINI SENTINEL SYSTEM, V14; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, MEAS METH REP; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Glance LG, 2016, ANN SURG, V263, P698, DOI 10.1097/SLA.0000000000001363; HCUP Cost-to-Charge Ratio Files (CCR), HEALTHC COST UT PROJ; HCUP Databases, 2006, HEALTHC COST UT PROJ; HCUP Elixhauser Comorbidity Software, 2017, HCUP EL COM SOFTW; Healthcare Cost and Utilization Project, HCUP QUAL CONTR PROC; Healthcare Cost and Utilization Project (HCUP), AG HEALTHC RES QUAL; Healthcare Cost and Utilization Project (HCUP), 2015, INTR HCUP NAT READM; Hu J, 2014, HLTH AFF, V33, P1; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kostick Karen, 2011, J AHIMA, V82, P60; Martsolf GR, 2016, J HLTH CARE ORG PROV, V53, P1, DOI DOI 10.1177/0046958016667596; National Academies of Sciences Engineering and Medicine, 2016, ACC SOC RISK FACT ME; Silow-Carroll S, 2011, SYNTHESIS REPORT, V1473, P1; Trudnak T, 2014, HEALTH AFFAIR, V33, P1337, DOI 10.1377/hlthaff.2013.0632; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	30	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180767	10.1371/journal.pone.0180767	http://dx.doi.org/10.1371/journal.pone.0180767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700736	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800073
J	Cheng, YY; Kao, TW; Chang, YW; Wu, CJ; Peng, TC; Wu, LW; Yang, HF; Liaw, FY; Chen, WL				Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang			Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere length	PLOS ONE			English	Article							NATIONAL-HEALTH; OBESITY; PREVALENCE	The mechanism of cellular aging likely involves decreased telomere length and is associated with age-related diseases such as cardiovascular disease. Metabolic syndrome (MetS) is an important risk factor for CVD. The purpose of this study was to investigate the association between LTL and MetS. We evaluated 7370 participants in the National Health and Nutrition Examination Survey (1999-2002). The association between LTL and individual MetS components and the number of MetS components was analyzed by multivariable regression models, adjusting for gender, race/ethnicity, albumin, C-reactive protein, alanine transaminase, uric acid and medical condition. An increase in the number of MetS components was strongly associated with shorter telomere length, especially in female participants (p for trend < 0.05). In addition, triglycerides were negatively associated with LTL in female participants (p < 0.001). Waist circumstance was associated with decreased LTL (p < 0.05) in both males and females. In summary, our study indicated that an increment of MetS component is strongly associated with shorter LTL, especially in the female population.	[Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Cheng, Yuan-Yuei; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Peng, Tao-Chun; Wu, Li-Wei; Yang, Hui-Fang; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chang, Yaw-Wen; Wu, Li-Wei; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Div Family Med, Dept Community Med, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, WL (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020; Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Aviv A, 2012, MUTAT RES-FUND MOL M, V730, P68, DOI 10.1016/j.mrfmmm.2011.05.001; Avogaro A, 2010, PFLUG ARCH EUR J PHY, V459, P301, DOI 10.1007/s00424-009-0721-8; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Breuer HWM, 2001, CURR MED RES OPIN, V17, P60, DOI 10.1185/03007990152005379; Buxton JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099133; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Diker-Cohen T, 2013, LEUKEMIA LYMPHOMA, V54, P2023, DOI 10.3109/10428194.2012.757765; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gray KE, 2014, EPIDEMIOLOGY, V25, P139, DOI 10.1097/EDE.0000000000000017; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Guarner V, 2012, AGING DIS, V3, P269; Hunt SC, 2015, CIRC-CARDIOVASC GENE, V8, P4, DOI 10.1161/CIRCGENETICS.114.000964; Kyo S, 1999, CANCER RES, V59, P5917; Laimer M, 2016, INT J OBESITY, V40, P773, DOI 10.1038/ijo.2015.238; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Loprinzi PD, 2017, J SPORTS SCI, P1; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188; Revesz D, 2015, J CLIN ENDOCR METAB, V100, P3050, DOI 10.1210/JC.2015-1995; Revesz D, 2014, J CLIN ENDOCR METAB, V99, P4607, DOI 10.1210/jc.2014-1851; Robertson JD, 2001, BONE MARROW TRANSPL, V27, P1283, DOI 10.1038/sj.bmt.1703069; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1; Shin YA, 2016, J EXERC REHABIL, V12, P238, DOI 10.12965/jer.1632584.292; Tamura Y, 2016, GERIATR GERONTOL INT, V16, P66, DOI 10.1111/ggi.12738; Tellechea ML, 2017, J HUM HYPERTENS, V31, P99, DOI 10.1038/jhh.2016.45; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Verhulst S, 2016, DIABETOLOGIA, V59, P1258, DOI 10.1007/s00125-016-3915-6; Wang CQ, 2017, CLIN ENDOCRINOL, V86, P552, DOI 10.1111/cen.13283; Wulaningsih W, 2016, AGING-US, V8, P2689, DOI 10.18632/aging.101036; Yeap BB, 2016, J CLIN ENDOCR METAB, V101, P1299, DOI 10.1210/jc.2015-4139; Yeh JK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090058; Zhou YL, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0089-2; Zuliani G, 2009, ATHEROSCLEROSIS, V203, P626, DOI 10.1016/j.atherosclerosis.2008.07.038	47	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180687	10.1371/journal.pone.0180687	http://dx.doi.org/10.1371/journal.pone.0180687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686726	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100090
J	Emukule, GO; Spreeuwenberg, P; Chaves, SS; Mott, JA; Tempia, S; Bigogo, G; Nyawanda, B; Nyaguara, A; Widdowson, MA; van der Velden, K; Paget, JW				Emukule, Gideon O.; Spreeuwenberg, Peter; Chaves, Sandra S.; Mott, Joshua A.; Tempia, Stefano; Bigogo, Godfrey; Nyawanda, Bryan; Nyaguara, Amek; Widdowson, Marc-Alain; van der Velden, Koos; Paget, John W.			Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013	PLOS ONE			English	Article							EXCESS MORTALITY; YOUNG-CHILDREN; VERBAL AUTOPSY; UNITED-STATES; SOUTH-AFRICA; RURAL KENYA; INFECTION; DEATHS; BURDEN; AGE	Background Influenza and respiratory syncytial virus (RSV) associated mortality has not been wellestablished in tropical Africa. Methods We used the negative binomial regression method and the rate-difference method (i. e. deaths during low and high influenza/RSV activity months), to estimate excess mortality attributable to influenza and RSV using verbal autopsy data collected through a health and demographic surveillance system in Western Kenya, 2007-2013. Excess mortality rates were calculated for a) all-cause mortality, b) respiratory deaths (including pneumonia), c) HIV-related deaths, and d) pulmonary tuberculosis (TB) related deaths. Results Using the negative binomial regression method, the mean annual all-cause excess mortality rate associated with influenza and RSV was 14.1 (95% confidence interval [ CI] 0.0-93.3) and 17.1 (95% CI 0.0-111.5) per 100,000 person-years (PY) respectively; and 10.5 (95% CI 0.0-28.5) and 7.3 (95% CI 0.0-27.3) per 100,000 PY for respiratory deaths, respectively. Highest mortality rates associated with influenza were among >= 50 years, particularly among persons with TB (41.6[ 95% CI 0.0-122.7]); and with RSV were among < 5 years. Using the rate-difference method, the excess mortality rate for influenza and RSV was 44.8 (95% CI 36.8-54.4) and 19.7 (95% CI 14.7-26.5) per 100,000 PY, respectively, for all-cause deaths; and 9.6 (95% CI 6.3-14.7) and 6.6 (95% CI 3.9-11.0) per 100,000 PY, respectively, for respiratory deaths. Conclusions Our study shows a substantial excess mortality associated with influenza and RSV in Western Kenya, especially among children < 5 years and older persons with TB, supporting recommendations for influenza vaccination and efforts to develop RSV vaccines.	[Emukule, Gideon O.; Chaves, Sandra S.; Mott, Joshua A.; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Kenya Country Off, Nairobi, Kenya; [Emukule, Gideon O.; van der Velden, Koos; Paget, John W.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [Spreeuwenberg, Peter; Paget, John W.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Chaves, Sandra S.; Mott, Joshua A.; Tempia, Stefano] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Mott, Joshua A.] US PHS, Rockville, MD USA; [Tempia, Stefano] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Bigogo, Godfrey; Nyawanda, Bryan; Nyaguara, Amek] Kenya Govt Med Res Ctr, Kisumu, Kenya	Radboud University Nijmegen; Netherlands Institute for Health Services Research; Centers for Disease Control & Prevention - USA; United States Public Health Service; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Kenya Medical Research Institute	Emukule, GO (corresponding author), Ctr Dis Control & Prevent, Kenya Country Off, Nairobi, Kenya.; Emukule, GO (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.	uyr9@cdc.gov	van der Velden, J./H-8101-2014; Bigogo, Godfrey/W-3591-2019		Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention research collaboration	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention research collaboration(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by The Kenya Medical Research Institute and U.S. Centers for Disease Control and Prevention research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Beeler JA, 2013, MICROB PATHOGENESIS, V55, P9, DOI 10.1016/j.micpath.2012.11.013; Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Emukule GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138708; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Jansen AGSC, 2008, VACCINE, V26, P5567, DOI 10.1016/j.vaccine.2008.08.003; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kessaram T, 2015, INFLUENZA OTHER RESP, V9, P14, DOI 10.1111/irv.12292; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; (KNBS) KNBoS and Macro I, 2010, KEN DEM HLTH SURV; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; Moyes J, 2013, J INFECT DIS, V208, pS217, DOI 10.1093/infdis/jit479; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Park M, 2015, AM J PREVENTIVE MED; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; UNITAID, 2015, MAL MED LANDSC; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Walaza S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129173; WHO Collaborating Centre for Influenza at CDC Atlanta, CDC PROT REALT RTPCR; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; World Health Organization, 2012 WHO VERB AUT IN; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	46	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180890	10.1371/journal.pone.0180890	http://dx.doi.org/10.1371/journal.pone.0180890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686692	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100119
J	Hayat, T; Haider, F; Muhammad, T; Alsaedi, A				Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer; Alsaedi, Ahmed			Three-dimensional rotating flow of carbon nanotubes with Darcy-Forchheimer porous medium	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER ENHANCEMENT; STRETCHING SURFACE; THERMAL-CONDUCTIVITY; NATURAL-CONVECTION; MAGNETIC-FIELD; NANOFLUID; FLUID; CHANNEL; NANOPARTICLES	Here we are concerned with the Darcy-Forchheimer three-dimensional flow of carbon nanotubes in a rotating frame. Flow is generated by stretching of the surface. Xue model is adopted for nanofluid transport mechanism. Results for single wall carbon nanotubes (SWCNTs) and multi wall carbon nanotubes are achieved and compared. Flow saturating porous space obeys Darcy-Forchheimer expression. Boundary layer approximations are invoked to simplify governing partial differential system. Optimal homotopy analysis method (OHAM) is utilized for solutions of governing model. The optimal values of auxiliary parameters are computed. Plots have been displayed in order to analyze how the velocities and temperature fields get affected by various flow parameters. Skin-friction coefficients and local Nusselt number are presented through numerical data for both SWCNTs and MWCNTs. Moreover the skin-friction coefficients and local Nusselt number are enhanced for larger values of nanoparticles volume fraction.	[Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	taseer@math.qau.edu.pk	Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Muhammad, Taseer/0000-0002-0838-2731; Alsaedi, Ahmed/0000-0003-3452-8922				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Bakar S.A., 2016, FRONT HEAT MASS TRAN, V7, P38; Choi SUS, 2001, APPL PHYS LETT, V79, P2252, DOI 10.1063/1.1408272; Dehghan M, 2010, NUMER METH PART D E, V26, P448, DOI 10.1002/num.20460; Ding YL, 2006, INT J HEAT MASS TRAN, V49, P240, DOI 10.1016/j.ijheatmasstransfer.2005.07.009; Ellahi R, 2016, INT J NUMER METHOD H, V26, P2160, DOI 10.1108/HFF-11-2014-0348; Ellahi R, 2016, APPL NANOSCI, V6, P641, DOI 10.1007/s13204-015-0481-z; Ellahi R, 2015, IEEE T NANOTECHNOL, V14, P726, DOI 10.1109/TNANO.2015.2435899; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1782; Hayat T, 2017, J MOL LIQ, V229, P541, DOI 10.1016/j.molliq.2017.01.005; Hayat T, 2017, J MOL LIQ, V229, P495, DOI 10.1016/j.molliq.2016.12.095; Hayat T, 2017, J TAIWAN INST CHEM E, V70, P119, DOI 10.1016/j.jtice.2016.11.002; Hayat T, 2016, INT J NUMER METHOD H, V26, P2355, DOI 10.1108/HFF-08-2015-0333; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2017, INT J HEAT MASS TRAN, V112, P248, DOI 10.1016/j.ijheatmasstransfer.2017.04.123; Hayat T, 2017, J MOL LIQ, V233, P278, DOI 10.1016/j.molliq.2017.03.035; Hayat T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174938; Hayat T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168824; Hayat T, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110346; Hayat T, 2016, J MOL LIQ, V221, P1121, DOI 10.1016/j.molliq.2016.06.083; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Imtiaz M, 2016, INT J HEAT MASS TRAN, V101, P948, DOI 10.1016/j.ijheatmasstransfer.2016.05.114; Iqbal Z, 2017, PHYSICA E, V91, P128, DOI 10.1016/j.physe.2017.04.022; Javed T, 2011, INT J NUMER METHOD H, V21, P903, DOI 10.1108/09615531111162855; Jha B. K., 2011, APPL MATH, V2, P1432; Kamali R, 2010, INT COMMUN HEAT MASS, V37, P1153, DOI 10.1016/j.icheatmasstransfer.2010.06.001; Karimipour A, 2016, J MAGN MAGN MATER, V419, P420, DOI 10.1016/j.jmmm.2016.06.063; Khan U, 2017, APPL THERM ENG, V113, P1107, DOI 10.1016/j.applthermaleng.2016.11.104; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Malvandi A., 2013, J THERMODYN, V2013, DOI DOI 10.1155/2013/764827; Muskat M., 1946, FLOW HOMOGENEOUS FLU, V763, P100; Mustafa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149304; Nazar R, 2004, MECH RES COMMUN, V31, P121, DOI 10.1016/j.mechrescom.2003.09.004; Pal D, 2012, INT COMMUN HEAT MASS, V39, P913, DOI 10.1016/j.icheatmasstransfer.2012.05.012; Ramasubramaniam R, 2003, APPL PHYS LETT, V83, P2928, DOI 10.1063/1.1616976; Rosali H, 2015, J MOL LIQ, V211, P965, DOI 10.1016/j.molliq.2015.08.026; Sadiq MA, 2016, RESULTS PHYS, V6, P884, DOI 10.1016/j.rinp.2016.10.019; Safaei MR, 2014, NUMER HEAT TR A-APPL, V66, P1321, DOI 10.1080/10407782.2014.916101; Seddeek MA, 2006, J COLLOID INTERF SCI, V293, P137, DOI 10.1016/j.jcis.2005.06.039; Shafique Z, 2016, RESULTS PHYS, V6, P627, DOI 10.1016/j.rinp.2016.09.006; Shehzad N, 2016, J MOL LIQ, V222, P446, DOI 10.1016/j.molliq.2016.07.052; Shehzad SA, 2016, J MOL LIQ, V224, P274, DOI 10.1016/j.molliq.2016.09.109; Sheikholeslami M, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110324; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Takhar HS, 2003, INT J THERM SCI, V42, P23, DOI 10.1016/S1290-0729(02)00004-2; Turkyilmazoglu M, 2016, FILOMAT, V30, P1633, DOI 10.2298/FIL1606633T; Ul Haq R, 2017, RESULTS PHYS, V7, P57, DOI 10.1016/j.rinp.2016.11.057; Umavathi JC, 2017, INT J THERM SCI, V111, P511, DOI 10.1016/j.ijthermalsci.2016.10.002; WANG CY, 1988, Z ANGEW MATH PHYS, V39, P177, DOI 10.1007/BF00945764; Wang JL, 2013, EXP THERM FLUID SCI, V44, P716, DOI 10.1016/j.expthermflusci.2012.09.013; Xue QZ, 2005, PHYSICA B, V368, P302, DOI 10.1016/j.physb.2005.07.024; Zaimi K, 2013, APPL MATH MECH-ENGL, V34, P945, DOI 10.1007/s10483-013-1719-9; Zeeshan A, 2016, J MOL LIQ, V215, P549, DOI 10.1016/j.molliq.2015.12.110	55	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179576	10.1371/journal.pone.0179576	http://dx.doi.org/10.1371/journal.pone.0179576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686643	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100018
J	Nedelkou, IP; Maurer, A; Schubert, A; Leon, J; Pillen, K				Nedelkou, Ioanna-Pavlina; Maurer, Andreas; Schubert, Anne; Leon, Jens; Pillen, Klaus			Exotic QTL improve grain quality in the triparental wheat population SW84	PLOS ONE			English	Article							TURGIDUM SSP DICOCCOIDES; BREAD-MAKING QUALITY; CHROMOSOME-DOUBLED HYBRIDS; SYNTHETIC HEXAPLOID WHEAT; PROTEIN-CONTENT; TRITICUM-AESTIVUM; GENETIC-ANALYSIS; WINTER-WHEAT; POLYPLOID WHEAT; SEDIMENTATION VOLUME	Developing the tri-parental exotic wheat population SW84 Genetic diversity of cultivated wheat was markedly reduced, first, during domestication and, second, since the onset of modern elite breeding. There is an increasing demand for utilizing genetic resources to increase genetic diversity and, simultaneously, to improve agronomic performance of cultivated wheat. To locate favorable effects of exotic wheat alleles, we developed the tri-parental wheat population SW84. The population was derived from crossing the hexaploid spring wheat cultivars Triso and Devon with one synthetic exotic donor accession, Syn084L, followed by two rounds of backcrossing and three rounds of selfing. SW84 consists of 359 BC2F4 lines, split into two families, D84 (Devon*Syn084L) and T84 (Triso*Syn084L). Studying the genetic control of grain quality in SW84 As a case study, grain quality of SW84 was studied in replicated field trials. Transgressive segregation was observed for all studied grain quality traits by evaluating SW84 for two years at two locations under low and high nitrogen supply. Subsequently, a genome-wide association study (GWAS) was carried out based on genomic data derived from a 90k Infinium iSELECT single nucleotide polymorphism (SNP) array. In total, GWAS yielded 37 marker-trait associations, summarized to 16 quantitative trait loci (QTL). These SNPs indicate genetic regulators of grain protein content, grain hardness, sedimentation value and sedimentation ratio. The majority of exotic QTL alleles (75%) exerted favorable effects, increasing grain protein content and sedimentation value in ten and two cases, respectively. For instance, two exotic QTL alleles were associated with a substantial increase of grain protein content and sedimentation value by 1.09% and 7.31 ml, respectively. This finding confirms the potential of exotic germplasm to improve grain quality in cultivated wheat. So far, the molecular nature of most of the detected QTL is unknown. However, two QTL correspond to known genes controlling grain quality: The major QTL on chromosome 6B, increasing grain protein content by 0.70%, on average, co-localizes with the NAM-B1 gene, known to control grain protein content as well as iron and zinc content. Likewise, the major QTL on chromosome 5D, reducing grain hardness by 8.98%, on average, co-localizes with the gene for puroindoline b (Pinb-D1) at the Ha locus. In total, 13 QTL were detected across families, whereas one and three QTL were exclusively detected in families D84 and T84, respectively. Likewise, ten QTL were detected across nitrogen treatments, whereas one and five QTL were exclusively detected under low and high N treatments, respectively. Our data indicate that most effects in SW84 act across families and N levels. Merging of data from two families or two N treatments may, thus, be considered in association studies to increase sample size and, as a result, QTL detection power. Utilizing favorable exotic QTL alleles in wheat breeding Our study serves as a model how favorable exotic QTL alleles can be located in exotic germplasm of wheat. In future, the localized favorable exotic QTL alleles will be utilized in wheat breeding programs to simultaneously improve grain quality and selectively expand genetic diversity of the elite wheat gene pool.	[Nedelkou, Ioanna-Pavlina; Maurer, Andreas; Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany; [Schubert, Anne; Leon, Jens] Univ Bonn, Inst Crop Sci & Resource Conservat, Crop Genet & Biotechnol Unit, Katzenburgweg 5, Bonn, Germany	Martin Luther University Halle Wittenberg; University of Bonn	Pillen, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	klaus.pillen@landw.uni-halle.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Maurer, Andreas/0000-0002-2916-7475	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF) [312862]; Federal State of Saxony-Anhalt	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal State of Saxony-Anhalt	This work was funded by the German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF, project 312862) and the Federal State of Saxony-Anhalt.	Arbelbide M, 2006, THEOR APPL GENET, V112, P885, DOI 10.1007/s00122-005-0190-1; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Blanco A, 1998, PLANT BREEDING, V117, P413, DOI 10.1111/j.1439-0523.1998.tb01965.x; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Brevis JC, 2010, J CEREAL SCI, V51, P357, DOI 10.1016/j.jcs.2010.02.004; Brevis JC, 2010, CROP SCI, V50, P93, DOI 10.2135/cropsci2009.02.0057; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Capparelli R, 2005, PLANT MOL BIOL, V58, P857, DOI 10.1007/s11103-005-8270-9; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chatzav M, 2010, ANN BOT-LONDON, V105, P1211, DOI 10.1093/aob/mcq024; de Sa RM, 2006, J I BREWING, V112, P9, DOI 10.1002/j.2050-0416.2006.tb00701.x; Deng ZY, 2013, J INTEGR AGR, V12, P2125, DOI 10.1016/S2095-3119(13)60352-4; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; FAOSTAT, 2016, UN FOOD AGR ORG STAT; Feiz L, 2009, GENETICS, V183, P853, DOI 10.1534/genetics.109.106013; Flaete NES, 2003, J CEREAL SCI, V37, P129, DOI 10.1006/jcrs.2001.0447; Galande AA, 2001, THEOR APPL GENET, V103, P601, DOI 10.1007/PL00002915; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2010, MOL BREEDING, V26, P145, DOI 10.1007/s11032-009-9359-7; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Hagenblad J, 2012, THEOR APPL GENET, V125, P1677, DOI 10.1007/s00122-012-1943-2; Hagenblad J, 2012, GENET RESOUR CROP EV, V59, P1185, DOI 10.1007/s10722-011-9754-x; HOLM S, 1979, SCAND J STAT, V6, P65; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Huang HB, 2008, J FOOD ENG, V87, P303, DOI 10.1016/j.jfoodeng.2007.12.022; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; ICC, DET PROT NEAR INFR R, V159; Iqbal M, 2007, PLANT BREEDING, V126, P244, DOI 10.1111/j.1439-0523.2007.01346.x; (IWGSC) TIWGSC, 2014, SCIENCE, V345; Krystkowiak K, 2016, J APPL GENETICS; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Laidig F, 2017, THEOR APPL GENET, V130, P223, DOI 10.1007/s00122-016-2810-3; LANGE W, 1992, EUPHYTICA, V59, P197, DOI 10.1007/BF00041273; LANGE W, 1992, EUPHYTICA, V59, P213, DOI 10.1007/BF00041274; LEVY AA, 1989, EUPHYTICA, V41, P113, DOI 10.1007/BF00022420; Li Y, 2009, GEOPHYS J INT, V178, P1493, DOI 10.1111/j.1365-246X.2009.04232.x; Long DS, 2008, AGRON J, V100, P247, DOI [10.2134/agrojnl2007.0052, 10.2134/agronj2007.0052]; Mahjourimajd S., 2016, PLOS ONE, V11; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Moore CM, 2015, EUPHYTICA, V204, P371, DOI 10.1007/s10681-014-1346-3; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Naz AA, 2008, THEOR APPL GENET, V116, P1095, DOI 10.1007/s00122-008-0738-y; Naz AA, 2015, PLANT BREEDING, V134, P514, DOI 10.1111/pbr.12301; Naz AA, 2012, MOL BREEDING, V30, P1219, DOI 10.1007/s11032-012-9710-2; Nevo E, 2001, ISR J PLANT SCI, V49, pS77, DOI 10.1092/XJQN-9T4H-VTL3-CDXU; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Olson EL, 2013, THEOR APPL GENET, V126, P2477, DOI 10.1007/s00122-013-2148-z; Pasha I, 2010, FOOD SCI TECHNOL INT, V16, P511, DOI 10.1177/1082013210379691; Perretant MR, 2000, THEOR APPL GENET, V100, P1167, DOI 10.1007/s001220051420; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Randhawa HS, 2013, PLANT BREEDING; Roder MS, 1998, GENETICS, V149, P2007; Ross AS, 2009, PASSING TEST WHEAT E, P455; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saal B, 2011, EUPHYTICA, V177, P223, DOI 10.1007/s10681-010-0252-6; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Shaaf S, 2016, MOL GENET GENOMICS, V291, P1259, DOI 10.1007/s00438-016-1180-5; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; Suprayogi Y, 2009, THEORETICAL APPL GEN; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Trethowan RM, 2009, SYNTHETIC WHEAT EMER, P369; Turner AS, 2004, J CEREAL SCI, V40, P51, DOI 10.1016/j.jcs.2004.03.001; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Utz HF, 2000, GENETICS, V154, P1839; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; Wang G, 2011, THEOR APPL GENET, V124, P207; Wang L, 2012, J GENET, V91, P303, DOI 10.1007/s12041-012-0190-2; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2012, MOL BREEDING, V29, P661, DOI 10.1007/s11032-011-9580-z; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weightman RM, 2008, J CEREAL SCI, V47, P457, DOI 10.1016/j.jcs.2007.05.011; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Wurschum T, 2016, THEOR APPL GENET, P1; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang W, 2008, THEOR APPL GENET, V117, P1361, DOI 10.1007/s00122-008-0869-1; Zhao LA, 2010, EUPHYTICA, V174, P325, DOI 10.1007/s10681-009-0109-z	97	6	7	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179851	10.1371/journal.pone.0179851	http://dx.doi.org/10.1371/journal.pone.0179851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686676	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100022
J	Williams, KE; Huyvaert, KP; Piaggio, AJ				Williams, Kelly E.; Huyvaert, Kathryn P.; Piaggio, Antoinette J.			Clearing muddied waters: Capture of environmental DNA from turbid waters	PLOS ONE			English	Article							FERAL PIG ERADICATION; EXTRACELLULAR DNA; EDNA; MITOCHONDRIAL; PERSISTENCE; PCR; BIODIVERSITY; COMMUNITY; PROGRAM; SAMPLES	Understanding the differences in efficiencies of various methods to concentrate, extract, and amplify environmental DNA (eDNA) is vital for best performance of eDNA detection. Aquatic systems vary in characteristics such as turbidity, eDNA concentration, and inhibitor load, thus affecting eDNA capture efficiency. Application of eDNA techniques to the detection of terrestrial invasive or endangered species may require sampling at intermittent water sources that are used for drinking and cooling; these water bodies may often be stagnant and turbid. We present our best practices technique for the detection of wild pig eDNA in water samples, a protocol that will have wide applicability to the detection of elusive vertebrate species. We determined the best practice for eDNA capture in a turbid water system was to concentrate DNA from a 15 mL water sample via centrifugation, purify DNA with the DNeasy mericon Food kit, and remove inhibitors with Zymo Inhibitor Removal Technology columns. Further, we compared the sensitivity of conventional PCR to quantitative PCR and found that quantitative PCR was more sensitive in detecting lower concentrations of eDNA. We show significant differences in efficiencies among methods in each step of eDNA capture, emphasizing the importance of optimizing best practices for the system of interest.	[Williams, Kelly E.; Piaggio, Antoinette J.] USDA, Wildlife Serv, Natl Wildlife Res Ctr, Wildlife Genet Lab, Ft Collins, CO 80524 USA; [Williams, Kelly E.; Huyvaert, Kathryn P.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Williams, Kelly E.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	United States Department of Agriculture (USDA); Colorado State University; University of Washington; University of Washington Seattle	Williams, KE (corresponding author), USDA, Wildlife Serv, Natl Wildlife Res Ctr, Wildlife Genet Lab, Ft Collins, CO 80524 USA.; Williams, KE (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.; Williams, KE (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	kellwill@rams.colostate.edu	Huyvaert, Kathryn P/A-2710-2009	Huyvaert, Kathryn P/0000-0003-3302-030X; Piaggio, Antoinette/0000-0002-4701-0746				Amberg JJ, 2013, DETECTION ENV DNA BI; [Anonymous], 1996, MANAGING VERTEBRATE; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Caldwell JM, 2007, ENVIRON SCI TECHNOL, V41, P3277, DOI 10.1021/es062912s; Chavarria PM, 2007, LANDSCAPE LEVEL SURV; Coyne KJ, 2001, AQUAT MICROB ECOL, V24, P275, DOI 10.3354/ame024275; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Farrington HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117803; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Furlan EM, 2016, MOL ECOL RESOUR, V16, P641, DOI 10.1111/1755-0998.12483; GARBER RC, 1983, ANAL BIOCHEM, V135, P416, DOI 10.1016/0003-2697(83)90704-2; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hashizume H, 2017, ACTA TROP, V169, P1, DOI 10.1016/j.actatropica.2017.01.008; HONE J, 1983, AUST WILDLIFE RES, V10, P269; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Martellini A, 2005, WATER RES, V39, P541, DOI 10.1016/j.watres.2004.11.012; Matheson C.D., 2010, OPEN ENZYME INHIB J, V3, P38, DOI [10.2174/1874940201003010038, DOI 10.2174/1874940201003010038]; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Nielsen KM, 2006, SOIL BIOL, V8, P141; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Perez-Mendez A, 2014, J VIROL METHODS, V206, P95, DOI 10.1016/j.jviromet.2014.05.025; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pilliod D, APPL ENV DNA INVASIV, P4; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Sutton JT, 2011, MOL ECOL RESOUR, V11, P514, DOI 10.1111/j.1755-0998.2011.02981.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Taylor R. B., 1993, FERAL SWINE COMPENDI, P17; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; United States Department of Agriculture U, 2014, BUDG SUMM ANN PERF P; Valiere N, 2000, MOL ECOL, V9, P2150, DOI 10.1046/j.1365-294X.2000.11142.x; West B.C., 2009, MANAGING WILD PIGS T; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Zarzoso-Lacoste D, 2013, MOL ECOL RESOUR, V13, P117, DOI 10.1111/1755-0998.12029	61	34	35	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179282	10.1371/journal.pone.0179282	http://dx.doi.org/10.1371/journal.pone.0179282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686659	Green Published, gold			2022-12-27	WOS:000405464100012
J	Glavatska, O; Muller, K; Butenschoen, O; Schmalwasser, A; Kandeler, E; Scheu, S; Totsche, KU; Ruess, L				Glavatska, Olena; Mueller, Karolin; Butenschoen, Olaf; Schmalwasser, Andreas; Kandeler, Ellen; Scheu, Stefan; Totsche, Kai Uwe; Ruess, Liliane			Disentangling the root- and detritus-based food chain in the micro-food web of an arable soil by plant removal	PLOS ONE			English	Article							NEMATODE COMMUNITY COMPOSITION; FREE-LIVING NEMATODES; ORGANIC-MATTER; DECOMPOSITION PATHWAYS; FAUNAL ANALYSIS; CARBON; DIVERSITY; RHIZOSPHERE; INDICATORS; DYNAMICS	Soil food web structure and function is primarily determined by the major basal resources, which are living plant tissue, root exudates and dead organic matter. A field experiment was performed to disentangle the interlinkage of the root- and detritus-based soil food chains. An arable site was cropped either with maize, amended with maize shoot litter or remained bare soil, representing food webs depending on roots, aboveground litter and soil organic matter as predominant resource, respectively. The soil micro-food web, i.e. microorganisms and nematodes, was investigated in two successive years along a depth transect. The community composition of nematodes was used as model to determine the changes in the rhizosphere, detritusphere and bulk soil food web. In the first growing season the impact of treatments on the soil micro-food web was minor. In the second year plant-feeding nematodes increased under maize, whereas after harvest the Channel Index assigned promotion of the detritivore food chain, reflecting decomposition of root residues. The amendment with litter did not foster microorganisms, instead biomass of Gram-positive and Gram-negative bacteria as well as that of fungi declined in the rooted zone. Likely higher grazing pressure by nematodes reduced microbial standing crop as bacterial and fungal feeders increased. However, populations at higher trophic levels were not promoted, indicating limited flux of litter resources along the food chain. After two years of bare soil microbial biomass and nematode density remained stable, pointing to soil organic matter-based resources that allow bridging periods with deprivation. Nematode communities were dominated by opportunistic taxa that are competitive at moderate resource supply. In sum, removal of plants from the system had less severe effects than expected, suggesting considerable food web resilience to the disruption of both the root and detrital carbon channel, pointing to a legacy of organic matter resources in arable soils.	[Glavatska, Olena; Ruess, Liliane] Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany; [Mueller, Karolin; Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Dept, Stuttgart, Germany; [Butenschoen, Olaf; Scheu, Stefan] Georg August Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Schmalwasser, Andreas; Totsche, Kai Uwe] Friedrich Schiller Univ Jena, Inst Geosci, Hydrogeol Sect, Jena, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	Humboldt University of Berlin; University Hohenheim; University of Gottingen; Friedrich Schiller University of Jena; University of Gottingen	Ruess, L (corresponding author), Humboldt Univ, Ecol Grp, Inst Biol, Berlin, Germany.	liliane.ruess@biologie.hu-berlin.de	Totsche, Kai Uwe/E-2086-2013; Scheu, Stefan/H-7049-2015	Totsche, Kai Uwe/0000-0002-2692-213X; Butenschoen, Olaf/0000-0003-1866-9805; Muller, Karolin/0000-0003-4465-5677; Kandeler, Ellen/0000-0002-2854-0012	Deutsche Forschungsgemeinschaft, Germany [FOR 918];  [RU780/9-1];  [KA 1590/9-2];  [SCHE 376/23-2]	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); ; ; 	This study was performed within the framework of the Research Unit "Carbon flow in belowground food webs assessed by stable isotope tracers" (FOR 918) of the Deutsche Forschungsgemeinschaft (<http://www.dfg.de> www.dfg.de), Germany. OG received funding by the grant RU780/9-1, KM by the grant KA 1590/9-2 and OB by the grant SCHE 376/23-2.	Alphei J., 1999, AFZ/Der Wald, Allgemeine Forst Zeitschrift fur Waldwirtschaft und Umweltvorsorge, V54, P64; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 1999, PLANT SOIL, V212, P23, DOI 10.1023/A:1004642218792; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Crotty FV, 2014, ECOL EVOL, V4, P1, DOI 10.1002/ece3.905; de Ruiter Peter C., 2005, P3; Dibbern D, 2014, SOIL BIOL BIOCHEM, V69, P187, DOI 10.1016/j.soilbio.2013.10.040; Dmowska E, 1995, EUR J SOIL BIOL, V31, P189; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Drijber RA, 2000, SOIL BIOL BIOCHEM, V32, P1419, DOI 10.1016/S0038-0717(00)00060-2; Duncan LW, 2007, J NEMATOL, V39, P176; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2003, APPL SOIL ECOL, V23, P93, DOI 10.1016/S0929-1393(03)00044-1; Ferris H, 1996, APPL SOIL ECOL, V3, P161, DOI 10.1016/0929-1393(95)00071-2; Ferris H, 2006, J NEMATOL, V38, P3; Ferris H, 2010, J NEMATOL, V42, P63; FRECKMAN DW, 1993, AGR ECOSYST ENVIRON, V45, P239, DOI 10.1016/0167-8809(93)90074-Y; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gorres JH, 1998, SOIL BIOL BIOCHEM, V30, P219, DOI 10.1016/S0038-0717(97)00107-7; Griffiths BS, 2003, NEMATOLOGY, V5, P889, DOI 10.1163/156854103773040808; Hanel L, 2003, APPL SOIL ECOL, V22, P255, DOI 10.1016/S0929-1393(02)00152-X; Heijboer A, 2017, FOOD WEBS S IN PRESS; Helfrich M, 2006, GEODERMA, V136, P331, DOI 10.1016/j.geoderma.2006.03.048; Kerry BR, 2000, ANNU REV PHYTOPATHOL, V38, P423, DOI 10.1146/annurev.phyto.38.1.423; Kramer S, 2013, SOIL BIOL BIOCHEM, V61, P76, DOI 10.1016/j.soilbio.2013.02.006; Kramer S, 2012, PEDOBIOLOGIA, V55, P111, DOI 10.1016/j.pedobi.2011.12.001; Leroy BLM, 2009, NEMATOLOGY, V11, P23, DOI 10.1163/156854108X398381; Marschner B, 2008, J PLANT NUTR SOIL SC, V171, P91, DOI 10.1002/jpln.200700049; McSorley R, 1999, J NEMATOL, V31, P619; McSorley R, 1999, J NEMATOL, V31, P37; McSorley R, 1997, APPL SOIL ECOL, V6, P147, DOI 10.1016/S0929-1393(97)00001-2; Moll J, 2015, MICROB ECOL, V70, P390, DOI 10.1007/s00248-015-0569-8; Moore JC, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P375; NEHER DA, 1995, PLANT SOIL, V170, P167, DOI 10.1007/BF02183065; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pate E, 2000, APPL SOIL ECOL, V14, P5, DOI 10.1016/S0929-1393(99)00051-7; Pausch J, 2013, PLANT SOIL, V364, P273, DOI 10.1007/s11104-012-1363-8; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; Pendall E, 2007, SOIL BIOL BIOCHEM, V39, P2628, DOI 10.1016/j.soilbio.2007.05.016; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; RUESS L, 1995, NEMATOLOGICA, V41, P106, DOI 10.1163/003925995X00080; Ruess L, 2003, NEMATOLOGY, V5, P179, DOI 10.1163/156854103767139662; Ruess L, 2007, SOIL BIOL BIOCHEM, V39, P1990, DOI 10.1016/j.soilbio.2007.03.002; Ruess L, 2004, NEMATOL MONOGR PERSP, V2, P547; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Sanchez-Moreno S, 2006, NEMATOLOGY, V8, P703, DOI 10.1163/156854106778877857; Scharroba A, 2012, SOIL BIOL BIOCHEM, V50, P1, DOI 10.1016/j.soilbio.2012.03.002; Scheu S, 2005, SOIL BIOL, V3, P253; Scheunemann N, 2015, OECOLOGIA, V179, P1135, DOI 10.1007/s00442-015-3415-2; Scheunemann N, 2015, SOIL BIOL BIOCHEM, V81, P81, DOI 10.1016/j.soilbio.2014.11.006; Sereda E, 2015, BASIC APPL ECOL, V16, P746, DOI 10.1016/j.baae.2015.07.005; Tao J, 2009, SOIL BIOL BIOCHEM, V41, P898, DOI 10.1016/j.soilbio.2008.12.002; Thoden TC, 2011, NEMATOLOGY, V13, P133, DOI 10.1163/138855410X541834; Todorovic GR, 2010, J PLANT NUTR SOIL SC, V173, P662, DOI 10.1002/jpln.200800311; Ugarte CM, 2013, SOIL BIOL BIOCHEM, V64, P103, DOI 10.1016/j.soilbio.2013.03.035; Uren NC, 2001, BOOKS SOIL PLANT ENV, P19; Villenave C, 2001, APPL SOIL ECOL, V17, P43, DOI 10.1016/S0929-1393(00)00129-3; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053; Yeates G. W, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0021913, DOI 10.1002/9780470015902.A0021913]; Yeates GW, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P1, DOI 10.1079/9781845933852.0001; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang XK, 2015, SOIL BIOL BIOCHEM, V80, P118, DOI 10.1016/j.soilbio.2014.10.003	65	13	13	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180264	10.1371/journal.pone.0180264	http://dx.doi.org/10.1371/journal.pone.0180264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704438	Green Published, gold			2022-12-27	WOS:000405649700035
J	Meeremans, P; Yochum, N; Kochzius, M; Ampe, B; Tuyttens, FAM; Uhlmann, SS				Meeremans, Pieter; Yochum, Noelle; Kochzius, Marc; Ampe, Bart; Tuyttens, Frank A. M.; Uhlmann, Sven Sebastian			Inter-rater reliability of categorical versus continuous scoring of fish vitality: Does it affect the utility of the reflex action mortality predictor (RAMP) approach?	PLOS ONE			English	Article							CRAB CHIONOECETES-BAIRDI; DISCARD MORTALITY; DELAYED MORTALITY; OBSERVER BIAS; IMPAIRMENT; SURVIVAL; LAMENESS; PERSPECTIVES; INDICATORS; STRESS	Scoring reflex responsiveness and injury of aquatic organisms has gained popularity as predictors of discard survival. Given this method relies upon the individual interpretation of scoring criteria, an evaluation of its robustness is done here to test whether protocol-instructed, multiple raters with diverse backgrounds (research scientist, technician, and student) are able to produce similar or the same reflex and injury score for one of the same flatfish (European plaice, Pleuronectes platessa) after experiencing commercial fishing stressors. Interrater reliability for three raters was assessed by using a 3-point categorical scale ('absent', 'weak', 'strong') and a tagged visual analogue continuous scale (tVAS, a 10 cm bar split in three labelled sections: 0 for 'absent', 'weak', 'moderate', and 'strong') for six reflex responses, and a 4-point scale for four injury types. Plaice (n = 304) were sampled from 17 research beam-trawl deployments during four trips. Fleiss kappa (categorical scores) and intra-class correlation coefficients (ICC, continuous scores) indicated variable inter-rater agreement by reflex type (ranging between 0.55 and 0.88, and 67% and 91% for Fleiss kappa and ICC, respectively), with least agreement among raters on extent of injury (Fleiss kappa between 0.08 and 0.27). Despite differences among raters, which did not significantly influence the relationship between impairment and predicted survival, combining categorical reflex and injury scores always produced a close relationship of such vitality indices and observed delayed mortality. The use of the continuous scale did not improve fit of these models compared with using the reflex impairment index based on categorical scores. Given these findings, we recommend using a 3-point categorical over a continuous scale. We also determined that training rather than experience of raters minimised inter-rater differences. Our results suggest that cost-efficient reflex impairment and injury scoring may be considered a robust technique to evaluate lethal stress and damage of this flatfish species on-board commercial beam-trawl vessels.	[Meeremans, Pieter; Kochzius, Marc] Vrije Univ Brussel, Brussels, Belgium; [Meeremans, Pieter; Ampe, Bart; Tuyttens, Frank A. M.; Uhlmann, Sven Sebastian] Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium; [Yochum, Noelle] Oregon State Univ, Corvallis, OR 97331 USA; [Tuyttens, Frank A. M.] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Meeremans, Pieter] Minist Agr Anim Husb & Fisheries, Paramaribo, Suriname; [Yochum, Noelle] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA	Vrije Universiteit Brussel; Institute For Agricultural & Fisheries Research; Oregon State University; Ghent University; National Oceanic Atmospheric Admin (NOAA) - USA	Uhlmann, SS (corresponding author), Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium.	sven.uhlmann@gmx.net	Tuyttens, Frank/HCH-1899-2022; Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719; Tuyttens, Frank/0000-0002-1348-218X; Uhlmann, Sven Sebastian/0000-0003-2830-5845	European Maritime and Fisheries Fund [LV-01-090415]	European Maritime and Fisheries Fund	This work was supported by the European Maritime and Fisheries Fund (Grant Number: LV-01-090415).	Agresti A., 2003, INTRO CATEGORICAL DA, P372; Barkley AS, 2012, T AM FISH SOC, V141, P638, DOI 10.1080/00028487.2012.683477; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benoit HP, 2015, ICES J MAR SCI, V72, P1834, DOI 10.1093/icesjms/fsv039; Benoit HP, 2013, ICES J MAR SCI, V70, P99, DOI 10.1093/icesjms/fss132; Benoit HP, 2010, FISH RES, V106, P436, DOI 10.1016/j.fishres.2010.09.018; Brenninkmeyer C, 2007, ANIM WELFARE, V16, P127; Brownscombe JW, 2017, FISH RES, V186, P693, DOI 10.1016/j.fishres.2016.04.018; Brownscombe JW, 2015, ENVIRON BIOL FISH, V98, P2287, DOI 10.1007/s10641-015-0444-y; Burghardt GM, 2012, ETHOLOGY, V118, P511, DOI 10.1111/j.1439-0310.2012.02040.x; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Davis MW, 2007, ICES J MAR SCI, V64, P1535, DOI 10.1093/icesjms/fsm087; Davis MW, 2006, FISH RES, V82, P1, DOI 10.1016/j.fishres.2006.09.004; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Depestele J, 2014, FISH RES, V154, P82, DOI 10.1016/j.fishres.2014.01.018; Esaiassen M, 2013, FOOD CONTROL, V29, P231, DOI 10.1016/j.foodcont.2012.05.065; European Union, 2013, OFF J EUR UNION L, VL 354, P40; Fanshawe TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002925; Fleiss J., 2003, STAT METHODS RATES P, P800, DOI [10.1198/tech.2004.s812, DOI 10.1198/TECH.2004.S812]; Foppen W, 2016, EUR RADIOL, V26, P1963, DOI 10.1007/s00330-015-4013-8; Gibbons J, 2012, ANIM WELFARE, V21, P379, DOI 10.7120/09627286.21.3.379; Hammarberg M, 2016, EQUINE VET J, V48, P78, DOI 10.1111/evj.12385; Hammond CF, 2013, ICES J MAR SCI, V70, P1308, DOI 10.1093/icesjms/fst085; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Humborstad OB, 2009, FISH B-NOAA, V107, P395; Main J, 1988, P GEAR SEL SURV WORK, P17; March S, 2007, ANIM WELFARE, V16, P131; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Mullan S, 2011, VET J, P190; Nalon E, 2014, ANIMAL, P1; Pollock KH, 2007, FISHERIES MANAG ECOL, V14, P123, DOI 10.1111/j.1365-2400.2007.00532.x; Raby GD, 2012, J APPL ECOL, V49, P90, DOI 10.1111/j.1365-2664.2011.02073.x; Revelle W., 2012, INTRO PSYCHOMETRIC T, P1; Roberts MBV., 1986, BIOL FUNCTIONAL APPR; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Soetaert M, 2015, ICES J MAR SCI, V72, P973, DOI 10.1093/icesjms/fsu176; Stacy NI, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot003; STECF, 2014, STECF1401 PUBL OFF 2, DOI 10.2788/26264; Stoner AW, 2008, FISH B-NOAA, V106, P337; Stoner AW, 2012, FISH RES, V119, P108, DOI 10.1016/j.fishres.2011.12.014; Talwar B, 2016, ICES J MAR SCI, V73, P2356, DOI 10.1093/icesjms/fsw087; Therneau TM, 2015, R TOP DOC, P128; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Tuyttens FAM, 2009, ANIM WELFARE, V18, P399; Uhlmann SS, 2007, DIS AQUAT ORGAN, V76, P173, DOI 10.3354/dao076173; Uhlmann SS, 2016, ICES J MAR SCI, V73, P1244, DOI 10.1093/icesjms/fsv252; Vieira A, 2015, APPL ANIM BEHAV SCI, V171, P94, DOI 10.1016/j.applanim.2015.08.015; Vieira APGF, 2005, J AM DENT ASSOC, V136, P895, DOI 10.14219/jada.archive.2005.0290; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; Yochum N, 2015, FISH RES, V161, P226, DOI 10.1016/j.fishres.2014.07.012	51	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0179092	10.1371/journal.pone.0179092	http://dx.doi.org/10.1371/journal.pone.0179092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704390	Green Published, gold			2022-12-27	WOS:000405649700009
J	Suberviola, B; Rellan, L; Riera, J; Iranzo, R; Campos, AG; Robles, JC; Vicente, R; Minambres, E; Santibanez, M				Suberviola, Borja; Rellan, Luzdivina; Riera, Jordi; Iranzo, Reyes; Garcia Campos, Ascension; Carlos Robles, Juan; Vicente, Rosario; Minambres, Eduardo; Santibanez, Miguel			Role of biomarkers in early infectious complications after lung transplantation	PLOS ONE			English	Article							ISHLT WORKING GROUP; HEART-TRANSPLANTATION; POSTOPERATIVE COURSE; LIVER-TRANSPLANTATION; INTERNATIONAL-SOCIETY; BACTERIAL-INFECTION; CARDIAC-SURGERY; ACUTE REJECTION; PROCALCITONIN; RECIPIENTS	Background Infections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis. Methods Multicentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days. Results We included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively). Conclusions In the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.	[Suberviola, Borja] Hosp Univ Marques de Valdecilla IDIVAL, Crit Care Dept, Santander, Spain; [Rellan, Luzdivina] Complexo Hosp Univ A Coruna, Dept Anesthesiol, La Coruna, Spain; [Riera, Jordi] Hosp Valle De Hebron, Crit Care Dept, Barcelona, Spain; [Iranzo, Reyes] Hosp Univ Puerta de Hierro Majadahonda, Dept Anesthesiol, Madrid, Spain; [Garcia Campos, Ascension] Hosp Univ 12 Octubre, Dept Anesthesiol, Madrid, Spain; [Carlos Robles, Juan] Hosp Univ Reina Sofia, Transplant Coordinat Unit, Cordoba, Spain; [Vicente, Rosario] Hosp Univ & Politecn La Fe, Dept Anesthesiol, Valencia, Spain; [Minambres, Eduardo] Hosp Univ Marques Valdecilla IDIVAL, Crit Care Dept, Transplant Coordinat Unit, Santander, Spain; [Santibanez, Miguel] Univ Cantabria IDIVAL, Nurse Sch, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Universitari Vall d'Hebron; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario 12 de Octubre; Hospital Universitari i Politecnic La Fe; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Suberviola, B (corresponding author), Hosp Univ Marques de Valdecilla IDIVAL, Crit Care Dept, Santander, Spain.	bsuberviola@yahoo.es	Santibanez, Miguel/L-3323-2017; Miñambres, Eduardo/H-7761-2019; Riera, Jordi/K-6387-2019	Santibanez, Miguel/0000-0003-2634-615X; Riera, Jordi/0000-0002-1738-4448	Mutua Madrilena Foundation [FMM 14/01]	Mutua Madrilena Foundation	This study has been supported by a grant from the Mutua Madrilena Foundation (Code: FMM 14/01).	Adamik B, 2000, INTENS CARE MED, V26, P1259, DOI 10.1007/s001340000610; Carboni GL, 2008, EUR J CARDIO-THORAC, V33, P777, DOI 10.1016/j.ejcts.2008.02.013; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Cooper D, 2001, TRANSPLANT P, V33, P1808, DOI 10.1016/S0041-1345(00)02690-7; Dahaba AA, 2009, MINERVA ANESTESIOL, V75, P447; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; de Perrot M, 2005, J HEART LUNG TRANSPL, V24, P1460, DOI 10.1016/j.healun.2005.02.017; Desmard M, 2015, J HEART LUNG TRANSPL, V34, P189, DOI 10.1016/j.healun.2014.09.025; Eyraud D, 2008, CRIT CARE, V12, DOI 10.1186/cc6942; Hamandi B, 2009, AM J TRANSPLANT, V9, P1657, DOI 10.1111/j.1600-6143.2009.02664.x; Hamandi B, 2014, CLIN INFECT DIS, V59, P1074, DOI 10.1093/cid/ciu522; Hammer S, 1998, TRANSPL IMMUNOL, V6, P235, DOI 10.1016/S0966-3274(98)80013-0; Hammer S, 2000, INTENS CARE MED, pS182; Husain S, 2011, J HEART LUNG TRANSPL, V30, P361, DOI 10.1016/j.healun.2011.01.701; Jebali MA, 2007, ANESTHESIOLOGY, V107, P232, DOI 10.1097/01.anes.0000271871.07395.ad; Jensen JU, 2011, CRIT CARE MED, V39, P2048, DOI 10.1097/CCM.0b013e31821e8791; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Kuse ER, 2001, TRANSPLANT INT, V14, P55, DOI 10.1007/s001470050744; Liu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129450; Madershahian N, 2008, J CARDIAC SURG, V23, P468, DOI 10.1111/j.1540-8191.2008.00625.x; Madershahian N, 2007, J CARDIAC SURG, V22, P199, DOI 10.1111/j.1540-8191.2007.00385.x; Matot I, 2008, ANESTHESIOLOGY, V109, P269, DOI 10.1097/ALN.0b013e31817f5b90; Moreno I, 2008, TRANSPL P, V40, P3082, DOI 10.1016/j.transproceed.2008.08.124; Perrakis A, 2010, TRANSPL P, V42, P4187, DOI 10.1016/j.transproceed.2010.08.070; Saito T, 2013, AM J TRANSPLANT, V13, P3192, DOI 10.1111/ajt.12492; Sammons C, 2014, ANN PHARMACOTHER, V48, P116, DOI 10.1177/1060028013508085; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Staehler M, 1997, TRANSPL P, V29, P584, DOI 10.1016/S0041-1345(96)00314-4; Suberviola B, 2012, TRANSPL INFECT DIS, V14, P461, DOI 10.1111/j.1399-3062.2012.00780.x; Todd JL, 2014, AM J RESP CRIT CARE, V190, P19, DOI 10.1164/rccm.201402-0384UP; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; van den Broek MAJ, 2010, LIVER TRANSPLANT, V16, P402, DOI 10.1002/lt.21987; Yu XY, 2014, TRANSPL P, V46, P26, DOI 10.1016/j.transproceed.2013.07.074; Yusen RD, 2015, J HEART LUNG TRANSPL, V34, P1264, DOI 10.1016/j.healun.2015.08.014	34	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180202	10.1371/journal.pone.0180202	http://dx.doi.org/10.1371/journal.pone.0180202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704503	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649700031
J	Hayashi, Y; Yawata, S; Funabiki, K; Hikida, T				Hayashi, Yuichiro; Yawata, Satoshi; Funabiki, Kazuo; Hikida, Takatoshi			In vivo calcium imaging from dentate granule cells with wide-field fluorescence microscopy	PLOS ONE			English	Article							HIPPOCAMPAL PLACE CELLS; CELLULAR RESOLUTION; VIRTUAL NAVIGATION; UNIT-ACTIVITY; DYNAMICS; CORTEX; GYRUS; RAT; DECONVOLUTION; ENVIRONMENTS	A combination of genetically-encoded calcium indicators and micro-optics has enabled monitoring of large-scale dynamics of neuronal activity from behaving animals. In these studies, wide-field microscopy is often used to visualize neural activity. However, this method lacks optical sectioning capability, and therefore its axial resolution is generally poor. At present, it is unclear whether wide-field microscopy can visualize activity of densely packed small neurons at cellular resolution. To examine the applicability of wide-field microscopy for small-sized neurons, we recorded calcium activity of dentate granule cells having a small soma diameter of approximately 10 micrometers. Using a combination of high numerical aperture (0.8) objective lens and independent component analysis-based image segmentation technique, activity of putative single granule cell activity was separated from wide-field calcium imaging data. The result encourages wider application of wide-field microscopy in in vivo neurophysiology.	[Hayashi, Yuichiro; Yawata, Satoshi; Funabiki, Kazuo] Osaka Biosci Inst, Suita, Osaka, Japan; [Hayashi, Yuichiro; Hikida, Takatoshi] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan; [Hayashi, Yuichiro] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan; [Hayashi, Yuichiro] Kansai Med Univ, Inst Biomed Sci, Hirakata, Osaka, Japan; [Yawata, Satoshi] Kyoto Univ, Grad Sch Med, Dept Physiol, Kyoto, Japan; [Funabiki, Kazuo] Fdn Biomed Res Innovat, IBRI Lab, Kobe, Hyogo, Japan; [Hikida, Takatoshi] Osaka Univ, Inst Prot Res, Osaka, Japan	Kyoto University; Hokkaido University; Kansai Medical University; Kyoto University; Institute for Biomedical Research & Innovation (IBRI); Osaka University	Hayashi, Y (corresponding author), Osaka Biosci Inst, Suita, Osaka, Japan.; Hayashi, Y (corresponding author), Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan.; Hayashi, Y (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan.; Hayashi, Y (corresponding author), Kansai Med Univ, Inst Biomed Sci, Hirakata, Osaka, Japan.	hayashiy16@gmail.com	Hikida, Takatoshi/J-5561-2017; Hayashi, Yuichiro/O-2163-2017	Hikida, Takatoshi/0000-0002-8653-311X; Hayashi, Yuichiro/0000-0001-9870-0053	PRESTO, Japan Science and Technology Agency; Japan Society for the promotion of science KAKENHI [24650223, 15H04275, 16K14579, 16H06568]; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [15H04275] Funding Source: KAKEN	PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the promotion of science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by PRESTO, Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/presto/en/index.html (to YH); Japan Society for the promotion of science KAKENHI, https://www.jsps.go.jp/english/index.html, 24650223 (to YH), 15H04275, 16K14579, 16H06568 (to TH); the Takeda Science Foundation, http://www.takeda-sci.or.jp/ (to TH); and the Naito Foundation, https://www.naito-f.or.jp/en/ (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Barretto Robert P J, 2012, Cold Spring Harb Protoc, V2012, P1029, DOI 10.1101/pdb.top071464; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goto A, 2015, P NATL ACAD SCI USA, V112, P6718, DOI 10.1073/pnas.1507121112; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohammed AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20986; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yamaguchi T, 2015, P NATL ACAD SCI USA, V112, P11383, DOI 10.1073/pnas.1514731112; Youngstrom IA, 2012, LEARN MEMORY, V19, P84, DOI 10.1101/lm.023523.111; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180452	10.1371/journal.pone.0180452	http://dx.doi.org/10.1371/journal.pone.0180452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28700611	gold, Green Published, Green Submitted			2022-12-27	WOS:000405649600031
J	Ronje, EI; Barry, KP; Sinclair, C; Grace, MA; Barros, N; Allen, J; Balmer, B; Panike, A; Toms, C; Mullin, KD; Wells, RS				Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Barros, Nelio; Allen, Jason; Balmer, Brian; Panike, Anna; Toms, Christina; Mullin, Keith D.; Wells, Randall S.			A common bottlenose dolphin (Tursiops truncatus) prey handling technique for marine catfish (Ariidae) in the northern Gulf of Mexico	PLOS ONE			English	Article							FORAGING BEHAVIOR; BAY; PATTERNS; SHARKS; SPECIALIZATION; PERFORMANCE; KINEMATICS; MORTALITY; HABITATS; ECOLOGY	Few accounts describe predator-prey interactions between common bottlenose dolphins (Tursiops truncatus Montagu 1821) and marine catfish (Ariopsis felis Linnaeus 1766, Bagre marinus Mitchill 1815). Over the course of 50,167 sightings of bottlenose dolphin groups in Mississippi Sound and along the Florida coast of the Gulf of Mexico, severed catfish heads were found floating and exhibiting movements at the surface in close proximity to 13 dolphin groups that demonstrated feeding behavior. These observations prompted a multi-disciplinary approach to study the predator-prey relationship between bottlenose dolphins and marine catfish. A review was conducted of bottlenose dolphin visual survey data and dorsal fin photographs from sightings where severed catfish heads were observed. Recovered severed catfish heads were preserved and studied, whole marine catfish were collected and examined, and stranding network pathology reports were reviewed for references to injuries related to fish spines. Photographic identification analysis confirms eight dolphins associated with severed catfish heads were present in three such sightings across an approximately 350 km expanse of coast between the Mississippi Sound and Saint Joseph Bay, FL. An examination of the severed catfish heads indicated interaction with dolphins, and fresh-caught whole hardhead catfish (A. felis) were examined to estimate the presumed total length of the catfish before decapitation. Thirty-eight instances of significant trauma or death in dolphins attributed to ingesting whole marine catfish were documented in stranding records collected from the southeastern United States of America. Bottlenose dolphins typically adhere to a ram-feeding strategy for prey capture followed by whole prey ingestion; however, marine catfish skull morphology may pose a consumption hazard due to rigid spines that can puncture and migrate through soft tissue, prompting a prey handling technique for certain dolphins, facilitating consumption of the posterior portion of the fish without the head.	[Ronje, Errol I.; Barry, Kevin P.; Sinclair, Carrie; Grace, Mark A.; Mullin, Keith D.] NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA; [Barros, Nelio; Allen, Jason; Balmer, Brian; Wells, Randall S.] Mote Marine Lab, Chicago Zool Soc Sarasota Dolphin Res Program, Sarasota, FL USA; [Balmer, Brian] NOAA, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Panike, Anna] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marine Mammal Pathobiol Lab, St Petersburg, FL USA; [Toms, Christina] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Central Florida	Ronje, EI (corresponding author), NOAA, Mississippi Labs, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA.	errol.ronje@noaa.gov		Ronje, Errol/0000-0003-3312-5662; Balmer, Brian/0000-0001-9734-4042				Ajmal N, 2003, WILD ENVIRON MED, V14, P101, DOI 10.1580/1080-6032(2003)014[0101:CSEACO]2.0.CO;2; Allen SJ, 2011, MAR MAMMAL SCI, V27, P449, DOI 10.1111/j.1748-7692.2010.00409.x; Anderson DK, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P378; [Anonymous], 1977, THESIS; Armbruster JW, 2011, AM FISH S S, V77, P15; Armstrong, 1996, STOCK ASSESSMENT HAR; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; AVISE JC, 1987, EVOLUTION, V41, P991, DOI 10.1111/j.1558-5646.1987.tb05872.x; BAIRD RW, 1995, CAN J ZOOL, V73, P1300, DOI 10.1139/z95-154; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Balmer Brian, 2016, Gulf of Mexico Science, V33, P93; BANNER A, 1972, B MAR SCI, V22, P251; Barros N.B., 1990, P309; Barros N. B., 1993, THESIS; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Barros Nelio B., 2000, Aquatic Mammals, V26, P2; Barry KP, 2008, J FISH BIOL, V73, P650, DOI 10.1111/j.1095-8649.2008.01963.x; Best Robin C., 1993, Mammalian Species, V426, P1; Bethea DM, 2006, B MAR SCI, V78, P287; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Brower K, 1979, WAKE WHALE; Carrasquillo-Casado B, 2002, J AQUAT ANIM HEALTH, V14, P65, DOI 10.1577/1548-8667(2002)014&lt;0065:FPAPCB&gt;2.0.CO;2; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Chesney EJ, 2000, ECOL APPL, V10, P350; Christmas J. Y., 1983, MENHADEN FISHERY GUL; Christmas JY, 1966, GULF RES REP, V2; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Connor RC, 2000, MAR MAMMAL SCI, V16, P646, DOI 10.1111/j.1748-7692.2000.tb00959.x; Costa Daniel P., 1999, P176; DARNELL REZNEAT M., 1958, PUBL INST MARINE SCI PUBL [PORT ARANSAS TEXAS], V5, P353; Defran RH., 1980, CETACEAN BEHAV MECH, P319; dos Santos M.E., 1987, Aquatic Mammals, V13, P65; dos Santos ME, 2009, REV BRAS ZOOCIENCIAS, V9; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fertl D., 1994, THESIS; Finn J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004217; Fish M. P., 1970, SOUNDS W N ATLANTIC; Franks J. S., 1970, Gulf Res. Reps, V3, P3; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Gregory W. K., 1933, FISH SKULLS STUDY EV; GUNTER G, 1947, COPEIA, P217; Gunter G., 1938, ECOL MONOGR, V8, P314; Gunter Gordon, 1942, JOUR MAMMAL, V23, P267, DOI 10.2307/1374993; HALSTEAD BRUCE W., 1953, TRANS AMER MICROSC SOC, V72, P297, DOI 10.2307/3223475; HOESE HD, 1971, J MAMMAL, V52, P222, DOI 10.2307/1378455; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; Hubard Carrie W., 2004, Aquatic Mammals, V30, P299, DOI 10.1578/AM.30.2.2004.299; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kemp RJ., 1949, REPORT STOMACH ANAL; Leatherwood S., 1975, MARINE FISHERIES REV, V37; LeBlanc BD, 1992, GULF RES REP, V8; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; LJUNGBLAD DK, 1982, J ACOUST SOC AM, V72, P1726, DOI 10.1121/1.388666; Lodi L, 1999, BIOCIENCIAS, V7, P29; Maresh JL, 2004, MAR MAMMAL SCI, V20, P498, DOI 10.1111/j.1748-7692.2004.tb01175.x; Marley SA, 2013, AQUAT MAMM, V39, P107, DOI 10.1578/AM.39.2.2013.107; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; MCBEE JT, 1982, GULF RES REP, V7, P115; McCabe EJB, 2010, MAR BIOL, V157, P931, DOI 10.1007/s00227-009-1371-2; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Melancon R.A.S., 2011, NOAA TECHNICAL MEMOR; Merriman D., 1940, ZOOLOGICA, V25, P11; MODDE T, 1980, GULF RES REP, V6, P377; Mullin K, 1990, NE GULF SCI, P113; Mullin KD, 1988, THESIS; Nowacek D.P., 1999, DISSERTATION; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Overstreet RM, 1982, FOOD CONTENT 6 COMME; Patterson EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022243; Perry HM, 1975, GULF RES REP, V5; Pitman Robert L., 2002, Pacific Science, V56, P447, DOI 10.1353/psc.2002.0043; Reynosa J, 1986, VET MEXICO, P213; Rigley L, 1981, P PA ACAD SCI; Rommel S., 1990, P29; Rommel SA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1033; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Scott M.D., 1990, P235; Shane S.H., 1990, P245; Sinclair C, 2016, THESIS; Smith HC, 2016, AUST J ZOOL; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Snyder RA, 2009, ACCUMULATION POLLUTA; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Stephens D., 2007, FORAGING BEHAV ECOLO; Stolen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066828; Tavolga W. N., 1962, B AM MUS NAT HIST, V124, P1; TAVOLGA WN, 1977, J EXP BIOL, V67, P97; Urian KW, NMFSSEFSC393 NOAA; VALENTINE JF, 1991, B MAR SCI, V48, P597; Ward, 1957, COPEIA, V1957, P295; Waring GT, 238 NOAA NMFS NE NAT; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447; Weiss Jessica, 2006, Aquatic Mammals, V32, P10, DOI 10.1578/AM.32.1.2006.10; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R.S., 2014, PRIMATES CETACEANS F, P149, DOI DOI 10.1007/978-4-431-54523-1_8; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Wingo W.M., 1983, SPECIES PROFILES LIF; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	114	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181179	10.1371/journal.pone.0181179	http://dx.doi.org/10.1371/journal.pone.0181179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704486	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600064
J	Yang, Y; Qin, ML; Bao, PH; Xu, WC; Xu, J				Yang, Yi; Qin, Meiling; Bao, Puhua; Xu, Wangchao; Xu, Jin			Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of alpha-synuclein via exosome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEURODEGENERATIVE DISEASES; NEUROTRANSMITTER RELEASE; MISFOLDED PROTEINS; PARKINSONS-DISEASE; TAU PATHOLOGY; PROPAGATION; ENDOCYTOSIS; HUNTINGTIN; PATHWAYS	Autophagy-lysosomal pathway is a cellular protective system to remove aggregated proteins and damaged organelles. Meanwhile, exosome secretion has emerged as a mode to selectively clear the neurotoxic proteins, such as alpha-synuclein. Mounting evidence suggests that these two cellular processes are coordinated to facilitate the clearance of toxic cellular waste; however the regulators for the transition between these two processes are unclear. Here we show that SCAMP5, a secretory carrier membrane protein significantly induced in the brains of Huntington's disease patients, is quickly and transiently induced by protein stress and autophagic stimulation, and is regulated by the master autophagy transcriptional regulator TFEB. Ironically, SCAMP5 inhibits autophagy flux by blocking the fusion of autophagosomes and lysosomes. Although autophagy is blocked, SCAMP5 does not cause significant protein aggregation in cells. Instead, it promotes the Golgi fragmentation and stimulates the unconventional secretion of the co-localizing alpha-synuclein via exosome as an exosome component. Therefore, we have identified SCAMP5 as a novel coordinator of autophagy and exosome secretion, which is induced upon protein stress to channel the efficient clearance of toxic proteins via the exosomes rather than autophagy-lysosomal pathway.	[Yang, Yi; Qin, Meiling; Bao, Puhua; Xu, Wangchao; Xu, Jin] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [Yang, Yi; Xu, Wangchao] Univ Chinese Acad Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, J (corresponding author), Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China.	Jin.Xu@ion.ac.cn		Xu, Jin/0000-0001-6617-5311	National Science Foundation of China [81371402]; Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program [12PJ1410000]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program	This work was supported by National Science Foundation of China grant (81371402); Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience; Shanghai Pujiang Talent Program (12PJ1410000) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorogiannis EI, 2004, NEUROPATH APPL NEURO, V30, P215, DOI 10.1111/j.1365-2990.2004.00558.x; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Babcock DT, 2015, P NATL ACAD SCI USA, V112, pE5427, DOI 10.1073/pnas.1516217112; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; BIEDLER JL, 1973, CANCER RES, V33, P2643; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dubnikov T, 2016, COLD SPRING HARBOR P; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Howitt J, 2016, J BIOL CHEM; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Siman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142340; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Thery C, 2001, CURRENT PROTOCOLS CE; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Waxman EA, 2009, MOL BASIS DIS, V1792, P616; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhao H, 2014, J NEUROSCI, V34, P10085, DOI 10.1523/JNEUROSCI.2156-14.2014; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	43	41	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2017	12	7							e0180892	10.1371/journal.pone.0180892	http://dx.doi.org/10.1371/journal.pone.0180892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TI	28700687	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649400021
J	Balhouse, BN; Patterson, L; Schmelz, EM; Slade, DJ; Verbridge, SS				Balhouse, Brittany N.; Patterson, Logan; Schmelz, Eva M.; Slade, Daniel J.; Verbridge, Scott S.			N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro	PLOS ONE			English	Article							CELL-DEATH; HUMAN-MILK; MICROBIOME; HYPOXIA; CARCINOMA; APOPTOSIS; TISSUE; ENHANCEMENT; RESISTANCE; PATHWAYS	It is well documented that the tumor microenvironment profoundly impacts the etiology and progression of breast cancer, yet the contribution of the resident microbiome within breast tissue remains poorly understood. Tumor microenvironmental conditions, such as hypoxia and dense tumor stroma, predispose progressive phenotypes and therapy resistance, however the role of bacteria in this interplay remains uncharacterized. We hypothesized that the effect of individual bacterial secreted molecules on breast cancer viability and proliferation would be modulated by these tumor- relevant stressors differentially for cells at varying stages of progression. To test this, we incubated human breast adenocarcinoma cells (MDA-MB-231, MCF-DCIS. com) and non-malignant breast epithelial cells (MCF-10A) withN-(3-oxododecanoyl)-L-homoserine lactone (OdDHL), a quorum- sensing molecule from Pseudomonas aeruginosa that regulates bacterial stress responses. This molecule was selected because Pseudomonas was recently characterized as a significant fraction of the breast tissue microbiome and OdDHL is documented to impact mammalian cell viability. After OdDHL treatment, we demonstrated the greatest decrease in viability with the more malignant MDA-MB-231 cells and an intermediate MCF-DCIS. com (ductal carcinoma in situ) response. The responses were also culture condition (i.e. microenvironment) dependent. These results contrast the MCF-10A response, which demonstrated no change in viability in any culture condition. We further determined that the observed trends in breast cancer viability were due to modulation of proliferation for both cell types, as well as the induction of necrosis for MDA-MB-231 cells in all conditions. Our results provide evidence that bacterial quorum-sensing molecules interact with the host tissue environment to modulate breast cancer viability and proliferation, and that the effect of OdDHL is dependent on both cell type as well as microenvironment. Understanding the interactions between bacterial signaling molecules and the host tissue environment will allow for future studies that determine the contribution of bacteria to the onset, progression, and therapy response of breast cancer.	[Balhouse, Brittany N.; Verbridge, Scott S.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Balhouse, Brittany N.; Verbridge, Scott S.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Patterson, Logan; Slade, Daniel J.] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Patterson, Logan] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Virginia; Virginia Polytechnic Institute & State University	Verbridge, SS (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA.; Verbridge, SS (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA.	sverb@vt.edu	Schmelz, Eva M/E-6579-2012; Slade, Daniel/E-1329-2015	Verbridge, Scott/0000-0002-4074-8799; Slade, Daniel/0000-0001-5634-7220; Patterson, Logan/0000-0002-4825-0565	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R21EB019123]; Junior Faculty Award from the Virginia Tech Institute for Critical Technology and Applied Science; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019123] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Junior Faculty Award from the Virginia Tech Institute for Critical Technology and Applied Science; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the R21 Award from the National Institute of Biomedical Imaging and Bioengineering (www.nibib.nih.gov) of the National Institutes of Health (R21EB019123 awarded to S.S.V.), and by the Junior Faculty Award (awarded to S.S.V.) from the Virginia Tech Institute for Critical Technology and Applied Science (www.ictas.vt.edu). The manuscript was published with financial support (awarded to S.S.V.) from Virginia Tech's Open Access Subvention Fund (http://www.lib.vt.edu/oafund/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; DelNero P, 2015, BIOMATERIALS, V55, P110, DOI 10.1016/j.biomaterials.2015.03.035; Dolnick R, 2005, CANCER RES, V65, P5917, DOI 10.1158/0008-5472.CAN-05-0431; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Eke I, 2015, SEMINARS CANC BIOL; Garcia-Contreras R, 2015, ISME J, V9, P115, DOI 10.1038/ismej.2014.98; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gomez-Gallego C, 2016, SEMIN FETAL NEONAT M, V21, P400, DOI 10.1016/j.siny.2016.05.003; Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751; Hoashi M, 2016, REPROD SCI, V23, P902, DOI 10.1177/1933719115623645; Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Koumoutsakos P, 2013, ANNU REV FLUID MECH, V45, P325, DOI 10.1146/annurev-fluid-120710-101102; Kumar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106480; Lazenby JJ, 2011, ROLE N 3 OXODODECANO; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; McGuire MK, 2017, CURR OPIN BIOTECH, V44, P63, DOI 10.1016/j.copbio.2016.11.013; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nelson MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-825; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reid G, 2016, FUTURE MED; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; So Jae Young, 2012, Mol Cell Pharmacol, V4, P31; Tao S, 2016, SCI REPORTS, P6; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Yen TH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0261-4; Zhao GP, 2016, ONCOTARGET, V7, P5924, DOI 10.18632/oncotarget.6827	46	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180372	10.1371/journal.pone.0180372	http://dx.doi.org/10.1371/journal.pone.0180372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692660	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800037
J	Ellis, GA; Thomas, CS; Chanana, S; Adnani, N; Szachowicz, E; Braun, DR; Harper, MK; Wyche, TP; Bugni, TS				Ellis, Gregory A.; Thomas, Chris S.; Chanana, Shaurya; Adnani, Navid; Szachowicz, Emily; Braun, Doug R.; Harper, Mary Kay; Wyche, Thomas P.; Bugni, Tim S.			Brackish habitat dictates cultivable Actinobacterial diversity from marine sponges	PLOS ONE			English	Article							SELECTIVE ISOLATION; HALICHONDRIN-B; METABOANALYST; MICROORGANISMS; METABOLOMICS; EVOLUTION; SEDIMENTS; BACTERIA; ERIBULIN; TUBULIN	Bacterial communities associated with marine invertebrates such as sponges and ascidians have demonstrated potential as sources of bio-medically relevant small molecules. Metagenomic analysis has shown that many of these invertebrates harbor populations of Actinobacteria, many of which are cultivable. While some populations within invertebrates are transmitted vertically, others are obtained from the environment. We hypothesized that cultivable diversity from sponges living in brackish mangrove habitats have associations with Actinobacterial populations that differ from those found in clear tropical waters. In this study, we analyzed the cultivable Actinobacterial populations from sponges found in these two distinct habitats with the aim of understanding the secondary metabolite potential. Importantly, we wanted to broadly evaluate the potential differences among these groups to guide future Actinobacterial collection strategies for the purposes of drug discovery.	[Ellis, Gregory A.; Thomas, Chris S.; Chanana, Shaurya; Adnani, Navid; Szachowicz, Emily; Braun, Doug R.; Wyche, Thomas P.; Bugni, Tim S.] Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, 425 N Charter St, Madison, WI 53706 USA; [Harper, Mary Kay] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Ellis, Gregory A.] Naval Res Lab, Washington, DC 20375 USA; [Wyche, Thomas P.] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; University of Utah; United States Department of Defense; United States Navy; Naval Research Laboratory; Harvard University; Harvard Medical School	Bugni, TS (corresponding author), Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, 425 N Charter St, Madison, WI 53706 USA.	tim.bugni@wisc.edu	Chanana, Shaurya/GPK-7010-2022	Chanana, Shaurya/0000-0002-3021-2210; Ellis, Gregory/0000-0001-5559-3809	National Institutes of Health (NIH) through the National Institutes for General Medical Science (NIGMS) [R01-GM104192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104192] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Institutes for General Medical Science (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grant R01-GM104192 through the National Institutes for General Medical Science (NIGMS).	Alday PH, 2009, BIOCHEMISTRY-US, V48, P7927, DOI 10.1021/bi900776u; Bose U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091488; Cheng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138528; Covington BC, 2016, NAT PROD REP; Dai HQ, 2010, INT J SYST EVOL MICR, V60, P1807, DOI 10.1099/ijs.0.017053-0; Duncan KR, 2015, J IND MICROBIOL BIOT, V42, P57, DOI 10.1007/s10295-014-1529-x; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fuerst JA, 2014, APPL MICROBIOL BIOT, V98, P7331, DOI 10.1007/s00253-014-5861-x; GAUZE GF, 1957, PROBLEMS CLASSIFICAT; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; HIRATA Y, 1986, PURE APPL CHEM, V58, P701, DOI 10.1351/pac198658050701; Hodges TW, 2012, MAR BIOTECHNOL, V14, P270, DOI 10.1007/s10126-011-9410-7; Hou YP, 2012, ORG LETT, V14, P5050, DOI 10.1021/ol3022758; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Kim BY, 2011, SYST APPL MICROBIOL, V34, P606, DOI 10.1016/j.syapm.2011.03.008; Lee MY, 2015, J MICROBIOL BIOTECHN, V25, P1265, DOI 10.4014/jmb.1503.03005; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Magarvey NA, 2004, APPL ENVIRON MICROB, V70, P7520, DOI 10.1128/AEM.70.12.7520-7529.2004; Newman S, 2007, CURR OPIN INVEST DR, V8, P1057; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Sipkema D, 2015, ENVIRON MICROBIOL, V17, P3807, DOI 10.1111/1462-2920.12827; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Supong K, 2013, INT J SYST EVOL MICR, V63, P3970, DOI 10.1099/ijs.0.050906-0; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; Vicente J, 2013, MAR BIOTECHNOL, V15, P413, DOI 10.1007/s10126-013-9493-4; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Xi LJ, 2012, INT J MOL SCI, V13, P5917, DOI 10.3390/ijms13055917; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	36	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0176968	10.1371/journal.pone.0176968	http://dx.doi.org/10.1371/journal.pone.0176968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692665	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800002
J	Khan, Z; Dreger, S; Shah, SMH; Pohlabeln, H; Khan, S; Ullah, Z; Rehman, B; Zeeb, H				Khan, Zohaib; Dreger, Steffen; Shah, Syed Majid Hussain; Pohlabeln, Hermann; Khan, Sheraz; Ullah, Zakir; Rehman, Basheer; Zeeb, Hajo			Oral cancer via the bargain bin: The risk of oral cancer associated with a smokeless tobacco product (Naswar)	PLOS ONE			English	Article							HARM REDUCTION; EPIDEMIOLOGY; SMOKING; EUROPE	In the wake of smokeless tobacco (SLT) being advocated as a mean of tobacco harm reduction, it is pertinent to establish individual health risks associated with each SLT product. This case-control study was aimed at assessing the risk of oral cancer associated with a smokeless tobacco product (Naswar). The study was conducted from September 2014 till May 2015 in Khyber Pakhtunkhwa, Pakistan. Exposure and covariate information was collected through a structured questionnaire. Conditional logistic regression was used to calculate odds ratios (OR) along with their 95% confidence intervals (CI). 84 oral cancer cases (62% males) and 174 age-and sex-matched controls were recruited. Ever users of Naswar had more than a 20-fold higher risk of oral cancer compared to never-users (OR 21.2, 95% CI 8.4-53.8). Females had a higher risk of oral cancer with the use of Naswar (OR 29.0, 95% CI 5.4-153.9) as compared to males (OR 21.0, 95% CI 6.1-72.1). Based on this result, 68% (men) and 38% (women) of the oral cancer burden in Pakistan is attributable to Naswar. The risk estimates observed in this study are comparable to risk estimates reported by previous studies on other forms of SLT use and the risk of oral cancer in Pakistan. The exposureresponse relationship also supports a strong role of Naswar in the etiology of oral cancer in Pakistan. Although still requiring further validation through independent studies, these findings may be used for smokeless tobacco control in countries where Naswar use is common.	[Khan, Zohaib; Dreger, Steffen; Pohlabeln, Hermann; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Khan, Zohaib; Zeeb, Hajo] Univ Bremen, Hlth Sci Bremen, Bremen, Germany; [Shah, Syed Majid Hussain] Ayub Med Coll, Dent Sect, Abbottabad, Pakistan; [Khan, Zohaib; Khan, Sheraz] Khyber Med Univ, Peshawar, Pakistan; [Ullah, Zakir] Khyber Teaching Hosp, Peshawar, Pakistan; [Rehman, Basheer] Khyber Coll Dent, Peshawar, Pakistan	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Khyber Medical University	Khan, Z (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.; Khan, Z (corresponding author), Univ Bremen, Hlth Sci Bremen, Bremen, Germany.; Khan, Z (corresponding author), Khyber Med Univ, Peshawar, Pakistan.	khan@leibniz-bips.de	Zeeb, Hajo/I-2701-2019	Zeeb, Hajo/0000-0001-7509-242X; Khan, Sheraz/0000-0001-6679-9052	Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany; Leibniz Association Open Access fund	Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany; Leibniz Association Open Access fund	We received internal funding for this research study from our institute i.e. Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany. The publication of this paper was also supported by the Leibniz Association Open Access fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayo-Yusuf OA, 2012, TOB CONTROL, V21, P245, DOI 10.1136/tobaccocontrol-2011-050367; Baig S, 2015, EUR J BIOTECHNOL BIO, V3, P39; Basharat S, 2012, J PUBLIC HEALTH-UK, V34, P60, DOI 10.1093/pubmed/fdr044; Bates C, 2003, TOB CONTROL, V12, P360, DOI 10.1136/tc.12.4.360; Begum N, 2009, JPMI, V23, P28; Cancela MD, 2012, ORAL ONCOL, V48, P484, DOI 10.1016/j.oraloncology.2011.12.013; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; Piemonte ED, 2010, J ORAL PATHOL MED, V39, P513, DOI 10.1111/j.1600-0714.2010.00901.x; DEAN AG, 1991, AM J PREV MED, V7, P178, DOI 10.1016/S0749-3797(18)30936-X; Eriksen M, 2013, TOBACCO ATLAS; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Guha N., 2013, INT J CANC; Gupta PC, 1996, CRIT REV TOXICOL, V26, P183, DOI 10.3109/10408449609017930; IARC, 2007, SMOK TOB SOM TOB SPE; Imam SZ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-231; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Jafarey N A, 1977, J Pak Med Assoc, V27, P340; Jayalekshmi PA, 2011, CANCER SCI, V102, P460, DOI 10.1111/j.1349-7006.2010.01785.x; Khan M, 2007, J PAK DENT ASS, V16; Khan Z, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/394696; Lagiou P, 2009, EUR J CANCER PREV, V18, P76, DOI 10.1097/CEJ.0b013e32830c8dca; Lee PN, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-36; Mejia AB, 2010, TOB CONTROL, V19, P297, DOI 10.1136/tc.2009.031427; Merchant A, 2000, INT J CANCER, V86, P128, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;128::AID-IJC20&gt;3.0.CO;2-M; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; Naswar Khattak S., 2013, EXPRESS TRIBUNE; O'Connor RJ, 2012, TOB CONTROL, V21, P181, DOI 10.1136/tobaccocontrol-2011-050281; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; PTC, 2010, PAK TOB IND EC IMP 2; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schreiner M., 2010, J ASIAN AFR STUD, V45, P326; Shah SH, 1991, J POST GRADUATE MED, V5, P53; Siddiqi K, 2016, NICOTINE TOB RES, V18, P424, DOI 10.1093/ntr/ntv067; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Ullah N, 2011, INT J BCR, V1, P13; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weitkunat R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-334; Xue JP, 2014, CANCERS, V6, P1138, DOI 10.3390/cancers6021138; Zakiullah, 2012, TOB CONTROL, V21, P396, DOI 10.1136/tc.2010.042630	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180445	10.1371/journal.pone.0180445	http://dx.doi.org/10.1371/journal.pone.0180445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692704	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800041
J	Lin, NH; Messing, A; Perng, MD				Lin, Ni-Hsuan; Messing, Albee; Perng, Ming-Der			Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; ALPHA-B-CRYSTALLIN; ALEXANDER-DISEASE; FILAMENT PROTEIN; ALZHEIMERS-DISEASE; ROSENTHAL FIBERS; MESSENGER-RNA; REACTIVE ASTROCYTES; CEREBROSPINAL-FLUID; RAT-BRAIN	Alexander disease (AxD) is a neurodegenerative disease caused by heterozygous mutations in the GFAP gene, which encodes the major intermediate filament protein of astro-cytes. This disease is characterized by the accumulation of cytoplasmic protein aggregates, known as Rosenthal fibers. Antibodies specific to GFAP could provide invaluable tools to facilitate studies of the normal biology of GFAP and to elucidate the pathologic role of this IF protein in disease. While a large number of antibodies to GFAP are available, few if any of them have defined epitopes. Here we described the characterization of a panel of commonly used anti-GFAP antibodies, which recognized epitopes at regions extending across the rod domain of GFAP. We show that all of the antibodies are useful for immunoblotting and immunostaining, and identify a subset that preferentially recognized human GFAP. Using these antibodies, we demonstrate the presence of biochemically modified forms of GFAP in brains of human AxD patients and mouse AxD models. These data suggest that this panel of anti-GFAP antibodies will be useful for studies of animal and cell-based models of AxD and related diseases in which cytoskeletal defects associated with GFAP modifications occur.	[Lin, Ni-Hsuan; Perng, Ming-Der] Natl Tsing Hua Univ, Inst Mol Med, Coll Life Sci, Hsinchu, Taiwan; [Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA	National Tsing Hua University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Perng, MD (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Coll Life Sci, Hsinchu, Taiwan.	mdperng@life.nthu.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [1032 311-B-007-010, 104-2918-I-007-008]; National Institute of Child Health and Human Development grant [HD03352, HD076892, HD090256]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Institute of Child Health and Human Development grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Ministry of Science and Technology, Taiwan (MOST 1032 311-B-007-010 and 104-2918-I-007-008) and the National Institute of Child Health and Human Development grant (HD03352, HD076892, and HD090256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTSEN M, 1984, J NEUROCHEM, V42, P86, DOI 10.1111/j.1471-4159.1984.tb09702.x; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Chen YS, 2011, EXP CELL RES, V317, P2252, DOI 10.1016/j.yexcr.2011.06.017; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Cho WS, 2009, EXP CELL RES, V315, P1260, DOI 10.1016/j.yexcr.2008.12.012; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; COUREL MN, 1986, J NEUROIMMUNOL, V11, P271, DOI 10.1016/0165-5728(86)90080-9; Cunningham R, 2013, J PROTEOME RES, V12, P719, DOI 10.1021/pr300785h; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eng LF, 1998, J NEUROSCI RES, V53, P353, DOI 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Fujita K, 1998, NEUROCHEM RES, V23, P169, DOI 10.1023/A:1022476724381; GHEUENS J, 1984, J NEUROCHEM, V43, P964, DOI 10.1111/j.1471-4159.1984.tb12831.x; GOLDMAN JE, 1988, AM J PATHOL, V130, P569; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Heaven MR, 2016, J PROTEOME RES, V15, P2265, DOI 10.1021/acs.jproteome.6b00316; Hesse M, 2001, J CELL SCI, V114, P2569; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Inekci D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00090; Ishigami A, 2015, J NEUROSCI RES, V93, P1664, DOI 10.1002/jnr.23620; IWAKI T, 1993, ACTA NEUROPATHOL, V85, P475; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jany PL, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0080-15.2015; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; JIE Z, 1986, ACTA PATH MICRO IM A, V94, P353; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kyllerman M, 2005, NEUROPEDIATRICS, V36, P319, DOI 10.1055/s-2005-872876; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Leroy K, 2001, ACTA NEUROPATHOL, V102, P1; Lin NH, 2016, MOL BIOL CELL, V27, P3980, DOI 10.1091/mbc.E16-06-0362; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080779; MCLENDON RE, 1986, J NEUROPATH EXP NEUR, V45, P692, DOI 10.1097/00005072-198611000-00007; Messing A, 1998, AM J PATHOL, V152, P391; Moody LR, 2017, J BIOL CHEM; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PEGRAM CN, 1985, NEUROCHEM PATHOL, V3, P119; Pekny T, 2014, APMIS, V122, P76, DOI 10.1111/apm.12088; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; ROYDS JA, 1986, ACTA NEUROPATHOL, V70, P320, DOI 10.1007/BF00686091; Sembritzki O, 2002, NEURO-ONCOLOGY, V4, P171, DOI 10.1093/neuonc/4.3.171; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2008, AUTOPHAGY, V4, P701, DOI 10.4161/auto.6028; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Thomsen R, 2013, GLIA, V61, P1922, DOI 10.1002/glia.22569; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Ylagan LR, 1997, MODERN PATHOL, V10, P1239; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	70	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180694	10.1371/journal.pone.0180694	http://dx.doi.org/10.1371/journal.pone.0180694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700643	Green Submitted, gold, Green Published			2022-12-27	WOS:000405544800066
J	Zhang, Y; Li, PY; Zhu, XY; Su, SW; Guo, Q; Xu, P; Yao, DZ				Zhang, Yi; Li, Peiyang; Zhu, Xuyang; Su, Steven W.; Guo, Qing; Xu, Peng; Yao, Dezhong			Extracting time-frequency feature of singlechannel vastus medialis EMG signals for knee exercise pattern recognition	PLOS ONE			English	Article							CLASSIFICATION; TRANSFORM	The EMG signal indicates the electrophysiological response to daily living of activities, particularly to lower-limb knee exercises. Literature reports have shown numerous benefits of the Wavelet analysis in EMG feature extraction for pattern recognition. However, its application to typical knee exercises when using only a single EMG channel is limited. In this study, three types of knee exercises, i.e., flexion of the leg up (standing), hip extension from a sitting position (sitting) and gait (walking) are investigated from 14 healthy untrained subjects, while EMG signals from the muscle group of vastus medialis and the goniometer on the knee joint of the detected leg are synchronously monitored and recorded. Four types of lower-limb motions including standing, sitting, stance phase of walking, and swing phase of walking, are segmented. The Wavelet Transform (WT) based Singular Value Decomposition (SVD) approach is proposed for the classification of four lower-limb motions using a single-channel EMG signal from the muscle group of vastus medialis. Based on lower-limb motions from all subjects, the combination of five-level wavelet decomposition and SVD is used to comprise the feature vector. The Support Vector Machine (SVM) is then configured to build a multiple-subject classifier for which the subject independent accuracy will be given across all subjects for the classification of four types of lower-limb motions. In order to effectively indicate the classification performance, EMG features from time-domain (e. g., Mean Absolute Value (MAV), Root-Mean-Square (RMS), integrated EMG (iEMG), Zero Crossing (ZC)) and frequency-domain (e.g., Mean Frequency (MNF) and Median Frequency (MDF)) are also used to classify lower-limb motions. The five-fold cross validation is performed and it repeats fifty times in order to acquire the robust subject independent accuracy. Results show that the proposed WT-based SVD approach has the classification accuracy of 91.85% +/- 0.88% which outperforms other feature models.	[Zhang, Yi; Guo, Qing] Univ Elect Sci & Technol China, Sch Aeronaut & Astronaut, Chengdu 611731, Peoples R China; [Zhang, Yi; Li, Peiyang; Zhu, Xuyang; Xu, Peng; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Zhang, Yi; Li, Peiyang; Zhu, Xuyang; Xu, Peng; Yao, Dezhong] Univ Elect Sci & Technol China, Ctr Informat BioMed, Chengdu 610054, Peoples R China; [Su, Steven W.] Univ Technol Sydney, Ctr Hlth Technol, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Technology Sydney	Zhang, Y (corresponding author), Univ Elect Sci & Technol China, Sch Aeronaut & Astronaut, Chengdu 611731, Peoples R China.; Zhang, Y; Xu, P (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.; Zhang, Y; Xu, P (corresponding author), Univ Elect Sci & Technol China, Ctr Informat BioMed, Chengdu 610054, Peoples R China.; Su, SW (corresponding author), Univ Technol Sydney, Ctr Hlth Technol, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia.	yi.zhang@uestc.edu.cn; steven.su@uts.edu.au; xupeng@uestc.edu.cn		Su, Steven/0000-0002-5720-8852	Fundamental Research Funds for the Central Universities [ZYGX2015J118]; National Natural Science Foundation [61522105, 51675087]; China Postdoctoral Science Foundation funded project [2017M612950]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation)	This study was supported by the following fundings: Fundamental Research Funds for the Central Universities, ZYGX2015J118, http:// www.uestc.edu.cn/;National Natural Science Foundation, 61522105,http://www.nsfc.gov.cn/; National Natural Science Foundation, 51675087, http://www.nsfc.gov.cn/;and the China Postdoctoral Science Foundation funded project 2017M612950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INT J BIOELECTROMAGN; Attenberger A, 2013, 2013 20TH ANNUAL IEEE INTERNATIONAL CONFERENCE AND WORKSHOPS ON THE ENGINEERING OF COMPUTER BASED SYSTEMS (ECBS 2013), P196, DOI 10.1109/ECBS.2013.17; Au SK, 2006, IEEE INT CONF ROBOT, P2939, DOI 10.1109/ROBOT.2006.1642148; BILODEAU M, 1992, MED BIOL ENG COMPUT, V30, P640, DOI 10.1007/BF02446797; Biometrics, 2017, THE DATALOG MWX8; Chen XP, 2008, P IEEE RAS-EMBS INT, P73, DOI 10.1109/BIOROB.2008.4762784; Cheng CC, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1791; Cheng QA, 2011, IEEE T PATTERN ANAL, V33, P1217, DOI 10.1109/TPAMI.2010.195; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Gibson AS, 2001, SPORTS MED, V31, P637, DOI 10.2165/00007256-200131090-00001; Gunn SR, 1998, NETWORK PERFORMANCE; HAGG G, 1981, PFLUG ARCH EUR J PHY, V391, P78, DOI 10.1007/BF00580699; Hamedi M, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL AND IMAGE PROCESSING APPLICATIONS (ICSIPA), P169, DOI 10.1109/ICSIPA.2015.7412184; Han JD, 2015, IEEE T IND ELECTRON, V62, P4267, DOI 10.1109/TIE.2014.2387337; John A, 2015, C ADV ROB 2015 JUL, P69; Katsis CD, 2007, COMPUT BIOL MED, V37, P1232, DOI 10.1016/j.compbiomed.2006.11.010; Kiguchi K, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3600; Lee S, 2005, ADV ROBOTICS, V19, P773, DOI 10.1163/1568553054455095; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; MathWorks, 2016, DAUBECHIES WAVELET F; MathWorks, 2016, SUPPORT VECTOR MACHI; Merletti R, 1996, J ELECTROMYO KINESIO, V6, P3; Mohr M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142048; Oladazimi M, 2012, INT C COMP AUT ENG 2, P142; Ombao H, 2012, ANNALS OF THE INSTIT, V54, P171; Oonishi Y, 2010, IEEE T IND ELECTRON, V57, P3191, DOI 10.1109/TIE.2010.2051931; Phinyomark A, 2012, MEASUREMENT SCI REV, V11, P45; Phinyomark A., 2009, J COMPUT, V1, P71; Simpson RC, 2005, J REHABIL RES DEV, V42, P423, DOI 10.1682/JRRD.2004.08.0101; STULEN FB, 1981, IEEE T BIO-MED ENG, V28, P515, DOI 10.1109/TBME.1981.324738; Vapnik V., 2013, THE NATURE OF STATIS; Vapnik V N, 1998, STATISTICAL LEARNING; Vapnik VN, 1963, AUTOMAT REM CONTR, V24, P774; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Xu Zhang, 2010, Proceedings of the 2010 Seventh International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2010), P2234, DOI 10.1109/FSKD.2010.5569532; Zeilig G, 2012, J SPINAL CORD MED, V35, P96, DOI 10.1179/2045772312Y.0000000003; Zhang XD, 2007, LECT NOTES COMPUT SC, V4561, P294; [张羿 Zhang Yi], 2015, [载人航天, Manned Spaceflight], V21, P179; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	41	14	14	11	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180526	10.1371/journal.pone.0180526	http://dx.doi.org/10.1371/journal.pone.0180526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692691	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800050
J	Zhao, XJ; Larkin, TM; Lauver, MA; Ahmad, S; Ducruet, AF				Zhao, Xue-Jun; Larkin, Timothy M.; Lauver, Molly A.; Ahmad, Saif; Ducruet, Andrew F.			Tissue plasminogen activator mediates deleterious complement cascade activation in stroke	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; INJURY; INFLAMMATION; MICE; DEFICIENCY; PROTECTION; PATHWAY	The use of intravenous tissue plasminogen activator (tPA) in the treatment of ischemic stroke is limited by its propensity to exacerbate brain edema and hemorrhage. The mechanisms underlying these deleterious effects of tPA remain incompletely understood. The purpose of this study was to delineate a pathway of tPA-mediated complement cascade activation in stroke and to determine whether complement inhibition ameliorates the adverse effects of post-ischemic tPA administration. We found that tPA promotes C3 cleavage both in vitro and in ischemic brain through a plasmin-mediated extrinsic pathway. Using cell culture models, we then showed that the C3a-receptor is strongly expressed on ischemic endothelium and that exogenous C3a dramatically enhances endothelial cell permeability. Next, we assessed the effect of tPA administration on brain edema and hemorrhage in a transient model of focal cerebral ischemia in C57BL/6 mice. We found that intravenous tPA exacerbates brain edema and hemorrhage in stroke, and that these effects are abrogated by a small-molecule antagonist of the C3a receptor. These findings establish for the first time that intravenous tPA dramatically upregulates complement cascade activation in ischemic brain and that pharmacologic complement inhibition protects against the adverse effects of tPA-mediated thrombolysis in stroke.	[Zhao, Xue-Jun; Larkin, Timothy M.; Lauver, Molly A.; Ducruet, Andrew F.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Ahmad, Saif] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barrow Neurological Institute	Ducruet, AF (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.; Ducruet, AF (corresponding author), Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	andrew.ducruet@barrowbrainandspine.com			Neurosurgeon Research Career Development Program Award [K12]; NINDS; UPP/UPMC Academic Foundation Award; Pittsburgh Foundation	Neurosurgeon Research Career Development Program Award; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UPP/UPMC Academic Foundation Award; Pittsburgh Foundation	This work was supported by a Neurosurgeon Research Career Development Program Award (K12) from the NINDS and a UPP/UPMC Academic Foundation Award (A.F.D.) as well as a Walter L. Copeland Award from the Pittsburgh Foundation (X-J.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; BENNETT WR, 1987, J AM COLL CARDIOL, V10, P627, DOI 10.1016/S0735-1097(87)80206-1; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Berkhemer OA, 2015, NEW ENGL J MED, V373, P1076, DOI 10.1056/NEJMc1508744; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Ducruet AF, 2011, TRANSL STROKE RES, V2, P588, DOI 10.1007/s12975-011-0104-2; Ducruet AF, 2011, NEUROL RES, V33, P717, DOI 10.1179/1743132810Y.0000000022; Elvington A, 2012, J IMMUNOL, V189, P4640, DOI 10.4049/jimmunol.1201904; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kilic E, 1999, NEUROREPORT, V10, P107, DOI 10.1097/00001756-199901180-00021; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhang YR, 2014, J NEUROL SCI, V347, P148, DOI 10.1016/j.jns.2014.09.036; Zhang Y, 2011, NEUROSURGERY, V69, P942, DOI 10.1227/NEU.0b013e318222afb2	37	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180822	10.1371/journal.pone.0180822	http://dx.doi.org/10.1371/journal.pone.0180822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700732	Green Published, gold, Green Submitted			2022-12-27	WOS:000405544800082
J	Asakawa, N; Uchida, K; Sakakibara, M; Omote, K; Noguchi, K; Tokuda, Y; Kamiya, K; Hatanaka, KC; Matsuno, Y; Yamada, S; Asakawa, K; Fukasawa, Y; Nagai, T; Anzai, T; Ikeda, Y; Ishibashi-Ueda, H; Hirota, M; Orii, M; Akasaka, T; Uto, K; Shingu, Y; Matsui, Y; Morimoto, SI; Tsutsui, H; Eishi, Y				Asakawa, Naoya; Uchida, Keisuke; Sakakibara, Mamoru; Omote, Kazunori; Noguchi, Keiji; Tokuda, Yusuke; Kamiya, Kiwamu; Hatanaka, Kanako C.; Matsuno, Yoshihiro; Yamada, Shiro; Asakawa, Kyoko; Fukasawa, Yuichiro; Nagai, Toshiyuki; Anzai, Toshihisa; Ikeda, Yoshihiko; Ishibashi-Ueda, Hatsue; Hirota, Masanori; Orii, Makoto; Akasaka, Takashi; Uto, Kenta; Shingu, Yasushige; Matsui, Yoshiro; Morimoto, Shin-Ichiro; Tsutsui, Hiroyuki; Eishi, Yoshinobu			Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients	PLOS ONE			English	Article							LYMPH-NODES; CORTICOSTEROID-THERAPY; DILATED CARDIOMYOPATHY; IMMUNE-RESPONSE; LOCALIZATION; TH1; DNA	Background Although rare, cardiac sarcoidosis (CS) is potentially fatal. Early diagnosis and intervention are essential, but histopathologic diagnosis is limited. We aimed to detect Propionibacterium acnes, a commonly implicated etiologic agent of sarcoidosis, in myocardial tissues obtained from CS patients. Methods and results We examined formalin-fixed paraffin-embedded myocardial tissues obtained by surgery or autopsy and endomyocardial biopsy from patients with CS (n = 26; CS-group), myocarditis (n = 15; M-group), or other cardiomyopathies (n = 39; CM-group) using immunohistochemistry (IHC) with a P. acnes-specific monoclonal antibody. We found granulomas in 16 (62%) CS-group samples. Massive (>= 14 inflammatory cells) and minimal (< 14 inflammatory cells) inflammatory foci, respectively, were detected in 16 (62%) and 11 (42%) of the CS-group samples, 10 (67%) and 10 (67%) of the M-group samples, and 1 (3%) and 18 (46%) of the CM-group samples. P. acnes-positive reactivity in granulomas, massive inflammatory foci, and minimal inflammatory foci were detected in 10 (63%), 10 (63%), and 8 (73%) of the CS-group samples, respectively, and in none of the M-group and CMgroup samples. Conclusions Frequent identification of P. acnes in sarcoid granulomas of originally aseptic myocardial tissues suggests that this indigenous bacterium causes granuloma in many CS patients. IHC detection of P. acnes in massive or minimal inflammatory foci of myocardial biopsy samples without granulomas may be useful for differentiating sarcoidosis from myocarditis or other cardiomyopathies.	[Asakawa, Naoya; Sakakibara, Mamoru; Omote, Kazunori; Noguchi, Keiji; Tokuda, Yusuke; Kamiya, Kiwamu] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Uchida, Keisuke] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo, Japan; [Hatanaka, Kanako C.; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Yamada, Shiro] Otaru Kyokai Hosp, Dept Cardiovasc Med, Otaru, Hokkaido, Japan; [Asakawa, Kyoko] Sapporo City Gen Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Fukasawa, Yuichiro] Sapporo City Gen Hosp, Dept Pathol, Sapporo, Hokkaido, Japan; [Nagai, Toshiyuki; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Ikeda, Yoshihiko; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Hirota, Masanori] Machida Municipal Hosp, Dept Cardiovasc Surg, Tokyo, Japan; [Orii, Makoto; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan; [Uto, Kenta] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Shingu, Yasushige; Matsui, Yoshiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Morimoto, Shin-Ichiro] Fujita Hlth Univ, Sch Med, Dept Cardiol, Aichi, Japan; [Tsutsui, Hiroyuki] Kyushu Univ, Dept Cardiovasc Med, Fukuoka, Japan; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo, Japan; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan	Hokkaido University; Tokyo Medical & Dental University (TMDU); Hokkaido University; Sapporo City General Hospital; Sapporo City General Hospital; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Wakayama Medical University; Tokyo Women's Medical University; Hokkaido University; Fujita Health University; Kyushu University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sakakibara, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan.	mike.s@ninus.ocn.ne.jp	Shingu, Yasushige/E-1939-2012	Shingu, Yasushige/0000-0001-8471-5166; Omote, Kazunori/0000-0002-8132-7173	Japan Ministry of Education, Culture, Sports, Science and Technology [23591024]	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science and Technology (23591024, http://www.mext.go.jp/). M.S. received the funding.	ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Blauwet LA, 2013, HEART FAIL REV, V18, P733, DOI 10.1007/s10741-012-9358-3; CARR I, 1980, VIRCHOWS ARCH B, V32, P147, DOI 10.1007/BF02889023; Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083; EISHI Y, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/935289; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; HOMMA JY, 1978, JPN J EXP MED, V48, P251; Iida Tu K, 2014, J MYCOBACT DIS, V4, P1, DOI [10.4172/2161-1068.1000142, DOI 10.4172/2161-1068.1000142]; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; Izumi T, 2011, CIRC J, V75, DOI 10.1253/circj.CJ-88-0008; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; Kanzaki Y, 2001, JPN CIRC J, V65, P797, DOI 10.1253/jcj.65.797; Maisch B, 2005, HERZ, V30, P535, DOI 10.1007/s00059-005-2730-5; Nagai T, 2015, CIRC J, V79, P1593, DOI 10.1253/circj.CJ-14-1275; Nakasuka Kosuke, 2014, J Cardiol Cases, V9, P35, DOI 10.1016/j.jccase.2013.09.004; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Padilla M, 2006, LUNG BIOL HLTH DIS S, V210, P515; Ponikowski P, 2016, EUR J HEART FAIL; Rosen Y, 2007, SEMIN RESP CRIT CARE, V28, P36, DOI 10.1055/s-2007-970332; Schupp JC, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0070-7; Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Tsuda T, 2006, JPN J SARCOIDOSIS OT, V27, P89; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243; Yorozu P, 2015, RESPIR INVESTIG, V53, P161, DOI 10.1016/j.resinv.2015.02.005; Zhou Y, 2015, CLIN EXP IMMUNOL, V181, P511, DOI 10.1111/cei.12650	30	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179980	10.1371/journal.pone.0179980	http://dx.doi.org/10.1371/journal.pone.0179980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686683	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100029
J	Kooiman, K; van Rooij, T; Qin, B; Mastik, F; Vos, HJ; Versluis, M; Klibanov, AL; de Jong, N; Villanueva, FS; Chen, XC				Kooiman, Klazina; van Rooij, Tom; Qin, Bin; Mastik, Frits; Vos, Hendrik J.; Versluis, Michel; Klibanov, Alexander L.; de Jong, Nico; Villanueva, Flordeliza S.; Chen, Xucai			Focal areas of increased lipid concentration on the coating of microbubbles during short tone-burst ultrasound insonification	PLOS ONE			English	Article							CONTRAST AGENT MICROBUBBLES; COMPRESSION-ONLY BEHAVIOR; DRUG-DELIVERY; ENHANCED ULTRASOUND; COATED MICROBUBBLES; COLLAPSE TRANSITIONS; SINGLE MICROBUBBLES; NONLINEAR RESPONSE; MONOLAYERS; BUBBLES	Acoustic behavior of lipid-coated microbubbles has been widely studied, which has led to several numerical microbubble dynamics models that incorporate lipid coating behavior, such as buckling and rupture. In this study we investigated the relationship between microbubble acoustic and lipid coating behavior on a nanosecond scale by using fluorescently labeled lipids. It is hypothesized that a local increased concentration of lipids, appearing as a focal area of increased fluorescence intensity (hot spot) in the fluorescence image, is related to buckling and folding of the lipid layer thereby highly influencing the microbubble acoustic behavior. To test this hypothesis, the lipid microbubble coating was fluorescently labeled. The vibration of the microbubble (n = 177; 2.3-10.3 mu m in diameter) upon insonification at an ultrasound frequency of 0.5 or 1 MHz at 25 or 50 kPa acoustic pressure was recorded with the UPMC Cam, an ultra-high-speed fluorescence camera, operated at -4-5 million frames per second. During short tone-burst excitation, hot spots on the microbubble coating occurred at relative vibration amplitudes > 0.3 irrespective of frequency and acoustic pressure. Around resonance, the majority of the microbubbles formed hot spots. When the microbubble also deflated acoustically, hot spot formation was likely irreversible. Although compression-only behavior (defined as substantially more microbubble compression than expansion) and subharmonic responses were observed in those microbubbles that formed hot spots, both phenomena were also found in microbubbles that did not form hot spots during insonification. In conclusion, this study reveals hot spot formation of the lipid monolayer in the microbubble's compression phase. However, our experimental results show that there is no direct relationship between hot spot formation of the lipid coating and microbubble acoustic behaviors such as compression-only and the generation of a subharmonic response. Hence, our hypothesis that hot spots are related to acoustic buckling could not be verified.	[Kooiman, Klazina; Qin, Bin; Villanueva, Flordeliza S.; Chen, Xucai] Univ Pittsburgh, Med Ctr, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15260 USA; [Kooiman, Klazina] Netherlands Heart Inst, Utrecht, Netherlands; [Kooiman, Klazina; van Rooij, Tom; Mastik, Frits; Vos, Hendrik J.; de Jong, Nico] Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands; [Vos, Hendrik J.; de Jong, Nico] Delft Univ Technol, Fac Appl Sci, Lab Acoust Wavefield Imaging, Delft, Netherlands; [Versluis, Michel] Univ Twente, Phys Fluids Grp, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands; [Versluis, Michel] Univ Twente, MESA Inst Nanotechnol, Enschede, Netherlands; [Klibanov, Alexander L.] Univ Virginia, Dept Med, Cardiovasc Div, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; University of Twente; University of Twente; University of Virginia	Kooiman, K (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15260 USA.; Kooiman, K (corresponding author), Netherlands Heart Inst, Utrecht, Netherlands.; Kooiman, K (corresponding author), Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands.	k.kooiman@erasmusmc.nl	Versluis, Michel/F-3541-2011; Mastik, Frits/F-1960-2011; De Jong, Nicolaas/F-1949-2011	Versluis, Michel/0000-0002-2296-1860; Mastik, Frits/0000-0001-9160-4077; De Jong, Nicolaas/0000-0001-8902-0099; Kooiman, Klazina/0000-0002-0607-4989	Netherlands Heart Institute; Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center; Center for Translational Molecular Medicine; Dutch Heart Foundation (PARISk)	Netherlands Heart Institute; Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center; Center for Translational Molecular Medicine; Dutch Heart Foundation (PARISk)	This research was financially supported by the Netherlands Heart Institute (fellowship to K.K.), the Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center, and the Center for Translational Molecular Medicine and the Dutch Heart Foundation (PARISk).	Alzaraa A, 2013, HEPATOL RES, V43, P809, DOI 10.1111/hepr.12044; Azmin M, 2012, CURR PHARM DESIGN, V18, P2118, DOI 10.2174/138161212800099955; Baoukina S, 2008, P NATL ACAD SCI USA, V105, P10803, DOI 10.1073/pnas.0711563105; Borden MA, 2006, LANGMUIR, V22, P4291, DOI 10.1021/la052841v; Borden MA, 2005, IEEE T ULTRASON FERR, V52, P1992, DOI 10.1109/TUFFC.2005.1561668; Cantisani V, 2015, EUR J RADIOL, V84, P1675, DOI 10.1016/j.ejrad.2015.05.008; Chen X., 2015, ULTRASOUND MED BIOL; Chen XC, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4809168; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; Correas JM, 1997, ACTA RADIOL, V38, P101; Daeichin V., 2015, INT J HYPERTHER, V31, P106; De Jong N, 2007, ULTRASOUND MED BIOL, V33, P653, DOI 10.1016/j.ultrasmedbio.2006.09.016; Denham SLW, 2016, ULTRASOUND Q, V32, P116, DOI 10.1097/RUQ.0000000000000182; Doinikov AA, 2009, ULTRASONICS, V49, P269, DOI 10.1016/j.ultras.2008.09.007; Eisenbrey JR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/640397; Emmer M, 2009, IEEE T ULTRASON FERR, V56, P2370, DOI 10.1109/TUFFC.2009.1325; Feinstein SB, 2010, J NUCL CARDIOL, V17, P106, DOI 10.1007/s12350-009-9165-y; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Frinking PJA, 2010, IEEE T ULTRASON FERR, V57, P1762, DOI 10.1109/TUFFC.2010.1614; Gelderblom E. C., 2012, THESIS; Gong YJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865805; Gopal A, 2001, J PHYS CHEM B, V105, P10348, DOI 10.1021/jp012532n; Helfield B, 2016, P NATL ACAD SCI USA, V113, P9983, DOI 10.1073/pnas.1606915113; Helfield BL, 2013, J ACOUST SOC AM, V133, P1158, DOI 10.1121/1.4774379; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Kim DH, 2003, LANGMUIR, V19, P8455, DOI 10.1021/la034779c; Klibanov AL, 2006, INVEST RADIOL, V41, P354, DOI 10.1097/01.rli.0000199292.88189.0f; Kooiman K, 2014, EUR J LIPID SCI TECH, V116, P1217, DOI 10.1002/ejlt.201300434; Kooiman K, 2014, ADV DRUG DELIVER REV, V72, P28, DOI 10.1016/j.addr.2014.03.003; Kwan JJ, 2012, ADV COLLOID INTERFAC, V183, P82, DOI 10.1016/j.cis.2012.08.005; Lee KYC, 2008, ANNU REV PHYS CHEM, V59, P771, DOI 10.1146/annurev.physchem.58.032806.104619; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; Lozano MM, 2009, SOFT MATTER, V5, P1822, DOI 10.1039/b820070j; Lozano MM, 2009, LANGMUIR, V25, P3705, DOI 10.1021/la803774q; Luan Y, 2014, ULTRASOUND MED BIOL, V40, P1834, DOI 10.1016/j.ultrasmedbio.2014.02.031; Marmottant P, 2005, J ACOUST SOC AM, V118, P3499, DOI 10.1121/1.2109427; Mortimer AJ, 1982, PHYS CHARACTERISITCS; O'Brien JP, 2011, J ACOUST SOC AM, V130, pEL180, DOI 10.1121/1.3630219; Overvelde M, 2010, ULTRASOUND MED BIOL, V36, P2080, DOI 10.1016/j.ultrasmedbio.2010.08.015; Owen J, 2015, ULTRASOUND MED BIOL, V41, P3253, DOI 10.1016/j.ultrasmedbio.2015.07.024; Paul S, 2010, J ACOUST SOC AM, V127, P3846, DOI 10.1121/1.3418685; PROSPERETTI A, 1974, J ACOUST SOC AM, V56, P878, DOI 10.1121/1.1903341; Pu G, 2006, LANGMUIR, V22, P2993, DOI 10.1021/la0530337; Renaud G, 2014, ULTRASOUND MED BIOL, V40, P1282, DOI 10.1016/j.ultrasmedbio.2013.12.018; Segers T, 2016, J ACOUST SOC AM, V140, P2506, DOI 10.1121/1.4964270; Segers T, 2016, LANGMUIR, V32, P3937, DOI 10.1021/acs.langmuir.6b00616; Shih R, 2016, LANGMUIR, V32, P1939, DOI 10.1021/acs.langmuir.5b03948; Sijl J, 2011, J ACOUST SOC AM, V130, P3271, DOI 10.1121/1.3626155; Sijl J, 2011, J ACOUST SOC AM, V129, P1729, DOI 10.1121/1.3505116; Sijl J, 2010, J ACOUST SOC AM, V128, P3239, DOI 10.1121/1.3493443; Sijl J, 2008, J ACOUST SOC AM, V124, P4091, DOI 10.1121/1.2997437; Sutton JT, 2013, EXPERT OPIN DRUG DEL, V10, P573, DOI 10.1517/17425247.2013.772578; Takamoto DY, 2001, BIOPHYS J, V81, P153, DOI 10.1016/S0006-3495(01)75688-3; Talu E, 2008, LANGMUIR, V24, P1745, DOI 10.1021/la703065v; van der Meer SM, 2007, J ACOUST SOC AM, V121, P648, DOI 10.1121/1.2390673; van Rooij T, 2013, IEEE ULTR S P; van Rooij T, 2016, J CONTROL RELEASE, V238, P197, DOI 10.1016/j.jconrel.2016.07.037; van Rooij T, 2015, ULTRASOUND MED BIOL, V41, P1432, DOI 10.1016/j.ultrasmedbio.2015.01.004; Vos HJ, 2008, ULTRASOUND MED BIOL, V34, P685, DOI 10.1016/j.ultrasmedbio.2007.10.001; Wang SY, 2016, INVEST RADIOL, V51, P758, DOI 10.1097/RLI.0000000000000310	60	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180747	10.1371/journal.pone.0180747	http://dx.doi.org/10.1371/journal.pone.0180747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686673	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100098
J	Krishnan, S; Alcock, KJ; Carey, D; Bergstrom, L; Karmiloff-Smith, A; Dick, F				Krishnan, Saloni; Alcock, Katherine J.; Carey, Daniel; Bergstrom, Lina; Karmiloff-Smith, Annette; Dick, Frederic			Fractionating nonword repetition: The contributions of short-term memory and oromotor praxis are different	PLOS ONE			English	Article							WORKING-MEMORY; LANGUAGE IMPAIRMENT; INHERITED SPEECH; PHONOLOGICAL MEMORY; CHILDREN; VOCABULARY; SKILLS; MOTOR; ACCURACY; FLUENCY	The ability to reproduce novel words is a sensitive marker of language impairment across a variety of developmental disorders. Nonword repetition tasks are thought to reflect phonological short-term memory skills. Yet, when children hear and then utter a word for the first time, they must transform a novel speech signal into a series of coordinated, precisely timed oral movements. Little is known about how children's oromotor speed, planning and co-ordination abilities might influence their ability to repeat novel nonwords, beyond the influence of higher-level cognitive and linguistic skills. In the present study, we tested 35 typically developing children between the ages of 5-8 years on measures of nonword repetition, digit span, memory for non-verbal sequences, reading fluency, oromotor praxis, and oral diadochokinesis. We found that oromotor praxis uniquely predicted nonword repetition ability in school-age children, and that the variance it accounted for was additional to that of digit span, memory for non-verbal sequences, articulatory rate (measured by oral diadochokinesis) as well as reading fluency. We conclude that the ability to compute and execute novel sensorimotor transformations affects the production of novel words. These results have important implications for understanding motor/language relations in neurodevelopmental disorders.	[Krishnan, Saloni; Carey, Daniel; Bergstrom, Lina; Karmiloff-Smith, Annette; Dick, Frederic] Birkbeck Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Krishnan, Saloni] Univ Oxford, Dept Expt Psychol, Oxford, England; [Alcock, Katherine J.] Univ Lancaster, Dept Psychol, Lancaster, England	University of London; Birkbeck University London; University of Oxford; Lancaster University	Krishnan, S (corresponding author), Birkbeck Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.; Krishnan, S (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	saloni.krishnan@psy.ox.ac.uk	Alcock, Katie/F-8219-2011; Krishnan, Saloni/I-2642-2019	Alcock, Katie/0000-0001-5219-5442; Krishnan, Saloni/0000-0002-6466-141X; Dick, Frederic/0000-0002-2933-3912	British Academy Small Research Grant [SG111144]; ESRC [ES/L008955/1] Funding Source: UKRI	British Academy Small Research Grant; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by a British Academy Small Research Grant (SG111144). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Alcock KJ, 2000, BRAIN LANG, V75, P17, DOI 10.1006/brln.2000.2322; Alloway TP, 2004, J EXP CHILD PSYCHOL, V87, P85, DOI 10.1016/j.jecp.2003.10.002; Archibald L, 2007, PSYCHONOMIC B REV; Archibald LMD, 2013, TOP LANG DISORD, V33, P255, DOI 10.1097/TLD.0b013e31829cf5e7; Archibald LMD, 2009, J ACOUST SOC AM, V125, P1712, DOI 10.1121/1.3076200; Audition Carey D., 2015, AUDITION LEARNING EX, P1; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baniqued PL, 2013, ACTA PSYCHOL, V142, P74, DOI 10.1016/j.actpsy.2012.11.009; Berman R.A., 2007, BLACKWELL HDB LANGUA, P347, DOI [10.1002/9780470757833.ch17, DOI 10.1002/9780470757833.CH17]; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; Brookman A, 2013, PEERJ, V1, DOI 10.7717/peerj.217; Cleary M, 2001, EAR HEARING, V22, P395, DOI 10.1097/00003446-200110000-00004; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; De Cara B, 2003, J CHILD LANG, V30, P695, DOI 10.1017/S0305000903005725; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Edwards J, 1998, APPL PSYCHOLINGUIST, V19, P279, DOI 10.1017/S0142716400010079; Efron B, 2000, J AM STAT ASS; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Evans JL, 2009, J SPEECH LANG HEAR R, V52, P321, DOI 10.1044/1092-4388(2009/07-0189); Fawcett AJ, 1995, J MOT BEHAV; Fawcett Angela J, 2002, Dyslexia, V8, P189, DOI 10.1002/dys.222; Ferguson AN, 2002, J EXP CHILD PSYCHOL, V81, P141, DOI 10.1006/jecp.2001.2646; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; GATHERCOLE SE, 1991, APPL PSYCHOLINGUIST, V12, P349, DOI 10.1017/S0142716400009267; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Gathercole SE, 2005, J CHILD PSYCHOL PSYC, V46, P598, DOI 10.1111/j.1469-7610.2004.00379.x; Gathercole SE, 1997, DEV PSYCHOL, V33, P966, DOI 10.1037/0012-1649.33.6.966; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Gernsbacher MA, 2008, J CHILD PSYCHOL PSYC, V49, P43, DOI 10.1111/j.1469-7610.2007.01820.x; GILLAM RB, 1995, J SPEECH HEAR RES, V38, P393, DOI 10.1044/jshr.3802.393; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Heim S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00534; Hsu HJ, 2014, DEVELOPMENTAL SCI, V17, P352, DOI 10.1111/desc.12125; HULME C, 1984, J EXP CHILD PSYCHOL, V38, P241, DOI 10.1016/0022-0965(84)90124-3; Humes LE, 2005, J SPEECH LANG HEAR R, V48, P224, DOI 10.1044/1092-4388(2005/016); KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; Krishnan S, 2016, TRENDS COGN SCI, V20, P701, DOI 10.1016/j.tics.2016.06.012; Krishnan S, 2015, CEREB CORTEX, V25, P3261, DOI 10.1093/cercor/bhu120; Krishnan S, 2015, NEUROPSYCHOLOGIA, V67, P82, DOI 10.1016/j.neuropsychologia.2014.11.032; Krishnan S, 2013, J SPEECH LANG HEAR R, V56, P1800, DOI 10.1044/1092-4388(2013/12-0206); Laws G, 2004, J CHILD PSYCHOL PSYC, V45, P326, DOI 10.1111/j.1469-7610.2004.00224.x; LeBarton ES, 2013, DEVELOPMENTAL SCI, V16, P815, DOI 10.1111/desc.12069; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; MacDonald MC, 2016, CURR DIR PSYCHOL SCI, V25, P47, DOI 10.1177/0963721415620776; Melby-Lervag M, 2012, PSYCHOL SCI, V23, P1092, DOI 10.1177/0956797612443833; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Metsala JL, 1998, WORD RECOGNITION IN BEGINNING LITERACY, P89; Munson B, 2005, J SPEECH LANG HEAR R, V48, P61, DOI 10.1044/1092-4388(2005/006); Nash HM, 2013, J CHILD PSYCHOL PSYC, V54, P958, DOI 10.1111/jcpp.12091; Nation K, 2011, DEVELOPMENTAL SCI, V14, P649, DOI 10.1111/j.1467-7687.2010.01008.x; Nation K, 2010, J CHILD PSYCHOL PSYC, V51, P1031, DOI 10.1111/j.1469-7610.2010.02254.x; Nip ISB, 2011, J COMMUN DISORD, V44, P149, DOI 10.1016/j.jcomdis.2010.08.002; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Pickering S., 2001, WORKING MEMORY TEST; Putnam AL, 2014, MEM COGNITION, V42, P409, DOI 10.3758/s13421-013-0374-x; Reuterskiold C, 2015, NONWORD REPETITION S, P1; Rvachew S, 2006, CAN J SPEECH-LANG PA, V30, P6; Sasisekaran J, 2010, DEVELOPMENTAL SCI, V13, P521, DOI 10.1111/j.1467-7687.2009.00911.x; Stark RE, 1997, CHILD NEUROPSYCHOL, V3, P81, DOI 10.1080/09297049708401370; Stiles J, 2012, DEV PSYCHOBIOL, V54, P343, DOI 10.1002/dev.20628; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torres Elisabeth B, 2013, FRONT INTEGR NEUROSC, V24, P7; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Wagner R, 1999, CTOPP COMPREHENSIVE; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Yaruss JS, 2002, J FLUENCY DISORD, V27, P65	76	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0178356	10.1371/journal.pone.0178356	http://dx.doi.org/10.1371/journal.pone.0178356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TL	28704379	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000405649700007
J	Plourde, BT; Burgess, TL; Eskew, EA; Roth, TM; Stephenson, N; Foley, JE				Plourde, Benjamin T.; Burgess, Tristan L.; Eskew, Evan A.; Roth, Tara M.; Stephenson, Nicole; Foley, Janet E.			Are disease reservoirs special? Taxonomic and life history characteristics	PLOS ONE			English	Article							IDENTIFYING RESERVOIRS; INFECTIOUS-DISEASES; PATHOGEN; HOST; MAMMALS; RISK; DOMESTICATION; IMPUTATION; EMERGENCE; EVOLUTION	Pathogens that spill over between species cause a significant human and animal health burden. Here, we describe characteristics of animal reservoirs that are required for pathogen spillover. We assembled and analyzed a database of 330 disease systems in which a pathogen spills over from a reservoir of one or more species. Three-quarters of reservoirs included wildlife, and 84% included mammals. Further, 65% of pathogens depended on a community of reservoir hosts, rather than a single species, for persistence. Among mammals, the most frequently identified reservoir hosts were rodents, artiodactyls, and carnivores. The distribution among orders of mammalian species identified as reservoirs did not differ from that expected by chance. Among disease systems with high priority pathogens and epidemic potential, we found birds, primates, and bats to be overrepresented. We also analyzed the life history traits of mammalian reservoir hosts and compared them to mammals as a whole. Reservoir species had faster life history characteristics than mammals overall, exhibiting traits associated with greater reproductive output rather than long-term survival. Thus, we find that in many respects, reservoirs of spillover pathogens are indeed special. The described patterns provide a useful resource for studying and managing emerging infectious diseases.	[Plourde, Benjamin T.; Roth, Tara M.; Stephenson, Nicole; Foley, Janet E.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Burgess, Tristan L.] Univ Calif Davis, Karen C Drayer Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Eskew, Evan A.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Eskew, Evan A.] EcoHlth Alliance, New York, NY USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; EcoHealth Alliance	Plourde, BT (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	btplourde@ucdavis.edu	Eskew, Evan/H-8478-2019	Eskew, Evan/0000-0002-1153-5356; Plourde, Benjamin/0000-0002-7196-913X	National Science Foundation Graduate Research Fellowship [1148897]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (www.nsfgrfp.org) under Grant No. 1148897 to EAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Ashford RW, 1997, BELG J ZOOL, V127, P85; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Brisson D, 2011, INTERDISCIP PERSPECT, V2011, P1; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Caron A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0217-9; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cox R, 2016, TRANSBOUND EMERG DIS, V63, P79, DOI 10.1111/tbed.12221; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Edberg SC, 2005, CLIN INFECT DIS, V40, P123, DOI 10.1086/426549; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fujimaki Y., 1978, Journal of the Mammalogical Society of Japan, V7, P135; Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hays J.N., 2005, EPIDEMICS PANDEMICS; Herring AD, 2014, BEEF CATTLE PRODUCTI; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Huang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060827, 10.1371/journal.pone.0074617]; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Kaneko Y, 1998, RES POPUL ECOL, V40, P21, DOI 10.1007/BF02765219; Klempa B, 2010, J INFECT DIS, V201, P1031, DOI 10.1086/651169; Koffler BR, 1972, MAMMALIAN SPECIES, P1; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; McIntyre KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103529; McIntyre KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019558; Menghani S, 2012, ACTA TROP, V124, P1, DOI 10.1016/j.actatropica.2012.06.001; MENNELLA JA, 1990, BEHAV ECOL SOCIOBIOL, V27, P183; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Nutter FB, 2004, JAVMA-J AM VET MED A, V225, P1399, DOI 10.2460/javma.2004.225.1399; OIE, 2015, AN HLTH WORLD; Ostfeld RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107387; Paemelaere E, 2011, CAN J ZOOL, V89, P692, DOI 10.1139/Z11-033; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; R Core Team, 2013, R LANG ENV STAT COMP; Reed Kurt D, 2003, Clin Med Res, V1, P5; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Stekhoven D.J, 2013, MISSFOREST NONPARAME; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Swinton J., 2002, P83; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; Wilson D. E., 2005, MAMMAL SPECIES WORLD	57	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2017	12	7							e0180716	10.1371/journal.pone.0180716	http://dx.doi.org/10.1371/journal.pone.0180716			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TL	28704402	Green Published, gold			2022-12-27	WOS:000405649700048
J	Macagnan, KL; Alves, MI; Rodrigues, AA; Furlan, L; Rodrigues, RD; de Oliveira, PD; Vendruscolo, CT; Moreira, AD				Macagnan, Karine Laste; Alves, Mariane Igansi; Rodrigues, Amandaa Avila; Furlan, Ligia; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Vendruscolo, Claire Tondo; Moreira, Angelita da Silveira			Complete factorial design to adjust pH and sugar concentrations in the inoculum phase of Ralstonia solanacearum to optimize P(3HB) production	PLOS ONE			English	Article							CUPRIAVIDUS-NECATOR; POLY(3-HYDROXYBUTYRATE) PRODUCTION; LIPASE PRODUCTION; POLYHYDROXYALKANOATES; BACTERIAL; RECOVERY; GLYCEROL; CULTURE; OIL	Poly(3-hydroxybutyrate) (P(3HB)) is a biodegradable plastic biopolymer that accumulates as lipophilic inclusions in the cytoplasm of some microorganisms. The biotechnological process by which P(3HB) is synthesized occurs in two phases. The first phase involves cell growth in a complex culture medium, while the second phase involves polymer accumulation in the presence of excess carbon sources. As such, the efficiency of the second phase depends on the first phase. The aim of this study was to evaluate culture media with different concentrations of sucrose and glucose and different pH values in the inoculum phase of Ralstonia solanacearum RS with the intention of identifying methods by which the biomass yield could be increased, subsequently enhancing the yield of P(3HB). The culture medium was formulated according to the experimental planning type of central composite rotational design 2(2). The independent variables were pH and sugar concentration (sucrose and glucose), and the dependent variables were OD600nm, dry cell weight (DCW), and P(3HB) yield. The highest cell growth, estimated by the OD600nm (20.6) and DCW (5.35) values, was obtained when sucrose was used in the culture medium at a concentration above 35 g. L (-1) in combination with an acidic pH. High polymer (45%) accumulation was also achieved under these conditions. Using glucose, the best results for OD600nm (12.5) and DCW (2.74) were also obtained at acidic pH but with a sugar concentration at the minimum values evaluated. Due to the significant accumulation of polymer in the cells that were still in the growth phase, the accumulating microorganism P(3HB) Ralstonia solanacearum RS can be classified as having type II metabolism in relation to the polymer accumulation phase, which is different from other Ralstonia spp. studied until this time.	[Macagnan, Karine Laste; Rodrigues, Amandaa Avila; de Oliveira, Patricia Diaz; Vendruscolo, Claire Tondo; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Unidade Biotecnol, Pelotas, RS, Brazil; [Alves, Mariane Igansi; Moreira, Angelita da Silveira] Univ Fed Pelotas, Dept Ciencia & Tecnol Agroind, Pelotas, RS, Brazil; [Furlan, Ligia; Rodrigues, Rosane da Silva; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Unidade Biotecnol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Dept Ciencia & Tecnol Agroind, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil.	angelitadasilveiramoreira@gmail.com	Vendruscolo, Claire Tondo/AAN-2723-2020; Macagnan, Karine Laste/N-9398-2018; da S. Moreira, Angelita/L-8545-2017; Diaz, Patrícia Silva/L-9364-2017	Vendruscolo, Claire Tondo/0000-0003-0357-5988; Macagnan, Karine Laste/0000-0002-8643-3397; da S. Moreira, Angelita/0000-0001-8711-6521; Diaz, Patrícia Silva/0000-0001-9601-296X	CAPES; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We gratefully acknowledge the financial support received from the funding agencies CAPES and CNPq.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FG, 2010, APPL BIOCHEM BIOTECH, V160, P1528, DOI 10.1007/s12010-009-8683-z; Barbosa M, 2005, UNIV SCI, V10, P45; Borah B, 2002, J APPL MICROBIOL, V92, P776, DOI 10.1046/j.1365-2672.2002.01590.x; Burkert JFD, 2005, J CHEM TECHNOL BIOT, V80, P61, DOI 10.1002/jctb.1157; Burkert JFM, 2004, BIORESOURCE TECHNOL, V91, P77, DOI 10.1016/S0960-8524(03)00152-4; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Cavalheiro JMBT, 2009, PROCESS BIOCHEM, V44, P509, DOI 10.1016/j.procbio.2009.01.008; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Crochemore A. G., 2012, African Journal of Biotechnology, V11, P15144; Pradella JGD, 2010, BIORESOURCE TECHNOL, V101, P8355, DOI 10.1016/j.biortech.2010.05.046; Rios DAD, 2015, CIENC AGROTEC, V39, P401, DOI 10.1590/S1413-70542015000400011; Dalcanton F, 2010, QUIM NOVA, V33, P552, DOI 10.1590/S0100-40422010000300011; de Barros Neto B., 2001, COMO FAZER EXPERIMEN; HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305; JEANES A, 1974, FOOD TECHNOL-CHICAGO, V28, P34; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Kanjanachumpol P, 2013, BIOPROC BIOSYST ENG, V36, P1463, DOI 10.1007/s00449-013-0885-7; Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053; Khuri A.I, 1996, RESPONSE SURFACE DES, P2; Kirbas Z, 1999, B ENVIRON CONTAM TOX, V63, P335; Kulpreecha S, 2009, J BIOSCI BIOENG, V107, P240, DOI 10.1016/j.jbiosc.2008.10.006; Kunasundari B, 2011, EXPRESS POLYM LETT, V5, P620, DOI 10.3144/expresspolymlett.2011.60; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; Macagnan KL, 2017, QUIM NOVA, V40, P125, DOI 10.21577/0100-4042.20160162; Manera AP, 2008, FOOD TECHNOL BIOTECH, V46, P66; Franchetti SM, 2006, QUIM NOVA, V29, P811, DOI 10.1590/S0100-40422006000400031; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Naranjo JM, 2013, BIORESOURCE TECHNOL, V133, P38, DOI 10.1016/j.biortech.2013.01.129; Ng KS, 2010, POLYM DEGRAD STABIL, V95, P1365, DOI 10.1016/j.polymdegradstab.2010.01.021; Pereira D. D., 2001, Revista Cientifica Rural, V6, P22; RAMSAY J A, 1990, Biotechnology Techniques, V4, P221, DOI 10.1007/BF00158833; Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2; Rodrigues AA, 2015, REV BRASILEIRA TECNO, V9, P1771; Rodriguez-Contreras A, 2013, J APPL MICROBIOL, V114, P1378, DOI 10.1111/jam.12151; Rodriguez-Contreras A, 2015, BIOCHEM ENG J, V94, P50, DOI 10.1016/j.bej.2014.11.007; Rosa CFC, 2015, INT J ENG RES APPL, V5, P41; Sathish A, 2014, J POLYM ENVIRON, V22, P272, DOI 10.1007/s10924-014-0647-x; Scarminio IS, 1995, PLANEJAMENTO OTIMIZA, V2, P299; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3, P373; Silva-Santisteban BOY, 2005, ENZYME MICROB TECH, V36, P717, DOI 10.1016/j.enzmictec.2004.12.008; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; Vinhas GM, 2007, QUIM NOVA, V6, P1587	44	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0180563	10.1371/journal.pone.0180563	http://dx.doi.org/10.1371/journal.pone.0180563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA7TK	28704411	Green Published, Green Submitted, gold			2022-12-27	WOS:000405649600034
J	Spencer, S; Meer, T; Muller, A				Spencer, Sarah; Meer, Talia; Muller, Alex			"The care is the best you can give at the time" : Health care professionals' experiences in providing gender affirming care in South Africa	PLOS ONE			English	Article							SEX REASSIGNMENT; TRANSGENDER; OUTCOMES; SOCIETY; GAY	Background While the provision of gender affirming care for transgender people in South Africa is considered legal, ethical, and medically sound, and is-theoretically-available in both the South African private and public health sectors, access remains severely limited and unequal within the country. As there are no national policies or guidelines, little is known about how individual health care professionals providing gender affirming care make clinical decisions about eligibility and treatment options. Method Based on an initial policy review and service mapping, this study employed semi- structured interviews with a snowball sample of twelve health care providers, representing most providers currently providing gender affirming care in South Africa. Data were analysed thematically using NVivo, and are reported following COREQ guidelines. Results Our findings suggest that, whilst a small minority of health care providers offer gender affirming care, this is almost exclusively on their own initiative and is usually unsupported by wider structures and institutions. The ad hoc, discretionary nature of services means that access to care is dependent on whether a transgender person is fortunate enough to access a sympathetic and knowledgeable health care provider. Conclusion Accordingly, national, state- sanctioned guidelines for gender affirming care are necessary to increase access, homogenise quality of care, and contribute to equitable provision of gender affirming care in the public and private health systems.	[Spencer, Sarah; Meer, Talia; Muller, Alex] Univ Cape Town, Gender Hlth & Justice Res Unit, Cape Town, Western Cape, South Africa	University of Cape Town	Muller, A (corresponding author), Univ Cape Town, Gender Hlth & Justice Res Unit, Cape Town, Western Cape, South Africa.	alexandra.muller@uct.ac.za	Spencer, Sarah/ABH-3813-2020	Spencer, Sarah/0000-0002-7034-6387; Muller, Alex/0000-0002-3254-7591; Meer, Talia/0000-0002-1301-9822				American Medical Association House of Delegates, 2008, RAD PHYS PERF MEAS S, P1; Ao B., 2016, WEEKEND ARGUS   0521; APA American Journal of Psychiatry American Psychiatric Association, 2013, AM J PSYCHIAT, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596]; Bauer G. R., 2013, SERVICE SOCIAL, V59, P35, DOI [10.7202/1017478ar, DOI 10.7202/1017478AR]; Britnell M., 2015, SEARCH PERFECT HLTH, P234; Callen-Lorde Community Health Center: Transgender Health Services, 2014, PROT PROV HORM THER; Center of Excellence for Transgender Health, 2011, PRIM CAR PROT TRANSG; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Colizzi M, 2015, PSYCHIAT RES, V226, P173, DOI 10.1016/j.psychres.2014.12.045; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Council for Medical Schemes, 2015, PMB LIST ALL COND; Dahl M., 2015, ENDOCRINE THERAPY TR; De Cuypere G, 2005, ARCH SEX BEHAV, V34, P679, DOI 10.1007/s10508-005-7926-5; De Villiers A., 2013, GUIDE GEN PRACTICE H; de Villiers A, 2013, ADULT TRANSGENDER PA; Drescher J, 2012, AM PSYCHIAT ASS POSI; Drescher J, 2015, INT REV PSYCHIATR, V27, P386, DOI 10.3109/09540261.2015.1053847; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; Fassinger RE., 2007, HDB COUNSELING PSYCH, V2nd edition, P19, DOI DOI 10.1037/11482-001; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Kelley L, 2008, TEACH LEARN MED, V20, P248, DOI 10.1080/10401330802199567; Klein T., 2008, ANTHR MATTERS, V10; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Meer T, 2017, HEALTH PLACE, V45, P92, DOI 10.1016/j.healthplace.2017.03.010; Msimango Z., 2015, SUNDAY TIMES LI 1018; Muller A, 2016, SOC SCI MED, V148, P71, DOI 10.1016/j.socscimed.2015.11.048; Muller A, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-174; Muller A, 2013, SEXUAL REPROD HLTH T; Muller A, THESE ARE T IN PRESS; Newfield E, 2006, QUAL LIFE RES, V15, P1447, DOI 10.1007/s11136-006-0002-3; Nkoana T, 2012, NEW VOICES PSYCHOL, V8, P120; Obedin-Maliver J, 2011, JAMA-J AM MED ASSOC, V306, P971, DOI 10.1001/jama.2011.1255; Reisner SL, 2016, LANCET, P214; Republic of South Africa, 1996, CONSTITUTION REPUBLI, p[1241, 56]; Royal College of Psychiatrists, 2013, 181 CR ROYAL COLL PS; Sharpe A., 2002, TRANSGENDER JURISPRU; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Stevens M., 2012, TRANSGENDER ACCESS S; Suess A., 2014, TSQ TRANSGENDER STUD, V1, P73, DOI [DOI 10.1215/23289252-2399650, https://doi.org/10.1215/23289252-2399650]; Victor CJ, 2014, S AFR J PSYCHOL, V44, P292, DOI 10.1177/0081246314533635; Wilson D, 2014, S Afr Med J, V104, P449; Winter S, 2016, LANCET, P568; World Health Organization, 1992, ICD 10 CLASSIFICATIO	44	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2017	12	7							e0181132	10.1371/journal.pone.0181132	http://dx.doi.org/10.1371/journal.pone.0181132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA7TK	28704458	Green Published, gold, Green Submitted			2022-12-27	WOS:000405649600062
J	Jadeja, SD; Mansuri, MS; Singh, M; Dwivedi, M; Laddha, NC; Begum, R				Jadeja, Shahnawaz D.; Mansuri, Mohmmad Shoab; Singh, Mala; Dwivedi, Mitesh; Laddha, Naresh C.; Begum, Rasheedunnisa			A case- control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; CLASS-I; GENERALIZED VITILIGO; GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; PROGRESSION; MUTATIONS; PEPTIDE	Background Autoimmunity has been implicated in the destruction of melanocytes from vitiligo skin. Major histocompatibility complex (MHC) class-II linked genes proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1), involved in antigen processing and presentation have been reported to be associated with several autoimmune diseases including vitiligo. Methods PSMB8 rs2071464 polymorphism was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and TAP1 rs1135216 polymorphism was genotyped by amplification refractory mutation system-polymerase chain reaction (ARMSPCR) in 378 patients with vitiligo and 509 controls. Transcript levels of PSMB8 and TAP1 were measured in the PBMCs of 91 patients and 96 controls by using qPCR. Protein levels of PSMB8 were also determined by Western blot analysis.` Objectives To explore PSMB8 rs2071464 and TAP1 rs1135216 single nucleotide polymorphisms and to estimate the expression of PSMB8 and TAP1 in patients with vitiligo and unaffected controls from Gujarat. Results The frequency of `TT' genotype of PSMB8 polymorphism was significantly lowered in patients with generalized and active vitiligo (p = 0.019 and p = 0.005) as compared to controls suggesting its association with the activity of the disease. However, TAP1 polymorphism was not associated with vitiligo susceptibility. A significant decrease in expression of PSMB8 at both transcript level (p = 0.002) as well as protein level (p = 0.0460) was observed in vitiligo patients as compared to controls. No significant difference was observed between patients and controls for TAP1 transcripts (p = 0.553). Interestingly, individuals with the susceptible CC genotype of PSMB8 polymorphism showed significantly reduced PSMB8 transcript level as compared to that of CT and TT genotypes (p = 0.009 and p = 0.003 respectively). Conclusions PSMB8 rs2071464 was associated with generalized and active vitiligo from Gujarat whereas TAP1 rs1135216 showed no association. The down-regulation of PSMB8 in patients with risk genotype ` CC' advocates the vital role of PSMB8 in the autoimmune basis of vitiligo.	[Jadeja, Shahnawaz D.; Mansuri, Mohmmad Shoab; Singh, Mala; Dwivedi, Mitesh; Laddha, Naresh C.; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Dwivedi, Mitesh/Q-1276-2019; jadeja, shahnawaz/AAD-4948-2021; Begum, Rasheedunnisa/AAF-2981-2020	Dwivedi, Mitesh/0000-0001-8497-0765; jadeja, shahnawaz/0000-0002-9533-6302; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Babalghith A., 2014, INT J CURR MICROBIOL, V3, P1; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Dani P, 2017, BRIT J DERMATOLOGY; de Vijlder HC, 2004, PIGM CELL RES, V17, P270, DOI 10.1111/j.1600-0749.2004.00145.x; DENG GY, 1995, AM J HUM GENET, V56, P528; Dey-Rao R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3510-3; Dinh HV, 2007, J INVEST DERMATOL, V127, P2689; DJILALISAIAH I, 1994, HUM IMMUNOL, V40, P8, DOI 10.1016/0198-8859(94)90015-9; Dwivedi M, 2013, BRIT J DERMATOL, V169, P1114, DOI 10.1111/bjd.12467; Dwivedi M, 2015, AUTOIMMUN REV, V14, P49, DOI 10.1016/j.autrev.2014.10.002; Dwivedi M, 2013, J INTERF CYTOK RES, V33, P646, DOI 10.1089/jir.2012.0171; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; Elhawary NA, 2014, DIS MARKERS, V2014; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; FALABELLA R, 1995, J AM ACAD DERMATOL, V32, P228, DOI 10.1016/0190-9622(95)90131-0; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; FU YE, 1993, J CLIN INVEST, V91, P2301, DOI 10.1172/JCI116459; Fu YN, 1998, ANN NY ACAD SCI, V842, P138, DOI 10.1111/j.1749-6632.1998.tb09642.x; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GRIMES PE, 1986, J AM ACAD DERMATOL, V14, P196, DOI 10.1016/S0190-9622(86)70021-2; Groettrup M, 2001, BIOCHIMIE, V83, P367, DOI 10.1016/S0300-9084(01)01251-2; HALDER RM, 1986, J AM ACAD DERMATOL, V14, P733, DOI 10.1016/S0190-9622(86)70085-6; Handa Sanjeev, 1999, Journal of Dermatology (Tokyo), V26, P653; Harris JE, 2013, EXP DERMATOL, V22, P785, DOI 10.1111/exd.12264; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Jin Y, 2011, J INVEST DERMATOL, V131, P1308, DOI 10.1038/jid.2011.12; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Kumagai S, 1997, ARTHRITIS RHEUM, V40, P1685, DOI 10.1002/art.1780400919; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Laddha NC, 2014, EXP DERMATOL, V23, P352, DOI 10.1111/exd.12372; Laddha NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081736; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Quadri SA, 1998, IMMUNOL LETT, V61, P25, DOI 10.1016/S0165-2478(97)00157-0; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Seif Eldin NS, 2006, J MED HUM GENET, V7, P241; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Song R, 1996, J IMMUNOL, V156, P4182; Taudt A, 2016, NAT REV GENET, V17, P319, DOI 10.1038/nrg.2016.45; Tazi-Ahnini R, 2008, BRIT J DERMATOL, V159, P591, DOI 10.1111/j.1365-2133.2008.08718.x; Teisserenc H, 1997, IMMUNOL LETT, V57, P183, DOI 10.1016/S0165-2478(97)00072-2; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uebel S, 1999, CURR OPIN IMMUNOL; Valia AK, 1996, TXB ATLAS DERMATOLOG, P500; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; VANBLEEK GM, 1990, NATURE, V348, P213; Ward LD, 2011, NUCLEIC ACIDS RES, V40, P930; Xu Wen, 2013, Zhonghua Yi Xue Za Zhi, V93, P123; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003; Zhang XJ, 2004, J DERMATOL SCI, V35, P165, DOI 10.1016/j.jdermsci.2004.05.003	72	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							0180958	10.1371/journal.pone.0180958	http://dx.doi.org/10.1371/journal.pone.0180958			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700671	Green Submitted, Green Published, gold			2022-12-27	WOS:000405544800104
J	McLennan, MR; Hasegawa, H; Bardi, M; Huffman, MA				McLennan, Matthew R.; Hasegawa, Hideo; Bardi, Massimo; Huffman, Michael A.			Gastrointestinal parasite infections and self-medication in wild chimpanzees surviving in degraded forest fragments within an agricultural landscape mosaic in Uganda	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; MOUNTAINS NATIONAL-PARK; INTESTINAL PARASITES; MAHALE MOUNTAINS; GREAT APES; GIARDIA-DUODENALIS; GORILLA-BERINGEI; ECOSYSTEM HEALTH; RUBONDO ISLAND; WORM INFECTION	Monitoring health in wild great apes is integral to their conservation and is especially important where they share habitats with humans, given the potential for zoonotic pathogen exchange. We studied the intestinal parasites of wild chimpanzees (Pan troglodytes schweinfurthii) inhabiting degraded forest fragments amid farmland and villages in Bulindi, Uganda. We first identified protozoan and helminth parasites infecting this population. Sixteen taxa were demonstrated microscopically (9 protozoa, 5 nematodes, 1 cestode, and 1 trematode). DNA sequence analysis enabled more precise identification of larval nematodes (e.g. Oesophagostomum stephanostomum, O. bifurcum, Strongyloides fuelleborni, Necator sp. Type II) and tapeworm proglottids (genus Bertiella). To better understand the ecology of infections, we used multidimensional scaling analysis to reveal general patterns of association among parasites, climate, and whole leaf swallowing -a prevalent self-medicative behaviour at Bulindi linked to control of nodular worms (Oesophagostomum spp.). Prevalence of parasites varied with climate in diverse ways. For example, Oesophagostomum sp. was detected in faeces at higher frequencies with increasing rainfall but was most clearly associated with periods of low temperature. Certain parasites occurred together within chimpanzee hosts more or less frequently than expected by chance. For example, the commensal ciliate Troglodytella abrassarti was negatively associated with Balantidium coli and Oesophagostomum sp., possibly because the latter taxa make the large intestine less suitable for T. abrassarti. Whole leaves in faeces showed independent associations with the prevalence of Oesophagostomum sp., Strongyloides sp., and hookworm by microscopic examination, and with egestion of adult O. stephanostomum by macroscopic inspection. All parasites identified to species or genus have been reported in wild chimpanzees inhabiting less-disturbed environments than Bulindi. Nevertheless, several disease- causing taxa infecting these chimpanzees are potentially transmissible between apes and humans (e.g. rhabditoid and strongyle nematodes), underscoring the importance of identifying and reducing risks of pathogen exchange in shared landscapes.	[McLennan, Matthew R.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford, England; [McLennan, Matthew R.] Bulindi Chimpanzee & Community Project, Hoima, Uganda; [Hasegawa, Hideo] Oita Univ, Fac Med, Dept Infect Dis Control, Yufu, Oita, Japan; [Hasegawa, Hideo] Oita Univ, Fac Med, Dept Biol, Yufu, Oita, Japan; [Bardi, Massimo] Randolph Macon Coll, Dept Psychol & Behav Neurosci, Ashland, VA 23005 USA; [Huffman, Michael A.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Oxford Brookes University; Oita University; Oita University; Kyoto University	McLennan, MR (corresponding author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford, England.; McLennan, MR (corresponding author), Bulindi Chimpanzee & Community Project, Hoima, Uganda.	mmclennan@brookes.ac.uk		McLennan, Matthew/0000-0002-5925-1483; Huffman, Michael A/0000-0002-6166-7795; Bardi, Massimo/0000-0001-9333-3493	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/CS-ANT/121124/2010]; Leverhulme Trust, UK [ECF-2013-057]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Leverhulme Trust, UK(Leverhulme Trust)	M.M's fieldwork for this study was conducted in 2012-13. It was supported by a grant awarded to Dr Kimberley Hockings, (Lisbon University, hock@fcsh.unl.pt) from Fundacao para a Ciencia e a Tecnologia, Portugal, (ref: PTDC/CS-ANT/121124/2010). www.fct.pt/. During some of the preparation of this manuscript (between Jan and Aug 2016), M.M. was supported by a fellowship from the Leverhulme Trust, UK. (Ref: ECF-2013-057). https://www.leverhulme.ac.uk/. Coauthors did not receive any funding for this research, and did not contribute funds from any other source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ancrenaz M, 2015, ORYX, V49, P465, DOI 10.1017/S0030605313001270; Arcus Foundation, 2015, STAT AP IND AGR APE; Ashford RW, 2000, ANN TROP MED PARASIT, V94, P173, DOI 10.1080/00034980057518; ASHFORD RW, 1990, ANN TROP MED PARASIT, V84, P337, DOI 10.1080/00034983.1990.11812477; Bakuza JS, 2009, INT J PRIMATOL, V30, P43, DOI 10.1007/s10764-008-9329-7; Barelli C, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22610; Beaver PC, 1984, CLIN PARASITOLOGY, V9th; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Cibot M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004133; Garcia LMC, 2015, INTERCIENCIA, V40, P179; Dolezalova J, 2015, PARASITOLOGY, V142, P1278, DOI 10.1017/S003118201500058X; Drakulovski P, 2014, PARASITOL RES, V113, P2541, DOI 10.1007/s00436-014-3904-y; DURETTEDESSET MC, 1992, SYST PARASITOL, V23, P159, DOI 10.1007/BF00010868; Ebbert MA, 2015, PARASITOLOGY, V142, P958, DOI 10.1017/S0031182015000104; Estrada A, 2012, AM J PRIMATOL, V74, P696, DOI 10.1002/ajp.22033; Fowler A, 2007, PRIMATES, V48, P73, DOI 10.1007/s10329-006-0001-6; Fruth B, 2014, AM J PRIMATOL, V76, P146, DOI 10.1002/ajp.22217; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Garriga RM, 2017, ORYX; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Gilardi KV, 2015, BEST PRACTICE GUIDE; Gillespie TR, 2010, AM J PHYS ANTHROPOL, V143, P534, DOI 10.1002/ajpa.21348; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Hasegawa H, 2017, PARASITOL INT, V66, P12, DOI 10.1016/j.parint.2016.11.003; Hasegawa H, 2016, PARASITOL INT, V65, P367, DOI 10.1016/j.parint.2016.05.004; Hasegawa H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002715; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P507; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P29; Hill C.M., 2015, STATE OF THE APES, VII, P29; Hockings KJ, 2015, TRENDS ECOL EVOL, V30, P215, DOI 10.1016/j.tree.2015.02.002; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hogan JN, 2014, J WILDLIFE DIS, V50, P21, DOI 10.7589/2012-09-229; Howells ME, 2011, AM J PRIMATOL, V73, P173, DOI 10.1002/ajp.20884; Huffman MA, 1997, PRIMATES, V38, P111, DOI 10.1007/BF02382002; Huffman MA, 2009, CAM S BIO EVOL ANTHR, V57, P1; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 1997, YEARB PHYS ANTHROPOL, V40, P171; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman Michael A., 1993, African Study Monographs, V14, P227; Huffman MA, 2009, CAM S BIO EVOL ANTHR, V57, P331; Hussain Shaik, 2013, PLoS One, V8, pe63685, DOI 10.1371/journal.pone.0063685; Jirku-Pomajbikova K, 2016, PARASITOLOGY, V143, P741, DOI 10.1017/S0031182016000263; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kalousova B, 2014, INT J PRIMATOL, V35, P463, DOI 10.1007/s10764-014-9753-9; Kaur T, 2009, CAM S BIO EVOL ANTHR, V57, P199; Keita MB, 2014, MICROB PATHOGENESIS, V77, P149, DOI 10.1016/j.micpath.2014.09.003; Kooriyama T, 2012, PRIMATES, V53, P365, DOI 10.1007/s10329-012-0311-9; Kouassi RYW, 2015, PARASITE, V22, DOI 10.1051/parasite/2015001; Kowalewski MM, 2011, AM J PRIMATOL, V73, P75, DOI 10.1002/ajp.20803; Krief S, 2005, INT J PRIMATOL, V26, P467, DOI 10.1007/s10764-005-2934-9; Krief S, 2008, J MED PRIMATOL, V37, P188, DOI 10.1111/j.1600-0684.2008.00285.x; Krief S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000630; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Kuglerova L, 2016, ECOSYSTEMS, V19, P170, DOI 10.1007/s10021-015-9927-0; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Makouloutou P, 2014, HELMINTHOLOGIA, V51, P83, DOI 10.2478/s11687-014-0214-y; Masi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049805; Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x; McCarthy MS, 2017, INT J PRIMATOL, V38, P321, DOI 10.1007/s10764-016-9916-y; McCarthy MS, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0052-x; MCGREW WC, 1989, AM J PRIMATOL, V17, P147, DOI 10.1002/ajp.1350170204; McKinney T, 2015, AM J PRIMATOL, V77, P715, DOI 10.1002/ajp.22395; McLennan MR, 2017, INT J PRIMATOL, V38, P105, DOI 10.1007/s10764-017-9962-0; McLennan MR, 2016, PRIMATES, V57, P377, DOI 10.1007/s10329-016-0528-0; McLennan MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05956; McLennan MR, 2013, INT J PRIMATOL, V34, P585, DOI 10.1007/s10764-013-9683-y; McLennan MR, 2012, ORYX, V46, P598, DOI 10.1017/S0030605312000592; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; McLennan MR, 2012, AM J PRIMATOL, V74, P642, DOI 10.1002/ajp.22017; McLennan MR, 2012, TROP CONSERV SCI, V5, P79, DOI 10.1177/194008291200500108; McLennan Matthew R., 2008, Primate Conservation, V23, P45, DOI 10.1896/052.023.0105; Modry D, 2015, PARASITES AFRICAN GR; Muehlenbein MP, 2005, AM J PRIMATOL, V65, P167, DOI 10.1002/ajp.20106; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Murray S, 2000, J ZOO WILDLIFE MED, V31, P176, DOI 10.1638/1042-7260(2000)031[0176:IPOBPC]2.0.CO;2; Narat V, 2015, ECOHEALTH, V12, P621, DOI 10.1007/s10393-015-1058-8; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Ota N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150471; Parsons MB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003529; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Petrzelkova KJ, 2010, AM J PRIMATOL, V72, P307, DOI 10.1002/ajp.20783; Pomajbikova K, 2012, J EUKARYOT MICROBIOL, V59, P97, DOI 10.1111/j.1550-7408.2011.00586.x; Pomajbikova K, 2010, AM J PHYS ANTHROPOL, V142, P42, DOI 10.1002/ajpa.21191; Profousova I, 2011, FOLIA MICROBIOL, V56, P339, DOI 10.1007/s12223-011-0053-x; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; STUNKARD HORACE W., 1940, AMER JOUR TROP MED, V20, P305; Su HH, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-22; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Terio KA, 2016, AM J PRIMATOL; UBOS, 2014, NATL POPULATION HOUS; Wenz-Mucke A, 2013, PARASITOLOGY, V140, P709, DOI 10.1017/S003118201200203X; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094; Zommers Z, 2013, CONSERV LETT, V6, P264, DOI 10.1111/j.1755-263X.2012.00288.x	106	25	26	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0180431	10.1371/journal.pone.0180431	http://dx.doi.org/10.1371/journal.pone.0180431			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28692673	Green Published, Green Submitted, gold			2022-12-27	WOS:000405544800039
J	Zhu, ZD; Ren, ZJ; Fan, XT; Pan, Y; Lv, S; Pan, CY; Lei, AM; Zeng, WX				Zhu, Zhendong; Ren, Zhanjun; Fan, Xiaoteng; Pan, Yang; Lv, Shan; Pan, Chuanying; Lei, Anmin; Zeng, Wenxian			Cysteine protects rabbit spermatozoa against reactive oxygen species-induced damages	PLOS ONE			English	Article							OXIDATIVE STRESS PARAMETERS; CRYOPRESERVED BOAR SEMEN; BUBALIS BULL SPERMATOZOA; THAWED RAM SPERMATOZOA; FREEZE-THAWING PROCESS; OXIDIZED GLUTATHIONE; LIPID-PEROXIDATION; EGG-YOLK; SUPEROXIDE-DISMUTASE; POSTTHAW QUALITY	The process of cryopreservation results in over-production of reactive oxygen species, which is extremely detrimental to spermatozoa. The aim of this study was to investigate whether addition of cysteine to freezing extender would facilitate the cryosurvival of rabbit spermatozoa, and if so, how cysteine protects spermatozoa from cryodamages. Freshly ejaculated semen was diluted with Tris-citrate-glucose extender supplemented with different concentrations of cysteine. The motility, intact acrosomes, membrane integrity, mitochondrial potentials, 8-hydroxyguanosine level and sperm-zona pellucida binding capacity were examined. Furthermore, glutathione peroxidase (GPx) activity, glutathione content (GSH), and level of reactive oxygen species (ROS) and hydrogen peroxide of spermatozoa were analyzed. The values of motility, intact acrosomes, membrane integrity, mitochondrial potentials and sperm-zona pellucida binding capacity of the frozen-thawed spermatozoa in the treatment of cysteine were significantly higher than those of the control. Addition of cysteine to extenders improved the GPx activity and GSH content of spermatozoa, while lowered the ROS, DNA oxidative alterations and lipid peroxidation level, which makes spermatozoa avoid ROS to attack DNA, the plasma membrane and mitochondria. In conclusion, cysteine protects spermatozoa against ROS-induced damages during cryopreservation and post-thaw incubation. Addition of cysteine is recommended to facilitate the improvement of semen preservation for the rabbit breeding industry.	[Zhu, Zhendong; Ren, Zhanjun; Fan, Xiaoteng; Pan, Yang; Pan, Chuanying; Zeng, Wenxian] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Lv, Shan; Lei, Anmin] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zeng, WX (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zengwenxian2013@126.com	Zeng, Wen/GPS-8058-2022; pan, chuanying/AAM-7092-2021	zhu, zhendong/0000-0001-7002-7119; Fan, Xiaoteng/0000-0002-6405-8135; LEI, An-min/0000-0002-5066-8709	National Natural Science Foundation of China [31072029, 31272439, 31230048]; Agricultural Scientific and Technological Innovation and Project of Shaanxi Province [2016NY-108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Scientific and Technological Innovation and Project of Shaanxi Province	This study was supported by the National Natural Science Foundation of China (grant no. 31072029, no. 31272439 and no. 31230048) for W Zeng, http://www.nsfc.gov.cn/. The present study was supported by Agricultural Scientific and Technological Innovation and Project of Shaanxi Province (grant no. 2016NY-108) for Zhanjun Ren, and the URL of the funder's website is http://www.sninfo.gov.cn:8083/initSnFirstPageList.do?method=initSnFirstPageList.	AITKEN RJ, 1993, J REPROD FERTIL, V97, P441; ALVAREZ JG, 1984, BIOL REPROD, V30, P323, DOI 10.1095/biolreprod30.2.323; Anghel A, 2010, ROM BIOTECH LETT, V15, P26; Ansari MS, 2012, REPROD BIOL, V12, P271, DOI 10.1016/j.repbio.2012.10.001; Ansari MS, 2011, PAK J ZOOL, V43, P41; Atessahin A, 2008, SMALL RUMINANT RES, V77, P38, DOI 10.1016/j.smallrumres.2008.03.002; BANNAI S, 1988, J CELL PHYSIOL, V137, P360, DOI 10.1002/jcp.1041370221; Bilodeau JF, 2001, THERIOGENOLOGY, V56, P275, DOI 10.1016/S0093-691X(01)00562-3; Bromfield EG, 2014, REPRODUCTION, V147, P153, DOI 10.1530/REP-13-0393; Bucak MN, 2008, SMALL RUMINANT RES, V75, P128, DOI 10.1016/j.smallrumres.2007.09.002; Chanapiwat P, 2009, ASIAN J ANDROL, V11, P600, DOI 10.1038/aja.2009.40; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Clulow JR, 2010, REPROD FERT DEVELOP, V22, P710, DOI 10.1071/RD09033; Coyan K, 2011, CRYOBIOLOGY, V63, P1, DOI 10.1016/j.cryobiol.2011.04.001; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Hamilton TRD, 2016, REPRODUCTION, V151, P379, DOI 10.1530/REP-15-0403; El-Sheshtawy R. I., 2008, Global Veterinaria, V2, P146; Fujii J, 2003, ASIAN J ANDROL, V5, P231; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; Gonzalez-Rojo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114161; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Huang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23171; JONES R, 1977, J REPROD FERTIL, V50, P261, DOI 10.1530/jrf.0.0500261; Kaeoket K, 2010, ASIAN J ANDROL, V12, P760, DOI 10.1038/aja.2010.48; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Marco-Jimenez F, 2006, CRYOLETTERS, V27, P261; Mata-Campuzano M, 2012, REPROD DOMEST ANIM, V47, P907, DOI 10.1111/j.1439-0531.2012.01990.x; Memon AA, 2012, ANIM REPROD SCI, V136, P55, DOI 10.1016/j.anireprosci.2012.10.020; Michael A, 2007, THERIOGENOLOGY, V68, P204, DOI 10.1016/j.theriogenology.2007.04.053; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; OHYASHIKI T, 1988, BIOCHIM BIOPHYS ACTA, V939, P383, DOI 10.1016/0005-2736(88)90084-3; Partyka A, 2013, CRYOBIOLOGY, V67, P132, DOI 10.1016/j.cryobiol.2013.06.002; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Salmon VM, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.128553; Santiani A, 2014, THERIOGENOLOGY, V82, P884, DOI 10.1016/j.theriogenology.2014.07.002; Sapanidou V, 2015, THERIOGENOLOGY, V84, P1273, DOI 10.1016/j.theriogenology.2015.07.005; Sariozkan S, 2009, CRYOBIOLOGY, V58, P134, DOI 10.1016/j.cryobiol.2008.11.006; Sharafi M, 2015, CELL TISSUE BANK, V16, P261, DOI 10.1007/s10561-014-9458-5; Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5; Sinowatz F, 2003, REPROD DOMEST ANIM, V38, P141, DOI 10.1046/j.1439-0531.2003.00401.x; Stradaioli G, 2007, THERIOGENOLOGY, V67, P1249, DOI 10.1016/j.theriogenology.2007.01.009; Thuwanut P, 2008, THERIOGENOLOGY, V70, P233, DOI 10.1016/j.theriogenology.2008.04.005; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Topraggaleh TR, 2014, ANDROLOGIA, V46, P777, DOI 10.1111/and.12148; Tuncer PB, 2010, CRYOBIOLOGY, V61, P303, DOI 10.1016/j.cryobiol.2010.09.009; Uysal O, 2007, ACTA VET BRNO, V76, P383, DOI 10.2754/avb200776030383; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Zhu Z, 2017, REPRODUCTION FERTILI; Zhu ZD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145383	49	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2017	12	7							e0181110	10.1371/journal.pone.0181110	http://dx.doi.org/10.1371/journal.pone.0181110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA6HV	28700739	gold, Green Published, Green Submitted			2022-12-27	WOS:000405544800123
J	Acquadro, A; Barchi, L; Gramazio, P; Portis, E; Vilanova, S; Comino, C; Plazas, M; Prohens, J; Lanteri, S				Acquadro, Alberto; Barchi, Lorenzo; Gramazio, Pietro; Portis, Ezio; Vilanova, Santiago; Comino, Cinzia; Plazas, Mariola; Prohens, Jaime; Lanteri, Sergio			Coding SNPs analysis highlights genetic relationships and evolution pattern in eggplant complexes	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; INTERSPECIFIC HYBRIDS; POPULATION-STRUCTURE; WILD RELATIVES; DIVERSITY; INTROGRESSION; HYBRIDIZATION; AETHIOPICUM; VESPERTILIO; MACROCARPON	Brinjal (Solanum melongena), scarlet (S. aethiopicum) and gboma (S. macrocarpon) eggplants are three Old World domesticates. The genomic DNA of a collection of accessions belonging to the three cultivated species, along with a representation of various wild relatives, was characterized for the presence of single nucleotide polymorphisms (SNPs) using a genotype-by-sequencing approach. A total of 210 million useful reads were produced and were successfully aligned to the reference eggplant genome sequence. Out of the 75,399 polymorphic sites identified among the 76 entries in study, 12,859 were associated with coding sequence. A genetic relationships analysis, supported by the output of the FastSTRUCTURE software, identified four major sub-groups as present in the germplasm panel. The first of these clustered S. aethiopicum with its wild ancestor S. anguivi; the second, S. melongena, its wild progenitor S. insanum, and its relatives S. incanum, S. lichtensteinii and S. linneanum; the third, S. macrocarpon and its wild ancestor S. dasyphyllum; and the fourth, the New World species S. sisymbriifolium, S. torvum and S. elaeagnifolium. By applying a hierarchical FastSTRUCTURE analysis on partitioned data, it was also possible to resolve the ambiguous membership of the accessions of S. campylacanthum, S. violaceum, S. lidii, S. vespertilio and S. tomentsum, as well as to genetically differentiate the three species of New World Origin. A principal coordinates analysis performed both on the entire germplasm panel and also separately on the entries belonging to sub-groups revealed a clear separation among species, although not between each of the domesticates and their respective wild ancestors. There was no clear differentiation between either distinct cultivar groups or different geographical provenance. Adopting various approaches to analyze SNP variation provided support for interpretation of results. The genotyping-by-sequencing approach showed to be highly efficient for both quantifying genetic diversity and establishing genetic relationships among and within cultivated eggplants and their wild relatives. The relevance of these results to the evolution of eggplants, as well as to their genetic improvement, is discussed.	[Acquadro, Alberto; Barchi, Lorenzo; Portis, Ezio; Comino, Cinzia; Lanteri, Sergio] Univ Turin, DISAFA Plant Genet & Breeding, Largo Braccini 2, Turin, Italy; [Gramazio, Pietro; Vilanova, Santiago; Prohens, Jaime] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera 14, Valencia, Spain; [Plazas, Mariola] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Camino Vera 14, Valencia, Spain	University of Turin; Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Lanteri, S (corresponding author), Univ Turin, DISAFA Plant Genet & Breeding, Largo Braccini 2, Turin, Italy.; Prohens, J (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera 14, Valencia, Spain.	jprohens@btc.upv.es; sergio.lanteri@unito.it	Gramazio, Pietro/O-3143-2017; De La O Plazas Ávila, Maria/AAA-8711-2019; vilanova, santiago/AAA-5743-2019; Prohens, Jaime/ABF-1229-2021; Prohens, Jaime/H-2228-2015; BARCHI, Lorenzo/ABC-4206-2020	Gramazio, Pietro/0000-0003-2226-7999; De La O Plazas Ávila, Maria/0000-0001-8090-7312; vilanova, santiago/0000-0003-4939-9713; Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065; BARCHI, Lorenzo/0000-0001-6414-4239; PORTIS, Ezio/0000-0002-1548-6096; ACQUADRO, Alberto/0000-0002-5322-9701	European Union's Horizon Research and Innovation Programme [677379]; Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional [AGL2015-64755-R]; Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives; Government of Norway; Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme [FCJI-2015-24835]	European Union's Horizon Research and Innovation Programme; Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional; Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives; Government of Norway; Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme	This work has been funded in part by European Unions Horizon 2020 Research and Innovation Programme under grant agreement No 677379 (G2P-SOL project: Linking genetic resources, genomes and phenotypes of Solanaceous crops) and by Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional (grant AGL2015-64755-R from MINECO/FEDER). Funding has also been received from the initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives", which is supported by the Government of Norway. This last project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew and implemented in partnership with national and international gene banks and plant breeding institutes around the world. For further information see the project website:http://www.cwrdiversity.org/. Pietro Gramazio is grateful to Universitat Politecnica de Valencia for a pre-doctoral (Programa FPI de la UPV-Subprograma 1/2013 call) contract. Mariola Plazas is grateful to Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Santiago Grisolia Programme (FCJI-2015-24835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2016, ACTA HORTIC, V1147, P1, DOI 10.17660/ActaHortic.2016.1147.1; Acquadro A, 2009, THEOR APPL GENET, V118, P1573, DOI 10.1007/s00122-009-1005-6; Anderson GJ, 2006, AN JARDIN BOT MADRID, V63, P159; Ano G., 2001, TROPICAL PLANT BREED, P200; Bajaj D, 2015, SCI REPORTS, V5, P357; Barchi L, 2016, 20 EUC GEN C ZUR; Bletsos FA, 1998, PLANT BREEDING, V117, P159, DOI 10.1111/j.1439-0523.1998.tb01471.x; BOYD JW, 1984, ECON BOT, V38, P210, DOI 10.1007/BF02858833; Bukenya Z. R., 1994, East African Agricultural and Forestry Journal, V59, P187; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Daunay M.-C., 2012, HDB VEGETABLES, P257, DOI DOI 10.1016/B978-0-08-040826-2.50028-X; Daunay MC., 1991, SOLANACEAE, P389; Davidar P, 2015, AM J BOT, V102, P129, DOI 10.3732/ajb.1400404; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Docimo T, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01233; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Emanuelli F, GENETIC DIVERSITY PO; Flint-Garcia SA, 2013, J AGR FOOD CHEM, V61, P8267, DOI 10.1021/jf305511d; Fowler C, 2003, INT TREATY PLANT GEN, VI; Frary A, 2006, GENOME MAPPING MOL B, VV; Frary A, 2014, EUPHYTICA, V197, P211, DOI 10.1007/s10681-013-1060-6; Furini A, 2004, THEOR APPL GENET, V108, P197, DOI 10.1007/s00122-003-1439-1; GLEDDIE S, 1986, THEOR APPL GENET, V71, P613, DOI 10.1007/BF00264265; Harlan JR, 1992, CROPS MAN, V2nd; Harper DAT, PAST PALAEONTOLOGICA; Isshiki S, 2008, SCI HORTIC-AMSTERDAM, V117, P186, DOI 10.1016/j.scienta.2008.04.003; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kashyap V, 2003, SCI HORTIC-AMSTERDAM, V97, P1, DOI 10.1016/S0304-4238(02)00140-1; Khan MMR, 2013, HORTSCIENCE, V48, P422; Knapp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057039; Kouassi B, 2016, SCI HORTIC-AMSTERDAM, V213, P199, DOI 10.1016/j.scienta.2016.10.039; Kumchai J, 2013, GENET MOL RES, V12, P755, DOI 10.4238/2013.March.13.4; Kwon YI, 2008, BIORESOURCE TECHNOL, V99, P2981, DOI 10.1016/j.biortech.2007.06.035; Lanteri S, 2014, APPL VEGETABLE GENOM; Lester R. N., 1986, Solanaceae: biology and systematics, P433; Lester R. N., 1990, Plant Genetic Resources Newsletter, P17; Lester R. N., 2003, Schriften zu Genetischen Ressourcen, P137; Lester R.N., 2011, SOLANUM IN AFRICA; Lester R. N., 1991, SOLANACEAE, P369; LESTER RN, 1989, EUPHYTICA, V40, P67; Lester RN, 1998, ANN BOT-LONDON, V82, P445, DOI 10.1006/anbo.1998.0695; Levin RA, 2006, AM J BOT, V93, P157, DOI 10.3732/ajb.93.1.157; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2015, EUPHYTICA, V201, P463, DOI 10.1007/s10681-014-1234-x; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Mennella G, 2010, J AGR FOOD CHEM, V58, P7597, DOI 10.1021/jf101004z; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Mutegi E, 2015, AM J BOT, V102, P140, DOI 10.3732/ajb.1400403; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Plazas M, 2016, J AM SOC HORTIC SCI, V141, P34, DOI 10.21273/JASHS.141.1.34; Plazas M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00318; Plazas M, 2013, J AGR FOOD CHEM, V61, P8871, DOI 10.1021/jf402429k; Portis E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089499; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2007, GENET RESOUR CROP EV, V54, P451, DOI 10.1007/s10722-006-9174-5; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Raj A, 2014, GENETICS, P197; Ranil RHG, 2017, GENET RESOU IN PRESS; Rotino GL, 2014, ALIEN GENE TRANSFER, P381, DOI DOI 10.1007/978-1-4614-9572-7_; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; SAKATA Y, 1991, EUPHYTICA, V55, P21, DOI 10.1007/BF00022555; Sakata Y, 1997, EUPHYTICA, V97, P295, DOI 10.1023/A:1003000612441; Salas P, 2011, EUPHYTICA, V182, P261, DOI 10.1007/s10681-011-0490-2; Schippers R. R., 2000, African indigenous vegetables: an overview of the cultivated species; SIHACHAKR D, 1988, PLANT SCI, V57, P215, DOI 10.1016/0168-9452(88)90127-6; Stern S, 2011, TAXON, V60, P1429, DOI 10.1002/tax.605018; Stommell JR, 2003, J AM SOC HORTIC SCI, V128, P704, DOI 10.21273/JASHS.128.5.0704; Sunseri F., 2010, African Journal of Plant Science, V4, P231; Syfert MM, 2016, AM J BOT, V103, P635, DOI 10.3732/ajb.1500539; Toppino L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00256; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Vorontsova MS, 2013, BOT J LINN SOC, V173, P176, DOI 10.1111/boj.12053; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Zhang YJ, 2014, J AGR FOOD CHEM, V62, P2906, DOI 10.1021/jf404574c	76	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180774	10.1371/journal.pone.0180774	http://dx.doi.org/10.1371/journal.pone.0180774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686642	gold, Green Published			2022-12-27	WOS:000405464100099
J	Harbertson, J; Hale, BR; Tran, BR; Thomas, AG; Grillo, MP; Jacobs, MB; McAnany, J; Shaffer, RA				Harbertson, Judith; Hale, Braden R.; Tran, Bonnie R.; Thomas, Anne G.; Grillo, Michael P.; Jacobs, Marni B.; McAnany, Jennifer; Shaffer, Richard A.			Self-reported HIV-positive status but subsequent HIV-negative test result using rapid diagnostic testing algorithms among seven sub-Saharan African military populations	PLOS ONE			English	Article							ADOLESCENTS; UGANDA	HIV rapid diagnostic tests (RDTs) combined in an algorithm are the current standard for HIV diagnosis in many sub-Saharan African countries, and extensive laboratory testing has confirmed HIV RDTs have excellent sensitivity and specificity. However, false-positive RDT algorithm results have been reported due to a variety of factors, such as suboptimal quality assurance procedures and inaccurate interpretation of results. We conducted HIV serosurveys in seven sub-Saharan African military populations and recorded the frequency of personnel self-reporting HIV positivity, but subsequently testing HIV-negative during the serosurvey. The frequency of individuals who reported they were HIV-positive but subsequently tested HIV-negative using RDT algorithms ranged from 3.3 to 91.1%, suggesting significant rates of prior false-positive HIV RDT algorithm results, which should be confirmed using biological testing across time in future studies. Simple measures could substantially reduce false-positive results, such as greater adherence to quality assurance guidelines and prevalence-specific HIV testing algorithms as described in the World Health Organization's HIV testing guidelines. Other measures to improve RDT algorithm specificity include classifying individuals with weakly positive test lines as HIV indeterminate and retesting. While expansion of HIV testing in resource-limited countries is critical to identifying HIV-infected individuals for appropriate care and treatment, careful attention to potential causes of false HIV-positive results are needed to prevent the significant medical, psychological, and fiscal costs resulting from individuals receiving a false-positive HIV diagnosis.	[Harbertson, Judith; Hale, Braden R.; Tran, Bonnie R.; Thomas, Anne G.; Grillo, Michael P.; Jacobs, Marni B.; McAnany, Jennifer; Shaffer, Richard A.] Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA 92152 USA; [Harbertson, Judith] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Harbertson, Judith; Tran, Bonnie R.; Thomas, Anne G.; Jacobs, Marni B.; McAnany, Jennifer] Leidos Inc, Reston, VA 20190 USA; [Hale, Braden R.] Univ Calif San Diego, La Jolla, CA 92093 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Diego	Harbertson, J (corresponding author), Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA 92152 USA.; Harbertson, J (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Harbertson, J (corresponding author), Leidos Inc, Reston, VA 20190 USA.	judith.harbertson.ctr@mail.mil		Harbertson, Judith/0000-0003-2685-7750				Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Evangeli M, 2016, AIDS CARE, V28, P943, DOI 10.1080/09540121.2016.1139040; Everett DB, 2007, TROP MED INT HEALTH, V12, P1323, DOI 10.1111/j.1365-3156.2007.01933.x; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson C, 2014, ARE WE DELIVERING WR; Kagulire SC, 2011, INT J STD AIDS, V22, P308, DOI 10.1258/ijsa.2009.009352; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Laforgerie E, 2010, J VIROL METHODS, V165, P105, DOI 10.1016/j.jviromet.2009.12.007; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Merchant M, 2014, J CLIN VIROL, V59, P172, DOI 10.1016/j.jcv.2013.11.012; Mwangala SM, 2014, 16 ANN M INT C INF D; Organization WH Control CfD, 2001, GUID US HIV TEST TEC; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2013, HIV ASS OP CHAR HIV; World Health Organization, 2002, GUID APPR EV HIV TES; World Health Organization, 2014, WHO REM NAT PROGR RE; World Health Organization, 2012, SERV DEL APPR HIV TE	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180796	10.1371/journal.pone.0180796	http://dx.doi.org/10.1371/journal.pone.0180796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686678	Green Published, gold, Green Submitted			2022-12-27	WOS:000405464100107
J	Kubota, Y; Fujioka, K; Takekawa, M				Kubota, Yuji; Fujioka, Ko; Takekawa, Mutsuhiro			WGA-based lectin affinity gel electrophoresis: A novel method for the detection of OGlcNAc-modified proteins	PLOS ONE			English	Article							WHEAT-GERM-AGGLUTININ; LINKED N-ACETYLGLUCOSAMINE; O-GLCNACYLATION; CELLULAR COFACTOR; CRYSTAL-STRUCTURE; IDENTIFICATION; COMPLEX; PHOSPHORYLATION; GLYCOSYLATION; PEPTIDES	Post-translational modification with O-linked beta-N-acetylglucosamine (O-GlcNAc) occurs selectively on serine and/or threonine residues of cytoplasmic and nuclear proteins, and dynamically regulates their molecular functions. Since conventional strategies to evaluate the O-GlcNAcylation level of a specific protein require time-consuming steps, the development of a rapid and easy method for the detection and quantification of an O-GlcNAcylated protein has been a challenging issue. Here, we describe a novel method in which O-GlcNAcylated and non-O-GlcNAcylated forms of proteins are separated by lectin affinity gel electrophoresis using wheat germ agglutinin (WGA), which primarily binds to N-acetylglucosamine residues. Electrophoresis of cell lysates through a gel containing copoly-merized WGA selectively induced retardation of the mobility of O-GlcNAcylated proteins, thereby allowing the simultaneous visualization of both the O-GlcNAcylated and the unmodified forms of proteins. This method is therefore useful for the quantitative detection of O-GlcNAcylated proteins.	[Kubota, Yuji; Fujioka, Ko; Takekawa, Mutsuhiro] Univ Tokyo, Inst Med Sci, Div Cell Signaling & Mol Med, Tokyo, Japan; [Fujioka, Ko; Takekawa, Mutsuhiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Takekawa, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Cell Signaling & Mol Med, Tokyo, Japan.; Takekawa, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan.	takekawa@ims.u-tokyo.ac.jp		Kubota, Yuji/0000-0002-8744-7176; Takekawa, Mutsuhiro/0000-0002-8027-3847	KAKENHI [15H04703]; Grants-in-Aid for Scientific Research [16K15212] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grant no. 15H04703 to MT, no. 16H06574 to MT, no. 15K19019 to YK, no. 17K08650 to YK from Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson NJ, 1997, J CHROMATOGR B, V699, P133, DOI 10.1016/S0378-4347(97)00202-8; AUB JC, 1965, P NATL ACAD SCI USA, V54, P400, DOI 10.1073/pnas.54.2.400; BARSOMIAN GD, 1990, J BIOL CHEM, V265, P6967; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Chalkley RJ, 2001, J AM SOC MASS SPECTR, V12, P1106, DOI 10.1016/S1044-0305(01)00295-1; Chavelas E.A., 2004, REV SOC QUIM ME XICO, V48, P279; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mizuguchi-Hata C, 2013, BBA-MOL CELL RES, V1833, P2682, DOI 10.1016/j.bbamcr.2013.06.008; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Popov M, 2000, ANAL BIOCHEM, V279, P90, DOI 10.1006/abio.1999.4443; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; RODRIGUEZROMERO A, 1989, BIOCHIM BIOPHYS ACTA, V998, P21, DOI 10.1016/0167-4838(89)90113-1; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sarge KD, 2009, METHODS MOL BIOL, V590, P265, DOI 10.1007/978-1-60327-378-7_17; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WRIGHT CS, 1987, J MOL BIOL, V194, P501, DOI 10.1016/0022-2836(87)90678-4; WRIGHT CS, 1992, J BIOL CHEM, V267, P14345; Zachara N. E., 2011, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1706S95, 10.1002/0471142727.mb1706s95]	34	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180714	10.1371/journal.pone.0180714	http://dx.doi.org/10.1371/journal.pone.0180714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686627	gold, Green Published, Green Submitted			2022-12-27	WOS:000405464100095
J	Marshall, PWM; Schabrun, S; Knox, MF				Marshall, Paul W. M.; Schabrun, Siobhan; Knox, Michael F.			Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain	PLOS ONE			English	Article							AVOIDANCE BELIEFS QUESTIONNAIRE; RANDOMIZED CONTROLLED-TRIAL; ROUTINE-CLINICAL-PRACTICE; MUSCULOSKELETAL PAIN; PSYCHOLOGICAL DISTRESS; HOSPITAL ANXIETY; TAMPA SCALE; EXERCISES; MODEL; THERAPY	Background Chronic low back pain is a worldwide burden that is not being abated with our current knowledge and treatment of the condition. The fear-avoidance model is used to explain the relationship between pain and disability in patients with chronic low back pain. However there are gaps in empirical support for pathways proposed within this model, and no evidence exists as to whether physical activity moderates these pathways. Methods This was a cross-sectional study of 218 people with chronic low back pain. Multiple mediation analyses were conducted to determine the role of fear, catastrophizing, depression, and anxiety in the relationship between pain and disability. Separate analyses were performed with physical activity as the moderator. Individuals were classified as performing regular structured physical activity if they described on average once per week for > 30-minutes an activity classified at least moderate intensity (>= 4-6 METs), activity prescribed by an allied health professional for their back pain, leisure time sport or recreation, or self-directed physical activity such as resistance exercise. Results Fear, catastrophizing, and depression significantly mediated the relationship between pain and disability (p<0.001). However the mediating effect of catastrophizing was conditional upon weekly physical activity. That is, the indirect effect for catastrophizing mediating the relationship between pain and disability was only significant for individuals reporting weekly physical activity (B = 1.31, 95% CI 0.44 to 2.23), compared to individuals reporting no weekly physical activity (B = 0.21, 95% CI -0.50 to 0.97). Catastrophizing also mediated the relationship between pain and fear (B = 0.37, 95% CI 0.15 to 0.62), with higher scores explaining 53% of the total effect of pain on fear. Conclusions These results support previous findings about the importance of fear and depression as factors that should be targeted in low back pain patients to reduce back pain related disability. We have also extended understanding for the mediating effect of catastrophizing on back pain related disability. Back pain patients engaged with regular physical activity may require counselling with regards to negative pain perceptions.	[Marshall, Paul W. M.; Schabrun, Siobhan; Knox, Michael F.] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia	Western Sydney University	Marshall, PWM (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	p.marshall@westernsydney.edu.au		Knox, Michael/0000-0001-8728-4293; Schabrun, Siobhan/0000-0002-9083-3107				ACSM, 2013, GUID EX TEST PRESCR, V9th; Albaladejo C, 2010, SPINE, V35, P483, DOI 10.1097/BRS.0b013e3181b9c9a7; Balthazard P, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-162; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bergbom S, 2012, BEHAV RES THER, V50, P726, DOI 10.1016/j.brat.2012.08.008; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cassidy EL, 2012, PAIN, V153, P644, DOI 10.1016/j.pain.2011.11.027; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Da Luz MA, 2014, PHYS THER, V94, P623, DOI 10.2522/ptj.20130277; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Friedrich M, 1998, ARCH PHYS MED REHAB, V79, P475, DOI 10.1016/S0003-9993(98)90059-4; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gay CW, 2015, EUR J PAIN, V19, P48, DOI 10.1002/ejp.519; GREENOUGH CG, 1993, ACTA ORTHOP SCAND, V64, P1, DOI 10.3109/17453679309153927; HARKAPAA K, 1991, PAIN, V46, P35, DOI 10.1016/0304-3959(91)90031-R; Henry SM, 2014, SPINE J, V14, P2799, DOI 10.1016/j.spinee.2014.03.024; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Johnston M, 1997, PHYSIOTHER THEORY PR, V13, P67, DOI DOI 10.3109/09593989709036449; Kopec JA, 2000, SPINE, V25, P3110, DOI 10.1097/00007632-200012150-00005; Kovacs FM, 2012, SPINE J, V12, P545, DOI 10.1016/j.spinee.2012.06.002; Kovacs FM, 2011, SPINE, V36, P339, DOI 10.1097/BRS.0b013e3181cfba29; Lame IE, 2008, J HEALTH PSYCHOL, V13, P820, DOI 10.1177/1359105308093866; Lee H, 2015, PAIN, V156, P988, DOI 10.1097/j.pain.0000000000000146; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lin CWC, 2011, PAIN, V152, P607, DOI 10.1016/j.pain.2010.11.034; Linden M, 2014, J BACK MUSCULOSKELET, V27, P563, DOI 10.3233/BMR-140518; Mannion AF, 2012, EUR SPINE J, V21, P1301, DOI 10.1007/s00586-012-2155-9; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Marshall PW, 2008, ARCH PHYS MED REHAB, V89, P1305, DOI 10.1016/j.apmr.2007.11.051; Marshall PWM, 2013, SPINE, V38, pE952, DOI 10.1097/BRS.0b013e318297c1e5; Martin L.M., 2013, PROBLEM WORTH SOLVIN; Moix J, 2011, PAIN MED, V12, P1008, DOI 10.1111/j.1526-4637.2011.01155.x; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; O'Keeffe M, 2016, J PAIN, V17, P755, DOI 10.1016/j.jpain.2016.01.473; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rasmussen-Barr E, 2009, SPINE, V34, P221, DOI 10.1097/BRS.0b013e318191e7cb; REVILL SI, 1976, ANAESTHESIA, V31, P1191, DOI 10.1111/j.1365-2044.1976.tb11971.x; Ross C, 2015, J PAIN, V16, P836, DOI 10.1016/j.jpain.2015.05.007; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Summers S, 2001, J Perianesth Nurs, V16, P35; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Tabachnick B. G., 2013, USING MULTIVARIATE S; Unsgaard-Tondel M, 2010, PHYS THER, V90, P1426, DOI 10.2522/ptj.20090421; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WADDELL G, 1992, BAILLIERE CLIN RHEUM, V6, P523, DOI 10.1016/S0950-3579(05)80126-8; Walker B F, 2003, Asia Pac J Public Health, V15, P79, DOI 10.1177/101053950301500202; Wertli MM, 2014, SPINE, V39, P263, DOI 10.1097/BRS.0000000000000110; Wideman TH, 2013, PAIN, V154, P2262, DOI 10.1016/j.pain.2013.06.005; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	103	109	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180788	10.1371/journal.pone.0180788	http://dx.doi.org/10.1371/journal.pone.0180788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686644	Green Submitted, Green Published, gold			2022-12-27	WOS:000405464100106
J	Mellink, E; Riojas-Lopez, ME; Cardenas-Garcia, M				Mellink, Eric; Riojas-Lopez, Monica E.; Cardenas-Garcia, Melinda			Biodiversity conservation in an anthropized landscape: Trees, not patch size drive, bird community composition in a low-input agro-ecosystem	PLOS ONE			English	Article							HABITAT HETEROGENEITY; RODENT ASSEMBLAGES; DIVERSITY; PLATEAU; ALPHA	One of the most typical agro-ecosystems in the Llanos de Ojuelos, a semi-arid region of central Mexico, is that of fruit-production orchards of nopales (prickly pear cacti). This perennial habitat with complex vertical structure provides refuge and food for at least 112 species of birds throughout the year. Nopal orchards vary in their internal structure, size and shrub/tree composition, yet these factors have unknown effects on the animals that use them. To further understand the conservation potential of this agro-ecosystem, we evaluated the effects of patch-size and the presence of trees on bird community composition, as well as several habitat variables, through an information-theoretical modelling approach. Community composition was obtained through a year of census transects in 12 orchards. The presence of trees in the orchards was the major driver of bird communities followed by seasonality; bird communities are independent of patch size, except for small orchard patches that benefit black-chin sparrows, which are considered a sensitive species. At least 55 species of six trophic guilds (insectivores, granivores, carnivores, nectivores, omnivores, and frugivores) used the orchards. Orchards provide adequate habitat and food resources for several sensitive species of resident and migratory sparrows. The attributes that make orchards important for birds: trees, shrubs, herb seeds, and open patches can be managed to maintain native biodiversity in highly anthropized regions with an urgent need to find convergence between production and biological conservation.	[Mellink, Eric; Cardenas-Garcia, Melinda] Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Riojas-Lopez, Monica E.] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Zapopan, Jalisco, Mexico; [Cardenas-Garcia, Melinda] Tulipanes 1128 Fraccionamiento Jardines de Fatima, Los Mochis, Sinaloa, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad de Guadalajara	Riojas-Lopez, ME (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Zapopan, Jalisco, Mexico.	monica.riojas@academicos.udg.mx		Riojas-Lopez, Monica E./0000-0003-2246-3519	Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico [Ciencia Basica-2010-01 / 157186]; Consejo Nacional de Ciencia y Tecnologoia, Mexico	Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico; Consejo Nacional de Ciencia y Tecnologoia, Mexico	This project was supported by funds from Consejo Nacionalde Cienciay Tecnologoia and Secretaroia de Educacioin Pubiica, Mexico to MERL (Ciencia Basica-2010-01 / 157186). MCG held a master in science scholarship from Consejo Nacional de Ciencia y Tecnologoia, Mexico. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M. A., 1983, AGROECOLOGY SCI BASI; [Anonymous], 2010, R LANG ENV STAT COMP; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Gonthier DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1358; Harris D. R., 1978, Hawkes, J. G. : Conservation and agriculture., P61; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Haslem A, 2008, ECOL APPL, V18, P185, DOI 10.1890/07-0692.1; Hays RL, 1981, ESTIMATING WILDLIFE; Helzer CJ, 1999, ECOL APPL, V9, P1448; Inglese P, 2002, CACTI BIOL USES, P163, DOI [10.1525/california/9780520231573.003.0010, DOI 10.1525/CALIFORNIA/9780520231573.003.0010]; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; LeHouerou HN, 1996, J ARID ENVIRON, V33, P135, DOI 10.1006/jare.1996.0053; Loumou A, 2003, AGRIC HUMAN VALUES, V20, P87, DOI 10.1023/A:1022444005336; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Martinez JA, 2004, ARDEOLA, V51, P215; MELLINK E, 1991, AGR ECOSYST ENVIRON, V36, P37, DOI 10.1016/0167-8809(91)90034-U; Mellink E., 2002, CACTI BIOL USES, P109; Mellink E, 2016, J ARID ENVIRON, V124, P1, DOI 10.1016/j.jaridenv.2015.07.005; Millenium Ecosystem Assessment, 2005, EC HUM WELL BEING BI, V1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Nabhan GP, 1982, J ETHNOBIOL, V2, P124; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Rey PJ, 2011, J APPL ECOL, V48, P228, DOI 10.1111/j.1365-2664.2010.01902.x; Riojas-Lopez ME, 2012, J ARID ENVIRON, V85, P27, DOI 10.1016/j.jaridenv.2012.04.004; Riojas-Lopez ME, 2005, BIODIVERS CONSERV, V14, P2251, DOI 10.1007/s10531-004-5289-1; Riojas-Lopez ME, 2014, JALISCO MUNDO CONT A, VIII, P323; Riojas-Lopez ME, 2011, DIVERS DISTRIB, V17, P739, DOI 10.1111/j.1472-4642.2011.00764.x; Riojas-López Mónica E., 2006, Acta Zool. Mex, V22, P85; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; Scherr SJ, 2008, PHILOS T R SOC B, V363, P477, DOI 10.1098/rstb.2007.2165; Servicio de Informacion Agroalimentaria y Pesquera, PROD ANN 2013; Shake CS, 2012, CONDOR, V114, P268, DOI 10.1525/cond.2012.110107; Southwood TRE, 2000, ECOLOGICAL METHODS; Telleria JL, 2008, ARDEOLA, V55, P203; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	44	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0179438	10.1371/journal.pone.0179438	http://dx.doi.org/10.1371/journal.pone.0179438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	28686608	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100017
J	Viana, KA; Daher, A; Maia, LC; Costa, PS; Martins, CD; Paiva, SM; Costa, LR				Viana, Karolline Alves; Daher, Anelise; Maia, Lucianne Cople; Costa, Paulo Sucasas; Martins, Carolina de Castro; Paiva, Saul Martins; Costa, Luciane Rezende			What is the level of evidence for the amnestic effects of sedatives in pediatric patients? A systematic review and meta-analyses	PLOS ONE			English	Review							PLACEBO-CONTROLLED TRIAL; ORAL MIDAZOLAM; HUMAN-MEMORY; PREANESTHETIC MEDICATION; RETROGRADE FACILITATION; PROCEDURAL-SEDATION; CONSCIOUS SEDATION; DENTAL EXTRACTIONS; NITROUS-OXIDE; CHILDREN	Background Studies have suggested that benzodiazepines are amnestic drug par excellence, but when taken together, what level of evidence do they generate? Are other sedatives as amnestic as benzodiazepines? The aim of this study was to assess the level of scientific evidence for the amnestic effect of sedatives in pediatric patients who undergo health procedures. Methods The literature was searched to identify randomized controlled trials that evaluated anterograde and retrograde amnesia in 1-19-year-olds who received sedative drugs during health procedures. Electronic databases, including PubMed, Scopus and Cochrane Library besides clinical trial registries and grey literature were searched. Two independent reviewers performed data extraction and risk of bias assessment using the Cochrane Collaboration's Tool. The meta-analyses were performed by calculating relative risk (RR) to 95% confidence intervals (CI). The quality of the evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation approach. Results Fifty-four studies were included (4,168 participants). A higher occurrence of anterograde amnesia was observed when benzodiazepines, the most well-studied sedatives (n = 47), were used than when placebo was used (n = 12) (RR = 3.10; 95% CI: 2.30-4.19, P<0.001; I-2 = 14%), with a moderate level of evidence. Higher doses of alpha2-adrenergic agonists (clonidine/dexmedetomidine) produced more anterograde amnesia than lower doses (n = 2) (RR = 1.83; 95% CI: 1.03-3.25; P =0.038; I-2 = 0%), with a low level of evidence; benzodiazepines' amnestic effects were not dose-dependent (n = 3) (RR = 1.54; 95% CI: 0.96-2.49; P = 0.07; I-2 = 12%) but the evidence was low. A qualitative analysis showed that retrograde amnesia did not occur in 8 out of 10 studies. Conclusions In children, moderate evidence support that benzodiazepines induce anterograde amnesia, whereas the evidence for other sedatives is weak and based on isolated and small studies. Further clinical trials focused on the amnesia associated with non-benzodiazepine sedatives are therefore needed.	[Viana, Karolline Alves; Daher, Anelise] Univ Fed Goias, Programa Posgrad Odontol, Goiania, Go, Brazil; [Maia, Lucianne Cople] Univ Fed Rio de Janeiro, Dept Odontopediat & Ortodontia, Rio De Janeiro, RJ, Brazil; [Costa, Paulo Sucasas] Univ Fed Goias, Fac Med, Dept Pediat, Goiania, Go, Brazil; [Martins, Carolina de Castro; Paiva, Saul Martins] Univ Fed Minas Gerais, Fac Odontol, Dept Odontopediat & Ortodontia, Belo Horizonte, MG, Brazil; [Costa, Luciane Rezende] Univ Fed Goias, Dept Saude Oral, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal do Rio de Janeiro; Universidade Federal de Goias; Universidade Federal de Minas Gerais; Universidade Federal de Goias	Costa, LR (corresponding author), Univ Fed Goias, Dept Saude Oral, Goiania, Go, Brazil.	lsucasas@ufg.br	Costa, Luciane Rezende/H-1732-2012; Maia, Lucianne Cople/E-9938-2011; Costa, Paulo S/L-5460-2016; Daher, Anelise/K-7385-2013; Paiva, Saul Martins/H-5757-2012; Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014	Costa, Luciane Rezende/0000-0001-7637-0049; Maia, Lucianne Cople/0000-0003-1026-9401; Costa, Paulo S/0000-0001-9370-9139; Daher, Anelise/0000-0002-0863-031X; Paiva, Saul Martins/0000-0002-3968-1638; Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Alves Viana, Karolline/0000-0002-4647-2682	State of Goias Research Foundation (Fundacao de Amparo e Pesquisa do Estado de Goias - FAPEG); Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)	State of Goias Research Foundation (Fundacao de Amparo e Pesquisa do Estado de Goias - FAPEG); Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study is partially funded by the State of Goias Research Foundation (Fundacao de Amparo e Pesquisa do Estado de Goias - FAPEG)and by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES).). The funders had no role in study design	Andrade C, 2015, J CLIN PSYCHIAT, V76, pE1320, DOI 10.4088/JCP.15f10377; Auden SM, 2000, ANESTH ANALG, V90, P299, DOI 10.1097/00000539-200002000-00011; BAHALOMARA N, 1994, EUR J CLIN PHARMACOL, V47, P319; Buffett-Jerrott SE, 2003, PSYCHOPHARMACOLOGY, V168, P377, DOI 10.1007/s00213-003-1429-7; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; BURTLES R, 1983, BRIT J ANAESTH, V55, P275, DOI 10.1093/bja/55.4.275; Coldwell Susan E., 1999, Pediatric Dentistry, V21, P18; Committee on Quality Management and Departmental Administration, 2020, CONT DEPTH SED DEF G; Conway A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009491.pub2; Cote CJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1212; DEJONG PC, 1988, ACTA ANAESTH SCAND, V32, P485; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dubost J, 1991, Cah Anesthesiol, V39, P9; FELD LH, 1990, ANESTHESIOLOGY, V73, P831, DOI 10.1097/00000542-199011000-00006; FELL D, 1985, ANAESTHESIA, V40, P12, DOI 10.1111/j.1365-2044.1985.tb10494.x; FLAITZ CM, 1986, J DENT CHILD, V53, P17; Funk W, 2000, BRIT J ANAESTH, V84, P335, DOI 10.1093/oxfordjournals.bja.a013435; Galeotti N, 2004, BEHAV BRAIN RES, V153, P409, DOI 10.1016/j.bbr.2003.12.016; Ghadami Yazdi A, 2014, IRAN J PED HEMATOL O, V3, P187; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P1277, DOI 10.1097/00000542-200405000-00033; Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P987, DOI 10.1097/00000542-200404000-00033; Ghoneim MM, 1997, ANESTHESIOLOGY, V87, P734, DOI 10.1097/00000542-199710000-00002; Godambe SA, 2003, PEDIATRICS, V112, P116, DOI 10.1542/peds.112.1.116; GORDON NH, 1969, BRIT J ANAESTH, V41, P136, DOI 10.1093/bja/41.2.136; Heden L, 2009, PEDIATR BLOOD CANCER, V53, P1200, DOI 10.1002/pbc.22233; HINRICHS JV, 1984, PSYCHOPHARMACOLOGY, V84, P158, DOI 10.1007/BF00427439; Jensen B, 2002, ACTA PAEDIATR, V91, P920, DOI 10.1080/080352502760148649; Jensen B, 1998, ACTA ODONTOL SCAND, V56, P229, DOI 10.1080/00016359850142844; Kain ZN, 2000, ANESTHESIOLOGY, V93, P676, DOI 10.1097/00000542-200009000-00016; Kaviani Nasser, 2014, J Dent (Shiraz), V15, P123; Kennedy RM, 1998, PEDIATRICS, V102, P956, DOI 10.1542/peds.102.4.956; Koirala Bandana, 2006, J Clin Pediatr Dent, V30, P273; Kupietzky Ari, 1996, Pediatric Dentistry, V18, P32; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee-Jayaram JJ, 2010, PEDIATR EMERG CARE, V26, P408, DOI 10.1097/PEC.0b013e3181e057cd; Lembert N, 2002, ANN FR ANESTH, V21, P263, DOI 10.1016/S0750-7658(02)00588-9; Li BL, 2014, ANAESTHESIA, V69, P240, DOI 10.1111/anae.12533; Liacouras CA, 1998, GASTROINTEST ENDOSC, V47, P455, DOI 10.1016/S0016-5107(98)70244-5; LINDGREN L, 1979, BRIT J ANAESTH, V51, P321, DOI 10.1093/bja/51.4.321; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marx CM, 1997, J CLIN ONCOL, V15, P94, DOI 10.1200/JCO.1997.15.1.94; Millar K, 2007, ANAESTHESIA, V62, P923, DOI 10.1111/j.1365-2044.2007.05148.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; PADFIELD NL, 1986, BRIT J ANAESTH, V58, P487, DOI 10.1093/bja/58.5.487; Payne K A, 1991, Acta Anaesthesiol Belg, V42, P101; PETERS CG, 1982, BRIT J ANAESTH, V54, P623, DOI 10.1093/bja/54.6.623; PIOTROWSKI R, 1989, ANAESTHESIST, V38, P16; Pringle B, 2003, HEALTH PSYCHOL, V22, P263, DOI 10.1037/0278-6133.22.3.263; Raadal M, 1999, J DENT RES, V78, P1197, DOI 10.1177/00220345990780060201; Reder LM, 2007, PSYCHON B REV, V14, P261, DOI 10.3758/BF03194062; RICHARDSON FJ, 1979, BRIT J ANAESTH, V51, P313, DOI 10.1093/bja/51.4.313; Sienkiewicz E, 2015, EUR J PEDIATR, V174, P1475, DOI 10.1007/s00431-015-2555-z; Singh C, 2014, PEDIATR ANESTH, V24, P1252, DOI 10.1111/pan.12493; Singh Neerja, 2002, J Clin Pediatr Dent, V26, P161; Singh Vinita, 2005, Indian Journal of Pediatrics, V72, P741, DOI 10.1007/BF02734144; Stewart SH, 2006, PSYCHOPHARMACOLOGY, V188, P489, DOI 10.1007/s00213-006-0402-7; Sullivan D C, 2001, Pediatr Dent, V23, P223; Toomarian Lida, 2013, Dent Res J (Isfahan), V10, P173; TWERSKY RS, 1993, ANESTHESIOLOGY, V78, P51, DOI 10.1097/00000542-199301000-00009; Van de Velde A, 1987, Acta Anaesthesiol Belg, V38, P207; van Houtem CMHH, 2015, APPL COGNITIVE PSYCH, V29, P515, DOI 10.1002/acp.3127; Veselis RA, 2012, ANESTHESIOLOGY, V117, P940, DOI 10.1097/ALN.0b013e31826be6d6; Viana KA, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0192-x; Wilson KE, 2007, ACTA ANAESTH SCAND, V51, P1062, DOI 10.1111/j.1399-6576.2007.01391.x; Wilson KE, 2006, ANAESTHESIA, V61, P1138, DOI 10.1111/j.1365-2044.2006.04835.x; Yun MJ., 2003, KOREAN J ANESTHESIOL, V45, P715; Zsigmond EK, 1996, INT J CLIN PHARM TH, V34, P84	68	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180248	10.1371/journal.pone.0180248	http://dx.doi.org/10.1371/journal.pone.0180248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA5DZ	28686702	Green Published, Green Submitted, gold			2022-12-27	WOS:000405464100045
